Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,0.725209079468423,1.8432241697609382,0.0,1.0,0.57,19/42,21.75%,NUP42;NUP37;PHC1;RNF2;NUP54;HNRNPC;NDC1;NUP214;AAAS;NUP188;NUP205;SCMH1;PHC3;NUP210;NUP85;NUP153;NUP50;SUMO2;PCGF2
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.7030786659682975,1.836622135596409,0.0,0.6517626983262536,0.6,15/40,20.89%,NUP42;NUP37;NUP54;WDR33;EIF4E;NDC1;NUP214;AAAS;NUP188;NUP205;NUP210;NUP85;CPSF2;NUP153;NUP50
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.6383794066126046,1.8210608961392387,0.0,0.5554151690084596,0.65,24/60,20.91%,LCMT2;THUMPD1;RPP40;ADAT2;RTRAF;FTSJ1;TSEN2;NSUN6;ADAT1;TSEN15;TRIT1;TRMT61A;DTWD1;DTWD2;THG1L;KARS1;ZBTB8OS;TRMT1;ANKRD16;POP1;CLP1;NSUN2;TRPT1;CDKAL1
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.7059124677796697,1.8025238515110114,0.0,0.5469139164215954,0.71,15/39,20.89%,NUP42;NUP37;NUP54;WDR33;EIF4E;NDC1;NUP214;AAAS;NUP188;NUP205;NUP210;NUP85;CPSF2;NUP153;NUP50
prerank,CellMarker_Augmented_2021__Pancreatic Ductal Stem cell:Pancreas,0.8100994795686547,1.794360451667817,0.0,0.4964731510728678,0.77,6/20,4.87%,CPA1;ACE2;GOLT1A;EHF;ARHGEF16;TMEM54
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.6822184649705121,1.7918715149327382,0.0,0.42506262934320876,0.79,15/37,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;AAAS;NUP188;NUP205;VHL;PIAS4;MDM2;NUP210;NUP85;NUP153;NUP50
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,-0.7519667190845528,-1.7839659881072913,0.0,0.08394200669998353,0.07,48/81,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,-0.7585519090009002,-1.7783194688435127,0.0,0.041971003349991765,0.07,48/79,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,0.7379704957562717,1.7776451390566796,0.0,0.45663871038013293,0.84,14/30,20.89%,NUP42;NUP37;NUP54;NDC1;MAP4K5;NUP214;MAP4K2;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.7549166945494884,-1.7759872007650093,0.0,0.02798066889999451,0.07,48/85,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,-0.7774328284026311,-1.7710446459640916,0.0,0.02564894649166163,0.09,21/58,11.40%,GBP2;SOCS3;TRIM22;SP100;GBP1;B2M;CIITA;ICAM1;HLA-A;TRIM5;IRF1;HLA-C;HLA-DRA;GBP7;CD44;TRIM17;IFNGR2;STAT1;IRF7;HLA-B;HLA-E
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,-0.7479581053076267,-1.7692906649582818,0.0,0.020519157193329307,0.09,48/82,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,0.6907571716806798,1.76876467119174,0.0,0.45623388882837745,0.87,14/39,21.32%,NUP42;NUP37;NUP54;NDC1;NUP214;AAAS;NUP188;NUP205;PIAS4;NUP210;NUP85;NUP153;NUP50;SUMO2
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.7086486039869401,1.755181890736777,0.0,0.49370237245196397,0.91,15/33,21.38%,NUP42;HSPA1A;NUP37;NUP54;XPO1;NDC1;NUP214;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50;PBRM1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Blood,-0.8210372167972927,-1.7544440660253329,0.0,0.026426187294439255,0.13,13/26,11.20%,CD24;P2RY13;MYO1F;DOCK8;TAGAP;SLA;ARHGAP15;GATA1;IGSF6;CLEC12A;CA1;CTSS;SYK
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,-0.7999144825440473,-1.7529771197530388,0.014492753623188406,0.02398343048570958,0.14,10/35,9.63%,COL8A1;COL4A1;COL4A2;COL5A1;COL4A4;COL27A1;COL6A2;COL24A1;COL11A2;COL10A1
prerank,Reactome_2022__Repression Of WNT Target Genes R-HSA-4641265,-0.9134454789297765,-1.752782003628848,0.0,0.020985501674995882,0.14,1/13,0.11%,LEF1
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,0.6776798267014135,1.7526135845672683,0.0,0.456800639000835,0.92,11/55,6.41%,FGF6;ATP6V0D2;FLT3;PDE3B;ATP6V1A;NRAS;PIK3R4;TRIB3;THEM4;AKT2;ATP6V1G1
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.7147209058511612,-1.7488192275720629,0.0,0.019690100337033174,0.15,48/103,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,-0.7317864041015623,-1.743205698792704,0.0,0.019586468229996157,0.17,48/83,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.8281763676698357,1.7413682260547563,0.0,0.4997706066217122,0.95,3/15,4.00%,ITGA1;BMP2;PPP1R15B
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,0.7733708104081769,1.7413364500572042,0.0,0.45812305606990283,0.95,3/20,6.41%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,0.6972775411873788,1.741148215831546,0.0,0.4237547443298451,0.95,14/32,21.38%,NUP42;NUP37;NUP54;XPO1;NDC1;NUP214;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50;PBRM1
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,0.6996830858757735,1.740613772866771,0.0,0.3975347638238391,0.96,13/35,20.89%,NUP42;NUP37;NUP54;XPO1;NDC1;NUP214;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,-0.738429963789181,-1.7404391840111513,0.0,0.017805880209087414,0.17,49/82,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;EEF1A2;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7985797234452883,-1.7397011605658483,0.0,0.018653779266663006,0.19,18/43,11.40%,GBP2;TRIM22;SP100;GBP1;B2M;CIITA;ICAM1;HLA-A;TRIM5;IRF1;HLA-C;HLA-DRA;CD44;IFNGR2;STAT1;IRF7;HLA-B;HLA-E
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Tooth,-0.7550813403626521,-1.7341058047825935,0.0,0.022241044510252043,0.22,13/42,5.43%,IPCEF1;MYO1F;GPR183;DOCK8;RASGRP2;TAGAP;P2RY14;GPR171;SLA;ITM2A;ARHGAP9;GAB3;ARHGAP15
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,0.6950680632929859,1.7303876632856343,0.0,0.44659913589659805,0.97,19/49,21.75%,NUP42;NUP37;PHC1;RNF2;NUP54;NDC1;NUP214;AAAS;NUP188;HDAC2;NUP205;SCMH1;PHC3;NUP210;NUP85;NUP153;NUP50;SUMO2;PCGF2
prerank,CellMarker_Augmented_2021__Serous Acinar cell:Salivary Gland,-0.74603233327529,-1.7283402583276166,0.0,0.018653779266663006,0.27,49/78,19.71%,ANXA1;GBP2;S100A10;SP100;GBP1;TGFBR2;B2M;FOSL2;HLA-A;ADGRE5;IRF1;S100A6;NLRC5;PDCD1LG2;PARP14;CD44;TIMP1;IFIT3;PSMB9;PARP9;EMP1;BIRC3;HLA-B;APOL6;PRDM1;HLA-E;DDX60;RUNX2;IFIH1;MVP;SP110;SP140L;IFI44;ZNFX1;SRGN;ANXA2;EMP3;STAT6;DOCK10;ETS1;NMI;PLP2;GBP3;SAMD9L;PARP12;PLAUR;LGALS1;KLF6;GLIPR1
prerank,CellMarker_Augmented_2021__Muller Glia Precursor cell:Retina,-0.74603233327529,-1.7283402583276166,0.0,0.018653779266663006,0.27,49/78,19.71%,ANXA1;GBP2;S100A10;SP100;GBP1;TGFBR2;B2M;FOSL2;HLA-A;ADGRE5;IRF1;S100A6;NLRC5;PDCD1LG2;PARP14;CD44;TIMP1;IFIT3;PSMB9;PARP9;EMP1;BIRC3;HLA-B;APOL6;PRDM1;HLA-E;DDX60;RUNX2;IFIH1;MVP;SP110;SP140L;IFI44;ZNFX1;SRGN;ANXA2;EMP3;STAT6;DOCK10;ETS1;NMI;PLP2;GBP3;SAMD9L;PARP12;PLAUR;LGALS1;KLF6;GLIPR1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Amniotic Fluid,-0.74603233327529,-1.7283402583276166,0.0,0.018653779266663006,0.27,49/78,19.71%,ANXA1;GBP2;S100A10;SP100;GBP1;TGFBR2;B2M;FOSL2;HLA-A;ADGRE5;IRF1;S100A6;NLRC5;PDCD1LG2;PARP14;CD44;TIMP1;IFIT3;PSMB9;PARP9;EMP1;BIRC3;HLA-B;APOL6;PRDM1;HLA-E;DDX60;RUNX2;IFIH1;MVP;SP110;SP140L;IFI44;ZNFX1;SRGN;ANXA2;EMP3;STAT6;DOCK10;ETS1;NMI;PLP2;GBP3;SAMD9L;PARP12;PLAUR;LGALS1;KLF6;GLIPR1
prerank,CellMarker_Augmented_2021__Myometrial Stem cell:Myometrium,-0.74603233327529,-1.7283402583276166,0.0,0.018653779266663006,0.27,49/78,19.71%,ANXA1;GBP2;S100A10;SP100;GBP1;TGFBR2;B2M;FOSL2;HLA-A;ADGRE5;IRF1;S100A6;NLRC5;PDCD1LG2;PARP14;CD44;TIMP1;IFIT3;PSMB9;PARP9;EMP1;BIRC3;HLA-B;APOL6;PRDM1;HLA-E;DDX60;RUNX2;IFIH1;MVP;SP110;SP140L;IFI44;ZNFX1;SRGN;ANXA2;EMP3;STAT6;DOCK10;ETS1;NMI;PLP2;GBP3;SAMD9L;PARP12;PLAUR;LGALS1;KLF6;GLIPR1
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Oral Cavity,-0.74603233327529,-1.7283402583276166,0.0,0.018653779266663006,0.27,49/78,19.71%,ANXA1;GBP2;S100A10;SP100;GBP1;TGFBR2;B2M;FOSL2;HLA-A;ADGRE5;IRF1;S100A6;NLRC5;PDCD1LG2;PARP14;CD44;TIMP1;IFIT3;PSMB9;PARP9;EMP1;BIRC3;HLA-B;APOL6;PRDM1;HLA-E;DDX60;RUNX2;IFIH1;MVP;SP110;SP140L;IFI44;ZNFX1;SRGN;ANXA2;EMP3;STAT6;DOCK10;ETS1;NMI;PLP2;GBP3;SAMD9L;PARP12;PLAUR;LGALS1;KLF6;GLIPR1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Myometrium,-0.74603233327529,-1.7283402583276166,0.0,0.018653779266663006,0.27,49/78,19.71%,ANXA1;GBP2;S100A10;SP100;GBP1;TGFBR2;B2M;FOSL2;HLA-A;ADGRE5;IRF1;S100A6;NLRC5;PDCD1LG2;PARP14;CD44;TIMP1;IFIT3;PSMB9;PARP9;EMP1;BIRC3;HLA-B;APOL6;PRDM1;HLA-E;DDX60;RUNX2;IFIH1;MVP;SP110;SP140L;IFI44;ZNFX1;SRGN;ANXA2;EMP3;STAT6;DOCK10;ETS1;NMI;PLP2;GBP3;SAMD9L;PARP12;PLAUR;LGALS1;KLF6;GLIPR1
prerank,CellMarker_Augmented_2021__Prostate Stem cell:Prostate,-0.74603233327529,-1.7283402583276166,0.0,0.018653779266663006,0.27,49/78,19.71%,ANXA1;GBP2;S100A10;SP100;GBP1;TGFBR2;B2M;FOSL2;HLA-A;ADGRE5;IRF1;S100A6;NLRC5;PDCD1LG2;PARP14;CD44;TIMP1;IFIT3;PSMB9;PARP9;EMP1;BIRC3;HLA-B;APOL6;PRDM1;HLA-E;DDX60;RUNX2;IFIH1;MVP;SP110;SP140L;IFI44;ZNFX1;SRGN;ANXA2;EMP3;STAT6;DOCK10;ETS1;NMI;PLP2;GBP3;SAMD9L;PARP12;PLAUR;LGALS1;KLF6;GLIPR1
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,0.7116502482893868,1.7279522456557088,0.0,0.43002169335221296,0.97,13/33,20.89%,NUP42;NUP37;NUP54;XPO1;NDC1;NUP214;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.7139268709332641,1.7267461225921843,0.0,0.4160613030747644,0.97,13/33,20.89%,NUP42;NUP37;NUP54;EIF4E;NDC1;NUP214;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,-0.7149510098911336,-1.7257338692575357,0.0,0.01820964166507579,0.28,50/100,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;PAPSS2;RPL9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;NNMT;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.8200022581806767,-1.7229428996408147,0.0,0.01992562785302639,0.31,4/25,6.53%,LEF1;SP100;MSX2;GATA1
prerank,CellMarker_Augmented_2021__Decidual cell:Blood,-0.7370000281961369,-1.7220814475898565,0.0,0.01946481314782227,0.31,32/81,13.56%,CXCL2;ANXA1;GBP2;IL1R1;SOCS3;C3;DUSP1;SP100;GBP1;TYMP;ICAM1;FOSL2;ZFP36;ADGRE5;S100A6;CD44;TNFRSF14;PARP9;IL4R;NDRG1;BIRC3;IER3;PRDM1;CD55;HLA-E;CSRNP1;TMBIM1;IFIH1;MVP;ARRDC2;HLA-F;APOL3
prerank,CellMarker_Augmented_2021__Secretory cell:Lung,-0.7780353761640997,-1.7206647123787981,0.0,0.020208260872218255,0.32,12/35,8.55%,CXCL2;CP;IL1R1;C3;PLAAT4;IFITM3;HLA-A;PLK2;PODXL;CTSC;HLA-DRA;RARRES1
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,0.7255551346297701,1.7187946678560273,0.0,0.43702735520620284,0.98,14/32,21.32%,NUP42;NUP37;NUP54;NDC1;NUP214;AAAS;NUP188;NUP205;PIAS4;NUP210;NUP85;NUP153;NUP50;SUMO2
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.7874119255746533,1.7185116467596278,0.0,0.4152190737163135,0.98,2/29,2.36%,ACP3;ABCA1
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.6861180469620097,1.7161298920522758,0.0,0.40806012416948045,0.98,13/32,21.38%,NUP42;NUP37;NUP54;NDC1;NUP214;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50;PBRM1
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.7500224551011834,-1.7119000811889944,0.0,0.02686144214399473,0.41,5/45,2.23%,ANXA1;PIF1;RECQL4;BLM;RPS27A
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.741206236367199,-1.7115655204995663,0.0,0.025828309753841084,0.41,47/85,20.53%,RPL19;RPL3;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPS9;RPL12;RPL5;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,Reactome_2022__tRNA Processing R-HSA-72306,0.5656083250526269,1.7090481616398474,0.0,0.42155417589466165,0.98,33/95,20.91%,LCMT2;NUP42;RPP40;ADAT2;RTRAF;TYW3;NUP37;FTSJ1;NUP54;TP53RK;TSEN2;RPP14;NSUN6;ADAT1;NDC1;TSEN15;NUP214;TRIT1;TRMT61A;AAAS;NUP188;TRMT11;THG1L;ZBTB8OS;NUP205;MTO1;TRMT5;NUP210;NUP85;NSUN2;NUP153;NUP50;CDKAL1
prerank,CellMarker_Augmented_2021__Epithelial cell:Corneal Epithelium,-0.7640152405396955,-1.7067376422805838,0.0,0.027635228543204455,0.45,35/73,14.41%,KLF2;GBP2;FOSB;TRIM22;DUSP1;SP100;GBP1;GPR183;TGFBR2;B2M;TAGAP;ZFP36;ADGRE5;IRF1;NLRC5;HLA-C;CD44;PLK3;TNFRSF14;PSMB9;BTG1;CTSS;EPSTI1;BIRC3;HLA-B;PRDM1;HLA-E;CSRNP1;MVP;SP110;HLA-F;SP140L;APOL3;FOS;BTN3A1
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.717172238633135,1.7066534031047407,0.0,0.42094080990715343,0.98,13/32,20.89%,NUP42;NUP37;NUP54;EIF4E;NDC1;NUP214;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.7033333977484187,-1.7060616705776637,0.0,0.027314462497613688,0.46,24/117,12.07%,GGT5;LEF1;ANXA1;IL1R1;SP100;POU4F1;MX1;CIITA;TIMP2;IFITM3;NLRP12;APP;BST2;TIMP1;PLSCR1;CHI3L1;SRF;IL1RAPL1;OSMR;STAT1;PTPN7;ISG15;SELP;SIGIRR
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.907543167344081,1.7056017045591736,0.0,0.4055959929848821,0.99,4/12,4.61%,TFB2M;FASTKD1;TFB1M;MTERF1
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,-0.8062070623517715,-1.7055578652231203,0.0,0.026694201364362576,0.46,19/42,13.26%,GBP2;IFI6;SOCS3;MX1;IFIT1;IFITM3;HLA-A;IRF1;IFI35;HLA-C;BST2;IFIT3;STAT1;IRF7;ISG15;HLA-B;HLA-E;HLA-F;IFIT2
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,0.6803443196011422,1.7045203950687424,0.0,0.39436366166842146,0.99,14/39,21.75%,PPARGC1A;PHC1;RNF2;TRIM28;NRIP1;EP300;SCMH1;NCOA2;ING3;PHC3;PIAS4;DAXX;SUMO2;PCGF2
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.7478081660594565,-1.7028289660117324,0.0,0.028291565221105555,0.5,23/62,11.40%,GBP2;TRIM22;SP100;GBP1;TLR2;B2M;CIITA;ICAM1;HLA-A;TRIM5;IRF1;CCL2;HLA-C;HLA-DRA;GBP7;CD44;IFNGR2;RPL13A;STAT1;WNT5A;IRF7;HLA-B;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.9209133059165139,1.7021725020605654,0.0,0.3881105180989725,0.99,1/9,0.60%,RGCC
prerank,CellMarker_Augmented_2021__Zymogenic Chief cell:Gastric Epithelium,-0.7600937664757447,-1.7006791758834323,0.0,0.02827213420103612,0.51,24/52,18.61%,GBP2;IL1R1;IL13RA1;TYMP;TGFBR2;TLR2;ICAM1;C1RL;SIGLEC1;ITGA5;IL4R;CTSS;TMBIM1;CTSZ;MVP;TNFRSF1A;FES;TNFAIP2;LTBR;CEBPD;STAT6;CTSA;SLC7A7;NUMB
prerank,CellMarker_Augmented_2021__Thecal cell:Ovary,-0.7600937664757447,-1.7006791758834323,0.0,0.02827213420103612,0.51,24/52,18.61%,GBP2;IL1R1;IL13RA1;TYMP;TGFBR2;TLR2;ICAM1;C1RL;SIGLEC1;ITGA5;IL4R;CTSS;TMBIM1;CTSZ;MVP;TNFRSF1A;FES;TNFAIP2;LTBR;CEBPD;STAT6;CTSA;SLC7A7;NUMB
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,0.7102589071564841,1.7001882384721478,0.0,0.38495415560005475,0.99,12/32,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,KEGG_2021_Human__Collecting duct acid secretion,0.7392142341039569,1.6989444177466133,0.0,0.3782532632476357,0.99,4/18,6.41%,ATP6V0D2;ATP6V1A;CA2;ATP6V1G1
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Embryonic Stem Cell,-0.7134568324753072,-1.6968177099897417,0.0,0.02880362974999435,0.53,21/89,11.27%,ENPP2;IL1R1;COL4A1;IL13RA1;SPARC;C1R;MYOF;TIMP2;GPNMB;APP;PDCD1LG2;BGN;CCL2;TBC1D9;MMP14;SRPX2;FAM20C;EMP1;THBS2;IGFBP7;FN1
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Embryonic Stem Cell,-0.7134568324753072,-1.6968177099897417,0.0,0.02880362974999435,0.53,21/89,11.27%,ENPP2;IL1R1;COL4A1;IL13RA1;SPARC;C1R;MYOF;TIMP2;GPNMB;APP;PDCD1LG2;BGN;CCL2;TBC1D9;MMP14;SRPX2;FAM20C;EMP1;THBS2;IGFBP7;FN1
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.7702911916119848,1.6923650894676936,0.0,0.4072504810659696,1.0,1/16,0.33%,SLC2A5
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,0.7149902308357484,1.6897027498481674,0.0,0.40297891572675704,1.0,14/36,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;SLC25A5;AAAS;NUP188;SGIP1;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,0.7117674961550905,1.6876566843123388,0.0,0.39974778830676877,1.0,13/33,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;AAAS;NUP188;SGIP1;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.768736221421265,1.6874296906374968,0.0,0.3883152794516024,1.0,2/31,2.36%,ACP3;ABCA1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8179257211809253,-1.6866953842344377,0.0136986301369863,0.03497583612499314,0.66,19/38,13.26%,GBP2;IFI6;SP100;MX1;IFIT1;IFITM3;HLA-A;IRF1;IFI35;HLA-C;BST2;IFIT3;STAT1;IRF7;ISG15;HLA-B;HLA-E;HLA-F;IFIT2
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8179257211809253,-1.6866953842344377,0.0136986301369863,0.03497583612499314,0.66,19/38,13.26%,GBP2;IFI6;SP100;MX1;IFIT1;IFITM3;HLA-A;IRF1;IFI35;HLA-C;BST2;IFIT3;STAT1;IRF7;ISG15;HLA-B;HLA-E;HLA-F;IFIT2
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.7188407510925298,-1.6853037807753877,0.0,0.035290933747740824,0.66,47/87,20.53%,RPL19;RPL3;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,CellMarker_Augmented_2021__Cancer cell:Esophagus,-0.6906665688917151,-1.6839161396614302,0.0,0.03558944728508073,0.68,28/74,15.73%,CXCL2;IL1R1;THBS1;C3;MET;A4GALT;MYOF;MMP14;PAPSS2;RARRES1;SRPX2;P4HA2;OSMR;CDC42EP1;EMP1;IGFBP7;FN1;PRSS23;CFH;HRH1;C1S;ITGA3;ROBO4;DLC1;LTBR;SAMD4A;TNS2;PLAT
prerank,CellMarker_Augmented_2021__Adipose Multilineage-Differentiating Stress-Enduring cell:Adipose Tissue,-0.7050590143774088,-1.6826943918639194,0.0,0.035633501419651124,0.7,23/70,14.43%,COL4A1;ANGPTL2;SPARC;C1R;COL4A2;CSPG4;COL5A1;COX7A1;COL6A2;THY1;LMOD1;BGN;CCL2;MMP14;PODN;LDB2;ELN;THBS2;IGFBP7;AEBP1;PRRX1;C1S;ROBO4
prerank,CellMarker_Augmented_2021__Myofibroblast:Liver,-0.6852645405654095,-1.6811333985614756,0.0,0.03637486956999286,0.73,22/82,12.74%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;COL5A1;COL6A2;SULF1;THY1;LMOD1;BGN;PODN;LDB2;ELN;THBS2;IGFBP7;FN1;SLIT3;AEBP1;IGFBP5;PRRX1
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.8329234044625317,-1.680075143501925,0.0,0.03617013296828558,0.73,3/28,2.72%,GGT5;AWAT1;ALOX12
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.704234703956981,-1.6788357144103945,0.0,0.0368634209317388,0.74,49/89,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;ATF3;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.624705937653039,1.6787261562075617,0.0,0.42116622190756275,1.0,22/63,17.39%,ABCD2;CEL;PEX13;ABCD1;ACADM;MCAT;PHYH;ABHD1;CPT2;LPIN3;ABCD3;EHHADH;PLA2G15;SCP2;ECHDC1;AIG1;ACOX1;PEX2;ACADS;SLC25A17;ACAD10;BDH2
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,-0.7678866504233526,-1.677440723469478,0.0,0.037307558533326006,0.77,6/31,5.71%,CACNA1H;COL4A1;COL4A2;COL4A4;COL6A2;GFRA2
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.7108511630766036,1.676936169895914,0.0,0.42111255238365575,1.0,11/31,19.78%,NR1D1;CCDC88C;FBXL3;BTRC;PLK1;DERL1;MUL1;PEX2;EP300;MDM2;PYHIN1
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,0.5850350640653181,1.6752527164565523,0.0,0.4177282153466985,1.0,28/96,17.64%,G0S2;NR1D1;MED21;PPARGC1A;PEX11A;ABCA1;ALAS1;TRIB3;CDK8;GRHL1;ACADM;NCOA3;NFYC;CHD9;MED22;CPT2;ESRRA;MED11;TIAM2;BMAL1;ACOX1;MED9;EP300;MED28;NRF1;CPT1A;NCOA2;FAM120B
prerank,CellMarker_Augmented_2021__Basal cell:Undefined,-0.7560004932592045,-1.674687125970376,0.0,0.03921533141287109,0.8,29/76,12.81%,ANXA1;GBP2;IL1R1;S100A10;IL13RA1;GBP1;TYMP;B2M;ICAM1;FOSL2;MYOF;HLA-A;S100A6;GPNMB;IFI35;KLF4;CD44;TIMP1;IFIT3;PLSCR1;EMP1;IER3;CD55;HLA-E;ADIRF;IL18;TMBIM1;MVP;CD63
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.9414556796222753,-1.6731680973496479,0.0,0.039587464888140377,0.8,2/7,2.79%,P2RY12;SHTN1
prerank,KEGG_2021_Human__Malaria,-0.8007123624154869,-1.6724573723305463,0.016129032258064516,0.03994341864709361,0.81,10/26,11.79%,THBS1;MET;TLR2;ICAM1;IL12A;CCL2;THBS3;THBS2;SELP;IL18
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,0.5848399637852436,1.6703574975563216,0.0,0.431701702791998,1.0,28/98,17.64%,G0S2;NR1D1;MED21;PPARGC1A;PEX11A;ABCA1;ALAS1;TRIB3;CDK8;GRHL1;ACADM;NCOA3;NFYC;CHD9;MED22;CPT2;ESRRA;MED11;TIAM2;BMAL1;ACOX1;MED9;EP300;MED28;NRF1;CPT1A;NCOA2;FAM120B
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Chorionic Villus,-0.737690129002907,-1.6698346359611478,0.0,0.04207022558013359,0.84,14/44,7.47%,GBP2;TRIM22;SP100;GPR183;CIITA;TAGAP;EVI2A;SLA;GAB3;NLRC5;HLA-DRA;CD44;TNFRSF14;CMAHP
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.7017753494545304,1.6693840253522203,0.0,0.4247477681362879,1.0,13/37,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;RAE1;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.7087370840296917,-1.6683389097079893,0.0,0.042359623751380575,0.86,48/90,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.8162447745821977,-1.6679719269830635,0.015384615384615385,0.041875831006794505,0.86,2/16,7.04%,ENPP2;PDXDC1
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Embryonic Stem Cell,-0.6917970667715121,-1.6674357140467537,0.0,0.04215754114265839,0.87,21/74,14.02%,ENPP2;COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;COL5A1;COL6A2;THY1;LMOD1;BGN;PODN;LDB2;ELN;THBS2;CACNA1C;AEBP1;PRRX1;RASL12;C1S
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Lung,-0.8043133906830101,-1.6672856844638206,0.0,0.04133092268888078,0.87,7/20,7.03%,CD24;MET;PDPN;KLF4;THY1;ABCB1;CD44
prerank,Reactome_2022__Glutathione Synthesis And Recycling R-HSA-174403,-0.9525934495890235,-1.6669467596068532,0.0,0.04053609725255614,0.87,1/9,0.04%,GGT5
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Undefined,-0.7288958829359066,-1.6668137894038606,0.0,0.03977126522892301,0.87,15/41,11.34%,P2RY13;MYO1F;CIITA;TAGAP;P2RY14;EVI2A;SLA;ARHGAP9;GAB3;ARHGAP15;HLA-DRA;IGSF6;RCSD1;CTSS;SELP
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Anterior Cruciate Ligament,-0.7339961215118602,-1.6653275088520603,0.0,0.041107402458016626,0.89,28/74,12.69%,ANXA1;THBS1;COL8A1;COL4A1;SPARC;C1R;MYOF;TIMP2;S100A6;MMP19;COL6A2;ITGA5;THY1;PDCD1LG2;BGN;CCL2;MMP14;CD44;TIMP1;SRPX2;OSMR;EMP1;THBS2;IGFBP7;FN1;COPZ2;APCDD1L;HRH1
prerank,CellMarker_Augmented_2021__Neutrophil:Vagina,-0.8495120746207653,-1.6650149139419252,0.0,0.040529574952113255,0.89,8/20,10.15%,CD24;P2RY13;MYO1F;TLR2;IGSF6;CLEC12A;OR52K3P;CTSS
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.8241065756071323,-1.6624330613681346,0.0,0.04280376135296779,0.89,2/16,0.47%,LEF1;HPN
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,-0.8342847937597635,-1.6616144110605635,0.0,0.042707336742096876,0.89,1/15,0.04%,GGT5
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6942909434078869,-1.6608455294963211,0.0,0.042935854001715706,0.89,48/105,20.53%,RPL19;RPL3;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;HELZ2;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPS9;RPL12;RPL5;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.5823377752710267,1.6605699621543604,0.0,0.4601398697466664,1.0,23/52,24.10%,LCMT2;THUMPD1;ADAT2;TFB1M;FTSJ1;PUS7L;APOBEC3F;NSUN6;TRIT1;TRMT61A;DTWD1;DTWD2;THG1L;TRMT1;ANKRD16;NSUN3;NSUN2;CDKAL1;RBM15;MEPCE;URM1;JMJD6;ADARB1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.7780379769203655,1.6597042354547948,0.0,0.4548915857883463,1.0,7/15,16.19%,PRDX6;GDE1;LYPLA2;PLA2G4C;MGLL;GPCPD1;ABHD6
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord Blood,-0.749197867365402,-1.6584273376867074,0.0,0.04394703928925691,0.89,30/54,19.05%,GBP2;TMEM204;TRIM22;RFTN1;SP100;GBP1;B2M;ZFP36;EVI2A;SLA;GAB3;NLRC5;HLA-DRA;TNFRSF14;CMAHP;CTSS;HLA-B;HLA-E;MVP;APOL3;IFI44;SRGN;CD74;STAT6;DOCK10;FERMT3;CD4;GBP3;WDFY4;SAMD9L
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.8400170285416988,1.6578102126285692,0.0,0.45456270242241265,1.0,5/13,12.91%,TOP3B;MTERF1;HMGB1;TOP1MT;ERCC3
prerank,CellMarker_Augmented_2021__Amniotic Fluid Stem cell:Amniotic Fluid,-0.7404343201313399,-1.6578021310392759,0.0,0.04377620779515269,0.9,30/77,12.74%,ANXA1;IL1R1;THBS1;COL8A1;SPARC;C1R;TGFBR2;MYOF;TIMP2;S100A6;MMP19;COL6A2;THY1;PDCD1LG2;BGN;CCL2;MMP14;CD44;TIMP1;SRPX2;OSMR;EMP1;THBS2;IGFBP7;COPZ2;CFH;MVP;APCDD1L;HRH1;PRRX1
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone,-0.7404343201313399,-1.6578021310392759,0.0,0.04377620779515269,0.9,30/77,12.74%,ANXA1;IL1R1;THBS1;COL8A1;SPARC;C1R;TGFBR2;MYOF;TIMP2;S100A6;MMP19;COL6A2;THY1;PDCD1LG2;BGN;CCL2;MMP14;CD44;TIMP1;SRPX2;OSMR;EMP1;THBS2;IGFBP7;COPZ2;CFH;MVP;APCDD1L;HRH1;PRRX1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovial Fluid,-0.7404343201313399,-1.6578021310392759,0.0,0.04377620779515269,0.9,30/77,12.74%,ANXA1;IL1R1;THBS1;COL8A1;SPARC;C1R;TGFBR2;MYOF;TIMP2;S100A6;MMP19;COL6A2;THY1;PDCD1LG2;BGN;CCL2;MMP14;CD44;TIMP1;SRPX2;OSMR;EMP1;THBS2;IGFBP7;COPZ2;CFH;MVP;APCDD1L;HRH1;PRRX1
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Lung,-0.6765210623835027,-1.654759369312005,0.0,0.04648640229946177,0.92,29/86,13.19%,IL1R1;THBS1;COL4A1;IL13RA1;TGFBR2;COL4A2;FOSL2;MYOF;TIMP2;MMP19;ITGA5;KLF4;PDCD1LG2;CCL2;FILIP1L;TBC1D9;MMP14;SVIL;PAPSS2;SRPX2;FAM20C;EMP1;IGFBP7;FN1;COPZ2;PRSS23;CFH;HRH1;TNFRSF1A
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Subcutaneous Adipose Tissue,-0.7106619663592764,-1.652930500294391,0.0,0.04721737876874073,0.92,23/57,19.24%,IL1R1;IL13RA1;TGFBR2;TLR2;FOSL2;IFITM3;ITGA5;KLF4;DYSF;IGFBP7;BMX;NAMPT;TNFRSF1A;SLC22A4;TNFAIP2;SERPING1;PLAC9;LTBR;CEBPD;BCL6;NUMB;ADM;CD36
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.7264234377740273,1.6524369658806826,0.0,0.474369894347021,1.0,3/21,6.41%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,CellMarker_Augmented_2021__Pericyte:Brain,-0.6765379908586114,-1.652233590045951,0.0,0.0470649199958882,0.92,21/78,12.75%,COL4A1;ANGPTL2;CALD1;C1R;COL4A2;CSPG4;COL5A1;COL6A2;SULF1;THY1;LMOD1;BGN;PODN;ARHGEF17;SRPX2;THBS2;FN1;SLIT3;IGFBP5;PRRX1;C1QTNF1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.6588441399659046,-1.6522287463122483,0.0,0.04635181514746565,0.92,37/118,14.02%,COL4A1;SOCS3;ANGPTL2;SPARC;CALD1;C1R;COL4A2;COL5A1;ITGA2;PHEX;COL6A2;SULF1;ITGA5;NOD1;THY1;LMOD1;BGN;MMP14;PODN;CD44;COL11A2;OLFML1;SRPX2;OSMR;EMP1;WNT5A;THBS2;IGFBP7;ALPL;FN1;SFRP4;RUNX2;IGFBP5;PRRX1;C1QTNF1;PTH1R;C1S
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,-0.6819481890130145,-1.6519782796330542,0.0,0.04593841162685666,0.92,19/74,13.62%,CP;C3;SERPINA10;CHGB;LAMB1;APP;TIMP1;SERPIND1;NOTUM;SGPP2;FAM20C;FAM20A;IGFBP7;FN1;SHISA5;PRSS23;IGFBP5;GPC3;F5
prerank,CellMarker_Augmented_2021__Periosteum-derived Progenitor cell:Periosteum,-0.6982025366256963,-1.651705926739441,0.0,0.04540000689165776,0.92,19/79,10.60%,IL1R1;ANGPTL2;C3;SPARC;C1R;MYOF;TIMP2;GPNMB;THY1;PDCD1LG2;BGN;CCL2;MMP14;RARRES1;SRPX2;EMP1;CD9;THBS2;IGFBP7
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.6345017214002981,1.651259606472649,0.0,0.468605630397879,1.0,16/48,17.39%,ABCD2;ABCD1;ACADM;MCAT;CPT2;ABCD3;EHHADH;ETFDH;SCP2;ECHDC1;ACOX1;PEX2;ACADS;SLC25A17;ACAD10;BDH2
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.6849306351109555,-1.6505152658920617,0.0,0.0459585865990248,0.93,30/89,15.16%,COL4A1;ANGPTL2;SPARC;C1R;TLR2;COL4A2;ICAM1;COL5A1;COL6A2;SULF1;B4GALNT1;THY1;LMOD1;BGN;MMP14;PODN;TLR3;LDB2;ELN;SRPX2;THBS2;IGFBP7;AEBP1;CFH;PRRX1;SNED1;MMRN2;C1S;ROBO4;SERPING1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.7136080391880786,-1.6504579461556976,0.0,0.04530203536189587,0.93,47/88,20.53%,RPL19;RPL3;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPS9;RPL12;RPL5;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.7074771642164177,1.6491455041986003,0.0,0.46905323796729964,1.0,6/25,7.53%,LIMD1;MEN1;GREM1;SOX9;RORB;RANBP3L
prerank,CellMarker_Augmented_2021__Stem cell:Placenta,-0.6878646982656748,-1.6479769246124878,0.0,0.04611628763147243,0.94,30/77,17.25%,COL4A1;ANGPTL2;SPARC;C1R;COL4A2;CSPG4;COL5A1;TIMP2;COX7A1;COL6A2;THY1;PDCD1LG2;BGN;MMP14;PODN;SRPX2;EMP1;THBS2;IGFBP7;FN1;COPZ2;PRRX1;C1QTNF1;C1S;ROBO4;TNS2;PLAT;COL12A1;PXDC1;TEK
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Breast,-0.6878646982656748,-1.6479769246124878,0.0,0.04611628763147243,0.94,30/77,17.25%,COL4A1;ANGPTL2;SPARC;C1R;COL4A2;CSPG4;COL5A1;TIMP2;COX7A1;COL6A2;THY1;PDCD1LG2;BGN;MMP14;PODN;SRPX2;EMP1;THBS2;IGFBP7;FN1;COPZ2;PRRX1;C1QTNF1;C1S;ROBO4;TNS2;PLAT;COL12A1;PXDC1;TEK
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.6031088800437827,1.6467988829335631,0.0,0.4710616549682568,1.0,20/79,14.94%,RANBP17;NXT2;GDAP1;ABCD2;NUP62CL;SAMM50;PPP1R10;PEX13;ABCD1;AKT1;IPO5;RAB8B;IPO8;TOMM22;ABCD3;NUP214;NXT1;RANBP6;PEX2;NUP188
prerank,CellMarker_Augmented_2021__Side-population cell:Undefined,-0.7742067007466188,-1.645471960552859,0.0,0.04829540111505901,0.95,13/37,10.38%,CD24;ANXA1;THBS1;S100A10;TGFBR2;MYOF;ITGA2;S100A6;KLF4;CD44;EMP1;CD9;TGFA
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.7767044743886881,-1.6424564155272574,0.0,0.05230620537611586,0.97,11/30,14.41%,IL1R1;RASGRP1;HLA-A;IL12A;TLR3;ZFPM1;ISG15;IL18;FADD;SLC11A1;BTN3A1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.9153290434600305,-1.641909753924115,0.0,0.05310109164576735,0.97,3/9,7.04%,ENPP2;CYP1B1;PDXDC1
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.6711513065748318,-1.6417398928886728,0.0,0.05252511530349846,0.97,29/80,19.03%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;COL5A1;SULF1;THY1;LMOD1;BGN;PODN;LDB2;GFAP;ELN;THBS2;FN1;SLIT3;IGFBP5;PRRX1;RASL12;C1S;TNS2;COL12A1;TEK;AQP1;PCDH18;PDGFRA;SVEP1
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.6929202920390618,-1.6414715247656855,0.0,0.05232748469609363,0.98,24/80,12.74%,ECM2;COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;COL5A1;ABCA8;ASPN;SULF1;THY1;LMOD1;BGN;PODN;MYH11;ELN;ITGA8;ITGA11;THBS2;SLIT3;SFRP4;IGFBP5;PRRX1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6964965665369122,-1.6397250106122083,0.0,0.05345025212947669,0.98,48/97,20.53%,RPL19;RPL3;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPS9;RPL12;RPL5;MAN1A1;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,CellMarker_Augmented_2021__T cell:Skin,-0.8302186491833659,-1.6365344414060727,0.0,0.05785032810547388,0.99,15/22,13.87%,GBP2;GPR183;CD5;B2M;TAGAP;IRF1;GPR171;NLRC5;CD44;PSMB9;BIRC3;PRDM1;HLA-E;P2RY10;SP140
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.7567042477733337,1.6352410318811281,0.0,0.5291385701036065,1.0,6/20,12.34%,BMP2;GPATCH2;PPP6R1;PPP1R36;PPP1R26;ZCCHC9
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Peripheral Blood,-0.8352836624631866,-1.6315243068580692,0.0,0.06563798579457045,0.99,10/18,12.44%,P2RY13;P2RY12;TUBB1;GFI1B;GATA1;CLEC12A;F13A1;CA1;SELP;CMTM2
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.9213932641909569,-1.6311495081472052,0.0,0.06563366779011057,0.99,1/10,0.04%,GGT5
prerank,CellMarker_Augmented_2021__Stromal cell:Undefined,-0.8203046500610988,-1.6308097935642483,0.0,0.06540196998982456,0.99,7/20,7.17%,TLR2;ICAM1;TIMP2;PDPN;THY1;TLR3;TIMP1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.7316908171628177,1.6296944212791216,0.0,0.5463471662491377,1.0,9/21,17.57%,GDAP1;PLD6;MFF;CHCHD3;OPA1;THG1L;MIEF2;VPS11;MIGA1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.7950763244314227,-1.6289428318888017,0.0,0.06731092638994662,1.0,4/43,3.17%,GGT5;CD24;CXCL2;IL12A
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.844512082231917,1.6282403276493547,0.05,0.5435873393223876,1.0,1/10,0.16%,DGKB
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Uterus,-0.7045173061755491,-1.6282354847096034,0.0,0.0676199498416534,1.0,35/81,19.38%,IL1R1;SOCS3;C3;TYMP;C1R;ICAM1;C1RL;EPS8L2;ZFP36;IFITM3;ITPKC;IFI35;SLC16A3;MAP3K6;PLD2;RHBDF2;IL4R;HELZ2;IER3;TMBIM1;SBNO2;CTSZ;MVP;TRIM47;TNFRSF1A;TNFAIP2;LTBR;JUNB;STAT6;PML;GADD45B;CTSA;IL15RA;PARP12;BHLHE40
prerank,CellMarker_Augmented_2021__M1 macrophage:Lung,-0.7436848185587204,-1.6272548469902302,0.0,0.06825088649331995,1.0,20/39,14.14%,GBP2;GBP1;TYMP;TLR2;MX1;B2M;ICAM1;IRF1;IFI35;SIGLEC1;TNFRSF14;IFIT3;PSMB9;PARP9;CTSS;EPSTI1;HLA-E;IFIH1;APOL3;IFI44
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.7643056814826928,-1.6260491647409319,0.013513513513513514,0.0691925068147151,1.0,11/33,10.15%,CD24;P2RY13;IL13RA1;IGHG1;GFI1B;POU2F3;IRAG2;IL4R;IRF7;KLF3;CTSS
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.8180438035294657,-1.6243299461790164,0.0,0.07097012571569489,1.0,6/19,9.67%,SOCS3;NLRC5;PARP14;PARP9;IFNGR2;STAT1
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.6463910561632565,-1.623375096768121,0.0,0.07164747036513745,1.0,39/100,19.03%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;COL5A1;COL6A2;SULF1;THY1;LMOD1;BGN;CCL2;PODN;LDB2;TIMP1;GFAP;SYP;SRPX2;THBS2;IGFBP7;MEG3;FN1;SLIT3;IGFBP5;PRRX1;C1QTNF1;RASL12;C1S;PNPLA3;TNS2;RELN;COL12A1;TEK;VCL;PCDH18;PTPN21;PDGFRA;SVEP1
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.8482261533483922,1.623181862556256,0.05128205128205128,0.5655443210268508,1.0,2/7,6.63%,SLC35G1;LETM1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.7584685674674374,-1.6228965900619334,0.0,0.0713664251718961,1.0,10/29,19.00%,CLIC1;P2RY12;GATA1;FN1;MYH9;PIK3CB;TLN1;VCL;FERMT3;PDGFRA
prerank,CellMarker_Augmented_2021__Germinal Stem cell:Ovary,-0.706362584891943,-1.6227332580084461,0.0,0.07031039877434517,1.0,30/76,18.03%,IL1R1;IFI6;SCN1B;C1ORF87;C3;GBP1;SPARC;C1R;MYOF;IFIT1;IFITM3;MAOB;BGN;TIMP1;IFIT3;CD9;ZYX;IGFBP7;MAP1LC3A;CFH;RNASE1;IFIT2;C1S;ANKRD35;SERPING1;CEBPD;PXDC1;TEK;ADGRF5;CTSA
prerank,CellMarker_Augmented_2021__Germline Stem cell:Ovarian Cortex,-0.706362584891943,-1.6227332580084461,0.0,0.07031039877434517,1.0,30/76,18.03%,IL1R1;IFI6;SCN1B;C1ORF87;C3;GBP1;SPARC;C1R;MYOF;IFIT1;IFITM3;MAOB;BGN;TIMP1;IFIT3;CD9;ZYX;IGFBP7;MAP1LC3A;CFH;RNASE1;IFIT2;C1S;ANKRD35;SERPING1;CEBPD;PXDC1;TEK;ADGRF5;CTSA
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Endometrium,-0.7302485086669693,-1.622078844022265,0.0,0.0703571891905659,1.0,33/69,17.34%,ANXA1;CP;S100A10;SOCS3;GBP1;TGFBR2;FOSL2;MYOF;HLA-A;S100A6;MMP14;TLR3;PARP14;CD44;PLSCR1;RARRES1;EMP1;B3GNT5;CLCA4;IGFBP7;PRDM1;DDX60;IL18;TMBIM1;MVP;FOS;CD74;SNTB1;VWA5A;F3;ANXA2;CCL28;SLC28A3
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.8393265835521153,-1.6212791748131086,0.015151515151515152,0.07090441904048787,1.0,4/18,5.98%,CXCL2;DUSP1;DOCK8;CCL2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.8591939335519035,-1.6183000227726623,0.016129032258064516,0.07481356152693568,1.0,3/17,1.91%,SLC28A2;RPE65;B2M
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Muscle,-0.6917681862910725,-1.6181565664823707,0.0,0.07422240592419595,1.0,28/79,17.25%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;CSPG4;LAMB1;COL5A1;THY1;BGN;MMP14;EDIL3;SRPX2;EMP1;THBS2;IGFBP7;FN1;PRRX1;C1QTNF1;C1S;ROBO4;TNS2;PLAT;COL12A1;MCAM;PXDC1;TEK
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.5810400038090298,1.6178794366564528,0.0,0.5785478291087701,1.0,16/50,20.89%,NUP42;NUP37;NUP54;IPO8;NDC1;NUP214;RAE1;AAAS;NUP188;POLR2C;NUP205;PUM2;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.5810400038090298,1.6178794366564528,0.0,0.5785478291087701,1.0,16/50,20.89%,NUP42;NUP37;NUP54;IPO8;NDC1;NUP214;RAE1;AAAS;NUP188;POLR2C;NUP205;PUM2;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.6106090692625209,1.617223815948391,0.0,0.5719642740442218,1.0,12/68,10.04%,G0S2;LEPR;KSR2;PPARGC1A;ADIPOR1;ELOVL6;PDGFC;ESRRG;PRKAB1;SIRT6;HSF1;CPT2
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,-0.8100625121405544,-1.6162961227566728,0.0,0.07587813337116567,1.0,3/19,7.11%,APIP;CDKN2A;SEPTIN4
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Undefined,-0.6987280120598498,-1.6153662752462647,0.0,0.07634588009139395,1.0,22/58,14.02%,COL4A1;ANGPTL2;C1R;ABCA8;ASPN;COX7A1;COL6A2;SULF1;PLN;LMOD1;BGN;PODN;MYH11;OLFML1;ELN;ITGA8;THBS2;SLIT3;SFRP4;PRRX1;RASL12;C1S
prerank,PanglaoDB_Augmented_2021__B Cells,-0.6679989364192844,-1.6149104780269974,0.0,0.07604270221461093,1.0,21/71,15.49%,CD24;CD5;TAGAP;TMC8;IGHG1;ARHGAP9;HLA-DRA;ACAP1;IFIT3;RCSD1;WAS;IRAG2;CRELD2;CTSS;BIRC3;CD55;P2RY10;SP140;BLNK;CD74;CD37
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.8247677753638863,1.614515393943531,0.044444444444444446,0.5754181162716694,1.0,5/12,10.74%,ELOVL6;ELOVL4;ABCD1;ELOVL2;HACD2
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.5739125524419544,1.6141396918708744,0.0,0.5669681532931724,1.0,39/93,25.88%,MRPL10;MRPS30;MRPL15;PTCD3;MRRF;MTIF2;FASTKD2;MRPS9;MRPL58;GATC;MRPS2;MRPL50;QRSL1;MRPL37;GFM2;MRPL18;MRPL42;MRPL52;MRPL41;MRPS31;MRPS27;MRPL9;MRPS7;MRPS35;MRPS14;LARS2;MRPL47;NOA1;MRPL4;MRPS11;MRPL1;MTRF1;MRPS10;MRPL17;MRPS21;MRPL24;MRPL13;MRPL3;MRPS16
prerank,CellMarker_Augmented_2021__DCLK1+ Progenitor cell:Large Intestine,-0.7144929075630343,-1.613638774541553,0.0,0.07649933719459778,1.0,26/80,8.77%,COL8A1;IFI6;OGN;C3;GBP1;SPARC;C1R;MX1;ICAM1;COL5A1;PDPN;CTHRC1;SERPINF1;SPON2;ZNF469;MATN2;ASPN;COLEC12;TPST1;GFRA2;CCL2;GSTM5;BASP1;IFIT3;OLFML1;PIEZO2
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone Marrow,-0.761158636694167,-1.6133591275095782,0.0,0.07610741940798506,1.0,11/28,11.20%,P2RY13;MYO1F;TLR2;SLA;SIGLEC1;HLA-DRA;IGSF6;CLEC12A;FBP1;CTSS;SYK
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,0.6240981151777188,1.6127858751145432,0.0,0.5631144166342987,1.0,27/80,18.13%,NR1D1;PPARGC1A;TFB2M;TFB1M;SAMM50;ALAS1;DMAC2L;POLG2;MTERF1;GLUD1;PRKAB1;CHD9;ESRRA;CHCHD3;TMEM11;ATP5PB;SIRT5;MAPK12;ATP5MC2;DNAJC11;ATP5MC1;NRF1;APOOL;ATP5F1A;MTX2;NCOA2;CAMK4
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,-0.7155041431819721,-1.612271773881522,0.013888888888888888,0.07738548032407723,1.0,11/43,10.15%,COL8A1;COL4A1;COL4A2;COL5A1;COL4A4;COL27A1;COL6A2;COL24A1;COL11A2;COL10A1;CTSS
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.7502424821693865,1.612031341798503,0.0,0.5589835960202296,1.0,5/19,3.42%,CPA1;ACE2;CEL;ANXA4;AMY2B
prerank,CellMarker_Augmented_2021__Myofibroblast:Lung,-0.6746735217939214,-1.6117060499026896,0.0,0.07754120008887368,1.0,20/73,12.74%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;COL5A1;ASPN;COL6A2;SULF1;THY1;LMOD1;BGN;PODN;SRPX2;THBS2;FN1;SLIT3;IGFBP5;PRRX1
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,-0.665129145963129,-1.6116681633994374,0.0,0.0767883729035448,1.0,49/107,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;EIF2B2;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,-0.7071078302004399,-1.6111793850464395,0.0,0.07640874968844653,1.0,6/50,5.71%,CACNA1H;COL4A1;COL4A2;COL4A4;COL6A2;GFRA2
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.6729573778431502,-1.6109063085639885,0.0,0.07594752987141366,1.0,23/83,12.75%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;CSPG4;COL5A1;SPON2;COL6A2;SULF1;THY1;LMOD1;BGN;MMP14;PODN;TIMP1;SRPX2;THBS2;FN1;IGFBP5;PRRX1;C1QTNF1
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,-0.6361622885826261,-1.6105411349495555,0.0,0.07628691803866428,1.0,35/144,13.59%,GBP2;IFI6;SOCS3;TRIM22;SP100;GBP1;MX1;B2M;CIITA;ICAM1;RPS27A;IFIT1;IFITM3;HLA-A;TRIM5;IRF1;IFI35;HLA-C;HLA-DRA;BST2;GBP7;CD44;IFIT3;TRIM17;IFNGR2;STAT1;IRF7;ISG15;HLA-B;HLA-E;UBC;HLA-F;KPNA7;IFIT2;HERC5
prerank,CellMarker_Augmented_2021__Megakaryocyte:Umbilical Cord Blood,-0.8164174162482754,-1.6101553239063966,0.014492753623188406,0.07627129373051462,1.0,12/29,8.01%,P2RY13;P2RY12;LMO2;GMPR;GAB3;TUBB1;DYSF;GFI1B;GATA1;TM6SF1;CLEC12A;F13A1
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.676093103389364,-1.6099597445147167,0.0,0.0757377982262197,1.0,27/69,19.03%,COL4A1;ANGPTL2;CALD1;C1R;COL4A2;MATN2;ASPN;SULF1;LMOD1;BGN;PODN;MYH11;ELN;SRPX2;THBS2;SLIT3;IGFBP5;SLCO2A1;RASL12;C1S;SERPING1;TNS2;COL12A1;TEK;AQP1;PDGFRA;SVEP1
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.6759565217253738,-1.6097911729623307,0.0,0.07512852383545926,1.0,50/101,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;SEC11C;RPS21;RPS7;RPL8;RPS6;RPS15;SSR4;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.6748611103531509,-1.6092341675394928,0.0,0.07529343631271249,1.0,48/99,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,CellMarker_Augmented_2021__Epithelial cell:Undefined,-0.8847297784355446,-1.6092123562620215,0.0,0.07461511706665203,1.0,6/18,6.56%,CD24;ST6GAL1;IL1R1;ICAM1;SFTPD;CEACAM1
prerank,KEGG_2021_Human__Coronavirus disease,-0.645801293259369,-1.6088963869815802,0.0,0.07444856546605683,1.0,65/159,17.95%,C3;C1R;RPL19;TLR2;MX1;RPL3;RPS27A;RPL36AL;RPS27;IL12A;RPS14;RPS4X;RPL27A;RPL35;RPL7A;CCL2;RPL37A;RPL27;TLR3;RPL9;RPL21;F13A1;RPL13A;PRKCG;STAT1;RPS11;RPS16;RPL24;ISG15;RPLP1;RPS13;RPL38;SYK;SELP;RPL36A-HNRNPH2;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;IFIH1;RPS21;RPS7;RPS18;TNFRSF1A;RPL8;FOS;C1S;RPS6;RPS15;PIK3CB;RPL26L1;RPS9;RPL12;RPL5;PIK3CD;FAU;RPL23;RPL4;PRKCB;RPL18A;RPL41;RPL7;RPS12
prerank,Reactome_2022__FRS-mediated FGFR1 Signaling R-HSA-5654693,0.7580440816425165,1.6087240027071674,0.034482758620689655,0.5721085377244837,1.0,2/14,3.57%,FGF6;NRAS
prerank,CellMarker_Augmented_2021__Granulosa cell:Undefined,-0.6595377443636253,-1.608324334472006,0.0,0.07461511706665203,1.0,28/90,17.25%,COL4A1;ANGPTL2;SPARC;CALD1;COL4A2;CSPG4;LAMB1;COL5A1;COL27A1;SULF1;MAMDC2;THY1;LMOD1;BGN;MAP1B;EDIL3;SRPX2;FN1;PRRX1;C1S;ROBO4;DLC1;TNS2;PLAT;COL12A1;MCAM;AFAP1L1;TEK
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Peripheral Blood,-0.7238903799261074,-1.6067763239878288,0.0,0.07747863581372748,1.0,27/65,17.71%,IL1R1;THBS1;COL4A1;SPARC;C1R;TGFBR2;MMP19;COX7A1;COL6A2;ITGA5;BGN;CCL2;MMP14;PODN;SRPX2;EMP1;IGFBP7;COPZ2;CFH;MMRN2;C1S;ROBO4;PLAC9;TNS2;AFAP1L1;TEK;ADGRF5
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Mammary Gland,-0.7028927490725924,-1.6045851501751514,0.0,0.07923801018925981,1.0,29/75,18.03%,ANXA1;SPARC;TGFBR2;C1RL;IFITM3;S100A6;ITGA5;HLA-C;DYSF;SVIL;IL4R;ZYX;PYGL;SELP;HLA-E;BMX;TMBIM1;MYH9;MVP;TNFRSF1A;TMEM256-PLSCR3;WDR1;TLN1;CAPN1;HDAC7;VCL;ETS1;TGFB1;CTSA
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.6511179809531865,-1.604191895238685,0.0,0.07903734922038679,1.0,56/142,20.87%,GGT5;RPL19;RPL3;RPS27A;WARS1;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;CARNS1;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPS9;RPL12;RPL5;EEF1A2;RPL23;RPL4;RHD;RPL18A;RPL41;RPL7;RPS12;RPS20;COPS5;MRPL23;RPL15;MRPL51;RPL11;RPS25;RPL29;RPL36;GGTA1
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.9270654323231173,-1.6032237660777149,0.0,0.07955757140226359,1.0,3/8,4.70%,CDKN2A;B2M;ARG2
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Placenta,-0.7245016388447578,-1.6026630082511644,0.0,0.0797528105087414,1.0,28/60,19.00%,ENPP2;GGT5;TMEM204;APLNR;RAMP3;SIGLEC1;THY1;BGN;PODN;LDB2;MYH11;F13A1;ELN;IGFBP7;AEBP1;CFH;RNASE1;APOL3;C1S;ROBO4;SERPING1;TEK;MRC1;ADGRF5;AQP1;A2M;CD4;PDGFRA
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.6857452916417183,-1.600907568173712,0.0,0.08112042664284122,1.0,21/77,13.26%,IFI44L;IFI6;TLR2;MX1;IFIT1;IFITM3;TRIM5;IRF1;NLRC5;TLR3;BST2;IFIT3;PLSCR1;STAT1;IRF7;ISG15;MAP3K14;IFIH1;FADD;RNASE1;IFIT2
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.6358468913269845,-1.6005690414269444,0.0,0.08122166389026184,1.0,43/165,11.69%,KLF2;IL1R1;COL8A1;COL4A1;ANGPTL2;FOSB;SPARC;C1R;COL4A2;FOSL2;LAMB1;ADAMTS10;COL5A1;COL4A4;CTHRC1;SPON2;FBLN7;ASPN;COX7A1;COL6A2;SULF1;PI16;KLF4;THY1;LMOD1;BGN;MMP14;PODN;GSTM5;CYP1B1;CD44;ELN;LRRK1;SRPX2;IGF1;THBS2;IGFBP7;HHIP;P4HTM;FN1;SLIT3;CD55;COPZ2
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.8077110635108187,1.5985562382421943,0.020833333333333332,0.6361770685836692,1.0,4/11,10.74%,ELOVL6;ELOVL4;ELOVL2;HACD2
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.7174417011363574,1.5959561234770003,0.0,0.6333921754948688,1.0,13/33,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;RAE1;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.7174417011363574,1.5959561234770003,0.0,0.6333921754948688,1.0,13/33,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;RAE1;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.8617173024454634,-1.5957516379491306,0.0,0.08748776639529963,1.0,3/12,10.60%,TJP3;LSR;ARHGEF18
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.6662397598836987,-1.5951456706607539,0.0,0.08784095236637621,1.0,17/74,17.53%,ENPP2;THBS1;SPARC;PROX1;RAB11A;EGF;VIL1;WNT5A;FGF1;MAPRE2;FGF7;HYAL1;GPI;PIK3CB;PIK3CD;TEK;ETS1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.6290470099681215,-1.5944762027488848,0.0,0.08796091036312637,1.0,24/99,14.62%,GGT5;CXCL2;ANXA1;THBS1;TLR2;CIITA;ADGRE5;SIGLEC1;TPST1;PRDX5;NOD1;CCL2;CD44;CHI3L1;MMP25;IL18;HRH1;TNFRSF1A;TAC4;SLC11A1;APOL3;FOS;HYAL1;BLNK
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.6577346450619967,-1.59430140288761,0.0,0.08747719873842369,1.0,48/111,19.04%,ECM2;COL4A1;ANGPTL2;APLNR;SPARC;C1R;COL4A2;ICAM1;CSPG4;P2RY14;ABCA8;ASPN;COX7A1;COL6A2;THY1;LMOD1;BGN;PODN;LDB2;ZIC1;ELN;THBS2;ALPL;SLIT3;GLI1;IGFBP5;SLC38A11;PRRX1;C1QTNF1;RASL12;PTH1R;C1S;ROBO4;PDZD2;SERPING1;TNS2;MCAM;PDE5A;TEK;NOTCH3;ADGRF5;AQP1;ANGPT2;PCDH18;HIGD1B;PDGFRA;SVEP1;ADM
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.6740826231858106,-1.5923767418777086,0.0,0.09073198235304886,1.0,48/100,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,KEGG_2021_Human__Ether lipid metabolism,-0.7725538737263514,-1.5918917323384347,0.0,0.09045602485659601,1.0,6/32,10.92%,ENPP2;PLB1;UGT8;PLD1;PLD2;LPCAT4
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,0.7098319900491109,1.5899497473189266,0.02857142857142857,0.6739524084682379,1.0,4/22,5.89%,POLD3;SLC19A1;RFC3;STN1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.5541447146281466,1.589795082537387,0.0,0.6640422853961684,1.0,25/91,21.51%,NUP62CL;NUP42;U2AF1;NUP37;NUP54;WDR33;EIF4E;NDC1;NUP214;NXT1;SMG7;RAE1;AAAS;NUP188;THOC3;DDX25;NUP205;THOC1;AGFG1;NUP210;NUP85;CPSF2;NUP153;NUP50;SMG1
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.6467076733774226,-1.589428112996036,0.0,0.09532521845719914,1.0,33/103,17.30%,ENPP2;NPY;RIMBP2;TAGLN3;CDH22;PCSK2;CHGB;STMN2;CCK;SH3GL2;LRRTM1;SYT4;ELAVL4;GAP43;SYP;PLPPR1;SCG5;CPLX2;CA10;HPCA;SST;CALY;KCNB2;GAD2;GLP1R;KCNC1;GDAP1L1;RAB3C;PTPRN;TCEAL5;SYT13;VWA5B2;SULT4A1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.8715379967399479,1.5884178154581896,0.023809523809523808,0.6639338905544415,1.0,3/9,7.32%,ABCD2;ABCD1;MID1IP1
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.8892457949810157,1.5877339320665496,0.023809523809523808,0.6581614905959362,1.0,2/6,8.97%,SNX18;SPIRE2
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.6586782612639734,-1.5870921223640109,0.0,0.09924393500466802,1.0,20/79,13.62%,CP;C3;SERPINA10;CHGB;LAMB1;APP;TIMP1;SERPIND1;NOTUM;SGPP2;FAM20C;IGF1;FAM20A;IGFBP7;FN1;SHISA5;PRSS23;IGFBP5;GPC3;F5
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.7468610537499549,-1.5870045922144917,0.0,0.0985469036452003,1.0,9/34,12.29%,GGT5;ANXA1;WNT8B;CCL2;TLR3;CYP1B1;ALPL;IL18;IGFBP5
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.9116052868613825,-1.5868661529514738,0.0,0.09793234114998078,1.0,3/9,4.70%,CDKN2A;B2M;ARG2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.6786091390183768,1.5846111743654463,0.06451612903225806,0.6702045690173346,1.0,11/27,20.01%,GDAP1;ABCD2;PEX13;ABCD1;RAB8B;ABCD3;PEX2;SLC25A17;PEX6;ZFAND6;PEX12
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.9182309196527723,-1.5843384451312803,0.0,0.10188380965875862,1.0,2/11,0.10%,PRAME;KLF2
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreatic Islet,0.6378900998398813,1.583667935507521,0.0,0.6654001243510148,1.0,5/44,3.42%,CPA1;FGL1;CEL;SDC4;AMY2B
prerank,Reactome_2022__Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,-0.8780665987313319,-1.5834572032185,0.0,0.10280776073104042,1.0,1/15,0.02%,ENPP2
prerank,CellMarker_Augmented_2021__Stem cell:Molar,-0.6768240597582568,-1.5829788598069674,0.0,0.10294642091526801,1.0,18/72,11.27%,THBS1;COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;CSPG4;COL5A1;COL6A2;THY1;BGN;MMP14;SRPX2;EMP1;THBS2;IGFBP7;FN1
prerank,Reactome_2022__Formation Of Apoptosome R-HSA-111458,-0.9212984951583256,-1.582762693063276,0.0,0.10252618231266646,1.0,1/10,0.48%,APIP
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Pluripotent Stem Cell,-0.776862383315561,-1.5827100978815571,0.014492753623188406,0.10115560447914682,1.0,9/25,10.81%,P2RY13;MYO1F;TAGAP;SLA;ARHGAP9;HLA-DRA;CLEC12A;CTSS;ALPL
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Embryonic Stem Cell,-0.776862383315561,-1.5827100978815571,0.014492753623188406,0.10115560447914682,1.0,9/25,10.81%,P2RY13;MYO1F;TAGAP;SLA;ARHGAP9;HLA-DRA;CLEC12A;CTSS;ALPL
prerank,Reactome_2022__Digestion And Absorption R-HSA-8963743,0.8743724946313711,1.5819664773989277,0.0,0.6682420494946364,1.0,4/9,3.42%,SLC2A5;MGAM;CEL;AMY2B
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Corneal Endothelium,-0.6703295980749912,-1.581845958923941,0.0,0.10245962699389717,1.0,20/81,12.56%,ANXA1;THBS1;COL8A1;COL4A1;TUBB6;SPARC;COL4A2;MYOF;TIMP2;COL6A2;ITGA5;MMP14;TIMP1;SRPX2;CLIC4;EMP1;IGFBP7;FN1;TPM4;APCDD1L
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.7957055446108465,-1.5814154023117868,0.0,0.10212268286930364,1.0,7/24,5.98%,CD24;IL13RA1;GPR87;ICAM1;FLG;DUOXA1;CCL2
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.5803605845728758,1.5812519046702775,0.0,0.6625824743458988,1.0,13/78,10.04%,G0S2;LEPR;KSR2;PPARGC1A;ADIPOR1;ELOVL6;ACACB;PDGFC;ESRRG;PRKAB1;SIRT6;HSF1;CPT2
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.8035626260801949,-1.5809621028402872,0.0,0.10212608648870897,1.0,7/20,13.76%,TLR2;B2M;RPS27A;PGK1;DUSP16;UBC;RNF213
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.6963130687160051,-1.5808488649807193,0.013333333333333334,0.10186295892402762,1.0,26/65,15.87%,TYMP;ZFP36;ADGRE5;IRF1;IFI35;TMC6;PIM3;HLA-C;ANO9;RPS6KA1;RHBDF2;IL4R;HELZ2;IRF7;MMP25;CD55;HLA-E;SBNO2;SIGIRR;TC2N;IFIH1;ARRDC2;HLA-F;ST6GALNAC2;PRKCD;JUNB
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.864333753634613,-1.5801574911115297,0.0,0.10246348965979077,1.0,4/11,6.84%,CIITA;IFITM3;TRIM5;BST2
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.7415951941459868,-1.5798355631792196,0.0,0.10239873900256206,1.0,10/29,13.63%,P2RY13;MYO1F;TLR2;SIGLEC1;IGSF6;CLEC12A;CTSS;PILRA;SLC11A1;CLEC5A
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.8502444529453865,1.5795940306937328,0.02631578947368421,0.664704903757002,1.0,1/12,1.07%,LIMD1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.8509252144822798,-1.5789626941265726,0.018867924528301886,0.10292190098879099,1.0,2/11,5.06%,KLF2;KLF4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.8751601129750748,-1.5786906555696416,0.0,0.1027253261004428,1.0,4/10,9.10%,CACNA1H;KCNB1;SYT4;SYT1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Skin,-0.6619426135790727,-1.5785728672841346,0.0,0.10233849245952015,1.0,21/78,17.25%,COL4A1;IL13RA1;COL4A2;MYOF;TIMP2;PODXL;BGN;MMP14;STEAP3;ARHGEF17;PAPSS2;SRPX2;FAM20C;CDC42EP1;EMP1;FN1;SLCO2A1;ROBO4;TNS2;PXDC1;TEK
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.8955596595041734,-1.5777715623892536,0.016666666666666666,0.10285131718947753,1.0,3/9,3.31%,CIITA;IFITM3;TRIM5
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.7972565551071881,-1.5777587290089345,0.018518518518518517,0.10227854482265565,1.0,4/20,6.47%,CDKN2A;SUV39H1;CENPV;POLE3
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.786219611338662,-1.5775711427007064,0.0136986301369863,0.1020286102457007,1.0,4/24,0.81%,ANXA1;PIF1;RECQL4;BLM
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.9568698317559345,1.576769008000475,0.022727272727272728,0.6742660139973645,1.0,2/6,2.60%,DIRAS3;KDM1B
prerank,KEGG_2021_Human__Ribosome,-0.6453295442378457,-1.5766828218135158,0.0,0.10328434828857033,1.0,53/120,20.53%,RPL19;RPL3;RPS27A;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPL36A-HNRNPH2;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;MRPL20;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;MRPL23;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.8252808475126631,-1.5763038001378755,0.0,0.10321757860886863,1.0,5/18,6.92%,CCBE1;C3;SULF1;BRCA1;CYP1B1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.7713350554376595,-1.5759767246869534,0.0,0.10290462337172372,1.0,6/28,6.56%,KLF2;EPN1;THBS1;ITGA5;KLF4;CEACAM1
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.803198385320048,-1.5752865075498308,0.0,0.10382300828682173,1.0,9/21,13.03%,CACNA1H;SCN1B;KCNJ2;SCN9A;YWHAH;SCN2A;CACNA1C;SCN1A;SCN3B
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Undefined,-0.7267104615258785,-1.5749236802146764,0.0,0.1035101869110908,1.0,14/33,12.43%,ANXA1;GBP2;SP100;GPR87;FOSL2;ZFP36;DUOX1;ZNF750;DUOXA1;CD44;BIRC3;IL18;IFIH1;MVP
prerank,KEGG_2021_Human__Circadian rhythm,0.6736520570137204,1.5730691029031552,0.0,0.6886425283890749,1.0,7/27,9.33%,NR1D1;CUL1;RORB;PRKAB1;FBXL3;CSNK1E;BTRC
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.6906973404083526,-1.571902372079097,0.0,0.10895502889846347,1.0,12/41,7.63%,CD24;CXCL2;P2RY13;MYO1F;DOCK8;NR1I3;TLR2;TAGAP;ARG2;CEACAM1;IGSF6;CLEC12A
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Placenta,-0.6952828359724316,-1.5712576810394363,0.0,0.10969625678427954,1.0,20/66,11.47%,GGT5;OGN;NEXN;ABCA8;C1QTNF7;RAMP3;ASPN;PLN;LMOD1;BGN;FILIP1L;PODN;MYH11;OLFML1;ELN;ITGA8;ITGA11;CACNA1C;SLIT3;AEBP1
prerank,KEGG_2021_Human__Amphetamine addiction,-0.6993481249907973,-1.570880704430656,0.0,0.10929201442134606,1.0,15/53,13.97%,GRIN2D;FOSB;GRIN3A;MAOB;GRIN2A;GRIA3;GRIA1;SLC18A2;PRKCG;PPP3CC;CREB5;CACNA1C;ADCY5;GRIN2B;FOS
prerank,CellMarker_Augmented_2021__Monocyte:Kidney,-0.7392112576385439,-1.5698906103204766,0.014084507042253521,0.10708651060491725,1.0,18/31,20.36%,GBP2;TYMP;TLR2;IFI35;SIGLEC1;IGSF6;TNFRSF14;CLEC12A;CTSS;HLA-E;MVP;TNFAIP2;SRGN;CTSA;SLC7A7;SAMD9L;PLAUR;SPI1
prerank,CellMarker_Augmented_2021__Macrophage:Visceral Adipose Tissue,-0.7392112576385439,-1.5698906103204766,0.014084507042253521,0.10708651060491725,1.0,18/31,20.36%,GBP2;TYMP;TLR2;IFI35;SIGLEC1;IGSF6;TNFRSF14;CLEC12A;CTSS;HLA-E;MVP;TNFAIP2;SRGN;CTSA;SLC7A7;SAMD9L;PLAUR;SPI1
prerank,CellMarker_Augmented_2021__Macrophage:Artery,-0.7392112576385439,-1.5698906103204766,0.014084507042253521,0.10708651060491725,1.0,18/31,20.36%,GBP2;TYMP;TLR2;IFI35;SIGLEC1;IGSF6;TNFRSF14;CLEC12A;CTSS;HLA-E;MVP;TNFAIP2;SRGN;CTSA;SLC7A7;SAMD9L;PLAUR;SPI1
prerank,CellMarker_Augmented_2021__Macrophage:Retinal Pigment Epithelium,-0.7392112576385439,-1.5698906103204766,0.014084507042253521,0.10708651060491725,1.0,18/31,20.36%,GBP2;TYMP;TLR2;IFI35;SIGLEC1;IGSF6;TNFRSF14;CLEC12A;CTSS;HLA-E;MVP;TNFAIP2;SRGN;CTSA;SLC7A7;SAMD9L;PLAUR;SPI1
prerank,CellMarker_Augmented_2021__Macrophage:Eye,-0.7392112576385439,-1.5698906103204766,0.014084507042253521,0.10708651060491725,1.0,18/31,20.36%,GBP2;TYMP;TLR2;IFI35;SIGLEC1;IGSF6;TNFRSF14;CLEC12A;CTSS;HLA-E;MVP;TNFAIP2;SRGN;CTSA;SLC7A7;SAMD9L;PLAUR;SPI1
prerank,CellMarker_Augmented_2021__Macrophage:Lymph Node,-0.7392112576385439,-1.5698906103204766,0.014084507042253521,0.10708651060491725,1.0,18/31,20.36%,GBP2;TYMP;TLR2;IFI35;SIGLEC1;IGSF6;TNFRSF14;CLEC12A;CTSS;HLA-E;MVP;TNFAIP2;SRGN;CTSA;SLC7A7;SAMD9L;PLAUR;SPI1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.7567849978425523,-1.5691257125175413,0.016129032258064516,0.10854668487380281,1.0,4/29,8.26%,ENPP2;FSCN1;CLRN1;VIL1
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,0.6658641714846634,1.5665606510637475,0.037037037037037035,0.7273833641941692,1.0,8/31,5.72%,FGF6;FLT3;PDE3B;NRAS;PIK3R4;TRIB3;THEM4;AKT2
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.7510768878154187,-1.5664705572378221,0.0,0.11465249695607506,1.0,9/25,11.40%,GBP2;TLR2;HLA-A;IL12A;GBP7;TNFRSF14;LYG1;ROMO1;HLA-E
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.7307593458504168,-1.5664429395617845,0.0,0.11407068654583619,1.0,11/44,10.01%,ANXA1;DHCR24;MET;COL5A1;ALOX12;LSR;FLG;ABCA12;FA2H;CLIC4;WNT5A
prerank,CellMarker_Augmented_2021__Endometrial Stromal Stem cell:Endometrium Stroma,-0.6612339915646771,-1.5660353391950725,0.0,0.11411393280298965,1.0,23/65,18.09%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;COL5A1;COL6A2;THY1;LMOD1;BGN;PODN;LDB2;THBS2;IGFBP7;PRRX1;C1S;ROBO4;DLC1;COL12A1;TEK;LTBP1;PCDH18
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Amniotic Membrane,-0.6625039344954501,-1.5657465834267061,0.0,0.11325508840473968,1.0,24/80,15.97%,THBS1;COL4A1;ANGPTL2;C1R;COL4A2;MYOF;TIMP2;THY1;PDCD1LG2;BGN;MMP14;SRPX2;OSMR;EMP1;THBS2;IGFBP7;FN1;COPZ2;HRH1;PRRX1;C1S;TNS2;PLAT;COL12A1
prerank,CellMarker_Augmented_2021__Dental Pulp cell:Dental Pulp,-0.6625039344954501,-1.5657465834267061,0.0,0.11325508840473968,1.0,24/80,15.97%,THBS1;COL4A1;ANGPTL2;C1R;COL4A2;MYOF;TIMP2;THY1;PDCD1LG2;BGN;MMP14;SRPX2;OSMR;EMP1;THBS2;IGFBP7;FN1;COPZ2;HRH1;PRRX1;C1S;TNS2;PLAT;COL12A1
prerank,CellMarker_Augmented_2021__Macrophage:Undefined,-0.8645748347483972,-1.5656897035572233,0.015384615384615385,0.11264012864869584,1.0,4/15,4.39%,CXCL2;TLR2;GPNMB;SIGLEC1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.9374472843042496,-1.5646389852872662,0.0,0.113842917583311,1.0,3/9,3.17%,THBS1;APLNR;IL12A
prerank,Reactome_2022__Regulation Of IFNG Signaling R-HSA-877312,-0.8723767913939793,-1.5637982323761155,0.0,0.11464983631147846,1.0,3/11,9.67%,SOCS3;IFNGR2;STAT1
prerank,CellMarker_Augmented_2021__Fibroblast:Peripheral Blood,-0.6454909691137516,-1.5637755392517432,0.0,0.11414594580327217,1.0,18/75,12.74%,COL4A1;ANGPTL2;CALD1;C1R;COL4A2;LAMB1;COL5A1;SULF1;THY1;LMOD1;BGN;SRPX2;WNT5A;THBS2;FN1;SLIT3;IGFBP5;PRRX1
prerank,CellMarker_Augmented_2021__CD1C-CD141- Dendritic cell:Blood,-0.6076414450722114,-1.563217299250804,0.0,0.11461830844198134,1.0,48/225,14.65%,GBP2;P2RY13;IFI6;DUSP1;GBP1;TYMP;TLR2;MYOF;IFITM3;WARS1;PTP4A3;ARHGEF3;IRF1;IMPDH1;CDH23;TESC;SLA;TMC6;DENND3;SVIL;TIMP1;TNFRSF14;IFIT3;CLEC12A;IFNGR2;SH3BP2;CDC42EP3;PIK3IP1;SCIMP;KLF3;CTSS;ISG15;PILRA;PYGL;APOL6;HLA-E;DDX60;NAMPT;TMBIM1;CHST15;GNG2;TSPAN32;IFIT2;SLC11A1;UBXN11;NR4A1;ARRDC3;ZNFX1
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Small Intestine,0.7376933916282659,1.563197198955109,0.027777777777777776,0.7434804375028443,1.0,1/25,0.01%,CPA1
prerank,CellMarker_Augmented_2021__Stromal cell:Embryoid Body,-0.6603009073182913,-1.5616031175980452,0.0,0.11840861609212235,1.0,21/71,12.75%,THBS1;COL4A1;ANGPTL2;SPARC;C1R;COL4A2;COL5A1;COL6A2;SULF1;LMOD1;BGN;PODN;SRPX2;EMP1;THBS2;IGFBP7;FN1;SLIT3;COPZ2;PRRX1;C1QTNF1
prerank,KEGG_2021_Human__Type I diabetes mellitus,-0.7885611251070003,-1.5614275680345115,0.016129032258064516,0.11810507101407205,1.0,12/18,16.36%,HLA-A;IL12A;HLA-C;HLA-DRA;ICA1;HLA-B;HLA-E;GAD1;HLA-F;GAD2;PTPRN;HLA-DRB1
prerank,CellMarker_Augmented_2021__Effector CD4+ Memory T (Tem) cell:Blood,-0.7186411039659663,-1.5602992599020888,0.01639344262295082,0.11976574188255226,1.0,14/34,13.87%,MYO1F;GPR183;DOCK8;CD5;TAGAP;SLA;ARHGAP9;ARHGAP15;ACAP1;RCSD1;WAS;PTPN7;P2RY10;SP140
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.8769659624754635,-1.5598132386833317,0.015625,0.12024837369074853,1.0,4/14,6.56%,GBP1;CD160;THY1;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.8991098393957304,-1.5591048243539092,0.05263157894736842,0.1208303791823733,1.0,2/8,0.78%,ANXA1;CDKN2A
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,-0.6797987876761195,-1.5574489931636404,0.014285714285714285,0.12437589695397931,1.0,17/56,16.48%,COL8A1;COL4A1;COL4A2;COL5A1;COL4A4;COL27A1;COL6A2;COL24A1;COL11A2;P4HA2;P3H2;COL10A1;P4HA3;PPIB;TLL1;COL12A1;COL9A2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.8254079094883368,-1.5573434570644902,0.015873015873015872,0.12409944817682747,1.0,5/17,6.92%,CCBE1;C3;SULF1;BRCA1;CYP1B1
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.6534929549005077,-1.5571134975961738,0.012658227848101266,0.12418676252115425,1.0,22/74,16.48%,OPTC;COL8A1;COL4A1;COL4A2;COL5A1;COL4A4;COL27A1;COL6A2;SCX;COL24A1;CYP1B1;COL11A2;P4HA2;P3H2;COL10A1;P4HA3;PPIB;TLL1;LAMA3;ITGB4;COL12A1;COL9A2
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.7131385790708132,1.555477088071459,0.0,0.7868381560953176,1.0,13/35,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;RAE1;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,Reactome_2022__SHC-mediated cascade:FGFR1 R-HSA-5654688,0.7557730789104928,1.554357715708546,0.02631578947368421,0.7849101703488294,1.0,2/12,3.57%,FGF6;NRAS
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,0.6895279212380288,1.5540085391569565,0.0,0.7785921963789298,1.0,8/27,15.54%,SNAPC5;POLR3B;POLR3F;BRF2;SNAPC1;SNAPC3;BDP1;POU2F1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.7173615970161846,1.5539820666163733,0.0,0.7688155006111655,1.0,2/21,2.98%,RGCC;DACH1
prerank,CellMarker_Augmented_2021__Hepatoblast:Liver,-0.644903400218991,-1.5532893029154835,0.0,0.13400998017121912,1.0,24/77,14.02%,ENPP2;ANGPTL2;OGN;APLNR;SPARC;SERPINF1;ABCA8;ASPN;COLEC12;PLN;FILIP1L;GYPE;LDB2;OLFML1;ELN;IGF1;FAM20A;ITGA11;CACNA1C;AEBP1;PRRX1;ITGA9;RASL12;C1S
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.9275537731661132,1.5519957203906705,0.02,0.7767460258313795,1.0,3/6,6.76%,ERCC8;LIG4;ERCC6
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.8851294863770232,-1.5513566140373447,0.015873015873015872,0.13817047975935356,1.0,2/11,1.34%,DUSP1;DOCK8
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Whartons Jelly,-0.688460320795046,-1.5503732094310312,0.0,0.13823962905186477,1.0,25/66,16.68%,TMEM204;TGFBR2;HIC1;ICAM1;ZNF469;MMP19;ITGA5;PDCD1LG2;BGN;CCL2;MMP14;TIMP1;TNFRSF14;EMP1;IGFBP7;COPZ2;CTSZ;MVP;APOL3;ROBO4;SRGN;PLAC9;TLN1;STAT6;PML
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone,-0.688460320795046,-1.5503732094310312,0.0,0.13823962905186477,1.0,25/66,16.68%,TMEM204;TGFBR2;HIC1;ICAM1;ZNF469;MMP19;ITGA5;PDCD1LG2;BGN;CCL2;MMP14;TIMP1;TNFRSF14;EMP1;IGFBP7;COPZ2;CTSZ;MVP;APOL3;ROBO4;SRGN;PLAC9;TLN1;STAT6;PML
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,0.5584756780320385,1.5502841194641988,0.0,0.7794654969254686,1.0,34/78,23.92%,H2BC18;MSL2;H2BC21;KAT2B;H2BC4;ZZZ3;H2AC6;TAF12;KANSL2;SAP130;KAT2A;ELP2;EP400;KAT7;MBIP;EP300;TADA1;BRPF3;NCOA2;ING3;MCRS1;DR1;ELP6;ELP3;KAT14;TADA2B;KAT6B;SUPT20H;USP22;ENY2;RUVBL1;TRRAP;H2BC5;EPC1
prerank,Reactome_2022__Gastrulation R-HSA-9758941,-0.9284591770757546,-1.5500964379178424,0.03571428571428571,0.1381984291906539,1.0,1/7,0.11%,LEF1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.7985222799450894,-1.5494272296285516,0.0,0.13920507468785148,1.0,6/20,6.23%,COL8A1;DUSP1;COL4A2;LAMB1;ITGA5;MMP14
prerank,CellMarker_Augmented_2021__Dendritic cell:Thymus,-0.7338413599095829,-1.549328688306964,0.0,0.13871267773827065,1.0,10/26,10.58%,MYO1F;GPR183;TAGAP;ARHGAP9;IGSF6;WAS;LAT2;CTSS;PTPN7;PILRA
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.6572113841626949,-1.5489862438289252,0.0,0.13891637205200097,1.0,21/84,13.26%,IFI44L;IFI6;TLR2;MX1;IFIT1;IFITM3;TRIM5;IRF1;NLRC5;TLR3;BST2;IFIT3;PLSCR1;STAT1;IRF7;ISG15;MAP3K14;IFIH1;FADD;RNASE1;IFIT2
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Placenta,-0.7723584634021133,-1.5486730488501725,0.014285714285714285,0.1390197444294464,1.0,11/20,13.56%,P2RY13;MYO1F;TUBB1;GFI1B;GATA1;CLEC12A;CA1;SELP;CMTM2;TSPAN32;SLC11A1
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.7673280885524607,-1.5484877496405112,0.016666666666666666,0.13868254742754693,1.0,8/23,15.97%,COL8A1;COL4A2;LAMB1;ITGA5;MMP14;FN1;LAMA3;COL12A1
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,0.7329586124732158,1.5483047822136482,0.08108108108108109,0.787346778044959,1.0,1/17,0.37%,ITGA1
prerank,CellMarker_Augmented_2021__HES1High Progenitor cell:Stomach,-0.6704712657408892,-1.5482559832049203,0.0,0.13888321594632688,1.0,34/84,18.07%,ECM2;C1R;MATN2;PLXDC1;ASPN;COX7A1;LMOD1;PODN;OMD;APOD;MYH11;ELN;OSMR;GALNT15;FBXO32;THBS2;SLIT3;ADIRF;PRRX1;FGF7;SNED1;MMRN2;C1S;ROBO4;PDZD2;ALS2CL;TNS2;LAMA3;ITGB4;COL12A1;FMO2;ADGRF5;AQP1;ITIH5
prerank,CellMarker_Augmented_2021__Regulatory B cell:Undefined,-0.7945649891182838,-1.5480529477117753,0.019230769230769232,0.13712919271159701,1.0,7/20,8.69%,CD24;TAGAP;TMC8;IGHG1;ARHGAP9;ACAP1;WAS
prerank,CellMarker_Augmented_2021__Naive B cell:Blood,-0.7945649891182838,-1.5480529477117753,0.019230769230769232,0.13712919271159701,1.0,7/20,8.69%,CD24;TAGAP;TMC8;IGHG1;ARHGAP9;ACAP1;WAS
prerank,CellMarker_Augmented_2021__Transitional B cell:Peripheral Blood,-0.7945649891182838,-1.5480529477117753,0.019230769230769232,0.13712919271159701,1.0,7/20,8.69%,CD24;TAGAP;TMC8;IGHG1;ARHGAP9;ACAP1;WAS
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.7052782471337112,-1.5474274666715735,0.0,0.13814265615082322,1.0,9/44,9.54%,ARHGAP4;EPS8L2;SHTN1;PDPN;ARHGEF3;ARHGDIG;WAS;CDC42EP1;CDC42EP3
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.898377517091831,-1.546919689894691,0.0,0.13843566135970212,1.0,1/9,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.8475582629358358,-1.5463185577821563,0.0,0.1387728124232051,1.0,4/11,6.56%,CD24;APOLD1;MAFF;CEACAM1
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Peripheral Blood,-0.6603125635852329,-1.5462166475549026,0.012658227848101266,0.13826293677551724,1.0,31/65,20.21%,ANGPTL2;APLNR;SPARC;C1R;ABCA8;RAMP3;MAOB;BGN;PODN;LDB2;ELN;IGFBP7;SLCO2A1;RNASE1;ITGA9;RASL12;C1S;ROBO4;SERPING1;MCAM;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ITIH5;A2M;PDGFRA;CX3CL1;C1QB
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.6909305429386579,-1.5462150999749973,0.02564102564102564,0.13757162209163964,1.0,8/52,10.92%,ENPP2;AGPAT4;PLAAT4;PLB1;ANGPTL3;PLPPR1;PLPPR5;LPCAT4
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.8976530255560509,-1.54620599510841,0.01818181818181818,0.13697999103280895,1.0,1/8,0.34%,RASGRP1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.8095505441247068,1.546127492695379,0.023809523809523808,0.795172014116477,1.0,1/12,0.54%,PTCD2
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.9057348625120893,-1.5460968440663503,0.0,0.1365789085910623,1.0,1/12,0.18%,ANXA1
prerank,KEGG_2021_Human__Circadian entrainment,-0.643360293078901,-1.546048655944739,0.02666666666666667,0.13599799662394704,1.0,22/79,17.30%,CACNA1H;GRIN2D;NOS1AP;GRIN2A;ADCY7;GNG3;GRIA3;GRIA1;ITPR3;PRKCG;CACNA1C;ADCY5;GNG2;NOS1;GRIN2B;RASD1;FOS;ADCY3;GUCY1A1;ADCY8;PRKCB;RYR2
prerank,CellMarker_Augmented_2021__Leukocyte:Peripheral Blood,-0.6796174249127248,-1.5457296740736108,0.0,0.13615430062775105,1.0,14/43,10.35%,MYO1F;GPR183;DOCK8;TAGAP;TMC8;SLA;ARHGAP9;ARHGAP15;GPR18;ACAP1;RCSD1;WAS;PATL2;PTPN7
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.6575123802560678,1.5452765907879682,0.030303030303030304,0.7913249282939404,1.0,5/21,18.25%,MYO10;CCDC88C;KIF1B;MAP6;CCDC88A
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.923334752671718,-1.5450303436338753,0.0,0.1370825290986723,1.0,1/10,0.04%,GGT5
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.853911899692855,1.5444550078666752,0.046511627906976744,0.7878527088731739,1.0,1/8,0.25%,LEPR
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.8476418921887695,1.5441893343691049,0.0,0.7801799935001855,1.0,1/12,0.33%,SLC2A5
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,0.6574348479133454,1.5440219702171707,0.043478260869565216,0.7721458976085149,1.0,8/36,5.72%,FGF6;FLT3;PDE3B;NRAS;PIK3R4;TRIB3;THEM4;AKT2
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,0.5987819155919327,1.543882257773662,0.0,0.7637633276452577,1.0,18/51,20.89%,NUP42;RPP40;RTRAF;NUP37;NUP54;TSEN2;RPP14;NDC1;TSEN15;NUP214;AAAS;NUP188;ZBTB8OS;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.6788350220041218,-1.543671095118269,0.014084507042253521,0.13981279217343534,1.0,23/59,19.24%,ANXA1;SOCS3;IL13RA1;ICAM1;IL12A;FSCN1;CCL2;TIMP1;CCND1;F13A1;STAT1;IL4R;FN1;IL18;FOS;CEBPD;STAT6;BCL6;NDN;TGFB1;CDKN1A;LAMA5;CD36
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.7812493975542689,-1.5431946464359412,0.015873015873015872,0.13994840193781474,1.0,4/20,7.79%,ANXA1;THBS1;RHOBTB2;XKR4
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.8842414136713779,1.5425630641726618,0.043478260869565216,0.7637125265093512,1.0,2/5,5.84%,BCL10;FAM3A
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.9057435341130777,-1.5423513122845716,0.03773584905660377,0.14133825059740815,1.0,1/5,0.33%,THBS1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.7106078531744807,1.542053266541885,0.09090909090909091,0.7573363932421946,1.0,3/11,4.15%,WNT7A;CEL;NLGN3
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.9372165761434734,1.54182969859312,0.02127659574468085,0.7499342511875893,1.0,2/5,1.65%,VEGFD;VEGFC
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.9693589710623629,-1.5417439521366436,0.0,0.14222391034175835,1.0,1/6,0.11%,LEF1
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.6379423905933389,-1.5417278843367725,0.0,0.14159106738600397,1.0,7/101,4.35%,CACNA1H;CD24;CP;KCNQ1;ANK3;MAOB;PODXL
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Membrane,-0.6616963595003749,-1.5410805283603293,0.0,0.14242293079902418,1.0,25/81,17.22%,ANXA1;COL4A1;GBP1;SPARC;C1R;TGFBR2;MYOF;GPNMB;PDCD1LG2;MMP14;CD44;SRPX2;P3H2;OSMR;EMP1;IGFBP7;COPZ2;CFH;HRH1;C1S;ROBO4;COL12A1;ANXA2;PXDC1;AFAP1L1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Embryo,-0.6995240843662004,-1.5398674084473185,0.013333333333333334,0.1443468155045314,1.0,6/44,8.80%,GGT5;KCNQ1;SIGLEC1;COL6A2;PODN;FBP1
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Embryonic Stem Cell,-0.6763674947536809,-1.539083186161176,0.014285714285714285,0.14482829089514293,1.0,15/57,11.27%,C3;SP100;ABCA6;TLR2;KMO;GPNMB;GPR34;SIGLEC1;ACSM5;PLD1;HLA-DRA;IGSF6;CHI3L1;CTSS;APOL6
prerank,CellMarker_Augmented_2021__Anterior Foregut Endoderm cell:Lung,-0.6763674947536809,-1.539083186161176,0.014285714285714285,0.14482829089514293,1.0,15/57,11.27%,C3;SP100;ABCA6;TLR2;KMO;GPNMB;GPR34;SIGLEC1;ACSM5;PLD1;HLA-DRA;IGSF6;CHI3L1;CTSS;APOL6
prerank,Reactome_2022__Interleukin-10 Signaling R-HSA-6783783,-0.849923451428758,-1.5389325847414344,0.0,0.14454509887563055,1.0,6/13,7.17%,CXCL2;IL1R1;ICAM1;IL12A;CCL2;TIMP1
prerank,Reactome_2022__Prolonged ERK Activation Events R-HSA-169893,0.7713012541875076,1.5382062687659495,0.0625,0.7684617111095708,1.0,1/13,0.43%,NGF
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,0.6297416411168779,1.537880585473911,0.03571428571428571,0.7623745016474751,1.0,8/33,5.72%,FGF6;FLT3;PDE3B;NRAS;PIK3R4;TRIB3;THEM4;AKT2
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.880806171773012,-1.5375678921309388,0.0,0.14745985230475503,1.0,1/8,1.55%,SUV39H1
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,-0.6708764466447243,-1.5373424926661132,0.0,0.14738204862992496,1.0,11/61,6.69%,CXCL2;ANXA1;NPY;TAC3;C3;APLNR;ACKR4;GPNMB;APP;CCL2;UTS2
prerank,Reactome_2022__FRS-mediated FGFR2 Signaling R-HSA-5654700,0.7122094494928208,1.53733422301505,0.034482758620689655,0.7566744524722957,1.0,2/15,3.57%,FGF6;NRAS
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.6917821440718321,1.5372924879913923,0.05405405405405406,0.7483593485989738,1.0,8/20,16.37%,GDAP1;ABCD2;PEX13;ABCD1;RAB8B;ABCD3;PEX2;SLC25A17
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.7171062663280512,-1.5367676779391175,0.0,0.14863125956969558,1.0,14/39,15.88%,CD24;TAGAP;IGHG1;KLF4;PDK1;CD9;PRDM1;P2RY10;CCR10;PPIB;SSR4;CD74;CD37;MAN1A1
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Undefined,0.5563468251495738,1.5363720586496044,0.0,0.7472477817294382,1.0,38/93,27.28%,UBN2;ANKRD26;CEP290;CHD9;ZNF518A;MDN1;PCM1;NIPBL;BRWD1;ZNF451;ALMS1;NEK1;BDP1;NHLRC2;CEP192;MGA;HELZ;ERCC6L2;KANSL1L;SHPRH;HERC1;ANKRD17;PIKFYVE;USP47;FRYL;SMG1;AKAP11;TRIP12;TRIP11;SCAF11;RBM26;TTC21B;HECTD1;MYCBP2;ZNF644;UBR3;CLASP2;RALGAPA1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.7276814237582855,-1.5362057276436167,0.0,0.14948576535613503,1.0,6/32,7.39%,CDKN2A;GPNMB;KLF4;CCL2;GFI1B;PLK3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.6281363257423053,-1.5359257693612574,0.0,0.14935741899194038,1.0,14/87,9.24%,ENPP2;EFNA1;SOCS3;CSPG4;IL12A;IL15;ITGA5;GATA1;PARP14;PTK6;CD44;TNFRSF14;PARP9;IGF1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.6718759916960728,1.5359225612323872,0.029411764705882353,0.7414067309805704,1.0,10/25,20.01%,GDAP1;ABCD2;PEX13;ABCD1;RAB8B;ABCD3;PEX2;SLC25A17;PEX6;PEX12
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.7408856483268582,-1.5355169890074833,0.0,0.14961006221791934,1.0,9/23,13.21%,RASGRP1;HLA-A;IL12A;CD160;HLA-DRA;HLA-B;HLA-E;FADD;HLA-F
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,0.5782728754246459,1.5354414648424302,0.0,0.736413468765667,1.0,18/55,20.89%,NUP42;NUP37;H2BC21;H2BC4;NUP54;IPO8;H2AC6;NDC1;NUP214;H3-3B;AAAS;NUP188;POLR2C;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,Reactome_2022__Binding Of TCF/LEF:CTNNB1 To Target Gene Promoters R-HSA-4411364,-0.9336019106254072,-1.5354205633725817,0.0,0.14910419508420497,1.0,1/6,0.11%,LEF1
prerank,CellMarker_Augmented_2021__Follicular B cell:Undefined,-0.9095727841523231,-1.535338866941131,0.0,0.1486865141098363,1.0,1/9,0.05%,CD24
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.9057482949205142,1.535297478372316,0.0,0.7291390113449401,1.0,3/9,4.61%,TFB2M;TFB1M;MTERF1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.8520092049999107,-1.5352896177186666,0.017543859649122806,0.14806437292913763,1.0,2/12,0.99%,THBS1;MET
prerank,Reactome_2022__SHC-mediated cascade:FGFR4 R-HSA-5654719,0.80106718794134,1.5347323080032156,0.02564102564102564,0.7253221477931476,1.0,2/10,3.57%,FGF6;NRAS
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.9264738326306403,-1.5343499894270713,0.0,0.1495204040330077,1.0,2/7,2.09%,TLCD2;ANK3
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.5796170350706037,1.5340201035338599,0.0,0.7234536737494999,1.0,13/70,15.10%,RANBP17;NUP62CL;NUP42;U2AF1;RITA1;RANBP3L;XPO1;EIF4E;NUP214;RAE1;XPO7;NUP188;THOC3
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,0.6257815758948664,1.5338790542619338,0.03571428571428571,0.7095254179231959,1.0,8/34,5.72%,FGF6;FLT3;PDE3B;NRAS;PIK3R4;TRIB3;THEM4;AKT2
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,0.6257815758948664,1.5338790542619338,0.03571428571428571,0.7095254179231959,1.0,8/34,5.72%,FGF6;FLT3;PDE3B;NRAS;PIK3R4;TRIB3;THEM4;AKT2
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.8854203340370269,1.533278032644747,0.0,0.7058306647787096,1.0,1/8,1.59%,AMER2
prerank,Reactome_2022__Cytochrome C-Mediated Apoptotic Response R-HSA-111461,-0.8509161329765436,-1.5330452276826814,0.0,0.15211909375424743,1.0,1/12,0.48%,APIP
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.8795511137952061,-1.532000949226267,0.017857142857142856,0.15366769704255426,1.0,2/12,1.14%,MET;NR4A3
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.6363019240168885,-1.5317985789833266,0.0,0.15377095671795227,1.0,25/113,10.68%,CXCL2;ANXA1;P2RY13;P2RY6;NPY;TAC3;C3;APLNR;GPR183;P2RY12;ACKR4;P2RY14;GNRHR;GPNMB;CHRM1;APP;GPR18;CCL2;UTS2;PLPPR1;S1PR3;PLPPR5;CHRM3;SST;MCHR2
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.6492108353876705,-1.5312974742749812,0.0,0.15440278864611234,1.0,32/92,19.03%,COL4A1;ANGPTL2;CALD1;C1R;COL4A2;ABCA8;MATN2;ASPN;COX7A1;LMOD1;BGN;PODN;CYP1B1;MYH11;ELN;THBS2;TPM4;IGFBP5;PRRX1;C1QTNF1;RNASE1;RASL12;RASD1;C1S;TNS2;COL12A1;TEK;ADGRF5;AQP1;PTPN21;PDGFRA;SVEP1
prerank,CellMarker_Augmented_2021__Villous Stromal cell:Placenta,-0.6444098956064135,-1.5311965634633367,0.0,0.15405588572620163,1.0,22/70,15.97%,COL4A1;ANGPTL2;C1R;COL4A2;CSPG4;GPNMB;COX7A1;LMOD1;BGN;MMP14;PODN;SRPX2;EMP1;THBS2;FN1;COPZ2;PRRX1;C1QTNF1;RHBDF1;C1S;TNS2;COL12A1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.6943895181652588,-1.5303240218709138,0.0,0.1554077844099262,1.0,10/36,19.00%,CLIC1;P2RY12;GATA1;FN1;MYH9;PIK3CB;TLN1;VCL;FERMT3;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8942171305964532,-1.5296926218120381,0.0,0.15634600768976817,1.0,3/9,0.33%,KLF2;EPN1;THBS1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Vein,-0.6630141853025023,-1.5291464172006897,0.0,0.15719611841241551,1.0,22/71,12.74%,GGT5;ECM2;ANGPTL2;APLNR;SPARC;C1R;ABCA8;ASPN;COX7A1;THY1;BGN;FILIP1L;PODN;LDB2;ELN;GALNT15;THBS2;IGFBP7;SLIT3;AEBP1;CFH;PRRX1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.8917921827118446,1.528812579822208,0.0,0.7233287985346265,1.0,1/8,0.30%,ACE2
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.8917921827118446,1.528812579822208,0.0,0.7233287985346265,1.0,1/8,0.30%,ACE2
prerank,KEGG_2021_Human__Renin-angiotensin system,0.7705012176096709,1.528787759548313,0.05714285714285714,0.7163061888401154,1.0,1/12,0.30%,ACE2
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.7265828363505779,-1.528611892065542,0.0,0.15799910472874393,1.0,7/37,5.98%,ANXA1;DOCK8;HLA-A;IL15;THY1;PDCD1LG2;CCL2
prerank,KEGG_2021_Human__Fat digestion and absorption,0.6968741810022129,1.5286069675901024,0.07894736842105263,0.7103995430920603,1.0,3/20,2.65%,CEL;ABCA1;MTTP
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.8322065577285178,-1.5284645353450914,0.0,0.15760459035727406,1.0,4/12,9.67%,SOCS3;PARP9;IFNGR2;STAT1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.6100890505993852,-1.5276940336707183,0.0,0.15883376879813266,1.0,39/124,19.30%,LEF1;COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;COL5A1;SULF1;THY1;LMOD1;BGN;FILIP1L;PODN;LDB2;ITGA8;SRPX2;THBS2;FGF1;FN1;IGFBP5;PRRX1;AMOTL2;RASD1;C1S;ROBO4;SFRP2;DLC1;TNS2;SNCG;COL12A1;PML;TEK;MRC1;ANGPT2;PCDH18;PDGFRA;SVEP1;ARID5B
prerank,CellMarker_Augmented_2021__Platelet:Peripheral Blood,-0.7777333781150215,-1.5273953557833135,0.0,0.15847874654282604,1.0,12/24,12.98%,TSPAN16;RASGRP2;ALOX12;NLRP12;TUBB1;GFI1B;GP6;GATA1;NRGN;PRSS57;CMTM2;TSPAN32
prerank,CellMarker_Augmented_2021__Platelet:Plasma,-0.7777333781150215,-1.5273953557833135,0.0,0.15847874654282604,1.0,12/24,12.98%,TSPAN16;RASGRP2;ALOX12;NLRP12;TUBB1;GFI1B;GP6;GATA1;NRGN;PRSS57;CMTM2;TSPAN32
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.6158194010530336,1.5273854949780876,0.03571428571428571,0.7121620738481648,1.0,8/33,23.19%,PTCD2;RBM23;PAPOLA;IWS1;QKI;SLTM;RBM39;JMJD6
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.7216168994450339,-1.5265945899466122,0.0,0.15964981376551957,1.0,5/29,6.31%,CDKN2A;GPNMB;KLF4;CCL2;GFI1B
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.524463631769093,1.526460432558728,0.0,0.7127150753641476,1.0,27/93,22.51%,NUP42;U2AF1;NUP37;NUP54;WDR33;EIF4E;NDC1;NUP214;NXT1;SMG7;RAE1;AAAS;NUP188;THOC3;IWS1;DDX25;NUP205;THOC1;AGFG1;PCID2;NUP210;NUP85;CPSF2;NUP153;NUP50;SMG1;ENY2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.69056772236725,-1.5260043082694792,0.014285714285714285,0.16038363965316296,1.0,12/46,14.41%,IL1R1;RASGRP1;HLA-A;IL12A;PDCD1LG2;TLR3;ZFPM1;ISG15;IL18;FADD;SLC11A1;BTN3A1
prerank,CellMarker_Augmented_2021__Eosinophil:Undefined,-0.8608222411577484,-1.5258524932578243,0.015384615384615385,0.16002775366732683,1.0,1/10,0.05%,CD24
prerank,Reactome_2022__ARMS-mediated Activation R-HSA-170984,0.9365187261704521,1.5249902989833082,0.0,0.7169654518117975,1.0,1/6,0.43%,NGF
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.9280881757424948,-1.523407096918549,0.017241379310344827,0.1658798883547884,1.0,1/8,0.17%,ST6GAL1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.7547321019906074,-1.522459717676175,0.014285714285714285,0.16746180851944586,1.0,3/25,5.61%,ABCA5;ABCA8;ABCA12
prerank,Reactome_2022__RAS Signaling Downstream Of NF1 Loss-Of-Function Variants R-HSA-6802953,0.811378078894278,1.5224340471839066,0.08108108108108109,0.7325770747692834,1.0,3/6,13.51%,SPRED1;NRAS;SPRED2
prerank,CellMarker_Augmented_2021__Colony-forming cell:Prostate,-0.6583483165883887,-1.5223698298014732,0.0,0.16700483937715302,1.0,24/82,17.22%,THBS1;COL4A1;MET;CALD1;TGFBR2;MYOF;LAMB1;ITGA2;APP;SVIL;SRPX2;OSMR;EMP1;CD9;TGFA;SLC44A3;AMOTL2;ITGA3;ALS2CL;LAMA3;ITGB4;COL12A1;F3;AFAP1L1
prerank,CellMarker_Augmented_2021__Hair Follicle cell:Hair Follicle,-0.7316850444702151,-1.5218209621223375,0.01282051282051282,0.16792208233724595,1.0,25/62,14.75%,GGT5;GBP2;SP100;GBP1;TGFBR2;CIITA;FOSL2;ZFP36;IRF1;GAB3;NLRC5;CD44;TNFRSF14;CMAHP;MYH11;CTSS;IGFBP7;APOL6;SELP;HLA-E;CFH;SP140L;APOL3;ROBO4;SRGN
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.8923535773345648,-1.5213637973964487,0.01694915254237288,0.16826315525498053,1.0,4/10,8.26%,ENPP2;PDPN;CD44;VIL1
prerank,Reactome_2022__Class I Peroxisomal Membrane Protein Import R-HSA-9603798,0.6942209930574408,1.520959836330145,0.05714285714285714,0.7363592607655686,1.0,7/18,16.37%,GDAP1;ABCD2;PEX13;ABCD1;ABCD3;PEX2;SLC25A17
prerank,CellMarker_Augmented_2021__Basophil:Umbilical Cord Blood,-0.7176707866169425,-1.5207334051585781,0.015151515151515152,0.16943220155772654,1.0,11/30,10.35%,MYO1F;GPR183;DOCK8;TAGAP;TMC8;SLA;ARHGAP9;ARHGAP15;RCSD1;CTSS;PTPN7
prerank,Reactome_2022__Leading Strand Synthesis R-HSA-69109,0.829406277458588,1.5190247507657875,0.0,0.7422366349476686,1.0,3/12,5.74%,POLD3;SLC19A1;RFC3
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.5585640520106552,-1.5186810381123832,0.0,0.17495439747684738,1.0,91/376,17.04%,CXCL2;ANXA1;GBP2;IL1R1;IFI6;SOCS3;TRIM22;SP100;IL13RA1;GBP1;MX1;B2M;CIITA;ICAM1;RPS27A;IFIT1;IFITM3;HLA-A;IL12A;TRIM5;IRF1;INPP5D;STAT4;IFI35;SLA;ST18;DUOX1;IL15;FSCN1;NOD1;CCL2;HLA-C;HLA-DRA;CEACAM1;BST2;CD44;TIMP1;CCND1;TNFRSF14;IFIT3;PSMB9;F13A1;IFNGR2;CA1;LMNB1;OSMR;STAT1;IL4R;TCP1;IRF7;ISG15;PSMB6;BIRC3;HLA-B;SYK;FN1;HLA-E;IL17RE;IL18;NUMBL;PSMC3;TNIP2;MAP3K14;GREM2;PIM1;UBC;TNFRSF1A;HLA-F;IFIT2;IL7;FOS;IL3RA;PIK3CB;PSMA8;LTBR;VAV1;IL1RAP;PRKCD;PIK3CD;JUNB;IL27RA;PSMA7;HLA-DRB1;F3;ANXA2;CEBPD;STAT6;PML;BCL6;NDN;IRS2
prerank,CellMarker_Augmented_2021__Neuron:Brain,-0.7306222773119916,-1.5181757659261599,0.05405405405405406,0.1756002353456148,1.0,13/27,19.26%,LNX1;KCNK1;SLITRK1;GRIA3;GLRA2;NELL1;GFAP;SYP;SST;TMEM130;RELN;ENO2;CNTN4
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.8145447946635286,-1.5180138106319756,0.0,0.1752709099895656,1.0,6/18,8.45%,GRIN2D;PLK2;GRIN2A;SLC24A2;SLC24A1;SLC8A3
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.8923537911592642,-1.518006100106654,0.05555555555555555,0.1745726195115195,1.0,3/8,4.38%,MET;PROX1;CCDC39
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.735267869495196,1.517667808113256,0.02702702702702703,0.7453530646429024,1.0,5/13,16.37%,SLC19A1;SLC25A24;SLC25A41;SLC25A5;SLC25A17
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,0.7162394537525993,1.517613460267788,0.037037037037037035,0.7387993319536724,1.0,8/23,14.99%,H2BC21;H2BC4;EED;DNMT3B;RBBP4;H2AC6;H3-3B;AEBP2
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6520075020642826,-1.5173215625796679,0.013333333333333334,0.1757674558281401,1.0,16/65,15.80%,ENPP2;EFNA1;CSPG4;IL15;ITGA5;APP;GATA1;CD44;TNFRSF14;IGF1;DMTN;FGF7;CD74;SFRP2;PRKCD;RELN
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,-0.6401986404853445,-1.5168160649424618,0.013888888888888888,0.17669479056346993,1.0,19/72,16.48%,COL8A1;COL4A1;COL4A2;COL5A1;COL4A4;COL27A1;COL6A2;COL24A1;COL11A2;P4HA2;P3H2;COL10A1;CTSS;P4HA3;PPIB;TLL1;ITGB4;COL12A1;COL9A2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.8928521448741229,-1.5164988849329173,0.0,0.1769905828057395,1.0,1/9,0.47%,HPN
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.5296780498901025,1.516458137981939,0.0,0.7393832780858506,1.0,24/88,21.51%,NUP42;U2AF1;NUP37;NUP54;WDR33;EIF4E;NDC1;NUP214;NXT1;SMG7;RAE1;AAAS;NUP188;THOC3;DDX25;NUP205;THOC1;AGFG1;NUP210;NUP85;CPSF2;NUP153;NUP50;SMG1
prerank,CellMarker_Augmented_2021__Microglial cell:Brain,-0.8046448772542621,-1.5153435187999866,0.06153846153846154,0.17958834548885363,1.0,5/16,6.44%,KLF2;GPR183;P2RY12;CCL2;HLA-DRA
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.7188752206768075,1.515172820110132,0.0,0.7434370244676427,1.0,8/18,17.57%,GDAP1;PLD6;MFF;CHCHD3;OPA1;THG1L;MIEF2;MIGA1
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,0.678153062685207,1.5149638620868622,0.023809523809523808,0.7389436596373418,1.0,10/32,13.16%,ACE2;SDC4;SDC3;PIK3R4;GPC5;VCP;RNF103-CHMP3;HSPG2;PIK3C3;CHMP2B
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.5627768105225449,1.5149246816350375,0.0625,0.7331597489568037,1.0,33/78,25.88%,MRPL10;MRPS30;MRPL15;PTCD3;MRRF;MRPS9;MRPL58;MRPS2;MRPL50;MRPL37;GFM2;MRPL18;MRPL42;MRPL52;MRPL41;MRPS31;MRPS27;MRPL9;MRPS7;MRPS35;MRPS14;MRPL47;MRPL4;MRPS11;MRPL1;MTRF1;MRPS10;MRPL17;MRPS21;MRPL24;MRPL13;MRPL3;MRPS16
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.8823948177892507,1.514849891316169,0.02040816326530612,0.7273778281729485,1.0,2/6,1.65%,VEGFD;VEGFC
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Undefined,-0.7006858836140094,-1.5148395462295892,0.0,0.18063562032053745,1.0,19/48,13.56%,TRIM22;CIITA;TAGAP;P2RY14;GPR34;EVI2A;SLA;ARHGAP9;ARHGAP15;THY1;HLA-DRA;CMAHP;MYH11;F13A1;RCSD1;CTSS;SELP;ELMO1;APOL3
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.8528664276909992,1.514725205028066,0.023255813953488372,0.7219820841002389,1.0,2/6,9.15%,CHPT1;PLA2G4C
prerank,GO_Biological_Process_2021__somite development (GO:0061053),0.8676995472189893,1.5145699210925052,0.0,0.7171532854509847,1.0,1/8,0.08%,MEOX2
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.6134178535338026,-1.5145469084777403,0.0,0.18073116877039255,1.0,22/101,12.60%,KCNT2;DEPP1;RIMBP2;PGR;PCSK2;CHGB;STMN2;RCAN2;PROX1;GC;SH3GL2;SYT4;GRIA3;LDB2;EDIL3;PLPPR1;SCG5;SST;SHC2;KCNB2;IGFBP5;F10
prerank,CellMarker_Augmented_2021__Limbal Mesenchymal cell:Sclerocorneal Tissue,-0.6363414095440502,-1.5145245876484466,0.0,0.18006681109931866,1.0,19/74,14.43%,COL4A1;ANGPTL2;SPARC;C1R;COL4A2;COL5A1;TIMP2;COL6A2;THY1;BGN;CCL2;PODN;LDB2;THBS2;IGFBP7;AEBP1;PRRX1;STK32B;ROBO4
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),0.9485167588809211,1.5145035929413335,0.027777777777777776,0.7112714664343027,1.0,2/5,3.04%,ACP3;NT5C1A
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.6806222540313174,1.514058799100368,0.06451612903225806,0.709233976144889,1.0,8/23,20.01%,ABCD2;PEX11A;MFF;ABCD1;ABCD3;PEX2;PEX6;PEX12
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.6671237939396053,1.5136929504371357,0.0,0.7050929604558713,1.0,14/29,27.46%,RUNX1;PHC1;RNF2;YAF2;CSNK2A2;EP300;SMARCA2;SCMH1;PHC3;PBRM1;SMARCC1;ARID1B;CBX6;ARID2
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.9814224333217203,-1.513370726366199,0.0,0.18340482201759592,1.0,1/5,1.64%,COL4A2
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.9318704619651167,-1.513179093815438,0.0,0.18323750864252814,1.0,1/5,2.20%,ZFP36
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.6027504938183296,-1.513071898620789,0.0,0.18296427173431914,1.0,34/155,11.51%,ECM2;THBS1;COL8A1;COL4A1;SPARC;COL4A2;ICAM1;LAMB1;ADAMTS10;COL5A1;THSD4;ITGA2;COL4A4;ADAMTSL2;MMP19;COL27A1;COL6A2;MMP21;ITGA5;APP;BGN;COL24A1;MMP14;MARCOL;CD44;COL11A2;ELN;ITGA8;COL10A1;ADAM19;MMP25;ITGA11;FN1;MMP24
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.5566788853591429,1.5129641687716582,0.05555555555555555,0.7032309863453716,1.0,35/84,25.88%,MRPL10;MRPS30;MRPL15;PTCD3;MRRF;MRPS9;MRPL58;MRPS2;MRPL50;APEH;MRPL37;GFM2;MRPL18;MRPL42;MRPL52;MRPL41;MRPS31;MRPS27;MRPL9;MRPS7;MRPS35;MRPS14;MRPL47;MRPL4;MRPS11;MRPL1;MTRF1;MRPS10;MRPL17;MRPS21;ABCE1;MRPL24;MRPL13;MRPL3;MRPS16
prerank,CellMarker_Augmented_2021__Neutrophil:Undefined,-0.8506543890143362,-1.5120912163673375,0.03076923076923077,0.18536303175861504,1.0,4/12,7.03%,CD24;TLR2;CEACAM1;CD44
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.7849835486244908,-1.5120871740713622,0.0,0.18465822935649104,1.0,5/25,3.62%,GGT5;ANXA1;POU4F1;WNT8B;RAMP3
prerank,CellMarker_Augmented_2021__Microglial cell:Embryonic Prefrontal Cortex,-0.569286494099042,-1.5120685188927663,0.0,0.1839587663665043,1.0,75/350,16.06%,CD24;KLF2;P2RY13;ARHGAP4;C3;FOSB;TAGLN3;DUSP1;SP100;IL13RA1;IPCEF1;MYO1F;GPR183;DOCK8;P2RY12;B2M;TAGAP;ZFP36;TIMP2;PDPN;SERPINF1;INPP5D;ATP8B4;GPR34;EVI2A;ARHGAP9;NNAT;CTSC;TMC6;BEX1;HLA-C;ELAVL4;IGSF6;BST2;TM6SF1;CCND1;SYNGR2;RCSD1;WAS;RPS6KA1;LAT2;IRAG2;SYT1;P3H2;BLVRB;IGF1;RHBDF2;PFN2;MLLT11;B3GNT5;CTSS;HLA-B;SYK;IER3;HLA-E;LPAR6;TMBIM1;MYH9;CD63;TNFRSF1A;FES;RNF213;FOS;EGFL7;NR4A1;BLNK;RASSF4;SRGN;CD74;CD37;VAV1;STMN1;RTN1;JUNB;TLN1
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,-0.8044177399111878,-1.5119204829293649,0.0,0.18379251949153624,1.0,5/17,13.76%,RPS27A;PGK1;DUSP16;UBC;RNF213
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.7700875658513686,-1.5118447388698444,0.0,0.18345220511876098,1.0,9/20,13.21%,B2M;HLA-A;CD160;TNFRSF14;WNT5A;SCIMP;CD55;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),-0.9006210535909096,-1.5117247141535635,0.029850746268656716,0.1831843042591401,1.0,2/7,0.96%,CACNA1H;SERPINA10
prerank,Reactome_2022__FRS-mediated FGFR4 Signaling R-HSA-5654712,0.8036064699566944,1.5117131107763007,0.03571428571428571,0.7063352552548332,1.0,2/12,3.57%,FGF6;NRAS
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.5400732339931178,1.5115499684784606,0.037037037037037035,0.7018634135715063,1.0,14/66,18.45%,ATP6V0D2;ATP6V1A;EIF2S1;ATP6V1G1;MIOS;SESN2;EIF2AK4;MAPK8;WDR24;DAP;PRKD1;SESN3;EIF2AK3;SLC38A9
prerank,CellMarker_Augmented_2021__Basophil:Lung,-0.7210951782723366,-1.5114413061788585,0.0,0.18333602458354611,1.0,19/37,19.24%,P2RY13;GBP1;TLR2;GPR34;SLA;SIGLEC1;HLA-DRA;IGSF6;F13A1;RASGEF1B;CTSS;LPAR6;CLEC5A;MSR1;HLA-DRB1;MRC1;FRMD4B;CD4;CD36
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.6031721613619746,-1.5113634916866108,0.0,0.18296653009327266,1.0,34/155,11.51%,ECM2;THBS1;COL8A1;COL4A1;SPARC;COL4A2;ICAM1;LAMB1;ADAMTS10;COL5A1;THSD4;ITGA2;COL4A4;ADAMTSL2;MMP19;COL27A1;COL6A2;MMP21;ITGA5;APP;BGN;COL24A1;MMP14;MARCOL;CD44;COL11A2;ELN;ITGA8;COL10A1;ADAM19;MMP25;ITGA11;FN1;MMP24
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.6372992978312165,-1.5107713380257473,0.01282051282051282,0.18401607806206266,1.0,18/70,14.82%,MET;STMN2;PSRC1;PROX1;APP;LMOD1;CAV3;SYNPO2L;BAIAP2;BAIAP2L1;VIL1;CDC42EP1;PFN2;CDC42EP3;DCTN1;FES;MYLK3;WDR1
prerank,CellMarker_Augmented_2021__Mesodermal Embryonic Stem cell:Germ,-0.6807330584021704,-1.5095525274830084,0.013888888888888888,0.18729495713870864,1.0,25/61,18.20%,ENPP2;GGT5;APLNR;SPARC;ABCA8;RAMP3;BGN;PODN;LDB2;GALNT15;IGFBP7;SELP;AEBP1;RNASE1;PCDH12;ITGA9;ROBO4;SERPING1;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;A2M
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,0.5692963231204603,1.5088729891733688,0.0,0.71329557419308,1.0,17/57,15.19%,H2BC21;KAT2B;H2BC4;ERCC6;UBTF;ERCC2;RBBP4;H2AC6;POLR1F;ERCC3;KAT2A;GTF2H5;H3-3B;GTF2H2;DPEP2;RRN3;HDAC2
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.5920192302014331,-1.5087037077623522,0.011111111111111112,0.1892467054645462,1.0,29/140,13.63%,IFI6;C3;TRIM22;SP100;TLR2;MX1;B2M;CIITA;TRIM61;IFIT1;IFITM3;SFTPD;TRIM5;SLA;COLEC12;APP;NLRC5;TLR3;BST2;PTK6;TRIM17;IRF7;ISG15;SYK;HLA-E;IFIH1;SLC11A1;FES;CLEC5A
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),-0.919134915793029,-1.5085214613298024,0.018867924528301886,0.18906596055258804,1.0,2/7,3.17%,CDKN2A;IL12A
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Germ,-0.7174813240941783,-1.5077766839737288,0.013513513513513514,0.19048640287636162,1.0,14/39,11.34%,P2RY13;TRIM22;CIITA;P2RY14;IGHG1;SLA;GAB3;HLA-DRA;CMAHP;MYH11;F13A1;RCSD1;CTSS;SELP
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.7446344685205978,-1.5070609590521284,0.0,0.1920660945220229,1.0,12/37,10.01%,GBP2;SP100;GBP1;TLR2;CIITA;IFITM3;CCL2;BST2;GBP7;RPL13A;STAT1;WNT5A
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.9130724676550993,1.5068987661403161,0.0,0.7214238809409252,1.0,1/6,2.79%,LIG4
prerank,KEGG_2021_Human__Amoebiasis,-0.6581821127289544,-1.506731414187638,0.0,0.19248537446179795,1.0,9/62,4.70%,CXCL2;IL1R1;COL4A1;TLR2;COL4A2;LAMB1;COL4A4;IL12A;ARG2
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),-0.9800321695907794,-1.50654780614837,0.0,0.19246390304737498,1.0,1/5,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.8356922928684251,1.505899532856139,0.05128205128205128,0.7225179151690085,1.0,1/11,0.67%,POLD3
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.7515873299703149,1.5050019944649724,0.025,0.7230677781633623,1.0,3/12,8.19%,SLC19A1;SLC25A24;SLC25A41
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,0.6509731330119806,1.5049846976061685,0.0,0.7175929106655606,1.0,6/26,20.15%,NUP37;NUP54;NDC1;NUP188;NUP205;NUP85
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.7101613496866646,1.5038927951593748,0.05555555555555555,0.7207677765758634,1.0,6/17,11.00%,ABCD2;ACACB;ABCD1;MID1IP1;CPT2;ABCD3
prerank,CellMarker_Augmented_2021__B cell:Undefined,-0.7193609708868083,-1.5038844887117289,0.03225806451612903,0.19992422778785046,1.0,8/32,13.00%,CD24;IL13RA1;CD5;ADGRE5;BST2;CD9;CD63;CCR10
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,0.5595035719083286,1.5038145615163223,0.0,0.7158226420616138,1.0,15/44,21.38%,NUP42;NUP37;NUP54;GTF2F2;NDC1;NUP214;AAAS;NUP188;POLR2C;NUP205;NUP210;NUP85;NUP153;NUP50;PBRM1
prerank,Reactome_2022__Frs2-mediated Activation R-HSA-170968,0.7749277884194565,1.503802017842242,0.058823529411764705,0.7104405169333311,1.0,1/11,0.43%,NGF
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.6273016109643212,-1.5037735122921105,0.0,0.19960881003807315,1.0,35/107,17.72%,THBS1;COL4A1;ANGPTL2;C3;APLNR;CALD1;C1R;COL4A2;CDH6;CLDN16;MAOB;LMOD1;BGN;LDB2;NRGN;IGF1;SPSB1;IGFBP7;IGFBP5;C1QTNF1;SLCO2A1;RNASE1;RASL12;MMRN2;C1S;ROBO4;SLC14A2;SERPING1;TNS2;PXDC1;FMO2;TEK;SHROOM4;ADGRF5;AQP1
prerank,Reactome_2022__Regulation Of Localization Of FOXO Transcription Factors R-HSA-9614399,0.7291244380408957,1.5032733447192659,0.09090909090909091,0.7080993572600996,1.0,2/12,6.69%,AKT2;AKT1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.7341360755160139,-1.5028511167450274,0.0,0.20186053992138897,1.0,4/27,7.61%,LEF1;HPN;LRRC19;POU2F3
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.9237928624334109,-1.502339475481142,0.0,0.20286814746947385,1.0,1/7,0.02%,ENPP2
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.8999467939690822,-1.502308993284959,0.0,0.20218183095232437,1.0,2/7,3.62%,RPE65;RBP2
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreas,0.5558412423633955,1.5021780420465813,0.0,0.7104108458020524,1.0,23/86,12.50%,RNF6;PDIK1L;LIG4;TRAM1;CFAP97;SSX2IP;KRR1;TMEM267;ZNF800;ZBTB33;FBXL3;FAM199X;TWF1;MIER3;LMBRD2;SLC25A46;ABCD3;GPR180;STT3B;MBLAC2;SOCS4;MANEA;UHMK1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6509212272691742,1.5012637122445605,0.08108108108108109,0.7108547383663192,1.0,3/17,4.15%,WNT7A;CEL;NLGN3
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,-0.6001939759209233,-1.5012302587577009,0.0,0.20466425661833437,1.0,24/145,11.16%,CXCL2;ANXA1;P2RY13;NPY;C3;APLNR;GPR183;P2RY12;RGSL1;PDE4A;ACKR4;P2RY14;ADCY7;GNG3;APP;GPR18;ITPR3;GRM6;PRKCG;S1PR3;PPP3CC;SST;MCHR2;ADCY5
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.8037089649920588,-1.5010302064443324,0.05263157894736842,0.20433770175559368,1.0,1/14,0.05%,CD24
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.9641641068122456,-1.500654292094836,0.0,0.20447160150545696,1.0,1/6,0.33%,THBS1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.540246459128221,1.50000678665622,0.038461538461538464,0.7130296330276932,1.0,14/65,18.45%,ATP6V0D2;ATP6V1A;EIF2S1;ATP6V1G1;MIOS;SESN2;EIF2AK4;MAPK8;WDR24;DAP;PRKD1;SESN3;EIF2AK3;SLC38A9
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.8780743196028714,1.4988280810191175,0.0196078431372549,0.7151730074765834,1.0,1/5,1.83%,MACIR
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.5774972673804166,1.4977208880733897,0.09090909090909091,0.7171224484305377,1.0,21/49,17.39%,ABCD2;PPARGC1A;ADIPOR1;PEX13;ABCD1;ACADM;CYP4V2;MCAT;PHYH;CPT2;ABCD3;EHHADH;ADH5;SCP2;ECHDC1;ACOX1;PEX2;ACADS;SLC25A17;ACAD10;BDH2
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,-0.7449394697250363,-1.4975881250132625,0.014285714285714285,0.21380100851790676,1.0,4/19,12.88%,RPS27A;GFAP;UBC;RNASE1
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation R-HSA-76046,0.6267927863878552,1.497145100052075,0.06060606060606061,0.7149148604001018,1.0,8/35,15.54%,SNAPC5;POLR3B;POLR3F;BRF2;SNAPC1;SNAPC3;BDP1;POU2F1
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,-0.5866024137279169,-1.496866225444818,0.0,0.21572088287823873,1.0,60/190,17.95%,FLRT3;RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;LDB2;ARHGAP39;AKAP5;RPL9;PSMB9;RPL21;RPL13A;NELL2;PFN2;RPS11;RPS16;RPLP1;RPS13;PSMB6;RPL38;SLIT3;RPS3A;RPS8;RPL10A;PSMC3;RPLP2;RPS23;RPS21;RPS7;UBC;RNASE1;RPL8;RPS6;ELOB;RPS15;RPL26L1;RPS9;PSMA8;RPL12;RPL5;PSMA7;FAU;RPL23;RPL4;GPC1;PSME1;RPL18A;RBX1;RPL41;RPL7;RPS12
prerank,KEGG_2021_Human__Phagosome,-0.6260830380749587,-1.496717611454233,0.0,0.21555478263699474,1.0,21/100,13.21%,THBS1;C3;TUBB6;C1R;TLR2;ITGA2;SFTPD;HLA-A;COLEC12;ITGA5;TUBB1;HLA-C;THBS3;HLA-DRA;CTSS;THBS2;M6PR;HLA-B;HLA-E;NOS1;HLA-F
prerank,CellMarker_Augmented_2021__Endothelial cell:Intervertebral Disc,-0.7075966239127075,-1.49667066694339,0.0,0.21487346428623233,1.0,23/51,18.20%,GGT5;APLNR;PDPN;RAMP3;GPR34;SIGLEC1;PODN;LDB2;MYH11;F13A1;SELP;RNASE1;PCDH12;ITGA9;ROBO4;SERPING1;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ITIH5;A2M
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),0.8659633343139778,1.4952257134568103,0.10526315789473684,0.72142071597654,1.0,1/5,0.48%,DAO
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.7403215872016725,1.494608564076211,0.0625,0.7200920148929739,1.0,1/8,12.29%,MAPK12
prerank,Reactome_2022__Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,-0.763938010377536,-1.4945142918978238,0.043478260869565216,0.22201213496168057,1.0,5/24,5.53%,GRIN2D;GRIN3A;NEFL;GRIN2A;KIF17
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Pancreas,-0.5983078706086248,-1.4944090652372433,0.012658227848101266,0.22169792300259109,1.0,27/89,19.00%,TAGLN3;STMN2;NEFL;NEFM;CNTNAP1;SNCB;LZTS1;ZDHHC22;SLITRK1;BEX1;RND2;GAP43;NYAP1;MLLT11;TCEAL2;C11ORF87;CRMP1;KCNC1;GDAP1L1;JPH4;CCDC184;PTPRN;TCEAL5;SULT4A1;ENO2;FSD1;PNMA2
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.7649730523674761,-1.4941309769658506,0.0,0.2218649842230158,1.0,7/23,19.45%,IFI6;IL12A;IFIH1;VWCE;LGALS8;GSDME;EIF5A
prerank,Reactome_2022__Mitochondrial Translation Termination R-HSA-5419276,0.5390723483157859,1.493806585422043,0.045454545454545456,0.7211598697929162,1.0,32/73,25.88%,MRPL10;MRPS30;MRPL15;PTCD3;MRRF;MRPS9;MRPL58;MRPS2;MRPL50;MRPL37;GFM2;MRPL18;MRPL42;MRPL52;MRPL41;MRPS31;MRPS27;MRPL9;MRPS7;MRPS35;MRPS14;MRPL47;MRPL4;MRPS11;MRPL1;MRPS10;MRPL17;MRPS21;MRPL24;MRPL13;MRPL3;MRPS16
prerank,KEGG_2021_Human__Arachidonic acid metabolism,-0.7289958338788907,-1.4936822529865885,0.013513513513513514,0.2223173965842567,1.0,3/31,3.17%,GGT5;ALOX12;PLB1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.5578638702307481,1.4929877418549313,0.0,0.7219767474696132,1.0,13/42,13.59%,ERCC8;PRIMPOL;MEN1;MAPK10;ERCC6;ERCC2;TYR;DCT;MAPK8;DRD2;ERCC3;FECH;GTF2H2
prerank,KEGG_2021_Human__Bladder cancer,-0.6907246022863726,-1.4922171738436265,0.014084507042253521,0.22676396972467205,1.0,5/32,7.85%,THBS1;CDKN2A;TYMP;CCND1;EGF
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,0.5654337550239364,1.4921668591390267,0.0,0.7229387027431714,1.0,17/58,15.19%,H2BC21;KAT2B;H2BC4;ERCC6;UBTF;ERCC2;RBBP4;H2AC6;POLR1F;ERCC3;KAT2A;GTF2H5;H3-3B;GTF2H2;DPEP2;RRN3;HDAC2
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.8990447362903278,-1.4915913021005263,0.015384615384615385,0.2281135888287688,1.0,2/9,1.11%,TMEM204;APLNR
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.7316382915652775,-1.491281328674438,0.04225352112676056,0.2282252081561489,1.0,4/30,12.36%,LEF1;PDE6B;WNT5A;GNG2
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.7217367643412501,1.4906384744516497,0.06896551724137931,0.727536420013737,1.0,5/15,15.97%,NXT2;XPO1;NXT1;AAAS;NUP205
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Fetal Liver,-0.6264288454183995,-1.4904762727575227,0.0,0.23031450697256986,1.0,24/80,14.02%,COL4A1;ANGPTL2;SPARC;C1R;COL4A2;COL5A1;ASPN;COL6A2;SULF1;THY1;LMOD1;BGN;PODN;LDB2;ELN;ITGA11;THBS2;FN1;SLIT3;AEBP1;IGFBP5;PRRX1;RASL12;C1S
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.9535921797575726,-1.4903669623083529,0.0,0.2297920257983889,1.0,1/6,0.54%,EFNA1
prerank,Reactome_2022__Mitochondrial Translation Initiation R-HSA-5368286,0.5402135993262226,1.4903626730188388,0.0,0.7247462409427337,1.0,32/73,25.88%,MRPL10;MRPS30;MRPL15;PTCD3;MTIF2;MRPS9;MRPL58;MTFMT;MRPS2;MRPL50;MRPL37;MRPL18;MRPL42;MRPL52;MRPL41;MRPS31;MRPS27;MRPL9;MRPS7;MRPS35;MRPS14;MRPL47;MRPL4;MRPS11;MRPL1;MRPS10;MRPL17;MRPS21;MRPL24;MRPL13;MRPL3;MRPS16
prerank,CellMarker_Augmented_2021__Endothelial cell:Skin,-0.7109642791703569,-1.490127083909303,0.0136986301369863,0.22974094364376763,1.0,20/45,18.20%,GGT5;APLNR;RAMP3;GPR34;SIGLEC1;DYSF;MYH11;F13A1;SELP;BMX;RNASE1;PCDH12;MMRN2;ROBO4;TEK;SHROOM4;MRC1;ADGRF5;AQP1;A2M
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.7602890934103488,-1.4900372270471467,0.057971014492753624,0.2292238575551772,1.0,3/19,6.31%,CD24;SCX;GFI1B
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.6230468814713507,-1.4899820666769863,0.012345679012345678,0.22864823456595731,1.0,25/87,15.16%,IL1R1;P2RY6;IL13RA1;TLR2;ITGA2;SLC39A14;SERPINF1;SIGLEC1;MMP19;CCL2;DYSF;MMP14;ITPR3;F13A1;CHI3L1;FAM20C;SNX10;CTSZ;RNASE1;CLEC5A;PTH1R;EGFL7;TNFAIP2;RASSF4;SERPING1
prerank,CellMarker_Augmented_2021__CD1C+ B Dendritic cell:Blood,-0.7243209571770419,-1.489861472610714,0.0410958904109589,0.2282926098330678,1.0,8/29,10.69%,ANXA1;IL13RA1;NLRP12;MTMR11;ITGA5;F13A1;LAT2;CREB5
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),-0.9235056648643349,-1.489685345494352,0.01639344262295082,0.22803167790006526,1.0,1/5,0.11%,LEF1
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.6382776798356204,1.4895114609168867,0.03225806451612903,0.7249041057177426,1.0,3/28,6.41%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.8243139891290453,-1.4887130116458978,0.0,0.2309939212149766,1.0,3/11,7.22%,CD24;PODXL;BASP1
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Undefined,-0.8041713184832904,-1.4886112694807332,0.045454545454545456,0.23063410365438097,1.0,5/14,10.81%,CD24;PODXL;THY1;CD9;ALPL
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.6446747775719363,-1.4874557571327496,0.0,0.23341608108513937,1.0,10/61,5.06%,KLF2;EPN1;THBS1;ISM1;SPARC;COL4A2;SERPINF1;CD160;SULF1;KLF4
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Oral Cavity,-0.6986012859301476,-1.4872483261066571,0.014285714285714285,0.2335368098091833,1.0,12/49,7.03%,CD24;CP;IL1R1;C3;IL13RA1;MYOF;IFITM3;S100A6;KLF4;DUOXA1;MMP14;CD44
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.5989539534842638,-1.4872084218518116,0.0,0.2329905481780928,1.0,30/109,14.18%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;CSPG4;COL5A1;CHAD;COL6A2;SULF1;THY1;LMOD1;BGN;MMP14;PODN;ELN;COL10A1;STAT1;EMP1;THBS2;IGFBP7;FN1;SLIT3;AEBP1;RUNX2;IGFBP5;PRRX1;C1S;CRTAC1
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9215909354771471,-1.4871571254933895,0.0,0.23244782222098997,1.0,1/5,0.41%,SLC28A2
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.7212071244966116,-1.487143900300839,0.0,0.23178825075866416,1.0,4/33,4.18%,SCN1B;PKP2;ANK3;CHRM1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestinal Crypt,-0.6852527934452348,-1.4870725682873511,0.04225352112676056,0.23122289090992246,1.0,14/46,10.38%,CD24;ANXA1;THBS1;S100A10;IL13RA1;MYOF;ITGA2;S100A6;PLK2;CD44;OSMR;EMP1;CD9;TGFA
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.8479764895142949,1.486836161807932,0.024390243902439025,0.7368512980435472,1.0,4/8,13.24%,ZC3H8;SNAPC5;SNAPC1;SNAPC3
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.882560887665085,-1.486520134294935,0.0,0.2326042571697193,1.0,1/6,0.11%,LEF1
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.6647899754255198,-1.4854500677889357,0.014084507042253521,0.23564550549643937,1.0,12/50,12.36%,MX1;ZFP36;IFIT1;IFITM3;PROX1;TRIM5;BST2;HEXIM1;PLSCR1;STAT1;ISG15;IFIH1
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Peripheral Blood,-0.7066821256685079,-1.4850033694063134,0.0,0.23655843643264998,1.0,22/51,18.20%,GGT5;APLNR;RAMP3;GPR34;SIGLEC1;DYSF;LDB2;MYH11;F13A1;SELP;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;SERPING1;TEK;SHROOM4;MRC1;ADGRF5;AQP1;A2M
prerank,Reactome_2022__Aflatoxin Activation And Detoxification R-HSA-5423646,-0.8435462883823137,-1.4845044327216175,0.06666666666666667,0.23770244436947716,1.0,1/11,0.04%,GGT5
prerank,Reactome_2022__VEGF Binds To VEGFR Leading To Receptor Dimerization R-HSA-195399,0.942712997278282,1.4843154156190173,0.02127659574468085,0.7497726948165898,1.0,2/5,1.65%,VEGFD;VEGFC
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.6092910959410247,-1.484222006233428,0.0,0.23804229396461574,1.0,25/118,13.93%,IL1R1;COL4A1;ANGPTL2;CALD1;COL4A2;THY1;GFRA2;LMOD1;BGN;MAP1B;EFNB3;SCARA3;GAP43;ARHGEF17;EDIL3;SHC2;NUAK1;DAB2IP;ADCY5;IGFBP5;NOS1;AMOTL2;CRMP1;TNFRSF1A;PTH1R
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.6689944119644106,-1.4838119403860295,0.015384615384615385,0.2391449808823926,1.0,11/44,6.48%,LEF1;SP100;CD5;TAGAP;SKAP1;TMC8;GPR171;SLA;ARHGAP9;ARHGAP15;ACAP1
prerank,CellMarker_Augmented_2021__Glomerular Epithelial cell:Renal Glomerulus,-0.7367679246817534,-1.4832807211645127,0.0,0.2393706753231505,1.0,9/41,8.11%,CLIC1;EPS8L2;TJP3;OVOL2;LSR;ITPR3;ANO9;SYNGR2;BAIAP2L1
prerank,CellMarker_Augmented_2021__Podocyte:Renal Glomerulus,-0.7367679246817534,-1.4832807211645127,0.0,0.2393706753231505,1.0,9/41,8.11%,CLIC1;EPS8L2;TJP3;OVOL2;LSR;ITPR3;ANO9;SYNGR2;BAIAP2L1
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,-0.7161805958001509,-1.483120800982082,0.028985507246376812,0.23926386562505722,1.0,5/26,11.27%,RASGRP1;RASGRP2;THPO;SYK;FN1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.7841533703200316,-1.483046813499658,0.019230769230769232,0.23877999690566445,1.0,5/15,7.85%,KLF2;HPN;APP;KLF4;EGF
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.7100683792124278,-1.4829122849374314,0.012987012987012988,0.23850189205233419,1.0,19/42,18.41%,RPS27A;RPS27;RPS14;RPS4X;SNRPD2;RPS11;RPS16;RPS13;RPS3A;RPS8;RPS23;RPS21;RPS7;RPS6;RPS15;RPS9;FAU;RPS12;RPS20
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.6434100747349872,1.4823122452056425,0.05555555555555555,0.7584693698691004,1.0,5/28,13.24%,ZC3H8;SNAPC5;RO60;SNAPC1;SNAPC3
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.6258119270033725,-1.4822311646815696,0.0,0.23992918254907575,1.0,19/73,11.47%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL5A1;ABCA8;COL6A2;THY1;LMOD1;BGN;PODN;LDB2;ELN;GALNT15;ITGA11;THBS2;IGFBP7;AEBP1
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.6255009967521001,-1.482187121314218,0.014492753623188406,0.23941895395190774,1.0,22/62,11.27%,P2RY13;MYO1F;GBP1;TYMP;TLR2;MX1;ICAM1;TAGAP;IFIT1;IFITM3;DYSF;HLA-DRA;IGSF6;CD44;TNFRSF14;IFIT3;CLEC12A;PLSCR1;IRF7;CTSS;PILRA;FN1
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.7481861742013618,-1.482053570989479,0.030303030303030304,0.23919884644251715,1.0,1/21,0.17%,ST6GAL1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.7440424452178287,-1.4819784960325755,0.04838709677419355,0.2387225984678468,1.0,3/24,4.28%,ANXA1;THBS1;DUOX1
prerank,CellMarker_Augmented_2021__Endoderm Progenitor cell:Adipose Tissue,-0.7092658447832519,-1.4819380581394246,0.013888888888888888,0.23819221812829167,1.0,19/47,18.20%,GGT5;APLNR;RAMP3;SLA;SIGLEC1;HLA-DRA;MYH11;F13A1;SELP;RNASE1;ITGA9;ROBO4;CD74;SERPING1;TEK;SHROOM4;MRC1;ADGRF5;A2M
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.705053196342353,-1.481852884822688,0.013888888888888888,0.23794942820645737,1.0,7/27,13.21%,B2M;HLA-A;MFSD6;HLA-C;HLA-B;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.6940865340401987,-1.4813306244710795,0.014925373134328358,0.23906887622457312,1.0,3/29,1.53%,THBS1;MET;P2RY12
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.8442594172549397,1.480812246093546,0.044444444444444446,0.7654110223822272,1.0,3/8,7.14%,SOX8;SOX9;RORB
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.7462286163103851,-1.4807332598171006,0.014705882352941176,0.24049243603035683,1.0,3/25,4.35%,COL4A1;MET;PODXL
prerank,CellMarker_Augmented_2021__B cell:Spleen,-0.6713923240109501,-1.4806032943374037,0.029850746268656716,0.240104007751111,1.0,13/33,15.54%,MYO1F;DOCK8;TAGAP;TMC8;ARHGAP9;ARHGAP15;ACAP1;RCSD1;WAS;PTPN7;P2RY10;CD37;VAV1
prerank,CellMarker_Augmented_2021__Endothelial cell:Undefined,-0.7480479677392693,-1.480527891520315,0.029850746268656716,0.23960554723700114,1.0,9/20,17.25%,A4GALT;ICAM1;PDPN;F8;PROCR;IL3RA;APLN;MCAM;TEK
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,0.582153235721306,1.480438614995212,0.0,0.7623345456978856,1.0,16/48,20.89%,NUP42;NUP37;NUP54;SNRPF;NDC1;NUP214;AAAS;NUP188;NUP205;CLNS1A;WDR77;GEMIN4;NUP210;NUP85;NUP153;NUP50
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,0.6911043024642285,1.4802287147435564,0.06451612903225806,0.7588563997451918,1.0,4/16,12.89%,AKT2;YES1;AKT1;PPP2R5A
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.5937133022530179,1.480067662473457,0.058823529411764705,0.7554231330951134,1.0,10/49,11.03%,ASCL1;NCSTN;BMP2;POFUT1;MAML3;KAT2B;PBX1;NOTCH2;HEYL;DTX4
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Lymphoid Tissue,-0.6921534942656622,-1.4800616402813478,0.0,0.24070657510165444,1.0,18/29,21.57%,DOCK8;TAGAP;LMO2;INPP5D;HLA-DRA;CLEC12A;RCSD1;WAS;CTSS;SYK;P2RY10;CD37;FERMT3;WDFY4;NAPSB;SPI1;PTPRC;PTAFR
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.7972468088403674,1.4798383348380268,0.0,0.7524698443552599,1.0,3/11,9.29%,WNT7A;CXXC4;STIL
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.8044292824087746,-1.4798277433822888,0.03076923076923077,0.24093534058797667,1.0,3/15,5.65%,CACNA1H;KCNB1;SYT4
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,0.6238997055805062,1.4792622194786575,0.07894736842105263,0.7511425215603813,1.0,11/48,11.90%,NR1D1;PPARGC1A;TFB2M;TFB1M;ALAS1;POLG2;MTERF1;GLUD1;CHD9;ESRRA;SIRT5
prerank,CellMarker_Augmented_2021__Granulosa cell:Ovary,-0.648436230704032,-1.4792508838797145,0.028169014084507043,0.24230424023547484,1.0,5/58,6.37%,GRIN2D;TUBB6;COL4A2;FSCN1;ANLN
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.6316292195861885,1.4790684461238266,0.045454545454545456,0.7476080439469331,1.0,15/39,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;RAE1;AAAS;NUP188;EP300;NUP205;JMJD8;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.7412442953304759,-1.4790238897730212,0.046153846153846156,0.24241585466632148,1.0,3/18,4.28%,THBS1;P2RY12;DUOX1
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Undefined,-0.6230827804045984,-1.4790142669343125,0.0,0.24172419601637193,1.0,27/78,18.20%,ENPP2;KCNT2;APLNR;SPARC;RCAN2;RAMP3;GRIN2A;SULF1;BGN;GRIA3;LDB2;ZNF385D;CACNA1C;HECW2;RNASE1;ITGA9;RASL12;RGS7BP;TMEM132C;RASSF4;SERPING1;TEK;SHROOM4;MRC1;ADGRF5;AQP1;A2M
prerank,Reactome_2022__Mitochondrial Translation Elongation R-HSA-5389840,0.5202626596416499,1.4785302189955771,0.0,0.74604283707785,1.0,30/73,25.88%,MRPL10;MRPS30;MRPL15;PTCD3;MRPS9;MRPL58;MRPS2;MRPL50;MRPL37;MRPL18;MRPL42;MRPL52;MRPL41;MRPS31;MRPS27;MRPL9;MRPS7;MRPS35;MRPS14;MRPL47;MRPL4;MRPS11;MRPL1;MRPS10;MRPL17;MRPS21;MRPL24;MRPL13;MRPL3;MRPS16
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.7029397526321981,1.4782722050048198,0.0,0.7430094760919289,1.0,5/23,10.09%,CHAMP1;ZNF207;SGO2;NSL1;PLK1
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.9115092390585704,-1.4782563937992466,0.01639344262295082,0.24343733829955777,1.0,1/7,2.19%,KDELR3
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),-0.9410223812691155,-1.4781888134806462,0.0,0.24291182469818245,1.0,1/8,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.572124563550003,-1.476883177064687,0.0,0.2468608229716182,1.0,45/217,11.51%,ECM2;OPTC;THBS1;COL8A1;COL4A1;SPARC;COL4A2;ICAM1;LAMB1;ADAMTS10;COL5A1;TIMP2;THSD4;ITGA2;SCUBE3;COL4A4;ADAMTSL2;MMP19;COL27A1;COL6A2;MMP21;ITGA5;APP;SCX;BGN;COL24A1;MMP14;MARCOL;CYP1B1;CD44;TIMP1;COL11A2;ELN;ITGA8;P4HA2;P3H2;KIF9;COL10A1;ADAM19;CTSS;MMP25;ITGA11;P4HA3;FN1;MMP24
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.8158796287233299,-1.4767674347427242,0.0,0.2465745162594824,1.0,5/17,9.67%,IFITM3;IRF1;BST2;PLSCR1;STAT1
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),-0.9152387120702827,-1.4767245679081231,0.03225806451612903,0.2459898961773396,1.0,1/7,0.18%,ANXA1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.6133136779147967,1.476349905617857,0.03125,0.7507151663249085,1.0,2/24,0.45%,SLC6A13;SLC26A7
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.874930426967225,-1.4760131620321377,0.017241379310344827,0.24812789476428557,1.0,1/10,0.17%,ST6GAL1
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,0.5713042708892268,1.4754648407340436,0.0,0.7523783462267529,1.0,16/46,27.47%,ATP6V0D2;ATP6V1A;ATP6V1G1;MIOS;SESN2;WDR24;KICS2;SLC38A9;KPTN;LAMTOR3;FNIP2;RPTOR;NPRL3;NPRL2;SESN1;RHEB
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8586702298316238,1.4749756609944373,0.046511627906976744,0.7506136639886455,1.0,1/5,0.65%,ASCL1
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.5972904096776349,-1.4745533634753398,0.012658227848101266,0.2526936377402605,1.0,16/92,12.60%,CACNA1H;LEF1;POU4F1;TGFBR2;RAMP3;NLRP12;KLF4;CCL2;CYP1B1;IL1RAPL1;PTPN7;SLIT3;IL18;SIGIRR;IGFBP5;NOS1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.7686420655661221,-1.4743220948327116,0.0,0.2529614675335735,1.0,5/17,12.36%,CD24;KLF4;PARP9;WNT5A;IFIH1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovarian Cortex,-0.6477831978585542,-1.4741588571381259,0.024691358024691357,0.2522829570560504,1.0,24/75,12.75%,ANXA1;S100A10;GBP1;TGFBR2;FOSL2;MYOF;S100A6;CEMIP;FLG;PDCD1LG2;FILIP1L;MMP14;CD44;TIMP1;SRPX2;OSMR;EMP1;IGFBP7;NDRG1;LGR5;MVP;HRH1;PRRX1;C1QTNF1
prerank,CellMarker_Augmented_2021__Stem cell:Stomach,-0.6477831978585542,-1.4741588571381259,0.024691358024691357,0.2522829570560504,1.0,24/75,12.75%,ANXA1;S100A10;GBP1;TGFBR2;FOSL2;MYOF;S100A6;CEMIP;FLG;PDCD1LG2;FILIP1L;MMP14;CD44;TIMP1;SRPX2;OSMR;EMP1;IGFBP7;NDRG1;LGR5;MVP;HRH1;PRRX1;C1QTNF1
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.7943364869388209,-1.473766458956445,0.031746031746031744,0.25300528200761313,1.0,1/15,0.33%,THBS1
prerank,CellMarker_Augmented_2021__Neuron:Undefined,-0.6854115773154905,-1.473717928922525,0.030303030303030304,0.2524139615668082,1.0,6/28,8.20%,CD24;L1CAM;NEFM;THY1;SYP;NEFH
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Breast,-0.7741808141617539,-1.4736535832243005,0.03389830508474576,0.25198590963652195,1.0,5/15,12.48%,CD24;CD44;LGR5;GLI1;PROCR
prerank,KEGG_2021_Human__Fructose and mannose metabolism,-0.713979540898209,-1.4735370807519288,0.07692307692307693,0.2517463030945375,1.0,9/26,17.23%,ALDOB;GMPPB;HK2;ENOSF1;FBP1;PFKFB4;PMM1;PFKL;PFKFB3
prerank,Reactome_2022__FGFR1c Ligand Binding And Activation R-HSA-190373,0.8000970507695502,1.473520503426801,0.07317073170731707,0.7570952913537413,1.0,1/7,0.16%,FGF6
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.795929949898502,-1.4734818385965958,0.06349206349206349,0.2511106052701212,1.0,4/14,7.01%,FLRT3;P2RY12;GAP43;APOD
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.8397767787613489,-1.473347001839795,0.0,0.2510333665900357,1.0,2/14,0.81%,RECQL4;BLM
prerank,CellMarker_Augmented_2021__Vascular Endothelial cell:Placenta,-0.7077331338607563,-1.4733227649868874,0.0,0.25042962136953656,1.0,20/46,18.20%,GGT5;APLNR;ICAM1;RAMP3;SIGLEC1;PODN;MYH11;SELP;CFH;RNASE1;PCDH12;APOL3;MMRN2;ROBO4;SERPING1;TEK;MRC1;ADGRF5;AQP1;A2M
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.6381544585656974,1.473106311963261,0.0,0.7556668966101491,1.0,12/30,23.95%,MTHFS;SLC39A8;OAT;GLUD1;GLS;RIMKLB;GLUL;PRODH;DDAH1;ALDH4A1;GCLC;GOT2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.7374191870361664,-1.4729799018577936,0.0,0.25080137588671136,1.0,2/23,3.94%,KLF2;ATF3
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Brain,-0.6963649112544252,-1.4729627278273594,0.04054054054054054,0.25020167415257266,1.0,18/40,18.97%,GGT5;APLNR;RAMP3;GPR34;SIGLEC1;MYH11;F13A1;SELP;BMX;RNASE1;PCDH12;MMRN2;ROBO4;MSR1;MRC1;ADGRF5;A2M;WDFY4
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.8087014168470442,1.4728227915095429,0.025,0.7527534820690015,1.0,6/10,14.25%,WNT7A;SOX8;PEF1;KLHL12;CDH2;TAPT1
prerank,CellMarker_Augmented_2021__Lymphocyte:Peripheral Blood,-0.7099084198389599,-1.4727737540080093,0.0625,0.25012784691741125,1.0,7/21,10.35%,MYO1F;SLA;ARHGAP9;CLEC12A;WAS;CTSS;PTPN7
prerank,CellMarker_Augmented_2021__Mesoderm cell:Germ,-0.834971976591825,-1.472664249571649,0.014925373134328358,0.24979390448151526,1.0,4/13,7.03%,CD5;ICAM1;THY1;CD44
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,0.6556156570878737,1.4723831141670891,0.034482758620689655,0.7514360669794274,1.0,7/28,5.72%,FGF6;FLT3;PDE3B;PIK3R4;TRIB3;THEM4;AKT2
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,-0.6886098324996373,-1.4722934658058449,0.02666666666666667,0.2502152480741385,1.0,5/28,7.79%,AMN;RPS27A;LSR;VLDLR;LDLR
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.626912172099391,1.4722423077877658,0.047619047619047616,0.7478403466095438,1.0,17/44,20.89%,NUP42;NUP37;NUP54;RUBCNL;NDC1;NUP214;RAE1;AAAS;NUP188;EP300;NUP205;JMJD8;NOA1;NUP210;NUP85;NUP153;NUP50
prerank,CellMarker_Augmented_2021__Astroglial Progenitor cell:Embryo,-0.662735998127415,-1.4722050438619216,0.0,0.24967565387893242,1.0,13/67,14.41%,KLF2;GBP2;TMEM204;B2M;HLA-A;HLA-C;TNFRSF14;PIK3IP1;HLA-B;HLA-E;TSPAN32;APOL3;BTN3A1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.557974378206318,-1.4721304813209162,0.0,0.24931990294085593,1.0,80/290,18.92%,CXCL2;LEF1;ANXA1;GBP2;IL1R1;SOCS3;DUSP1;IL13RA1;POU4F1;GBP1;DOCK8;TLR2;ICAM1;ZFP36;RPS27A;IFIT1;IL12A;IRF1;INPP5D;STAT4;SLA;DUOX1;NLRP12;FSCN1;YBX3;CCL2;BRCA1;GBP7;TIMP1;CCND1;F13A1;CHI3L1;IFNGR2;RPL13A;ST3GAL6;IL1RAPL1;OSMR;STAT1;IL4R;WNT5A;PTPN7;DAB2IP;SYK;FN1;IL18;NUMBL;SBNO2;SIGIRR;GREM2;PIM1;UBC;TNFRSF1A;IL7;FOS;MYLK3;HYAL1;IL3RA;PIK3CB;VAV1;IL1RAP;PIK3CD;JUNB;IL27RA;F3;CEBPD;STAT6;ERBIN;BCL6;NDN;GPER1;DAPK3;TGFB1;PLP2;GSDME;CDKN1A;AKAP6;CD4;LAMA5;GBP3;SHMT1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.5163291972277324,1.471945486890872,0.0,0.7450249604330357,1.0,27/83,25.97%,DERL2;USP13;TMUB2;VCP;RNF103-CHMP3;ECPAS;AUP1;UGGT1;STT3B;DERL1;FBXO27;TMEM129;UBE4A;POMT2;RCN3;ERLIN1;RHBDD1;DNAJB14;RHBDD2;DNAJC18;UGGT2;TMUB1;SEL1L;UBQLN1;DNAJB12;DNAJB2;UBE2J2
prerank,Reactome_2022__Signaling By Activated Point Mutants Of FGFR1 R-HSA-1839122,0.8403348022673728,1.4718113784192204,0.041666666666666664,0.7413759020654336,1.0,1/6,0.16%,FGF6
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.810194054031156,1.4715839511682958,0.07142857142857142,0.734798188709578,1.0,1/7,0.30%,ACE2
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.810194054031156,1.4715839511682958,0.07142857142857142,0.734798188709578,1.0,1/7,0.30%,ACE2
prerank,CellMarker_Augmented_2021__Fibroblast:Undefined,-0.7768534554016717,-1.4715601313666158,0.06349206349206349,0.2507954245603559,1.0,3/17,7.03%,IL1R1;THY1;CD44
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),-0.9623798045772848,-1.4714898047913596,0.0,0.25041285500399124,1.0,3/6,2.77%,CCBE1;APLNR;PROX1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.6635458408953111,-1.4709966340105143,0.011904761904761904,0.25144167025242314,1.0,7/47,8.03%,ANXA1;GBP2;IL1R1;GBP1;APP;CCL2;CHI3L1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.749815137513934,-1.4709425630248512,0.05128205128205128,0.2510338733091745,1.0,5/23,4.46%,ANXA1;MET;PROX1;CCDC39;LSR
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.7173530366882594,1.4707821256254248,0.0,0.7350716976649647,1.0,8/18,20.43%,FAM47E;MSH2;PLK1;NIPBL;PPHLN1;TASOR;MCM9;WAPL
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Stomach,-0.9197406326353832,-1.4705525079599544,0.018867924528301886,0.25146925382982316,1.0,2/6,7.03%,CD24;CD44
prerank,CellMarker_Augmented_2021__Naive T cell:Bone Marrow,-0.7058356554916938,-1.4702446478712679,0.03333333333333333,0.25197850330921484,1.0,13/29,15.49%,MYO1F;GPR183;DOCK8;CD5;TAGAP;SLA;ARHGAP9;RCSD1;WAS;CTSS;P2RY10;SP140;CD37
prerank,Reactome_2022__Drug ADME R-HSA-9748784,-0.6456155537366357,-1.4700756191631956,0.029850746268656716,0.25164860643844694,1.0,9/48,13.64%,GGT5;SLC28A2;ACSM5;ABCB1;GLYAT;GLYATL2;RNASE1;CYP3A4;SLC38A1
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.8150689916520826,-1.4700624436049199,0.01639344262295082,0.2510171841425885,1.0,8/15,16.59%,S100A10;RFTN1;CAV3;FA2H;FLOT1;EMP2;ANXA2;CLN3
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.9230734380002235,-1.4699016661217348,0.05454545454545454,0.25106978580535616,1.0,2/6,2.77%,CCBE1;PROX1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.6985791631254887,-1.4697485851086907,0.046153846153846156,0.25089584512304147,1.0,9/31,12.78%,CD24;ANXA1;IL15;PDCD1LG2;IGF1;HHLA2;SYK;IL18;FADD
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.9533357905503992,-1.469337572457227,0.0,0.2513747189886604,1.0,1/6,0.02%,ENPP2
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.8477667893643877,1.4693161501878353,0.022222222222222223,0.739836978000126,1.0,1/8,0.65%,ASCL1
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.6631843928328632,-1.4688724153984563,0.02702702702702703,0.25295124807180025,1.0,7/34,14.80%,ECM2;PDPN;THY1;MINK1;DMTN;EMP2;PIK3CB
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.5478341591954308,1.4688479240234058,0.0,0.7388479105398831,1.0,31/78,25.88%,MRPL10;MRPS30;MRPL15;PTCD3;MRPS9;MRPL58;MRPS2;MRPL50;MRPL37;GFM2;MRPL18;MRPL42;MRPL52;MRPL41;MRPS31;MRPS27;MRPL9;MRPS7;MRPS35;MRPS14;MRPL47;MRPL4;MRPS11;MRPL1;MRPS10;MRPL17;MRPS21;MRPL24;MRPL13;MRPL3;MRPS16
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.7163200755352873,-1.468755135679482,0.0136986301369863,0.2528484866105565,1.0,11/34,21.32%,S100A10;SKAP1;THY1;EMP2;TEK;CCL28;CD36;CX3CL1;RRAS;SFRP1;RIN2
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7956017949474439,1.4686945618095264,0.02857142857142857,0.735487155621128,1.0,2/12,4.00%,ITGA1;PPP1R15B
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Peripheral Blood,-0.690639562499312,-1.4686098362758175,0.012987012987012988,0.2527711449161282,1.0,21/52,12.43%,ANXA1;IL1R1;S100A10;SP100;TGFBR2;FOSL2;MYOF;S100A6;KLF4;PARP14;CD44;PLSCR1;PARP9;EMP1;TGFA;CD55;DDX60;IL18;TMBIM1;IFIH1;MVP
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.6784439979767649,-1.4684864735028582,0.0,0.25257018682601423,1.0,15/38,14.75%,GBP2;SP100;TYMP;GPR183;TLR2;CIITA;IRF1;IGSF6;CTSS;BIRC3;APOL6;HLA-E;IFIH1;CLEC5A;SRGN
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.8312912553237858,-1.468397171776433,0.07575757575757576,0.25227133578536165,1.0,1/9,0.10%,KLF2
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.8151749317601891,1.467708200172743,0.05263157894736842,0.7369033033299139,1.0,3/6,10.09%,INTS13;NUP54;PLK1
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.8630893611052213,1.4673215113164912,0.02702702702702703,0.7349921899444669,1.0,1/5,10.69%,NIPBL
prerank,CellMarker_Augmented_2021__Blast cell:Bone Marrow,-0.6913557654342091,-1.4672935327364074,0.014084507042253521,0.25611935024862703,1.0,15/50,15.16%,GGT5;IL1R1;TGFBR2;SIGLEC1;DYSF;PODN;F13A1;IGFBP7;SELP;CFH;RNASE1;APOL3;FES;ROBO4;SERPING1
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.794153297140221,1.4672678376102188,0.08108108108108109,0.7311393844911268,1.0,3/8,6.83%,PLIN5;LMO3;PTGIS
prerank,Reactome_2022__SHC-mediated cascade:FGFR2 R-HSA-5654699,0.7101932983247208,1.4669869942509888,0.02702702702702703,0.7284628883321836,1.0,2/13,3.57%,FGF6;NRAS
prerank,KEGG_2021_Human__Inflammatory bowel disease,-0.7062635575344512,-1.4669414464051096,0.043478260869565216,0.25640333269045096,1.0,11/28,17.95%,TLR2;IL12A;STAT4;HLA-DRA;IFNGR2;STAT1;IL4R;IL18;HLA-DRB1;STAT6;TGFB1
prerank,Reactome_2022__Synthesis Of Wybutosine At G37 Of tRNA(Phe) R-HSA-6782861,0.9058185531915464,1.4666677209196077,0.04,0.7263169613440199,1.0,2/5,3.14%,LCMT2;TYW3
prerank,Reactome_2022__Rap1 Signaling R-HSA-392517,-0.8116220885043969,-1.466345339517833,0.0,0.257839409468809,1.0,2/14,1.49%,RASGRP1;RASGRP2
prerank,CellMarker_Augmented_2021__Oocyte:Ovary,-0.6818730243413278,-1.466027473133801,0.0,0.2584111469014366,1.0,7/28,12.66%,FOSB;EFCAB8;GP6;PP2D1;NLRP5;PATL2;CCDC73
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.6870724931564772,-1.46560188005162,0.02857142857142857,0.25954145759768027,1.0,5/33,5.90%,ANXA1;SFTPD;GPNMB;IL15;PDCD1LG2
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Undefined,-0.6256189069686452,-1.4655825706512753,0.013888888888888888,0.25621230928151734,1.0,23/69,14.02%,ECM2;ANGPTL2;SPARC;C1R;ABCA8;ASPN;COL6A2;SULF1;LMOD1;BGN;FILIP1L;PODN;OLFML1;ELN;ITGA8;ITGA11;THBS2;IGFBP7;SLIT3;SFRP4;PRRX1;FGF7;C1S
prerank,CellMarker_Augmented_2021__Peritubular Myoid cell:Testis,-0.6256189069686452,-1.4655825706512753,0.013888888888888888,0.25621230928151734,1.0,23/69,14.02%,ECM2;ANGPTL2;SPARC;C1R;ABCA8;ASPN;COL6A2;SULF1;LMOD1;BGN;FILIP1L;PODN;OLFML1;ELN;ITGA8;ITGA11;THBS2;IGFBP7;SLIT3;SFRP4;PRRX1;FGF7;C1S
prerank,CellMarker_Augmented_2021__Myofibroblast:Undefined,-0.6256189069686452,-1.4655825706512753,0.013888888888888888,0.25621230928151734,1.0,23/69,14.02%,ECM2;ANGPTL2;SPARC;C1R;ABCA8;ASPN;COL6A2;SULF1;LMOD1;BGN;FILIP1L;PODN;OLFML1;ELN;ITGA8;ITGA11;THBS2;IGFBP7;SLIT3;SFRP4;PRRX1;FGF7;C1S
prerank,CellMarker_Augmented_2021__Fibroblast:Corneal Endothelium,-0.6256189069686452,-1.4655825706512753,0.013888888888888888,0.25621230928151734,1.0,23/69,14.02%,ECM2;ANGPTL2;SPARC;C1R;ABCA8;ASPN;COL6A2;SULF1;LMOD1;BGN;FILIP1L;PODN;OLFML1;ELN;ITGA8;ITGA11;THBS2;IGFBP7;SLIT3;SFRP4;PRRX1;FGF7;C1S
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Blood Vessel,-0.6256189069686452,-1.4655825706512753,0.013888888888888888,0.25621230928151734,1.0,23/69,14.02%,ECM2;ANGPTL2;SPARC;C1R;ABCA8;ASPN;COL6A2;SULF1;LMOD1;BGN;FILIP1L;PODN;OLFML1;ELN;ITGA8;ITGA11;THBS2;IGFBP7;SLIT3;SFRP4;PRRX1;FGF7;C1S
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.599529216946143,-1.4655598558588547,0.0,0.25562408340424536,1.0,49/126,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;POLR2I;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.7717238271818495,-1.4654867811724452,0.05357142857142857,0.25515876472471427,1.0,2/11,2.75%,NR4A3;WNT8B
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,-0.6382802775748363,-1.4650835246741856,0.014285714285714285,0.2561068232906335,1.0,6/62,7.37%,GGT5;ACSM5;TPST1;GSTM5;GLYAT;PAPSS2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Liver,-0.8271671683171254,-1.464653361441441,0.01694915254237288,0.2568114930753119,1.0,4/13,7.03%,CD24;ICAM1;THY1;CD44
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),-0.984595117904945,-1.4645687888274108,0.0,0.2564180856592184,1.0,1/5,0.69%,NPY
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.7977488781484179,1.4640056079015733,0.1,0.7370866253885533,1.0,3/10,8.28%,CEBPA;ZC3H8;AR
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.5779180787328229,1.4639631338950851,0.0,0.7332446493500774,1.0,18/55,21.74%,METTL8;LCMT2;TFB2M;TYW3;TFB1M;FTSJ1;NSUN6;ZCCHC4;TRMT61A;CBLL1;MTO1;NSUN3;FBL;TRMT5;VIRMA;NSUN2;RBM15;MEPCE
prerank,CellMarker_Augmented_2021__Stromal cell:Amniotic Membrane,-0.6274906078287101,-1.4637954269238513,0.03896103896103896,0.2585423299376931,1.0,23/84,17.53%,ANXA1;SOCS3;RFTN1;AGPAT4;SPARC;ADAMTS10;COL6A2;ITGA5;PDCD1LG2;CCL2;TIMP1;IFFO1;CMTM3;CDC42EP3;IGFBP7;ITPRIP;GNG2;STK32B;SRGN;TLN1;EMP3;DOCK10;ETS1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.923565093864398,1.4637352865778674,0.027777777777777776,0.7306148962333995,1.0,1/7,0.12%,SPSB4
prerank,KEGG_2021_Human__Mannose type O-glycan biosynthesis,0.642249790732331,1.4635356697047897,0.025,0.7277072214355735,1.0,8/20,17.17%,FUT9;CRPPA;POMK;FKRP;MGAT5B;POMT2;B3GAT2;B4GALT3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.7702725561963029,-1.4633854509836708,0.028169014084507043,0.259306469653587,1.0,5/18,5.91%,APLNR;RAMP3;CEMIP;THY1;TRPC3
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.6712018579891362,-1.463235776274229,0.02666666666666667,0.2589805708819745,1.0,10/37,13.64%,SLC6A15;SLC25A45;PDPN;SLC38A4;SLC7A14;SLC3A1;SLC7A2;SLC43A2;SLC38A11;SLC38A1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.6403431754171147,-1.462887597121832,0.04054054054054054,0.259315795108535,1.0,10/43,12.78%,THBS1;RASGRP1;TLR2;APP;TLR3;WNT5A;SYK;HLA-E;IFIH1;FADD
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.894112934945906,1.4628390789537473,0.045454545454545456,0.7281825602898927,1.0,3/5,9.12%,MOXD1;TYR;DCT
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.8228208048381129,-1.4625688728552633,0.05172413793103448,0.2600957056186727,1.0,1/8,0.33%,THBS1
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Adipose Tissue,-0.6888585364838744,-1.4620811424960716,0.0136986301369863,0.26134038490179123,1.0,28/58,18.20%,GGT5;APLNR;SPARC;ABCA8;RAMP3;BGN;DYSF;PODN;MYH11;GALNT15;IGFBP7;SELP;BMX;CFH;RNASE1;PCDH12;MMRN2;ROBO4;ADAMTS4;MCAM;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Urine-derived Stem cell:Urine,-0.8460589433218365,-1.461781093195994,0.01639344262295082,0.26211131192618076,1.0,3/12,7.03%,CD24;THY1;CD44
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.79290404788331,1.461756711802984,0.02631578947368421,0.7331383246924934,1.0,3/8,6.17%,ACP3;TMEM100;SCN11A
prerank,Reactome_2022__Multifunctional Anion Exchangers R-HSA-427601,0.8211383955611464,1.4616763222719231,0.06666666666666667,0.7294798230387919,1.0,3/7,14.18%,SLC26A7;SLC26A3;SLC26A2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.7154499415725571,-1.4616066320593921,0.0,0.2619923298002819,1.0,7/29,13.03%,SCN1B;ANK3;CAV3;YWHAH;GLRX;HECW2;SCN3B
prerank,Reactome_2022__Nucleotide-like (Purinergic) Receptors R-HSA-418038,-0.8215662250176702,-1.461245520834806,0.015384615384615385,0.262688008775177,1.0,7/10,12.84%,P2RY13;P2RY6;P2RY12;P2RY14;LPAR6;LPAR4;P2RY10
prerank,KEGG_2021_Human__mRNA surveillance pathway,0.5006722893705147,1.4604576744802937,0.0,0.7329968897118445,1.0,13/81,13.72%,NXT2;PABPC1L;WDR82;NUDT21;WDR33;CSTF3;CPSF6;PAPOLA;CPSF7;NXT1;PPP2R5A;PPP1CC;SMG7
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.6998860951133385,1.460298912830365,0.13513513513513514,0.7300338800382943,1.0,5/14,18.19%,PRKRA;DROSHA;AGO3;TSN;CLP1
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.7228819099665892,-1.4601384539310258,0.04918032786885246,0.26579315333195447,1.0,10/25,17.69%,C3;C1R;HLA-DRA;CD55;CFH;C1S;SUSD4;SERPING1;HLA-DRB1;CR1L
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.8790642812759457,-1.4598990808259655,0.05263157894736842,0.26610565013410825,1.0,3/9,5.98%,ANXA1;MSMP;CCL2
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,-0.5894086113749563,-1.4598971678958226,0.013888888888888888,0.2654469727822911,1.0,12/50,17.58%,CACNA1H;ADCY7;ITPR3;LDLR;CREB5;CACNA1C;ADCY5;CYP21A2;NR4A1;ADCY3;ADCY8;CREB3
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.9112829244300596,1.4595989876729871,0.02564102564102564,0.725971549032422,1.0,1/5,3.41%,PASK
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.9112829244300596,1.4595989876729871,0.02564102564102564,0.725971549032422,1.0,1/5,3.41%,PASK
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Venous Blood,-0.6474071107283028,-1.4595914747976042,0.012658227848101266,0.26591998665698485,1.0,5/69,3.77%,CD24;ST6GAL1;KCNQ1;PTP4A3;TJP3
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.8627082211807936,1.4594112513494362,0.0,0.722914805469507,1.0,2/9,3.70%,DGKB;DGKE
prerank,Reactome_2022__Erythropoietin Activates RAS R-HSA-9027284,0.7293430504614731,1.459373799811428,0.029411764705882353,0.7194805797570135,1.0,3/13,3.80%,EPOR;NRAS;EPX
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.7707811671993765,-1.4588091058940356,0.06060606060606061,0.2683892896212117,1.0,4/13,10.15%,HPN;LMO2;GATA1;CTSS
prerank,KEGG_2021_Human__Antigen processing and presentation,-0.649480371212244,-1.4579869521252575,0.039473684210526314,0.27059438032034006,1.0,15/42,19.85%,B2M;CIITA;HLA-A;HLA-C;HLA-DRA;CTSS;HLA-B;HLA-E;HLA-F;CD74;HLA-DRB1;PSME1;HSPA5;CD4;PDIA3
prerank,Reactome_2022__Interleukin-6 Signaling R-HSA-1059683,-0.8052552117852725,-1.456928999286359,0.017241379310344827,0.27418312319161287,1.0,2/10,9.67%,SOCS3;STAT1
prerank,CellMarker_Augmented_2021__Central Nervous System Stem cell:Fetal Brain,-0.6630182794597361,-1.4566759168622445,0.02666666666666667,0.2743565016591964,1.0,18/50,13.38%,CD24;CP;ABO;APLNR;P2RY14;RAMP3;IGHG1;SLA;ITM2A;HLA-DRA;CEACAM1;MYH11;F13A1;RASGEF1B;SELP;LDLRAD4;RNASE1;ITGA9
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.631607785311224,1.4565084460692888,0.047619047619047616,0.7334037872715576,1.0,15/40,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;RAE1;AAAS;NUP188;EP300;NUP205;JMJD8;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.7546365936979087,1.4563560563618645,0.0625,0.7305872376180622,1.0,2/10,1.65%,VEGFD;VEGFC
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.8998233099285501,1.4559303480197214,0.0392156862745098,0.7290651203259287,1.0,1/5,1.63%,BMP2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.8111539419581433,-1.455855606612498,0.0,0.2766901429517343,1.0,4/13,11.30%,HPN;PIEZO2;LHFPL5;SCN1A
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.5512352877959832,1.4556521649871241,0.0,0.7266996655734265,1.0,19/61,20.91%,LCMT2;THUMPD1;ADAT2;TYW3;FTSJ1;PUS10;TPRKB;NSUN6;TRIT1;TRMT61A;DTWD1;DTWD2;THG1L;TRMT1;MTO1;ANKRD16;TRMT5;NSUN2;CDKAL1
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.7291896782268545,-1.455194263923477,0.014492753623188406,0.27839971294820165,1.0,5/25,10.73%,CENPV;KIF14;HTR2B;SVIL;FGF1
prerank,CellMarker_Augmented_2021__Follicular Dendritic cell:Spleen,-0.6976382123691491,-1.4548099624665658,0.03125,0.2789238038162074,1.0,14/27,21.37%,MYO1F;TAGAP;ARHGAP9;IGSF6;CLEC12A;WAS;LAT2;SCIMP;CD37;WDFY4;PSTPIP1;NAPSB;SPI1;PTPRC
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.7062032098311931,-1.4545879345046138,0.029411764705882353,0.27906144115999365,1.0,12/27,18.00%,ANXA1;NPY;CHRM1;HTR2B;CCL2;CHRM3;HRH1;CNR1;HTR1E;HTR2C;CHRM5;HTR2A
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.7600072646498122,-1.4545587012169712,0.04918032786885246,0.27852255202144294,1.0,6/18,18.26%,TMEM204;ITGA5;DAB2IP;MMRN2;PRKCB;NIBAN2
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.5374464831066589,1.4544419374858701,0.05555555555555555,0.7292565284396788,1.0,19/73,20.89%,NUP42;U2AF1;NUP37;NUP54;WDR33;EIF4E;NDC1;NUP214;NXT1;AAAS;NUP188;THOC3;NUP205;THOC1;NUP210;NUP85;CPSF2;NUP153;NUP50
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.5897551128575216,1.454277891148046,0.06060606060606061,0.7268570961768871,1.0,16/39,27.75%,SMARCAD1;ERCC6;HNRNPC;RBBP4;HDAC2;SMARCA2;MBD3;CHD4;ACTR6;PBRM1;MTA2;SMARCC1;ARID1B;INO80;VPS72;CHD8
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.8708098129559585,1.454244014011336,0.0625,0.7235228569782247,1.0,1/7,0.65%,ASCL1
prerank,CellMarker_Augmented_2021__B cell:Bone Marrow,-0.9359008841263543,-1.4541647546345007,0.0,0.27919987931295726,1.0,2/5,2.29%,CD24;LMO2
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Germ,-0.8498212945610129,-1.4541515497122388,0.016666666666666666,0.2785511461646889,1.0,2/10,4.35%,CD24;PODXL
prerank,KEGG_2021_Human__Allograft rejection,-0.7929936052277797,-1.4541241913413783,0.09259259259259259,0.27799499101361447,1.0,8/13,16.36%,HLA-A;IL12A;HLA-C;HLA-DRA;HLA-B;HLA-E;HLA-F;HLA-DRB1
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.6483253440710199,-1.4540916138739992,0.0,0.2775307494243474,1.0,8/63,8.03%,GGT5;GBP2;GBP1;ZFP36;YBX3;CCL2;BRCA1;CHI3L1
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.8952088895901109,-1.4540650156899528,0.018867924528301886,0.2769129046268351,1.0,3/7,10.39%,COL4A2;ITGA2;ITGA11
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.5365692376592589,1.4535670203675801,0.0,0.7239812599057531,1.0,15/75,15.95%,DIRAS3;KDM1B;KAT2B;EED;ERCC6;DNMT3B;SMYD5;RBBP4;POLR1F;PPHLN1;KAT2A;DDX21;TASOR;AEBP2;EP300
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.989592356741407,-1.453449460801596,0.0,0.2788517931565325,1.0,1/5,0.05%,CD24
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,-0.6898720800905794,-1.4533545707283155,0.030303030303030304,0.27847744107120426,1.0,8/32,11.70%,ABO;B3GALT2;A4GALT;B4GALNT1;FUT2;ST3GAL6;B3GNT5;B3GNT2
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.7730318605754752,-1.4531466427505968,0.015384615384615385,0.2784363876794082,1.0,2/22,1.94%,MET;ICAM1
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.7842689663078452,-1.4527292732327777,0.06666666666666667,0.2791452074656663,1.0,2/15,6.99%,NEFL;HAP1
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.8086613901816876,-1.4524560579199564,0.08064516129032258,0.27938873875694203,1.0,1/13,0.69%,NPY
prerank,CellMarker_Augmented_2021__Fibroblast:Pancreas,-0.6081110083512226,-1.4523871729059894,0.0,0.27901664658394526,1.0,23/95,13.52%,KCNT2;COL4A1;ANGPTL2;SPARC;CALD1;COL4A2;STMN2;COL5A1;SULF1;THY1;BGN;MAP1B;GRIA3;CSMD2;GAP43;EDIL3;THBS2;PCDHB5;C11ORF87;IGFBP5;PRRX1;CRMP1;NLGN1
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.765119531917081,-1.452322846159089,0.05714285714285714,0.27873387775104075,1.0,1/18,0.02%,ENPP2
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.806144452897067,1.4522429497073879,0.023255813953488372,0.7278412313285684,1.0,2/6,9.17%,NLGN3;ATP1A2
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.7176401006226059,-1.4521568089723356,0.029850746268656716,0.2787145473566978,1.0,2/31,6.51%,GGT5;GSTM5
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.7048385441385245,1.4520558487918118,0.05128205128205128,0.7255513482305387,1.0,7/12,28.35%,ZNF304;TRIM28;PPHLN1;TASOR;RESF1;SETDB1;ATF7IP
prerank,CellMarker_Augmented_2021__Stem cell:Eye,-0.9247126843411135,-1.45146864737119,0.041666666666666664,0.2803732757533718,1.0,2/5,7.03%,THY1;CD44
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.8050276395210783,-1.4512265111642098,0.0625,0.2805458830501392,1.0,3/15,5.06%,KLF2;NOS1AP;KLF4
prerank,KEGG_2021_Human__Cocaine addiction,-0.663272155809397,-1.4511407527963522,0.02702702702702703,0.28026218826110777,1.0,10/40,14.45%,GRIN2D;FOSB;GRIN3A;MAOB;GRIN2A;SLC18A2;CREB5;ADCY5;GRIN2B;BDNF
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.6093141450668583,1.4507260261196375,0.0,0.731190661519947,1.0,10/31,16.99%,SAMM50;MAIP1;CHCHD3;TMEM11;OPA1;SLC25A5;DNAJC11;APOOL;BAD;MTX2
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8675210341914944,1.4505383455142893,0.041666666666666664,0.7287967023496182,1.0,1/5,0.30%,ACE2
prerank,KEGG_2021_Human__Staphylococcus aureus infection,-0.7328021490167077,-1.4503621632137682,0.05970149253731343,0.28268482431603115,1.0,8/21,16.36%,C3;C1R;ICAM1;HLA-DRA;SELP;CFH;C1S;HLA-DRB1
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Liver,-0.6181153166723882,-1.450246862278264,0.0,0.2825270318096668,1.0,26/70,18.20%,ENPP2;APLNR;ABCA6;ABCA8;RAMP3;COLEC12;PLN;LDB2;MYH11;ITGA8;CACNA1C;HECW2;ELMO1;RNASE1;ITGA9;RASL12;MMRN2;ADAMTS4;CD200;TEK;SHROOM4;MRC1;ADGRF5;ANGPT2;ITIH5;A2M
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.7319925788655234,-1.4500185304316404,0.015384615384615385,0.2829084721574503,1.0,3/23,5.61%,ABCA5;ABCA8;ABCA12
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.702497261766846,-1.4493486078872302,0.04,0.28496441598611916,1.0,7/29,13.03%,SCN1B;PKP2;ANK3;ATP1A1;YWHAH;NOS1;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.7951662669517496,-1.4490719954619249,0.057971014492753624,0.28529561715197466,1.0,5/15,11.79%,IL1R1;B2M;HLA-A;CD55;IL18
prerank,Reactome_2022__RUNX3 Regulates WNT Signaling R-HSA-8951430,-0.8927974998187866,-1.4486430058492992,0.03571428571428571,0.2864809769944392,1.0,2/6,7.35%,LEF1;CCND1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.8074215922691576,-1.448470307713551,0.031746031746031744,0.28644436102732745,1.0,1/11,0.99%,MET
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Blood Vessel,-0.5829613358472138,-1.4481452047185221,0.0,0.2831467238010706,1.0,21/89,13.79%,COL4A1;ANGPTL2;SPARC;COL4A2;COL5A1;SULF1;THY1;LMOD1;BGN;MAP1B;SCARA3;GAP43;LDB2;EDIL3;THBS2;FGF1;SLIT3;IGFBP5;PRRX1;CRMP1;RASL12
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Pancreas,-0.5829613358472138,-1.4481452047185221,0.0,0.2831467238010706,1.0,21/89,13.79%,COL4A1;ANGPTL2;SPARC;COL4A2;COL5A1;SULF1;THY1;LMOD1;BGN;MAP1B;SCARA3;GAP43;LDB2;EDIL3;THBS2;FGF1;SLIT3;IGFBP5;PRRX1;CRMP1;RASL12
prerank,CellMarker_Augmented_2021__Fibroblast:Synovium,-0.5829613358472138,-1.4481452047185221,0.0,0.2831467238010706,1.0,21/89,13.79%,COL4A1;ANGPTL2;SPARC;COL4A2;COL5A1;SULF1;THY1;LMOD1;BGN;MAP1B;SCARA3;GAP43;LDB2;EDIL3;THBS2;FGF1;SLIT3;IGFBP5;PRRX1;CRMP1;RASL12
prerank,CellMarker_Augmented_2021__Testis Somatic cell:Testis,-0.5829613358472138,-1.4481452047185221,0.0,0.2831467238010706,1.0,21/89,13.79%,COL4A1;ANGPTL2;SPARC;COL4A2;COL5A1;SULF1;THY1;LMOD1;BGN;MAP1B;SCARA3;GAP43;LDB2;EDIL3;THBS2;FGF1;SLIT3;IGFBP5;PRRX1;CRMP1;RASL12
prerank,CellMarker_Augmented_2021__Retinal Ganglion cell:Embryonic Stem Cell,-0.5829613358472138,-1.4481452047185221,0.0,0.2831467238010706,1.0,21/89,13.79%,COL4A1;ANGPTL2;SPARC;COL4A2;COL5A1;SULF1;THY1;LMOD1;BGN;MAP1B;SCARA3;GAP43;LDB2;EDIL3;THBS2;FGF1;SLIT3;IGFBP5;PRRX1;CRMP1;RASL12
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Embryo,-0.5829613358472138,-1.4481452047185221,0.0,0.2831467238010706,1.0,21/89,13.79%,COL4A1;ANGPTL2;SPARC;COL4A2;COL5A1;SULF1;THY1;LMOD1;BGN;MAP1B;SCARA3;GAP43;LDB2;EDIL3;THBS2;FGF1;SLIT3;IGFBP5;PRRX1;CRMP1;RASL12
prerank,CellMarker_Augmented_2021__Fibroblast:Embryonic Stem Cell,-0.5829613358472138,-1.4481452047185221,0.0,0.2831467238010706,1.0,21/89,13.79%,COL4A1;ANGPTL2;SPARC;COL4A2;COL5A1;SULF1;THY1;LMOD1;BGN;MAP1B;SCARA3;GAP43;LDB2;EDIL3;THBS2;FGF1;SLIT3;IGFBP5;PRRX1;CRMP1;RASL12
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.9138452535759976,-1.4474666002661807,0.017543859649122806,0.28517227045192906,1.0,2/8,0.81%,RECQL4;BLM
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.8624353398546234,1.447245763818798,0.022727272727272728,0.745700854930218,1.0,4/8,12.91%,TOP3B;HMGB1;TOP1MT;ERCC3
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.7442575656210078,-1.4472398912892976,0.02666666666666667,0.28513932769164807,1.0,5/23,6.99%,P2RY6;APLNR;CEMIP;THY1;HAP1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8251446994185024,-1.4468630837880359,0.04918032786885246,0.28562817044893724,1.0,5/10,12.77%,TLR2;B2M;RPS27A;PGK1;UBC
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.8528316033264854,1.4463722657424884,0.05,0.7481647228529378,1.0,3/9,4.85%,BMP2;EFNB2;GREM1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.7628672961904892,-1.4463015813851505,0.013513513513513514,0.2869475888754645,1.0,2/20,1.14%,KCNQ1;NR4A3
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.7084044435865363,1.4458964518231232,0.08108108108108109,0.7480017587115197,1.0,1/13,1.17%,FAM47E
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.9087533833623477,-1.4456904443446048,0.037037037037037035,0.2889258528062536,1.0,2/6,0.78%,ANXA1;CDKN2A
prerank,Reactome_2022__Suppression Of Phagosomal Maturation R-HSA-9637687,-0.8190372760093664,-1.444705719336233,0.06153846153846154,0.2914963906737206,1.0,2/10,12.77%,RPS27A;UBC
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.8823931519057593,1.444144960808465,0.020833333333333332,0.7455026446909562,1.0,3/6,6.63%,ELOVL6;ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.8823931519057593,1.444144960808465,0.020833333333333332,0.7455026446909562,1.0,3/6,6.63%,ELOVL6;ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.8823931519057593,1.444144960808465,0.020833333333333332,0.7455026446909562,1.0,3/6,6.63%,ELOVL6;ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.8823931519057593,1.444144960808465,0.020833333333333332,0.7455026446909562,1.0,3/6,6.63%,ELOVL6;ELOVL4;ELOVL2
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.5463996819605701,-1.4441117548779911,0.0,0.2930628669488708,1.0,86/326,18.85%,CP;C3;SERPINA10;CHGB;RPL19;RPL3;LAMB1;RPS27A;WARS1;RPS27;SFTPD;RPS14;RPS4X;PHEX;RPL27A;RPL35;APP;ATP23;RPL7A;DENND3;RPL37A;RPL27;TIMP1;RPL9;SERPIND1;RPL21;NOTUM;RPL13A;ST3GAL6;FAM20C;IGF1;CHRM3;RPS11;RPS16;RPL24;RPLP1;IGFBP7;RPS13;USP6;RPL38;DAB2IP;FN1;RPS3A;SHISA5;BAP1;RPS8;RPL10A;RPL10;PRSS23;RPLP2;RPS23;IGFBP5;SEC11C;RPS21;RPS7;RPS18;GPC3;RPL8;F5;RPS6;RPS15;B4GALT7;RPS9;UBE2S;TMEM208;RPL12;APH1A;RPL5;PLAT;EEF1A2;ITIH2;RPL23;RPL4;PIGH;FBXL2;SPP1;RPL18A;RPL41;LTBP1;RPL7;RPS12;RPS20;COPS5;PAPPA;TF;MRPL23
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.7876328138369711,1.4439162420220168,0.06060606060606061,0.7438198758712375,1.0,3/9,6.17%,ACP3;TMEM100;SCN11A
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.6654785165798089,1.4435910775325922,0.08108108108108109,0.7423109235537836,1.0,10/25,16.31%,SAMM50;DMAC2L;LETM1;CHCHD3;ATP5PB;ATP5MC2;DNAJC11;ATP5MC1;APOOL;ATP5F1A
prerank,CellMarker_Augmented_2021__Mast cell:Undefined,-0.8353497138797843,-1.4435119046304108,0.015873015873015872,0.2945398730667564,1.0,1/9,0.05%,CD24
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.7721672301404241,-1.4434266984705215,0.02857142857142857,0.2940749771145118,1.0,5/14,11.40%,LEF1;ZFPM1;PRKCQ;SYK;HLA-E
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.7035351911464363,-1.443390745364028,0.013157894736842105,0.29357104154252683,1.0,4/28,3.30%,CP;B2M;SLC39A14;TMC8
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.7526171973099727,1.4431861424187766,0.045454545454545456,0.7411832810917878,1.0,3/10,16.63%,BMP2;NFKB1;ERLIN1
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR4 R-HSA-5654716,0.7112863528157309,1.44313233024694,0.1,0.7379766300904275,1.0,2/17,3.57%,FGF6;NRAS
prerank,CellMarker_Augmented_2021__M2 macrophage:Lung,-0.6979027860167746,-1.4428200491342364,0.015151515151515152,0.2949961949742278,1.0,15/30,20.36%,TYMP;TLR2;GPR34;SIGLEC1;HLA-DRA;IGSF6;CLEC12A;CTSS;CLEC5A;MSR1;MRC1;SLC7A7;CD4;C1QB;SPI1
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Heart,-0.8370940604640642,-1.4422408078824578,0.017241379310344827,0.29647645884899154,1.0,2/9,3.82%,FABP3;KCNJ2
prerank,Reactome_2022__Arachidonic Acid Metabolism R-HSA-2142753,-0.6749455302535898,-1.4421892026251386,0.012345679012345678,0.2962767107375786,1.0,6/36,10.43%,GGT5;AWAT1;ALOX12;CYP1B1;FA2H;CYP4F22
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.7249779299918795,-1.4421362859090725,0.045454545454545456,0.2958130978466668,1.0,8/15,16.36%,HLA-A;IL12A;HLA-DRA;HLA-B;HLA-E;FADD;HLA-F;HLA-DRB1
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),-0.9101887450958123,-1.4420802312077794,0.0,0.2952905449925346,1.0,3/7,8.80%,THBS1;ANK3;FBP1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.8620734352526868,-1.4409385265824122,0.0,0.29939315722994125,1.0,1/7,0.02%,ENPP2
prerank,Reactome_2022__N-Glycan Antennae Elongation R-HSA-975577,-0.8039401611836716,-1.4408945517793788,0.0,0.29888533742561013,1.0,1/14,0.17%,ST6GAL1
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.8315472903689625,1.44083374832264,0.09523809523809523,0.7483182093587109,1.0,1/8,0.48%,DAO
prerank,Reactome_2022__PI-3K cascade:FGFR1 R-HSA-5654689,0.7021198659187995,1.4402942954185018,0.10526315789473684,0.7480067116308132,1.0,1/13,0.16%,FGF6
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.586981107788801,-1.4402011101652905,0.0,0.30068115627454417,1.0,54/151,18.41%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;LDB2;RPL9;PSMB9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;PSMB6;RPL38;SLIT3;RPS3A;RPS8;RPL10A;PSMC3;RPLP2;RPS23;RPS21;RPS7;UBC;RPL8;RPS6;ELOB;RPS15;RPL26L1;RPS9;PSMA8;RPL12;RPL5;PSMA7;FAU;RPL23;RPL4;PSME1;RPL18A;RBX1;RPL41;RPL7;RPS12;RPS20
prerank,Reactome_2022__AMPK Inhibits chREBP Transcriptional Activity R-HSA-163680,0.8537494889426299,1.4399172157158344,0.08695652173913043,0.7473373864997871,1.0,1/7,3.54%,ADIPOR1
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,-0.7154400214527686,-1.4397678313148274,0.02631578947368421,0.3018648837051243,1.0,2/27,6.51%,GGT5;GSTM5
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.813416105133415,-1.4393792609264628,0.029411764705882353,0.3025409824811906,1.0,2/16,5.68%,S100A10;THY1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.7917557652406809,-1.439222578809475,0.014925373134328358,0.30249209152746753,1.0,5/15,13.21%,RASGRP1;IL12A;CD160;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.7501869650573124,1.4385511944475393,0.07692307692307693,0.7520595274883222,1.0,5/13,20.52%,EIF3E;EIF2AK4;EIF4EBP2;C8ORF88;EIF4EBP1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.9150912734193664,-1.4384996093861258,0.038461538461538464,0.30486519934529066,1.0,2/5,3.94%,THBS1;ATF3
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.7356877364004963,-1.438332070883449,0.04411764705882353,0.3047715970120744,1.0,3/21,6.70%,CENPV;KIF14;SVIL
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Deciduous Tooth,-0.6661934203552935,-1.4379783600825184,0.0,0.3054556354916067,1.0,25/56,18.20%,GGT5;APLNR;ABCA6;ABCA8;RAMP3;PLXDC1;PLN;PODN;MYH11;SELP;AEBP1;CFH;RNASE1;PCDH12;MMRN2;ROBO4;MCAM;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.6209825583623104,-1.4375842801664207,0.02531645569620253,0.3062759642706578,1.0,11/68,3.86%,HPN;ALDOB;GRAMD2A;THSD4;PROX1;GC;ABCA8;S100A6;MATN2;MAOB;BHMT
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.7210183415310552,-1.4375687843014844,0.043478260869565216,0.3056640021749046,1.0,3/24,5.06%,KLF2;NOS1AP;KLF4
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.7091913990858915,-1.4373674433436383,0.014705882352941176,0.3057675219283901,1.0,3/23,1.53%,THBS1;GPR183;P2RY12
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.6347912205081168,1.4372856950313673,0.06060606060606061,0.7556668966101491,1.0,12/23,29.27%,VCP;AUP1;UGGT1;DERL1;POMT2;FBXL17;ZYG11B;UGGT2;KLHL15;NGLY1;RNF5;YME1L1
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,0.5523140090375966,1.436909965920458,0.08571428571428572,0.75426061068148,1.0,11/39,15.03%,LCMT2;ADAT2;TYW3;FTSJ1;TP53RK;NSUN6;ADAT1;TRIT1;TRMT61A;TRMT11;THG1L
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.655061717569994,-1.4368293506912988,0.014285714285714285,0.30709574532119677,1.0,5/36,8.73%,KLF2;APP;KLF4;LDLR;LTBP4
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.6881003307364827,1.4367441997367099,0.10526315789473684,0.7513994027520604,1.0,6/17,16.65%,HSPA1A;PLK1;CEP97;CHMP2B;HNRNPU;VPS4B
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.6135082086888154,1.4366366923333647,0.0,0.748765138954443,1.0,13/33,21.77%,TFB2M;PTCD3;FASTKD2;GATC;MRPS2;QRSL1;GFM2;MRPS7;MRPS14;LARS2;MRPL47;NOA1;MRPS11
prerank,CellMarker_Augmented_2021__Inflammatory cell:Muscle,-0.6879222269351035,-1.436266522905303,0.0410958904109589,0.30670967107255886,1.0,12/38,13.56%,GGT5;SLA;SIGLEC1;GAB3;HLA-DRA;MYH11;F13A1;SELP;ELMO1;RNASE1;PCDH12;APOL3
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Subcutaneous Adipose Tissue,-0.6879222269351035,-1.436266522905303,0.0410958904109589,0.30670967107255886,1.0,12/38,13.56%,GGT5;SLA;SIGLEC1;GAB3;HLA-DRA;MYH11;F13A1;SELP;ELMO1;RNASE1;PCDH12;APOL3
prerank,CellMarker_Augmented_2021__Endothelial cell:Lymph Node,-0.6879222269351035,-1.436266522905303,0.0410958904109589,0.30670967107255886,1.0,12/38,13.56%,GGT5;SLA;SIGLEC1;GAB3;HLA-DRA;MYH11;F13A1;SELP;ELMO1;RNASE1;PCDH12;APOL3
prerank,CellMarker_Augmented_2021__Immature Endothelial cell:Subcutaneous Adipose Tissue,-0.6879222269351035,-1.436266522905303,0.0410958904109589,0.30670967107255886,1.0,12/38,13.56%,GGT5;SLA;SIGLEC1;GAB3;HLA-DRA;MYH11;F13A1;SELP;ELMO1;RNASE1;PCDH12;APOL3
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.9268418186635626,-1.4361520353823143,0.0,0.30525605173640497,1.0,1/5,0.41%,SLC28A2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.9268418186635626,-1.4361520353823143,0.0,0.30525605173640497,1.0,1/5,0.41%,SLC28A2
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.9268418186635626,-1.4361520353823143,0.0,0.30525605173640497,1.0,1/5,0.41%,SLC28A2
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Brain,-0.6886976543689803,-1.4355867155903985,0.028985507246376812,0.3066020656757037,1.0,15/44,17.71%,GGT5;APLNR;LMO2;RAMP3;SIGLEC1;DYSF;SELP;RNASE1;PCDH12;FES;MMRN2;ROBO4;TEK;MRC1;ADGRF5
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.696513714897653,1.4354311723456528,0.11764705882352941,0.7523733926581091,1.0,2/11,4.15%,WNT7A;NLGN3
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.8777441150683696,-1.4351696500003197,0.04918032786885246,0.30745771730998817,1.0,1/8,2.05%,ABCA5
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood,-0.6521912746248247,-1.4350459169393768,0.013888888888888888,0.3073809996379065,1.0,25/53,19.05%,TRIM22;RFTN1;GBP1;GPR183;TAGAP;EVI2A;SLA;GAB3;NLRC5;HLA-DRA;IFFO1;CMAHP;RCSD1;GNG2;ELMO1;APOL3;SP140;SRGN;CD74;MCAM;DOCK10;ETS1;SYNE3;WDFY4;SAMD9L
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.5688664606541062,1.43484456649769,0.06896551724137931,0.7532534230416805,1.0,9/36,19.94%,NXT2;RITA1;SNRPF;XPO1;NXT1;AAAS;NUP205;GEMIN4;MALT1
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.8538117555625058,-1.4347955303170254,0.03508771929824561,0.30745908228137514,1.0,2/7,9.67%,IFIT1;STAT1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.8644288821407026,1.4347689724158175,0.14,0.7505959740144756,1.0,5/7,12.57%,NUDT16L1;ERCC6;HSF1;CYREN;TFIP11
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Pancreas,-0.8867341820382713,-1.4343582138812254,0.04,0.30857744565813505,1.0,5/7,10.74%,CD24;MET;THY1;CD44;LGR5
prerank,Reactome_2022__MET Activates RAS Signaling R-HSA-8851805,0.817484319831179,1.4341972281232112,0.025,0.7512285910383558,1.0,2/9,3.57%,MUC20;NRAS
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.6201163141729071,-1.4341949956285631,0.0,0.30863350871203565,1.0,11/82,11.78%,CD24;IFI6;POU4F1;HIC1;BRCA1;CYP1B1;PDK1;MLLT11;SCN2A;DAB2IP;BCL2L2
prerank,CellMarker_Augmented_2021__Endothelial cell:Heart,-0.6635468551741995,-1.434177338748863,0.0,0.30803684260206576,1.0,27/58,18.20%,GGT5;APLNR;ANO2;RAMP3;SIGLEC1;COX7A1;DYSF;LDB2;APOD;MYH11;F13A1;SELP;BMX;RNASE1;PCDH12;ITGA9;RASL12;MMRN2;ROBO4;SERPING1;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;A2M
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.6691634686133202,-1.433965427053826,0.03225806451612903,0.3081703923818013,1.0,8/29,15.81%,CDKN2A;B2M;IL15;ARG2;WNT5A;IFIH1;PRKCD;ECHDC3
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.8735555229408553,1.4333751735153728,0.0784313725490196,0.7529399247658601,1.0,1/6,0.65%,ASCL1
prerank,CellMarker_Augmented_2021__Osteocyte:Bone,-0.8690953649295656,-1.4332165022660568,0.016129032258064516,0.310501329883409,1.0,6/7,11.27%,SPARC;PDPN;PHEX;BGN;CD44;FN1
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.8157018447725491,-1.432918986278751,0.08333333333333333,0.31110612844431523,1.0,1/10,1.91%,B2M
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.5525779541600502,-1.43273350178718,0.0,0.3111183899118437,1.0,53/268,16.48%,OPTC;COL8A1;COL4A1;MYO1F;COL4A2;B2M;STMN2;COL5A1;RPS27A;NEFL;RHOBTB2;COL4A4;KIF14;POF1B;MYO15A;COL27A1;COL6A2;CLRN1;APP;SCX;LMOD1;COL24A1;RND2;CYP1B1;GFAP;PLK3;MYH11;COL11A2;P4HA2;NLRP5;P3H2;COL10A1;P4HA3;STMN4;RHOF;DCTN1;KIF2C;TPM4;MYO1E;CORO7;ELMO1;UBC;EMP2;PPIB;B4GALT7;TLL1;APH1A;LAMA3;STMN1;ITGB4;COL12A1;RHOD;COL9A2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tooth,-0.8514964687963527,-1.4324613869116243,0.04838709677419355,0.3114535283668092,1.0,2/8,5.68%,CD24;THY1
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,-0.7103112080511716,-1.432446277101376,0.07462686567164178,0.3108963211110501,1.0,4/23,11.27%,RASGRP1;RASGRP2;SYK;FN1
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.7208209468206457,1.4324372554258777,0.05405405405405406,0.7543910953561318,1.0,5/13,14.93%,ZNF304;TRIM28;SIRT6;PPHLN1;TASOR
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,0.6723329855178266,1.4324171844063274,0.10526315789473684,0.7511882673737742,1.0,8/19,19.94%,MAML3;KAT2B;NOTCH2;KAT2A;EP300;HEY1;HEY2;HES5
prerank,Reactome_2022__HuR (ELAVL1) Binds And Stabilizes mRNA R-HSA-450520,-0.8847752050074761,-1.4320432682943793,0.05454545454545454,0.312025133311433,1.0,1/8,0.02%,ENPP2
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.7658450452359286,-1.431915623654824,0.08333333333333333,0.3118655120715987,1.0,3/15,5.93%,C3;APP;SRRM4
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.7401342185745343,-1.4318541616557183,0.03333333333333333,0.3114427449481543,1.0,4/16,12.29%,P2RY6;NR4A3;IGF1;IGFBP5
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),-0.8919474928864237,-1.4313123560847083,0.01639344262295082,0.31249771866043496,1.0,1/5,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),-0.8919474928864237,-1.4313123560847083,0.01639344262295082,0.31249771866043496,1.0,1/5,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.6688900533928126,1.4311139461129525,0.13157894736842105,0.7558452729162158,1.0,8/12,29.64%,KAT2B;NAA30;NAA11;EP300;NAA50;NAA25;NAA15;NAA35
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.7348487495971214,-1.4304938538421312,0.03225806451612903,0.31503536249451647,1.0,3/20,5.98%,CXCL2;ANXA1;CCL2
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.9155472122728082,-1.4304696361857143,0.02,0.3144974849106931,1.0,1/6,0.05%,CD24
prerank,CellMarker_Augmented_2021__Granulocyte:Blood,-0.6693750248292364,-1.4295951024163038,0.058823529411764705,0.3174127080015377,1.0,10/31,10.12%,TSPAN16;MYO1F;NLRP12;GFI1B;IGSF6;SLC26A8;CLEC12A;CA1;LAT2;SCIMP
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.5823066098385317,-1.4295335020950364,0.012195121951219513,0.3170025482562252,1.0,40/129,17.72%,ECM2;IL1R1;ANGPTL2;C3;C1R;TLR2;SERPINF1;ABCA8;MAOB;ASPN;COX7A1;COL6A2;LMOD1;BGN;TRIP10;RSPO3;PODN;CYP1B1;TIMP1;OLFML1;SRPX2;THBS2;IGFBP7;EPSTI1;APOL6;COPZ2;CFH;F10;C1QTNF1;FGF7;C1S;ROBO4;SERPING1;PLAC9;TNS2;STAT6;PXDC1;FMO2;ADGRF5;AQP1
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of CaMKII/CaMKK/CaMKIV Cascasde R-HSA-442729,0.7508867856049481,1.4294764210326043,0.0625,0.7606077955495231,1.0,2/8,18.13%,KPNA2;CAMK4
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.6048874728679978,-1.4289550699469649,0.05194805194805195,0.31852628660126553,1.0,16/62,11.40%,GBP2;TLR2;SFTPD;HLA-A;IL12A;COLEC12;NOD1;TLR3;GBP7;TNFRSF14;ISG15;LYG1;ROMO1;SYK;SELP;HLA-E
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.9371724266912052,-1.4289135445811976,0.017543859649122806,0.31807845878761154,1.0,2/5,5.16%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.6655680039653874,1.4285096948751297,0.07142857142857142,0.7639792324728606,1.0,4/21,9.61%,LIG4;MEN1;HSF1;ATR
prerank,Reactome_2022__Regulation Of IFNA/IFNB Signaling R-HSA-912694,-0.7724972966688625,-1.4275803085409333,0.05172413793103448,0.32296205928750277,1.0,2/9,9.67%,SOCS3;STAT1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.731969307188599,-1.4273099827076141,0.029850746268656716,0.32346761393696627,1.0,8/20,17.19%,RFTN1;LAT2;SYK;BMX;BLNK;PIK3CD;SH2B2;PRKCB
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.749886671002659,1.427283395985212,0.10344827586206896,0.7677543649775358,1.0,4/9,15.99%,SLC2A5;DRD2;SPX;GPR37L1
prerank,Reactome_2022__Chemokine Receptors Bind Chemokines R-HSA-380108,-0.8085974626269634,-1.4272061513729415,0.017241379310344827,0.32312327128913293,1.0,3/13,5.98%,CXCL2;ACKR4;CCL2
prerank,CellMarker_Augmented_2021__Keratinocyte Progenitor cell:Skin,-0.6425327570061257,-1.427201465294194,0.0125,0.3225043435146639,1.0,26/63,17.72%,ECM2;C3;APLNR;C1R;ABCA8;RAMP3;ASPN;TLR3;OMD;APOD;MYH11;EMP1;IGFBP7;ADIRF;CFH;SLCO2A1;RNASE1;MMRN2;C1S;ROBO4;ITGB4;FMO2;TEK;MRC1;ADGRF5;AQP1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.7074149596494167,-1.4271735636676723,0.045454545454545456,0.3219796525585326,1.0,10/25,13.03%,SCN1B;KCNQ1;PKP2;KCNJ2;GJC1;ATP1A1;CAV3;CACNA1C;SCN1A;SCN3B
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.8098995452889296,1.4271270815238257,0.06818181818181818,0.7655670894961174,1.0,3/7,16.65%,VCP;CHMP2B;VPS4B
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.8680127279415957,-1.4269386813656242,0.0,0.32248316435560137,1.0,4/6,8.45%,KCNJ2;CAV3;C12ORF57;SLC8A3
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.8052909312072047,1.426841285006864,0.075,0.7638268290651409,1.0,3/8,13.51%,SPRED1;SPRY1;SPRED2
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.6703478159693513,1.4266994849679686,0.0975609756097561,0.7614371563855193,1.0,4/15,10.95%,MGAM;PGM2;AGL;PYGM
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.8392846979356198,-1.4265903612648203,0.0851063829787234,0.32366135829549203,1.0,3/6,15.76%,CCL2;PRKCH;PRKCD
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.92099214021424,-1.4259041663808332,0.017241379310344827,0.32585706580013174,1.0,2/7,0.81%,RECQL4;BLM
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.8404804477379226,-1.4256210875607487,0.03125,0.32607680554030055,1.0,2/11,1.34%,RASGRP1;DOCK8
prerank,Reactome_2022__Endosomal/Vacuolar Pathway R-HSA-1236977,-0.8145037830924431,-1.425501370665557,0.0,0.32591388609571253,1.0,7/10,13.21%,B2M;HLA-A;HLA-C;CTSS;HLA-B;HLA-E;HLA-F
prerank,Reactome_2022__Digestion R-HSA-8935690,0.8118895522400303,1.4245046360005926,0.043478260869565216,0.7715359014389621,1.0,3/8,3.42%,MGAM;CEL;AMY2B
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.749119225192789,1.4242137453969592,0.05555555555555555,0.7701217696116958,1.0,3/10,11.98%,SOX9;NUDT21;SOX5
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.6890200627407286,1.4241121571626265,0.12195121951219512,0.767454675679171,1.0,7/16,20.58%,RTRAF;TSEN2;TSEN15;ZBTB8OS;CLP1;ERN1;TRPT1
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.8416351645579373,1.4238153399064954,0.05405405405405406,0.7656025169174305,1.0,1/5,0.33%,SLC2A5
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.7901975144079205,-1.4237570561652284,0.016666666666666666,0.3325743836570035,1.0,3/13,7.62%,ZFP36;IFITM3;HEXIM1
prerank,Reactome_2022__P2Y Receptors R-HSA-417957,-0.830830443449662,-1.4235363603229432,0.03076923076923077,0.33292468374666606,1.0,7/8,12.84%,P2RY13;P2RY6;P2RY12;P2RY14;LPAR6;LPAR4;P2RY10
prerank,Reactome_2022__Neddylation R-HSA-8951664,0.452787378083524,1.4232533330757244,0.0,0.7657166469359683,1.0,43/203,13.96%,SPSB4;SEM1;ERCC8;SPSB2;COMMD6;PSMD10;KBTBD7;FEM1C;SOCS6;DCAF17;ELOC;ASB13;PSMA1;PSMD11;DCAF13;KEAP1;FBXL14;DCUN1D2;COPS2;COPS8;CUL1;PSMB5;ASB8;COMMD1;VCP;DCUN1D1;FBXO30;FBXL3;LMO7;FBXO9;ASB7;FBXO15;BTRC;UBE2D1;PSMD14;FEM1B;COPS7A;CUL2;FBXO27;PSMD12;FBXO10;DCUN1D5;DCAF4
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.6093258354073178,-1.4232475102889666,0.07462686567164178,0.33374358563921097,1.0,14/56,20.03%,THBS1;CDKN2A;SKAP1;THY1;PLET1;MINK1;EMP2;SEMA3E;PIK3CB;VCL;CCL28;DAPK3;CD36;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.7050390906465512,1.4229007428301328,0.04878048780487805,0.7646732122758699,1.0,7/11,28.35%,ZNF304;TRIM28;PPHLN1;TASOR;RESF1;SETDB1;ATF7IP
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.8204263806348304,-1.4228064279906392,0.06666666666666667,0.3339134522203335,1.0,6/12,7.70%,MET;ALOX12;LSR;FLG;ABCA12;FA2H
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.8204263806348304,-1.4228064279906392,0.06666666666666667,0.3339134522203335,1.0,6/12,7.70%,MET;ALOX12;LSR;FLG;ABCA12;FA2H
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Undefined,-0.6059938659038261,-1.4224481633644448,0.024390243902439025,0.3349593369473331,1.0,20/82,12.48%,CD24;MET;ICAM1;L1CAM;ABCA5;ITGA2;PDPN;PODXL;KLF4;THY1;ABCB1;CD44;GFAP;CLEC12A;CD9;LGR5;CD55;FOXM1;GLI1;PROCR
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.8249382384280145,1.4222313096810901,0.09523809523809523,0.765297041816949,1.0,1/6,2.91%,ADRA1A
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),-0.8220350779798207,-1.421930128779088,0.03389830508474576,0.33634198923890835,1.0,1/14,0.34%,RASGRP1
prerank,KEGG_2021_Human__Autoimmune thyroid disease,-0.763105344676671,-1.421814152911587,0.07936507936507936,0.3361439666891855,1.0,7/14,16.36%,HLA-A;HLA-C;HLA-DRA;HLA-B;HLA-E;HLA-F;HLA-DRB1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.7649277520943745,-1.4217705293041922,0.045454545454545456,0.33560721835798013,1.0,3/15,9.68%,CXCL2;CCL2;THPO
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.6024088437805534,1.4217124768190708,0.06666666666666667,0.7654569130844505,1.0,16/39,31.08%,SNAPC5;POLR3B;POLR3F;BRF2;SNAPC1;SNAPC3;BDP1;POU2F1;NFIB;GTF3C3;POLR1D;POLR3E;POLR2K;POLR3H;POLR2E;GTF3C4
prerank,Reactome_2022__WNT Mediated Activation Of DVL R-HSA-201688,0.8796593563419699,1.4212193416873289,0.022727272727272728,0.766026845999159,1.0,4/5,12.05%,PIP5K1B;CSNK1E;CSNK2A2;DVL2
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,-0.5827829642754102,-1.4209345498654369,0.028985507246376812,0.33799720692262325,1.0,17/75,17.58%,CACNA1H;ADCY7;ATP1A1;ITPR3;LDLR;ATP1B1;PRKCG;CREB5;CACNA1C;ADCY5;LIPE;CYP21A2;NR4A1;ADCY3;ADCY8;PRKCB;CREB3
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.6599357771079017,-1.4205892270802973,0.0,0.33890072255464093,1.0,9/36,14.78%,MX1;IFIT1;IFITM3;PROX1;BST2;PLSCR1;ISG15;IFIH1;APOBEC3H
prerank,CellMarker_Augmented_2021__Epithelial cell:Airway Epithelium,-0.9522793928829363,-1.4202766580312312,0.03333333333333333,0.33817496606014863,1.0,1/5,0.05%,CD24
prerank,CellMarker_Augmented_2021__Epithelial cell:Lung,-0.9522793928829363,-1.4202766580312312,0.03333333333333333,0.33817496606014863,1.0,1/5,0.05%,CD24
prerank,CellMarker_Augmented_2021__Epithelial cell:Skin,-0.9522793928829363,-1.4202766580312312,0.03333333333333333,0.33817496606014863,1.0,1/5,0.05%,CD24
prerank,Reactome_2022__Hydrolysis Of LPC R-HSA-1483115,0.8389246908145456,1.4200396311879386,0.023809523809523808,0.770051880907065,1.0,4/5,16.11%,PLA2G4C;PLA2G15;PLBD1;GPCPD1
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.6989235485428805,1.4197157394046276,0.029411764705882353,0.768921293976691,1.0,4/15,5.69%,SLC39A10;RUNX1;LPXN;FOXP1
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,0.63855330540299,1.4197081007310266,0.07317073170731707,0.7658578625265847,1.0,11/26,16.99%,SAMM50;DMAC2L;CHCHD3;TMEM11;ATP5PB;ATP5MC2;DNAJC11;ATP5MC1;APOOL;ATP5F1A;MTX2
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Jejunum,-0.6870832372680211,-1.4196962596965481,0.02564102564102564,0.3387476947546279,1.0,8/34,7.03%,CD24;ANXA1;S100A10;FOSL2;MYOF;S100A6;KLF4;CD44
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Breast,-0.6870832372680211,-1.4196962596965481,0.02564102564102564,0.3387476947546279,1.0,8/34,7.03%,CD24;ANXA1;S100A10;FOSL2;MYOF;S100A6;KLF4;CD44
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.7206836364663047,1.419523034359512,0.1,0.7637633276452578,1.0,5/13,6.69%,ABCD2;AKT2;PLIN5;ABCD1;AKT1
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.7933651593851773,-1.4194327922830756,0.02,0.3394107931284239,1.0,3/11,7.79%,THBS1;RHOBTB2;XKR4
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.7006271523068262,-1.4192658773229125,0.07692307692307693,0.3395444510394186,1.0,11/29,18.41%,NEFL;GRIN2A;APP;CCL2;GRIA3;GRIA1;GRIN2B;NLGN1;RELN;CAPN1;LRRC7
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.6284394727412211,-1.419155826432793,0.023529411764705882,0.33939709851816646,1.0,5/41,7.85%,TLR2;DYSF;BST2;PLSCR1;EGF
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,0.6467349054783618,1.4189651761239384,0.0,0.7639254696106512,1.0,3/21,6.41%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,Reactome_2022__Scavenging By Class A Receptors R-HSA-3000480,-0.8439231863096017,-1.4189483002956698,0.0,0.33947778402745055,1.0,3/11,4.57%,COL4A1;COL4A2;COLEC12
prerank,Reactome_2022__Phospholipase C-mediated Cascade: FGFR1 R-HSA-5654219,0.7885541044159063,1.4189065698182999,0.023255813953488372,0.7613641489999459,1.0,1/8,0.16%,FGF6
prerank,Reactome_2022__Erythropoietin Activates STAT5 R-HSA-9027283,0.8635077415293768,1.4189043955897018,0.06818181818181818,0.7583784072391617,1.0,2/7,3.80%,EPOR;EPX
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colon,-0.7460931921363954,-1.4187250910411222,0.11864406779661017,0.33989002296747384,1.0,3/11,10.74%,CD24;CD44;LGR5
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.9409881483885189,1.4186583323310367,0.021739130434782608,0.7568328670170279,1.0,3/5,5.13%,DSCAM;SOX8;SOX9
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.7344266225565945,1.4186489543472989,0.1,0.7539762021916632,1.0,6/13,18.82%,RAD54B;TPRKB;SMC6;RAD52;MSH3;DMC1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.9337843500342891,1.4184619311871258,0.0,0.7520642986146819,1.0,1/5,0.97%,DSCAM
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.5829744836700886,-1.418223609859998,0.011494252873563218,0.34108522556286136,1.0,32/95,20.01%,KCNT2;HPN;KCNQ1;KCNV1;LRRC55;KCNB1;KCNK1;KCNJ13;KCNJ2;SLC24A2;ATP1A1;KCNH8;SLC24A1;SLC9A2;ATP1B1;KCNG1;KCNB2;KCNK12;SLC12A7;KCNC1;KCND3;SLC9A5;KCNH7;KCNK10;KCNAB3;KCNV2;KCNE4;KCNF1;HCN1;ABCC9;KCNQ5;KCNC2
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.8877653111705036,-1.4176713988262666,0.017543859649122806,0.3432504196027933,1.0,1/6,0.18%,ANXA1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.6868133841487616,1.4175588940743868,0.125,0.7552438398533595,1.0,5/15,19.67%,PRKRA;DROSHA;AGO3;TSN;PUM2
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.8083810175848054,-1.4174588000583437,0.07017543859649122,0.34337543398689724,1.0,7/11,12.78%,RFTN1;COLEC12;TLR3;SCARA3;SCIMP;TNIP2;FADD
prerank,CellMarker_Augmented_2021__Beta cell:Undefined,-0.6922225027689746,-1.4173347676469834,0.017241379310344827,0.3433439575987554,1.0,9/24,12.98%,TSPAN16;MYO1F;ARHGAP9;TUBB1;ACAP1;GATA1;MMP25;CMTM2;TSPAN32
prerank,Reactome_2022__DNA Methylation R-HSA-5334118,0.707699490491554,1.4171465323004875,0.058823529411764705,0.7546060565437539,1.0,5/14,13.59%,H2BC21;H2BC4;DNMT3B;H2AC6;H3-3B
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.7943171428401279,-1.417023809130366,0.06578947368421052,0.3441604970636925,1.0,3/13,6.69%,KCNB1;PIM3;BMP8A
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.7472593775388365,-1.4168016333931455,0.07692307692307693,0.34423131554129044,1.0,4/24,11.00%,CDKN2A;B2M;ARG2;NUAK1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.6766394300579542,-1.416726687305089,0.03076923076923077,0.3439225901946953,1.0,2/39,0.33%,ANXA1;THBS1
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.8817118619011186,1.4164596963761107,0.07894736842105263,0.7557537548741272,1.0,4/7,10.39%,DNA2;PRIMPOL;POLG2;MGME1
prerank,Reactome_2022__EGFR Transactivation By Gastrin R-HSA-2179392,0.8371236527959853,1.4163975869351977,0.07894736842105263,0.7531720421614171,1.0,2/6,5.64%,NRAS;EGFR
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.6802486489139664,1.416299388299103,0.03333333333333333,0.7512133464590245,1.0,10/19,25.08%,VCP;AUP1;UGGT1;DERL1;POMT2;DNAJB14;DNAJC18;UGGT2;DNAJB12;KLHL15
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.8716914872488815,-1.4160395361837435,0.022727272727272728,0.3461102051571892,1.0,2/7,5.06%,KLF2;KLF4
prerank,Reactome_2022__Mitochondrial Translation R-HSA-5368287,0.5454912046593688,1.4159625498305264,0.06666666666666667,0.7504287510768286,1.0,34/79,25.88%,MRPL10;MRPS30;MRPL15;PTCD3;MRRF;MTIF2;MRPS9;MRPL58;MTFMT;MRPS2;MRPL50;MRPL37;GFM2;MRPL18;MRPL42;MRPL52;MRPL41;MRPS31;MRPS27;MRPL9;MRPS7;MRPS35;MRPS14;MRPL47;MRPL4;MRPS11;MRPL1;MRPS10;MRPL17;MRPS21;MRPL24;MRPL13;MRPL3;MRPS16
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.8553132590917063,-1.4158600024042742,0.08928571428571429,0.3463316310807792,1.0,3/5,12.78%,NLRC5;WNT5A;FADD
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.6481649345289524,1.4156985676008067,0.03125,0.7493506619837661,1.0,7/27,17.23%,RNF6;FOXP1;RNF14;AR;HEYL;EP300;NCOA2
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.7981208125205506,1.4156389036333774,0.1111111111111111,0.7470022949760853,1.0,5/9,12.01%,PPP1R3D;PPP1R3G;AKT1;RUBCNL;PPP1R3F
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),0.8520570573643812,1.415531045405314,0.023809523809523808,0.7446715187325068,1.0,3/5,8.21%,TMEM167B;TRAPPC11;TMEM167A
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.939306405107504,-1.4155083769344585,0.017543859649122806,0.34722089862909855,1.0,1/5,1.30%,ALDOB
prerank,CellMarker_Augmented_2021__B cell:Peripheral Blood,-0.8577568430540108,-1.415463312136111,0.034482758620689655,0.34678915877032945,1.0,2/8,1.59%,CD24;CD5
prerank,Reactome_2022__Erythropoietin Activates Phospholipase C Gamma (PLCG) R-HSA-9027277,0.8538549061223182,1.415358964949897,0.02564102564102564,0.7432463269102695,1.0,2/7,3.80%,EPOR;EPX
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.8277780136000202,-1.4152678669509478,0.07936507936507936,0.34640784239627564,1.0,1/9,2.20%,ZFP36
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.8277780136000202,-1.4152678669509478,0.07936507936507936,0.34640784239627564,1.0,1/9,2.20%,ZFP36
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.731710818323583,-1.4149959212199406,0.06451612903225806,0.34693306256538203,1.0,1/17,0.33%,THBS1
prerank,Reactome_2022__Serotonin Neurotransmitter Release Cycle R-HSA-181429,-0.7628962928953056,-1.4148352857745037,0.05970149253731343,0.3471505697039999,1.0,6/17,15.24%,SYN3;SLC18A2;SYN2;CPLX1;SYT1;PPFIA1
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),0.82850253570511,1.4143392354097981,0.044444444444444446,0.746003349679521,1.0,1/6,1.54%,METAP1D
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,0.6650168379711217,1.4142533798261283,0.09375,0.7437861337356672,1.0,6/15,17.23%,H2BC21;KLKB1;H2BC4;H2AC6;H3-3B;NCOA2
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.5727886118777137,-1.413868789054021,0.024691358024691357,0.35047059645829487,1.0,22/123,13.19%,S100A10;PKP2;MRAP2;FYB1;ANK3;KCNB1;RAMP3;TESC;RAB11A;ZDHHC22;ABCA12;CAV3;ATP1B1;KCNB2;PDZK1;FLOT1;PLEKHF1;TSPAN32;EMP2;FYB2;SCN3B;TNFRSF1A
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.54404105649752,1.4137089479334144,0.05555555555555555,0.7445131416786339,1.0,14/44,16.99%,SAMM50;DMAC2L;MAIP1;LETM1;CHCHD3;TMEM11;ATP5PB;OPA1;ATP5MC2;DNAJC11;ATP5MC1;APOOL;ATP5F1A;MTX2
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.7143355980096959,-1.4136187910216087,0.05333333333333334,0.35091787475244174,1.0,11/33,18.15%,ALDOB;LDHA;HK2;ENOSF1;GAPDHS;PGK1;ENO4;GPI;PFKL;PGAM1;ENO2
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.7308177336957538,-1.4133815070122342,0.043478260869565216,0.35131284285548664,1.0,1/16,0.33%,THBS1
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.822390518451378,1.4131005306718272,0.046511627906976744,0.7453181495885578,1.0,2/7,6.48%,DAO;MOXD1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.6094420259955466,-1.4130918670513508,0.0136986301369863,0.3520099702301298,1.0,19/57,15.49%,MYO1F;DOCK8;RASGRP2;TAGAP;P2RY14;STAG3;TMC8;ARHGAP9;GPR18;ACAP1;RCSD1;WAS;IL4R;CTSS;BIRC3;P2RY10;SP140;CD74;CD37
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.8272266878954466,1.4127296596357144,0.05,0.7444564536384599,1.0,2/6,8.57%,MSRB1;MSRB3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.8317626193217607,-1.4126795153746654,0.07017543859649122,0.3529234429305565,1.0,3/8,2.09%,SCN1B;PKP2;ANK3
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.7368878242951258,-1.4125636554262728,0.04054054054054054,0.35285892185776857,1.0,10/23,18.15%,ALDOB;LDHA;HK2;GAPDHS;PGK1;ENO4;GPI;PFKL;PGAM1;ENO2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.8061332917500266,1.41230835806684,0.047619047619047616,0.7440147336970909,1.0,2/6,13.33%,CSGALNACT1;DSE
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.7371242278619643,-1.4122184011607908,0.05,0.3538179067378202,1.0,3/13,10.44%,ANXA1;RAB11FIP5;RIMS2
prerank,KEGG_2021_Human__Legionellosis,-0.6547661115890716,-1.4121915918503538,0.04225352112676056,0.3532496655381713,1.0,4/42,3.17%,CXCL2;C3;TLR2;IL12A
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.8071730637991001,-1.4119848525738103,0.05660377358490566,0.35336877014025325,1.0,2/10,11.74%,NR4A3;PINK1
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreatic Islet,-0.6069424022276063,-1.4119009557733686,0.02197802197802198,0.35307032474226824,1.0,15/89,14.82%,CLIC1;S100A10;IFITM3;ITGA5;HLA-C;TIMP1;CMTM3;TAGLN2;ZYX;SHISA5;CD63;TNFRSF1A;TMEM256-PLSCR3;SSR4;WDR1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.8080581839675827,1.4117888388880757,0.08,0.745018863067006,1.0,2/8,6.41%,ATP6V1A;ATP6V1G1
prerank,CellMarker_Augmented_2021__Epithelial cell:Epithelium,-0.681718952455241,-1.4117634158232841,0.0,0.3529061865011808,1.0,18/47,18.20%,GGT5;ABO;APLNR;RAMP3;SIGLEC1;MYH11;F13A1;SELP;BMX;RNASE1;ITGA9;MMRN2;ROBO4;TEK;MRC1;ADGRF5;AQP1;A2M
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Small Intestine,-0.6028214841804946,-1.4114316515662002,0.012658227848101266,0.3534741541787185,1.0,17/83,12.84%,COL4A1;ANGPTL2;CALD1;COL4A2;LAMB1;COL5A1;SULF1;LMOD1;BGN;SCARA3;CLDN18;SRPX2;THBS2;FN1;IGFBP5;PRRX1;AMOTL2
prerank,CellMarker_Augmented_2021__Liver Bud Hepatic cell:Liver,-0.5899456831400095,-1.4111441368012334,0.011764705882352941,0.3539903129518878,1.0,24/148,14.02%,IL1R1;P2RY6;IFI6;MET;GBP1;C1R;IFITM3;SERPINF1;GC;S100A6;SCN9A;AKR1C1;FILIP1L;POLE3;STEAP3;TIMP1;OSMR;POLE4;MT1H;CFH;EMP2;SP110;F5;C1S
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),-0.7793753655765184,-1.411016398379365,0.06349206349206349,0.3539745129580715,1.0,7/14,18.89%,ITGA2;SCX;ITGA8;ITGA3;ITGB4;CRB2;TBX20
prerank,KEGG_2021_Human__Pentose and glucuronate interconversions,0.7154421019335495,1.4108272803492061,0.05,0.7485209161748139,1.0,4/12,19.26%,CRPPA;DCXR;UGP2;AKR1B1
prerank,CellMarker_Augmented_2021__Circulating Stem Like cell:Peripheral Blood,-0.6783685162513861,-1.4098699516434356,0.058823529411764705,0.3575969174311355,1.0,14/41,14.94%,TRIM22;SP100;IRF1;IL15;NLRP12;HELB;PARP14;CD44;GPR82;APOL6;PRDM1;SP110;SP140L;SLC14A2
prerank,Reactome_2022__Small Interfering RNA (siRNA) Biogenesis R-HSA-426486,0.7238393423251006,1.4097810351997855,0.10416666666666667,0.7530206984523445,1.0,3/8,17.81%,PRKRA;AGO3;TSN
prerank,KEGG_2021_Human__Peroxisome,0.5171841355183542,1.4093597056634686,0.09090909090909091,0.752432207376458,1.0,20/69,16.77%,DAO;ABCD2;PEX11A;PEX13;ABCD1;PMVK;PHYH;ABCD3;EHHADH;PIPOX;PRDX1;ECH1;SCP2;GNPAT;ACOX1;PEX2;CAT;DDO;SLC25A17;ACSL3
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.8760392647990246,-1.4092235914915845,0.07692307692307693,0.35925858246051945,1.0,2/5,12.06%,ITGA5;TNIP2
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.6620495134075177,-1.4090302887365123,0.06666666666666667,0.35956313038744414,1.0,7/35,4.12%,GBP2;IL1R1;GPR183;CD5;TAGAP;GPR171;SLA
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.7712654018836527,-1.409022642037755,0.0847457627118644,0.3589618793272664,1.0,4/12,10.01%,DOCK8;APP;TNFRSF14;WNT5A
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood Vessel,-0.6340070001124254,-1.4089872351051638,0.038461538461538464,0.35842842766964794,1.0,11/50,5.06%,IL1R1;IL13RA1;TYMP;A4GALT;ICAM1;PDPN;PLXDC1;PODXL;CD160;COLEC12;KLF4
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Bone Marrow,-0.5856099176034584,-1.408951701866058,0.0,0.35792963450514353,1.0,18/83,12.84%,COL4A1;ANGPTL2;CALD1;C1R;COL4A2;LAMB1;COL5A1;THY1;BGN;SCARA3;EDIL3;SRPX2;OSMR;THBS2;FGF1;FN1;PRRX1;AMOTL2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.7301247323074822,1.408417268245234,0.10256410256410256,0.7549762333175483,1.0,5/15,13.75%,DERL2;VCP;AUP1;DERL1;TMEM129
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.8497603380684584,-1.4081725801407017,0.03076923076923077,0.3606560954530871,1.0,3/6,13.87%,ALOX12;DUOX1;NOXA1
prerank,CellMarker_Augmented_2021__Migration Phase Fetal Germ cell:Fetal Gonad,-0.5675216378797686,-1.4081106277787792,0.025,0.36020415095311087,1.0,17/117,12.02%,ST6GAL1;TOMM7;TMSB10;IFITM3;PDPN;RPS14;LDHA;TP53I3;CTSC;RNF181;DBI;NDUFB11;SNRPD2;RPA3;PSMB6;TPM4;PSMC3
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.7942222293930091,-1.4080705068670762,0.07017543859649122,0.3597211751764446,1.0,2/15,1.53%,THBS1;P2RY12
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.7114103380405152,1.408033384999644,0.10638297872340426,0.7543444795410812,1.0,4/15,13.16%,ADAMTS9;STT3B;ADAMTS12;FBXO27
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,0.5554005014680924,1.407908390260262,0.11538461538461539,0.7523457271535172,1.0,14/39,20.89%,NUP42;KPNA2;NUP37;NUP54;NDC1;NUP214;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;KPNA4;NUP50
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Large Intestine,-0.7696753578985177,-1.4078879993214801,0.07936507936507936,0.3597933131852697,1.0,2/15,1.31%,ARHGAP4;TYMP
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.6154225900614898,-1.407772910889677,0.0,0.35968646153906997,1.0,14/62,17.37%,CD24;SOCS3;VRK2;IFNGR2;STAT1;BIRC3;SYK;SIGIRR;FADD;TNFRSF1A;IL7;CD74;USP18;CDC37
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.8216552952299613,-1.407501801182694,0.057692307692307696,0.3600666018794656,1.0,3/7,15.76%,CCL2;PRKCH;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.8671934055309971,-1.4074183992060239,0.09090909090909091,0.35984629916931593,1.0,4/6,11.74%,TOMM7;HK2;ATP5IF1;PINK1
prerank,CellMarker_Augmented_2021__Cancer cell:Blood,-0.8182701840764892,-1.4072983044550462,0.029850746268656716,0.35969141788716225,1.0,3/11,9.84%,CD24;CD44;FOLH1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.8695080275177067,-1.4071877227420124,0.018518518518518517,0.3596661644244392,1.0,3/7,7.25%,PKP2;NEFL;GFAP
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.6988788960351947,1.40718470442454,0.08823529411764706,0.7537777293686235,1.0,4/13,10.13%,AGMO;GK;MOGAT1;LPIN3
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.7881795060922498,1.4069795848094309,0.11904761904761904,0.7495470590671794,1.0,5/8,18.07%,ABHD17A;LYPLA2;ABHD17B;ABHD17C;LYPLAL1
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.7881795060922498,1.4069795848094309,0.11904761904761904,0.7495470590671794,1.0,5/8,18.07%,ABHD17A;LYPLA2;ABHD17B;ABHD17C;LYPLAL1
prerank,CellMarker_Augmented_2021__Granulosa cell:Fetal Gonad,-0.5571697840708258,-1.4069208334497385,0.023529411764705882,0.36010814810557124,1.0,38/138,16.62%,GGT5;IFI6;C1R;PLAG1;ICAM1;RPS27A;IFITM3;RPS27;RPS14;LDHA;SCN9A;ATP1A1;HLA-DRA;POLE3;CHI3L1;OSMR;PLEKHA4;TAGLN2;MLLT11;RPS11;PGK1;BIRC3;AEBP1;RPS23;GNG2;GPC3;SPINT2;RPL8;EMILIN2;TMEM132C;C1S;SRGN;RPL12;PRAF2;HLA-DRB1;DHRS13;CEBPD;EMP3
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.7994773000933306,-1.4069203066630263,0.047619047619047616,0.3588845863042325,1.0,5/12,13.21%,RASGRP1;IL12A;CD160;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.7994773000933306,-1.4069203066630263,0.047619047619047616,0.3588845863042325,1.0,5/12,13.21%,RASGRP1;IL12A;CD160;HLA-E;HLA-F
prerank,CellMarker_Augmented_2021__Fibroblast:Heart,-0.5852195229785843,-1.4066937114832263,0.023809523809523808,0.3592134555517622,1.0,13/83,9.26%,COL4A1;CALD1;MYOF;TIMP2;TPST1;APP;RAB11FIP5;TBC1D9;TEAD2;CCND1;PAPSS2;FAM20C;CDC42EP1
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.6883232848373798,1.406487849908085,0.125,0.7497408772630484,1.0,6/17,17.26%,DERL2;VCP;AUP1;DERL1;TMEM129;RHBDD1
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,-0.5590444218687707,-1.4061987590662723,0.024096385542168676,0.36045308804218196,1.0,24/138,13.97%,CXCL2;LEF1;C3;ICAM1;ZFP36;RPS27A;HLA-A;GNG3;HLA-C;TLR3;ITPR3;CCND1;STAT1;IRF7;PPP3CC;HLA-B;SYK;HLA-E;GNG2;UBC;FADD;TNFRSF1A;HLA-F;FOS
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Small Intestine,-0.8062437009198189,-1.406020330737433,0.03333333333333333,0.36066635032452965,1.0,1/9,0.05%,CD24
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.6058434186113324,1.4059181977110549,0.0,0.7503296688788466,1.0,3/28,6.41%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.7496591414157631,-1.4053097123477891,0.11940298507462686,0.36301529925012815,1.0,4/14,6.33%,SCN1B;KCNQ1;NOS1AP;CAV3
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8419540711472414,1.405097394541332,0.15789473684210525,0.7528890966940385,1.0,4/7,13.27%,RUNX1;TWSG1;HMGB1;TARM1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.8276194598359888,1.4050543181685355,0.09523809523809523,0.7506291172994146,1.0,1/5,6.09%,ZNF304
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.6619473426702297,1.4050421703950717,0.10810810810810811,0.7481494491092695,1.0,3/17,13.16%,ADAMTS9;STT3B;FBXO27
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.674880599176722,-1.4049764433158953,0.05555555555555555,0.36400335480254514,1.0,7/32,8.45%,GRIN2D;GRIN2A;HTR2B;SLC24A2;SLC24A1;ITPR3;SLC8A3
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.8480765861739761,-1.404946540761668,0.01694915254237288,0.3634626922699457,1.0,2/10,1.45%,COL4A1;TGFBR2
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,-0.6802692943743611,-1.4044995467301795,0.04411764705882353,0.3647162811891007,1.0,4/35,7.60%,LEF1;CDKN2A;CCND1;ANAPC11
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovary,-0.8080730257335975,-1.4043777517054408,0.06666666666666667,0.36477797893620456,1.0,2/11,7.03%,CD24;CD44
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.7134813158910752,1.4041593100036809,0.1,0.7508462629593602,1.0,2/13,4.39%,YAE1;LTO1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.7859663569718486,1.4031387601404788,0.1,0.7546541471610838,1.0,2/8,9.80%,ABCA1;PRKACB
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.8121601517038612,1.4029844385722743,0.13157894736842105,0.7529625407644038,1.0,1/8,0.43%,NGF
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.6815224232039031,1.402567695204969,0.08888888888888889,0.7529459799687711,1.0,4/14,10.95%,MGAM;PGM2;AGL;PYGM
prerank,Reactome_2022__Maturation Of Nucleoprotein R-HSA-9683610,-0.7894245900871472,-1.4013761345258253,0.05357142857142857,0.3764901754363103,1.0,2/10,7.83%,PARP14;PARP9
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.7706124384542938,-1.4012770379101225,0.07692307692307693,0.376216111622656,1.0,1/12,0.33%,THBS1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),-0.6892592397197522,-1.401242349298389,0.03278688524590164,0.3757696700077528,1.0,4/22,10.01%,ANXA1;FLG;CLIC4;WNT5A
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.8574554134085276,-1.4012073200422226,0.03389830508474576,0.37526182084596343,1.0,1/7,0.18%,ANXA1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.6320033087645076,1.401207122337585,0.09090909090909091,0.757671727152176,1.0,6/22,17.37%,SNF8;VPS37A;PTPN23;VPS37B;VPS4B;UBAP1L
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.7859559318584076,-1.401176529889766,0.0847457627118644,0.37478708528281085,1.0,4/11,15.27%,FABP3;LIPI;LIPH;PNPLA3
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),-0.8188625342309338,-1.401098822292684,0.043478260869565216,0.3744706999170694,1.0,5/11,12.77%,GRIN3A;GRIN2A;ADCY7;GLRA2;GRIN2B
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.7084701855214142,1.4010699243461655,0.09375,0.7557565520046621,1.0,3/9,10.13%,CEL;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.8040747059420725,1.4009978278869781,0.11904761904761904,0.7536628475769092,1.0,3/6,14.67%,PLIN5;ABHD5;GPLD1
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.7109842449537787,1.3999850586817533,0.10810810810810811,0.7570790014169457,1.0,5/9,27.14%,CHPT1;PLA2G4C;GNPAT;AGPS;FAR1
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.8839792609078357,1.399920624864213,0.02040816326530612,0.754804726325426,1.0,1/6,0.41%,SLC6A13
prerank,Reactome_2022__FGFR2c Ligand Binding And Activation R-HSA-190375,0.8454371458074398,1.3997643613792106,0.06382978723404255,0.7530763997237764,1.0,1/6,0.16%,FGF6
prerank,Reactome_2022__Protein Repair R-HSA-5676934,0.8328506052316251,1.3997356879138334,0.06521739130434782,0.7505661450580304,1.0,2/6,8.57%,MSRB1;MSRB3
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Small Intestine,-0.6469644903496286,-1.3996821493152545,0.08333333333333333,0.3793665410926549,1.0,10/32,19.83%,KCNT2;MX1;CC2D2A;SRPX2;GABRB2;GAD2;SYT16;SV2B;HCN1;ADAMTS16
prerank,KEGG_2021_Human__Glutamatergic synapse,-0.5590735822633877,-1.3996635379629714,0.05,0.3787779550420809,1.0,24/91,17.19%,GRIN2D;GRIN3A;GRIN2A;ADCY7;GNG3;GRIA3;PLD1;GRIA1;ITPR3;GRM6;PRKCG;PLD2;GRIK1;PPP3CC;CACNA1C;ADCY5;GNG2;GRIN2B;SLC38A1;GRM7;GRIK2;ADCY3;ADCY8;PRKCB
prerank,"Reactome_2022__Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",-0.7402820657879733,-1.3993707194163918,0.05970149253731343,0.3794858723554997,1.0,5/21,7.16%,GRIN2D;NEFL;GRIN2A;GRIA3;GRIA1
prerank,"Reactome_2022__Synthesis, Secretion, And Deacylation Of Ghrelin R-HSA-422085",-0.723640354009115,-1.3992238128717145,0.07272727272727272,0.37945959994038186,1.0,4/12,12.53%,KLF4;IGF1;ACHE;SEC11C
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),0.7840852723139915,1.3991528761184648,0.1,0.7516124047894666,1.0,4/7,13.37%,MRRF;MTIF2;DENR;GFM2
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.9130551391810777,-1.3990577363327217,0.04,0.37949559436420327,1.0,1/5,0.81%,C3
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.6291296503172902,1.3989778027611022,0.08108108108108109,0.750249615712265,1.0,7/27,14.99%,EED;DNMT3B;SMYD5;RBBP4;PPHLN1;TASOR;AEBP2
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR4 R-HSA-5654228,0.8429546307625307,1.3985550268683176,0.0425531914893617,0.7496440069886523,1.0,1/6,0.16%,FGF6
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR2 R-HSA-5654696,0.6380109443752212,1.3985150102422172,0.13333333333333333,0.7474017899284755,1.0,2/20,3.57%,FGF6;NRAS
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.7620343918696063,-1.3983470590215754,0.043478260869565216,0.3820300201393038,1.0,5/16,16.81%,PLK2;PLK3;ZWILCH;WEE2;WEE1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.7657099950467555,-1.3983036741097532,0.10714285714285714,0.3815658436705785,1.0,5/9,19.78%,SP100;FOXM1;TFAP4;RPS6KA6;KAT5
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),0.9001578454275565,1.3982695994003373,0.018867924528301886,0.7465865058689155,1.0,1/5,0.41%,SLC6A13
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.6317038426561356,-1.3981306655354304,0.05172413793103448,0.38156723111883056,1.0,3/35,1.22%,THBS1;CDKN2A;GBP1
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,-0.62534189618282,-1.3980811418493693,0.0379746835443038,0.3812134509570444,1.0,12/46,16.65%,THBS1;COL4A1;COL4A2;COL4A4;COL6A2;THBS3;STAT1;THBS2;PIK3CB;PLAT;COL9A2;STAT6
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.7812745984214267,-1.3980244918007838,0.06153846153846154,0.38076834223744593,1.0,5/14,11.79%,RFTN1;IL12A;IL15;PRKCQ;IL18
prerank,Reactome_2022__PI-3K cascade:FGFR4 R-HSA-5654720,0.744946088408218,1.3977647424261197,0.125,0.7467396553315683,1.0,1/11,0.16%,FGF6
prerank,CellMarker_Augmented_2021__B cell:Thyroid,-0.716377820402108,-1.39757487368174,0.017857142857142856,0.3820484841059206,1.0,9/21,15.49%,TAGAP;TMC8;IGHG1;ARHGAP9;ACAP1;WAS;P2RY10;SP140;CD37
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.8349544462248417,-1.3971264655459945,0.046875,0.38373927792886486,1.0,2/8,6.62%,SOCS3;PARP14
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.7570879732459729,-1.3970120914935071,0.04477611940298507,0.3835683361707581,1.0,6/20,12.58%,TLR2;IRF1;TLR3;IRF7;BIRC3;FLOT1
prerank,KEGG_2021_Human__Graft-versus-host disease,-0.7666119821522507,-1.39625491751923,0.07272727272727272,0.38646097373971616,1.0,7/11,16.36%,HLA-A;HLA-C;HLA-DRA;HLA-B;HLA-E;HLA-F;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),-0.8302911635574016,-1.3962053553428506,0.12121212121212122,0.38613323081992423,1.0,1/5,5.72%,PLN
prerank,Reactome_2022__Signaling By Leptin R-HSA-2586552,-0.8425089532461876,-1.396048829338801,0.1016949152542373,0.3861881846704643,1.0,1/8,0.69%,SOCS3
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.6873942899299448,-1.3960453425499508,0.08955223880597014,0.3855876382564058,1.0,3/22,8.06%,ENPP2;CYP1B1;ANGPTL3
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.7666338862820664,1.3960236427341832,0.023809523809523808,0.7531685190855257,1.0,5/9,22.00%,ATP5PB;ATP5MC2;ATP5MC1;ATP5F1A;ATP5F1C
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.6593534751205788,-1.3960176667652346,0.029850746268656716,0.3850194815195003,1.0,7/31,12.15%,ANXA1;OVOL3;OVOL2;FLG;CLIC4;WNT5A;GLI1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.5661276229726024,-1.3959593604415912,0.04597701149425287,0.3846810310659397,1.0,33/97,17.39%,KCNQ1;CDH22;PCSK2;CCK;PROX1;KCNB1;ST18;MYO15A;SLC24A2;SRRM4;TCEAL6;SLC7A14;SYP;XKR4;MOG;MOBP;UNC13C;CPLX2;SCN1A;STMN4;SYNPR;SCN3B;GAD2;TAS1R1;CNDP1;SGSM1;SLC4A10;CNTN2;GABRA1;CNTNAP5;SV2B;PRKCB;RPH3A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Oral Mucosa,-0.5875600964618382,-1.3959474556312672,0.0273972602739726,0.38408586480285145,1.0,26/66,17.72%,GGT5;ANGPTL2;APLNR;SPARC;C1R;ABCA8;COX7A1;THY1;LMOD1;BGN;PODN;LDB2;ELN;GALNT15;THBS2;IGFBP7;AEBP1;PRRX1;RASL12;C1S;ROBO4;TNS2;TEK;SHROOM4;ADGRF5;AQP1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.7384766085739364,1.3958288585369025,0.06818181818181818,0.7519744333653494,1.0,3/12,9.28%,WNT7A;INTU;SALL1
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.8779076877536587,-1.3954718995823943,0.10714285714285714,0.38552153221410185,1.0,3/7,6.63%,PLK2;SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.5617421735886061,-1.395451259067148,0.024691358024691357,0.3850478650570827,1.0,22/120,13.19%,S100A10;PKP2;MRAP2;FYB1;ANK3;KCNB1;RAMP3;TESC;RAB11A;ZDHHC22;ABCA12;CAV3;ATP1B1;KCNB2;PDZK1;FLOT1;PLEKHF1;TSPAN32;EMP2;FYB2;SCN3B;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.5215012969438961,1.3954474148728375,0.02631578947368421,0.7518518792680395,1.0,14/56,20.97%,CDKL1;TESK1;TBC1D19;ODAD3;CEP97;KCTD17;TBC1D5;TAPT1;CCDC88A;CEP120;EVI5L;TBC1D22B;SAXO1;TBC1D7
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.7282898805669743,1.3953381903502613,0.08333333333333333,0.7501212766430907,1.0,1/14,0.44%,WNT7A
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.7082676731867703,-1.395327283676334,0.06451612903225806,0.3849228480552104,1.0,8/23,17.69%,C3;C1R;CD55;CFH;C1S;SUSD4;SERPING1;CR1L
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.8464527759146787,1.3951717825126788,0.10638297872340426,0.7484018032954726,1.0,1/5,0.94%,SLC19A1
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.7909881645615051,1.3951165730699853,0.075,0.7462573905417822,1.0,2/9,1.65%,VEGFD;VEGFC
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.7735734103406039,-1.39485887514983,0.015384615384615385,0.3863351376391272,1.0,4/17,6.56%,GBP1;CD160;THY1;CEACAM1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.672824274074367,-1.394754198635849,0.015625,0.38635888137556934,1.0,8/30,13.03%,SCN1B;KCNQ1;PVALEF;ATP1B1;RCSD1;TNNT1;NOS1;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.7826912958506255,-1.394584886563088,0.05084745762711865,0.38662285497780924,1.0,2/13,8.72%,ANXA1;SRPX2
prerank,CellMarker_Augmented_2021__Progenitor cell:Stomach,-0.6446667835996005,-1.3945549345729387,0.013157894736842105,0.3848089320674992,1.0,15/51,11.88%,CCNB2;TYMS;ERCC6L;KIF14;DEPDC1B;POLQ;BRCA1;ANLN;CENPE;SHCBP1;NUF2;CCNB1;FANCI;FOXM1;KIF2C
prerank,CellMarker_Augmented_2021__Oxyntic Stem cell:Stomach,-0.6446667835996005,-1.3945549345729387,0.013157894736842105,0.3848089320674992,1.0,15/51,11.88%,CCNB2;TYMS;ERCC6L;KIF14;DEPDC1B;POLQ;BRCA1;ANLN;CENPE;SHCBP1;NUF2;CCNB1;FANCI;FOXM1;KIF2C
prerank,CellMarker_Augmented_2021__Oxyntic Progenitor cell:Stomach,-0.6446667835996005,-1.3945549345729387,0.013157894736842105,0.3848089320674992,1.0,15/51,11.88%,CCNB2;TYMS;ERCC6L;KIF14;DEPDC1B;POLQ;BRCA1;ANLN;CENPE;SHCBP1;NUF2;CCNB1;FANCI;FOXM1;KIF2C
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,0.5407225035650585,1.394371755394976,0.02857142857142857,0.7478205150958264,1.0,12/41,17.40%,RUNX1;H2BC21;MAML3;KAT2B;H2BC4;SIRT6;H2AC6;NOTCH2;KAT2A;H3-3B;EP300;AGO3
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.7935350135936117,-1.3939896066113486,0.10638297872340426,0.3863421531477108,1.0,3/5,20.40%,CHRM1;PRKCH;HES1
prerank,CellMarker_Augmented_2021__Leydig Precursor cell:Fetal Gonad,-0.5384975500241306,-1.393963866254703,0.023255813953488372,0.38587398500583475,1.0,56/184,18.09%,OGN;CALD1;C1R;COL5A1;RPS27A;NEFL;C1QTNF7;MATN2;COL6A2;SULF1;CTSC;THY1;BGN;GSTM5;CYP1B1;RPL9;OLFML1;ELN;RPL13A;LTBP4;SYT1;IGF1;CDC42EP1;ABCA10;SCG5;WNT5A;RPL24;ITGA11;SCN2A;RIMS2;RPS3A;RPL10A;RPL10;RPS23;CFH;IGFBP5;F10;RPS7;RPS18;GPC3;EMP2;RPL8;NLGN1;C1S;RPS6;RPL12;DLC1;PLAC9;RPL5;RPL23;PDE5A;RPL18A;ANGPT2;RPL7;RPS12;PCDH18
prerank,CellMarker_Augmented_2021__Placenta cell:Placenta,0.7035007312283492,1.3936649351290213,0.1935483870967742,0.7495180783909168,1.0,6/16,15.85%,EFNA2;ARHGEF16;SLC26A3;KRT8;SOWAHA;CGN
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.8185372997087051,-1.3933943201801617,0.08333333333333333,0.38704360665016324,1.0,1/7,5.65%,SYT4
prerank,Reactome_2022__RNA Polymerase III Chain Elongation R-HSA-73780,0.6230391987689406,1.3933921048770463,0.05405405405405406,0.7483621166095843,1.0,2/17,5.65%,POLR3B;POLR3F
prerank,Reactome_2022__Influenza Infection R-HSA-168255,-0.5583976947801497,-1.3932657966390385,0.011494252873563218,0.3869619576376629,1.0,47/145,18.41%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;POLR2I;RPS11;RPS16;ISG15;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;KPNA7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;TGFB1;RPS20
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,-0.5570168397320497,-1.3932070121012048,0.0,0.3865840057719962,1.0,46/174,14.60%,CXCL2;ANXA1;P2RY13;P2RY6;NPY;TAC3;C3;APLNR;GPR183;P2RY12;ACKR4;P2RY14;WNT8B;ADGRE5;GNRHR;RAMP3;GPNMB;CHRM1;GNG3;APP;GPR18;CCL2;UTS2;PLPPR1;GRM6;GIPR;S1PR3;PLPPR5;WNT5A;CHRM3;SST;MCHR2;CD55;LPAR6;PTRH2;LPAR4;GNG2;C1QTNF1;P2RY10;RXFP1;PTH1R;HTR1E;TAS1R1;GLP1R;GRM7;PTH2R
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5847354687884261,1.393133221076329,0.10714285714285714,0.7472134710420576,1.0,4/28,6.64%,PRDX6;HSPA1A;ZPR1;SF3B4
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Undefined,-0.7707706108893183,-1.3928196089001759,0.057971014492753624,0.38753966655828376,1.0,2/16,2.78%,IL1R1;ITGA2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.7278247539812855,-1.3927543113482281,0.10294117647058823,0.3871176537194169,1.0,6/19,11.18%,NR4A3;SKAP1;THY1;CCL2;CD44;PRKCQ
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.8366097111407591,1.3926841678047435,0.075,0.7479671992093578,1.0,3/6,13.51%,SPRED1;SPRY1;SPRED2
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.6978213418357596,-1.3925598055916486,0.08955223880597014,0.3872725280979198,1.0,2/18,1.47%,MET;MRAP2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Prostate,-0.67928007263191,-1.3918607504776588,0.10526315789473684,0.38943079464289354,1.0,6/24,7.03%,CD24;A4GALT;PSCA;ITGA2;ITGA5;CD44
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.6827946718493314,1.391849026915086,0.0975609756097561,0.7499637502206384,1.0,6/15,20.58%,RTRAF;TSEN2;TSEN15;ZBTB8OS;CLP1;TRPT1
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),0.8189448236545682,1.3911204782019269,0.15789473684210525,0.7513081909996078,1.0,1/6,0.33%,SLC2A5
prerank,CellMarker_Augmented_2021__Megakaryocyte:Fetal Kidney,-0.8549184206006247,-1.3908262981763109,0.038461538461538464,0.3932151940210059,1.0,2/6,1.83%,RASGRP2;FYB1
prerank,CellMarker_Augmented_2021__Progenitor cell:Breast,-0.9212234737747194,-1.390545122446992,0.04918032786885246,0.39393256687551326,1.0,2/5,7.03%,CD24;CD44
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),-0.9038191957761843,-1.390315248978994,0.03773584905660377,0.3943983801868199,1.0,1/6,0.94%,DUSP1
prerank,CellMarker_Augmented_2021__PP cell:Pancreas,0.6954247480557452,1.3900483837281878,0.08571428571428572,0.7546986983988672,1.0,1/18,0.01%,CPA1
prerank,CellMarker_Augmented_2021__Macrophage:Brain,-0.6673104751601073,-1.3900324920786324,0.05405405405405406,0.3947895214811889,1.0,8/30,15.12%,CIITA;FOSL2;ARG2;SYNGR2;PTPN7;PIM1;SPINT2;CD74
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7318657406530854,1.3897448147278337,0.1,0.7538660082116855,1.0,5/12,14.42%,ADRA1A;LMBRD2;ADRB2;DRD2;ZDHHC21
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.5986975800935775,1.3894105312877811,0.02702702702702703,0.7535313162501638,1.0,11/23,22.16%,EAF2;ERCC6;HTATSF1;KAT7;HMGN1;THOC1;CCNT1;ZMYND11;CCAR2;CCNT2;WDR43
prerank,CellMarker_Augmented_2021__Malignant Mesothelioma cell:Pleura,-0.6685761126715111,-1.389268276927881,0.07142857142857142,0.39667743280915535,1.0,9/22,13.52%,GPR87;PSCA;ZNF750;DUOXA1;MACC1;TMC4;DNAH3;KPNA7;CXCL17
prerank,CellMarker_Augmented_2021__Malignant Mesothelioma cell:Lung,-0.6685761126715111,-1.389268276927881,0.07142857142857142,0.39667743280915535,1.0,9/22,13.52%,GPR87;PSCA;ZNF750;DUOXA1;MACC1;TMC4;DNAH3;KPNA7;CXCL17
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),-0.8922992563522537,-1.3892158480639274,0.0,0.3956871087189031,1.0,2/5,7.22%,CD24;BASP1
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),-0.8922992563522537,-1.3892158480639274,0.0,0.3956871087189031,1.0,2/5,7.22%,CD24;BASP1
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,-0.5723175517525136,-1.3886156594520231,0.024096385542168676,0.39752598292344227,1.0,49/135,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;ATF3;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.7647948708806502,-1.3882512306439574,0.10344827586206896,0.39853233697633444,1.0,5/10,19.78%,SP100;FOXM1;TFAP4;RPS6KA6;KAT5
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.6204351004751186,1.3882453975205113,0.14285714285714285,0.7582169799454589,1.0,1/24,0.44%,WNT7A
prerank,KEGG_2021_Human__Pertussis,-0.6385288901581458,-1.3881630694527107,0.027777777777777776,0.3983045321364643,1.0,6/46,5.29%,C3;C1R;IL12A;IRF1;ITGA5;NOD1
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.575080854400722,-1.3881361226746927,0.0,0.39777376749408216,1.0,45/127,19.03%,COL4A1;ANGPTL2;OGN;CALD1;C1R;COL4A2;COL5A1;NEXN;ABCA8;SPON2;GJC1;COX7A1;SULF1;THY1;PLN;LMOD1;BGN;PODN;LDB2;HEXIM1;MYH11;ELN;ITGA8;THBS2;HHIP;SLIT3;IGFBP5;OBSCN;SLC38A11;PRRX1;ITGA9;RASL12;C1S;PRXL2C;TNS2;SNCG;COL12A1;VASN;TEK;NOTCH3;AQP1;PCDH18;SMTN;PDGFRA;SVEP1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.6125290957771017,-1.3879043974532745,0.08333333333333333,0.3980964827551851,1.0,10/50,19.14%,THBS1;S100A10;THY1;APOD;DMTN;DLC1;TEK;VCL;DAPK3;PHLDB2
prerank,Reactome_2022__Defective Factor VIII Causes Hemophilia A R-HSA-9662001,-0.9059317221491049,-1.3874935739447818,0.06779661016949153,0.3990669021939968,1.0,2/5,4.67%,F8;TPST1
prerank,Reactome_2022__Activation Of PPARGC1A (PGC-1alpha) By Phosphorylation R-HSA-2151209,0.8244421140499516,1.3873154334184055,0.07894736842105263,0.7604247992925092,1.0,3/8,12.29%,PPARGC1A;PRKAB1;MAPK12
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.6010632808474996,-1.387310684688606,0.02631578947368421,0.399199512315508,1.0,14/60,8.69%,THBS1;FOSB;MYO1F;NR1I3;GAB3;TUBB1;GFI1B;GATA1;CEACAM1;CD44;TMCC2;CLEC12A;UROD;CA1
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.9066169504662815,-1.3872299035562687,0.05555555555555555,0.3990586615382884,1.0,2/5,7.17%,TIMP2;TIMP1
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.8471367826034816,1.3867422198847061,0.0851063829787234,0.7609798161755464,1.0,3/5,14.24%,MTHFS;QDPR;DHFR
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.6769109473363668,-1.386586971098738,0.04225352112676056,0.40109930141617767,1.0,4/32,2.99%,ANXA1;GBP1;ZFP36;SFTPD
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.8412086633571105,-1.3862198194439428,0.01639344262295082,0.4020591455916773,1.0,6/9,11.79%,TGFBR2;HLA-A;SYK;CD55;HLA-E;IL18
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.8697057381558323,-1.3858430376839332,0.08928571428571429,0.4029588252780906,1.0,2/7,1.95%,EFNA1;GRIN3A
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.8937618589088734,-1.3857855336347125,0.01694915254237288,0.40254170066796585,1.0,2/7,6.62%,POLQ;PMS2
prerank,Reactome_2022__DNA Strand Elongation R-HSA-69190,0.6175087392517546,1.3857755463598078,0.05128205128205128,0.7635133151531714,1.0,4/25,5.74%,POLD3;SLC19A1;DNA2;RFC3
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.76475793529944,-1.3856946987951422,0.07936507936507936,0.4022969872578721,1.0,3/16,5.06%,KLF2;NOS1AP;KLF4
prerank,CellMarker_Augmented_2021__Pyramidal cell:Undefined,0.7595068219745493,1.3856429598037159,0.04878048780487805,0.7617676935736071,1.0,2/9,0.55%,FEZF2;POU3F1
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.7132440992610966,-1.3856353094617417,0.046875,0.4019391048550356,1.0,4/24,4.57%,COL4A1;SPARC;COL4A2;COLEC12
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.6732591974423797,-1.3856061106407975,0.04838709677419355,0.40146857100058175,1.0,1/23,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.6722600999924,1.3851801179303285,0.17647058823529413,0.7616914970206232,1.0,3/12,4.85%,SOX8;BMP2;GREM1
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,-0.5820110857930446,-1.3851536950967924,0.02531645569620253,0.4025894415702406,1.0,28/67,22.72%,KCNQ1;KCNV1;KCNB1;KCNK1;KCNJ2;GNG3;KCNH8;KCNG1;KCNB2;GNG2;KCNC1;KCND3;KCNMB4;KCNH7;KCNK10;KCNAB3;KCNV2;KCNF1;HCN1;GABBR2;ABCC9;KCNQ5;KCNC2;KCNK13;KCNJ6;KCNQ4;GNB4;GNB5
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.9181656945562088,1.38493558386749,0.044444444444444446,0.7609956115041779,1.0,1/5,1.63%,BMP2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.7681119548953855,-1.3844416473319354,0.06349206349206349,0.40518106408629334,1.0,2/12,4.67%,SULT1C3;TPST1
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.8734367986845282,-1.3842828369878133,0.05,0.4053021827461521,1.0,1/6,0.17%,ST6GAL1
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.9015606119851519,-1.3840718332224782,0.05660377358490566,0.404851917336683,1.0,1/5,0.18%,ANXA1
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.9015606119851519,-1.3840718332224782,0.05660377358490566,0.404851917336683,1.0,1/5,0.18%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.8274370174597127,-1.3839560055289488,0.03636363636363636,0.40460667143506657,1.0,2/7,4.77%,PDPN;FSCN1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.8471903928037975,1.3837876484694251,0.11904761904761904,0.7651127328177758,1.0,3/7,10.39%,DNA2;PRIMPOL;MGME1
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.8330253989719614,-1.3834308219646168,0.125,0.4060221547469288,1.0,2/6,8.69%,SHTN1;WAS
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.728010671497906,-1.3832347154365712,0.045454545454545456,0.4061691877069484,1.0,1/16,2.20%,ZFP36
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.6346757294006937,-1.3831902929149131,0.10666666666666667,0.40583891493245167,1.0,6/41,6.80%,ANXA1;MET;SIX3;PROX1;LSR;GCM2
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,0.6309546531817393,1.3830000070633228,0.08695652173913043,0.7676639647119203,1.0,8/23,18.23%,CNOT9;EIF4E;CNOT2;PAIP1;CNOT8;CNOT6L;CNOT1;CNOT4
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.7535030903744488,-1.38294244710295,0.04918032786885246,0.4060978161972176,1.0,1/14,1.22%,GBP1
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.7989048386649308,1.3828502578123512,0.11627906976744186,0.7659662722341277,1.0,3/6,15.55%,ASCL1;FOXJ1;RCN3
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.6247543385744715,-1.3823929763642855,0.08064516129032258,0.4078801255092153,1.0,11/38,20.03%,LEF1;ACKR4;PRKCQ;CCR10;NR4A1;PRKCD;DEFB109B;CCL28;ABCC1;PDGFRA;CX3CL1
prerank,Reactome_2022__STAT5 Activation R-HSA-9645135,0.8104359065461024,1.3821989165505857,0.13953488372093023,0.7671380562568887,1.0,1/6,2.43%,FLT3
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.8727122410174523,-1.382048010540969,0.034482758620689655,0.40876350434942077,1.0,1/8,0.81%,BLM
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Pluripotent Stem Cell,-0.6068438264899134,-1.3816171659236294,0.038461538461538464,0.4097278915306122,1.0,15/67,15.16%,IL13RA1;SPARC;TLR2;LMO2;TIMP2;SIGLEC1;DYSF;CHI3L1;IFNGR2;ST3GAL6;FAM20C;CLEC5A;TNFAIP2;RASSF4;SERPING1
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.711834887396767,1.3816122876031494,0.19047619047619047,0.7686421949696077,1.0,5/12,19.50%,VCP;CBFA2T3;IFNLR1;IDE;NOA1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.739257331473262,1.3815807724917324,0.10526315789473684,0.7664830839810316,1.0,5/11,15.31%,VCP;AUP1;UGGT1;DERL1;POMT2
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.623968657941343,-1.3814153133860645,0.08333333333333333,0.4099516012119096,1.0,7/52,12.59%,ENPP2;PLAAT4;PLB1;DBI;LPCAT4;ACHE;SLC44A3
prerank,Reactome_2022__p75NTR Negatively Regulates Cell Cycle Via SC1 R-HSA-193670,0.8695683407740908,1.3812744532766406,0.11627906976744186,0.7662597272144163,1.0,2/5,6.07%,NGF;PRDM4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.6775098984931832,1.3812551726873499,0.0967741935483871,0.76408686455309,1.0,2/16,2.88%,RGCC;SERPINF2
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.6567096916016356,-1.381251507733064,0.045454545454545456,0.41000784428372483,1.0,16/31,26.70%,UNC13C;CPLX1;SYT1;CPLX2;STX19;RIMS2;SYT5;SYT2;CDK5;DOC2B;STX1B;RIMS1;STX3;STX4;RIMS3;RAB3A
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.6744064953393718,-1.381017366905809,0.09722222222222222,0.4104247817667349,1.0,5/20,14.79%,PLK2;SLC24A2;SLC24A1;ACHE;PNKD
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,0.5088019398046633,1.380863346535078,0.04,0.7637713122912491,1.0,22/65,20.89%,H2BC18;NUP42;NUP37;H2BC21;H2BC4;NUP54;RNF103-CHMP3;SNF8;VPS37A;H2AC6;NDC1;NUP214;CHMP2B;VPS37B;AAAS;NUP188;NUP205;CHMP6;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.9141046699187118,1.3808543378875626,0.019230769230769232,0.7615182995706259,1.0,1/5,3.02%,SDC4
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.5545598644674545,-1.3807347078466412,0.011363636363636364,0.41102064300942903,1.0,46/147,14.75%,GGT5;S100A10;COL4A1;ANGPTL2;APOLD1;APLNR;SPARC;C1R;TGFBR2;ICAM1;PROX1;PDPN;ABCA8;RAMP3;USHBP1;PODXL;F8;COX7A1;CASZ1;LMOD1;BGN;PODN;CYP1B1;LDB2;HEXIM1;CLIC4;EMP1;CD9;IGFBP7;CD55;ADIRF;BMX;CFH;PRKCH;PROCR;C1QTNF1;SLCO2A1;RNASE1;PCDH12;RASL12;MMRN2;C1S;EGFL7;ROBO4;MFSD2A;SRGN
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Plasma,-0.645835250655854,-1.3804698752579578,0.07575757575757576,0.41117074788006747,1.0,12/30,17.69%,GAB3;TUBB1;ARHGAP15;GYPE;GFI1B;GP6;GATA1;CA1;ANK1;RHD;PRKCB;CR1L
prerank,CellMarker_Augmented_2021__Erythroblast:Fetal Liver,-0.645835250655854,-1.3804698752579578,0.07575757575757576,0.41117074788006747,1.0,12/30,17.69%,GAB3;TUBB1;ARHGAP15;GYPE;GFI1B;GP6;GATA1;CA1;ANK1;RHD;PRKCB;CR1L
prerank,Reactome_2022__Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,0.7022009301574585,1.3803050535622439,0.05405405405405406,0.7623123202009264,1.0,4/11,22.04%,AKT1;WASL;ZDHHC21;DDAH1
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),-0.9081797889846484,-1.3801282618434618,0.031746031746031744,0.4116524838758561,1.0,1/5,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.7369732393032384,1.379996674157432,0.09523809523809523,0.7619050265631038,1.0,1/7,0.30%,ACE2
prerank,CellMarker_Augmented_2021__Parietal Progenitor cell:Stomach,-0.8932778391730603,-1.3795192343285785,0.037037037037037035,0.4137309048428041,1.0,1/5,0.18%,ANXA1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.7381410580785158,1.3794417522912221,0.09302325581395349,0.7625275565925307,1.0,6/11,20.09%,ARV1;ABCA1;RELCH;STARD4;NPC2;SERAC1
prerank,Reactome_2022__Lagging Strand Synthesis R-HSA-69186,0.7275179642899507,1.379376503290359,0.02631578947368421,0.7604696774690706,1.0,4/17,5.74%,POLD3;SLC19A1;DNA2;RFC3
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Adipose Tissue,-0.5762015517638964,-1.379095812466784,0.0125,0.41196721296975813,1.0,22/91,17.65%,COL4A1;ANGPTL2;CALD1;COL4A2;CSPG4;LAMB1;COL5A1;COL27A1;BGN;MAP1B;SCARA3;EDIL3;NUAK1;DAB2IP;FN1;AMOTL2;TNS2;PLAT;COL12A1;MCAM;AFAP1L1;LARP6
prerank,CellMarker_Augmented_2021__Progenitor cell:Fetal Liver,-0.5762015517638964,-1.379095812466784,0.0125,0.41196721296975813,1.0,22/91,17.65%,COL4A1;ANGPTL2;CALD1;COL4A2;CSPG4;LAMB1;COL5A1;COL27A1;BGN;MAP1B;SCARA3;EDIL3;NUAK1;DAB2IP;FN1;AMOTL2;TNS2;PLAT;COL12A1;MCAM;AFAP1L1;LARP6
prerank,CellMarker_Augmented_2021__Tumor-propagating cell:Undefined,-0.5762015517638964,-1.379095812466784,0.0125,0.41196721296975813,1.0,22/91,17.65%,COL4A1;ANGPTL2;CALD1;COL4A2;CSPG4;LAMB1;COL5A1;COL27A1;BGN;MAP1B;SCARA3;EDIL3;NUAK1;DAB2IP;FN1;AMOTL2;TNS2;PLAT;COL12A1;MCAM;AFAP1L1;LARP6
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone,-0.5762015517638964,-1.379095812466784,0.0125,0.41196721296975813,1.0,22/91,17.65%,COL4A1;ANGPTL2;CALD1;COL4A2;CSPG4;LAMB1;COL5A1;COL27A1;BGN;MAP1B;SCARA3;EDIL3;NUAK1;DAB2IP;FN1;AMOTL2;TNS2;PLAT;COL12A1;MCAM;AFAP1L1;LARP6
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Molar,-0.5762015517638964,-1.379095812466784,0.0125,0.41196721296975813,1.0,22/91,17.65%,COL4A1;ANGPTL2;CALD1;COL4A2;CSPG4;LAMB1;COL5A1;COL27A1;BGN;MAP1B;SCARA3;EDIL3;NUAK1;DAB2IP;FN1;AMOTL2;TNS2;PLAT;COL12A1;MCAM;AFAP1L1;LARP6
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone Marrow,-0.5762015517638964,-1.379095812466784,0.0125,0.41196721296975813,1.0,22/91,17.65%,COL4A1;ANGPTL2;CALD1;COL4A2;CSPG4;LAMB1;COL5A1;COL27A1;BGN;MAP1B;SCARA3;EDIL3;NUAK1;DAB2IP;FN1;AMOTL2;TNS2;PLAT;COL12A1;MCAM;AFAP1L1;LARP6
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.6189847269196033,1.3790766942433408,0.13333333333333333,0.7603348970615925,1.0,7/24,14.50%,RANBP17;NUP42;STYX;RANBP3L;XPO1;NUP214;XPO7
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.5971161412229963,-1.3788830310409121,0.024691358024691357,0.4123330637753089,1.0,14/63,15.97%,COL4A1;CALD1;COL4A2;COL5A1;COL6A2;LMOD1;BGN;RSPO3;ITGA8;IGFBP7;IGFBP5;PTH1R;PLAT;COL12A1
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.7522480127284024,-1.3784640135701411,0.04477611940298507,0.4136781910071207,1.0,6/16,13.20%,IFI6;CEACAM1;EGF;RHBDF2;WDR54;RHBDF1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.6716431770971159,1.378182002517299,0.10256410256410256,0.763289275741173,1.0,2/14,6.66%,ABCA1;ABHD5
prerank,Reactome_2022__Long-term Potentiation R-HSA-9620244,-0.7077468471740559,-1.3781789390792052,0.11267605633802817,0.41438038228087104,1.0,5/23,7.31%,GRIN2D;NEFL;GRIN2A;GRIA1;NRGN
prerank,Reactome_2022__Modulation By Mtb Of Host Immune System R-HSA-9637628,-0.8664661229662847,-1.3780342480563892,0.07017543859649122,0.41325295606145734,1.0,3/7,2.23%,TLR2;B2M;RPS27A
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8664661229662847,-1.3780342480563892,0.07017543859649122,0.41325295606145734,1.0,3/7,2.23%,TLR2;B2M;RPS27A
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8664661229662847,-1.3780342480563892,0.07017543859649122,0.41325295606145734,1.0,3/7,2.23%,TLR2;B2M;RPS27A
prerank,Reactome_2022__RAF Activation R-HSA-5673000,0.5748547295149351,1.3777750082476121,0.09090909090909091,0.762885044278636,1.0,14/30,33.80%,NRAS;SHOC2;PPP2R5A;PPP1CC;PHB1;MAP2K2;BRAF;PPP2R1B;ARAF;PPP2R5B;CAMK2D;PPP2R1A;PPP2R5E;MARK3
prerank,Reactome_2022__RNA Polymerase I Promoter Opening R-HSA-73728,0.718183729150766,1.377739923352036,0.14705882352941177,0.7608498568808469,1.0,6/13,14.32%,H2BC21;H2BC4;UBTF;H2AC6;H3-3B;DPEP2
prerank,CellMarker_Augmented_2021__Neuron:Adipose Tissue,-0.566785004700049,-1.3777212015686782,0.0641025641025641,0.4140327963318028,1.0,25/96,15.88%,TAGLN3;STMN2;ELAVL2;SNCB;SH3GL2;ZDHHC22;SLITRK1;SYT4;MAP1B;JPH3;GAP43;SYT1;CPLX2;NYAP1;PLPPR5;HPCA;STMN4;C11ORF87;CRMP1;TMEM151A;GABRG2;CNTN2;KCNC1;GDAP1L1;PHYHIP
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Lung,-0.6535331833947331,-1.3771969482488602,0.02857142857142857,0.4156742303155962,1.0,14/36,13.52%,CP;IL1R1;C3;SFTPD;DUOX1;DUOXA1;ARHGEF38;CD44;CLDN18;TMC4;CAPN8;MVP;SLCO2A1;CXCL17
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.8239494100250361,1.3770552943045242,0.07894736842105263,0.7622138382575042,1.0,4/7,12.01%,PPP1R3D;PPP1R3G;AKT1;PPP1R3F
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.8707256264235183,-1.3768559295781273,0.05454545454545454,0.4164887522537236,1.0,1/7,2.14%,KMO
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.8071621314556404,-1.3766180757659785,0.08771929824561403,0.41708558403599316,1.0,3/6,18.14%,APP;DCTN1;MAPT
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.808546949705057,-1.3763884734632075,0.030303030303030304,0.4175059846528479,1.0,3/13,2.16%,HPN;COL4A1;LAMB1
prerank,Reactome_2022__Maturation Of Protein 3A R-HSA-9683673,-0.8536347957922655,-1.37617273845419,0.05357142857142857,0.4177507156776638,1.0,1/8,0.17%,ST6GAL1
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.6581914550755741,-1.376064528308805,0.07547169811320754,0.4176597258650042,1.0,7/28,15.30%,THBS1;CDKN2A;APOD;PLET1;DMTN;SEMA3E;DLC1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.6937456844962533,1.3759674999402938,0.12121212121212122,0.7655187143166711,1.0,3/18,5.86%,DGKB;DGKE;MOGAT1
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.6602930802054303,-1.3758124721901195,0.031746031746031744,0.41838526725357644,1.0,19/35,21.57%,MYO1F;TLR2;CIITA;TAGAP;GPNMB;SIGLEC1;HLA-DRA;IGSF6;CTSS;ACHE;HLA-F;CD74;HLA-DRB1;PRKCB;WDFY4;NAPSB;SPI1;PTPRC;PTAFR
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.7254383169565202,1.3758108819183448,0.17073170731707318,0.7640763896452819,1.0,2/9,5.99%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.8089536194836875,1.3756167656129843,0.17073170731707318,0.7629975113764098,1.0,2/7,2.60%,DIRAS3;KDM1B
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.7101799046552826,1.3755223909457956,0.08571428571428572,0.7613451322395065,1.0,1/16,1.07%,LIMD1
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Tonsil,-0.6243087955666442,-1.3754788869995127,0.025974025974025976,0.41913545433912497,1.0,21/66,17.04%,S100A10;IL13RA1;A4GALT;MYOF;ITGA2;KLF4;CCND1;CDC42EP1;EMP1;SPSB1;CD9;ADIRF;MYO1E;SLC44A3;CD63;RHBDF1;DSTN;LAMA3;ITGB4;RHOD;PXDC1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8608136568437287,-1.375226863477901,0.06779661016949153,0.41876402040853683,1.0,5/6,13.21%,HLA-A;HLA-C;HLA-B;HLA-E;HLA-F
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8608136568437287,-1.375226863477901,0.06779661016949153,0.41876402040853683,1.0,5/6,13.21%,HLA-A;HLA-C;HLA-B;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.7076578716860031,-1.3752170650582243,0.078125,0.41820655485716945,1.0,2/12,5.06%,ANXA1;KLF4
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.9046462114507953,-1.3747515195293654,0.08163265306122448,0.41972331966748644,1.0,3/5,5.62%,CIITA;NLRP12;NLRC5
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.6847294538764142,-1.3745082869436982,0.046875,0.4200682497447255,1.0,6/20,8.36%,IHO1;STAG3;MEIOB;RNF212B;SYCE2;SYCE1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),-0.9001932932070094,-1.3744895032119793,0.09615384615384616,0.419524555581073,1.0,1/5,1.11%,APLNR
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.6077755903277426,-1.374481447943298,0.09859154929577464,0.4189824038122109,1.0,5/30,14.80%,C3;B2M;LRPAP1;FLOT1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.8250848965722758,-1.3743975413611278,0.11764705882352941,0.41870600572069216,1.0,3/7,8.24%,RAMP3;CCL2;GRM6
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.6065896737472793,-1.3743972459124392,0.0410958904109589,0.4181137765754012,1.0,15/82,14.33%,COL4A1;ANGPTL2;FABP3;LAMB1;COX7A1;SULF1;LMOD1;PLD1;CAV3;TNNT1;IL4R;PRKCQ;PRRX1;RASL12;ITGA3
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.6973386757863959,-1.374386589909876,0.05084745762711865,0.41756274111258285,1.0,5/22,11.20%,EFNA1;P2RY12;TESC;CYP1B1;SYK
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.7754581722363991,-1.3743364768204134,0.06779661016949153,0.4171842749532327,1.0,4/13,7.93%,ANK3;TESC;GLRX;ATP1B1
prerank,CellMarker_Augmented_2021__Proerythroblast:Germ,-0.6451316652268253,-1.3741368974610204,0.0821917808219178,0.4176213356806223,1.0,15/33,22.63%,ICAM1;SIGLEC1;EHBP1L1;ADCY7;GAB3;TNFRSF14;CTSS;CTSZ;FES;SRGN;FERMT3;WDFY4;SPI1;SH2B3;FPR3
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.7891905162172042,-1.373839247886961,0.08196721311475409,0.41828017278257146,1.0,1/10,1.11%,APLNR
prerank,Reactome_2022__Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,-0.7219097789851875,-1.3738326930599385,0.07042253521126761,0.41773199932206223,1.0,3/21,4.48%,GRIN2D;NEFL;GRIN2A
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.6814186176487737,1.3734140804057098,0.125,0.7697848093102734,1.0,4/16,12.58%,COX18;COX10;SMIM20;COX19
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.7883043230912141,1.3725318048471453,0.06818181818181818,0.7723171841625759,1.0,3/9,9.95%,OTUD3;TNFAIP3;OTUB2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colorectum,-0.7448388110510485,-1.3723910421783976,0.1111111111111111,0.42328119881534476,1.0,3/13,10.74%,CD24;CD44;LGR5
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.7370288183899245,-1.3720851232028948,0.058823529411764705,0.4232972987435067,1.0,8/20,18.15%,ALDOB;HK2;GAPDHS;PGK1;GPI;PFKL;PGAM1;ENO2
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.7370288183899245,-1.3720851232028948,0.058823529411764705,0.4232972987435067,1.0,8/20,18.15%,ALDOB;HK2;GAPDHS;PGK1;GPI;PFKL;PGAM1;ENO2
prerank,CellMarker_Augmented_2021__Eosinophil:Blood,-0.8377557596806265,-1.3720557521363224,0.05660377358490566,0.4227842596919096,1.0,4/8,14.46%,ICAM1;CD44;IL4R;IL3RA
prerank,CellMarker_Augmented_2021__Stem cell:Fetal Liver,-0.5619736489728044,-1.371672020228409,0.05194805194805195,0.4239246949241846,1.0,12/85,6.98%,KCNT2;COL4A1;ANGPTL2;SPARC;COL4A2;STMN2;THY1;BGN;MAP1B;GRIA3;GAP43;LDB2
prerank,CellMarker_Augmented_2021__Serotonergic neuron:Undefined,-0.6202539338620421,-1.3714375789043176,0.09230769230769231,0.42416563676486574,1.0,9/39,10.36%,NPY;RIMBP2;CHGB;MYT1;SYT4;ELAVL4;SYP;CPLX1;SST
prerank,Reactome_2022__Interleukin-21 Signaling R-HSA-9020958,-0.8233957259643407,-1.3714059385585609,0.08620689655172414,0.42370541876704715,1.0,2/7,9.67%,STAT4;STAT1
prerank,Reactome_2022__Triglyceride Biosynthesis R-HSA-75109,0.8394538256240418,1.3713037956693217,0.07894736842105263,0.7764956306476991,1.0,4/8,10.13%,AGMO;GK;MOGAT1;LPIN3
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.4944054414480053,1.3712555303178608,0.0,0.7745373424271833,1.0,21/70,25.97%,DERL2;TMUB2;VCP;RNF103-CHMP3;ECPAS;AUP1;STT3B;DERL1;FBXO27;TMEM129;UBE4A;ERLIN1;DNAJB14;RHBDD2;DNAJC18;TMUB1;SEL1L;UBQLN1;DNAJB12;DNAJB2;UBE2J2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.6793665745841528,-1.3711071757650457,0.09090909090909091,0.42432166226306484,1.0,9/26,13.03%,SCN1B;KCNQ1;PKP2;KCNJ2;ATP1A1;ATP1B1;CACNA1C;SCN1A;SCN3B
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.6079059857443316,-1.3709141437934556,0.0547945205479452,0.42457398703963,1.0,9/54,7.78%,TLCD2;A4GALT;MYOF;ANK3;COL5A1;DYSF;CAV3;FA2H;PLSCR1
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,0.5709730487996927,1.3708589740081754,0.08571428571428572,0.7742093112160451,1.0,17/52,19.36%,CNOT9;EXOSC1;DCP1B;EXOSC6;EIF4E;DIS3;EDC3;CNOT2;LSM5;LSM7;PAIP1;CNOT8;CNOT6L;CNOT1;EXOSC8;CNOT4;PATL1
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.690778109905141,-1.3708583476138851,0.06451612903225806,0.4242055426306646,1.0,4/24,9.10%,CACNA1H;KCNB1;SYT4;SYT1
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.7149240982466648,1.3707444133177722,0.08333333333333333,0.7727432798324286,1.0,3/13,10.09%,ZNF207;FBXO5;PLK1
prerank,Reactome_2022__Glutamate And Glutamine Metabolism R-HSA-8964539,0.7097883647921126,1.3707280889475972,0.16216216216216217,0.770685513065061,1.0,4/10,16.49%,OAT;GLUD1;RIMKLB;GLUL
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.7345438326274518,-1.3706410694774795,0.125,0.4245218313328811,1.0,4/16,5.68%,APLNR;RAMP3;CEMIP;THY1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.5970783115343351,-1.3705707290820857,0.0945945945945946,0.42437347831658334,1.0,10/45,12.78%,THBS1;RASGRP1;TLR2;APP;TLR3;WNT5A;SYK;HLA-E;IFIH1;FADD
prerank,CellMarker_Augmented_2021__Neural Stem cell:Brain,-0.6676267285056132,-1.3705655078449317,0.08928571428571429,0.42380100026322715,1.0,1/19,0.05%,CD24
prerank,CellMarker_Augmented_2021__Gonocyte:Gonad,-0.6579035325498929,-1.3703336768810013,0.03076923076923077,0.42387955087382784,1.0,4/28,8.68%,PIF1;RPL39L;ZNF850;LRRK1
prerank,CellMarker_Augmented_2021__Ovarian Germ Stem cell:Ovary,-0.6579035325498929,-1.3703336768810013,0.03076923076923077,0.42387955087382784,1.0,4/28,8.68%,PIF1;RPL39L;ZNF850;LRRK1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.8851752104427009,-1.3701685233483476,0.07407407407407407,0.4240147517922245,1.0,2/6,2.83%,NOS1AP;LRRC55
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,-0.6686815733357564,-1.369827437851783,0.057971014492753624,0.4246741393678636,1.0,10/26,18.67%,CXCL2;ACKR4;CCL2;TNFRSF14;IL18;CCR10;TNFRSF1A;LTBR;CCL28;TNFRSF10A
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.6686808830810504,1.3695441457073456,0.10344827586206896,0.7745585690254028,1.0,4/19,9.29%,SOX8;BMP2;LIG4;STIL
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.7346438929628578,-1.3694768442923742,0.01639344262295082,0.4253061672799165,1.0,5/17,11.30%,CACNA1H;ANK3;SCN9A;SCN2A;SCN1A
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.804510641283836,1.369344671112157,0.10204081632653061,0.7733235455655689,1.0,3/9,8.68%,DSCAM;RORB;CEP290
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.6668731529090051,-1.3693313366964084,0.05714285714285714,0.42541334357666066,1.0,10/31,17.36%,SLC28A2;ABO;ALDOB;SLC18A2;VIL1;SLC3A1;CYP3A4;ADH4;CDH17;CYP3A5
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,-0.6948694526426541,-1.3693307233765035,0.030303030303030304,0.4248321778067472,1.0,8/26,17.42%,SCN1B;SCN9A;SCN2A;CACNA1C;SCN1A;SCN3B;CACNB1;FGF12
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.6823613822492518,-1.3692532464711669,0.04838709677419355,0.4245707044957329,1.0,4/24,3.31%,TRIM22;CIITA;IFITM3;TRIM5
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.6057545201447346,-1.3692468865647793,0.024390243902439025,0.4240176841616334,1.0,17/74,8.11%,CD24;ST6GAL1;IL1R1;CDKN2A;PGR;ICAM1;PSCA;ITGA2;POF1B;OVOL2;PLEKHG6;ITGA5;BRCA1;ANLN;CEACAM1;CRYBA1;BAIAP2L1
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.6589786935709557,-1.3687049452363726,0.07894736842105263,0.4259025806306193,1.0,4/36,2.09%,TLCD2;S100A10;RFTN1;ANK3
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.7204223156824556,1.3685252560020114,0.16666666666666666,0.7748195037272708,1.0,4/12,18.09%,RPP40;RPP14;RPP25L;POP1
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.7598580810706494,1.3683935282404027,0.14893617021276595,0.77327830692784,1.0,6/8,23.79%,NOTCH2;HEYL;HEY1;HEY2;JAG1;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.8286824429065456,1.368204315446425,0.09523809523809523,0.7723683806300078,1.0,2/5,12.81%,HSPA1A;SLC25A5
prerank,Reactome_2022__Removal Of Flap Intermediate R-HSA-69166,0.7389180423361186,1.3677603864886638,0.08888888888888889,0.7723329747408659,1.0,2/11,1.45%,POLD3;DNA2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.6731492934132765,-1.3676264342909865,0.07352941176470588,0.430367525594526,1.0,9/24,13.21%,B2M;HLA-A;IL12A;HLA-DRA;HLA-B;CD55;HLA-E;FADD;HLA-F
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Salivary Gland,-0.5854162016449802,-1.3670632076309561,0.06578947368421052,0.4322893120555913,1.0,13/72,11.27%,COL4A1;TUBB6;MET;COL4A2;LAMB1;ITGA2;PDPN;MMP14;SRPX2;P3H2;OSMR;WNT5A;FN1
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,0.638132695444442,1.36704732425886,0.1,0.7740011098393789,1.0,6/18,16.08%,H2BC21;H2BC4;H2AC6;ORC5;H3-3B;SLC25A15
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.8543305201923003,-1.3669599506167651,0.017857142857142856,0.432183800529861,1.0,3/9,2.47%,SP100;MX1;IFIT1
prerank,CellMarker_Augmented_2021__Luminal progenitor:Breast,-0.9132901534784941,-1.3668387233445167,0.034482758620689655,0.4320533326357745,1.0,2/5,7.03%,CD24;CD44
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.7126967665366613,-1.3668053776364737,0.109375,0.43168374316432967,1.0,5/26,5.16%,SCN1B;KCNQ1;PKP2;KCNJ2;CTNNA3
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.823224648101488,-1.3667913252956223,0.15254237288135594,0.43113893469703635,1.0,3/9,12.77%,RPS27A;ISG15;UBC
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.5677924700187409,-1.3667513386163648,0.0410958904109589,0.43070872410526134,1.0,27/74,19.24%,CD24;ACKR4;GPR18;TRPC3;CAV3;JPH3;ITPR3;S1PR3;CACNA1C;ADCY5;CD55;LPAR6;LPAR4;C1QTNF1;P2RY10;CCR10;TAC4;GLP1R;CIB2;JPH4;HTR2C;ADCY8;RYR2;GPER1;PLCE1;PDGFRA;CD36
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryo,-0.6682879192667346,-1.3666106146506847,0.07246376811594203,0.43068136800803575,1.0,10/31,13.15%,P2RY13;RAMP3;GPR34;SLA;SIGLEC1;HLA-DRA;F13A1;SELP;RNASE1;PCDH12
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.7138179947218887,-1.3663401955925103,0.06557377049180328,0.43131850097366087,1.0,3/17,7.37%,SULT1C3;TPST1;PAPSS2
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),-0.8183241755900198,-1.3662841877610992,0.03333333333333333,0.4303996992324893,1.0,1/8,0.67%,KCNQ1
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),-0.8183241755900198,-1.3662841877610992,0.03333333333333333,0.4303996992324893,1.0,1/8,0.67%,KCNQ1
prerank,PanglaoDB_Augmented_2021__Neurons,-0.5360898489915974,-1.366215858443643,0.0,0.4301606447758192,1.0,70/259,15.75%,NPY;TAGLN3;CDH22;PCSK2;NRN1;STMN2;PPP1R14C;CCK;NEFM;PROX1;TCEAL3;SNCB;KCNK1;TESC;MATN2;SH3GL2;ZDHHC22;SLITRK1;LRRTM1;BEX1;SYT4;SLC32A1;SRRM4;ELAVL4;GRIA3;SPOCK3;GAP43;HAP1;NRGN;IFIT3;TCEAL6;ZIC1;SYP;RIT2;NEFH;NCALD;VSNL1;ARHGDIG;CPLX1;IGF1;CPLX2;CA10;HPCA;TCEAL2;SCN2A;OGFOD1;MEG3;SCN1A;CALY;STMN4;GAD1;C11ORF87;GNG2;SYNPR;SCN3B;SLC11A1;GAD2;RGS7BP;MAP7D2;GABRG2;NMT1;TMEM130;CNTN2;KCNC1;GDAP1L1;PCP4;SYT5;RGS17;RAB3C;GABRA1
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.508423290545103,-1.3658896357170314,0.0,0.43125642360749117,1.0,71/265,17.42%,ZIC4;GRIN2D;NPY;TAGLN3;CDH22;PCSK2;NRN1;STMN2;L1CAM;PDE4A;CCK;NEFM;TCEAL3;SNCB;RAMP3;SH3GL2;ZDHHC22;SLITRK1;LRRTM1;SYT4;VLDLR;ELAVL4;CALN1;SPOCK3;GAP43;HAP1;NRGN;TCEAL6;SYP;RIT2;NCALD;TMEM163;IGSF21;PRKCG;CPLX1;SYT1;CPLX2;CA10;PLPPR5;HPCA;SST;TCEAL2;SHISA9;STMN4;GAD1;C11ORF87;EID2;SYNPR;NOS1;ELMO1;SHISA8;GAD2;RGS7BP;VIP;GABRG2;SEMA3E;CNTN2;KCNC1;GDAP1L1;RGS17;RAB3C;PRKCD;RELN;CACNB1;TCEAL5;SYT13;SV2B;ADCY8;PRKCB;SULT4A1;FGF12
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6331228522468717,-1.365836882519079,0.04054054054054054,0.4308674341827815,1.0,14/43,18.48%,NR4A3;ALDOB;LDHA;SLC16A3;HK2;PDHX;GAPDHS;PGK1;ENO4;GPI;PFKL;PGAM1;ENO2;PCK2
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.7897124754938252,-1.3654325564048277,0.06779661016949153,0.43189716928747085,1.0,1/8,2.77%,PROX1
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.6162056275430643,1.3648093339962708,0.11904761904761904,0.7849258246778062,1.0,7/23,20.00%,GPATCH2;PPP1R36;PPP1R26;ZCCHC9;PPP1R1B;STYXL1;PPP4R4
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.5848175515718377,-1.3647354308096076,0.05,0.4343772194612552,1.0,24/83,16.60%,IL1R1;IL13RA1;TYMP;ICAM1;FOSL2;ZFP36;KLF4;HLA-C;SYNGR2;FBP1;RHBDF2;IL4R;HELZ2;IER3;TMBIM1;SBNO2;CTSZ;IFIH1;MVP;TNFRSF1A;TNFAIP2;LTBR;JUNB;CEBPD
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryo,-0.6366465007587221,-1.3646907038103269,0.07894736842105263,0.4339112151889663,1.0,5/37,10.81%,CD24;CHST4;PODXL;LRRK1;ALPL
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.8809100228573736,1.363950207791798,0.030303030303030304,0.7871359052801233,1.0,2/5,10.96%,PPP1R15B;NCK1
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.6405982011547623,-1.3639087301369333,0.07246376811594203,0.4365306392397107,1.0,9/37,13.61%,SLC32A1;SYN3;SYN2;CPLX1;SYT1;CPLX2;RIMS2;GAD1;GAD2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.7464314014685833,-1.36365848502041,0.0625,0.43702786571034746,1.0,3/13,7.04%,C3;NR4A3;ACSL5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.8031300253657349,-1.3634942235418146,0.11764705882352941,0.4370666956652564,1.0,4/9,11.79%,RFTN1;IL15;PRKCQ;IL18
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.5943859610875627,-1.363357078274711,0.0759493670886076,0.4371300972066162,1.0,12/53,11.12%,THBS1;ISM1;SPARC;COL4A2;SERPINF1;CD160;SULF1;KLF4;STAT1;THBS2;PGK1;DAB2IP
prerank,CellMarker_Augmented_2021__Activated B cell:Undefined,-0.6894578956442786,-1.3633509975752132,0.04918032786885246,0.43657728833219084,1.0,9/27,10.15%,MYO1F;DOCK8;TAGAP;TMC8;ARHGAP9;HLA-DRA;WAS;LAT2;CTSS
prerank,Reactome_2022__Apoptotic Cleavage Of Cell Adhesion Proteins R-HSA-351906,0.8231060767555225,1.3632199315111784,0.17073170731707318,0.7889961072939706,1.0,2/6,11.67%,OCLN;CASP3
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.7023160882750835,1.3632060894308684,0.11363636363636363,0.7868636853823653,1.0,2/12,1.38%,ASCL1;SOX8
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.7517857529545355,-1.3628304662308814,0.058823529411764705,0.43842533578527015,1.0,5/12,21.26%,NLRP12;PTK6;HHIP;GLRA1;OPTN
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.874642727983864,-1.3624632843385407,0.06666666666666667,0.43931001896126637,1.0,4/7,11.12%,TLR2;PRDX4;TLR3;DAB2IP
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.6575323909267238,-1.3624089710025813,0.03225806451612903,0.43898969614986993,1.0,10/34,10.34%,CP;FMO6P;C1ORF87;POF1B;DUOX1;ZNF750;DUOXA1;FUT2;TMC4;CLCA4
prerank,CellMarker_Augmented_2021__Pericyte:Skeletal Muscle,-0.5782932614802496,-1.3620249563868077,0.04878048780487805,0.43999387363548087,1.0,28/81,18.20%,ENPP2;APLNR;SPARC;ABCA8;RAMP3;PLXDC1;PLN;PODN;LDB2;MYH11;ELN;ITGA8;GALNT15;CACNA1C;AEBP1;ELMO1;PCDH12;TMEM132C;ROBO4;ADAMTS4;MCAM;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ITIH5;A2M
prerank,Reactome_2022__Interleukin-35 Signaling R-HSA-8984722,-0.76251686749583,-1.3614220241780155,0.06451612903225806,0.4419623764833778,1.0,7/11,22.98%,IL12A;STAT4;STAT1;IL27RA;IL12RB2;TYK2;STAT3
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7433884746137321,-1.3609042493576815,0.08823529411764706,0.4437668078097425,1.0,2/16,3.27%,RPS27;RPS14
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.7983240639999111,-1.3608907079242016,0.09836065573770492,0.4432714169977315,1.0,2/13,2.20%,ANXA1;ZFP36
prerank,Reactome_2022__Synthesis Of Leukotrienes (LT) And Eoxins (EX) R-HSA-2142691,-0.7738543032669211,-1.360828102760545,0.11666666666666667,0.4430455456021352,1.0,1/11,0.04%,GGT5
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.6857983251916304,-1.3605516931664214,0.0625,0.4438065277353785,1.0,4/26,10.14%,KCNQ1;KCNJ13;KCNJ2;CHRM3
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.6420451276260066,1.360018753507099,0.12195121951219512,0.8009050685069453,1.0,7/17,19.61%,MTHFS;SLC19A1;MTHFD2L;DHFR;DHFR2;SLC46A1;PM20D2
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,-0.5647657654099087,-1.3599029585333455,0.024390243902439025,0.4461585145331588,1.0,36/117,15.75%,NPY;TAGLN3;CDH22;STMN2;CCK;SNCB;SH3GL2;PLP1;SLITRK1;LRRTM1;SYT4;ELAVL4;GAP43;GFAP;NRGN;TCEAL6;RIT2;ZNF536;ARHGDIG;CPLX2;CA10;HPCA;SST;TCEAL2;SCN2A;STMN4;C11ORF87;SYNPR;SCN3B;GAD2;RGS7BP;GABRG2;CNTN2;KCNC1;RAB3C;GABRA1
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.7273351003552654,1.3598916960653977,0.10256410256410256,0.7994833884377859,1.0,4/8,24.16%,TMX3;PRDX3;CHCHD4;LOXL2
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,-0.6602009909787732,-1.3598450494311802,0.05194805194805195,0.4458447554933152,1.0,7/38,7.95%,CACNA1H;ANXA1;CALD1;LMOD1;DYSF;CAV3;MYH11
prerank,KEGG_2021_Human__Leishmaniasis,-0.6410518624029656,-1.359752898920239,0.07352941176470588,0.4457016128032068,1.0,12/43,17.95%,C3;TLR2;IL12A;HLA-DRA;IFNGR2;STAT1;FOS;EEF1A2;HLA-DRB1;PRKCB;CR1L;TGFB1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.4981779450573775,1.3597027866380855,0.04,0.7984643850575736,1.0,11/67,12.64%,RANBP17;NXT2;NUP62CL;PPP1R10;SNRPF;AKT1;IPO5;IPO8;NUP214;NXT1;RANBP6
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.6770885779143239,1.3595608231978837,0.09090909090909091,0.796814373480378,1.0,10/17,24.80%,GREM1;SOX9;ADAMTS12;TRPS1;SOX5;MDK;EFEMP1;BMPR1B;LOXL2;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.5821752366685987,-1.3595102854343668,0.041666666666666664,0.44615237125259644,1.0,6/43,11.17%,NLRP12;KLF4;THY1;PIM3;PTK6;HHIP
prerank,CellMarker_Augmented_2021__Theca Interna cell:Ovarian Follicle,-0.5967051250317783,-1.3595015364759129,0.0821917808219178,0.4456341897699947,1.0,28/71,14.02%,ECM2;ANGPTL2;OGN;C1R;SERPINF1;ABCA8;C1QTNF7;RAMP3;ASPN;COX7A1;PLN;LMOD1;BGN;PODN;OMD;LDB2;MYH11;OLFML1;ELN;ITGA8;IGF1;GALNT15;SLIT3;AEBP1;SFRP4;PRRX1;RASL12;C1S
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.8680875735093865,1.3594694653599106,0.02564102564102564,0.7949011218821479,1.0,1/5,3.54%,ADIPOR1
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5887091189872254,1.3593342095394056,0.05714285714285714,0.7935708265837326,1.0,7/31,17.28%,RNF6;RUNX1;RNF14;AR;EP300;NCOA2;UFM1
prerank,CellMarker_Augmented_2021__Liver Stem cell:Fetal Liver,-0.5639207693863618,-1.3590526289023885,0.03614457831325301,0.44686916289853057,1.0,15/86,13.20%,COL4A1;ANGPTL2;CALD1;COL4A2;LAMB1;COL5A1;THY1;BGN;SCARA3;THBS2;NUAK1;FN1;IGFBP5;AMOTL2;RHBDF1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.7296399700640562,-1.35897558853376,0.06060606060606061,0.44667717234920085,1.0,3/21,11.45%,S100A10;THY1;MAPRE2
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.5803286371396743,-1.3588393009982316,0.0547945205479452,0.4466784818195506,1.0,7/56,6.53%,CACNA1H;NR4A3;LMO2;RAMP3;AKR1C1;ATP1A1;GATA1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.5964835922209302,-1.3588244478711382,0.05063291139240506,0.44613822657707375,1.0,13/68,12.78%,THBS1;RASGRP1;TLR2;ZFP36;ARG2;APP;TLR3;IGF1;WNT5A;SYK;HLA-E;IFIH1;FADD
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Fetal Pancreas,-0.5760050929932966,-1.3588190660923378,0.04878048780487805,0.445575325369672,1.0,23/94,20.78%,TAGLN3;NEFL;NEFM;CNTNAP1;SNCB;GNG3;GAP43;TMCC2;SYP;NYAP1;HPCA;TCEAL2;CALY;TMEM151A;CACNB1;CCDC184;PTPRN;ENO2;FSD1;SYNGR3;PRR36;STX1B;NAP1L3
prerank,Reactome_2022__Axon Guidance R-HSA-422475,-0.5044430169290748,-1.3586679208346886,0.0,0.4456380664574415,1.0,112/463,17.95%,CACNA1H;CD24;COL4A1;EFNA1;SCN1B;FLRT3;RPL19;COL4A2;RPL3;L1CAM;ANK3;LAMB1;RPS27A;RPL39L;RPL36AL;RPS27;ITGA2;SHTN1;COL4A4;CNTNAP1;RPS14;RPS4X;RPL27A;SH3GL2;SCN9A;DOK1;COL6A2;RPL35;ITGA5;RPL7A;GFRA2;TRPC3;RPL37A;VLDLR;RPL27;EFNB3;GAP43;LDB2;ARHGAP39;AKAP5;RPL9;PSMB9;RPL21;MYH11;RPL13A;RPS6KA1;NELL2;PFN2;DOK6;RPS11;RPS16;RPLP1;SCN2A;RPS13;PSMB6;CACNA1C;UNC5B;RPL38;PRKCQ;SLIT3;SCN1A;RPS3A;RPS8;RPL10A;PSMC3;MYH9;RPLP2;RPS23;RPS21;RPS7;UBC;GRIN2B;RNASE1;CRMP1;SCN3B;RAP1GAP;ITGA9;RPL8;FES;SEMA3E;RPS6;ELOB;RPS15;PIK3CB;RPL26L1;CNTN2;RPS9;PSMA8;RPL12;APH1A;RPL5;RELN;DPYSL2;ANK1;CACNB1;TLN1;PSMA7;FAU;COL9A2;RPL23;RPL4;IRS2;SH3KBP1;GPC1;PSME1;CDK5;RPL18A;RBX1;RPL41;LIMK2;RPL7;RPS12
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.7250859985637663,-1.3584852399241927,0.07142857142857142,0.4458924588973418,1.0,8/21,18.15%,ALDOB;HK2;GAPDHS;PGK1;GPI;PFKL;PGAM1;ENO2
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lymph Node,-0.5964968410271957,-1.3584572229493026,0.0375,0.44537993256777736,1.0,7/50,4.84%,P2RY13;IPCEF1;MYO1F;RASGRP2;SLA;NLRP12;ARHGAP9
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.5268071025876951,-1.3581455734513976,0.0,0.44600468773542534,1.0,36/210,13.72%,ANXA1;CCBE1;IL1R1;RASGRP1;C3;RFTN1;TLR2;HLA-A;IL12A;IRF1;IL15;SULF1;APP;HTR2B;NOD1;BRCA1;TLR3;CYP1B1;TNFRSF14;ZFPM1;CHI3L1;WNT5A;IRF7;SCIMP;ISG15;HHLA2;PRKCQ;SYK;HLA-E;IL18;IFIH1;FLOT1;FADD;CXCL17;SLC11A1;IL7
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.6541255124818584,-1.358025981391244,0.06060606060606061,0.4459232508432757,1.0,2/26,2.09%,AMN;ANK3
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),0.8730743435975566,1.3572955288972062,0.0625,0.8020792758966424,1.0,1/5,0.41%,SLC6A13
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),-0.9318756779928374,-1.3571728507014975,0.020833333333333332,0.44920542744266545,1.0,1/5,0.99%,MET
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.844190861558634,-1.3571323595465086,0.11764705882352941,0.44881040562536956,1.0,4/7,14.25%,GRIN2D;GRIN2A;GRIN2B;PDLIM4
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.6155117400172652,1.3566242565161484,0.07407407407407407,0.8041555224759669,1.0,7/20,12.31%,PPP1R3D;PASK;PPP1R3G;AKT2;AKT1;PPP1R3F;EPM2AIP1
prerank,Reactome_2022__Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,0.6778135868140533,1.3566031105717158,0.09090909090909091,0.8020636477555795,1.0,4/13,15.95%,MAML3;KAT2B;KAT2A;EP300
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.515287239791126,-1.35631664195861,0.0,0.45190207858639087,1.0,37/202,19.17%,ENPP2;LEF1;THBS1;LAMB1;SHTN1;PDPN;GPNMB;RAB11A;PODXL;SEMA3B;CEMIP;MMP14;EGF;ANGPTL3;VIL1;PLET1;IGF1;FGF1;DAB2IP;FN1;DMTN;F10;HYAL1;SEMA3E;DDRGK1;PIK3CD;MGAT5;RHOD;F3;SEMA4G;GPER1;TGFB1;FERMT3;HSPA5;NUMB;PDGFRA;MYO1C
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.6607834615130811,-1.3562220875289661,0.12857142857142856,0.45180166267141875,1.0,7/27,12.58%,TLR2;IRF1;TLR3;IRF7;ISG15;IFIH1;FLOT1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.8036388806169644,-1.3561957557697657,0.11666666666666667,0.4513455141137367,1.0,3/9,10.82%,PKP2;CTNNA3;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.8093859793498049,1.3559969968839998,0.058823529411764705,0.8037412314142289,1.0,4/8,5.99%,ABCD2;AKT2;PLIN5;ABCD1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.741258075862868,-1.3557636108090747,0.05,0.45294078131676835,1.0,5/19,10.82%,PKP2;NOS1AP;CTNNA3;CAV3;CACNA1C
prerank,Reactome_2022__Acyl Chain Remodelling Of PI R-HSA-1482922,0.750366339744151,1.3557412497914976,0.15151515151515152,0.8035059662853111,1.0,2/8,14.98%,PLA2G4C;PLBD1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.7939694077939148,-1.355706586002476,0.04918032786885246,0.45259087030371825,1.0,2/12,2.20%,ANXA1;ZFP36
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.8389794698775825,1.3555566889298434,0.038461538461538464,0.8021443671228596,1.0,2/5,1.63%,RGCC;BMP2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.8210622537667713,1.3554855311941387,0.06382978723404255,0.8003163531905345,1.0,1/6,0.60%,RGCC
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.7589458840645595,-1.355398538472989,0.07352941176470588,0.4533530346361172,1.0,4/17,10.55%,CCNB2;VRK2;LMNB1;CCNB1
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,-0.5989938101786063,-1.3553113132747936,0.06493506493506493,0.45305071239172545,1.0,13/41,23.48%,IL12A;STAT4;CA1;LMNB1;STAT1;TCP1;IL27RA;ANXA2;AURKAIP1;IL12RB2;TYK2;STAT3;GSTO1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6976000265532725,1.3547820383231566,0.25806451612903225,0.8026304135049438,1.0,3/8,6.69%,SOX9;PLIN5;AKT1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.8657748186353348,1.3546698594588376,0.09090909090909091,0.8012816983691616,1.0,2/6,5.86%,RGCC;ATF5
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.4948431441101113,1.354405226854007,0.0,0.8007621996241769,1.0,27/69,28.78%,INTS13;ZC3H8;SNAPC5;GTF2F2;GTF2A2;INTS7;SNAPC1;SNAPC3;INTS8;TAF8;POLR2C;POU2F1;INTS14;RPRD1B;CCNT1;CCNT2;TAF13;GTF2B;RPAP2;INTS4;POLR2A;INTS6;RPRD2;INTS9;INTS11;POLR2K;POLR2D
prerank,PanglaoDB_Augmented_2021__Basophils,-0.592713568018777,-1.3540650050227339,0.05063291139240506,0.45784298049637034,1.0,15/69,10.60%,P2RY13;MYO1F;GPR183;TLR2;L1CAM;SIGLEC1;CD44;SLC26A8;CLEC12A;F13A1;GRM6;IL4R;CTSS;PDK3;IGFBP7
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.49529227764164035,1.3540505031152898,0.0,0.8003918327002147,1.0,27/68,28.78%,INTS13;ZC3H8;SNAPC5;GTF2F2;GTF2A2;INTS7;SNAPC1;SNAPC3;INTS8;TAF8;POLR2C;POU2F1;INTS14;RPRD1B;CCNT1;CCNT2;TAF13;GTF2B;RPAP2;INTS4;POLR2A;INTS6;RPRD2;INTS9;INTS11;POLR2K;POLR2D
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.7646079382840054,1.3539013247979301,0.16326530612244897,0.7988256039010792,1.0,1/6,1.63%,BMP2
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.835098734871194,-1.3537659019171826,0.11320754716981132,0.45891358853698916,1.0,2/6,12.58%,HTR2B;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.8389028921691312,-1.3535023944017854,0.1206896551724138,0.45941694321256227,1.0,2/5,10.67%,SRF;LRPAP1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.6433185447367186,-1.353492026328154,0.041666666666666664,0.45892055943954047,1.0,5/33,6.29%,THBS1;SP100;ICAM1;TMC8;BRCA1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5362982138873165,-1.3534106504065349,0.024390243902439025,0.45874218672016154,1.0,53/161,20.53%,RPL19;RPL3;ZFP36;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;PATL2;HELZ2;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;MRTO4;RPS15;RPS9;RPL12;SAMD4A;RPL5;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;EXOSC7;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.6261569000467792,1.3523441475888822,0.1111111111111111,0.8045812731053766,1.0,7/27,18.02%,NCSTN;MID1IP1;MSH2;MAPK8;MSH3;POT1;ABL2
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.5926853683357755,-1.3520899504028667,0.029850746268656716,0.4641416484365923,1.0,26/59,21.37%,MYO1F;GPR183;DOCK8;TAGAP;SERPINF1;SLA;ARHGAP9;HLA-DRA;BST2;WAS;IRF7;CTSS;P2RY10;IL3RA;BLNK;CD37;BCL11A;SLC15A4;ETV6;CD4;WDFY4;PSTPIP1;NAPSB;SPI1;PACSIN1;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.8421534507419801,1.3520585122500164,0.09302325581395349,0.8040586421046065,1.0,3/5,13.51%,SPRED1;SPRY1;SPRED2
prerank,Reactome_2022__FGFR4 Ligand Binding And Activation R-HSA-190322,0.8497668685062562,1.3519887452048154,0.06,0.8023211137052103,1.0,1/5,0.16%,FGF6
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.5553401917328735,-1.3514593863685735,0.012987012987012988,0.46639129165218784,1.0,19/123,10.54%,RASGRP1;CDKN2A;ARHGAP4;RASGRP2;EPS8L2;SHTN1;PDPN;ARHGEF3;PLK2;RALGDS;PLD1;USP50;RIT2;ARHGDIG;WAS;IGF1;CDC42EP1;CDC42EP3;SHC2
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Brain,-0.5609946882870779,-1.3512278684294143,0.0273972602739726,0.46687043408950735,1.0,18/94,13.79%,COL4A1;ANGPTL2;SPARC;COL4A2;CSPG4;PLP1;THY1;LMOD1;BGN;GAP43;LDB2;EDIL3;THBS2;FGF1;BAALC;IGFBP5;PRRX1;RASL12
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.8747151268899556,-1.351074575735014,0.1016949152542373,0.4669047954367878,1.0,1/5,1.41%,SLC6A15
prerank,Reactome_2022__Interaction Between L1 And Ankyrins R-HSA-445095,-0.6780321524955306,-1.3510432728108601,0.09836065573770492,0.4664377505629084,1.0,7/24,13.03%,SCN1B;L1CAM;ANK3;SCN9A;SCN2A;SCN1A;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.8340350270276982,-1.3507653120160386,0.061224489795918366,0.4666003315068909,1.0,1/6,0.33%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.8340350270276982,-1.3507653120160386,0.061224489795918366,0.4666003315068909,1.0,1/6,0.33%,THBS1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.6136982961931331,1.3506870647206177,0.02857142857142857,0.8061442886707019,1.0,7/20,20.22%,HMGB1;DNASE1L2;CASP3;EXOG;DFFB;DNASE1L1;FBH1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.5616903855334382,-1.3506259141712458,0.07142857142857142,0.4667742387231545,1.0,34/101,19.43%,COL4A1;ANGPTL2;CALD1;C1R;COL4A2;ABCA8;MATN2;MAOB;LMOD1;BGN;ADAM21;IGF1;THBS2;IGFBP5;NOS1;F10;C1QTNF1;SLCO2A1;AMOTL2;RASL12;C1S;ASS1;SERPING1;TNS2;COL12A1;FMO2;TEK;MLANA;ADGRF5;AQP1;PTPN21;PDGFRA;SVEP1;PLAUR
prerank,Reactome_2022__Interleukin-23 Signaling R-HSA-9020933,-0.7855641241398472,-1.3505056616142814,0.09259259259259259,0.4661591024937387,1.0,1/6,3.77%,STAT4
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.7855641241398472,-1.3505056616142814,0.09259259259259259,0.4661591024937387,1.0,1/6,3.77%,STAT4
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.7186590612809931,-1.3504429172103791,0.07936507936507936,0.46585846508518564,1.0,1/12,0.99%,MET
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.8498865096235424,1.3503440659299908,0.05084745762711865,0.8054486165929398,1.0,2/5,6.41%,ATP6V1A;ATP6V1G1
prerank,Reactome_2022__Formation Of Cornified Envelope R-HSA-6809371,-0.7521637344220418,-1.3502711701737617,0.030303030303030304,0.46602087211300225,1.0,9/15,21.23%,PKP2;SPINK9;FLG;CELA2A;KAZN;SPINK6;CAPN1;CAPNS1;PCSK6
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,0.5281182299190336,1.350191502591065,0.04,0.8042961711369264,1.0,13/57,15.95%,CNOT9;RARB;H2BC21;H2BC4;EED;NCOA3;PBX1;YY1;RBBP4;H2AC6;H3-3B;POLR2C;EP300
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Heart,-0.9028663337677926,-1.3499378665846762,0.03571428571428571,0.46672540661447115,1.0,2/5,7.62%,CALD1;HEXIM1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.5768053704290304,1.3499373678787931,0.05405405405405406,0.8033217381153611,1.0,6/33,17.36%,MAML3;KAT2B;ENHO;ROBO1;EP300;POGLUT1
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.7941448860259566,1.3498938616648526,0.12121212121212122,0.8013503953597625,1.0,1/7,0.43%,NGF
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.7660795556571156,-1.3498909942801995,0.0784313725490196,0.46636753949014337,1.0,2/13,0.47%,CCBE1;HPN
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.6589549247230246,-1.3498331334093308,0.1095890410958904,0.4659299532384271,1.0,1/23,0.44%,TMEM204
prerank,CellMarker_Augmented_2021__Basal cell:Lung,-0.5979816020178328,-1.3496341314345823,0.05405405405405406,0.46596496581219793,1.0,17/44,20.47%,S100A10;TUBB6;FAT2;GPNMB;TIMP1;ZYX;CLCA4;SOX15;PLAT;CCND2;GPC1;PLP2;RARG;IFI27L2;NXN;ZNF385A;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.8932619467231884,-1.3495798652443838,0.0392156862745098,0.4656323299950646,1.0,2/5,7.17%,TIMP2;TIMP1
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,0.5647928277765684,1.3494863317065346,0.1,0.8013019440817568,1.0,14/54,15.19%,H2BC21;H2BC4;DNMT3B;UBTF;ERCC2;H2AC6;POLR1F;ERCC3;SAP130;GTF2H5;H3-3B;GTF2H2;DPEP2;HDAC2
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.5659479047432231,-1.3494855228618132,0.038461538461538464,0.465541428438613,1.0,34/86,22.18%,HPN;KCNQ1;KCNV1;LRRC55;KCNB1;KCNK1;KCNJ13;KCNJ2;SLC24A2;KCNH8;SLC24A1;SLC9A2;KCNG1;KCNB2;KCNK12;KCNC1;KCND3;SLC9A5;KCNMB4;KCNH7;KCNK10;AQP1;KCNAB3;KCNV2;KCNF1;HCN1;ABCC9;KCNQ5;KCNC2;ATP1B3;KCNK13;KCNJ6;KCNQ4;SLC9A7
prerank,Reactome_2022__RHOBTB3 ATPase Cycle R-HSA-9706019,0.7842175326742411,1.3493966941079687,0.09803921568627451,0.7999721404101435,1.0,4/8,17.60%,CCNE1;RAB9A;RHOBTB3;VHL
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.7202768296412887,-1.3493884645601595,0.06451612903225806,0.46541637594139107,1.0,2/18,5.61%,ABCA8;ABCA12
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.5062304464497975,-1.349052875844533,0.0,0.46634448166657516,1.0,24/275,7.44%,PRAME;LEF1;ANXA1;THBS1;HPN;APIP;IFI6;DHCR24;MET;POU4F1;RPS27A;NAA38;PDPN;KIF14;PLK2;PRDX5;HTR2B;SCX;PIM3;GATA1;CD44;NUAK2;PLK3;IFIT3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.581120561907868,-1.3489454846232054,0.06666666666666667,0.4661044514186586,1.0,13/67,17.95%,THBS1;MET;SPARC;PROX1;EGF;WNT5A;FGF1;GPI;PIK3CB;PIK3CD;TEK;ETS1;TGFB1
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),-0.8839840898132993,-1.3486715282311559,0.05660377358490566,0.46686961865939425,1.0,1/5,0.71%,FLRT3
prerank,CellMarker_Augmented_2021__Epithelial cell:Ovary,-0.8820398301554613,-1.3486226052875059,0.1,0.4665383167812043,1.0,1/5,0.05%,CD24
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.7277384112581158,1.3485952949200524,0.16279069767441862,0.8016318980656083,1.0,2/8,8.16%,KDM1B;KDM5A
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.7621464363848687,-1.3484929061515039,0.05,0.46656085639555356,1.0,4/13,11.51%,ANXA1;GCM2;CD9;MMP24
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.7030923766102134,-1.348354058581657,0.12280701754385964,0.46651509550133125,1.0,2/17,5.68%,ICAM1;THY1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.6724883594681648,-1.3483316693362737,0.08108108108108109,0.4660491112275172,1.0,5/24,13.20%,EFNA1;CTSC;ATP5IF1;PINK1;RHBDF1
prerank,CellMarker_Augmented_2021__CD14+ Endothelial Progenitor cell:Blood,-0.6040545323429439,-1.3482114685456767,0.02564102564102564,0.4659927376536393,1.0,21/57,18.20%,C3;APLNR;RAMP3;GPR34;SIGLEC1;DYSF;LDB2;F13A1;IGFBP7;SELP;RNASE1;ITGA9;ROBO4;RASSF4;SERPING1;FMO2;TEK;MRC1;ADGRF5;AQP1;A2M
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.6225471044713159,1.3480156456032546,0.15151515151515152,0.8027732817775842,1.0,6/21,8.28%,CEBPA;ZC3H8;TENM1;POLR3F;BRF2;AR
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.6359472006338421,-1.3480136598712062,0.0136986301369863,0.4662651521071179,1.0,12/34,16.59%,GRIN3A;KCNB1;GRIN2A;APP;GRIA3;GRM6;GRIK1;GRIN2B;GRID2;GRM7;GRIK2;CLN3
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.7104531907090631,-1.3476149277942377,0.07575757575757576,0.467465066707473,1.0,3/24,2.77%,PKP2;TGFBR2;PROX1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.7203919225788116,-1.3474957855637095,0.11594202898550725,0.4673506552148982,1.0,6/17,10.10%,PLN;CCL2;CAV3;EGF;GRM6;PLPP4
prerank,CellMarker_Augmented_2021__Neutrophil:Blood,-0.8252763228688856,-1.3474574113047624,0.13333333333333333,0.467010688068956,1.0,1/6,1.62%,TLR2
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.6197234129797798,-1.347426009848355,0.1206896551724138,0.4665249293499286,1.0,14/35,19.27%,OVOL3;RBP2;OVOL2;ZNF750;POU2F3;WAS;EMP1;GLI1;FGF7;LAMA3;ALDH3A2;HLA-DRB1;SVEP1;FLG2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.727226711555822,-1.347364676699374,0.11290322580645161,0.4661529875557459,1.0,2/12,4.77%,PDPN;FSCN1
prerank,CellMarker_Augmented_2021__Epithelial cell:Endometrium,-0.6418502327005596,-1.347354850280415,0.07042253521126761,0.4656019307428117,1.0,15/34,19.43%,MYO1F;ATP8B4;ADCY7;CLEC12A;LAT2;PRSS57;CTSS;PTPN7;FES;EMILIN2;VAV1;NMI;FERMT3;SLC7A7;PLAUR
prerank,CellMarker_Augmented_2021__Muller cell:Retina,-0.6009831419220403,-1.3472564914152827,0.04878048780487805,0.4653556066211135,1.0,9/58,8.03%,P2RY13;TLR2;LMO2;CDH23;SIGLEC1;LRRC4;TM6SF1;F13A1;CHI3L1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.759573735370302,-1.347207913917826,0.11475409836065574,0.46491907254090353,1.0,4/10,12.60%,CACNA1H;ERVW-1;CD9;NOS1
prerank,CellMarker_Augmented_2021__Macrophage:Lung,-0.8527780741378943,-1.3469478250644389,0.12244897959183673,0.46557097759842625,1.0,2/7,5.98%,ICAM1;CCL2
prerank,CellMarker_Augmented_2021__Plasmablast:Peripheral Blood,-0.7397254573317338,-1.346848808162314,0.05084745762711865,0.46499129983727877,1.0,2/13,3.94%,CD24;IGHG1
prerank,CellMarker_Augmented_2021__Immature Transitional B cell:Blood,-0.7397254573317338,-1.346848808162314,0.05084745762711865,0.46499129983727877,1.0,2/13,3.94%,CD24;IGHG1
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.8617608153478028,1.3468442913004863,0.020833333333333332,0.8068487243207018,1.0,2/6,4.85%,LEPR;GREM1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.6781312434620922,-1.3468423787518726,0.10294117647058823,0.4644791037399088,1.0,5/27,8.66%,APLNR;TGFBR2;CCDC39;MMP21;SRF
prerank,KEGG_2021_Human__Glycerolipid metabolism,0.5154009371515503,1.3464441278337882,0.0,0.8065898225533552,1.0,6/46,5.86%,DGKB;CEL;GK;ALDH7A1;DGKE;MOGAT1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.6023020735523618,1.3462637058086286,0.12903225806451613,0.8057978010291871,1.0,3/21,7.29%,IBA57;CIAO3;LYRM4
prerank,CellMarker_Augmented_2021__MKI67+ Progenitor cell:Large Intestine,-0.5831597481405572,-1.3462041625496743,0.0759493670886076,0.46690230999392746,1.0,18/61,14.86%,CCNB2;APOLD1;APLNR;NRN1;INPP5D;RAMP3;PODXL;BGN;ANLN;LDB2;NUF2;NCAPD3;CCNB1;SLCO2A1;MMRN2;EGFL7;ROBO4;CDKN3
prerank,Reactome_2022__FGFR1 Ligand Binding And Activation R-HSA-190242,0.7584432158515044,1.346005506739873,0.10526315789473684,0.8052622128567284,1.0,1/8,0.16%,FGF6
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.6470608539791753,-1.3459450776308646,0.10666666666666667,0.4674142324488927,1.0,6/30,13.03%,SCN1B;CAV3;YWHAH;CHRM3;PDZK1;SCN3B
prerank,CellMarker_Augmented_2021__Basal Progenitor cell:Breast,-0.6510681382314736,-1.3457869472987587,0.13043478260869565,0.46742408583654305,1.0,5/29,7.03%,CD24;EPS8L2;ITGA2;OVOL2;CD44
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.8320221817041499,-1.3456342543155386,0.08064516129032258,0.46760066584841836,1.0,3/7,11.73%,TLR2;CCL2;NAMPT
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.8705498583210645,-1.3453562685949727,0.05357142857142857,0.4683653077537969,1.0,1/5,1.14%,NR4A3
prerank,Reactome_2022__CD163 Mediating An Anti-Inflammatory Response R-HSA-9662834,-0.848615285203711,-1.344876246332393,0.0851063829787234,0.4696715528794163,1.0,3/6,12.04%,PLK2;RHBDF2;MYH9
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.7511680097816715,-1.3448238467388727,0.11290322580645161,0.46935744363838766,1.0,4/11,14.82%,CNTNAP1;PLP1;TENM4;MYRF
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.6209396664201139,-1.3446941622877628,0.06944444444444445,0.46935386954352193,1.0,5/36,9.91%,IL12A;STAT4;CA1;LMNB1;TCP1
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.6293344257649335,-1.3446498800861137,0.05555555555555555,0.46902983022214334,1.0,20/41,19.43%,IL1R1;S100A10;GPR87;FOSL2;MAFF;PLEKHG6;KLF4;ADAM19;IER3;CD55;TMEM40;IL18;SMAGP;LTBR;SH2D3A;ANXA2;MLANA;CD4;BHLHE40;PLAUR
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.8891393423844711,-1.3446006456060202,0.03389830508474576,0.46866240690089417,1.0,2/5,5.16%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.8035875960304868,1.3444609128496094,0.1956521739130435,0.8105786910971532,1.0,3/6,10.47%,LIG4;MSH2;EXOSC6
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.7539972241561363,-1.3443258058538199,0.12698412698412698,0.46936524733978174,1.0,4/12,6.33%,SCN1B;KCNQ1;NOS1AP;CAV3
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.7851025491619753,-1.3441198976251387,0.16666666666666666,0.46908315562730574,1.0,1/6,5.06%,KLF4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.7851025491619753,-1.3441198976251387,0.16666666666666666,0.46908315562730574,1.0,1/6,5.06%,KLF4
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7325232424671482,1.3440629485162068,0.0975609756097561,0.8103131529758485,1.0,6/12,14.25%,SOX8;PEF1;KLHL12;HEYL;CDH2;TAPT1
prerank,Reactome_2022__Glycerophospholipid Catabolism R-HSA-6814848,0.8074144656832055,1.3438783098220644,0.024390243902439025,0.8088792141945392,1.0,1/7,4.84%,GDE1
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.807103821661167,-1.3438711294445114,0.06779661016949153,0.46970611679943663,1.0,3/8,11.79%,LEF1;HLA-E;IL18
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.6399899947989129,1.3438415407369417,0.15789473684210525,0.8071744858129143,1.0,3/13,17.40%,PRKRA;DROSHA;AGO3
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.5729413672736662,-1.3437376155530474,0.1038961038961039,0.46989967253857445,1.0,4/74,3.17%,GGT5;ANXA1;WNT8B;IL12A
prerank,Reactome_2022__Plasma Lipoprotein Assembly R-HSA-8963898,0.7711164048290453,1.3435676192559138,0.125,0.8066697931405235,1.0,2/9,9.80%,ABCA1;PRKACB
prerank,Reactome_2022__Prevention Of Phagosomal-Lysosomal Fusion R-HSA-9636383,-0.8468722024275896,-1.3433160478127921,0.0967741935483871,0.4709695667726455,1.0,2/7,12.77%,RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),0.7603638337521642,1.3431936035409928,0.1111111111111111,0.8067757820808793,1.0,4/7,14.92%,MSH2;GTF2H2;MSH3;POT1
prerank,Reactome_2022__Integration Of Provirus R-HSA-162592,0.713631239884031,1.3431180504632563,0.11627906976744186,0.8050886148118055,1.0,2/10,15.21%,LIG4;SGIP1
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,0.5989739244562216,1.3429435699564576,0.11428571428571428,0.8039048562723987,1.0,6/22,15.45%,EPOR;NRAS;EPX;PIK3CA;PIK3R1;CRKL
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.7831112764736673,-1.3427942121445207,0.07352941176470588,0.4728908196956036,1.0,3/10,11.17%,NLRP12;PTK6;HHIP
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.5756104211902122,-1.3426592059858862,0.0684931506849315,0.47278473722816045,1.0,18/75,16.59%,PCSK2;C1R;MMEL1;C1RL;PHEX;ATP23;MMP14;KLK6;ADAM19;CTSS;AEBP1;SEC11C;SRGN;MYRF;TMEM208;APH1A;F3;CLN3
prerank,CellMarker_Augmented_2021__Delta cell:Pancreas,0.6889551148528648,1.3426487514744594,0.2857142857142857,0.8034678595010453,1.0,6/14,9.92%,POU3F1;RGS2;EHF;LCORL;ETV1;ERBB4
prerank,Reactome_2022__Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,0.7066989266112531,1.3425376777673013,0.15384615384615385,0.8020747005867505,1.0,6/11,22.56%,PIK3R4;RNF103-CHMP3;PIK3C3;CHMP2B;CHMP6;BECN1
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.8549085226292885,-1.3423776856816831,0.06896551724137931,0.47334510959979004,1.0,2/5,7.96%,TGFBR2;ZFPM1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.7471207478037155,-1.3421059365787555,0.11475409836065574,0.4738059933732403,1.0,4/14,12.60%,CACNA1H;ERVW-1;IGF1;NOS1
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.8192491242404181,-1.3420671343057884,0.16071428571428573,0.4734050242861999,1.0,1/7,5.65%,SYT4
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.5332384168485625,1.3418590822221736,0.07407407407407407,0.8036380879142319,1.0,6/43,8.50%,POLD3;APEX2;DNA2;RFC3;ERCC6;PRMT6
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,0.567927057243715,1.3416844109010662,0.16129032258064516,0.8025781889297574,1.0,11/36,23.55%,H2BC18;H2BC21;H2BC4;RBBP4;H2AC6;HDAC2;HDAC10;CHD4;SAP30L;H2BC5;MTA2
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5777145451536894,-1.341378768728645,0.02702702702702703,0.4759978668529987,1.0,22/80,11.20%,CXCL2;P2RY6;NR4A3;MYO1F;TLR2;TAGAP;ADGRE5;GPNMB;GPR34;GPR171;SLA;SIGLEC1;CCL2;HLA-DRA;IGSF6;PARP14;CLEC12A;F13A1;IL4R;SCIMP;CTSS;SYK
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,0.6733053199568652,1.34101275605567,0.16666666666666666,0.803779501178493,1.0,7/22,13.59%,H2BC21;H2BC4;EED;DNMT3B;RBBP4;H2AC6;H3-3B
prerank,Reactome_2022__CaMK IV-mediated Phosphorylation Of CREB R-HSA-111932,0.6928691575923228,1.3407144161208184,0.16666666666666666,0.8032395626012879,1.0,1/10,2.95%,KPNA2
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.6171938257829238,-1.3407135620976303,0.07246376811594203,0.47847596049034896,1.0,6/37,10.10%,MTMR7;MTMR11;SGPP2;PLPPR1;PLPPR5;PLPP4
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.7226557456195065,1.3406483324283214,0.09090909090909091,0.801647153242788,1.0,3/12,14.11%,DNA2;HUS1;RAD9B
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.8445000046883229,1.34045262534417,0.06666666666666667,0.8004671483377507,1.0,4/6,14.18%,ABCD2;ABCD1;ABCD3;ACOX1
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreas,-0.8287992533006996,-1.3404471826520525,0.07352941176470588,0.47892872507173373,1.0,2/8,6.98%,PGR;LDB2
prerank,Reactome_2022__Digestion Of Dietary Carbohydrate R-HSA-189085,0.8268747253032551,1.3403499383967865,0.0784313725490196,0.7990235091698121,1.0,2/5,3.42%,MGAM;AMY2B
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),0.8191821786168423,1.340169760207004,0.1276595744680851,0.798231356639588,1.0,2/5,3.86%,MYORG;SELENON
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.6212090837602601,1.3401589503557054,0.14285714285714285,0.7964246749698666,1.0,6/22,20.44%,METTL8;TRMT61A;CBLL1;VIRMA;DKC1;NSUN2
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.8306461147158708,1.3401027719643566,0.1111111111111111,0.7950275178640054,1.0,2/6,2.59%,RNF6;UBE2T
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.6269588298101976,-1.3400839472216581,0.07352941176470588,0.4800745308244795,1.0,10/36,18.48%,THBS1;KCNB1;SLC39A14;EIF2B2;PDK3;IRS2;PFKL;ADCY8;GPER1;PCK2
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.6985794844788193,-1.339609105633299,0.078125,0.4815968168625458,1.0,2/15,2.75%,SIX3;WNT8B
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.7642997411009117,-1.339545756555248,0.06349206349206349,0.4812653410683897,1.0,2/16,2.20%,ANXA1;ZFP36
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.7051212238894143,-1.3395407920388194,0.10606060606060606,0.48074009811106827,1.0,5/14,19.40%,APP;IGF1;MFSD2A;PPIB;GHR
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.8054385324910538,1.3395100973722198,0.08888888888888889,0.7964640188283133,1.0,3/7,6.76%,ERCC8;LIG4;ERCC6
prerank,CellMarker_Augmented_2021__Chondrocyte:Cartilage,-0.559006780981919,-1.3395053646617203,0.0379746835443038,0.48037799616117116,1.0,13/88,6.79%,COL4A1;ANGPTL2;CALD1;COL4A2;LAMB1;COL5A1;COL27A1;SULF1;THY1;LMOD1;BGN;MAP1B;SCARA3
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.5859279580219169,1.3394587019456994,0.12903225806451613,0.794833856885154,1.0,3/22,7.29%,IBA57;CIAO3;LYRM4
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.7747108594255862,1.3392949564693768,0.12244897959183673,0.7940077006266802,1.0,3/7,17.81%,PRKRA;DROSHA;TSN
prerank,Reactome_2022__Negative Regulation Of Activity Of TFAP2 (AP-2) Family Transcription Factors R-HSA-8866904,0.8194422553249341,1.3391925687538835,0.11764705882352941,0.7926027645472619,1.0,2/7,4.75%,KCTD1;KCTD15
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.6874754825539111,1.3391634274300102,0.13513513513513514,0.7908344714139289,1.0,6/13,26.39%,SNF8;VTA1;LEPROTL1;CHMP6;TMEM50B;VPS25
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Corneal Epithelium,-0.586923520527198,-1.3388519477464453,0.1267605633802817,0.4825937564381712,1.0,17/51,18.19%,C3;DUOX1;ZNF750;DUOXA1;RHBDL2;PLD1;FUT2;TMPRSS11D;MACC1;APOL6;TMEM40;IL18;ALS2CL;LTBR;SH2D3A;ALPK1;NUPR1
prerank,Reactome_2022__Ethanol Oxidation R-HSA-71384,0.7740816438289476,1.338746494842484,0.2,0.7910777988582758,1.0,4/6,19.38%,ALDH1A1;ADH5;ACSS1;ALDH2
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.6649578586826161,-1.3387278580420605,0.07575757575757576,0.48259653300225325,1.0,3/19,10.67%,APP;WDR54;LRPAP1
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.686840164342557,1.3385454439103317,0.08823529411764706,0.7902680246950708,1.0,6/12,15.62%,AKT2;AKT1;ERBB4;ZNF703;CSF1R;ID2
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,-0.5145996190968467,-1.3385357308075059,0.03296703296703297,0.4826961220848726,1.0,38/209,11.74%,OPTC;THBS1;COL8A1;COL4A1;SPARC;COL4A2;ICAM1;LAMB1;COL5A1;TIMP2;ITGA2;SCUBE3;COL4A4;ASPN;MMP19;COL27A1;COL6A2;ITGA5;BGN;COL24A1;MMP14;CEACAM1;SPOCK3;CD44;TIMP1;COL11A2;ITGA8;LTBP4;P4HA2;P3H2;COL10A1;ADAM19;CTSS;ITGA11;P4HA3;FN1;MMP24;CAPN8
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.6109671422991646,-1.3385328600164743,0.05333333333333334,0.4821507658262878,1.0,7/37,11.20%,MX1;RAMP3;CAV3;CEACAM1;ARR3;CD9;SYK
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.5544534084074165,-1.3385154086724744,0.038461538461538464,0.48166032920025065,1.0,33/114,17.42%,NPY;RIMBP2;CDH22;SIX3;PCSK2;CHGB;STMN2;PROX1;SH3GL2;LRRTM1;SYT4;ELAVL4;JPH3;NKX6-2;SYP;PLPPR1;IGSF21;CPLX2;CA10;SST;TCEAL2;MEG3;KCNB2;SCN3B;NPTX2;GAD2;KCNC1;PCP4;RAB3C;TCEAL5;SYT13;SULT4A1;FGF12
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),-0.7941257494624265,-1.3384378378056128,0.125,0.4813854312706718,1.0,1/8,0.99%,MET
prerank,CellMarker_Augmented_2021__Langerhans cell:Skin,-0.6868118887013509,-1.3383868429396062,0.058823529411764705,0.4810897480558949,1.0,14/21,22.63%,P2RY13;SIGLEC1;HLA-DRA;IGSF6;F13A1;CLEC5A;HLA-DRB1;CD4;WDFY4;NAPSB;C1QB;SPI1;PTAFR;FPR3
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.789732671671461,-1.338315156467334,0.10344827586206896,0.4807947430136289,1.0,1/9,0.81%,BLM
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),0.8276414103813552,1.3381456226052806,0.17391304347826086,0.7903541062392675,1.0,3/5,7.69%,ACP3;TPK1;SLC25A19
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.5649277507968327,-1.3381063642255147,0.038461538461538464,0.4811841720453809,1.0,28/90,20.09%,COL4A1;ANGPTL2;CALD1;COL4A2;CSPG4;LAMB1;COL5A1;LMOD1;BGN;CCL2;SRPX2;FN1;ACHE;IGFBP5;PRRX1;C1QTNF1;AMOTL2;RHBDF1;TNS2;COL12A1;CAPN1;AFAP1L1;GPC1;ANGPT2;PTPN21;SYNC;NNMT;ANTXR1
prerank,KEGG_2021_Human__Adherens junction,-0.5755005042385497,-1.3378829470072702,0.05333333333333334,0.48178613990391,1.0,6/64,8.69%,LEF1;MET;TGFBR2;CTNNA3;BAIAP2;WAS
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.7466478841709855,-1.3374548837400413,0.057971014492753624,0.4830902457968194,1.0,2/18,6.59%,POU4F1;TLR3
prerank,CellMarker_Augmented_2021__Gonadal Endothelial cell:Fetal Gonad,-0.5026054077252872,-1.3371270163855677,0.0,0.48391225323620635,1.0,45/401,11.67%,GGT5;CLIC1;CD24;ST6GAL1;TMEM204;EFNA1;SOCS3;TUBB6;SP100;TGFBR2;LAMB1;LMO2;WARS1;ARHGEF3;ITM2A;COL6A2;FSCN1;TP53I3;ITGA5;APP;KLF4;THY1;DENND3;PIM3;LDB2;CCND1;EDIL3;GTPBP2;ITGA8;ST3GAL6;PIEZO2;PLD2;CDC42EP1;TAGLN2;POLE4;RAPH1;ICA1;CREB5;DAB2IP;FN1;HLA-E;RAPGEF5;TMEM44;LPAR6;ITPRIP
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.729536900711681,-1.3370084617190852,0.08620689655172414,0.4839560315329342,1.0,5/14,9.67%,TYMS;DUOX1;AKR1C1;TRPC3;STAT1
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.7489008612513022,-1.3367008871413575,0.16129032258064516,0.4846264600936406,1.0,5/13,16.15%,ANXA1;LTBP4;RIMS2;VIP;PTPRN
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Uterus,-0.5852979078377619,-1.3364676338447306,0.0125,0.48497703934135344,1.0,30/75,22.95%,COL4A1;THSD4;ITGA2;BGN;SRPX2;OSMR;EMP1;IGFBP7;CFH;SLCO2A1;MMRN2;C1S;ROBO4;DLC1;TNS2;PLAT;LAMA3;COL12A1;ATP8B1;AFAP1L1;TEK;SHROOM4;ADGRF5;NNMT;KIAA1217;WWTR1;SH3D19;CAV2;FBLIM1;PTPRB
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.763210339191139,1.3364023947768084,0.14583333333333334,0.7965392262143285,1.0,1/10,1.13%,SLIT1
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,-0.524555284421445,-1.3362410286321733,0.0375,0.4853056243416093,1.0,43/172,18.86%,IL1R1;CCNB2;CDKN2A;TGFBR2;B2M;ICAM1;ZFP36;HLA-A;VAC14;MSX2;IL15;ADCY7;HLA-C;HLA-DRA;CCND1;ANAPC11;SRF;PPP3CC;CREB5;HLA-B;ADCY5;HLA-E;MAP3K14;CCNE2;TNFRSF1A;HLA-F;FOS;PIK3CB;LTBR;PIK3CD;CDK2;CCND2;TLN1;ADCY3;HLA-DRB1;ADCY8;ETS1;CREB3;FDPS;TGFB1;CDKN1A;CD4;IL15RA
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.8522808491760823,-1.3362018118221077,0.06349206349206349,0.48493474068601905,1.0,3/6,11.77%,RPS6KA1;SELP;SOX15
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,-0.6381617147560481,-1.3361408171226532,0.12698412698412698,0.48475504272284514,1.0,4/27,7.83%,ST6GAL1;RPS27A;PARP14;PARP9
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8453868702304767,-1.3360796341130436,0.05084745762711865,0.4844595617584931,1.0,6/7,13.21%,B2M;HLA-A;HLA-C;HLA-B;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.762205159216191,-1.3359467605896236,0.09375,0.48446017114669976,1.0,6/10,22.98%,IL12A;STAT4;STAT1;IL27RA;IL12RB2;STAT3
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.6468475694411079,1.3355546349735534,0.20833333333333334,0.7985953927758705,1.0,4/14,19.21%,COX18;SMIM20;COX19;FASTKD3
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),-0.8665426547598686,-1.3355069570281983,0.05555555555555555,0.4857465198755732,1.0,1/6,0.18%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.645473937445145,-1.3353249347420537,0.06896551724137931,0.4858719989011462,1.0,7/22,12.60%,IFIT1;PLN;TIMP1;PARP9;ATP5IF1;TMBIM1;NOS1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.7621754294689845,-1.335005539068963,0.11864406779661017,0.48693303848964514,1.0,2/11,10.55%,DUSP1;CCNB1
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.6008025858575912,-1.3349803888921201,0.02702702702702703,0.4864792197601523,1.0,13/60,16.79%,SLC28A2;SLC6A15;SLC32A1;SYN3;SLC18A2;SYN2;CPLX1;SYT1;GAD1;GAD2;SLC38A1;PPFIA1;SLC29A4
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),-0.7168797395561585,-1.3349175674002234,0.1724137931034483,0.48619428502570133,1.0,3/10,20.65%,KLK6;MYRF;HJV
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.8334036926797921,-1.3349033261511682,0.125,0.4857108772198298,1.0,2/6,6.56%,HPN;CEACAM1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.6451661850980076,-1.3348639802671918,0.12121212121212122,0.4853227655108288,1.0,4/23,10.68%,NPY;GLRA2;HCRTR2;MCHR2
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.7060602976278274,-1.3348055235760763,0.07017543859649122,0.48491461169885847,1.0,1/16,0.33%,THBS1
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,-0.5999151151635437,-1.3343119213372303,0.10526315789473684,0.4868678166380157,1.0,7/35,16.98%,IL12A;STAT4;CA1;LMNB1;TCP1;ANXA2;AURKAIP1
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,-0.6771789313461276,-1.3342961042746955,0.06578947368421052,0.48643798215180606,1.0,7/26,12.77%,EPN1;RPS27A;SH3GL2;EGF;SH3GL3;TGFA;UBC
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.8410093651354579,-1.3338787539691153,0.12280701754385964,0.48779111727036983,1.0,3/8,9.61%,CENPH;CENPE;NUF2
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.9076122156450281,-1.3338657332432309,0.034482758620689655,0.48732998334157107,1.0,2/6,3.86%,APIP;BHMT
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.7963198386653529,-1.3338505186893856,0.1,0.48685947971179594,1.0,5/9,11.26%,P4HA2;P3H2;OGFOD1;P4HTM;P4HA3
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.7093855922365757,1.333835506567672,0.17073170731707318,0.805150049598517,1.0,2/9,4.85%,EFNB2;GREM1
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),-0.818935421209972,-1.3338339734673992,0.11363636363636363,0.48640041026564323,1.0,1/8,1.55%,SUV39H1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.521049191135419,1.3336557323164566,0.0,0.8042912883174832,1.0,10/52,8.94%,RGCC;ERCC8;PPP1R10;EGFR;BRCC3;UBE2N;TRIM28;ERCC6;SIRT6;HMGB1
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,0.5633835787565346,1.3335283376139768,0.10714285714285714,0.8032289515100624,1.0,11/39,14.70%,H2BC21;H2BC4;UBTF;ERCC2;H2AC6;POLR1F;ERCC3;GTF2H5;H3-3B;GTF2H2;RRN3
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.6111489328893678,-1.3334915703686754,0.07246376811594203,0.4872495791205941,1.0,8/45,14.31%,ENPP2;RAB11A;CEACAM1;VIL1;PFN2;DAB2IP;EMP2;HYAL1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.5926757285488282,-1.3329939445514065,0.0958904109589041,0.4890191866862744,1.0,17/61,20.36%,EFNA1;LAMB1;PROX1;KIF14;POF1B;ATRNL1;ITGA8;FN1;RADIL;TMEFF2;RELN;MICALL2;TEK;FERMT3;LAMA5;ANTXR1;SPI1
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.8253290978397012,1.3329253300082575,0.125,0.8039829957872432,1.0,2/6,5.64%,BMP2;EGFR
prerank,CellMarker_Augmented_2021__Trophoblast cell:Placenta,-0.5644692586310237,-1.3328875943607235,0.0641025641025641,0.4888698000263192,1.0,20/78,17.22%,ANXA1;COL4A1;TUBB6;COL4A2;MYOF;LAMB1;COL5A1;MMP14;SRPX2;OSMR;EMP1;FN1;HRH1;PDLIM4;ITGA3;PLAT;COL12A1;ANXA2;PXDC1;AFAP1L1
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.5469751821719012,-1.332724257621427,0.05263157894736842,0.48915503436184044,1.0,19/78,17.99%,THBS1;P2RY12;TLR2;IFI35;IL15;NLRP12;APP;TLR3;PLSCR1;WNT5A;SCIMP;DDX60;IL18;TNFRSF1A;ETS1;ABCC1;NMI;TGFB1;SLC15A4
prerank,Reactome_2022__Metabolism Of Angiotensinogen To Angiotensins R-HSA-2022377,0.7545865810563833,1.332684710435205,0.07692307692307693,0.8035717023793071,1.0,2/7,8.20%,ACE2;KCTD11
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.711121782094516,1.3325457764999962,0.1111111111111111,0.8005699601604187,1.0,3/11,18.98%,AP3S1;AP3B1;BLOC1S4
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.711121782094516,1.3325457764999962,0.1111111111111111,0.8005699601604187,1.0,3/11,18.98%,AP3S1;AP3B1;BLOC1S4
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.6974363665037158,-1.332544823008313,0.11290322580645161,0.48928470522762635,1.0,7/17,13.03%,SCN1B;PKP2;KCNJ2;ATP1A1;CACNA1C;SCN1A;SCN3B
prerank,CellMarker_Augmented_2021__Basophil:Undefined,-0.7168025207453714,-1.33242305798688,0.06060606060606061,0.48918710738360605,1.0,6/15,14.46%,TLR2;ICAM1;CD44;CD9;CD63;IL3RA
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),0.7498548695043984,1.3319687658947317,0.21052631578947367,0.80173351319196,1.0,4/10,18.09%,RPP40;RPP14;RPP25L;POP1
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.4728393579181243,1.3317471878330147,0.13043478260869565,0.8011007290959533,1.0,31/89,27.75%,CHRAC1;SMARCAD1;SOX9;KAT2B;ERCC6;HNRNPC;KDM5A;RBBP4;BAZ1A;KAT2A;HDAC2;SMARCA2;DR1;MBD3;CHD4;DAXX;TADA2B;PBRM1;RUVBL1;ZBTB1;BAHD1;MTA2;SMARCC1;ARID1B;PADI4;BAZ1B;BAZ2B;INO80;HCFC2;MYSM1;CHD8
prerank,Reactome_2022__Cytokine Signaling In Immune System R-HSA-1280215,-0.4916091062015394,-1.3313051345869213,0.020618556701030927,0.4933254728931628,1.0,101/477,17.67%,CXCL2;ANXA1;GBP2;IL1R1;IFI6;SOCS3;TRIM22;SP100;IL13RA1;GBP1;MX1;B2M;CIITA;ICAM1;RPS27A;IFIT1;IFITM3;HLA-A;IL12A;TRIM5;IRF1;INPP5D;STAT4;IFI35;IL15;FSCN1;APP;NOD1;NLRC5;CCL2;HLA-C;KCNH8;HLA-DRA;BST2;GBP7;CD44;TIMP1;CCND1;TNFRSF14;IFIT3;PSMB9;F13A1;TRIM17;IFNGR2;CA1;RPS6KA1;LMNB1;IL1RAPL1;OSMR;STAT1;IL4R;TCP1;IRF7;PTPN7;ISG15;PSMB6;BIRC3;HLA-B;SYK;FN1;HLA-E;IL17RE;IL18;PSMC3;TNIP2;SIGIRR;MAP3K14;UBC;TNFRSF1A;HLA-F;KPNA7;IFIT2;HERC5;IL7;FOS;IL3RA;ELOB;BLNK;PDZD2;PIK3CB;PSMA8;LTBR;VAV1;IL1RAP;PRKCD;IL27RA;PSMA7;HLA-DRB1;ANXA2;CEBPD;STAT6;PML;USP18;BCL6;NDN;AURKAIP1;IRS2;PSME1;ALPK1;RIPK2;RBX1
prerank,CellMarker_Augmented_2021__Neuron:Embryonic Prefrontal Cortex,-0.7665769712954877,-1.3310942015356346,0.16,0.49357364621421507,1.0,3/9,8.39%,B2M;SLA;NEUROD2
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.8105136679396627,-1.3310773506269908,0.07017543859649122,0.4931014461935085,1.0,2/8,0.67%,KCNT2;KCNQ1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.6645146809388979,-1.331031115477836,0.12698412698412698,0.4926919176902484,1.0,5/24,11.28%,APLNR;TGFBR2;PROX1;ZFPM1;SLIT3
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.4896182473674248,1.3310153956659188,0.0,0.8027684312130452,1.0,28/70,28.78%,INTS13;ZC3H8;SNAPC5;GTF2F2;GTF2A2;INTS7;SNAPC1;SNAPC3;INTS8;TAF8;POLR2C;POU2F1;INTS14;RPRD1B;CCNT1;CCNT2;TAF13;GTF2B;SSU72;RPAP2;INTS4;POLR2A;INTS6;RPRD2;INTS9;INTS11;POLR2K;POLR2D
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.6231522687049242,-1.3309116449203129,0.12857142857142856,0.49260136898417173,1.0,8/36,13.61%,SLC32A1;SYN3;SYN2;CPLX1;SYT1;CPLX2;GAD1;GAD2
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.49411749639340363,1.3308384995305333,0.0,0.8018559743355334,1.0,34/92,25.88%,MRPL10;MRPS30;EEF1D;EEFSEC;MRPL15;PTCD3;MRPS9;MRPL58;MRPS2;MRPL50;MRPL37;GFM2;MRPL18;MRPL42;MRPL52;MRPL41;MRPS31;MRPS27;MRPL9;MRPS7;MRPS35;MRPS14;MRPL47;MRPL4;MRPS11;MRPL1;MRPS10;MRPL17;MRPS21;MRPL24;MRPL13;EEF2;MRPL3;MRPS16
prerank,CellMarker_Augmented_2021__Ureteric Bud cell:Fetal Kidney,0.5398121080392296,1.3308210985406737,0.043478260869565216,0.800108920596885,1.0,15/66,15.47%,SPSB4;MEX3A;CDC25A;GULP1;PLEKHG4B;MID1;DNMT3B;RAI14;ZIC2;SEPHS1;TENM3;MDK;TUBB2B;HDAC2;CTSV
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.7803832934046497,1.330801632237846,0.13636363636363635,0.7983696836534875,1.0,4/6,17.67%,NBDY;CNOT2;CNOT6L;CNOT1
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.7677225211349601,-1.3307746913645513,0.12121212121212122,0.4925725152618447,1.0,1/9,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.5751301370007627,1.330765728576809,0.14705882352941177,0.7968659232835928,1.0,3/22,4.12%,MSH4;POLD3;PMS1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.8622072222549224,1.3303117074853765,0.1,0.7973379709087399,1.0,1/5,1.63%,BMP2
prerank,Reactome_2022__InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.736446673715159,-1.3298418690445704,0.12307692307692308,0.49584038620403736,1.0,5/15,17.27%,RPS27A;SH3GL2;SH3GL3;UBC;SH3KBP1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.8182722443528045,-1.3296748489485242,0.14814814814814814,0.4955714600246928,1.0,2/6,9.54%,CDC42EP1;CDC42EP3
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.8182722443528045,-1.3296748489485242,0.14814814814814814,0.4955714600246928,1.0,2/6,9.54%,CDC42EP1;CDC42EP3
prerank,Reactome_2022__Activated Point Mutants Of FGFR2 R-HSA-2033519,0.7401662702345988,1.3296083369853606,0.06382978723404255,0.7993192543376619,1.0,1/8,0.16%,FGF6
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.8620064481116934,-1.3293918146744688,0.09090909090909091,0.4960497067460368,1.0,1/5,7.19%,IFFO1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.6580207008679371,1.3293755519183863,0.16666666666666666,0.7986779148717511,1.0,6/18,17.33%,MTHFS;SLC19A1;MTHFD2L;DHFR;DHFR2;SLC46A1
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.7064398885168245,1.3293470876005458,0.21052631578947367,0.7969861606582017,1.0,5/7,15.62%,AKT2;AKT1;ERBB4;ZNF703;ID2
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.5226307249523388,1.3292992536906196,0.08333333333333333,0.79555209638487,1.0,9/51,10.63%,RGCC;NAF1;CCT7;POLG2;GREM1;RFC3;MAP3K4;ATR;CCT3
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,0.4675323064721479,1.3291526431051155,0.0,0.7945987219663415,1.0,25/80,20.89%,NUP42;PLD6;NUP37;H2BC21;H2BC4;NUP54;TDRD6;IPO8;H2AC6;PRKRA;DROSHA;NDC1;NUP214;H3-3B;AAAS;NUP188;PIWIL4;POLR2C;NUP205;AGO3;TSN;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.7520732533624137,-1.3290705128322535,0.1,0.49681232113545803,1.0,3/13,12.35%,PLN;CAV3;HECW2
prerank,CellMarker_Augmented_2021__T Helper2 (Th2) cell:Undefined,-0.7799718189622813,-1.3289737391931973,0.07692307692307693,0.49665687297490246,1.0,1/11,0.32%,IL1R1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.6351512860000265,1.3285760857301894,0.1388888888888889,0.7954432090800677,1.0,5/18,13.37%,SLC6A13;SLC47A1;SFXN2;SLC22A2;SLC6A1
prerank,Reactome_2022__Metabolism Of Amine-Derived Hormones R-HSA-209776,-0.8397390946797401,-1.3282624837296608,0.11666666666666667,0.498790259126038,1.0,1/8,4.28%,DUOX1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.75494290009601,-1.3281724333039828,0.08823529411764706,0.4985923549739762,1.0,4/9,18.56%,FES;CD74;HLA-DRB1;CD4
prerank,CellMarker_Augmented_2021__Regulatory B cell:Peripheral Blood,-0.6757565064219803,-1.3281689471900038,0.1,0.4980599660018971,1.0,5/22,8.69%,MYO1F;TAGAP;ARHGAP9;CLEC12A;WAS
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8431864118043539,-1.3280723260476666,0.08928571428571429,0.4979748030317863,1.0,3/5,13.56%,COL5A1;RPS23;SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.6519328460935518,-1.328006590912187,0.046875,0.49768728667760775,1.0,9/26,14.79%,ANXA1;IL12A;SYT4;IL1RAPL1;RHBDF2;TNFRSF1A;RHBDF1;GRM7;PNKD
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.73256729746528,-1.3277485151032826,0.09230769230769231,0.4981692048623028,1.0,4/19,9.24%,POU4F1;MSX2;GATA1;IGF1
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),0.8289579476759409,1.3277144874266327,0.09090909090909091,0.7979742998348356,1.0,3/5,10.68%,MTERF3;FASTKD2;MRPS2
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.7612471623636735,-1.3276438288666346,0.10714285714285714,0.49808420034295026,1.0,1/12,0.33%,THBS1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.6345502604361907,1.3276323954778382,0.10526315789473684,0.7967738529552875,1.0,6/22,16.65%,HSPA1A;PLK1;CEP97;CHMP2B;HNRNPU;VPS4B
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,-0.7446135425085018,-1.327600377513766,0.07575757575757576,0.49781768716086916,1.0,4/14,12.77%,TGFBR2;RPS27A;ARHGEF18;UBC
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.7166819553219108,-1.3275525873928502,0.10144927536231885,0.49755175022350595,1.0,2/17,8.80%,KCNQ1;FBP1
prerank,CellMarker_Augmented_2021__Endothelial cell:Ovary,-0.8714068582783759,-1.327440649257415,0.08620689655172414,0.4974576156594056,1.0,1/6,0.05%,CD24
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.7387739030047951,-1.3273500822071522,0.10606060606060606,0.49730331597268196,1.0,4/11,13.52%,P2RY12;EPS8L2;PLEKHM1;NLGN1
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.6606861045484814,-1.326792803374875,0.14285714285714285,0.49900869643847967,1.0,8/25,17.65%,C1R;C1RL;GRIN2A;MMP14;PGK1;FADD;PLAT;RIPK2
prerank,CellMarker_Augmented_2021__Microglial cell:Undefined,-0.8128840043455241,-1.326558074860307,0.16129032258064516,0.49949560068623133,1.0,1/7,1.53%,P2RY12
prerank,Reactome_2022__Removal Of Flap Intermediate From C-strand R-HSA-174437,0.6446769802409702,1.3258222122376617,0.17391304347826086,0.8044882578998745,1.0,2/15,1.45%,POLD3;DNA2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.7850479831019649,-1.325659043730688,0.19047619047619047,0.5031405656071056,1.0,2/5,4.27%,KCNQ1;GJC1
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.6920982249822353,1.3256480468471021,0.16216216216216217,0.8036986650384739,1.0,5/9,24.19%,NAF1;NUFIP1;ZNHIT3;RUVBL1;ZNHIT6
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.6096139349842038,-1.3254741452352938,0.11594202898550725,0.5032412964029446,1.0,2/32,4.40%,MET;SEMA3B
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.8803540277376513,-1.3252771461609572,0.06451612903225806,0.5034719071383132,1.0,2/5,2.46%,THBS1;NOS1AP
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.5357430650271824,-1.325276464995094,0.05128205128205128,0.5029322802281971,1.0,7/100,6.51%,KLF2;IL1R1;DUSP1;ICAM1;CCL2;CAV3;GSTM5
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.5887628985080586,1.3251887353995757,0.125,0.8039720815988912,1.0,11/18,29.47%,ZNF706;NCOA3;CNOT2;KAT2A;CNOT1;WDR43;LOXL2;ESRRB;TAF5L;ZC3H13;REST
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.5354202392734487,-1.3251676498369072,0.037037037037037035,0.5028831210331276,1.0,14/118,11.39%,GRIN2D;COL4A1;SIX3;TGFBR2;PROX1;CIC;GRIN2A;NNAT;HAP1;APOD;ZIC1;CA10;B3GNT5;ZFHX2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Serum,-0.6324992085456946,-1.324879827494944,0.12,0.5035722379356588,1.0,13/33,13.35%,CD24;TJP3;OVOL2;CD44;ANO9;FBP1;MACC1;TMC4;ILDR1;CAPN8;TC2N;BSPRY;SPINT2
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.6468370963969076,1.324648575404367,0.15789473684210525,0.8050065356295969,1.0,5/15,20.44%,METTL8;TRMT61A;CBLL1;VIRMA;NSUN2
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.5604861328068358,-1.3244319289205406,0.038461538461538464,0.504917547660834,1.0,28/98,17.71%,GBP2;COL4A1;C1R;COL4A2;MATN2;COBLL1;SULF1;BGN;SCARA3;SRPX2;OSMR;FGF1;FN1;IL17RE;IGFBP5;C1QTNF1;SLCO2A1;AMOTL2;FRAS1;C1S;TNS2;LAMA3;COL12A1;RHOD;F3;PXDC1;FMO2;ADGRF5
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.651196826458589,-1.3242722596545355,0.0945945945945946,0.5049062430748209,1.0,2/28,6.34%,KLF2;GLRA2
prerank,CellMarker_Augmented_2021__Platelet:Liver,-0.612487875441313,-1.3242631548601722,0.058823529411764705,0.5038705615757619,1.0,16/48,18.04%,MYO1F;ALOX12;RGL4;TUBB1;GFI1B;GP6;GATA1;WAS;MMP25;PILRA;TSPAN32;CD37;TLN1;MAX;TGFB1;FERMT3
prerank,CellMarker_Augmented_2021__T Helper cell:Lung,-0.612487875441313,-1.3242631548601722,0.058823529411764705,0.5038705615757619,1.0,16/48,18.04%,MYO1F;ALOX12;RGL4;TUBB1;GFI1B;GP6;GATA1;WAS;MMP25;PILRA;TSPAN32;CD37;TLN1;MAX;TGFB1;FERMT3
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.645359899735354,1.3240197516656302,0.12121212121212122,0.8069197585263373,1.0,7/23,22.27%,DERL2;VCP;AUP1;DERL1;TMEM129;PREB;SEL1L
prerank,CellMarker_Augmented_2021__Vascular Stem cell:Blood,-0.5882055157494095,-1.323812518324012,0.013513513513513514,0.5047324131754943,1.0,12/53,11.88%,CCNB2;TYMS;KIF14;DEPDC1B;POLQ;ANLN;CENPE;NUF2;CCNB1;FANCI;FOXM1;KIF2C
prerank,CellMarker_Augmented_2021__Vascular Progenitor cell:Blood,-0.5882055157494095,-1.323812518324012,0.013513513513513514,0.5047324131754943,1.0,12/53,11.88%,CCNB2;TYMS;KIF14;DEPDC1B;POLQ;ANLN;CENPE;NUF2;CCNB1;FANCI;FOXM1;KIF2C
prerank,CellMarker_Augmented_2021__Myeloid cell:Blood,-0.6523292761357774,-1.3235133388910354,0.06666666666666667,0.5054342484100918,1.0,11/30,12.98%,RASGRP2;ALOX12;NLRP12;TUBB1;GFI1B;GP6;GATA1;NRGN;MMP25;CMTM2;TSPAN32
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),0.7760266439412447,1.3230609144332814,0.10256410256410256,0.8104649874388439,1.0,3/6,13.44%,TNFAIP3;GREM1;ENPP3
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.8272862203525533,1.3228970915479,0.1568627450980392,0.8095000200313742,1.0,2/5,6.83%,LMO3;PTGIS
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.8454333102692835,-1.3227668485490915,0.10344827586206896,0.508498462172682,1.0,2/5,7.10%,TYMS;CMPK2
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),-0.8282558365387374,-1.3225682685396474,0.10526315789473684,0.5089280561577391,1.0,1/6,0.47%,HPN
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.775577637644554,-1.3223352644847035,0.06060606060606061,0.5092086950819812,1.0,3/10,6.90%,CHRM1;HTR2B;GAP43
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.6870288460731537,-1.322153371880746,0.14285714285714285,0.5093901477755871,1.0,5/19,13.03%,SCN1B;CAV3;YWHAH;NOS1;SCN3B
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.7494643201877408,-1.3216141733988007,0.10606060606060606,0.5111568869798363,1.0,2/11,10.67%,SRF;LRPAP1
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.8355993747111092,-1.321602426192143,0.11764705882352941,0.5101582582581365,1.0,1/5,5.53%,KIF17
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.8355993747111092,-1.321602426192143,0.11764705882352941,0.5101582582581365,1.0,1/5,5.53%,KIF17
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Visceral Adipose Tissue,-0.5563352931956155,-1.3214669251329805,0.04819277108433735,0.5096247802490061,1.0,25/91,17.47%,COL4A1;ANGPTL2;TAGLN3;STMN2;RCAN2;PDPN;PLP1;THY1;LDB2;EDIL3;TENM4;TCEAL2;THBS2;FGF1;BAALC;RASL12;RGS7BP;TMEM132C;PHYHIP;F3;TCEAL5;CD200;NDN;TEK;SHROOM4
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Visceral Adipose Tissue,-0.5563352931956155,-1.3214669251329805,0.04819277108433735,0.5096247802490061,1.0,25/91,17.47%,COL4A1;ANGPTL2;TAGLN3;STMN2;RCAN2;PDPN;PLP1;THY1;LDB2;EDIL3;TENM4;TCEAL2;THBS2;FGF1;BAALC;RASL12;RGS7BP;TMEM132C;PHYHIP;F3;TCEAL5;CD200;NDN;TEK;SHROOM4
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Fat Pad,-0.8847260736681717,-1.3211991987260296,0.09375,0.5103336985296617,1.0,2/5,7.03%,THY1;CD44
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.5138994561523523,-1.3211643980539074,0.011363636363636364,0.5099449993124218,1.0,57/191,20.53%,RPL19;RPL3;RPS27A;WARS1;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;GTPBP2;RPL13A;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;EEF1A2;GARS1;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;COPS5;MRPL23;PPA1;RPL15;MRPL51;RPL11;DARS2;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.6734035753360774,-1.3210642132688502,0.07936507936507936,0.509772200483408,1.0,3/26,1.45%,COL4A1;MET;TGFBR2
prerank,CellMarker_Augmented_2021__Stem cell:Submandibular Gland,-0.6004047227689522,-1.3209428582508984,0.05194805194805195,0.5096681281728145,1.0,25/60,18.82%,GGT5;APLNR;ABCA8;RAMP3;MAOB;BGN;GSTM5;LDB2;CFH;SLCO2A1;RNASE1;ITGA9;RASL12;MMRN2;C1S;ROBO4;DLC1;TNS2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;A2M;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.5922112474194569,-1.3207797229609022,0.08,0.5098374460864411,1.0,12/53,13.58%,MET;PSRC1;LMOD1;CAV3;BAIAP2;BAIAP2L1;CDC42EP1;PFN2;CDC42EP3;DCTN1;PINK1;FES
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.8125546928795324,-1.3206014905557342,0.11666666666666667,0.5100746319118817,1.0,4/7,15.95%,ITGA2;ITGA8;ITGA3;ITGB4
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.7642247879740205,-1.3200832536078329,0.11290322580645161,0.5117619557161487,1.0,2/9,7.85%,KCNQ1;EGF
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.8085960294377972,-1.3200757004918973,0.06896551724137931,0.5112866683147762,1.0,1/9,0.81%,BLM
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.531335283029458,-1.3198410621284102,0.07317073170731707,0.5117256290387537,1.0,40/134,17.72%,COL4A1;TAMALIN;ANGPTL2;CALD1;C1R;COL4A2;COL5A1;COL4A4;COX7A1;SULF1;ITGA5;PI16;LMOD1;BGN;SCARA3;CYP1B1;SRPX2;SQOR;IGFBP7;FN1;BMX;IGFBP5;TRIM47;PROCR;C1QTNF1;SLCO2A1;AMOTL2;ITGA9;MMRN2;C1S;ROBO4;TNS2;ITGB4;COL12A1;PXDC1;AFAP1L1;TEK;ENPP4;ADGRF5;AQP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.6905943170878038,-1.3197614883387616,0.10294117647058823,0.5113969495936561,1.0,1/18,0.18%,ANXA1
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.7293673900125173,-1.3197320252915938,0.16071428571428573,0.5109623050476475,1.0,5/9,21.77%,GATA1;ZFPM1;THPO;ZNF385A;SH2B3
prerank,CellMarker_Augmented_2021__Schwann cell:Undefined,-0.8014590182022205,-1.3196541212639337,0.16981132075471697,0.5107319533068226,1.0,2/6,7.25%,GAP43;GFAP
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.5824167166550784,-1.3196102845119084,0.07894736842105263,0.5104053275070229,1.0,13/54,15.79%,MET;EPS8L2;ARHGEF3;GPR18;SYNPO2L;RIT2;ARHGEF18;LPAR6;LPAR4;P2RY10;ITGA3;DLC1;STMN1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7378302688214667,-1.3195556728754019,0.12727272727272726,0.5100987089930951,1.0,5/12,10.82%,PKP2;GJC1;ATP1A1;ATP1B1;CACNA1C
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6334918611298259,-1.319358674238268,0.1388888888888889,0.5105458281897549,1.0,11/34,13.92%,THBS1;OGN;NR4A3;IL12A;APOD;ELN;IGF1;STAT1;IL18;IGFBP5;VIP
prerank,CellMarker_Augmented_2021__Endothelial cell:White Adipose Tissue,-0.6020320024013766,-1.3193154561015972,0.09090909090909091,0.510230053364257,1.0,26/59,17.72%,GGT5;COL4A1;ANGPTL2;APLNR;SPARC;COL4A2;RAMP3;COX7A1;BGN;DYSF;PODN;LDB2;IGFBP7;CFH;SLCO2A1;RNASE1;RASL12;MMRN2;ROBO4;TNS2;MCAM;AFAP1L1;TEK;SHROOM4;ADGRF5;AQP1
prerank,CellMarker_Augmented_2021__Merkel cell:Skin,0.4971925505704667,1.31926305452119,0.045454545454545456,0.8252857565042968,1.0,8/54,7.64%,ACE2;GOLT1A;EFNA2;ARHGEF16;TMEM54;SOX9;MYO5B;PLEKHA6
prerank,CellMarker_Augmented_2021__B cell:Fetal Liver,-0.8305662011098409,-1.3191668522671833,0.11320754716981132,0.5102810691954921,1.0,2/7,3.94%,CD24;IGHG1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.8494409050101726,-1.319139747671374,0.10294117647058823,0.5098218402566251,1.0,2/7,3.16%,B2M;HLA-A
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.8089546688227469,1.3190786668190766,0.15555555555555556,0.8244390706128022,1.0,1/5,2.74%,CARD18
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.7554102049906398,-1.319051237219035,0.11428571428571428,0.5098058642878724,1.0,6/12,16.36%,B2M;HLA-A;HLA-DRA;HLA-E;HLA-F;HLA-DRB1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.4346140744738155,1.3188573186675006,0.0,0.8238144583890278,1.0,14/107,10.13%,TBC1D4;ATP6V0D2;PDK4;PDE3B;ATP6V1A;TRIB3;KAT2B;AKT2;ATP6V1G1;AKT1;AP3S1;RAB8B;INSIG2;LPIN3
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,-0.6889612193401432,-1.3185536458382834,0.05970149253731343,0.5112883710531437,1.0,8/23,16.21%,C3;C1R;AKR1C1;CD55;CFH;C1S;SERPING1;PSMA7
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.5241688280429215,-1.3184196229321006,0.04597701149425287,0.5113188970075472,1.0,20/202,10.89%,TLCD2;EPN1;A4GALT;MX1;MYOF;ANK3;RPS27A;SH3GL2;SUN3;DYSF;TRIP10;CAV3;SYNGR2;SYP;LDLR;EGF;SYT1;WNT5A;TGFA;M6PR
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.5930100688389259,-1.3183207375523134,0.0684931506849315,0.5111864032541649,1.0,7/50,8.06%,AMN;RPS27A;LSR;LPA;VLDLR;LDLR;ANGPTL3
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.782856536105707,-1.3183136982675134,0.0784313725490196,0.5107094505282023,1.0,4/9,13.03%,KCNQ1;GJC1;CACNA1C;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.6370426025751202,-1.318198949329359,0.06060606060606061,0.5106639479960365,1.0,8/36,6.59%,TLR2;PTP4A3;IFI35;NLRP12;APP;NOD1;LRRC19;TLR3
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.6645715007275569,-1.3180236780206318,0.12307692307692308,0.5107714385368192,1.0,9/21,19.14%,MET;WAS;ARHGEF18;TMEFF2;PPFIA1;DLC1;STMN1;RHPN2;PHLDB2
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.4634760567282167,1.3179652409504798,0.08695652173913043,0.8264380078888302,1.0,24/74,20.08%,GDAP1;ABCD2;ZDHHC14;ZDHHC11;TRAM1;PEX13;ABCD1;VPS37A;RAB8B;ZDHHC18;ABCD3;TAOK2;SSR1;ZDHHC20;VPS37B;ZDHHC21;PEX2;SLC25A17;GOLGA7;ZDHHC11B;RAB3IP;ICMT;PEX12;PIKFYVE
prerank,CellMarker_Augmented_2021__Corneal Epithelial Stem cell:Eye,-0.7296881003401647,-1.3178120699442437,0.17307692307692307,0.5111460098643488,1.0,5/9,5.89%,GPR87;FAT2;ZNF750;ABCA12;DUOXA1
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.835153960384678,-1.317765739932113,0.06896551724137931,0.5108713198036148,1.0,2/7,6.91%,GBP2;GBP7
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.7194448539443025,-1.3176985348231676,0.06349206349206349,0.5105781369960523,1.0,3/14,10.73%,ITGA5;KLF4;FGF1
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,0.5490912999178745,1.3176135146552994,0.125,0.8261743238930065,1.0,10/39,15.95%,DDX56;H2BC21;KAT2B;H2BC4;ERCC6;H2AC6;POLR1F;KAT2A;H3-3B;EP300
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,-0.5526543816672924,-1.3174551209701792,0.037037037037037035,0.5110374140320085,1.0,33/136,17.72%,CACNA1H;ANXA1;SCN1B;KCNQ1;CALD1;KCNK1;KCNJ2;SCN9A;PLN;LMOD1;DYSF;CAV3;ITPR3;ATP1B1;MYH11;SLC8A3;TNNT1;SCN2A;CACNA1C;SCN1A;TPM4;SCN3B;KCNK12;KCND3;CACNB1;TLN1;GUCY1A1;ANXA2;PDE5A;VCL;RYR2;FGF12;KCNK10
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.8465295256667241,-1.317301771400958,0.12698412698412698,0.510651956350375,1.0,1/5,1.14%,NR4A3
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.8465295256667241,-1.317301771400958,0.12698412698412698,0.510651956350375,1.0,1/5,1.14%,NR4A3
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.5230625871051167,1.3172594105680848,0.14285714285714285,0.8259841130425848,1.0,16/64,20.89%,NUP42;U2AF1;NUP37;NUP54;NDC1;NUP214;NXT1;AAAS;NUP188;THOC3;NUP205;THOC1;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.7682549470628953,-1.3171704056467164,0.11940298507462686,0.5107776700215002,1.0,6/13,19.00%,CELA2A;PRKCQ;SYK;SELP;C1QTNF1;PDGFRA
prerank,Reactome_2022__Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,0.6304155282159913,1.31696237933429,0.11764705882352941,0.8256743807578855,1.0,4/15,14.84%,FLT3;NRAS;PIK3CA;PIK3R1
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.8389788474252832,-1.316835027030747,0.078125,0.511471840959554,1.0,2/6,0.90%,S100A10;RFTN1
prerank,Reactome_2022__SUMOylation Of Transcription Factors R-HSA-3232118,-0.6808716876323915,-1.3168307810908424,0.15517241379310345,0.5109809869777677,1.0,2/16,1.90%,CDKN2A;HIC1
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.7209353702555733,-1.3167754988315645,0.12903225806451613,0.5106424777648423,1.0,2/15,7.17%,TIMP2;TIMP1
prerank,Reactome_2022__Maturation Of Spike Protein R-HSA-9683686,0.8706639323694852,1.31671691622686,0.14285714285714285,0.8251738421955931,1.0,4/5,12.70%,MOGS;MOGAT1;PRKCSH;GANAB
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,-0.7183833545971994,-1.3165968961282704,0.09230769230769231,0.5109566862855802,1.0,4/15,19.40%,SOCS3;STAT1;IRS2;GHR
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),-0.8781403990547652,-1.3165189916596,0.07547169811320754,0.51075104931353,1.0,2/5,10.08%,CDKN2A;IRF7
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.508909591328462,-1.3165099029847016,0.011904761904761904,0.5102723400205268,1.0,30/186,13.56%,CACNA1H;HPN;SCN1B;KCNQ1;KCNV1;SLC6A15;LRRC55;KCNB1;SLC39A14;KCNK1;KCNJ2;SCN9A;SLC24A2;SLC4A11;ATP1A1;TRPC3;KCNH8;SLC24A1;SLC9A2;ATP1B1;SLC8A3;SCN2A;CACNA1C;SCN1A;KCNG1;SLC24A5;KCNB2;SCN3B;KCNK12;SLC11A1
prerank,PanglaoDB_Augmented_2021__Platelets,-0.5474336293794709,-1.3161971591810024,0.060240963855421686,0.5108874454912129,1.0,18/91,11.40%,THBS1;P2RY13;MYO1F;SPARC;RASGRP2;P2RY12;ALOX12;ITGA2;HLA-A;ADGRE5;TUBB1;NRGN;CLEC12A;F13A1;CTSS;CD9;SELP;HLA-E
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.771921671162117,1.315921300048038,0.2619047619047619,0.8276709283865112,1.0,2/6,12.03%,THEM4;NAIF1
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.7397923398696296,1.3157784330138511,0.1388888888888889,0.8265226249220438,1.0,5/8,25.23%,ABCD1;PEX6;ZFAND6;PEX12;PEX16
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.7477163939217759,-1.3153717832379013,0.12698412698412698,0.5137036225696268,1.0,1/15,0.54%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.5541532782476121,1.3153338486931254,0.14285714285714285,0.8270495779804592,1.0,8/21,30.56%,NOL11;UBTF;EIF2AK3;DHX33;WDR43;WDR75;PWP1;MTOR
prerank,CellMarker_Augmented_2021__Natural Killer cell:Peripheral Blood,0.7910974630621856,1.314518475787704,0.11363636363636363,0.8297174898714524,1.0,2/6,0.40%,ITGA1;CD247
prerank,Reactome_2022__PI-3K cascade:FGFR2 R-HSA-5654695,0.6593169198040159,1.3141464207443185,0.13157894736842105,0.8295701685742232,1.0,1/14,0.16%,FGF6
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.5531514390123529,-1.3140718212415745,0.07692307692307693,0.5184415537011415,1.0,4/79,2.75%,CD24;LEF1;RPS27A;WNT8B
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.6926651154183678,-1.3140143083498415,0.109375,0.5181730587025503,1.0,6/14,20.03%,TRIM5;SCIMP;CD55;SIGIRR;CD36;CX3CL1
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone Marrow,-0.5462535618059718,-1.3139865734441898,0.04819277108433735,0.5178018888589191,1.0,26/88,18.20%,ENPP2;ANGPTL2;APLNR;STMN2;RCAN2;PLP1;THY1;BGN;LDB2;ELN;CACNA1C;BAALC;IGFBP5;ITGA9;RASL12;RGS7BP;TMEM132C;ROBO4;SERPING1;TCEAL5;NDN;TEK;SHROOM4;ADGRF5;AQP1;A2M
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.7958393441014868,-1.313492173321993,0.09375,0.5194374493883738,1.0,4/9,16.81%,PLK2;ZWILCH;WEE2;WEE1
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.6772200005426564,-1.3134677767628407,0.08450704225352113,0.5189814762739611,1.0,5/29,6.95%,GGT5;OGN;CSPG4;BGN;OMD
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,0.5870424146658559,1.3134387264842882,0.13333333333333333,0.8308936942569983,1.0,4/22,15.95%,HSPA1A;HSF1;MRPL18;EP300
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.702080740768347,1.313199891387887,0.12121212121212122,0.8302239269521023,1.0,7/11,26.84%,PEX13;PEX2;PEX6;PEX12;PEX16;PEX5L;PEX5
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.4491076022482916,1.3130491250317868,0.05,0.8288721272192571,1.0,11/51,18.40%,KAT2B;ERCC6;SERTAD2;POLR1F;H1-2;KAT2A;DDX21;ASF1A;EP300;SPHK2;ATAD2B
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),-0.8910273145218648,-1.3129885845735212,0.05263157894736842,0.5204441835216965,1.0,2/5,6.91%,IL15;PTK6
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.8572881464630797,-1.31297091956205,0.09259259259259259,0.5200441889141932,1.0,2/6,8.48%,DUOX1;DIO1
prerank,CellMarker_Augmented_2021__FOXP3+ Natural Regulatory T (Treg) cell:Blood,-0.6352973531638088,-1.312970668269919,0.12698412698412698,0.5195236241605253,1.0,9/29,6.48%,MYO1F;GPR183;CD5;TAGAP;GPR171;SLA;ARHGAP9;ARHGAP15;ACAP1
prerank,Reactome_2022__Chk1/Chk2(Cds1) Mediated Inactivation Of Cyclin B:Cdk1 Complex R-HSA-75035,-0.7122464073749709,-1.3127901324004665,0.14754098360655737,0.519852847492998,1.0,3/12,16.81%,YWHAH;CCNB1;WEE1
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.7715426454215341,-1.312711799498354,0.1694915254237288,0.519613041140857,1.0,2/8,5.04%,C3;APP
prerank,Reactome_2022__SUMOylation Of DNA Methylation Proteins R-HSA-4655427,0.7304921953705327,1.3125933031637282,0.16666666666666666,0.8290577054981805,1.0,6/13,21.75%,PHC1;RNF2;DNMT3B;SCMH1;PHC3;PCGF2
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.7022377866316499,-1.3120168554810223,0.09230769230769231,0.5220079547277752,1.0,3/17,8.39%,GBP1;RIT2;NEUROD2
prerank,CellMarker_Augmented_2021__Epithelial cell:Placenta,-0.6238336526275118,-1.3117668671061888,0.1111111111111111,0.5224639023417054,1.0,15/40,16.51%,MET;A4GALT;MYOF;PSCA;EPS8L2;ITGA2;BAIAP2L1;SRPX2;OSMR;AMOTL2;ITGA3;LAMA3;ITGB4;RHOD;ANXA2
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.6346109930844311,-1.3116999580567188,0.12698412698412698,0.5222222118901697,1.0,7/38,8.06%,CCBE1;COL4A1;APLNR;TGFBR2;PROX1;CYP1B1;ANGPTL3
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.6633236373290344,1.3114880373123632,0.20588235294117646,0.8329111040706926,1.0,6/11,21.32%,SEPHS1;PSPH;SRR;CTH;SERINC5;PHGDH
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.741288558749074,-1.3112524892516504,0.14285714285714285,0.5235679657254031,1.0,6/12,11.40%,HLA-A;IL12A;HLA-DRA;SYK;CD55;HLA-E
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.6986002398216444,-1.3110841219707576,0.1076923076923077,0.5239190190651722,1.0,4/14,4.94%,MAOB;PRDX4;DUOX1;PRDX5
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.466771939108431,1.3109420605663837,0.0,0.8341436078605942,1.0,13/66,13.59%,MTERF1;NUDT21;SNRPF;UBTF;ERCC2;WDR33;CSTF3;PAPOLA;POLR1F;CPSF7;ERCC3;GTF2H5;GTF2H2
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5843374936516751,-1.3109287849392197,0.08823529411764706,0.5240748720186658,1.0,10/55,7.44%,LEF1;CD5;TAGAP;SKAP1;GPR171;MAFF;CD160;ARHGAP9;THY1;IFIT3
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.573919769429152,-1.3109150288166604,0.1111111111111111,0.523628979404626,1.0,6/54,12.02%,LEF1;CDKN2A;CCND1;SRF;CCNB1;RUNX2
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.8535743134406057,-1.3108481113146524,0.08333333333333333,0.5233226260668282,1.0,3/5,11.73%,TLR2;CCL2;NAMPT
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5727542837638059,1.3104206227316273,0.10810810810810811,0.8348792106587355,1.0,16/28,29.15%,EXOSC1;DCP1B;EXOSC6;DIS3;EDC3;LSM5;LSM7;CNOT8;EXOSC8;PATL1;DCP1A;EXOSC5;DDX6;LSM1;LSM6;CNOT7
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.5798530753878155,-1.310414333882631,0.09722222222222222,0.524669862779567,1.0,16/64,17.53%,THBS1;SP100;SPARC;PROX1;CEACAM1;SVBP;EGF;WNT5A;FGF1;DAB2IP;EMP2;GPI;PIK3CB;PIK3CD;TEK;ETS1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Hippocampus,-0.5783026277725765,-1.3104127187526657,0.09090909090909091,0.5241509014909621,1.0,15/59,16.83%,CCNB2;TYMS;BLM;DEPDC1B;CENPH;MIS18A;GINS2;LMNB1;NUF2;FANCI;KIF2C;CENPU;CDKN3;OIP5;CDCA7
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.8037176534505611,1.3103703361402201,0.14634146341463414,0.8333915216357104,1.0,2/5,14.67%,JAM2;GPLD1
prerank,CellMarker_Augmented_2021__Endothelial Stem cell:Blood Vessel,-0.7277924004565822,-1.3103097487070456,0.1746031746031746,0.5240845642286521,1.0,5/12,16.53%,ICAM1;ITGA5;SELP;TNFRSF1A;MCAM
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.7192445952927032,-1.3099682087751614,0.06944444444444445,0.5250955998800878,1.0,1/17,0.02%,ENPP2
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.5148262963773061,-1.3099250241933602,0.06976744186046512,0.5247433202090028,1.0,26/168,13.52%,S100A10;RFTN1;PKP2;MRAP2;FYB1;ANK3;KCNB1;RAMP3;TESC;RAB11A;ZDHHC22;LRRC4;ABCA12;THY1;CAV3;ATP1B1;KCNB2;PDZK1;FLOT1;PLEKHF1;TSPAN32;EMP2;FYB2;SCN3B;TNFRSF1A;NLGN1
prerank,Reactome_2022__Complement Cascade R-HSA-166658,-0.6571515083693535,-1.3099052664190967,0.09722222222222222,0.5243090332006196,1.0,8/27,16.21%,C3;C1R;AKR1C1;CD55;CFH;C1S;SERPING1;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.6514319090257465,-1.3097298285972105,0.15942028985507245,0.5245273817611175,1.0,9/24,19.14%,MET;WAS;ARHGEF18;TMEFF2;PPFIA1;DLC1;STMN1;RHPN2;PHLDB2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.8295683429395246,1.3095904180871143,0.06666666666666667,0.8354084126444112,1.0,1/5,6.09%,ZNF304
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.7500023242476387,1.308985489318746,0.18604651162790697,0.8365791149340428,1.0,3/6,15.27%,PRUNE1;BNIPL;MINPP1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.6720113976201016,-1.3089845030667362,0.10294117647058823,0.5271480984502407,1.0,9/24,15.76%,SOCS3;THY1;PARP14;PTK6;SH3BP5;MVP;DMTN;SFRP2;PRKCD
prerank,GO_Biological_Process_2021__chitin metabolic process (GO:0006030),-0.859013169999386,-1.3087553159267313,0.109375,0.527074523587237,1.0,2/5,8.03%,CHI3L2;CHI3L1
prerank,GO_Biological_Process_2021__chitin catabolic process (GO:0006032),-0.859013169999386,-1.3087553159267313,0.109375,0.527074523587237,1.0,2/5,8.03%,CHI3L2;CHI3L1
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.7975316420333134,-1.3084077161227723,0.2033898305084746,0.5279659613126741,1.0,2/5,19.24%,MFSD2A;CD36
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.8093269107781774,-1.308354389721172,0.10714285714285714,0.5276772309302261,1.0,3/8,11.79%,ANXA1;NFKBID;IL18
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.7498297676168671,-1.3082700293426213,0.14285714285714285,0.5275259573043974,1.0,4/15,12.55%,PDPN;CEACAM1;CD44;TMEFF2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5684722225716767,1.3081016721198286,0.15151515151515152,0.839045757364193,1.0,16/30,29.15%,EXOSC1;DCP1B;EXOSC6;DIS3;EDC3;LSM5;LSM7;CNOT8;EXOSC8;PATL1;DCP1A;EXOSC5;DDX6;LSM1;LSM6;CNOT7
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.8163286347462246,-1.307964175588634,0.125,0.5282775816462632,1.0,3/6,15.76%,IL15;SYK;PRKCD
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.7201035299369183,-1.3077045016197226,0.13636363636363635,0.5289275467746032,1.0,4/13,7.93%,KCNQ1;KCNJ2;ATP1A1;ATP1B1
prerank,KEGG_2021_Human__Taurine and hypotaurine metabolism,-0.8237389612788988,-1.3075766381769525,0.12903225806451613,0.5289301859573595,1.0,1/7,0.04%,GGT5
prerank,Reactome_2022__Carnitine Metabolism R-HSA-200425,0.7066682169425905,1.307554371926446,0.20833333333333334,0.8399956134772572,1.0,5/10,22.71%,MID1IP1;CPT2;SLC22A5;CPT1A;SLC25A20
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,-0.4874050641705452,-1.3075273973953065,0.0,0.5285964701744251,1.0,113/484,17.95%,CACNA1H;CD24;COL4A1;EFNA1;SCN1B;FLRT3;RPL19;COL4A2;RPL3;L1CAM;ANK3;LAMB1;RPS27A;RPL39L;RPL36AL;RPS27;ITGA2;SHTN1;COL4A4;CNTNAP1;RPS14;RPS4X;RPL27A;SH3GL2;SCN9A;DOK1;COL6A2;RPL35;ITGA5;RPL7A;GFRA2;TRPC3;RPL37A;VLDLR;RPL27;EFNB3;GAP43;LDB2;ARHGAP39;AKAP5;RPL9;PSMB9;RPL21;MYH11;RPL13A;RPS6KA1;NELL2;MAG;PFN2;DOK6;RPS11;RPS16;RPLP1;SCN2A;RPS13;PSMB6;CACNA1C;UNC5B;RPL38;PRKCQ;SLIT3;SCN1A;RPS3A;RPS8;RPL10A;PSMC3;MYH9;RPLP2;RPS23;RPS21;RPS7;UBC;GRIN2B;RNASE1;CRMP1;SCN3B;RAP1GAP;ITGA9;RPL8;FES;SEMA3E;RPS6;ELOB;RPS15;PIK3CB;RPL26L1;CNTN2;RPS9;PSMA8;RPL12;APH1A;RPL5;RELN;DPYSL2;ANK1;CACNB1;TLN1;PSMA7;FAU;COL9A2;RPL23;RPL4;IRS2;SH3KBP1;GPC1;PSME1;CDK5;RPL18A;RBX1;RPL41;LIMK2;RPL7;RPS12
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8290329793517385,-1.3074389751347932,0.11666666666666667,0.5279763506152335,1.0,2/5,9.67%,STAT4;STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8290329793517385,-1.3074389751347932,0.11666666666666667,0.5279763506152335,1.0,2/5,9.67%,STAT4;STAT1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.5204189554464042,1.3073760164960304,0.05263157894736842,0.8390678471584692,1.0,12/67,12.64%,RANBP17;NXT2;NUP62CL;KPNA2;PPP1R10;NUP54;AKT1;IPO5;IPO8;NUP214;NXT1;RANBP6
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.6952580834871589,-1.3070374746365465,0.11475409836065574,0.5292760606016778,1.0,4/12,14.80%,IFIT1;PLN;ATP5IF1;PAM16
prerank,CellMarker_Augmented_2021__Semilunar Valve cell:Heart,-0.6662494039780537,-1.3067001595727077,0.13636363636363635,0.530165761409993,1.0,9/19,15.78%,GPR87;PSCA;ITGA2;ABCA12;DUOXA1;OSMR;KPNA7;CXCL17;LAMA3
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,-0.6122425468755941,-1.306002519061166,0.1267605633802817,0.5325735398679523,1.0,4/41,7.67%,APIP;LDHA;BHMT;LDHAL6A
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.6548989738243197,-1.3057899399699344,0.09523809523809523,0.5327804949365557,1.0,8/25,17.69%,C3;C1R;CD55;CFH;C1S;SUSD4;SERPING1;CR1L
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.5586091347035591,1.305565128543645,0.17142857142857143,0.8464546567548185,1.0,8/35,10.28%,CPAMD8;ASCL1;ADAMTS18;FREM2;ZDHHC16;SMG9;PBX1;ATF6
prerank,Reactome_2022__FGFR2 Ligand Binding And Activation R-HSA-190241,0.7153599728737717,1.3054315419434481,0.13333333333333333,0.8453562633328109,1.0,1/9,0.16%,FGF6
prerank,CellMarker_Augmented_2021__Transitional B cell:Blood,-0.6322978566033827,-1.3053910104222153,0.07575757575757576,0.5338086823831801,1.0,11/25,15.12%,CD24;IGHG1;HLA-DRA;CEACAM1;MACC1;ILDR1;CTSS;SYK;TC2N;BLNK;CD74
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.5961696939916552,-1.3053645890370287,0.0375,0.5333285072150469,1.0,8/53,16.14%,ECM2;P2RY12;IL12A;SYK;RNASE10;HYAL1;SFRP2;RHOD
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.7187808210195994,-1.3053291150907602,0.125,0.5329664092600243,1.0,3/9,12.60%,AKAP5;CACNA1C;NOS1
prerank,Reactome_2022__Uptake Of Dietary Cobalamins Into Enterocytes R-HSA-9758881,-0.838713713607118,-1.3048953675739223,0.05172413793103448,0.5343155402878617,1.0,1/5,1.14%,AMN
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.8015893117919398,-1.3045923823556276,0.1111111111111111,0.5350684582222993,1.0,4/8,18.03%,GFAP;PLK3;EEF1A2;CTSA
prerank,Reactome_2022__Sensory Perception Of Taste R-HSA-9717189,-0.7475679349846409,-1.3045091575488568,0.08823529411764706,0.534912395724333,1.0,6/14,14.50%,SCN1B;KCNJ2;SCN9A;ITPR3;SCN2A;TAS1R1
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.6866401281402253,-1.304447475784408,0.14084507042253522,0.534693796072914,1.0,5/19,17.27%,RPS27A;SH3GL2;SH3GL3;UBC;SH3KBP1
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.5514396138552057,1.3042298251132518,0.09090909090909091,0.84959644513808,1.0,3/30,6.41%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.5434650210224167,1.3042172737929225,0.06896551724137931,0.8478766142774766,1.0,4/29,3.54%,ACE2;GOLT1A;EFNA2;ARHGEF16
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.6878531890936923,-1.303971909220455,0.0967741935483871,0.5362154404485806,1.0,5/18,12.77%,TGFBR2;GRIN3A;GRIN2A;SLIT3;GRIN2B
prerank,KEGG_2021_Human__Osteoclast differentiation,-0.5578966251479368,-1.3037566315007136,0.03896103896103896,0.5364977437501348,1.0,16/81,15.87%,IL1R1;SOCS3;FOSB;TGFBR2;FOSL2;IFNGR2;STAT1;PPP3CC;SYK;MAP3K14;TNFRSF1A;FOS;BLNK;PIK3CB;PIK3CD;JUNB
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.7202911917937035,-1.3037434485040957,0.1791044776119403,0.5360097235247508,1.0,1/10,2.07%,IHO1
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),0.7123995990174329,1.303572975401088,0.15,0.8495985817584772,1.0,4/9,16.37%,SLC25A24;SLC25A41;SLC25A5;SLC25A17
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.7416208261987945,-1.3035306266940192,0.1206896551724138,0.5365241842958998,1.0,6/14,21.67%,MET;GPNMB;FGF7;TSC2;CX3CL1;SCG2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Thyroid,-0.8472618331686383,-1.3035298387794432,0.11764705882352941,0.5360102722419765,1.0,2/5,7.03%,CD24;CD44
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.7118244448440398,1.303445220268024,0.125,0.8485484134485314,1.0,1/8,2.36%,ABCA1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.6176310875842518,1.3034393076828132,0.11428571428571428,0.8468638794243879,1.0,4/18,12.34%,GPATCH2;PPP1R36;PPP1R26;ZCCHC9
prerank,CellMarker_Augmented_2021__Myogenic Endothelial cell:Skeletal Muscle,-0.5909617686951883,-1.3034391475484313,0.08333333333333333,0.5358008023618726,1.0,23/55,18.20%,APLNR;P2RY14;RAMP3;GPR34;SLA;PLXDC1;SIGLEC1;LDB2;MYH11;F13A1;SELP;LDLRAD4;ELMO1;RNASE1;PCDH12;ROBO4;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ITIH5;A2M
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.7545198485403181,-1.3033225795852554,0.1875,0.535832484451042,1.0,2/11,9.67%,IRF1;STAT1
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,0.5796231128879793,1.3033036386918926,0.10714285714285714,0.8458461810791071,1.0,3/30,5.17%,FGF6;NRAS;TRIM24
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.6494688653642811,-1.3031316766757441,0.14285714285714285,0.5362560669983666,1.0,4/25,8.66%,APLNR;TGFBR2;CCDC39;SRF
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.8051918929833538,-1.3028793805529233,0.17543859649122806,0.5367856376282344,1.0,1/6,6.33%,CAV3
prerank,CellMarker_Augmented_2021__Preadipocyte Progenitor cell:Adipose Tissue,-0.5501041726750968,-1.30264236950022,0.09210526315789473,0.53719861273237,1.0,32/72,18.20%,ECM2;ANGPTL2;APLNR;SPARC;C1R;ABCA8;ASPN;COX7A1;THY1;LMOD1;BGN;PODN;LDB2;OLFML1;ELN;ITGA8;GALNT15;SLIT3;AEBP1;IGFBP5;PRRX1;ITGA9;RASL12;C1S;ROBO4;TEK;SHROOM4;ADGRF5;AQP1;ITIH5;PCDH18;A2M
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,-0.6095917558857161,-1.3025679585927852,0.09375,0.5370245395831644,1.0,12/35,17.19%,RGSL1;ADCY7;GNG3;PRKCG;ADCY5;PRKCQ;GNG2;PRKCH;RGS17;PRKCD;ADCY8;PRKCB
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.6625476837617239,-1.3025457811953733,0.07575757575757576,0.5366378144787719,1.0,3/22,3.68%,LEF1;POU4F1;TESC
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5742707128472962,1.302316435573337,0.11764705882352941,0.8487850478577604,1.0,2/15,6.64%,PRDX6;SF3B4
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.5748625053892413,-1.3021306909766628,0.07894736842105263,0.5376792288051543,1.0,8/60,7.35%,ANXA1;CDKN2A;KIF14;GPNMB;KLF4;CCL2;GFI1B;CCND1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.560655777844326,1.301573018008832,0.11538461538461539,0.8506013288312819,1.0,8/28,15.28%,RGCC;SERPINF2;RUNX1;AKT1;RAB27A;ADGRB1;HDAC2;ZBTB20
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,-0.6460638146772466,-1.3015276491350924,0.14285714285714285,0.5397638436520308,1.0,6/22,15.24%,SYN3;SLC18A2;SYN2;CPLX1;SYT1;PPFIA1
prerank,KEGG_2021_Human__Glutathione metabolism,-0.6189057057919805,-1.3014063116600483,0.125,0.5398092233515069,1.0,2/40,6.51%,GGT5;GSTM5
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.5917799628791429,-1.3013470091313537,0.12162162162162163,0.5395539347979668,1.0,16/57,14.73%,C1ORF87;TEKT2;RSPH4A;CFAP126;ECT2L;TMEM212;CCDC39;DCDC2B;ANKUB1;DNAH3;FAM81B;CCDC181;DRC3;CXCL17;DRC1;AKAP14
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Placenta,-0.5702611476825674,-1.3012717260817575,0.04,0.539263800618076,1.0,25/67,20.23%,COL4A1;FLRT3;COL4A2;COL5A1;SULF1;MAMDC2;THY1;BGN;SCARA3;SRPX2;WNT5A;DAB2IP;IGFBP5;SLCO2A1;AMOTL2;PDLIM4;ASS1;LAMA3;COL12A1;F3;NOTCH3;PTPN21;SVEP1;ANTXR1;KIAA1217
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.6400331783953889,-1.3012399823080645,0.14516129032258066,0.5388595043787022,1.0,2/27,4.40%,THBS1;SEMA3B
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR2 R-HSA-5654221,0.7349898708835269,1.3010762693827023,0.047619047619047616,0.8512338717982109,1.0,1/9,0.16%,FGF6
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.6227673653210475,-1.3008682102502458,0.17142857142857143,0.5397694946684826,1.0,7/30,18.28%,P2RY6;NR4A3;IGF1;IGFBP5;APLN;GPER1;CDKN1A
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.635871629321265,-1.3008126853472306,0.1,0.5394183280195038,1.0,5/25,10.03%,ANXA1;RAMP3;STAT4;STAT1;EIF2B2
prerank,Reactome_2022__Transport Of Nucleosides And Free Purine And Pyrimidine Bases Across Plasma Membrane R-HSA-83936,-0.7394628812607524,-1.3007300927272463,0.08695652173913043,0.5391910092838879,1.0,1/11,0.41%,SLC28A2
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),-0.8204505391524385,-1.3006486074315695,0.16666666666666666,0.5390871882790333,1.0,1/7,0.24%,CCBE1
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.8714697331652872,-1.3005230314153908,0.14035087719298245,0.5391152985232464,1.0,2/5,9.95%,ANK3;MLLT11
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Peripheral Blood,-0.6874561097738018,-1.3004901231600243,0.12903225806451613,0.5387572945959118,1.0,4/17,6.56%,CD24;ICAM1;ITGA5;CEACAM1
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.6884465622930236,1.3004549483695491,0.2,0.8526090243824469,1.0,2/13,5.94%,CSPG5;MFF
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.8288972934736626,-1.300371041421111,0.1724137931034483,0.5386980033146186,1.0,4/8,13.52%,P2RY12;SFTPD;CCL2;CXCL17
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.609736490814629,-1.3003303840650327,0.14864864864864866,0.5384724281643388,1.0,7/31,9.02%,SERPINA10;TIMP2;SERPINF1;SPOCK3;TIMP1;SERPIND1;SERPINE3
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.6208532428017685,-1.2999302209377905,0.1527777777777778,0.5394721960712512,1.0,8/24,18.14%,MET;STMN2;PSRC1;CAV3;DCTN1;FES;ANKRD53;MAPT
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.6487542589441166,1.2998879639918417,0.1,0.8534378740085357,1.0,3/12,12.49%,PIK3R4;TRAPPC8;PIK3C3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-0.90194742589114,-1.299360735048142,0.1206896551724138,0.5415714846510652,1.0,2/5,5.91%,MLIP;TRPC3
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.6802396836090892,-1.2992402231714246,0.18055555555555555,0.5415709117241758,1.0,3/10,7.93%,KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.6504289325987723,1.2989056813218316,0.08571428571428572,0.8563550125662097,1.0,6/17,14.18%,CEL;CYP4F3;CYP4F12;LPIN3;PLA2G15;ACOX1
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.7260240203789323,1.2987103860444003,0.1891891891891892,0.8555795276728413,1.0,2/6,21.02%,SLC25A19;ABCC5
prerank,Reactome_2022__Loss Of Function Of TGFBR1 In Cancer R-HSA-3656534,-0.8003285336618347,-1.298458405877183,0.15789473684210525,0.5436704984303917,1.0,1/6,1.45%,TGFBR2
prerank,Reactome_2022__SMAD2/3 Phosphorylation Motif Mutants In Cancer R-HSA-3304356,-0.8003285336618347,-1.298458405877183,0.15789473684210525,0.5436704984303917,1.0,1/6,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.8512962552268726,1.2984223229832446,0.1276595744680851,0.8555015449073594,1.0,3/5,10.39%,DNA2;PRIMPOL;MGME1
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.7998783031475403,-1.2983698019017604,0.17647058823529413,0.543485087055978,1.0,3/6,6.33%,MYOF;DYSF;CAV3
prerank,CellMarker_Augmented_2021__Induced Regulatory T (Treg) cell:Peripheral Blood,-0.6616017525102987,-1.2983508485175868,0.13793103448275862,0.5431173120066098,1.0,7/22,4.84%,MYO1F;GPR183;CD5;TAGAP;GPR171;SLA;ARHGAP9
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.4829136922800119,1.298169955281361,0.0,0.8550885146345673,1.0,6/61,4.85%,SPSB4;MEX3A;CSPG5;EFNA2;POU3F2;MID1
prerank,Reactome_2022__Beta Oxidation Of octanoyl-CoA To hexanoyl-CoA R-HSA-77348,0.8124432594882434,1.2978874601598351,0.14285714285714285,0.8547663624608736,1.0,1/5,6.45%,ACADM
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.7087456771918617,-1.297863482131253,0.11290322580645161,0.5447060008133444,1.0,4/14,13.03%,SCN1B;KCNJ2;CACNA1C;SCN3B
prerank,Reactome_2022__HDL Assembly R-HSA-8963896,0.8416708218549707,1.2978259234523102,0.07317073170731707,0.8533765563358798,1.0,2/5,9.80%,ABCA1;PRKACB
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.7117721506738416,-1.2976127352056914,0.11475409836065574,0.5451454095370127,1.0,4/15,9.67%,P2RY6;DUOX1;TRPC3;STAT1
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.7583955951407495,-1.29749625463469,0.14035087719298245,0.5451328395831178,1.0,2/11,3.79%,MET;POF1B
prerank,KEGG_2021_Human__Complement and coagulation cascades,-0.6152367951554358,-1.2974440324998147,0.07142857142857142,0.5449035901673961,1.0,18/39,20.21%,C3;C1R;F8;SERPIND1;F13A1;CD55;CFH;PROCR;F10;F5;C1S;SERPING1;PLAT;F3;CR1L;A2M;PLAUR;C1QB
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Lung,-0.5361259171702474,-1.2974075749080263,0.10843373493975904,0.5445448655003574,1.0,21/82,17.22%,MET;MYOF;LAMB1;ITGA2;PLK2;SCARA3;CCND1;SRPX2;P4HA2;OSMR;EMP1;PRSS23;AMOTL2;RHBDF1;DSTN;ITGA3;TNS2;LAMA3;COL12A1;PXDC1;AFAP1L1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.5946746039332294,-1.2972577058817771,0.0958904109589041,0.5448357087107156,1.0,7/46,8.06%,CD24;FABP3;ABCA5;AKR1C1;CAV3;LDLR;ANGPTL3
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.5620938276527259,-1.2972401628364572,0.06493506493506493,0.5444431358251943,1.0,19/77,17.51%,CP;IL1R1;C1ORF87;C3;KCNJ2;PLD1;HLA-DRA;ST3GAL6;FAM20A;ANKUB1;CTSS;APOL6;CLMN;RASSF4;CD74;MSR1;ERICH3;FMO2;MRC1
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,-0.6970475442785177,-1.297215809534594,0.14925373134328357,0.5440426539175784,1.0,6/21,17.27%,RPS27A;SH3GL2;SH3GL3;UBC;LRIG1;SH3KBP1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.5587401807568307,-1.297091106134209,0.1095890410958904,0.5440656859376669,1.0,14/53,18.19%,TLR2;IFI35;IL15;NLRP12;APP;TLR3;OSMR;WNT5A;IL18;TNFRSF1A;ETS1;ABCC1;NMI;NUPR1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.6498767565225421,-1.297083585246531,0.12,0.5430867840881975,1.0,9/23,18.90%,ACOT1;ACSM5;ACOT4;GLYAT;DBI;ACOT2;OXSM;ACOT8;ACOT6
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.6498767565225421,-1.297083585246531,0.12,0.5430867840881975,1.0,9/23,18.90%,ACOT1;ACSM5;ACOT4;GLYAT;DBI;ACOT2;OXSM;ACOT8;ACOT6
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,0.4244540226044562,1.296599229409283,0.0,0.857504123676846,1.0,43/126,22.10%,NUP42;ELOC;NUP37;NUP54;GTF2F2;ELOA;ERCC2;RNF103-CHMP3;VPS37A;XPO1;GTF2A2;NMT2;VTA1;NDC1;TAF12;NUP214;ERCC3;CHMP2B;GTF2H5;TAF4;GTF2H2;VPS37B;AAAS;NUP188;SGIP1;TAF2;POLR2C;NUP205;VPS4B;TAF3;CHMP6;CCNT1;NUP210;NUP85;NEDD4L;NUP153;GTF2H3;NUP50;NELFA;RNGTT;CCNT2;TAF13;CTDP1
prerank,CellMarker_Augmented_2021__Naive B cell:Peripheral Blood,-0.6257267854227654,-1.296553062864495,0.08333333333333333,0.5441487932530116,1.0,13/31,19.11%,TAGAP;TMC8;ARHGAP9;ACAP1;RCSD1;WAS;PATL2;PTPN7;P2RY10;SP140;CD37;NLRC3;PSTPIP1
prerank,CellMarker_Augmented_2021__Naive B cell:Undefined,-0.6257267854227654,-1.296553062864495,0.08333333333333333,0.5441487932530116,1.0,13/31,19.11%,TAGAP;TMC8;ARHGAP9;ACAP1;RCSD1;WAS;PATL2;PTPN7;P2RY10;SP140;CD37;NLRC3;PSTPIP1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.7196868558979271,-1.296253953082508,0.14814814814814814,0.5448758617836869,1.0,2/12,4.75%,THBS1;SULF1
prerank,CellMarker_Augmented_2021__Epithelial Hair Follicle Stem cell:Hair Follicle,-0.6134831876347565,-1.2961075518266512,0.14705882352941177,0.5449752237087554,1.0,3/35,3.93%,CD24;EPS8L2;OVOL2
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.7286814119554869,-1.2959658321738667,0.1694915254237288,0.5449886778946847,1.0,8/11,25.61%,UNC13C;SYT1;RIMS2;SYT5;SYT2;DOC2B;RIMS1;RIMS3
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.8154639375821465,-1.2955903773593953,0.13114754098360656,0.5459784759831191,1.0,1/7,0.89%,TEKT2
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.7792947411827225,-1.2954414642775118,0.1935483870967742,0.5461107799802598,1.0,1/8,0.17%,ST6GAL1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.6230273893596454,1.2954272525035082,0.1388888888888889,0.8616377181582572,1.0,6/18,17.22%,ACVR1C;HMGB1;CASP3;EXOG;BLCAP;DFFB
prerank,CellMarker_Augmented_2021__Primitive Vesicle cell:Fetal Kidney,-0.8877897204841388,-1.2951217801478974,0.08928571428571429,0.5470207946544298,1.0,1/5,1.70%,KREMEN2
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.8524461458358903,-1.2950110227045775,0.05263157894736842,0.5469639974623773,1.0,2/6,3.16%,ANXA1;HLA-A
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.8747805811781936,-1.2946330317125665,0.08771929824561403,0.5480934319751897,1.0,1/6,7.39%,PLK3
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.776205830696525,1.2943116280598244,0.1,0.8650910054278764,1.0,3/7,19.78%,PDE12;RO60;PYHIN1
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,-0.5270364961119749,-1.294180045796789,0.04938271604938271,0.5495873979187221,1.0,18/91,13.38%,CD24;SCN1B;L1CAM;ANK3;LAMB1;ITGA2;SHTN1;CNTNAP1;SH3GL2;SCN9A;ITGA5;GAP43;RPS6KA1;SCN2A;SCN1A;RNASE1;SCN3B;ITGA9
prerank,Reactome_2022__RNA Polymerase III Transcription Termination R-HSA-73980,0.5950176847225339,1.2941572244116872,0.11428571428571428,0.8641780115005713,1.0,8/21,30.40%,POLR3B;POLR3F;NFIB;POLR1D;POLR3E;POLR2K;POLR3H;POLR2E
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.6175627185216853,1.293896304923654,0.18181818181818182,0.8639521986915119,1.0,4/16,8.36%,MTHFS;OAT;GLUD1;GLS
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.70003466137824,-1.2936574012242508,0.1694915254237288,0.5511552945241841,1.0,1/16,0.33%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.838483077195149,-1.293619541711511,0.1568627450980392,0.5507204950921972,1.0,1/7,1.45%,TGFBR2
prerank,KEGG_2021_Human__Cushing syndrome,-0.4982399992171808,-1.2933062609519128,0.012345679012345678,0.5516043260084605,1.0,15/125,12.19%,CACNA1H;LEF1;CDKN2A;WNT8B;AIPL1;ADCY7;ITPR3;CCND1;LDLR;WNT5A;CREB5;CACNA1C;ADCY5;CYP21A2;CCNE2
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.7437639048413157,-1.2932739881546753,0.13114754098360656,0.5512293706518955,1.0,2/11,3.20%,P2RY12;SKAP1
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.5528774421743776,-1.2931675648171335,0.10126582278481013,0.551177592471654,1.0,16/53,22.73%,ST6GAL1;SLC17A5;GMPPB;ST3GAL6;EGFL7;ST6GALNAC2;GNE;PMM1;CTSA;UAP1;ST8SIA3;GFPT2;ST6GALNAC3;ST8SIA1;DPM3;NEU4
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.7663435199569688,1.2930505041966067,0.12727272727272726,0.8660823023769716,1.0,2/8,6.41%,ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.6696232155369506,-1.292621803491241,0.11594202898550725,0.5528386645298612,1.0,5/17,13.52%,P2RY12;EPS8L2;PFN2;PLEKHM1;NLGN1
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.7715471240446045,-1.2924895566798786,0.16129032258064516,0.552844817766437,1.0,3/6,22.35%,PLSCR1;SIGIRR;APOL2
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.6599938293060615,1.292179425124114,0.125,0.8686215240046079,1.0,5/18,17.67%,LIMD1;CNOT8;HELZ;AGO3;CNOT1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.6497686711037349,-1.2920127983580045,0.12307692307692308,0.5539563615314416,1.0,1/19,0.33%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.6497686711037349,-1.2920127983580045,0.12307692307692308,0.5539563615314416,1.0,1/19,0.33%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.7212248881188625,-1.2918288223745695,0.109375,0.5543078646939733,1.0,5/14,17.65%,TLR3;STAT1;IRF7;IFIH1;RIPK2
prerank,CellMarker_Augmented_2021__CD8+ T cell:Lung,0.45518117800920016,1.2916801942945726,0.15,0.8693969570071233,1.0,20/72,17.50%,COMMD6;DERL2;PSMA1;EXOSC1;C1D;SLC25A19;TPRKB;HAUS1;C1ORF174;LSM8;GTF2A2;TMEM11;MED11;LSM5;ITGAE;CDC26;ZBTB8OS;MRPL52;PPIE;TMA7
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.714568238242933,1.2912670687354901,0.20930232558139536,0.8679030868321015,1.0,1/11,2.75%,INPP1
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.714568238242933,1.2912670687354901,0.20930232558139536,0.8679030868321015,1.0,1/11,2.75%,INPP1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.7932308588850896,-1.2912071300529036,0.08064516129032258,0.5563890595927113,1.0,2/11,4.37%,ANXA1;IL15
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),-0.7484000177639847,-1.2911666235414971,0.21666666666666667,0.556113686139282,1.0,3/8,7.70%,B3GALT2;UGT8;FA2H
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.6173590030029383,-1.2910353822467482,0.125,0.5561252729337661,1.0,9/31,23.12%,EFNA1;HAP1;IGF1;RTN1;RTN2;TMED10;RTN4;GSAP;SP1
prerank,CellMarker_Augmented_2021__Mucosal-associated Invariant T cell:Liver,-0.612859064656508,-1.2910226898513455,0.0958904109589041,0.5556822792103904,1.0,11/44,16.60%,DUSP1;B3GALT2;P2RY14;GPR171;CD160;PDK3;RUNX2;TC2N;APOL3;SLC4A10;CEBPD
prerank,Reactome_2022__Keratinization R-HSA-6805567,-0.7098932573377785,-1.2909363102717124,0.07246376811594203,0.555542850874072,1.0,10/18,21.23%,PKP2;SPINK9;FLG;CELA2A;KAZN;SPINK6;CAPN1;KRTAP5-11;CAPNS1;PCSK6
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.7964031690705384,-1.2906978918494163,0.1774193548387097,0.55599185598911,1.0,4/8,19.31%,SIX3;DAB2IP;RYR2;COL4A3
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.5372744387261427,-1.2904034502107866,0.08641975308641975,0.5566667188988106,1.0,27/115,17.57%,COL4A1;ANGPTL2;CALD1;COL4A2;CSPG4;LAMB1;GPNMB;FLG;FILIP1L;MMP14;CCND1;SRPX2;OSMR;EMP1;THBS2;FN1;PRRX1;AMOTL2;RHBDF1;TNS2;PLAT;COL12A1;PXDC1;AFAP1L1;GPC1;CTNS;MLANA
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.6508987694137924,-1.2903073878296425,0.14084507042253522,0.5565603313932961,1.0,3/20,3.78%,SP100;WARS1;GPNMB
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.7570667629205056,-1.29024189277917,0.1724137931034483,0.5562865359653595,1.0,4/8,15.75%,WNT5A;GABRB2;GABRG2;GABRA1
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),0.789429503824308,1.290228512756212,0.14583333333333334,0.8691402164878745,1.0,1/5,3.58%,HSPA1A
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),0.789429503824308,1.290228512756212,0.14583333333333334,0.8691402164878745,1.0,1/5,3.58%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.8136559123631366,-1.2899804753512165,0.11320754716981132,0.5569928066756238,1.0,1/5,0.99%,MET
prerank,KEGG_2021_Human__Serotonergic synapse,-0.5325178094076709,-1.2896313914207351,0.12345679012345678,0.5576559859154062,1.0,14/76,12.36%,DUSP1;ALOX12;CYP4X1;MAOB;GNG3;APP;HTR2B;ITPR3;SLC18A2;PRKCG;GABRB2;CACNA1C;ADCY5;GNG2
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.7460546323705288,1.2895447927566137,0.1590909090909091,0.870515236155295,1.0,4/7,16.63%,BRPF1;PHF14;KAT7;BRPF3
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.5928027802612763,1.2894670540998487,0.19444444444444445,0.8691541937310747,1.0,6/29,17.29%,ITGA1;PPP1R15B;PPP6R1;PPP1R1B;STYXL1;MAGI2
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,0.42071000011173,1.2894224759305508,0.0,0.8677767144392959,1.0,44/137,22.10%,NUP42;LIG4;ELOC;NUP37;NUP54;GTF2F2;ELOA;ERCC2;RNF103-CHMP3;VPS37A;XPO1;GTF2A2;NMT2;VTA1;NDC1;TAF12;NUP214;ERCC3;CHMP2B;GTF2H5;TAF4;GTF2H2;VPS37B;AAAS;NUP188;SGIP1;TAF2;POLR2C;NUP205;VPS4B;TAF3;CHMP6;CCNT1;NUP210;NUP85;NEDD4L;NUP153;GTF2H3;NUP50;NELFA;RNGTT;CCNT2;TAF13;CTDP1
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),-0.828151011339801,-1.2891314037198447,0.14516129032258066,0.5593459403043108,1.0,1/6,0.11%,LEF1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Undefined,-0.5886193514808093,-1.2886958531691417,0.10666666666666667,0.5606153715146617,1.0,13/54,11.34%,GBP2;SP100;GAB3;GYPE;IGSF6;PARP14;TM6SF1;CLEC12A;F13A1;CA1;CTSS;APOL6;SELP
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.6621045883341364,1.288599385258982,0.16129032258064516,0.8700532742741652,1.0,5/17,18.80%,SDC4;SNF8;SMPD3;VPS4B;CHMP6
prerank,Reactome_2022__Processive Synthesis On Lagging Strand R-HSA-69183,0.6969329017445225,1.288351957558947,0.13953488372093023,0.8700153883129718,1.0,2/12,1.45%,POLD3;DNA2
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),0.7930639341951837,1.288178751678478,0.2,0.8692033384955221,1.0,2/6,5.58%,CYP4F3;CYP4F12
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.5602864821834939,1.2880357364130632,0.14705882352941177,0.8682440899574109,1.0,5/20,23.01%,UQCRHL;UQCRC2;MTFR1;SDHB;SLC25A14
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.6747196268210305,-1.2880024026695112,0.15873015873015872,0.5628586016737417,1.0,6/20,14.59%,SOCS3;RPS27A;STAT1;SYK;UBC;ELOB
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.5830721259575079,1.2879584836379427,0.17647058823529413,0.8668170690586097,1.0,2/17,1.38%,NGF;SOX8
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.6213238008717595,1.2878131231584824,0.16666666666666666,0.8658445559225062,1.0,4/15,15.48%,GIT1;CASK;MDK;AJAP1
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.7691755910728648,-1.2874581946189143,0.13559322033898305,0.5649394570666452,1.0,1/6,1.55%,SUV39H1
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.7661791088531695,-1.2874480514613837,0.16129032258064516,0.5644517019971809,1.0,5/9,17.63%,PLSCR1;CD74;CD200;MYO18A;GPER1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6186812002352663,1.2874018901567665,0.10526315789473684,0.8662418831762667,1.0,1/11,1.06%,UQCRHL
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.7471831205817154,1.287357091684494,0.1320754716981132,0.8648053665369174,1.0,3/7,16.82%,RAB22A;ALS2;PICALM
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.8013946552106741,1.287014495216733,0.1590909090909091,0.8646927584287614,1.0,3/8,4.85%,CHAMP1;CRIPT;MID1
prerank,CellMarker_Augmented_2021__Endothelial cell:Brain,-0.8740558274060753,-1.2869844065014304,0.09803921568627451,0.5659533333081851,1.0,1/5,0.74%,APOLD1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.5559237135800821,-1.28688347235877,0.09722222222222222,0.5658728681014041,1.0,10/66,9.10%,OTOS;HPN;KCNQ1;EPS8L2;CDH23;CLRN1;CEMIP;NDUFB9;COL11A2;MYO3A
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.7524371004363453,-1.2868434985724944,0.15384615384615385,0.5654769435218243,1.0,1/9,3.07%,CNTNAP1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In3:Brain,-0.761745195493184,-1.2863651568978691,0.12857142857142856,0.5668657815048116,1.0,5/11,16.24%,KMO;IGFBP5;SHISA8;SLC12A7;SYT2
prerank,CellMarker_Augmented_2021__Ito Cell (Hepatic Stellate cell):Liver,-0.8651157259243754,-1.2861314569758833,0.14754098360655737,0.5672904444891924,1.0,2/5,7.77%,GFAP;SYP
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),-0.778177367490664,-1.2859492675592998,0.19642857142857142,0.5670368207692765,1.0,3/6,7.70%,B3GALT2;UGT8;FA2H
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),-0.778177367490664,-1.2859492675592998,0.19642857142857142,0.5670368207692765,1.0,3/6,7.70%,B3GALT2;UGT8;FA2H
prerank,CellMarker_Augmented_2021__M1 macrophage:Peripheral Blood,-0.8771699644435585,-1.285911909872935,0.1111111111111111,0.5666581563399598,1.0,2/5,1.62%,IL1R1;TLR2
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),0.706079426972593,1.2858456323677478,0.27906976744186046,0.8684438129497479,1.0,2/6,12.46%,SOD3;PRDX1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.8017159083469825,1.2857263138244,0.13513513513513514,0.8672442919329878,1.0,3/7,12.98%,JAM2;AKT1;WASL
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.6793308025447963,-1.2856535722158964,0.12307692307692308,0.5670401926857759,1.0,3/13,2.79%,P2RY12;ITGA2;SHTN1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.593107192159326,1.2853552520091387,0.15384615384615385,0.8673815325940822,1.0,5/26,10.69%,WNT7A;ZNF358;INTU;SALL1;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.683649018885234,-1.2852582919783646,0.10144927536231885,0.5681396408239887,1.0,6/19,12.84%,ARHGEF3;GPR18;SYNPO2L;LPAR6;LPAR4;P2RY10
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.637507655345683,1.285093526379058,0.16666666666666666,0.867138317867082,1.0,5/13,6.66%,ABCD2;AKT2;PLIN5;ABCD1;ABHD5
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.6926036223386256,-1.2848357423451304,0.14754098360655737,0.569303117450964,1.0,6/17,18.61%,GBP1;MRAP2;TMBIM1;PPFIA1;TGFB1;NUMB
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,0.5911111159070948,1.2847382076315927,0.17647058823529413,0.8671066950805006,1.0,6/17,14.84%,TRIB3;THEM4;AKT2;AKT1;PIK3CA;PIK3R1
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,-0.6615864899595137,-1.2845840023336457,0.14705882352941177,0.57003609477212,1.0,7/20,23.14%,CPLX1;SYT1;PPFIA1;SLC1A6;SLC17A7;ARL6IP5;RIMS1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.6217164565271548,-1.2843153883601492,0.14705882352941177,0.5704631931249836,1.0,7/32,12.29%,THBS1;P2RY6;NR4A3;IGF1;STAT1;IL18;IGFBP5
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),-0.7966633721056864,-1.2843103846592767,0.18181818181818182,0.5699848134739917,1.0,3/6,9.24%,CDKN2A;IL12A;IGF1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.640278109551265,1.2842384170638173,0.125,0.8679163772726566,1.0,7/13,24.80%,BMP2;SPRY1;HEYL;HEY1;HEY2;RBPJ;TGFBR1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.7581069686816202,1.2841971655550584,0.1702127659574468,0.8665610136876883,1.0,4/8,16.16%,DPH5;DPH3;DPH1;CPEB3
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.450577872165744,1.2840796517264286,0.0,0.8653782762667924,1.0,23/92,20.77%,ABCB10;RFWD3;RCC2;UCP3;XPO1;UGGT1;BRPF1;NDC1;STT3B;GANAB;DDX21;ZDHHC5;NUP188;URB2;NUP205;DCAF1;CNOT1;DHX15;CHD4;UBAP2L;NUP85;NSUN2;NUP153
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.7322697854685348,1.2836002453493884,0.125,0.8663539721117721,1.0,4/7,25.23%,PEX6;ZFAND6;PEX12;PEX16
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,0.5579209851358391,1.2835858099278041,0.1111111111111111,0.8647793515433326,1.0,10/25,23.55%,H2BC21;H2BC4;ERCC6;RBBP4;H2AC6;H3-3B;HDAC2;CHD4;H2BC5;MTA2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.5930582377314155,-1.2835828843203902,0.08108108108108109,0.572580630723588,1.0,15/53,16.18%,PSCA;NEFL;GRIN2A;APP;GRIA3;GRIA1;MINK1;SHISA9;DLGAP3;GRIN2B;SHISA8;NLGN1;NPTX2;RELN;CAPN1
prerank,CellMarker_Augmented_2021__Pit Progenitor cell:Stomach,-0.5710816841141501,-1.2835496126264856,0.15873015873015872,0.5722982763128278,1.0,11/43,19.21%,GBP2;SBSPON;RSPO3;VSNL1;SRF;FBXO32;PPP1R14A;MICALL1;BCL11A;LAMA5;BMPER
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),-0.7836279176809442,-1.2833123233389505,0.1694915254237288,0.5728859438985096,1.0,1/5,6.29%,BRCA1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.6564123503548863,1.2832794300275712,0.14285714285714285,0.8646065590488456,1.0,2/11,6.66%,PLIN5;ABHD5
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.545674967474499,-1.2832576123960189,0.06578947368421052,0.5725792298451717,1.0,12/82,13.76%,CCNB2;ERCC6L;RPS27;CENPH;CENPE;ZWILCH;NUF2;SPC24;CCNB1;KIF2C;CENPN;CENPU
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.6459741263707488,-1.283235529710782,0.10294117647058823,0.5721747903770021,1.0,4/21,7.93%,KCNT2;KCNQ1;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),-0.7172722298165947,-1.2830927671496475,0.13793103448275862,0.5722210419691567,1.0,4/15,8.70%,ABO;B3GALT2;FUT2;ST3GAL6
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.5768023508609788,1.2829287464186403,0.125,0.8646215841984527,1.0,5/17,22.80%,ARV1;GNB3;PANK2;TTC39B;ABCB11
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.6792905970375366,-1.282881729555272,0.11864406779661017,0.5725860106450235,1.0,2/16,4.75%,THBS1;SULF1
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.6614185999088988,1.2825884697679077,0.2558139534883721,0.8649479555045397,1.0,1/8,1.63%,BMP2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.597513083865137,-1.2825279460361598,0.0759493670886076,0.5734567036815862,1.0,6/40,12.29%,ANXA1;STAT4;STAT1;CELA2A;EIF2B2;IGFBP5
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.6940340649676024,1.2824587349229846,0.17142857142857143,0.863988361625143,1.0,5/10,25.19%,PLD6;VAT1;MUL1;ZDHHC6;PID1
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,0.43524385008870015,1.2823756687602241,0.0,0.8628667954102822,1.0,19/90,20.89%,NUP42;HSPA1A;NUP37;BAG2;NUP54;VCP;HSF1;NDC1;NUP214;AAAS;MRPL18;NUP188;EP300;NUP205;CCAR2;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.6350175921450324,-1.2823432421005956,0.19047619047619047,0.573722032572095,1.0,4/26,5.98%,C3;SFTPD;IL15;CCL2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.5700805150947859,-1.2822161023194796,0.11688311688311688,0.5736933940809771,1.0,7/61,7.39%,CENPV;KIF14;PLK2;RAB11A;DCDC1;SVIL;PLK3
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.6983413647748091,-1.2821741912750386,0.16666666666666666,0.5733634126733081,1.0,1/12,0.08%,CXCL2
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Brain,-0.5139646234728941,-1.2818908101275124,0.07058823529411765,0.5740513380431101,1.0,20/132,9.28%,ANGPTL2;DHCR24;TAGLN3;TMSB10;CSPG4;MYT1;ZDHHC9;PLP1;THY1;UGT8;OPALIN;KCNH8;GAP43;APOD;FA2H;KLK6;MOBP;PLPPR1;RPL13A;MAG
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.7119456030059776,-1.28184624540959,0.14492753623188406,0.5737134883958769,1.0,1/16,0.85%,TUBB6
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.7136377803936717,1.2816525659593048,0.21951219512195122,0.8638552719718207,1.0,1/12,2.75%,INPP1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.5817645668586836,-1.2814986458961621,0.17567567567567569,0.5746923912049975,1.0,11/33,16.90%,SERPINA10;TIMP2;SERPINF1;SPOCK3;TIMP1;SERPIND1;SERPINE3;SPINK6;SERPING1;UBXN1;CRB2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.6524398939043159,-1.2814554687210258,0.12857142857142856,0.5743870413007286,1.0,1/17,2.75%,WNT8B
prerank,KEGG_2021_Human__Insulin secretion,-0.5502831867813732,-1.2813919052628469,0.13333333333333333,0.5741876568443222,1.0,18/66,17.58%,CCK;ADCY7;ATP1A1;ITPR3;ATP1B1;PRKCG;CHRM3;RIMS2;CREB5;CACNA1C;ADCY5;GLP1R;ADCY3;KCNMB4;ADCY8;PRKCB;RYR2;CREB3
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.7577435089557313,-1.2812535133714251,0.19402985074626866,0.5742155110313961,1.0,4/10,20.15%,YBX3;BIRC3;NUPR1;CASP8
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.7327543516073056,1.280822104668771,0.19444444444444445,0.8660560908067716,1.0,5/8,23.80%,BLMH;ADO;TST;CTH;TXN2
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.73298511251805,-1.2807792657238717,0.09090909090909091,0.5758625685329599,1.0,4/12,16.32%,APP;LDLR;PFDN6;PFDN1
prerank,KEGG_2021_Human__Cell adhesion molecules,-0.5168152664831923,-1.280516153988622,0.11392405063291139,0.5763500082265709,1.0,21/92,13.52%,CD99L2;ICAM1;L1CAM;CNTNAP1;HLA-A;CLDN16;SIGLEC1;LRRC4;PDCD1LG2;HLA-C;HLA-DRA;CLDN20;CLDN18;ITGA8;MAG;HLA-B;SELP;HLA-E;HLA-F;ITGA9;NLGN1
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.7703807026254341,1.280210414819036,0.09090909090909091,0.8672820515658966,1.0,3/5,16.19%,LYPLA2;MGLL;ABHD6
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.5065148743520435,-1.2800327885849674,0.047619047619047616,0.5777337303031217,1.0,25/143,11.12%,THBS1;ISM1;SP100;APLNR;SPARC;COL4A2;WARS1;SERPINF1;GPNMB;HK2;CD160;SULF1;KLF4;BRCA1;CEACAM1;CYP1B1;CHI3L1;ANGPTL3;BTG1;STAT1;WNT5A;THBS2;PGK1;FGF1;DAB2IP
prerank,CellMarker_Augmented_2021__Paneth cell:Large Intestine,-0.5050379689644996,-1.2795777081797393,0.0625,0.5792200343026858,1.0,57/178,21.77%,CXCL2;NR4A3;TLR2;ICAM1;LMO2;INPP5D;GPR34;SLA;SIGLEC1;ADCY7;CTSC;GFRA2;NINJ2;HLA-DRA;IGSF6;F13A1;CHI3L1;WAS;LAT2;RHBDF2;RASGEF1B;SNX10;BIRC3;LPAR6;NAMPT;CTSZ;CORO7;MTHFD2;FES;TNFAIP2;SRGN;LOC100130357;CD74;CD37;VAV1;HLA-DRB1;IRS2;PRKCB;PFKFB3;MRC1;RIPK2;COTL1;FERMT3;CD4;UAP1L1;WDFY4;PLAUR;C1QB;SPI1;ATP1B3;CD163L1;GNL3;RSAD2;EIF4A3;PTPRC;PTAFR;SH2B3
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Corneal Endothelium,-0.5281198287888283,-1.2793972701910927,0.08974358974358974,0.5790249166663225,1.0,26/74,18.20%,ENPP2;APLNR;RCAN2;RAMP3;LDB2;ELN;ITGA8;CACNA1C;AEBP1;IGFBP5;RNASE1;ITGA9;RASL12;RGS7BP;TMEM132C;SFRP2;SERPING1;RAI2;CD200;FMO2;TEK;SHROOM4;ADGRF5;AQP1;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Breast,-0.5281198287888283,-1.2793972701910927,0.08974358974358974,0.5790249166663225,1.0,26/74,18.20%,ENPP2;APLNR;RCAN2;RAMP3;LDB2;ELN;ITGA8;CACNA1C;AEBP1;IGFBP5;RNASE1;ITGA9;RASL12;RGS7BP;TMEM132C;SFRP2;SERPING1;RAI2;CD200;FMO2;TEK;SHROOM4;ADGRF5;AQP1;ITIH5;A2M
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.7587376655189928,-1.279279135044089,0.15254237288135594,0.5790242622972381,1.0,3/10,13.92%,CAV3;NOS1;VIP
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.7594410690258212,-1.279226767679521,0.19696969696969696,0.5786856199593342,1.0,3/6,7.39%,DOCK8;APP;TNFRSF14
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),-0.7216189123267968,-1.279019324375418,0.13559322033898305,0.5791194420089094,1.0,4/14,8.70%,ABO;B3GALT2;FUT2;ST3GAL6
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.8181250638218207,-1.278944429563392,0.12962962962962962,0.5789580379801332,1.0,2/6,5.37%,TMSB10;PFN4
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.734991357071475,1.2787056016252858,0.20588235294117646,0.8728158000112604,1.0,4/9,19.77%,RFWD3;FEM1B;THOC1;CCAR2
prerank,CellMarker_Augmented_2021__Eosinophil:Sinonasal Mucosa,-0.6163166055201332,-1.2785579614341192,0.16176470588235295,0.5800811650609877,1.0,13/25,15.54%,TMC8;GAB3;SPNS3;GFI1B;GATA1;WAS;LAT2;PRSS57;PTPN7;TSPAN32;FES;SRGN;VAV1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.7562401346747665,-1.278509290560157,0.15789473684210525,0.5798229754856987,1.0,5/11,15.13%,P2RY12;SKAP1;PODXL;SYK;SFRP2
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.7049026530889186,-1.2785054473508362,0.1388888888888889,0.5793488841570168,1.0,4/15,13.13%,GRIN2D;GRIN2A;GRIN2B;GRID2
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.6619642052240884,1.2783044623742768,0.14285714285714285,0.8730412331098393,1.0,4/13,17.22%,HMGB1;CASP3;EXOG;DFFB
prerank,Reactome_2022__DSCAM Interactions R-HSA-376172,0.6768834718749044,1.2782609755061565,0.16666666666666666,0.8716494890627862,1.0,3/11,12.29%,DSCAM;MAPK8;MAPK12
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.5856216809945974,-1.2782341783226059,0.08641975308641975,0.580100511537826,1.0,4/40,10.39%,CACNA1H;CAV3;IGF1;ITGA11
prerank,Reactome_2022__Activation Of Matrix Metalloproteinases R-HSA-1592389,-0.6727441944498675,-1.2781394335458154,0.125,0.5799709544294173,1.0,5/15,11.51%,TIMP2;MMP14;SPOCK3;TIMP1;MMP24
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),-0.796298726956197,-1.2780772787453765,0.15151515151515152,0.5797137442619541,1.0,1/8,0.18%,ANXA1
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.547884901524956,-1.2779498438288412,0.14864864864864866,0.5796486229399833,1.0,12/53,16.18%,PSCA;TJP3;PTK6;ANO9;SYNGR2;RHBDF2;TMC4;IL4R;TMCO4;PRKCD;SH2D3A;CAPN1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.6574538014374558,-1.277655387819502,0.2033898305084746,0.5805091213272598,1.0,5/19,15.85%,CXCL2;CCL2;SYK;PPIB;PIK3CD
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.56297052619935,-1.2774234362324264,0.11267605633802817,0.5807862146376067,1.0,8/59,8.45%,CACNA1H;KCNQ1;PLN;ATP1A1;CAV3;ITPR3;ATP1B1;SLC8A3
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.6582154521443819,-1.277414895068251,0.1016949152542373,0.580345994324025,1.0,6/18,12.78%,CD24;PDCD1LG2;IGF1;HHLA2;IL18;FADD
prerank,Reactome_2022__Beta Oxidation Of decanoyl-CoA To octanoyl-CoA-CoA R-HSA-77346,0.7883329125749998,1.2773643981251566,0.1794871794871795,0.8746333742521522,1.0,1/6,6.45%,ACADM
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.7707038689713741,1.277285332825943,0.17142857142857143,0.8733049330059969,1.0,4/6,21.32%,PSPH;SRR;SERINC5;PHGDH
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),-0.7047994046302062,-1.277195363905041,0.1746031746031746,0.5807182511292375,1.0,1/14,0.34%,RASGRP1
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.661268748180011,-1.2770740541090342,0.15873015873015872,0.580827479910997,1.0,3/19,7.93%,SCN1B;KCNQ1;ATP1B1
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,-0.6600027350258082,-1.2770712570744578,0.25,0.5803406821339292,1.0,3/17,9.67%,SOCS3;OSMR;STAT1
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.5261086767765569,1.2770316884631179,0.11428571428571428,0.8729784164483528,1.0,10/29,19.94%,ASCL1;HES6;AKT1;NOTCH2;HEYL;PRUNE1;HEY1;YTHDF2;HEY2;HES5
prerank,CellMarker_Augmented_2021__T Helper cell:Liver,-0.7847091178781096,-1.276981763046752,0.1774193548387097,0.5801880996420988,1.0,4/7,18.56%,DUSP1;ABCB1;SLC4A10;CD4
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.7618423631936606,-1.2767991752844192,0.22641509433962265,0.5803371557310936,1.0,5/9,18.20%,CD55;SUSD4;SERPING1;CR1L;A2M
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.6132744443349507,1.2765771883087214,0.17857142857142858,0.8734859288773226,1.0,4/17,19.52%,RAB33B;PDE4DIP;MAP2K2;MYO5A
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Embryonic Prefrontal Cortex,-0.5154319384509523,-1.2764807613671274,0.0641025641025641,0.5810961288885577,1.0,27/120,16.83%,CLIC1;CCNB2;APOLD1;STMN2;SHTN1;BTG3;LDHA;SLA;DEPDC1B;GAP43;GINS2;SYT1;TAGLN2;NUF2;RPA3;CCNB1;CREB5;KIF2C;GNG2;PCSK1N;CENPN;CENPU;CDKN3;SFRP2;RTN1;OIP5;CDCA7
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.7987146563527022,1.2762008981626132,0.16279069767441862,0.8737280207880512,1.0,3/5,19.35%,RUNX1;HMGB1;GLI3
prerank,GO_Biological_Process_2021__tricuspid valve development (GO:0003175),-0.8242731620559465,-1.2759022944982097,0.14754098360655737,0.5828593440130152,1.0,1/5,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),-0.7957969962317394,-1.2756677747983889,0.13333333333333333,0.5832826348132301,1.0,1/5,1.31%,TYMP
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.8133578267806048,-1.2756299629583778,0.23529411764705882,0.5829859310895183,1.0,1/6,4.43%,ITM2A
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.8025820073762375,-1.2756028924200578,0.21052631578947367,0.5825791655136311,1.0,1/7,5.68%,THY1
prerank,Reactome_2022__Defective GALNT3 Causes HFTC R-HSA-5083625,0.7912363871613763,1.2755761462477921,0.22916666666666666,0.8751229895073159,1.0,2/5,2.45%,GALNT3;MUC20
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.6547218220084735,-1.2755419461437059,0.19402985074626866,0.5822677774392259,1.0,3/20,13.52%,TJP3;ARHGEF18;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.5392461368514734,-1.2754885501610294,0.07792207792207792,0.5820357567971808,1.0,9/62,12.78%,THBS1;IFI6;ICAM1;BRCA1;GATA1;IGF1;UNC5B;TMBIM1;FADD
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.8312476730081264,-1.2752322260300246,0.13043478260869565,0.5827021563067268,1.0,1/5,3.00%,SLC39A14
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.6697019622066736,1.2751409879596394,0.25,0.87540171022811,1.0,4/9,15.95%,KAT2B;KAT2A;KAT7;EP300
prerank,Reactome_2022__TICAM1-dependent Activation Of IRF3/IRF7 R-HSA-9013973,-0.7367424340621094,-1.2749822247637295,0.14492753623188406,0.5832651107831486,1.0,4/12,12.77%,RPS27A;TLR3;IRF7;UBC
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),-0.6321952074233863,-1.2748458028881662,0.13043478260869565,0.5833080815962036,1.0,1/27,0.11%,LEF1
prerank,Reactome_2022__Signal Regulatory Protein Family Interactions R-HSA-391160,-0.7272974062032183,-1.2748156092703204,0.13846153846153847,0.5829502459114273,1.0,1/9,1.83%,FYB1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.8635891155475468,-1.2744290965847296,0.11764705882352941,0.5841396433319841,1.0,2/5,9.67%,COL4A1;STAT1
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6567262827096372,1.2744001340780067,0.20512820512820512,0.8770509341394749,1.0,3/10,18.53%,NOVA1;PCBP4;PCBP3
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),0.7739335095160361,1.2743657693958146,0.23404255319148937,0.8755736500891323,1.0,2/5,16.09%,MRPL18;TST
prerank,CellMarker_Augmented_2021__Adventitial cell:Undefined,-0.8831506255422611,-1.2742528515524723,0.12727272727272726,0.5844014110035298,1.0,3/5,7.03%,CSPG4;THY1;CD44
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.5765232438531654,-1.274037053942352,0.07246376811594203,0.5848194931770281,1.0,21/74,19.03%,COL4A1;CALD1;COL4A2;CSPG4;LAMB1;COL5A1;LMOD1;TEAD2;SCARA3;DAB2IP;GLI1;IGFBP5;PRRX1;AMOTL2;RHBDF1;PDGFRL;COL12A1;NOTCH3;PCDH18;PTPN21;SVEP1
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,0.5254876616470994,1.2740298125239735,0.16129032258064516,0.8754682362562419,1.0,3/33,6.82%,FGF6;NRAS;GTF2F2
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),-0.7893418971497494,-1.273854430909414,0.30612244897959184,0.5850410947416428,1.0,1/5,1.13%,POU4F1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.7158952698164516,-1.2737230830678836,0.13114754098360656,0.5850354119081905,1.0,3/15,9.24%,NR4A3;TRPC3;IGF1
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),0.8565041529963675,1.2736456030493866,0.11904761904761904,0.8757443726768024,1.0,3/7,4.85%,CHAMP1;CRIPT;MID1
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),-0.7855383373447408,-1.2736118134932048,0.140625,0.5850297386017014,1.0,2/6,16.90%,SCX;CRB2
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Brain,-0.7706090503196027,-1.2723274869660814,0.20689655172413793,0.589562536169231,1.0,3/6,21.63%,GFAP;DPYSL3;DCX
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.6619024462098673,1.2722846155580367,0.2,0.881146319362631,1.0,2/12,9.46%,FAM47E;SERTAD2
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.6019856227976708,1.2722175041014596,0.2647058823529412,0.8800120843592265,1.0,4/15,18.23%,ASAH2B;QDPR;DHFR;SPHK2
prerank,Reactome_2022__RUNX3 Regulates NOTCH Signaling R-HSA-8941856,0.6968626874961769,1.2719818295377159,0.07142857142857142,0.8796002588526108,1.0,6/13,23.79%,MAML3;KAT2B;KAT2A;EP300;JAG1;RBPJ
prerank,Reactome_2022__Biotin Transport And Metabolism R-HSA-196780,0.7032104847425168,1.271738924474999,0.1282051282051282,0.87895082984797,1.0,2/9,12.43%,ACACB;SLC5A6
prerank,Reactome_2022__Blood Group Systems Biosynthesis R-HSA-9033658,-0.723934282398289,-1.2714644031955504,0.15517241379310345,0.5924096878235379,1.0,4/11,8.70%,ABO;B3GALT2;FUT2;ST3GAL6
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,0.5319681739255075,1.2714540962956071,0.13333333333333333,0.8788008288156764,1.0,18/44,26.42%,KAT2B;ERCC6;UBTF;ERCC2;RBBP4;POLR1F;ERCC3;KAT2A;GTF2H5;GTF2H2;RRN3;HDAC2;CHD4;GTF2H3;MTA2;POLR1D;CCNH;POLR1B
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.6542289137803693,-1.2714045056256429,0.18032786885245902,0.5921561124814055,1.0,6/23,12.11%,ANK3;ABCB1;GLRX;ATP1B1;CTSS;PDZK1
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.5627567705685352,1.2712645080644605,0.25925925925925924,0.8783138837263408,1.0,6/26,15.95%,KCTD1;KCTD15;EGFR;YY1;WWOX;EP300
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.7455811699771123,-1.2712497854454314,0.09230769230769231,0.5925263118438269,1.0,2/13,0.81%,ANXA1;BLM
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.8768688045509558,-1.271180787537308,0.14814814814814814,0.5922964186348866,1.0,1/5,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.7622261805121942,-1.2710425245119794,0.18867924528301888,0.5923780645183158,1.0,2/7,17.19%,ITGA5;PRKCB
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.5788951702222211,-1.270989081354619,0.1282051282051282,0.5921253607800782,1.0,8/49,12.36%,MX1;IFIT1;IFITM3;PROX1;BST2;PLSCR1;ISG15;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.7207153278956321,-1.270839390916248,0.16666666666666666,0.5921681834477883,1.0,3/12,12.29%,NR4A3;IGF1;IGFBP5
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.4725512065129205,1.270687428941178,0.1,0.8792356084535585,1.0,8/54,12.50%,RNF6;UBE2T;KBTBD7;TNFAIP3;RNF146;UBE2G1;UBE2D1;FBXO38
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.557390782151693,-1.270619240873302,0.08823529411764706,0.5925368328370163,1.0,12/54,8.80%,CXCL2;IL1R1;C3;TYMP;NRN1;PPP1R14C;SFTPD;SIGLEC1;KLF4;DUOXA1;CLDN18;FBP1
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.6628486824183586,-1.2705958262265744,0.17391304347826086,0.5921915910001054,1.0,3/15,12.36%,P2RY12;GNG3;GNG2
prerank,Reactome_2022__Condensation Of Prophase Chromosomes R-HSA-2299718,0.5712264427892844,1.270589779505256,0.16216216216216217,0.878156148542349,1.0,9/22,15.16%,RAB33B;KMT5A;H2BC21;H2BC4;NCAPH2;H2AC6;PLK1;H3-3B;MCPH1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7467197400229664,-1.2701298569359094,0.2222222222222222,0.5936441306238314,1.0,2/9,7.83%,PARP14;PARP9
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),0.7550208465178854,1.2700455812643152,0.16666666666666666,0.8779600845476402,1.0,3/6,15.65%,DPH5;DPH3;DPH1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),0.7550208465178854,1.2700455812643152,0.16666666666666666,0.8779600845476402,1.0,3/6,15.65%,DPH5;DPH3;DPH1
prerank,KEGG_2021_Human__Viral myocarditis,-0.5907346806617583,-1.2699721567446058,0.10666666666666667,0.5937319916959277,1.0,9/37,13.21%,ICAM1;HLA-A;HLA-C;HLA-DRA;CCND1;HLA-B;CD55;HLA-E;HLA-F
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD Domain Mutants R-HSA-2691232,-0.6676156960234216,-1.2699655836066976,0.22033898305084745,0.5932551440902649,1.0,2/13,12.77%,RPS27A;UBC
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.6702874890104311,-1.269896337575613,0.1864406779661017,0.5930804525665503,1.0,5/17,15.85%,CXCL2;CCL2;SYK;PPIB;PIK3CD
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.8335840439319466,-1.2698484165304234,0.16981132075471697,0.5927747943700548,1.0,1/6,1.11%,APLNR
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.6872908905953246,1.2698199490706124,0.2631578947368421,0.8773213954342098,1.0,1/5,12.61%,ADRB2
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.6126898600002523,-1.26981126379501,0.12280701754385964,0.5924619272626904,1.0,6/24,15.33%,THBS1;RHOBTB2;XKR4;MYH9;ELMO1;MSR1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),-0.766641174746512,-1.2697772685534232,0.18867924528301888,0.5921572854642915,1.0,3/7,6.56%,LEF1;TESC;CEACAM1
prerank,CellMarker_Augmented_2021__Abnormal Plasma cell:Peripheral Blood,-0.5325220346104225,-1.2696990705968854,0.1038961038961039,0.5919763757201701,1.0,10/93,8.31%,ENPP2;CP;RIMBP2;STMN2;RCAN2;PROX1;GFRA2;ELAVL4;ZNF536;NCALD
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.7057862185834235,1.269560663709662,0.1836734693877551,0.8768617226280054,1.0,5/9,22.71%,ACACB;MID1IP1;CPT2;CPT1A;SLC25A20
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.7014967832437727,-1.2693581858436895,0.22580645161290322,0.5930193416123424,1.0,5/13,18.26%,POU4F1;IGF1;DDRGK1;TGFB1;NIBAN2
prerank,Reactome_2022__Defensins R-HSA-1461973,-0.7811318594799337,-1.2693581552273168,0.22950819672131148,0.5925304550982349,1.0,4/6,18.56%,TLR2;TSPAN32;DEFB109B;CD4
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.5594699259376833,-1.2692874843056594,0.09333333333333334,0.5923189539217124,1.0,13/87,13.56%,GGT5;CXCL2;ZFP36;IL12A;PDCD1LG2;CCL2;WNT5A;DAB2IP;SELP;SBNO2;TNIP2;NOS1;SLC11A1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.45349453379444504,1.2692569768107735,0.10344827586206896,0.8768939087004191,1.0,8/66,7.53%,LIMD1;BMP2;MEN1;GREM1;SOX9;RORB;FBXO5;RANBP3L
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.5978870313236084,-1.269239125360509,0.1111111111111111,0.5920617421810361,1.0,12/33,22.72%,KCNB1;GNG3;AKAP5;ITPR3;ADCY5;GNG2;GLP1R;ADCY8;KCNC2;ITPR1;GNB4;GNB5
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),-0.8159769042739025,-1.2692178824427056,0.16393442622950818,0.591666890974966,1.0,2/5,12.99%,HLA-A;EMP2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.8009681006988969,-1.2689337209565772,0.14754098360655737,0.5924989025821625,1.0,2/7,12.29%,NR4A3;IGFBP5
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.8733883820082358,-1.268304750509498,0.09803921568627451,0.5945164674487613,1.0,3/5,10.25%,P2RY12;CCL2;CD9
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression Linked To Triglyceride Lipolysis In Adipose R-HSA-9031528,0.7771333865422084,1.2681687801468107,0.15384615384615385,0.8806847412151337,1.0,1/5,2.41%,PLIN1
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.7149694147122045,-1.2679018612410005,0.15151515151515152,0.5957196882375368,1.0,1/12,1.31%,TYMP
prerank,Reactome_2022__Zinc Efflux And Compartmentalization By SLC30 Family R-HSA-435368,0.7539610706472184,1.2677775466263108,0.2765957446808511,0.8815896648125127,1.0,4/6,18.41%,SLC30A7;SLC30A6;SLC30A8;SLC30A1
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.6832292327916926,1.267249186637884,0.15555555555555556,0.8827646059677113,1.0,4/9,17.94%,GREM1;SOX9;ADAMTS12;EFEMP1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.5290711520239061,-1.2672136268711187,0.06896551724137931,0.5982664550376968,1.0,31/124,15.95%,NPY;APLNR;NRN1;RCAN2;BCAS1;CTHRC1;MATN2;ART3;SEMA3B;PLP1;THY1;LMOD1;GAP43;APOD;GFAP;TCEAL6;MAG;HAPLN2;SHC2;NDRG1;FGF1;DAB2IP;ADCY5;IGFBP5;RASL12;TMEM132C;CNTN2;TNS2;STMN1;PHYHIP;ITGB4
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.7144620866409198,-1.267059803898321,0.1875,0.5984257663921566,1.0,5/13,12.44%,PDPN;CD44;VIL1;WAS;DMTN
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,0.42055258492252007,1.267040917437902,0.0,0.8820463422829133,1.0,65/200,25.05%,H2BC18;KDM1B;SMYD2;KMT5A;MSL2;H2BC21;KAT2B;H2BC4;EED;ZZZ3;KDM5A;PRMT6;RBBP4;H2AC6;TAF12;BRWD1;KMT2A;PRMT3;KANSL2;SAP130;KAT2A;ELP2;EP400;KAT7;NFKB1;MBIP;AEBP2;HDAC2;EP300;TADA1;SMARCA2;BRPF3;NCOA2;ING3;MCRS1;SETD3;ASH2L;DR1;EHMT1;WDR77;HDAC10;CHD4;ELP6;ELP3;SAP30L;KAT14;TADA2B;KAT6B;SUPT20H;KMT2C;PBRM1;SMYD3;USP22;ENY2;RUVBL1;TRRAP;JMJD6;H2BC5;RIOX2;MTA2;EPC1;SETD6;PRMT1;SMARCC1;ARID1B
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),-0.7740201560541395,-1.2669731283573735,0.24444444444444444,0.5982795178382351,1.0,3/5,17.69%,CD55;CFH;CR1L
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.5239578844153225,-1.2668994220446816,0.10465116279069768,0.5980801247787325,1.0,7/99,7.89%,ENPP2;B4GALNT1;ABCA12;UGT8;PDXDC1;FA2H;SGPP2
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.810120019962308,-1.2668813882048773,0.1896551724137931,0.5976295972651605,1.0,3/6,5.75%,CLDN16;LETM2;SLC4A11
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.6451440432563448,-1.2668687405242625,0.08823529411764706,0.5971874190941685,1.0,4/29,8.26%,SPARC;PDPN;CD44;VIL1
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,0.4778300318042494,1.2665842825250353,0.08695652173913043,0.8824387676615308,1.0,14/71,18.68%,KSR2;SPRED1;NRAS;DUSP6;TRIM24;CNKSR1;AP3B1;SHOC2;PPP1CC;SPRED2;TENT4A;QKI;PHB1;MAP2K2
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.7609680920199245,1.266546657723814,0.1875,0.8810830163942905,1.0,2/7,5.94%,PEX11A;MFF
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.8202611002887594,-1.266545029506676,0.20689655172413793,0.5981381488834062,1.0,3/6,7.96%,LEF1;GPR183;ZFPM1
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.6310811123223342,-1.2664981239406112,0.14705882352941177,0.597893912794884,1.0,5/27,10.60%,ANXA1;TYMP;TSPYL2;SCG5;IGFBP7
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.8110835135757248,-1.2663784585967646,0.14035087719298245,0.597855144533949,1.0,1/6,0.18%,ANXA1
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.4445957010466956,1.266374945072587,0.1,0.8806619517391765,1.0,17/73,20.89%,NUP42;HSPA1A;NUP37;BAG2;NUP54;HSF1;NDC1;NUP214;AAAS;MRPL18;NUP188;NUP205;CCAR2;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.7349094987288076,-1.2663297368504296,0.11666666666666667,0.5975356461022153,1.0,2/10,2.47%,MX1;IFIT1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.5616564662484993,1.2662888209531087,0.10714285714285714,0.879410574764944,1.0,2/27,4.00%,ITGA1;PPP1R15B
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.8666128625485546,1.2662593666545892,0.13725490196078433,0.8780089809701924,1.0,1/5,3.26%,MITF
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.7910005009252503,1.2661963743757632,0.13333333333333333,0.8769784216195283,1.0,3/6,9.92%,ZSWIM6;SALL1;ERBB4
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.6413228673273763,-1.2661949375364132,0.17105263157894737,0.597117930140419,1.0,6/26,12.78%,RPS27A;TLR3;IRF7;BIRC3;UBC;FADD
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.6413228673273763,-1.2661949375364132,0.17105263157894737,0.597117930140419,1.0,6/26,12.78%,RPS27A;TLR3;IRF7;BIRC3;UBC;FADD
prerank,Reactome_2022__Defective B3GALTL Causes PpS R-HSA-5083635,-0.5943938748214415,-1.2661706904347543,0.16216216216216217,0.5967392438780215,1.0,7/33,5.72%,THBS1;ADAMTS10;THSD4;SPON2;SBSPON;ADAMTSL2;THSD7B
prerank,Reactome_2022__Voltage Gated Potassium Channels R-HSA-1296072,-0.5998290954698322,-1.2661146512635217,0.16393442622950818,0.5964822020654682,1.0,14/30,20.01%,KCNQ1;KCNV1;KCNB1;KCNH8;KCNG1;KCNB2;KCNC1;KCND3;KCNH7;KCNAB3;KCNV2;KCNF1;KCNQ5;KCNC2
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.6696579615657926,1.2656935687325839,0.24324324324324326,0.877721854520177,1.0,4/8,17.10%,TGFBRAP1;VPS39;VPS11;VPS8
prerank,Reactome_2022__Plasma Lipoprotein Remodeling R-HSA-8963899,-0.6816124400137451,-1.2656312772626324,0.19672131147540983,0.5976994370455607,1.0,2/17,8.06%,LPA;ANGPTL3
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.7707388812229696,-1.2656044532497992,0.15517241379310345,0.5973060955383173,1.0,2/10,3.82%,KCNQ1;KCNJ2
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.7866514275172043,1.2654155368169724,0.175,0.8773676907048886,1.0,1/6,2.98%,DACH1
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.6348560825518933,1.265300386941643,0.15,0.8765736000677727,1.0,1/16,0.98%,ATP6V0D2
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.715852525046998,-1.265197430022839,0.171875,0.5984376880027144,1.0,2/13,9.24%,NR4A3;IGF1
prerank,Reactome_2022__NADE Modulates Death Signaling R-HSA-205025,0.7819552720519763,1.2646466251281039,0.1951219512195122,0.8778883583507263,1.0,1/5,0.43%,NGF
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,-0.5638671543832986,-1.2646379101992664,0.1388888888888889,0.6001178655587074,1.0,11/45,11.27%,THBS1;COL4A1;COL4A2;ICAM1;ITGA2;COL4A4;ITGA5;CD44;ITGA8;ITGA11;FN1
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.6178746490615722,-1.264533181284603,0.1323529411764706,0.5999721403308731,1.0,7/33,17.34%,SLC28A2;APOD;SLCO3A1;SLCO2A1;SLCO1A2;SLC29A4;SLC28A3
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.5490821324942722,-1.264476211964582,0.14516129032258066,0.5998266503334307,1.0,5/52,12.02%,LEF1;CDKN2A;CCND1;CCNB1;RUNX2
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),0.6655381507467159,1.2644550654543543,0.2,0.877344558705967,1.0,4/10,17.70%,COPS2;COPS8;COPS7A;COPS7B
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6979287531757935,1.264274068224713,0.18421052631578946,0.8768025900364425,1.0,3/9,13.02%,PGAP1;GAS1;SCFD1
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.5504169231580169,-1.2642538870333828,0.09333333333333334,0.6002831298123283,1.0,9/46,10.44%,ANXA1;SEPTIN5;HAP1;SEPTIN4;CPLX1;IL1RAPL1;SYT1;CPLX2;RIMS2
prerank,KEGG_2021_Human__Primary immunodeficiency,-0.6705071964862553,-1.2642200263780148,0.203125,0.5999873112071882,1.0,7/16,24.47%,CIITA;BLNK;CD4;RAG1;IKBKG;PTPRC;ADA
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.5820223803485771,-1.2642124146302989,0.136986301369863,0.5995567966469838,1.0,5/38,9.91%,IL12A;STAT4;CA1;LMNB1;TCP1
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.6936515490728419,1.264209724537421,0.1,0.8755766277756065,1.0,4/13,16.65%,SDC4;SNF8;SMPD3;VPS4B
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.47810480498120467,1.2639612512862977,0.1,0.875077481044283,1.0,10/63,15.53%,DNA2;KPNA2;PDE12;GTF2F2;HNRNPC;DNASE1L2;LSM8;EXD2;HNRNPU;POLR2C
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.6301937809860484,-1.2639421523206524,0.09836065573770492,0.6002750151061036,1.0,6/25,16.85%,LEF1;HLA-DRA;TESPA1;IL7;HLA-DRB1;BCL6
prerank,Reactome_2022__Regulation Of FOXO Transcriptional Activity By Acetylation R-HSA-9617629,0.679988991893693,1.2639109368284205,0.2647058823529412,0.8738205422786153,1.0,5/10,25.15%,TXNIP;KAT2B;EP300;TXN2;FOXO4
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.7339844921739188,1.2638236464898747,0.1956521739130435,0.8728331752952544,1.0,2/6,15.51%,HSPA1A;CPNE1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.6494134737879914,-1.2637108688260668,0.13333333333333333,0.6008421288790621,1.0,3/19,3.62%,RPE65;GC;RBP2
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,0.4672491538591594,1.2634737300898404,0.09090909090909091,0.8731169601734291,1.0,9/81,7.54%,FGF6;PIP5K1B;FLT3;TRIB3;THEM4;EGFR;AKT2;AKT1;STRN
prerank,CellMarker_Augmented_2021__Thymocyte:Undefined,-0.6252472789365005,-1.2634173209096204,0.15517241379310345,0.6015881270886906,1.0,9/25,15.49%,GPR183;TAGAP;ARHGAP9;ACAP1;WAS;PTPN7;P2RY10;SP140;CD37
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.8243032099707084,-1.2633691291317934,0.10344827586206896,0.6012924482072656,1.0,3/5,12.44%,ANK3;PDPN;DMTN
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.7231815647794007,-1.2632166303419432,0.18181818181818182,0.6010313446248285,1.0,4/10,13.45%,STAG3;SYCE2;SYCE1;TEX11
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.7231815647794007,-1.2632166303419432,0.18181818181818182,0.6010313446248285,1.0,4/10,13.45%,STAG3;SYCE2;SYCE1;TEX11
prerank,CellMarker_Augmented_2021__Interstitial cell:Dorsolateral Prefrontal Cortex,-0.5425583692811209,-1.263207830156484,0.10666666666666667,0.6006397444094365,1.0,12/76,13.56%,GBP2;SP100;B2M;IFI35;GLRX;PSMB9;PARP9;CTSS;IFIH1;SP110;SP140L;APOL3
prerank,Reactome_2022__2-LTR Circle Formation R-HSA-164843,0.7400547343132874,1.2631518870140848,0.16279069767441862,0.8730786406709509,1.0,2/8,15.21%,LIG4;SGIP1
prerank,CellMarker_Augmented_2021__Progenitor cell:Corneal Epithelium,-0.5706338765413571,-1.2630667466747727,0.15584415584415584,0.6008158456440954,1.0,15/48,16.72%,THBS1;MET;GPR87;MYOF;ITGA2;SRPX2;OSMR;EMP1;PRSS23;ITGA3;LAMA3;COL12A1;RHOD;ANXA2;ATP8B1
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,-0.7016911997498009,-1.2630582916356716,0.11475409836065574,0.6003579438241561,1.0,3/15,12.77%,RPS27A;VLDLR;UBC
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.5018057704159087,-1.2628300920210198,0.07058823529411765,0.6006308335279439,1.0,25/155,14.33%,CD24;TMEM204;SP100;TRIM5;OVOL2;NLRP12;SULF1;APP;CAV3;RSPO3;PTK6;TIMP1;LFNG;ZIC1;PLSCR1;SLC8A3;TSPYL2;IGFBP7;HHIP;CD55;GLI1;IGFBP5;CD63;VEPH1;ITGA3
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),-0.8274045444183262,-1.2627717972872232,0.17857142857142858,0.6004417815424467,1.0,1/5,1.91%,B2M
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.6182313209844159,1.2624139380921542,0.29411764705882354,0.8748133111239221,1.0,4/18,12.02%,SLC6A13;SLC47A1;SLC3A2;SLC22A2
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,0.4953569518059678,1.2622577239190478,0.04,0.8740379736040644,1.0,12/53,15.95%,DDX56;H2BC21;KAT2B;H2BC4;ERCC6;RBBP4;H2AC6;POLR1F;KAT2A;H3-3B;HDAC2;EP300
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.42435436141194904,1.2620779218473386,0.15,0.873528375260538,1.0,27/89,21.91%,PSMD10;CEBPA;HSPA1A;TRIB3;KEAP1;BAG2;COMMD1;VCP;RNF14;CSNK1E;CBFA2T3;XPO1;PLK1;RCHY1;TRIB2;EIF3H;FHIT;COP1;UBQLN4;ZYG11B;MDM2;CCAR2;SMAD7;RNF217;SUMO2;NUB1;DDA1
prerank,Reactome_2022__Activation Of Arylsulfatases R-HSA-1663150,0.6241654526821581,1.2620126271640135,0.21052631578947367,0.8724574674686877,1.0,4/12,23.13%,ARSF;ARSJ;ARSK;ARSB
prerank,Reactome_2022__O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,-0.5905124145651912,-1.2619472941282328,0.1506849315068493,0.6034363713966918,1.0,7/34,5.72%,THBS1;ADAMTS10;THSD4;SPON2;SBSPON;ADAMTSL2;THSD7B
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),-0.8211658058883511,-1.261752793461361,0.2037037037037037,0.6036244062139055,1.0,4/5,17.63%,P2RY6;HRH1;PTH1R;GPER1
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",-0.819177381241189,-1.2617339051788092,0.21818181818181817,0.6031883687390536,1.0,2/5,8.80%,ALDOB;FBP1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.6145899797218194,-1.2616636754857367,0.11864406779661017,0.6030720833160577,1.0,2/24,4.82%,MTMR7;MTMR11
prerank,CellMarker_Augmented_2021__PDX1+ Pancreatic Progenitor cell:Embryonic Stem Cell,-0.5894734996299505,-1.2616511942020254,0.18571428571428572,0.6026520062363683,1.0,7/39,8.11%,CD24;PKP2;TJP3;OVOL2;LSR;FA2H;BAIAP2L1
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Testis,0.7059220089351689,1.2616222708970617,0.14285714285714285,0.8730762987280895,1.0,1/7,0.90%,ETV5
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.5097794826123602,-1.2609682424739006,0.1511627906976744,0.6049588040885495,1.0,45/135,20.74%,THBS1;SPARC;F8;APP;ABCA12;RAB11FIP5;SYT4;TIMP1;SYNGR2;EGF;F13A1;GTPBP2;CPLX1;SYT1;IGF1;CPLX2;TAGLN2;RAB11FIP1;CD9;RIMS2;FN1;SELP;MYH9;CD63;F5;SRGN;WDR1;SERPING1;SYT5;TLN1;SYT2;SYT13;VCL;CDK5;TGFB1;FERMT3;A2M;SYNGR3;TF;SELENOP;CD36;RAB27B;TMED10;STEAP2;SYT12
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,0.5807977786972259,1.260890780712754,0.21052631578947367,0.8747592513308622,1.0,6/18,13.99%,NGF;NRAS;RALB;RALA;MAPK12;SHC3
prerank,CellMarker_Augmented_2021__Circulating Precursor cell:Peripheral Blood,-0.5677142073998431,-1.2608670196880227,0.09210526315789473,0.604915413361786,1.0,19/44,18.97%,P2RY14;GPR34;SLA;ITM2A;HLA-DRA;MYH11;F13A1;RASGEF1B;SELP;LPAR6;LDLRAD4;ELMO1;RNASE1;CD74;HLA-DRB1;MRC1;A2M;CD4;WDFY4
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.46960459328410503,-1.260785176914578,0.010869565217391304,0.6047537486836507,1.0,69/345,18.59%,PRAME;LEF1;ANXA1;THBS1;HPN;APIP;IFI6;DHCR24;POU4F1;RPS27A;NAA38;ALOX12;PDPN;KIF14;PLK2;PRDX5;ITGA5;KLF4;HTR2B;SCX;CCL2;PIM3;GATA1;CD44;NUAK2;PLK3;IFIT3;PRKCG;RPS6KA1;IGF1;MAG;WNT5A;UNC5B;BIRC3;RPS3A;PINK1;BCL2L2;PTRH2;RPL10;PRKCH;PIM1;UBC;CLEC5A;IL7;RNF213;VIP;BDNF;CD74;THOC6;DDRGK1;PRKCD;CCND2;NRBP2;CLN3;TEK;AHI1;MYO18A;SNX6;RIPK2;AQP1;LRP2;HIPK3;CDKN2D;NUPR1;NIBAN2;HSPA5;COPS5;VSTM2L;FOXB1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.5677604747909992,-1.2607633082998764,0.19736842105263158,0.6043558422155708,1.0,6/42,8.87%,THBS1;IFI6;DHCR24;KLF4;CD44;RPS6KA1
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.631512149520802,1.2607235571074995,0.24390243902439024,0.8739903895068731,1.0,4/12,18.78%,RAB23;EFL1;OPA1;AK4
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Adipose Tissue,-0.5243551712458777,-1.260447714189002,0.14473684210526316,0.605117965427118,1.0,13/86,12.05%,THBS1;MET;MYOF;LAMB1;KDELR3;ITGA2;CCND1;PAPSS2;SRPX2;OSMR;CLIC4;FN1;PRSS23
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.5166494807569554,-1.2604288248110491,0.0875,0.6047130215433413,1.0,25/82,19.24%,CD24;ACKR4;CDH23;PLN;TRPC3;CAV3;ITPR3;S1PR3;WNT5A;HCRTR2;CACNA1C;ADCY5;CD55;C1QTNF1;CCR10;TAC4;GLP1R;CIB2;CLN3;ADCY8;RYR2;GPER1;PLCE1;PDGFRA;CD36
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.5677696894510644,-1.2603688523569885,0.16176470588235295,0.6044193134162977,1.0,14/54,15.49%,RASGRP2;TAGAP;TMC8;ARHGAP9;GPR18;ACAP1;RCSD1;WAS;CTSS;ZBTB32;P2RY10;IL7;SP140;CD37
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.7037050165098762,-1.2603003242041628,0.208955223880597,0.6043028823567534,1.0,1/18,0.04%,GGT5
prerank,Reactome_2022__Wax And Plasmalogen Biosynthesis R-HSA-8848584,-0.8337454638211887,-1.26017757428405,0.16393442622950818,0.604311778831452,1.0,1/6,0.40%,AWAT1
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.6189036474376515,-1.260071190889631,0.13333333333333333,0.6043647948210171,1.0,5/29,11.28%,APLNR;TGFBR2;PROX1;ZFPM1;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.6251252545531233,-1.2600084999798784,0.1506849315068493,0.604211932999934,1.0,6/30,10.15%,P2RY6;ANK3;LRRC55;CCL2;HAP1;CTSS
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.7232179656853891,-1.2598360702740885,0.14754098360655737,0.6044118242702226,1.0,3/9,18.65%,DCTN1;CLMN;SYNE3
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.6884298881952635,1.2598020223312805,0.2619047619047619,0.8763560972603603,1.0,2/10,10.40%,PUS10;DROSHA
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.6542926194993746,-1.2595775914052911,0.15873015873015872,0.6050370183069885,1.0,3/17,9.67%,SOCS3;ST18;STAT1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.5201523914466678,-1.2595758557341186,0.14285714285714285,0.6045760251945355,1.0,35/104,20.36%,RIMBP2;CDH22;STMN2;MYT1;SNCB;ZDHHC22;SLITRK1;LRRTM1;ATRNL1;SYT4;JPH3;GAP43;SLC18A2;SYP;PRKCG;CPLX2;HPCA;SCN2A;CALY;STMN4;KCNB2;GAD2;GABRG2;CNTN2;KCNC1;GDAP1L1;SYT13;SULT4A1;MAPT;CELF4;ST8SIA3;PRR36;PTPN5;CHRNA6;PAK5
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.6583948538004132,1.2595511866193847,0.15789473684210525,0.8758104881771074,1.0,4/14,15.19%,SMARCAD1;SIRT6;ELK4;HDAC2
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.5261604759515675,1.2595463305636296,0.14285714285714285,0.8743747332784565,1.0,1/28,0.54%,RNF6
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.6090317440969923,-1.259527920480597,0.1388888888888889,0.6043135772559433,1.0,6/21,15.76%,TMSB10;PFN4;VIL1;PFN2;KANK3;PRKCD
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.5397921162012649,-1.2595220645893699,0.08641975308641975,0.603875838536093,1.0,21/90,16.77%,C1ORF87;ANGPTL2;TEKT2;RSPH4A;SIX3;CFAP126;TMEM212;EFNB3;GFAP;SPAG17;NME9;FAM81B;CFAP61;DRC3;CXCL17;DRC1;AKAP14;DNAH2;ZBBX;ERICH3;USP18
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.6282050841626498,-1.259501112100844,0.13157894736842105,0.6035119385407705,1.0,7/29,13.20%,KCNB1;IL12A;RAB11FIP5;BMP8A;RHBDF2;RAB11FIP1;RHBDF1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.6578235006908693,-1.2593867895647735,0.19047619047619047,0.6034775352801585,1.0,1/17,0.51%,IFI6
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),-0.8435959003417766,-1.25938445688921,0.18867924528301888,0.6030049608594222,1.0,1/6,6.23%,MMP14
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.5767371561892464,-1.2593597191201282,0.10526315789473684,0.6026061063488384,1.0,11/43,13.93%,P2RY6;P2RY12;CHRM1;HTR2B;GPR18;LPAR6;LPAR4;HRH1;P2RY10;VIP;PTH1R
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.6398026265033208,-1.2591031371997574,0.19696969696969696,0.6032215093582345,1.0,4/18,11.67%,ZFP36;MAFF;ABCA12;SFRP4
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.6682022768333267,1.259068220320505,0.20512820512820512,0.8752255200067169,1.0,4/7,15.95%,KAT2B;KAT2A;KAT7;EP300
prerank,Reactome_2022__Synaptic Adhesion-Like Molecules R-HSA-8849932,-0.6711406027731966,-1.2589881077225993,0.15942028985507245,0.6032603068308713,1.0,6/21,12.77%,GRIN2D;GRIN2A;GRIA3;GRIA1;FLOT1;GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.5625062956000284,1.2588131200843449,0.16666666666666666,0.8749622515382365,1.0,3/18,10.13%,WNT7A;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.6104962651241256,1.258753737120282,0.10810810810810811,0.8737752903527565,1.0,1/9,4.54%,DUSP6
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.7904599928226019,-1.2583791724584168,0.19047619047619047,0.6052284939661836,1.0,2/6,9.24%,KLF4;DLEC1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.7144931851937573,1.2583442548969346,0.2,0.8744013654219798,1.0,1/9,0.60%,RGCC
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.5010708207304138,-1.2583412557677922,0.011494252873563218,0.6049091774204222,1.0,73/271,20.53%,PIF1;TYMS;RECQL4;BLM;RPL19;RPL3;RPS27A;WARS1;RPS27;RPS14;RPS4X;RPL27A;GCNT1;HELB;RPL35;SCX;RPL7A;RPL37A;RPL27;BRCA1;POLE3;RPL9;RPL21;DONSON;GTPBP2;RPL13A;POLR2I;RPA3;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;PAX8;RPA1;RPL8;RPS6;RPS15;RPS9;RPL12;RPL5;EEF1A2;CDK2;CDC7;RPL23;RPL4;POLD1;RPL18A;RPL41;RPL7;RPS12;RPS20;COPS5;RBMS1;MRPL23;RPL15;MRPL51;KAT5;RPL11;SET;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.617157550766325,-1.258253194585525,0.1323529411764706,0.6049174903887616,1.0,2/23,5.86%,THBS1;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.5024840447352946,-1.2581399045477306,0.10588235294117647,0.6048604150139261,1.0,16/120,7.96%,LEF1;ANXA1;THBS1;GBP1;ZFP36;SFTPD;IL12A;GPNMB;NLRP12;ADCY7;KLF4;NLRC5;PDCD1LG2;CEACAM1;APOD;ZFPM1
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",-0.5290103114462604,-1.2579481223798907,0.10256410256410256,0.605224408704836,1.0,20/82,18.28%,PDE4A;ADCY7;MMP14;PLD1;GCM2;ITPR3;PRKCG;PLD2;MMP25;CREB5;ADCY5;MMP24;RUNX2;PTH1R;FOS;ADCY3;ADCY8;PRKCB;CREB3;CDKN1A
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.711723462092759,-1.2576481826039727,0.22580645161290322,0.6060592576358583,1.0,5/14,15.79%,STMN2;KIF14;STMN4;KIF2C;STMN1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.7937860874491391,1.2574435216007263,0.16279069767441862,0.8751505909767537,1.0,2/7,11.56%,CEL;CYP46A1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.7937860874491391,1.2574435216007263,0.16279069767441862,0.8751505909767537,1.0,2/7,11.56%,CEL;CYP46A1
prerank,Reactome_2022__Estrogen-stimulated Signaling Thru PRKCZ R-HSA-9634635,0.7777752096246824,1.257169606510412,0.175,0.8750181754993857,1.0,1/5,3.57%,NRAS
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,-0.6500695734387939,-1.2571324262211971,0.2318840579710145,0.6077552022689043,1.0,6/22,15.54%,PDPN;GP6;SYK;RNASE1;PIK3CB;VAV1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.5056874250946826,-1.2567272311617876,0.07407407407407407,0.6087461001754758,1.0,11/137,7.68%,CD24;LEF1;COL4A1;COL4A2;LAMB1;GJC1;PODXL;KLF4;THY1;TEAD2;ZIC1
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.822342365031042,-1.2564482040747966,0.23728813559322035,0.6093230225157842,1.0,3/5,9.82%,PCSK2;CEACAM1;CELA2A
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.6932137732559103,-1.2563979884097782,0.19696969696969696,0.6090820437915601,1.0,6/16,12.58%,RFTN1;IFIT1;COLEC12;TLR3;IFIH1;FLOT1
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Fetal Liver,-0.5362258356398891,-1.256391134575923,0.11538461538461539,0.6086319265375775,1.0,24/77,18.09%,COL4A1;ANGPTL2;APLNR;SPARC;RCAN2;SULF1;THY1;LMOD1;BGN;LDB2;IGFBP5;SLCO2A1;RNASE1;ITGA9;RASL12;RGS7BP;ROBO4;SFRP2;SERPING1;TEK;SHROOM4;ADGRF5;AQP1;PCDH18
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,-0.4772006954888238,-1.2563852740001178,0.09090909090909091,0.6081608491950562,1.0,68/303,18.86%,CXCL2;ANXA1;IL1R1;SOCS3;IL13RA1;ICAM1;RPS27A;IL12A;INPP5D;STAT4;IL15;FSCN1;APP;NOD1;NLRC5;CCL2;KCNH8;TIMP1;CCND1;PSMB9;F13A1;CA1;RPS6KA1;LMNB1;IL1RAPL1;OSMR;STAT1;IL4R;TCP1;PTPN7;PSMB6;SYK;FN1;IL17RE;IL18;PSMC3;TNIP2;SIGIRR;UBC;TNFRSF1A;IL7;FOS;IL3RA;BLNK;PIK3CB;PSMA8;VAV1;IL1RAP;IL27RA;PSMA7;ANXA2;CEBPD;STAT6;USP18;BCL6;NDN;AURKAIP1;IRS2;PSME1;ALPK1;RIPK2;RBX1;TGFB1;CDKN1A;CD4;LAMA5;RAG1;IL15RA
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.5355203131011093,1.256355907484938,0.11627906976744186,0.8773806229670652,1.0,3/30,5.12%,WNT7A;SOX21;PSMD11
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.69212667891405,1.2563317973329071,0.15217391304347827,0.8760730775675948,1.0,4/8,17.94%,GREM1;SOX9;ADAMTS12;EFEMP1
prerank,CellMarker_Augmented_2021__Myeloid cell:Bone Marrow,-0.5984880980738965,-1.2562805203565477,0.125,0.6081810097873773,1.0,3/28,4.39%,CD24;TLR2;SIGLEC1
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,0.5554344128137502,1.2560437494664716,0.27586206896551724,0.8759763794559358,1.0,11/23,27.78%,CCT7;COPS2;HNRNPC;CPSF7;TXNL1;RBMX;RBM15;RNF20;ROCK2;VIM;RBBP6
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.4254929712595508,1.255831570659549,0.08333333333333333,0.87575222300624,1.0,58/176,24.38%,SPSB4;RNF6;FBXO45;KLHL8;SPSB2;FEM1C;ELOC;WDR91;RNF150;PSMD11;KEAP1;FBXL14;ANAPC1;RNF146;RNF14;UBE2G1;BTRC;PLK1;FBXO8;RNF114;UBE2D1;RCHY1;PSMD14;FBXO10;UBE4A;CDC26;UBE3B;FBXO21;RNF11;RC3H1;KCTD21;NDFIP1;CNOT4;UBQLN4;RNF166;UBL7;RC3H2;MDM2;RNF217;NEDD4L;FEM1A;PSMF1;RNF34;NUB1;BUB3;MIB1;TRIP12;CDC34;RNF130;RNF20;FBXL7;RLIM;UBE2A;UBE3C;ITCH;RNF168;UBQLN1;RNF13
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7500166791678642,1.255749547878302,0.20930232558139536,0.8747087307971995,1.0,2/6,10.55%,TNFAIP3;TIRAP
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.665222888215466,1.2556879096160407,0.18181818181818182,0.8707096249500781,1.0,2/12,10.09%,ZNF207;PLK1
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.665222888215466,1.2556879096160407,0.18181818181818182,0.8707096249500781,1.0,2/12,10.09%,ZNF207;PLK1
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.665222888215466,1.2556879096160407,0.18181818181818182,0.8707096249500781,1.0,2/12,10.09%,ZNF207;PLK1
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.7378798678265304,1.2555920528917082,0.22727272727272727,0.8696989627256086,1.0,3/7,10.47%,LIG4;MSH2;EXOSC6
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.6844979872192878,-1.2555480368281293,0.140625,0.6106157512962223,1.0,2/13,1.14%,C3;NR4A3
prerank,Reactome_2022__Common Pathway Of Fibrin Clot Formation R-HSA-140875,-0.7743727869086728,-1.255463424155718,0.14545454545454545,0.6105331538359161,1.0,5/9,13.62%,F8;SERPIND1;F13A1;PROCR;F5
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.8603304254024039,-1.255347938662829,0.14814814814814814,0.6104075037962279,1.0,1/5,0.18%,ANXA1
prerank,Reactome_2022__Initial Triggering Of Complement R-HSA-166663,-0.7663054999508259,-1.2552876986411532,0.17142857142857143,0.61024609188446,1.0,2/9,1.43%,C3;C1R
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.6331510545651696,1.2552672695571554,0.25,0.8698485262510509,1.0,4/11,25.30%,KEAP1;NFKBIE;PKD2;LATS1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.619355658554086,-1.2550268221480414,0.18518518518518517,0.6107316313523711,1.0,3/35,3.82%,APIP;B2M;KCNJ2
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.5238778427242943,-1.254899211380817,0.08974358974358974,0.61078562004512,1.0,23/103,17.72%,CACNA1H;RASGRP2;B2M;ANK3;ADCY7;SYT4;GLRA2;NEUROD2;FBP1;SYT1;CLIC4;MT1H;WNT5A;HPCA;CPNE9;DMTN;NLGN1;FOS;SYT5;SYT2;SYT13;ADCY8;AQP1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.5164765341021131,-1.2547378421916926,0.1111111111111111,0.6109830162880852,1.0,11/106,5.04%,NPY;FLRT3;POU4F1;CFAP126;STMN2;L1CAM;LAMB1;RAB11A;SH3GL2;PLP1;APP
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.7353756881954275,-1.2545877339426843,0.15217391304347827,0.611129925966931,1.0,2/10,5.06%,KLF2;KLF4
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.7392933395525976,-1.2545595220345238,0.14925373134328357,0.610782327808559,1.0,3/12,11.72%,CCNB2;CCNB1;DCTN1
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex In Cancer R-HSA-3304351,-0.7755232803516589,-1.254469863232555,0.17857142857142858,0.6101745611425438,1.0,1/7,1.45%,TGFBR2
prerank,Reactome_2022__Loss Of Function Of SMAD2/3 In Cancer R-HSA-3304349,-0.7755232803516589,-1.254469863232555,0.17857142857142858,0.6101745611425438,1.0,1/7,1.45%,TGFBR2
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,0.6201223150084881,1.2543928902356403,0.12903225806451613,0.8724884263193787,1.0,4/16,15.95%,NRAS;PRKACB;NFKB1;EP300
prerank,"Reactome_2022__Activation Of NIMA Kinases NEK9, NEK6, NEK7 R-HSA-2980767",-0.8050346380382885,-1.254222389543072,0.21311475409836064,0.6106075217039669,1.0,2/6,10.55%,CCNB2;CCNB1
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.8437583564389507,-1.2541884869536462,0.1774193548387097,0.6102613881680272,1.0,3/7,6.27%,PODXL;FSCN1;PLD1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.6641631025302083,-1.2535698257967458,0.18840579710144928,0.6121351130429811,1.0,10/16,15.76%,ALOX12;PDPN;CEACAM1;CELA2A;CD9;PRKCQ;SYK;DMTN;C1QTNF1;PRKCD
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.7654171853047188,-1.2535312572519413,0.21428571428571427,0.6118382554268932,1.0,2/9,9.95%,IFI6;MLLT11
prerank,Reactome_2022__Transport Of Fatty Acids R-HSA-804914,-0.8126372378001362,-1.2534697932176344,0.2631578947368421,0.6115988529920877,1.0,1/5,7.01%,APOD
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.7934249136727254,-1.2530884288381186,0.22,0.6125488164913556,1.0,2/5,11.20%,MMP14;SYK
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),-0.8266256150721133,-1.2526814527052998,0.26785714285714285,0.6138672760500702,1.0,3/5,8.48%,YBX3;TLR3;RCSD1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.5763772442629371,-1.2524619886113755,0.08571428571428572,0.6142666764000827,1.0,8/38,18.62%,C3;B2M;CALY;FLOT1;GPC3;NLGN1;CLN3;TF
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.6137627267345092,1.2523173168911887,0.1935483870967742,0.8805801964114848,1.0,3/14,12.63%,NT5C1A;VCP;NUDT15
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.7264312853810793,-1.2522824218082291,0.20408163265306123,0.614573122929887,1.0,2/10,10.90%,CDKN2A;ROMO1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.5202186498893525,1.252250384481786,0.08571428571428572,0.8796322517921472,1.0,7/31,17.47%,NAF1;CCT7;MAP3K4;ATR;CCT3;POT1;PKIB
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.5769718232832581,-1.2521921698448664,0.15625,0.6144319233866627,1.0,6/36,4.36%,CACNA1H;KCNQ1;ANK3;KCNB1;KCNJ2;SCN9A
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.7541994250772143,-1.251860520533034,0.1746031746031746,0.6153051935138969,1.0,3/8,13.94%,HAP1;NEFH;DRC1
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.7478155216651388,-1.251800395248035,0.1864406779661017,0.615036080836252,1.0,1/8,1.39%,DGAT2L6
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,0.5481131299155287,1.251625557797114,0.13793103448275862,0.881202209505805,1.0,4/23,6.69%,TRIB3;THEM4;AKT2;AKT1
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),-0.7354686113082685,-1.251335128018462,0.23076923076923078,0.6165874304677351,1.0,2/6,15.12%,WNT5A;CD74
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.5105816799117138,-1.2509363762861265,0.11392405063291139,0.617725986246414,1.0,44/121,17.15%,GRIN2D;SPINK8;TAGLN3;CDH22;STMN2;CCK;KCNB1;SNCB;GRIN2A;SLITRK1;LRRTM1;SYT4;SLC32A1;SRRM4;ELAVL4;GRIA3;GAP43;GRIA1;GFAP;NRGN;TCEAL6;RIT2;IGSF21;CPLX2;CA10;HPCA;TCEAL2;CALY;STMN4;KCNB2;C11ORF87;SYNPR;GRIN2B;GAD2;GABRG2;CNTN2;KCNC1;PCP4;RAB3C;GABRA1;KCND3;TCEAL5;OXTR;ADCY8
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6625400011095274,-1.2508495184787276,0.18461538461538463,0.6176607146185544,1.0,2/13,7.01%,SP100;APOD
prerank,Reactome_2022__Apoptosis Induced DNA Fragmentation R-HSA-140342,0.6451709276541431,1.25053844651154,0.2857142857142857,0.884148204165914,1.0,4/10,17.22%,HMGB1;CASP3;H1-2;DFFB
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.772361869973262,-1.249973483879858,0.23728813559322035,0.6206409126688933,1.0,3/7,14.80%,IL12A;DAB2IP;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.7090265368959949,-1.2497828886199864,0.21428571428571427,0.6208912547051771,1.0,2/13,6.53%,MSX2;GATA1
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,0.5507931601234395,1.2497596591077964,0.17647058823529413,0.8864044324431039,1.0,10/26,31.08%,POLR3B;POLR3F;BDP1;GTF3C3;POLR1D;POLR3E;POLR2K;POLR3H;POLR2E;GTF3C4
prerank,CellMarker_Augmented_2021__Tuft Progenitor cell:Small Intestine,-0.7852330902023059,-1.249672062519319,0.19047619047619047,0.6209225087969028,1.0,4/8,16.03%,ARG2;CCL2;IER3;GSS
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.6854767253458631,-1.2496158710515366,0.16129032258064516,0.6206435243005333,1.0,6/16,18.61%,GBP1;MRAP2;TMBIM1;PPFIA1;TGFB1;NUMB
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.6130252017687272,1.2494102351939453,0.20588235294117646,0.8864723596519167,1.0,4/13,20.77%,NUP54;NDC1;NUP205;NUP153
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.7246005047376087,-1.249235705915994,0.19642857142857142,0.6217034121601499,1.0,2/10,0.47%,THBS1;HPN
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.5856236943254276,-1.249211259579472,0.11940298507462686,0.6212905153336642,1.0,12/41,18.74%,EFNA1;LAMB1;KIF14;ATRNL1;ITGA8;FN1;RADIL;TMEFF2;MICALL2;TEK;FERMT3;LAMA5
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.5784443752368129,-1.2491247151690965,0.1111111111111111,0.6211595954144079,1.0,7/47,8.06%,CD24;FABP3;ABCA5;AKR1C1;CAV3;LDLR;ANGPTL3
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.7746721708764075,-1.2490713466292258,0.1323529411764706,0.6209445301780746,1.0,2/8,16.52%,ACOT4;OXSM
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.47942861803390363,1.2489809172951696,0.125,0.8866293249124276,1.0,13/67,12.18%,SPSB4;PSMD10;BCL10;PEF1;TRIB3;DCUN1D2;UBE2N;COMMD1;DCUN1D1;PLK1;UBE2D1;RCHY1;DERL1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.7464531286186995,-1.2489063113202177,0.23333333333333334,0.6211230914100688,1.0,3/7,11.40%,HLA-A;IRF1;HLA-E
prerank,CellMarker_Augmented_2021__Stem cell:Deciduous Tooth,-0.8385904900374277,-1.248832526141083,0.13333333333333333,0.6204976304785248,1.0,2/5,7.03%,THY1;CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Skeletal Muscle,-0.8385904900374277,-1.248832526141083,0.13333333333333333,0.6204976304785248,1.0,2/5,7.03%,THY1;CD44
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.6332150988156295,-1.2488236068600105,0.2112676056338028,0.6200384488550498,1.0,6/26,18.13%,PIF1;RPA1;NOP10;ANKRD28;CDK2;TINF2
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),0.6439646043275322,1.2485381038167327,0.2,0.887177887885769,1.0,5/12,15.94%,TNFAIP3;FOXJ1;SAMSN1;ID2;RC3H1
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,0.5401810735424097,1.2483772188955313,0.20588235294117646,0.8866748616449085,1.0,10/27,31.08%,POLR3B;POLR3F;BDP1;GTF3C3;POLR1D;POLR3E;POLR2K;POLR3H;POLR2E;GTF3C4
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.7315567830888863,1.248361984101302,0.22857142857142856,0.8854272208391849,1.0,5/10,21.41%,PSMD10;PSMD11;POMP;PSMG2;PSMG1
prerank,Reactome_2022__Elevation Of Cytosolic Ca2+ Levels R-HSA-139853,-0.6623340601576164,-1.2483032379537111,0.1746031746031746,0.6216385944954236,1.0,5/11,21.59%,TRPC3;ITPR3;P2RX6;ITPR1;P2RX7
prerank,CellMarker_Augmented_2021__Clara cell:Lung,-0.6403804498941194,-1.2481328628520596,0.17647058823529413,0.6220328696870246,1.0,10/29,14.73%,FMO6P;C1ORF87;MROH9;CFAP126;DUOXA1;DNAH3;FAM81B;CXCL17;DRC1;AKAP14
prerank,CellMarker_Augmented_2021__Erythroid precursor:Bone Marrow,-0.5371727855266311,-1.2481239519304352,0.12,0.6216155198802379,1.0,14/61,18.48%,ARHGAP4;TMC8;DOK1;WAS;RPS6KA1;LAT2;NFKBID;THOC6;CD37;VAV1;IL27RA;MIIP;FERMT3;PCK2
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.7523515212249399,-1.2480417297336135,0.15625,0.6215271577231739,1.0,3/9,20.15%,YBX3;BIRC3;CASP8
prerank,Reactome_2022__NOTCH2 Intracellular Domain Regulates Transcription R-HSA-2197563,0.6778166812100961,1.2478331663548878,0.23809523809523808,0.8864185561151585,1.0,5/10,23.79%,MAML3;NOTCH2;EP300;HES5;RBPJ
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.7081188416261636,1.247481702456035,0.2641509433962264,0.8866275119812657,1.0,2/7,18.29%,ME2;FH
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.5242654170029776,-1.2474110566485956,0.1794871794871795,0.6234983832653218,1.0,9/54,16.12%,ST6GAL1;RPS27A;ZDHHC9;PARP14;PARP9;TUSC3;UBC;ST6GALNAC2;MGAT5
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.8071113417689917,-1.2470553992049755,0.15517241379310345,0.6244272385707824,1.0,1/5,14.98%,BOK
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.5747728893880995,-1.2470464222610955,0.13043478260869565,0.6239954053940977,1.0,4/33,11.91%,CACNA1H;ATP1B1;SLC7A2;SFXN3
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.8129751825096527,-1.2470002489377938,0.21052631578947367,0.6237383563153867,1.0,1/5,1.53%,P2RY12
prerank,Reactome_2022__Serine Biosynthesis R-HSA-977347,0.731375960174842,1.2468231142652904,0.25806451612903225,0.8882327975833335,1.0,4/7,21.32%,PSPH;SRR;SERINC5;PHGDH
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.6766980594004569,1.2465429354063655,0.16216216216216217,0.8884206208066843,1.0,8/10,31.84%,SESN2;EIF2AK4;SESN3;SESN1;GCN1;IMPACT;MTOR;LARS1
prerank,Reactome_2022__Formation Of Xylulose-5-Phosphate R-HSA-5661270,0.7990077213898427,1.2464130138038352,0.16363636363636364,0.8836214221298103,1.0,1/5,5.53%,DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.7990077213898427,1.2464130138038352,0.16363636363636364,0.8836214221298103,1.0,1/5,5.53%,DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.7990077213898427,1.2464130138038352,0.16363636363636364,0.8836214221298103,1.0,1/5,5.53%,DCXR
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.7990077213898427,1.2464130138038352,0.16363636363636364,0.8836214221298103,1.0,1/5,5.53%,DCXR
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.6323091547585455,-1.2464113088882696,0.19117647058823528,0.6256602852615937,1.0,6/17,17.01%,TYMP;APP;SLC8A3;DLGAP3;NPTX2;HTR2C
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.776651229265271,1.2464040431323735,0.18604651162790697,0.8822732205553423,1.0,2/5,12.75%,PTPRK;CASK
prerank,Reactome_2022__Hormone Ligand-Binding Receptors R-HSA-375281,-0.8203649330709786,-1.246294108701602,0.1875,0.6256458091548859,1.0,1/5,3.51%,GNRHR
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.7703315649192385,-1.2461814004416338,0.15254237288135594,0.6256452546066581,1.0,3/9,11.12%,EFNA1;NELL1;DAB2IP
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Undefined,-0.5494954874404444,-1.246150964237833,0.13157894736842105,0.6252627359327887,1.0,23/65,17.72%,COL4A1;ANGPTL2;APLNR;ALDOB;RCAN2;GC;RAMP3;SULF1;BGN;LDB2;MYO3A;SLCO2A1;RNASE1;ITGA9;RASL12;RGS7BP;ROBO4;SERPING1;RAI2;TEK;SHROOM4;ADGRF5;AQP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.7775561288961372,1.2460652033720458,0.14634146341463414,0.8825909475778165,1.0,2/6,8.94%,AGER;HMGB1
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,-0.5998879920597124,-1.2459942387256147,0.15492957746478872,0.6253873809349467,1.0,7/28,14.80%,INPP5D;STAT4;IL15;STAT1;SYK;IL3RA;PIK3CB
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.5738979462931092,-1.2458705860043473,0.16883116883116883,0.6254841026296418,1.0,18/52,18.41%,RPS27A;RPS27;RPS14;RPS4X;RPS11;RPS16;RPS13;RPS3A;RPS8;RPS23;RPS21;RPS7;RPS6;RPS15;RPS9;FAU;RPS12;RPS20
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.687991676731742,-1.245861597795725,0.20634920634920634,0.6250609802189214,1.0,4/10,22.92%,STEAP3;ATOX1;STEAP2;STEAP4
prerank,CellMarker_Augmented_2021__Immature neuron:Undefined,-0.5223483022348451,-1.2455129552670257,0.10666666666666667,0.6259887039279642,1.0,18/91,11.44%,TAGLN3;STMN2;MYT1;ELAVL2;SNCB;SH3GL2;ZDHHC22;CAMK2N2;SLITRK1;B4GALNT1;SYT4;GAP43;SYP;SYT1;PLPPR5;HPCA;RIMS2;STMN4
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7095349242820568,1.245343311722927,0.3018867924528302,0.8830839610231832,1.0,2/7,5.13%,SOX8;SOX9
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.7095349242820568,1.245343311722927,0.3018867924528302,0.8830839610231832,1.0,2/7,5.13%,SOX8;SOX9
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.5591618899822575,-1.2452844377351955,0.16216216216216217,0.626492988679254,1.0,8/46,4.84%,MYO1F;CD5;TAGAP;ITGA2;SPON2;GPR171;SLA;ARHGAP9
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.8020664119525186,-1.245155145917287,0.15384615384615385,0.6260691938391612,1.0,1/6,3.07%,CNTNAP1
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.8020664119525186,-1.245155145917287,0.15384615384615385,0.6260691938391612,1.0,1/6,3.07%,CNTNAP1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.57477213900868,-1.2451327130171004,0.17142857142857143,0.6257162412413033,1.0,13/37,16.18%,HPN;TIMP2;SCUBE3;MMP19;MMP14;CD44;TIMP1;KIF9;CTSS;FLOT1;ADAMTS4;TLL1;CAPN1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.7745192887073289,1.245016730659839,0.16666666666666666,0.88327709673125,1.0,2/5,10.96%,EIF2AK4;NCK1
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.7644675553988222,-1.2449600114506594,0.21052631578947367,0.6259708864192806,1.0,3/8,8.06%,TLCD2;FABP3;ANGPTL3
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.6648203452997883,-1.2448743205112833,0.23880597014925373,0.6258942677445187,1.0,3/12,10.15%,LMO2;GATA1;CTSS
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.8015050387034242,-1.2448693642244726,0.19642857142857142,0.6249773218804187,1.0,4/6,19.50%,CD74;HLA-DRB1;CD4;LGALS1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.8015050387034242,-1.2448693642244726,0.19642857142857142,0.6249773218804187,1.0,4/6,19.50%,CD74;HLA-DRB1;CD4;LGALS1
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.610835586023569,-1.2447976652545534,0.22058823529411764,0.6248259448240908,1.0,10/28,21.05%,RPS27A;BIRC3;FLOT1;UBC;FADD;FASN;CDC37;TNFRSF10A;CASP8;GNL3
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.6734297101580656,1.2445983334808772,0.25,0.8839042643638758,1.0,2/9,14.98%,PLA2G4C;PLBD1
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.6092011977300249,-1.2445277038493958,0.16417910447761194,0.6252246443519776,1.0,8/25,18.51%,SLC6A15;SLC38A4;SLC3A1;SLC7A2;SLC43A2;SLC38A1;SLC7A7;SLC25A29
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.6032408919932446,-1.2444035720714455,0.27941176470588236,0.6251419891866471,1.0,8/23,15.79%,STMN2;KIF14;VIL1;STMN4;KIF2C;DSTN;WDR1;STMN1
prerank,Reactome_2022__Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,-0.6827823437312481,-1.2443836062845879,0.10606060606060606,0.6247368921505029,1.0,4/14,16.51%,CPLX1;SYT1;PPFIA1;SH2D3C
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.4878985029760725,-1.2443007964788555,0.022727272727272728,0.6245792791002941,1.0,32/157,19.17%,LEF1;THBS1;LAMB1;PDPN;GPNMB;DUOX1;PODXL;SEMA3B;CEMIP;MMP14;EGF;ANGPTL3;VIL1;PLET1;IGF1;FGF1;F10;SEMA3E;CCDC25;DDRGK1;PIK3CD;MGAT5;RHOD;F3;SEMA4G;GPER1;TGFB1;FERMT3;HSPA5;NUMB;PDGFRA;MYO1C
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.6967028615268909,-1.2439678095121975,0.24074074074074073,0.6253744602346066,1.0,2/17,4.28%,ANXA1;DUOX1
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.7088754810363918,1.2438517557193907,0.22,0.8856925206578004,1.0,2/6,4.85%,BMP2;GREM1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.6440690831261981,-1.2438173257215233,0.23076923076923078,0.6254699841700437,1.0,4/17,15.41%,ANK3;TMC8;FAM20A;CIB2
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,-0.5979228703446218,-1.2437898051051894,0.18421052631578946,0.6250932069810708,1.0,8/27,19.82%,L1CAM;SHTN1;SH3GL2;RPS6KA1;DPYSL2;RPS6KA6;NUMB;DNM1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Adipose Tissue,-0.8210000347464721,-1.2437362720371776,0.16393442622950818,0.6248332264769547,1.0,3/5,10.81%,THY1;CD44;ALPL
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.6529672033275509,-1.2434996576590578,0.15873015873015872,0.6247787035200336,1.0,5/20,15.71%,OGN;OMD;ST3GAL6;B3GNT2;CHST6
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,-0.6529672033275509,-1.2434996576590578,0.15873015873015872,0.6247787035200336,1.0,5/20,15.71%,OGN;OMD;ST3GAL6;B3GNT2;CHST6
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.7541369337966143,-1.2434805147872319,0.26666666666666666,0.6244240031842471,1.0,4/10,17.31%,CNTNAP1;TENM4;CD9;GPC1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.5611071610014492,-1.2434297006631514,0.15942028985507245,0.6242743584695655,1.0,14/44,16.60%,ANXA1;PGR;EPS8L2;OVOL2;BTG1;TMC4;WNT5A;CD9;SLC44A3;PTH1R;CD74;ITGB4;RHOD;CEBPD
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,-0.4936301045932444,-1.2433910314855807,0.11764705882352941,0.6240499902365952,1.0,27/154,16.93%,ARHGAP4;DOCK8;TAGAP;VRK2;PLEKHG6;DEPDC1B;ARHGAP9;PLEKHG2;ARHGAP15;ARHGAP39;BAIAP2;BAIAP2L1;WAS;PLD2;CDC42EP1;NHS;ARHGEF18;RNASE1;NOXA1;DLC1;VAV1;RASGRF2;MCAM;ERBIN;ARHGAP22;EMD;DOCK10
prerank,Reactome_2022__DNA Replication Initiation R-HSA-68952,-0.8020671631511945,-1.2433905806141194,0.14285714285714285,0.6235944792948167,1.0,2/7,9.64%,POLE3;POLE4
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.48797555553204086,-1.243329097261457,0.07407407407407407,0.6234049491827854,1.0,43/149,20.53%,RPL19;RPL3;RPS27;RPS14;RPL27A;RPL35;EMG1;RPL7A;RPL37A;RPL27;RPL9;RPL21;NOB1;RPL13A;RPS16;RPL24;RPLP1;RPL38;RPL10A;RPL10;RPLP2;RPS7;RPL8;RPS6;MRTO4;RPS15;RPS9;RPL12;PES1;RPL5;RPL23;RPL4;DDX54;RPL18A;RPL41;RPL7;MAPT;RPL15;RPL11;EXOSC7;RPS25;RPL29;RPL36
prerank,Reactome_2022__Regulation Of Cytoskeletal Remodeling And Cell Spreading By IPP Complex Components R-HSA-446388,0.6607376252721636,1.2431657984944307,0.3181818181818182,0.8870246812296059,1.0,4/8,17.40%,TESK1;PARVA;RSU1;ARHGEF6
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,-0.5909541137834331,-1.2430968948540377,0.1,0.6238819017560971,1.0,6/48,12.36%,LEF1;GNG3;ITPR3;PDE6B;WNT5A;GNG2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.7430473316104207,-1.2429093901888497,0.23076923076923078,0.6240728504912831,1.0,2/10,10.55%,CCNB2;CCNB1
prerank,Reactome_2022__Signaling By NTRK3 (TRKC) R-HSA-9034015,0.5780434803682303,1.2421842456081724,0.15151515151515152,0.8898410341303937,1.0,3/15,14.84%,NRAS;PIK3CA;PIK3R1
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.5678922262709364,-1.2421706220020623,0.13043478260869565,0.6266325784000953,1.0,11/35,10.58%,CXCL2;MYO1F;TYMP;TLR2;GPNMB;SIGLEC1;IGSF6;CLEC12A;PLET1;CTSS;PILRA
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.4686150295376768,-1.2419723425780098,0.031914893617021274,0.6269840455186163,1.0,59/304,18.34%,ENPP2;LEF1;ANXA1;THBS1;ARHGAP4;TMSB10;LAMB1;NEXN;PDPN;KIF14;GPNMB;PODXL;SEMA3B;SULF1;CEMIP;THY1;MMP14;PODN;CEACAM1;BST2;CYP1B1;LDB2;EGF;ANGPTL3;VIL1;PLET1;IGSF10;CLIC4;IGF1;MINK1;SST;FGF1;IGFBP5;LDLRAD4;TMEFF2;F10;AMOTL2;FGF7;SEMA3E;ROBO4;CD74;SFRP2;DLC1;DDRGK1;PIK3CD;MGAT3;MGAT5;RHOD;F3;FGF22;CLN3;DOCK10;VCL;SEMA4G;GPER1;TGFB1;FERMT3;MCTP1;HSPA5
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.4825617676835422,-1.2419056608206025,0.09411764705882353,0.6267452929188693,1.0,52/163,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;EMG1;RPL7A;RPL37A;RPL27;RPL9;RPL21;NOB1;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;PES1;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;EXOSC7;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.718150141634197,1.241761738261132,0.2619047619047619,0.8902643029126076,1.0,1/7,2.53%,SRI
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.5936903671165717,1.241668944364947,0.1388888888888889,0.8892715643578428,1.0,7/15,24.95%,ADAT1;YARS2;THG1L;KARS1;POP1;TRPT1;FARS2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.6316847425992177,-1.2415750461236972,0.19117647058823528,0.6277599550521401,1.0,10/26,22.18%,CALD1;FSCN1;BAIAP2;BAIAP2L1;DMTN;ADD2;RHOD;DPYSL3;NEDD9;MYO1B
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),-0.8213885097639362,-1.2415176941988815,0.18181818181818182,0.6275886701534085,1.0,1/6,0.18%,ANXA1
prerank,CellMarker_Augmented_2021__Paneth cell:Undefined,0.4318859224122517,1.2414805606544361,0.07142857142857142,0.8886952780217549,1.0,28/82,20.54%,TMEM177;GOLT1A;REEP6;PEX11A;RIDA;CISD1;CLDN12;TCAIM;PHYH;MPC2;ABCD3;EHHADH;C1ORF53;ADH5;SCP2;PAIP1;PRDX3;MOCS2;MTX2;COQ9;FH;MRPS35;PDSS2;C1GALT1C1;ICMT;TMED2;CRYZ;NR2F6
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.6479620390276191,-1.2413965669581328,0.26785714285714285,0.6276543567608146,1.0,4/16,15.79%,MET;ITGA3;DLC1;STMN1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.7068079084797814,-1.2413766062085885,0.2318840579710145,0.6272671209199252,1.0,4/13,13.21%,B2M;HLA-A;CD55;HLA-F
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.6864903568903208,1.2412117654988668,0.2564102564102564,0.8887915526980933,1.0,3/10,19.47%,BLMH;TST;CTH
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.5770446953328525,-1.241119049170346,0.1506849315068493,0.6278732429702605,1.0,9/31,13.19%,SOCS3;IL12A;IL15;PARP14;PTK6;PARP9;IGF1;IL18;TNFRSF1A
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.5971847411988906,-1.2411064433664234,0.16216216216216217,0.6275066556491773,1.0,18/46,18.41%,RPS27A;RPS27;RPS14;RPS4X;RPS11;RPS16;RPS13;RPS3A;RPS8;RPS23;RPS21;RPS7;RPS6;RPS15;RPS9;FAU;RPS12;RPS20
prerank,CellMarker_Augmented_2021__Mesothelial cell:Lung,-0.5161141295062042,-1.240660362925581,0.11538461538461539,0.6279656738687095,1.0,12/95,11.00%,KCNT2;COL4A1;TRAM1L1;CALD1;SLC6A15;COL4A2;MAP1B;EFNB3;GAP43;EDIL3;PFN2;NUAK1
prerank,CellMarker_Augmented_2021__Interstitial cell:Bladder,-0.5161141295062042,-1.240660362925581,0.11538461538461539,0.6279656738687095,1.0,12/95,11.00%,KCNT2;COL4A1;TRAM1L1;CALD1;SLC6A15;COL4A2;MAP1B;EFNB3;GAP43;EDIL3;PFN2;NUAK1
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Germ,-0.5161141295062042,-1.240660362925581,0.11538461538461539,0.6279656738687095,1.0,12/95,11.00%,KCNT2;COL4A1;TRAM1L1;CALD1;SLC6A15;COL4A2;MAP1B;EFNB3;GAP43;EDIL3;PFN2;NUAK1
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.5670472682651901,-1.2404645061654065,0.16,0.6283335778091118,1.0,18/53,18.41%,RPS27A;RPS27;RPS14;RPS4X;RPS11;RPS16;RPS13;RPS3A;RPS8;RPS23;RPS21;RPS7;RPS6;RPS15;RPS9;FAU;RPS12;RPS20
prerank,CellMarker_Augmented_2021__Pluripotent Very Small Embryonic-Like cell:Ovary,-0.597363588515616,-1.2399830310537023,0.20512820512820512,0.629924811313599,1.0,3/33,8.68%,CD24;CHST4;LRRK1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.410161233892917,1.239871754533068,0.0,0.893266968783797,1.0,49/276,15.49%,TBC1D4;RANBP17;NXT2;NUP62CL;NUP42;TMED5;ARFIP1;TRAK2;RAB23;COX18;SCFD2;TBC1D12;PPP1R10;MAIP1;AKT2;ARL5A;RABL3;AKT1;RANBP3L;IPO5;STX7;SNF8;DNAJC27;ARFIP2;IPO8;XPO1;AP1S3;C17ORF75;RAB22A;RAB1B;AP3B1;NUP214;RAB28;COPB2;NXT1;SNX31;RANBP6;SCFD1;SEC23IP;NAPB;TBC1D5;SEC31B;XPO7;TMED3;RAB21;NUP188;SNX27;TBC1D8B;ARCN1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),-0.8176845108497582,-1.2397818417768587,0.18518518518518517,0.6298302857722066,1.0,2/6,10.55%,DUSP1;CCNB1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),-0.8176845108497582,-1.2397818417768587,0.18518518518518517,0.6298302857722066,1.0,2/6,10.55%,DUSP1;CCNB1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.38888630598889273,1.2397649297911268,0.0,0.8924300295019374,1.0,85/352,20.49%,TTC29;PTCD2;ATAD3C;LIMD1;ABCD2;CSPG5;REEP6;PPARGC1A;PEX11A;TFB2M;CATIP;LIG4;AFG1L;TMED5;TFB1M;ALAS1;TNFAIP3;PI4K2A;POLG2;MTERF1;GORASP2;PLIN5;ABCD1;BLZF1;TRAPPC11;ZFYVE16;STX7;SYNE1;FMNL3;TTC17;AUP1;GABPB1;TRAPPC12;DIAPH3;DNAJC28;ATL2;ABCD3;ESRRA;BRWD1;TMEM11;TRAPPC8;OPA1;BRWD3;MICAL2;SIRT5;VAPA;WASL;GOLGA5;CHMP2B;MICAL1;SEC23IP;MDK;SEC31B;PRKD1;VAPB;TMED3;PEX2;MIEF2;NRF1;MTFR1;HPS3;PRDX3;VPS11;PDZD8;EIF2AK3;VPS4B;MSTO1;MTX2;ABI2;TNIK;FGD4;TOR1B;YTHDF2;EPS15;PEX6;KLHL20;CHMP6;GOLGA8N;DYRK3;ZMYM3;TMED2;PEX12;PIKFYVE;RAB3GAP1;PYROXD2
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.5477699189694938,-1.2396138791230646,0.10126582278481013,0.6299139698620586,1.0,13/66,12.78%,RFTN1;TLR2;RPS27A;SFTPD;COLEC12;TLR3;SCARA3;SCIMP;CTSS;BIRC3;TNIP2;UBC;FADD
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Ligament,-0.6499708113470404,-1.2395185562207887,0.15942028985507245,0.6297896734006432,1.0,6/15,16.53%,ADGRE5;THY1;CD44;ITGA3;CD74;MCAM
prerank,Reactome_2022__Eicosanoids R-HSA-211979,0.7077624925650088,1.239496353111674,0.175,0.8922633908440665,1.0,3/7,6.83%,CYP4F3;CYP4F12;PTGIS
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bladder,-0.8389250236847161,-1.2393320010980398,0.17647058823529413,0.6299804720582576,1.0,2/5,7.03%,CD24;CD44
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.5517329354445109,-1.2391053886397287,0.12857142857142856,0.630385254112104,1.0,7/58,5.35%,LEF1;HPN;EFNA1;TGFBR2;PDPN;OVOL2;ZNF750
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5878109817313718,-1.2390309991789228,0.14925373134328357,0.6302140518958113,1.0,7/25,15.12%,NLRC5;PARP14;PARP9;WNT5A;FADD;IL7;CD74
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.5243097973297627,1.2387672446856444,0.2413793103448276,0.8938069084791537,1.0,7/60,3.54%,LEPR;NR1D1;PPARGC1A;CEBPA;PDK4;MCU;ADIPOR1
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.6217370708790448,-1.2387453217084718,0.19047619047619047,0.6309256395261366,1.0,8/19,17.30%,GRIN2D;GRIN2A;JPH3;ITPR3;CACNA1C;GRIN2B;JPH4;RYR2
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.6282555884038532,-1.2385981420788217,0.14285714285714285,0.6310749908352152,1.0,6/27,18.13%,PIF1;RPA1;NOP10;ANKRD28;CDK2;TINF2
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.7516942028153577,1.238563157696904,0.23255813953488372,0.8922437451869516,1.0,4/5,24.77%,GDE1;NAAA;NAPEPLD;GDPD1
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.7516942028153577,1.238563157696904,0.23255813953488372,0.8922437451869516,1.0,4/5,24.77%,GDE1;NAAA;NAPEPLD;GDPD1
prerank,CellMarker_Augmented_2021__Exhausted CD8+ T cell:Liver,-0.4976180308165615,-1.2385146470107413,0.08433734939759036,0.6309370443942212,1.0,34/210,12.84%,GBP2;IFI6;GBP1;TYMP;MX1;WARS1;BTG3;LDHA;ATP8B4;PHEX;GCNT1;IFI35;SLA;ITM2A;ARHGAP9;PRDX5;RALGDS;HLA-DRA;PARP14;BST2;AKAP5;SYNGR2;PLSCR1;LAT2;PTPN7;EPSTI1;PRDM1;DDX60;MAPRE2;MYO1E;PRKCH;MTHFD2;CD63;P2RY10
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.6754575184906964,-1.238189100823479,0.21052631578947367,0.631973495999256,1.0,6/13,17.69%,ICAM1;WNT5A;CD55;CFH;NOXA1;CR1L
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7078287040835571,1.2381603197835866,0.2,0.892810226630072,1.0,3/9,12.79%,ADRA1A;ADRB2;DRD2
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.7493296453899517,-1.2381182424589625,0.2033898305084746,0.6318551049954443,1.0,5/8,22.89%,HK2;FBP1;PFKL;GFPT2;HK1
prerank,CellMarker_Augmented_2021__Activated B cell:Peripheral Blood,-0.6398901788776008,-1.2380863429377849,0.13846153846153847,0.6315636694570189,1.0,11/23,12.84%,CD5;B2M;ADGRE5;SKAP1;IRF1;NLRC5;HLA-C;PSMB9;TAGLN2;HLA-E;P2RY10
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,0.5811514549620923,1.238004531528994,0.15151515151515152,0.8919984948164192,1.0,5/24,14.84%,FGF6;TRIM24;CPSF6;PIK3CA;PIK3R1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.47862585858548357,1.2379644803955538,0.11538461538461539,0.8909007276808979,1.0,12/51,16.99%,GDAP1;SLC25A24;ABCB10;COX18;MAIP1;MFF;TOMM22;SLC25A5;TIMM23;FLVCR1;BAD;MTX2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.6517632843724047,-1.2378240571206418,0.15789473684210525,0.6321447574111299,1.0,7/25,10.99%,THBS1;SPARC;IL12A;SULF1;CCL2;STAT1;ATP5IF1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.6743355989708376,-1.2377289946750487,0.14492753623188406,0.6320464552664475,1.0,5/17,20.67%,HAP1;IGF1;RTN1;RTN2;RTN4
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.6111949923399665,-1.2377195897628546,0.25,0.6316159023182176,1.0,2/24,6.11%,STMN2;MAP1B
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Placenta,0.6536753561780423,1.237628792791203,0.2894736842105263,0.8908228345980226,1.0,1/9,0.37%,ITGA1
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),-0.7609577691217391,-1.2375488853764658,0.16363636363636364,0.6318569141555027,1.0,4/6,22.93%,CRMP1;DPYSL2;DPYSL3;DPYD
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Umbilical Cord Blood,-0.5897229726569465,-1.2374575917636403,0.1527777777777778,0.6316992815787846,1.0,16/42,13.52%,CP;FMO6P;C1ORF87;MROH9;ITGA2;POF1B;DUOXA1;FUT2;TLR3;CMAHP;RARRES1;CLCA4;CAPN8;CFH;SLCO2A1;CXCL17
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.6157140559369363,-1.2374421441039636,0.15625,0.6312897951322848,1.0,8/26,13.03%,CACNA1H;SCN1B;SCN9A;YWHAH;SCN2A;ATP5IF1;SCN1A;SCN3B
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.5227369748096938,-1.2373729670826588,0.21052631578947367,0.6311195318554317,1.0,20/63,18.75%,HPN;NR4A3;B2M;LAMB1;ZFP36;FUT2;SGPP2;IGF1;TGFA;FGF1;DAB2IP;FGF7;NR4A1;HYAL1;SFRP2;DEAF1;TGFB1;TINF2;NUPR1;NLRC3
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,-0.6715265615123626,-1.2371305469351621,0.22033898305084745,0.6316583010482661,1.0,3/15,9.67%,SOCS3;STAT4;STAT1
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.8120227686442543,-1.236944950970595,0.2909090909090909,0.6319712421460553,1.0,1/5,5.75%,SLC4A11
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,-0.5739733818750336,-1.236763795319722,0.17105263157894737,0.6322903541711052,1.0,18/52,18.41%,RPS27A;RPS27;RPS14;RPS4X;RPS11;RPS16;RPS13;RPS3A;RPS8;RPS23;RPS21;RPS7;RPS6;RPS15;RPS9;FAU;RPS12;RPS20
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.7559578954111912,-1.236744533036644,0.25,0.631895120126382,1.0,1/5,12.07%,SIGIRR
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.6444720095801447,1.2366909283471808,0.16216216216216217,0.8938580705014303,1.0,3/13,10.44%,BMP2;SOX9;HEYL
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Foreskin,0.47118635069135373,1.236414571255523,0.15789473684210525,0.8937591095197414,1.0,42/88,29.35%,TMED5;ARFIP1;TRAM1;TMEM260;NCOA4;TTC17;SACM1L;CMTM6;AFTPH;STT3B;ZNF33A;TRAPPC8;UHMK1;FBXO38;PPP2R5A;ZDHHC20;GPBP1L1;VPS4B;PICALM;DENND4C;CEPT1;MFSD8;SP3;PRKAA1;ACAP2;WDR11;SEL1L;RBM39;MON2;CMTR2;ITCH;EFCAB14;PKN2;SPOPL;SCAF11;VPS54;CD2AP;CCPG1;SCYL2;ABHD3;TM9SF2;XRN1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.6165580051633187,1.2362295006285227,0.19444444444444445,0.8932387539483716,1.0,1/12,0.45%,SLC26A7
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,0.5814211080641253,1.2362180709713417,0.21428571428571427,0.8919788746910882,1.0,5/22,12.58%,BMP2;SMAD5;ZFYVE16;UBE2D1;ACVR2A
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.6230336672349467,-1.2361694318023768,0.21739130434782608,0.6338057465279209,1.0,1/22,0.03%,CACNA1H
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Parotid Gland,-0.5223269099192211,-1.2361334868332814,0.1038961038961039,0.6334760071555728,1.0,20/87,18.09%,COL4A1;ANGPTL2;SPARC;COL4A2;PDPN;SULF1;THY1;TENM4;WNT5A;THBS2;UNC5B;IGFBP5;CRMP1;RASL12;PDLIM4;SFRP2;NDN;NOTCH3;ANOS1;PCDH18
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.5324662642363881,-1.235837546295918,0.1038961038961039,0.6342021106545668,1.0,25/92,15.83%,ENPP2;APLNR;P2RY12;RAMP3;MAOB;GRIN2A;PLP1;GRIA3;OPALIN;GFAP;TCEAL6;CHI3L1;IGSF21;GALNT15;CA10;TGFA;BAALC;SYNPR;RNASE1;RGS7BP;TMEM132C;RASSF4;SERPING1;RTN1;KCND3
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.7968616504128301,-1.235640249878161,0.22033898305084745,0.6346437558770721,1.0,2/5,17.53%,PML;ETS1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.6135914329252941,-1.235617101432633,0.18309859154929578,0.6342680157853274,1.0,4/26,11.81%,TOMM7;ARIH2;PINK1;BAP1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.5676575649742758,1.2355929535787855,0.13793103448275862,0.8931780907781531,1.0,8/32,16.65%,SDC4;CADPS2;RAB27A;SNF8;SMPD3;STXBP5;RAB9A;VPS4B
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.6540291323057278,-1.235229810150594,0.22641509433962265,0.6354001156415126,1.0,4/18,7.39%,SFTPD;GPNMB;PDCD1LG2;TNFRSF14
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.7289794888406593,1.2349349749681713,0.15,0.8947935685749286,1.0,3/8,16.33%,METAP1D;NAA30;METAP1
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.7384373040763894,-1.2347027238817532,0.22033898305084745,0.6370633959353474,1.0,1/6,8.66%,SRF
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),0.7244230291800118,1.2345553581922453,0.23529411764705882,0.8949957752987422,1.0,2/7,4.85%,TNFAIP3;GREM1
prerank,CellMarker_Augmented_2021__CD8+ Regulatory T cell:Undefined,-0.592013358194719,-1.2345512978533033,0.2459016393442623,0.6371008352848408,1.0,6/28,4.84%,GPR183;CD5;TAGAP;GPR171;SLA;ARHGAP9
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.5680182341545391,-1.23454799726897,0.1794871794871795,0.6366653091890535,1.0,7/38,12.77%,TLR2;RPS27A;SFTPD;NOD1;TLR3;CTSS;UBC
prerank,KEGG_2021_Human__Non-homologous end-joining,0.6821108432667464,1.2344498916550528,0.2127659574468085,0.8940253754422184,1.0,1/9,2.79%,LIG4
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.787347263102933,-1.2343054871005887,0.1111111111111111,0.6370508473130816,1.0,5/8,16.36%,TGFBR2;HLA-DRA;PRKCQ;CD55;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.7384161809835135,1.234261590989104,0.23255813953488372,0.8936931333007108,1.0,3/7,15.62%,BMP2;SERPINE2;ID2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.7167016935174002,-1.234221245343996,0.25862068965517243,0.6369963905836069,1.0,3/8,20.01%,MAPRE2;FGF7;EPB41L4B
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.7131432844274831,1.2340555654649705,0.32,0.8933785634533594,1.0,2/6,19.01%,PLEKHA3;TTPA
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.7925995886117383,-1.2339302208494316,0.18181818181818182,0.6373789402306099,1.0,1/5,1.62%,TLR2
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.7925995886117383,-1.2339302208494316,0.18181818181818182,0.6373789402306099,1.0,1/5,1.62%,TLR2
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.6392607289361995,1.2338822721692804,0.2702702702702703,0.8928315510933705,1.0,1/8,2.84%,PDK4
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),-0.824542419824803,-1.2337733185448723,0.23333333333333334,0.637416000506144,1.0,2/5,3.07%,ANK3;CNTNAP1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.7766683198453466,-1.2336778309793948,0.23214285714285715,0.6374268464204687,1.0,5/7,21.92%,CEACAM1;HLA-E;HLA-F;PTPRC;KLRD1
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.512409292719982,1.2336058131796974,0.21052631578947367,0.8927355506538622,1.0,19/50,21.32%,NUP42;NUP37;NUP54;TRIM28;NDC1;NUP214;ZNF451;RAE1;AAAS;NUP188;KIAA1586;NUP205;EYA1;PIAS4;NUP210;NUP85;NUP153;NUP50;SUMO2
prerank,CellMarker_Augmented_2021__T cell:Eye,-0.5577640681011218,-1.2333485451296171,0.1774193548387097,0.6383200388019771,1.0,12/34,13.87%,GPR183;CD5;TAGAP;GPR171;SLA;ARHGAP9;ARHGAP15;ACAP1;RCSD1;PTPN7;P2RY10;SP140
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.6626700616908253,1.233268070883493,0.21052631578947367,0.892889135335492,1.0,1/12,3.16%,DERL2
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.7635809974869174,1.2332155544303192,0.2916666666666667,0.8918473650863719,1.0,1/5,3.00%,PDE12
prerank,Reactome_2022__Ubiquinol Biosynthesis R-HSA-2142789,0.7432181309888515,1.2331641515485998,0.15,0.8908086409490912,1.0,5/8,21.67%,COQ3;COQ2;COQ9;PDSS2;COQ6
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.541899147346348,-1.2331053717855176,0.1388888888888889,0.6387874369181287,1.0,15/57,15.95%,CD24;EFNA1;KCNQ1;TJP3;OVOL2;FA2H;TMC4;CHRM3;LGR5;C1ORF115;SLC44A3;SLCO2A1;AATK;ALS2CL;ITGB4
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.6337228237640221,-1.2329705062242264,0.18518518518518517,0.6389539450977053,1.0,8/29,17.43%,CENPV;CENPH;MIS18A;CENPE;CENPN;CENPU;OIP5;CENPP
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Brain,-0.5971332773276526,-1.232689316969086,0.18461538461538463,0.6394854692235109,1.0,3/22,7.03%,CD24;THY1;CD44
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.5602177196296951,-1.2320868646748235,0.16417910447761194,0.6414371183610668,1.0,2/32,2.09%,AMN;ANK3
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.5970457163008349,-1.2320477989674996,0.136986301369863,0.6411650435717783,1.0,5/32,11.81%,TOMM7;ARIH2;ATP5IF1;PINK1;BAP1
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.7802450916286492,-1.231409510509467,0.1875,0.643236461048769,1.0,2/7,5.75%,PDPN;SLC4A11
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.6728883931750325,-1.231350142643129,0.21212121212121213,0.6429830232718869,1.0,2/19,2.77%,PKP2;PROX1
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.7712109016737805,1.231254228859472,0.08,0.8977488206231478,1.0,2/6,21.51%,ADRB2;FYCO1
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,-0.4916889857300717,-1.231196396256672,0.09302325581395349,0.643022419577969,1.0,49/161,15.75%,GRIN2D;P2RY13;P2RY6;NPY;TAC3;C3;APLNR;GRIN3A;CCK;P2RY14;GNRHR;CHRM1;GRIN2A;HTR2B;GRIA3;GLRA2;UTS2;GRIA1;GRM6;GIPR;GRIK1;S1PR3;HCRTR2;CHRM3;GABRE;GABRB2;SST;CHRNA5;GABRD;MCHR2;LPAR6;LPAR4;HRH1;GRIN2B;P2RY10;GRID2;TAC4;RXFP1;CNR1;VIP;PTH1R;HTR1E;GABRG2;GLP1R;GRM7;PTH2R;GRIK2;APLN;GABRA1
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),0.7694551622191868,1.2309987915478806,0.1956521739130435,0.8961747414034247,1.0,2/5,2.79%,WNT7A;ZNF358
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),0.7694551622191868,1.2309987915478806,0.1956521739130435,0.8961747414034247,1.0,2/5,2.79%,WNT7A;ZNF358
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.8330774404220604,-1.2309826035166784,0.18867924528301888,0.6434254837300503,1.0,2/5,6.56%,IL12A;CEACAM1
prerank,CellMarker_Augmented_2021__Trophectoderm cell:Embryo,-0.5578100181315749,-1.2309372061154062,0.1506849315068493,0.6431854245682802,1.0,22/66,17.93%,CD24;EFNA1;FABP3;MYOF;S100A6;SUN3;BASP1;OLFML1;FBXL18;TAGLN2;SH3GL3;SLC19A3;SLC7A2;GALNT10;EMP2;FASN;ATP8B1;ANKRD6;SLC28A3;LRP2;FRMD4B;SYBU
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.7557218791140469,-1.2308976917177572,0.26666666666666666,0.6428613810901613,1.0,1/6,0.33%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5663016187882695,1.2308034463645967,0.16666666666666666,0.8957947783972461,1.0,8/32,11.15%,NGF;ASCL1;BRINP3;BMP2;BEND6;KCTD11;HEYL;ZC4H2
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.48888432177839447,-1.2307009423677355,0.13095238095238096,0.6432248278052942,1.0,43/160,16.71%,ENPP2;CDH22;BCAS1;SNCB;ST18;ZDHHC9;PLP1;VLDLR;NINJ2;OPALIN;ANLN;EFNB3;NKX6-2;GFAP;TCEAL6;FA2H;KLK6;MOG;MOBP;TMEM163;IGSF21;MAG;CPLX2;CA10;FAM163B;HAPLN2;HPCA;CREB5;ADCY5;STMN4;SYNPR;ARRDC2;RGS7BP;TMEM151A;PLLP;MYRF;CNTN2;ADAMTS4;PHYHIP;ITGB4;MCAM;FASN;TCEAL5
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.6755154155449612,-1.2305289033698408,0.21428571428571427,0.6433286894657302,1.0,3/15,2.99%,GBP1;ZFP36;SFTPD
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,0.604237003451112,1.2303829685470347,0.21212121212121213,0.8959752653813193,1.0,7/16,24.69%,EXOSC1;AKT1;EXOSC6;DIS3;EXOSC8;DCP1A;EXOSC5
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.7090812381958806,1.2303053176649372,0.21951219512195122,0.8951038665759521,1.0,2/7,14.77%,VAT1;MUL1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.5789032094714773,-1.230258604400861,0.20270270270270271,0.6440343505797255,1.0,9/38,18.14%,MET;STMN2;PSRC1;CAV3;DCTN1;FES;STMN1;ANKRD53;MAPT
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.7639095938779089,-1.2300505532500292,0.21666666666666667,0.6443186114521157,1.0,3/7,11.40%,HLA-A;IRF1;HLA-E
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.49458452123212104,-1.2300245915860382,0.13793103448275862,0.6439755148635372,1.0,37/122,18.74%,C3;C1R;MATN2;MAOB;SLC16A3;SEMA3B;SCX;LMOD1;BGN;GATA1;ARHGEF17;FAM20C;CDC42EP1;SHC2;DAB2IP;CD55;IGFBP5;F10;C1QTNF1;SLCO2A1;AMOTL2;RHBDF1;RASL12;PTH1R;C1S;GPRC5C;BOK;SERPING1;TNS2;VASN;PXDC1;PFKFB3;AQP1;CTSA;PTPN21;TF;LAMA5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.7451420921652409,-1.2290526608276715,0.18333333333333332,0.6476052183564518,1.0,2/9,6.84%,IL12A;BST2
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.7091365483213553,-1.2289360512188388,0.16417910447761194,0.6476153248932062,1.0,1/12,0.74%,RIMBP2
prerank,Reactome_2022__Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.6551009330691467,-1.2287900214616605,0.234375,0.6477802205987894,1.0,5/17,12.77%,RPS27A;RSPO3;LGR5;RSPO4;UBC
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.6710795599872748,-1.2284181303452093,0.21428571428571427,0.6487248148905661,1.0,3/21,12.77%,RPS27A;FGF1;UBC
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.7603482070029077,1.2281723651050875,0.1956521739130435,0.9024040662008145,1.0,2/6,8.49%,MAP3K4;YY1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.42545326259500776,1.2281693802982745,0.13333333333333333,0.9011327742076026,1.0,24/92,21.51%,NUP42;U2AF1;NUP37;NUP54;WDR33;EIF4E;NDC1;NUP214;NXT1;SMG7;RAE1;AAAS;NUP188;THOC3;DDX25;NUP205;THOC1;AGFG1;NUP210;NUP85;CPSF2;NUP153;NUP50;SMG1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.644798631643612,1.2281656328710857,0.25,0.8998651511667523,1.0,3/13,11.68%,PPARGC1A;ENOX2;ETFDH
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.6155300710555518,1.2281151471285985,0.21212121212121213,0.8987645097981977,1.0,4/14,14.18%,ABCD1;EHHADH;SCP2;ACOX1
prerank,Reactome_2022__CHL1 Interactions R-HSA-447041,0.640051375760454,1.2277940048010973,0.2926829268292683,0.8988902375539933,1.0,3/9,7.50%,ITGA1;ITGA10;CHL1
prerank,Reactome_2022__Olfactory Signaling Pathway R-HSA-381753,-0.6584195891185833,-1.2275557266688484,0.22058823529411764,0.6515747062423445,1.0,5/17,7.40%,OR51M1;ANO2;OR52N2;LDB2;OR51I2
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.8017414248819218,-1.2275150317768093,0.203125,0.6512666433477212,1.0,1/5,6.32%,OPALIN
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,-0.5463631148775515,-1.2273052526979462,0.21052631578947367,0.6515958067975732,1.0,12/58,17.27%,HPN;LAMB1;RPS27A;ITGA2;SH3GL2;SH3GL3;UBC;RNASE1;SPINT2;ITGA3;LRIG1;SH3KBP1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Cartilage,-0.5063824642029682,-1.2272997214460093,0.1125,0.6511467400802765,1.0,27/92,22.78%,COL4A1;CALD1;COL4A2;LAMB1;APP;MAP1B;SCARA3;ARHGEF17;EDIL3;SRPX2;OSMR;NUAK1;FN1;AMOTL2;PLAT;COL12A1;MCAM;GPC1;LARP6;PTPN21;DPYSL3;ANTXR1;WWTR1;SH3D19;MYO1B;CNN3;DST
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.7292756085755231,1.227119049804511,0.2826086956521739,0.9006116246237336,1.0,2/6,7.79%,ZC3H8;IDO1
prerank,Reactome_2022__Interleukin-2 Signaling R-HSA-9020558,-0.7064126359346901,-1.2269619177756557,0.22580645161290322,0.6511952234573,1.0,1/7,11.20%,SYK
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),-0.7064126359346901,-1.2269619177756557,0.22580645161290322,0.6511952234573,1.0,1/7,11.20%,SYK
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),-0.7064126359346901,-1.2269619177756557,0.22580645161290322,0.6511952234573,1.0,1/7,11.20%,SYK
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.6495214785550714,1.226925596219286,0.2222222222222222,0.9002627273144469,1.0,2/9,1.24%,CD200R1;NR1D1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Dental Pulp,-0.765458246306047,-1.2268616178518998,0.22413793103448276,0.6511451010750383,1.0,2/7,7.03%,THY1;CD44
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.6967782175988583,1.2268513188087151,0.16666666666666666,0.8992165415328176,1.0,5/12,21.18%,PSMD10;KEAP1;NFKBIB;NFKBIE;PKD2
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.4914048140935293,-1.2265858773075726,0.12195121951219512,0.651677978144286,1.0,19/127,8.00%,COL4A1;ANGPTL2;APLNR;SPARC;TLR2;COL4A2;RCAN2;COL5A1;KCNJ2;PLP1;THY1;LMOD1;BGN;GSTM5;SCARA3;LDB2;CD44;EDIL3;DBI
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.6423478963876665,-1.2265380606061562,0.18055555555555555,0.6513651344271656,1.0,7/21,14.33%,PROX1;PDPN;CCDC39;CHI3L1;FGF1;FGF7;ITGA3
prerank,CellMarker_Augmented_2021__White Blood cell:Blood,-0.5456879135363628,-1.2264973064202296,0.18571428571428572,0.6506064876920358,1.0,14/39,10.35%,MYO1F;GPR183;DOCK8;TAGAP;TMC8;EVI2A;SLA;ARHGAP9;ARHGAP15;ACAP1;RCSD1;WAS;CTSS;PTPN7
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Undefined,-0.5456879135363628,-1.2264973064202296,0.18571428571428572,0.6506064876920358,1.0,14/39,10.35%,MYO1F;GPR183;DOCK8;TAGAP;TMC8;EVI2A;SLA;ARHGAP9;ARHGAP15;ACAP1;RCSD1;WAS;CTSS;PTPN7
prerank,Reactome_2022__STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,0.6391607927660179,1.2264630030057624,0.25,0.8997138717729807,1.0,1/10,2.43%,FLT3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5616616796233052,1.2264604314190994,0.12903225806451613,0.8984285662418764,1.0,4/20,10.07%,BMP2;CARF;SMAD5;SESN2
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.6144706326300966,-1.2261769975889494,0.2463768115942029,0.6515087940104886,1.0,9/26,20.15%,RPS27A;BIRC3;FLOT1;UBC;FADD;FASN;CDC37;TNFRSF10A;CASP8
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.7583382690858551,-1.2260451699410482,0.21666666666666667,0.6516182605430616,1.0,1/7,6.33%,CAV3
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.6696802611334043,-1.225608326080448,0.15789473684210525,0.652888653874678,1.0,2/11,1.45%,LEF1;TGFBR2
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.6656674100098103,-1.2255567171917523,0.23636363636363636,0.6526655181831483,1.0,5/15,18.93%,CNTNAP1;PLP1;EIF2B2;MYRF;PRDM8
prerank,Reactome_2022__Synthesis Of diphthamide-EEF2 R-HSA-5358493,0.6943830330997975,1.2251992444551592,0.25,0.9024021005567588,1.0,3/8,15.65%,DPH5;DPH3;DPH1
prerank,Reactome_2022__Adrenoceptors R-HSA-390696,0.7592105288597883,1.2250129357669994,0.16666666666666666,0.9017463498928845,1.0,2/5,12.61%,ADRA1A;ADRB2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.6514926652361182,-1.224984088977006,0.14285714285714285,0.6546406223788332,1.0,4/21,9.24%,NR4A3;MLIP;CAV3;IGF1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.5487355309012216,-1.2247382224872034,0.1927710843373494,0.6552378710324084,1.0,15/50,22.42%,EFNA1;STMN2;THY1;EFNB3;MAG;PAQR3;CRMP1;NLGN1;PTPRO;BCL11A;DPYSL3;STX1B;RTN4;ITM2C;OMG
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.503457970938843,-1.2245828972097845,0.07894736842105263,0.6554525767969609,1.0,16/116,9.44%,NPY;RIMBP2;TAGLN3;CDH22;CHGB;STMN2;TTLL7;LRRTM1;SYT4;MAP1B;ELAVL4;PLD1;GAP43;SLC18A2;PLD2;CPLX2
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.6950349801193959,1.2244472646786484,0.2222222222222222,0.9028499546732281,1.0,1/8,3.16%,DERL2
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.642852609826007,1.224381172690365,0.35135135135135137,0.9018573127803468,1.0,3/11,8.69%,RPP40;RCL1;TBL3
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.7804035353062558,-1.2242266967340372,0.23333333333333334,0.6562646228573581,1.0,2/8,8.03%,CHI3L2;CHI3L1
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.7346128774770561,1.2240993779863811,0.24444444444444444,0.9017035438848294,1.0,2/5,13.56%,PRIMPOL;DDX21
prerank,CellMarker_Augmented_2021__CD4+ Regulatory T cell:Undefined,-0.6182518340208034,-1.2240055105135397,0.22950819672131148,0.6561584316176157,1.0,8/22,8.69%,MYO1F;CD5;TAGAP;GPR171;SLA;ARHGAP9;ACAP1;WAS
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Ascites,-0.6182518340208034,-1.2240055105135397,0.22950819672131148,0.6561584316176157,1.0,8/22,8.69%,MYO1F;CD5;TAGAP;GPR171;SLA;ARHGAP9;ACAP1;WAS
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.8125921835363488,-1.2239809390092296,0.22950819672131148,0.6558072376808011,1.0,3/6,13.52%,SFTPD;CCL2;CXCL17
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.697506838561832,1.2239323571417893,0.2222222222222222,0.9011488294532813,1.0,3/6,23.98%,ADRB2;GPR37L1;ADRB1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.5825942274418549,-1.223722823633455,0.17105263157894737,0.6563441925791597,1.0,7/29,17.04%,ALDOB;APOD;FBP1;GALK1;CHST15;PMM1;IRS2
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.6887674481546133,-1.2236176303629467,0.21666666666666667,0.656329168328132,1.0,5/13,13.35%,SP100;SPOCK3;WAS;CD9;SPINT2
prerank,Reactome_2022__Negative Regulation Of TCF-dependent Signaling By WNT Ligand Antagonists R-HSA-3772470,-0.737883242488938,-1.2232138330434188,0.24,0.6574159151868816,1.0,3/9,15.13%,KREMEN2;WNT5A;SFRP2
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),0.7157618269501811,1.223164822219095,0.25,0.9029364345867111,1.0,2/5,20.07%,AKR1C3;PDCD7
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.5099763429200801,-1.2230649053888123,0.12,0.6575710295695001,1.0,10/81,11.73%,CACNA1H;GRIN3A;CDH23;RAMP3;SLC24A2;TRPC3;SLC24A1;SLC8A3;CACNA1C;SLC24A5
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.7482330162840256,1.223054633148228,0.23529411764705882,0.9021574072877521,1.0,2/6,12.23%,DCXR;FGGY
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.7196165523631418,-1.2228872006489453,0.2878787878787879,0.6577638735175658,1.0,4/10,11.20%,ANK3;CELA2A;PRKCQ;SYK
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.46778471359580726,1.2227155717949,0.18518518518518517,0.9023717908046539,1.0,14/60,20.70%,U2AF1;NUDT21;WDR33;CSTF3;PAPOLA;CPSF7;TENT4A;MTPAP;THOC3;THOC1;TENT4B;CLP1;RPRD1B;CPSF2
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,-0.6991430053868125,-1.2224916045204417,0.20588235294117646,0.6586768256839944,1.0,2/15,12.77%,RPS27A;UBC
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.6169154830684092,1.2224663654198153,0.2558139534883721,0.9020108378550722,1.0,2/14,11.71%,ARFIP2;CSF1R
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.6301238111393104,-1.2223990800050952,0.24242424242424243,0.658533977936341,1.0,3/18,9.09%,SIX3;PROX1;SHCBP1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6446033823886816,-1.2221644857287102,0.2222222222222222,0.6590223715004796,1.0,2/18,3.06%,PIF1;CENPV
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.749649131615666,-1.2218529493613068,0.23728813559322035,0.6599010898584912,1.0,5/8,17.89%,IFI35;DYSF;SYK;SBNO2;NMI
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.5465409403927003,-1.221797553956982,0.1780821917808219,0.6596505712698255,1.0,27/67,21.72%,TYMP;A4GALT;MYOF;EPS8L2;ITGA2;SLC16A3;DUOXA1;RARRES1;SRPX2;EMP1;FBXO32;CD9;ADIRF;ITGA3;LTBR;LAMA3;ITGB4;RHOD;CAPN1;ANXA2;PLP2;HEBP2;MYO1C;NNMT;RRAS;OPTN;DNPH1
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.8044771604508061,-1.2217662125284607,0.23636363636363636,0.6593185209269019,1.0,1/5,0.81%,C3
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,-0.6255325069770123,-1.221752450657516,0.24242424242424243,0.6589239842171446,1.0,5/24,15.71%,OGN;OMD;ST3GAL6;B3GNT2;CHST6
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.6756845953142399,1.221619862256495,0.2564102564102564,0.903978481824584,1.0,2/8,10.29%,SESN2;ANKRD2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),-0.7883394023686008,-1.2216172786149164,0.26785714285714285,0.6589953806876208,1.0,2/5,3.68%,LEF1;TESC
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Osteoarthritic Cartilage,-0.8014034237501185,-1.22143370929125,0.19672131147540983,0.6594249240018697,1.0,4/5,10.25%,ICAM1;THY1;CD44;CD9
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.7257259821887723,1.2213669146360657,0.21428571428571427,0.9036322061479355,1.0,2/7,8.36%,GLUD1;GLS
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.8160111860538839,-1.2209492606998458,0.125,0.6607645952017783,1.0,2/5,8.80%,ALDOB;FBP1
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.6331070227325878,1.2207789023106868,0.17073170731707318,0.9051151281543244,1.0,3/13,10.44%,BMP2;SOX9;HEYL
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.6490299142268574,-1.2206575859219961,0.16923076923076924,0.6613116234432753,1.0,5/19,10.82%,PKP2;CTNNA3;PLN;CAV3;CACNA1C
prerank,CellMarker_Augmented_2021__Retinal Progenitor cell:Retina,-0.4972846054792924,-1.2202076088952973,0.12345679012345678,0.6621088748306945,1.0,22/86,17.25%,ENPP2;APLNR;STMN2;RCAN2;ITM2A;PLP1;LRRC4;LDB2;ITGA8;CACNA1C;AEBP1;BAALC;ITGA9;RGS7BP;TMEM132C;SFRP2;RAB3C;CCND2;CD200;NDN;GALNT8;TEK
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Periodontal Ligament,-0.4972846054792924,-1.2202076088952973,0.12345679012345678,0.6621088748306945,1.0,22/86,17.25%,ENPP2;APLNR;STMN2;RCAN2;ITM2A;PLP1;LRRC4;LDB2;ITGA8;CACNA1C;AEBP1;BAALC;ITGA9;RGS7BP;TMEM132C;SFRP2;RAB3C;CCND2;CD200;NDN;GALNT8;TEK
prerank,KEGG_2021_Human__Hematopoietic cell lineage,-0.5725614411028247,-1.2200131956656146,0.17142857142857143,0.6623845520859009,1.0,16/43,16.36%,CD24;IL1R1;CD5;ITGA2;ITGA5;HLA-DRA;CD44;THPO;IL4R;CD9;CD55;IL7;ITGA3;IL3RA;CD37;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.7025367194691722,-1.2199980400861903,0.20588235294117646,0.6619838162975434,1.0,6/13,16.59%,SYP;SHISA9;SHISA8;SLC4A10;GRIK2;CLN3
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.7286876405003189,-1.2199703164440134,0.1864406779661017,0.6616336617222266,1.0,5/11,21.66%,WNT5A;IFIH1;IL7;CD74;AGPAT2
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.7185503910298967,-1.219918303675125,0.203125,0.6613402379216085,1.0,3/9,10.01%,TGFBR2;STAT1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.5261303094087667,1.2199002802411523,0.08333333333333333,0.9073241626462152,1.0,7/29,17.47%,NAF1;CCT7;MAP3K4;ATR;CCT3;POT1;PKIB
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,-0.5086310292635128,-1.2196819188333954,0.17333333333333334,0.6617281388481399,1.0,13/75,17.28%,CD99L2;ICAM1;CLDN16;CTNNA3;THY1;CLDN20;CLDN18;PRKCG;PIK3CB;VAV1;PIK3CD;PRKCB;VCL
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.6240496040725209,1.2193307225508165,0.25,0.9084965631616323,1.0,2/10,0.94%,SLC6A13;SLC19A1
prerank,Reactome_2022__DNA Repair R-HSA-73894,0.3973525575641229,1.2192925815413316,0.125,0.9074018543275248,1.0,53/262,16.56%,POLD3;SEM1;SLC19A1;FANCF;ERCC8;DNA2;UBE2T;LIG4;KPNA2;POLG2;H2BC21;COPS2;H2BC4;RFC3;COPS8;BRCC3;UBE2N;ERCC6;INO80D;VCP;ERCC2;SIRT6;YY1;DCLRE1B;RAD52;H2AC6;MSH2;XRCC2;HUS1;TDP2;MAPK8;RCHY1;COPS7A;RRAD;NFRKB;ERCC3;GTF2H5;GTF2H2;RAD9B;POLK;ATRIP;PALB2;MSH3;POT1;ALKBH3;POLR2C;RAD51B;EP300;AQR;PPIE;EYA1;HERC2;HMGN1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.7224754466317016,-1.2192395471150916,0.25396825396825395,0.6632517279349212,1.0,4/10,13.21%,IL12A;HLA-E;IL18;HLA-F
prerank,Reactome_2022__SARS-CoV-2 Modulates Autophagy R-HSA-9754560,0.671864580479064,1.2192306921457325,0.4,0.9063892437290018,1.0,4/9,27.23%,VPS39;VPS11;VPS16;VPS41
prerank,CellMarker_Augmented_2021__Pancreatic Polypeptide cell:Pancreas,0.6675881602036421,1.2191711429816043,0.24390243902439024,0.9055215359887507,1.0,5/10,21.90%,LMO3;ETV1;ID2;ID4;THSD7A
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.5717827001187501,-1.2191595432832345,0.18666666666666668,0.6631200174023002,1.0,7/33,14.76%,RPS27A;NLRC5;ISG15;IFIH1;UBC;HERC5;PDZD2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),-0.7180930838425885,-1.2190698388493817,0.21875,0.6630071866089607,1.0,4/7,22.93%,CRMP1;DPYSL2;DPYSL3;DPYD
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.5202648782888437,1.2190586973799165,0.11764705882352941,0.9047350666806643,1.0,7/30,15.04%,TNFAIP3;USP13;BRCC3;USP27X;OTUB2;PSMD14;SPATA2
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.5152811915926365,1.2190203629396275,0.16666666666666666,0.9035886916215855,1.0,4/28,5.45%,DGKB;GK;DGKE;LYPLA2
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.8178935144764015,-1.2190084589104606,0.32142857142857145,0.6623336885277293,1.0,1/5,2.20%,ZFP36
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.8178935144764015,-1.2190084589104606,0.32142857142857145,0.6623336885277293,1.0,1/5,2.20%,ZFP36
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.65175624535401,1.2189398180180304,0.27906976744186046,0.9026341512247927,1.0,7/12,23.79%,BMP2;NOTCH2;HEYL;HEY1;HEY2;JAG1;RBPJ
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.7184225881645354,1.2189049013530424,0.20588235294117646,0.9015723588288995,1.0,3/7,23.26%,SIRT5;AKR1C3;PPTC7
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,-0.5287990804679219,-1.2187672605783788,0.10810810810810811,0.6627940389668924,1.0,26/87,21.64%,SCN1B;KCNQ1;KCNK1;KCNJ2;SCN9A;PLN;ITPR3;ATP1B1;SLC8A3;SCN2A;CACNA1C;SCN1A;SCN3B;KCNK12;KCND3;CACNB1;RYR2;FGF12;KCNK10;KCNE4;ABCC9;KCNIP4;ATP1B3;WWTR1;ITPR1;KCNK13
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.7645334399157229,-1.2187384150103258,0.2698412698412698,0.6624827527291145,1.0,2/6,11.72%,CBLN2;DCTN1
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.7152205967128886,1.2185287093347346,0.2682926829268293,0.901877466688702,1.0,2/6,4.15%,CHRNA4;NLGN3
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.5169662686653689,-1.218431459258352,0.175,0.6632592934455728,1.0,12/101,9.24%,GGT5;ALOX12;ACOT1;LDHA;SLC16A3;AKR1C1;ACOT4;GLYAT;PDHX;FA2H;ANGPTL3;IGF1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.5583116275193335,1.2182917339016242,0.1875,0.9015554884246291,1.0,7/16,30.19%,HSF1;ATR;MDM2;WRN;TSPYL5;KDM1A;MAP3K20
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.6702743148520922,-1.2182239880855312,0.26229508196721313,0.6635690766361104,1.0,1/14,2.79%,SHTN1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.5093734565273887,-1.2181261723619803,0.09523809523809523,0.6634502670448243,1.0,17/123,11.27%,CD24;RASGRP1;APIP;DUSP1;VRK2;TRIM5;CAV3;CEACAM1;EGF;RIT2;IGF1;THPO;MINK1;WDR54;DAB2IP;SYK;FN1
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,-0.47255540013403224,-1.2179943099728063,0.03296703296703297,0.663561066852219,1.0,74/323,17.65%,CXCL2;ANXA1;RASGRP1;P2RY13;P2RY6;NPY;TAC3;C3;APLNR;GPR183;RASGRP2;P2RY12;RGSL1;PDE4A;ACKR4;P2RY14;ARHGEF3;GNRHR;RAMP3;GPNMB;CHRM1;ADCY7;GNG3;ITGA5;APP;PLEKHG2;GPR18;TRPC3;ARHGEF38;UTS2;ARHGEF17;ITPR3;GRM6;PRKCG;GIPR;RPS6KA1;S1PR3;CHRM3;PPP3CC;SST;ARHGEF18;MCHR2;ADCY5;PRKCQ;LPAR6;PTRH2;LPAR4;GNG2;PRKCH;OBSCN;C1QTNF1;P2RY10;RXFP1;PTH1R;HTR1E;TAS1R1;GLP1R;GRM7;PTH2R;APLN;VAV1;RGS17;RASGRF2;PRKCD;HTR2C;OXTR;ADCY8;PRKCB;CHRM5;RGR;CCL28;CDK5;GPER1;RIPK2
prerank,Reactome_2022__Termination Of O-glycan Biosynthesis R-HSA-977068,-0.6864543599129801,-1.2179350508492548,0.1875,0.6633184750923615,1.0,1/11,0.17%,ST6GAL1
prerank,CellMarker_Augmented_2021__Urothelium cell:Undefined,-0.6266682452347744,-1.217914801989968,0.18032786885245902,0.6629337629619549,1.0,6/19,10.58%,TSPAN16;KCNQ1;CLEC12A;OR52K3P;FBP1;PILRA
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.8108246461320721,-1.2177934302714424,0.17307692307692307,0.6629580383166582,1.0,1/6,5.89%,LMOD1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Embryo,-0.5347011992226627,-1.2174316535966632,0.14473684210526316,0.6641326803299096,1.0,5/53,7.93%,CD24;OVOL2;CD44;FA2H;ATP1B1
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.5977851870532276,-1.2174141029642342,0.16901408450704225,0.6637914593582749,1.0,6/27,16.98%,STAT4;CA1;LMNB1;TCP1;ANXA2;AURKAIP1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.5137824160367443,1.2173914814273745,0.15789473684210525,0.9037984543290929,1.0,3/28,4.13%,MEOX2;ACE2;SGCD
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,-0.5761887949934543,-1.2173585136557281,0.18571428571428572,0.6635001043197595,1.0,5/30,12.16%,SH3GL2;APP;AP1S1;M6PR;CTSZ
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.6761241918687024,-1.2172455228725243,0.2,0.6634560413364461,1.0,3/12,12.04%,MYOF;DYSF;MYH9
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.7631945302985776,-1.216888068210452,0.23636363636363636,0.6645408863748696,1.0,5/6,23.70%,FADD;TNFRSF10A;CASP8;SPI1;ZDHHC3
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex2:Brain,-0.7302956138192731,-1.216845177639163,0.26229508196721313,0.6643174232227161,1.0,6/8,24.50%,OVOL2;CLMN;ADCY8;PAH;LAMA2;TRHDE
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.6978738092077431,1.216840524842744,0.16666666666666666,0.9049891734526999,1.0,4/8,19.94%,BMP2;SERPINE2;ID2;HES5
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Subcutaneous Adipose Tissue,-0.7818247121022845,-1.2168362318399404,0.2413793103448276,0.6639340841100854,1.0,2/6,7.03%,THY1;CD44
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,0.43314299595406197,1.2168137749678065,0.15,0.9038223039118376,1.0,22/93,15.95%,DDX56;H2BC21;KAT2B;H2BC4;EED;ERCC6;DNMT3B;UBTF;ERCC2;RBBP4;H2AC6;POLR1F;ERCC3;SAP130;KAT2A;GTF2H5;H3-3B;GTF2H2;DPEP2;AEBP2;HDAC2;EP300
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,-0.47793784201857614,-1.216440515355523,0.10344827586206896,0.6648871817820476,1.0,31/158,15.03%,TLR2;B2M;RPS27A;RPS27;SFTPD;HLA-A;RPS14;RPS4X;NLRP12;NOD1;HLA-C;YWHAH;SNRPD2;STAT1;IRF7;RPS11;RPS16;ISG15;RPS13;HLA-B;HLA-E;RPS3A;RPS8;RPS23;IFIH1;RPS21;RPS7;HLA-F;RPS6;RPS15;RPS9
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,0.4388406729090446,1.2161865202774889,0.16666666666666666,0.9054145406204005,1.0,28/95,20.89%,H2BC18;NUP42;NUP37;H2BC21;H2BC4;EGFR;NUP54;TRIM28;EED;RNF103-CHMP3;SNF8;VPS37A;RBBP4;H2AC6;NDC1;NUP214;CHMP2B;VPS37B;NFKB1;AAAS;NUP188;NUP205;CHMP6;DAXX;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.7258880914425452,-1.2158720393647502,0.23333333333333334,0.6667249535383476,1.0,4/10,7.93%,KCNQ1;KCNJ2;ATP1A1;ATP1B1
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Endometrium,-0.6354609524577555,-1.2157316000177802,0.234375,0.6668572381674586,1.0,7/18,21.37%,ICAM1;THY1;CD44;LGR5;MCAM;ABCG2;PTPRC
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.4306244183837453,1.2157214545222639,0.14285714285714285,0.9060072921517853,1.0,19/76,20.89%,NUP42;HSPA1A;NUP37;BAG2;NUP54;HSF1;ATR;NDC1;NUP214;RAE1;AAAS;NUP188;EP300;NUP205;CCAR2;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.6363476791149066,-1.2156955647676706,0.203125,0.6665715431758024,1.0,10/26,22.18%,CALD1;FSCN1;BAIAP2;BAIAP2L1;DMTN;ADD2;RHOD;DPYSL3;NEDD9;MYO1B
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.8284664119332374,-1.2154602754320463,0.2909090909090909,0.6670414629404878,1.0,1/5,2.46%,NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),0.6730499565299156,1.2154157114735378,0.24444444444444444,0.9061015428428474,1.0,1/7,2.57%,NAF1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.7154410077846223,-1.2153654981146436,0.21568627450980393,0.6670014671268208,1.0,5/11,23.18%,ITM2A;NECAB1;SOAT1;ITM2C;NECAB2
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),-0.705423786123484,-1.2152666104944727,0.18032786885245902,0.6670351088326983,1.0,1/9,0.43%,P2RY6
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.5021989558413982,-1.2152184222387474,0.08536585365853659,0.6667561758639953,1.0,13/97,14.31%,EFNA1;DUSP1;IL12A;KIF14;TESC;PODXL;FUT2;ARHGDIG;MINK1;NUAK1;IL18;FES;HYAL1
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,0.5451679868302243,1.2151590229930576,0.0967741935483871,0.9059164247740369,1.0,3/26,6.41%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.7234525889867387,-1.2151283075375705,0.1864406779661017,0.6667164461530974,1.0,3/10,11.44%,TLR2;TLR3;DDX60
prerank,Reactome_2022__CLEC7A (Dectin-1) Induces NFAT Activation R-HSA-5607763,-0.7288824081619445,-1.2151155311689368,0.25862068965517243,0.6663401682332681,1.0,4/10,23.65%,ITPR3;ITPR1;NFATC2;AHCYL1
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.820680556824658,-1.2150416162272617,0.22413793103448276,0.6661662115683501,1.0,3/5,11.88%,IL15;IL18;TMBIM1
prerank,Reactome_2022__Nef Mediated Downregulation Of MHC Class I Complex Cell Surface Expression R-HSA-164940,-0.7289283937658482,-1.2150191479184191,0.1694915254237288,0.6657968993628444,1.0,3/9,8.96%,B2M;HLA-A;AP1S1
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Peripheral Blood,-0.5432290584057746,-1.2149847346790543,0.23529411764705882,0.665519690607837,1.0,12/38,14.05%,GPR183;CD5;TAGAP;GPR171;EVI2A;SLA;ARHGAP9;ARHGAP15;CTSS;P2RY10;SP140;THEMIS
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.6058183273832299,-1.2149294552291778,0.19718309859154928,0.6652855725890491,1.0,8/22,19.40%,STAT4;IL15;CCL2;PTK6;STAT1;STAT6;NMI;GHR
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.49805581227837886,-1.2147982038624068,0.1625,0.6653506604748203,1.0,21/111,19.82%,AMN;SPARC;MX1;SFTPD;RAMP3;COLEC12;VLDLR;LDLR;AP1S1;CD9;M6PR;SYK;MSR1;MICALL1;CLN3;MRC1;LRP2;ADM;CD36;CLTB;DNM1
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.688076964712835,-1.2147196805689198,0.1694915254237288,0.6652876471461657,1.0,6/12,23.42%,ANGPTL3;IL18;GCKR;PNPLA8;SCARB1;MTLN
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.7081642159374607,1.2145381074886479,0.2,0.9072338552990863,1.0,1/7,3.12%,MCU
prerank,"Reactome_2022__Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",-0.7421801329741812,-1.2143974713149945,0.2153846153846154,0.6659618511083605,1.0,5/11,14.50%,SCN1B;SCN9A;ITPR3;SCN2A;TAS1R1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.5216077969110373,1.2143634426097447,0.25806451612903225,0.9066456374130907,1.0,4/26,7.96%,NAF1;PPP1R10;MAP3K4;SIRT6
prerank,KEGG_2021_Human__RNA degradation,0.43547723789710385,1.2142912951829476,0.11538461538461539,0.9056575099168691,1.0,21/70,18.23%,PNLDC1;PABPC1L;CNOT9;EXOSC1;C1D;MPHOSPH6;DCP1B;LSM8;EXOSC6;DIS3;EDC3;CNOT2;LSM5;TENT4A;LSM7;CNOT8;CNOT6L;TENT4B;CNOT1;EXOSC8;CNOT4
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),-0.7522940899966727,-1.2141167719637622,0.3064516129032258,0.6665255900435811,1.0,3/6,17.20%,CHRM1;CHRM3;CHRM5
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.7996150556145425,-1.2141076221273848,0.17857142857142858,0.6661273093832787,1.0,3/6,12.99%,DMTN;CD63;EMP2
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.6997609357703649,-1.2140597867558165,0.2631578947368421,0.6658693905371139,1.0,2/12,6.69%,KCNB1;BMP8A
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.6415552722059523,1.2139201960157728,0.23076923076923078,0.9061679832227701,1.0,1/12,1.63%,BMP2
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.7441489901279448,1.2139138007461008,0.26666666666666666,0.90495217754373,1.0,3/5,17.33%,SLC19A1;ABCC2;SLC46A1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.772398082999906,-1.2135519708926015,0.20689655172413793,0.667422500321845,1.0,2/6,5.22%,FABP3;HTR2B
prerank,Reactome_2022__Nef And Signal Transduction R-HSA-164944,0.7178863532224905,1.2134815562225858,0.23255813953488372,0.9055545021474009,1.0,1/6,0.40%,CD247
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,0.40687571837882375,1.2133540542410304,0.15384615384615385,0.9048343132743313,1.0,51/246,17.58%,NR1D1;PPARGC1A;TFB2M;TFB1M;SAMM50;BBS10;ALAS1;BBS9;DMAC2L;POLG2;MTERF1;EXOC8;GLUD1;EXOC6;PRKAB1;HAUS1;CSNK1E;CNGA4;CEP290;CHD9;CEP152;PLK1;PCM1;CCT3;CEP97;ESRRA;CHCHD3;TMEM11;ATP5PB;SIRT5;MAPK12;ATP5MC2;ALMS1;C2CD3;SCLT1;DNAJC11;TTC8;UNC119B;TCTN3;IQCB1;CEP192;TUBG1;RAB8A;ATP5MC1;NRF1;APOOL;ATP5F1A;MTX2;NCOA2;MKKS;EXOC5
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5564436072165656,1.2131531901016546,0.2727272727272727,0.904468854383774,1.0,5/26,19.67%,PUS10;PRKRA;DROSHA;AGO3;PUM2
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.7446284802248044,-1.2129878352287478,0.25396825396825395,0.6692164755790787,1.0,4/7,17.21%,B2M;GREM2;BDNF;PTPRF
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.474935694597474,1.212830974753893,0.07142857142857142,0.904808991542463,1.0,10/47,12.98%,MSRB1;ZNF207;CATIP;WASHC5;MID1IP1;TTC17;SPIRE2;DIAPH3;CASQ1;WASL
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),0.7198377001393967,1.212626144704821,0.27906976744186046,0.9042303966076746,1.0,2/5,14.64%,PRUNE1;BNIPL
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.7434484434082775,-1.2125880795800137,0.2413793103448276,0.670146425931662,1.0,3/6,11.26%,P4HA2;P4HTM;P4HA3
prerank,Reactome_2022__FGFR2 Mutant Receptor Activation R-HSA-1839126,0.5515411268281954,1.2125614886732345,0.2,0.9032256252487534,1.0,1/24,0.16%,FGF6
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.7789225099042769,-1.2125233453713584,0.24193548387096775,0.6699350790464225,1.0,1/7,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.4775146801001827,1.212460724102983,0.14705882352941177,0.9024218829444173,1.0,11/41,18.09%,ERCC8;EGFR;BRCC3;UBE2N;TRIM28;ERCC6;RAD52;KAT7;EYA1;CEBPG;EYA2
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.49483138051391323,-1.2124398307227324,0.1780821917808219,0.6698391536016013,1.0,18/80,13.21%,CACNA1H;RIMBP2;STMN2;LRRTM1;SYT4;TMEM74B;SLC18A2;PLPPR1;CPLX1;SYT1;CPLX2;FAM163B;SHC2;ADCY5;CALY;F10;RAP1GAP;PCSK1N
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),-0.7714839569067795,-1.21226148246369,0.23529411764705882,0.6700522302491109,1.0,3/7,7.70%,B3GALT2;UGT8;FA2H
prerank,Reactome_2022__Acyl Chain Remodeling Of DAG And TAG R-HSA-1482883,-0.7625191031488647,-1.2121807958611488,0.19230769230769232,0.6694251038709235,1.0,1/5,1.39%,DGAT2L6
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.7625191031488647,-1.2121807958611488,0.19230769230769232,0.6694251038709235,1.0,1/5,1.39%,DGAT2L6
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.5584209645109035,1.211688949596185,0.1935483870967742,0.903209590275803,1.0,2/16,0.62%,WNT7A;SLITRK2
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.5584209645109035,1.211688949596185,0.1935483870967742,0.903209590275803,1.0,2/16,0.62%,WNT7A;SLITRK2
prerank,Reactome_2022__Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,-0.6624008801956809,-1.2116519884751065,0.22727272727272727,0.67120359803938,1.0,2/19,2.46%,GRIN2D;NEFL
prerank,Reactome_2022__Activated NTRK2 Signals Thru FRS2 And FRS3 R-HSA-9028731,0.6656977838568293,1.2115505636392354,0.2692307692307692,0.9025458510450974,1.0,1/8,3.57%,NRAS
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.5218270050350965,-1.2114565234809413,0.1875,0.6714877277468457,1.0,41/96,22.53%,MET;A4GALT;GRAMD2A;ICAM1;THSD4;PDPN;COL4A4;SEMA3B;SCARA3;AKAP5;CLDN18;OSMR;DAB2IP;RADIL;SLC44A3;SLCO2A1;AMOTL2;EMP2;RHBDF1;ITGA3;SEMA3E;LAMA3;ITGB4;COL12A1;RHOD;F3;PXDC1;PTPRF;GPC1;NOTCH3;PTPN21;LAMA5;COL4A3;ANTXR1;KIAA1217;WWTR1;P2RX7;SH3D19;EPB41L1;CTNND1;FBLIM1
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,-0.5767117919133269,-1.2113963424047982,0.14102564102564102,0.6712342125114108,1.0,6/41,8.70%,SPARC;LAMB1;ITGA2;ASPN;BGN;ITGA8
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.7673438587069743,-1.2113819630127367,0.22641509433962265,0.6708663998163625,1.0,3/6,21.76%,MAPT;HEBP2;ARL6IP5
prerank,Reactome_2022__Neurotoxicity Of Clostridium Toxins R-HSA-168799,-0.7132976181226394,-1.2111418369088145,0.288135593220339,0.6712768058595753,1.0,7/9,25.89%,SYT1;SYT2;SV2B;SV2C;STX1B;VAMP1;SV2A
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.5661798889028902,1.2107706732986872,0.14285714285714285,0.904357256447154,1.0,4/21,9.00%,PDE3A;ADCY1;SOX9;PDE7B
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.7634560819470763,-1.2106964335478447,0.20634920634920634,0.6726266007727577,1.0,3/9,6.56%,ANXA1;NLRP12;CEACAM1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.5651540132767181,1.2106760479995264,0.3333333333333333,0.9034209901445305,1.0,5/32,9.03%,H2BC18;H2BC21;SOX9;ANP32B;RBBP4
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.5047421844715659,-1.2105162590580139,0.13157894736842105,0.6729691070102832,1.0,36/105,20.36%,CDH22;STMN2;SNCB;SH3GL2;SLITRK1;SLC32A1;GAP43;GFAP;TCEAL6;ZNF536;SYN2;IGSF21;CA10;HPCA;SST;STMN4;GAD1;C11ORF87;SYNPR;GAD2;RGS7BP;VIP;GABRG2;CNTN2;KCNC1;PHYHIP;TCEAL5;SULT4A1;GADD45B;ST8SIA3;PARM1;GABBR2;PTPN5;KCNC2;PLPPR4;PAK5
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,0.4723320140492727,1.2105142875383086,0.08,0.9030017634278567,1.0,12/61,9.05%,SEM1;OTUD3;PSMD10;PSMA1;PSMD11;USP13;AKT2;AKT1;PSMB5;FRK;RNF146;CSNK2A2
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.7640013921899363,1.2105035203295471,0.2619047619047619,0.9018128744145518,1.0,1/5,6.72%,LMO3
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.7814190968911032,-1.2104698119494535,0.24285714285714285,0.6727034191410722,1.0,3/5,20.21%,C1R;C1S;C1QB
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Umbilical Cord Blood,-0.528246584232785,-1.2102599309973092,0.18181818181818182,0.6730995554081637,1.0,15/74,13.33%,ANXA1;CP;SPON2;LDHA;GCNT1;MAMDC2;PLD1;CLEC12A;F13A1;SHCBP1;NUF2;IGFBP7;PYGL;CCNE2;CCDC181
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.7503796083829292,-1.2101993045244162,0.29508196721311475,0.6729062409944555,1.0,3/6,24.26%,PLN;SLC9A1;TRDN
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.6211108151302535,-1.210180354528344,0.1891891891891892,0.6725630324326433,1.0,13/27,26.85%,APP;SYP;SHISA9;SHISA8;SLC4A10;GRIK2;CLN3;MCTP1;NSMF;NETO1;SLC8A2;RAB3A;SHISA7
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.782238449223702,-1.210153933479302,0.38181818181818183,0.6722322692996536,1.0,3/7,10.12%,TNFRSF14;WNT5A;SCIMP
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.4362405569544123,1.2100550512952393,0.14285714285714285,0.9020308204196194,1.0,10/74,9.29%,MEOX2;SOX8;BMP2;ANXA4;ZNF358;EHF;SOX9;FOXJ1;SALL1;STIL
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.7310324078474335,1.2098196810290942,0.3225806451612903,0.9017507730658676,1.0,1/6,3.07%,ARFIP1
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Corneal Endothelium,-0.5096962445825313,-1.2097806838442815,0.12345679012345678,0.673089535538796,1.0,15/82,13.79%,COL4A1;ANGPTL2;APLNR;COL4A2;PROX1;CYP4X1;SULF1;LMOD1;BGN;LDB2;UNC5B;IGFBP5;SLCO2A1;ITGA9;RASL12
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.4830777431926365,-1.209714572456968,0.16470588235294117,0.6728367830667275,1.0,21/118,16.79%,ARHGAP4;TAGAP;ARHGEF3;DEPDC1B;ARHGAP9;PLEKHG2;ARHGAP15;TRIP10;ARHGAP39;ARHGEF17;ARHGDIG;ARHGEF18;RHOF;FOXM1;OBSCN;DLC1;VAV1;RASGRF2;RELN;RHOD;ARHGAP22
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.7582758651127877,-1.2094778006313662,0.2857142857142857,0.6733690839324304,1.0,2/6,16.28%,GMPPB;PMM1
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.8120557860338402,-1.2094576271092818,0.20689655172413793,0.6729967474833938,1.0,2/6,9.49%,FSCN1;KIF9
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,0.40353983102787305,1.2094517092826218,0.09090909090909091,0.9020133820452857,1.0,24/219,9.05%,FGF6;PIP5K1B;SEM1;OTUD3;FLT3;PSMD10;NR2E1;PSMA1;TRIB3;PSMD11;THEM4;PHC1;RNF2;USP13;EGFR;AKT2;AKT1;EED;PSMB5;FRK;STRN;RNF146;RBBP4;CSNK2A2
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.4652314266190265,-1.2092630296397762,0.06593406593406594,0.6734086106590297,1.0,71/229,20.50%,GRIN2D;NPY;RIMBP2;SNCB;CHRM1;GRIN2A;PLP1;HTR2B;SLC32A1;SYN3;GRIA3;GLRA2;UTS2;HAP1;GRIA1;AKAP5;SLC18A2;NRGN;RIT2;SYN2;UNC13C;CPLX1;RPS6KA1;CBLN2;SYT1;GRIK1;MINK1;HCRTR2;CHRM3;GABRE;GABRB2;SST;CHRNA5;GABRD;PCDHB5;GAD1;HRH1;GRIN2B;GRID2;NLGN1;NPTX2;GAD2;HTR1E;GABRG2;PDLIM4;APBA2;SLC12A7;GRM7;GRIK2;SYT5;SNCG;GABRA1;CACNB1;KCNMB4;HTR2C;CHRM5;CHRNE;CDK5;TBC1D24;HTR2A;SLC1A6;PTCHD1;GLRA1;GABBR2;SLC17A7;GABRA6;CHRNA6;GABRG3;GABRA3;PCDHB4;CDH8
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.5788945903289191,-1.2092547171081178,0.2054794520547945,0.6730068323497398,1.0,11/37,17.20%,P2RY12;CHRM1;ADCY7;AKAP5;CHRM3;ADCY5;HTR1E;GRM7;ADCY3;ADCY8;CHRM5
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Undefined,-0.5574336232233975,-1.209240804846217,0.16883116883116883,0.6726294685921166,1.0,15/37,16.53%,ICAM1;CSPG4;ITGA2;ADGRE5;ITGA5;THY1;CD44;IL4R;CD9;CD55;CD63;TNFRSF1A;ITGA3;ITGB4;MCAM
prerank,Reactome_2022__MET Activates PTK2 Signaling R-HSA-8874081,-0.6705224809836529,-1.2091139899297851,0.2608695652173913,0.6726227974623946,1.0,2/15,2.78%,LAMB1;ITGA2
prerank,CellMarker_Augmented_2021__Plasmablast:Blood,-0.5589078714223992,-1.2089958998691317,0.20967741935483872,0.6726459713681342,1.0,12/34,14.05%,CD5;TAGAP;GPR171;SLA;ARHGAP9;ARHGAP15;GPR18;ACAP1;RCSD1;PTPN7;P2RY10;THEMIS
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.7132407014783178,-1.208978924126939,0.28125,0.6722576352147231,1.0,5/12,10.00%,DUSP1;SULF1;TIMP1;IGF1;WEE2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Eye,-0.5478031272265447,-1.2087648382656728,0.17142857142857143,0.6726803109861939,1.0,4/38,4.46%,CD24;PKP2;OVOL2;LSR
prerank,CellMarker_Augmented_2021__Buccal Epithelial Stem cell:Oral Mucosa,-0.6306790815752816,-1.208623772240045,0.21153846153846154,0.6720059670444047,1.0,6/12,5.89%,GPR87;FAT2;DUOX1;ZNF750;ABCA12;DUOXA1
prerank,CellMarker_Augmented_2021__Basal cell:Salivary Gland,-0.6306790815752816,-1.208623772240045,0.21153846153846154,0.6720059670444047,1.0,6/12,5.89%,GPR87;FAT2;DUOX1;ZNF750;ABCA12;DUOXA1
prerank,CellMarker_Augmented_2021__Basal cell:Submandibular Gland,-0.6306790815752816,-1.208623772240045,0.21153846153846154,0.6720059670444047,1.0,6/12,5.89%,GPR87;FAT2;DUOX1;ZNF750;ABCA12;DUOXA1
prerank,CellMarker_Augmented_2021__Monocyte:Fetal Kidney,-0.459480248708359,-1.2085747573009427,0.04081632653061224,0.6717559993719736,1.0,129/574,19.59%,CLIC1;ANXA1;GBP2;TLCD2;EPN1;THBS1;P2RY13;S100A10;SOCS3;FOSB;DUSP1;MYO1F;SPARC;TYMP;TOMM7;TLR2;ZFP36;WARS1;SHTN1;HLA-A;RGL4;S100A6;TESC;EVI2A;SLA;SLC16A3;HK2;NLRP12;MTMR11;PRDX5;KLF4;PALM2AKAP2;DENND3;PIM3;HLA-C;NDUFA2;RALGDS;BEST1;HLA-DRA;IGSF6;CYP1B1;CD44;TIMP1;BASP1;PLK3;GLRX;CLEC12A;PLSCR1;LDLR;SLCO3A1;IFNGR2;WAS;FBP1;LAT2;BTG1;BLVRB;TAGLN2;CDC42EP3;NFKBID;POLE4;RAB11FIP1;SCIMP;CTSS;ZYX;SNX10;PILRA;LRPAP1;PGK1;PYGL;HLA-B;IER3;CD55;HLA-E;CSRNP1;ITPRIP;NAMPT;CARD19;SLC43A2;CMTM2;PRRX1;CD63;TNFRSF1A;SLC11A1;CLEC5A;EMILIN2;NOP10;TNFAIP2;SRGN;CD74;NUDT16;CD37;IL1RAP;SH2B2;ATOX1;SRA1;HLA-DRB1;ANXA2;CEBPD;EMP3;STAT6;BCL6;PRKCB;SH3KBP1;VCL;PSME1;PGAM1;RIPK2;COTL1;PLP2;IER2;SMCO4;MCTP1;NIBAN2;CDKN1A;HEBP2;SLC7A7;CD4;NUMB;RBMS1;ADM;CAPNS1;PSTPIP1;CLTB;TMEM258;PLAUR;GABARAPL2;LGALS1;KLF6;ARPC3
prerank,Reactome_2022__InlA-mediated Entry Of Listeria Monocytogenes Into Host Cells R-HSA-8876493,-0.747908189027052,-1.2085237861678946,0.25862068965517243,0.671577638458106,1.0,2/8,12.77%,RPS27A;UBC
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.6803757811692173,1.2083910673020255,0.25,0.9056126562074003,1.0,5/7,28.77%,NUFIP1;ZNHIT3;RUVBL1;ZNHIT6;PIH1D2
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.6953089282161857,-1.2083642961194183,0.2222222222222222,0.6718210254027962,1.0,3/8,25.82%,BDNF;XBP1;HDAC5
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,0.558456214506241,1.208250912140711,0.1794871794871795,0.9050136992295972,1.0,7/18,21.67%,COQ3;AKT1;DHFR;COQ2;COQ9;PDSS2;COQ6
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),-0.7158499206577148,-1.2079684618469606,0.18518518518518517,0.6729006748566534,1.0,1/9,0.55%,PIF1
prerank,CellMarker_Augmented_2021__T Helper1 (Th1) cell:Undefined,-0.704436916159074,-1.2078102094811252,0.26153846153846155,0.6730776882500057,1.0,8/11,21.92%,STAT4;STAT1;IL18;LTBR;STAT6;CD4;IL12RB2;KLRD1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.50996805704253,-1.2073485688754912,0.20270270270270271,0.6745047776826504,1.0,14/56,17.99%,TLR2;IFI35;IL15;NLRP12;APP;TLR3;PLSCR1;WNT5A;IL18;TNFRSF1A;ETS1;ABCC1;NMI;SLC15A4
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.42657558225728304,1.2073176722985144,0.13636363636363635,0.9079697604150279,1.0,25/79,31.14%,WASHC2C;PHETA1;VTI1A;VPS50;RAB7B;TBC1D5;RAB9A;RHOBTB3;SNX5;VAMP3;TBC1D23;RIC1;PIKFYVE;VPS29;SNX2;SNX3;RGP1;SNX1;VPS54;WASHC2A;SNX12;VTI1B;VPS26B;SURF4;VPS26A
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.5021301085588634,-1.2073096480949157,0.1875,0.6742482538868941,1.0,23/78,15.12%,ANXA1;NR4A3;MYO1F;TAGAP;KMO;PDPN;HLA-A;SLA;PDCD1LG2;HLA-C;HLA-DRA;TLR3;IGSF6;CLEC12A;ADAM19;SCIMP;CTSS;HLA-B;P2RY10;SLC11A1;PPP1R14A;ASS1;CD74
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.7010904282891848,-1.2062809858997012,0.2857142857142857,0.6777204442514111,1.0,1/8,0.69%,SOCS3
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.579988421027365,-1.2057442177801487,0.20754716981132076,0.6794612483422044,1.0,10/23,24.22%,KLF4;SRF;FOS;APLN;ETS1;TGFB1;SPI1;GNL3;STAT3;PPARG
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.5062969453736327,1.2056479888489755,0.1875,0.9134934681934351,1.0,2/20,6.64%,PRDX6;SF3B4
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,0.5188274713476796,1.2056399256422246,0.19444444444444445,0.9122883316918606,1.0,3/33,7.39%,KSR2;NRAS;CNKSR1
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.6069409286737234,-1.2055479436210659,0.27941176470588236,0.679704470249592,1.0,8/24,14.33%,PROX1;PDPN;CCDC39;BASP1;CHI3L1;FGF1;FGF7;ITGA3
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.6040457369303311,-1.2053817150933142,0.2608695652173913,0.6798587815880659,1.0,5/24,15.71%,OGN;OMD;ST3GAL6;B3GNT2;CHST6
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.8307282439920887,-1.2051766676321194,0.15873015873015872,0.6801899904368708,1.0,1/5,1.32%,GPR183
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.7091895682511067,1.2051345334747512,0.2702702702702703,0.9130427415998278,1.0,1/6,12.98%,WASL
prerank,Reactome_2022__Pexophagy R-HSA-9664873,-0.7458085499623643,-1.2046939726036066,0.16666666666666666,0.6816180614324828,1.0,2/11,12.77%,RPS27A;UBC
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.5273231213504009,-1.204472089754103,0.1388888888888889,0.6820892346641307,1.0,10/63,9.10%,OTOS;KCNQ1;EPS8L2;CDH23;CLRN1;CEMIP;NDUFB9;COL11A2;PIEZO2;MYO3A
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.6679752806823603,-1.2044284255105768,0.25,0.681787972716733,1.0,2/14,5.34%,A4GALT;B4GALNT1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.5962576061512935,-1.2043544515256712,0.15151515151515152,0.6816814013512762,1.0,7/45,11.18%,THBS1;NR4A3;TESC;GATA1;ZFPM1;THPO;PRKCQ
prerank,Reactome_2022__mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,0.6064712821298476,1.2039874927034362,0.21052631578947367,0.9161218248212843,1.0,4/14,17.71%,EXOSC1;EXOSC6;DIS3;EXOSC8
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.7152838269813198,-1.2039400074277233,0.29310344827586204,0.68275774352464,1.0,1/7,0.94%,DUSP1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.5748002364932422,-1.2037582668013584,0.2361111111111111,0.6828859256000762,1.0,5/23,11.12%,THBS1;SP100;SVBP;PFN2;DAB2IP
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.5838445190658981,-1.2036187869730874,0.21621621621621623,0.6831373643347116,1.0,4/29,15.85%,NR4A3;PLEKHM1;MYH9;PIK3CD
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.6016047513909372,-1.2036178457658844,0.2112676056338028,0.6827071770775738,1.0,2/18,8.06%,APLNR;ANGPTL3
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,-0.48998808314689773,-1.203574885358253,0.2073170731707317,0.6824536210750076,1.0,14/116,12.78%,CXCL2;GBP2;GBP1;NLRP12;NOD1;CCL2;GBP7;ITPR3;STAT1;IRF7;BIRC3;NAMPT;IL18;FADD
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.7547072951790749,1.203523280325701,0.23404255319148937,0.9168394248477222,1.0,1/7,1.39%,NCSTN
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.6809932100798088,-1.203319069538168,0.19402985074626866,0.68292189811452,1.0,3/14,13.03%,SCN1B;CAV3;SCN3B
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.5256415820954407,-1.2031721801593567,0.21621621621621623,0.683014400489914,1.0,8/53,6.59%,TLR2;PTP4A3;IFI35;NLRP12;APP;NOD1;LRRC19;TLR3
prerank,Reactome_2022__FCGR Activation R-HSA-2029481,0.7775847248807926,1.2028378950123866,0.15555555555555556,0.9186559160226964,1.0,2/6,6.46%,CD247;YES1
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.6961915507127672,-1.202589645393577,0.25396825396825395,0.6848936593561469,1.0,2/12,6.20%,ABCA12;ABCB1
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Undefined,-0.7312436943615045,-1.2023843807554835,0.2631578947368421,0.6851370357833139,1.0,1/10,0.32%,IL1R1
prerank,Reactome_2022__Regulation Of PTEN Localization R-HSA-8948747,-0.7415317547101398,-1.20212256148621,0.24561403508771928,0.685660966758502,1.0,3/9,16.68%,RPS27A;UBC;PML
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.627510645320738,1.2020986822959605,0.1956521739130435,0.9201111056706327,1.0,1/8,1.03%,GALNT3
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.8031657951825689,-1.2019795184657416,0.26785714285714285,0.68582169082509,1.0,3/5,16.51%,B2M;BDNF;ANXA2
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.7187919195656839,-1.20176747045344,0.22727272727272727,0.6860406526411769,1.0,4/8,18.39%,SLC3A1;CLN3;SLC15A4;SLC7A7
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.7525360693603433,-1.201660259640146,0.2786885245901639,0.6859264456202369,1.0,2/6,13.59%,ISG15;HERC5
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.5343779404872767,-1.201547747442419,0.2028985507246377,0.6859407867757519,1.0,13/43,17.44%,SERPINA10;TIMP2;SERPINF1;SPOCK3;TIMP1;PSMB9;SERPIND1;SERPINE3;BIRC3;SERPING1;APH1A;CRB2;PSME1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.6821025572690833,-1.201432585523151,0.19718309859154928,0.6859726088484582,1.0,3/12,7.78%,TLR2;DYSF;PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.7370460848177103,-1.2013451456932092,0.27450980392156865,0.6858120240448862,1.0,4/8,21.77%,KLF4;SIGIRR;PTPRC;SH2B3
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.6684326651257109,-1.2013382314676717,0.20967741935483872,0.685406961917771,1.0,3/14,11.34%,SKAP1;KIF14;SELP
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.6769312492749454,-1.2012946625972931,0.234375,0.6851421341698405,1.0,3/15,11.34%,ICAM1;SYK;SELP
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.7544364201282986,1.2012776490344648,0.17073170731707318,0.9223339783029411,1.0,1/7,1.39%,NCSTN
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.6492117656182603,-1.2009280014498995,0.18181818181818182,0.6860471345390626,1.0,5/20,12.77%,TOMM7;RPS27A;MAP1LC3A;PINK1;UBC
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.7762492677572634,-1.2009126045554908,0.2549019607843137,0.6857066458919061,1.0,3/8,14.82%,STMN2;VIL1;WDR1
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.6905310981622789,-1.20066857549725,0.3333333333333333,0.6864183989898756,1.0,5/8,29.96%,PARP9;DDX11;DTX3L;KDM4D;HMBOX1
prerank,Reactome_2022__Regulation Of Gene Expression By Hypoxia-inducible Factor R-HSA-1234158,0.695306071030578,1.200517366542456,0.3,0.924195431552185,1.0,2/9,15.95%,EPX;EP300
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.619589026835857,-1.2004572463412477,0.25,0.6867343538305211,1.0,2/16,6.53%,LEF1;GATA1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.5377362190717808,-1.2000171457407416,0.18421052631578946,0.6879205025325967,1.0,10/61,11.20%,THBS1;IFI6;DHCR24;NLRP12;KLF4;NOD1;CD44;RPS6KA1;NLRP2;SYK
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5560532650187922,-1.1999611535492425,0.24285714285714285,0.6876899016277465,1.0,9/40,15.12%,ANXA1;GPR183;IL12A;IL15;PDCD1LG2;HLA-E;IL18;IL7;CD74
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.6557816309565971,-1.1997805411026434,0.2,0.6879986804231506,1.0,1/13,5.04%,APP
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.6642693076937914,-1.1997499500644386,0.2222222222222222,0.6877103864298443,1.0,3/18,13.52%,SEPTIN5;RIMS2;NLGN1
prerank,Reactome_2022__APC Truncation Mutants Have Impaired AXIN Binding R-HSA-5467337,0.6154457499727801,1.1997154393598133,0.2647058823529412,0.9261408105379777,1.0,8/12,36.93%,PPP2R5A;PPP2R1B;AXIN1;PPP2R5B;PPP2R1A;PPP2R5E;PPP2CB;GSK3B
prerank,CellMarker_Augmented_2021__B cell:Synovium,-0.6093021779434462,-1.1996266823730486,0.25,0.6869922073443784,1.0,9/21,21.37%,TAGAP;IGHG1;ARHGAP9;P2RY10;SP140;CD37;WDFY4;NAPSB;PTPRC
prerank,CellMarker_Augmented_2021__B cell:Salivary Gland,-0.6093021779434462,-1.1996266823730486,0.25,0.6869922073443784,1.0,9/21,21.37%,TAGAP;IGHG1;ARHGAP9;P2RY10;SP140;CD37;WDFY4;NAPSB;PTPRC
prerank,CellMarker_Augmented_2021__B cell:Brain,-0.6093021779434462,-1.1996266823730486,0.25,0.6869922073443784,1.0,9/21,21.37%,TAGAP;IGHG1;ARHGAP9;P2RY10;SP140;CD37;WDFY4;NAPSB;PTPRC
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.6430988192037779,-1.1995563182778786,0.2602739726027397,0.6868901711684938,1.0,4/16,12.77%,RPS27A;NDUFA2;IRF7;UBC
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.5916798474944333,1.1995073345209983,0.175,0.9257461356737865,1.0,2/16,6.55%,SLC6A13;SLC25A18
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.4638939131030127,-1.1994862402365805,0.12941176470588237,0.6866669829121459,1.0,47/172,17.95%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;EMG1;RPL7A;RPL37A;RPL27;RPL9;RPL21;NOB1;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;NOP10;RPS6;RPS15;RPL26L1;DIMT1;RPS9;RPL12;PES1;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.6184968156056994,1.1994020871334072,0.2857142857142857,0.9250277879890837,1.0,3/12,6.69%,PPARGC1A;AKT2;AKT1
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.7389004869312686,-1.1993929483629922,0.3,0.686611446992357,1.0,3/8,11.03%,GATA1;IGF1;NECAB1
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.6387059700707536,-1.1992658474389783,0.2786885245901639,0.6866944122618318,1.0,7/15,24.64%,ANGPTL3;IL18;GCKR;PNPLA8;SCARB1;MTLN;XBP1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.6784576764414383,-1.1992644503244745,0.14814814814814814,0.6862700028599394,1.0,3/10,17.65%,NOD1;ERBIN;RIPK2
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.5187922244273526,-1.1992605840509365,0.18571428571428572,0.6858806831162335,1.0,16/50,18.23%,ANXA1;SEPTIN5;HAP1;SEPTIN4;CPLX1;SYT1;RHBDF2;SCG5;CPLX2;RIMS2;RHBDF1;RAB3C;KCNMB4;SEPTIN1;MCTP1;RAB15
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.7645903834206367,-1.199067041046716,0.29310344827586204,0.6862748421562439,1.0,2/6,20.75%,TCP1;TBCE
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,-0.4605278589345729,-1.1990355063099998,0.07526881720430108,0.685966552798138,1.0,66/361,14.60%,CXCL2;ANXA1;RASGRP1;P2RY13;P2RY6;NPY;TAC3;C3;APLNR;GPR183;RASGRP2;P2RY12;RGSL1;PDE4A;ACKR4;P2RY14;WNT8B;ARHGEF3;ADGRE5;GNRHR;RAMP3;GPNMB;CHRM1;ADCY7;GNG3;ITGA5;APP;PLEKHG2;GPR18;TRPC3;CCL2;ARHGEF38;UTS2;ARHGEF17;ITPR3;PLPPR1;GRM6;PRKCG;GIPR;RPS6KA1;S1PR3;PLPPR5;WNT5A;CHRM3;PPP3CC;SST;ARHGEF18;MCHR2;ADCY5;PRKCQ;CD55;LPAR6;PTRH2;LPAR4;GNG2;PRKCH;OBSCN;C1QTNF1;P2RY10;RXFP1;PTH1R;HTR1E;TAS1R1;GLP1R;GRM7;PTH2R
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Bone Marrow,-0.5756380525145568,-1.1990119912844723,0.19047619047619047,0.6856413928542221,1.0,10/26,10.15%,P2RY13;IPCEF1;MYO1F;TAGAP;P2RY14;SLA;IGSF6;CLEC12A;F13A1;CTSS
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,0.5498839454153525,1.1989493626577092,0.13793103448275862,0.9257705612885623,1.0,7/23,15.95%,MAML3;KAT2B;AKT2;AKT1;MAP4K2;KAT2A;EP300
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,0.5075782405947485,1.1988442709158504,0.23333333333333334,0.9250834892878244,1.0,1/24,0.16%,FGF6
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.7969519970702295,1.198599892239545,0.2,0.9247951452211053,1.0,2/6,12.99%,BMP2;AKR1C3
prerank,Reactome_2022__NF-kB Activation Thru FADD/RIP-1 Pathway Mediated By Caspase-8 And -10 R-HSA-933543,-0.6706273517869747,-1.1985792216662514,0.22580645161290322,0.686954442315967,1.0,5/12,25.21%,IFIH1;FADD;CASP8;IKBKG;TRIM25
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.6206579401944315,-1.1985705954352164,0.19696969696969696,0.6865716429225664,1.0,9/21,28.76%,ITPR3;SYK;VAV1;ITPR1;NFATC2;AHCYL1;SHC1;TEC;VAV2
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5726449785602343,1.198559972636695,0.18181818181818182,0.923817463752862,1.0,1/17,1.28%,SRPRB
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.5335524344515995,-1.198522102040738,0.10256410256410256,0.6863672430229627,1.0,11/77,8.52%,CACNA1H;CALD1;MYOF;MYOT;GJC1;LMOD1;DYSF;CAV3;UTS2;MYH11;TNNT1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5900829182871467,-1.1984408704323697,0.23529411764705882,0.6861917750101769,1.0,8/24,18.28%,OGN;IL12A;APOD;IGFBP5;VIP;APLN;GPER1;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.46424924284676106,1.198310402995151,0.20689655172413793,0.9239127585003037,1.0,15/34,33.23%,MIOS;WDR24;PIK3CA;SLC38A9;GOLPH3;LAMTOR3;RPTOR;RHEB;WDR59;SIK3;LARS1;KLHL22;PIP4P1;MLST8;RICTOR
prerank,KEGG_2021_Human__Rheumatoid arthritis,-0.571929443674208,-1.1978766510156185,0.18181818181818182,0.687776421351084,1.0,6/44,6.44%,CXCL2;TLR2;ICAM1;IL15;CCL2;HLA-DRA
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.7040199000766598,-1.1978671456006675,0.26785714285714285,0.6873940575956063,1.0,5/10,22.98%,MX1;STAT1;IL27RA;TYK2;STAT3
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.7174693349201108,-1.197828132558698,0.2727272727272727,0.6871610270862781,1.0,4/8,18.14%,SYK;PRKCD;TGFB1;MAPT
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.621064301837549,-1.1976453010021677,0.25,0.6873631558856319,1.0,7/26,17.43%,CENPV;CENPH;MIS18A;CENPN;CENPU;OIP5;CENPP
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.5869557667035987,1.1974730383910717,0.3191489361702128,0.9263216707612744,1.0,7/16,28.37%,UBTF;EIF2AK3;DHX33;WDR43;MAF1;WDR75;POLR2K
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.545588104666859,-1.197367214231725,0.23529411764705882,0.6880053620879091,1.0,9/52,11.12%,THBS1;HPN;SPARC;B2M;SULF1;CEACAM1;STAT1;ATP5IF1;DAB2IP
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.6276959245919888,1.1973358656639386,0.2727272727272727,0.9254920622651034,1.0,7/14,24.66%,AIFM2;COQ3;COQ2;COQ9;PDSS2;COQ6;UBIAD1
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),-0.7115126016030857,-1.1973254931591508,0.21052631578947367,0.6877723853696567,1.0,4/8,18.19%,ZFP36;BOK;TEK;NUPR1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.48332695063844344,1.1969591755652182,0.16666666666666666,0.9259500046974346,1.0,8/54,8.19%,SLC6A13;SLC19A1;SLC39A8;SFXN2;SLC25A18;SLC25A19;SLC3A2;SLC25A41
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.6135782933841635,-1.1966539212067364,0.21666666666666667,0.6900070646679601,1.0,2/25,6.29%,CD24;BRCA1
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.8018127022989328,-1.1964312767578282,0.21153846153846154,0.6904067372766087,1.0,3/6,7.23%,TIMP2;TIMP1;SVBP
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.6013978980838635,-1.196390148018758,0.2602739726027397,0.6901327876699971,1.0,3/26,7.17%,EFNA1;TIMP2;TIMP1
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,-0.5214288555469582,-1.1962046471278038,0.1794871794871795,0.690509090702391,1.0,11/78,5.72%,ST6GAL1;THBS1;GCNT7;ADAMTS10;THSD4;SPON2;SBSPON;GCNT1;ADAMTSL2;CHST4;THSD7B
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In6:Brain,-0.5030258444104064,-1.196200306622738,0.1728395061728395,0.6900929745135889,1.0,17/82,17.37%,EPN1;SCN1B;RAMP3;MAOB;FAM20C;GABRD;C1ORF115;PINK1;DMTN;RNASE1;LDHD;EGFL7;PNKD;GPRC5C;AATK;RAI2;PPP1R1A
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,0.546997596077514,1.1961674349159688,0.20689655172413793,0.9278509966234615,1.0,1/21,0.16%,FGF6
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.513630138564171,-1.1960964017568214,0.17333333333333334,0.6901101158611181,1.0,10/70,13.54%,LEF1;SP100;IFIT1;TMC8;PLN;ZFPM1;LRPAP1;CTSZ;IFIT2;TFAP4
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.6125672661082678,1.1960322913024743,0.225,0.9272411626149044,1.0,1/10,1.63%,BMP2
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.6115803730891237,-1.195638636238346,0.21875,0.6913450242000067,1.0,4/29,8.66%,APLNR;TGFBR2;CCDC39;SRF
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.6444652026805328,-1.195591367152939,0.2638888888888889,0.6911168347020392,1.0,7/17,22.37%,TLR3;STAT1;IRF7;IFIH1;RIPK2;NLRC3;HSPD1
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.7875109425153195,-1.195530590611922,0.23809523809523808,0.6908946069765453,1.0,5/5,21.28%,ALPL;FES;SPP1;CDKN2D;SFRP1
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.4740995680815836,-1.195501630876469,0.15294117647058825,0.6906044875213626,1.0,8/136,5.98%,RASGRP1;S100A10;DOCK8;RASGRP2;ARHGAP9;ARHGAP15;THY1;CCL2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.7422074031785334,1.1952094605716141,0.2558139534883721,0.9296012392246327,1.0,1/5,0.44%,WNT7A
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5616710165708081,1.1951762944293842,0.2,0.9286419556553529,1.0,3/17,17.32%,ARFIP1;ARFIP2;ABI2
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.7355040618952642,-1.195121234209151,0.2833333333333333,0.6916317257252447,1.0,2/8,5.04%,GRIN3A;APP
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.7121777389317226,-1.1949712708493074,0.26865671641791045,0.6918634535732422,1.0,2/10,8.06%,RASGRP1;ANGPTL3
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.6773852733985259,-1.1949636657671319,0.23809523809523808,0.6914768869375137,1.0,4/9,21.56%,SYT1;KCNMB4;RYR2;CALM3
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6600874671190704,-1.1948647936653702,0.2830188679245283,0.6913854426554941,1.0,1/10,0.47%,HPN
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,0.4966667142649322,1.1944507850953978,0.21428571428571427,0.9306313587279635,1.0,14/31,36.86%,HSPA1A;HSF1;MRPL18;EP300;RPTOR;FKBP4;HSBP1;CAMK2D;MTOR;MLST8;PTGES3;HSPH1;HSPA2;CAMK2A
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Ovary,-0.6963850560424983,-1.1941873377400318,0.2857142857142857,0.6934460329510277,1.0,4/10,11.27%,ITGA5;CD44;WNT5A;FN1
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.6868529056590046,-1.194119005701136,0.25,0.6932969095708389,1.0,1/12,1.11%,APLNR
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.4938143262136333,-1.1936095460782066,0.17073170731707318,0.694703391342819,1.0,20/94,15.88%,TAGLN3;STMN2;SNCB;GNG3;CAMK2N2;SLITRK1;SLC32A1;EFNB3;JPH3;GAP43;ARHGAP39;PRKCG;NYAP1;HPCA;GAD1;C11ORF87;TMEM151A;CNTN2;KCNC1;PHYHIP
prerank,KEGG_2021_Human__cAMP signaling pathway,-0.47242774509637375,-1.1935878619172686,0.1348314606741573,0.694333232927884,1.0,36/157,17.58%,GRIN2D;NPY;GRIN3A;PDE4A;CHRM1;GRIN2A;ADCY7;PLN;ATP1A1;GRIA3;PLD1;GRIA1;ATP1B1;GIPR;PLD2;SST;CREB5;CACNA1C;ADCY5;HHIP;LIPE;GLI1;GRIN2B;VIP;FOS;HTR1E;BDNF;GLP1R;PIK3CB;VAV1;PIK3CD;ADCY3;OXTR;ADCY8;RYR2;CREB3
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.640274883964632,-1.1933889007093716,0.265625,0.6947261698596053,1.0,4/17,10.44%,YBX3;SLC4A11;RCSD1;SCN2A
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Umbilical Cord Blood,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Dendritic cell:Umbilical Cord Blood,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Keratinocyte:Epithelium,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Periodontal Ligament,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Stromal Vascular Fraction cell:Adipose Tissue,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Peripheral Blood,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Progenitor-like Angiogenesis-Promoting cell:Blood,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Bone Marrow,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Monocyte:Umbilical Cord Blood,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Adipose Tissue,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Cardiomyocyte Progenitor cell:Myocardium,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Blood,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Endothelial cell:Bladder,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Submandibular Gland Stem cell:Submandibular Gland,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Endothelial cell:Corpus Luteum,-0.5557742721711088,-1.1932812150729926,0.16216216216216217,0.688801436330477,1.0,28/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;ASPN;COX7A1;BGN;PODN;GSTM5;LDB2;MYH11;ELN;ITGA8;GALNT15;RNASE1;PCDH12;ITGA9;MMRN2;ROBO4;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6008949811359885,1.193253154836869,0.2222222222222222,0.934326070753074,1.0,1/14,1.63%,BMP2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Adipose Tissue,-0.610582676849629,-1.193221363001851,0.25,0.6885896586402966,1.0,5/21,13.19%,PODXL;ITGA5;THY1;CD44;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.601467757540722,-1.1930636002421646,0.30158730158730157,0.6886633095632341,1.0,7/31,13.56%,TLR2;SFTPD;IL15;DYSF;PLSCR1;SYK;SLC11A1
prerank,Reactome_2022__Microbial Modulation Of RIPK1-mediated Regulated Necrosis R-HSA-9686347,-0.7226730914365066,-1.1930144620599838,0.28,0.6884239268604601,1.0,3/5,27.54%,CASP8;GNL3;MLKL
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.6082630890139272,-1.1929414486023486,0.15714285714285714,0.6882797752290465,1.0,3/19,10.92%,PLB1;DBI;LPCAT4
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.6411670175442474,1.1925565747049174,0.2682926829268293,0.9359846526288467,1.0,4/9,20.40%,RALB;PIP4K2B;PIP4K2C;RAB3GAP1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.47987749489358283,-1.1924441372306163,0.16470588235294117,0.6895925993591904,1.0,28/114,19.58%,KCNV1;KCNK1;KCNJ13;KCNJ2;SCN9A;SLC4A11;SLC5A4;SLC18A2;ATP1B1;SLC8A3;PIEZO2;SCN2A;SCN1A;KCNG1;KCNB2;SCN3B;SLC22A4;KCNC1;KCND3;KCNMB4;CLN3;SLC29A4;AQP1;LRP2;KCNAB3;SLC25A29;KCNF1;ABCC9
prerank,CellMarker_Augmented_2021__Pericyte:Undefined,-0.6518879274744793,-1.1923927516891557,0.3,0.6893586686587762,1.0,3/14,7.03%,CSPG4;THY1;CD44
prerank,CellMarker_Augmented_2021__Fibroblast:Lung,-0.719750095914579,-1.1923881855356278,0.2,0.6889466192453519,1.0,2/8,5.68%,ADGRE5;THY1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.6776706576109884,-1.1921525607352415,0.20754716981132076,0.6892543597570389,1.0,4/15,15.30%,THBS1;APOD;DMTN;DLC1
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.6776706576109884,-1.1921525607352415,0.20754716981132076,0.6892543597570389,1.0,4/15,15.30%,THBS1;APOD;DMTN;DLC1
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.7823711587855349,1.1921210145393337,0.2653061224489796,0.9367281549369557,1.0,1/5,1.39%,NCSTN
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.43633121065252733,1.1920056067699683,0.2,0.9360546924773793,1.0,32/90,30.72%,U2AF1;PPARGC1A;SNRPF;SF3B4;HNRNPC;RP9;NOVA1;SMNDC1;SNRPN;SYNCRIP;DHX15;CCAR2;PDCD7;CDK12;MBNL1;USB1;SCAF11;SNRPB;SNRNP48;MAGOH;YJU2;SNRNP35;SCNM1;SRSF2;LSM1;KHSRP;SRPK2;LSM6;MAGOHB;SNRNP40;PTBP1;DHX16
prerank,Reactome_2022__Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,0.6689046962276689,1.1919331512957732,0.1875,0.9351089423070973,1.0,3/9,11.79%,GMPS;ATIC;ADSS2
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.529153874014154,-1.1919313941066563,0.1891891891891892,0.6895721212022711,1.0,14/71,8.20%,POU4F1;L1CAM;ANK3;CCK;SHTN1;S100A6;PLP1;APP;SLITRK1;MAP1B;GAP43;SVBP;BAIAP2;NEFH
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Endometrium,-0.5724866842274762,-1.1917182447923718,0.2542372881355932,0.6894505740338536,1.0,12/30,13.62%,IRF1;IGHG1;CEACAM1;ACSL5;ANO9;TNFRSF14;PARP9;RAB11FIP1;CTSS;APOL6;HLA-F;F5
prerank,CellMarker_Augmented_2021__Trophoblast cell:Endometrium,-0.5724866842274762,-1.1917182447923718,0.2542372881355932,0.6894505740338536,1.0,12/30,13.62%,IRF1;IGHG1;CEACAM1;ACSL5;ANO9;TNFRSF14;PARP9;RAB11FIP1;CTSS;APOL6;HLA-F;F5
prerank,CellMarker_Augmented_2021__Goblet cell:Small Intestine,-0.5985727429902009,-1.1917017984572074,0.19047619047619047,0.6890899376030412,1.0,5/23,7.77%,MYO1F;BCAS1;PLEKHG6;ATAD5;SYP
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,-0.548965409750845,-1.1915000778338547,0.2465753424657534,0.6894181437837734,1.0,5/47,10.26%,APIP;CDKN2A;SEPTIN4;YWHAH;PPP3CC
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.41501705822339763,1.1913973692230102,0.09090909090909091,0.9359803483438464,1.0,14/67,12.60%,PSMD10;CEBPA;HSPA1A;TRIB3;KEAP1;BAG2;VCP;SIRT6;RNF14;CSNK1E;CBFA2T3;PLK1;RCHY1;TRIB2
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.4872444453933325,-1.191227623323168,0.19736842105263158,0.6899956382578657,1.0,30/110,19.26%,KCNT2;RIMBP2;PCSK2;CHGB;STMN2;NEFM;GNRHR;SULF1;SYT4;THY1;GRIA3;GAP43;GRIA1;ZNF385D;ZNF536;SST;CACNA1C;C11ORF87;FGF7;GAD2;TMEM130;RAB3C;PTPRN;TCEAL5;SEZ6L2;PCDH18;CELF4;ST8SIA3;PDGFRA;CNTN4
prerank,Reactome_2022__Myoclonic Epilepsy Of Lafora R-HSA-3785653,-0.7295285650504659,-1.1911475480347498,0.32142857142857145,0.6898793062199993,1.0,3/7,19.33%,RPS27A;UBC;GYS1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.4999651369067391,-1.1909989445932456,0.1686746987951807,0.6901787492187198,1.0,22/79,13.59%,C3;B2M;ICAM1;SFTPD;HLA-A;IRF1;IL15;ADCY7;CD160;COLEC12;HLA-C;HLA-DRA;NPDC1;PLSCR1;IRF7;PILRA;BIRC3;HLA-B;SYK;HLA-E;HLA-F;HERC5
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.5445767913624575,-1.1909565375766213,0.15492957746478872,0.6899239832807831,1.0,9/48,13.97%,CD24;RASGRP1;HTR2B;EGF;FGF1;DAB2IP;DIRAS1;NEK10;DIRAS2
prerank,KEGG_2021_Human__Platelet activation,-0.49124898762984204,-1.190932277346522,0.1728395061728395,0.6895975615366995,1.0,17/91,18.04%,RASGRP1;RASGRP2;P2RY12;ITGA2;ADCY7;GP6;ITPR3;ADCY5;SYK;MYLK3;PIK3CB;PIK3CD;TLN1;ADCY3;GUCY1A1;ADCY8;FERMT3
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,-0.5538774223369219,-1.1905767374487701,0.25333333333333335,0.6905604743881404,1.0,7/44,12.77%,EPN1;RPS27A;SH3GL2;EGF;SH3GL3;TGFA;UBC
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,0.529359789842091,1.1901088961537885,0.22580645161290322,0.9404169041817584,1.0,3/28,7.39%,KSR2;NRAS;CNKSR1
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.6361894782435836,1.18978622537835,0.3,0.9404892278818138,1.0,9/13,29.40%,PPARGC1A;SLC25A18;ETFDH;SLC25A22;SDHB;ETFRF1;SLC25A12;UQCRFS1;NDUFA5
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.7030990919029492,-1.1893450503039509,0.3050847457627119,0.6946293659877909,1.0,4/11,7.93%,KCNQ1;KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.7097492962631536,-1.1893279413961495,0.25396825396825395,0.6942896860110407,1.0,3/9,17.30%,TGFBR2;SFRP2;RYR2
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.7667369903711735,-1.1892558721960353,0.32142857142857145,0.6941989044318353,1.0,1/6,1.41%,SLC6A15
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.7339389082528319,-1.1892056658228338,0.21818181818181817,0.6939592208071025,1.0,2/8,7.96%,TGFBR2;ZFPM1
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),-0.7290916996288483,-1.1889404791855336,0.2727272727272727,0.6944478806470942,1.0,4/6,26.84%,TAS1R1;CD36;ASIC2;ASIC3
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.7057878928578509,-1.1888938809302372,0.2962962962962963,0.6941807714566801,1.0,5/12,12.78%,SKAP1;IRF1;ADCY7;IRF7;FADD
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.42266627303184057,1.1888748492975658,0.08333333333333333,0.9429144578075157,1.0,23/64,26.32%,ELOC;EAF2;GTF2F2;ELOA;ERCC2;ERCC3;GTF2H5;GTF2H2;ELP2;IWS1;POLR2C;ELP4;PCID2;CCNT1;GTF2H3;NELFA;CCNT2;CTDP1;CDK12;MLLT3;CCNH;TCEA1;POLR2A
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.4808491042688566,-1.1887721761997612,0.1590909090909091,0.6942279959505431,1.0,15/113,13.20%,COL4A1;MET;COL4A2;CSPG4;LAMB1;BARX2;LMOD1;SCARA3;ARHGEF17;SRPX2;NUAK1;DAB2IP;IGFBP5;AMOTL2;RHBDF1
prerank,Reactome_2022__Presynaptic Depolarization And Calcium Channel Opening R-HSA-112308,0.6398942353453922,1.1887395752029177,0.225,0.9422956027887528,1.0,6/12,17.19%,CACNG2;CACNB4;CACNB3;CACNA1B;CACNA2D1;CACNA2D3
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,-0.5710047358395267,-1.1886957426882236,0.17391304347826086,0.6940439194918748,1.0,6/21,19.10%,CDKN2A;APP;LMNB1;CAPN1;CDK5;CAPNS1
prerank,CellMarker_Augmented_2021__Exhausted CD4+ T cell:Liver,-0.4900247431249711,-1.188683576873202,0.1794871794871795,0.6936674695911715,1.0,15/91,12.39%,CDKN2A;WARS1;ITGA2;PHEX;IFI35;ITM2A;ARHGAP9;BST2;AKAP5;ADAM19;RAB11FIP1;BBLN;EPSTI1;MAP1LC3A;OGG1
prerank,Reactome_2022__Activated NTRK2 Signals Thru PI3K R-HSA-9028335,0.7396644176856721,1.1886457448166525,0.2916666666666667,0.9415924392969376,1.0,4/5,22.86%,PIK3CA;PIK3R1;PIGU;NTRK2
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.48693945817903694,-1.1885937360295271,0.20253164556962025,0.6935554321917664,1.0,29/126,13.52%,FLRT3;CDH22;TGFBR2;ICAM1;L1CAM;NEXN;MYOT;CDH6;FAT2;CDH23;CLDN16;SLITRK1;LRRC4;CEACAM1;CLDN20;CLDN18;TENM4;IGSF21;IL1RAPL1;MAG;CDH7;CDH19;CDH9;PCDHB5;SELP;MMP24;CDH12;GRID2;NLGN1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.6078825892821338,-1.1884281131169798,0.25396825396825395,0.6936633710210778,1.0,4/20,6.33%,CACNA1H;KCNQ1;PLN;CAV3
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.47320613948962803,1.1882821814364337,0.2692307692307692,0.941720091097726,1.0,9/35,16.58%,NR1D1;ID1;ALDH1A1;NOVA1;PGAM5;LAMA4;LGR4;ABHD6;PCTP
prerank,GO_Biological_Process_2021__nose development (GO:0043584),-0.7211451244391289,-1.1881551795825924,0.3181818181818182,0.694243569350276,1.0,1/6,2.77%,PROX1
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),-0.7463125854542974,-1.1879501373065526,0.3269230769230769,0.6946034992969011,1.0,2/5,6.90%,APP;GAP43
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.692654496234469,-1.187682629419667,0.2,0.6951275979665302,1.0,5/10,12.78%,CD24;IGF1;HHLA2;IL18;FADD
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.7205161162627811,1.1875886626400378,0.2765957446808511,0.9422453307429868,1.0,2/7,10.94%,CACNG2;GPHN
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.7205161162627811,1.1875886626400378,0.2765957446808511,0.9422453307429868,1.0,2/7,10.94%,CACNG2;GPHN
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),0.8326968056675822,1.187407587172057,0.1951219512195122,0.9417736031572013,1.0,2/5,4.85%,EFNB2;GREM1
prerank,CellMarker_Augmented_2021__Mitotic Fetal Germ cell:Fetal Gonad,-0.44182354202182117,-1.187358206112974,0.020618556701030927,0.6960020039490306,1.0,99/534,18.23%,CLIC1;ST6GAL1;COL4A1;TUBB6;TAGLN3;FABP3;CALD1;TOMM7;COL4A2;RPL3;TMSB10;PPP1R14C;IFITM3;PDPN;GMPR;RPS14;RPS4X;LDHA;GMPPB;RPL27A;TJP3;GCNT1;PODXL;RPL35;KLF4;EMG1;CTSC;RPL7A;THY1;SLC4A11;PIM3;TRIP10;RND2;RPL27;TEAD2;RPL9;UROD;RNF181;RPL13A;IL4R;RPS16;CD9;ZYX;RPL24;WDR54;SNX10;RPS13;PSMB6;ALPL;LPCAT4;RPL38;PRDM1;HLA-E;RPS3A;SOX15;SHISA5;RPL10A;TPM4;RPS7;RPS18;CD63;PCSK1N;RPL8;SMAGP;FES;RASD1;NOP10;RPS6;ALKBH4;PLLP;WDR1;GPRC5C;ASS1;SFRP2;SERPING1;RPL12;THOC6;ADD2;RBM3;DPYSL2;JADE2;TRANK1;MGAT5;RPL23;RPL4;CLN3;GABARAPL1;CDCA7;PFKL;VCL;RTN2;RPL18A;PGAM1;RPL41;RPL7;CTSA;SMCO4;ENO2;RAB15
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.7590198766762978,-1.1869917852024972,0.2830188679245283,0.696913742138034,1.0,3/7,14.82%,CNTNAP1;PLP1;MYRF
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.48987568144901167,-1.1869833831849765,0.19047619047619047,0.696559282451713,1.0,45/123,21.87%,B3GALT2;PCSK2;STMN2;NEFM;PROX1;ZDHHC22;SLITRK1;SLC24A2;SYT4;SRRM4;GRIA1;TCEAL6;SYP;ZNF536;GRM6;CA10;SCN2A;SCN1A;STMN4;C11ORF87;SYNPR;SCN3B;GAD2;GABRG2;TMEM130;CNTN2;KCNC1;GDAP1L1;RAB3C;GABRA1;CNTNAP5;LRTM1;TCEAL5;SV2B;CELF4;ST8SIA3;HCN1;CNTN4;PTPN5;CNTNAP2;PAK5;PDC;VSTM2B;OPCML;VWC2L
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Hair Follicle,-0.5289990381750277,-1.1869465166942659,0.24285714285714285,0.6959172542425418,1.0,12/41,19.26%,ZNF850;USHBP1;DRAXIN;LRRK1;LCTL;SHISA9;TPTEP1;ZNF814;PCDH11X;GLB1L3;SLC1A6;ADGRG2
prerank,CellMarker_Augmented_2021__Amnion Epithelial cell:Amniotic Membrane,-0.5289990381750277,-1.1869465166942659,0.24285714285714285,0.6959172542425418,1.0,12/41,19.26%,ZNF850;USHBP1;DRAXIN;LRRK1;LCTL;SHISA9;TPTEP1;ZNF814;PCDH11X;GLB1L3;SLC1A6;ADGRG2
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.4955573322394251,-1.1866228950557745,0.2125,0.6966410226480853,1.0,24/95,15.16%,P2RY13;TGFBR2;TLR2;LMO2;GPR171;MAFF;SIGLEC1;THY1;DYSF;ABCB1;GFI1B;CD44;CLEC12A;F13A1;ARID3A;SELP;HLA-E;BAALC;PROCR;RNASE1;FES;ROBO4;IL3RA;SERPING1
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.737286137198304,-1.186546473605422,0.3137254901960784,0.6965334291549307,1.0,1/8,3.17%,IL12A
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.578750365921375,-1.1863822585291508,0.16393442622950818,0.696726300601366,1.0,2/27,2.20%,PIF1;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.5473985353887227,-1.1863649136720862,0.24285714285714285,0.6963731950400622,1.0,3/51,3.20%,ECM2;S100A10;SKAP1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5622871679108762,-1.1863395437563617,0.2328767123287671,0.6960750456819491,1.0,6/38,8.87%,THBS1;IFI6;DHCR24;KLF4;CD44;RPS6KA1
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.4251499981534832,1.186309521086618,0.1935483870967742,0.9454985750352444,1.0,9/41,16.58%,NR1D1;ID1;ALDH1A1;NOVA1;PGAM5;LAMA4;LGR4;ABHD6;PCTP
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.6383860959043584,-1.1861210012619645,0.22033898305084745,0.6965404035403076,1.0,3/15,5.90%,SFTPD;GPNMB;PDCD1LG2
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),0.7238245673247524,1.1860238620571482,0.3191489361702128,0.9454358766611187,1.0,1/5,9.41%,PGGT1B
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.6095904059919453,-1.1857619615716173,0.2923076923076923,0.697462845518691,1.0,5/18,16.24%,SYT4;SYT1;CPNE9;RIMS2;SYT2
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,0.4695574932241621,1.1857224222911456,0.16666666666666666,0.9453875217165268,1.0,23/53,30.93%,NR2E1;PHC1;RNF2;EED;RBBP4;HDAC2;SCMH1;PHC3;SLC38A9;CHD4;MAF1;LAMTOR3;MTA2;RPTOR;CBX6;PTEN;RHEB;EZH2;REST;MAPK1;KDM1A;MTOR;RCOR1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.43987471793220323,1.1857041223460865,0.2692307692307692,0.9442766310859384,1.0,14/71,13.66%,LEPR;SLC6A13;SLC19A1;AGER;SLC24A3;SLC15A2;ATP1A2;SLC4A4;ABCC2;SLC22A2;SLC5A6;SLCO1C1;SLC6A1;ATP8A1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3955034181563749,1.1856790303380185,0.09090909090909091,0.9431685142147271,1.0,36/115,26.52%,FAM47E;CHRAC1;HMGN4;SMARCAD1;SOX9;KAT2B;KDM5A;RBBP4;HP1BP3;BRWD1;BAZ1A;KAT2A;HMG20A;HDAC2;SMARCA2;HMGN1;CDAN1;HMGN3;DR1;EHMT1;HDAC10;DAXX;TADA2B;PBRM1;HMGN2;RUVBL1;ZBTB1;MTA2;LOXL2;SMARCC1;PADI4;BAZ1B;BAZ2B;SETDB1;INO80;HCFC2
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),-0.7084558436181355,-1.1855979089245092,0.3157894736842105,0.6976382771271252,1.0,1/7,0.81%,C3
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),-0.7435505269390393,-1.1855671063935693,0.2459016393442623,0.6973618518494548,1.0,4/7,21.38%,PLEKHM1;SYK;SPP1;ADAM8
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),-0.8011541436373969,-1.185553777170342,0.24074074074074073,0.697004172639455,1.0,1/5,3.17%,IL12A
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.38705103885547953,1.1855258585601771,0.05263157894736842,0.9424164962462233,1.0,36/155,16.99%,PTCD2;ATAD3C;GDAP1;PPARGC1A;TFB2M;AIFM2;PLD6;AFG1L;TFB1M;SAMM50;ALAS1;TRAK2;POLG2;MTERF1;RAB5IF;MFF;GABPB1;MGME1;TOMM22;ESRRA;CHCHD3;TMEM11;OPA1;SIRT5;DNM3;TMEM70;MUL1;THG1L;TIMM23;MIEF2;COX7A2L;NRF1;MTFR1;PRDX3;MSTO1;MTX2
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.6153192273483351,-1.1853035724241032,0.28125,0.6975274208647815,1.0,4/18,11.28%,EFNA1;TGFBR2;ZFPM1;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.7337042947443891,-1.1849418222879096,0.25,0.6984737622147145,1.0,2/6,10.82%,AKAP5;CACNA1C
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.610420949755082,-1.184431768244726,0.2236842105263158,0.7001356197165098,1.0,3/16,4.46%,MET;PROX1;LSR
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.5403353222690378,-1.1844203233109427,0.29577464788732394,0.6997554561495815,1.0,1/46,0.02%,ENPP2
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.3823370119888774,1.184193036205837,0.13333333333333333,0.9467339306739617,1.0,20/129,16.57%,ATP6V0D2;PDK4;ATP6V1A;EIF2S1;PIK3R4;ATP6V1G1;RALB;MIOS;GAS2L1;SESN2;XPR1;EIF2AK4;MAPK8;PIK3C3;WDR24;AKR1C3;DAP;PRKD1;SESN3;EIF2AK3
prerank,Reactome_2022__Release Of Apoptotic Factors From Mitochondria R-HSA-111457,-0.7025665114137124,-1.184053429930827,0.3,0.7005741314989904,1.0,2/6,18.20%,SEPTIN4;GSDME
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.6559176294525622,-1.1839425779919632,0.26229508196721313,0.7004976446518866,1.0,2/12,6.62%,SOCS3;PARP14
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.6181190659514196,-1.1838834158479918,0.23333333333333334,0.7003400019564634,1.0,4/26,13.13%,NPY;PROX1;DRAXIN;GRID2
prerank,CellMarker_Augmented_2021__Stem cell:Blood Vessel,-0.7777752978814947,-1.1837455986157845,0.36538461538461536,0.7004153085005204,1.0,1/6,5.68%,THY1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.4888215083204917,-1.1835716895485109,0.18421052631578946,0.7006365984593173,1.0,19/81,17.30%,THBS1;RASGRP2;SYT4;TRPC3;ITPR3;NEUROD2;SYT1;CLIC4;WNT5A;HPCA;CPNE9;DMTN;NLGN1;SYT5;SYT2;KCNMB4;SYT13;ADCY8;RYR2
prerank,KEGG_2021_Human__Autophagy,0.3929219386081287,1.1835647637277051,0.05,0.948206874352776,1.0,27/126,20.24%,RAB33B;NRAS;EIF2S1;PIK3R4;AKT2;MAPK10;AKT1;NRBF2;ATG4C;HMGB1;PRKACB;EIF2AK4;MAPK8;PIK3C3;ATG4A;RAB39B;PIK3CA;RAB7B;CFLAR;PIK3R1;RAB8A;EIF2AK3;BAD;SNAP29;MAP2K2;ERN1;PRKAA1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.6522624224431353,1.1835621185788694,0.2564102564102564,0.9470289776144495,1.0,1/6,14.38%,CFLAR
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.48630917630910964,-1.1833154594217812,0.14285714285714285,0.7011658247248865,1.0,26/80,18.79%,CD99L2;L1CAM;INPP5D;SLC16A3;ITGA5;GYPE;GP6;CEACAM1;CD44;ATP1B1;MAG;PSG8;PSG3;FN1;PROCR;ITGA3;PIK3CB;CD74;DEAF1;TEK;GPC1;ANGPT2;TGFB1;SLC7A7;TNFRSF10A;SELENOP
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.5403398693629256,-1.1833060128633048,0.22535211267605634,0.70076499104291,1.0,7/39,11.88%,PSRC1;KIF14;RAB11A;CENPE;NUF2;CCNB1;KIF2C
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.6289575926249206,1.1832341941376305,0.2727272727272727,0.947316584787027,1.0,4/8,19.77%,SPRED1;SPRED2;EP300;CCAR2
prerank,Reactome_2022__Netrin Mediated Repulsion Signals R-HSA-418886,-0.7734752325337922,-1.1830703104324658,0.2711864406779661,0.7012557256625337,1.0,1/8,10.87%,UNC5B
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.41823363509165273,1.1829816890201446,0.09090909090909091,0.9470135533484401,1.0,17/60,20.89%,LIMD1;NUP42;NUP37;NUP54;IPO8;NDC1;NUP214;RAE1;AAAS;NUP188;POLR2C;NUP205;PUM2;NUP210;NUP85;NUP153;NUP50
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,0.5846577571466982,1.1829429487301506,0.23333333333333334,0.9461641616726753,1.0,4/12,27.11%,RBBP4;E2F4;LIN52;TFDP2
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,0.3889749861450371,1.1826940626708535,0.3,0.9460454485663883,1.0,48/228,20.89%,NUP42;U2AF1;NUP37;SF3A1;NUP54;NUDT21;SNRPF;SF3B4;GTF2F2;HNRNPC;WDR33;CWC27;SMNDC1;LSM8;CSTF3;CPSF6;SNRPN;PAPOLA;SNRPB2;EIF4E;NDC1;NUP214;CPSF7;NXT1;LSM5;TFIP11;RBM17;LSM7;AAAS;NUP188;THOC3;HNRNPU;POLR2C;NUP205;AQR;PPIE;THOC1;PPWD1;SNRNP27;DHX15;NUP210;PDCD7;RBMX;NUP85;PPIL6;CPSF2;NUP153;NUP50
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.6551811794412399,-1.1826082352690632,0.3225806451612903,0.7023774004545305,1.0,4/10,19.14%,SCX;TENM4;CRB2;PHLDB2
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.5963759023701388,-1.182183256302696,0.22058823529411764,0.7034330451567735,1.0,3/23,7.93%,SCN1B;KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.43467234221495443,1.181962286814955,0.3076923076923077,0.9479981156288506,1.0,14/73,13.66%,LEPR;SLC6A13;SLC19A1;AGER;SLC24A3;SLC15A2;ATP1A2;SLC4A4;ABCC2;SLC22A2;SLC5A6;SLCO1C1;SLC6A1;ATP8A1
prerank,Reactome_2022__Aspartate And Asparagine Metabolism R-HSA-8963693,0.671893842968897,1.181923916137956,0.32432432432432434,0.9470108861950776,1.0,1/8,0.82%,GOLT1A
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.8251681201264068,-1.181884886534312,0.25396825396825395,0.7039429516264322,1.0,2/5,14.77%,P2RY12;GPI
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.625785062880857,1.1817950494778593,0.2926829268292683,0.9463052756379681,1.0,8/14,27.02%,ERI1;INTS7;INTS8;INTS6L;TOE1;INTS14;ELAC2;INTS6
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.49439385039333344,1.181776405225352,0.1388888888888889,0.9451970772839196,1.0,5/27,13.00%,RAB33B;COG6;COPB2;VTI1A;GOLGA5
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.427669289926803,1.1817685140365042,0.16,0.9440637516446252,1.0,23/62,26.32%,ELOC;EAF2;GTF2F2;ELOA;ERCC2;ERCC3;GTF2H5;GTF2H2;ELP2;IWS1;POLR2C;ELP4;PCID2;CCNT1;GTF2H3;NELFA;CCNT2;CTDP1;CDK12;MLLT3;CCNH;TCEA1;POLR2A
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.49908249386732534,1.1817371825450913,0.21212121212121213,0.9431001029288503,1.0,5/48,3.54%,LEPR;CEBPA;PDK4;MCU;ADIPOR1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5768232454409273,-1.1817155208692387,0.20588235294117646,0.7041505324852267,1.0,4/21,8.03%,CEMIP;APP;EGF;CHI3L1
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.8018681282905903,1.1816547361102656,0.28125,0.9422082707751801,1.0,2/6,12.04%,RFWD3;FEM1B
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,0.5273284227000843,1.181296558201762,0.3142857142857143,0.9424007886011196,1.0,9/22,19.94%,MAML3;KAT2B;PBX1;HEYL;KAT2A;EP300;HEY1;HEY2;HES5
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,-0.6261009153175664,-1.1811375234520205,0.20588235294117646,0.7059895408250731,1.0,5/20,18.13%,PIF1;NOP10;ANKRD28;CDK2;TINF2
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),-0.8006934055537496,-1.1811336840476716,0.38461538461538464,0.705614452421712,1.0,2/5,11.67%,ZFP36;SFRP4
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.5173896782536569,-1.1811328570193294,0.18421052631578946,0.7052075236717571,1.0,14/70,15.76%,CD24;RASGRP1;DUSP1;HTR2B;CAV3;EGF;FGF1;DAB2IP;PAQR3;DIRAS1;NEK10;DIRAS2;PIK3CB;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.6439676187243247,1.180944256517161,0.325,0.9427314054476454,1.0,4/12,17.67%,NUDT21;RC3H1;CNOT8;CNOT1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.6416501670743628,-1.1809410707135048,0.29411764705882354,0.7055160359470086,1.0,3/11,13.10%,SIX3;GCM2;PAX8
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.6847703588196201,-1.1807327905140552,0.265625,0.7058456833224804,1.0,4/11,12.58%,IFIT1;COLEC12;IFIH1;FLOT1
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.6605857619335154,1.1806734242125791,0.25,0.9427567337598926,1.0,1/7,10.85%,STARD4
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.580027659030571,-1.1806729492882029,0.208955223880597,0.7055896713630163,1.0,4/27,12.44%,ANXA1;DUOX1;VIL1;DMTN
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.5993634518574792,-1.1806439444453996,0.25757575757575757,0.7052856559612155,1.0,9/16,16.36%,HLA-A;IL12A;HLA-DRA;CEACAM1;HLA-B;HLA-E;FADD;HLA-F;HLA-DRB1
prerank,Reactome_2022__PI3K/AKT Activation R-HSA-198203,0.6741623919752493,1.180433970566775,0.38636363636363635,0.9425193599719464,1.0,1/7,0.43%,NGF
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.5752520309651776,1.180285057694861,0.3157894736842105,0.9418545679631135,1.0,3/18,17.54%,PRKRA;DROSHA;TENT4B
prerank,Reactome_2022__Metabolism Of Folate And Pterines R-HSA-196757,0.5744068818281691,1.1802152247709221,0.2222222222222222,0.9409983398663608,1.0,5/14,17.33%,SLC19A1;MTHFD2L;DHFR;DHFR2;SLC46A1
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.6660439372776025,1.1801661291333527,0.22916666666666666,0.9400891013715481,1.0,3/10,16.71%,LIG4;HMGB1;DCAF1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.6379505366696949,1.1801120939185452,0.25,0.939182069766286,1.0,4/7,33.18%,SLC25A46;TMCC1;SPAST;DNM1L
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.4423739785461588,1.1801118031978564,0.2,0.9380436672574783,1.0,9/63,6.69%,RITA1;BEND6;POFUT1;MAML3;KAT2B;ENHO;EGFR;LLGL1;AKT1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.5149178128562059,-1.179949445009163,0.21621621621621623,0.7073579603629625,1.0,7/72,6.04%,PIF1;ERCC6L;BLM;HK2;DEPDC1B;ATAD5;CENPH
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.48034001498026174,-1.179886420902936,0.16470588235294117,0.7072355277136542,1.0,16/118,16.80%,GBP2;TRAM1L1;GBP1;RAB11A;APP;FSIP2;ISG15;SNX10;IFT122;OBSCN;PAQR3;RPA1;MICALL1;DDRGK1;ALDH3A2;EMD
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.7449649117185229,1.1798730377935593,0.26666666666666666,0.9376764959813223,1.0,1/5,10.85%,STARD4
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.5717562955916191,1.1797180630246524,0.1891891891891892,0.9371731509543327,1.0,3/20,3.19%,THUMPD1;TFB2M;TFB1M
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.5712626891243918,1.1796855624051208,0.25,0.9361645058819753,1.0,8/21,25.55%,VCP;VTA1;CHMP2B;LEPROTL1;VPS4B;CHMP6;TMEM50B;SORT1
prerank,CellMarker_Augmented_2021__Stem cell:Liver,-0.6004275102344541,-1.1795407167095195,0.2459016393442623,0.7080668177639621,1.0,3/14,10.74%,THY1;CD44;LGR5
prerank,KEGG_2021_Human__Homologous recombination,0.4695326095895844,1.17890685578155,0.17142857142857143,0.9377835302334804,1.0,7/35,9.98%,POLD3;RAD54B;SEM1;TOP3B;BRCC3;RAD52;XRCC2
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.56741983483957,1.1784323936260133,0.21212121212121213,0.9383744060218655,1.0,2/11,10.44%,FOXP1;HEYL
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.6128489425976448,-1.1784055851341908,0.24615384615384617,0.711659883055773,1.0,5/17,16.24%,SYT4;SYT1;CPNE9;RIMS2;SYT2
prerank,KEGG_2021_Human__HIF-1 signaling pathway,-0.5050654986234564,-1.1782241838939456,0.2054794520547945,0.7118990647898966,1.0,26/87,18.62%,ALDOB;LDHA;HK2;TIMP1;LDHAL6A;EGF;IFNGR2;PDK1;PRKCG;IGF1;PGK1;ENO4;RPS6;ELOB;PIK3CB;LTBR;PIK3CD;PFKL;PRKCB;PFKFB3;TEK;RBX1;ANGPT2;ENO2;CDKN1A;TF
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.5341426472421608,-1.1781901212853627,0.24324324324324326,0.7116406094257586,1.0,11/44,20.97%,TOMM7;ARIH2;YWHAH;PPP3CC;PINK1;BAP1;NMT1;MICALL2;BBC3;CASP8;UBL5
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.7750054787968192,-1.1778310003640953,0.36363636363636365,0.7123979855464695,1.0,1/5,6.33%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.5268921469006013,-1.177792805875679,0.20512820512820512,0.7121609079306163,1.0,19/62,17.63%,GRIN2D;PLK2;GRIN2A;APP;SLC24A2;CCL2;SLC24A1;HAP1;AKAP5;SLC8A3;SYT1;RIMS2;FLOT1;GRIN2B;NLGN1;GRIK2;RELN;ADCY8;GPER1
prerank,CellMarker_Augmented_2021__Dendritic cell:Synovium,-0.5356369433311777,-1.177752927761061,0.1917808219178082,0.7119187629224323,1.0,9/28,10.12%,P2RY13;MYO1F;DOCK8;TAGAP;ARHGAP9;ARHGAP15;IGSF6;CLEC12A;SCIMP
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.5044309463463733,-1.17773404250433,0.16883116883116883,0.7115968587297612,1.0,23/93,20.76%,COL4A1;COL4A2;CSPG4;LAMB1;TEAD2;SCARA3;ARHGEF17;NUAK1;DAB2IP;AMOTL2;RHBDF1;BOK;COL12A1;MCAM;SEZ6L2;PTPRF;GPC1;LARP6;PTPN21;GLIS2;NXN;ANTXR1;CD276
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.5365241261139778,-1.1773430157993952,0.21739130434782608,0.7125978318598182,1.0,14/58,17.54%,PROX1;LMOD1;SYNPO2L;BAIAP2;BAIAP2L1;VIL1;CDC42EP1;PFN2;CDC42EP3;FES;MYLK3;WDR1;TEK;CDK5
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.5571807709751586,-1.1772379617096191,0.14285714285714285,0.7125690383353077,1.0,9/37,13.19%,SOCS3;IL12A;IL15;PARP14;PTK6;PARP9;IGF1;IL18;TNFRSF1A
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.6947127695874665,-1.1771876623578472,0.2786885245901639,0.7123804794755884,1.0,6/10,29.32%,DAB2IP;MMRN2;NIBAN2;EMILIN1;CADM4;CNMD
prerank,KEGG_2021_Human__RNA transport,0.38916230468819707,1.1771780631504978,0.15384615384615385,0.9421693059486068,1.0,39/145,21.39%,NXT2;PABPC1L;NUP42;RPP40;NUP37;EIF2S1;EIF3E;NUP54;XPO1;RPP14;EIF1AY;EIF4E;NDC1;NUP214;NXT1;RPP25L;EIF4EBP2;RAE1;EIF3H;PAIP1;AAAS;NUP188;THOC3;NUP205;THOC1;PYM1;POP1;FXR2;CLNS1A;EIF1AX;GEMIN4;NUP210;NUP85;EIF4EBP1;NUP153;NUP50;EIF3F;SUMO2;CYFIP2
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.6690363269924454,1.1771716958716092,0.3469387755102041,0.9399344096640945,1.0,1/6,5.80%,ANAPC1
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.6690363269924454,1.1771716958716092,0.3469387755102041,0.9399344096640945,1.0,1/6,5.80%,ANAPC1
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),-0.7704784403303149,-1.1769427389373848,0.3333333333333333,0.7128895231613517,1.0,3/5,16.72%,ABCB1;GABRE;ATP8B1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.5373156906177822,-1.1767597557253044,0.2112676056338028,0.7131904853964183,1.0,3/42,5.81%,A4GALT;B4GALNT1;UGT8
prerank,Reactome_2022__Linoleic Acid (LA) Metabolism R-HSA-2046105,0.7110990652558657,1.1767340179362642,0.3488372093023256,0.9402888232927435,1.0,2/7,6.63%,ABCD1;ELOVL2
prerank,CellMarker_Augmented_2021__Glial cell:Undefined,-0.6742903145897604,-1.1767240486905821,0.29310344827586204,0.712969989758887,1.0,2/13,7.25%,NEFL;GFAP
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.5992729200479673,-1.1766767363288908,0.26153846153846155,0.7127284875303255,1.0,4/26,6.56%,GBP1;CD160;THY1;CEACAM1
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.6844666725304211,1.1766467837035604,0.2558139534883721,0.9395021002543437,1.0,6/9,30.93%,SMARCAD1;HDAC2;SIRT2;HDAC9;REST;RCOR1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.6059846682021333,1.1764560287698307,0.2571428571428571,0.9393002798408127,1.0,3/15,8.51%,POLD3;RFC3;DCLRE1B
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6701386884664191,1.1763387522655617,0.3,0.9386926691493275,1.0,2/8,15.94%,RUNX1;RC3H1
prerank,Reactome_2022__Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,0.6152277658404179,1.1762456663610834,0.3076923076923077,0.9380053510600955,1.0,3/11,15.82%,CIAO3;ERCC2;CIAPIN1
prerank,Reactome_2022__Regulation Of TLR By Endogenous Ligand R-HSA-5686938,-0.6935836192659905,-1.1759793153979066,0.2833333333333333,0.7151004891195635,1.0,2/9,6.11%,TLR2;NDUFA2
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.7360683913112955,-1.175937026036169,0.2727272727272727,0.7148792828862379,1.0,2/7,11.74%,TOMM7;PINK1
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.5662309050794233,-1.1756934168100086,0.17142857142857143,0.7152207004945506,1.0,11/31,13.52%,PSCA;TJP3;POF1B;OVOL2;FUT2;CEACAM1;TMC4;CAPN8;LIPH;KPNA7;CXCL17
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.4788727785275574,-1.1756615956023264,0.16666666666666666,0.7149148393248739,1.0,17/85,14.45%,FLRT3;CDH22;POU4F1;PKP2;CDH6;GJC1;FSCN1;SLITRK1;CDH7;CDH19;CDH9;PCDHB5;FN1;ACHE;CDH12;NLGN1;BDNF
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Skeletal Muscle,-0.701530295534003,-1.1755674560781222,0.3333333333333333,0.7148371985964316,1.0,5/10,21.37%,THY1;CD44;MCAM;PDGFRA;PTPRC
prerank,CellMarker_Augmented_2021__Stem cell:Muscle,-0.6454115608688638,-1.1755288698176318,0.2413793103448276,0.7146166443309973,1.0,4/13,10.25%,CSPG4;THY1;CD44;CD9
prerank,KEGG_2021_Human__ECM-receptor interaction,-0.5255391550635001,-1.1755038416590318,0.19718309859154928,0.714306353394033,1.0,30/67,19.72%,THBS1;COL4A1;COL4A2;LAMB1;ITGA2;COL4A4;CHAD;COL6A2;ITGA5;THBS3;GP6;CD44;ITGA8;ITGA11;THBS2;FN1;ITGA9;FRAS1;ITGA3;LAMA3;RELN;ITGB4;COL9A2;SV2B;SPP1;LAMA5;CD36;COL4A3;AGRN;SV2C
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.6217945938279337,-1.175336302330048,0.26785714285714285,0.7145995145274453,1.0,3/14,11.79%,C3;APP;IL18
prerank,PanglaoDB_Augmented_2021__Microglia,-0.5123302881058805,-1.1753219943249118,0.22666666666666666,0.7142208495238395,1.0,13/59,7.63%,P2RY13;P2RY6;MYO1F;GPR183;P2RY12;TAGAP;GPR34;SLA;SIGLEC1;COLEC12;HLA-DRA;IGSF6;CLEC12A
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.6996509349001809,1.1751961736026242,0.2727272727272727,0.9410889991192449,1.0,1/8,1.63%,BMP2
prerank,CellMarker_Augmented_2021__Germ cell:Undefined,-0.6444008256236317,-1.1751755708310896,0.2647058823529412,0.7143129213516067,1.0,6/14,13.55%,PODXL;GAPDHS;PRDM1;MEA1;TEX11;TDRD1
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.6399753099112511,-1.1751247323867389,0.28125,0.7141144138625627,1.0,3/16,7.96%,CEACAM1;TLR3;ZFPM1
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.6388196786413138,-1.1750811996866581,0.3283582089552239,0.713842233798596,1.0,4/13,7.93%,KCNQ1;KCNJ2;ATP1A1;ATP1B1
prerank,Reactome_2022__rRNA Processing R-HSA-72312,-0.4500583404816866,-1.174964598854216,0.16091954022988506,0.7139132619847958,1.0,55/180,20.53%,RPL19;RPL3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;EMG1;RPL7A;RPL37A;RPL27;RPL9;RPL21;NOB1;RPL13A;RPS11;RPS16;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPLP2;RPS23;RPS21;RPS7;RPL8;NOP10;RPS6;RPS15;RPL26L1;DIMT1;RPS9;RPL12;PES1;RPL5;FAU;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;EXOSC7;MRM1;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),-0.6435516466968283,-1.1748924212324339,0.27941176470588236,0.7138260376298015,1.0,4/10,22.93%,CRMP1;DPYSL2;DPYSL3;DPYD
prerank,KEGG_2021_Human__Influenza A,-0.4732229294773085,-1.1748729723916969,0.20987654320987653,0.7134912486623459,1.0,27/113,18.67%,SOCS3;MX1;CIITA;ICAM1;IL12A;RAB11A;CCL2;HLA-DRA;TLR3;TMPRSS11D;IFNGR2;STAT1;IRF7;IL18;IFIH1;FADD;TNFRSF1A;KPNA7;PIK3CB;PIK3CD;HLA-DRB1;PML;PRKCB;NXF5;FDPS;CPSF4L;TNFRSF10A
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),-0.7043519595157917,-1.174836355114896,0.3269230769230769,0.7132095023116424,1.0,1/8,2.14%,KMO
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.6567457437505013,-1.1747806065886452,0.2459016393442623,0.712975445294687,1.0,1/10,0.33%,THBS1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.604537514197901,-1.1747229195032616,0.203125,0.712757433840582,1.0,6/16,17.32%,THBS1;WNT5A;TNIP2;CD74;CD200;MYO18A
prerank,KEGG_2021_Human__Thyroid cancer,-0.558555927243003,-1.1747154086233482,0.22972972972972974,0.7123661690973048,1.0,3/34,8.75%,LEF1;CCND1;GADD45A
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.4746489959910153,-1.1746452643824365,0.125,0.712238074501156,1.0,38/133,17.30%,DHCR24;TAGLN3;STMN2;NEFM;SH3GL2;SCN9A;CLGN;PLP1;SLITRK1;LRRTM1;SYT4;MAP1B;ELAVL4;GAP43;TCEAL6;ZNF536;NEFH;PIEZO2;CA10;TCEAL2;SCN2A;SYNM;STMN4;C11ORF87;SYNPR;CRMP1;SCN3B;RGS7BP;CNTN2;KCNC1;GDAP1L1;ADD2;RAB3C;SNCG;VWA5A;TCEAL5;ADCY8;SULT4A1
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,-0.59163353570454,-1.1745473892192386,0.25,0.7121573887990907,1.0,11/28,22.73%,ST6GAL1;SLC17A5;ST3GAL6;EGFL7;ST6GALNAC2;GNE;CTSA;ST8SIA3;ST6GALNAC3;ST8SIA1;NEU4
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Gingiva,-0.7494561527662309,-1.174416106180267,0.26785714285714285,0.7122972381201004,1.0,3/7,7.03%,ITGA5;THY1;CD44
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.7342954181959306,-1.1744020832209936,0.375,0.7119543239175393,1.0,4/6,22.09%,LDLR;MGAT3;LRP2;LAPTM4B
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.49412421891865616,1.17429785327366,0.19444444444444445,0.9437469895557249,1.0,10/21,30.11%,ERCC6;KAT7;HMGN1;THOC1;CCNT1;CCNT2;CDK12;SCAF8;CDK13;SUPT16H
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.5002576084279243,-1.17413901210596,0.2222222222222222,0.7125187946137819,1.0,8/89,8.70%,GGT5;OGN;CSPG4;BGN;GSTM5;OMD;PAPSS2;ST3GAL6
prerank,Reactome_2022__Phase 4 - Resting Membrane Potential R-HSA-5576886,-0.7370940610470029,-1.1741012889608058,0.2676056338028169,0.7122285394945045,1.0,5/8,21.64%,KCNK1;KCNJ2;KCNK12;KCNK10;KCNK13
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.6968550837433053,1.173995065022844,0.2926829268292683,0.9438917497634117,1.0,1/6,8.98%,XPO1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.49471613266212744,1.1731327950569665,0.19444444444444445,0.9459073840316887,1.0,2/24,0.60%,MEOX2;RGCC
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.6596790128706858,-1.1731248884927281,0.2727272727272727,0.7154473223115384,1.0,4/14,14.33%,TMEM204;SULF1;SFRP4;ITGA3
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.7834524506440372,-1.1725462791648111,0.2631578947368421,0.7170923091377568,1.0,1/5,5.75%,SLC4A11
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5286129569524198,-1.17250994123308,0.2222222222222222,0.7168261323690125,1.0,14/56,13.20%,EPN1;IFI6;SH3GL2;DOK1;CEACAM1;PTK6;HAP1;EGF;RHBDF2;TGFA;WDR54;DAB2IP;MVP;RHBDF1
prerank,Reactome_2022__Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,0.6163170706624996,1.172412369114932,0.32558139534883723,0.9479316822796956,1.0,6/13,22.00%,DMAC2L;ATP5PB;ATP5MC2;ATP5MC1;ATP5F1A;ATP5F1C
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.5014679729183977,-1.1723755896553643,0.23684210526315788,0.716894850942236,1.0,9/72,15.76%,THBS1;EFNA1;RPS4X;PLD1;TNFRSF1A;SAMD4A;RPL5;RBM3;PRKCD
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,0.42626183302890785,1.172361852721586,0.1875,0.9470368521568944,1.0,17/70,19.48%,MED21;PPARGC1A;PLIN1;CEBPA;CDK8;NCOA3;CHD9;MED22;MED11;NFKB1;MED9;EP300;MED28;NCOA2;FAM120B;MED30;MED23
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.7429731111321203,-1.1723597124260914,0.23529411764705882,0.7165663812525578,1.0,2/8,8.19%,BLM;DONSON
prerank,KEGG_2021_Human__Small cell lung cancer,-0.4827352934363699,-1.1722645518243844,0.18518518518518517,0.716520279412588,1.0,20/82,19.31%,COL4A1;COL4A2;LAMB1;ITGA2;COL4A4;CCND1;GADD45A;BIRC3;FN1;CCNE2;ITGA3;PIK3CB;LAMA3;PIK3CD;CDK2;MAX;GADD45B;CDKN1A;LAMA5;COL4A3
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.7032548059594803,1.172186239976445,0.32653061224489793,0.9465733945437013,1.0,2/6,11.19%,SOX8;ARX
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.5700524076277421,-1.1721325766757535,0.22058823529411764,0.7166412467790797,1.0,3/32,2.85%,LEF1;TGFBR2;PDPN
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.5746225618198275,1.1720049973300948,0.25,0.9461914226703674,1.0,5/18,15.62%,MCU;MFF;RALA;MUL1;MIEF2
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.7883806258576505,-1.1718062144142063,0.26666666666666666,0.7173202316265743,1.0,4/6,18.00%,HTR2B;HTR1E;HTR2C;HTR2A
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.6008014205862089,-1.1717965386813731,0.28,0.7169557643240627,1.0,7/23,14.33%,PROX1;PDPN;CCDC39;CHI3L1;FGF1;FGF7;ITGA3
prerank,Reactome_2022__Creation Of C4 And C2 Activators R-HSA-166786,-0.7702587036976779,-1.1717789923247814,0.2608695652173913,0.7166281781176621,1.0,4/6,21.38%,C1R;C1S;C1QB;MASP2
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.7434045220406402,1.1716494242396749,0.2857142857142857,0.9465062443308029,1.0,3/6,20.37%,EIF2AK4;EIF2AK3;SAXO1
prerank,KEGG_2021_Human__Human cytomegalovirus infection,-0.45882944947832005,-1.1716325659979994,0.2125,0.7167592303591372,1.0,40/164,23.12%,IL1R1;CDKN2A;B2M;HLA-A;ADCY7;GNG3;CCL2;HLA-C;ITPR3;CCND1;PRKCG;PPP3CC;CREB5;HLA-B;ADCY5;HLA-E;GNG2;FADD;TNFRSF1A;HLA-F;PIK3CB;PIK3CD;ADCY3;TSC2;ADCY8;PRKCB;CREB3;CDKN1A;PDGFRA;PDIA3;CX3CL1;CASP8;IKBKG;ITPR1;CALM3;GNB4;NFATC2;GNB5;STAT3;SP1
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.6486258919658108,1.1714828017720242,0.22857142857142856,0.9460584187743486,1.0,4/6,32.86%,SENP2;SENP5;SENP6;SENP1
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.710277579782029,1.171247525818827,0.2765957446808511,0.9455982971609614,1.0,2/5,12.79%,ATP1A2;DRD2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.6247864017924346,-1.1711744214596933,0.288135593220339,0.7180455880660793,1.0,2/22,1.45%,APLNR;TGFBR2
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.779622880591837,-1.1711486711706218,0.3333333333333333,0.7177595568245105,1.0,1/7,1.83%,PLAAT4
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),-0.6773302004622337,-1.1708294265802268,0.3333333333333333,0.7184408463935789,1.0,1/9,1.60%,GRAMD2A
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.5858812607416668,-1.1704694042947044,0.2602739726027397,0.7194123550380389,1.0,8/24,23.02%,SYNPO2L;VIL1;WAS;PFN2;CX3CL1;FHOD1;RDX;SLC9A1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord,-0.7138290143223617,-1.1704229914954722,0.24193548387096775,0.7191571994448849,1.0,2/9,7.03%,THY1;CD44
prerank,Reactome_2022__BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,0.5392878733265568,1.1704085243439228,0.23684210526315788,0.9479930119962154,1.0,9/19,22.44%,BBS10;BBS9;CCT3;TTC8;MKKS;RAB3IP;SMOX;BBS2;LZTFL1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.45349906721571787,-1.170344621021757,0.13793103448275862,0.7190632257603671,1.0,26/211,10.09%,ZIC4;GRIN2D;COL4A1;C3;TAGLN3;SIX3;TGFBR2;PROX1;CIC;SH3GL2;LSR;GRIN2A;NNAT;UGT8;HAP1;APOD;ZIC1;KLK6;MOG;SLC8A3;GRIK1;CA10;HAPLN2;EIF2B2;SH3GL3;B3GNT5
prerank,KEGG_2021_Human__Pancreatic secretion,0.45992697856380726,1.1702183529974406,0.21428571428571427,0.9475982965723119,1.0,5/65,5.23%,CPA1;CEL;AMY2B;ADCY1;CA2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.6445587018139407,-1.1701666840151412,0.24193548387096775,0.7192339124310603,1.0,3/14,6.33%,KCNQ1;PKP2;CAV3
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.775967805899876,-1.1701636969329343,0.32,0.7188341159260958,1.0,3/5,12.99%,CAV3;FLOT1;EMP2
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.5623548078166263,-1.1701437347097392,0.22727272727272727,0.7185228509304515,1.0,3/33,2.78%,THBS1;LAMB1;ITGA2
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.6500407995057297,-1.170082469882515,0.2711864406779661,0.7183206848866626,1.0,4/10,19.24%,IL18;PRKCH;MSR1;CD36
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.7141296745131588,1.1699165442654502,0.3111111111111111,0.9474306756196329,1.0,1/5,1.27%,AGMO
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.6907261625804659,-1.1698212486896682,0.3076923076923077,0.7188226594212427,1.0,1/11,2.00%,STMN2
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,0.48994785154196163,1.1697776048156991,0.2,0.9469312377333977,1.0,7/28,9.17%,SLC2A5;MGAM;AMY2B;AKT2;AKT1;PLCB4;ATP1A2
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,-0.4735623164998944,-1.1697070152783358,0.2073170731707317,0.7188429896491287,1.0,23/117,12.84%,ANXA1;RASGRP1;P2RY6;TAC3;RASGRP2;RGSL1;GNRHR;GPNMB;CHRM1;GNG3;APP;TRPC3;UTS2;ITPR3;RPS6KA1;CHRM3;MCHR2;PRKCQ;LPAR6;LPAR4;GNG2;PRKCH;P2RY10
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.6765484239596046,-1.1695362796546174,0.2459016393442623,0.7191114629157864,1.0,1/10,7.39%,PLK3
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.5183180802998064,-1.169200560475655,0.2535211267605634,0.7200462141969408,1.0,13/42,19.24%,ICAM1;GRIN2A;APP;NOD1;IGF1;CACNB1;RPL23;SNX6;CDK5;GPER1;RIPK2;ABCC1;CD36
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,-0.4775702246354637,-1.1690640868572348,0.15476190476190477,0.720158792192236,1.0,31/144,15.41%,SCN1B;RIMBP2;RPE65;OR51M1;ANO2;OR52N2;EPS8L2;PLB1;CDH23;KCNJ2;SCN9A;MYO15A;AKR1C1;SLC24A1;LDB2;ITPR3;OR51I2;SYP;LDLR;PDE6B;MYO3A;SCN2A;LHFPL5;PRKCQ;MYH9;MYO1E;GPC3;NMT1;TAS1R1;RDH12;CIB2
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,-0.6404168157408997,-1.168989485313766,0.2641509433962264,0.7200596227437253,1.0,2/15,7.37%,TPST1;PAPSS2
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.7126799003957482,-1.1689188292308197,0.2727272727272727,0.7198935001833027,1.0,2/6,25.06%,GRIN2B;FYN
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.57485284969455,-1.168668539243691,0.2571428571428571,0.7203256371267981,1.0,5/23,12.35%,DUSP1;CENPE;ANAPC11;CCNB1;HECW2
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.5153267993866973,-1.1685685486085708,0.2028985507246377,0.7202883756003926,1.0,6/50,10.61%,THBS1;SNCB;TRPC3;ITPR3;PLSCR1;NDRG1
prerank,CellMarker_Augmented_2021__Syncytiotrophoblast:Placenta,-0.6225426212249519,-1.168345456546886,0.25806451612903225,0.7207146671330998,1.0,4/15,10.41%,OPTC;GLDN;PSG8;PSG3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Intestine,-0.503290781372185,-1.168319670824038,0.18292682926829268,0.7196101539701271,1.0,18/89,12.84%,TRAM1L1;MYOF;ITGA2;PLK2;TPST1;STEAP1;APP;TBC1D9;CCND1;PAPSS2;ATP1B1;SRPX2;CLIC4;SPATA18;RAPH1;FN1;MYO1E;AMOTL2
prerank,CellMarker_Augmented_2021__Mucous Acinar cell:Salivary Gland,-0.503290781372185,-1.168319670824038,0.18292682926829268,0.7196101539701271,1.0,18/89,12.84%,TRAM1L1;MYOF;ITGA2;PLK2;TPST1;STEAP1;APP;TBC1D9;CCND1;PAPSS2;ATP1B1;SRPX2;CLIC4;SPATA18;RAPH1;FN1;MYO1E;AMOTL2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gastrointestinal Tract,-0.503290781372185,-1.168319670824038,0.18292682926829268,0.7196101539701271,1.0,18/89,12.84%,TRAM1L1;MYOF;ITGA2;PLK2;TPST1;STEAP1;APP;TBC1D9;CCND1;PAPSS2;ATP1B1;SRPX2;CLIC4;SPATA18;RAPH1;FN1;MYO1E;AMOTL2
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),0.6674575787753549,1.1678019733890088,0.3157894736842105,0.9533348451274102,1.0,2/7,12.46%,SOD3;PRDX1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.6089112168326748,-1.1675904170748457,0.3472222222222222,0.7219475066593624,1.0,10/20,24.26%,P2RY6;HAP1;ATP1B1;RYR2;AKAP6;STAC2;CALM3;SLC9A1;GSTO1;TRDN
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.6075994277627801,-1.1675686950589492,0.2982456140350877,0.7216269977594949,1.0,2/15,5.22%,NOS1AP;HTR2B
prerank,CellMarker_Augmented_2021__Lymphocyte:Blood,-0.5519793537619261,-1.1675343983946056,0.2608695652173913,0.7213633060328615,1.0,10/37,11.40%,GBP2;GBP1;TLR2;B2M;HLA-C;CLEC12A;OR52K3P;CTSS;HLA-B;HLA-E
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,0.4967272169945842,1.167526894189935,0.2727272727272727,0.9533467053005689,1.0,3/32,7.39%,KSR2;NRAS;CNKSR1
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,0.46479898554478727,1.1673689745420748,0.20833333333333334,0.9528421065311301,1.0,8/50,15.53%,FGF6;NRAS;TRIM24;GTF2F2;CPSF6;PIK3CA;PIK3R1;POLR2C
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.5614561372411808,1.1673622738059517,0.2777777777777778,0.9517699512263651,1.0,4/14,10.20%,FGL1;TNFAIP3;FOXJ1;SAMSN1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),-0.7904503774292846,-1.1672474250354195,0.24561403508771928,0.7218694497454212,1.0,1/5,0.24%,CCBE1
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",0.4657958604782883,1.1672336426213605,0.21428571428571427,0.9511626787086976,1.0,10/42,20.94%,ALDH7A1;AOX1;ACADM;EHHADH;DBT;ACADSB;ACADS;BCKDHB;ALDH2;HIBCH
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),-0.7830009400454805,-1.1672257264235555,0.3090909090909091,0.7215648948051542,1.0,3/6,17.15%,NEUROD2;CPLX2;ADCY8
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.5203535670671422,1.1671910010837432,0.2647058823529412,0.9502929084914405,1.0,4/24,10.29%,SOX8;SOX9;RANBP3L;ANKRD2
prerank,KEGG_2021_Human__Spliceosome,0.4374903948101788,1.1671778981579166,0.15789473684210525,0.9492406376836557,1.0,26/120,22.45%,U2AF1;HSPA1A;SF3A1;SNRPF;SF3B4;HNRNPC;RP9;SMNDC1;LSM8;SNRPB2;LSM5;SRSF8;RBM17;LSM7;THOC3;HNRNPU;AQR;PPIE;THOC1;ZMAT2;SNRNP27;DHX15;RBMX;CRNKL1;PPIH;PLRG1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.6365804608572359,-1.1671390952517595,0.3125,0.7211309313151614,1.0,4/11,22.98%,IL15;CD4;IL15RA;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.6365804608572359,-1.1671390952517595,0.3125,0.7211309313151614,1.0,4/11,22.98%,IL15;CD4;IL15RA;STAT3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.6856529566099578,-1.167028234858799,0.3230769230769231,0.7211753778448823,1.0,2/8,7.93%,LRRC55;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.6295201355459119,-1.16682434656092,0.36231884057971014,0.7215267494897651,1.0,7/16,21.16%,TLR2;IFI35;TLR3;FLOT1;SLC15A4;RTN4;RSAD2
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.5161630781277429,1.1664832057436103,0.21875,0.9506131580213525,1.0,2/21,5.17%,PIK3R4;TRIM24
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,0.5119009256621534,1.1661487953786596,0.3103448275862069,0.9509305213792263,1.0,11/28,19.32%,AKT2;AKT1;RBBP4;HDAC2;PIP4K2B;EP300;BRPF3;ING3;BRD7;CHD4;PIP4K2C
prerank,CellMarker_Augmented_2021__Lymphoid Stem cell:Peripheral Blood,0.4164664473091415,1.1660716011672734,0.18181818181818182,0.9500781859726847,1.0,28/93,21.89%,PAK1IP1;RPP40;PSMA1;MRPL15;UBE2N;SNRPF;AK6;TPRKB;ATIC;NDUFAF2;ERH;SLC25A5;OLA1;DCUN1D5;NDUFA8;MRPL18;TIMM23;DPM1;CDC123;MRPL9;MRPS35;FARSB;MRPL47;CHCHD4;DKC1;UTP4;PSMG1;PPIH
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,0.4930285705068519,1.1660566859105292,0.2,0.9490572737443538,1.0,9/38,17.33%,NR1D1;PPARGC1A;CHD9;XPO1;NRIP1;BMAL1;EP300;NCOA2;SLC46A1
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.5259906372214438,1.1659659900403407,0.3076923076923077,0.9483008030113294,1.0,8/31,16.46%,DNA2;ERCC6;ATR;INTS7;HUS1;RAD9B;ATRIP;HINFP
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.7460962306588507,-1.165778001901449,0.3392857142857143,0.7249662453644958,1.0,2/5,16.36%,HLA-DRA;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7155722844951502,1.1657321896380881,0.38095238095238093,0.9480041914725151,1.0,1/6,1.98%,PPARGC1A
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.583503574615854,-1.165578458417722,0.2535211267605634,0.7253100441324238,1.0,3/28,6.08%,MX1;MYOF;DYSF
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.5947992733745657,-1.1655484632099455,0.3013698630136986,0.7250711742170354,1.0,6/23,18.14%,STMN2;MAP1B;STMN4;MAPRE2;STMN1;MAPT
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),-0.7617553197670898,-1.1655419229962392,0.3333333333333333,0.7247100450726547,1.0,2/5,15.80%,VLDLR;RELN
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),-0.6994825919335034,-1.1652504348989685,0.33962264150943394,0.7254513942756964,1.0,3/6,22.84%,AEBP1;CHADL;EMILIN1
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.7228587173564437,-1.1648565918646323,0.34545454545454546,0.7265080985683283,1.0,1/5,1.92%,CIITA
prerank,Reactome_2022__mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,0.569944189341422,1.16481917874726,0.2727272727272727,0.9506237264068711,1.0,10/15,29.35%,DCP1B;EDC3;LSM5;LSM7;PATL1;DCP1A;DDX6;LSM1;LSM6;XRN1
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.5431584866851928,1.1647341404035,0.2631578947368421,0.9498419480155955,1.0,3/26,4.15%,WNT7A;SLITRK2;NLGN3
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.7254573083748594,-1.1646219613603441,0.32786885245901637,0.7270030152826806,1.0,3/6,22.09%,HSD17B14;CYP3A4;HSD11B1
prerank,Reactome_2022__KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,0.6211519537653702,1.1644644166929436,0.35294117647058826,0.9497924178981234,1.0,5/16,17.71%,EXOSC1;AKT1;EXOSC6;DIS3;EXOSC8
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.48393798294714696,-1.164342772789478,0.20689655172413793,0.7277317097631195,1.0,29/112,18.70%,P2RY6;KCNQ1;BLM;POU4F1;NR4A3;P2RY12;RAMP3;ATP1A1;CCL2;BRCA1;CYP1B1;GABRB2;ADCY5;IL18;IGFBP5;GNG2;DMTN;HRH1;FES;GABRG2;CIB2;ADCY3;ADCY8;SPP1;GPER1;AQP1;TGFB1;AKAP6;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.5044007699782372,-1.1643337387575623,0.2073170731707317,0.7273701139758216,1.0,15/82,14.11%,CD24;RASGRP1;PSRC1;PROX1;CEMIP;HTR2B;CCND1;EGF;WNT5A;FGF1;DAB2IP;DIRAS1;NEK10;DIRAS2;MTCP1
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,0.4996849842706453,1.164026674803505,0.25925925925925924,0.9505638122375837,1.0,2/30,3.57%,FGF6;NRAS
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.5246345039065803,-1.1639120355561319,0.2375,0.7284794370622865,1.0,14/63,20.29%,ANXA1;SFTPD;CHRM1;IL15;CALY;FLOT1;GPC3;SLC11A1;BOK;ANXA2;SYNGR3;IL15RA;DOC2B;CAMK1D
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.7276249833543198,-1.1633473112131836,0.28846153846153844,0.7301774736445494,1.0,4/7,18.14%,SYK;PRKCD;TGFB1;MAPT
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),-0.7054025871217536,-1.1632867775454594,0.3230769230769231,0.7300133643527177,1.0,3/8,20.01%,CDK2;AQP1;KCNC2
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),-0.7620946301855691,-1.163254824232831,0.2857142857142857,0.7297071936822642,1.0,1/6,1.60%,GRAMD2A
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.413373355831518,1.1632019848189368,0.23529411764705882,0.9523354964472003,1.0,20/104,12.99%,ETV5;PPARGC1A;PRDX6;SLC25A24;HSPA1A;SOD3;EIF2S1;KEAP1;EGFR;AKT1;BRF2;ADNP2;RAD52;ERMP1;SESN2;ANKRD2;PTPRK;MAPK8;PRDX1;AKR1C3
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.5257648657837558,-1.1629526185886176,0.23076923076923078,0.7303812636435874,1.0,11/59,15.79%,FMO6P;C1ORF87;MROH9;CYP4X1;FUT2;ATP1B1;SPAG17;DNAH3;CXCL17;AKAP14;ZBBX
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),0.7357084067873088,1.1628504731935625,0.3018867924528302,0.9526862417297791,1.0,4/5,26.07%,RPRD1B;CTDP1;SSU72;RPAP2
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.5668589025982979,-1.162747897539204,0.2698412698412698,0.7308719189331354,1.0,2/30,6.92%,ANXA1;CYP1B1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.6565886515831459,1.1626466491904124,0.30434782608695654,0.9521922255979706,1.0,3/7,27.02%,HUS1;CLSPN;TICRR
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.6039557070122749,1.1625937568502949,0.2553191489361702,0.9514010503734082,1.0,2/10,4.85%,BMP2;GREM1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periodontal Ligament,-0.7343165692338625,-1.1625112294140036,0.3050847457627119,0.7312453910948175,1.0,5/7,21.37%,THY1;CD44;MCAM;PDGFRA;PTPRC
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.504434600299894,-1.162396442577423,0.19230769230769232,0.7311875955591318,1.0,13/60,13.03%,SCN1B;SLC6A15;KCNK1;SCN9A;SLC24A2;SLC4A11;SLC24A1;SLC5A4;ATP1B1;SLC8A3;SCN2A;SCN1A;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.6865234783004921,1.1622427081278714,0.3,0.9514666666666667,1.0,2/8,12.24%,IL17D;TICAM1
prerank,CellMarker_Augmented_2021__Oviduct-derived Stem cell:Oviduct,-0.643684304795746,-1.162136747594367,0.3548387096774194,0.7316415498572527,1.0,3/14,7.03%,ICAM1;THY1;CD44
prerank,KEGG_2021_Human__Ubiquinone and other terpenoid-quinone biosynthesis,0.6615950585587014,1.162130756548475,0.32608695652173914,0.9508980975699766,1.0,4/9,22.06%,COQ3;COQ2;COQ6;VKORC1L1
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.424372004553897,1.1619979946207057,0.17647058823529413,0.950395448832966,1.0,18/82,16.24%,ETV5;PPARGC1A;PRDX6;SLC25A24;HSPA1A;SOD3;EIF2S1;KEAP1;BRF2;ADNP2;RAD52;ERMP1;SESN2;PRDX1;PIK3CA;PRKD1;CAT;PRDX3
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.4987001861218507,-1.1619669244102038,0.22077922077922077,0.7318924729425997,1.0,13/61,13.03%,SCN1B;SLC6A15;KCNK1;SCN9A;SLC24A2;ATP1A1;SLC24A1;SLC9A2;ATP1B1;SLC8A3;SCN2A;SCN1A;SCN3B
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.7003566029448476,-1.1616980185038048,0.25757575757575757,0.7324619484971433,1.0,3/12,5.98%,MSMP;GPR183;CCL2
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.5820248345343065,1.1615335494043322,0.3235294117647059,0.9510429374586532,1.0,2/16,2.97%,CPA1;CYP4F3
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.4103894717987476,1.1614807344008247,0.19230769230769232,0.9502317794779636,1.0,26/90,21.32%,NUP42;NUP37;KAT2B;NUP54;TRIM28;VCPKMT;NDC1;NUP214;SIRT5;ZNF451;RAE1;AAAS;NUP188;KIAA1586;P3H4;EP300;NUP205;EYA1;PIAS4;HDAC10;CTH;NUP210;NUP85;NUP153;NUP50;SUMO2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.5098084634120696,-1.1613662392130317,0.2777777777777778,0.7332331250463854,1.0,11/42,10.58%,P2RY13;MYO1F;TYMP;TLR2;SIGLEC1;HLA-DRA;IGSF6;CLEC12A;IRF7;CTSS;PILRA
prerank,CellMarker_Augmented_2021__M1 macrophage:Brain,-0.49930593236517634,-1.1613520037628693,0.19230769230769232,0.7328913161905156,1.0,20/76,24.66%,ADGRE5;IFI35;BLVRB;TAGLN2;TNIP2;CARD19;MVP;TMEM256-PLSCR3;JUNB;EMP3;PLP2;LGALS1;AGTRAP;IKBKG;FRMD8;RRAS;AGPAT2;LRP10;MAP2K3;CAPG
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.6569853790424602,1.1611255497447397,0.22857142857142856,0.9505559653830539,1.0,5/10,24.86%,NT5C1A;ADSS2;AK4;AK3;NT5E
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.5208478288957569,1.1610122924859365,0.22580645161290322,0.949888728317208,1.0,7/25,23.56%,MEN1;WDR82;KMT2A;BEND3;ASH2L;KMT2C;TET3
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,-0.4650039547803195,-1.1609936296956826,0.21428571428571427,0.7337170019841645,1.0,50/143,19.89%,CDH22;STMN2;SNCB;PLP1;ZDHHC22;SLITRK1;LRRTM1;SLC24A2;SYT4;SLC32A1;SRRM4;ELAVL4;GRIA3;GAP43;ITPR3;TCEAL6;SYP;RIT2;IGSF21;CPLX1;CPLX2;CA10;HPCA;TCEAL2;CALY;STMN4;GAD1;C11ORF87;SYNPR;GRID2;SHISA8;GAD2;GABRG2;CNTN2;KCNC1;GDAP1L1;PCP4;RAB3C;GABRA1;SYT2;TCEAL5;PDE5A;SULT4A1;CELF4;SLC1A6;ST8SIA3;HCN1;PDE1A;PTPN5;CNTNAP2
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.6558705988374358,-1.1609783699500102,0.3,0.7333500525179034,1.0,3/9,20.01%,MAPRE2;FGF7;EPB41L4B
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.7774733587648966,1.1607791837128367,0.22448979591836735,0.9498655781522571,1.0,3/7,14.52%,LIG4;MSH2;MSH3
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.6585775898814644,1.1605761013176936,0.39473684210526316,0.9498296434990624,1.0,2/8,19.75%,GINS3;MCM6
prerank,Reactome_2022__Response To Metal Ions R-HSA-5660526,-0.6666186125105535,-1.1605283153265251,0.2923076923076923,0.7345379817886545,1.0,2/10,9.88%,SNCB;MT1H
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.45090179126650554,-1.1603394443726687,0.2073170731707317,0.7349427613829818,1.0,24/106,18.86%,FLRT3;APLNR;POU4F1;PKP2;TGFBR2;MMP21;HTR2B;SYNPO2L;ZFPM1;SRF;SMYD4;CACNA1C;IFT122;FN1;GPC3;PDLIM4;DLC1;APLN;TSC2;TEK;FGF12;TGFB1;CDKN1A;PLCE1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.7247333709972302,-1.1603036403320999,0.26785714285714285,0.7338580078182685,1.0,2/6,22.98%,STAT1;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.7247333709972302,-1.1603036403320999,0.26785714285714285,0.7338580078182685,1.0,2/6,22.98%,STAT1;STAT3
prerank,Reactome_2022__Interleukin-9 Signaling R-HSA-8985947,-0.7247333709972302,-1.1603036403320999,0.26785714285714285,0.7338580078182685,1.0,2/6,22.98%,STAT1;STAT3
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.5752276451747349,1.16013210570925,0.3170731707317073,0.9502169294150175,1.0,5/18,15.92%,TEX15;APOBEC3F;SMYD5;PIWIL4;ZNF91
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.5797216979114781,-1.1601146093713532,0.2571428571428571,0.7342169799915991,1.0,9/29,20.30%,SEPTIN5;CPLX1;CPLX2;RIMS2;PNKD;KCNMB4;GPER1;MCTP1;STX1B
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.5697129000622363,-1.1600878796895626,0.265625,0.733891391790345,1.0,6/26,13.21%,B2M;HLA-A;HLA-C;HLA-B;HLA-E;HLA-F
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,0.40870707894956515,1.1599967716989732,0.1111111111111111,0.9496299386824218,1.0,17/69,12.01%,NXT2;RPP40;GNL3L;IMP4;RIOK2;RCL1;RIOK1;AK6;CSNK2A1;TBL3;XPO1;CSNK2A2;EFL1;MDN1;DROSHA;NXT1;RPP25L
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.6618313161015834,1.1599867201545355,0.34146341463414637,0.9486220888839605,1.0,2/8,5.50%,MITF;USP13
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,-0.5971241422917322,-1.1598922232758797,0.28125,0.7342399029892359,1.0,8/21,14.80%,B2M;HLA-C;HLA-B;SYK;HLA-E;RNASE1;CLEC5A;PIK3CB
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),0.5205196302150716,1.1596532366156915,0.3783783783783784,0.9487027294944902,1.0,10/31,20.44%,LCMT2;TYW3;FTSJ1;NSUN6;TRMT1L;TRMT61A;TRMT1;MTO1;TRMT5;NSUN2
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.6295418189044244,1.1596378140351054,0.3076923076923077,0.9476981937824985,1.0,2/9,1.24%,CD200R1;NR1D1
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Germ,-0.5189352703715543,-1.1596143906940666,0.2222222222222222,0.7343883405527548,1.0,11/36,10.15%,MYO1F;GPR183;DOCK8;CIITA;TAGAP;SLA;ARHGAP9;ARHGAP15;HLA-DRA;RCSD1;CTSS
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Germ,-0.5189352703715543,-1.1596143906940666,0.2222222222222222,0.7343883405527548,1.0,11/36,10.15%,MYO1F;GPR183;DOCK8;CIITA;TAGAP;SLA;ARHGAP9;ARHGAP15;HLA-DRA;RCSD1;CTSS
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.6500353277282899,-1.1594320561685594,0.38235294117647056,0.7346004854962856,1.0,2/12,2.77%,PKP2;PROX1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.685880138187239,-1.1593925176580928,0.3333333333333333,0.7343608583274515,1.0,1/7,2.72%,ALOX12
prerank,KEGG_2021_Human__Base excision repair,0.516334171368647,1.1592821820405872,0.2727272727272727,0.9481749510643486,1.0,2/29,0.81%,POLD3;APEX2
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.6664152791492602,-1.1592065465290968,0.26229508196721313,0.7345226453656085,1.0,4/12,12.99%,TIMP1;DMTN;CD63;EMP2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.7156969436391114,-1.1589359902566565,0.3220338983050847,0.7350701642294993,1.0,2/7,4.35%,SKAP1;PODXL
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,0.45519875523062486,1.1588813025444578,0.21875,0.9485742212279308,1.0,15/53,17.40%,POFUT1;RUNX1;H2BC21;MAML3;KAT2B;H2BC4;SIRT6;H2AC6;NOTCH2;KAT2A;RFNG;H3-3B;EP300;POGLUT1;AGO3
prerank,Reactome_2022__Activated NTRK3 Signals Thru RAS R-HSA-9034864,0.6689098472001797,1.1586714764181691,0.3902439024390244,0.9483237902509587,1.0,1/6,3.57%,NRAS
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.7370776916334358,-1.1585296986226894,0.25862068965517243,0.7361380383480295,1.0,1/6,5.29%,SCX
prerank,KEGG_2021_Human__Choline metabolism in cancer,0.42114570505093024,1.1582726111392727,0.17647058823529413,0.9488236575536434,1.0,19/87,16.11%,DGKB;PIP5K1B;NRAS;DGKE;EGFR;AKT2;PDGFD;PDGFC;MAPK10;AKT1;CHPT1;PLA2G4C;MAPK8;SLC22A2;PIK3CA;SLC22A5;PIK3R1;DGKH;GPCPD1
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.7626392990547609,-1.1582391715628024,0.2982456140350877,0.7367341661575044,1.0,1/5,1.91%,B2M
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.7134926638115907,1.1581372789307938,0.29545454545454547,0.9482054061126207,1.0,1/5,6.56%,SEC22B
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.5904238030544159,-1.157991323762942,0.2727272727272727,0.7372295804217616,1.0,1/26,0.17%,ST6GAL1
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",-0.7710175161778259,-1.1578762514879224,0.32075471698113206,0.7372493671558875,1.0,2/5,9.37%,RSPO3;PLEKHA4
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.557950964250134,-1.1577814545251295,0.24324324324324326,0.737179162685904,1.0,10/36,18.48%,ALDOB;SLC39A14;FBP1;GAPDHS;PGK1;CHST15;GPI;PGAM1;ENO2;PCK2
prerank,Reactome_2022__HIV Infection R-HSA-162906,0.36628237230310734,1.1577811729365763,0.1,0.9483365972961861,1.0,42/207,15.97%,CD247;SEM1;NUP42;PSMD10;LIG4;ELOC;NUP37;PSMA1;PSMD11;NUP54;GTF2F2;PSMB5;ELOA;ERCC2;RNF103-CHMP3;VPS37A;AP2B1;XPO1;BTRC;AP1B1;AP1S3;GTF2A2;NMT2;VTA1;NDC1;TAF12;PSMD14;NUP214;SLC25A5;ERCC3;CHMP2B;GTF2H5;TAF4;GTF2H2;PSMD12;VPS37B;AAAS;NUP188;SGIP1;TAF2;POLR2C;NUP205
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.7665826506628357,-1.1577731965671012,0.2807017543859649,0.7368092940653794,1.0,1/7,2.77%,PROX1
prerank,Reactome_2022__Nectin/Necl Trans Heterodimerization R-HSA-420597,0.7214854424389643,1.1577577010584204,0.35,0.9473909866076347,1.0,4/6,26.15%,NECTIN3;PVR;NECTIN2;CADM1
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation Of Unsaturated Fatty Acids R-HSA-77288,0.7191496967620818,1.1577551718277643,0.36363636363636365,0.9463336305957958,1.0,2/6,20.79%,ACADM;DECR1
prerank,CellMarker_Augmented_2021__Bile Duct cell:Liver,-0.5276246246912382,-1.1575548611232522,0.2625,0.7372686563958046,1.0,14/44,17.21%,MET;EPS8L2;ITGA2;OVOL2;CCND1;BAIAP2L1;SLC44A3;AMOTL2;RHBDF1;ITGA3;LAMA3;ITGB4;RHOD;PTPRF
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.6687501698237391,1.157357445598449,0.358974358974359,0.9465549257103648,1.0,2/8,11.79%,NT5C1A;ADSS2
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.6116825540052513,1.1573388074889408,0.3,0.9455639681285558,1.0,6/11,20.12%,SMYD2;KMT5A;METTL18;SETD3;EHMT1;CSKMT
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.5650449917171928,1.1573325471378448,0.23684210526315788,0.9445247812935398,1.0,3/15,11.32%,KLRG1;RAB23;VEZF1
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.6386312518469699,1.1572745692480522,0.37777777777777777,0.9436264426936467,1.0,3/9,19.77%,MFF;ERBB4;CCAR2
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.5887432125713922,-1.1572513285890724,0.2727272727272727,0.7379770426732635,1.0,1/27,0.17%,ST6GAL1
prerank,Reactome_2022__Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427,0.6207297854470146,1.157231448817205,0.25,0.9427552591260489,1.0,1/9,0.40%,CD247
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.5106130419122967,-1.1569681516089323,0.18181818181818182,0.7386298072616733,1.0,14/53,17.28%,CDH22;PKP2;CDH6;CNTNAP1;GJC1;FSCN1;CD9;CDH7;CDH19;CDH9;CDH12;WDR1;TLN1;VCL
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.6393396505496292,-1.1569293197394868,0.28125,0.7383147887832507,1.0,3/12,12.99%,HLA-A;CD55;EMP2
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.4863329433780803,-1.1568563035513295,0.24358974358974358,0.7381246646839899,1.0,18/72,17.72%,THBS1;APLNR;HK2;BRCA1;CYP1B1;CHI3L1;ANGPTL3;BTG1;WNT5A;FGF1;HYAL1;SFRP2;PIK3CD;F3;PRKCB;TEK;ETS1;AQP1
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.5971173468406709,1.1567748244403309,0.3684210526315789,0.9435196551765501,1.0,2/17,4.24%,PRNT;GCNA
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7760133513021372,1.1567581385894279,0.28888888888888886,0.942524993336705,1.0,2/5,15.67%,NCK1;NCK2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.6124124881492276,-1.1566978761371647,0.22580645161290322,0.7382833192940356,1.0,3/25,5.22%,P2RY6;P2RY12;HTR2B
prerank,CellMarker_Augmented_2021__Neuron:Embryo,-0.4778689332623592,-1.15663596509795,0.24675324675324675,0.7381382078545331,1.0,35/93,21.95%,CDH22;NEFL;NEFM;SNCB;ZDHHC22;SLC32A1;GAP43;TCEAL6;SYP;RIT2;CPLX2;CA10;TCEAL2;CALY;STMN4;SCN3B;APBA2;TMEM130;CNTN2;KCNC1;GDAP1L1;GABRA1;JPH4;TCEAL5;CELF4;ST8SIA3;PNMA2;PTPN5;STX1B;PAK5;NAP1L3;LHFPL4;VSTM2B;OPCML;HPCAL4
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5449872350741378,1.156544826155153,0.2972972972972973,0.9420340809013354,1.0,9/19,25.53%,HSPA1A;DCUN1D2;DCUN1D1;DCUN1D5;DAXX;ITCH;UBQLN1;TGFBR1;DNAJB2
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.7026308573207435,1.156488589824802,0.32,0.9412561814444638,1.0,1/6,2.36%,ABCA1
prerank,Reactome_2022__RHOT2 GTPase Cycle R-HSA-9013419,0.6607683276376353,1.1562792032452962,0.3333333333333333,0.941042996064993,1.0,4/7,25.67%,TRAK2;MYO19;MFN2;RAP1GDS1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.48538089668057377,-1.1562078900347315,0.1891891891891892,0.7393313489666283,1.0,20/84,17.72%,THBS1;APLNR;HK2;ITGA5;KLF4;BRCA1;CYP1B1;CHI3L1;ANGPTL3;BTG1;WNT5A;FGF1;HYAL1;SFRP2;PIK3CD;F3;PRKCB;TEK;ETS1;AQP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.7174510717170259,-1.1561156063502944,0.25806451612903225,0.7392405221642118,1.0,2/10,12.29%,NR4A3;IGFBP5
prerank,CellMarker_Augmented_2021__Trophoblast Stem cell:Undefined,-0.5631664500061967,-1.1560848999592928,0.2898550724637681,0.7389311543440745,1.0,4/26,4.46%,GPR87;OVOL2;MSX2;LSR
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.7086207048248757,-1.1559456416545182,0.25396825396825395,0.7387005792138164,1.0,3/10,8.45%,SLC24A2;SLC24A1;SLC8A3
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.7086207048248757,-1.1559456416545182,0.25396825396825395,0.7387005792138164,1.0,3/10,8.45%,SLC24A2;SLC24A1;SLC8A3
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.568570786016989,1.1557247217937978,0.3076923076923077,0.9422674642328337,1.0,4/16,5.66%,RIOK2;KAT2B;RIOK1;METTL18
prerank,Reactome_2022__Regulation Of Innate Immune Responses To Cytosolic DNA R-HSA-3134975,-0.6563505061463927,-1.155692318301975,0.3125,0.7391163145494648,1.0,3/11,18.52%,RPS27A;UBC;DDX41
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.6575697162893319,-1.155630388774798,0.37735849056603776,0.7389514663881591,1.0,3/8,12.06%,THBS1;WNT5A;TNIP2
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.7087537443780629,-1.155526313005417,0.3333333333333333,0.7389255569123241,1.0,3/7,21.76%,MAPT;HEBP2;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.7011403258196718,-1.1553783641375148,0.3333333333333333,0.7390433179719739,1.0,2/7,5.68%,ICAM1;THY1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.7003411107344503,-1.1553304323228077,0.30303030303030304,0.7387500560158671,1.0,3/9,16.32%,LDLR;PFDN6;PFDN1
prerank,Reactome_2022__Disinhibition Of SNARE Formation R-HSA-114516,-0.7375400258301624,-1.1551758097195086,0.34545454545454546,0.7389766401793422,1.0,3/5,25.60%,PRKCG;PRKCB;STX4
prerank,CellMarker_Augmented_2021__Muscle Satellite cell:Muscle,-0.5066891426196969,-1.1548990165504118,0.21052631578947367,0.7394255238471507,1.0,17/72,16.45%,C1ORF87;TAGLN3;PPP1R14C;PDPN;DUOXA1;FUT2;TENM4;ANKRD65;EMP1;B3GNT5;CLCA4;IGFBP7;MAP1LC3A;PDLIM4;CHST6;VWA5A;F3
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.5843253152252524,-1.1548089032692574,0.2153846153846154,0.7394241453400952,1.0,5/24,11.93%,SOCS3;ST18;ST3GAL6;STAT1;SBNO2
prerank,Reactome_2022__Regulation Of Signaling By NODAL R-HSA-1433617,0.7125792514160831,1.1547017528621342,0.3170731707317073,0.9451620221868536,1.0,2/5,12.58%,ACVR1C;ACVR2A
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.4925128453659538,-1.1546415162844383,0.1917808219178082,0.7395709709887672,1.0,9/69,6.17%,ENPP2;ANGPTL2;ALDOB;PROX1;ABCA8;GRIN2A;THY1;BGN;GRIA3
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.6501890549739577,-1.1546071503240576,0.288135593220339,0.7392584560407232,1.0,1/10,0.67%,KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.6529187010037301,-1.1544842498090673,0.3230769230769231,0.7393262561887967,1.0,3/10,12.60%,PLN;CAV3;NOS1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Bone Marrow,-0.639756079205837,-1.1541590096544077,0.3424657534246575,0.7400253129591707,1.0,3/12,10.81%,THY1;CD44;ALPL
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,-0.5090441155621508,-1.1540377216201325,0.24,0.7401419325782373,1.0,13/56,19.43%,NRN1;PSCA;CNTN5;ART3;THY1;PLET1;ALPL;SPRN;PIGA;PIGH;PIGC;CNTN4;PLAUR
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.64742915188941,1.1540028813261298,0.29545454545454547,0.9467782968980557,1.0,4/9,22.42%,ACSS1;PDHA1;MLYCD;DLAT
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.5502435311347872,1.1539390953980795,0.3103448275862069,0.9460368263330904,1.0,5/13,20.70%,NUDT21;CPSF6;CPSF7;ERN1;CPSF2
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.5402221946500851,-1.1537539734759201,0.16,0.7407314249736177,1.0,15/61,16.45%,COL4A1;COL4A2;MYOF;MMP14;MYH11;SRPX2;OSMR;EMP1;AMOTL2;RHBDF1;ITGA3;LAMA3;COL12A1;RHOD;F3
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.69728808389639,1.1537263488642122,0.3125,0.9459439870749151,1.0,1/5,2.79%,LIG4
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.7269989068649771,-1.153512482492709,0.2807017543859649,0.7413104460046591,1.0,4/7,19.11%,ATP5IF1;PINK1;MAPT;SREBF1
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,0.38291169163538147,1.1534383922691072,0.16,0.9460129249256826,1.0,28/161,13.78%,SEM1;NCSTN;PSMD10;CNTN1;POFUT1;RUNX1;PSMA1;H2BC21;MAML3;PSMD11;KAT2B;H2BC4;EGFR;CDK8;CUL1;AKT1;PSMB5;SIRT6;PBX1;H2AC6;NOTCH2;HEYL;DTX4;PSMD14;KAT2A;RFNG;H3-3B;PSMD12
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.5009283407466283,1.1533092199430195,0.3076923076923077,0.9453740499918897,1.0,5/19,17.36%,HSPA1A;BBS10;TMEM35A;PSMG2;MKKS
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.622820261256097,-1.1530638994681361,0.328125,0.7424253366546828,1.0,4/18,13.92%,PLN;CAV3;NOS1;VIP
prerank,Reactome_2022__Platelet Adhesion To Exposed Collagen R-HSA-75892,0.6182675586260726,1.1529812090822424,0.2972972972972973,0.9455922789835444,1.0,2/9,1.25%,ITGA1;ITGA10
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.6415245394240565,-1.152813792283743,0.3225806451612903,0.7428503568775089,1.0,3/12,9.00%,SCX;TENM4;NLRP5
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.6564636232898234,-1.1528117147505796,0.375,0.7424636813544492,1.0,4/11,19.10%,WNT5A;CD74;TGFB1;CUEDC2
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.5683514437984288,-1.152488384003808,0.2608695652173913,0.7431339366123234,1.0,6/26,11.20%,THBS1;TLR2;TLR3;SCIMP;HLA-B;SYK
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.5961472528133152,1.1524312985617284,0.39473684210526316,0.9468134575067818,1.0,3/13,11.91%,FHDC1;TMED5;VTI1A
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.5216154921597227,-1.1524230255089916,0.22972972972972974,0.7429390664957994,1.0,10/48,12.88%,SOCS3;RPS27A;GPNMB;DOK1;PTK6;CCND1;EGF;ELMO1;UBC;RNASE1
prerank,Reactome_2022__Glycogen Storage Diseases R-HSA-3229121,-0.6464696407309558,-1.1524018470585236,0.3157894736842105,0.7426265881629771,1.0,3/12,12.77%,RPS27A;GYG2;UBC
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.48476544170479974,-1.1523306130015973,0.18840579710144928,0.7424616277921039,1.0,26/100,14.15%,KCNT2;RIMBP2;CDH22;PCSK2;CHGB;STMN2;RCAN2;PROX1;MAOB;LRRTM1;SYT4;ELAVL4;GRIA3;ATP1B1;PLPPR1;IGSF21;CPLX2;SST;SHC2;UNC5B;KCNB2;GPC5-AS1;NPTX2;GAD2;RGS7BP;GABRG2
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.5370573073839261,-1.1519578448606564,0.18181818181818182,0.7434884466544807,1.0,4/36,9.24%,LEF1;SP100;EGF;IGF1
prerank,Reactome_2022__Erythropoietin Activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276,0.6588676216995768,1.1519102113992925,0.27906976744186046,0.9477349827114316,1.0,4/10,14.84%,EPOR;EPX;PIK3CA;PIK3R1
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,0.4842030431970834,1.1518765268240578,0.2777777777777778,0.9468127144980519,1.0,5/29,5.89%,POLD3;SLC19A1;DNA2;RFC3;STN1
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.6717027949511584,-1.1516703964731365,0.3333333333333333,0.7440681816522449,1.0,3/8,12.07%,KLF4;APOD;SIGIRR
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.5656352201130922,-1.151565792895362,0.27631578947368424,0.7440741742355681,1.0,5/27,9.24%,MYOF;DYSF;CAV3;MYH11;IGF1
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.48963481374813494,1.1514412922735842,0.23333333333333334,0.9478804028116227,1.0,6/36,12.04%,SMYD2;RFWD3;KMT5A;UBE2N;FBXO5;FEM1B
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.6943631283174682,-1.1514032258389104,0.38333333333333336,0.7442857927398538,1.0,2/8,12.36%,IRF7;IFIH1
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.45205218978844597,-1.1513972062102447,0.16304347826086957,0.7439295505754748,1.0,42/163,22.28%,COL4A1;ANGPTL2;MET;CALD1;COL4A2;LAMB1;THSD4;COL4A4;PODXL;SULF1;SCARA3;ARHGEF17;NUAK1;DAB2IP;TDRD5;RHPN1;MYO1E;AMOTL2;RHBDF1;PTH1R;ITGA3;SEMA3E;TNS2;LAMA3;COL12A1;CRB2;PTPRF;PTPRO;MAPT;PTPN21;PLCE1;ADM;COL4A3;ANTXR1;KIAA1217;CDKN1C;WWTR1;OPTN;SH3D19;MYO1B;EPB41L1;CTNND1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.6164354645055137,-1.151371847422936,0.296875,0.7436176998589347,1.0,4/15,11.60%,KCNJ2;ATP1A1;ATP1B1;TMPRSS3
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.78348644134368,1.1512578436046061,0.35,0.9475273503490458,1.0,2/5,4.92%,COX18;COX10
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Keratinocytes R-HSA-8939242,-0.6871648778842188,-1.1510869308328626,0.3584905660377358,0.7442789491101439,1.0,1/7,0.69%,SOCS3
prerank,KEGG_2021_Human__Type II diabetes mellitus,-0.5275687903253309,-1.1509700596728234,0.2608695652173913,0.7442848155905994,1.0,7/34,17.04%,SOCS3;HK2;CACNA1C;PIK3CB;PRKCD;PIK3CD;IRS2
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,-0.595458820300633,-1.150933400195248,0.3142857142857143,0.7439976846307615,1.0,7/27,18.41%,GRIN2D;NEFL;RPS6KA1;GRIN2B;RASGRF2;RPS6KA6;LRRC7
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.5434452071963752,-1.1507487719332306,0.22857142857142856,0.744237962536606,1.0,8/29,19.25%,KCNQ1;DUOX1;STAT1;IGFBP5;DMTN;AQP1;AKAP6;HCN1
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.6477323882091391,-1.1505834557365815,0.2807017543859649,0.7444877452664334,1.0,2/9,7.96%,EFNA1;ZFPM1
prerank,Reactome_2022__eNOS Activation R-HSA-203615,0.6809413393386656,1.1505170422037505,0.2926829268292683,0.9489122778769639,1.0,3/8,22.04%,AKT1;ZDHHC21;DDAH1
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5462914389682285,-1.1504690590229487,0.29850746268656714,0.7445812498814012,1.0,6/24,17.37%,NLRC5;WNT5A;ISG15;FADD;USP18;CDC37
prerank,Reactome_2022__Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,0.5969571933231648,1.1504497343158278,0.3333333333333333,0.9481158096768085,1.0,6/10,36.41%,PPP2R1B;TFDP2;PPP2R1A;RB1;PRIM1;PPP2CB
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.4359488469462466,1.1503792362643435,0.18181818181818182,0.947431714543294,1.0,16/59,21.70%,PRDX6;GDE1;CPNE3;PIGP;PLA2G4C;CSF1R;PLA2G15;GPLD1;DGKH;CPNE1;GPCPD1;ABHD6;PON1;SERINC5;PLCB1;PIGF
prerank,Reactome_2022__DNA Replication R-HSA-69306,0.3970903284748118,1.1501477599075818,0.17647058823529413,0.9473999740934976,1.0,14/117,6.89%,POLD3;SEM1;SLC19A1;CCNE1;DNA2;PSMD10;PSMA1;H2BC21;PSMD11;H2BC4;RFC3;ANAPC1;CUL1;PSMB5
prerank,Reactome_2022__RNA Polymerase I Transcription Termination R-HSA-73863,0.5065032994227427,1.1501392159941912,0.34375,0.9464114514054607,1.0,13/29,30.40%,UBTF;ERCC2;POLR1F;ERCC3;GTF2H5;GTF2H2;GTF2H3;POLR1D;CCNH;POLR1B;POLR2K;POLR1A;POLR2E
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.581332140114323,1.1498490964450048,0.2894736842105263,0.9465279312642346,1.0,5/15,12.84%,DUSP19;MAP3K4;DVL2;SASH1;TAOK3
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.45330218891039337,-1.1497823866966148,0.11764705882352941,0.7466384689754717,1.0,32/195,17.63%,KLF2;CCBE1;P2RY6;C3;TLR2;SLC39A14;DEPDC1B;SULF1;ITGA5;RSPO3;HAP1;KLK6;IGF1;SCIMP;RIMS2;FGF1;DAB2IP;GLI1;DMTN;RSPO4;CD63;EMP2;NLGN1;IL7;BDNF;CD74;RELN;MGAT5;F3;PRKCB;TEK;GPER1
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,0.3854791812665267,1.1497418020659642,0.11764705882352941,0.9458729876057143,1.0,28/120,18.09%,POLD3;SEM1;SLC19A1;DNA2;LIG4;KPNA2;H2BC21;H2BC4;RFC3;BRCC3;UBE2N;SIRT6;RAD52;XRCC2;HUS1;TDP2;MAPK8;RRAD;RAD9B;POLK;ATRIP;PALB2;RAD51B;EYA1;HERC2;DCLRE1C;PIAS4;EYA2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Kidney,-0.473631366596393,-1.1496876514854208,0.26506024096385544,0.7465992510039963,1.0,26/92,19.26%,RIMBP2;LRRC55;LRRC4;GFRA2;ELAVL4;KCNH8;PDE6B;NCALD;NELL2;RASGEF1B;GNG2;LDLRAD4;ELMO1;TMEM132C;RAB3C;RTN1;JPH4;CCND2;SH2D3C;TCEAL5;CD200;GALNT8;PRKCB;PTPRO;ST8SIA3;CNTN4
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Eye,-0.47030215268661274,-1.1495953963740864,0.23376623376623376,0.7461511706665203,1.0,13/98,13.20%,COL4A1;ANGPTL2;COL4A2;LAMB1;MAP1B;TEAD2;SCARA3;ARHGEF17;NUAK1;DAB2IP;AMOTL2;CRMP1;RHBDF1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Spinal Cord,-0.47030215268661274,-1.1495953963740864,0.23376623376623376,0.7461511706665203,1.0,13/98,13.20%,COL4A1;ANGPTL2;COL4A2;LAMB1;MAP1B;TEAD2;SCARA3;ARHGEF17;NUAK1;DAB2IP;AMOTL2;CRMP1;RHBDF1
prerank,CellMarker_Augmented_2021__Platelet:Blood,-0.5781221230433352,-1.1495252955046211,0.2328767123287671,0.7459761091301281,1.0,4/24,12.81%,ITGA2;CD9;SELP;CD63
prerank,CellMarker_Augmented_2021__Effector CD8+ Memory T (Tem) cell:Peripheral Blood,-0.505831406779773,-1.1493549170882826,0.23943661971830985,0.7462678175405171,1.0,19/59,23.75%,MYO1F;SPON2;GAB3;PATL2;TAGLN2;SH3BP5;PRSS23;DSTN;SAMD3;EMP3;PRKCB;VCL;RASSF1;LGALS1;CASP8;ADAM8;KLRD1;LITAF;MBP
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.5786488527819414,-1.1492976878408834,0.22727272727272727,0.7460880198512945,1.0,6/25,14.59%,SOCS3;RPS27A;STAT1;SYK;UBC;ELOB
prerank,KEGG_2021_Human__Thyroid hormone synthesis,-0.5029868470410309,-1.148929883211495,0.3013698630136986,0.7471416368222722,1.0,15/54,18.34%,DUOX1;ADCY7;ATP1A1;ITPR3;ATP1B1;PRKCG;CREB5;ADCY5;PAX8;ADCY3;ADCY8;PRKCB;CREB3;LRP2;HSPA5
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.7335666538016566,-1.1488348759539742,0.3333333333333333,0.747141121491286,1.0,1/6,2.85%,PDPN
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),-0.7374349281136824,-1.1487752987315856,0.31666666666666665,0.7469708505146913,1.0,2/5,17.76%,LDLR;LRP2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.6494844353605127,1.1487102257394732,0.3111111111111111,0.9488755152725593,1.0,3/11,5.26%,CARD18;TNFAIP3;GIT1
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.5605134202735029,1.148629466756273,0.2962962962962963,0.9482560967365137,1.0,1/10,6.78%,NOL11
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.646683078646887,1.148491269792847,0.3023255813953488,0.9477356220806241,1.0,3/10,16.33%,METAP1D;NAA11;METAP1
prerank,Reactome_2022__AKT Phosphorylates Targets In Nucleus R-HSA-198693,0.5991875421904478,1.1484453883032584,0.32432432432432434,0.946935938682779,1.0,2/10,6.69%,AKT2;AKT1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.6218300336260669,-1.148431037166312,0.2711864406779661,0.747779982993339,1.0,5/17,12.06%,IL12A;THY1;CCL2;PRKCQ;TNIP2
prerank,KEGG_2021_Human__IL-17 signaling pathway,-0.5122605438372684,-1.1482384032955717,0.2638888888888889,0.7480504645554895,1.0,3/53,5.98%,CXCL2;FOSB;CCL2
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.7412160382022646,-1.1481937453509168,0.29411764705882354,0.7474386396039703,1.0,3/6,17.69%,CD55;SUSD4;CR1L
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.7412160382022646,-1.1481937453509168,0.29411764705882354,0.7474386396039703,1.0,3/6,17.69%,CD55;SUSD4;CR1L
prerank,Reactome_2022__Biosynthesis Of Specialized Proresolving Mediators (SPMs) R-HSA-9018678,-0.631705866867859,-1.1481778896634174,0.31746031746031744,0.7470896647478825,1.0,2/11,13.02%,ALOX12;CYP3A4
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.7047637220286123,-1.1481267386427583,0.3230769230769231,0.7468812693366255,1.0,1/7,0.33%,THBS1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6810339945703681,-1.1481164508211092,0.3333333333333333,0.746542610076002,1.0,3/10,22.98%,STAT6;GHR;STAT3
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,0.4169297553103919,1.1479943784867936,0.1875,0.9478790102366254,1.0,17/125,9.05%,SEM1;OTUD3;PSMD10;NR2E1;PSMA1;PSMD11;PHC1;RNF2;USP13;AKT2;AKT1;EED;PSMB5;FRK;RNF146;RBBP4;CSNK2A2
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.4837623951834475,-1.1479846346472578,0.2625,0.7465907081893753,1.0,10/72,13.76%,ERCC6L;RPS27;CENPH;CENPE;ZWILCH;NUF2;SPC24;KIF2C;CENPN;CENPU
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.6536346429749963,-1.1479062421553232,0.3384615384615385,0.7464601359545808,1.0,2/14,7.29%,RAMP3;AKAP5
prerank,KEGG_2021_Human__Alcoholism,-0.4702751105909402,-1.1478965982859082,0.2375,0.7460980947296518,1.0,13/102,12.77%,GRIN2D;NPY;FOSB;GRIN3A;MAOB;GRIN2A;GNG3;SLC18A2;SHC2;CREB5;ADCY5;GNG2;GRIN2B
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5810355215504627,-1.1478173094746822,0.23943661971830985,0.7459245089225871,1.0,2/23,2.23%,TLR2;RPS27A
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),-0.7140196622825539,-1.1477386180326434,0.38181818181818183,0.7459101657664341,1.0,2/7,4.06%,TJP3;SH3GL2
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.6893518258155101,1.147730334747183,0.35714285714285715,0.9479930406127353,1.0,3/6,23.83%,OARD1;FHIT;MACROD2
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,-0.5782183965868573,-1.147727455220514,0.323943661971831,0.7455778752810005,1.0,4/25,14.33%,LAMB1;ITGA2;RNASE1;ITGA3
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.6647229086643265,1.147600929915612,0.2702702702702703,0.9476087181462219,1.0,2/8,2.59%,RNF6;UBE2T
prerank,Reactome_2022__Highly Calcium Permeable Nicotinic Acetylcholine Receptors R-HSA-629597,0.699163703698744,1.1474861040218896,0.46808510638297873,0.9459818065713873,1.0,2/5,7.96%,CHRNA4;CHRNB4
prerank,Reactome_2022__Highly Calcium Permeable Postsynaptic Nicotinic Acetylcholine Receptors R-HSA-629594,0.699163703698744,1.1474861040218896,0.46808510638297873,0.9459818065713873,1.0,2/5,7.96%,CHRNA4;CHRNB4
prerank,CellMarker_Augmented_2021__Induced Pluripotent Stem cell:Undefined,-0.6063173773511878,-1.147344291399785,0.3114754098360656,0.7465797164472979,1.0,3/18,10.81%,PODXL;KLF4;ALPL
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.6324456331207011,1.1472324215346317,0.30303030303030304,0.9448336279536672,1.0,9/10,36.77%,SESN2;SESN3;RPTOR;SESN1;MTOR;LARS1;KLHL22;UBR2;UBR1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.6324456331207011,1.1472324215346317,0.30303030303030304,0.9448336279536672,1.0,9/10,36.77%,SESN2;SESN3;RPTOR;SESN1;MTOR;LARS1;KLHL22;UBR2;UBR1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.6400416316075273,-1.147221370597681,0.24193548387096775,0.7466516848676897,1.0,3/15,9.59%,SYNGR2;SYP;STX19
prerank,Reactome_2022__RHOT1 GTPase Cycle R-HSA-9013425,0.6962530992151506,1.1467652725359865,0.3,0.9456027237735731,1.0,4/5,30.39%,TRAK2;MYO19;RAP1GDS1;RHOT1
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.584724756826359,-1.1466464835505388,0.28125,0.7481089035601591,1.0,2/23,3.56%,ITPKC;INPP5D
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.578353423193469,-1.1466315054342426,0.27941176470588236,0.7477713571646815,1.0,3/21,5.61%,PLAAT4;ZFP36;ABCA12
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),0.7145412072681399,1.1465983363868026,0.35135135135135137,0.9451751172153043,1.0,1/5,3.84%,TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.6079940654047007,-1.1465621230688234,0.2602739726027397,0.7476503924932072,1.0,5/19,20.67%,HAP1;IGF1;RTN1;RTN2;RTN4
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,0.42799953514821,1.146548328031012,0.15,0.9443384309717648,1.0,17/71,15.97%,H2BC18;NUP42;NUP37;H2BC21;H2BC4;EGFR;NUP54;TRIM28;EED;RBBP4;H2AC6;NDC1;NUP214;NFKB1;AAAS;NUP188;NUP205
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.7372045520863728,1.146289654131053,0.425531914893617,0.9441780822049943,1.0,5/5,26.30%,C17ORF75;TBC1D23;WDR11;TRIP11;FAM91A1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.5508556008816994,-1.1462636760394382,0.28169014084507044,0.7482019337321395,1.0,8/33,19.17%,MYO1F;MYO15A;SYT4;HAP1;MYO1E;CLN3;MYO1H;MYO1C
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.5858241666572032,1.1459693512865308,0.21951219512195122,0.9442827979535261,1.0,5/16,16.85%,THEM4;NAIF1;SLC25A5;MUL1;BAD
prerank,CellMarker_Augmented_2021__T2 (Transitional) B cell:Bone Marrow,-0.5684905807823994,-1.14572936613359,0.22950819672131148,0.7489708164785506,1.0,7/26,6.48%,MYO1F;CD5;TAGAP;SLA;ARHGAP9;ARHGAP15;ACAP1
prerank,CellMarker_Augmented_2021__T1 (Transitional) B cell:Bone Marrow,-0.5684905807823994,-1.14572936613359,0.22950819672131148,0.7489708164785506,1.0,7/26,6.48%,MYO1F;CD5;TAGAP;SLA;ARHGAP9;ARHGAP15;ACAP1
prerank,CellMarker_Augmented_2021__Transitional B cell:Bone Marrow,-0.5684905807823994,-1.14572936613359,0.22950819672131148,0.7489708164785506,1.0,7/26,6.48%,MYO1F;CD5;TAGAP;SLA;ARHGAP9;ARHGAP15;ACAP1
prerank,KEGG_2021_Human__Basal transcription factors,0.4736532315038295,1.1457089156205025,0.2222222222222222,0.9441829490253532,1.0,15/38,23.28%,GTF2F2;ERCC2;GTF2A2;TAF12;ERCC3;GTF2H5;TAF4;GTF2H2;GTF2H2C;TAF8;TAF2;TAF3;GTF2H3;TAF13;GTF2B
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.5446596371544545,-1.1456694170254087,0.25333333333333335,0.748792032016965,1.0,7/37,12.58%,TLR2;IRF1;TLR3;IRF7;ISG15;IFIH1;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.7085141316747757,1.1456561467322697,0.3333333333333333,0.9423046253602112,1.0,4/6,28.73%,PTGIS;SIRPA;ROCK2;KHSRP
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.7085141316747757,1.1456561467322697,0.3333333333333333,0.9423046253602112,1.0,4/6,28.73%,PTGIS;SIRPA;ROCK2;KHSRP
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.5764841024406553,-1.1455252269290193,0.21739130434782608,0.7488769026651673,1.0,5/20,15.27%,FABP3;LIPI;LIPE;LIPH;PNPLA3
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.5869990890582598,-1.1453179793874058,0.2542372881355932,0.7491771430732275,1.0,1/20,0.33%,THBS1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.6560987691214519,-1.1452503579800006,0.3220338983050847,0.7489698150965008,1.0,1/11,2.91%,KCNB1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.4742131701514289,-1.1451428276442046,0.20987654320987653,0.7489492375565197,1.0,19/98,13.93%,COL4A1;ANGPTL2;CALD1;COL4A2;LAMB1;SULF1;NNAT;THY1;LMOD1;BGN;MAP1B;SCARA3;ZIC1;SLIT3;IGFBP5;PRRX1;AMOTL2;RASL12;PTH1R
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.6592502667983005,1.145111178691532,0.28205128205128205,0.9433334952941926,1.0,4/9,18.06%,GALNT3;MGAT5B;POGLUT1;GALNT1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.578350837427851,-1.1448910479116445,0.296875,0.7493828351422415,1.0,4/21,7.87%,TYMP;KIF14;NKX6-2;TENM4
prerank,Reactome_2022__Gain-of-function MRAS Complexes Activate RAF Signaling R-HSA-9726842,0.7037474134245485,1.1448769305384838,0.3333333333333333,0.9433667337327701,1.0,4/7,25.09%,SHOC2;PPP1CC;BRAF;ARAF
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.6260650889920262,-1.1446858187292548,0.32142857142857145,0.7498016541090743,1.0,2/12,5.22%,NOS1AP;HTR2B
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.37780800737909054,1.144571007712862,0.125,0.9436151236325372,1.0,53/258,16.55%,CHRNA4;POLD3;APEX2;FANCF;ERCC8;DNA2;UBE2T;LIG4;KPNA2;PRIMPOL;MEN1;RFWD3;PMS1;RFC3;SMARCAL1;BRCC3;UBE2N;TRIM28;ERCC6;COMMD1;VCP;ERCC2;WDR33;CSNK1E;PRMT6;DCLRE1B;RAD52;MSH2;ATR;SLC30A9;XRCC2;MGME1;HUS1;TDP2;MAPK8;ERCC3;EXD2;GTF2H5;GTF2H2;GTF2H2C;TENT4A;RAD9B;POLK;ATRIP;MSH3;APTX;ALKBH3;RAD51B;ASF1A;BACH1;EYA1;HINFP;HERC2
prerank,KEGG_2021_Human__Phosphonate and phosphinate metabolism,0.6785639166237577,1.1445337422225066,0.3469387755102041,0.9426685745178522,1.0,3/6,27.45%,CHPT1;CEPT1;PCYT1B
prerank,KEGG_2021_Human__Ovarian steroidogenesis,-0.5447012590210748,-1.1443046375238304,0.32857142857142857,0.7506164250480692,1.0,10/29,17.15%,ACOT1;ADCY7;ACOT4;CYP1B1;LDLR;IGF1;ADCY5;ACOT2;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5295843759267639,-1.1441838657749466,0.2361111111111111,0.7506523256942744,1.0,4/39,9.85%,ZFP36;IFITM3;HEXIM1;POLR2I
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.6191542353157569,1.1441607396985218,0.2727272727272727,0.9429649027262634,1.0,3/10,16.16%,NUDT21;HSF1;CPEB3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),0.7577370898197178,1.1441225562732287,0.3023255813953488,0.9421044612280662,1.0,1/5,0.64%,CD200R1
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),-0.7320799019133319,-1.1437947069261618,0.3333333333333333,0.7517377628714468,1.0,1/5,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),-0.7747254441521583,-1.1437598810645646,0.34375,0.7514583425284312,1.0,2/6,8.06%,ANXA1;ANGPTL3
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.6014238544800494,-1.143730617599687,0.28125,0.7512125691287572,1.0,4/22,5.35%,HPN;EFNA1;OVOL2;ZNF750
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.5296467207112106,-1.143521658027938,0.2857142857142857,0.7515196102052151,1.0,2/40,6.92%,ANXA1;CYP1B1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5120806337194743,1.1431463472705903,0.22727272727272727,0.9440914847585914,1.0,5/19,17.98%,MSL2;KMT2A;KANSL2;KAT7;MCRS1
prerank,CellMarker_Augmented_2021__Immune cell:Undefined,-0.6931913778821066,-1.143145973766258,0.29508196721311475,0.7524214685976572,1.0,1/8,1.59%,CD5
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,-0.557733410206608,-1.1429158734036697,0.28,0.7528893725648862,1.0,6/28,12.04%,AGPAT4;DDHD2;PLD2;LPCAT4;LIPI;LIPH
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.7241255560689535,-1.1428992204615849,0.3225806451612903,0.7525387345510507,1.0,3/8,15.93%,NOS1AP;NOS1;CACNB1
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.44151042158456094,-1.1428673358163728,0.15217391304347827,0.7522835292939399,1.0,68/298,18.05%,APIP;RPL19;RPL3;KMO;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;BHMT;DUOX1;ARG2;RPL35;SLC25A21;RPL7A;RPL37A;RPL27;PAPSS2;RPL9;PSMB9;RPL21;PDHX;RPL13A;SQOR;FOLH1;CARNS1;GPT2;RPS11;RPS16;RPLP1;RPS13;TMLHE;PSMB6;RPL38;RPS3A;RPS8;RPL10A;PSMC3;CYP21A2;RPLP2;RPS23;RPS21;RPS7;LDHD;RPL8;SLC38A1;OAZ2;RPS6;RPS15;RPL26L1;RPS9;ASS1;PSMA8;RPL12;RPL5;PSMA7;FAU;RPL23;RPL4;PSME1;SOAT1;RPL18A;RPL41;RPL7;RPS12;PAH
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.6022998273064112,-1.1428606804491444,0.3088235294117647,0.7519288058138106,1.0,4/21,10.17%,NPY;ABCA6;GLYAT;FBXO32
prerank,Reactome_2022__Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.6109485293858943,-1.1427691170423335,0.3333333333333333,0.7518118898329821,1.0,7/18,16.45%,F8;SERPIND1;F13A1;PROCR;F5;SERPING1;F3
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,0.3703114566540364,1.1427321018065462,0.1,0.9447184196844319,1.0,28/255,9.92%,FGF6;PIP5K1B;SEM1;OTUD3;FLT3;PSMD10;NR2E1;KPNA2;ADCY1;PSMA1;TRIB3;PSMD11;THEM4;PHC1;RNF2;USP13;EGFR;AKT2;AKT1;EED;PSMB5;FRK;STRN;RNF146;RBBP4;CSNK2A2;PRKACB;ERBB4
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.692982384440449,-1.1426779421817714,0.3728813559322034,0.751728318411642,1.0,3/8,17.53%,ABCA12;DBI;SPP1
prerank,CellMarker_Augmented_2021__Osteoblast:Bone Marrow,-0.5156689811756852,-1.1426529225974982,0.22972972972972974,0.7510635538185952,1.0,13/55,15.16%,P2RY13;C10ORF105;LRRC4;DYSF;LDB2;MMP25;ALPL;CMTM2;WDR86;OAZ2;PPP1R14A;SFRP2;SERPING1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryoid Body,-0.5156689811756852,-1.1426529225974982,0.22972972972972974,0.7510635538185952,1.0,13/55,15.16%,P2RY13;C10ORF105;LRRC4;DYSF;LDB2;MMP25;ALPL;CMTM2;WDR86;OAZ2;PPP1R14A;SFRP2;SERPING1
prerank,Reactome_2022__Interleukin-15 Signaling R-HSA-8983432,-0.5958344554498654,-1.1426142907775925,0.2753623188405797,0.7507861798440599,1.0,4/12,22.98%,IL15;IL15RA;GAB2;STAT3
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.7623695954427281,-1.142571562893293,0.3,0.7505138244767275,1.0,3/6,19.16%,HAP1;SEPTIN9;CEP135
prerank,Reactome_2022__p75NTR Regulates Axonogenesis R-HSA-193697,0.6935304710060323,1.1423966283301523,0.38461538461538464,0.9449044227470962,1.0,1/8,0.43%,NGF
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,-0.5326838064884007,-1.1423573736364272,0.23943661971830985,0.7507909431744719,1.0,15/47,18.48%,ALDOB;LDHA;HK2;LDHAL6A;FBP1;GAPDHS;PGK1;ENO4;ADH4;GPI;ALDH3A2;PFKL;PGAM1;ENO2;PCK2
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.6158272213043711,-1.1422736426964397,0.29411764705882354,0.750656091483837,1.0,4/14,23.56%,RAMP3;ANXA2;OPTN;ECE1
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.560347021185057,-1.1422438720380999,0.2876712328767123,0.7503984053981285,1.0,9/33,18.48%,ALDOB;SLC39A14;FBP1;GAPDHS;PGK1;GPI;PGAM1;ENO2;PCK2
prerank,Reactome_2022__OAS Antiviral Response R-HSA-8983711,0.7244830997860925,1.1421829693460703,0.37209302325581395,0.9448645231169235,1.0,2/5,14.15%,PDE12;RNASEL
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.6036316077276614,1.1420411143258087,0.2727272727272727,0.9444690060137234,1.0,3/12,7.96%,LIG4;PPP1R10;SIRT6
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),0.6168374262792016,1.1420377597953306,0.35,0.9434821000513266,1.0,2/11,4.99%,CHAMP1;RCC2
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.7452087493023514,1.1419788144642542,0.2558139534883721,0.9426983975028761,1.0,1/5,5.23%,CA2
prerank,CellMarker_Augmented_2021__Retinoid Acid Signaling-Responsive Fetal Germ cell:Fetal Gonad,-0.44556184376135494,-1.1419527225938624,0.1511627906976744,0.7510013423663673,1.0,14/172,8.85%,CD24;LEF1;NPY;MYO1F;DOCK8;B2M;NEXN;COX7A1;PRDX5;NNAT;SPOCK3;CCND1;PDE6B;TSPYL2
prerank,Reactome_2022__Activated NTRK2 Signals Thru RAS R-HSA-9026519,0.6548137952188279,1.1417971841760444,0.39473684210526316,0.9425664077748636,1.0,1/6,3.57%,NRAS
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.711440468988032,1.1417900092355946,0.3111111111111111,0.9415963750620242,1.0,2/6,17.84%,PON2;PON1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.6931081755629368,1.1417546873376636,0.3333333333333333,0.9407463112356754,1.0,2/6,3.84%,NR1D1;TNFAIP3
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.6854327855860987,-1.141692408806598,0.2777777777777778,0.7516131181924225,1.0,1/12,1.11%,APLNR
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",0.4303704936555835,1.141625969115311,0.2631578947368421,0.9404518038435913,1.0,6/74,7.54%,FGF6;PIP5K1B;FLT3;EGFR;AKT1;STRN
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.47988865751442045,-1.1416000762565992,0.3076923076923077,0.7516056301736078,1.0,13/78,16.36%,HLA-A;SH3GL2;MFSD6;HLA-DRA;CENPE;AP1S1;CTSS;HLA-E;DCTN1;KIF2C;HLA-F;CD74;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.5637859785368544,1.1414183632001627,0.375,0.940287383733672,1.0,7/14,14.25%,BMP2;SOX9;TRPS1;SOX5;KAT2A;MDK;TAPT1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.4264082049059594,-1.1413820704029698,0.12371134020618557,0.7520135172882801,1.0,80/413,19.24%,PRAME;LEF1;THBS1;HPN;IL13RA1;TGFBR2;TLR2;ZFP36;PROX1;PDPN;SFTPD;IL12A;RPS4X;KIF14;RAMP3;COPS9;IL15;COLEC12;HTR2B;SCX;TRPC3;MMP14;PTK6;TIMP1;CCND1;EGF;TENM4;SRF;RPS6KA1;OSMR;IGF1;S1PR3;THPO;WNT5A;TGFA;FGF1;ROMO1;FN1;NAMPT;FOXM1;GLI1;FLOT1;EMP2;FGF7;SLC11A1;IL7;NOXA1;VIP;HYAL1;RPS6;MFSD2A;MYRF;RPS9;SFRP2;DDRGK1;PRKCD;ECHDC3;CDK2;CCND2;RHOD;CAPN1;CDC7;FGF22;RPL23;FASN;IRS2;RYR2;ETS1;GPER1;RIPK2;TGFB1;MAPT;NUPR1;SPDYA;AKAP6;IER5;IL15RA;PDGFRA;CAPNS1;CD36
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Abdominal Adipose Tissue,-0.7156310845846813,-1.141175710208675,0.3333333333333333,0.7520264509916623,1.0,2/8,7.03%,THY1;CD44
prerank,CellMarker_Augmented_2021__Fibroblast:Vocal Fold,-0.7156310845846813,-1.141175710208675,0.3333333333333333,0.7520264509916623,1.0,2/8,7.03%,THY1;CD44
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.5891333748795402,-1.141171298087328,0.2835820895522388,0.7516700123848786,1.0,11/20,25.61%,SYT4;SYT1;RIMS2;SYT5;SYT2;SYT13;DOC2B;SYT12;RIMS1;SYT17;RIMS3
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.6848660079918479,-1.1410392330875907,0.28846153846153844,0.751855647103876,1.0,2/8,9.68%,TESC;THPO
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.48205297574514827,-1.141014929430703,0.2625,0.7515655689897566,1.0,10/76,13.76%,ERCC6L;RPS27;CENPH;CENPE;ZWILCH;NUF2;SPC24;KIF2C;CENPN;CENPU
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.64950968130375,-1.1409359199930464,0.36764705882352944,0.751407545903872,1.0,1/16,0.81%,BLM
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.5097839294293712,-1.140811102443205,0.30864197530864196,0.7515130739353039,1.0,11/64,12.15%,ANXA1;SIX3;OVOL3;PROX1;OVOL2;AKR1C1;BASP1;VIL1;TAGLN2;PGK1;GLI1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.5192058580504074,-1.1407946314212913,0.27631578947368424,0.7511954007958371,1.0,9/58,12.06%,CXCL2;TLR2;ZFP36;PDCD1LG2;CCL2;WNT5A;DAB2IP;SBNO2;TNIP2
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.5171050667672165,-1.1407210508292758,0.22784810126582278,0.7511881609370146,1.0,5/63,10.55%,CCNB2;TUBB6;VRK2;LMNB1;CCNB1
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.8330901663262328,-1.1407055853073458,0.2653061224489796,0.7508662749927361,1.0,5/5,16.72%,PODXL;FSCN1;PLD1;RAP1GAP;ATP8B1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.5087192017380735,1.1404961857840843,0.2619047619047619,0.9427101312576049,1.0,8/23,19.10%,ABHD17A;LYPLA2;ABHD17B;SIRT6;SIRT5;ABHD17C;LYPLAL1;HDAC10
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.5773663784616383,-1.1403283263627282,0.3939393939393939,0.7518026931217447,1.0,1/21,2.00%,STMN2
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.614498317758045,-1.1401237534974054,0.2542372881355932,0.752104803938501,1.0,5/14,12.58%,SKAP1;KLF4;THY1;CD44;FLOT1
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.6660906686824991,-1.1396885408414823,0.288135593220339,0.7534101073947239,1.0,3/15,5.22%,P2RY6;P2RY12;HTR2B
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.6938486839521378,1.1396723451553172,0.3541666666666667,0.9444465827244409,1.0,5/7,27.47%,AKT1;BAD;CLOCK;RFX3;RHEB
prerank,CellMarker_Augmented_2021__Pericyte:Subcutaneous Adipose Tissue,-0.5298065676021374,-1.1394666477547641,0.25333333333333335,0.7538704607298856,1.0,26/58,18.20%,GGT5;APLNR;ABCA8;RAMP3;COX7A1;BGN;PODN;LDB2;MYH11;GALNT15;IGFBP7;SELP;CFH;RNASE1;PCDH12;MMRN2;ROBO4;MCAM;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ANGPT2;ITIH5;A2M
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.6181927532608482,1.1394376420004875,0.32558139534883723,0.9445366849305987,1.0,3/9,15.48%,ACADM;ETFDH;ACADS
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.6182962575844269,1.1392981531019792,0.35714285714285715,0.9440170659539557,1.0,3/10,10.29%,SOX8;SOX9;ANKRD2
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.6996427144846111,1.1392368521275784,0.358974358974359,0.9432057777125654,1.0,2/5,19.39%,ENPP3;DCK
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.49926319988900103,-1.139046861107982,0.2564102564102564,0.7548128577242952,1.0,9/60,12.06%,CXCL2;ZFP36;PDCD1LG2;CCL2;WNT5A;DAB2IP;IL18;SBNO2;TNIP2
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.6246115130139503,-1.1390400710095947,0.2542372881355932,0.7544667108215387,1.0,3/16,8.96%,B2M;HLA-A;AP1S1
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.7292536137447037,1.139005829245456,0.3448275862068966,0.9431448122753324,1.0,1/5,3.84%,TNFAIP3
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Undefined,-0.5137705922690657,-1.1389679069770593,0.2702702702702703,0.7543642621399256,1.0,18/57,16.86%,ICAM1;CSPG4;ITGA2;ADGRE5;ITGA5;THY1;CD44;IL4R;CD9;ALPL;FN1;CD55;CD63;TNFRSF1A;ITGA3;ITGB4;MCAM;CD200
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.5273152961668253,1.1387867756030714,0.3103448275862069,0.9431073436811642,1.0,9/17,29.88%,PTPN23;RAB21;VPS11;DNAJC13;MAP2K2;EZR;SNX3;SNX12;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.5685092213710798,-1.1386761878465987,0.3472222222222222,0.7549354729390361,1.0,3/30,3.82%,KCNQ1;NOS1AP;KCNJ2
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.6132489167450005,-1.1383505117121964,0.2459016393442623,0.7557679185240455,1.0,1/18,1.14%,AMN
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.47055846919385985,-1.1383438206036833,0.2625,0.7554032956534923,1.0,6/100,5.98%,RASGRP1;S100A10;DOCK8;RASGRP2;THY1;CCL2
prerank,CellMarker_Augmented_2021__Megakaryocyte:Undefined,-0.6742261965206003,-1.1382685445346787,0.34328358208955223,0.7552585491267086,1.0,3/9,14.46%,CD9;SELP;IL3RA
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.613404708634931,1.1380017280269374,0.34146341463414637,0.9452295564209628,1.0,3/8,20.59%,COMMD1;WNK3;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.7708790518698125,-1.1375948693158788,0.3492063492063492,0.756906502856308,1.0,3/5,19.16%,HAP1;SEPTIN9;CEP135
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.4470138027560892,-1.1374344622523598,0.18292682926829268,0.7570784220528446,1.0,26/127,18.84%,GBP2;GBP1;ZFP36;ST18;YBX3;CCL2;BRCA1;TNFRSF14;PSMB9;CHI3L1;STAT1;PSMB6;BIRC3;DAB2IP;PSMC3;MAP3K14;TNFRSF1A;HYAL1;PSMA8;LTBR;PSMA7;ERBIN;PSME1;GPER1;GSDME;GBP3
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.47386949804410294,-1.1374310379759045,0.2727272727272727,0.7567092097314515,1.0,27/91,19.56%,THBS1;SPARC;F8;APP;TIMP1;EGF;F13A1;GTPBP2;IGF1;TAGLN2;CD9;FN1;SELP;CD63;F5;SRGN;WDR1;SERPING1;TLN1;VCL;TGFB1;FERMT3;A2M;TF;SELENOP;CD36;RAB27B
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.7185219082845398,-1.1374284133372605,0.3709677419354839,0.7563357053236064,1.0,1/6,6.33%,CAV3
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.4347539223929679,1.1374219444325027,0.21739130434782608,0.9463561727423891,1.0,5/38,5.49%,DNA2;RIDA;HSPA1A;ZPR1;NUDT16L1
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,0.4993105480214878,1.1374049450678594,0.25,0.9454185045384887,1.0,1/24,0.16%,FGF6
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.44840523927825676,-1.137239446700954,0.1978021978021978,0.7566427568075105,1.0,44/192,18.79%,THBS1;RASGRP1;SPARC;RASGRP2;P2RY12;PDPN;F8;GNG3;APP;TRPC3;GP6;TIMP1;ITPR3;EGF;SGPP2;F13A1;GTPBP2;PRKCG;IGF1;TAGLN2;THPO;CD9;PRKCQ;SYK;FN1;GNG2;PRKCH;CD63;RNASE1;F5;SRGN;PIK3CB;WDR1;SERPING1;VAV1;PRKCD;TLN1;PRKCB;VCL;TGFB1;FERMT3;HSPA5;TF;SELENOP
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.5265955650672665,1.1372012034782368,0.36666666666666664,0.9451693789833645,1.0,4/20,10.43%,SAMM50;COX18;MAIP1;TOMM22
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.6330361526088426,-1.1371296022061481,0.2857142857142857,0.7566514882517237,1.0,5/15,14.80%,CCBE1;IL12A;DAB2IP;CD63;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.6962127321949699,-1.1370472374670144,0.32142857142857145,0.7565950530703106,1.0,4/7,18.75%,PIK3IP1;DAB2IP;TSC2;NLRC3
prerank,CellMarker_Augmented_2021__Monocyte:Liver,-0.5573088219479906,-1.136983122182876,0.22727272727272727,0.7564177269861027,1.0,9/21,10.58%,P2RY13;MYO1F;TYMP;TLR2;SIGLEC1;IGSF6;CLEC12A;CTSS;PILRA
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.51775557747255,-1.1369204227472764,0.3235294117647059,0.7562638251792302,1.0,1/46,0.11%,LEF1
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.6707729013888992,1.136769609279289,0.2765957446808511,0.9449630027087302,1.0,6/7,32.10%,EEFSEC;SEPSECS;SECISBP2;SELENOT;SECISBP2L;DIO2
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.6707729013888992,1.136769609279289,0.2765957446808511,0.9449630027087302,1.0,6/7,32.10%,EEFSEC;SEPSECS;SECISBP2;SELENOT;SECISBP2L;DIO2
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.49969586914541947,-1.1367687422374428,0.28169014084507044,0.7564632623936566,1.0,18/60,18.86%,P2RY12;RCAN2;ACKR4;HTR2B;ATP1B1;LAT2;CHRM3;PPP3CC;CACNA1C;SELP;NUDT4;DMTN;CCR10;RCAN3;RYR2;MCTP1;PPP1R9A;PLCE1
prerank,Reactome_2022__Keratan Sulfate Degradation R-HSA-2022857,-0.732860925736258,-1.1366720400765107,0.3442622950819672,0.7564999306780056,1.0,2/7,6.95%,OGN;OMD
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.6360384457091726,-1.1366597913210195,0.2833333333333333,0.7561651581922028,1.0,3/13,4.61%,IHO1;MEIOB;RNF212B
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.6345364696869477,1.1365416168281937,0.35135135135135137,0.9449819508054234,1.0,3/8,16.49%,GLUD1;GLS;GLUL
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),-0.7610784294125578,-1.1364971394114334,0.42105263157894735,0.7563689870707969,1.0,2/5,12.36%,TLR3;IFIH1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.4049051201852902,1.1363863536656156,0.23529411764705882,0.9447342905426852,1.0,18/96,16.89%,CD247;PPARGC1A;MITF;OCLN;SOX9;LPXN;NUP54;TCAP;LLGL1;MDN1;NDC1;KMT2A;CAPZA1;WASL;NUP205;VAMP3;PICALM;PARD6B
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5156490632368405,1.1359911257293955,0.2631578947368421,0.9452628719057066,1.0,3/18,6.91%,ABCD2;ABCD1;RAB27A
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,0.4603723641740529,1.1358982196671723,0.2857142857142857,0.944575909875986,1.0,7/32,15.45%,NGF;NRAS;RALB;RALA;MAPK12;SHC3;CRKL
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.740863076622948,-1.135883800881783,0.4032258064516129,0.7582932875536718,1.0,3/5,18.05%,ALPL;SPP1;CDKN2D
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.5809672861432581,-1.1358780479309496,0.3225806451612903,0.7579442160080686,1.0,2/20,6.03%,IHO1;HROB
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,-0.6099411795178198,-1.1358684395599028,0.2777777777777778,0.757604757936066,1.0,2/16,2.78%,THBS1;ITGA2
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.5262262357724278,-1.135860833853699,0.3116883116883117,0.7572610059348234,1.0,9/55,8.45%,SLC39A14;KCNJ13;KCNJ2;SLC24A2;ATP1A1;SLC24A1;SLC9A2;ATP1B1;SLC8A3
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,-0.5101389587405702,-1.1355026371672514,0.2876712328767123,0.7581766095089001,1.0,10/44,18.28%,CDKN2A;RPS27A;PTK6;CCND1;CCNE2;UBC;CDK2;CCND2;CDKN2D;CDKN1A
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.6240787958807235,-1.1352860041148525,0.30434782608695654,0.7584343512104167,1.0,1/13,0.94%,DUSP1
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.5017667188234904,-1.1349973003216867,0.21621621621621623,0.7589230443240619,1.0,22/73,18.41%,ANK3;NEFL;GRIN2A;APP;GRIA3;JPH3;GRIA1;MINK1;CTSS;HPCA;SHISA9;KCNG1;NOS1;GRIN2B;SHISA8;NLGN1;RELN;JPH4;CACNB1;CAPN1;FGF12;LRRC7
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),-0.7452743851859711,-1.134977428107883,0.37037037037037035,0.7585978078233893,1.0,3/5,17.72%,YBX3;RCSD1;AQP1
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.7078054472692448,1.1349616091287857,0.35555555555555557,0.9469754104813147,1.0,2/6,19.45%,RORB;RP1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.7177771431746678,1.134772031969919,0.3541666666666667,0.9466459296047587,1.0,2/7,14.42%,PSMD10;NFKBIB
prerank,KEGG_2021_Human__Pentose phosphate pathway,-0.5809294398238676,-1.1346315899526995,0.3150684931506849,0.7594462614860983,1.0,6/23,17.07%,ALDOB;FBP1;RBKS;GPI;GLYCTK;PFKL
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5602719835029908,-1.1345118332126487,0.2463768115942029,0.7594304452137783,1.0,3/27,8.19%,BLM;BRCA1;DONSON
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.5776015095813675,1.1344540677953088,0.2682926829268293,0.946674581046287,1.0,3/14,18.04%,GNL3L;MUL1;PIAS4
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.5421530546367366,-1.134310530484778,0.35526315789473684,0.7596638539156022,1.0,8/33,18.62%,C3;B2M;EGF;SFRP4;CD63;ANXA2;AHI1;TF
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.684515970361163,-1.1341765337536949,0.3157894736842105,0.7597586505964549,1.0,4/7,22.84%,TNFRSF1A;TGFB1;CHADL;EMILIN1
prerank,KEGG_2021_Human__TNF signaling pathway,-0.4741293428513953,-1.1340006072865199,0.1518987341772152,0.7599732246065736,1.0,17/87,15.87%,CXCL2;SOCS3;ICAM1;IRF1;IL15;CCL2;MMP14;CREB5;BIRC3;DAB2IP;MAP3K14;FADD;TNFRSF1A;FOS;PIK3CB;PIK3CD;JUNB
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.7299676227561268,-1.1333527855825445,0.40350877192982454,0.7619617232020738,1.0,1/7,3.97%,RAB11A
prerank,Reactome_2022__Noncanonical Activation Of NOTCH3 R-HSA-9017802,0.6822679165094249,1.1333039814087578,0.37254901960784315,0.9495599637403629,1.0,1/6,1.39%,NCSTN
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,0.48067833459172116,1.1328376522138606,0.23333333333333334,0.9501264566286844,1.0,7/27,14.84%,TRIB3;THEM4;AKT2;YES1;AKT1;PIK3CA;PIK3R1
prerank,CellMarker_Augmented_2021__Dendritic cell:Bone Marrow,-0.5649441291150921,-1.1328051504197114,0.2727272727272727,0.7635060941916526,1.0,11/25,21.57%,GPR183;TAGAP;HLA-DRA;CTSS;CD74;HLA-DRB1;WDFY4;NAPSB;SPI1;PTPRC;PTAFR
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.45886641666617306,1.132738899879753,0.17142857142857143,0.949542205773911,1.0,3/23,7.46%,SLIT1;NLGN3;ALCAM
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.5208946270049765,-1.1326817996804186,0.2465753424657534,0.7636908792069906,1.0,5/45,2.16%,CXCL2;S100A10;EFNA1;C3;EPS8L2
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.5650990148094192,1.1325796053525776,0.2564102564102564,0.9490854661041934,1.0,4/9,19.38%,ALDH1A1;ADH5;ACSS1;ALDH2
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.6285665669077611,-1.132525141071819,0.32786885245901637,0.763889285879393,1.0,2/11,10.67%,WDR54;LRPAP1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.4588041404665301,-1.1323697124165493,0.2804878048780488,0.7641150912324931,1.0,29/145,18.27%,NPY;FLRT3;POU4F1;STMN2;L1CAM;LAMB1;SHTN1;CNTNAP1;RAB11A;SH3GL2;PLP1;APP;SVBP;NEFH;NYAP1;MINK1;DAB2IP;STMN4;NLGN1;BDNF;GRM7;MICALL1;STMN1;MICALL2;DOCK10;CDK5;TBC1D24;MAPT;PPP1R9A
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.5455894446089052,-1.1322850447902255,0.3076923076923077,0.7640234954050086,1.0,10/27,19.24%,ICAM1;RAMP3;GRIN2A;APP;IGF1;CACNB1;SNX6;CDK5;ABCC1;CD36
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,0.4915906395902527,1.1322557247401672,0.21875,0.9492147574620531,1.0,6/30,17.55%,BET1;SEC22B;STX7;VTI1A;VAMP3;SNAP29
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.555230478011556,-1.1316853461372653,0.29333333333333333,0.7656733155197348,1.0,4/26,12.77%,ALDOB;RPS27A;GYG2;UBC
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Embryonic Prefrontal Cortex,-0.4812122007625353,-1.1315151422523504,0.2638888888888889,0.7658198404348898,1.0,16/104,10.25%,CD24;C2ORF80;ANGPTL2;SPARC;TMSB10;B2M;STMN2;SHTN1;ELAVL4;APOD;DBI;NEUROD2;SYT1;CA10;MLLT11;CD9
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.4913414965504645,1.1313702625609843,0.2894736842105263,0.9514984695132643,1.0,7/27,14.77%,PSMD10;HSPA1A;AKT1;VAT1;OPA1;SLC25A5;MUL1
prerank,Reactome_2022__Activation Of Caspases Thru Apoptosome-Mediated Cleavage R-HSA-111459,0.6906437342656111,1.1313660562874723,0.38095238095238093,0.9495781900591509,1.0,1/6,11.67%,CASP3
prerank,Reactome_2022__SMAC (DIABLO) Binds To IAPs R-HSA-111463,0.6906437342656111,1.1313660562874723,0.38095238095238093,0.9495781900591509,1.0,1/6,11.67%,CASP3
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.6438614925984133,-1.1313417545294353,0.3090909090909091,0.7660580212274251,1.0,1/13,2.20%,ZFP36
prerank,KEGG_2021_Human__Ascorbate and aldarate metabolism,0.5895302171329986,1.131338987400665,0.41304347826086957,0.9487352181281351,1.0,3/9,19.38%,ALDH7A1;RGN;ALDH2
prerank,Reactome_2022__FGFR3 Ligand Binding And Activation R-HSA-190239,0.6825489112357919,1.131236960000468,0.3953488372093023,0.9482820508911105,1.0,1/6,1.03%,GALNT3
prerank,Reactome_2022__Mitochondrial Iron-Sulfur Cluster Biogenesis R-HSA-1362409,0.5866347446416136,1.1312180320953402,0.30952380952380953,0.9473736584996675,1.0,2/11,7.29%,SLC25A37;LYRM4
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,0.4954733298120907,1.131163695889261,0.3055555555555556,0.9465924036184991,1.0,7/18,17.29%,NCK1;CASK;WASL;PIK3CA;PIK3R1;NCK2;MAGI2
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.634018426641917,-1.1310714072022052,0.35714285714285715,0.766612522247759,1.0,1/7,2.18%,COL5A1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),0.7100358016489386,1.1309925913281238,0.3684210526315789,0.9462110359165304,1.0,2/5,14.77%,SIRPA;MUL1
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.6712072374144078,1.130859338124683,0.375,0.9457281112480235,1.0,2/7,14.66%,GAS1;SERPINE2
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.719119136919243,-1.1307762155089545,0.42592592592592593,0.767212332950636,1.0,2/5,18.14%,PLSCR1;MAPT
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.5644829766396013,-1.1307135994925968,0.26153846153846155,0.7670736528169666,1.0,7/19,19.40%,STAT4;CCL2;STAT1;THPO;STAT6;NMI;GHR
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6822642928116007,-1.1305860160423284,0.288135593220339,0.7670817004969188,1.0,4/11,12.60%,ANK3;GLRX;ATP1B1;NOS1
prerank,Reactome_2022__Developmental Biology R-HSA-1266738,-0.416296132680838,-1.130581660601751,0.08,0.7667280199606742,1.0,158/707,20.65%,CACNA1H;CD24;LEF1;COL4A1;EFNA1;SCN1B;FLRT3;PKP2;RPL19;COL4A2;RPL3;L1CAM;ANK3;LAMB1;RPS27A;RPL39L;RPL36AL;RPS27;ITGA2;SHTN1;COL4A4;CNTNAP1;RPS14;RPS4X;RPL27A;SH3GL2;SCN9A;DOK1;SPINK9;COL6A2;RPL35;ITGA5;KLF4;RPL7A;FLG;GFRA2;TRPC3;RPL37A;VLDLR;RPL27;EFNB3;GAP43;LDB2;ARHGAP39;AKAP5;RPL9;PSMB9;RPL21;PDHX;MYH11;RPL13A;RPS6KA1;NELL2;MAG;PFN2;DOK6;CELA2A;POLR2I;HELZ2;RPS11;RPS16;RPLP1;SCN2A;RPS13;PSMB6;KAZN;CACNA1C;UNC5B;RPL38;PRKCQ;SLIT3;SCN1A;ADIRF;RPS3A;RPS8;RPL10A;PSMC3;MYH9;RPLP2;RPS23;RPS21;RPS7;UBC;GRIN2B;RNASE1;CRMP1;SPINK6;SCN3B;RAP1GAP;ITGA9;RPL8;FES;SEMA3E;RPS6;ELOB;RPS15;PIK3CB;RPL26L1;CNTN2;RPS9;PSMA8;RPL12;APH1A;RPL5;RELN;DPYSL2;CDK2;ANK1;CACNB1;TLN1;CAPN1;PSMA7;FAU;COL9A2;RPL23;RPL4;CEBPD;PML;IRS2;SH3KBP1;GPC1;PSME1;CDK5;RPL18A;RBX1;RPL41;LIMK2;RPL7;RPS12;TGFB1;RPS6KA6;CDKN1A;RARG;RPS20;NUMB;KRTAP5-11;CAPNS1;SREBF1;ZNF467;CD36;RPL15;COL4A3;CLTB;AGRN;ARPC3;DPYSL3;DNM1;RPL11;TRPC5;STX1B;SPI1;H2AZ1;RPS25;RPL29;RPL36;MYL6;HJV;WWTR1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.5745860462255246,-1.1305532277580024,0.3484848484848485,0.7664341808995552,1.0,7/21,18.61%,GBP1;MRAP2;TMBIM1;DMTN;PPFIA1;TGFB1;NUMB
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.7342371193321295,-1.1304427841134441,0.3333333333333333,0.7664242333712408,1.0,4/6,21.64%,KCNK1;KCNK12;KCNK10;KCNK13
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,0.5710125585190924,1.1301979842130567,0.2222222222222222,0.9470520316674449,1.0,3/14,13.55%,CDC25A;RBBP4;E2F4
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.4617093950517267,-1.1301467376532102,0.23333333333333334,0.7669949401951273,1.0,20/158,11.27%,RASGRP1;P2RY6;APIP;GBP1;GPR183;ICAM1;PSCA;RAMP3;GPNMB;APP;HTR2B;CCL2;CEACAM1;CD44;CHI3L1;THPO;SCIMP;DAB2IP;SYK;FN1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.5659655581999857,1.1299138591220619,0.2916666666666667,0.9469890469200638,1.0,8/23,20.48%,PRELID2;MTTP;SLC25A19;SCP2;PRELID3B;PCTP;NPC2;TRIAP1
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.6012562867788394,1.1298277420176344,0.3333333333333333,0.9463481029662708,1.0,4/13,8.28%,SERPINB9;TRIM24;NCOA4;AR
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.48389035169024974,-1.129710898028779,0.2692307692307692,0.7681728664739795,1.0,14/70,14.47%,POU4F1;ANK3;CCK;SHTN1;S100A6;APP;SLITRK1;MAP1B;BAIAP2;NEFH;MINK1;SLITRK4;SLITRK5;MFSD2A
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.5630091417214969,-1.1296642440833777,0.3,0.7679519758672505,1.0,7/21,12.55%,COL5A1;PDPN;ITGA5;CEACAM1;CD44;PLET1;TMEFF2
prerank,CellMarker_Augmented_2021__M2 macrophage:Brain,-0.52587386238866,-1.1295297621861082,0.3235294117647059,0.7672814785742096,1.0,11/34,10.15%,P2RY13;MYO1F;TLR2;GPR34;SLA;SIGLEC1;HLA-DRA;IGSF6;CLEC12A;F13A1;CTSS
prerank,CellMarker_Augmented_2021__M2 macrophage:Serum,-0.52587386238866,-1.1295297621861082,0.3235294117647059,0.7672814785742096,1.0,11/34,10.15%,P2RY13;MYO1F;TLR2;GPR34;SLA;SIGLEC1;HLA-DRA;IGSF6;CLEC12A;F13A1;CTSS
prerank,CellMarker_Augmented_2021__Kupffer cell:Fetal Liver,-0.52587386238866,-1.1295297621861082,0.3235294117647059,0.7672814785742096,1.0,11/34,10.15%,P2RY13;MYO1F;TLR2;GPR34;SLA;SIGLEC1;HLA-DRA;IGSF6;CLEC12A;F13A1;CTSS
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.48360751676644936,1.1294377704300989,0.28,0.9468068365574085,1.0,12/44,18.21%,LEPR;FLT3;RABL3;PBX1;MSH2;TOX;SLC25A5;KAT7;DCAF1;CHD7;CEBPG;GPR89B
prerank,Reactome_2022__Trafficking And Processing Of Endosomal TLR R-HSA-1679131,-0.6698733318471204,-1.1292501020957593,0.36538461538461536,0.768014202280136,1.0,2/10,10.15%,TLR3;CTSS
prerank,Reactome_2022__Translation R-HSA-72766,-0.43013751545611195,-1.1292274819400114,0.22580645161290322,0.7677210268092615,1.0,62/257,20.53%,RPL19;RPL3;RPS27A;WARS1;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;EIF2B2;RPS11;RPS16;RPLP1;RPS13;RPL38;DLGAP3;RPS3A;RPS8;RPL10A;RPLP2;RPS23;SEC11C;RPS21;RPS7;RPL8;RPS6;RPS15;SSR4;RPL26L1;RPS9;RPL12;MRPL20;RPL5;EEF1A2;GARS1;FAU;RPL23;RPL4;AURKAIP1;RPL18A;RPL41;RPL7;RPS12;RPS20;MRPL23;PPA1;GADD45GIP1;RPL15;MRPL51;RPL11;DARS2;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5998702205248356,-1.1287767569139124,0.34375,0.7683782092607406,1.0,3/15,10.87%,IFI6;GATA1;UNC5B
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5998702205248356,-1.1287767569139124,0.34375,0.7683782092607406,1.0,3/15,10.87%,IFI6;GATA1;UNC5B
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.6832137179619805,-1.1286055702603166,0.39215686274509803,0.7685084075729549,1.0,1/7,5.90%,PDCD1LG2
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.6738375061922295,1.128600307088996,0.2619047619047619,0.9489954484524761,1.0,2/7,8.50%,PRDM4;PRMT6
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.4689107448537794,1.128063521652514,0.30303030303030304,0.9501173928021692,1.0,8/36,7.54%,LEPR;TFCP2L1;MUC20;EHF;ALDH1A1;TRIM29;CYP4F12;CAPN13
prerank,Reactome_2022__Uptake And Function Of Diphtheria Toxin R-HSA-5336415,-0.7133082295145694,-1.1280394410634813,0.36363636363636365,0.769770802434206,1.0,1/5,10.25%,CD9
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.4730352841748512,-1.1280123495343497,0.3125,0.7694820305534065,1.0,10/54,19.00%,ANXA1;PRDX5;CYP1B1;ROMO1;FOS;PRKCD;ANKZF1;AQP1;MAPT;PDGFRA
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.6838673301963286,-1.1279621208920596,0.37735849056603776,0.7693025732829145,1.0,2/8,17.65%,NOD1;RIPK2
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.6962516077665405,-1.127960242437621,0.3888888888888889,0.7689461979105923,1.0,1/6,16.59%,CLN3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.7232858199914405,1.1278757695570745,0.4523809523809524,0.9498371615379242,1.0,4/7,24.36%,VCP;TFIP11;DYRK3;ZFAND1
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.6813962353881203,-1.1276378667843665,0.3389830508474576,0.7696658252603356,1.0,1/8,1.45%,TGFBR2
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,0.49071791371417245,1.1275893858095738,0.3225806451612903,0.9500424681949148,1.0,11/32,19.55%,NT5C1A;AOX1;SIRT6;SIRT5;NADK2;ENPP3;NADSYN1;CD38;NT5M;NNT;NMRK1
prerank,Reactome_2022__IRAK4 Deficiency (TLR2/4) R-HSA-5603041,-0.6615190398378464,-1.1275565410120485,0.3050847457627119,0.7695863417977413,1.0,2/10,6.11%,TLR2;NDUFA2
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.4547897494394221,-1.1275384191182198,0.21333333333333335,0.7692575535403449,1.0,8/104,8.72%,CD24;THBS1;CDKN2A;APP;NLRC5;LDB2;EGF;SRPX2
prerank,Reactome_2022__Miro GTPase Cycle R-HSA-9715370,0.6176972281064418,1.1272649234065717,0.375,0.9503938428752902,1.0,5/8,30.39%,TRAK2;MYO19;MFN2;RAP1GDS1;RHOT1
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.5748171952931351,-1.1271003743017316,0.26785714285714285,0.7703657339857088,1.0,3/21,7.01%,THBS1;TLR2;APOD
prerank,KEGG_2021_Human__MicroRNAs in cancer,-0.4478451046176026,-1.1270999392408132,0.2804878048780488,0.7699915884131078,1.0,25/135,18.28%,THBS1;EFNA1;CDKN2A;MET;FSCN1;ITGA5;ABCB1;BRCA1;CYP1B1;CD44;CCND1;PRKCG;BCL2L2;CCNE2;PIM1;PIK3CB;STMN1;PIK3CD;CCND2;IRS2;PRKCB;NOTCH3;RASSF1;ABCC1;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.42953476998409656,1.1268989418960804,0.23809523809523808,0.9507445196913548,1.0,4/47,4.15%,ACE2;WNT7A;SLITRK2;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.46365588763646526,-1.1265510531653606,0.27586206896551724,0.771469601166321,1.0,20/170,11.12%,CD24;RASGRP1;P2RY6;GPR183;ICAM1;TRIM5;RAMP3;GPNMB;APP;HTR2B;CCL2;CD44;EGF;RIT2;CHI3L1;IGF1;THPO;SCIMP;FGF1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.5851571995331667,-1.1265460722709912,0.2903225806451613,0.771122435584872,1.0,4/17,18.35%,PSRC1;DCTN1;ANKRD53;FSD1
prerank,KEGG_2021_Human__DNA replication,0.4568005245342292,1.126394119093171,0.21428571428571427,0.9515443024442589,1.0,3/29,5.74%,POLD3;DNA2;RFC3
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),-0.7656761772713344,-1.1258580285815787,0.36363636363636365,0.7731457765499937,1.0,2/5,11.18%,NFKBID;PRKCQ
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,-0.5487914737739426,-1.125373795798399,0.35384615384615387,0.7743398070522797,1.0,1/24,1.24%,PGR
prerank,Reactome_2022__Expression And Translocation Of Olfactory Receptors R-HSA-9752946,-0.6532105038239706,-1.1253129152741714,0.3225806451612903,0.7741725091434042,1.0,4/12,7.40%,OR51M1;OR52N2;LDB2;OR51I2
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),-0.7397729205822026,-1.1252840894695666,0.375,0.7739285901556189,1.0,2/6,20.30%,UNC13C;STX1B
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucose-dependent Insulinotropic Polypeptide (GIP) R-HSA-400511",-0.6490117142816338,-1.1252725189756834,0.40350877192982454,0.7736217047511389,1.0,2/8,12.75%,SEC11C;C1QTNF1
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,0.4577002218880043,1.1247074145113236,0.25925925925925924,0.9566675507694303,1.0,6/50,5.74%,POLD3;SLC19A1;POLG2;H2BC21;H2BC4;RFC3
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.74725052554613,-1.1246322118999212,0.3793103448275862,0.7753501560643374,1.0,2/7,7.35%,GPR183;LFNG
prerank,Reactome_2022__Signaling By FGFR4 In Disease R-HSA-5655291,0.6819853637458788,1.124553322694321,0.4166666666666667,0.9564386128189118,1.0,5/9,23.66%,NRAS;PIK3CA;PIK3R1;PIGU;SOS1
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.5875678601445211,-1.1244180614985348,0.375,0.7757374356542643,1.0,2/9,7.40%,OR51M1;OR51I2
prerank,Reactome_2022__PTK6 Regulates RTKs And Their Effectors AKT1 And DOK1 R-HSA-8849469,-0.6829399732665206,-1.1243383739598263,0.4098360655737705,0.7756960883353721,1.0,4/9,12.77%,RPS27A;DOK1;PTK6;UBC
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.5786768667703589,1.1242773291814703,0.3333333333333333,0.9566025363882957,1.0,5/20,18.57%,TEX15;DNMT3B;BEND3;METTL4;EHMT1
prerank,Reactome_2022__Mitophagy R-HSA-5205647,-0.5687350030066833,-1.1242212672761909,0.3055555555555556,0.7756547809655804,1.0,5/25,12.77%,TOMM7;RPS27A;MAP1LC3A;PINK1;UBC
prerank,Reactome_2022__Defects In Cobalamin (B12) Metabolism R-HSA-3296469,-0.632665092582285,-1.1241902850243664,0.29310344827586204,0.7753883350796483,1.0,1/12,1.14%,AMN
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.7393735088081401,-1.1241703820327669,0.3898305084745763,0.7750681296455364,1.0,1/6,0.81%,BLM
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.7184927433236734,-1.1239945271371126,0.4166666666666667,0.7752971383677848,1.0,3/5,19.11%,ATP5IF1;PINK1;SREBF1
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Death Genes With Uncertain Roles In P53-Dependent Apoptosis R-HSA-6803205,-0.6521271855909437,-1.1238363879931659,0.3050847457627119,0.7754764586602304,1.0,4/10,16.85%,TP53I3;NDRG1;BCL2L14;BCL6
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.6363345402550031,1.1237282664578279,0.3953488372093023,0.9574045699867932,1.0,1/7,3.84%,TNFAIP3
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.6412655666242046,-1.123614020161545,0.373134328358209,0.7759028248752051,1.0,2/10,10.88%,C12ORF57;IFT122
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Liver,-0.5263887060475814,-1.12359510942771,0.3026315789473684,0.7752320263552323,1.0,17/33,19.56%,ITGA2;PLEKHG6;DUOXA1;MACC1;TMC4;CD9;TMEM40;IL18;TMBIM1;LIPH;SPINT2;ALS2CL;LTBR;CAPN1;VCL;TNFRSF10A;RAB27B
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Lung,-0.5263887060475814,-1.12359510942771,0.3026315789473684,0.7752320263552323,1.0,17/33,19.56%,ITGA2;PLEKHG6;DUOXA1;MACC1;TMC4;CD9;TMEM40;IL18;TMBIM1;LIPH;SPINT2;ALS2CL;LTBR;CAPN1;VCL;TNFRSF10A;RAB27B
prerank,Reactome_2022__Role Of Second Messengers In Netrin-1 Signaling R-HSA-418890,-0.6710004013875932,-1.1235891327887786,0.3157894736842105,0.7748814019191452,1.0,2/9,19.98%,TRPC3;TRPC5
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,-0.49903974609474944,-1.1235100015565647,0.2876712328767123,0.7747643991808965,1.0,18/60,23.65%,KCNB1;GNG3;AKAP5;ITPR3;CHRM3;CACNA1C;ADCY5;GNG2;GLP1R;SYT5;ADCY8;CD36;KCNC2;ITPR1;GNB4;GNB5;GNA14;AHCYL1
prerank,CellMarker_Augmented_2021__Naive Regulatory T (Treg) cell:Peripheral Blood,-0.5197380862902586,-1.1233719475938932,0.2923076923076923,0.7748672289414504,1.0,12/35,10.35%,MYO1F;GPR183;CD5;TAGAP;GPR171;EVI2A;SLA;ARHGAP9;ARHGAP15;RCSD1;CTSS;PTPN7
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.6266656403035682,-1.123165263670767,0.3709677419354839,0.7753016224566154,1.0,1/15,1.31%,FABP3
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.4669758445887313,1.1230906330718007,0.2692307692307692,0.9587197389174368,1.0,4/30,10.46%,PEX11A;HP1BP3;EPS8;RAB22A
prerank,CellMarker_Augmented_2021__CD14++CD16- monocyte:Blood,-0.5334539388074054,-1.1230024700916141,0.3125,0.7743644526413029,1.0,9/21,10.58%,P2RY13;MYO1F;TLR2;SLA;SIGLEC1;IGSF6;CLEC12A;CTSS;PILRA
prerank,CellMarker_Augmented_2021__Classical monocyte:Blood,-0.5334539388074054,-1.1230024700916141,0.3125,0.7743644526413029,1.0,9/21,10.58%,P2RY13;MYO1F;TLR2;SLA;SIGLEC1;IGSF6;CLEC12A;CTSS;PILRA
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Blood,-0.5334539388074054,-1.1230024700916141,0.3125,0.7743644526413029,1.0,9/21,10.58%,P2RY13;MYO1F;TLR2;SLA;SIGLEC1;IGSF6;CLEC12A;CTSS;PILRA
prerank,CellMarker_Augmented_2021__Intermediate monocyte:Blood,-0.5334539388074054,-1.1230024700916141,0.3125,0.7743644526413029,1.0,9/21,10.58%,P2RY13;MYO1F;TLR2;SLA;SIGLEC1;IGSF6;CLEC12A;CTSS;PILRA
prerank,Reactome_2022__Competing Endogenous RNAs (ceRNAs) Regulate PTEN Translation R-HSA-8948700,0.6298149088527268,1.122800474627256,0.38461538461538464,0.9588697493701978,1.0,4/10,22.75%,VAPA;CNOT6L;AGO3;TNRC6B
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.6283147569996578,1.122650498267656,0.3611111111111111,0.9586621045212064,1.0,3/8,10.96%,PPP1R15B;TMEM33;NCK1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.41423210580107583,1.1225372415482884,0.2903225806451613,0.958120173438183,1.0,14/61,17.33%,MTHFS;SLC19A1;CD320;FLAD1;TPK1;AOX1;SLC25A19;CUBN;SLC5A6;MTHFD2L;DHFR;PANK2;DHFR2;SLC46A1
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Adipose Tissue,-0.6667529007873408,-1.1223138423204895,0.36065573770491804,0.7763942586242644,1.0,3/11,7.03%,KLF4;THY1;CD44
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6688098435445333,-1.1222093372127708,0.36507936507936506,0.7763663603219847,1.0,3/9,14.80%,IL12A;DAB2IP;PIK3CB
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.5675271730241969,-1.1221593148114795,0.29508196721311475,0.7761419450909396,1.0,2/16,2.93%,TYMS;GMPR
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.45927226678690714,-1.1220558342475075,0.3132530120481928,0.7761231238060867,1.0,19/100,14.43%,ENPP2;TMSB10;NEXN;KIF14;DUOX1;CEACAM1;SPOCK3;LDB2;EGF;WAS;MINK1;SST;FGF1;AMOTL2;FGF7;SPINT2;FES;CCDC25;ROBO4
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),0.6520392281533052,1.1219345273598107,0.391304347826087,0.9595297757531613,1.0,4/7,25.58%,DCLRE1B;TFIP11;DCLRE1C;DCLRE1A
prerank,Reactome_2022__Nef Mediated CD8 Down-regulation R-HSA-182218,0.7047436019982896,1.1218157957698505,0.37777777777777777,0.9589991916194339,1.0,1/6,8.89%,AP2B1
prerank,CellMarker_Augmented_2021__Specialist Antigen Presenting cell:Undefined,-0.5797483531270775,-1.121723009975372,0.2923076923076923,0.7769388317097519,1.0,3/20,4.39%,CD5;TLR2;SIGLEC1
prerank,CellMarker_Augmented_2021__B cell:Kidney,-0.42619285334499274,-1.121590656242115,0.11827956989247312,0.7770177781570291,1.0,65/515,14.26%,CD24;KLF2;ST6GAL1;SP100;IL13RA1;GPR183;RASGRP2;CIITA;TAGAP;RHOBTB2;COL4A4;IL12A;STAG3;INPP5D;GMPPB;COBLL1;GNG3;AKR1C1;THY1;GPR18;UGT8;PIM3;HLA-DRA;PARP14;NKX6-2;NUAK2;BASP1;SYNGR2;FA2H;PRCD;RCSD1;IFNGR2;TPD52;IRAG2;IGF1;PFN2;NFKBID;ADAM19;SCIMP;RPS11;CCNB1;RPS13;ALPL;BIRC3;SYK;CD55;HLA-E;RAPGEF5;ZBTB32;LAGE3;DMTN;GPR160;STRADB;GPC3;CCR10;SP110;SHISA8;LDHD;SPINT2;SP140L;IL7;CNR1;SP140;EGFL7;NR4A1
prerank,CellMarker_Augmented_2021__Stem cell:Periodontal Ligament,-0.5806062551009673,-1.1215294867895154,0.3181818181818182,0.7768469809559502,1.0,9/16,26.55%,KLF4;THY1;CD44;MCAM;PDGFRA;PTPRC;PECAM1;CDH1;ENG
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.6296483472187344,1.121469036921922,0.40625,0.959370664843556,1.0,3/12,3.97%,RGCC;SERPINF2;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.6231423083760181,-1.12133176604427,0.38095238095238093,0.7771308824347576,1.0,3/10,12.60%,AKAP5;CACNA1C;NOS1
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.7113522847868354,-1.1212821008007299,0.3037974683544304,0.7769691025543046,1.0,2/9,4.80%,CDH23;CLRN1
prerank,Reactome_2022__Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,0.5308118608287385,1.1211802793781442,0.3235294117647059,0.9593858017374615,1.0,4/23,5.74%,POLD3;SLC19A1;POLG2;RFC3
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.5194006539909473,-1.121173058131916,0.3283582089552239,0.7770122680117488,1.0,12/37,11.40%,C3;B2M;ICAM1;HLA-A;SIGLEC1;CD160;COLEC12;HLA-C;NPDC1;PILRA;HLA-B;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.3980921856830384,1.1208823542322373,0.2,0.9594675201660459,1.0,23/75,21.91%,PSMD10;CEBPA;HSPA1A;TRIB3;KEAP1;USP13;BAG2;VCP;RNF14;CSNK1E;CBFA2T3;PLK1;RCHY1;TRIB2;TMTC3;COP1;ZYG11B;MDM2;SMAD7;RNF217;SUMO2;NUB1;DDA1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.6218670749288606,1.120802340015126,0.3333333333333333,0.9587727085767261,1.0,7/13,21.01%,RARB;SALL1;NIPBL;ID2;RBPMS2;GLI3;PCSK5
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.5264217831707464,-1.1207206221308035,0.3076923076923077,0.7782346030407188,1.0,7/32,8.69%,MYO1F;CD5;TAGAP;TMC8;SLA;ARHGAP9;WAS
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.6623845688784021,1.1206113747304907,0.43478260869565216,0.9585224617588088,1.0,2/6,3.44%,LIMD1;MEN1
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.5464566544662173,-1.1205740634932777,0.28169014084507044,0.77830381022749,1.0,5/23,11.79%,IGF1;WNT5A;FGF1;PINK1;IL18
prerank,CellMarker_Augmented_2021__pro-Natural Killer Cell (pro-NK cell):Peripheral Blood,0.4644832828264873,1.1205682542323812,0.2727272727272727,0.9576970980603058,1.0,4/33,2.78%,C1ORF162;CD247;TNFSF13B;RGS2
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),-0.7154232512097292,-1.120445865896116,0.40625,0.7779532426559217,1.0,3/7,20.01%,CDK2;AQP1;KCNC2
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),-0.7154232512097292,-1.120445865896116,0.40625,0.7779532426559217,1.0,3/7,20.01%,CDK2;AQP1;KCNC2
prerank,KEGG_2021_Human__Nucleotide excision repair,0.449454395217159,1.1204074464849896,0.2692307692307692,0.9572272181059683,1.0,9/42,13.61%,POLD3;ERCC8;RFC3;ERCC6;ERCC2;ERCC3;GTF2H5;GTF2H2;GTF2H2C
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,-0.45995483556728206,-1.120366760688874,0.29411764705882354,0.7778315057877363,1.0,17/75,16.48%,OPTC;LAMB1;TIMP2;SCUBE3;MMP19;MMP14;SPOCK3;CD44;TIMP1;CTSS;MMP24;CAPN8;ADAMTS4;TLL1;COL12A1;CAPN1;COL9A2
prerank,Reactome_2022__CDC6 Association With ORC:origin Complex R-HSA-68689,0.7307793246668297,1.12034601319606,0.3404255319148936,0.9564378690092167,1.0,3/5,26.00%,ORC5;SLC25A15;ORC6
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.6414416278812813,1.1201833839392001,0.3902439024390244,0.9561246482927058,1.0,1/7,6.63%,LETM1
prerank,CellMarker_Augmented_2021__T Helper2 (Th2) cell:Brain,-0.5429569662493691,-1.1201788134582944,0.30158730158730157,0.77816268953656,1.0,10/27,15.49%,CD5;TAGAP;TMC8;ARHGAP9;ACAP1;WAS;PTPN7;P2RY10;SP140;CD37
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.6417518679492669,-1.1199465805268196,0.38181818181818183,0.7786089240765202,1.0,3/10,12.06%,THBS1;WNT5A;TNIP2
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.49936671314601677,1.1198351244202749,0.27586206896551724,0.9565066918356595,1.0,4/34,12.98%,WNT7A;TMEM106B;TAOK2;WASL
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.47029113757371477,-1.1198037077677023,0.32098765432098764,0.7787930668630585,1.0,29/98,19.56%,THBS1;SPARC;F8;APP;TIMP1;EGF;SGPP2;F13A1;GTPBP2;PRKCG;IGF1;TAGLN2;CD9;FN1;CD63;F5;SRGN;WDR1;SERPING1;TLN1;PRKCB;VCL;TGFB1;FERMT3;HSPA5;TF;SELENOP;CD36;RAB27B
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,0.49793447972762267,1.119719006358506,0.2647058823529412,0.9560397952885543,1.0,3/36,7.39%,KSR2;NRAS;CNKSR1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.4999891350137595,-1.1195013703917054,0.33766233766233766,0.779278474007721,1.0,18/62,17.15%,GGT5;PLK2;RAMP3;ADCY7;GIPR;RHBDF2;ADCY5;SYK;MYH9;GNG2;RXFP1;VIP;PTH1R;GLP1R;PTH2R;ADCY3;HLA-DRB1;ADCY8
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.7131241232668183,1.1194806727582047,0.325,0.955782897633321,1.0,3/6,24.19%,ZNHIT3;FBL;ZNHIT6
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.5026735152948684,-1.1192652199160018,0.2608695652173913,0.7798697597922459,1.0,9/41,14.42%,CENPV;FAT2;SEMA3B;HTR2B;PDXDC1;RADIL;AMOTL2;GPC3;SEMA3E
prerank,CellMarker_Augmented_2021__Dendritic cell:Blood,-0.5279142948205019,-1.1192094430638704,0.36507936507936506,0.7796544565526327,1.0,10/25,10.58%,P2RY13;GPR183;TAGAP;SLA;ARHGAP9;IGSF6;CLEC12A;LAT2;CTSS;PILRA
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In1:Brain,-0.47519030643583715,-1.1190866419794658,0.3013698630136986,0.7797138081605494,1.0,25/89,17.17%,RIMBP2;STMN2;NEFL;NEFM;LRRC55;ZDHHC22;LRRTM1;ELAVL4;KCNH8;GAP43;ZNF536;NELL2;TCEAL2;STMN4;CNR1;TMEM132C;CNTN2;KCNC1;GDAP1L1;RAB3C;JPH4;MGAT3;TCEAL5;CRB2;GALNT8
prerank,CellMarker_Augmented_2021__Neutrophil:Pluripotent Stem Cell,-0.5137048955886357,-1.1190850684586133,0.3333333333333333,0.7793527739912448,1.0,8/23,10.15%,P2RY13;MYO1F;TAGAP;SLA;ARHGAP9;IGSF6;CLEC12A;CTSS
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.5164891180531127,1.1189448732325473,0.3235294117647059,0.9566259166999362,1.0,4/20,12.49%,WDR91;SNF8;PTPN23;PIK3C3
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.4313894752821969,1.1188468194931953,0.1,0.9559515748032604,1.0,7/57,6.91%,RGCC;BMP2;NMB;CADPS2;APBB3;MYOM1;RAB27A
prerank,Reactome_2022__Hemostasis R-HSA-109582,-0.4234059717215238,-1.1187859674903042,0.16842105263157894,0.7800225067033556,1.0,91/405,18.91%,THBS1;RASGRP1;S100A10;SPARC;DOCK8;RASGRP2;P2RY12;CD99L2;L1CAM;ITGA2;PDPN;IRF1;INPP5D;MAFF;SLC16A3;F8;GNG3;ITGA5;APP;TRPC3;GYPE;GP6;GATA1;CEACAM1;CD44;TIMP1;ITPR3;SERPIND1;CENPE;EGF;SGPP2;ATP1B1;ZFPM1;F13A1;GTPBP2;SLC8A3;PRKCG;IGF1;MAG;KIF9;TAGLN2;THPO;PSG8;MAFK;CD9;PSG3;PRKCQ;SYK;FN1;KIF2C;GNG2;PRKCH;PROCR;CD63;RNASE1;F5;ITGA3;SRGN;PIK3CB;WDR1;CD74;SERPING1;VAV1;PLAT;PRKCD;CDK2;SH2B2;TLN1;GUCY1A1;KCNMB4;F3;ANXA2;WEE1;DOCK10;PDE5A;DEAF1;PRKCB;TEK;VCL;GPC1;CDK5;ANGPT2;TGFB1;FERMT3;HSPA5;SLC7A7;TF;TNFRSF10A;P2RX6;SELENOP;AKAP10
prerank,CellMarker_Augmented_2021__Extravillous Trophoblast cell:Placenta,-0.5060806996756647,-1.1186028141402904,0.28205128205128205,0.7802584125673666,1.0,17/55,17.25%,ENPP2;GBP1;PDPN;HLA-A;PDCD1LG2;MMP14;MT1H;PSG3;EPSTI1;MAP1LC3A;MVP;SERPING1;VWA5A;GABARAPL1;CD200;NDN;TEK
prerank,CellMarker_Augmented_2021__Endothelial cell:Adipose Tissue,-0.7181218015496537,-1.1184743391653358,0.36363636363636365,0.7803085291484178,1.0,5/7,26.55%,MCAM;ABCG2;PTPRC;PECAM1;ENG
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.47013195214155107,1.1183399063257495,0.2727272727272727,0.9565404217550316,1.0,14/40,20.40%,SDC4;RALB;CNOT2;G3BP1;KCTD17;TAPT1;PIP4K2B;CNOT6L;CNOT1;CCDC88A;CEP120;PIP4K2C;SAXO1;RAB3GAP1
prerank,CellMarker_Augmented_2021__Hematopoietic Precursor cell:Fetal Liver,-0.7149237048272584,-1.118272917858328,0.42592592592592593,0.7807163056855002,1.0,3/5,21.37%,THY1;IL3RA;PTPRC
prerank,Reactome_2022__Reactions Specific To Complex N-glycan Synthesis Pathway R-HSA-975578,-0.6832467032353856,-1.118242035431756,0.45454545454545453,0.7804130340521894,1.0,2/7,20.34%,MAN2A2;CHST10
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.3285764309387241,1.1182171206796445,0.0,0.9559222783070833,1.0,82/341,21.37%,SPSB4;RNF6;RNF25;FBXO45;KLHL8;NUP42;SPSB2;UBE2T;BCL10;RFWD3;ELOC;NUP37;MSL2;MKRN3;TRIM24;KEAP1;DCUN1D2;PEX13;CUL1;NUP54;UBE2N;TRIM28;COMMD1;VCP;DCUN1D1;RNF103-CHMP3;RNF14;FBXL3;LMO7;FBXO9;UBE2G1;BTRC;PLK1;NDC1;DTX4;UBE2D1;RCHY1;NUP214;DERL1;ZNF451;CUL2;TSPAN17;RAE1;TMEM129;FBXO10;DCUN1D5;MUL1;PEX2;AAAS;NUP188;KIAA1586;RNF26;CBLL1;FBXL17;NUP205;VPS11;EYA1;KLHL24;HERC2;UFM1;VHL;MARCHF3;TRIM52;PIAS4;CNOT4;UBE2E3;MKRN1;KLHL20;SHPRH;MDM2;NUP210;PEX12;NUP85;FBH1;TRIM7;NEDD4L;NUP153;NUP50;EIPR1;RNF34;SUMO2;NUB1
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.6446338681725685,-1.1181829279890652,0.36507936507936506,0.7802732919646214,1.0,1/11,0.48%,APIP
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),0.6712585710640255,1.1181273843191601,0.37254901960784315,0.955272474256766,1.0,1/5,2.21%,KCNE1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.5054923288010668,-1.1180644014240386,0.2987012987012987,0.7802880277122031,1.0,18/61,17.15%,GGT5;PLK2;RAMP3;ADCY7;GIPR;RHBDF2;ADCY5;SYK;MYH9;GNG2;RXFP1;VIP;PTH1R;GLP1R;PTH2R;ADCY3;HLA-DRB1;ADCY8
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.473491778580185,-1.118057827906979,0.3157894736842105,0.7799413105196011,1.0,19/73,16.14%,ECM2;L1CAM;ITGA2;SIGLEC1;THY1;THBS3;CD44;ANGPTL3;ITGA8;ZYX;ITGA11;FN1;CD63;EMP2;ITGA3;PPFIA1;DLC1;ITGB4;RHOD
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.484293157668477,-1.1180543360671829,0.23376623376623376,0.779577298039258,1.0,19/61,18.74%,FYB1;ITGA2;ITGA5;THY1;CEACAM1;ANGPTL3;ZYX;ISG15;ITGA11;SYK;FN1;MYH9;FYB2;LAMA3;ITGB4;CDH17;ERBIN;FERMT3;LAMA5
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.772349985424089,-1.1178241493917176,0.37254901960784315,0.7799182101888932,1.0,3/5,21.92%,HLA-E;HLA-F;KLRD1
prerank,CellMarker_Augmented_2021__Plasma cell:Kidney,0.6490589182568731,1.1178092080257933,0.3333333333333333,0.9557289780794845,1.0,2/8,14.88%,MUC20;PNOC
prerank,CellMarker_Augmented_2021__T cell:Fetal Liver,-0.5558555127483532,-1.1177588482230874,0.35,0.7797746298024424,1.0,8/28,8.69%,MYO1F;CD5;TAGAP;TMC8;SLA;ARHGAP9;ACAP1;WAS
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.45267166436961814,1.1176703432570827,0.2,0.9553210862608065,1.0,7/25,16.53%,DCHS1;FAT4;STK4;CASP3;DVL2;AMOTL1;MOB1B
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5837181730649543,-1.1175856356377476,0.3484848484848485,0.7800491351121897,1.0,3/18,10.87%,IFI6;GATA1;UNC5B
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.5050245319226591,1.1173738849558914,0.22580645161290322,0.9553617020770535,1.0,9/34,18.04%,LIG4;H2BC21;H2BC4;BRCC3;UBE2N;TDP2;HERC2;DCLRE1C;PIAS4
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.6241262461845205,-1.1173653008034101,0.3076923076923077,0.7803585607927276,1.0,6/18,20.77%,RPS27A;NLRC5;UBC;USP18;CASP8;IKBKG
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.5610129717848704,-1.117330356093587,0.359375,0.7800963019757657,1.0,11/23,21.38%,IFI35;NLRC5;PLSCR1;WNT5A;HLA-E;FADD;NMI;SLC15A4;SPI1;TRIM62;ADAM8
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.760290705591506,1.1172211136661425,0.36666666666666664,0.9550858632911275,1.0,2/6,21.53%,PUS10;RPUSD4
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.6432460981306645,1.1171671707167805,0.4166666666666667,0.9534360297964622,1.0,2/7,7.46%,SLIT1;ALCAM
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.6432460981306645,1.1171671707167805,0.4166666666666667,0.9534360297964622,1.0,2/7,7.46%,SLIT1;ALCAM
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.5970810141161101,-1.1171202710161243,0.38333333333333336,0.7804669195718205,1.0,4/17,25.82%,MMP14;BDNF;XBP1;HDAC5
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,-0.5528755511369174,-1.117031233638261,0.30158730158730157,0.7803585483706881,1.0,2/30,2.23%,CDKN2A;RPS27A
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6322570849276173,1.1170298929478237,0.34146341463414637,0.9530758082476237,1.0,3/8,22.09%,STXBP6;VAMP3;VAMP4
prerank,Reactome_2022__Transcriptional Regulation Of Testis Differentiation R-HSA-9690406,0.7231662331706439,1.1169146513494144,0.3269230769230769,0.9527054097473456,1.0,1/5,5.13%,SOX9
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.5422427538036002,1.1167899387071774,0.34285714285714286,0.9522922916907496,1.0,9/18,23.28%,NUDT21;HSF1;CPSF6;CPSF7;ZC3H14;CPEB3;CCNT1;VIRMA;RNF20
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.3934857217870939,1.1167159427879512,0.2608695652173913,0.9516087919594016,1.0,18/111,14.58%,BET1;FHDC1;TMED5;PI4K2A;GORASP2;BLZF1;SEC22B;TRAPPC11;SYNE1;TRAPPC12;DNAJC28;ATL2;TRAPPC8;VTI1A;GOLGA5;SEC23IP;PRKD1;TMED3
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.6388146759781426,-1.1163167272509043,0.3225806451612903,0.7825633477950464,1.0,5/10,11.27%,ANXA1;THBS1;FLG;F13A1;FN1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.5678998679043799,1.1161220063794557,0.34375,0.9529421924584599,1.0,2/11,21.51%,ADRB2;FYCO1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.6329735419048464,-1.1160978762200078,0.38333333333333336,0.7829191208156037,1.0,4/9,16.36%,HLA-A;NOD1;HLA-B;HLA-DRB1
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,0.39726855952831636,1.1160336252642091,0.2777777777777778,0.9523459870215613,1.0,12/102,6.89%,POLD3;SEM1;SLC19A1;CCNE1;DNA2;PSMD10;PSMA1;PSMD11;RFC3;ANAPC1;CUL1;PSMB5
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.44491591168382444,-1.1159532595718509,0.2911392405063291,0.7830816194168342,1.0,21/86,20.40%,FLRT3;APLNR;POU4F1;PKP2;TGFBR2;ZFPM1;SRF;SMYD4;CACNA1C;FN1;PDLIM4;TSC2;CRB2;TEK;FGF12;TGFB1;CDKN1A;PLCE1;NXN;CASP8;CXADR
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.5249920316713195,-1.1158948978417387,0.3333333333333333,0.7829196279663406,1.0,11/47,18.48%,ALDOB;SLC39A14;APOD;FBP1;GAPDHS;PGK1;GPI;IRS2;PGAM1;ENO2;PCK2
prerank,CellMarker_Augmented_2021__Endometrial Progenitor cell:Endometrium,0.4062860456944618,1.115787623725838,0.29411764705882354,0.9521511055717736,1.0,24/99,25.98%,IRF2BP1;TPRN;GIT1;PCBP4;SMYD5;PTPN23;CCDC106;MON1A;TAOK2;WDR24;TMEM201;SCYL1;SLC25A22;UBQLN4;NDUFV1;FXR2;EVI5L;ZNF768;MAST2;ALDH4A1;HSPBP1;SNTA1;ENDOG;OGDH
prerank,CellMarker_Augmented_2021__Bipolar cell:Retina,0.40209625806002547,1.1157247503985652,0.25,0.9514487356575333,1.0,17/70,15.75%,MEX3A;EFNA2;CDH24;UBE2T;KPNA2;CDC25A;LMO1;MANEAL;JPH1;CCT3;TENM3;TMEM132A;MDK;TUBG1;HDAC2;P3H4;THAP10
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),-0.6989711812141837,-1.1155649642225256,0.43103448275862066,0.7835507276415089,1.0,3/5,21.76%,SLC43A2;GRM7;ARL6IP5
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.5593617918044086,-1.1152683620098962,0.27631578947368424,0.7841462041634298,1.0,5/33,11.12%,TIMP2;NELL1;TIMP1;PRKCG;DAB2IP
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5203066956262987,-1.1151402090553246,0.28,0.784259677488396,1.0,3/35,8.19%,BLM;BRCA1;DONSON
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.5389093234226675,-1.1150171091059082,0.25675675675675674,0.784390543220437,1.0,8/41,15.64%,RPL3;RPS27;RPS14;RPL24;RPL10;RPS15;MRPL20;RPL5
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.535007721255196,-1.1149841380828533,0.3220338983050847,0.7841496099134263,1.0,4/25,9.19%,SOCS3;CYP1B1;EGF;CRLF3
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.6016334148782158,1.1149223018511472,0.3055555555555556,0.9531118614530006,1.0,8/12,38.54%,USP13;UBQLN1;NFE2L2;UBQLN2;ATXN3;BCAP31;RNFT1;SGTA
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,-0.5783921609698145,-1.1146651679060042,0.3333333333333333,0.784831101901283,1.0,4/18,13.38%,L1CAM;ITGA5;RNASE1;ITGA9
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.5740924654542862,-1.1145334341785644,0.2878787878787879,0.7849178304352246,1.0,2/23,1.14%,C3;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.6235628524341541,-1.1144739614302326,0.3548387096774194,0.7847381199594745,1.0,3/11,5.98%,THBS1;CD160;CCL2
prerank,Reactome_2022__G0 And Early G1 R-HSA-1538133,0.5252627572203441,1.1144564308894642,0.23076923076923078,0.9537688201957926,1.0,4/19,13.55%,CCNE1;CDC25A;RBBP4;E2F4
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.47722060320287246,1.1143975828312962,0.2,0.9530453660498227,1.0,10/28,14.80%,ABCD2;ELOVL6;CYP4F12;ELOVL4;ABCD1;ELOVL2;HACD2;ABCD3;ACOX1;PEX2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),0.6969614560467643,1.1143304896308883,0.4146341463414634,0.9515703132745135,1.0,1/5,17.20%,GINS3
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),0.6969614560467643,1.1143304896308883,0.4146341463414634,0.9515703132745135,1.0,1/5,17.20%,GINS3
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,0.4251036696009403,1.1139669603012494,0.2222222222222222,0.9518824318304183,1.0,13/64,13.78%,SEM1;LIMD1;PSMD10;ELOC;EPX;PSMA1;PSMD11;PSMB5;UBE2D1;PSMD14;EGLN3;CUL2;PSMD12
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.6227673895174071,-1.1139390384320822,0.3620689655172414,0.7858493445034316,1.0,1/13,2.20%,ZFP36
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.6227673895174071,-1.1139390384320822,0.3620689655172414,0.7858493445034316,1.0,1/13,2.20%,ZFP36
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,0.3513005359932063,1.1139102086120511,0.13333333333333333,0.9512279078223691,1.0,28/159,16.57%,DERL2;HSPA1A;EIF2S1;TRAM1;MOGS;CUL1;BAG2;MAPK10;DNAJB11;VCP;MAN1A2;UGGT1;UBE2G1;PRKCSH;ATF6;EIF2AK4;MAPK8;STT3B;UBE2D1;DERL1;DNAJA2;GANAB;SSR1;SEC24A;SEC31B;STT3A;SEC23B;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.4524618248790847,1.1138021458937553,0.27586206896551724,0.9507247547663582,1.0,2/30,1.76%,LEPR;REEP6
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.7551784194624245,-1.1137387240535757,0.3333333333333333,0.7861229318954823,1.0,1/6,7.58%,CENPE
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.4584981322889734,-1.1135662106259965,0.2857142857142857,0.7862655128091292,1.0,13/119,8.66%,NPY;FLRT3;POU4F1;STMN2;L1CAM;LAMB1;RAB11A;SH3GL2;PLP1;APP;SRRM4;TENM4;SRF
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.7233552769917564,-1.1135271098155946,0.43333333333333335,0.7860463856417886,1.0,1/5,0.18%,ANXA1
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,0.44717147251780903,1.113243311643157,0.2962962962962963,0.9518295949272515,1.0,13/56,25.32%,KSR2;NRAS;TRIM24;CNKSR1;AP3B1;TENT4A;QKI;MAP2K2;BCL2L11;BRAF;CNKSR2;ARAF;ARRB1
prerank,Reactome_2022__Biosynthesis Of DHA-derived SPMs R-HSA-9018677,-0.6331667260620599,-1.1132279770627305,0.39344262295081966,0.7865241495088404,1.0,2/10,13.02%,ALOX12;CYP3A4
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.6935856704787037,-1.1132231130176327,0.43333333333333335,0.7861745384071253,1.0,1/6,7.95%,MYH11
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.5783703328933327,-1.1131155135656892,0.35714285714285715,0.7861863223901908,1.0,3/21,6.59%,TLR2;NDUFA2;TLR3
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.6497115726239535,-1.1131125034270668,0.34615384615384615,0.7858284983607626,1.0,3/8,16.17%,SLCO3A1;SLCO2A1;SLCO1A2
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,-0.5431181585145649,-1.1128073487987915,0.27941176470588236,0.7865184357710789,1.0,3/35,10.88%,KIF17;DYNLT5;IFT122
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6447098009133745,1.1127794854891657,0.37142857142857144,0.9524935051337188,1.0,6/12,28.80%,SAXO2;PCM1;SAXO1;DAG1;CLASP2;BICD2
prerank,Reactome_2022__Displacement Of DNA Glycosylase By APEX1 R-HSA-110357,-0.6676376419229366,-1.112605472880815,0.38596491228070173,0.7868558543480834,1.0,1/8,12.39%,OGG1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.4004429905968485,1.1123421452819269,0.1724137931034483,0.9530385352851357,1.0,16/59,27.46%,H2BC18;H2BC21;SOX9;ANP32B;H1-2;ASF1A;DAXX;ACTR6;KAT6B;H2BC5;SART3;SMARCC1;PADI4;INO80;VPS72;ARID2
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.629516089574062,1.1122977684612998,0.41379310344827586,0.952247122937545,1.0,3/13,3.97%,RGCC;SERPINF2;RUNX1
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Endometrium,-0.48241051856916967,-1.1121639271686306,0.30303030303030304,0.7878703306279026,1.0,12/47,12.65%,ST6GAL1;KCNQ1;TAGAP;INPP5D;SLA;ITM2A;ARHGAP9;HLA-DRA;PDE6B;RASGEF1B;LDLRAD4;ELMO1
prerank,Reactome_2022__Organic Cation/Anion/Zwitterion Transport R-HSA-549132,0.6239035744084981,1.112016557801493,0.32608695652173914,0.9526952993138685,1.0,4/8,14.76%,RUNX1;SLC22A15;SLC22A2;SLC22A5
prerank,Reactome_2022__ERKs Are Inactivated R-HSA-202670,0.6157502716459136,1.1119098475527247,0.325,0.952161616169896,1.0,7/10,36.41%,DUSP6;PPP2R1B;MAPK7;MAPK1;PPP2R1A;VRK3;PPP2CB
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.5539478984622599,1.1118851199756714,0.4117647058823529,0.9513306466252769,1.0,6/14,14.67%,EFNB2;GREM1;AKT1;ROBO1;EPHB4;GPLD1
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.5884670561456788,-1.1117828669783019,0.3787878787878788,0.7887015782817748,1.0,4/17,12.77%,RPS27A;TLR3;BIRC3;UBC
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.5555446326462341,-1.111749362557544,0.32432432432432434,0.7884258401906205,1.0,5/20,15.39%,TEKT2;CCDC39;DNAH3;DRC1;DNAH2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),-0.7328368506687906,-1.1117250576156057,0.37254901960784315,0.7881330141950723,1.0,4/5,26.51%,MSR1;SCARB1;EHD1;SREBF2
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.6220011902273699,-1.1116700280470018,0.3559322033898305,0.7879748160947958,1.0,6/12,23.77%,CYP1B1;HSD17B14;CYP3A4;CYP3A5;HSD17B7;CYP2D6
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.6323211118977952,1.1114666643384916,0.32653061224489793,0.9518954962270689,1.0,1/6,5.85%,PLIN5
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.6258181354639333,1.111437616584306,0.3953488372093023,0.9511833006946191,1.0,3/9,18.76%,RTRAF;RBFOX1;SIDT1
prerank,KEGG_2021_Human__Chemokine signaling pathway,-0.45409611216150714,-1.1114064035897704,0.3037974683544304,0.788414586952067,1.0,20/118,17.32%,CXCL2;RASGRP2;ADCY7;GNG3;CCL2;WAS;STAT1;SHC2;ADCY5;GNG2;ELMO1;CCR10;PIK3CB;VAV1;PRKCD;PIK3CD;ADCY3;ADCY8;PRKCB;CCL28
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.695856175627154,1.1113059303587092,0.5,0.9506955282769745,1.0,4/7,24.16%,SOX9;SOX5;BMPR1B;LOXL2
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,-0.4788039642624065,-1.1111381158420164,0.33783783783783783,0.7890271507729495,1.0,14/71,17.96%,CXCL2;IL1R1;ICAM1;GADD45A;BIRC3;PRKCQ;SYK;MAP3K14;TNFRSF1A;BLNK;LTBR;PRKCB;GADD45B;CARD11
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.5134529293556289,-1.1110829804482287,0.3466666666666667,0.7888254777591646,1.0,10/42,21.20%,KCNB1;ITPR3;GIPR;CELA2A;CACNA1C;PAX8;GLP1R;HTR2C;KCNC2;ITPR1
prerank,CellMarker_Augmented_2021__Myotube:Muscle,0.44937668774185513,1.1110587138327417,0.25,0.950781787442747,1.0,7/33,10.95%,SLC2A5;CCDC141;AMY2B;MYOM1;AGBL1;CASQ1;PYGM
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Fetal Liver,-0.6841543991271593,-1.1109470842833506,0.4482758620689655,0.7888922047932898,1.0,4/6,24.88%,THY1;IL3RA;PTPRC;PECAM1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.4689653831176629,-1.110938116330355,0.24050632911392406,0.7885610610344921,1.0,23/123,13.35%,MYO1F;RHOBTB2;PROX1;POF1B;MYO15A;CLRN1;GAS2L3;LMOD1;RND2;SVIL;BAIAP2;BAIAP2L1;VIL1;WAS;NLRP5;RHOF;TPM4;MYO1E;DMTN;CORO7;ELMO1;EMP2;DSTN
prerank,CellMarker_Augmented_2021__Gonadal Mitotic Phase Fetal Germ cell:Fetal Gonad,-0.4356941183739793,-1.1108933088429205,0.25,0.7883728503829316,1.0,46/230,18.34%,COL4A1;TAGLN3;FABP3;A4GALT;COL4A2;PPP1R14C;PDPN;RPS4X;GMPPB;RPL27A;TJP3;MEIOB;PODXL;THY1;TEAD2;RPL13A;CDC42EP1;RAB11FIP1;CD9;RPS13;ALPL;SOX15;RPS8;RPL10A;RPL10;PRSS23;MVP;CD63;BSPRY;ZNF490;RASD1;WDR1;GPRC5C;SFRP2;ADD2;CCND2;TRANK1;SYT2;RPL23;GABARAPL1;CDCA7;RPL41;RPL7;CTSA;RAB15;HSPA5
prerank,CellMarker_Augmented_2021__Stem cell:Adipose Tissue,-0.6944487225353193,-1.1108402518520701,0.36666666666666664,0.7882150541124439,1.0,6/8,26.55%,THY1;CD44;ABCG2;PTPRC;PECAM1;ENG
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.7270432086956871,1.1107879091969508,0.3958333333333333,0.9506876279209918,1.0,3/5,24.36%,VCP;DYRK3;ZFAND1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.7623207584353116,-1.1105418429385634,0.4444444444444444,0.7888432807613112,1.0,1/5,5.64%,YBX3
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,-0.59670305627697,-1.1103964177496366,0.4032258064516129,0.7889184771804869,1.0,1/16,0.41%,SLC28A2
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.5243366598375311,-1.1103139738992083,0.3424657534246575,0.7887908455674678,1.0,6/32,9.54%,LMOD1;BAIAP2;BAIAP2L1;CDC42EP1;PFN2;CDC42EP3
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.4296960285553312,-1.1102358943784276,0.19318181818181818,0.7886503959213124,1.0,61/178,20.39%,NPY;SNCB;CHRM1;GRIN2A;PLP1;HTR2B;GRIA3;GLRA2;UTS2;HAP1;GRIA1;AKAP5;SLC18A2;NRGN;RIT2;SYN2;UNC13C;CPLX1;RPS6KA1;SYT1;GRIK1;MINK1;HCRTR2;CHRM3;GABRE;GABRB2;SST;CHRNA5;GABRD;PCDHB5;GAD1;HRH1;GRIN2B;NLGN1;NPTX2;GAD2;HTR1E;GABRG2;APBA2;SLC12A7;GRM7;GRIK2;SYT5;SNCG;GABRA1;CACNB1;KCNMB4;HTR2C;CHRM5;CHRNE;CDK5;HTR2A;SLC1A6;PTCHD1;GLRA1;GABBR2;GABRA6;CHRNA6;GABRG3;GABRA3;PCDHB4
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),0.5609512645131421,1.1101515123791785,0.42105263157894735,0.9522356308792946,1.0,5/15,16.31%,DMAC2L;ATP5PB;ATP5MC2;ATP5MC1;ATP5F1A
prerank,Reactome_2022__Acyl Chain Remodelling Of PG R-HSA-1482925,-0.7039871936063608,-1.1101072434468424,0.39285714285714285,0.7886307567229506,1.0,1/7,10.92%,LPCAT4
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.5589388443188055,-1.1099682002840578,0.20634920634920634,0.7887403766319314,1.0,1/21,0.95%,SP100
prerank,CellMarker_Augmented_2021__Epithelial cell:Thymus,-0.4999548385854239,-1.1099249043160362,0.3150684931506849,0.7885398602096945,1.0,16/55,20.23%,EFNA1;PKP2;OVOL2;BAIAP2L1;SLC44A3;EMP2;TTC39A;GPRC5C;LAMA3;RHOD;PTPRF;RHPN2;PTPN21;LAMA5;EPB41L4B;KIAA1217
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.6065953361375052,-1.109850800265919,0.35185185185185186,0.7883782653562367,1.0,5/13,20.23%,SULF1;WNT5A;DEAF1;PDGFRA;KIAA1217
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.5966508403555794,1.109840477014403,0.36585365853658536,0.9526165503779118,1.0,9/15,28.19%,INTS7;INTS8;INTS6L;TOE1;INTS14;INTS4;INTS6;INTS9;INTS11
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.6673742543207409,-1.1094724920792294,0.2962962962962963,0.7891245565278434,1.0,3/8,19.89%,CNTN2;AGRN;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.5816073387739955,-1.1094649298455646,0.36065573770491804,0.7887865375242804,1.0,5/16,14.77%,TNFRSF14;WNT5A;SCIMP;HLA-E;GPI
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),-0.6986547959719257,-1.1094630568466435,0.34615384615384615,0.7884230414240389,1.0,1/7,0.33%,THBS1
prerank,Reactome_2022__MyD88 Deficiency (TLR2/4) R-HSA-5602498,-0.6715363196210341,-1.109428213356668,0.38333333333333336,0.7881500988357735,1.0,2/9,6.11%,TLR2;NDUFA2
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),-0.7200194903730038,-1.1093696188770252,0.375,0.7879761729817362,1.0,3/6,20.30%,NLGN1;GPER1;STX1B
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.5243156406744338,1.109345199761346,0.3333333333333333,0.9534620018847056,1.0,2/18,2.91%,ACE2;ADRA1A
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.49595327455125976,-1.109316968782599,0.2625,0.7877380246275644,1.0,19/53,13.56%,MYO1F;TAGAP;ALOX12;PROX1;SPON2;ARHGAP9;GATA1;PLK3;CLEC12A;SYP;PDE6B;F13A1;WAS;CD9;PILRA;SELP;ACHE;TSPAN32;SLC11A1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.5986879757702032,-1.109249221833367,0.36065573770491804,0.787590189511207,1.0,2/15,3.28%,ABCA5;ABCA8
prerank,Reactome_2022__Crosslinking Of Collagen Fibrils R-HSA-2243919,0.5876933153791947,1.1091841615805387,0.35294117647058826,0.9531755463345816,1.0,1/9,2.31%,TLL2
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),0.7259840707979336,1.1090894581577804,0.38636363636363635,0.9526996520963902,1.0,1/5,5.78%,SF3A1
prerank,Reactome_2022__Synthesis Of PI R-HSA-1483226,-0.7190137954403428,-1.108849079951294,0.3275862068965517,0.7885316995153548,1.0,1/5,12.64%,PITPNM2
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.5126693699983125,1.1080664618866263,0.3055555555555556,0.9552824581267852,1.0,5/16,15.95%,MAML3;KAT2B;PBX1;HEYL;EP300
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.45065616220161914,1.1079758141807576,0.2692307692307692,0.9546896120658646,1.0,8/43,8.97%,ERCC8;EGFR;BRCC3;UBE2N;TRIM28;ERCC6;HMGB1;SPIRE2
prerank,Reactome_2022__Recycling Of Bile Acids And Salts R-HSA-159418,-0.6138266280830462,-1.1079116099629838,0.34375,0.7912982885469801,1.0,6/11,26.77%,SLC51A;SLC51B;SLCO1A2;SLC27A5;FABP6;SLC10A1
prerank,Reactome_2022__Axonal Growth Inhibition (RHOA Activation) R-HSA-193634,-0.6747177027628706,-1.1075042693720658,0.4166666666666667,0.7923186317086793,1.0,4/7,26.95%,MAG;RTN4;OMG;MCF2
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.5691992109354023,-1.1074917284327894,0.3442622950819672,0.791993389915746,1.0,7/17,23.58%,COL5A1;C12ORF57;IFT122;RARG;FBN2;STAT3;NKD1
prerank,Reactome_2022__PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,0.5576966682263019,1.107340406997719,0.3235294117647059,0.9560028210805416,1.0,4/19,5.74%,POLD3;SLC19A1;POLG2;RFC3
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.6433846517483364,-1.107337264620047,0.38333333333333336,0.7921136033800189,1.0,4/11,13.10%,ARG2;CYP1B1;NOS1;GCHFR
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.7119493747811336,-1.107334530691694,0.3584905660377358,0.7917545269058232,1.0,3/7,7.61%,CLDN16;CLDN20;CLDN18
prerank,CellMarker_Augmented_2021__Muscle cell:Embryoid Body,-0.4770755674065945,-1.1071988098426437,0.2926829268292683,0.7918661867968796,1.0,10/74,6.98%,KCNT2;COL4A1;ANGPTL2;APLNR;COL4A2;RCAN2;CTNNA3;THY1;LMOD1;LDB2
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.6266834106337822,-1.1071661327760594,0.4090909090909091,0.7915802187980726,1.0,1/13,0.81%,BLM
prerank,KEGG_2021_Human__Longevity regulating pathway,0.36763196959647787,1.1071320987659858,0.23809523809523808,0.9559151192633384,1.0,18/89,16.20%,PPARGC1A;ADIPOR1;NRAS;HSPA1A;ADCY1;AKT2;AKT1;PRKAB1;PRKACB;SESN2;EIF4E;EIF4EBP2;PIK3CA;NFKB1;PIK3R1;HDAC2;CAT;SESN3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.5314931327533531,-1.107011402121386,0.37142857142857144,0.7917431263592735,1.0,1/22,0.55%,PIF1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.4295525495312956,1.1068322382811353,0.28125,0.9560797024196422,1.0,6/38,11.68%,UQCRHL;SDHAF4;PPARGC1A;COX10;LYRM7;ETFDH
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,-0.5545080333972926,-1.106739778525239,0.4050632911392405,0.792234717385055,1.0,2/33,2.23%,CDKN2A;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.48082875943582454,-1.106616473894042,0.31645569620253167,0.7922776555076095,1.0,11/66,18.52%,TLR2;IRF1;TLR3;STAT1;IRF7;ISG15;IFIH1;FLOT1;STAT6;RIPK2;DDX41
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),0.7018971798255751,1.1066006900062204,0.3469387755102041,0.9560445686946069,1.0,2/5,14.45%,AGBL1;AGBL2
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.4983661517201895,-1.106556193090746,0.3561643835616438,0.7920773554849924,1.0,17/47,19.24%,P2RY12;RCAN2;ACKR4;HTR2B;LAT2;CHRM3;NUDT4;NOS1;HRH1;CCR10;GUCY1A1;RCAN3;RYR2;MCTP1;PPP1R9A;PLCE1;CD36
prerank,KEGG_2021_Human__Focal adhesion,-0.42759161249881694,-1.1064917696964993,0.27710843373493976,0.7919284149848468,1.0,38/170,17.53%,THBS1;COL4A1;MET;COL4A2;LAMB1;ITGA2;COL4A4;CHAD;COL6A2;ITGA5;THBS3;CAV3;CCND1;EGF;PRKCG;ITGA8;IGF1;ZYX;ITGA11;THBS2;SHC2;BIRC3;FN1;ITGA9;MYLK3;ITGA3;PIK3CB;VAV1;LAMA3;RELN;PIK3CD;ITGB4;CCND2;TLN1;COL9A2;PRKCB;VCL;SPP1
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.7058487178522239,1.1064892340281431,0.32608695652173914,0.9554537597472263,1.0,3/6,20.74%,SPX;MKKS;BBS2
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.5767381089503298,-1.1062622475021173,0.3508771929824561,0.7923167167035313,1.0,1/18,0.78%,CDKN2A
prerank,CellMarker_Augmented_2021__Neutrophil:Kidney,0.47070972555239715,1.1061769285374594,0.32432432432432434,0.9556287889418816,1.0,5/28,6.66%,G0S2;MSRB1;RGS2;SLC25A37;ABHD5
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.4923125732621143,-1.106157308139899,0.3116883116883117,0.7922615405212089,1.0,20/65,18.04%,LMO2;ADGRE5;TMC8;ADCY7;GAB3;TUBB1;GFI1B;GATA1;CD44;LMNB1;PRSS57;PTPN7;PIM1;TSPAN32;IL27RA;ETS1;CR1L;BCL11A;NMI;FERMT3
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.6110829329136882,-1.1061433837558738,0.3448275862068966,0.7919423657978354,1.0,1/14,0.81%,C3
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.40440301851428206,1.1061277106149139,0.2,0.9550185223682308,1.0,22/97,16.56%,POLD3;ERCC8;LIG4;COPS2;RFC3;COPS8;ERCC6;COMMD1;ERCC2;SLC30A9;HUS1;COPS7A;ERCC3;GTF2H5;GTF2H2;GTF2H2C;POLK;POLR2C;EP300;AQR;PPIE;HMGN1
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),0.6472268775138349,1.1059070914556788,0.40476190476190477,0.9547544510408615,1.0,1/5,2.59%,UBE2T
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.63153511699972,-1.105833836463714,0.3972602739726027,0.7925131765983383,1.0,1/11,1.11%,APLNR
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.6347586983860661,-1.1055844730197226,0.3387096774193548,0.792900502966435,1.0,4/12,13.10%,ARG2;CYP1B1;NOS1;GCHFR
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.6825402859149411,-1.1055665971973094,0.38596491228070173,0.792589979561343,1.0,3/7,22.81%,LDLR;TGFB1;ACMSD
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.4738750961221204,-1.1055285322164015,0.29411764705882354,0.7923265012030958,1.0,13/103,10.12%,RASGRP1;P2RY6;GPR183;ICAM1;RAMP3;GPNMB;APP;HTR2B;CCL2;CD44;CHI3L1;THPO;SCIMP
prerank,KEGG_2021_Human__Ferroptosis,-0.5488460641673452,-1.1054233386790822,0.27941176470588236,0.7922969663011353,1.0,4/36,7.04%,CP;SLC39A14;STEAP3;ACSL5
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.7094568976954572,-1.1049421513156565,0.37142857142857144,0.7934821625034265,1.0,1/7,1.32%,GPR183
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.6157681011654871,-1.1048879070395556,0.37254901960784315,0.7933332605094179,1.0,2/11,7.83%,PARP14;PARP9
prerank,CellMarker_Augmented_2021__CD4+ T cell:Undefined,-0.772713372693199,-1.104786078056416,0.43548387096774194,0.7932948211789465,1.0,4/5,21.37%,CD5;SELP;CD4;PTPRC
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.7595044567905422,-1.104776350094563,0.43636363636363634,0.7929425514918559,1.0,1/5,5.11%,ATP23
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.4886379320525657,1.10477570332101,0.2682926829268293,0.9576354158248744,1.0,7/24,19.46%,NR1D1;PGM2;AGL;PYGM;UGP2;PPP1R3C;PYGB
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.6974264903957503,-1.1047255710273949,0.4642857142857143,0.7927474633755868,1.0,2/6,12.78%,SKAP1;FADD
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.614035571688865,1.1046020786884647,0.43902439024390244,0.9574320454826736,1.0,2/10,5.26%,HSPA1A;GIT1
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.585713987466367,1.1045939075239024,0.38461538461538464,0.9565929543771668,1.0,4/10,12.75%,ABHD17A;LYPLA2;ABHD17B;ABHD17C
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.6930145821466503,1.1045617523086046,0.38461538461538464,0.9558700059372404,1.0,3/8,7.57%,CASS4;MCU;EFS
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.5508903912339345,1.1044119501894676,0.3793103448275862,0.9554918701793175,1.0,14/25,24.73%,TRIB3;DCUN1D2;UBE2N;FBXO5;DCUN1D1;PLK1;FEM1B;DCUN1D5;SMAD7;FEM1A;DCUN1D4;ARRDC4;FBXW7;AXIN1
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.5221570457050688,-1.104369389419134,0.3382352941176471,0.7935949945351161,1.0,7/39,7.03%,MYO1F;CD5;TAGAP;GPR171;SLA;ARHGAP9;CD44
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.6933138071424416,-1.1043226378793052,0.3898305084745763,0.7934294368278492,1.0,1/7,1.14%,NR4A3
prerank,Reactome_2022__NOTCH4 Activation And Transmission Of Signal To Nucleus R-HSA-9013700,0.7099607964926188,1.1042390302591572,0.425,0.9552496163630048,1.0,1/8,1.39%,NCSTN
prerank,Reactome_2022__Josephin Domain DUBs R-HSA-5689877,-0.6285142841431505,-1.1041773111572442,0.39705882352941174,0.7935307539105569,1.0,2/11,12.77%,RPS27A;UBC
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Dorsolateral Prefrontal Cortex,-0.4707815855862306,-1.104008630570657,0.30864197530864196,0.7937250786782775,1.0,39/94,20.01%,GRIN2A;SLITRK1;TTLL7;SRRM4;MAP1B;GRIA3;OPALIN;GAP43;GRIA1;GFAP;TCEAL6;IL1RAPL1;SYT1;FRMPD4;HPCA;SCN2A;FGF1;STMN4;C11ORF87;SYNPR;GRIN2B;SCN3B;GAD2;GABRG2;SYT16;BDNF;TMEM130;CNTN2;GRIK2;GABRA1;PHYHIP;AKAP6;CELF4;PNMA2;GABBR2;SLC17A7;PDE1C;PTPN5;KCNC2
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),-0.6992846374582479,-1.1039683020688926,0.3958333333333333,0.7934666298222781,1.0,2/6,7.04%,THBS1;ACSL5
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.6586648120391984,1.103955621567431,0.4166666666666667,0.9554857261271626,1.0,6/8,31.86%,TRIT1;MTO1;TRMT5;RPUSD4;TRMT61B;HSD17B10
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.6751371164976745,-1.1038943834894719,0.38181818181818183,0.7934071296111014,1.0,1/7,4.15%,ST18
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.7607169280969732,-1.1037908128007807,0.40816326530612246,0.7933476833194637,1.0,1/5,7.78%,PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.5062637140073126,-1.1037093426335878,0.28125,0.7932122564477458,1.0,6/32,15.79%,MET;FBP1;DAB2IP;ITGA3;DLC1;STMN1
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.7337934258362238,-1.103548960022101,0.40350877192982454,0.7933387299884364,1.0,1/5,1.62%,TLR2
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.5905277462994629,1.1034064861346253,0.3018867924528302,0.9563857260023255,1.0,3/9,23.68%,UBXN2B;PARD6A;CEP72
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Blood,-0.5196961341260725,-1.1032412234081415,0.31343283582089554,0.7938238155977929,1.0,9/27,14.05%,CD5;TAGAP;GPR171;ARHGAP9;ARHGAP15;ACAP1;PATL2;P2RY10;THEMIS
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.69743058148063,-1.1030676237959063,0.41818181818181815,0.7940469214113622,1.0,1/5,0.33%,THBS1
prerank,CellMarker_Augmented_2021__Follicular T cell:Undefined,-0.5688920047965658,-1.1030031321283575,0.39344262295081966,0.7938776913535361,1.0,8/19,12.84%,CD5;TAGAP;TMC8;ARHGAP9;ACAP1;WAS;PTPN7;P2RY10
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.43463551458795446,1.102904033652336,0.23076923076923078,0.9572218557764406,1.0,20/52,20.89%,NUP42;NUP37;ABCD1;NUP54;NDC1;NUP214;RAE1;AAAS;NUP188;COX7A2L;EP300;NUP205;BEND3;JMJD8;SPHK2;AK4;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.7275595779245498,-1.1025846777699517,0.39285714285714285,0.794838124595235,1.0,1/5,10.67%,LRPAP1
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.6969478468129096,-1.102420079671051,0.3793103448275862,0.7950225557777573,1.0,2/6,14.47%,LDLR;MFSD2A
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.42806140304804663,1.1023666559803997,0.24242424242424243,0.9581807897387107,1.0,2/44,2.78%,G0S2;BCL10
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.5495483991496223,-1.1021077187208677,0.3108108108108108,0.7956615852528461,1.0,6/29,16.44%,POLE3;POLE4;RPA3;RPA1;CDK2;CDC7
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.5638042449929899,1.1020656736537153,0.35555555555555557,0.9583305473201968,1.0,4/13,20.95%,TMEM33;ATL2;ZFYVE27;RAB18
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.45104726004539347,-1.101789911994423,0.3125,0.7963926334612306,1.0,21/111,17.67%,GBP2;IL1R1;GBP1;RPS27A;ST18;NOD1;CCL2;PSMB9;PSMB6;DAB2IP;PSMC3;TNIP2;UBC;MYLK3;HYAL1;PSMA8;IL1RAP;PSMA7;PSME1;RIPK2;RBX1
prerank,CellMarker_Augmented_2021__Fat Cell (adipocyte):Adipose Tissue,0.5307967001893381,1.101667639609118,0.2926829268292683,0.9587385855322175,1.0,2/14,3.54%,PPARGC1A;ADIPOR1
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.6296229714799145,-1.1015900180673182,0.3088235294117647,0.7966055628056924,1.0,1/11,0.33%,THBS1
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,0.5209551328129226,1.1015383132728618,0.2857142857142857,0.9581952687818445,1.0,2/22,8.16%,KDM1B;KDM5A
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.5577992634411274,-1.101472831749707,0.3382352941176471,0.7966080456486414,1.0,3/24,8.55%,TYMS;GLRX;NUDT13
prerank,Reactome_2022__Drug-mediated Inhibition Of CDK4/CDK6 Activity R-HSA-9754119,-0.7209376095899438,-1.1014263002145175,0.3877551020408163,0.7963877569204986,1.0,3/5,23.98%,CCND1;CCND2;CDK6
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.5784261918099686,1.101413257200499,0.3055555555555556,0.9577871448168443,1.0,1/10,1.38%,SOX8
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.6758202632809137,-1.1013031698328641,0.4,0.7963903356374112,1.0,1/6,11.85%,FOXM1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.621358664847389,-1.1010423280160535,0.36666666666666664,0.7967582607031154,1.0,4/13,11.28%,APLNR;TGFBR2;ZFPM1;SLIT3
prerank,CellMarker_Augmented_2021__T Helper cell:Undefined,-0.5667801737577346,-1.1008216713623862,0.3150684931506849,0.7971132620428829,1.0,7/19,19.00%,IL13RA1;CD5;SELP;CCR10;CD200;CD4;PDGFRA
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,0.3830871074876777,1.1008187624381696,0.2222222222222222,0.958772143430157,1.0,6/74,7.54%,FGF6;FLT3;EGFR;AKT2;AKT1;STRN
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.583903899725958,-1.1002435902669192,0.3181818181818182,0.7980865129413303,1.0,8/19,23.06%,APP;IGF1;GAPDHS;PRXL2C;PFKFB4;PFKFB3;P2RX7;PFKFB2
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.583903899725958,-1.1002435902669192,0.3181818181818182,0.7980865129413303,1.0,8/19,23.06%,APP;IGF1;GAPDHS;PRXL2C;PFKFB4;PFKFB3;P2RX7;PFKFB2
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),-0.6117290770321789,-1.0997149565835647,0.3,0.7993836072749143,1.0,1/15,0.24%,CCBE1
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.617271762376438,1.0996855552102252,0.34210526315789475,0.9616616926260756,1.0,1/8,0.44%,WNT7A
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.6782263172578938,-1.0994489900686024,0.40384615384615385,0.7995996509092578,1.0,2/5,16.36%,HLA-DRA;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.6782263172578938,-1.0994489900686024,0.40384615384615385,0.7995996509092578,1.0,2/5,16.36%,HLA-DRA;HLA-DRB1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.5900375965935667,-1.0994387519811673,0.373134328358209,0.7993077436306332,1.0,8/19,22.15%,HTR2B;ITPR3;HTR2C;RYR2;HTR2A;ITPR1;PTPRC;ERO1A
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.6959560821987345,1.0993739399126796,0.4090909090909091,0.9617971773176205,1.0,1/5,6.66%,ABHD5
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.4585135410473834,1.0988243449389716,0.28125,0.9627244263432865,1.0,5/27,12.84%,MEN1;DUSP19;MARVELD3;SIRPA;TAOK3
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.5542749082878766,-1.098630785618285,0.34328358208955223,0.8014597517223191,1.0,4/22,17.54%,SLC6A15;SLC43A2;SLC38A1;CTNS
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.6574883124907979,1.0984634621301692,0.3157894736842105,0.9632081036134088,1.0,2/11,15.49%,TBCCD1;ARCN1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.502660586724152,1.0981568048024433,0.3235294117647059,0.9633007505523642,1.0,8/21,19.75%,S1PR1;SOX9;FBXO5;SGMS2;ANKH;ECM1;HEY1;HEY2
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.7201650479438324,-1.0980725093529664,0.4090909090909091,0.8028444392673313,1.0,4/7,25.47%,CCDC39;DRC1;DNAAF1;CCDC40
prerank,KEGG_2021_Human__GnRH secretion,-0.5029909688037821,-1.0980669154184117,0.3561643835616438,0.8024929418849912,1.0,12/54,19.98%,CACNA1H;ITPR3;PRKCG;CACNA1C;PIK3CB;PIK3CD;PRKCB;SPP1;GPER1;HCN1;GABBR2;TRPC5
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreas,-0.4473136708940189,-1.0979478890205514,0.3125,0.802501128867898,1.0,21/98,19.00%,CHGB;NOS1AP;ASPHD1;CAMK2N2;TTLL7;B4GALNT1;MAP1B;EFNB3;ARHGAP39;SYT1;HPCA;TMEM151A;CKMT1B;SYT13;SEZ6L2;VWA5B2;PTPRF;SULT4A1;LARP6;PTPN21;PNMA2
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.5962588974533254,1.0979439404964324,0.35,0.9631572976060633,1.0,4/13,15.44%,TEX15;APOBEC3F;SMYD5;PIWIL4
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.5434247088632088,1.0978440340001816,0.3333333333333333,0.9625734122525101,1.0,1/11,7.15%,FBXO5
prerank,Reactome_2022__Glycogen Synthesis R-HSA-3322077,-0.66830582570291,-1.0977058244086597,0.38181818181818183,0.8029979991079182,1.0,3/11,12.77%,RPS27A;GYG2;UBC
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4652058914096027,1.0975638489491126,0.2903225806451613,0.962779014736619,1.0,5/22,15.78%,NR1D1;TNFAIP3;TICAM1;RAB7B;LGR4
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.6869075760897626,1.0973562979891909,0.4,0.9627284924091781,1.0,4/6,16.85%,AKT2;AKT1;VCP;BAD
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.5670616942169252,1.0973553768762958,0.2857142857142857,0.9618808292121439,1.0,2/13,3.97%,OCLN;RUNX1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.4472705891199025,-1.097344010281094,0.29411764705882354,0.8039661964688365,1.0,31/115,20.39%,FLRT3;POU4F1;L1CAM;ANK3;MYOT;SNCB;APP;SLITRK1;LRRC4;ARHGAP39;SLC8A3;UNC13C;CBLN2;PCDHB5;ACHE;DCTN1;NLGN1;SEMA3E;BDNF;CNTN2;PPFIA1;SNCG;CACNB1;PTPRF;CDK5;MAPT;AGRN;DOK7;CX3CL1;C1QB;PCDHB4
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.6447505486532228,-1.0972912656185876,0.3968253968253968,0.8034473048362167,1.0,1/7,1.67%,MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.6447505486532228,-1.0972912656185876,0.3968253968253968,0.8034473048362167,1.0,1/7,1.67%,MX1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.6623449592374834,-1.0972440505631613,0.43333333333333335,0.8032424088199437,1.0,2/8,14.60%,OGFOD1;GLE1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),0.6262543049541731,1.097062997891552,0.37209302325581395,0.9618107836624339,1.0,2/9,2.81%,COQ3;GK
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood,-0.5080275372213452,-1.096940322986168,0.34210526315789475,0.8039420457985167,1.0,23/58,18.20%,APLNR;RAMP3;ITM2A;HLA-DRA;LDB2;MYH11;F13A1;SELP;RNASE1;ITGA9;RASL12;ROBO4;CD74;SERPING1;CD200;FMO2;TEK;SHROOM4;MRC1;ADGRF5;AQP1;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Neutrophil:Lung,-0.5090299309720646,-1.0968247823114878,0.2878787878787879,0.8038620813320739,1.0,9/31,10.15%,P2RY13;MYO1F;TAGAP;NLRP12;ARHGAP9;IGSF6;CLEC12A;LAT2;CTSS
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.5699526221862719,1.096754207981439,0.3611111111111111,0.9620367373846632,1.0,3/17,7.72%,KPNA2;NUP54;IPO5
prerank,Reactome_2022__Signaling By RNF43 Mutants R-HSA-5340588,0.6824021789422399,1.0967324314105593,0.38461538461538464,0.9612735299180326,1.0,1/5,6.10%,FZD8
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.4233560405274501,-1.0967100947487167,0.30120481927710846,0.8039862139732054,1.0,33/155,15.80%,FLRT3;TAGLN3;STMN2;NEFL;NEFM;ELAVL2;SNCB;SH3GL2;ZDHHC22;SLITRK1;ATRNL1;SYT4;MAP1B;EFNB3;GAP43;EDIL3;ZNF536;TMEM163;SYT1;PLPPR5;STMN4;INSYN2A;ACHE;CRMP1;GRID2;NLGN1;CNR1;SLITRK5;CNTN2;KCNC1;GDAP1L1;CIB2;RELN
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.5047036315827308,-1.09659035218826,0.35064935064935066,0.80392294889065,1.0,10/56,16.14%,RHOBTB2;FSCN1;RND2;BST2;BAIAP2;RHOF;DMTN;DLC1;PRKCD;RHOD
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.707754696947886,-1.096483515854949,0.44642857142857145,0.8038639003200474,1.0,2/6,12.25%,PODXL;MYO1E
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.5467634422376455,-1.0963381733661663,0.3333333333333333,0.8040668723219108,1.0,2/20,2.79%,L1CAM;SHTN1
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.6480006367420517,-1.0962758302175704,0.35384615384615387,0.8039413103553977,1.0,1/10,1.31%,TYMP
prerank,Reactome_2022__Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,0.5085571912830991,1.096142582881053,0.34285714285714286,0.962181901050319,1.0,5/19,12.89%,ALG6;ALG3;MOGS;RFT1;ALG11
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.6711359773521022,-1.0955339985202555,0.3709677419354839,0.8059720543325961,1.0,1/9,2.14%,KMO
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,0.41678429413915535,1.0955337899642443,0.24,0.963353192602186,1.0,10/73,6.89%,SEM1;NCSTN;PSMD10;PSMA1;MAML3;PSMD11;KAT2B;CUL1;AKT1;PSMB5
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,-0.5233458320868704,-1.095520150700983,0.39436619718309857,0.8056464279135107,1.0,13/35,18.96%,ST6GAL1;GCNT7;GCNT1;CHST4;B3GNT5;GALNT10;B3GNT2;GALNT12;ST6GALNAC2;MUC6;GALNT8;GALNTL6;MUCL1
prerank,KEGG_2021_Human__Olfactory transduction,-0.5038894239949925,-1.0951904358193487,0.32857142857142857,0.8062218189858675,1.0,6/39,8.45%,OR51M1;ANO2;OR52N2;OR51I2;NCALD;SLC8A3
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.5362471115609214,-1.0951833638361932,0.37333333333333335,0.8058756263034451,1.0,11/46,19.62%,KCNQ1;NOS1AP;KCNJ2;CAV3;GNG2;CD63;KCNMB4;KCNAB3;AKAP6;GABBR2;KCNIP4
prerank,Reactome_2022__Regulated Proteolysis Of p75NTR R-HSA-193692,0.6416569130445865,1.0951409366491458,0.3333333333333333,0.9639530915296083,1.0,1/8,1.39%,NCSTN
prerank,Reactome_2022__Pregnenolone Biosynthesis R-HSA-196108,0.5892048190805736,1.0950608304891363,0.34210526315789475,0.9633534114204221,1.0,6/10,28.44%,STARD3NL;STARD4;AKR1B1;FDX1;CYP11A1;STARD3
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Lymph,-0.7162793632619812,-1.0948919060822506,0.36065573770491804,0.8059468964268789,1.0,2/7,7.03%,THY1;CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Tonsil,-0.7162793632619812,-1.0948919060822506,0.36065573770491804,0.8059468964268789,1.0,2/7,7.03%,THY1;CD44
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.48745416605247127,1.094729609888099,0.34375,0.96347529317794,1.0,5/40,5.64%,HSPA1A;RIOK2;ZPR1;RIOK1;EGFR
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,-0.4471243447585263,-1.09462413487962,0.2823529411764706,0.8064714102409495,1.0,16/102,16.89%,AGPAT4;DGAT2L6;PLAAT4;PLB1;DDHD2;PLD2;LPCAT4;ACHE;LIPI;LIPH;SLC44A3;PITPNM2;MFSD2A;PNPLA3;SH2D3C;CHKB
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.5364289459233125,-1.0945266352519207,0.37142857142857144,0.8063825010117867,1.0,10/30,16.14%,GPR87;EPS8L2;ABCA12;BAIAP2L1;HR;KPNA7;ITGA3;LAMA3;ITGB4;RHOD
prerank,CellMarker_Augmented_2021__Monocyte:Spleen,-0.5133950890388237,-1.0944951443899722,0.3384615384615385,0.8061446391823834,1.0,11/25,13.63%,P2RY13;MYO1F;TLR2;SLA;SIGLEC1;IGSF6;CLEC12A;CTSS;PILRA;SLC11A1;CLEC5A
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.46389347486924387,-1.0943135377615592,0.3026315789473684,0.806271126071433,1.0,18/84,19.33%,EPN1;RPS27A;SH3GL2;LDLR;EGF;SYT1;WNT5A;SH3GL3;TGFA;M6PR;UBC;SYT2;SH3KBP1;LRP2;COPS5;CD4;TF;CLTB
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.5696620088290718,1.0943000827859428,0.3235294117647059,0.9640937504323212,1.0,3/9,14.86%,ZSWIM6;ZSWIM5;TUBB2B
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.530569616509773,-1.0940526141875708,0.3076923076923077,0.806757340864838,1.0,4/24,8.72%,ANXA1;THBS1;KLF4;SRPX2
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.43176080102956976,-1.0940053262950478,0.3058823529411765,0.8065940458612483,1.0,9/135,5.35%,PRAME;HPN;EFNA1;SIX3;PKP2;ABCA5;COL5A1;OVOL2;ZNF750
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.44129283334548924,1.0939181497246449,0.3,0.9644679923182589,1.0,17/39,27.21%,PPARGC1A;MFF;PRMT6;CSNK2A2;MUL1;MIEF2;EP300;GOLPH3;MYO19;USP36;FZD5;MARCHF5;FBXW7;INF2;PID1;HAX1;STOX1
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,-0.4614015993814701,-1.0937469257263495,0.35365853658536583,0.8072160568480619,1.0,27/93,19.56%,THBS1;SPARC;F8;APP;TIMP1;EGF;SGPP2;F13A1;GTPBP2;IGF1;TAGLN2;CD9;FN1;CD63;F5;SRGN;WDR1;SERPING1;TLN1;VCL;TGFB1;FERMT3;HSPA5;TF;SELENOP;CD36;RAB27B
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.42011321463352325,1.0935557236035471,0.2727272727272727,0.9647909632211451,1.0,2/59,0.43%,G0S2;NGF
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.5207931305966641,-1.0935423538943603,0.32857142857142857,0.807490546687323,1.0,6/54,13.58%,THBS1;NR4A3;GATA1;ZFPM1;PRKCQ;FES
prerank,KEGG_2021_Human__Pancreatic cancer,-0.4684358405122073,-1.0935275189735687,0.2876712328767123,0.8071867658190389,1.0,10/72,10.38%,CDKN2A;TGFBR2;RALGDS;PLD1;CCND1;EGF;GADD45A;PLD2;STAT1;TGFA
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.6945692032691622,-1.093422745691684,0.40625,0.8071845205724227,1.0,2/7,9.67%,TGFBR2;STAT1
prerank,CellMarker_Augmented_2021__Cholinergic neuron:Spinal Cord,-0.47751054089175915,-1.09327462079832,0.25333333333333335,0.8072689047697664,1.0,16/58,11.84%,RIMBP2;CHGB;STMN2;MYT1;LRRTM1;SYT4;SRRM4;ELAVL4;GLRA2;NELL1;GAP43;ZNF536;HCRTR2;SST;STMN4;KCNB2
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.6815857786778602,1.0929736760055473,0.4166666666666667,0.9659323902681665,1.0,1/7,7.37%,SLC4A7
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.45828395945507167,-1.092899101856877,0.29213483146067415,0.8081655031533928,1.0,11/82,14.33%,THBS1;TGFBR2;RPS27A;ADAMTSL2;ASPN;LTBP4;EID2;LDLRAD4;UBC;VEPH1;ITGA3
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,0.4179603195756114,1.0928191157720277,0.27586206896551724,0.9656675353779988,1.0,12/57,13.78%,SEM1;LIMD1;PSMD10;ELOC;PSMA1;PSMD11;PSMB5;UBE2D1;PSMD14;EGLN3;CUL2;PSMD12
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.6823378120211733,-1.0927853715715146,0.4074074074074074,0.8081380995597177,1.0,4/7,21.59%,EMP1;EMP2;EMP3;P2RX7
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.6923430894409909,1.0925253326798356,0.425531914893617,0.9658674533003345,1.0,2/5,20.40%,TMEM33;RAB3GAP1
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),-0.6988314759252866,-1.0924751128087646,0.43859649122807015,0.8087822232705568,1.0,3/6,22.79%,PLSCR1;P2RX7;ANO7
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.47868250196259177,1.0924169590061164,0.3076923076923077,0.9653106762987101,1.0,3/24,4.98%,ACE2;OCLN;TRIB3
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",0.5571359158919161,1.092386287648657,0.3695652173913043,0.9645836046263015,1.0,1/13,1.08%,CHAMP1
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.5339410930487499,-1.0923766030977546,0.34615384615384615,0.8087298645992967,1.0,4/32,6.92%,AWAT1;ALOX12;CYP4Z1;CYP1B1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.41765886041324907,-1.09222917895729,0.2682926829268293,0.8087886845412063,1.0,42/188,20.53%,RPL19;RPL3;RPS27;RPS14;RPL27A;RPL35;EMG1;RPL7A;RPL37A;RPL27;RPL9;RPL21;NOB1;RPL13A;RPS16;RPL24;RPLP1;RPL38;RPL10A;RPL10;RPLP2;RPS7;RPL8;RPS6;MRTO4;RPS15;RPS9;RPL12;PES1;RPL5;RPL23;RPL4;DDX54;RPL18A;RPL41;RPL7;RPL15;RPL11;EXOSC7;RPS25;RPL29;RPL36
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.5341685792954519,-1.0922148885213165,0.3287671232876712,0.8084895172585974,1.0,2/36,2.23%,LEF1;RPS27A
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.654566676393347,-1.0920707724796712,0.41379310344827586,0.8086306390083216,1.0,5/5,34.57%,AQP1;AQP11;SLC26A6;SLC5A11;SLC2A13
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.6538192002290988,1.0920375172065493,0.475,0.9650758842511328,1.0,1/6,10.09%,PLK1
prerank,Reactome_2022__Cell-extracellular Matrix Interactions R-HSA-446353,0.5374280509222595,1.091982306777091,0.35135135135135137,0.9643905419036479,1.0,4/14,17.40%,TESK1;PARVA;RSU1;ARHGEF6
prerank,Reactome_2022__Phase 3 - Rapid Repolarisation R-HSA-5576890,-0.6869417300355073,-1.0919740203652997,0.43548387096774194,0.8086853143385662,1.0,1/6,0.67%,KCNQ1
prerank,Reactome_2022__MET Activates PI3K/AKT Signaling R-HSA-8851907,0.6534705420609352,1.0918873694932543,0.39215686274509803,0.9638671948929372,1.0,4/6,23.66%,PIK3CA;PIK3R1;PIGU;SOS1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.5065996995355199,-1.091697587740829,0.4166666666666667,0.8091919053115445,1.0,5/40,12.78%,CCBE1;CTSC;ATP5IF1;PINK1;FADD
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Esophagus,-0.5068160919042659,-1.0916001272680125,0.36363636363636365,0.8091559323859999,1.0,14/45,19.04%,CDKN2A;CEACAM1;TMPRSS11D;MACC1;GPT2;ISG15;LIPH;GPR160;MBD6;BLNK;CACNB1;VASN;AGFG2;ADM
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Germ,0.408141587348132,1.091578171188681,0.2,0.9639572065221023,1.0,14/65,12.55%,DGKB;ZNF804B;AMER2;GABRG1;DNAH7;CRB1;GRIA2;TMEM232;UNC79;NRXN1;MGAT4D;DNAH12;GRM1;GABRB1
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.7147432622538138,1.0915735974449752,0.4146341463414634,0.9622626181847063,1.0,3/5,27.14%,GNPAT;AGPS;FAR1
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.7147432622538138,1.0915735974449752,0.4146341463414634,0.9622626181847063,1.0,3/5,27.14%,GNPAT;AGPS;FAR1
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.4923588857017883,-1.0915225866521372,0.379746835443038,0.8090009419192955,1.0,8/54,13.59%,ANXA1;IL1R1;IRF1;LRRC19;WNT5A;BIRC3;SBNO2;HERC5
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.3972710043064245,1.0914727421988342,0.21428571428571427,0.9617730400097809,1.0,20/74,19.92%,SDHAF4;SAMM50;COX18;NDUFB1;DMAC2;NDUFAF3;SMIM20;LYRM7;NDUFAF4;NDUFAF2;COX19;NDUFV3;NDUFA8;TIMMDC1;NDUFS1;NDUFV1;CHCHD4;NDUFAF7;FASTKD3;UQCC1
prerank,CellMarker_Augmented_2021__Memory B cell:Blood,-0.5305238617066133,-1.0914385555544523,0.3770491803278688,0.8067657219430769,1.0,9/24,15.49%,CD5;TAGAP;TMC8;ARHGAP9;ACAP1;WAS;P2RY10;SP140;CD37
prerank,CellMarker_Augmented_2021__Double-negative Memory B cell:Peripheral Blood,-0.5305238617066133,-1.0914385555544523,0.3770491803278688,0.8067657219430769,1.0,9/24,15.49%,CD5;TAGAP;TMC8;ARHGAP9;ACAP1;WAS;P2RY10;SP140;CD37
prerank,CellMarker_Augmented_2021__Class-switched Memory B cell:Peripheral Blood,-0.5305238617066133,-1.0914385555544523,0.3770491803278688,0.8067657219430769,1.0,9/24,15.49%,CD5;TAGAP;TMC8;ARHGAP9;ACAP1;WAS;P2RY10;SP140;CD37
prerank,CellMarker_Augmented_2021__Non-switched Memory B cell:Peripheral Blood,-0.5305238617066133,-1.0914385555544523,0.3770491803278688,0.8067657219430769,1.0,9/24,15.49%,CD5;TAGAP;TMC8;ARHGAP9;ACAP1;WAS;P2RY10;SP140;CD37
prerank,CellMarker_Augmented_2021__Switched Memory B cell:Peripheral Blood,-0.5305238617066133,-1.0914385555544523,0.3770491803278688,0.8067657219430769,1.0,9/24,15.49%,CD5;TAGAP;TMC8;ARHGAP9;ACAP1;WAS;P2RY10;SP140;CD37
prerank,CellMarker_Augmented_2021__Double-negative B cell:Peripheral Blood,-0.5305238617066133,-1.0914385555544523,0.3770491803278688,0.8067657219430769,1.0,9/24,15.49%,CD5;TAGAP;TMC8;ARHGAP9;ACAP1;WAS;P2RY10;SP140;CD37
prerank,CellMarker_Augmented_2021__IgG Memory B cell:Undefined,-0.5305238617066133,-1.0914385555544523,0.3770491803278688,0.8067657219430769,1.0,9/24,15.49%,CD5;TAGAP;TMC8;ARHGAP9;ACAP1;WAS;P2RY10;SP140;CD37
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.490063884922189,1.091181955756832,0.3142857142857143,0.9617845468558688,1.0,4/23,9.95%,OTUD3;TNFAIP3;USP27X;OTUB2
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,-0.5557925757447869,-1.091162124737875,0.36065573770491804,0.8073241125861865,1.0,3/16,11.73%,PARP14;PARP9;NAMPT
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.5644977152422627,1.0911210370726188,0.3055555555555556,0.9611663109938534,1.0,5/11,23.28%,GTF2A2;TAF12;BDP1;DR1;GTF2B
prerank,Reactome_2022__Nucleotide Biosynthesis R-HSA-8956320,0.5912467791636415,1.0910294733451498,0.36363636363636365,0.9605891116829575,1.0,3/11,11.79%,GMPS;ATIC;ADSS2
prerank,Reactome_2022__Regulation Of PTEN mRNA Translation R-HSA-8943723,0.604825427435079,1.0909576503923948,0.4,0.9600528405520075,1.0,5/11,26.47%,VAPA;CNOT6L;AGO3;TNRC6B;PTEN
prerank,KEGG_2021_Human__Dopaminergic synapse,-0.4299578155603964,-1.0908919475136092,0.32098765432098764,0.8078983694183567,1.0,17/108,13.97%,MAOB;GRIN2A;GNG3;GRIA3;GRIA1;ITPR3;SLC18A2;PRKCG;PPP3CC;CREB5;CACNA1C;ADCY5;SCN1A;CALY;GNG2;GRIN2B;FOS
prerank,CellMarker_Augmented_2021__Liver Progenitor cell:Fetal Liver,-0.44774426723132593,-1.0908211354599489,0.2962962962962963,0.8077773064646676,1.0,22/90,22.28%,COL4A2;TEAD2;EFNB3;SCARA3;ARHGEF17;UNC5B;DAB2IP;IGFBP5;AMOTL2;RHBDF1;COL12A1;PTPRF;GPC1;NOTCH3;PTPN21;LAMA5;ANTXR1;KIAA1217;CD276;MYO1B;EPB41L1;CTNND1
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.5376698112590994,1.090810265502519,0.3103448275862069,0.9596172049327141,1.0,3/12,11.84%,NUDT21;CPSF6;CPSF7
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.6350988552197099,-1.090745164760706,0.40350877192982454,0.8076440934702459,1.0,4/10,21.37%,EGF;MGAT5;HES1;PTPRC
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.6886299785055445,-1.090651569933613,0.3620689655172414,0.8075804179319344,1.0,4/7,22.78%,LAMA3;ITGB4;PLEC;DST
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,-0.4794119960323501,-1.0906373725433076,0.36,0.8072596453713805,1.0,3/57,5.29%,CXCL2;MET;NOD1
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.5908146789580793,-1.0905532262031685,0.34545454545454546,0.8068024617145771,1.0,1/15,1.14%,AMN
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.5908146789580793,-1.0905532262031685,0.34545454545454546,0.8068024617145771,1.0,1/15,1.14%,AMN
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,-0.47410402495437265,-1.090535200222762,0.3291139240506329,0.8064906026387986,1.0,9/70,8.87%,GRIN2D;GRIN3A;NEFL;GRIN2A;KIF17;GRIA3;GRIA1;NRGN;RPS6KA1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.729994462651739,-1.0905166960017156,0.42857142857142855,0.8061830907049095,1.0,1/6,3.97%,RAB11A
prerank,CellMarker_Augmented_2021__Lymphoid-primed Multipotent Progenitor cell:Umbilical Cord Blood,-0.49603180097706295,-1.0904794996390152,0.2926829268292683,0.8059695235244853,1.0,14/59,19.75%,PRAME;SSC4D;LDB2;LAT2;ADAM19;PROX2;SNX10;RNF213;STK32B;ARFGAP1;ETS1;EDC4;DPYSL3;PDE1A
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6665853679718947,-1.0902678480312114,0.3968253968253968,0.8062161770611833,1.0,2/11,7.77%,APP;SYP
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.40259255473960587,1.0902675287720716,0.25,0.960676403925557,1.0,12/64,13.14%,RANBP17;NXT2;NUP62CL;PPP1R10;AKT1;IPO5;IPO8;RALA;NUP214;NXT1;RANBP6;TSPAN17
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.5113813705197591,-1.0900129336383386,0.3333333333333333,0.8067067747824042,1.0,13/47,18.56%,LEF1;GPR183;TGFBR2;IL15;SNX10;SBNO2;MYH9;PIK3CD;CDK2;HLA-DRB1;PML;CDKN1A;CD4
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.47151177814244477,-1.0898596849894664,0.3888888888888889,0.8067739195087238,1.0,14/76,16.59%,PCSK2;MMEL1;TESC;PHEX;NNAT;MMP14;ADAM19;CTSS;AEBP1;TSPAN32;SRGN;APH1A;F3;CLN3
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.7330462914103553,-1.0898135249875385,0.4375,0.8065929933731925,1.0,2/5,18.34%,DDRGK1;HSPA5
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,-0.4519615313063666,-1.0896927178471127,0.2926829268292683,0.8066926411971256,1.0,13/97,13.76%,ERCC6L;RPS27;CENPH;CENPE;ZWILCH;SRF;PFN2;NUF2;SPC24;KIF2C;RNASE1;CENPN;CENPU
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.6692688816234282,-1.0896532689542169,0.40350877192982454,0.8065484681701669,1.0,1/6,6.02%,DENND3
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,-0.5394552259527541,-1.089598638992931,0.38235294117647056,0.8063678764838064,1.0,6/27,13.62%,F8;CTSC;GRIA1;TGFA;CTSZ;F5
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.5724443837882948,-1.0895731398061974,0.3424657534246575,0.8061143853936045,1.0,1/22,0.85%,TUBB6
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.5236704575439004,-1.0895587303925278,0.3333333333333333,0.8058246024267086,1.0,9/24,19.24%,ICAM1;GRIN2A;APP;IGF1;CACNB1;SNX6;CDK5;ABCC1;CD36
prerank,Reactome_2022__Sodium/Proton Exchangers R-HSA-425986,-0.7452260265575352,-1.0892081829662166,0.4,0.80659752582932,1.0,5/6,24.64%,SLC9A2;SLC9A5;SLC9A7;SLC9A1;SLC9A9
prerank,CellMarker_Augmented_2021__Lymphoid cell:Peripheral Blood,-0.49008745311796076,-1.0891672218295656,0.36363636363636365,0.8063847995023768,1.0,15/47,20.36%,P2RY13;RASGRP2;TAGAP;ARHGAP9;GNG2;ELMO1;CD37;SH2D3C;PRKCB;KLHL14;PTPRO;BCL11A;WDFY4;NAPSB;SPI1
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.44998937604035105,-1.0891167200036729,0.345679012345679,0.8061884645790772,1.0,9/71,10.43%,P2RY12;EPS8L2;FSCN1;CLRN1;ANLN;CDC42EP1;CDC42EP3;PLPPR5;PLEKHM1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.5875535067102211,1.0889991265921581,0.38235294117647056,0.9640425409361503,1.0,5/10,23.21%,PTPN23;RAB21;VPS11;EIPR1;EZR
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.4757430785559849,-1.0889522960991007,0.3291139240506329,0.8063284407758007,1.0,16/70,20.76%,SH3GL2;APP;ARHGEF17;SCG5;HSD17B14;SST;ZFHX2;CRMP1;TMEM151A;PCP4;SEZ6L2;SPP1;LRP2;GLIS2;PRR36;CD276
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.399846998361565,1.0887256612544696,0.23809523809523808,0.9640022714084707,1.0,7/60,7.02%,ATP6V0D2;PDK4;ATP6V1A;AKT2;ATP6V1G1;AKT1;AP3S1
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,-0.5914502583178418,-1.088208816848852,0.4,0.8082737610801944,1.0,4/17,12.88%,KIF14;MYH11;MYH9;RNASE1
prerank,Reactome_2022__Resolution Of Abasic Sites (AP Sites) R-HSA-73933,0.4709603441381719,1.088148682386857,0.39285714285714285,0.9650449080289181,1.0,4/35,5.74%,POLD3;SLC19A1;POLG2;RFC3
prerank,CellMarker_Augmented_2021__Neural Stem cell:Undefined,0.4410433258079747,1.0879628947245232,0.3870967741935484,0.9649641290075134,1.0,9/43,16.66%,ASCL1;SOX21;RUNX1;SOX9;NOTCH2;CDH2;PMP2;ID2;NR2F1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.46765336104254823,-1.0878852910196732,0.3333333333333333,0.8089468323670286,1.0,8/90,9.94%,PIF1;RECQL4;BLM;HELB;BRCA1;POLE3;DONSON;RPA3
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.46419848102405803,1.0878266457432513,0.36363636363636365,0.9645959015679262,1.0,7/33,17.29%,OTUD3;TRIB3;THEM4;AKT1;DRD2;MUL1;MAGI2
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.5753994455634186,-1.0877970034423745,0.3770491803278688,0.8089236455621425,1.0,1/14,0.81%,C3
prerank,Reactome_2022__Purine Salvage R-HSA-74217,-0.624578808518,-1.0877577129842746,0.423728813559322,0.8087589785823294,1.0,1/10,2.93%,GMPR
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,0.44589771600937383,1.087725002222783,0.3888888888888889,0.9640598781460343,1.0,8/41,13.78%,SEM1;PSMD10;PSMA1;PSMD11;PSMB5;MRC2;PSMD14;PSMD12
prerank,CellMarker_Augmented_2021__Responder T cell:Peripheral Blood,-0.5337821712842235,-1.087203944902269,0.3582089552238806,0.8101381595981368,1.0,9/26,10.15%,MYO1F;GPR183;DOCK8;CD5;TAGAP;SLA;ARHGAP9;WAS;CTSS
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.6795505913213614,-1.0869065941724934,0.41818181818181815,0.8107446276291032,1.0,5/6,29.91%,CX3CL1;FRRS1L;NECAB2;FYN;SHANK3
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,0.36550919168222396,1.0868148142502922,0.2777777777777778,0.9663065691486452,1.0,23/118,15.21%,CD247;SEM1;NUP42;PSMD10;ELOC;NUP37;PSMA1;PSMD11;NUP54;PSMB5;AP2B1;XPO1;BTRC;AP1B1;AP1S3;NDC1;PSMD14;NUP214;SLC25A5;PSMD12;AAAS;NUP188;SGIP1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6212531593367735,-1.0867400060194612,0.4117647058823529,0.8109346962798553,1.0,2/12,8.19%,BLM;DONSON
prerank,CellMarker_Augmented_2021__Granulocyte:Peripheral Blood,-0.6137663417016305,-1.0866255845031207,0.49206349206349204,0.8109550940081057,1.0,4/8,21.37%,CD44;CD63;IL3RA;PTPRC
prerank,CellMarker_Augmented_2021__Lymphoblast:Fetal Liver,-0.6272392038515315,-1.0865521815474681,0.38333333333333336,0.8108181433405272,1.0,2/9,1.59%,LEF1;CD5
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.5088818147268587,-1.0865152008920185,0.36507936507936506,0.8106329225586967,1.0,13/37,21.38%,SKAP1;IFI35;IL15;HLA-DRA;PLSCR1;FADD;CD74;HLA-DRB1;NMI;SLC15A4;RSAD2;PTPRC;ADAM8
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.6677726701661596,-1.0863602817010853,0.4603174603174603,0.8107300063213333,1.0,1/6,1.14%,NR4A3
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.6282994661472943,-1.0863155757806309,0.43333333333333335,0.8105087235835126,1.0,4/12,22.57%,PPP3CC;HRH1;PLCE1;NFATC2
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.5574470816526995,1.086256717982878,0.38235294117647056,0.9672041730211602,1.0,2/10,4.15%,CEL;NLGN3
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.5855867921412365,-1.0862499212445795,0.37681159420289856,0.8103722021789285,1.0,4/16,11.06%,PKD2L2;CAV3;PIEZO2;LHFPL5
prerank,CellMarker_Augmented_2021__Stem cell:Bone,-0.6999439550017941,-1.0862163011252777,0.45,0.8101150361277363,1.0,4/6,21.37%,THY1;RUNX2;MCAM;PTPRC
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.45254049417461717,-1.0861460164440646,0.3170731707317073,0.8099788023548454,1.0,15/70,19.24%,GBP1;MRAP2;RAMP3;MMP14;AKAP5;TMBIM1;PRKCH;ITGA3;PPFIA1;CLN3;CDK5;GPER1;TGFB1;NUMB;STAC2
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.5234916767490994,-1.0860205028264551,0.3561643835616438,0.8100276955292072,1.0,5/32,9.67%,PTP4A3;FAT2;ANLN;CYP1B1;STAT1
prerank,Reactome_2022__SHC1 Events In ERBB4 Signaling R-HSA-1250347,0.5911092972286609,1.0857789120478551,0.34782608695652173,0.9680705648465152,1.0,4/10,23.66%,NRAS;ERBB4;NRG3;SOS1
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,0.40811337972478423,1.0856739597865455,0.35,0.9674840139099572,1.0,5/49,9.92%,FGF6;FLT3;EGFR;STRN;ERBB4
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.6738910605906779,-1.0856335567362634,0.4423076923076923,0.810711739899999,1.0,2/7,13.13%,PROX1;GRID2
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),-0.6108140727131296,-1.085413141908686,0.38333333333333336,0.811069698036822,1.0,6/16,23.97%,B4GALNT1;ST8SIA3;B3GALT4;ST6GALNAC3;NEU4;ST8SIA4
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.5775355263322766,-1.085181837596178,0.36363636363636365,0.8114313646031713,1.0,7/21,17.23%,APP;EGF;IGF1;GAPDHS;PRXL2C;PFKFB4;PFKFB3
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.48408999067840724,-1.0851091599352782,0.35135135135135137,0.8112868273697217,1.0,13/58,19.68%,SULT1C3;ACOT1;ACSM5;TPST1;ACOT4;GLYAT;DBI;ACOT2;OXSM;SULT4A1;ACOT8;ACOT6;HINT1
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Stomach,-0.6959842543228818,-1.0850944049204716,0.4,0.809604468781943,1.0,2/7,18.56%,PDCD1LG2;CD4
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Skin,-0.6959842543228818,-1.0850944049204716,0.4,0.809604468781943,1.0,2/7,18.56%,PDCD1LG2;CD4
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Lung,-0.6959842543228818,-1.0850944049204716,0.4,0.809604468781943,1.0,2/7,18.56%,PDCD1LG2;CD4
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Blood,-0.6959842543228818,-1.0850944049204716,0.4,0.809604468781943,1.0,2/7,18.56%,PDCD1LG2;CD4
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Intestine,-0.6959842543228818,-1.0850944049204716,0.4,0.809604468781943,1.0,2/7,18.56%,PDCD1LG2;CD4
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.43472053535872346,1.0849557898169215,0.2903225806451613,0.9693351644127496,1.0,10/41,24.54%,SMARCAD1;SIRT6;ELK4;MIER3;PRDM5;HDAC2;HDAC10;MIER2;MTA2;SIRT2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.45232465214729195,1.0849402589697532,0.34375,0.9685514034182124,1.0,19/51,19.44%,PNLDC1;CNOT9;PDE12;EXOSC1;DCP1B;EXOSC6;DIS3;EDC3;CNOT2;LSM5;LSM7;RC3H1;CNOT8;CNOT6L;CNOT1;EXOSC8;CNOT4;PATL1;RC3H2
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.6256483844961254,1.0848251410324605,0.35714285714285715,0.9682220105215467,1.0,3/7,22.02%,ERCC2;ERCC3;USH2A
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.647923987330878,-1.0847671423396374,0.391304347826087,0.8103981824258749,1.0,1/9,8.80%,FBP1
prerank,Reactome_2022__Dissolution Of Fibrin Clot R-HSA-75205,-0.6391281094337206,-1.0845936153297295,0.4057971014492754,0.8105107120934317,1.0,1/8,0.37%,S100A10
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),-0.6832457951200408,-1.0843858071379848,0.4032258064516129,0.810771191077633,1.0,2/6,17.76%,NLGN1;LRP2
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,0.4314424709692499,1.0843764094493855,0.3333333333333333,0.9689164884100416,1.0,10/37,19.17%,B4GALNT3;ALG3;MAN1A2;STT3B;MGAT4C;MGAT4D;ALG11;STT3A;B4GALT3;ALG13
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,0.37734941204898276,1.0843729600679939,0.2631578947368421,0.9680859754135449,1.0,18/89,14.30%,POLD3;SEM1;SLC19A1;DNA2;H2BC21;H2BC4;RFC3;BRCC3;UBE2N;SIRT6;RAD52;XRCC2;HUS1;RRAD;RAD9B;POLK;ATRIP;PALB2
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.47422048010403,-1.0842556904904128,0.2916666666666667,0.8107554795203812,1.0,7/56,10.73%,BLM;PLK2;RAB11A;HTR2B;PLK3;NLRP5;FGF1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.5620952660398522,1.084249643145232,0.4473684210526316,0.9675613949412393,1.0,5/14,16.31%,DMAC2L;ATP5PB;ATP5MC2;ATP5MC1;ATP5F1A
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.5048256868629508,-1.0841174885729241,0.34782608695652173,0.8107757617178719,1.0,14/37,19.10%,TIMP2;SCUBE3;MMP19;MMP14;CD44;TIMP1;KIF9;CTSS;FLOT1;ADAMTS4;TLL1;CAPN1;A2M;CAPNS1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.45884662801508536,1.0841164171513968,0.38461538461538464,0.9672143722377902,1.0,3/20,16.84%,NT5C1A;NUDT15;FHIT
prerank,CellMarker_Augmented_2021__Adventitial cell:Skeletal Muscle,-0.5126524618307903,-1.0840590797023957,0.4,0.8106042138953137,1.0,11/39,8.48%,P2RY13;MYO1F;TAGAP;P2RY14;EVI2A;SLA;ARHGAP9;GAB3;HLA-DRA;F13A1;RCSD1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.5073446255585062,1.0836346407428061,0.375,0.9681426475393556,1.0,4/15,12.67%,CD200R1;TNFAIP3;FOXJ1;SIRPA
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.7208569035244337,-1.0835474753960206,0.49056603773584906,0.8114753321780512,1.0,1/5,6.29%,BRCA1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.7208569035244337,-1.0835474753960206,0.49056603773584906,0.8114753321780512,1.0,1/5,6.29%,BRCA1
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.5513528894682963,-1.083098190603829,0.38461538461538464,0.8124012211215065,1.0,6/19,12.99%,THBS1;ZNF750;DUOXA1;MYH11;ADIRF;EMP2
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.40790932358027626,1.0830299539662025,0.37037037037037035,0.9693632249609482,1.0,24/81,17.26%,ERCC8;CDC25A;PRIMPOL;MEN1;EIF2S1;EGFR;MAP3K4;AKT1;ERCC6;ERCC2;YY1;MSH2;ATR;PTPRK;EIF2AK4;MAPK8;ERCC3;GTF2H2;POLK;SMPD1;CAT;EP300;NOC2L;RHBDD1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.48786323094529255,1.0828966546179262,0.3333333333333333,0.9688882956886319,1.0,6/31,12.43%,SLC6A13;SLC19A1;SLC47A1;ATP1A2;SLC22A2;SLC5A6
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Pancreas,-0.4859245436555357,-1.082826617624055,0.32051282051282054,0.8108863103613454,1.0,4/62,4.02%,CD24;CP;MAOB;SVOPL
prerank,CellMarker_Augmented_2021__Neural Stem cell:Bone Marrow,-0.4859245436555357,-1.082826617624055,0.32051282051282054,0.8108863103613454,1.0,4/62,4.02%,CD24;CP;MAOB;SVOPL
prerank,CellMarker_Augmented_2021__Dermal Papilla cell:Hair Follicle,-0.4859245436555357,-1.082826617624055,0.32051282051282054,0.8108863103613454,1.0,4/62,4.02%,CD24;CP;MAOB;SVOPL
prerank,CellMarker_Augmented_2021__Ductal cell:Pancreas,-0.4859245436555357,-1.082826617624055,0.32051282051282054,0.8108863103613454,1.0,4/62,4.02%,CD24;CP;MAOB;SVOPL
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Larynx,-0.4859245436555357,-1.082826617624055,0.32051282051282054,0.8108863103613454,1.0,4/62,4.02%,CD24;CP;MAOB;SVOPL
prerank,CellMarker_Augmented_2021__Early Hematopoietic cell:Blood,-0.4859245436555357,-1.082826617624055,0.32051282051282054,0.8108863103613454,1.0,4/62,4.02%,CD24;CP;MAOB;SVOPL
prerank,CellMarker_Augmented_2021__Progenitor cell:Embryonic Stem Cell,-0.4859245436555357,-1.082826617624055,0.32051282051282054,0.8108863103613454,1.0,4/62,4.02%,CD24;CP;MAOB;SVOPL
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.7568589757332256,-1.082732683787717,0.45161290322580644,0.810826885944816,1.0,1/6,4.38%,CCDC39
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.6022890136149733,-1.0827127702666695,0.40625,0.8105090945302758,1.0,4/10,29.36%,EIF2B2;INHA;EIF2B4;EIF2B5
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.5493651511528178,-1.0824047114738486,0.421875,0.811038027902582,1.0,6/24,20.36%,CDKN2A;SRF;PRKCD;PML;CDKN1A;SPI1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.4903291483068151,1.0822663341816294,0.34615384615384615,0.9701941433673856,1.0,7/31,14.70%,UBTF;ERCC2;POLR1F;ERCC3;GTF2H5;GTF2H2;RRN3
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.5682494928461532,-1.0821970507896788,0.42857142857142855,0.811240784606797,1.0,5/22,13.60%,ANK3;KCNB1;CEMIP;PDZK1;SLC51B
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bone Marrow,-0.4669162392783218,-1.0819840947170922,0.32432432432432434,0.8116180741464563,1.0,4/55,3.17%,SP100;TGFBR2;TLR2;PLB1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.6274824474287637,-1.0818642790496569,0.484375,0.811665624784564,1.0,3/12,6.13%,ZFP36;YBX3;ELAVL4
prerank,Reactome_2022__Downregulation Of ERBB4 Signaling R-HSA-1253288,-0.6592596475156312,-1.0816218425415105,0.39344262295081966,0.812097953471654,1.0,2/9,12.77%,RPS27A;UBC
prerank,CellMarker_Augmented_2021__Nucleus Pulposus cell:Intervertebral Disc,-0.46181417014094683,-1.0815755400252685,0.33783783783783783,0.8119073287872273,1.0,15/83,12.82%,COL4A1;ANGPTL2;CALD1;COL4A2;COL5A1;COLEC12;SULF1;LMOD1;BGN;ITGA8;WNT5A;IGFBP5;PRRX1;C1QTNF1;SLCO2A1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.5064186376290811,-1.0813406332722846,0.323943661971831,0.8123272957954916,1.0,1/29,0.54%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),-0.6323890368414831,-1.0811634045772365,0.42028985507246375,0.8124893665589881,1.0,2/9,16.51%,RAMP3;ANXA2
prerank,CellMarker_Augmented_2021__Memory T cell:Liver,-0.5441608254863831,-1.0811166863639896,0.32142857142857145,0.810901688481302,1.0,6/25,6.48%,CD5;TAGAP;GPR171;SLA;ARHGAP9;ACAP1
prerank,CellMarker_Augmented_2021__Memory T cell:Peripheral Blood,-0.5441608254863831,-1.0811166863639896,0.32142857142857145,0.810901688481302,1.0,6/25,6.48%,CD5;TAGAP;GPR171;SLA;ARHGAP9;ACAP1
prerank,CellMarker_Augmented_2021__T cell:Brain,-0.5441608254863831,-1.0811166863639896,0.32142857142857145,0.810901688481302,1.0,6/25,6.48%,CD5;TAGAP;GPR171;SLA;ARHGAP9;ACAP1
prerank,CellMarker_Augmented_2021__T cell:Tonsil,-0.5441608254863831,-1.0811166863639896,0.32142857142857145,0.810901688481302,1.0,6/25,6.48%,CD5;TAGAP;GPR171;SLA;ARHGAP9;ACAP1
prerank,CellMarker_Augmented_2021__Naive T cell:Umbilical Cord Blood,-0.5441608254863831,-1.0811166863639896,0.32142857142857145,0.810901688481302,1.0,6/25,6.48%,CD5;TAGAP;GPR171;SLA;ARHGAP9;ACAP1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.6658288875464348,-1.08106665460197,0.45614035087719296,0.8107161689460697,1.0,1/7,0.54%,EFNA1
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6365328968543648,1.0810522358033061,0.40625,0.9735888522898991,1.0,2/8,2.48%,BMP2;MYORG
prerank,CellMarker_Augmented_2021__Basal cell:Epithelium,-0.5262699954336376,-1.0808856998387673,0.39705882352941174,0.8109693007400921,1.0,13/35,17.04%,MYOF;EPS8L2;MAP3K6;DUOXA1;SRPX2;CDC42EP1;ITGA3;LAMA3;ITGB4;RHOD;CAPN1;ANXA2;PXDC1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.63043953423644,-1.080854742781842,0.3870967741935484,0.8107444224116671,1.0,1/9,0.18%,ANXA1
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.6936244026648024,1.0808473064325856,0.47619047619047616,0.9733751153118247,1.0,4/5,29.28%,ALKBH3;JMJD6;ALKBH1;FTO
prerank,Reactome_2022__RUNX1 Regulates Estrogen Receptor Mediated Transcription R-HSA-8931987,0.6661375152125123,1.0803067713351853,0.3902439024390244,0.9744396166519907,1.0,4/6,29.80%,RUNX1;GPAM;AXIN1;ESR1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.3481804534683824,1.0802590872304207,0.375,0.9737381982785053,1.0,73/274,26.51%,U2AF1;PPARGC1A;SF3A1;NUDT21;SNRPF;SF3B4;GTF2F2;HNRNPC;ERCC2;WDR33;NOVA1;CWC27;SMNDC1;RAVER2;RBM41;LSM8;CSTF3;CPSF6;SNRPN;PAPOLA;SNRPB2;CPSF7;SPEN;LSM5;TFIP11;ERCC3;GTF2H5;SRSF8;RAVER1;GTF2H2;SYNCRIP;RBM17;LSM7;THOC3;HNRNPU;POLR2C;AQR;PPIE;THOC1;ZMAT2;PPWD1;SNRNP27;CLP1;RPRD1B;DHX15;PSPC1;PDCD7;RBMX;ERN1;CPSF2;GTF2H3;CRNKL1;RBM15;RNGTT;PPIH;USP49;PLRG1;RBM19;SART3;SUGP1;CMTR2;PRPF40B;MTREX;CCNH;HNRNPD;SCAF11;SRSF9;POLR2A;CSTF1;SNRPB;SNRNP48;ZCCHC8;MAGOH
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.6963584564032201,-1.0802570523484198,0.4166666666666667,0.8120393503741812,1.0,2/6,11.39%,TGFBR2;CD55
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.6619736516665591,-1.0800603193806877,0.49056603773584906,0.8122600381352608,1.0,2/14,3.31%,TRIM22;TRIM5
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.5786656012925975,-1.0799333856360847,0.3548387096774194,0.8123267343228849,1.0,2/17,3.28%,ABCA5;ABCA8
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.37319723127971705,1.0798697449550725,0.2727272727272727,0.9742941839270878,1.0,8/94,2.75%,G0S2;LEPR;GOLT1A;FGL1;PHLDA1;PLIN1;MTTP;CEBPA
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,-0.49677985314829787,-1.0796456361833497,0.37333333333333335,0.8129216087938951,1.0,10/36,25.60%,RAB11A;ARHGDIG;CREB5;DCTN1;ADCY3;CREB3;DYNC1LI2;DCTN2;DCTN6;STX4
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.5331810888412267,-1.0795172018654715,0.38028169014084506,0.8129209825958832,1.0,6/35,9.19%,CLIC1;SLC4A11;BEST1;SLC26A8;ANO9;CLIC4
prerank,KEGG_2021_Human__Phenylalanine metabolism,-0.7058849099660424,-1.0795029537668683,0.36666666666666664,0.8125973818634386,1.0,2/8,7.02%,MAOB;GLYAT
prerank,CellMarker_Augmented_2021__Progenitor cell:Skin,-0.4657309436944279,-1.0794707665041434,0.36486486486486486,0.8123370472498617,1.0,3/56,3.93%,CD24;PKP2;OVOL2
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.6415555756933597,1.0794003128794627,0.4473684210526316,0.9750340778110669,1.0,1/7,3.98%,ALDH1A1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.6057147602712851,-1.0791892429095893,0.39285714285714285,0.8128679470183636,1.0,4/12,13.76%,RSPO3;SFRP4;GPC3;RNF213
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.648167891628595,1.0791402017271559,0.4318181818181818,0.9751213773392474,1.0,2/7,5.26%,HSPA1A;GIT1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.6923723466699593,-1.0790646485363964,0.4827586206896552,0.8129302842959744,1.0,3/6,11.20%,IRF1;TNFRSF14;SYK
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.5818258926450444,-1.0787706838481386,0.4090909090909091,0.8135902449082018,1.0,5/17,19.17%,MYO1F;MYO15A;MYO1E;MYO1H;MYO1C
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.6045715866207153,-1.078642492265889,0.43103448275862066,0.8136522252652708,1.0,3/13,14.82%,TENM4;RIMS2;MYRF
prerank,CellMarker_Augmented_2021__Bone Marrow Stromal cell:Bone Marrow,-0.5049875641238046,-1.0784307405399978,0.38028169014084506,0.8139891670012864,1.0,11/39,16.45%,MET;GPR87;ITGA2;OVOL2;BAIAP2L1;SLC44A3;ITGA3;LAMA3;ITGB4;RHOD;F3
prerank,KEGG_2021_Human__Notch signaling pathway,0.4076014451913939,1.0781829170982817,0.3333333333333333,0.9773356615772033,1.0,14/50,19.94%,NCSTN;MAML3;KAT2B;NOTCH2;HEYL;DTX4;DVL2;KAT2A;RFNG;HDAC2;EP300;HEY1;HEY2;HES5
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.4483682656941982,-1.0781791848781082,0.3253012048192771,0.8144004401139595,1.0,17/67,22.73%,ST6GAL1;SLC17A5;GMPPB;ST3GAL6;EGFL7;ST6GALNAC2;GNE;PMM1;CTSA;UAP1;ST8SIA3;GFPT2;DPAGT1;ST6GALNAC3;ST8SIA1;DPM3;NEU4
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.3920101289890341,1.0781108568769067,0.3181818181818182,0.9767706311277161,1.0,24/57,33.23%,MIOS;FBXO9;WDR24;PIK3CA;SLC38A9;DYRK3;PRKAA1;TBCK;MINAR1;TBC1D7;GOLPH3;LAMTOR3;RPTOR;NPRL3;ARAF;EPM2A;NPRL2;RHEB;WDR59;SIRT1;LARS1;ITFG2;MLST8;RICTOR
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.6108971706617731,-1.077970606975695,0.40298507462686567,0.8145797649797504,1.0,2/14,10.92%,PLAAT4;LPCAT4
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.49317414971795615,-1.0779646507836351,0.3150684931506849,0.8142880821022802,1.0,3/38,10.32%,LEF1;POLE3;TAF10
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),-0.6812183558653172,-1.077957166845565,0.4444444444444444,0.8139652672856547,1.0,3/5,21.77%,THPO;ZNF385A;SH2B3
prerank,CellMarker_Augmented_2021__Endothelial cell:Cornea,-0.6487953060947963,-1.077844121114258,0.421875,0.813917159448418,1.0,4/11,10.74%,ICAM1;THY1;CD44;LGR5
prerank,Reactome_2022__Protein Localization R-HSA-9609507,0.3606909149972455,1.0777337540688618,0.2727272727272727,0.9770598439326552,1.0,34/141,19.13%,DAO;GDAP1;ABCD2;GRPEL2;SAMM50;PEX13;ABCD1;CS;PHYH;TOMM22;ABCD3;EHHADH;CHCHD3;UBE2D1;PIPOX;VAPA;COX19;ECH1;SERP1;GNPAT;ACOX1;COQ2;PEX2;ATP5MC1;TIMM23;GFER;DDO;ATP5F1A;SLC25A17;MTX2;IDE;PEX6;CHCHD4;ZFAND6
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.7139108238653253,1.077616983153407,0.3191489361702128,0.9757298741912848,1.0,1/5,7.93%,SNF8
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.7139108238653253,1.077616983153407,0.3191489361702128,0.9757298741912848,1.0,1/5,7.93%,SNF8
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.7016612569502447,-1.0776099506894576,0.423728813559322,0.8143471931031735,1.0,2/7,6.95%,OGN;OMD
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.45765217182584983,-1.0775456994870352,0.38961038961038963,0.8142480414711547,1.0,24/97,16.71%,APLNR;STMN2;L1CAM;RCAN2;RAMP3;MAOB;PLP1;THY1;APOD;GFAP;SLC18A2;ZNF536;IGSF21;SHC2;ADCY5;IGFBP5;RASL12;RGS7BP;TMEM132C;CRTAC1;CCDC3;CNTN2;PHYHIP;TCEAL5
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.6193839173213334,-1.0774988108199597,0.45901639344262296,0.8140549993908002,1.0,3/10,8.52%,PVALEF;RCSD1;TNNT1
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.49561449448844336,-1.0773832717139373,0.35294117647058826,0.8141047828418881,1.0,3/30,7.23%,TUBB6;TTLL7;SVBP
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.5916354550620038,1.077349517283995,0.3488372093023256,0.9757387610734392,1.0,4/11,14.23%,ZNF502;VAPA;CHMP2B;VPS37B
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.49313481438469564,1.077310661986104,0.2972972972972973,0.9750035618180412,1.0,2/24,5.81%,RAB33B;ARL5A
prerank,Reactome_2022__Organic Cation Transport R-HSA-549127,0.6328145161352958,1.0772072190066948,0.3953488372093023,0.9744530605729026,1.0,4/7,14.76%,RUNX1;SLC22A15;SLC22A2;SLC22A5
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.44524984885771257,-1.0771828735010904,0.3194444444444444,0.814365787968017,1.0,9/63,11.00%,CDH22;PKP2;CDH6;TJP3;GJC1;FSCN1;CDH7;CDH19;CDH9
prerank,KEGG_2021_Human__p53 signaling pathway,-0.45806579033596817,-1.0771475223079743,0.3,0.8141338328828033,1.0,12/62,12.19%,THBS1;CCNB2;CDKN2A;TP53I3;STEAP3;CCND1;GADD45A;IGF1;GORAB;CCNB1;SHISA5;CCNE2
prerank,KEGG_2021_Human__Endometrial cancer,-0.4764917629668074,-1.0771136416639118,0.33783783783783783,0.8138825271949087,1.0,5/56,8.75%,LEF1;CTNNA3;CCND1;EGF;GADD45A
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.5508151636036615,1.0769519097348002,0.34210526315789475,0.9744340709806948,1.0,10/18,27.02%,INTS7;EXOSC6;INTS8;INTS6L;EXOSC8;TOE1;INTS14;USB1;EXOSC5;INTS6
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.528298210793506,1.0768173032031036,0.3611111111111111,0.9739910149152062,1.0,9/20,37.27%,AP3B1;BLOC1S4;PIKFYVE;AP1M1;RAB32;GPR143;BLOC1S2;HPS1;AP1G1
prerank,CellMarker_Augmented_2021__Multilymphoid Progenitor cell:Umbilical Cord Blood,-0.39141817533774986,-1.076704612962243,0.19387755102040816,0.814788013271925,1.0,48/441,14.68%,LEF1;IFI44L;ARHGAP4;FOSB;DUSP1;RSPH4A;TMSB10;HIC1;ICAM1;RPS27;CNTNAP1;SERPINF1;RGL4;TMC8;SPATA21;ARHGAP9;CASZ1;SYT4;SYN3;PIM3;THBS3;COL24A1;ACAP1;NUAK2;CMPK2;BASP1;IFNGR2;LRRK1;BTG1;GRIK1;IGF1;CRELD2;CHRM3;ZYX;CACNA1C;CDH9;HLA-B;CSRNP1;RHPN1;SLC43A2;HECW2;SP110;SLC38A1;AKAP17A;MBD6;SLITRK5;BTN3A1;PLLP
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreatic Acinar Tissue,-0.49167187464766654,-1.0765703501389416,0.3484848484848485,0.8141828304898959,1.0,10/33,8.69%,ARHGAP4;MYO1F;GPR183;CD5;TAGAP;TMC8;SLA;ARHGAP9;RCSD1;WAS
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreatic Acinar Tissue,-0.49167187464766654,-1.0765703501389416,0.3484848484848485,0.8141828304898959,1.0,10/33,8.69%,ARHGAP4;MYO1F;GPR183;CD5;TAGAP;TMC8;SLA;ARHGAP9;RCSD1;WAS
prerank,CellMarker_Augmented_2021__Definitive Endoderm cell:Germ,-0.49167187464766654,-1.0765703501389416,0.3484848484848485,0.8141828304898959,1.0,10/33,8.69%,ARHGAP4;MYO1F;GPR183;CD5;TAGAP;TMC8;SLA;ARHGAP9;RCSD1;WAS
prerank,Reactome_2022__Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.5439104722623325,-1.0765519747756152,0.38095238095238093,0.813908624840911,1.0,3/26,8.55%,TYMS;GLRX;NUDT13
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,0.4074825970870925,1.0764862127602532,0.3181818181818182,0.9742324714725049,1.0,27/80,21.57%,AKT2;AKT1;TRAPPC11;RAB27A;RAB8B;TRAPPC12;RAB1B;CCZ1B;MON1A;TRAPPC8;RAB39B;SBF2;RAB7B;GDI2;ALS2;RAB21;RAB8A;RAB9A;DENND5B;DENND4C;GAPVD1;RIC1;RAB3IP;TRAPPC13;RAB3GAP1;RAB18;RAB31
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.5772433986146306,1.0763771508206892,0.37142857142857144,0.9737903387615487,1.0,4/12,20.77%,CPSF6;IWS1;NSUN2;NUP153
prerank,GO_Biological_Process_2021__negative regulation of lipoprotein lipase activity (GO:0051005),-0.676204700004321,-1.0763370632106393,0.4126984126984127,0.814223427864974,1.0,1/5,8.06%,ANGPTL3
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.4156471464234931,-1.0762446647571564,0.3333333333333333,0.8141014397294125,1.0,26/146,15.22%,RIMBP2;TAGLN3;STMN2;CCK;NEFM;MFSD6;CASZ1;LRRTM1;ATRNL1;SYT4;GFRA2;MAP1B;ELAVL4;JPH3;GAP43;SLC7A14;ZNF536;CPLX2;CA10;STMN4;CRMP1;RGS7BP;VIP;CNTN2;KCNC1;GDAP1L1
prerank,CellMarker_Augmented_2021__Pericyte:Adipose Tissue,-0.7347534286548001,-1.0762385802847587,0.3559322033898305,0.8137886522556047,1.0,5/5,26.55%,CSPG4;MCAM;PTPRC;PECAM1;ENG
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.6508594602641119,-1.0761747986798162,0.46296296296296297,0.8136981020611487,1.0,1/5,7.58%,PDHX
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Germ,-0.6131623734394905,-1.0759622554137092,0.3898305084745763,0.8140630723956945,1.0,3/10,18.82%,THY1;TEK;ABCG2
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.659533839830571,-1.075914350324029,0.4,0.813867424437429,1.0,1/10,3.93%,ART3
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.5070658444576563,-1.0757978160832742,0.45588235294117646,0.8138625224708022,1.0,2/32,3.28%,AGPAT4;ABCA8
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.440878087171513,-1.0755930290814917,0.3815789473684211,0.814125884442747,1.0,13/103,13.76%,ERCC6L;WDR62;RPS27;PLK2;CENPH;CENPE;ZWILCH;NUF2;SPC24;CCNB1;KIF2C;CENPN;CENPU
prerank,Reactome_2022__rRNA Processing In Mitochondrion R-HSA-8868766,0.5886921527785419,1.0753351522377046,0.3409090909090909,0.9763966202650142,1.0,1/8,3.19%,TFB1M
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.6772257440713803,-1.0751870539092958,0.4489795918367347,0.8150691126488122,1.0,1/7,4.01%,MAFF
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.5865422249727237,1.075084189591524,0.4117647058823529,0.9764529115337066,1.0,3/9,14.84%,WDR91;PPP2R5A;PIK3R1
prerank,Reactome_2022__Neuronal System R-HSA-112316,-0.40977954186583615,-1.0750220352163578,0.2765957446808511,0.8152618301694776,1.0,87/317,20.30%,GRIN2D;KCNQ1;KCNV1;GRIN3A;NEFL;KCNB1;KCNK1;KCNJ2;LRRTM2;GRIN2A;ADCY7;GNG3;SLITRK1;LRRTM1;KIF17;SLC32A1;SYN3;GRIA3;GLRA2;KCNH8;GRIA1;AKAP5;SLC18A2;NRGN;NCALD;SYN2;PRKCG;CPLX1;RPS6KA1;IL1RAPL1;SYT1;GRIK1;GABRB2;CHRNA5;ADCY5;KCNG1;DLGAP3;ACHE;GAD1;KCNB2;GNG2;FLOT1;SLITRK4;GRIN2B;RNASE1;NLGN1;GAD2;SLC38A1;GABRG2;SLITRK5;APBA2;KCNC1;PPFIA1;IL1RAP;RASGRF2;GABRA1;IL1RAPL2;KCND3;CACNB1;SYT2;KCNMB4;SH2D3C;KCNH7;ADCY8;PRKCB;PTPRF;CHRNE;KCNK10;KCNAB3;KCNV2;MAPT;RPS6KA6;LRRC7;SLC1A6;KCNF1;HCN1;GLRA1;GABBR2;SLC17A7;ABCC9;ALDH5A1;KCNQ5;GABRA6;CHRNA6;KCNC2;GABRG3;GABRA3
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.5717634674308824,1.074851125165618,0.4117647058823529,0.9764995096728591,1.0,6/13,15.95%,SOX8;PEF1;KLHL12;CDH2;TAPT1;FBXL17
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.5124791918632636,-1.0745968244207091,0.3472222222222222,0.8162465127401674,1.0,13/37,24.73%,NLRC5;PARP14;ISG15;SLIT3;SIGIRR;CCDC3;USP18;PTPRC;SH2B3;SLIT2;RFFL;PPARG;STAT2
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,-0.4884310735691584,-1.0744709959999266,0.352112676056338,0.8162445122763137,1.0,13/45,21.05%,RPS27A;IRF1;BIRC3;IL18;FLOT1;UBC;FADD;FASN;CDC37;GSDME;TNFRSF10A;CASP8;GNL3
prerank,KEGG_2021_Human__Bile secretion,-0.48554776947784717,-1.0744635553053938,0.3888888888888889,0.8159282547162152,1.0,21/48,23.02%,SLC51A;ADCY7;ATP1A1;ABCB1;LDLR;ATP1B1;ADCY5;CYP3A4;SLC51B;SLC4A2;ADCY3;SLCO1A2;ADCY8;AQP1;ABCG2;ATP1B3;SLC27A5;SCARB1;ABCG5;SLC22A1;SLC9A1
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.4536918944956341,-1.0742541462595119,0.3972602739726027,0.8163142007065342,1.0,14/95,11.49%,RASGRP1;CDKN2A;RASGRP2;SHTN1;PLK2;RALGDS;PLD1;USP50;RIT2;PLD2;IGF1;SHC2;ARHGEF18;RAPGEF5
prerank,Reactome_2022__Serotonin Receptors R-HSA-390666,-0.7525400474482142,-1.0741646954411919,0.44680851063829785,0.8162540269130567,1.0,3/5,18.00%,HTR1E;HTR2C;HTR2A
prerank,CellMarker_Augmented_2021__Monocyte:Lung,-0.5124709690745339,-1.0740878358106059,0.323943661971831,0.8161784035097137,1.0,9/26,10.58%,P2RY13;TYMP;TLR2;SIGLEC1;IGSF6;CLEC12A;F13A1;CTSS;PILRA
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.4343531177575167,1.0740686906149326,0.4444444444444444,0.978157095445835,1.0,3/31,4.15%,NGF;CEL;NLGN3
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.5813344126166089,1.0739441143035642,0.3488372093023256,0.9777710033606408,1.0,4/12,14.18%,ABCD1;ELOVL2;SCP2;ACOX1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.6515544683369077,1.073842539364217,0.4146341463414634,0.9773089755968799,1.0,1/6,1.86%,RPP40
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.351131680516446,1.0737285710546445,0.2727272727272727,0.9769146854530951,1.0,97/231,34.61%,U2AF1;SF3A1;NUDT21;SNRPF;SF3B4;GTF2F2;HNRNPC;WDR33;NOVA1;CWC27;SMNDC1;RAVER2;RBM41;LSM8;CSTF3;SNRPN;PAPOLA;SNRPB2;CPSF7;SPEN;LSM5;TFIP11;SRSF8;RAVER1;SYNCRIP;RBM17;LSM7;HNRNPU;POLR2C;AQR;PPIE;ZMAT2;PPWD1;SNRNP27;CLP1;DHX15;PSPC1;PDCD7;RBMX;CPSF2;CRNKL1;RBM15;PPIH;USP49;PLRG1;RBM19;SART3;SUGP1;PRPF40B;MTREX;HNRNPD;SRSF9;POLR2A;CSTF1;SNRPB;SNRNP48;ZCCHC8;MAGOH;SNRNP35;SRSF2;POLR2K;POLR2D;PRCC;LSM6;PPIL3;MAGOHB;PABPC1;SNRNP40;CSTF2T;HNRNPH1;POLR2E;PTBP1;DHX16;RBM15B;CTNNBL1;HNRNPL;FRG1;SF3B3;EFTUD2;CCAR1;ELAVL1;BUD31;PCF11;RBM22;SFPQ;HNRNPH3;DDX5;METTL14;SART1;HNRNPR;DDX46;METTL3;SF1;TRA2A;CDC5L;BCAS2;RALY
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.6218955398690026,1.0736910945682459,0.4523809523809524,0.9761674386926736,1.0,5/8,32.77%,METTL4;NSUN3;ALKBH1;TSFM;MTRES1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.5746836961521233,-1.0736680472344962,0.3380281690140845,0.8172415910694132,1.0,2/16,4.68%,HELB;POLQ
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.5701447496486732,-1.0735974668952966,0.359375,0.8170920584836779,1.0,5/17,22.46%,OVOL2;VEPH1;TGFB1;WWTR1;NODAL
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,0.34534418608837625,1.0735792643628044,0.2777777777777778,0.9757365774481266,1.0,12/169,6.34%,FGF6;ITGA1;PIP5K1B;ACTR3C;ITGA10;ACTR3B;NRAS;GIT1;EGFR;PDGFD;PDGFC;ARHGEF12
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.5988332498964127,-1.0735312984536942,0.423728813559322,0.8170007011716653,1.0,4/12,19.00%,PROX1;MYLK3;FHOD3;PDGFRA
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.48054761888772773,1.0733654828051045,0.36,0.9757930452426332,1.0,7/33,14.70%,UBTF;ERCC2;POLR1F;ERCC3;GTF2H5;GTF2H2;RRN3
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),0.5794421921777958,1.073272516482417,0.375,0.975258358159565,1.0,1/9,1.08%,CHAMP1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.4398801982277985,1.0732395563653787,0.4411764705882353,0.9745531158765652,1.0,5/32,6.13%,BMP2;ADAMTS9;SGCD;SMAD5;TCAP
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.6320496229479955,-1.0729805886203247,0.3880597014925373,0.8183678341567867,1.0,4/11,11.93%,IFI35;DYSF;SYK;SBNO2
prerank,CellMarker_Augmented_2021__Leydig cell:Testis,-0.48039443783110125,-1.0729261793821265,0.3835616438356164,0.8182296212325646,1.0,11/57,15.47%,ZNF850;MEIOB;ATAD5;CALN1;ARID3A;PRSS57;CDH9;PDCD6IPP2;TMEM266;PCDH11X;ADD2
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,0.421123112803765,1.0727155247962832,0.3,0.9753242262545097,1.0,17/43,23.40%,BBS10;BBS9;EXOC8;EXOC6;CNGA4;CCT3;TTC8;UNC119B;RAB8A;MKKS;EXOC5;RAB3IP;SMOX;BBS2;ARL3;LZTFL1;EXOC7
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.5750673946500287,-1.072440180271662,0.4166666666666667,0.8192974862161121,1.0,5/18,15.64%,RPL3;RPL24;RPL10;MRPL20;RPL5
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,-0.454688089931381,-1.0723168092232818,0.3815789473684211,0.8193328676611068,1.0,15/61,17.30%,LEF1;PKP2;ITGA2;ITGA5;CTNNA3;SLC8A3;ITGA8;ITGA11;CACNA1C;ITGA9;ITGA3;CACNB1;ITGB4;EMD;RYR2
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.46624726582120585,1.0721751926216414,0.3333333333333333,0.9763127551379697,1.0,13/47,21.09%,ANKRD50;SNF8;PTPN23;CMTM6;WASHC2C;VPS50;SNX31;VPS39;SNX27;EPS15;ACAP2;EIPR1;VPS29
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.6746082769181208,1.072172308847252,0.41025641025641024,0.9755038886235617,1.0,3/6,25.66%,TAMM41;GPAM;PGS1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.423036141164323,-1.072016889558883,0.3448275862068966,0.8198471160011918,1.0,48/211,18.74%,EFNA1;SCN1B;POU4F1;L1CAM;ANK3;CCK;NEXN;SHTN1;S100A6;SEMA3B;DOK1;APP;SLITRK1;GFRA2;VLDLR;MAP1B;EFNB3;BAIAP2;DRAXIN;NEFH;DOK6;WNT5A;UNC5B;PRKCQ;SLIT3;SLITRK4;RAP1GAP;SLITRK5;SEMA3E;ROBO4;BDNF;PIK3CB;CNTN2;LAMA3;RELN;PIK3CD;LRTM1;IRS2;SH3KBP1;GPC1;NOTCH3;CDK5;SEMA4G;ANOS1;PTPRO;NIBAN2;VSTM2L;LAMA5
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5591796369871762,-1.0718701714115486,0.4461538461538462,0.8199362872070273,1.0,7/18,28.23%,SEMA3B;SEMA3E;SEMA4G;SEMA4C;SEMA6D;SEMA3C;SEMA3D
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,0.3532765791123436,1.0717029506048181,0.16666666666666666,0.9761393590080648,1.0,17/116,9.85%,DGKB;PIP5K1B;NRAS;DGKE;ADCY1;LPAR3;EGFR;AKT2;PDGFD;PDGFC;AKT1;CYTH3;RALB;SHC4;PLCB4;PLA2G4C;RALA
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.4157872315334135,-1.0714207823146957,0.3448275862068966,0.8211135860645746,1.0,38/175,20.77%,IFI6;DHCR24;TGFBR2;TLR2;MX1;IRF1;HK2;APP;SEPTIN4;PLK3;PLSCR1;GADD45A;SCN2A;IER3;CSRNP1;BCL2L14;ELMO1;FADD;IFIT2;BOK;DLC1;TCHP;PRKCD;TSC2;CDK5;DAPK3;DDX41;TNFRSF10A;IFI27L2;BBC3;ZNF385A;TRPC5;CASP8;PAK5;RELT;PAK6;RTN4;IKBKG
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.4033987528975047,1.0711614273876247,0.25806451612903225,0.9757099000754376,1.0,12/82,11.34%,MUC20;PSMD10;BCL10;TAB3;NRAS;PSMA1;PSMD11;CUL1;PSMB5;BTRC;PRKACB;PSMD14
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.4033987528975047,1.0711614273876247,0.25806451612903225,0.9757099000754376,1.0,12/82,11.34%,MUC20;PSMD10;BCL10;TAB3;NRAS;PSMA1;PSMD11;CUL1;PSMB5;BTRC;PRKACB;PSMD14
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.4033987528975047,1.0711614273876247,0.25806451612903225,0.9757099000754376,1.0,12/82,11.34%,MUC20;PSMD10;BCL10;TAB3;NRAS;PSMA1;PSMD11;CUL1;PSMB5;BTRC;PRKACB;PSMD14
prerank,Reactome_2022__Glucuronidation R-HSA-156588,0.6547185578326419,1.0711531074908183,0.4423076923076923,0.974895451077044,1.0,3/5,34.19%,UGP2;ABHD10;SLC35D1
prerank,CellMarker_Augmented_2021__Dendritic cell:Undefined,-0.6139939125611658,-1.071143721983492,0.42424242424242425,0.8216071735644651,1.0,4/11,21.37%,ADAM19;IRF7;IL12RB2;PTPRC
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,-0.435984108076327,-1.0710834009277668,0.3372093023255814,0.8214718771514854,1.0,9/137,8.00%,GGT5;AWAT1;ALOX12;ACOT1;ACOT4;CYP1B1;ACSL5;FA2H;DBI
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.4944754050886308,-1.0708569079630366,0.33783783783783783,0.8219687627602794,1.0,5/41,3.93%,CD24;EFNA1;EPS8L2;TJP3;OVOL2
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.6803180235936857,1.070770421642124,0.42857142857142855,0.9755382326284139,1.0,3/7,27.65%,CSF1R;PARD6A;FERMT2
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.660516763555038,1.0706362795643278,0.48717948717948717,0.9752259134202278,1.0,2/6,24.42%,XPO1;ABCE1
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.637064501351531,-1.0705045173186032,0.43283582089552236,0.8228196674004856,1.0,2/7,13.93%,FGF1;PTH1R
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.6042688881123061,-1.0704161205829172,0.36065573770491804,0.8227610560362547,1.0,3/11,12.39%,PLAAT4;SFRP4;PRKCH
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.4152289469792963,1.0704130614765417,0.34285714285714286,0.9753293850448302,1.0,15/46,20.22%,ERCC8;SPRED1;EGFR;BRCC3;UBE2N;TRIM28;ERCC6;ATR;SPRED2;EYA1;CEBPG;EYA2;FXR2;CCAR2;FBH1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.6132856821844023,1.0703143706832663,0.41304347826086957,0.9747725761497239,1.0,2/9,5.99%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.5220179440470051,1.070273018062869,0.35294117647058826,0.9740753587475961,1.0,1/17,0.30%,ACE2
prerank,Reactome_2022__Translocation Of ZAP-70 To Immunological Synapse R-HSA-202430,0.6591089474819992,1.070245733323736,0.391304347826087,0.9733510561498342,1.0,1/5,0.40%,CD247
prerank,CellMarker_Augmented_2021__Effector Regulatory T (Treg) cell:Peripheral Blood,-0.48382137837414646,-1.0701356366590649,0.35526315789473684,0.8234184655942393,1.0,11/35,10.35%,MYO1F;GPR183;TAGAP;EVI2A;SLA;ARHGAP9;ARHGAP15;RCSD1;WAS;CTSS;PTPN7
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.5066334513667868,1.0700676135274967,0.4074074074074074,0.9731547276585852,1.0,8/24,17.67%,ARFIP1;LLGL1;DISP1;SCFD1;P3H1;STXBP5;NDFIP1;GAPVD1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.523848465359966,-1.0698214949033655,0.38961038961038963,0.8240714850083503,1.0,5/31,7.61%,CLDN16;POF1B;LSR;CLDN20;CLDN18
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Brain,-0.45920617205280617,-1.0697405745865767,0.38961038961038963,0.824027814499797,1.0,36/91,20.36%,CDH22;STMN2;SNCB;ZDHHC22;GNG3;SLITRK1;SYT4;SLC32A1;SRRM4;ELAVL4;TCEAL6;SYP;RIT2;CPLX2;CA10;HPCA;STMN4;C11ORF87;SYNPR;SCN3B;GAD2;DIRAS2;GABRG2;CNTN2;KCNC1;GDAP1L1;RAB3C;GABRA1;TCEAL5;CELF4;ST8SIA3;HCN1;SLC17A7;PTPN5;KCNC2;PAK5
prerank,KEGG_2021_Human__Fatty acid degradation,0.4482075670539312,1.0695316741658585,0.2857142857142857,0.9742651637912292,1.0,12/36,19.38%,ALDH7A1;ACADM;CPT2;EHHADH;ADH5;CYP2U1;ACOX1;ACADSB;ACADS;CPT1A;ACSL3;ALDH2
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.6394243834726347,1.069502288547917,0.4666666666666667,0.9735331131398637,1.0,2/8,11.56%,CEL;CYP46A1
prerank,KEGG_2021_Human__Retinol metabolism,-0.5028474822891871,-1.0693366839736658,0.375,0.8248991840051555,1.0,7/24,17.36%,RPE65;RDH13;CYP3A4;ADH4;CYP3A7-CYP3A51P;RDH12;CYP3A5
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.6469225164894203,-1.0692783882777368,0.4,0.8247322333869004,1.0,4/7,21.92%,CEACAM1;HLA-F;PTPRC;KLRD1
prerank,Reactome_2022__Packaging Of Telomere Ends R-HSA-171306,0.5476931141431317,1.0691815174169916,0.41379310344827586,0.9738719685269968,1.0,4/15,14.92%,H2BC21;H2BC4;H2AC6;POT1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5378044500173654,1.0687767145279006,0.3076923076923077,0.974454026874348,1.0,7/13,37.37%,PCBP4;RBMX;SRSF9;PTBP1;SAP18;U2AF2;SFSWAP
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,-0.39843682132150715,-1.0685897317990214,0.3516483516483517,0.8264630658741239,1.0,39/238,15.03%,ST6GAL1;TLR2;B2M;RPS27A;RPS27;SFTPD;HLA-A;RPS14;RPS4X;ZDHHC9;NLRP12;NOD1;HLA-C;PARP14;YWHAH;PARP9;SNRPD2;STAT1;IRF7;RPS11;RPS16;ISG15;RPS13;HLA-B;HLA-E;RPS3A;RPS8;RPS23;IFIH1;RPS21;RPS7;TUSC3;UBC;GPC3;HLA-F;RPS6;RPS15;ST6GALNAC2;RPS9
prerank,Reactome_2022__Heme Biosynthesis R-HSA-189451,0.5469849900520538,1.0684167639612068,0.4090909090909091,0.97477282554131,1.0,5/11,16.38%,ALAS1;HMBS;COX10;FECH;FLVCR1
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.6785534266824487,-1.0682459009632665,0.4838709677419355,0.827209482794815,1.0,2/6,10.08%,TLR3;IRF7
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.4831968703191483,1.0682432155207255,0.27586206896551724,0.9745856557660024,1.0,3/25,3.54%,ARV1;PDK4;ADIPOR1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.5587547342171597,-1.0680279188842432,0.39655172413793105,0.8275906538928691,1.0,7/16,27.16%,HLA-DRA;DDX60;HLA-DRB1;MYO18A;PTPRC;XBP1;RPS19
prerank,KEGG_2021_Human__Oocyte meiosis,-0.45305889657620324,-1.0678529907681817,0.3246753246753247,0.8277451492070635,1.0,23/102,18.31%,CCNB2;PGR;SPDYE1;STAG3;ADCY7;ITPR3;YWHAH;ANAPC11;RPS6KA1;IGF1;PPP3CC;CCNB1;ADCY5;CCNE2;SPDYE5;SPDYE17;SPDYE3;CDK2;ADCY3;ADCY8;RBX1;RPS6KA6;SPDYA
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.7221763117283877,-1.0676760932853426,0.38461538461538464,0.8279417032364466,1.0,1/5,0.67%,KCNQ1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.5010044717952965,-1.067336298312649,0.3283582089552239,0.8286977857403087,1.0,8/45,12.78%,ANXA1;TLR2;KLF4;NOD1;TLR3;CHI3L1;SYK;FADD
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.5318256175540926,-1.0671203922138077,0.41025641025641024,0.8289436018159699,1.0,7/26,18.19%,CTSC;CAV3;ATP5IF1;DAB2IP;PSMC3;DDRGK1;NUPR1
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.42131239730092895,1.0670794307127738,0.2608695652173913,0.9777375706201487,1.0,3/26,6.69%,OCLN;AKT2;AKT1
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.390912828322757,1.0670041134384145,0.3333333333333333,0.9771277581731679,1.0,64/162,31.50%,U2AF1;PPARGC1A;SF3A1;NUDT21;SNRPF;SF3B4;HNRNPC;RP9;NOVA1;TSEN2;FASTKD2;CSTF3;CPSF6;SNRPN;DROSHA;NUFIP1;LSM5;TFIP11;SYNCRIP;TENT4A;RNASEL;MTPAP;HNRNPU;THOC1;TENT4B;CLP1;DHX15;CCAR2;PDCD7;DKC1;RNGTT;CDK12;MBNL1;NOL9;USB1;RBM39;ADARB1;HNRNPD;SCAF11;SRSF9;SNRPB;SNRNP48;ZCCHC8;MAGOH;YJU2;SNRNP35;SCNM1;PRKACA;SRSF2;M1AP;TENT2;LSM1;KHSRP;SRPK2;LSM6;KIN;MAGOHB;SNRNP40;HNRNPH1;PTBP1;DHX16;HNRNPL;PIWIL2;TUT4
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.4730243261014833,-1.066993444736916,0.3246753246753247,0.8289479042657374,1.0,15/56,17.35%,B2M;ANK3;KCNJ13;KCNJ2;CHRM1;SYT4;ATP1A1;YWHAH;SYT1;PDZK1;NOS1;SYT5;SYT2;SYT13;SNX6
prerank,CellMarker_Augmented_2021__Beige Adipogenic Precursor cell:Adipose Tissue,0.3953535579933933,1.0669781667408196,0.34615384615384615,0.9755846219655938,1.0,14/80,8.09%,MEOX2;PCDH19;TMEM100;NDNF;JAM2;RNF150;FAT4;EML1;PTGIS;TMEM47;GAS1;ZFHX4;NOVA1;PYGO1
prerank,CellMarker_Augmented_2021__Brown Adipogenic Precursor cell:Adipose Tissue,0.3953535579933933,1.0669781667408196,0.34615384615384615,0.9755846219655938,1.0,14/80,8.09%,MEOX2;PCDH19;TMEM100;NDNF;JAM2;RNF150;FAT4;EML1;PTGIS;TMEM47;GAS1;ZFHX4;NOVA1;PYGO1
prerank,CellMarker_Augmented_2021__Monocyte:Bone Marrow,-0.5035243452515153,-1.0667578902304813,0.4126984126984127,0.8293274228810086,1.0,7/21,10.15%,P2RY13;MYO1F;TLR2;SLA;IGSF6;CLEC12A;CTSS
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,-0.42521058563558045,-1.066712638928181,0.27058823529411763,0.8291134138268513,1.0,14/122,14.29%,GGT5;MAOB;ACSM5;TPST1;GSTM5;CYP1B1;GLYAT;PAPSS2;CYP4F22;CYP21A2;GLYATL2;CYP3A4;SLC38A1;CYP3A7-CYP3A51P
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.4484347679703986,1.066681107889548,0.3333333333333333,0.975677200673779,1.0,4/19,10.94%,CEL;NLGN3;NRXN1;GPHN
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,0.37786091172916614,1.0665849120287945,0.3,0.9752387355413576,1.0,14/84,16.01%,VEGFD;VEGFC;NRAS;TRIB3;THEM4;AKT2;AKT1;PRKACB;NCK1;MAPK12;PIK3CA;PIK3R1;NCK2;ABI1
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.6088608355290234,-1.0663631793891872,0.38095238095238093,0.8297947781083415,1.0,5/13,22.35%,PLSCR1;SIGIRR;MYLK3;F3;APOL2
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.6249569136683287,-1.0659938359161876,0.42424242424242425,0.8305520649253393,1.0,4/11,32.60%,LPCAT4;OSBPL10;MBOAT1;PLAAT3
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.6312442252347592,-1.0659386462962952,0.40298507462686567,0.8303569295733481,1.0,1/9,8.19%,DONSON
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.5297123428265647,-1.065874047703806,0.425,0.8302307308391789,1.0,5/34,15.90%,CDKN2A;RPS27A;PRDM1;UBC;CDK2
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.6551722452622825,1.0658705708116936,0.4375,0.9769321199328447,1.0,4/6,29.88%,CSF1R;PTK2;IL33;MAPK1
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.5484074166647028,-1.0658068664479987,0.36923076923076925,0.830096996731628,1.0,12/26,27.30%,SYT1;CD9;GUCY2C;SYT2;SV2B;SV2C;ANTXR1;STX1B;VAMP1;MAP2K3;SV2A;MAP2K1
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,-0.4410398533803,-1.0657007147794635,0.33766233766233766,0.8301771690046262,1.0,12/96,7.16%,STMN2;NEFL;NEFM;SH3GL2;GJC1;PLP1;ZDHHC22;LRRTM1;SRRM4;MAP1B;GAP43;GRIA1
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.5861803529906146,-1.06562068856913,0.4166666666666667,0.8301008098457455,1.0,3/13,14.47%,C3;LDLR;MFSD2A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Cartilage,-0.5449317698590876,-1.0655839763938573,0.4090909090909091,0.8299291461786783,1.0,5/20,16.53%,ITGA5;THY1;CD44;TNFRSF1A;MCAM
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.6349387921742902,1.0655656090205226,0.325,0.977097754255059,1.0,4/6,30.88%,TST;CTH;GCLC;CDO1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.5914230819055539,1.0655346357998465,0.4418604651162791,0.9756179504355085,1.0,2/11,3.55%,NR1D1;PGM2
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.5914230819055539,1.0655346357998465,0.4418604651162791,0.9756179504355085,1.0,2/11,3.55%,NR1D1;PGM2
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.6212907738146067,1.0654111188238062,0.4864864864864865,0.9751998793970301,1.0,1/7,3.30%,SPRED1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Muscle,-0.5610009183758954,-1.0653818202994496,0.4696969696969697,0.8295750168313186,1.0,4/18,13.19%,ITGA5;THY1;CD44;TNFRSF1A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone,-0.5610009183758954,-1.0653818202994496,0.4696969696969697,0.8295750168313186,1.0,4/18,13.19%,ITGA5;THY1;CD44;TNFRSF1A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tendon,-0.5610009183758954,-1.0653818202994496,0.4696969696969697,0.8295750168313186,1.0,4/18,13.19%,ITGA5;THY1;CD44;TNFRSF1A
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.592119118290626,1.0651424991042948,0.4864864864864865,0.9754034611575466,1.0,4/11,24.49%,RNF14;AR;DAXX;PLPP1
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.5670164268383452,1.0651355403404892,0.34285714285714286,0.9746528660236318,1.0,3/9,14.67%,GRAMD1C;GRAMD1B;GPLD1
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),-0.6586687037474626,-1.0650812651208048,0.47368421052631576,0.8301464956412553,1.0,2/7,14.82%,TENM4;MYRF
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.4784383534465223,1.064975367822706,0.36666666666666664,0.9744031618093266,1.0,6/29,13.59%,UBTF;ERCC2;POLR1F;ERCC3;GTF2H5;GTF2H2
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.418725062112881,-1.0648640087629002,0.2876712328767123,0.830466252951837,1.0,34/134,18.56%,RFTN1;FYB1;HLA-A;SKAP1;INPP5D;THY1;HLA-DRA;PSMB9;MOG;WAS;LAT2;NFKBID;EIF2B2;PSMB6;HHLA2;PRKCQ;SYK;BMX;PSMC3;FYB2;THEMIS;BTN3A1;BLNK;PIK3CB;PSMA8;PIK3CD;SH2B2;PSMA7;HLA-DRB1;PRKCB;PSME1;RIPK2;CARD11;CD4
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.6817707707947013,1.0646545392866973,0.32608695652173914,0.9729918962366337,1.0,1/5,16.63%,ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.6817707707947013,1.0646545392866973,0.32608695652173914,0.9729918962366337,1.0,1/5,16.63%,ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.6817707707947013,1.0646545392866973,0.32608695652173914,0.9729918962366337,1.0,1/5,16.63%,ERLIN1
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.4548510784057376,-1.0645103531355966,0.3088235294117647,0.8311586727142527,1.0,15/70,18.31%,TYMS;CDKN2A;PLK2;CCND1;PLK3;CRLF3;CCNE2;CDKN3;CDK2;MAX;CDC7;CDK5;CDKN2D;CDKN1A;SPDYA
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,0.46464384466509767,1.0644759814304596,0.425,0.9729011463309372,1.0,8/20,18.23%,RGCC;CNOT9;PLAGL1;CNOT2;CNOT8;CNOT6L;CNOT1;CNOT4
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.5717003522405464,1.064373962488262,0.42424242424242425,0.9724419259877165,1.0,4/12,19.17%,ALG6;ALG3;ALG11;ALG13
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5278361936408035,1.0642819412576965,0.45,0.9719282039548057,1.0,2/15,11.71%,FLT3;CSF1R
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.6992013889317651,1.064078128247852,0.4146341463414634,0.9710135760881629,1.0,2/5,15.61%,RBBP4;ASF1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.6992013889317651,1.064078128247852,0.4146341463414634,0.9710135760881629,1.0,2/5,15.61%,RBBP4;ASF1A
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.4911050905428638,1.0640234456103552,0.4117647058823529,0.9703828479540846,1.0,6/21,17.34%,CRPPA;TMTC4;FKRP;POMT2;TMTC3;DPM1
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.7111237032218103,1.0638924696186811,0.4146341463414634,0.969115282758222,1.0,4/5,28.90%,SMYD5;BEND3;SETD4;KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.7111237032218103,1.0638924696186811,0.4146341463414634,0.969115282758222,1.0,4/5,28.90%,SMYD5;BEND3;SETD4;KMT5B
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.534720823144478,-1.0635079674642802,0.38461538461538464,0.833721991685508,1.0,4/30,7.93%,KCNJ13;KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3981799265436979,1.063323569769328,0.3,0.970173666275216,1.0,31/68,26.73%,PSMD10;CEBPA;HSPA1A;TRIB3;KEAP1;BAG2;VCP;RNF14;CSNK1E;CBFA2T3;PLK1;RCHY1;TRIB2;COP1;ZYG11B;MDM2;PYHIN1;SMAD7;RNF217;SUMO2;NUB1;DDA1;PTK2;HSPBP1;SIRT2;FBXW7;AXIN1;DNAJB2;HECTD1;PTEN;ANKIB1
prerank,Reactome_2022__Synthesis Of PIPs At Late Endosome Membrane R-HSA-1660517,-0.6235165151319252,-1.0631839987703966,0.43103448275862066,0.8342946502751183,1.0,2/11,4.25%,MTMR7;VAC14
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.6059395053411489,-1.0631808904777296,0.423728813559322,0.8339622782820423,1.0,3/14,13.72%,MMP14;SYK;IL7
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.6628721502409923,-1.0628169929137679,0.43333333333333335,0.8347623208937398,1.0,1/8,0.54%,EFNA1
prerank,KEGG_2021_Human__Primary bile acid biosynthesis,0.5279231265469714,1.0626397419446527,0.42857142857142855,0.9715324846442194,1.0,3/11,13.22%,CYP7B1;CYP46A1;SCP2
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.48488225092652903,1.0625747421584215,0.3,0.9710045166151089,1.0,3/22,11.49%,FAM47E;DNMT3B;KMT2A
prerank,Reactome_2022__Aspirin ADME R-HSA-9749641,-0.5538948715097142,-1.0624512913226065,0.38596491228070173,0.8356110807204251,1.0,4/15,13.02%,ACSM5;GLYAT;GLYATL2;CYP3A4
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.5978591022224281,1.0623863578130204,0.43333333333333335,0.9710167269243517,1.0,4/9,14.67%,PDE3B;PLIN5;AKT1;GPLD1
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,-0.5151322629597155,-1.0622799887269614,0.38461538461538464,0.8358252096604927,1.0,5/25,20.62%,MMP19;MMP14;COL12A1;COL9A2;COL26A1
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.5886393242108625,-1.0622758041476699,0.423728813559322,0.8355003448715881,1.0,3/10,13.54%,POU2F3;PSMC3;TFAP4
prerank,CellMarker_Augmented_2021__Purkinje cell:Undefined,-0.5393382509377076,-1.0619890814541142,0.3972602739726027,0.8359874378342538,1.0,8/22,24.50%,GFAP;ITPR3;GAD1;PCP4;PDE5A;PDE1C;MBP;HDAC6
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.5905067671690877,1.0619361762864334,0.3939393939393939,0.9717961538888003,1.0,3/10,8.36%,DAO;GLUD1;GLS
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),0.6148425439799302,1.0618637115068044,0.42105263157894735,0.971241869615322,1.0,4/9,20.22%,DNASE1L2;DFFB;DNASE1L1;FBH1
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.45427980438414883,-1.061765837287859,0.3472222222222222,0.8363869321597275,1.0,3/80,2.23%,ENPP2;ZFP36;RPS27A
prerank,Reactome_2022__Acyl Chain Remodelling Of PC R-HSA-1482788,-0.5641667871253865,-1.0612840385007014,0.421875,0.8377184118005806,1.0,2/16,10.92%,PLB1;LPCAT4
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.597059872605982,-1.0611773419517097,0.48333333333333334,0.8376812195824107,1.0,5/13,23.97%,B4GALNT1;ST8SIA3;B3GALT4;ST6GALNAC3;ST8SIA4
prerank,Reactome_2022__Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.5422471629350438,-1.061165315520739,0.4520547945205479,0.8373751947294337,1.0,3/23,9.91%,TUBB6;PFDN6;TCP1
prerank,Reactome_2022__Acyl Chain Remodelling Of PS R-HSA-1482801,-0.6223415613408224,-1.0610864180660233,0.4492753623188406,0.8372662519830473,1.0,4/11,32.60%,LPCAT4;OSBPL10;MBOAT1;PLAAT3
prerank,Reactome_2022__Presynaptic Nicotinic Acetylcholine Receptors R-HSA-622323,0.645210818240648,1.060940630930775,0.4883720930232558,0.9727419318497951,1.0,2/6,7.96%,CHRNA4;CHRNB4
prerank,Reactome_2022__Acetylcholine Binding And Downstream Events R-HSA-181431,0.645210818240648,1.060940630930775,0.4883720930232558,0.9727419318497951,1.0,2/6,7.96%,CHRNA4;CHRNB4
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.4957035121442192,1.060841805043086,0.35294117647058826,0.9722519544831468,1.0,1/12,0.60%,RGCC
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),-0.6713572597335002,-1.0608115650315788,0.4166666666666667,0.837347424859095,1.0,1/8,2.14%,KMO
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),-0.6713572597335002,-1.0608115650315788,0.4166666666666667,0.837347424859095,1.0,1/8,2.14%,KMO
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.536374470503798,1.0607428588072811,0.34146341463414637,0.9717081809158876,1.0,5/18,20.77%,TSPAN33;NDC1;NUP205;BAD;NUP153
prerank,Reactome_2022__S Phase R-HSA-69242,0.3683541559632592,1.0606843758433457,0.3333333333333333,0.9711198303878332,1.0,15/139,6.89%,POLD3;SEM1;SLC19A1;CCNE1;DNA2;PSMD10;CDC25A;PSMA1;PSMD11;AKT2;RFC3;ANAPC1;CUL1;AKT1;PSMB5
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.5680350278562645,1.0605261458853423,0.38235294117647056,0.9701002351458192,1.0,4/18,18.57%,TEX15;DNMT3B;BEND3;EHMT1
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.5680350278562645,1.0605261458853423,0.38235294117647056,0.9701002351458192,1.0,4/18,18.57%,TEX15;DNMT3B;BEND3;EHMT1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.6099247782946247,1.060276759117104,0.4878048780487805,0.9700858671894855,1.0,1/6,2.42%,HS3ST5
prerank,"Reactome_2022__Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",-0.5551333060601584,-1.0600414139713155,0.3770491803278688,0.8391554207597327,1.0,1/16,1.14%,AMN
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.6800592509348655,1.0599506686768776,0.4807692307692308,0.9703886485989657,1.0,1/5,22.01%,GOLPH3
prerank,Reactome_2022__HS-GAG Degradation R-HSA-2024096,0.5054687121381556,1.0599033043694919,0.4358974358974359,0.9698127551702775,1.0,4/17,11.69%,SDC4;SDC3;GPC5;HSPG2
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,-0.48003919797165207,-1.0598259780802628,0.35714285714285715,0.8395334408608562,1.0,7/38,11.52%,DEPDC1B;STEAP3;ARHGAP39;BASP1;BAIAP2L1;LMNB1;RHOF
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.5801903288707174,-1.059804448488296,0.3939393939393939,0.839253852684782,1.0,4/14,13.10%,HPN;ZIC1;MYO3A;PAX8
prerank,Reactome_2022__mRNA Editing R-HSA-75072,-0.7053087653965181,-1.0597280812939018,0.4915254237288136,0.839155742192413,1.0,2/5,14.78%,APOBEC2;APOBEC3H
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.6131724907492448,-1.0594812695927045,0.37254901960784315,0.8395257541344906,1.0,1/8,12.39%,OGG1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.6409826883212062,-1.0593050733535014,0.4262295081967213,0.8397219080882926,1.0,1/8,2.72%,ALOX12
prerank,Reactome_2022__Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,-0.565952220534809,-1.0592663658947505,0.4027777777777778,0.8394841822945246,1.0,4/17,15.24%,SLC18A2;CPLX1;SYT1;PPFIA1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),0.6665399582967533,1.0592292249253472,0.475,0.9709294375052355,1.0,3/6,29.39%,GLUL;MCRS1;POLR1A
prerank,CellMarker_Augmented_2021__Ciliated Epithelial cell:Esophagus,-0.4044328270715478,-1.059195926848643,0.3541666666666667,0.8393861373285741,1.0,51/323,14.73%,CP;C1ORF87;TEKT2;RSPH4A;CFAP126;ECT2L;WARS1;KCNB1;ADGRE5;CLDN16;SVOPL;CCDC39;POLQ;TTLL7;KIF17;ARHGEF38;DCDC1;DYNLT5;ARHGAP39;BASP1;SPAG17;PZP;NELL2;DLEC1;ODAD1;KIF9;WDR90;PFN2;SPATA18;TSPAN19;ANKUB1;CIBAR2;WDR54;SPAG1;HHLA2;P4HTM;FAM81B;SLC7A2;RHPN1;CFAP61;LRRC74B;CCDC181;UBXN11;NEK10;TTLL6;DALRD3;DRC1;CES4A;SLC12A7;ST6GALNAC2;AKAP14
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.5239848261221681,-1.0591858796552323,0.4626865671641791,0.8390846758170609,1.0,5/24,11.12%,THBS1;SP100;SVBP;GADD45A;DAB2IP
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:White Adipose Tissue,0.4280810733588801,1.059162967421016,0.39285714285714285,0.9703811485488748,1.0,5/33,6.31%,PLIN4;PLIN1;PRELP;PLIN5;C4ORF36
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.4292419478896147,1.0590348134921646,0.29411764705882354,0.969896956486583,1.0,4/32,10.09%,FAM47E;MSH2;ATR;PLK1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.6162601342211642,-1.0590252968739884,0.4696969696969697,0.8392015857402498,1.0,2/8,13.31%,CCDC39;BBOF1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.44508694825834844,-1.058998009088167,0.36764705882352944,0.8389343307209899,1.0,14/50,17.76%,RPE65;RDH13;PLB1;RBP2;AKR1C1;CYP1B1;GPC3;CYP3A4;ADH4;RDH12;DHRS13;GPC1;CYP3A5;LRP2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone Marrow,-0.5770136718488984,-1.0589428950062252,0.45454545454545453,0.8387388050855361,1.0,6/15,21.37%,THY1;CD44;MCAM;CD4;PDGFRA;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.631053777932589,1.058936165512117,0.5,0.9693954860622106,1.0,1/6,16.62%,NDFIP1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.5324126245277154,-1.0589068163207094,0.421875,0.8385471995553282,1.0,2/18,6.23%,GBP1;MMP14
prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),0.4765721163333266,1.0588197995400381,0.3333333333333333,0.9689308835412949,1.0,8/26,25.98%,CS;SUCLA2;FH;PDHA1;OGDHL;DLAT;SDHB;OGDH
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.4088461210867605,1.0587908903729493,0.3333333333333333,0.9682057198955909,1.0,11/61,11.15%,NGF;ASCL1;BRINP3;BMP2;MOSMO;BEND6;KCTD11;HEYL;EIF2AK4;NREP;ZC4H2
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.5608218262950473,-1.0587424831877759,0.43548387096774194,0.8387431153328999,1.0,2/18,3.31%,TRIM22;TRIM5
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.5482855106797824,1.0585395130267476,0.39473684210526316,0.9682469785060184,1.0,3/10,20.90%,VDAC2;BAD;BCL2L11
prerank,CellMarker_Augmented_2021__Neuroepithelial cell:Undefined,0.6948920350130129,1.0585384988065023,0.4444444444444444,0.967478528523077,1.0,1/5,3.76%,OCLN
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.5956341616679595,1.058343934283203,0.43902439024390244,0.9666099335929591,1.0,3/9,16.65%,VTA1;CHMP2B;VPS4B
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.5956341616679595,1.058343934283203,0.43902439024390244,0.9666099335929591,1.0,3/9,16.65%,VTA1;CHMP2B;VPS4B
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.5996276381007667,1.0582723045491549,0.46511627906976744,0.9660958957172531,1.0,3/12,5.99%,AIFM2;SELENON;ABCD1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5218619116447878,-1.0581859077607114,0.4057971014492754,0.8401531357134586,1.0,6/31,18.13%,PIF1;RPA1;NOP10;ANKRD28;CDK2;TINF2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.6544227480805602,-1.0580268140584477,0.3770491803278688,0.8399684866077556,1.0,1/9,1.31%,TYMP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.6544227480805602,-1.0580268140584477,0.3770491803278688,0.8399684866077556,1.0,1/9,1.31%,TYMP
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.6317619866963144,-1.057769857241344,0.48148148148148145,0.8404150854188501,1.0,1/7,1.92%,CIITA
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.5147262307958399,1.0576482551009856,0.375,0.966936773661621,1.0,2/19,10.14%,ARV1;GNB3
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.40611245310117644,-1.0575658230055731,0.4,0.8407111937740267,1.0,66/320,20.53%,RPL19;RPL3;RPS27A;WARS1;RPS27;RPS14;RPS4X;TESC;RPL27A;RPL35;SCX;RPL7A;RPL37A;ELAVL4;RPL27;RPL9;RPL21;RPL13A;POLR2I;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;TSPAN32;PAX8;RPL8;DHX38;RPS6;GLE1;RPS15;RPS9;RPL12;THOC6;RPL5;RBM3;EEF1A2;RPL23;RPL4;DDX54;NXF5;RPL18A;RPL41;ANGPT2;RPL7;RPS12;RPS20;COPS5;RBMS1;MRPL23;RPL15;MRPL51;RPL11;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.5064907171798853,1.0574634321721743,0.38235294117647056,0.9667906696808539,1.0,5/13,14.25%,BMP2;SOX9;SOX5;MDK;TAPT1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.4462769525375393,-1.0573307776408076,0.375,0.8410633403946055,1.0,6/52,8.60%,L1CAM;NEXN;MYOT;FAT2;CEACAM1;IGSF21
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.40822315213196214,-1.0572979222164185,0.3829787234042553,0.8408264134463568,1.0,34/189,17.41%,PRAME;THBS1;HIC1;IL12A;NLRP12;SULF1;MMP14;PTK6;APOD;NOTUM;EGF;LRPAP1;IFT122;DAB2IP;HHIP;PRKCQ;SFRP4;TMBIM1;SIGIRR;IGFBP5;GPC3;MMRN2;EGFL7;BDNF;CBY1;PIK3CB;SFRP2;APLN;TNS2;PRKCD;TSC2;PRKCB;GPC1;NOTCH3
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.523646329727539,-1.0571025143381836,0.44,0.8410132856872009,1.0,10/28,20.75%,ACOT1;ACSM5;ACOT4;GLYAT;DBI;ACOT2;OXSM;ACOT8;ACOT6;HMGCS1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.6204062049782731,-1.05706781842581,0.40625,0.8407878109597251,1.0,1/7,8.00%,DBI
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.5754571184262018,-1.057016271044898,0.45454545454545453,0.8406336863738109,1.0,1/18,0.54%,EFNA1
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,-0.5841845940980882,-1.0567790246212498,0.4838709677419355,0.8409589476258084,1.0,3/14,7.61%,CLDN16;CLDN20;CLDN18
prerank,Reactome_2022__Activation Of Pre-Replicative Complex R-HSA-68962,-0.5252499918360577,-1.0567191633378838,0.4,0.8408198489913545,1.0,5/24,16.44%,POLE3;POLE4;RPA3;CDK2;CDC7
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,0.3659064296842185,1.056715184268564,0.2727272727272727,0.9683728025671077,1.0,22/74,23.28%,ELOC;GTF2F2;ELOA;ERCC2;GTF2A2;TAF12;ERCC3;GTF2H5;TAF4;GTF2H2;TAF2;IWS1;POLR2C;TAF3;CCNT1;GTF2H3;NELFA;CCNT2;TAF13;CTDP1;MLLT3;GTF2B
prerank,KEGG_2021_Human__Cellular senescence,-0.42251339913017705,-1.056653265138826,0.32558139534883723,0.84066589702306,1.0,27/132,18.28%,CCNB2;CDKN2A;TGFBR2;HLA-A;HLA-C;ITPR3;CCND1;GADD45A;PPP3CC;CCNB1;HLA-B;HLA-E;FOXM1;CCNE2;HLA-F;PIK3CB;PIK3CD;CDK2;CCND2;CAPN1;TSC2;HIPK4;ETS1;GADD45B;HIPK3;TGFB1;CDKN1A
prerank,Reactome_2022__Canonical Retinoid Cycle In Rods (Twilight Vision) R-HSA-2453902,-0.5518320304908302,-1.0566122593101912,0.43333333333333335,0.8404335341572662,1.0,1/11,1.04%,RPE65
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.472880151564659,1.0565219824629697,0.34285714285714286,0.9681989568094729,1.0,3/17,5.69%,BCL10;SLC39A10;FOXP1
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.4821008452279781,1.0564878910034312,0.34615384615384615,0.9675784213980984,1.0,5/17,21.11%,PDK4;CYP4F12;SLC12A9;SLC12A8;SLC12A2
prerank,CellMarker_Augmented_2021__SLC16A7+ cell:Lung,0.30337511889808955,1.056096989206251,0.0,0.9680575286148313,1.0,165/807,16.38%,LEPR;ATAD3C;ZMAT3;METTL8;LIMD1;NIPAL1;C3ORF62;GOLGA6L10;UTP23;CLHC1;PABPC1L;FBXO48;AGER;GSDMB;ST6GAL2;PRELID2;GUCA1B;IBA57;CEP19;SRFBP1;DNAH7;GOLGA6L4;MCU;ZNF426;LRRC2;CARF;LRRC36;DOC2A;DGKE;WDR17;OCLN;ADCY1;CCDC88C;PMS1;PLEKHG4B;JAM2;DMAC2L;PRELP;ZNF556;COX18;ZNF816-ZNF321P;ZNF555;CRPPA;MID1;UBN2;THEM4;DCUN1D2;CYP4F12;NCR3LG1;MANEAL;SCN11A;MAPK10;TDRD3;BLZF1;USP40;CSAD;ACBD7;NPIPA5;TIGD1;RAB27A;ZNF862;C15ORF40;ZNF320;ZFYVE16;CEP104;ZNF277;ARL16;TTC12;IDO1;SYNE1;GPATCH2;INTU;RNF14;ZNF561;ZNF696;DIPK2B;MSRB3;CEP290;ARFIP2;LRRC58;CAPRIN2;UGGT1;RPL7L1;CCDC142;ZNF587;AP1S3;ATR;LYRM7;C17ORF75;ZNF766;RBM41;SREK1IP1;ARAP1;ZNF665;NSUN6;ZNF875;XRCC2;ENGASE;CPT2;ADAT1;CSTF3;TIRAP;CLK4;FAM106A;ZNF761;ZNF669;ZNF793;SSH1;ICA1L;NSUN7;STXBP4;TMEM168;PIPOX;MARVELD3;DNAH12;QRSL1;COX19;ELMOD1;GRAMD1B;TUBD1;IKBIP;ABHD15;FAAH2;SNAPC1;KAT2A;GTF2H5;CD96;VPS39;GTF2H2;EXOG;MLLT10;ZNF429;DCTN5;CFLAR;SLC45A2;CNTN3;ZDHHC21;NFKBIB;AGBL2;ALS2;AP5B1;FHIP1B;DOP1A;TAF8;SLC22A5;SGK3;YARS2;ZNF519;MCPH1;DBT;BTBD7;ZNF264;WWOX;ZFYVE27;NPTXR;KIF1B;RC3H1;PTAR1;SLC25A15;ZNF34;PANK2;NPIPB6;TRIM3;VPS11;FLVCR1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.6765615766144429,-1.0559770905257342,0.4444444444444444,0.842055520784003,1.0,5/9,13.21%,HLA-A;CEACAM1;HLA-B;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.6028083657377831,1.0559636292484318,0.45454545454545453,0.9677147629719143,1.0,6/7,38.53%,AGO3;AGO4;DHX36;DDX3X;DHX9;AGO2
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),-0.652917638898926,-1.0558884394721009,0.4,0.8419872036897786,1.0,3/6,14.15%,GABRB2;HRH1;GABRG2
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryoid Body,-0.4618007246284446,-1.0557579465096687,0.4266666666666667,0.8420235279827876,1.0,10/60,6.98%,COL4A1;ANGPTL2;APLNR;SPARC;CALD1;COL4A2;RAMP3;BGN;RSPO3;LDB2
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.5624295199737563,-1.0556735255559813,0.4626865671641791,0.8419478109076677,1.0,5/21,20.15%,YBX3;BIRC3;FLOT1;CDC37;CASP8
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.4695822214234141,1.0555502636152736,0.2857142857142857,0.968362454381823,1.0,2/25,0.94%,SLC26A7;SLC19A1
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.6564647390458009,-1.0553818948904465,0.43859649122807015,0.8423984015045966,1.0,3/7,18.51%,SLC25A45;SLC22A4;SLC25A29
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.5235608181373788,-1.0553793563176321,0.38095238095238093,0.8420838266791147,1.0,4/34,8.70%,ABO;B3GALT2;FUT2;ST3GAL6
prerank,CellMarker_Augmented_2021__CD4+ Memory T cell:Lymphoid Tissue,-0.5321231629600849,-1.0553509731252972,0.49122807017543857,0.8418366301675277,1.0,6/24,8.69%,CD5;TAGAP;TMC8;ARHGAP9;ACAP1;WAS
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Retina,-0.43758793933218937,-1.055194485540347,0.3466666666666667,0.8420183252230294,1.0,12/93,9.68%,C1QL1;L1CAM;ASPHD1;FSCN1;CAMK2N2;B4GALNT1;MAP1B;ANLN;EFNB3;ARHGAP39;PFN2;NYAP1
prerank,CellMarker_Augmented_2021__Dendritic cell:Spleen,-0.4853820060723981,-1.0550850319229916,0.4166666666666667,0.8417108166501942,1.0,9/29,10.58%,P2RY13;MYO1F;TAGAP;ARHGAP9;IGSF6;CLEC12A;LAT2;CTSS;PILRA
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Thymus,-0.4853820060723981,-1.0550850319229916,0.4166666666666667,0.8417108166501942,1.0,9/29,10.58%,P2RY13;MYO1F;TAGAP;ARHGAP9;IGSF6;CLEC12A;LAT2;CTSS;PILRA
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.5581567402756948,-1.0550643931308006,0.41935483870967744,0.8414306539866612,1.0,4/11,14.84%,CYP1B1;CYP3A4;ADH4;RDH12
prerank,Reactome_2022__PI3K Events In ERBB4 Signaling R-HSA-1250342,0.663134814436249,1.0550238816373778,0.4791666666666667,0.969329929393422,1.0,4/7,19.73%,ERBB4;PIK3CA;PIK3R1;NRG3
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.5111613566998999,1.0550205239846338,0.42105263157894735,0.9685684761888709,1.0,5/19,7.19%,ABCB10;ALAS1;HMBS;COX10;SUCLA2
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.636461514380165,-1.055016852014957,0.4406779661016949,0.8412698132678982,1.0,1/8,1.45%,TGFBR2
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,-0.5464105387463762,-1.0549916313044874,0.4406779661016949,0.840997490695301,1.0,3/20,12.88%,MYH11;MYH9;RNASE1
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.6369597817496038,-1.0545841324822318,0.4603174603174603,0.8418745116401856,1.0,4/9,21.35%,VLDLR;DAB2IP;ALK;PACSIN1
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4816659335905039,-1.0545371586835175,0.3880597014925373,0.8416988168385089,1.0,3/43,2.85%,S100A10;GBP1;PDPN
prerank,KEGG_2021_Human__alpha-Linolenic acid metabolism,-0.5930888836184472,-1.0544458700201564,0.47619047619047616,0.841579000416953,1.0,1/12,3.17%,PLB1
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),-0.5946175013329251,-1.0544324437235875,0.36666666666666664,0.8412809876315752,1.0,1/11,2.93%,GMPR
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.5434261621914682,-1.0544284257403234,0.35526315789473684,0.8409497957135823,1.0,4/18,14.49%,KCNJ2;ATP1A1;ATP1B1;SLC12A7
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.501440839725717,-1.054424682276836,0.48,0.8406300017473347,1.0,1/37,0.11%,LEF1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.5640152727276931,1.0542786008774134,0.4,0.9700947928374134,1.0,3/12,10.63%,GNL3L;CCT7;CCT3
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.6993356585527829,-1.054122176354954,0.4482758620689655,0.8411563376237013,1.0,1/5,6.29%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.7000746878175421,-1.0541038660487263,0.4406779661016949,0.8408812179006434,1.0,4/5,28.78%,TGFB1;CUEDC2;TGFB2;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.48578676399748305,1.0540299505759907,0.3448275862068966,0.9701162716693257,1.0,3/18,6.69%,OCLN;AKT2;AKT1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.5113994293423456,-1.0539825360368433,0.4393939393939394,0.8409510707433034,1.0,8/27,15.12%,TLR2;APP;TLR3;WNT5A;SYK;IL18;IL7;CD74
prerank,Reactome_2022__Meiotic Recombination R-HSA-912446,0.4194346125822657,1.0539596342244208,0.36666666666666664,0.9696136061743069,1.0,5/30,5.63%,MSH4;TEX15;HID1;H2BC21;H2BC4
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.4966648814068436,-1.0538778964450288,0.38461538461538464,0.8409912236166539,1.0,1/37,0.11%,LEF1
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,-0.44107943862775645,-1.053705140339413,0.3291139240506329,0.8411350590174018,1.0,14/77,16.93%,VRK2;DEPDC1B;ARHGAP15;ARHGAP39;BAIAP2;BAIAP2L1;CDC42EP1;NHS;NOXA1;SLITRK5;MCAM;ERBIN;EMD;DOCK10
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.6465356376920859,1.053676019719091,0.47368421052631576,0.9697596960299366,1.0,1/5,2.42%,HS3ST5
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,-0.407072983510254,-1.0535206664886883,0.30434782608695654,0.8413046985295557,1.0,27/190,17.44%,CCNB2;ERCC6L;TUBB6;RPS27A;VRK2;RPS27;CENPH;PSMB9;CENPE;ANAPC11;ZWILCH;LMNB1;NUF2;SPC24;CCNB1;PSMB6;KIF2C;PSMC3;UBC;CENPN;CENPU;UBE2S;PSMA8;PSMA7;EMD;CENPP;PSME1
prerank,CellMarker_Augmented_2021__Periodontal Ligament Stem cell:Periodontal Ligament,-0.4846905233468778,-1.0533806631833271,0.3783783783783784,0.8413557667134196,1.0,13/34,12.65%,MYO1F;DOCK8;TAGAP;SLA;ARHGAP9;GAB3;ARHGAP15;HLA-DRA;F13A1;RCSD1;CTSS;SELP;ELMO1
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,-0.4404524746648432,-1.0532947509142285,0.3875,0.8412810053122374,1.0,12/87,15.10%,ERCC6L;RPS27;CENPH;CENPE;ANAPC11;ZWILCH;NUF2;SPC24;KIF2C;CENPN;CENPU;UBE2S
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.4150926242736538,1.0530729171285764,0.3548387096774194,0.9711472634310828,1.0,12/48,14.55%,ADAMTS9;GAL3ST2;GANC;MAN1A2;GAL3ST4;PRKCSH;ENGASE;STT3B;GANAB;FBXO27;ST8SIA5;ADAMTS13
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.46943306559652825,1.0529837797412283,0.375,0.970600658911418,1.0,4/18,6.09%,RAP2C;GREM1;PDGFD;PDGFC
prerank,Reactome_2022__Inwardly Rectifying K+ Channels R-HSA-1296065,-0.5317823648584643,-1.05292555596243,0.36486486486486486,0.8421419507310532,1.0,8/24,22.72%,KCNJ2;GNG3;GNG2;GABBR2;ABCC9;KCNJ6;GNB4;GNB5
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,0.3652417755637324,1.0528886279687213,0.3684210526315789,0.9702054514758741,1.0,18/93,14.30%,POLD3;SEM1;SLC19A1;DNA2;H2BC21;H2BC4;RFC3;BRCC3;UBE2N;SIRT6;RAD52;XRCC2;HUS1;RRAD;RAD9B;POLK;ATRIP;PALB2
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.4744170483404389,-1.052548767099025,0.36764705882352944,0.8428913112985663,1.0,9/52,13.19%,TLR2;RPS27A;PRDX4;TLR3;BIRC3;DAB2IP;MAP3K14;UBC;TNFRSF1A
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.5714235465123543,1.0523853851677467,0.4634146341463415,0.9708107481813335,1.0,3/10,9.28%,BMP2;FOXJ1;SALL1
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.5921591245685923,1.052327112281087,0.4166666666666667,0.970230318634377,1.0,1/8,10.83%,PHETA1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5109234554273065,1.0521900728320779,0.42857142857142855,0.9699511758967463,1.0,3/14,14.77%,HSPA1A;SLC25A5;MUL1
prerank,Reactome_2022__Fatty Acids R-HSA-211935,0.63625934572847,1.052141021715802,0.4523809523809524,0.9694429429689265,1.0,2/5,5.58%,CYP4F3;CYP4F12
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.5828553617584251,-1.05213760252123,0.4782608695652174,0.8437841940430065,1.0,5/15,19.17%,MYO1F;MYO15A;MYO1E;MYO1H;MYO1C
prerank,KEGG_2021_Human__Toxoplasmosis,-0.4356669712154078,-1.0521332708332587,0.35294117647058826,0.8434537159026464,1.0,9/85,11.02%,TLR2;CIITA;LAMB1;IL12A;HLA-DRA;LDLR;IFNGR2;STAT1;BIRC3
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.49894361334666804,1.0518857045166603,0.3225806451612903,0.9695000459839874,1.0,1/17,0.43%,NGF
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.46676329917754683,1.0516477964956545,0.4230769230769231,0.9696099451224267,1.0,14/43,23.42%,H2BC18;H2BC21;SOX9;ANP32B;RBBP4;H1-2;ASF1A;NOC2L;CDAN1;DAXX;KAT6B;H2BC5;SART3;BAHD1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periosteum,-0.45075698022956023,-1.0516405720114226,0.3717948717948718,0.8446262880540701,1.0,19/91,17.65%,COL4A1;CALD1;COL4A2;APP;THY1;BGN;SCARA3;EDIL3;SRPX2;OSMR;THBS2;FN1;AMOTL2;ITGA3;BDNF;PLAT;COL12A1;PXDC1;LARP6
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,-0.42649411186399666,-1.0515347124208134,0.3855421686746988,0.8446279187104133,1.0,13/130,9.54%,ARHGAP4;DOCK8;TAGAP;DEPDC1B;ARHGAP9;PLEKHG2;STEAP3;ARHGAP39;BAIAP2;ARHGDIG;WAS;CDC42EP1;CDC42EP3
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.5051732568687003,1.051533837514473,0.4,0.9691824277817088,1.0,6/21,12.99%,EGFR;AKT1;MT1E;HSF1;MAPK8;AKR1C3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.5665091322807476,-1.0514615208886777,0.4411764705882353,0.8444450763671603,1.0,3/15,16.59%,OGFOD1;GLE1;CLN3
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.5257815731461599,-1.051460782517587,0.43478260869565216,0.8441148596068859,1.0,1/24,2.00%,STMN2
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.5672799684446777,1.0514493253528872,0.3939393939393939,0.9679424628848208,1.0,6/13,24.66%,COQ3;COQ2;COQ9;PDSS2;COQ6;UBIAD1
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.5672799684446777,1.0514493253528872,0.3939393939393939,0.9679424628848208,1.0,6/13,24.66%,COQ3;COQ2;COQ9;PDSS2;COQ6;UBIAD1
prerank,KEGG_2021_Human__Hepatocellular carcinoma,-0.4178404070531737,-1.0514300929100167,0.379746835443038,0.8438438881697949,1.0,12/140,10.54%,LEF1;CDKN2A;MET;TGFBR2;WNT8B;GSTM5;CCND1;PRKCG;GADD45A;WNT5A;TGFA;SHC2
prerank,CellMarker_Augmented_2021__T Helper1 (Th1) cell:Brain,-0.5299077960782025,-1.051397417281881,0.423728813559322,0.843262067745319,1.0,5/22,6.48%,CD5;TAGAP;GPR171;ARHGAP9;ACAP1
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Brain,-0.5299077960782025,-1.051397417281881,0.423728813559322,0.843262067745319,1.0,5/22,6.48%,CD5;TAGAP;GPR171;ARHGAP9;ACAP1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.3774893651197751,1.051250373521873,0.28125,0.9680005077332217,1.0,9/77,13.78%,WNT7A;PSMD10;PSMA1;PSMD11;PSMB5;AP2B1;PSMD14;DVL2;PSMD12
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial cell proliferation (GO:1905563),-0.7206587485592814,-1.050814835235431,0.5217391304347826,0.8445014360065456,1.0,3/5,24.22%,CCL2;COL4A3;PPARG
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.4222199851757634,-1.050709752469775,0.3291139240506329,0.8445472798093187,1.0,14/92,13.21%,TLR2;B2M;SFTPD;HLA-A;NLRP12;NOD1;HLA-C;STAT1;IRF7;ISG15;HLA-B;HLA-E;IFIH1;HLA-F
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.5246450896510724,-1.050669001606786,0.35294117647058826,0.8443465779343643,1.0,2/26,2.23%,TGFBR2;RPS27A
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.4540873657452954,1.050539257654778,0.375,0.969717886092229,1.0,3/24,10.09%,INSC;LLGL1;PLK1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.6128938601299168,-1.0505238569118993,0.43283582089552236,0.844466002558562,1.0,5/7,37.29%,ITGA3;FYN;IGF1R;PICK1;PRNP
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.4871331784731561,1.0504617073751983,0.45161290322580644,0.969283166462258,1.0,5/22,20.13%,PLD6;JAM2;DDX25;MKKS;FAM9B
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.5045321135728047,1.0502715257340094,0.375,0.9692260760570148,1.0,6/22,12.99%,EGFR;AKT1;MT1E;HSF1;MAPK8;AKR1C3
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,-0.42829987610452924,-1.050262256603565,0.4,0.84479856110057,1.0,20/128,16.79%,ARHGAP4;TAGAP;ARHGEF3;PLEKHG6;DEPDC1B;ARHGAP9;ANLN;ARHGAP39;ARHGEF17;ARHGEF18;RHPN1;OBSCN;FLOT1;DLC1;VAV1;RASGRF2;DDRGK1;MCAM;ERBIN;ARHGAP22
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.6007518184241925,-1.0502082899826988,0.4576271186440678,0.8445943225568607,1.0,5/13,24.89%,SELP;DMTN;RYR2;PTPRC;GRM5
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.40422412069293895,1.0501749960232016,0.3181818181818182,0.9688011680597671,1.0,9/50,14.03%,NR1D1;ADAMTS9;SOCS6;TRIM24;VCP;UBE2G1;STT3B;FBXO27;ATE1
prerank,KEGG_2021_Human__Long-term potentiation,-0.4658655796746532,-1.0501615382039324,0.3561643835616438,0.84440126524434,1.0,13/58,18.23%,GRIN2D;GRIN2A;GRIA1;ITPR3;PRKCG;RPS6KA1;PPP3CC;CACNA1C;GRIN2B;ADCY8;PRKCB;PPP1R1A;RPS6KA6
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.41519843967196113,-1.049943356820011,0.3793103448275862,0.8446783764309104,1.0,41/238,18.28%,THBS1;CCNB2;CDKN2A;DHCR24;DUSP1;POU4F1;PROX1;IL12A;IRF1;PIM3;BRCA1;PTK6;CCND1;GADD45A;TSPYL2;CRLF3;CCNB1;BIRC3;DAB2IP;BAP1;FOXM1;TFAP4;NR4A1;CDKN3;PES1;JUNB;NUDT6;SRA1;RPL23;PML;TSC2;CDK5;GPER1;GADD45B;GMNC;RASSF1;DAPK3;TGFB1;CDKN2D;NUPR1;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.6165359551681029,1.049821938418908,0.40625,0.9690246307738957,1.0,2/6,5.69%,BCL10;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.5923567208181486,-1.0497750761216262,0.4142857142857143,0.8448267999513888,1.0,1/12,0.67%,KCNQ1
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.5333157396560498,-1.0497474935639426,0.47692307692307695,0.8445678349603247,1.0,1/23,2.75%,WNT8B
prerank,CellMarker_Augmented_2021__Pancreatic Endoderm cell:Embryonic Stem Cell,-0.45857184178327826,-1.0497074850639496,0.38271604938271603,0.8443604210447027,1.0,30/82,22.68%,MET;MYOF;ITGA2;PLK2;MMP14;SCARA3;SRPX2;P4HA2;OSMR;EMP1;SLC44A3;HRH1;AMOTL2;RHBDF1;PDLIM4;ITGA3;LAMA3;COL12A1;F3;PXDC1;GPC1;PTPN21;ANTXR1;WWTR1;CD276;SH3D19;MYO1B;EPB41L1;CAV2;AHNAK2
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.5360406496552049,-1.049629775747417,0.43333333333333335,0.8442558246359848,1.0,8/22,15.12%,TLR2;APP;TLR3;WNT5A;IL18;SIGIRR;IL7;CD74
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.44832722667800484,1.049457792218973,0.3076923076923077,0.9694489099648003,1.0,6/31,11.84%,NUDT21;SNRPF;WDR33;CSTF3;PAPOLA;CPSF7
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.45967045964097186,1.0494241211206914,0.3333333333333333,0.9687975885522913,1.0,5/27,23.39%,ZNF207;SLAIN2;TUBG1;TPX2;TUBGCP3
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.5433972758291973,-1.0494230267577715,0.45588235294117646,0.8445361133370183,1.0,7/24,15.82%,RSPH4A;CCDC39;SPAG17;CFAP74;SPAG1;DRC1;LRGUK
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.3474739013543396,1.0493676492882296,0.23529411764705882,0.9682607954045466,1.0,46/191,23.92%,TFB2M;ELOC;MTERF1;TRIM24;COPS2;EAF2;ERCC6;GTF2F2;ELOA;UBTF;BRF2;ERCC2;THAP1;HSF1;GTF2A2;RO60;TAF12;SOX5;ERCC3;SNAPC3;GTF2H5;TAF4;DDX21;GTF2H2;NFKBIB;NFKB1;TAF2;IWS1;POLR2C;TAF3;THRB;CCNT1;RBMX;GTF2H3;MED4;NELFA;RNGTT;CCNT2;TAF13;CTDP1;GTF3C3;PARP1;MLLT3;GTF2B;TRIP11;EPC1
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,-0.48291879752087996,-1.049176078673507,0.42105263157894735,0.8449700425671948,1.0,6/36,16.24%,STMN2;KIF14;DEPDC1B;EPSTI1;UBXN11;ALDH3A2
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.631070539523021,-1.0491567921284,0.453125,0.8446895582375126,1.0,2/9,10.15%,RAB11FIP5;CTSS
prerank,Reactome_2022__MET Receptor Recycling R-HSA-8875656,0.624858176310267,1.0490267637793769,0.4634146341463415,0.9687893941021384,1.0,4/9,23.66%,RAB4A;CRKL;PIGU;SOS1
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.6339979514839637,1.0488531447073517,0.5263157894736842,0.9685760447300585,1.0,2/5,7.07%,CYP7B1;CXCL13
prerank,Reactome_2022__Acyl Chain Remodelling Of PE R-HSA-1482839,-0.5746028120586083,-1.048750392911422,0.4492753623188406,0.8454452084191696,1.0,2/17,10.92%,PLAAT4;LPCAT4
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.580823582835212,1.0486935677952147,0.4418604651162791,0.9682671854892648,1.0,4/9,20.55%,FUT9;MDK;ZDHHC21;NFAT5
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.5218500336414162,-1.0486693259248918,0.4375,0.8453440506468982,1.0,4/25,5.98%,THBS1;ICAM1;CD160;CCL2
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.5670389189184479,1.0486039179878346,0.32432432432432434,0.9678108014096434,1.0,2/12,7.96%,CHRNA4;CHRNB4
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.6318415814289,1.048557037792764,0.475,0.9671985329908618,1.0,2/7,7.43%,PPARGC1A;VCP
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.6045239727547884,1.048407125482904,0.4791666666666667,0.966804515816763,1.0,5/7,39.14%,TRIT1;ELAC2;HSD17B10;TRMT10A;TRMT10C
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.4893373933445953,1.048309721876691,0.35294117647058826,0.9663503017156176,1.0,2/18,8.22%,MTHFS;PTDSS1
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),0.6811569220398851,1.048188800711509,0.4,0.9659488582491561,1.0,2/5,6.69%,S1PR1;AKT1
prerank,Reactome_2022__CRMPs In Sema3A Signaling R-HSA-399956,-0.5655012133682296,-1.047920027674242,0.4827586206896552,0.8472729423107226,1.0,5/16,19.63%,CRMP1;FES;DPYSL2;CDK5;DPYSL3
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.6858691169870734,-1.0477291053989732,0.47368421052631576,0.8475513890478671,1.0,2/6,5.98%,MSMP;CCL2
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.5377972480414286,1.0477208007076584,0.36585365853658536,0.9666320959747965,1.0,3/14,10.95%,PGM2;AGL;PYGM
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.33742959941833317,1.0476120048699609,0.4,0.9662397168020069,1.0,78/278,23.38%,NR1D1;PPARGC1A;INTS13;NR2E1;ELOC;RARB;ZC3H8;SNAPC5;MAML3;TRIM24;KAT2B;COPS2;ESRRG;NUDT21;SNRPF;EAF2;ERCC6;GTF2F2;ELOA;RORB;ERCC2;NRBF2;WDR33;AR;NR3C1;GTF2A2;CSTF3;NOTCH2;INTS7;PAPOLA;TAF12;ESRRA;CPSF7;SOX5;ERCC3;SNAPC1;SNAPC3;GTF2H5;TAF4;INTS8;DDX21;GTF2H2;ELP2;TAF8;NFKB1;TAF2;IWS1;POLR2C;POU2F1;NR2F1;NR1D2;ELP4;NR3C2;CLP1;TAF3;PCID2;HDAC10;INTS14;RPRD1B;THRB;CCNT1;MED23;RBMX;NR2F6;CPSF2;GTF2H3;MED4;NELFA;RNGTT;CCNT2;TAF13;CTDP1;CDK12;PARP1;MLLT3;ZBTB1;GTF2B;NR2C2
prerank,KEGG_2021_Human__African trypanosomiasis,-0.576749137550536,-1.0473915022417517,0.4,0.8481914365609621,1.0,4/16,11.79%,ICAM1;IL12A;PRKCG;IL18
prerank,Reactome_2022__Transport Of Organic Anions R-HSA-879518,-0.6511143742362769,-1.0473497802182983,0.4528301886792453,0.8479834157270303,1.0,3/7,16.17%,SLCO3A1;SLCO2A1;SLCO1A2
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),0.6118460884576413,1.0472166380885182,0.35714285714285715,0.9666445913157472,1.0,4/9,25.58%,DCLRE1B;TFIP11;DCLRE1C;DCLRE1A
prerank,Reactome_2022__Synthesis Of Prostaglandins (PG) And Thromboxanes (TX) R-HSA-2162123,0.5698915808349685,1.0471116189177359,0.3870967741935484,0.9661835802615925,1.0,2/9,12.99%,PTGIS;AKR1C3
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.4516814565000125,-1.0470829449891503,0.4117647058823529,0.8484255916027309,1.0,12/89,12.85%,ST6GAL1;PLAAT4;ACOT1;ACSM5;ABCA12;ACOT4;GLYAT;DBI;NIT1;AEBP1;MTHFD2;ACOT2
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.47452002391693854,-1.0469243758203117,0.44285714285714284,0.8485060271944975,1.0,2/45,1.91%,CP;B2M
prerank,CellMarker_Augmented_2021__CD4+ Cytotoxic T cell:Liver,-0.4571661854063672,-1.04691586812424,0.3974358974358974,0.8481959549373009,1.0,12/57,18.20%,AGPAT4;MYO1F;SPON2;PZP;PATL2;SH3BP5;PRSS23;DSTN;SAMD3;VCL;RASSF1;A2M
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,0.4033783215325826,1.0467035219361998,0.3888888888888889,0.9667089249780795,1.0,10/65,14.81%,HMMR;HAUS1;CSNK1E;CEP290;CEP152;PLK1;PCM1;ALMS1;CEP192;TUBG1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.39656502717779085,1.0466173754723906,0.2631578947368421,0.9661967307438568,1.0,11/71,12.98%,EPHA6;NCSTN;EFNA2;EFNB2;GIT1;YES1;AP2B1;ARHGEF28;EFNA5;EPHB4;WASL
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.46723049763816576,-1.0465632340144286,0.375,0.8489329837631236,1.0,15/64,20.40%,L1CAM;MYOT;SNCB;TJP3;APP;SLC8A3;CBLN2;SEMA3E;PPFIA1;SNCG;TGFB1;MAPT;MYO9A;AGRN;CXADR
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.4547403746669553,-1.0462034715885755,0.3972602739726027,0.8495636975549284,1.0,13/83,12.30%,SPATA12;TSKS;MAEL;BRCA1;MARCHF11;GSG1;TSACC;SPATA18;GAPDHS;CREB5;DNAH3;DEPDC4;BCL2L14
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.5048811741132669,-1.0461415816069632,0.3918918918918919,0.84941029931127,1.0,2/32,5.04%,TRAM1L1;APP
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.4320822821476258,-1.0461412505027738,0.3717948717948718,0.8490821417293646,1.0,20/143,15.68%,APLNR;POU4F1;PGR;OVOL2;SH3GL2;APP;KLF4;PARP14;LDLR;PARP9;IGF1;WDR54;LRPAP1;PINK1;PTRH2;CCDC3;SFRP2;MSR1;APLN;DDRGK1
prerank,CellMarker_Augmented_2021__Thymic Emigrant cell:Blood,-0.4931935640360397,-1.046037062480703,0.40298507462686567,0.8490892946361082,1.0,9/28,10.15%,MYO1F;GPR183;DOCK8;TAGAP;SLA;ARHGAP9;ARHGAP15;RCSD1;CTSS
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.6308455503797945,1.0458939901305266,0.4146341463414634,0.9679385047416961,1.0,3/6,16.37%,PEX13;PHYH;SLC25A17
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.43558662625958816,-1.0458776675714685,0.39285714285714285,0.8492165775397631,1.0,22/89,20.62%,TGFBR2;KIF14;ADCY7;TLR3;CHI3L1;IGF1;MINK1;WNT5A;FGF1;ADCY5;PINK1;IL18;STRADB;EMP2;SLC11A1;PRKCD;ADCY3;ADCY8;TNFRSF10A;GHR;PAK5;PAK6
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.6030429520589548,1.045833382416451,0.5,0.9673312646709163,1.0,2/6,29.31%,PID1;APPL2
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Breast,-0.7028198427176812,-1.0457677457066212,0.48,0.8492309505158171,1.0,1/5,7.03%,CD44
prerank,KEGG_2021_Human__Hepatitis C,-0.4283950718524464,-1.0457128230962573,0.3246753246753247,0.8490343295976883,1.0,18/110,15.90%,SOCS3;MX1;IFIT1;CLDN16;TLR3;CLDN20;CCND1;YWHAH;CLDN18;LDLR;EGF;STAT1;IRF7;FADD;TNFRSF1A;PIK3CB;PIK3CD;CDK2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.6707515118002094,-1.045612788696914,0.4666666666666667,0.8489724019186508,1.0,1/7,0.67%,KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.46034398304512997,-1.045467321265518,0.4266666666666667,0.8490486448013532,1.0,12/44,19.41%,L1CAM;SHTN1;SYT4;SYT1;CPNE9;RIMS2;BDNF;PPIB;SYT2;MAPT;GHR;AGRN
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.49089526122456617,1.045410184092598,0.40540540540540543,0.9679230968127405,1.0,3/19,16.65%,ATF5;CHMP2B;VPS4B
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.6200107869352526,1.0453866168382597,0.5405405405405406,0.9672306590623095,1.0,1/7,3.04%,NT5C1A
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.38459327659990294,-1.0453863315573706,0.3541666666666667,0.8489940265572284,1.0,86/545,18.45%,PRAME;LEF1;ANXA1;THBS1;HPN;APIP;IFI6;DHCR24;RPS27A;NAA38;PDPN;ARHGEF3;KIF14;PLK2;TP53I3;PRDX5;HTR2B;SCX;PLEKHG2;PIM3;GATA1;STEAP3;CYP1B1;CD44;NUAK2;SEPTIN4;ARHGEF17;PLK3;IFIT3;GADD45A;RPS6KA1;IGF1;STAT1;MLLT11;WNT5A;ARHGEF18;NDRG1;TFPT;BIRC3;DAB2IP;RPS3A;SFRP4;PINK1;BCL2L2;RPL10;BCL2L14;OBSCN;PIM1;UBC;FADD;PAX8;GRID2;IFIT2;TFAP4;CLEC5A;IL7;VIP;RPS6;BOK;CD74;SFRP2;THOC6;VAV1;APH1A;RASGRF2;DDRGK1;CCND2;SRA1;CLN3;BCL6;TEK;AHI1;MYO18A;CDK5;GPER1;RIPK2;AQP1;GADD45B;LRP2;HIPK3;DAPK3;NUPR1;NIBAN2;HSPA5;RARG;COPS5
prerank,CellMarker_Augmented_2021__Eosinophil:Lung,-0.5785173884568157,-1.0453718066785074,0.421875,0.8487070050031176,1.0,8/15,9.47%,P2RY13;TSPAN16;MYO1F;NLRP12;CLEC12A;OR52K3P;LAT2;PRSS57
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5755285279991801,-1.0452525790908596,0.45454545454545453,0.8487651093961744,1.0,3/15,5.98%,THBS1;CD160;CCL2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.5238204194684277,-1.0449226356720942,0.4393939393939394,0.8493602812822069,1.0,3/25,6.33%,NOS1AP;HTR2B;CAV3
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.6169171349422058,1.0448062321951646,0.5,0.968303643166531,1.0,2/6,3.86%,MYORG;SELENON
prerank,Reactome_2022__SOS-mediated Signaling R-HSA-112412,0.5716061721507544,1.0446242496828095,0.4186046511627907,0.9679473734461943,1.0,1/6,3.57%,NRAS
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,0.5427907505638405,1.0443558003785771,0.3611111111111111,0.9681760110601888,1.0,8/13,36.93%,PPP2R5A;PPP2R1B;AXIN1;PPP2R5B;PPP2R1A;PPP2R5E;PPP2CB;GSK3B
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.6367861182687811,-1.044291302815386,0.46551724137931033,0.8508329004445886,1.0,2/6,16.25%,GUCY2C;GUCY1A1
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Blood,-0.5076079408012869,-1.044142856553905,0.3870967741935484,0.8509191210539933,1.0,10/28,10.15%,MYO1F;GPR183;DOCK8;TAGAP;SLA;ARHGAP9;ARHGAP15;RCSD1;WAS;CTSS
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.4193713325195148,-1.04404757715328,0.39325842696629215,0.8508385288517568,1.0,25/215,12.44%,CXCL2;P2RY6;KCNQ1;POU4F1;NR4A3;P2RY12;TLR2;ZFP36;WNT8B;RAMP3;TESC;PRDX5;PDCD1LG2;CCL2;GLRA2;PTK6;WNT5A;PDK3;ROMO1;DAB2IP;SBNO2;TNIP2;IGFBP5;GNG2;DMTN
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.4278012517603908,1.043923319913607,0.2916666666666667,0.9685932189777087,1.0,1/38,0.01%,CPA1
prerank,CellMarker_Augmented_2021__Epidermal Transit Amplifying cell:Foreskin,0.39495193117272637,1.043919358457925,0.375,0.9678685723346135,1.0,18/80,13.27%,NMB;MRPL15;UBE2N;SNRPF;GTF2F2;AP3S1;MPHOSPH6;AK6;VDAC2;RALA;TOMM22;SNRPB2;NDUFAF2;PSMD14;POMP;PRDX1;NUDT15;ECHDC1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.5064593249763352,1.0436719006165707,0.40540540540540543,0.96784810086256,1.0,4/20,9.29%,CFAP53;ODAD3;FOXJ1;STIL
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.4679161364282367,1.043393831511679,0.42424242424242425,0.9678704985969989,1.0,5/24,12.84%,DUSP19;MAP3K4;DVL2;SASH1;TAOK3
prerank,KEGG_2021_Human__Pyrimidine metabolism,-0.49012828997316976,-1.0433697238256645,0.4657534246575342,0.8524646678856136,1.0,4/45,10.89%,TYMS;TYMP;CMPK2;ENTPD3
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.48395419330973977,-1.0433460384484468,0.4117647058823529,0.8522096775999491,1.0,10/43,11.85%,THBS1;TGFBR2;AKR1C1;BRCA1;CYP1B1;GADD45A;PDK3;ROMO1;PINK1;FOXM1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.5232609485162136,-1.0431803884169677,0.4594594594594595,0.852392988411414,1.0,6/26,21.74%,APP;IGF1;MFSD2A;GHR;SPAAR;OLFM1
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),0.5240440864062903,1.0431759137469956,0.3448275862068966,0.9679527907639721,1.0,3/10,18.40%,H1-2;ASF1A;ATAD2B
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.43409986346396445,-1.0429150596454446,0.42105263157894735,0.8527752174643263,1.0,34/101,20.36%,CDH22;STMN2;GRIN2A;SLITRK1;SRRM4;GAP43;GRIA1;TCEAL6;RIT2;CPLX2;CA10;HPCA;SCN2A;SCN1A;STMN4;C11ORF87;SYNPR;GRIN2B;SCN3B;GAD2;DIRAS2;GABRG2;TMEM130;CNTN2;KCNC1;GABRA1;CNTNAP5;CELF4;SLC1A6;ST8SIA3;SLC17A7;PTPN5;KCNC2;PAK5
prerank,CellMarker_Augmented_2021__Monocyte:Peripheral Blood,0.46810563835995067,1.0428699728824493,0.3870967741935484,0.9682402719863761,1.0,1/18,0.37%,ITGA1
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.6531643914763927,-1.0428491398738724,0.4827586206896552,0.8526542649357263,1.0,1/7,5.22%,HTR2B
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.72180659174229,-1.0427242013323683,0.4915254237288136,0.8527142299669258,1.0,1/5,4.00%,IFI35
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.4794828738372892,1.0426979425588165,0.41379310344827586,0.9680315200545601,1.0,6/25,12.67%,ABCD2;MACIR;IL17D;ABCD1;TICAM1;SIRPA
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.699447359575003,1.0426902356164027,0.4489795918367347,0.967361824126971,1.0,3/5,24.01%,DRD2;CHD7;SELENOT
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,0.5398620469725551,1.0424618945335056,0.4,0.967230866609888,1.0,8/14,36.93%,PPP2R5A;PPP2R1B;AXIN1;PPP2R5B;PPP2R1A;PPP2R5E;PPP2CB;GSK3B
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.4575072542528848,-1.0424289049439988,0.3875,0.8533019492447939,1.0,5/86,4.68%,APIP;BLM;B2M;KCNJ2;POLQ
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.4451191508452326,-1.0422121550951307,0.3950617283950617,0.8536145739660213,1.0,18/81,14.60%,GGT5;PLK2;RAMP3;ADCY7;GNG3;ITPR3;GIPR;RHBDF2;ADCY5;SYK;PTRH2;MYH9;GNG2;C1QTNF1;RXFP1;PTH1R;GLP1R;PTH2R
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,-0.41390838132600516,-1.0421944468997482,0.33707865168539325,0.8533273191641755,1.0,16/154,13.76%,CCNB2;ERCC6L;RPS27;CENPH;CENPE;MZT2B;ZWILCH;NUF2;SPC24;CCNB1;DCTN1;KIF2C;HAUS7;CEP76;CENPN;CENPU
prerank,CellMarker_Augmented_2021__Vaginal cell:Vagina,-0.5141899846729117,-1.0421897142618726,0.3939393939393939,0.8530186215329852,1.0,4/23,8.11%,GPR87;EPS8L2;OVOL2;BAIAP2L1
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.6312559114902383,1.0419889520456533,0.5161290322580645,0.9679615323158287,1.0,3/8,26.17%,PLIN5;RHOC;PDPK1
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.5593169504809509,-1.0419641365758698,0.42857142857142855,0.8533057266048765,1.0,2/15,7.87%,OPALIN;TENM4
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.36043940842234434,1.041872446169915,0.3,0.9676343019622906,1.0,30/105,29.84%,WDR91;SNF8;PTPN23;WASHC2C;PHETA1;VTI1A;VPS50;PIK3C3;TBC1D5;RAB9A;RHOBTB3;SNX5;VAMP3;TBC1D23;RIC1;EPS15;KLHL20;PIKFYVE;VPS29;SNX2;BECN1;MON2;SORT1;RGP1;SNX1;VPS54;WASHC2A;AP2A1;VTI1B;VPS26B
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.6504345420127366,-1.0418355006748166,0.4909090909090909,0.8530028459476799,1.0,2/8,11.70%,B3GALT2;B3GNT2
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.6504345420127366,-1.0418355006748166,0.4909090909090909,0.8530028459476799,1.0,2/8,11.70%,B3GALT2;B3GNT2
prerank,KEGG_2021_Human__Porphyrin and chlorophyll metabolism,-0.5198150849508916,-1.0418296105417462,0.4426229508196721,0.8526875404635615,1.0,3/22,9.22%,CP;UROD;BLVRB
prerank,CellMarker_Augmented_2021__Monocyte:Undefined,-0.5063809185492394,-1.0417869293218285,0.37142857142857144,0.8524589722136656,1.0,10/23,13.63%,P2RY13;MYO1F;TLR2;SIGLEC1;IGSF6;CLEC12A;CTSS;PILRA;SLC11A1;CLEC5A
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.4207305503380365,-1.041711629912902,0.37349397590361444,0.85234586074429,1.0,15/114,14.45%,CD24;PRAME;CASZ1;KLF4;YWHAH;KLK6;SRF;LTBP4;RPS6KA1;ZFHX2;RUNX2;EMP2;NLGN1;FES;BDNF
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,0.4604212721459488,1.0416134364917118,0.3888888888888889,0.967869629601503,1.0,6/27,19.10%,MAML3;KAT2B;NOTCH2;KAT2A;HDAC2;HDAC10
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.48629421380780535,1.0415773410979738,0.4864864864864865,0.9672280983739431,1.0,7/21,15.16%,KMT5A;NCAPH2;CSNK2A1;CSNK2A2;PLK1;TENT4A;MCPH1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.5070071446531044,-1.0415347680723028,0.4266666666666667,0.8526073526512868,1.0,6/28,19.45%,DUSP1;DUSP16;TNS2;PTPRF;PTPRO;DUSP8
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5090719322684265,1.0414690844221204,0.45454545454545453,0.9669701817132749,1.0,2/16,5.75%,ALG6;ALG3
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.4917960839942809,1.0413645870271793,0.40476190476190477,0.9665851966729846,1.0,4/16,5.68%,SLC30A4;SLC39A10;SLC30A6;SLC39A8
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.5708647612218073,-1.0409720966264675,0.4583333333333333,0.8538909648485394,1.0,1/16,0.81%,BLM
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",-0.5091222056156014,-1.0409385060688328,0.4126984126984127,0.8536874734026745,1.0,4/20,12.36%,GNG3;CACNA1C;ADCY5;GNG2
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In8:Brain,0.43360212046698987,1.0408381686761259,0.4,0.9673809872503071,1.0,11/46,10.63%,MEX3A;NUP62CL;HMMR;UBE2T;KPNA2;CDC25A;ARHGEF16;DNMT3B;PLK1;ZIC2;CCT3
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.5811245317556767,1.040527392138239,0.4473684210526316,0.9677937937435227,1.0,3/10,16.00%,CSGALNACT1;GALT;UGP2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5252573197277723,-1.040517523210775,0.47560975609756095,0.8545704176113248,1.0,7/31,17.43%,CENPH;MIS18A;CABIN1;CENPN;CENPU;OIP5;CENPP
prerank,CellMarker_Augmented_2021__Natural Killer cell:Liver,-0.5041156913370242,-1.0404329490653237,0.4411764705882353,0.8545106436347976,1.0,8/22,10.58%,P2RY13;MYO1F;SLA;SIGLEC1;IGSF6;CLEC12A;F13A1;PILRA
prerank,GO_Biological_Process_2021__negative regulation of sphingolipid biosynthetic process (GO:0090155),-0.7078756794003999,-1.0403679863029043,0.5,0.8543610612987791,1.0,2/5,24.63%,ORMDL2;SPHK1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.6091719212133185,-1.0403348696144172,0.4126984126984127,0.8541109960101173,1.0,1/8,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.5524997853107716,-1.04028025343583,0.4430379746835443,0.8535934928167684,1.0,6/24,17.43%,CENPH;MIS18A;CENPN;CENPU;OIP5;CENPP
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.5524997853107716,-1.04028025343583,0.4430379746835443,0.8535934928167684,1.0,6/24,17.43%,CENPH;MIS18A;CENPN;CENPU;OIP5;CENPP
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),-0.4225024459994607,-1.0402168995944179,0.41975308641975306,0.8534839686824155,1.0,17/105,19.21%,SP100;SPARC;WARS1;GPNMB;LZTS1;CEACAM1;LFNG;HECW2;EMP2;BCL6;CRB2;ETS1;CDK5;TGFB1;MAPT;PHLDB2;BMPER
prerank,Reactome_2022__Activated NTRK2 Signals Thru FYN R-HSA-9032500,-0.6585368378268723,-1.0401306279274354,0.45454545454545453,0.8534247505108068,1.0,2/6,12.88%,GRIN2B;RNASE1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.33556051940627785,1.04004440243746,0.3333333333333333,0.9683755414902885,1.0,35/197,17.58%,TTC29;MACIR;FHDC1;CATIP;CEP19;SPAG16;BBS9;RAB23;SSX2IP;EXOC8;CEP20;EXOC6;INTU;DZIP1;CNGA4;TTC17;CEP290;RAB8B;PTPN23;FOXJ1;PARVA;PCM1;SCLT1;TEKT5;TTC8;NEK1;UNC119B;TCTN3;IQCB1;RAB8A;TMEM237;UBXN10;MKKS;SNAP29;EXOC5
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.62886838477096,1.0399080512744114,0.5,0.9680330150431448,1.0,2/6,14.48%,MAPK8;PRKD1
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.5763612828624987,1.0397299169883,0.4782608695652174,0.9677248613119761,1.0,2/7,22.65%,OTUB2;TRIP12
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR1 R-HSA-5654687,0.4457799197938409,1.039527568601612,0.4117647058823529,0.967586346667707,1.0,2/22,3.57%,FGF6;NRAS
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.5124678811308064,1.039510652188138,0.35294117647058826,0.9668986163672811,1.0,7/19,11.00%,ABCD2;ARV1;ACACB;ABCD1;MID1IP1;CPT2;ABCD3
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.6014645461208392,-1.0393071900365676,0.42857142857142855,0.8554418059009214,1.0,5/12,27.02%,LAMA3;AHI1;LAMA5;CELSR1;ZDHHC7
prerank,Reactome_2022__Retrograde Neurotrophin Signaling R-HSA-177504,0.5445659499337373,1.039229844755675,0.4117647058823529,0.9672508122105563,1.0,3/12,12.41%,NGF;AP2B1;DNM3
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,0.4070698162913756,1.0392119745488815,0.3333333333333333,0.9665643559198533,1.0,12/58,13.78%,SEM1;PSMD10;KBTBD7;SPRED1;NRAS;PSMA1;PSMD11;PSMB5;PSMD14;RASA2;SPRED2;PSMD12
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.46059872570731736,-1.039132217981132,0.45,0.8556363808742362,1.0,12/56,17.95%,TGFBR2;RPS27A;ADAMTSL2;ASPN;EID2;LDLRAD4;UBC;VEPH1;VASN;SNX6;LTBP1;TGFB1
prerank,GO_Biological_Process_2021__gap junction assembly (GO:0016264),-0.7064411984584237,-1.0391208821469056,0.5081967213114754,0.8553399174189255,1.0,1/5,4.27%,GJC1
prerank,Reactome_2022__Signal Amplification R-HSA-392518,-0.5144339192030414,-1.0391040889769112,0.38028169014084506,0.855079499210636,1.0,3/24,12.36%,P2RY12;GNG3;GNG2
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.6171774198822737,1.039006191695888,0.4473684210526316,0.9657422938677703,1.0,1/5,2.23%,CARNMT1
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.6171774198822737,1.039006191695888,0.4473684210526316,0.9657422938677703,1.0,1/5,2.23%,CARNMT1
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.521303455024491,1.0389878133086532,0.4666666666666667,0.965058488310511,1.0,6/15,19.47%,DAO;PSPH;SEPSECS;SRR;THNSL2;CTH
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,-0.40070125014600966,-1.0389599938086813,0.358695652173913,0.8551701581695187,1.0,27/191,17.44%,CCNB2;ERCC6L;TUBB6;RPS27A;VRK2;RPS27;CENPH;PSMB9;CENPE;ANAPC11;ZWILCH;LMNB1;NUF2;SPC24;CCNB1;PSMB6;KIF2C;PSMC3;UBC;CENPN;CENPU;UBE2S;PSMA8;PSMA7;EMD;CENPP;PSME1
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.4878680976810652,1.0388320564689846,0.42105263157894735,0.9649899929706997,1.0,4/19,4.92%,LEPR;SDHAF4;PPARGC1A;COX10
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.6013230023186225,-1.0385583916974945,0.4262295081967213,0.8559192846551147,1.0,2/10,11.85%,NUAK1;FOXM1
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreatic Islet,-0.4373122451242531,-1.038256334673542,0.41333333333333333,0.8564102468497361,1.0,18/72,21.16%,GC;GRIA3;SPOCK3;SLC38A4;HSD17B14;MLLT11;PDZK1;F10;EGFL7;TTC39A;RAB3C;PMM1;FGF12;MRC1;PLCE1;CD36;YIPF2;RSAD2
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.5450688795979154,1.038236876955252,0.40425531914893614,0.9658970149831001,1.0,3/10,23.21%,DNM3;FGD4;EZR
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),-0.6891258651381913,-1.0380244318166079,0.5254237288135594,0.8567685108691954,1.0,1/5,4.77%,FSCN1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.4020239281594293,1.038000535528071,0.35294117647058826,0.9658784147394355,1.0,15/61,17.28%,SLC26A7;SLC19A1;SLC25A24;CA2;SLC39A8;SLC4A7;SLC25A19;SLC25A41;SLC4A4;SLCO1C1;CYB5R4;CA3;CYB5R1;SLC25A17;CA12
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,-0.5524969114242622,-1.0379822610767633,0.4492753623188406,0.856565242423928,1.0,2/20,10.26%,PDE4A;PPP3CC
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.5615093846912241,1.037904587330316,0.42857142857142855,0.9647170256061225,1.0,3/12,14.00%,MCU;TIRAP;MDK
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.5615093846912241,1.037904587330316,0.42857142857142855,0.9647170256061225,1.0,3/12,14.00%,MCU;TIRAP;MDK
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.561695366310712,1.0378240544636128,0.4,0.9643052971287285,1.0,6/12,26.34%,SALL1;HEYL;HEY1;HEY2;MDM4;HECTD1
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.6809468582619095,-1.0375451255553676,0.4626865671641791,0.8574913623545315,1.0,4/6,30.99%,SLC12A7;RHD;RHCG;SLC12A4
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.46198441508582533,-1.0371438050989514,0.3561643835616438,0.8582453095764944,1.0,2/42,3.00%,CP;SLC39A14
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.5306122312588999,-1.0370805337298459,0.4927536231884058,0.8580667046971006,1.0,5/21,16.81%,CCNB2;CCNB1;FOXM1;CDK2;WEE1
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.657326610693774,-1.036947169169835,0.4716981132075472,0.8581416652114019,1.0,3/9,22.28%,ITM2A;ACOT8;ITM2C
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.5581243994063243,-1.0369394050063367,0.46551724137931033,0.8575210095960714,1.0,4/10,20.46%,CD44;CD74;ZNF385A;TAF9B
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.5581243994063243,-1.0369394050063367,0.46551724137931033,0.8575210095960714,1.0,4/10,20.46%,CD44;CD74;ZNF385A;TAF9B
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.5723433779701679,1.0367169725784129,0.4722222222222222,0.9669268980715472,1.0,2/9,18.19%,AGO3;CLP1
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,-0.41249655858174195,-1.0366423497879245,0.3888888888888889,0.8580560196425813,1.0,27/147,14.60%,GGT5;C3;PLK2;RAMP3;ADCY7;GNG3;ITPR3;BAIAP2;WAS;GIPR;RHBDF2;WNT5A;ADCY5;SYK;IL18;PTRH2;MYH9;MYO1E;GNG2;ELMO1;C1QTNF1;RNASE1;RXFP1;NOXA1;PTH1R;GLP1R;PTH2R
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.5194682737786176,1.036624717388118,0.37142857142857144,0.9664974026647523,1.0,4/15,14.00%,MCU;TIRAP;XG;MDK
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,-0.44815732446006956,-1.0365329562176246,0.4024390243902439,0.8580702823040859,1.0,21/85,17.21%,GRIN2D;LRRTM2;GRIN2A;SLITRK1;LRRTM1;GRIA3;GRIA1;IL1RAPL1;SYT1;DLGAP3;FLOT1;SLITRK4;GRIN2B;NLGN1;SLITRK5;APBA2;PPFIA1;IL1RAP;IL1RAPL2;SYT2;PTPRF
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.5326271976397201,-1.0364315898665193,0.4067796610169492,0.8580489080589225,1.0,4/17,10.88%,CYP1B1;C12ORF57;CACNA1C;IFT122
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,-0.5464140785143493,-1.036334810433533,0.3770491803278688,0.8579919377282903,1.0,8/22,20.47%,L1CAM;SLC16A3;ATP1B1;MAG;ITGA3;DEAF1;SLC7A7;ATP1B3
prerank,KEGG_2021_Human__Viral carcinogenesis,-0.40868422767965557,-1.0363045115429048,0.367816091954023,0.8577356575202515,1.0,22/152,15.96%,HPN;CDKN2A;C3;SP100;HLA-A;VAC14;HLA-C;CCND1;YWHAH;SRF;IRF7;CREB5;HLA-B;SYK;HLA-E;CCNE2;HLA-F;PIK3CB;LTBR;PIK3CD;CDK2;CCND2
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.6250163822665592,1.0362128230484826,0.4318181818181818,0.9668716115545863,1.0,1/6,2.33%,ADAT2
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Fluid,-0.6372764895563481,-1.0361904754108153,0.4745762711864407,0.8577144354107308,1.0,2/8,7.03%,THY1;CD44
prerank,Reactome_2022__PTK6 Promotes HIF1A Stabilization R-HSA-8857538,-0.7138692307816425,-1.0361549067905802,0.5263157894736842,0.8574869138525013,1.0,2/5,6.91%,GPNMB;PTK6
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Brain,-0.5021102311454678,-1.0356494082429355,0.41935483870967744,0.8587067804467244,1.0,10/28,10.35%,MYO1F;GPR183;CD5;TAGAP;GPR171;SLA;ARHGAP9;WAS;CTSS;PTPN7
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.5151945034190532,-1.035596499791451,0.4714285714285714,0.8585323709474051,1.0,8/28,19.00%,LMOD1;SYNPO2L;TNNT1;OBSCN;MYLK3;WDR1;FHOD3;PDGFRA
prerank,CellMarker_Augmented_2021__Mesoderm cell:Undefined,0.3749488575604527,1.035569769413502,0.32142857142857145,0.9681564155463214,1.0,22/95,21.72%,CDH24;LRFN3;LLGL1;TRIM28;SOX12;ERCC2;VAT1;PCBP4;CSNK1E;PRKCSH;CASKIN2;GANAB;CDH2;P3H4;TMEM201;SLC25A22;MBD3;LRFN4;GPSM1;NR2F6;BOP1;GPR176
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.6266708521355107,1.0355379528951965,0.5,0.967509785931028,1.0,2/6,9.28%,BMP2;SALL1
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,0.38631240612757234,1.0355163041303446,0.34615384615384615,0.9668307212976449,1.0,15/87,15.44%,DGKB;PIP5K1B;INPP1;DGKE;PI4K2A;IP6K2;PLCB4;IPMK;SACM1L;PIK3C2G;PIK3C3;PIK3CA;PIK3R1;PIP4K2B;DGKH
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Liver,-0.6695440081003264,-1.0353885233963795,0.5081967213114754,0.8588697408485426,1.0,2/6,7.03%,THY1;CD44
prerank,Reactome_2022__Activation Of ATR In Response To Replication Stress R-HSA-176187,0.4315088050556281,1.0352904163217804,0.4411764705882353,0.9667698673960526,1.0,8/30,16.08%,CDC25A;RFC3;HUS1;ORC5;RRAD;RAD9B;ATRIP;SLC25A15
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.3990335513271667,-1.0351506226961986,0.4367816091954023,0.859299199245744,1.0,36/175,18.74%,EFNA1;SCN1B;L1CAM;NEXN;SEMA3B;DOK1;GFRA2;VLDLR;EFNB3;GAP43;DRAXIN;DOK6;WNT5A;UNC5B;PRKCQ;SLIT3;RAP1GAP;SEMA3E;ROBO4;BDNF;PIK3CB;CNTN2;LAMA3;RELN;PIK3CD;LRTM1;IRS2;SH3KBP1;GPC1;NOTCH3;SEMA4G;ANOS1;PTPRO;NIBAN2;VSTM2L;LAMA5
prerank,Reactome_2022__RHO GTPases Activate IQGAPs R-HSA-5626467,0.5152283543121695,1.034857747916463,0.4375,0.9673591987715465,1.0,1/10,3.44%,MEN1
prerank,CellMarker_Augmented_2021__T cell:Peripheral Blood,-0.7197945087977875,-1.0347947276428773,0.5166666666666667,0.8599946103668532,1.0,1/6,1.59%,CD5
prerank,KEGG_2021_Human__Human papillomavirus infection,-0.3925410499524353,-1.0347756225803446,0.3548387096774194,0.859724152080615,1.0,48/263,17.58%,THBS1;COL4A1;COL4A2;MX1;LAMB1;WNT8B;ITGA2;COL4A4;HLA-A;CHAD;IRF1;COL6A2;ITGA5;HLA-C;THBS3;TLR3;CCND1;LFNG;EGF;ITGA8;STAT1;WNT5A;ISG15;ITGA11;THBS2;CREB5;HES7;HLA-B;FN1;HLA-E;CCNE2;FADD;TNFRSF1A;HLA-F;ITGA9;ITGA3;PIK3CB;LAMA3;RELN;PIK3CD;CDK2;ITGB4;CCND2;COL9A2;TSC2;NOTCH3;SPP1;CREB3
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.6385016813536031,1.0347162284394538,0.38636363636363635,0.9671564625567242,1.0,3/7,18.23%,KDM5A;PRKD1;SPHK2
prerank,CellMarker_Augmented_2021__FOXN4+ cell:Lung,-0.46067857406048235,-1.034602494303975,0.40540540540540543,0.859865432141292,1.0,5/57,7.99%,TYMS;CDKN2A;BTG3;YWHAH;NETO2
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.4717120029205751,-1.034544643453581,0.40789473684210525,0.8597441751704142,1.0,2/48,1.31%,TLCD2;FABP3
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.6272567335000565,1.0341446483227128,0.45098039215686275,0.9683188849601768,1.0,4/7,30.97%,P3H4;JMJD6;VIPAS39;PLOD1
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.4838938245310436,-1.0340609644373406,0.4166666666666667,0.8606794197672579,1.0,7/40,17.95%,TGFBR2;RPS27A;ITGA8;LTBP4;UBC;LTBP1;TGFB1
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,-0.4255343666178482,-1.034059136063789,0.4074074074074074,0.8603559575597601,1.0,24/107,16.06%,CXCL2;IL1R1;IL13RA1;TGFBR2;ACKR4;IL12A;IL15;CCL2;BMP8A;TNFRSF14;IFNGR2;OSMR;THPO;IL4R;IL17RE;IL18;CCR10;TNFRSF1A;CXCL17;IL7;IL3RA;LTBR;IL1RAP;IL27RA
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.5729974125934579,1.0339147971930367,0.46153846153846156,0.9683652286350943,1.0,9/15,28.19%,INTS7;INTS8;MEPCE;MTREX;INTS4;ZCCHC8;INTS6;INTS9;INTS11
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,0.3954771078126314,1.0337470578406827,0.29411764705882354,0.9681372704029945,1.0,11/48,17.32%,PIP5K1B;PI4K2A;PLEKHA6;PIK3C2G;PLEKHA3;RAB4A;PIK3CA;SBF2;PIK3R1;PIP4K2B;PIK3C2A
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.6333523680777401,-1.0336360645120994,0.5344827586206896,0.8613115132337846,1.0,3/7,15.12%,ICAM1;SLC11A1;CD74
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.3852119919542539,-1.0336271305199598,0.34782608695652173,0.8609951385776214,1.0,51/311,16.53%,PRAME;LEF1;THBS1;IL13RA1;NR4A3;TGFBR2;LAMB1;PROX1;RPS4X;S100A6;KIF14;COPS9;IL15;HTR2B;SCX;BST2;TIMP1;EGF;OSMR;IGF1;S1PR3;STAT1;THPO;WNT5A;TGFA;FGF1;ROMO1;FN1;NAMPT;SOX15;IL18;FOXM1;GLI1;PRKCH;PIM1;EMP2;FGF7;IL7;VIP;HYAL1;RPS6;RPS9;CD74;SFRP2;DDRGK1;CDK2;CCND2;CAPN1;CDC7;FGF22;RPL23
prerank,Reactome_2022__LDL Clearance R-HSA-8964038,-0.5672882512460464,-1.033588271012682,0.4745762711864407,0.860763954851444,1.0,2/14,7.79%,LSR;LDLR
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,0.48925934243386493,1.0335644104670354,0.4,0.96800099052577,1.0,9/23,14.79%,AGMO;PLIN1;GK;MOGAT1;ABHD5;PRKACB;LPIN3;PPP1CC;MGLL
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.4479244990221845,-1.0332797055892746,0.425,0.8614033618753619,1.0,23/92,22.76%,COL4A1;COL4A2;LAMB1;SCARA3;CCND1;WNT5A;NUAK1;DAB2IP;FN1;AMOTL2;RHBDF1;COL12A1;PTPRF;LARP6;PTPN21;ABCG2;ANTXR1;WWTR1;CD276;SH3D19;LAPTM4B;MYO1B;SLIT2
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),-0.6232508687056733,-1.0332730824261747,0.5084745762711864,0.8610943861780892,1.0,3/7,20.03%,FN1;FERMT3;CX3CL1
prerank,CellMarker_Augmented_2021__Idiopathic Pulmonary Fibrosis cell:Lung,-0.6737358790313781,-1.0332490900417226,0.53125,0.8608316074166115,1.0,3/5,8.73%,PDPN;SLC26A8;LTBP4
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.39069979907816826,1.033005886327874,0.4444444444444444,0.9687527911235189,1.0,2/33,3.70%,DGKB;DGKE
prerank,KEGG_2021_Human__Proteoglycans in cancer,-0.3995150670552927,-1.0329533289481598,0.3855421686746988,0.8613006178599927,1.0,27/160,18.28%,THBS1;MET;TLR2;ANK3;WNT8B;ITGA2;ITGA5;CAV3;CD44;ITPR3;CCND1;PRKCG;IGF1;WNT5A;FN1;CD63;GPC3;TFAP4;RPS6;PIK3CB;VAV1;PIK3CD;ANK1;PRKCB;GPC1;TGFB1;CDKN1A
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5426191148830005,1.0329279492719978,0.43243243243243246,0.9683094607059982,1.0,3/10,15.60%,CSGALNACT1;DSE;B3GAT2
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.56159116906468,1.0328355240361455,0.41304347826086957,0.9679164933597715,1.0,4/8,14.26%,RABL3;PBX1;TOX;KAT7
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.565875455293391,1.0327869550225122,0.42105263157894735,0.967341945194561,1.0,2/6,8.98%,LTV1;XPO1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.4882597117985277,-1.0326391332550133,0.453125,0.8617551413414722,1.0,5/46,10.09%,B4GALNT1;UGT8;FUT2;ST3GAL6;B3GNT5
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.5625338050260025,-1.032595034039805,0.4393939393939394,0.8616089528636074,1.0,1/15,1.09%,SIX3
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.6453475285324887,-1.0325758872581599,0.4642857142857143,0.8613393167096594,1.0,1/8,3.97%,RAB11A
prerank,Reactome_2022__Arachidonate Production From DAG R-HSA-426048,0.6238019576065573,1.0325558440478788,0.4782608695652174,0.9674218600722798,1.0,4/5,33.44%,MGLL;ABHD6;ABHD12;DAGLB
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.5781070250539602,1.0325112033385409,0.45454545454545453,0.9668402431442455,1.0,1/12,1.27%,AGMO
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.4591355330053864,-1.0324916252846577,0.36764705882352944,0.8612780898484375,1.0,6/31,11.20%,THBS1;TGFBR2;AKR1C1;GADD45A;ROMO1;SYK
prerank,CellMarker_Augmented_2021__Dopaminergic neuron:Midbrain,-0.4736689962780425,-1.032452594107049,0.47297297297297297,0.8606903120918035,1.0,13/50,18.74%,EFNA1;EPS8L2;KCNK1;SEMA3B;SCARA3;SLC44A3;AMOTL2;GPRC5C;ASS1;RHOD;PTPRF;RHPN2;LAMA5
prerank,CellMarker_Augmented_2021__Epithelial cell:Uterus,-0.4736689962780425,-1.032452594107049,0.47297297297297297,0.8606903120918035,1.0,13/50,18.74%,EFNA1;EPS8L2;KCNK1;SEMA3B;SCARA3;SLC44A3;AMOTL2;GPRC5C;ASS1;RHOD;PTPRF;RHPN2;LAMA5
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),-0.6831118069597933,-1.0319430925559865,0.5666666666666667,0.8617362190287928,1.0,4/5,28.34%,VIL1;STK24;ALOX5;CADM4
prerank,CellMarker_Augmented_2021__Medullary Thymus Epithelial cell:Thymus,-0.4499187656820743,-1.0318355210017045,0.4305555555555556,0.8614763294182347,1.0,12/43,12.84%,CD5;SKAP1;TMC8;TJP3;ACSL5;ANO9;RPS6KA1;RAB11FIP1;B3GNT2;TC2N;GPR160;P2RY10
prerank,CellMarker_Augmented_2021__Cortical Thymus Epithelial cell:Thymus,-0.4499187656820743,-1.0318355210017045,0.4305555555555556,0.8614763294182347,1.0,12/43,12.84%,CD5;SKAP1;TMC8;TJP3;ACSL5;ANO9;RPS6KA1;RAB11FIP1;B3GNT2;TC2N;GPR160;P2RY10
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.5923644844921742,-1.0318022157799478,0.4666666666666667,0.8612673113089414,1.0,4/12,7.93%,KCNJ2;PLN;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.5007588218698816,-1.0317097861265068,0.38571428571428573,0.8611640383789756,1.0,4/22,6.56%,SFTPD;GPNMB;PDCD1LG2;CEACAM1
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.6500939492572653,-1.0316088038177957,0.43333333333333335,0.8611417631885147,1.0,2/7,11.32%,IL12A;PRDM1
prerank,CellMarker_Augmented_2021__T cell:Spleen,-0.5455697430569647,-1.0315160717751484,0.43859649122807015,0.8610280647023951,1.0,5/20,4.84%,CD5;TAGAP;GPR171;SLA;ARHGAP9
prerank,Reactome_2022__SUMO Is Proteolytically Processed R-HSA-3065679,0.6615685395456993,1.031491555969705,0.5526315789473685,0.969126271573873,1.0,4/5,32.86%,SUMO2;SENP2;SENP5;SENP1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.34929738137172667,1.031426635177413,0.375,0.9686350726067238,1.0,108/254,34.61%,U2AF1;SF3A1;NUDT21;SNRPF;SF3B4;GTF2F2;HNRNPC;WDR33;NOVA1;CWC27;SMNDC1;RAVER2;RBM41;LSM8;CSTF3;SNRPN;PAPOLA;SNRPB2;CPSF7;SPEN;LSM5;TFIP11;SRSF8;RAVER1;SYNCRIP;RBM17;LSM7;HNRNPU;POLR2C;AQR;PPIE;ZMAT2;PPWD1;SNRNP27;CLP1;CLNS1A;WDR77;DHX15;PSPC1;GEMIN4;PDCD7;RBMX;CPSF2;CRNKL1;RBM15;PPIH;USP49;PLRG1;RBM19;SART3;SUGP1;PRPF40B;MTREX;HNRNPD;SCAF11;SRSF9;POLR2A;CSTF1;SNRPB;SNRNP48;ZCCHC8;MAGOH;SNRNP35;SCNM1;COIL;SRSF2;POLR2K;POLR2D;PRCC;DDX1;SRPK2;LSM6;PPIL3;MAGOHB;PABPC1;SNRNP40;CDK13;CSTF2T;HNRNPH1;POLR2E;PTBP1;DHX16;RBM15B;CTNNBL1;HNRNPL;STRAP;FRG1;SF3B3;EFTUD2;CCAR1;ELAVL1;BUD31;PCF11;RBM22;SFPQ;HNRNPH3;DDX5;METTL14;SART1;HNRNPR;DDX46;METTL3;SF1;TRA2A;TGS1;CDC5L;BCAS2;RALY
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.49872881598794605,-1.0312410914574466,0.4520547945205479,0.861459370094956,1.0,10/29,13.52%,CDH22;CDH6;CDH23;CDH7;CDH19;CDH9;PCDHB5;SELP;CDH12;NLGN1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.6105875003434837,-1.0312395340260319,0.4406779661016949,0.8611382953095522,1.0,1/12,1.31%,TYMP
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),-0.6427125926166156,-1.0311323132666135,0.49206349206349204,0.8611195763275524,1.0,1/7,7.29%,AKAP5
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.539845733556461,1.031124931837374,0.5,0.9689448035758933,1.0,3/10,17.60%,HSPA1A;NCK1;VHL
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.4025130933948726,-1.0309197835168582,0.45555555555555555,0.8614239414134103,1.0,41/186,22.44%,ANO2;CFAP126;PPP1R14C;PDE4A;IMPDH1;TESC;SCN9A;CLGN;EFNB3;ARHGAP39;KIF9;PFN2;NYAP1;CARNS1;CIBAR2;HPCA;WDR54;SLC16A11;ZBBX;CCDC184;SEZ6L2;PTPRF;GPC1;FGF12;LARP6;SYBU;RARG;VSTM2L;CNTN4;DUSP8;PDE1C;PRR36;EPB41L4B;FLRT1;CCDC28B;STOM;MAPK8IP1;CERS5;CLSTN2;EPB41L1;SLC4A3
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of Adenylate Cyclase R-HSA-442720,0.5858794457351093,1.0307973224901816,0.4473684210526316,0.9694107131658597,1.0,3/11,19.49%,ADCY1;PRKACB;PRKX
prerank,Reactome_2022__rRNA Modification In Mitochondrion R-HSA-6793080,0.6682656297020456,1.0306751898046569,0.4186046511627907,0.9690357054803947,1.0,1/5,3.19%,TFB1M
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.5240013827581221,-1.0306363345168628,0.484375,0.861861469117219,1.0,2/14,7.40%,OR51M1;OR51I2
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.569356215445978,-1.0305105515461037,0.5161290322580645,0.8618881160300165,1.0,5/19,18.95%,GMPPB;PMM1;UAP1;GFPT2;UAP1L1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.46207955600380796,-1.0301990765339513,0.4393939393939394,0.8623812627650806,1.0,4/39,7.36%,MAOB;PLP1;BASP1;YWHAH
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.6469118630735079,1.0299804430663626,0.4528301886792453,0.9704310505595911,1.0,3/5,29.88%,CSF1R;PTK2;MAPK1
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.49737718215208054,1.0299121935602427,0.45,0.9699406870175871,1.0,4/17,4.92%,ABCB10;ALAS1;HMBS;COX10
prerank,KEGG_2021_Human__Linoleic acid metabolism,-0.6028682477387368,-1.029849830122142,0.4603174603174603,0.8631861038173995,1.0,2/12,13.02%,PLB1;CYP3A4
prerank,CellMarker_Augmented_2021__Neutrophil:Brain,0.4461690662938761,1.0297294229595568,0.38235294117647056,0.9690113745726708,1.0,2/21,2.43%,C1ORF162;FLT3
prerank,CellMarker_Augmented_2021__Neutrophil:Spleen,0.4461690662938761,1.0297294229595568,0.38235294117647056,0.9690113745726708,1.0,2/21,2.43%,C1ORF162;FLT3
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,-0.4544809754679484,-1.0296839444870005,0.4,0.8633173738469054,1.0,9/56,14.32%,GRIN2D;LRRTM2;GRIN2A;LRRTM1;SYT1;DLGAP3;GRIN2B;NLGN1;APBA2
prerank,Reactome_2022__Pre-NOTCH Processing In Endoplasmic Reticulum R-HSA-1912399,0.654792167922041,1.0293431075727741,0.475,0.9694916273765125,1.0,3/6,17.36%,POFUT1;NOTCH2;POGLUT1
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,-0.45613844669668585,-1.029206536979594,0.47297297297297297,0.864380533471606,1.0,8/52,7.35%,THBS1;ADAMTS10;THSD4;SPON2;SBSPON;ADAMTSL2;THSD7B;LFNG
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.5156788121618897,-1.0291187660729455,0.4057971014492754,0.8642730932251902,1.0,4/37,7.93%,KCNQ1;NOS1AP;KCNJ2;ATP1B1
prerank,Reactome_2022__Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,-0.5320564574706186,-1.0290468729581117,0.45454545454545453,0.864092210860979,1.0,3/16,8.63%,GRIA3;GRIA1;PRKCG
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.45950125637602346,-1.028985140384909,0.44594594594594594,0.8639324628691987,1.0,14/37,21.28%,S100A6;IGF1;WNT5A;DAB2IP;FN1;B4GALT7;CD74;EMD;AQP1;CDKN1A;NLRC3;PDGFRA;FTH1;SFRP1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.4090732728201008,1.0288347546311443,0.35714285714285715,0.9704058850119006,1.0,8/41,16.89%,NR1D1;REEP6;TTL;CSNK1E;STXBP4;EFNA5;PARD6G;PARD6B
prerank,Reactome_2022__Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,0.48310685228294253,1.028834195026893,0.3939393939393939,0.9697042177053121,1.0,9/19,23.95%,DAO;DBT;DDO;LIAS;BCKDHB;PDHA1;DLAT;ALDH4A1;GOT2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.6667521742683034,-1.0283926403407733,0.4909090909090909,0.8652491840901902,1.0,1/6,0.54%,EFNA1
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,-0.40570532798247166,-1.0283471317523303,0.44047619047619047,0.8650681392048795,1.0,31/186,15.71%,THBS1;OGN;AMN;ALDOB;CSPG4;ADAMTS10;RPS27A;THSD4;SFTPD;SPON2;SBSPON;ADAMTSL2;THSD7B;BGN;CYP1B1;OMD;LFNG;PAPSS2;GYG2;CYP4F22;THBS2;GALK1;CYP21A2;UBC;GPC3;GALNT12;EGFL7;B4GALT7;ADAMTS4;GNE;CHST6
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.42152528886693175,-1.028288261318295,0.4375,0.8649117008852375,1.0,21/106,18.82%,LEF1;SEMA3B;APP;MAP1B;EFNB3;SCARA3;ARHGAP39;ARHGEF17;GFAP;NYAP1;KAZN;NUAK1;DAB2IP;AMOTL2;PHYHIP;SEZ6L2;PTPRF;GPC1;LARP6;PTPN21;ABCG2
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.6083336295948486,1.028280874393664,0.5128205128205128,0.9708217513382648,1.0,2/9,7.99%,TPRKB;SMC6
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,-0.4568272905014918,-1.0282147087243152,0.4375,0.8648077976802973,1.0,8/46,16.80%,VRK2;DEPDC1B;STEAP3;ARHGAP39;LMNB1;RHOD;MCAM;EMD
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.369214726689783,1.0282047689174072,0.34782608695652173,0.9703090317194867,1.0,9/78,6.49%,PIP5K1B;EPOR;FLT3;HCLS1;SOX9;EGFR;PDGFD;PDGFC;DIPK2A
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,-0.38405941302153085,-1.028196511362456,0.42045454545454547,0.8645362978850987,1.0,53/307,17.95%,ST6GAL1;IL1R1;TLR2;B2M;RPS27A;RPS27;SFTPD;HLA-A;RPS14;RPS4X;ZDHHC9;NLRP12;NOD1;HLA-C;PARP14;YWHAH;PARP9;ATP1B1;IFNGR2;SNRPD2;STAT1;IRF7;RPS11;RPS16;ISG15;RPS13;HLA-B;SYK;HLA-E;RPS3A;RPS8;RPS23;IFIH1;RPS21;RPS7;TUSC3;UBC;GPC3;HLA-F;RPS6;BLNK;RPS15;ST6GALNAC2;RPS9;VAV1;MGAT5;FAU;SH3KBP1;GPC1;MTA1;RIPK2;RBX1;RPS12
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.6815801437733531,-1.0281414002979614,0.5076923076923077,0.8643837262992312,1.0,1/6,13.60%,SLC51B
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,-0.4868382463390172,-1.0275044529714734,0.41333333333333333,0.86602892915361,1.0,10/30,22.72%,KCNJ2;ADCY7;GNG3;ADCY5;GNG2;ADCY8;GABBR2;KCNJ6;GNB4;GNB5
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.5121669569090861,1.0273034688452198,0.375,0.9721769119873901,1.0,7/14,31.50%,ERI1;MTPAP;TENT4B;TENT2;LSM1;XRN1;TUT4
prerank,CellMarker_Augmented_2021__Macrophage:Synovium,-0.5023525099099648,-1.027248209566416,0.4027777777777778,0.8663679041259927,1.0,7/28,7.63%,P2RY13;MYO1F;TYMP;TLR2;SIGLEC1;IGSF6;CLEC12A
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.62872114858492,1.0271936535312383,0.5833333333333334,0.9717456778142355,1.0,3/7,30.48%,SPHK2;SLC30A5;ATPSCKMT
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.40577593190719524,-1.027112242470525,0.3804347826086957,0.8663927063171698,1.0,22/124,19.17%,TOMM7;ANK3;ARIH2;KCNB1;CEMIP;AKAP5;YWHAH;PLK3;ZIC1;PPP3CC;PINK1;BAP1;PDZK1;SLC51B;OAZ2;NMT1;PRKCD;MICALL2;EMD;TGFB1;BBC3;MYO1C
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.4961567336355,1.0270895130989748,0.46875,0.9713232314449682,1.0,7/17,14.67%,EFNB2;ID1;GREM1;AKT1;ROBO1;EPHB4;GPLD1
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.5098901219173612,1.027067947552461,0.4,0.9699745721340365,1.0,1/11,1.85%,RAP2C
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.5098901219173612,1.027067947552461,0.4,0.9699745721340365,1.0,1/11,1.85%,RAP2C
prerank,Reactome_2022__Lewis Blood Group Biosynthesis R-HSA-9037629,-0.6441659752170423,-1.027025177480014,0.5098039215686274,0.8662710490806896,1.0,3/8,8.70%,B3GALT2;FUT2;ST3GAL6
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),-0.6755138124599541,-1.0270231147398199,0.5333333333333333,0.865954301222015,1.0,2/5,20.30%,GPER1;STX1B
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),0.5501600755603105,1.0269292061038269,0.4473684210526316,0.968325014682387,1.0,3/8,18.40%,H1-2;ASF1A;ATAD2B
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),0.5501600755603105,1.0269292061038269,0.4473684210526316,0.968325014682387,1.0,3/8,18.40%,H1-2;ASF1A;ATAD2B
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),0.5501600755603105,1.0269292061038269,0.4473684210526316,0.968325014682387,1.0,3/8,18.40%,H1-2;ASF1A;ATAD2B
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,0.3365822310704173,1.0268773114459724,0.5,0.9677604774087171,1.0,33/273,11.34%,SPSB4;RNF6;SEM1;RNF25;SPSB2;PSMD10;ANAPC13;KBTBD7;ELOC;ASB13;PSMA1;PSMD11;KEAP1;FBXL14;ANAPC1;CUL1;UBE2N;PSMB5;ASB8;BLMH;RNF14;FBXO30;FBXL3;LMO7;FBXO9;ASB7;UBE2G1;FBXO15;BTRC;RNF114;UBE2D1;RCHY1;PSMD14
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,-0.44336828769450765,-1.0268503307276537,0.36363636363636365,0.8660942048529491,1.0,20/70,18.00%,IL1R1;ALOX12;ADCY7;HTR2B;ITPR3;PRKCG;IGF1;ADCY5;PRKCQ;PRKCH;HRH1;PIK3CB;IL1RAP;PRKCD;PIK3CD;ADCY3;HTR2C;ADCY8;PRKCB;HTR2A
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.5864845607827861,1.0267659852213051,0.5,0.9674323875720168,1.0,3/7,20.08%,MID1IP1;SPHK2;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.6500801821244493,1.0265636331352206,0.4883720930232558,0.9673239977874658,1.0,2/5,27.93%,DRD2;DRD4
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.6234132837678534,-1.0263494105834141,0.453125,0.8669411803075938,1.0,3/8,23.02%,IGF1;AKAP6;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.6234132837678534,-1.0263494105834141,0.453125,0.8669411803075938,1.0,3/8,23.02%,IGF1;AKAP6;SLC9A1
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.6918111475709433,1.026301969413347,0.5319148936170213,0.96741860862267,1.0,4/5,26.48%,NFKB1;RC3H1;RC3H2;RELA
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Liver,0.37064497824147274,1.026272471198772,0.3333333333333333,0.9668320109375602,1.0,17/90,13.21%,RNF6;SRFBP1;TMED5;TNFAIP3;RUNX1;TRAM1;SLC30A7;SLC39A8;ZNF800;USP12;GLS;NR3C1;NCK1;AP3B1;UHMK1;CAPZA1;BAZ1A
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.6484046010522633,-1.0262018683503407,0.48333333333333334,0.8670422770818323,1.0,2/5,14.51%,ZNF473;LSM11
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.591126635589263,-1.026148964445438,0.4915254237288136,0.8669345653623934,1.0,4/13,7.93%,KCNJ2;PLN;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.5261429258763551,1.0259170611876245,0.42857142857142855,0.96725902913988,1.0,4/13,17.25%,KBTBD7;ALS2;ARHGAP24;ARHGAP44
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Embryo,-0.4546408757495838,-1.0257379277536798,0.4430379746835443,0.8676302566738044,1.0,17/65,19.14%,COL4A1;FLRT3;COL4A2;PDPN;RSPO3;VIL1;IGF1;FN1;SLCO2A1;RNASE1;GPC3;VWA5A;GCKR;SYT13;ITIH5;PDGFRA;PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.5638764440232549,-1.0256811272777966,0.36363636363636365,0.8674667854350638,1.0,2/16,10.99%,CTSC;ATP5IF1
prerank,CellMarker_Augmented_2021__Osteogenic Precursor-Like cell:Dermis,0.34646641703152076,1.0255735767688747,0.2857142857142857,0.9674911229713539,1.0,38/98,22.83%,MYO10;KCTD1;CNTN1;BICC1;GULP1;RNF150;PCDH7;EML1;MAPK10;FAM171B;ZFHX4;NOVA1;PYGO1;PBX1;DZIP1;GLRB;PLCB4;ERBB4;ARHGEF26;EFNA5;MPDZ;PRKD1;LRP1B;LONRF2;EYA1;LIFR;CSRNP3;LRRC4C;RASSF8;NEDD4L;BMPR1B;MARK1;SCD5;NFIB;LRRC49;DDAH1;PTK2;DNAL1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.5722166737208154,1.0254319450392346,0.5,0.9672293557049968,1.0,2/10,6.81%,ZPR1;SOX12
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.5339573258667402,-1.025412579995924,0.5166666666666667,0.867873335374544,1.0,6/18,21.26%,TNFRSF14;ROMO1;SELP;SLC11A1;AQP1;OPTN
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.45612618063548704,1.0253709072237231,0.4186046511627907,0.9667577549470953,1.0,5/24,15.62%,MCU;MFF;RALA;MUL1;MIEF2
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.4603937141754496,-1.025304126951945,0.4177215189873418,0.8678210538311641,1.0,2/53,2.75%,LEF1;WNT8B
prerank,Reactome_2022__Physiological Factors R-HSA-5578768,0.5890028254239829,1.0251513825447578,0.5476190476190477,0.966779652700893,1.0,1/7,5.34%,KAT2B
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),0.4958177367429787,1.0249683670981755,0.4482758620689655,0.966640051975709,1.0,9/20,31.14%,FASTKD2;MRPS27;NSUN3;FASTKD3;RPUSD4;MALSU1;ALKBH1;TSFM;UQCC2
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.40046782981579176,1.0248821400136354,0.28,0.9662666890451334,1.0,6/46,5.86%,SOX8;PPARGC1A;CEBPA;BBS9;AKT2;ATF5
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.5317809868022899,1.0248255916585676,0.42857142857142855,0.9656761864507839,1.0,1/12,0.55%,MSH4
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5249143351028696,1.0247615045433744,0.43902439024390244,0.965215421639217,1.0,4/16,24.58%,NAF1;POT1;PARP1;ERCC4
prerank,Reactome_2022__Signaling By Activin R-HSA-1502540,0.5379038701355289,1.0245769936030158,0.46153846153846156,0.9651417318952514,1.0,2/12,12.58%,ACVR1C;ACVR2A
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.5332699517392222,-1.0245612211936919,0.4225352112676056,0.869612660209745,1.0,5/16,17.39%,APP;EGF;TGFA;SNX6;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.5308824951401245,1.024546894402595,0.45714285714285713,0.9645452402742759,1.0,4/16,20.59%,SNF8;CHMP6;MDM2;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.43818197882919396,-1.0242237623110877,0.345679012345679,0.8702123401435954,1.0,12/83,14.21%,KLF2;RASGRP1;PLK2;APP;KLF4;WNT5A;DAB2IP;IL18;HECW2;GPC3;VIP;OAZ2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.5440636488338041,-1.024030378367904,0.5230769230769231,0.8704298931356551,1.0,5/14,18.19%,CPLX1;CPLX2;FLOT1;KCNMB4;MCTP1
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.42585601627177655,-1.0239446978072673,0.4,0.8704599834478395,1.0,3/69,0.95%,CDKN2A;BLM;SP100
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.40341757398852635,1.0238471104850204,0.46875,0.9657181768391552,1.0,9/46,18.29%,MTHFS;SLC19A1;ME2;PHYH;MTHFD2L;DHFR;DHFR2;SLC46A1;FH
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.5899465826148614,-1.0235711580231983,0.4807692307692308,0.8713013867687881,1.0,4/12,20.15%,GRIN2A;FADD;RIPK2;CASP8
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5231724630625965,1.0235180819874652,0.3902439024390244,0.9661584194373424,1.0,1/12,1.86%,RPP40
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.44741388251123015,-1.023321134688737,0.41025641025641024,0.8716950563218653,1.0,20/84,16.85%,ANXA1;SFTPD;GPNMB;IL15;NLRP12;HTR2B;LRRC19;MOG;IRF7;ISG15;HHLA2;HLA-B;IFIH1;FLOT1;SLC11A1;BTN3A1;SRGN;PIK3CD;HLA-DRB1;BCL6
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.690561510743511,-1.0231787552183906,0.543859649122807,0.8717038551140192,1.0,1/6,5.11%,ATP23
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.5944172747288362,1.023065523606499,0.5,0.9660663803075055,1.0,3/6,31.03%,IWS1;NSUN2;SETD2
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.5944172747288362,1.023065523606499,0.5,0.9660663803075055,1.0,3/6,31.03%,IWS1;NSUN2;SETD2
prerank,"Reactome_2022__Synthesis Of IP2, IP, And Ins In Cytosol R-HSA-1855183",-0.5570581839972443,-1.0230583393764194,0.45161290322580644,0.8716849403099415,1.0,1/13,2.00%,MTMR7
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.6366671701969457,1.0230471787758841,0.5625,0.9654553114607833,1.0,4/5,35.78%,NAA30;NAA25;NAA15;NAA16
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,-0.42891699867925853,-1.023027839883907,0.3918918918918919,0.8714306169440755,1.0,13/74,13.21%,TLR2;B2M;RPS27A;HLA-A;HLA-C;NDUFA2;PSMB9;PSMB6;HLA-B;HLA-E;PSMC3;UBC;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.47894192605803537,-1.022938071704846,0.48148148148148145,0.8713668270017956,1.0,4/46,9.85%,BLM;HELB;POLQ;POLR2I
prerank,Reactome_2022__Lipophagy R-HSA-9613354,0.6311427359146056,1.0225019272665843,0.4418604651162791,0.9664872799601882,1.0,4/7,32.82%,PRKAB1;PLIN2;PRKAB2;PLIN3
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.5995108434772265,1.0224699907382857,0.5,0.9659087967432946,1.0,4/7,23.21%,PTPN23;RAB21;VPS11;EZR
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.5570529255909205,1.0224656909475718,0.5476190476190477,0.9652431377525783,1.0,1/8,7.70%,VDAC2
prerank,CellMarker_Augmented_2021__Monocyte:Subcutaneous Adipose Tissue,-0.49258261671397097,-1.0223368047813428,0.4375,0.8723218200482282,1.0,8/25,10.15%,P2RY13;MYO1F;TAGAP;SLA;ARHGAP9;IGSF6;CLEC12A;CTSS
prerank,CellMarker_Augmented_2021__Macrophage:Subcutaneous Adipose Tissue,-0.49258261671397097,-1.0223368047813428,0.4375,0.8723218200482282,1.0,8/25,10.15%,P2RY13;MYO1F;TAGAP;SLA;ARHGAP9;IGSF6;CLEC12A;CTSS
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.5860108263165674,-1.0222041102766726,0.43548387096774194,0.8723891353590209,1.0,1/9,2.47%,IFIT1
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.5946572812460251,1.0221117976093377,0.48717948717948717,0.9656735484307728,1.0,2/7,9.12%,TYR;DCT
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.40672177439470647,1.022069740774156,0.42857142857142855,0.9651368017878227,1.0,12/85,10.30%,U2AF1;PPARGC1A;RIDA;HSPA1A;NUDT16L1;SF3A1;NUDT21;SNRPF;SF3B4;HSF1;CSTF3;CPSF6
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.6291456690608167,-1.0220060965847049,0.5245901639344263,0.8726084508599744,1.0,1/7,2.46%,NOS1AP
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.4425515671240186,-1.0219310482758563,0.4266666666666667,0.8724372563018289,1.0,18/56,25.90%,AGPAT4;ACSM5;ACSL5;LIPI;LIPH;CYP21A2;OLAH;MVK;OXSM;SREBF1;PAM;SCD;ACSM3;LSS;XBP1;ALOX5;CBR4;ACSL1
prerank,CellMarker_Augmented_2021__Cancer cell:Brain,0.3450997837186763,1.021545267283733,0.36666666666666664,0.965949836184445,1.0,25/89,23.16%,KPNA2;POFUT1;EIF2S1;RFC3;IPO5;ATIC;INTS7;DROSHA;CCT3;NDC1;LRPPRC;SYNCRIP;NUP188;STT3A;CAPRIN1;URB2;NUP205;POP1;FARSB;NUDCD1;NSUN2;UTP4;CSE1L;NEMP1;PARP1
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.637027933284558,-1.0214607730772494,0.4909090909090909,0.8734885946275467,1.0,1/6,6.47%,POLE3
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Liver,-0.3847436476658321,-1.021430104904076,0.3888888888888889,0.8732447122689009,1.0,45/327,12.84%,GBP2;IL1R1;IFI6;CDKN2A;TYMP;MX1;PDE4A;PTP4A3;BTG3;GCNT1;FBLN7;SLA;ARHGAP9;PRDX5;CTSC;PLEKHG2;PIM3;NINJ2;CEACAM1;BST2;AKAP5;GLRX;SYNGR2;ATP1B1;GADD45A;TSPYL2;LAT2;RAB11FIP1;BBLN;ISG15;ICA1;LRPAP1;PGK1;PSMB6;EPSTI1;GOLGA8B;BIRC3;PRDM1;ZBTB32;MAP1LC3A;NAMPT;MYO1E;LDLRAD4;DUSP16;P2RY10
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5819037903459212,1.0213754376723092,0.5454545454545454,0.9657486752912464,1.0,1/9,3.16%,DERL2
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.6128307942016222,-1.021342319223104,0.41379310344827586,0.8731597365650278,1.0,5/9,19.02%,ANK3;NOS1AP;KCNG1;AKAP6;KCNE4
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.5047835909772347,-1.0212442071384877,0.35064935064935066,0.8731679546375998,1.0,7/28,17.28%,EGF;WDR54;LRPAP1;SFRP4;FLOT1;CD63;AHI1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.4681653511086586,1.021187267891655,0.3548387096774194,0.9657151918904657,1.0,7/27,12.98%,MSRB1;CATIP;WASHC5;TTC17;SPIRE2;DIAPH3;WASL
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),-0.6769454997029485,-1.021045648299126,0.45,0.8733761516981896,1.0,4/6,27.22%,SYK;FES;ADGRE2;UNC13D
prerank,CellMarker_Augmented_2021__T Helper cell:Bone Marrow,-0.4903921400521042,-1.0210238944895662,0.48333333333333334,0.8731085441898508,1.0,5/26,6.48%,CD5;TAGAP;GPR171;GPR18;ACAP1
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.5789356539068937,-1.0207514500568442,0.4918032786885246,0.8735888015745483,1.0,4/10,7.39%,DOCK8;APP;APOD;TNFRSF14
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.5371647449783603,-1.0206104680549382,0.4931506849315068,0.8736244026529428,1.0,8/25,20.15%,TRIM5;IRF1;BIRC3;CD55;HERC5;CD36;CX3CL1;CASP8
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.4551201889478991,1.0205477501905602,0.43333333333333335,0.9670757299727514,1.0,9/33,20.40%,TBC1D12;SEC22B;RALB;RAB1B;SCFD1;PIP4K2B;PIP4K2C;PIKFYVE;RAB3GAP1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),-0.5390619365773723,-1.0205141271699478,0.4696969696969697,0.873546360852025,1.0,1/14,2.70%,ITPKC
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),-0.6696458011264721,-1.0199734719980786,0.58,0.874707373055388,1.0,1/5,0.71%,FLRT3
prerank,GO_Biological_Process_2021__regulation of germinal center formation (GO:0002634),0.6697558516615004,1.0199709509250936,0.5106382978723404,0.9680841183163242,1.0,3/5,15.94%,TNFAIP3;FOXJ1;RC3H1
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,0.3832824734649964,1.019917003798505,0.44,0.96756384880802,1.0,18/55,26.32%,ELOC;GTF2F2;ELOA;ERCC2;ERCC3;GTF2H5;GTF2H2;IWS1;POLR2C;CCNT1;GTF2H3;NELFA;CCNT2;CTDP1;MLLT3;CCNH;TCEA1;POLR2A
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.5883552940301816,1.0196279274530589,0.48,0.9676961114328486,1.0,3/5,11.77%,TPRKB;TP53RK;TRIT1
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,0.36982855203474874,1.018851645561791,0.375,0.9692579718822026,1.0,10/104,6.69%,WNT7A;ID1;NRAS;SMARCAD1;OTX1;ACVR1C;AKT2;SMAD5;FZD8;AKT1
prerank,Reactome_2022__Interleukin-27 Signaling R-HSA-9020956,-0.6070664071462565,-1.0186036823306066,0.5,0.8781897900828352,1.0,4/9,22.98%,STAT1;IL27RA;TYK2;STAT3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.4949833846675979,-1.018496475291028,0.43283582089552236,0.8781617379878439,1.0,8/20,19.00%,S100A6;IGF1;WNT5A;FN1;CD74;AQP1;CDKN1A;PDGFRA
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.46519580967880897,-1.0183964374039252,0.4857142857142857,0.8781371444235653,1.0,3/42,6.82%,CP;SLC39A14;STEAP3
prerank,CellMarker_Augmented_2021__Bulge Stem cell:Scalp,-0.42898002398786084,-1.0183461828634686,0.41333333333333333,0.8779304300179314,1.0,25/88,17.93%,RIMBP2;STMN2;LRRC55;ITM2A;PLP1;LRRTM1;SYT4;ELAVL4;KCNH8;LDB2;PDE6B;TCEAL2;CACNA1C;AEBP1;GNG2;ELMO1;CNR1;TMEM132C;RAB3C;JPH4;CCND2;TCEAL5;CD200;GALNT8;IQSEC3
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",0.430575290082157,1.0183272220557047,0.37037037037037035,0.9699921263934539,1.0,2/32,5.74%,POLD3;RFC3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),-0.6498921405819411,-1.0180915277960143,0.4838709677419355,0.8784658966766109,1.0,1/7,9.24%,IGF1
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.4326669663530082,1.017908477264984,0.36363636363636365,0.9705031539588699,1.0,13/34,22.27%,TVP23B;ABCA1;MTTP;TMEM167A;RAB8B;MON1A;RAB8A;RCN3;TANGO6;PREB;MIA2;GOLPH3;SEL1L
prerank,Reactome_2022__p38MAPK Events R-HSA-171007,0.5226734071798562,1.0174810217908572,0.4358974358974359,0.9711085857104809,1.0,4/12,12.29%,NRAS;RALB;RALA;MAPK12
prerank,Reactome_2022__Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,0.4628858010706632,1.0174201169362591,0.4,0.9706042261648281,1.0,3/14,14.10%,NRAS;EGFR;RPS6KA3
prerank,CellMarker_Augmented_2021__Epithelial cell:Mammary Epithelium,-0.4973580327723872,-1.017368368027409,0.49295774647887325,0.8801651132073015,1.0,8/36,16.18%,EPS8L2;TJP3;OVOL2;LSR;BAIAP2L1;ITGB4;RHOD;CAPN1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5385199618326957,-1.017301809578536,0.3888888888888889,0.8800059397031397,1.0,9/18,25.29%,THY1;PTK6;SH3BP5;MVP;SNX6;ZFYVE28;PTPRC;SRCIN1;HYAL2
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.40024960132987714,-1.0172849868426606,0.45569620253164556,0.879713053782241,1.0,42/161,20.53%,RPL19;RPL3;RPS27;RPS14;RPL27A;RPL35;EMG1;RPL7A;RPL37A;RPL27;RPL9;RPL21;NOB1;RPL13A;RPS16;RPL24;RPLP1;RPL38;RPL10A;RPL10;RPLP2;RPS7;RPL8;RPS6;MRTO4;RPS15;RPS9;RPL12;PES1;RPL5;RPL23;RPL4;DDX54;RPL18A;RPL41;RPL7;RPL15;RPL11;EXOSC7;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.5767583642263513,-1.0172801950383707,0.4426229508196721,0.8794032319744994,1.0,1/13,0.34%,RASGRP1
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.659930559905401,1.0172577504618567,0.5238095238095238,0.9704013602296216,1.0,3/5,28.95%,RAB7B;SNX3;SNX12
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.5666780783535519,1.017183579478685,0.5,0.9698823781701335,1.0,4/9,30.02%,MUL1;RNF26;ITCH;TRAF3IP1
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,-0.5149930547705461,-1.0169963784650289,0.45454545454545453,0.8797794386852441,1.0,1/27,1.70%,KREMEN2
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,0.5252163184624379,1.0169565005711456,0.5454545454545454,0.9700439039633273,1.0,2/13,6.46%,SOCS6;YES1
prerank,Reactome_2022__Beta Oxidation Of hexanoyl-CoA To butanoyl-CoA R-HSA-77350,0.6483702381461434,1.0168467221953414,0.5686274509803921,0.96963647972173,1.0,2/5,30.55%,ACADS;ECHS1
prerank,Reactome_2022__GLI Proteins Bind Promoters Of Hh Responsive Genes To Promote Transcription R-HSA-5635851,-0.6175331863653013,-1.0168351411950198,0.5,0.879864010691007,1.0,4/7,24.31%,HHIP;GLI1;BOC;GLI2
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.5721875286364364,1.0167722153933711,0.5,0.9692138360104843,1.0,4/8,23.28%,GTF2A2;TAF12;DR1;GTF2B
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.4004639525599544,1.0166554092900126,0.4642857142857143,0.968807556456734,1.0,15/43,25.88%,HSPA1A;HSF1;STT3B;DERL1;RHBDD1;TOR1B;ERP44;DAXX;ERN1;TM7SF3;DNAJB5;DNAJC4;HSPA13;DNAJB2;BAK1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.46645078242353794,-1.0166180400549536,0.4,0.8801952274100648,1.0,4/41,6.92%,AWAT1;ALOX12;CYP4Z1;CYP1B1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.4147481506391532,-1.016580648164577,0.4430379746835443,0.8799884404178222,1.0,19/124,14.45%,FLRT3;POU4F1;ANK3;CCK;SHTN1;CNTNAP1;S100A6;APP;SLITRK1;MAP1B;BAIAP2;NEFH;NYAP1;MINK1;DAB2IP;SLITRK4;NLGN1;SLITRK5;BDNF
prerank,KEGG_2021_Human__Nicotine addiction,-0.4845752820719456,-1.016569591485242,0.4714285714285714,0.8796790862027398,1.0,17/33,20.30%,GRIN2D;GRIN3A;GRIN2A;SLC32A1;GRIA3;GRIA1;GABRE;GABRB2;GABRD;GRIN2B;GABRG2;GABRA1;SLC17A7;GABRA6;CHRNA6;GABRG3;GABRA3
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.5399385545236544,-1.0165156815480525,0.49206349206349204,0.8795205583554726,1.0,6/20,18.14%,STMN2;KIF14;STMN4;KIF2C;STMN1;MAPT
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.4004047092872693,-1.0164871426319797,0.39285714285714285,0.879269767498519,1.0,12/170,7.77%,TLCD2;A4GALT;MYOF;ANK3;GOLGA8O;ATP8B4;SUN3;DYSF;CAV3;USP50;SYNGR2;SYP
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.642804831101549,1.016261848266723,0.4772727272727273,0.9693162094198188,1.0,3/5,23.79%,HEYL;HEY2;RBPJ
prerank,CellMarker_Augmented_2021__Luminal Progenitor cell:Breast,-0.4843967337179059,-1.01598680235305,0.391304347826087,0.8803085765584998,1.0,3/30,3.93%,CD24;TJP3;OVOL2
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.6289726702594156,1.0158437445823456,0.5476190476190477,0.9698950484323242,1.0,2/7,6.69%,ZC3H8;AKT1
prerank,"KEGG_2021_Human__Glycine, serine and threonine metabolism",0.40552784454570395,1.0157670416494022,0.3225806451612903,0.969497013760302,1.0,3/30,3.82%,DAO;ALDH7A1;ALAS1
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,0.4619450999824386,1.0157504506503128,0.4,0.968871415569417,1.0,8/21,18.34%,MCU;MAIP1;LETM1;VDAC2;MICU2;AKAP1;MICU3;PHB1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.5117249767975866,1.0157063847653995,0.4090909090909091,0.9683724548622824,1.0,4/16,16.90%,MCU;TIRAP;MDK;MPP1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.4781861819403849,-1.0157031058427228,0.5416666666666666,0.8809329313429112,1.0,6/32,12.43%,EFNA1;APP;THY1;PTK6;SH3BP5;MVP
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.5922393421807092,1.0156712777957495,0.5238095238095238,0.9678113443934161,1.0,3/9,8.69%,ARFIP1;WASHC5;ARFIP2
prerank,"Reactome_2022__Defective EXT1 Causes Exostoses 1, TRPS2 And CHDS R-HSA-3656253",0.5581221135901251,1.0156659305423803,0.45454545454545453,0.9671411149305398,1.0,4/12,11.69%,SDC4;SDC3;GPC5;HSPG2
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.4954170676466117,-1.015496877952868,0.38235294117647056,0.8812013882777676,1.0,3/30,6.11%,FLRT3;SH3GL2;MAP1B
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5423079686515542,-1.0154702211861597,0.43283582089552236,0.8809264340897051,1.0,5/15,18.89%,IGF1;GLI1;PIM1;AKAP6;TBX20
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.47599272034803536,-1.0153443511454363,0.47368421052631576,0.8809214814356626,1.0,8/40,17.15%,BLM;ADCY7;BRCA1;GLRA2;ADCY5;GNG2;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.5118418225082069,1.0151569420391449,0.40540540540540543,0.9680798931950004,1.0,4/18,12.02%,FLT3;ARMC6;CSF1R;PRRC2C
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.5821665525776563,-1.0148234416741475,0.49230769230769234,0.8820670308723013,1.0,1/7,1.67%,MX1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.40149433512038696,1.0147732399468294,0.3103448275862069,0.9685940741269693,1.0,16/55,20.39%,CCT7;HCLS1;ZPR1;TESK1;TRIM28;AKT1;IPO5;SESN2;PLK1;CCT3;KAT7;PIK3R1;EIF2AK3;MCRS1;PYHIN1;DKC1
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),-0.5793153656724059,-1.0145704646964124,0.4528301886792453,0.8825053145742262,1.0,1/10,2.70%,ITPKC
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.42316610205177563,1.0145639711109373,0.4,0.9686218704178108,1.0,4/39,4.15%,WNT7A;SLITRK2;LIG4;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.603418636663863,1.0145623196014222,0.4888888888888889,0.9679607607030534,1.0,2/6,5.69%,SLC39A10;FOXP1
prerank,CellMarker_Augmented_2021__Tumor Endothelial cell:Kidney,0.6061150004534582,1.014340385334908,0.46808510638297873,0.9672901081318614,1.0,3/7,3.34%,SLC10A6;CARD18;IL20RB
prerank,CellMarker_Augmented_2021__Tumor Endothelial cell:Colon,0.6061150004534582,1.014340385334908,0.46808510638297873,0.9672901081318614,1.0,3/7,3.34%,SLC10A6;CARD18;IL20RB
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.494147118180968,1.0142594837397947,0.42424242424242425,0.9669437573622429,1.0,9/24,24.92%,KAT2B;KAT2A;KAT7;EP300;PHF20L1;KAT6B;RUVBL1;TRRAP;NAA50
prerank,Reactome_2022__LGI-ADAM Interactions R-HSA-5682910,0.5205305399818201,1.0142466261965377,0.4444444444444444,0.9663012375640233,1.0,3/13,14.17%,CACNG2;LLGL1;ADAM22
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.5533615315700073,1.0142029282074532,0.40540540540540543,0.9657454143091879,1.0,2/7,5.85%,RGS2;PLIN5
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.5532851205747235,-1.0141765975561987,0.4262295081967213,0.8833833540169321,1.0,1/13,1.24%,PGR
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.279850034217358,1.014068956706884,0.0,0.9655411638203233,1.0,401/1648,20.26%,MEOX2;POU6F2;ZNF300;WNT7A;RNF6;POU3F1;ASCL1;ZNF697;ZNF287;TFCP2L1;ETV5;ZNF615;ZNF202;ZNF415;LIMD1;FAM47E;NR1D1;CCNE1;SOX8;ZNF117;ZNF783;KCTD1;BMP2;MED21;POU3F4;PPARGC1A;ZFP3;ZNF441;ZNF195;SOX21;IRF2BP1;ANXA4;ZNF212;ZNF525;CEBPA;NR2E1;BCL10;ZNF358;DACH1;ZNF778;ZSCAN25;ZBTB43;ZNF107;EHF;ID1;ZNF658;MITF;ZNF426;MEN1;CARF;POFUT1;ELOC;ZSCAN20;ZC3H8;RUNX1;HSF5;MTERF3;ZNF24;ZNF624;KMT5A;ZXDA;POU3F2;LCORL;ZNF556;ZBTB37;ZFP2;RBM23;ZNF555;HCLS1;SCML2;TENM1;TRIB3;HES6;OTX1;SOX9;ZNF616;ZNF319;PHC1;USP13;ZNF706;ZBTB9;EGFR;POLR3F;SLC39A8;FOXP1;MTF1;THAP11;SMAD5;ATF5;SMARCAL1;ZNF707;ZNF384;ZNF613;ZNF304;APBB3;ZNF74;MSANTD1;ZNF577;ESRRG;GRHL1;ZNF502;ZNF484;ZNF684;TRIM28;ZNF639;AKT1;EED;ERCC6;SOX12;ZNF786;ELOA;ZBTB40;ZNF883;RORB;FBXO5;KLF16;ZNF320;BRF2;ZNF852;TSHZ1;ZNF680;ZNF268;ZBTB39;THAP1;ZNF211;GLI4;SNF8;ZNF782;ZFHX4;RNF14;ZBTB18;PBX1;ZNF561;KDM5A;ZBTB33;DPF1;AR;CBFA2T3;ELK4;YY1;ZNF696;PRMT6;NR3C1;ZSCAN23;PHF10;CEP290;ZNF595;NFYC;ZNF774;HSF1;JDP2;ARID3B;HMGB1;YAF2;ETV1;SLC2A4RG;BRPF1;FOXJ1;ZNF12;ZBTB6;SALL1;BTRC;HSF2;ZNF133;ZNF518A;ZNF587;HP1BP3;ZNF510;ZNF543;ZNF496;TRIM16;ZNF155;EBF4;ZGLP1;ZNF341;ZNF665;LCOR;PHF14;ERBB4;ZNF875;ZNF181;ZIC2;FOXJ2;PPM1A;ZNF703;TIAL1;ATF6;ZNF347;ANKRD2;ZSCAN22;ZNF677;HEYL;HLF;PTPRK;NIPBL;ZXDB;FOXJ3;ZNF397;ZNF676;ZNF121;ZNF761;ZNF669;ZXDC;ZNF408;ESRRA;BRWD1;ARX;ZBTB2;ZNF33A;VEZF1;ZNF736;ZNF280D;ZNF792;MXD3;KMT2A;EMX2;MAGED1;ZNF793;PATZ1;BRWD3;APBB2;SALL3;PLAGL1;TGFBRAP1;ZNF214;SPEN;TRPS1;SOX5;DVL2;HEXIM2;CNOT2;ZNF254;ZNF276;ZNF283;TOX;HTATSF1;DAP;ZNF138;BAZ1A;KAT2A;ZEB2;KLF12;ZNF14;E2F4;ZNF382;ZNF324B;ZNF354B;GTF2H2;GTF2H2C;ELP2;ZNF527;HMG20A;MYNN;ZNF230;ZNF324;ZNF764;PRDM5;RPS6KA3;GPBP1L1;DHFR;KAT7;ZNF530;ZNF18;PLAGL2;ZNF416;ZNF429;ZNF189;NFKB1;ZNF43;ZNF519;AEBP2;MAMSTR;ZNHIT3;PURG;KARS1;HDAC2;ZBTB20;LHX2;ZNF558;POU2F1;ZNF264;ZNF75A;ID2;TNFSF4;ZNF91;ZNF425;EP300;TADA1;SMARCA2;NRF1;ZNF471;ZNF25;ZNF34;PPIE;BACH1;ETS2;MGA;SNX5;HINFP;PBX2;NR2F1;ZNF492;CDK18;THOC1;ZHX2;NR1D2;PICALM;ELP4;ZNF470;ZNF521;NKRF;SCMH1;FOXN2;ZNF322;ZNF688;ZBTB34;CREG1;IRF2BPL;CD38;OLIG1;ZFP82;NCOA2;ZNF248;ZNF865;PHC3;ZNF589;LANCL2;CHD7;ELK1;ZNF611;NR3C2;ZNF879;VHL;ZNF41;BRD7;MYPOP;CEBPG;EFEMP1;ZNF236;ZNF582;HOMEZ;HEY1;PIAS4;CAMK4;ZHX3;SETD3;ZNF251;PURA;MED30;METTL4;EHMT1;CSRNP3;MAP2K2;ZNF526;PHF20L1;ZNF699;CNBP;PCID2;VSX1;ETV3;WDR77;NLK;ZNF805;HDAC10;HESX1;CHD4;PRDM2;ZNF771;ZNF737;GLI3;NFXL1;CCNT1;MED23;DAXX;ZNF460;ZBTB10;ZNF30;ZNF770;ZMYND11;ZNF334;PSPC1;HEY2;MDM2;CCAR2;PYHIN1;BATF2;ID4;HES5;ZNF534;SP3;BBX;ZNF354A;SMAD7;ZNF75D;NUP85;ZNF253;ELP3;SAP30L;ZNF354C;ING1;ZNF224
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.6268204663139059,1.013955609193019,0.45161290322580644,0.9651268538179539,1.0,2/5,16.57%,JAM2;EIF2AK3
prerank,Reactome_2022__Infectious Disease R-HSA-5663205,-0.3705023838791345,-1.0138671977794484,0.42424242424242425,0.8838958602714658,1.0,135/750,17.95%,GGT5;ST6GAL1;IL1R1;C3;PCSK2;RPL19;TLR2;RPL3;B2M;RPS27A;RPL39L;RPL36AL;RPS27;SFTPD;HLA-A;RPS14;RPS4X;PLK2;RAMP3;RPL27A;SH3GL2;ZDHHC9;NLRP12;ADCY7;GNG3;RPL35;NOD1;RPL7A;RPL37A;HLA-C;RPL27;KCNH8;PARP14;ITPR3;YWHAH;RPL9;PSMB9;RPL21;PARP9;BAIAP2;ATP1B1;IFNGR2;RPL13A;WAS;GIPR;AP1S1;SYT1;SNRPD2;RHBDF2;STAT1;POLR2I;WNT5A;SH3GL3;IRF7;RPS11;RPS16;CD9;TAF10;ISG15;RPLP1;RPS13;PGK1;PSMB6;RPL38;HLA-B;ADCY5;SYK;HLA-E;RPS3A;IL18;PTRH2;RPS8;RPL10A;PSMC3;MYH9;RPLP2;RPS23;MYO1E;GNG2;IFIH1;RPS21;DUSP16;RPS7;TUSC3;ELMO1;C1QTNF1;UBC;RNASE1;GPC3;HLA-F;KPNA7;RPL8;RXFP1;RNF213;NOXA1;PTH1R;NMT1;RPS6;GLP1R;ELOB;PTH2R;BLNK;RPS15;ST6GALNAC2;RPL26L1;RPS9;PSMA8;RPL12;VAV1;RPL5;MGAT5;GUCY2C;PSMA7;FAU;SYT2;RPL23;RPL4;CEBPD;PML;SV2B;LRIG1;CBX1;ADCY8;SH3KBP1;GPC1;MTA1;PSME1;MRC1;RPL18A;RIPK2;RBX1;RPL41;RPL7;RPS12;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.42530825829415825,-1.0137656376224873,0.48148148148148145,0.8838080165303942,1.0,21/90,19.04%,GGT5;PLK2;RAMP3;ADCY7;GIPR;RHBDF2;ADCY5;SYK;MYH9;GNG2;RXFP1;VIP;PTH1R;GLP1R;PTH2R;ADCY3;HLA-DRB1;ADCY8;NMI;NLRC3;ADM
prerank,Reactome_2022__Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.5235587137883209,-1.0137325921505638,0.5142857142857142,0.8835668902368866,1.0,3/25,9.91%,TUBB6;PFDN6;TCP1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.5443640180414652,1.0134440806492138,0.5,0.9659042224884725,1.0,4/9,32.67%,PLXNA3;PLXNA2;PLXNB2;PLXNB3
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.39597182927488167,1.0133743394783887,0.4375,0.9655369101402086,1.0,4/48,5.94%,GDAP1;GRPEL2;SAMM50;MFF
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.5183980656851955,1.0132834003981932,0.37142857142857144,0.9651234555450321,1.0,6/13,25.19%,PPARGC1A;VCP;SPHK2;AK4;PARP1;PID1
prerank,Reactome_2022__Mitotic Telophase/Cytokinesis R-HSA-68884,0.5423474452343636,1.0131590567470101,0.4146341463414634,0.9648348720700589,1.0,5/11,29.42%,PLK1;NIPBL;WAPL;SMC3;PDS5B
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.5078926421891274,-1.013050637288579,0.4647887323943662,0.8851518030580804,1.0,5/28,11.12%,RASGRP1;DUSP1;GADD45A;MINK1;DAB2IP
prerank,CellMarker_Augmented_2021__Naive CD8+ T cell:Peripheral Blood,-0.43940707833586007,-1.0129898375875233,0.48148148148148145,0.8850159239513901,1.0,14/74,14.32%,LEF1;TMEM204;GPR183;RASGRP2;TOMM7;PDK1;NELL2;PIK3IP1;ARHGEF18;CD55;RPS8;SPINT2;SNED1;APBA2
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.40993507290600034,-1.012828529135896,0.40476190476190477,0.8851558659463469,1.0,27/119,17.89%,ANXA1;IL1R1;TLR2;IFI35;IL15;NLRP12;APP;KLF4;LRRC19;TLR3;WNT5A;BIRC3;IL18;SBNO2;TNFRSF1A;CXCL17;PRKCD;MVK;USP18;BCL6;CD200;TEK;SNX6;ETS1;GPER1;ABCC1;NMI
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,-0.4853541801722199,-1.012783462789228,0.44871794871794873,0.8849350161918974,1.0,5/44,11.18%,THBS1;NR4A3;GATA1;ZFPM1;PRKCQ
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.5117966696575973,1.0127422625466218,0.4117647058823529,0.9654472732300526,1.0,3/21,6.17%,SLITRK2;ABHD17A;ABHD17B
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.690346555151341,-1.012725206477155,0.5306122448979592,0.8848095692854572,1.0,1/5,11.74%,PINK1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.5427966387676054,1.0126112842104802,0.4473684210526316,0.9651588631632008,1.0,1/10,3.52%,DUSP19
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.41876419614695803,-1.0125836774652797,0.3950617283950617,0.8848508261653264,1.0,27/120,22.27%,DHCR24;SLC39A14;BHMT;ZDHHC9;SCARA3;ARHGEF17;GYG2;GPT2;DAB2IP;SLC7A2;SFRP4;F10;AMOTL2;RHBDF1;BOK;ASS1;PTPRF;GPC1;PGAM1;PTPN21;EPB41L4B;KIAA1217;CD276;BCAT1;SH3D19;MYO1B;EPB41L1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.35005762700032217,1.0124411768292445,0.391304347826087,0.9649716376825134,1.0,26/91,20.89%,RANBP17;NXT2;NUP62CL;INTS13;PPP1R10;AKT1;IPO5;ARL2BP;IPO8;PLK1;NUP214;NXT1;RANBP6;MORC3;TAF8;NUP188;HNRNPU;TOR1B;TAF3;IPO11;MDM2;PIKFYVE;NUP85;NOL8;NUP153;NUP50
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4285787343497343,1.012276051602668,0.40540540540540543,0.9647226859020093,1.0,1/24,0.43%,NGF
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.4044914090034413,-1.012191562308219,0.4625,0.8857452050511015,1.0,14/127,13.76%,ERCC6L;WDR62;RPS27;PLK2;RAB11A;CENPH;CENPE;ZWILCH;NUF2;SPC24;CCNB1;KIF2C;CENPN;CENPU
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.4316892287382018,-1.0121675274306832,0.4696969696969697,0.8854802913602877,1.0,9/65,11.77%,CENPV;KIF14;SVIL;PLSCR1;EGF;IGF1;TGFA;CCNB1;SOX15
prerank,Reactome_2022__AKT Phosphorylates Targets In Cytosol R-HSA-198323,0.5396688104685701,1.0121392750795608,0.4375,0.9644663317308714,1.0,5/12,19.77%,AKT2;AKT1;BAD;MKRN1;MDM2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.6188772885234595,1.0118058276857123,0.5384615384615384,0.964751931791667,1.0,2/5,28.12%,RBPJ;NFE2L2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.5532443062754316,1.0117997695624827,0.5384615384615384,0.964093847254292,1.0,1/7,4.10%,SERPINB9
prerank,Reactome_2022__Urea Cycle R-HSA-70635,-0.6225877628344965,-1.0117086178420618,0.453125,0.8864417203442785,1.0,3/6,15.09%,ARG2;CYP21A2;ASS1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.437998818291986,-1.011554146736869,0.4823529411764706,0.8865128806927031,1.0,13/81,14.28%,ANXA1;IL1R1;P2RY12;TRIM5;IRF1;LRRC19;PDE6B;WNT5A;BIRC3;CD55;SBNO2;HERC5;NMT1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.5569325415409612,-1.0109716041673766,0.4339622641509434,0.8879348269775792,1.0,6/13,20.40%,CYP1B1;CRLF3;MGAT5;OCIAD2;GHR;HES1
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.41340621295365126,1.010958947716975,0.4230769230769231,0.9656619366517709,1.0,6/27,8.12%,CSPG5;CHST11;NDNF;CSGALNACT1;CHST7;BCAN
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,0.3729808514096113,1.0109026580269436,0.42105263157894735,0.9652512133368671,1.0,20/104,18.68%,NGF;NRAS;AKT2;PRDM4;MAPK10;AKT1;SHC4;MAPK8;MAGED1;MAPK12;PIK3CA;SHC3;RPS6KA3;NFKBIB;NFKB1;PIK3R1;CRKL;BAD;CAMK4;MAP2K2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3374944506036479,1.010695205505065,0.5714285714285714,0.9653040173559174,1.0,63/312,19.44%,SPSB4;RNF6;ERCC8;FBXO45;KLHL8;SPSB2;PSMD10;KBTBD7;FEM1C;ELOC;TNFAIP3;PSMA1;WDR91;RNF150;PSMD11;KEAP1;FBXL14;ANAPC1;PSMB5;VCP;GID8;RNF146;RNF14;VPS37A;PTPN23;UBE2G1;BTRC;PLK1;FBXO8;RNF114;UBE2D1;RCHY1;PSMD14;FEM1B;KCTD17;PSMD12;FBXO10;ATE1;VPS37B;UBE4A;CDC26;UBE3B;FBXO21;RNF11;RC3H1;FBXL17;TRIM3;KCTD21;NDFIP1;VPS4B;SPOP;UBAP1L;COP1;CNOT4;RMND5A;UBQLN4;KCTD5;KLHL20;RNF166;UBE3D;KLHL42;UBL7;RC3H2
prerank,Reactome_2022__p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,-0.6037877317590952,-1.0105735213677698,0.49122807017543857,0.8887280651959818,1.0,2/11,16.06%,FN1;TLN1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.3712751278690903,1.0105553183105258,0.3157894736842105,0.9650945793849616,1.0,12/54,19.44%,MITF;METTL18;NOVA1;PCBP4;CLK4;RBM12B;RC3H1;YTHDF2;METTL4;PCBP3;RRP1B;RC3H2
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,0.3660955080818288,1.010538257538027,0.32,0.9645386721554947,1.0,15/103,11.34%,SEM1;MUC20;PSMD10;BCL10;TAB3;NRAS;PSMA1;PSMD11;CUL1;UBE2N;PSMB5;BTRC;PRKACB;UBE2D1;PSMD14
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.4995343169547519,1.0104361502240802,0.4444444444444444,0.964183730893512,1.0,4/13,17.49%,AKT2;AKT1;GPLD1;PPM1K
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,0.3651323149208372,1.0103176168520325,0.4166666666666667,0.9639062233837461,1.0,12/61,14.75%,SEM1;PSMD10;BCL10;PSMA1;PSMD11;CUL1;PSMB5;BTRC;PSMD14;PSMD12;NFKBIB;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.4256540608926085,1.0102605109643465,0.46875,0.9633983935615956,1.0,6/40,10.30%,HCLS1;ZPR1;ANP32B;TRIM28;IPO5;CPSF6
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),-0.6727429291709572,-1.0102547972932834,0.5192307692307693,0.8892392240267466,1.0,1/5,3.00%,SLC39A14
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.4912066630181829,-1.010223682103587,0.4225352112676056,0.8889736180288331,1.0,6/24,19.25%,KCNQ1;IGFBP5;DMTN;AQP1;AKAP6;HCN1
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),0.6414995912285064,1.0101649609039707,0.5434782608695652,0.9630526320323783,1.0,2/5,2.81%,COQ3;GK
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.43707337963112886,-1.009978802970575,0.4935064935064935,0.8892097965068385,1.0,10/63,13.02%,AWAT1;ALOX12;ACOT1;CYP4Z1;ACOT4;CYP1B1;ACSL5;GLYATL2;ACOT2;CYP3A4
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),0.6167461262513037,1.0099018566872076,0.52,0.9631757910542834,1.0,3/5,34.60%,GPLD1;ATG7;ATG12
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.5021715590256489,-1.0098970496681756,0.4691358024691358,0.8890799101692407,1.0,6/32,17.43%,CENPH;MIS18A;CENPN;CENPU;OIP5;CENPP
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.40859408097634536,-1.009894105067646,0.4268292682926829,0.8887706246385086,1.0,12/103,9.24%,THBS1;TLR2;CIITA;RPS4X;NLRP12;KLF4;ATAD5;NLRC5;CCL2;PLD1;EGF;IGF1
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),-0.6389986277077097,-1.009763180862859,0.5,0.8887933368410355,1.0,1/7,2.16%,LAMB1
prerank,CellMarker_Augmented_2021__Pit cell:Stomach,-0.6021594188952711,-1.0097236986623903,0.4897959183673469,0.8885723692619929,1.0,2/9,14.22%,GREM2;FAHD2B
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.4120468246126054,-1.0096301680641868,0.4375,0.8885207112284075,1.0,11/88,9.33%,FABP3;ABCA6;ABCA5;SLC51A;ABCA8;AKR1C1;ABCA12;CEACAM1;LDLR;SLCO3A1;ABCA10
prerank,KEGG_2021_Human__Galactose metabolism,0.47109744469391296,1.0093776173365987,0.4482758620689655,0.964173658319357,1.0,3/24,3.55%,MGAM;GANC;PGM2
prerank,Reactome_2022__RUNX3 Regulates YAP1-mediated Transcription R-HSA-8951671,-0.7177592609827964,-1.0093022421863986,0.6101694915254238,0.8891352970577056,1.0,2/5,20.65%,TEAD2;WWTR1
prerank,Reactome_2022__ABC Transporters In Lipid Homeostasis R-HSA-1369062,-0.5742728694961585,-1.0092641543331005,0.4423076923076923,0.8889820564577089,1.0,4/15,9.33%,ABCA6;ABCA5;ABCA12;ABCA10
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,-0.3901000747005638,-1.0090722107127728,0.46153846153846156,0.8891769956089559,1.0,54/207,20.30%,GRIN2D;GRIN3A;NEFL;KCNJ2;GRIN2A;ADCY7;GNG3;KIF17;SLC32A1;SYN3;GRIA3;GLRA2;GRIA1;AKAP5;SLC18A2;NRGN;NCALD;SYN2;PRKCG;CPLX1;RPS6KA1;SYT1;GRIK1;GABRB2;CHRNA5;ADCY5;ACHE;GAD1;GNG2;GRIN2B;RNASE1;GAD2;SLC38A1;GABRG2;PPFIA1;RASGRF2;GABRA1;CACNB1;SH2D3C;ADCY8;PRKCB;CHRNE;MAPT;RPS6KA6;LRRC7;SLC1A6;GLRA1;GABBR2;SLC17A7;ALDH5A1;GABRA6;CHRNA6;GABRG3;GABRA3
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.5577827890484943,1.008906402845056,0.47368421052631576,0.9649401007955233,1.0,6/10,37.55%,HUS1;CLSPN;TICRR;STK33;CHEK2;RAD17
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),-0.604500024098203,-1.0087228608118135,0.5185185185185185,0.8891128437976178,1.0,5/8,35.92%,RAB27B;HSPB1;MAP1A;MAPK8IP3;KIF5B
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),-0.604500024098203,-1.0087228608118135,0.5185185185185185,0.8891128437976178,1.0,5/8,35.92%,RAB27B;HSPB1;MAP1A;MAPK8IP3;KIF5B
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),-0.604500024098203,-1.0087228608118135,0.5185185185185185,0.8891128437976178,1.0,5/8,35.92%,RAB27B;HSPB1;MAP1A;MAPK8IP3;KIF5B
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.5693485356467306,1.0086842949553267,0.47619047619047616,0.9650004221072038,1.0,4/7,19.38%,ALDH1A1;ADH5;ACSS1;ALDH2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.5359889687801107,1.0083277592281297,0.45161290322580644,0.965443601209313,1.0,5/11,5.99%,ABCD2;PPARGC1A;AKT2;PLIN5;ABCD1
prerank,Reactome_2022__PP2A-mediated Dephosphorylation Of Key Metabolic Factors R-HSA-163767,0.6249419432107394,1.0082720685533695,0.5135135135135135,0.9650213233580405,1.0,4/6,36.41%,PPP2R1B;PPP2R1A;PFKFB1;PPP2CB
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),0.6097055305700816,1.0081616664311692,0.5945945945945946,0.9646990452372276,1.0,1/6,5.97%,TPK1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.4464279339292711,-1.008098088538238,0.4625,0.890468253097172,1.0,4/51,8.19%,BLM;BRCA1;CCND1;DONSON
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.4798077096047064,1.007990102361805,0.5483870967741935,0.964461277968864,1.0,6/17,24.23%,SRI;DRD2;GSTM2;GPR35;PKD2;UBQLN1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.45282546710187,-1.0079384081860776,0.4,0.8905745991117601,1.0,10/38,19.85%,IMPDH1;ADCY7;PAPSS2;ADCY5;ADCY3;GUCY2C;GUCY1A1;ADCY8;AK5;DCAKD
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,-0.41177440364432594,-1.007893473955173,0.4,0.8904043660800854,1.0,22/119,19.82%,EPN1;RPS27A;SH3GL2;TRIP10;LDLR;EGF;SYT1;WNT5A;SH3GL3;TGFA;M6PR;UBC;SYT2;ARFGAP1;SH3KBP1;LRP2;COPS5;CD4;TF;CLTB;ARPC3;DNM1
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,0.3305801707063418,1.0078554346733641,0.4166666666666667,0.9641703641441616,1.0,31/217,13.78%,SEM1;H2BC18;OTUD3;KDM1B;PSMD10;CDC25A;TNFAIP3;PSMA1;POLG2;H2BC21;PSMD11;KEAP1;KAT2B;USP13;H2BC4;BRCC3;USP12;PSMB5;INO80D;VCP;VDAC2;RNF146;YY1;H2AC6;OTUB2;UBE2D1;PSMD14;NFRKB;ADRB2;KAT2A;PSMD12
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.5323351871073181,-1.0077323007898824,0.4714285714285714,0.8905173998338332,1.0,5/14,17.01%,GPR18;LPAR6;LPAR4;P2RY10;HTR2C
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.5407207399962306,-1.007694722199871,0.46774193548387094,0.8903675277136981,1.0,5/11,24.64%,MMP14;SYK;SFRP1;INHA;XBP1
prerank,CellMarker_Augmented_2021__Corneal Epithelial Progenitor cell:Embryonic Stem Cell,-0.4170645042666093,-1.0076794955268855,0.47435897435897434,0.889430505892668,1.0,11/71,13.60%,EFNA1;MET;MATN2;PAPSS2;ATP1B1;RAPH1;C1ORF115;SLC7A2;SLC44A3;RAP1GAP;SLC51B
prerank,CellMarker_Augmented_2021__Stem cell:Limbal Epithelium,-0.4170645042666093,-1.0076794955268855,0.47435897435897434,0.889430505892668,1.0,11/71,13.60%,EFNA1;MET;MATN2;PAPSS2;ATP1B1;RAPH1;C1ORF115;SLC7A2;SLC44A3;RAP1GAP;SLC51B
prerank,CellMarker_Augmented_2021__Stem cell:Lacrimal Gland,-0.4170645042666093,-1.0076794955268855,0.47435897435897434,0.889430505892668,1.0,11/71,13.60%,EFNA1;MET;MATN2;PAPSS2;ATP1B1;RAPH1;C1ORF115;SLC7A2;SLC44A3;RAP1GAP;SLC51B
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.5251621871656904,1.0076492359169038,0.5,0.9640859330943926,1.0,3/14,16.16%,SEC24A;SEC31B;SEC23B
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.4922952758081822,-1.0076275901030072,0.47761194029850745,0.8892139485596018,1.0,12/23,28.33%,ITPR3;SYK;BLNK;VAV1;SH3KBP1;ITPR1;AHCYL1;FYN;CD22;ORAI2;PIK3AP1;ORAI1
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,0.4148202974675854,1.0075786552738104,0.39285714285714285,0.9636202225625522,1.0,8/41,12.54%,EPHA6;NCSTN;EFNA2;EFNB2;YES1;AP2B1;EFNA5;EPHB4
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,0.3717066390152319,1.0074401973070508,0.5,0.9634295567820456,1.0,21/63,23.28%,ELOC;GTF2F2;ELOA;ERCC2;GTF2A2;TAF12;ERCC3;GTF2H5;TAF4;GTF2H2;TAF2;POLR2C;TAF3;CCNT1;GTF2H3;NELFA;RNGTT;CCNT2;TAF13;CTDP1;GTF2B
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.6243733881079213,-1.0073675195184983,0.5217391304347826,0.8895928807973131,1.0,2/6,16.15%,RAB11FIP5;PTPRN
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.5906854991654492,-1.0072031044516718,0.463768115942029,0.8897597178975423,1.0,1/10,1.31%,TYMP
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.5068088695879912,-1.007155359663236,0.5072463768115942,0.8895802474999576,1.0,2/20,4.28%,PDPN;DUOX1
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,0.36428254166125584,1.0071215944557586,0.30434782608695654,0.963802850401269,1.0,8/77,9.15%,PIP5K1B;ACTR3C;MYO10;ACTR3B;AKT2;AKT1;MARCKSL1;PLA2G4C
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,0.4497243808253308,1.00704920578754,0.4117647058823529,0.9633458807812739,1.0,4/17,17.11%,VCPKMT;VCP;PRMT3;CAMKMT
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.6060542948354124,-1.0070038674962853,0.4909090909090909,0.889636094542981,1.0,1/6,6.29%,BRCA1
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.4694865916153307,-1.0069895879217332,0.46153846153846156,0.8893358875726018,1.0,6/39,12.60%,GRAMD2A;PLN;CAV3;EGF;PLPP4;NOS1
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,-0.37794909810602884,-1.006962996468354,0.3877551020408163,0.8891030449674521,1.0,52/386,16.94%,ARHGAP4;DOCK8;STMN2;TAGAP;VRK2;RHOBTB2;ARHGEF3;KIF14;PLEKHG6;DEPDC1B;ARHGAP9;PLEKHG2;ARHGAP15;TRIP10;RND2;ANLN;STEAP3;ARHGAP39;ARHGEF17;BASP1;BAIAP2;BAIAP2L1;ARHGDIG;WAS;LMNB1;PLD2;CDC42EP1;NHS;CDC42EP3;ARHGEF18;EPSTI1;RHOF;RHPN1;TPM4;OBSCN;FLOT1;RNASE1;UBXN11;NOXA1;SLITRK5;DLC1;VAV1;RASGRF2;DDRGK1;RHOD;ALDH3A2;MCAM;ERBIN;ARHGAP22;EMD;DOCK10;PDE5A
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.6318038480108916,-1.006825154239698,0.5490196078431373,0.8884994279829972,1.0,1/5,7.37%,PAPSS2
prerank,Reactome_2022__Transport And Synthesis Of PAPS R-HSA-174362,-0.6318038480108916,-1.006825154239698,0.5490196078431373,0.8884994279829972,1.0,1/5,7.37%,PAPSS2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.6318038480108916,-1.006825154239698,0.5490196078431373,0.8884994279829972,1.0,1/5,7.37%,PAPSS2
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,0.34792972363968994,1.006748449885495,0.35,0.9635665817963224,1.0,16/152,9.11%,SEM1;H2BC18;PSMD10;CDC25A;PSMA1;POLG2;H2BC21;PSMD11;KEAP1;USP13;H2BC4;USP12;PSMB5;VDAC2;RNF146;H2AC6
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.7013794034261145,1.006700340503968,0.574468085106383,0.9630495653488638,1.0,4/5,28.45%,WASHC2C;CARMIL2;CARMIL1;MTPN
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.5909546579727191,1.0065585423932257,0.4727272727272727,0.9622453731787687,1.0,5/7,40.23%,HGF;SIRT2;APPL2;NRP1;LGMN
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.5909546579727191,1.0065585423932257,0.4727272727272727,0.9622453731787687,1.0,5/7,40.23%,HGF;SIRT2;APPL2;NRP1;LGMN
prerank,KEGG_2021_Human__Salmonella infection,-0.3870713019325057,-1.0064699664377494,0.5054945054945055,0.8891422453434512,1.0,19/211,13.97%,LEF1;S100A10;TUBB6;TLR2;PODXL;TUBB1;NOD1;PFN4;PFN2;PLEKHM1;M6PR;BIRC3;ARPC5L;DCTN1;IL18;ELMO1;FADD;TNFRSF1A;FOS
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,-0.42000710473870695,-1.006419786832089,0.4268292682926829,0.8890137834188219,1.0,18/82,19.31%,COL4A1;TGFBR2;COL4A2;ICAM1;COL4A4;CCL2;CCND1;STAT1;FN1;PIM1;PIK3CB;PRKCD;PIK3CD;F3;PRKCB;TGFB1;PLCE1;COL4A3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.6171147175341389,-1.0060821380889773,0.49056603773584906,0.8895654994824882,1.0,2/7,22.95%,PTPRO;PTPRB
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.5704233995905214,-1.0060273248741798,0.5151515151515151,0.8893633004295921,1.0,1/10,5.11%,ATP23
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,0.45874434559068444,1.005999860049915,0.3611111111111111,0.9632780307350498,1.0,4/17,14.84%,NRAS;YES1;PIK3CA;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.49741893425071687,-1.005925954105589,0.43333333333333335,0.8893018529067409,1.0,3/20,7.85%,THBS1;APP;EGF
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,-0.41705505291548056,-1.0058738771870588,0.4383561643835616,0.8891065866934388,1.0,18/82,17.51%,TLR2;B2M;RPS27A;HLA-A;HLA-C;NDUFA2;PSMB9;CTSS;PSMB6;HLA-B;HLA-E;PSMC3;UBC;HLA-F;PSMA8;PSMA7;PSME1;MRC1
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.5248556381004309,-1.005870365759561,0.5606060606060606,0.8888077541077524,1.0,4/20,12.77%,RPS27A;NDUFA2;BIRC3;UBC
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.49395352921414654,1.0058526010476356,0.46153846153846156,0.9630886141305106,1.0,7/25,13.87%,TRIB3;DCUN1D2;UBE2N;DCUN1D1;BTRC;PLK1;DCUN1D5
prerank,Reactome_2022__NRIF Signals Cell Death From Nucleus R-HSA-205043,0.5486286911071898,1.005845760613518,0.4411764705882353,0.9624599920668527,1.0,2/13,1.39%,NGF;NCSTN
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.43678709289104645,-1.0058428298855957,0.5061728395061729,0.8885425775140003,1.0,13/77,13.10%,THBS1;HPN;TGFBR2;RAMP3;KLF4;AKR1C1;EGF;GADD45A;CCNB1;ROMO1;SFRP4;CD63;PAX8
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.5047507002882133,1.0056795474121223,0.475,0.9623168058514735,1.0,4/12,21.84%,GPHN;MOCS2;LIAS;NOXRED1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.5078840098328378,1.0055845492703988,0.4444444444444444,0.961946808066639,1.0,5/12,17.11%,PPEF1;GUCA1B;NMT2;METAP1;CAMKMT
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.6555531839300819,1.005573610993407,0.4772727272727273,0.9607095523363469,1.0,2/8,5.74%,POLG2;RFC3
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),0.6555531839300819,1.005573610993407,0.4772727272727273,0.9607095523363469,1.0,2/8,5.74%,POLG2;RFC3
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.5166836810187473,-1.005527787045882,0.5,0.8890799040977346,1.0,3/26,11.12%,SHTN1;IGSF10;DAB2IP
prerank,CellMarker_Augmented_2021__Lymphoid cell:Blood,0.387837306526634,1.0055146542132838,0.30434782608695654,0.960250745228048,1.0,5/59,3.13%,C1ORF162;CD247;ABCD2;LRRN3;KCNA2
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),0.611997485701568,1.0054614096591845,0.4772727272727273,0.9597397228002233,1.0,1/5,3.84%,TNFAIP3
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,-0.4041274112648893,-1.0053125452478566,0.47674418604651164,0.8894129974601145,1.0,38/150,20.30%,GRIN2D;GRIN3A;NEFL;KCNJ2;GRIN2A;ADCY7;GNG3;KIF17;GRIA3;GLRA2;GRIA1;AKAP5;NRGN;NCALD;PRKCG;RPS6KA1;GRIK1;GABRB2;CHRNA5;ADCY5;GNG2;GRIN2B;RNASE1;GABRG2;RASGRF2;GABRA1;ADCY8;PRKCB;CHRNE;MAPT;RPS6KA6;LRRC7;GLRA1;GABBR2;GABRA6;CHRNA6;GABRG3;GABRA3
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,0.41348389388826073,1.0052972705532142,0.34285714285714286,0.9596743339375056,1.0,13/50,15.23%,RAB33B;RAB23;RAB27A;RAB8B;RAB22A;RAB1B;RAB39B;RAB4A;RAB7B;RAB26;RAB21;RAB8A;RAB9A
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.4987264963290004,-1.005148500399065,0.4864864864864865,0.8895587799320246,1.0,6/26,13.60%,ANK3;KCNB1;CEMIP;PDZK1;DMTN;SLC51B
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.42795562460092895,1.005111583705414,0.3793103448275862,0.9596165685995052,1.0,7/24,18.26%,DAO;BLMH;IDO1;ACADSB;DDO;THNSL2;PRODH
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.5808413039859865,1.0050608554778664,0.5,0.958500235223166,1.0,5/7,38.73%,GABPA;MAPK1;PRKN;ATF4;LRRK2
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.5808413039859865,1.0050608554778664,0.5,0.958500235223166,1.0,5/7,38.73%,GABPA;MAPK1;PRKN;ATF4;LRRK2
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.5315062345883759,-1.0047755203068927,0.5081967213114754,0.8902254013648571,1.0,6/14,17.15%,ADCY7;ADCY5;ADCY3;GUCY2C;GUCY1A1;ADCY8
prerank,"Reactome_2022__SMAC, XIAP-regulated Apoptotic Response R-HSA-111469",-0.6125480019570667,-1.0047426599864824,0.4838709677419355,0.890020279262555,1.0,1/7,7.11%,SEPTIN4
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5550941906374649,-1.0045922144172876,0.4666666666666667,0.8895291733709731,1.0,1/11,7.60%,ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5550941906374649,-1.0045922144172876,0.4666666666666667,0.8895291733709731,1.0,1/11,7.60%,ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5550941906374649,-1.0045922144172876,0.4666666666666667,0.8895291733709731,1.0,1/11,7.60%,ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.5171950446791456,-1.0045872380077987,0.5172413793103449,0.8892212575366375,1.0,3/23,8.24%,TRPC3;CCL2;GRM6
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),0.53671681376001,1.0044107076545428,0.47368421052631576,0.959503905108164,1.0,3/9,30.43%,SLC5A6;PCCA;PDZD11
prerank,Reactome_2022__Activation Of G Protein Gated Potassium Channels R-HSA-1296041,-0.5271397808022831,-1.0043793585832772,0.44285714285714284,0.8894200594786275,1.0,7/19,22.72%,KCNJ2;GNG3;GNG2;GABBR2;KCNJ6;GNB4;GNB5
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.5057450690215942,1.004284528766189,0.5,0.9592584914969224,1.0,6/17,17.34%,CRPPA;TMTC4;FKRP;POMT2;TMTC3;DPM1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3592441067244433,1.0042563585298443,0.23809523809523808,0.9586979159786949,1.0,15/79,23.19%,PRDX6;RBM23;SF3B4;NOVA1;PCBP4;NSRP1;HNRNPU;RBFOX1;QKI;FXR2;RBMX;RBM15;MBNL1;RBM39;JMJD6
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.6635029152393955,1.004249240470146,0.475,0.9580780299461913,1.0,1/5,10.04%,ATIC
prerank,CellMarker_Augmented_2021__Unrestricted Somatic Stem cell:Undefined,-0.6701188983113134,-1.0041591207121532,0.559322033898305,0.8896986641875159,1.0,2/5,7.03%,THY1;CD44
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.5874715342388765,-1.004148945127414,0.5230769230769231,0.8894243160622199,1.0,2/8,4.94%,PRDX4;PRDX5
prerank,Reactome_2022__FGFR2b Ligand Binding And Activation R-HSA-190377,-0.6590426717413136,-1.0040928532149425,0.5686274509803921,0.8892633380096517,1.0,3/6,16.48%,FGF1;FGF7;FGF22
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,-0.38190259565828305,-1.0039716837638923,0.5,0.8892655206949142,1.0,65/252,19.40%,THBS1;COL4A1;EFNA1;MET;TLR2;COL4A2;LAMB1;ITGA2;COL4A4;CHAD;CHRM1;COL6A2;GNG3;ITGA5;THBS3;BRCA1;CCND1;YWHAH;EGF;ITGA8;OSMR;IGF1;IL4R;TGFA;ITGA11;THBS2;CREB5;FGF1;SYK;FN1;LPAR6;LPAR4;CCNE2;GNG2;FGF7;ITGA9;IL7;MTCP1;NR4A1;ITGA3;BDNF;RPS6;IL3RA;PIK3CB;LAMA3;RELN;PIK3CD;CDK2;ITGB4;CCND2;FGF22;COL9A2;TSC2;TEK;CDC37;SPP1;CREB3;ANGPT2;CDKN1A;PCK2;LAMA5;PDGFRA;COL4A3;GYS1;GHR
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.4838954826747284,-1.0039626518395874,0.44871794871794873,0.88896501032668,1.0,1/31,0.11%,LEF1
prerank,CellMarker_Augmented_2021__Proximal Tubular cell:Kidney,-0.5143316855878177,-1.0037667844477767,0.43103448275862066,0.8891900791323508,1.0,8/24,14.05%,CD5;TAGAP;GPR171;SLA;ARHGAP15;SELP;P2RY10;THEMIS
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,-0.4787351784444855,-1.0036566014981723,0.4925373134328358,0.8891523986797732,1.0,7/34,17.63%,ADCY7;GNG3;ITGA5;ADCY5;GNG2;ADCY8;GPER1
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.5801479686184827,-1.0033087805590732,0.4864864864864865,0.8897992264656607,1.0,3/11,17.49%,IGF1;SLC51B;SOAT1
prerank,Reactome_2022__Processing And Activation Of SUMO R-HSA-3215018,0.5814102465356256,1.0033002381732197,0.5,0.9603020923447226,1.0,4/8,32.86%,SUMO2;SENP2;SENP5;SENP1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.40230147732022836,1.0031649676692005,0.36363636363636365,0.9600792901604359,1.0,8/47,16.85%,PPARGC1A;PLD6;MCU;MFF;RALA;MUL1;MIEF2;BAD
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.3850878189842844,1.0031091459259096,0.3939393939393939,0.9596545054984503,1.0,10/56,11.34%,ERCC8;LIG4;SMARCAL1;BRCC3;UBE2N;ERCC6;DCLRE1B;HMGB1;CYREN;PSMD14
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.42845736592479333,1.0030697318405504,0.5,0.9591179800951086,1.0,3/29,4.15%,WNT7A;CEL;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.5047903340751917,1.003011021058809,0.42857142857142855,0.9586120903779737,1.0,3/16,3.97%,RGCC;BMP2;RUNX1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.44980071591987536,-1.0029498126496939,0.5074626865671642,0.8904788089669192,1.0,3/52,8.23%,TRIM22;TRIM5;TRIM17
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.6441507698269977,1.0029071992605876,0.5277777777777778,0.9581891141287641,1.0,2/5,25.69%,SEC61A1;SEC61A2
prerank,Reactome_2022__Histidine Catabolism R-HSA-70921,0.6114713576597671,1.0028376796126661,0.48484848484848486,0.9577293355956077,1.0,1/6,2.23%,CARNMT1
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.49702566171393703,1.002742682790775,0.45161290322580644,0.9573971029225975,1.0,2/17,5.74%,POLD3;RFC3
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.49061850651259065,-1.0026921744587352,0.5,0.8908524345399935,1.0,8/27,18.48%,KCNB1;SLC39A14;RAB11FIP5;PDK3;PTPRN;ADCY8;GPER1;PCK2
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.5109206106576285,-1.0024613202435368,0.5147058823529411,0.8911394955644515,1.0,5/22,17.26%,RPS27A;RPA3;UBC;RPA1;POLD1
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.5627931373768921,1.0023921789061605,0.4878048780487805,0.9576473552623455,1.0,4/10,18.05%,MCU;MAIP1;MICU2;MICU3
prerank,KEGG_2021_Human__Basal cell carcinoma,-0.4413879363173936,-1.0021637661074916,0.47297297297297297,0.8915424822435224,1.0,6/50,12.15%,LEF1;WNT8B;GADD45A;WNT5A;HHIP;GLI1
prerank,Reactome_2022__Anchoring Fibril Formation R-HSA-2214320,0.5959902998972183,1.0021326741333805,0.4772727272727273,0.9577257618231397,1.0,2/5,14.08%,TLL2;LAMA4
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.6110320150394184,-1.0020175893496657,0.46875,0.8916201342293414,1.0,2/9,16.44%,GINS2;CDC7
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),-0.5947363435045795,-1.0019939195382446,0.5,0.8913794297598557,1.0,2/9,4.21%,SULT1C3;CHST4
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.4819311247207262,-1.0019826699131786,0.5135135135135135,0.8910924939307656,1.0,7/37,19.49%,ATG9A;SPATA18;MAP1LC3A;PINK1;WDR45;GABARAPL1;GABARAPL2
prerank,"Reactome_2022__TICAM1,TRAF6-dependent Induction Of TAK1 Complex R-HSA-9014325",-0.5763404598848866,-1.0019107291724894,0.5,0.8909846792071312,1.0,3/11,12.77%,RPS27A;TLR3;UBC
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.6688818246979471,-1.0018375086105995,0.5740740740740741,0.8908636926336794,1.0,1/6,4.39%,SIGLEC1
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),0.5120572292026583,1.0018309782927854,0.42857142857142855,0.957841326966527,1.0,4/14,17.93%,RBBP4;H1-2;NOC2L;CDAN1
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.4420695804268846,1.0016119652988362,0.3870967741935484,0.9578077914533638,1.0,6/26,18.30%,UBE2T;ANAPC13;ANAPC1;CDC26;RNF26;UBE2E3
prerank,CellMarker_Augmented_2021__Monocyte:Plasma,-0.49539210182372173,-1.0015299749095505,0.4647887323943662,0.8909794306293732,1.0,10/25,13.63%,P2RY13;TYMP;TLR2;SIGLEC1;IGSF6;CLEC12A;CTSS;PILRA;SLC11A1;CLEC5A
prerank,CellMarker_Augmented_2021__Monocyte:Synovium,-0.49539210182372173,-1.0015299749095505,0.4647887323943662,0.8909794306293732,1.0,10/25,13.63%,P2RY13;TYMP;TLR2;SIGLEC1;IGSF6;CLEC12A;CTSS;PILRA;SLC11A1;CLEC5A
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.5492154887215007,-1.001432788291178,0.5223880597014925,0.8909082033864634,1.0,2/16,4.28%,ALOX12;DUOX1
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.4308394794845868,1.0013621089472087,0.40540540540540543,0.9578636105773748,1.0,9/39,10.69%,CPAMD8;ADAMTS18;FREM2;ZDHHC16;SMG9;PBX1;CEP290;ATF6;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.5833217866161544,-1.0013429889543548,0.4852941176470588,0.8907907229519292,1.0,3/10,11.40%,PRKCQ;SYK;HLA-E
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.38529495606832875,1.001287916935339,0.4,0.9573466561424404,1.0,13/70,14.90%,TBC1D4;PDE3B;TRIB3;KAT2B;AKT2;AKT1;RAB8B;INSIG2;LPIN3;EPM2AIP1;GPLD1;PIK3R1;RAB8A
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5714830856405146,-1.0012861811565943,0.5483870967741935,0.8906270385138508,1.0,2/13,13.34%,ZFP36;DND1
prerank,KEGG_2021_Human__Pathways in cancer,-0.3749014343966474,-1.0011760734628428,0.5,0.8905196561638815,1.0,72/406,17.95%,LEF1;RASGRP1;COL4A1;CDKN2A;IL13RA1;MET;TGFBR2;RASGRP2;COL4A2;LAMB1;WNT8B;ITGA2;COL4A4;IL12A;STAT4;IL15;ADCY7;GNG3;CTNNA3;RALGDS;PLD1;GSTM5;CCND1;EGF;IFNGR2;PRKCG;GADD45A;PLD2;IGF1;STAT1;IL4R;WNT5A;TGFA;FGF1;BIRC3;ADCY5;HHIP;FN1;LPAR6;GLI1;LPAR4;CCNE2;GNG2;PIM1;FADD;FGF7;PAX8;IL7;FOS;TXNRD2;ITGA3;IL3RA;ELOB;PIK3CB;LAMA3;PIK3CD;CDK2;CCND2;ADCY3;MAX;FGF22;STAT6;PML;ADCY8;PRKCB;NOTCH3;ETS1;RBX1;GADD45B;RASSF1;DAPK3;TGFB1
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.5708656494494458,1.0009696719836363,0.40625,0.9575959569626747,1.0,2/8,1.24%,LEPR;NR1D1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.49612355406131536,1.0007915890861092,0.44,0.9574289676159413,1.0,6/15,23.52%,NIPBL;GLI3;BMPR1B;PCSK5;MBNL1;MYH3
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.47963155706796606,-1.0006638424116512,0.5064935064935064,0.8915753201885603,1.0,3/52,3.82%,APIP;B2M;KCNJ2
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.5552161466248634,-1.00050415626881,0.4807692307692308,0.8916955659787202,1.0,2/11,16.10%,APP;ATOX1
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.5363347719092588,-1.0003404370399966,0.49206349206349204,0.8919114717008396,1.0,1/12,1.11%,APLNR
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.6685641692805008,-1.0000539899985674,0.4915254237288136,0.8923384493002023,1.0,2/6,9.24%,ALOX12;IGF1
prerank,Reactome_2022__Generic Transcription Pathway R-HSA-212436,0.30147530616596563,1.0,1.0,0.9567379625843877,1.0,217/975,17.67%,ZNF300;RGCC;ZNF697;ZNF287;ZNF804B;SEM1;ZNF615;ZNF202;ZNF415;CCNG2;NR1D1;CCNE1;DNA2;KCTD1;BMP2;PPARGC1A;ZNF441;ZNF195;AIFM2;PTPN4;ZNF212;CNOT9;PSMD10;NR2E1;ZNF778;ZSCAN25;ZNF658;ZNF426;MEN1;NRAS;SMYD2;ELOC;OCLN;RARB;RUNX1;PSMA1;ZNF624;KMT5A;TXNIP;ZNF556;H2BC21;COX18;ZFP2;MAML3;ZNF555;KCTD15;PSMD11;SOX9;ZNF616;LMO1;PHC1;KAT2B;RNF2;ZNF706;H2BC4;EGFR;AKT2;RFC3;ANAPC1;TACO1;CDK8;CUL1;ZNF707;ZNF613;ZNF304;ZNF74;ZNF577;ESRRG;ZNF484;YES1;ZNF684;TRIM28;AKT1;EED;GTF2F2;PSMB5;ZNF786;ELOA;RORB;ZNF320;ZNF680;ZNF268;ERCC2;PRKAB1;NRBF2;ZNF211;GRIA2;TP53RK;ZNF839;ZNF782;PCBP4;ZNF561;YY1;ZNF696;PRMT6;NR3C1;ZNF595;NFYC;ZNF774;YAF2;RBBP4;CSNK2A2;H2AC6;ZNF12;ZNF133;MSH2;ZNF587;ZNF510;ZNF543;ZNF496;ZNF155;ZNF665;ZNF875;SESN2;PPM1A;ZNF703;NOTCH2;ZNF347;RRM2B;ZNF677;HUS1;ZNF676;ZNF761;ZNF669;TAF12;LRPPRC;ESRRA;TTC5;TP53BP2;UBE2D1;ZNF33A;PSMD14;ZNF736;ZNF792;KMT2A;ZNF793;RBM14-RBM4;PLAGL1;ZNF214;CSF1R;RNF141;MAP4K2;CRH;SOCS4;RRAD;CNOT2;ZNF254;PRDX1;COX19;CRADD;ERCC3;ZNF138;KAT2A;GTF2H5;TAF4;ZNF14;E2F4;ZNF382;ZNF324B;ZNF354B;H3-3B;GTF2H2;PSMD12;ZNF324;ZNF764;RAD9B;ZNF530;ZNF18;ATRIP;ZNF416;ZNF429;ZNF189;NFKB1;CDC26;ZNF43;ZNF519;HDAC2;TAF2;PIP4K2B;ZNF558;CTSV;POLR2C;ZNF75A;COX7A2L;TMEM219;WWOX;ZNF425;EP300;SMARCA2;ZNF471;ZNF25;ZNF34;SESN3;MGA;BRPF3;NR2F1;RBFOX1;ZNF492;NR1D2;CNOT8;ZNF470;ZNF521;SCMH1;LIFR;ZNF688;NOC2L;CNOT6L;ZNF248;ING3;PHC3;ZNF589;AGO3;ZNF611;NR3C2;ZNF41;BRD7;CNOT1
prerank,CellMarker_Augmented_2021__Meiotic Prophase Fetal Germ cell:Fetal Gonad,0.26333811207823365,1.0,1.0,0.9567379625843877,1.0,237/877,22.84%,SLC26A7;NBPF10;RNF6;MSH4;GLCCI1;RANBP17;LCMT2;CCDC121;KLHL8;GLIPR1L2;ARV1;ZNF441;PDIK1L;CETN3;TBCCD1;PTPN4;ANKRD7;TEX15;PSMD10;DNAH7;SPAG16;IQUB;CARF;ANKRD50;LRRC36;DGKE;GSKIP;BBS10;KIF21A;AK1;LCORL;SNAP91;ME2;SCML2;ZNF800;C1D;MAPK10;USP40;CSAD;NUDT21;ABHD5;EAF2;CCNB1IP1;DNAJB11;ARHGAP5;C9ORF43;ZFYVE16;ZBTB18;DZIP1;TDRD6;FBXL3;TBC1D19;PIGP;C16ORF95;DNAJC27;NR3C1;ADNP2;SLC35G2;ZNF595;CHD9;VPS37A;RAVER2;FBXO15;PPP1R36;HSF2;ZDHHC13;C17ORF75;LYRM1;RBM41;PRKACB;GOLGA1;FAM204A;LCOR;FLYWCH2;CSTF3;NOTCH2;ITPRID2;PCM1;COG6;NIPBL;PLEKHF2;AFTPH;GARNL3;TAF12;BRWD1;TRMT1L;NSRP1;VEZF1;ERGIC3;NUP214;RASA2;TRAPPC8;TM2D1;RAB28;TSC22D2;ADSS2;NSUN7;SLC35F5;ZNF346;MYCBPAP;PLEKHA3;DNAH12;EPM2AIP1;ZCCHC9;VAPA;SH3RF1;SYDE2;NBPF8;FBXO38;ACVR2A;RANBP6;C1ORF146;ERCC3;SNAPC1;CHMP2B;BAZ1A;STK17B;SEC24A;RAE1;EP400;MLLT10;GALNS;RPS6KA3;RAD9B;POLK;TAPT1;UNC119B;TMEM70;ANKRD31;IQCB1;PAIP1;ZNF43;POT1;TASOR;MBIP;LEAP2;KIAA1586;STT3A;S100PBP;HDAC2;CDKN2C;ID2;SRR;THAP10;ILKAP;CIAPIN1;SCAF4;RC3H1;MGA;HINFP;HERC2;NR2F1;PARD6B;MTX2;GOLGA7;DENND5B;PIK3C2A;AGO3;GPR89B;TMEM175;CCDC88A;FH;UBE2E3;YTHDF2;DR1;ATAD2B;CD58;NPC2;SIMC1;CEP120;EPS15;SCEL;SOCS7;FXR2;KLHL20;DMC1;PCID2;CLNS1A;ZCCHC17;FBRS;RIBC2;HESX1;ALG13;LZIC;LUZP1;DCK;RAB3IP;HERC1;SEC22C;TMEM263;NUP210;PPP4R4;TMED2;PDHA1;FAM9B;STK31;NOL8;PPIL6;WDR11;NFAT5;FAM217B;MARK1;DECR1;ZNF398;CEP83;NCOA5;ZFR;VPS29;USP47;HFM1;CDIP1;RALGPS2;THAP2;SMG1;RBM15;PTPN13;TMEM116;STRIP2;LRRC49;AAGAB;RABL2A;DDAH1;CLIP4;ACBD3;CAND1;CDK12;ATPAF2;LZTFL1;MEX3C;FRA10AC1;PTK2;LAMTOR3;TRIP12;RNF182;GTF3C3;DNAL1;ZCCHC7
prerank,Reactome_2022__Gene Expression (Transcription) R-HSA-74160,0.32163347545687143,1.0,1.0,0.9567379625843877,1.0,267/1212,17.67%,ZNF300;RGCC;ZNF697;ZNF287;ZNF804B;SEM1;ZNF615;ZNF202;ZNF415;CCNG2;NR1D1;CCNE1;DNA2;KCTD1;NUP42;BMP2;U2AF1;PPARGC1A;TFB2M;INTS13;ZNF441;ZNF195;AIFM2;PLD6;PTPN4;ZNF212;CNOT9;PSMD10;NR2E1;ZNF778;ZSCAN25;ZNF658;ZNF426;MEN1;NRAS;SMYD2;ELOC;OCLN;DDX56;RARB;ZC3H8;NUP37;RUNX1;PSMA1;ZNF624;KMT5A;TXNIP;SNAPC5;ZNF556;H2BC21;COX18;MTERF1;ZFP2;MAML3;ZNF555;KCTD15;POLR3B;PSMD11;SOX9;ZNF616;LMO1;PHC1;KAT2B;RNF2;ZNF706;H2BC4;EGFR;POLR3F;AKT2;RFC3;ANAPC1;TACO1;CDK8;CUL1;ZNF707;ZNF613;ZNF304;NUP54;ZNF74;ZNF577;ESRRG;ZNF484;NUDT21;YES1;ZNF684;TRIM28;SNRPF;AKT1;EED;ERCC6;GTF2F2;PSMB5;DNMT3B;ZNF786;ELOA;UBTF;RORB;ZNF320;BRF2;ZNF680;ZNF268;ERCC2;PRKAB1;NRBF2;ZNF211;GRIA2;TP53RK;ZNF839;ZNF782;WDR33;PCBP4;ZNF561;TDRD6;YY1;ZNF696;PRMT6;NR3C1;ZNF595;NFYC;ZNF774;YAF2;IPO8;RBBP4;CSNK2A2;H2AC6;ZNF12;PRKRA;ZNF133;MSH2;ZNF587;ZNF510;ZNF543;ZNF496;ZNF155;ZNF665;ZNF875;GTF2A2;SESN2;PPM1A;ZNF703;CSTF3;NOTCH2;ZNF347;CPSF6;INTS7;RRM2B;ZNF677;DROSHA;PAPOLA;HUS1;NDC1;ZNF676;ZNF761;ZNF669;TAF12;LRPPRC;ESRRA;TTC5;TP53BP2;UBE2D1;ZNF33A;PSMD14;ZNF736;ZNF792;NUP214;KMT2A;ZNF793;RBM14-RBM4;PLAGL1;ZNF214;POLR1F;CSF1R;RNF141;CPSF7;MAP4K2;CRH;SOCS4;RRAD;CNOT2;ZNF254;PRDX1;COX19;CRADD;ERCC3;SNAPC1;ZNF138;SAP130;KAT2A;SNAPC3;GTF2H5;TAF4;ZNF14;INTS8;E2F4;ZNF382;ZNF324B;ZNF354B;H3-3B;GTF2H2;PSMD12;ZNF324;ZNF764;RAD9B;ZNF530;ZNF18;ATRIP;DPEP2;BDP1;ZNF416;ZNF429;ZNF189;RRN3;TAF8;NFKB1;CDC26;AAAS;ZNF43;ZNF519;NUP188;AEBP2;THOC3;HDAC2;TAF2;PIP4K2B;IWS1;PIWIL4;ZNF558;CTSV;POLR2C;POU2F1;ZNF75A;COX7A2L;TMEM219;WWOX;ZNF425;EP300;SMARCA2;NUP205;ZNF471;ZNF25;ZNF34;SESN3;MGA;BRPF3;NR2F1;RBFOX1;ZNF492;THOC1;NR1D2;CNOT8;ZNF470;ZNF521;SCMH1;LIFR;ZNF688;NOC2L;CNOT6L;ZNF248;ING3;PHC3;ZNF589;AGO3;ZNF611;NR3C2;ZNF41;BRD7;CNOT1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.2685959509922261,1.0,1.0,0.9567379625843877,1.0,330/1616,17.74%,MEOX2;POU6F2;ZNF300;WNT7A;POU3F1;RGCC;ASCL1;ZNF697;ZNF287;TFCP2L1;ETV5;ZNF615;ZNF202;ZNF415;NR1D1;SOX8;ZNF783;KCTD1;BMP2;RITA1;MED21;POU3F4;PPARGC1A;ZFP3;ZNF441;PRDM6;SOX21;IRF2BP1;RTRAF;ANXA4;ZNF212;KDM1B;ZNF525;PSMD10;CEBPA;NR2E1;ZNF358;SERPINF2;DACH1;ZNF778;ZSCAN25;ZBTB43;ZNF107;EHF;ID1;ZNF658;MITF;ZNF426;MEN1;CARF;SMYD2;ELOC;RARB;ZSCAN20;RUNX1;HSF5;ZNF24;ZNF624;KMT5A;ZXDA;POU3F2;LCORL;BCLAF3;ZNF556;ZBTB37;ZFP2;MAML3;ZNF555;HCLS1;GREM1;TRIB3;HES6;OTX1;SOX9;ZNF616;LMO1;ZNF319;KAT2B;RNF2;ZBTB9;EGFR;FOXP1;MTF1;THAP11;SMAD5;ATF5;CDK8;SMARCAL1;ZNF707;ZNF384;ZNF613;PRDM4;ZNF304;ZNF74;ZNF577;ESRRG;GRHL1;ZNF484;ZNF684;TRIM28;ZNF639;EED;EAF2;SOX12;DNMT3B;ZNF786;FRK;ELOA;ZBTB40;ZNF883;RORB;KLF16;ZNF320;ZNF852;TSHZ1;ZNF268;NCOA3;ZBTB39;THAP1;ZNF211;SNF8;SIRT6;ZNF782;ZFHX4;RNF14;ZBTB18;PBX1;ZNF561;ZBTB33;DPF1;AR;ELK4;YY1;ZNF696;NR3C1;ZSCAN23;LMO7;PHF10;ZNF595;NFYC;ZNF774;HSF1;CAPRIN2;JDP2;ARID3B;HMGB1;ETV1;SLC2A4RG;FOXJ1;ZNF12;ZBTB6;SALL1;NRIP1;GABPB1;HSF2;ZNF133;ZNF518A;ZNF587;ZNF510;ZNF543;ZNF496;SLC30A9;ZNF155;EBF4;ZGLP1;ZNF665;LCOR;PHF14;ZNF875;ZNF181;PLK1;ZIC2;KCNIP3;FOXJ2;LPIN3;PPM1A;TIAL1;MIER3;ATF6;ZNF347;ANKRD2;ZSCAN22;ZNF677;HEYL;HLF;NUFIP1;NIPBL;ZXDB;FOXJ3;ZNF397;ZNF121;ZNF761;ZNF669;NCK1;ZXDC;ZNF408;ESRRA;BRWD1;SSBP3;ARX;ZBTB2;UBE2D1;TENM2;ZNF33A;VEZF1;ZNF792;MXD3;KMT2A;EMX2;ZNF793;PATZ1;BRWD3;SALL3;PLAGL1;ZNF214;CSF1R;SPEN;TRPS1;SOX5;DVL2;HEXIM2;ZNF451;CNOT2;ZNF254;ZNF276;ACVR2A;ZNF283;TOX;HTATSF1;WASL;SAP130;BAZ1A;KAT2A;ZEB2;GTF2H5;KLF12;ZNF14;E2F4;ZNF382;ZNF324B;ZNF354B;GTF2H2;GTF2H2C;ELP2;ZNF527;MYNN;ZNF230;MLLT10;ZNF324;ZNF764;PRDM5;RPS6KA3;RNASEL;KAT7;ZNF530;ZNF18;PLAGL2;ZNF416;ZNF429;PRKD1;ZNF507;ZNF189;NFKB1;PEX2;PIK3R1;ZNF43;AEBP2;MAMSTR;PURG;MCPH1;HDAC2;FIZ1;ZBTB20;HNRNPU;LHX2;ZNF558;POU2F1;ZNF264;ZNF75A;ID2;NCK2;WWOX;ZNF91;ZNF425;EP300;TADA1;SMARCA2;NRF1;ZNF471;ZNF25;CPEB3;ZNF34;BACH1;ETS2;MGA;HINFP;PBX2;NR2F1;DCAF1;ZHX2;NR1D2;ELP4;ZNF470;ZNF521;NKRF;ZNF322;ZNF688;ZBTB34;CREG1;NOC2L;IRF2BPL;OLIG1;ZFP82;NCOA2;ZNF248;ZNF865;ZNF589;AGO3;ELK1;AKIRIN2;ZNF611;NR3C2;BEND3;ZNF879;VHL;ZNF41;BRD7;CNOT1;MYPOP;CEBPG
prerank,Reactome_2022__RNA Polymerase II Transcription R-HSA-73857,0.30993947808338324,1.0,1.0,0.9567379625843877,1.0,238/1087,17.67%,ZNF300;RGCC;ZNF697;ZNF287;ZNF804B;SEM1;ZNF615;ZNF202;ZNF415;CCNG2;NR1D1;CCNE1;DNA2;KCTD1;BMP2;U2AF1;PPARGC1A;INTS13;ZNF441;ZNF195;AIFM2;PTPN4;ZNF212;CNOT9;PSMD10;NR2E1;ZNF778;ZSCAN25;ZNF658;ZNF426;MEN1;NRAS;SMYD2;ELOC;OCLN;RARB;ZC3H8;RUNX1;PSMA1;ZNF624;KMT5A;TXNIP;SNAPC5;ZNF556;H2BC21;COX18;ZFP2;MAML3;ZNF555;KCTD15;PSMD11;SOX9;ZNF616;LMO1;PHC1;KAT2B;RNF2;ZNF706;H2BC4;EGFR;AKT2;RFC3;ANAPC1;TACO1;CDK8;CUL1;ZNF707;ZNF613;ZNF304;ZNF74;ZNF577;ESRRG;ZNF484;NUDT21;YES1;ZNF684;TRIM28;SNRPF;AKT1;EED;GTF2F2;PSMB5;ZNF786;ELOA;RORB;ZNF320;ZNF680;ZNF268;ERCC2;PRKAB1;NRBF2;ZNF211;GRIA2;TP53RK;ZNF839;ZNF782;WDR33;PCBP4;ZNF561;YY1;ZNF696;PRMT6;NR3C1;ZNF595;NFYC;ZNF774;YAF2;RBBP4;CSNK2A2;H2AC6;ZNF12;ZNF133;MSH2;ZNF587;ZNF510;ZNF543;ZNF496;ZNF155;ZNF665;ZNF875;GTF2A2;SESN2;PPM1A;ZNF703;CSTF3;NOTCH2;ZNF347;CPSF6;INTS7;RRM2B;ZNF677;PAPOLA;HUS1;ZNF676;ZNF761;ZNF669;TAF12;LRPPRC;ESRRA;TTC5;TP53BP2;UBE2D1;ZNF33A;PSMD14;ZNF736;ZNF792;KMT2A;ZNF793;RBM14-RBM4;PLAGL1;ZNF214;CSF1R;RNF141;CPSF7;MAP4K2;CRH;SOCS4;RRAD;CNOT2;ZNF254;PRDX1;COX19;CRADD;ERCC3;SNAPC1;ZNF138;KAT2A;SNAPC3;GTF2H5;TAF4;ZNF14;INTS8;E2F4;ZNF382;ZNF324B;ZNF354B;H3-3B;GTF2H2;PSMD12;ZNF324;ZNF764;RAD9B;ZNF530;ZNF18;ATRIP;ZNF416;ZNF429;ZNF189;TAF8;NFKB1;CDC26;ZNF43;ZNF519;THOC3;HDAC2;TAF2;PIP4K2B;IWS1;ZNF558;CTSV;POLR2C;POU2F1;ZNF75A;COX7A2L;TMEM219;WWOX;ZNF425;EP300;SMARCA2;ZNF471;ZNF25;ZNF34;SESN3;MGA;BRPF3;NR2F1;RBFOX1;ZNF492;THOC1;NR1D2;CNOT8;ZNF470;ZNF521;SCMH1;LIFR;ZNF688;NOC2L;CNOT6L;ZNF248;ING3;PHC3;ZNF589;AGO3;ZNF611;NR3C2;ZNF41;BRD7;CNOT1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.45455770588843286,-0.9999071997246137,0.4473684210526316,0.8924319037979854,1.0,4/29,12.35%,LZTS1;YWHAH;IL1RAPL1;HECW2
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,0.3947164321063602,0.999904122133656,0.5333333333333333,0.9564020142631948,1.0,20/42,30.40%,ELOC;GTF2F2;ELOA;ERCC2;ERCC3;GTF2H5;GTF2H2;POLR2C;CCNT1;GTF2H3;NELFA;CCNT2;CTDP1;CCNH;TCEA1;POLR2A;POLR2K;POLR2D;SUPT16H;POLR2E
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5575624727770341,-0.999719827005033,0.5333333333333333,0.8926374259543746,1.0,1/11,3.94%,ATF3
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,0.40619668031279743,0.9995848643169439,0.34615384615384615,0.9566802063092049,1.0,6/44,6.69%,CD247;TRIB3;THEM4;AKT2;YES1;AKT1
prerank,Reactome_2022__Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.5373209545178728,-0.999438737020583,0.5074626865671642,0.8931131474411349,1.0,2/20,9.91%,TUBB6;TCP1
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.39690623693589155,0.9993768971881805,0.5172413793103449,0.9566550792381958,1.0,8/44,8.12%,CSPG5;CHST11;SDC4;SDC3;CSGALNACT1;GPC5;CHST7;BCAN
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.4331642083542969,0.999299302644891,0.46875,0.9562829196538525,1.0,2/19,7.35%,NCOA4;ZFYVE16
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),0.6097320136176487,0.9988409824844581,0.5686274509803921,0.9570181785828825,1.0,2/5,25.53%,PDCL3;DNAJB2
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.5556972470135905,0.9988234326177926,0.40476190476190477,0.9564029000043961,1.0,6/10,30.11%,RBBP4;NOC2L;CDAN1;MTA2;M1AP;SUPT16H
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.5320964041269487,-0.9987726778023202,0.5,0.8945377002958904,1.0,5/14,20.40%,BEST1;ABCB1;ABCC1;ABCG2;CXADR
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.4106408763820031,-0.9985575389093632,0.5,0.8948147410707769,1.0,9/85,12.77%,LEF1;CDKN2A;RPS27A;TEAD2;CCND1;PSMB9;PSMB6;PSMC3;UBC
prerank,KEGG_2021_Human__Synaptic vesicle cycle,0.35375056263882987,0.9985096609585654,0.45,0.9568202163804208,1.0,5/61,8.89%,SLC6A13;ATP6V0D2;ATP6V1A;ATP6V1G1;AP2B1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.48501341680590354,0.9980208824006449,0.42424242424242425,0.9575757884587905,1.0,2/12,6.69%,FGL1;AKT1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.4215826882377067,-0.9979880403364226,0.4507042253521127,0.8960828975582634,1.0,15/83,17.67%,IL1R1;RPS27A;ST18;NOD1;PSMB9;PSMB6;PSMC3;TNIP2;UBC;PSMA8;IL1RAP;PSMA7;PSME1;RIPK2;RBX1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex1:Brain,0.45502312282452867,0.9979354010945716,0.4594594594594595,0.9571895185379555,1.0,3/13,14.66%,CCDC88C;PDGFD;SERPINE2
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Blood,-0.3810238377713881,-0.9978398619165857,0.5268817204301075,0.8962406770180733,1.0,15/260,6.21%,IFI44L;P2RY6;TUBB6;GPR183;TGFBR2;P2RY14;SERPINF1;SPON2;PHEX;COBLL1;SCN9A;APP;PDCD1LG2;COL24A1;SPNS3
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.5827435338041809,-0.9977606689447337,0.532258064516129,0.8961416417459428,1.0,2/8,11.72%,CBLN2;DCTN1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.5507050726041983,-0.9976449403196156,0.4868421052631579,0.8960920249623637,1.0,2/15,5.91%,P2RY12;TRPC3
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.5344860322789611,-0.9972930538493463,0.5217391304347826,0.8966771715542434,1.0,2/17,2.27%,B3GALT2;NDST4
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.4320109394945423,0.9972670433492928,0.5172413793103449,0.9584661190385029,1.0,9/31,17.22%,KMT5A;NCAPH2;CSNK2A1;CSNK2A2;PLK1;H1-2;TENT4A;MCPH1;DFFB
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,0.36517695010677287,0.9970730993738303,0.375,0.9584179116130782,1.0,3/56,6.82%,FGF6;NRAS;GTF2F2
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.45984560441284006,-0.9968020747475834,0.46835443037974683,0.8976794294222066,1.0,10/58,10.57%,CLIC1;ANO2;BEST1;GLRA2;SLC26A8;ANO9;CLIC4;GABRE;GABRB2;GABRD
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,0.38502074269901004,0.9966852868883707,0.4782608695652174,0.9588252237137058,1.0,18/74,16.56%,POLD3;SLC19A1;ERCC8;COPS2;RFC3;COPS8;ERCC6;ERCC2;COPS7A;ERCC3;GTF2H5;GTF2H2;POLK;POLR2C;EP300;AQR;PPIE;HMGN1
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.633561975089571,-0.9966348487400434,0.5614035087719298,0.8978692326548039,1.0,1/7,1.30%,ALDOB
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.42607477696522444,-0.9964868473697298,0.5128205128205128,0.8978880679876481,1.0,7/93,6.11%,COL4A1;CALD1;COL4A2;LAMB1;GJC1;THY1;MAP1B
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Lung,-0.4303407860798201,-0.9962845883124762,0.4691358024691358,0.897774682709961,1.0,10/64,11.49%,ANXA1;MAFF;LFNG;POU2F3;IRAG2;MLLT11;FGF1;ALPL;PRDM1;RAPGEF5
prerank,CellMarker_Augmented_2021__Brush Cell (Tuft cell):Lung,-0.4303407860798201,-0.9962845883124762,0.4691358024691358,0.897774682709961,1.0,10/64,11.49%,ANXA1;MAFF;LFNG;POU2F3;IRAG2;MLLT11;FGF1;ALPL;PRDM1;RAPGEF5
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.5149348000458134,0.9961274722052655,0.375,0.9599734818792058,1.0,4/12,14.67%,INSIG2;GRAMD1C;GRAMD1B;GPLD1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.5045841498714172,0.9960306141112656,0.4857142857142857,0.9596015832613365,1.0,2/11,4.15%,CEL;NLGN3
prerank,KEGG_2021_Human__Vibrio cholerae infection,-0.4646303204905971,-0.9959726720276452,0.4931506849315068,0.8983251838290637,1.0,2/43,2.19%,KCNQ1;KDELR3
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.6735282726024842,-0.995854435997248,0.48,0.898320867730343,1.0,1/5,6.33%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.3875170332345373,-0.9958230842768271,0.4936708860759494,0.8980869898727843,1.0,7/145,6.13%,RASGRP1;S100A10;DOCK8;RASGRP2;THY1;CCL2;TBC1D9
prerank,Reactome_2022__Phase 2 - Plateau Phase R-HSA-5576893,-0.5711293717457298,-0.9956729408181603,0.46551724137931033,0.8982696261590386,1.0,4/12,19.02%,KCNQ1;CACNA1C;CACNB1;KCNE4
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.4289527956874625,0.9956250360098465,0.42424242424242425,0.9600293348201769,1.0,5/36,8.09%,SLC6A13;SLC47A1;SFXN2;SLC25A18;SLC3A2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.4305416006052527,-0.9955884303169436,0.5,0.8981768499358862,1.0,16/61,20.77%,B2M;HLA-A;MFSD6;HLA-C;PSMB9;PSMB6;HLA-B;HLA-E;PSMC3;HLA-F;PSMA8;PSMA7;PSME1;CD36;PDIA3;IKBKG
prerank,CellMarker_Augmented_2021__Stem cell:Ovarian Cortex,-0.4512066058341506,-0.9954709340499626,0.417910447761194,0.8981562117964633,1.0,12/43,19.89%,ZDHHC22;RND2;DRAXIN;LRRK1;SHISA9;GRID2;PCDH11X;CHST6;SLCO1A2;GLB1L3;PTCHD1;CNTNAP2
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.4103424733057608,-0.9953537964499901,0.4305555555555556,0.898210910643644,1.0,2/102,1.14%,ENPP2;AMN
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.575356304565583,0.9952321461306161,0.6,0.9605444584140997,1.0,2/7,12.99%,PTGIS;AKR1C3
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,0.39807392804838226,0.9952297487749417,0.391304347826087,0.9599312740116676,1.0,14/57,15.19%,H2BC21;H2BC4;DNMT3B;UBTF;ERCC2;H2AC6;POLR1F;ERCC3;SAP130;GTF2H5;H3-3B;GTF2H2;DPEP2;HDAC2
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,-0.4641874521184254,-0.9949540928289456,0.5373134328358209,0.899120017632841,1.0,5/42,12.67%,MTMR7;ITPKC;INPP5D;NUDT4;PLCH2
prerank,KEGG_2021_Human__Tuberculosis,-0.41335113120869543,-0.9946825042708387,0.5,0.8995670510598353,1.0,20/108,17.95%,C3;TLR2;CIITA;IL12A;HLA-DRA;PLK3;IFNGR2;STAT1;CTSS;PPP3CC;SYK;IL18;FADD;TNFRSF1A;CD74;HLA-DRB1;MRC1;RIPK2;CR1L;TGFB1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3665021860653567,0.9946600853692912,0.43333333333333335,0.9608848533967909,1.0,9/77,13.78%,WNT7A;PSMD10;PSMA1;PSMD11;PSMB5;AP2B1;PSMD14;DVL2;PSMD12
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,0.37902278154504093,0.9946559299109523,0.3448275862068966,0.9603014922121773,1.0,8/56,7.43%,SEM1;PSMD10;DERL2;PSMA1;PSMD11;GPC5;PSMB5;VCP
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.49968725161733973,0.9944768812258694,0.5384615384615384,0.960186607457683,1.0,4/17,19.96%,NCSTN;NFKB1;RHBDD1;SPPL2A
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.5029254236560445,-0.9942718288530168,0.5205479452054794,0.9003834441717513,1.0,1/31,0.18%,ANXA1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.4130931410896434,-0.9941138091901743,0.5185185185185185,0.9004667180466092,1.0,25/105,22.28%,FLRT3;EFNB3;ARHGEF17;ATP1B1;GYG2;SHC2;DAB2IP;ADCY5;IGFBP5;SLC44A3;AMOTL2;SLC4A2;SLC4A10;SLC29A4;HTR2C;PTPRF;NOTCH3;AQP1;PTPN21;EPB41L4B;KIAA1217;PCDHB4;TOX3;EPB41L1;CTNND1
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.6489436071258847,-0.9940888584105277,0.6071428571428571,0.8998977893384592,1.0,1/6,6.62%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.6489436071258847,-0.9940888584105277,0.6071428571428571,0.8998977893384592,1.0,1/6,6.62%,PARP14
prerank,Reactome_2022__Defects In Biotin (Btn) Metabolism R-HSA-3323169,0.574740099867763,0.9940256392672864,0.55,0.9600521659289687,1.0,2/6,33.42%,PCCA;ACACA
prerank,Reactome_2022__Defective HLCS Causes Multiple Carboxylase Deficiency R-HSA-3371599,0.574740099867763,0.9940256392672864,0.55,0.9600521659289687,1.0,2/6,33.42%,PCCA;ACACA
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.5434992281568131,-0.9938488040477433,0.5,0.9001346883082296,1.0,3/14,9.24%,HTR2B;EGF;IGF1
prerank,KEGG_2021_Human__Gastric acid secretion,-0.44555196233826344,-0.9934279084405601,0.5147058823529411,0.9009200619490295,1.0,16/58,17.72%,KCNQ1;KCNJ2;ADCY7;ATP1A1;ITPR3;ATP1B1;PRKCG;CHRM3;SST;ADCY5;SLC4A2;MYLK3;ADCY3;ADCY8;PRKCB;KCNK10
prerank,KEGG_2021_Human__FoxO signaling pathway,-0.41807646375654867,-0.9933402745760223,0.5581395348837209,0.9008267152332848,1.0,24/114,18.83%,KLF2;CCNB2;TGFBR2;PLK2;CCND1;PLK3;EGF;GADD45A;IGF1;FBXO32;CCNB1;PIK3CB;PIK3CD;CDK2;CCND2;GABARAPL1;BCL6;IRS2;GADD45B;TGFB1;CDKN2D;CDKN1A;PCK2;RAG1
prerank,Reactome_2022__TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,0.5294120553336936,0.9933254682407845,0.5384615384615384,0.9613891857220471,1.0,1/10,0.93%,TNFSF13B
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,0.3160106826361439,0.9932791028135346,0.6363636363636364,0.9609021380541131,1.0,31/228,10.25%,WNT7A;PIP5K1B;SEM1;CXXC4;PSMD10;TMED5;MEN1;NRAS;CCDC88C;PSMA1;H2BC21;PSMD11;SOX9;PYGO2;H2BC4;AKT2;CUL1;FZD8;AKT1;PSMB5;NCOA3;RNF146;PYGO1;CSNK1E;AP2B1;XPO1;CSNK2A2;H2AC6;BTRC;GNB3;KLHL12
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.526878655732652,0.9931833602993388,0.4883720930232558,0.9605249870102621,1.0,4/11,18.96%,NUP214;UHMK1;AAAS;PTPN14
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.5371687163206719,0.9931459339185797,0.5384615384615384,0.9600682401180792,1.0,2/10,14.92%,NIPBL;POT1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.5907611937740992,-0.9930082415852242,0.4852941176470588,0.9014089643354307,1.0,1/9,1.31%,TYMP
prerank,CellMarker_Augmented_2021__Schwann cell:Intervertebral Disc,-0.4147722526394997,-0.9929958989120323,0.524390243902439,0.9001686867255281,1.0,29/91,18.88%,SNCB;PLP1;SLC24A2;SLC32A1;OPALIN;GRIA1;GFAP;TCEAL6;SYP;RIT2;MOG;MOBP;MAG;CA10;HAPLN2;SCN1A;STMN4;SYNPR;GRIN2B;GAD2;DIRAS2;GABRG2;TMEM130;CNTN2;GABRA1;ADCY8;RPH3A;MAPT;ST8SIA3
prerank,CellMarker_Augmented_2021__Glial cell:Sympathetic Ganglion,-0.4147722526394997,-0.9929958989120323,0.524390243902439,0.9001686867255281,1.0,29/91,18.88%,SNCB;PLP1;SLC24A2;SLC32A1;OPALIN;GRIA1;GFAP;TCEAL6;SYP;RIT2;MOG;MOBP;MAG;CA10;HAPLN2;SCN1A;STMN4;SYNPR;GRIN2B;GAD2;DIRAS2;GABRG2;TMEM130;CNTN2;GABRA1;ADCY8;RPH3A;MAPT;ST8SIA3
prerank,CellMarker_Augmented_2021__Astrocyte:Spinal Cord,-0.4147722526394997,-0.9929958989120323,0.524390243902439,0.9001686867255281,1.0,29/91,18.88%,SNCB;PLP1;SLC24A2;SLC32A1;OPALIN;GRIA1;GFAP;TCEAL6;SYP;RIT2;MOG;MOBP;MAG;CA10;HAPLN2;SCN1A;STMN4;SYNPR;GRIN2B;GAD2;DIRAS2;GABRG2;TMEM130;CNTN2;GABRA1;ADCY8;RPH3A;MAPT;ST8SIA3
prerank,CellMarker_Augmented_2021__Glial cell:Brain,-0.4147722526394997,-0.9929958989120323,0.524390243902439,0.9001686867255281,1.0,29/91,18.88%,SNCB;PLP1;SLC24A2;SLC32A1;OPALIN;GRIA1;GFAP;TCEAL6;SYP;RIT2;MOG;MOBP;MAG;CA10;HAPLN2;SCN1A;STMN4;SYNPR;GRIN2B;GAD2;DIRAS2;GABRG2;TMEM130;CNTN2;GABRA1;ADCY8;RPH3A;MAPT;ST8SIA3
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.39178685505855504,-0.99278287039456,0.39759036144578314,0.9003755095179162,1.0,38/144,17.50%,TAGLN3;POU4F1;STMN2;NEFL;NEFM;SNCB;SH3GL2;ZDHHC22;SLITRK1;LRRTM1;SYT4;JPH3;NELL1;GAP43;TMEM163;CA10;NYAP1;PLPPR5;HPCA;TCEAL2;LHFPL5;CALY;STMN4;DCTN1;C11ORF87;CRMP1;NARF;SYT16;CNTN2;KCNC1;GDAP1L1;SNCG;CCDC184;TCEAL5;SLC29A4;SULT4A1;FGF12;RTN2
prerank,KEGG_2021_Human__Calcium signaling pathway,-0.37973510492741896,-0.992641383762395,0.5054945054945055,0.9003672525751842,1.0,29/167,17.30%,CACNA1H;GRIN2D;MET;ITPKC;CHRM1;GRIN2A;ADCY7;HTR2B;PLN;ITPR3;EGF;SLC8A3;PRKCG;CHRM3;PPP3CC;FGF1;CACNA1C;NOS1;HRH1;FGF7;MYLK3;ADCY3;FGF22;HTR2C;OXTR;ADCY8;PRKCB;CHRM5;RYR2
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.6366262978459989,-0.9925850577190544,0.5283018867924528,0.8992188280101908,1.0,2/5,13.27%,RNASE10;TAC4
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),-0.6366262978459989,-0.9925850577190544,0.5283018867924528,0.8992188280101908,1.0,2/5,13.27%,RNASE10;TAC4
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.6366262978459989,-0.9925850577190544,0.5283018867924528,0.8992188280101908,1.0,2/5,13.27%,RNASE10;TAC4
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.6366262978459989,-0.9925850577190544,0.5283018867924528,0.8992188280101908,1.0,2/5,13.27%,RNASE10;TAC4
prerank,CellMarker_Augmented_2021__Bone Marrow Stem cell:Bone Marrow,-0.6116324120723501,-0.9924627587084255,0.5303030303030303,0.8992109886227815,1.0,2/8,7.03%,THY1;CD44
prerank,CellMarker_Augmented_2021__Mesothelial cell:Undefined,-0.46668711112877126,-0.9923412593517849,0.4861111111111111,0.8992811495942485,1.0,12/39,21.27%,EPS8L2;PLEKHG6;LSR;BAIAP2L1;ITGA3;ITGB4;RHOD;PLEC;LAMA5;AGRN;DOK7;DMKN
prerank,CellMarker_Augmented_2021__Plasma cell:Salivary Gland,-0.43786932936998796,-0.9920663586958973,0.42105263157894735,0.8996956191617415,1.0,19/73,20.76%,DHCR24;MET;EPS8L2;CCND1;BAIAP2L1;DAB2IP;SLC44A3;AMOTL2;RHBDF1;ASS1;RHOD;PTPRF;PTPN21;LAMA5;MYO1C;AGRN;EPB41L4B;KIAA1217;CD276
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.32210326869482825,0.9919707388186229,0.5,0.9627768590758099,1.0,85/339,20.96%,POU6F2;RNF6;LIMD1;ZNF117;BMP2;PPARGC1A;ZNF195;SOX21;ZNF212;CEBPA;MITF;POFUT1;HCLS1;HES6;COPS2;USP13;SLC39A8;ATF5;APBB3;ZNF74;ESRRG;ZNF502;SOX12;RORB;ZNF680;ZNF268;THAP1;GLI4;RNF14;NR3C1;NFYC;YAF2;SLC2A4RG;HP1BP3;ZNF341;ZNF875;ZNF703;ZNF676;ESRRA;ZNF33A;ZNF736;ZNF280D;MAGED1;PATZ1;APBB2;TGFBRAP1;DVL2;ZNF138;HMG20A;GPBP1L1;KAT7;ZNF519;ZNHIT3;EP300;SMARCA2;PPIE;BACH1;HINFP;ZNF492;NR1D2;FOXN2;NCOA2;CHD7;VHL;EFEMP1;CNBP;VSX1;NLK;HDAC10;PRDM2;ZNF737;NFXL1;MED23;DAXX;ZNF460;PSPC1;CCAR2;SP3;ZNF253;SAP30L;ZNF2;UTP4;KAT6B;ZNF398;ZNF430
prerank,KEGG_2021_Human__Non-small cell lung cancer,-0.4228982336452786,-0.9918610515070865,0.4189189189189189,0.9000026318012975,1.0,14/68,19.12%,CDKN2A;MET;CCND1;EGF;PRKCG;GADD45A;TGFA;PIK3CB;PIK3CD;PRKCB;GADD45B;RASSF1;CDKN1A;ALK
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.6448645057022783,-0.9918208647327168,0.484375,0.8997867613025848,1.0,1/6,11.74%,PINK1
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.47167409648696823,-0.9918136719558327,0.4411764705882353,0.8994899094190998,1.0,2/41,5.22%,LEF1;HTR2B
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.41398280931111936,-0.9913152296076783,0.5063291139240507,0.9004098148630117,1.0,16/84,15.30%,ARHGAP4;SULF1;THY1;PODN;SPOCK3;BST2;CYP1B1;WAS;CLIC4;IGFBP5;LDLRAD4;TMEFF2;SPINT2;CD74;SFRP2;DLC1
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.5851333455195553,-0.9912350044924811,0.47540983606557374,0.9003042902182518,1.0,1/6,1.67%,MX1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.5354351350231141,-0.991010681578281,0.5230769230769231,0.9006170414900677,1.0,3/16,12.99%,NLRC5;LDB2;EMP2
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3128646671118757,0.9906761107282954,0.5714285714285714,0.9661290944986202,1.0,39/291,13.78%,SPSB4;ERCC8;FBXO45;FBXO48;SPSB2;PSMD10;KBTBD7;FEM1C;DERL2;PSMA1;PSMD11;FBXL14;DMAC2;ANAPC1;CUL1;PSMB5;TMUB2;FBXO5;VCP;RNF103-CHMP3;GID8;ECPAS;FBXL3;FBXO9;AUP1;UBE2G1;BTRC;PLK1;STT3B;UBE2D1;PSMD14;FEM1B;DERL1;FBXO38;CUL2;KCTD17;FBXO27;TMEM129;PSMD12
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.5529701282338125,-0.9905504145709225,0.49230769230769234,0.9016328190120191,1.0,4/9,18.25%,ARIH2;WNT5A;SFRP2;ETV6
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.5452997784061676,0.9904338892727044,0.5714285714285714,0.9660765311489633,1.0,4/12,23.56%,WDR82;KMT2A;BEND3;TET3
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.39118152591696276,0.9900924739432182,0.3076923076923077,0.9664815016519623,1.0,11/45,13.41%,MSRB1;CATIP;WASHC5;VILL;TTC17;TWF1;SPIRE2;DIAPH3;MICAL2;WASL;MICAL1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),-0.6115187315947525,-0.9900134214004439,0.6229508196721312,0.9027450797343718,1.0,1/9,3.11%,AIPL1
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.6461162346467106,-0.9898803190830742,0.5689655172413793,0.9021322347009794,1.0,1/5,1.30%,ALDOB
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.6461162346467106,-0.9898803190830742,0.5689655172413793,0.9021322347009794,1.0,1/5,1.30%,ALDOB
prerank,Reactome_2022__Fructose Catabolism R-HSA-70350,-0.6461162346467106,-0.9898803190830742,0.5689655172413793,0.9021322347009794,1.0,1/5,1.30%,ALDOB
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.49723876725576155,0.9898566316250511,0.4857142857142857,0.9665448875819037,1.0,2/10,8.98%,LTV1;XPO1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.5489140136468389,-0.9898450697821941,0.47058823529411764,0.9019001986295722,1.0,4/14,12.58%,IFIT1;COLEC12;IFIH1;FLOT1
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,0.4085601378137557,0.9898239904527927,0.5,0.9660425300435828,1.0,8/38,17.79%,RAB33B;NAPSA;CYTH3;MAN1A2;COG6;VTI1A;SNAP29;RIC1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.551055752356206,-0.9894342421124853,0.5185185185185185,0.9027711214475921,1.0,1/15,2.20%,ZFP36
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.47555371220529286,0.9893127034594948,0.5294117647058824,0.9668018702771476,1.0,8/22,16.11%,GDAP1;PEX11A;WASHC5;MFF;OPA1;DNM3;MUL1;MTFR1
prerank,CellMarker_Augmented_2021__Enterocyte:Large Intestine,0.4556224983689403,0.9892985751849194,0.39473684210526316,0.9662637764545686,1.0,5/24,7.39%,EFNA2;MUC20;SLC41A2;NBEAL1;CNKSR1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.41155544032217656,-0.9892718002709183,0.5432098765432098,0.9028429165064895,1.0,18/83,18.23%,SEPTIN5;RAB11A;PLD1;HAP1;SEPTIN4;RIT2;CPLX1;SYT1;CPLX2;RIMS2;USP6;SYK;FES;RAB3C;ARFGAP1;TSC2;SEPTIN1;RAB15
prerank,Reactome_2022__WNT Ligand Biogenesis And Trafficking R-HSA-3238698,0.4941674010432263,0.9892273521909085,0.40540540540540543,0.965856657248675,1.0,2/16,3.03%,WNT7A;TMED5
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,0.37562082865624064,0.9890562787194296,0.4166666666666667,0.9659274732476673,1.0,9/50,16.76%,U2AF1;NUDT21;WDR33;CSTF3;CPSF6;PAPOLA;CPSF7;THOC3;THOC1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.6378247011001078,-0.9888542047214863,0.47368421052631576,0.9032738853589614,1.0,1/5,7.78%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.6378247011001078,-0.9888542047214863,0.47368421052631576,0.9032738853589614,1.0,1/5,7.78%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.523478114618968,0.9888076037555704,0.45454545454545453,0.9660415726578182,1.0,2/11,3.76%,PDE3A;OCLN
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.5695156835017561,0.988761624482722,0.5217391304347826,0.9655703543635703,1.0,3/9,14.24%,AIFM2;ABCD1;DHFR
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.44494063977737175,-0.9883987248046014,0.5540540540540541,0.9040849946758035,1.0,8/46,19.82%,MX1;RAMP3;CD9;SYK;TGFB1;ADM;CD36;DNM1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),0.5492087988971143,0.9883904091835105,0.5,0.9659083480584267,1.0,2/10,5.55%,RIOK2;RIOK1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.5040221559230315,-0.9883822434505279,0.5205479452054794,0.9038043383593127,1.0,4/28,7.61%,CLDN16;POF1B;CLDN20;CLDN18
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.562249508591177,0.9881544894897647,0.5227272727272727,0.965993381149776,1.0,7/11,28.72%,EXOSC6;TENT4B;FBL;DKC1;EXOSC5;FBLL1;LARP7
prerank,CellMarker_Augmented_2021__PROCR+ Progenitor cell:Small Intestine,0.49604279819301345,0.988132722300849,0.41379310344827586,0.9654221449153898,1.0,3/18,7.90%,MEOX2;RAB23;PI15
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.6142664615817651,0.9880961380597918,0.5555555555555556,0.9649020768288823,1.0,2/6,18.86%,RAE1;PCID2
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.4420352996808429,-0.9880192737167047,0.4925373134328358,0.9044081557702145,1.0,4/40,11.18%,PIF1;KLF4;TCP1;PRKCQ
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,0.3891877859829799,0.9876952552280668,0.4411764705882353,0.9654124697521598,1.0,7/50,7.43%,SEM1;PSMD10;DERL2;PSMA1;PSMD11;PSMB5;VCP
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.5563103839587541,0.9876194759047154,0.5102040816326531,0.9650154142815073,1.0,3/9,12.98%,CD200R1;AKT1;WASL
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.39294888646628795,0.9875934300606265,0.5185185185185185,0.9644750174669197,1.0,3/54,3.30%,FGF6;GALNT3;SPRED1
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,-0.499769392304408,-0.9875820373468671,0.5230769230769231,0.9052631975867127,1.0,6/26,13.16%,LDHA;SLC16A3;PDHX;LDHAL6A;PDK3;LDHD
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,0.3848488716843199,0.9875585858775959,0.4583333333333333,0.9639784322023156,1.0,7/48,12.98%,DSCAM;MYO10;NCK1;MAPK8;ROBO1;MAPK12;WASL
prerank,Reactome_2022__Response Of EIF2AK1 (HRI) To Heme Deficiency R-HSA-9648895,0.4530994133402201,0.9874936238368437,0.5161290322580645,0.9635543077773955,1.0,3/13,5.86%,EIF2S1;TRIB3;ATF5
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),-0.6201185253284848,-0.9874650171326371,0.578125,0.9052404302524848,1.0,1/5,0.99%,IPCEF1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Meniscus,-0.6512814531938489,-0.9874507380481692,0.5084745762711864,0.9049791062994538,1.0,2/5,7.03%,THY1;CD44
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.43211861666131995,0.9874497010236435,0.42857142857142855,0.9630661131927585,1.0,7/26,21.02%,ABCB10;HSPA1A;HSF1;RHBDD1;DAXX;ERN1;TM7SF3
prerank,KEGG_2021_Human__Th17 cell differentiation,-0.42320451445542306,-0.9873267095864776,0.5135135135135135,0.9049983497431072,1.0,15/69,18.56%,IL1R1;TGFBR2;HLA-DRA;IFNGR2;STAT1;IL4R;PPP3CC;PRKCQ;FOS;IL1RAP;IL27RA;HLA-DRB1;STAT6;TGFB1;CD4
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.4994966750232426,-0.9872781019193417,0.48333333333333334,0.9047952809685962,1.0,1/18,0.95%,SP100
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.4329474573287587,-0.9869762786701148,0.4788732394366197,0.9053266517569124,1.0,16/64,17.25%,THBS1;SPARC;PROX1;SULF1;HTR2B;FUT2;EGF;STAT1;WNT5A;ATP5IF1;VIP;EGFL7;NR4A1;PIK3CD;F3;TEK
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.4834459206064099,0.9869013023619089,0.5,0.9640779136144773,1.0,3/13,5.99%,ABCD2;MACIR;ABCD1
prerank,"Reactome_2022__Gamma-carboxylation, Transport, And Amino-Terminal Cleavage Of Proteins R-HSA-159854",-0.6644280742054952,-0.986869188870595,0.543859649122807,0.905274926319751,1.0,4/5,33.09%,GGCX;TTF2;PROS1;GAS6
prerank,Reactome_2022__Pyrimidine Catabolism R-HSA-73621,0.5824562827609374,0.9868440385143794,0.46875,0.9635684968748652,1.0,5/8,29.63%,NT5C1A;NT5M;NT5E;UPP2;NT5C3A
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.6674454330340667,-0.9867097534061596,0.5714285714285714,0.9053423169513636,1.0,2/5,7.95%,PROX1;MYH11
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),-0.5901146290707713,-0.9865803938419789,0.5737704918032787,0.9053292291345125,1.0,4/8,16.53%,SULF1;MYO1E;ITGA3;MCAM
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,-0.42216065486946147,-0.9865497725724073,0.524390243902439,0.90507815384965,1.0,19/84,18.31%,CCNB2;PGR;SPDYE1;ADCY7;ANAPC11;RPS6KA1;IGF1;CCNB1;ADCY5;SPDYE5;SPDYE17;SPDYE3;PIK3CB;PIK3CD;CDK2;ADCY3;ADCY8;RPS6KA6;SPDYA
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.6450561949888449,-0.9863222980696872,0.5882352941176471,0.9054188227368325,1.0,1/6,5.09%,EMG1
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.48311325125488436,0.9863080651424284,0.42424242424242425,0.9645715356101272,1.0,10/18,29.15%,CWC27;PPIL2;PPIE;PPWD1;PPIL6;PPIC;PPIH;FKBP4;PPID;PPIL3
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.4516489852688904,-0.9861244934000803,0.4931506849315068,0.9055824894642606,1.0,14/44,17.04%,RASGRP1;ARHGEF3;RASGEF1A;GPR18;SYNPO2L;IGF1;MAPRE2;LPAR6;LPAR4;P2RY10;PIK3CB;VAV1;ERBIN;IRS2
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,-0.4246641347015036,-0.9858644346171997,0.5375,0.905993432515599,1.0,13/76,16.93%,VRK2;DEPDC1B;ARHGAP39;BAIAP2L1;PLD2;CDC42EP1;NHS;SLITRK5;VAV1;MCAM;ERBIN;EMD;DOCK10
prerank,CellMarker_Augmented_2021__Eosinophil:Sputum,-0.4392449900734062,-0.9857230794955688,0.5263157894736842,0.9059962017137914,1.0,14/56,17.21%,EFNA1;EPS8L2;OVOL2;CCND1;CDC42EP1;CD9;SLC44A3;CD63;RHBDF1;BOK;ASS1;RHOD;PXDC1;PTPRF
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.43013956083741794,-0.985665170029716,0.47368421052631576,0.9058512798753127,1.0,14/55,17.15%,RASGRP2;SYT4;NEUROD2;SYT1;CLIC4;WNT5A;HPCA;CPNE9;DMTN;NLGN1;SYT5;SYT2;SYT13;ADCY8
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.5673150706503538,-0.9855517622280364,0.5423728813559322,0.9055007752516742,1.0,3/9,19.49%,MAP1LC3A;GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.5673150706503538,-0.9855517622280364,0.5423728813559322,0.9055007752516742,1.0,3/9,19.49%,MAP1LC3A;GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.39608482886850843,-0.985394803398138,0.4714285714285714,0.9055774784395632,1.0,28/119,18.56%,RFTN1;FYB1;HLA-A;SKAP1;INPP5D;THY1;HLA-DRA;PSMB9;MOG;WAS;NFKBID;EIF2B2;PSMB6;HHLA2;PRKCQ;PSMC3;FYB2;THEMIS;BTN3A1;PIK3CB;PSMA8;PIK3CD;PSMA7;HLA-DRB1;PSME1;RIPK2;CARD11;CD4
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),-0.6122608538575961,-0.9848135594511902,0.5849056603773585,0.9068372235209978,1.0,1/5,10.01%,WNT5A
prerank,Reactome_2022__Condensation Of Prometaphase Chromosomes R-HSA-2514853,-0.6031158661629192,-0.984475717062908,0.5555555555555556,0.9074358487554804,1.0,1/7,0.52%,CCNB2
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5586880480466497,0.9843037989171409,0.5121951219512195,0.9687921540129903,1.0,3/8,21.18%,SRI;GSTM2;PKD2
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5586880480466497,0.9843037989171409,0.5121951219512195,0.9687921540129903,1.0,3/8,21.18%,SRI;GSTM2;PKD2
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.5208441683123956,-0.9842841478318263,0.515625,0.9076623968865847,1.0,7/18,17.65%,CEACAM1;ACSL5;FBP1;IL4R;GUCY2C;CDH17;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.47481195958406963,-0.9842709079601004,0.5142857142857142,0.9073827287888673,1.0,7/27,18.14%,MET;PSRC1;CAV3;DCTN1;FES;ANKRD53;MAPT
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.5229652782765329,0.984204238334705,0.5277777777777778,0.9686028625615628,1.0,4/12,20.81%,FBLN1;HNRNPU;AGO3;GJA1
prerank,KEGG_2021_Human__Oxidative phosphorylation,0.34583990520969216,0.9841853201927654,0.5263157894736842,0.9680135827051858,1.0,16/90,16.31%,ATP6V0D2;UQCRHL;NDUFC2-KCTD14;ATP6V1A;NDUFB1;COX10;ATP6V1G1;COX11;ATP5PB;ATP5MC2;NDUFV3;NDUFA8;ATP5MC1;COX7A2L;UQCRC2;ATP5F1A
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.5903593700918892,-0.9841658382623182,0.5769230769230769,0.9073561961587875,1.0,2/10,17.15%,ABCB1;ADCY8
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.5068645028548671,-0.9839514145742999,0.46774193548387094,0.907672158469005,1.0,3/20,11.28%,EFNA1;ELN;SLIT3
prerank,CellMarker_Augmented_2021__Stem cell:Cartilage,-0.6424856600748879,-0.9838380153957454,0.5737704918032787,0.9076391455151906,1.0,4/7,16.53%,THY1;CD44;CD9;MCAM
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,-0.3946263619232226,-0.9838259873946917,0.5116279069767442,0.9073694645891681,1.0,29/163,17.77%,CCNB2;TLR2;B2M;HLA-A;TRIM5;GNG3;HLA-C;BST2;ITPR3;PRKCG;AP1S1;WEE2;PPP3CC;CCNB1;HLA-B;HLA-E;GNG2;FADD;TNFRSF1A;HLA-F;FOS;ELOB;APOBEC3H;PIK3CB;PIK3CD;WEE1;PRKCB;RBX1;LIMK2
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.6535928499940118,0.9837591538602096,0.5128205128205128,0.9685892581871353,1.0,3/5,25.16%,PGAP1;PIGU;PIGT
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.5494605548459579,-0.9837124603704571,0.5217391304347826,0.9073685522922343,1.0,1/11,7.15%,C12ORF57
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.4629233926423814,0.9836057916740193,0.4444444444444444,0.9684147279303412,1.0,6/11,33.74%,SESN2;SESN3;KPTN;SESN1;ITFG2;SZT2
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.554233692397308,0.9836033730562012,0.48717948717948717,0.967812412181769,1.0,1/9,3.58%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.3880901628599445,-0.9834772184097003,0.5176470588235295,0.9077096478826753,1.0,31/172,18.86%,HPN;CDKN2A;RASGRP2;PSRC1;TMC8;TP53TG5;KIF14;MMP14;CEACAM1;BST2;LTBP4;FBP1;TSPYL2;RPS6KA1;BTG1;CRLF3;PRKCQ;SLIT3;BAP1;HYAL1;MFSD2A;SFRP2;TCHP;PML;BCL6;NUBP1;TGFB1;CDKN2D;CDKN1A;AKAP6;PLCE1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.5089672409904548,0.983467810225259,0.4444444444444444,0.9675744296454005,1.0,9/10,40.89%,MKKS;BBS2;PTEN;CTNNA2;SPEF2;PAFAH1B1;BBS4;FBXW11;VPS51
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,0.390442811484084,0.9834568240825468,0.41935483870967744,0.9669876481122154,1.0,7/49,7.43%,SEM1;PSMD10;DERL2;PSMA1;PSMD11;PSMB5;VCP
prerank,CellMarker_Augmented_2021__Cytokine Induced Killer cell:Blood,-0.5389959789547012,-0.9833534281469243,0.48333333333333334,0.9074105371145936,1.0,4/16,4.12%,CD5;TAGAP;GPR171;SLA
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Liver,-0.5389959789547012,-0.9833534281469243,0.48333333333333334,0.9074105371145936,1.0,4/16,4.12%,CD5;TAGAP;GPR171;SLA
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.48559236260401667,-0.9831974480317985,0.5147058823529411,0.9075245616897796,1.0,8/31,12.58%,ANK3;SKAP1;PODXL;THY1;CD44;ADAM19;RNASE10;FLOT1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.4893089209199141,-0.9831956978897594,0.5522388059701493,0.9072203622433652,1.0,10/35,23.86%,A4GALT;B3GNT5;PGAP2;PIGA;PIGH;PIGC;ST8SIA3;ST8SIA1;DPM3;PGAP4
prerank,CellMarker_Augmented_2021__Multipotent Mesenchymal Stroma cell:Bone Marrow,-0.6311528326589729,-0.9829836651551108,0.5238095238095238,0.9074875352373405,1.0,1/6,5.68%,THY1
prerank,KEGG_2021_Human__Mismatch repair,0.4293062404189148,0.9829210731327188,0.5517241379310345,0.9679039188973952,1.0,3/20,9.38%,POLD3;RFC3;MSH2
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,0.34657422359802914,0.9828385203266399,0.5652173913043478,0.9675453634685333,1.0,12/57,14.30%,POLD3;SEM1;SLC19A1;DNA2;RFC3;XRCC2;HUS1;RRAD;RAD9B;POLK;ATRIP;PALB2
prerank,KEGG_2021_Human__Starch and sucrose metabolism,0.4441988087048089,0.9828048065358291,0.4375,0.967023703918923,1.0,5/27,5.37%,MGAM;GANC;AMY2B;PGM2;AGL
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Undefined,-0.4633246674629662,-0.9826478372723004,0.4861111111111111,0.907759861400369,1.0,8/29,16.34%,PSCA;EPS8L2;TJP3;OVOL2;TMC4;CXCL17;ITGB4;MICALL2
prerank,CellMarker_Augmented_2021__Epithelial cell:Bladder,-0.4633246674629662,-0.9826478372723004,0.4861111111111111,0.907759861400369,1.0,8/29,16.34%,PSCA;EPS8L2;TJP3;OVOL2;TMC4;CXCL17;ITGB4;MICALL2
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.47577641883737787,0.9826436126288729,0.5625,0.9668864540905374,1.0,3/17,6.16%,AGER;BMP2;MAP3K4
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.6131426439455518,0.9825648232412483,0.5526315789473685,0.9665505165447839,1.0,5/6,38.03%,NDUFV3;NDUFV1;NDUFB6;NDUFA12;COA6
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.4927501290708247,-0.982439928501083,0.5428571428571428,0.908061639578154,1.0,5/29,15.80%,EFNA1;EGF;TGFA;BDNF;RELN
prerank,KEGG_2021_Human__Protein digestion and absorption,-0.4281157930734992,-0.9823767200158392,0.4520547945205479,0.9079139148537678,1.0,20/66,10.64%,COL8A1;COL4A1;KCNQ1;COL4A2;COL5A1;COL4A4;KCNJ13;COL27A1;COL6A2;MEP1B;ATP1A1;COL24A1;ATP1B1;COL11A2;ELN;SLC8A3;COL10A1;CELA2A;CELA2B;SLC3A1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.39365933383712,-0.9820770588567524,0.5301204819277109,0.9084161153119801,1.0,12/138,9.24%,KLF2;THBS1;FABP3;NOS1AP;RPS4X;KLF4;ATAD5;DUOXA1;PLD1;LDLR;EGF;IGF1
prerank,KEGG_2021_Human__Folate biosynthesis,0.46884187517433357,0.981993735821539,0.5384615384615384,0.9674499969547247,1.0,7/20,19.26%,QDPR;GPHN;AKR1C3;DHFR;DHFR2;MOCS2;AKR1B1
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),-0.507971362310434,-0.9818683669621994,0.5882352941176471,0.9086695954587156,1.0,8/23,17.15%,ADCY7;GIPR;LGR5;ADCY5;RXFP1;GLP1R;ADCY3;ADCY8
prerank,Reactome_2022__Regulation Of Commissural Axon Pathfinding By SLIT And ROBO R-HSA-428542,-0.582902005218025,-0.9816455740792475,0.5384615384615384,0.9089929338346794,1.0,4/9,23.13%,NELL2;SLIT3;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),-0.6429311931297794,-0.9816136888428523,0.46774193548387094,0.908790996377736,1.0,4/7,27.22%,SYK;FES;ADGRE2;UNC13D
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.5969719558754513,-0.9815716818231675,0.5,0.9086273694769021,1.0,1/8,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.5018143806244585,0.9815645745640638,0.4827586206896552,0.9674662918908059,1.0,2/12,18.23%,ASAH2B;SPHK2
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.5018143806244585,0.9815645745640638,0.4827586206896552,0.9674662918908059,1.0,2/12,18.23%,ASAH2B;SPHK2
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.6175962019162486,0.9814591314202546,0.6,0.9670883255273572,1.0,1/5,4.35%,CSGALNACT1
prerank,Reactome_2022__Signaling By Rho GTPases R-HSA-194315,-0.36556069258390655,-0.9813854659054198,0.5510204081632653,0.9088263721948894,1.0,73/538,17.43%,ERCC6L;ARHGAP4;DOCK8;STMN2;TAGAP;VRK2;RHOBTB2;RPS27;ARHGEF3;KIF14;PLEKHG6;DEPDC1B;ARHGAP9;PLEKHG2;ARHGAP15;CENPH;TRIP10;RND2;ANLN;STEAP3;ARHGAP39;ARHGEF17;BASP1;YWHAH;CENPE;BAIAP2;MYH11;BAIAP2L1;ZWILCH;ARHGDIG;SRF;WAS;LMNB1;PLD2;CDC42EP1;NHS;PFN2;CDC42EP3;NUF2;SPC24;ARHGEF18;EPSTI1;RHOF;RHPN1;KIF2C;TPM4;MYH9;OBSCN;FLOT1;RNASE1;CENPN;UBXN11;CENPU;NOXA1;SLITRK5;PPP1R14A;PDZD2;DLC1;VAV1;RASGRF2;DDRGK1;PRKCD;RHOD;ALDH3A2;MCAM;ERBIN;ARHGAP22;EMD;DOCK10;PDE5A;PRKCB;CDC37;CENPP
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.3880844505672058,-0.9813547774175503,0.4823529411764706,0.9086056245935049,1.0,18/164,7.37%,ENPP2;IL1R1;DUSP1;APLNR;SPARC;C1R;A4GALT;KDELR3;ABCA8;RAMP3;MAOB;GPR34;SLA;HS3ST3A1;CCL2;PODN;LDB2;PAPSS2
prerank,CellMarker_Augmented_2021__Luminal cell:Prostate,-0.4419059539876636,-0.9813368465426573,0.5066666666666667,0.9083373601780501,1.0,19/64,20.23%,EFNA1;PKP2;EPS8L2;THSD4;OVOL2;CCND1;BAIAP2L1;SLC44A3;AMOTL2;EMP2;RHBDF1;ASS1;RHOD;PTPRF;RHPN2;PTPN21;LAMA5;EPB41L4B;KIAA1217
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.43625193887010805,-0.9812039651870446,0.4864864864864865,0.9083393008537614,1.0,7/59,7.81%,C3;MRAP2;SLC39A14;RAMP3;KLK6;SYP;PDE6B
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Bone Marrow,-0.629137260491113,-0.9811681943083168,0.5370370370370371,0.9081125932710623,1.0,4/7,21.37%,THY1;IL3RA;CD4;PTPRC
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.6191522936909282,0.9810736059832067,0.575,0.9670201350805774,1.0,2/5,8.28%,NCOA4;AR
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.6191522936909282,0.9810736059832067,0.575,0.9670201350805774,1.0,2/5,8.28%,NCOA4;AR
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.7036482851263166,-0.9810227371378736,0.5882352941176471,0.9082892105347207,1.0,3/5,25.54%,F3;ANGPT2;NTRK3
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,0.36285900619735434,0.9809665004175948,0.4411764705882353,0.9666997233543675,1.0,16/75,14.84%,CD247;SEM1;PSMD10;BCL10;PSMA1;PSMD11;CUL1;UBE2N;PSMB5;BTRC;UBE2D1;PSMD14;PIK3CA;PSMD12;NFKB1;PIK3R1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.5989966289344006,0.9808766194813808,0.6122448979591837,0.9664221114063044,1.0,3/6,33.21%,ITCH;TANK;OTUD4
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.5526008626697603,-0.9805586706676904,0.4339622641509434,0.9091892635254539,1.0,5/9,26.24%,SLCO3A1;SLCO2A1;ABCC1;ABCC6;ABCC4
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.5919577208162293,0.9805229766067254,0.6,0.9667875153696238,1.0,3/6,27.00%,VCP;SART3;TANK
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.44949364347595716,-0.9804357703794933,0.5,0.9091623600947875,1.0,3/44,0.95%,RECQL4;BLM;SP100
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.5216704132880253,0.9803344774246986,0.4864864864864865,0.966637236854914,1.0,2/12,5.13%,PDK4;SOX9
prerank,CellMarker_Augmented_2021__Preadipocyte:Adipose Tissue,-0.4853682596447779,-0.9803182334766742,0.4927536231884058,0.9091545029560836,1.0,10/29,11.34%,P2RY13;MYO1F;SLA;SIGLEC1;GAB3;IGSF6;CLEC12A;F13A1;CTSS;SELP
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.6084381524193128,-0.9802201251902533,0.5714285714285714,0.9090388624954029,1.0,1/7,4.70%,ARG2
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.6506405270168817,0.9800517971704893,0.6046511627906976,0.9668609818248554,1.0,2/5,6.18%,INTS13;LHFPL2
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.5053709864434174,0.9798814354905442,0.5263157894736842,0.9667178936671252,1.0,5/12,21.18%,NUDT21;CPSF6;CPSF7;FARSB;PKD2
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.6518551020436104,-0.9798748318417048,0.5454545454545454,0.9096363655781882,1.0,1/5,6.20%,ABCB1
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.47808107222722107,-0.9798566836413911,0.5064935064935064,0.9093527306432319,1.0,6/29,15.41%,ANK3;CLDN16;LETM2;FAM20A;SLC12A7;CIB2
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.4286884959316468,-0.9797072349000434,0.4625,0.9094113270666014,1.0,4/67,8.75%,ANXA1;BLM;BRCA1;GADD45A
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.45934216940103695,0.9794823519798719,0.4444444444444444,0.9672583241612803,1.0,11/18,36.07%,RIDA;YTHDF2;ROCK2;FTO;MEX3D;CELF1;METTL14;METTL3;ROCK1;YTHDF3;GIGYF2
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.47063229897079295,-0.97913586333651,0.5151515151515151,0.9106381193765467,1.0,2/32,5.91%,CP;TRPC3
prerank,Reactome_2022__Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658,-0.562799727512693,-0.9790916194584487,0.5692307692307692,0.9104462146588871,1.0,1/13,0.52%,CCNB2
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.38739769649468714,0.9789883361047437,0.4090909090909091,0.9680656175561059,1.0,6/48,7.15%,GNL3L;HSPA1A;TNFAIP3;BAG2;AKT1;FBXO5
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4739797823688118,0.9789633858609951,0.4634146341463415,0.9675209958367001,1.0,7/15,35.95%,AKT1;UBQLN1;NFE2L2;MAPK7;SIRT1;SFPQ;NME5
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.4716303354226008,-0.9789452437574274,0.4533333333333333,0.9105834755895656,1.0,6/33,12.43%,EPN1;SH3GL2;EGF;TGFA;DAB2IP;MVP
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.5738804091924548,-0.9786750441885215,0.4925373134328358,0.9109673363403661,1.0,1/8,2.05%,ABCA5
prerank,Reactome_2022__Fructose Metabolism R-HSA-5652084,-0.612282971753173,-0.9785906124980179,0.5789473684210527,0.9108450716461376,1.0,1/7,1.30%,ALDOB
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.5653760487313509,-0.9782467720712114,0.5645161290322581,0.911430861105503,1.0,3/8,18.28%,IL12A;HYAL1;CDKN1A
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.5414579116527284,-0.9782035535897486,0.5147058823529411,0.9112137367620953,1.0,4/12,16.52%,CYP4Z1;GLYATL2;OLAH;OXSM
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.5774916160633219,-0.9780964357018608,0.5740740740740741,0.9111673155304002,1.0,1/7,5.75%,SLC4A11
prerank,KEGG_2021_Human__ABC transporters,-0.4581456864289786,-0.9780582063431544,0.5238095238095238,0.9109251683966053,1.0,6/39,9.33%,ABCA6;ABCA5;ABCA8;ABCA12;ABCB1;ABCA10
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Tooth,-0.43396349743721274,-0.9778612272241783,0.4666666666666667,0.911080879938975,1.0,8/43,15.71%,ZNF850;GJC1;PODXL;DRAXIN;LRRK1;GRID2;PCDH11X;CHST6
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,0.35481228854769015,0.9778348169695356,0.48,0.9699584651259042,1.0,12/44,18.23%,RGCC;CCNE1;CNOT9;PCBP4;PLAGL1;CNOT2;E2F4;EP300;CNOT8;CNOT6L;CNOT1;CNOT4
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.46581835107725683,0.9774806952713856,0.48484848484848486,0.9705798737651025,1.0,4/22,7.32%,PDK4;ADIPOR1;TRIB3;MID1IP1
prerank,CellMarker_Augmented_2021__Macrophage:Alveolus,-0.474770763353638,-0.9774248398721374,0.5384615384615384,0.911911707502471,1.0,9/29,10.15%,MYO1F;DOCK8;TAGAP;TMC8;SLA;ARHGAP9;CLEC12A;WAS;CTSS
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.5064463416475118,-0.9774188574165071,0.5616438356164384,0.9116064708376521,1.0,5/25,18.28%,KIF14;GLI1;DDRGK1;PSME1;CDKN1A
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.5651170562247745,0.9773080563238611,0.5833333333333334,0.9704279904608772,1.0,2/10,9.81%,INSC;MAL
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.5924813874810196,0.9772015423742186,0.475,0.970185053733599,1.0,3/8,13.87%,DCUN1D2;DCUN1D1;DCUN1D5
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.36259811258933417,-0.9768232921224812,0.5204081632653061,0.9128874532258744,1.0,104/523,19.12%,PRAME;LEF1;THBS1;CDKN2A;IL13RA1;SIX3;NR4A3;FABP3;TGFBR2;WARS1;PROX1;PDPN;RPS4X;IRF1;BTG3;KIF14;TESC;STAT4;GPNMB;IFI35;ST18;CHRM1;COPS9;IL15;APP;KLF4;HTR2B;SCX;PODN;CYP1B1;TIMP1;IFIT3;EGF;ELN;BTG1;SHCBP1;P3H2;OSMR;IGF1;S1PR3;STAT1;THPO;SST;TGFA;IGFBP7;FGF1;ROMO1;NUAK1;DAB2IP;FN1;SFRP4;NAMPT;BAP1;FOXM1;EID2;GLI1;SQLE;EMP2;FGF7;TFAP4;FES;CLMN;IL7;VIP;RPS6;CDKN3;BOK;RPS9;SFRP2;DLC1;TNS2;DDRGK1;JUNB;CDK2;CCND2;NUDT6;CAPN1;CDC7;FGF22;RPL23;STAT6;PML;CDCA7;BCL6;CD200;TSC2;IRS2;ETS1;GPER1;NMI;TGFB1;CDKN2D;NUPR1;GSDME;NIBAN2;CDKN1A;SPDYA;RARG;TRAPPC14;ADAMTS8;IER5;PDGFRA;CAPNS1;ALK
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.4178796088530023,-0.9767292287444095,0.5142857142857142,0.9127932798706331,1.0,10/72,13.14%,GRIN2D;GRIN2A;SLC24A2;TRPC3;SLC24A1;SLC8A3;CACNA1C;SLC24A5;GRIN2B;MCUB
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.6398659318326985,0.9766039045182757,0.5510204081632653,0.9712400511100016,1.0,2/5,32.71%,GALC;GBA2
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.3597676168307462,0.9765509602041776,0.5714285714285714,0.9707936256460382,1.0,7/42,13.65%,BMP2;S1PR1;GREM1;GPM6B;ACVR2A;SGMS2;ANKH
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.6398859769834814,-0.9763689680736868,0.5490196078431373,0.9133892339398546,1.0,2/5,21.38%,OSMR;ADAM8
prerank,CellMarker_Augmented_2021__Neural Tube cell:Germ,0.494618112763245,0.9763540965507191,0.5263157894736842,0.9707820970082649,1.0,1/11,1.37%,CSPG5
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Blood,-0.42016834731309816,-0.9763191714062501,0.524390243902439,0.9129110451066293,1.0,21/68,18.20%,APLNR;RAMP3;MAOB;BGN;LDB2;ELN;IGFBP5;SLCO2A1;RNASE1;ITGA9;RASL12;TMEM132C;ROBO4;SERPING1;FMO2;TEK;SHROOM4;ADGRF5;AQP1;ITIH5;A2M
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood Vessel,-0.42016834731309816,-0.9763191714062501,0.524390243902439,0.9129110451066293,1.0,21/68,18.20%,APLNR;RAMP3;MAOB;BGN;LDB2;ELN;IGFBP5;SLCO2A1;RNASE1;ITGA9;RASL12;TMEM132C;ROBO4;SERPING1;FMO2;TEK;SHROOM4;ADGRF5;AQP1;ITIH5;A2M
prerank,KEGG_2021_Human__Lipid and atherosclerosis,-0.39254464811596507,-0.9758836831355588,0.5543478260869565,0.9137392921915183,1.0,17/150,15.85%,CXCL2;TLR2;ICAM1;IL12A;CCL2;VLDLR;POU2F3;LDLR;IRF7;PPP3CC;SELP;IL18;TNFRSF1A;FOS;PIK3CB;VAV1;PIK3CD
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.5897483074714895,-0.9757537458189904,0.559322033898305,0.9136953378855157,1.0,3/5,25.29%,HYAL1;CDKN1A;HYAL2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.445888807789584,0.9757160076579957,0.4666666666666667,0.9719327880306736,1.0,3/19,10.68%,SOX8;SOX9;LIN7C
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.4642390401575428,0.9755134884422231,0.5,0.9718715920291637,1.0,3/12,19.53%,UBE2N;POT1;DAXX
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,0.35702375401573605,0.9752038877065491,0.5,0.972069197705397,1.0,4/66,3.57%,FGF6;GALNT3;SPRED1;NRAS
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.5290708169898046,0.9751864803135458,0.4666666666666667,0.9715118245999652,1.0,1/12,0.43%,NGF
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.4592929769783589,0.9750996726108541,0.5365853658536586,0.9711367218801703,1.0,3/14,7.96%,SOX8;SOX9;SIRT6
prerank,CellMarker_Augmented_2021__Bipolar cell:Eye,-0.4152488479802923,-0.9747321377666708,0.5866666666666667,0.9158156291027318,1.0,21/93,20.30%,CNTNAP1;MAP1B;GRIA3;GFAP;SLC7A14;FRMPD4;DOK6;SCN2A;FGF1;SYNM;HHIP;C11ORF87;PITPNM2;RASGRF2;DPYSL2;HTR2A;PNMA2;PDE1C;AK5;DNM1;STX1B
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.5351974936657651,0.9745992640116691,0.4166666666666667,0.9718997692636092,1.0,4/10,21.32%,PSPH;SRR;SERINC5;PHGDH
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),-0.654096758489743,-0.9744456572878952,0.609375,0.916324454347359,1.0,2/5,13.52%,LRRC4;NLGN1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.43047615112498966,0.9743619330970512,0.37037037037037035,0.9720201419319163,1.0,6/29,10.14%,PDK4;ADIPOR1;AKT2;AKT1;RUBCNL;GNB3
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.44566791798770794,0.9742232530864782,0.6060606060606061,0.9719103203448983,1.0,2/19,1.92%,AGMO;ARV1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),-0.629485388937072,-0.973656408135099,0.5185185185185185,0.9180180520022577,1.0,1/5,17.54%,CDK5
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,-0.5186885513227929,-0.9736387235804358,0.5614035087719298,0.9177590264571537,1.0,2/20,3.00%,CP;SLC39A14
prerank,Reactome_2022__Defects Of Contact Activation System (CAS) And Kallikrein/Kinin System (KKS) R-HSA-9651496,-0.5972902676402629,-0.9736124754112581,0.5932203389830508,0.9175001753987758,1.0,2/10,4.67%,F8;TPST1
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.45413526034546436,0.9734147105592248,0.5909090909090909,0.9733751333139234,1.0,3/19,3.21%,ACE2;ANXA4;EHF
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.503189082629048,0.9733933131541798,0.5294117647058824,0.9728398998358698,1.0,2/11,12.63%,NT5C1A;NUDT15
prerank,KEGG_2021_Human__AMPK signaling pathway,0.3411874333752749,0.9732238797096938,0.5882352941176471,0.9727158607534305,1.0,8/102,7.68%,LEPR;PPARGC1A;ADRA1A;ADIPOR1;AKT2;ACACB;AKT1;PRKAB1
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,0.4513689381182914,0.9731670117683211,0.5263157894736842,0.9722512283637252,1.0,3/24,9.85%,TAB3;TNFAIP3;TRADD
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,0.45448902296595967,0.9729571874676698,0.5,0.9722736465602985,1.0,6/19,11.84%,NUDT21;WDR33;CSTF3;CPSF6;PAPOLA;CPSF7
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.32802933177452087,0.97275308033042,0.42857142857142855,0.9723099282191909,1.0,16/186,9.33%,SPSB4;ERCC8;NR1D1;FBXO45;SPSB2;PSMD10;KBTBD7;FEM1C;SOCS6;PSMA1;PSMD11;PSMB5;VCP;GID8;UBE2G1;BTRC
prerank,KEGG_2021_Human__Cell cycle,-0.40271661830746036,-0.9726574443808825,0.55,0.9195245453725692,1.0,18/104,18.28%,CCNB2;CDKN2A;CCND1;YWHAH;ANAPC11;GADD45A;WEE2;CCNB1;CCNE2;CDK2;CCND2;CDC7;WEE1;RBX1;GADD45B;TGFB1;CDKN2D;CDKN1A
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.6206943282202905,-0.9725395459881818,0.6101694915254238,0.9194724687669011,1.0,1/7,0.81%,BLM
prerank,Reactome_2022__TNFs Bind Their Physiological Receptors R-HSA-5669034,0.47887452538924064,0.9724939054524198,0.47619047619047616,0.972471107305375,1.0,1/15,0.93%,TNFSF13B
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.5320461591284278,-0.9723868014394751,0.4868421052631579,0.9195710633777917,1.0,1/8,1.32%,GPR183
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),0.5891042881913539,0.9721870374288543,0.5789473684210527,0.9726806478762416,1.0,1/7,3.58%,NMB
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.37287775348636915,-0.9721358293792215,0.5851063829787234,0.9199080187094729,1.0,35/373,11.52%,CD24;ARHGAP4;BLM;POU4F1;GBP1;TAGAP;VRK2;ARHGEF3;NLRP12;DEPDC1B;ARHGAP9;PLEKHG2;ARHGAP15;TRIP10;BRCA1;CEACAM1;ARHGAP39;ARHGEF17;AKAP5;PLK3;RIT2;ARHGDIG;MINK1;RPA3;WNT5A;TAF10;WDR54;ARHGEF18;FGF1;NUAK1;BIRC3;DAB2IP;IER3;PRDM1;RHOF
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.47590564450422135,-0.972095768463289,0.47761194029850745,0.9197116031103104,1.0,2/22,5.22%,KLF2;HTR2B
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5017043450138574,0.9718958785151264,0.5,0.9728344703377905,1.0,2/14,11.53%,HSPA1A;OPA1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.4697223047497682,-0.9718803153093526,0.4861111111111111,0.9199981232539146,1.0,8/33,12.60%,KCNQ1;ANK3;NOS1AP;KCNJ2;CTSS;PDZK1;GNG2;NOS1
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,0.3609884849225279,0.9718198419516487,0.38095238095238093,0.9723991834239718,1.0,15/81,14.75%,SEM1;PSMD10;PSMA1;H2BC21;PSMD11;H2BC4;ANAPC1;PSMB5;H2AC6;UBE2D1;PSMD14;ORC5;H3-3B;PSMD12;CDC26
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.6140861595120333,0.9714792994697549,0.58,0.9728438085516129,1.0,2/5,30.05%,BDP1;POLR3H
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.4137636382903109,0.9711069945098622,0.5333333333333333,0.9734747315076256,1.0,4/34,4.81%,C1ORF162;NR1D1;EPX;HCLS1
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),0.4801274636702318,0.971046789243857,0.5151515151515151,0.9730536823036727,1.0,1/16,1.18%,GRPEL2
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.6064415755056868,-0.9710436432985945,0.5409836065573771,0.9218796749106501,1.0,1/10,9.71%,HR
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.5746664581373324,0.9708758190584291,0.5,0.9730271070600913,1.0,2/7,25.53%,SLC36A4;SLC1A4
prerank,Reactome_2022__TLR3-mediated TICAM1-dependent Programmed Cell Death R-HSA-9013957,-0.6343911304472618,-0.9708724921215552,0.6037735849056604,0.9219992262055294,1.0,3/5,20.15%,TLR3;FADD;CASP8
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,-0.4351269614498691,-0.9708467322812456,0.5316455696202531,0.9217616571106205,1.0,13/58,18.41%,GRIN2D;NEFL;GRIN2A;GRIA1;NRGN;RPS6KA1;GRIN2B;RNASE1;RASGRF2;ADCY8;MAPT;RPS6KA6;LRRC7
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.4110471343480545,-0.970769708785034,0.5316455696202531,0.9216400900481463,1.0,26/103,18.82%,AMN;SLC6A15;SLC25A45;PDPN;RAMP3;SLC18A2;SLC38A4;SLC7A14;SLC3A1;SLC7A2;MYH9;SLC43A2;ARRDC2;SLC11A1;SLC38A1;SLC22A4;ARRDC3;SLC35F3;SLC29A4;AQP1;LRP2;ABCC1;SLC15A4;SLC7A7;SLC25A29;ABCG2
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,0.41092285195694833,0.9707674216709963,0.48,0.9726966396767932,1.0,6/41,9.88%,ATP13A5;ATP11C;SRI;ATP2C1;ATP1A2;ATP13A4
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.4803447175338215,-0.9706358077677805,0.5538461538461539,0.9217220434421457,1.0,3/38,0.95%,RECQL4;BLM;SP100
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.589504974301515,-0.9706046761958028,0.6031746031746031,0.9215192229805862,1.0,5/8,22.09%,YWHAH;HSD17B14;CYP3A4;SPP1;HSD11B1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.34439725315090686,0.9703571547008175,0.4782608695652174,0.973291599453637,1.0,16/100,12.58%,NGF;EPHA6;CASS4;GUCA1B;FLT3;EGFR;YES1;FRK;CNKSR1;EFS;SHC4;ERBB4;CSF1R;PTPRG;EPHB4;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.661046122372544,-0.9703229113512924,0.5409836065573771,0.9219076794411001,1.0,1/5,18.14%,MAPT
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,0.3908925797572005,0.9703204047686549,0.3333333333333333,0.972788899176939,1.0,7/49,6.89%,SEM1;PSMD10;PSMA1;PSMD11;CUL1;AKT1;PSMB5
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.38011827694436445,-0.970161298518138,0.6049382716049383,0.9219894607098649,1.0,37/179,17.91%,RPL19;RPL3;RPS27;RPS14;RPL27A;RPL35;EMG1;RPL7A;RPL37A;RPL27;RPL9;RPL21;NOB1;RPL13A;RPS16;RPL24;RPLP1;RPL38;RPL10A;RPL10;RPLP2;RPS7;RPL8;RPS6;MRTO4;RPS15;RPL26L1;RPS9;RPL12;PES1;RPL5;RPL23;RPL4;DDX54;RPL18A;RPL41;RPL7
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.47293394133928357,-0.9700781122790137,0.515625,0.9219055286029246,1.0,5/29,9.28%,B2M;THY1;EFNB3;YWHAH;MAG
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.42330602346262486,-0.9699198610795797,0.5194805194805194,0.9220091279004108,1.0,13/77,21.26%,TRIM22;TRIM5;PLK2;PLK3;PINK1;PLEKHF1;PIK3CB;TSC2;KAT5;TRIM65;SUPT5H;IKBKG;OPTN
prerank,Reactome_2022__TP53 Regulates Transcription Of Caspase Activators And Caspases R-HSA-6803207,0.5651563715317545,0.969891322002058,0.575,0.9734382372071524,1.0,2/9,20.79%,CRADD;CASP2
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,0.3904259661284991,0.9692076550470653,0.5862068965517241,0.9747413908310488,1.0,19/40,30.40%,ELOC;GTF2F2;ELOA;ERCC2;ERCC3;GTF2H5;GTF2H2;POLR2C;CCNT1;GTF2H3;NELFA;CTDP1;CCNH;TCEA1;POLR2A;POLR2K;POLR2D;SUPT16H;POLR2E
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.5908963955662208,-0.969182686118417,0.5094339622641509,0.9236744276728037,1.0,3/9,11.40%,SFTPD;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.5615923123729433,-0.9691021369831823,0.5254237288135594,0.9235993832452265,1.0,1/12,2.14%,KMO
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.49933807763387444,-0.9690385405059664,0.5806451612903226,0.9234401099249974,1.0,1/16,0.94%,DUSP1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.4678615571070889,0.9689191942314601,0.5128205128205128,0.9749342517073382,1.0,6/23,12.89%,GAL3ST2;GK;ALG6;GAL3ST4;RRM2B;ALG11
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.5298667831135999,-0.9686082471514073,0.5588235294117647,0.9242545094425864,1.0,6/13,28.73%,IGF1;IGFBP5;SLIT2;CCN4;LRP1;SERPINE1
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.6017473188065903,-0.968543260619607,0.5967741935483871,0.9241138397204318,1.0,1/6,6.13%,ELAVL4
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.5983666234689359,-0.9685156483597491,0.5,0.9238765961971438,1.0,1/6,7.78%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.4592957085707565,-0.968394593821048,0.44871794871794873,0.9238358996437581,1.0,4/34,9.53%,ALDOB;PLSCR1;ATP1B1;PFN2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Germ,-0.6241842243949379,-0.9682842533652546,0.5483870967741935,0.9238388575668083,1.0,2/6,7.03%,THY1;CD44
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.45842563413923504,-0.9682829391732838,0.5223880597014925,0.9235302941541274,1.0,3/38,5.04%,B2M;RPS27A;APP
prerank,Reactome_2022__Proton-coupled Monocarboxylate Transport R-HSA-433692,-0.6379674604402447,-0.9681408749808869,0.5961538461538461,0.9236112059771698,1.0,1/5,4.12%,SLC16A3
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5864399019879091,-0.9680470493142017,0.5692307692307692,0.9235301818574289,1.0,1/8,7.01%,APOD
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3641918422227956,0.968042005244636,0.5454545454545454,0.9769713112494564,1.0,6/53,6.09%,EPOR;FLT3;HCLS1;SOX9;PDGFD;PDGFC
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.5452919544177723,0.9677774203692218,0.6176470588235294,0.9770938046034991,1.0,2/13,14.11%,HUS1;RAD9B
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.5917091265625681,-0.9675679778777362,0.5178571428571429,0.9243734981678978,1.0,4/7,23.77%,NIT1;CYP3A4;CYP3A5;CYP2D6
prerank,Reactome_2022__Depolymerisation Of Nuclear Lamina R-HSA-4419969,-0.524961956199179,-0.9672904338536135,0.5285714285714286,0.9247589294187534,1.0,4/13,17.19%,LMNB1;CCNB1;EMD;PRKCB
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.43058511727375476,0.9670400040403495,0.5428571428571428,0.9785015621529835,1.0,4/21,16.16%,LLPH;CAPRIN2;CAPRIN1;CPEB3
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.38480129793235707,0.9666878575248894,0.5263157894736842,0.9788428099753662,1.0,4/38,6.66%,DGKB;PLD6;DGKE;ABHD5
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.5823223984277368,-0.9666625926045584,0.6617647058823529,0.9260864335927159,1.0,1/8,5.61%,RAB11FIP5
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.5258015517118194,-0.9665246672270273,0.5538461538461539,0.9261103971784405,1.0,3/14,16.77%,NLRC5;ISG15;USP18
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.43606575552360116,0.9665202593064414,0.46153846153846156,0.9787030567456079,1.0,6/26,15.29%,BMP2;TWSG1;GDF11;ACVR2A;GDF9;GDF10
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.3603023575713406,-0.9665198545352276,0.5604395604395604,0.9258142282885219,1.0,47/332,16.53%,LEF1;THBS1;HPN;POU4F1;TLR2;ANK3;NOS1AP;WARS1;RPS4X;RAMP3;TESC;OVOL2;IL15;APP;KLF4;HTR2B;SCX;ELAVL4;PLD1;BRCA1;TLR3;PLSCR1;EGF;IGF1;ADAM19;WNT5A;RIMS2;FGF1;HHLA2;FN1;SFRP4;FLOT1;RPS7;C1QTNF1;FGF7;SLC11A1;BTN3A1;PIK3CB;CD74;SAMD4A;RPL5;RBM3;DDRGK1;PIK3CD;F3;FGF22;RPL23
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.38508026917736615,0.9665152967009084,0.5263157894736842,0.9781380670101666,1.0,4/37,6.66%,DGKB;PLD6;DGKE;ABHD5
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5955725520914478,-0.9664974836012074,0.5333333333333333,0.9255710738761342,1.0,2/10,6.33%,MLIP;CAV3
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.3245389940103363,0.9664972704216916,0.3333333333333333,0.9776217614874385,1.0,33/206,14.00%,LIMD1;AMER2;BMP2;PSMD10;BICC1;GSKIP;CCDC88C;PSMA1;GREM1;PSMD11;SOX9;EGFR;GPC5;PSMB5;VCP;GID8;RNF146;CSNK1E;STK4;CAPRIN2;BTRC;PPM1A;ZNF703;KLHL12;INVS;PSMD14;DVL2;ZEB2;CSNK1G3;PSMD12;KANK1;TMEM170B;MDK
prerank,Reactome_2022__MAPK3 (ERK1) Activation R-HSA-110056,-0.5721587710304239,-0.9664181072719844,0.5294117647058824,0.9254243629827131,1.0,2/8,27.30%,TYK2;MAP2K1
prerank,CellMarker_Augmented_2021__Hemangioblast:Germ,-0.5957680790027725,-0.9663882350267229,0.5818181818181818,0.9251970243567094,1.0,4/6,25.67%,PODXL;TEK;PECAM1;CDH1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.42553812922859396,-0.9662746287778197,0.5606060606060606,0.9252057250948933,1.0,13/55,18.31%,CDKN2A;PLK2;CCND1;PLK3;CRLF3;CCNE2;CDKN3;CDK2;MAX;CDC7;CDKN2D;CDKN1A;SPDYA
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.5500828319225995,-0.9662503982351813,0.5084745762711864,0.9249755077015928,1.0,3/11,6.92%,RDH13;AKR1C1;CYP1B1
prerank,KEGG_2021_Human__Protein export,0.45954933379722607,0.9660233365620361,0.46875,0.9783876072682393,1.0,2/23,9.49%,SRPRB;SRP72
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.5469100242899112,0.965927759620149,0.45714285714285713,0.9779539622362527,1.0,3/9,15.09%,PGM2;GALT;GALK2
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,0.4001589543080595,0.9659143357269667,0.4444444444444444,0.9773976343709203,1.0,13/31,27.65%,PHC1;RNF2;EED;YAF2;RBBP4;MGA;PHC3;EHMT1;PCGF2;EPC1;E2F6;TFDP2;EZH2
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.4307612521445842,-0.9658761447834474,0.589041095890411,0.9256170283933445,1.0,13/55,20.46%,CDKN2A;RPS27A;ANAPC11;RPS6KA1;IGFBP7;UBC;FOS;UBE2S;CDK2;CDKN2D;CDKN1A;H2AZ1;ANAPC15
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.5183282000542816,0.9655300799046629,0.4444444444444444,0.9778954424059503,1.0,3/14,8.47%,PDE12;GIT1;CBFA2T3
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.5599916153641137,-0.9653183065103256,0.5932203389830508,0.9267604350821762,1.0,5/20,15.10%,RPS27A;ANAPC11;CCNB1;UBC;UBE2S
prerank,KEGG_2021_Human__Colorectal cancer,-0.42076775960623813,-0.9651372846084744,0.4868421052631579,0.9268894915804208,1.0,14/79,18.80%,LEF1;TGFBR2;RALGDS;CCND1;EGF;GADD45A;TGFA;FOS;PIK3CB;PIK3CD;GADD45B;TGFB1;CDKN1A;BBC3
prerank,Reactome_2022__Activation Of TFAP2 (AP-2) Family Of Transcription Factors R-HSA-8866907,0.5763459524395474,0.9651342070728083,0.6216216216216216,0.9783242844273723,1.0,2/7,15.95%,WWOX;EP300
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.49196520480636685,-0.9649562191273948,0.527027027027027,0.927058744574425,1.0,1/30,0.33%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.43863461824196853,-0.9649245426156156,0.5070422535211268,0.9268251964530784,1.0,12/43,22.46%,GRIN2A;NOD1;USP50;NLRP2;SYK;GRIN2B;FADD;GPER1;RIPK2;CASP8;ARL6IP5;NODAL
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex R-HSA-937042,-0.5591360358231209,-0.9648316145803898,0.515625,0.9267342459477266,1.0,2/10,12.77%,RPS27A;UBC
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.5786352519928795,-0.9647140041232486,0.5740740740740741,0.9267424133877039,1.0,1/7,10.01%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.5492989519339619,0.9646591301794532,0.525,0.978937085104059,1.0,1/8,1.02%,TMEM100
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.5531408168158601,-0.9646150689111509,0.5333333333333333,0.9266701178332069,1.0,3/10,8.24%,RPE65;PDE6B;GRM6
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.3902835157565418,-0.9646040591808785,0.5057471264367817,0.9264029800048155,1.0,26/120,24.11%,EFNA1;TGFBR2;KIF14;CENPE;MINK1;DAB2IP;STRADB;EMP2;SLC11A1;MTCP1;PRKCD;RELN;CDKN1A;SPDYA;CD4;DOK7;PAK5;PAK6;PTPRC;CALM3;STK3;NEDD9;MMD2;SRCIN1;MAP2K3;CAMK1
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.5184513432061857,0.9643445671879546,0.5675675675675675,0.9792418732767909,1.0,5/15,17.90%,STN1;DCLRE1B;TFIP11;POT1;DCLRE1C
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.6323381225989987,0.9643155931806616,0.5636363636363636,0.9787069173191246,1.0,1/5,0.64%,CD200R1
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.6145017826924608,0.9642968558087953,0.5652173913043478,0.9781589649144168,1.0,5/6,36.70%,TAOK2;SEMA3A;PTN;NRP1;CHRNA7
prerank,Reactome_2022__Gap Junction Trafficking R-HSA-190828,-0.5224611312179013,-0.9642505937388062,0.5362318840579711,0.9269276916531449,1.0,3/13,19.82%,GJB7;CLTB;DNM1
prerank,Reactome_2022__Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,0.4739090196000192,0.964105611556564,0.475,0.9781160552998754,1.0,9/15,22.22%,PI4K2A;PIK3R4;SACM1L;PIK3C2G;PIK3C3;FIG4;PIK3C2A;PIKFYVE;PI4KB
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,0.4630037213959739,0.9639450735573861,0.5714285714285714,0.9779165235338311,1.0,4/20,10.74%,ELOVL6;ELOVL4;ELOVL2;HACD2
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.415782162200278,-0.9637141204675336,0.48717948717948717,0.9280827102494035,1.0,15/92,19.14%,RHOBTB2;NEXN;FSCN1;RND2;BST2;BAIAP2;CLIC4;RHOF;DMTN;DLC1;PRKCD;RHOD;CLN3;MAPT;PHLDB2
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.582412898688468,-0.963181494305397,0.5166666666666667,0.9291009849155567,1.0,1/11,2.19%,KDELR3
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.48624283803326707,0.9631803441204894,0.5348837209302325,0.9797323431698772,1.0,6/14,22.73%,ACACB;PMVK;ACSS1;MLYCD;NUDT7;TDO2
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.5073021341303197,-0.9631767684895238,0.5373134328358209,0.9288025018695097,1.0,2/25,3.77%,ICAM1;TJP3
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.5088276833996846,0.9628914648638236,0.46153846153846156,0.9798246408900124,1.0,2/13,6.48%,DAO;MOXD1
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,0.37576794350877574,0.9625558224622814,0.4074074074074074,0.9802976078349303,1.0,15/62,16.56%,POLD3;SLC19A1;ERCC8;RFC3;ERCC6;ERCC2;ERCC3;GTF2H5;GTF2H2;POLK;POLR2C;EP300;AQR;PPIE;HMGN1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.3689193080981886,-0.9624979929849428,0.5795454545454546,0.9302491478330405,1.0,39/254,16.53%,KLF2;LEF1;HPN;POU4F1;TLR2;ANK3;NOS1AP;WARS1;RAMP3;TESC;OVOL2;APP;KLF4;SCX;BRCA1;TLR3;PLSCR1;EGF;IGF1;ADAM19;WNT5A;RIMS2;FGF1;FN1;SFRP4;RPS7;C1QTNF1;CD63;FGF7;SLC11A1;PIK3CB;CD74;RPL5;DDRGK1;PIK3CD;F3;FGF22;ANXA2;RPL23
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.5189043776253363,0.9622168804069702,0.525,0.9807835988044332,1.0,2/11,10.59%,CEP19;PCM1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3084879211457996,0.9621769121013203,0.5,0.9803046152552312,1.0,93/375,20.96%,POU6F2;RNF6;LIMD1;ZNF117;BMP2;PPARGC1A;ZNF195;SOX21;ZNF212;CEBPA;MITF;POFUT1;HCLS1;HES6;USP13;METTL18;SLC39A8;ATF5;APBB3;ZNF74;ESRRG;RABL3;ZNF502;SOX12;RORB;FBXO5;ZNF680;ZNF268;THAP1;GLI4;RNF14;NR3C1;NFYC;YAF2;SLC2A4RG;HP1BP3;ZNF341;ZNF875;ZNF703;EIF4E;ZNF676;ESRRA;ZNF33A;ZNF736;ZNF280D;MAGED1;PATZ1;APBB2;TGFBRAP1;DVL2;ORC5;ZNF138;HMG20A;GPBP1L1;KAT7;ZNF519;ZNHIT3;DDX25;EP300;SMARCA2;PPIE;BACH1;METAP1;HINFP;ZNF492;NR1D2;FOXN2;NCOA2;CHD7;VHL;EFEMP1;CCDC88A;CNBP;VSX1;NLK;HDAC10;PRDM2;ZNF737;NFXL1;MED23;DAXX;ZNF460;PSPC1;CCAR2;ANKRD17;SP3;ZNF253;SAP30L;ZNF2;UTP4;KAT6B;ZNF398;ZNF430
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex5:Brain,-0.6007791551392598,-0.9620686651372009,0.6101694915254238,0.9310681036649943,1.0,4/7,19.58%,RCSD1;TLL1;IL1RAPL2;ABCC9
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,0.35370775778779073,0.962064553432281,0.5714285714285714,0.9800298281554741,1.0,21/87,15.97%,NUP42;RAB33B;NUP37;KMT5A;H2BC21;GORASP2;H2BC4;NUP54;BLZF1;NCAPH2;H2AC6;PLK1;LPIN3;RAB1B;NDC1;NUP214;H3-3B;AAAS;NUP188;MCPH1;NUP205
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.5182560770250167,-0.9619589823215771,0.5714285714285714,0.9310408630471811,1.0,3/13,13.56%,SLC39A14;TRPC3;SLC11A1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.47151341513071277,-0.9616119464699239,0.5454545454545454,0.9316800672332166,1.0,10/34,21.35%,LZTS1;VLDLR;DAB2IP;HECW2;MFSD2A;BCL11A;ALK;CAMK1D;NSMF;PACSIN1
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Blood,-0.47706645055198726,-0.9614831678526183,0.5538461538461539,0.9316649794183799,1.0,5/23,16.53%,MMP14;CD9;JUNB;F3;MCAM
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4201947579338903,-0.9614806946089288,0.52,0.9313631575340321,1.0,11/64,19.21%,THBS1;SKOR1;SULF1;VWC2;DAB2IP;MMRN2;APLN;GPC1;LRP2;NIBAN2;BMPER
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),0.65052210686205,0.9614124632800959,0.5769230769230769,0.9811052596437371,1.0,3/5,31.86%,ACADSB;SDSL;HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.4239810236275703,-0.9612975836225885,0.5945945945945946,0.9314591454337124,1.0,6/60,11.85%,PRAME;GRIN3A;THY1;NEUROD2;PINK1;FOXM1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.5476709865528138,-0.9610795918934215,0.5666666666666667,0.931665994268642,1.0,1/8,2.09%,ANK3
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,-0.4049149014530735,-0.9610092202636286,0.625,0.9315338828798808,1.0,19/72,23.65%,PDE4A;ADCY7;GNG3;ITPR3;PRKCG;PPP3CC;ADCY5;GNG2;PRKCD;ADCY8;CDK5;PDE1C;PDE1A;ITPR1;GNB4;GNB5;GRK2;GNA14;AHCYL1
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,-0.39563878930616847,-0.960790586174363,0.5555555555555556,0.9318637383672431,1.0,15/98,17.54%,DOCK8;IRF1;MAFF;GATA1;CENPE;ZFPM1;KIF9;MAFK;KIF2C;RNASE1;CDK2;SH2B2;WEE1;DOCK10;CDK5
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),-0.6022132325759575,-0.9607569624605843,0.6065573770491803,0.93162391256974,1.0,1/5,6.13%,ELAVL4
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.5068338114169555,-0.9607145640994358,0.5,0.9314242481766675,1.0,2/26,4.38%,NPY;CCDC39
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.38731822606352617,0.960688224775272,0.5555555555555556,0.9824709149868661,1.0,18/69,17.70%,POLD3;ERCC8;COPS2;RFC3;COPS8;ERCC6;ERCC2;COPS7A;ERCC3;GTF2H5;GTF2H2;POLK;POLR2C;EP300;AQR;PPIE;HMGN1;COPS7B
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.5989919139457403,0.9606734706730479,0.5833333333333334,0.9819581918087154,1.0,2/5,12.63%,NT5C1A;NUDT15
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.5077634181534604,-0.9606626369002381,0.5535714285714286,0.9312585531486189,1.0,5/15,20.40%,CYP1B1;CRLF3;OCIAD2;GHR;HES1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),0.5003963158220958,0.9605864806263704,0.5517241379310345,0.9816492174655891,1.0,4/13,21.53%,FASTKD2;MRPS27;FASTKD3;RPUSD4
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.5183643027085986,-0.9605501470705667,0.5409836065573771,0.9312251982604612,1.0,5/14,18.86%,SRF;CHRM3;KCNB2;DAPK3;PLCE1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.43478583937080684,-0.9604491030913985,0.5405405405405406,0.9311734206208124,1.0,9/43,14.82%,BCAS1;CNTNAP1;PLP1;KLK6;SLC8A3;EIF2B2;SCN2A;PLLP;MYRF
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.5645131570978172,0.960287350944739,0.5526315789473685,0.9819970271721665,1.0,3/6,16.49%,GLUD1;GLS;GLUL
prerank,KEGG_2021_Human__MAPK signaling pathway,-0.3735344944628674,-0.9601515922166182,0.5888888888888889,0.9317055680505586,1.0,41/239,18.23%,CACNA1H;IL1R1;RASGRP1;EFNA1;DUSP1;MET;TGFBR2;RASGRP2;MAP3K6;EGF;PRKCG;SRF;GADD45A;RPS6KA1;IGF1;PPP3CC;PTPN7;TGFA;FGF1;CACNA1C;MAP3K14;DUSP16;FGF7;TNFRSF1A;FOS;NR4A1;BDNF;IL1RAP;RASGRF2;STMN1;CACNB1;MAX;FGF22;PTPRR;PRKCB;TEK;GADD45B;ANGPT2;TGFB1;MAPT;RPS6KA6
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.46835554421924896,-0.9598921865423418,0.559322033898305,0.9320622553340726,1.0,2/35,2.70%,AGPAT4;ITPKC
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.6562275078120569,-0.9598530721416219,0.6037735849056604,0.9319027651948121,1.0,1/5,4.06%,SH3GL2
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.4789559011768184,0.9598346157943315,0.5789473684210527,0.9828719458582313,1.0,3/18,10.63%,NAF1;CCT7;CCT3
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.56192315215897,0.9594748370570195,0.5121951219512195,0.9831712979786733,1.0,1/5,10.13%,NRXN1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.47583390762585714,-0.9594716310229525,0.5483870967741935,0.9326122114434751,1.0,6/33,13.92%,ZFP36;YBX3;ELAVL4;DND1;SLC11A1;VIP
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.5913702792340243,-0.9592765495998856,0.5254237288135594,0.9328240022090524,1.0,2/6,5.72%,PDPN;PLN
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.46338936882824433,-0.959223657793581,0.5945945945945946,0.9326183980497401,1.0,2/31,3.17%,THBS1;IL12A
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.43833348633107855,0.959217977309675,0.4857142857142857,0.9833081716801515,1.0,4/25,7.72%,HCLS1;ZPR1;TRIM28;IPO5
prerank,Reactome_2022__Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,0.3991920675551604,0.9589523942130563,0.5714285714285714,0.9834921396500879,1.0,9/33,14.16%,CYP4F3;CYP4F12;CYP7B1;PTGIS;CYP4V2;VDAC2;CYP3A43;CYP46A1;CYP2U1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.4505651767768323,-0.9588983672179137,0.5714285714285714,0.9328300011119579,1.0,1/47,0.52%,CCNB2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.4505651767768323,-0.9588983672179137,0.5714285714285714,0.9328300011119579,1.0,1/47,0.52%,CCNB2
prerank,CellMarker_Augmented_2021__Oocyte:Embryo,0.34800014848776206,0.9587933635036612,0.56,0.983352031369132,1.0,18/82,16.32%,ARV1;C5ORF22;KIF15;DUSP19;ZC3H8;NUP37;LMO3;TDRD6;RAI14;PPM1A;PTPRK;EPB41L5;MEST;ITGAE;DCUN1D5;TAPT1;NARS2;LANCL1
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,-0.4817980272583616,-0.9585416380813914,0.5569620253164557,0.9333295548327778,1.0,7/25,17.19%,ATP1A1;ATP1B1;PRKCG;IGF1;PIK3CB;PIK3CD;PRKCB
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),0.5809629742480233,0.9584089540493389,0.5,0.9838526759401873,1.0,2/5,11.25%,TSPAN12;ADAMTS12
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5219604622259267,0.9582856415436567,0.4473684210526316,0.9836923028969986,1.0,2/13,10.96%,PPP1R15B;NCK1
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.5949906072367847,0.9582745922568886,0.627906976744186,0.983134755488145,1.0,2/7,8.94%,AGER;HMGB1
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,-0.5124274428680566,-0.9580451705991794,0.5483870967741935,0.9342148473796019,1.0,5/18,14.80%,B2M;SYK;HLA-E;RNASE1;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.5583459307519338,-0.9580385768986253,0.5306122448979592,0.9339386746534786,1.0,1/9,2.05%,ABCA5
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.5912722621195929,-0.9579785088928977,0.578125,0.9337882257685953,1.0,4/7,12.58%,SKAP1;THY1;CD44;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.5720113335217722,-0.9579313279767847,0.5423728813559322,0.9335950215318592,1.0,2/9,12.39%,PLAAT4;PRKCH
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.5590866764599155,-0.9575509667924521,0.5818181818181818,0.9342648649608293,1.0,4/10,20.40%,IFT122;RYR2;TBX20;HES1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.3934802871745328,0.9575417135421581,0.42857142857142855,0.9848260241403575,1.0,4/42,4.15%,WNT7A;SLITRK2;SLIT1;NLGN3
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.3607893370809789,0.9575157467519521,0.6153846153846154,0.9843222817173601,1.0,19/58,27.72%,ZNF207;SGO2;NSL1;PLK1;EPS8;CEP192;TUBG1;AAAS;TOGARAM1;TPX2;ESPL1;CTDP1;KIF3B;PIBF1;MAP9;KIFC2;INO80;CLASP2;SMC3
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.5864533643311355,0.9573957628944623,0.6086956521739131,0.9840678884120759,1.0,5/6,38.54%,UBQLN1;NFE2L2;UBQLN2;BCAP31;SGTA
prerank,CellMarker_Augmented_2021__Stromal cell:Adipose Tissue,-0.6171084401498863,-0.957242653925843,0.5666666666666667,0.9347721420279024,1.0,2/5,7.03%,THY1;CD44
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.4489929917537431,0.9572331498071599,0.5945945945945946,0.9840288056562783,1.0,2/23,0.94%,SLC26A7;SLC19A1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.44043630055283783,0.9571325345157529,0.5476190476190477,0.9836674468341015,1.0,6/19,18.05%,MCU;MAIP1;LETM1;MICU2;PDZD8;MICU3
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.3669198769171003,-0.9570333840983494,0.5531914893617021,0.9350772586786033,1.0,57/270,18.75%,HPN;OGN;CDKN2A;FABP3;B2M;WARS1;PROX1;PDPN;IL12A;IRF1;BTG3;TESC;GPNMB;IFI35;ST18;APP;KLF4;PODN;NELL1;CYP1B1;APOD;IFIT3;BTG1;P3H2;WNT5A;SST;IGFBP7;DAB2IP;SFRP4;BAP1;IGFBP5;TFAP4;CLMN;VIP;B4GALT7;CDKN3;SFRP2;DLC1;TNS2;NUDT6;PML;EMD;CD200;TSC2;ETS1;GPER1;NMI;TGFB1;CDKN2D;TINF2;NUPR1;GSDME;NIBAN2;CDKN1A;RARG;ADAMTS8;NLRC3
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,0.31890412666483425,0.9567320760443562,0.375,0.9841856665610564,1.0,58/181,30.72%,U2AF1;SF3A1;NUDT21;SNRPF;SF3B4;GTF2F2;HNRNPC;WDR33;CWC27;SMNDC1;LSM8;CSTF3;CPSF6;SNRPN;PAPOLA;SNRPB2;CPSF7;LSM5;TFIP11;RBM17;LSM7;HNRNPU;POLR2C;AQR;PPIE;PPWD1;SNRNP27;DHX15;PDCD7;RBMX;PPIL6;CPSF2;CRNKL1;PPIH;PLRG1;SUGP1;MTREX;HNRNPD;SRSF9;POLR2A;CSTF1;SNRPB;SNRNP48;MAGOH;SNRNP35;SRSF2;POLR2K;POLR2D;PRCC;LSM6;PPIL3;MAGOHB;SNRNP40;CSTF2T;HNRNPH1;POLR2E;PTBP1;DHX16
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.5267446881708167,-0.9567175187553606,0.5901639344262295,0.9355808799484017,1.0,1/13,1.14%,NR4A3
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.4640663162066514,-0.9566817064223317,0.5675675675675675,0.9353751808913737,1.0,8/27,20.42%,CD160;HTR2B;IGF1;NYAP1;PIK3CB;PIK3CD;HTR2A;NYAP2
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,0.34364639431303734,0.9566141073551403,0.5217391304347826,0.9839789059259036,1.0,17/100,11.63%,SEM1;BMP2;PPARGC1A;PSMD10;RUNX1;PSMA1;PSMD11;SOX9;AKT2;CUL1;YES1;AKT1;PSMB5;NR3C1;ESRRA;PSMD14;RBM14-RBM4
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.5458246029089401,0.9565735705206478,0.5454545454545454,0.983497561245721,1.0,1/9,12.81%,SLC25A5
prerank,KEGG_2021_Human__Cholinergic synapse,-0.3887422887310939,-0.9565438435830981,0.5945945945945946,0.9354628957887889,1.0,21/92,17.58%,KCNQ1;KCNJ2;CHRM1;ADCY7;GNG3;ITPR3;PRKCG;CHRM3;CREB5;CACNA1C;ADCY5;ACHE;GNG2;FOS;PIK3CB;PIK3CD;ADCY3;ADCY8;PRKCB;CHRM5;CREB3
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Stem Cell,-0.44832748490063806,-0.9564781911196266,0.5211267605633803,0.9343792141859033,1.0,9/30,11.34%,P2RY13;MYO1F;SLA;GAB3;IGSF6;CLEC12A;RCSD1;CTSS;SELP
prerank,CellMarker_Augmented_2021__Endothelial cell:Eye,-0.44832748490063806,-0.9564781911196266,0.5211267605633803,0.9343792141859033,1.0,9/30,11.34%,P2RY13;MYO1F;SLA;GAB3;IGSF6;CLEC12A;RCSD1;CTSS;SELP
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Umbilical Cord Blood,-0.44832748490063806,-0.9564781911196266,0.5211267605633803,0.9343792141859033,1.0,9/30,11.34%,P2RY13;MYO1F;SLA;GAB3;IGSF6;CLEC12A;RCSD1;CTSS;SELP
prerank,CellMarker_Augmented_2021__Platelet:Bone Marrow,-0.44832748490063806,-0.9564781911196266,0.5211267605633803,0.9343792141859033,1.0,9/30,11.34%,P2RY13;MYO1F;SLA;GAB3;IGSF6;CLEC12A;RCSD1;CTSS;SELP
prerank,Reactome_2022__Miscellaneous Substrates R-HSA-211958,0.5894614950741914,0.9562692429616937,0.5625,0.9838407840085681,1.0,3/5,14.16%,CYP4F3;CYP3A43;CYP2U1
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.5353846379254533,0.95624589723409,0.5660377358490566,0.9833801751946734,1.0,1/8,1.24%,NR1D1
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,0.3610117393438902,0.9562368925111981,0.5714285714285714,0.982813049947745,1.0,15/75,14.20%,POLD3;SLC19A1;COPS2;RFC3;COPS8;UBE2N;INO80D;ERCC2;YY1;COPS7A;NFRKB;ERCC3;GTF2H5;GTF2H2;POLK
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,-0.4673501211007195,-0.9558564349094283,0.547945205479452,0.9355712101295852,1.0,3/29,12.77%,RPS27A;STAT1;UBC
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Eye,-0.4014983659280319,-0.9558308731255828,0.569620253164557,0.9353476909435671,1.0,25/84,19.74%,STMN2;RCAN2;PDPN;PLP1;THY1;GAP43;LDB2;IGSF21;TCEAL2;ADCY5;IGFBP5;CRMP1;GPC3;RASL12;RGS7BP;TMEM132C;SFRP2;TCEAL5;CD200;NDN;ANOS1;PCDH18;PARM1;DPYSL3;PABPC5
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.397483818183449,-0.955830402121811,0.5375,0.93504202176352,1.0,15/86,16.24%,HPN;L1CAM;SHTN1;SYT4;MMP14;RPS6KA1;SYT1;IGF1;CPNE9;RIMS2;HYAL1;BDNF;MFSD2A;SFRP2;SYT2
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.4258463825363249,-0.9557717304285448,0.5384615384615384,0.9349071847160529,1.0,9/65,16.32%,STMN2;CAV3;LDLR;PFDN6;PFN2;KANK3;PRKCD;STMN1;PFDN1
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.598181112599103,-0.9557190919768737,0.5454545454545454,0.9347328375800364,1.0,5/7,18.20%,F8;F10;SERPING1;F3;A2M
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.3575147541135703,-0.9556518573292796,0.6224489795918368,0.9346073245701725,1.0,71/418,18.40%,PRAME;CDKN2A;BLM;DUSP1;SP100;FABP3;TLR2;WARS1;PSRC1;PROX1;PDPN;TP53TG5;IRF1;BTG3;TESC;GPNMB;IFI35;ST18;PODXL;APP;KLF4;HTR2B;DYSF;PODN;BST2;CYP1B1;IFIT3;PLSCR1;ARHGDIG;FBP1;TSPYL2;BTG1;P3H2;CRLF3;CD9;SST;IGFBP7;LRPAP1;DAB2IP;SLIT3;SFRP4;BAP1;FOXM1;MYH9;NOS1;TFAP4;CLMN;NR4A1;HYAL1;APOBEC3H;CDKN3;SFRP2;DLC1;TNS2;TCHP;NUDT6;PML;BCL6;CD200;TSC2;ETS1;GPER1;GMNC;NMI;TGFB1;CDKN2D;NUPR1;GSDME;NIBAN2;CDKN1A;RARG
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,0.4819022137847295,0.9556396971866324,0.47368421052631576,0.98383148816273,1.0,1/13,2.79%,LIG4
prerank,CellMarker_Augmented_2021__Dendritic cell:Placenta,-0.4591171467201036,-0.9553806125463459,0.4426229508196721,0.9349598052608478,1.0,9/27,10.58%,MYO1F;GPR183;TAGAP;SLA;ARHGAP9;HLA-DRA;WAS;CTSS;PILRA
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,-0.37919868183484,-0.9552917046929783,0.6,0.9348738595017416,1.0,24/146,18.88%,ST6GAL1;ANK3;KDELR3;F8;CTSC;GRIA1;TGFA;CD55;COPZ2;DCTN1;CTSZ;MAN1C1;F5;ANKRD28;MAN1A1;ANK1;MGAT5;ARFGAP1;TRAPPC2L;GOLGB1;CFAP73;MAN2A2;PTGES2;ST8SIA3
prerank,CellMarker_Augmented_2021__Hepatocyte:Fetal Liver,-0.41673514965819203,-0.9551926382471564,0.5844155844155844,0.9348761889190489,1.0,22/74,22.28%,MET;LAMB1;EPS8L2;KDELR3;ITGA2;CCND1;BAIAP2L1;P4HA2;SLC44A3;AMOTL2;RHBDF1;RHOD;PTPRF;PTPN21;LAMA5;EPB41L4B;KIAA1217;WWTR1;CD276;SH3D19;MYO1B;CTNND1
prerank,KEGG_2021_Human__Proteasome,0.4049709406091448,0.9551267819088126,0.45714285714285713,0.9847150578957499,1.0,7/40,13.78%,SEM1;PSMA1;PSMD11;PSMB5;PSMD14;POMP;PSMD12
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.540720467160014,-0.954869145007272,0.5694444444444444,0.9352860170491154,1.0,2/16,1.31%,NR4A3;FABP3
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.4016260046843455,0.954734349092409,0.5517241379310345,0.9853571265895033,1.0,4/31,10.22%,RGCC;BMP2;AKT1;ZNF703
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.35705885038163754,0.954716678742247,0.5,0.9848502525679197,1.0,9/61,7.64%,ACE2;TMEM229A;KCNE1;EHF;ARHGEF16;TRIM29;MYO5B;CAPN13;PLEKHA6
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,0.426639207601357,0.9546774471628716,0.5555555555555556,0.9843840046609552,1.0,4/25,14.88%,HSPA1A;VCP;HSF1;MRPL18
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.4287558740024317,-0.9545848109165009,0.5616438356164384,0.9356408570208832,1.0,7/28,17.54%,GBP1;MMP14;PDZK1;GPC3;CLN3;GPC1;CDK5
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.41145724949833595,-0.9545552384257957,0.5308641975308642,0.9354150043892268,1.0,7/79,12.77%,CCNB2;RPS27A;CCNB1;DCTN1;HAUS7;CEP76;UBC
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.4936753346695869,0.954457157392433,0.6382978723404256,0.9843917083661697,1.0,1/11,6.91%,RAB27A
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.524617539368826,0.9544470971508013,0.6052631578947368,0.9838729684030163,1.0,1/6,5.13%,SOX9
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.363496125690822,-0.9544433584159744,0.6170212765957447,0.9353503168571888,1.0,50/273,18.56%,ENPP2;RASGRP1;EFNA1;C3;APLNR;CSPG4;RAMP3;GPNMB;IL15;CEMIP;ITGA5;APP;GATA1;BMP8A;CD44;CCND1;TNFRSF14;CENPE;EGF;CHI3L1;SLCO3A1;IGF1;PFN2;THPO;FAM20A;FGF1;PINK1;FLOT1;NOS1;FGF7;NEK10;MTCP1;BDNF;CD74;SFRP2;DDRGK1;RELN;SH2D3A;CCND2;HLA-DRB1;FGF22;SH2D3C;TEK;GPER1;RIPK2;LIMK2;TGFB1;CDKN1A;SPDYA;CD4
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.42316597947566725,0.9544428055350487,0.6333333333333333,0.9833015594929377,1.0,6/24,17.67%,CNOT9;FOXP1;HEYL;CNOT2;VPS11;CNOT1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.35813543127098413,0.9542299022802129,0.4827586206896552,0.9833764442718712,1.0,10/75,10.14%,NR1D1;ADIPOR1;ELOVL6;ACACB;PMVK;MID1IP1;RUBCNL;NFYC;CHD9;GNB3
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.5378235308123702,-0.9537722537027615,0.5507246376811594,0.9367616950160866,1.0,1/13,0.94%,DUSP1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.41177383693414693,0.9536317048851991,0.5172413793103449,0.9845155607305623,1.0,11/37,16.60%,WASHC5;PI4K2A;EXOC8;RAB27A;RAB22A;PHETA1;CHMP2B;ALS2;RNF26;VPS11;DNAJC13
prerank,Reactome_2022__Coenzyme A Biosynthesis R-HSA-196783,0.5773012244619979,0.9536194018054595,0.5757575757575758,0.9840046132078416,1.0,4/8,36.55%,PANK2;SLC25A16;PPCS;PANK1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.5420056966467917,0.9536083070400306,0.5789473684210527,0.9834543994918912,1.0,2/9,10.59%,CEP19;PCM1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.530047300582844,0.9536044279215038,0.5952380952380952,0.9828849095117841,1.0,1/7,4.10%,SERPINB9
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.578064353968454,-0.9535623504067395,0.6166666666666667,0.936906101907596,1.0,4/10,20.15%,IL15;HLA-DRB1;CD4;CASP8
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.5962709459233755,0.9533352806779294,0.5102040816326531,0.983192093674094,1.0,3/5,16.45%,NIPBL;ID2;RBPMS2
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.5548383278161431,0.9533019009468191,0.627906976744186,0.9826831164598268,1.0,1/6,4.10%,SERPINB9
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.5153242769875745,0.9532582094838802,0.5714285714285714,0.9822343924534377,1.0,1/7,10.84%,EIF2AK4
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.6178089641606211,0.9531829666186391,0.5263157894736842,0.9812524451995369,1.0,1/5,10.30%,CPSF6
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.6178089641606211,0.9531829666186391,0.5263157894736842,0.9812524451995369,1.0,1/5,10.30%,CPSF6
prerank,Reactome_2022__Circadian Clock R-HSA-400253,0.38211110272273907,0.9531732161011561,0.32,0.9806994694640714,1.0,14/63,17.23%,NR1D1;PPARGC1A;CUL1;FBXL3;CSNK1E;NR3C1;CHD9;NRIP1;BTRC;BMAL1;PPP1CC;EP300;CPT1A;NCOA2
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,0.3713211885806605,0.9531700789242333,0.6111111111111112,0.9801405257869619,1.0,22/101,16.56%,POLD3;SLC19A1;ERCC8;COPS2;RFC3;COPS8;UBE2N;ERCC6;INO80D;ERCC2;YY1;COPS7A;NFRKB;ERCC3;GTF2H5;GTF2H2;POLK;POLR2C;EP300;AQR;PPIE;HMGN1
prerank,Reactome_2022__RUNX3 Regulates p14-ARF R-HSA-8951936,-0.5680555495748995,-0.9527652774135269,0.5636363636363636,0.9384829862130819,1.0,2/9,7.35%,CDKN2A;CCND1
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.5787025367483041,0.9524643693594439,0.5714285714285714,0.9813865814270376,1.0,1/6,5.33%,EIF3E
prerank,Reactome_2022__FGFRL1 Modulation Of FGFR1 Signaling R-HSA-5658623,0.5683227698928303,0.952435283658692,0.5641025641025641,0.9808741271435966,1.0,3/6,21.20%,SPRED1;SPRED2;FGF17
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.491195914834371,0.952257810134303,0.5128205128205128,0.9807385628456937,1.0,3/14,11.53%,PSMD10;AKT1;OPA1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.5204379367763965,-0.9522161809511493,0.5671641791044776,0.9394398837736716,1.0,4/16,15.93%,NOS1AP;CAV3;NOS1;CACNB1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.4074681395380026,-0.9522074599375401,0.5641025641025641,0.9391647062167804,1.0,19/87,21.59%,P2RY6;KCNQ1;P2RY12;BRCA1;GLRA2;GABRB2;IGFBP5;DMTN;HRH1;GABRG2;CIB2;AQP1;AKAP6;HCN1;GLRA1;NSMF;SFRP1;SPAAR;P2RX7
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,0.4785620177596269,0.952150050011724,0.5135135135135135,0.9803788314996675,1.0,5/15,18.34%,MCU;MAIP1;MICU2;MICU3;PHB1
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,-0.4418140434283307,-0.9521118542484363,0.5662650602409639,0.9390867972493822,1.0,8/52,12.25%,EPS8L2;CDH23;MYO15A;SYP;MYO3A;LHFPL5;MYH9;MYO1E
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4790464573486416,-0.9518507536480812,0.5344827586206896,0.9393666161970532,1.0,5/19,19.24%,ABCA5;IL18;PRKCH;MSR1;CD36
prerank,Reactome_2022__Activation Of Ca-permeable Kainate Receptor R-HSA-451308,-0.5615395798761398,-0.9517742557038075,0.53125,0.9392523301121614,1.0,2/9,9.15%,NCALD;GRIK1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.5366633562815893,-0.9517680171876817,0.5070422535211268,0.9389684833753381,1.0,6/10,37.29%,ITGA3;FYN;IGF1R;SUPV3L1;PICK1;PRNP
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.41752030119078826,-0.9517401359583153,0.5903614457831325,0.9387332723292963,1.0,8/59,7.68%,RPE65;SIX3;CDH23;CLRN1;BEST1;SLC24A1;ARR3;CRYBA1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.42556468865091923,0.9517320361518475,0.6071428571428571,0.9811668663333066,1.0,2/20,2.78%,G0S2;BCL10
prerank,KEGG_2021_Human__RNA polymerase,0.38748705175344306,0.9516985944192932,0.5294117647058824,0.9807150426099064,1.0,13/29,30.40%,POLR3B;POLR3F;POLR1F;POLR2C;POLR1D;POLR3E;POLR2A;POLR1B;POLR2K;POLR2D;POLR1A;POLR3H;POLR2E
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),-0.5897948754229587,-0.9516795451497477,0.6122448979591837,0.9385708674414149,1.0,3/8,9.05%,APOLD1;CEACAM1;BTG1
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5303303881431947,-0.9516791757360733,0.6031746031746031,0.9382663343890328,1.0,1/15,1.14%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.4669564467152904,-0.9516289035696389,0.5507246376811594,0.9380951105192559,1.0,8/23,19.87%,EFNA1;PRKCG;RPS7;RPL5;RPL23;PML;GABARAPL2;RPL11
prerank,Reactome_2022__Advanced Glycosylation Endproduct Receptor Signaling R-HSA-879415,0.5078539961367843,0.9516147870410762,0.5348837209302325,0.9803427794262135,1.0,4/11,12.94%,AGER;HMGB1;PRKCSH;CAPZA1
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),-0.6191264293750671,-0.951610223201135,0.6031746031746031,0.9378665363072953,1.0,1/5,8.05%,CTU2
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,-0.5109432119195633,-0.9515765185936355,0.5471698113207547,0.9376592734003131,1.0,4/18,20.64%,MYH11;MYH9;LIMK2;MYL6
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.5746435477113316,0.9515539450504179,0.5681818181818182,0.9799906959967104,1.0,2/7,12.67%,YY1;SIRPA
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.30838189259399806,0.9515238857514682,0.6666666666666666,0.9794942910877981,1.0,27/134,18.23%,LCMT2;GAL3ST2;ALAS1;ESD;ELOVL6;ELOVL4;ELOVL2;CSNK2A1;CHPT1;CSNK2A2;PLA2G4C;GAL3ST4;LPIN3;ASL;HACD2;GPHN;VAPA;SGMS2;PRKD1;VAPB;GSTM2;SLC25A15;PCTP;MOCS2;CEPT1;DMD;SPHK2
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.579991864243917,-0.9515196551376136,0.5932203389830508,0.9371665954797643,1.0,1/9,6.10%,VLDLR
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.579991864243917,-0.9515196551376136,0.5932203389830508,0.9371665954797643,1.0,1/9,6.10%,VLDLR
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.44268345946397386,0.9514227738230062,0.4482758620689655,0.9791562579263322,1.0,2/32,2.60%,ABCA1;KDM1B
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.43523073333274387,-0.95139074830167,0.527027027027027,0.9372164916881904,1.0,7/47,17.86%,SP100;PDPN;EGF;CD9;FES;ETS1;DAPK3
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.3605079438477262,0.9512414440285284,0.52,0.9790683153140782,1.0,15/60,18.38%,PPP1R15B;EIF3E;MIF4GD;MTIF2;EIF2AK4;NCK1;UHMK1;EIF4EBP2;EIF3H;C8ORF88;PAIP1;NCK2;EIF2AK3;CDC123;YTHDF2
prerank,Reactome_2022__SEMA3A-Plexin Repulsion Signaling By Inhibiting Integrin Adhesion R-HSA-399955,-0.5321253610117535,-0.9510541267632259,0.578125,0.9376769923633425,1.0,5/14,25.06%,RNASE1;FES;TLN1;RRAS;FYN
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.3133643275855943,0.9508406131134289,0.5454545454545454,0.9794467464736168,1.0,52/293,16.55%,TBC1D4;ATP6V0D2;TVP23B;ABCA1;MTTP;TMED5;ARFIP1;ATP6V1A;TXNIP;RAB23;SCFD2;TBC1D12;ARL5A;RABL3;BLZF1;ATP6V1G1;CALCRL;STX7;TMEM167A;DNAJC27;CEP290;ARFIP2;RAB8B;C17ORF75;CMTM6;RAB22A;RAB1B;NDC1;AP3B1;MON1A;RAB28;COPB2;SNX31;SCFD1;CHMP2B;SEC23IP;NAPB;TBC1D5;UNC119B;SEC31B;TMED3;RAB26;RAB21;RAB8A;LRP1B;SNX27;TBC1D8B;ARCN1;RCN3;SCAMP4;TANGO6;HERC2
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,-0.37339258813495335,-0.9507620157348521,0.5402298850574713,0.9380889004056518,1.0,33/172,18.80%,APIP;CDKN2A;RPS27A;IRF1;NDUFA2;SEPTIN4;YWHAH;PSMB9;LMNB1;PPP3CC;PSMB6;UNC5B;BIRC3;PRKCQ;BMX;IL18;PSMC3;FLOT1;UBC;FADD;NMT1;PSMA8;PRKCD;PSMA7;FASN;CDC37;PSME1;DAPK3;MAPT;GSDME;PLEC;TNFRSF10A;BBC3
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.4268645659047045,-0.9507015207100789,0.5512820512820513,0.9379151596595594,1.0,10/62,15.79%,S100A10;MET;SYNPO2L;WAS;PFN2;ARHGEF18;TMEFF2;PPFIA1;DLC1;STMN1
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.5838532636881217,-0.9505982486642011,0.55,0.9378229756733605,1.0,3/8,17.76%,GC;CYP3A4;LRP2
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.42620660453452547,-0.9504631342097665,0.4852941176470588,0.9378544861077694,1.0,7/45,13.16%,LDHA;SLC16A3;PDHX;LDHAL6A;LDLR;PDK3;LDHD
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.5094360123476629,-0.9504332112504248,0.5454545454545454,0.9376237139245411,1.0,2/20,2.46%,C3;NOS1AP
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.4916660639250835,-0.9503992532571699,0.5694444444444444,0.9373840502632732,1.0,3/20,3.19%,AMN;PDPN;GC
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.4444851135718661,-0.9500842237517494,0.5694444444444444,0.9378404430724905,1.0,7/41,19.53%,ABCA8;ARG2;FA2H;CYP4F22;ASS1;RHD;PAM
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.5406538323860985,0.9500401661791804,0.5952380952380952,0.9808551942395236,1.0,3/7,24.52%,NFIB;RYK;SMO
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.3502747322338589,0.9495892853151663,0.5806451612903226,0.9814879780572061,1.0,15/63,16.36%,BET1;PEF1;SEC22B;PPP6R1;KLHL12;RAB1B;VAPA;SCFD1;CNIH1;SEC24A;SEC23IP;SEC31B;VAPB;SEC23B;CNIH3
prerank,GO_Biological_Process_2021__establishment of monopolar cell polarity (GO:0061162),-0.6281325428756109,-0.9491724517885142,0.6491228070175439,0.9397782426992667,1.0,1/5,4.77%,FSCN1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.4648700313402459,-0.9490834988178937,0.5538461538461539,0.9396826252499447,1.0,6/27,14.26%,PTP4A3;CYP1B1;STAT1;MYH9;EMP2;NR4A1
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.42041128640451186,0.9490541582160045,0.625,0.9825199346006046,1.0,5/20,8.12%,CSPG5;CHST11;CSGALNACT1;CHST7;BCAN
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.3852147203707542,-0.9490426417136669,0.569620253164557,0.9394666837120669,1.0,18/121,17.44%,LEF1;RPS27A;GNG3;ITPR3;PSMB9;PDE6B;PRKCG;WNT5A;PSMB6;PSMC3;GNG2;UBC;RNASE1;PRICKLE1;PSMA8;PSMA7;PRKCB;PSME1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.5601881964888002,-0.9489867971979484,0.5454545454545454,0.9392779595579877,1.0,3/9,23.00%,BRCA1;SET;TAF7
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.37649410215027246,-0.9489698359824434,0.5443037974683544,0.9389991260067169,1.0,5/145,1.90%,CDKN2A;BLM;SP100;PGR;HIC1
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.6228821247467355,-0.9488996989135355,0.546875,0.9388708089444107,1.0,1/5,5.61%,ABCA12
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.5028138637898792,-0.94867263499313,0.5245901639344263,0.9390461568795556,1.0,5/11,30.45%,KAT5;FAM161A;CAMK1;PARK7;TERF2IP
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.37010740693468164,-0.9486625731672166,0.5609756097560976,0.9387646627012547,1.0,13/151,13.10%,ENPP2;RIMBP2;AMN;PLB1;AKR1C1;PARP14;LDLR;PARP9;SLC19A3;NAMPT;MTHFD2;GPC3;GCHFR
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.5887740993487602,0.9485734148334961,0.5952380952380952,0.9832689610507082,1.0,2/5,8.94%,AGER;HMGB1
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.43747036279696666,-0.948528027468419,0.52,0.938792744246171,1.0,6/33,15.54%,INPP5D;SYK;IL3RA;BLNK;PIK3CB;VAV1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.5096174253531147,-0.9483140160707677,0.6166666666666667,0.9390550309515221,1.0,5/15,12.44%,TLR2;APP;GATA1;THPO;DMTN
prerank,CellMarker_Augmented_2021__Acinar cell:Salivary Gland,-0.421647458112153,-0.9482567615100983,0.581081081081081,0.9388848758542947,1.0,15/55,17.70%,IL13RA1;CALD1;ITGA5;YBX3;TBC1D9;PAPSS2;PYGL;SELP;BMX;CHST15;EGFL7;PXDC1;TEK;VCL;LTBP1
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.4984447981254439,0.9481941690080791,0.5294117647058824,0.9836635171142406,1.0,1/14,5.18%,ASAH2B
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,-0.49269828185029224,-0.947978363600184,0.5915492957746479,0.9393060134108517,1.0,4/22,12.36%,GNG3;NCALD;GRIK1;GNG2
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,0.3580557808069133,0.9479149575553553,0.5294117647058824,0.9838285614959904,1.0,21/67,25.32%,NCSTN;CNTN1;MAML3;KAT2B;CDK8;CUL1;HEYL;DTX4;KAT2A;HDAC2;EP300;HEY1;HDAC10;HEY2;HES5;MIB1;JAG1;RBPJ;ITCH;FBXW7;ARRB1
prerank,"Reactome_2022__SUMO Is Transferred From E1 To E2 (UBE2I, UBC9) R-HSA-3065678",0.5756865814124389,0.9477817424419496,0.5952380952380952,0.9836402185292016,1.0,1/5,21.32%,SUMO2
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),-0.589921106689181,-0.9476354570651155,0.5806451612903226,0.9398018791648096,1.0,3/8,15.80%,NEUROD2;DAB2IP;RELN
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,-0.3693317319424006,-0.9474869974539329,0.6024096385542169,0.9398745670506623,1.0,42/180,18.84%,CP;SLC28A2;SLC6A15;SLC39A14;SLC17A5;SLC16A3;SLC32A1;SLC24A1;SLC4A9;SLC5A4;APOD;SLC18A2;SLC38A4;SLC9A2;SLCO3A1;SLC8A3;SLC3A1;SLC7A2;SLC24A5;SLC43A2;SLC44A3;SLCO2A1;SLC20A2;SLC11A1;SLC38A1;SLC4A2;SLC25A26;SLC22A4;SLC12A7;SLC14A2;SLC4A10;SLC9A5;SLCO1A2;SLC29A4;SLC28A3;CTNS;SLC50A1;SLC15A4;SLC39A7;SLC7A7;SLC25A29;SLC1A6
prerank,Reactome_2022__Regulation Of BACH1 Activity R-HSA-9708530,-0.5848208110722881,-0.9474579282303692,0.5737704918032787,0.9396384105109266,1.0,4/11,17.67%,RPS27A;MAFK;UBC;RBX1
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,0.37863899771425463,0.9473818820043817,0.4482758620689655,0.9842430590129783,1.0,12/67,12.18%,SEM1;ABCA1;PSMD10;DERL2;PSMA1;PSMD11;ABCD1;PSMB5;VCP;PSMD14;ABCC2;DERL1
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.39046966627407675,-0.9473560985592622,0.5945945945945946,0.9395642476579775,1.0,12/95,10.74%,TAGLN3;SIX3;SNCB;ZDHHC22;MAP1B;RND2;EFNB3;GAP43;ZNF536;NEFH;HPCA;LGR5
prerank,Reactome_2022__Impaired BRCA2 Binding To PALB2 R-HSA-9709603,-0.4925569505083264,-0.9473137694595188,0.5396825396825397,0.9393882647209205,1.0,2/20,6.29%,BLM;BRCA1
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.4808830168970829,-0.9472621914332937,0.5409836065573771,0.9392153899584006,1.0,6/25,8.69%,CD5;TAGAP;GPR171;SLA;ARHGAP9;WAS
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.43920190513770574,0.947219293350805,0.4857142857142857,0.9840938931119598,1.0,4/24,7.72%,HCLS1;ZPR1;TRIM28;IPO5
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.5410955902286969,0.9471697393613121,0.5526315789473685,0.9836445475871745,1.0,3/9,20.77%,NDC1;NUP205;NUP153
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.36550853315522625,0.946904902895381,0.5666666666666667,0.983711243492172,1.0,8/46,12.53%,WNT7A;ASCL1;LIG4;HES6;HEYL;PCM1;SPEN;PRUNE1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),-0.5439703618039955,-0.9468332062296787,0.5806451612903226,0.9399648355029723,1.0,3/7,24.63%,SRF;GPER1;SPHK1
prerank,KEGG_2021_Human__PPAR signaling pathway,0.37118088706668845,0.9466745958128406,0.5925925925925926,0.9837256877174209,1.0,11/55,16.77%,PLIN4;PLIN1;GK;PLIN5;ACADM;CPT2;EHHADH;SCP2;ACOX1;CPT1A;ACSL3
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.40623674075159066,-0.9466252632286746,0.65,0.9401361075589939,1.0,11/66,15.76%,CDKN2A;DUSP1;CAV3;HEXIM1;SLC8A3;GADD45A;DAB2IP;PAQR3;TFAP4;PIK3CB;PRKCD
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.44445220644030753,-0.9466223730559414,0.5342465753424658,0.9398434686630494,1.0,8/38,14.63%,RPS27;RPS14;EMG1;NOB1;RPS16;RPS7;RPS6;RPS15
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5121744051896004,-0.9465206851327865,0.6027397260273972,0.9397604088409103,1.0,7/18,19.45%,HIC1;HEXIM1;RPS7;RPS15;RPL23;RPS20;EIF5A
prerank,Reactome_2022__SUMOylation R-HSA-2990846,-0.3734775158185311,-0.9464938262193573,0.5121951219512195,0.939527884971954,1.0,5/150,1.90%,CDKN2A;BLM;SP100;PGR;HIC1
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.6210039229851918,-0.9464798320632254,0.582089552238806,0.9392596375043243,1.0,1/6,11.44%,DDX60
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.6028773259767851,0.9464086556577317,0.6326530612244898,0.983948695037507,1.0,2/5,19.35%,AKT1;GLI3
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.6141796920742336,-0.946296976735746,0.5686274509803921,0.939377069388708,1.0,2/7,6.33%,MLIP;CAV3
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),-0.5749304815023661,-0.9460063052911273,0.5737704918032787,0.939778235946826,1.0,3/9,15.80%,NEUROD2;DAB2IP;RELN
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.4517104333664156,-0.9459943899734985,0.5352112676056338,0.9394892603856945,1.0,1/31,2.00%,STMN2
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.5206139964206069,-0.9459499781141423,0.5441176470588235,0.9392751088296706,1.0,1/19,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.5219555827708218,-0.9458881817957424,0.5238095238095238,0.9391476478664397,1.0,1/13,5.64%,YBX3
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.4370213147655705,-0.9458776866201672,0.5507246376811594,0.9388740696063096,1.0,7/32,4.84%,MYO1F;GPR183;CD5;TAGAP;GPR171;SLA;ARHGAP9
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,0.3900494995370373,0.9458711155589336,0.4857142857142857,0.9849987709917325,1.0,9/48,11.34%,SEM1;PSMD10;PSMA1;PSMD11;CUL1;PSMB5;FBXO5;BTRC;PSMD14
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.4025593336426193,0.9457890395580508,0.5897435897435898,0.984628323738707,1.0,5/31,7.72%,RAB23;HCLS1;ZPR1;TRIM28;IPO5
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),0.5871157489594412,0.9457634061329077,0.5833333333333334,0.9841346708765956,1.0,1/6,16.90%,MPP1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.4370165601510363,-0.9454688372157588,0.5641025641025641,0.939468630789678,1.0,1/50,0.52%,CCNB2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.39988590784741723,0.9454466052445716,0.59375,0.9843764412476905,1.0,4/19,6.69%,RGCC;PSMD10;EGFR;AKT1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5979642205790465,-0.945411921514194,0.5573770491803278,0.9392965040708301,1.0,1/7,5.72%,PLN
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.5164074954930362,0.9452751489765283,0.6363636363636364,0.9843319595015234,1.0,2/11,3.13%,CHRNA4;KCNA2
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.6074985093688761,-0.9452091156721333,0.6349206349206349,0.9394911244527612,1.0,1/6,3.86%,BHMT
prerank,Reactome_2022__GRB2 Events In ERBB2 Signaling R-HSA-1963640,0.48781703523971737,0.9447736254447076,0.5641025641025641,0.9849890647673911,1.0,3/12,9.92%,NRAS;EGFR;ERBB4
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.391823745126254,0.9447280030896287,0.5,0.9845287961479288,1.0,11/35,16.49%,ZDHHC16;ZDHHC14;KAT2B;ZDHHC18;ZDHHC13;KAT2A;ZDHHC20;ZDHHC5;ZDHHC21;EP300;GLUL
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.4614573681180717,-0.9446480078422163,0.5671641791044776,0.9405825513966312,1.0,6/32,19.14%,STMN2;STMN4;MAPRE2;STMN1;MAPT;PHLDB2
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.5259862050060498,-0.9445604788676817,0.5384615384615384,0.940541304781078,1.0,1/12,2.46%,NEFL
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.5717764097419116,0.944504453936119,0.6222222222222222,0.9847373460130125,1.0,5/9,39.32%,RIOX2;RIOX1;KDM4B;KDM8;KDM7A
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.3483258368589931,0.944142807651085,0.56,0.9852504313828901,1.0,9/64,14.07%,CDKL1;TBC1D12;TBC1D19;ODAD3;STIL;TRAPPC12;RAB1B;ALMS1;TBC1D5
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,0.417748572579044,0.9439504075068323,0.6206896551724138,0.985205577091609,1.0,4/28,9.80%,CD247;ADCY1;YES1;PRKACB
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.33279376039333897,0.9439006082333985,0.5,0.9847008967795811,1.0,18/107,12.91%,WNT7A;ASCL1;RUNX1;FUT9;POU3F2;TENM1;FZD8;ERCC6;RORB;ERCC2;PBX1;ADNP2;TDP2;TENM2;EMX2;CASP3;TENM3;ERCC3
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.4303795991785224,-0.9438240248395765,0.5692307692307692,0.9420337205711433,1.0,8/52,17.04%,TLCD2;SLC4A11;SLC4A9;ANGPTL3;SLC4A2;SLC4A10;PNPLA3;IRS2
prerank,Reactome_2022__Activation Of AP-1 Family Of Transcription Factors R-HSA-450341,0.5229796029352941,0.9437996617898287,0.5428571428571428,0.9844039431785735,1.0,2/9,10.97%,MAPK10;MAPK8
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.5925168168745797,-0.9437953455635174,0.6451612903225806,0.9417955561797384,1.0,1/7,2.20%,ZFP36
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.444011079904668,-0.9437728529963928,0.6197183098591549,0.9415426636072923,1.0,10/41,18.51%,SLC6A15;SLC17A5;SLC16A3;SLC16A11;SLC16A4;SLC16A14;SLC38A1;CLN3;SLC15A4;SLC25A29
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In5:Brain,0.5956399993993609,0.9437054025790025,0.5675675675675675,0.9840620403099049,1.0,3/5,12.71%,FREM2;PDGFD;TOX
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3894364119945975,0.9435332959456825,0.6129032258064516,0.983966237804502,1.0,6/26,17.67%,CNOT9;RUNX1;CNOT2;VPS11;UFM1;CNOT1
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.4586542771939049,-0.9435147189054544,0.5,0.9418373479017289,1.0,2/26,12.77%,RPS27A;UBC
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.3673729062763058,0.9434783950516784,0.5,0.9835732753483295,1.0,8/56,8.98%,PAK1IP1;NAF1;ZNF658;LTO1;RIOK2;RIOK1;LTV1;XPO1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex7:Brain,-0.3837484720051044,-0.9434634518091867,0.5581395348837209,0.9416470601365924,1.0,19/98,13.52%,KCNT2;STMN2;NEFM;PLP1;ZDHHC22;THY1;MAP1B;GRIA3;CSMD2;GAP43;LDB2;TENM4;ZNF536;IGSF21;CACNA1C;IGFBP5;PRRX1;GRID2;NLGN1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.34815494985398926,0.9434573293477755,0.5294117647058824,0.9830903390326836,1.0,10/42,20.19%,PDE12;RIDA;HSPA1A;NUDT16L1;NBDY;LSM5;RC3H1;AGO3;YTHDF2;ERN1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.38356331490399465,-0.9433649651249735,0.6477272727272727,0.9415966335089428,1.0,16/129,12.06%,CXCL2;POU4F1;ZFP36;WNT8B;RAMP3;TESC;ATP1A1;PDCD1LG2;CCL2;PTK6;WNT5A;PDK3;DAB2IP;ADCY5;SBNO2;TNIP2
prerank,Reactome_2022__Tryptophan Catabolism R-HSA-71240,-0.5393272969189971,-0.9432300607810321,0.6029411764705882,0.9416532396665244,1.0,1/13,2.14%,KMO
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.40809944061056463,-0.9432045296560522,0.5857142857142857,0.941391881375848,1.0,16/59,21.81%,B2M;HLA-A;HLA-C;PSMB9;PSMB6;HLA-B;HLA-E;PSMC3;HLA-F;PSMA8;PSMA7;PSME1;CD36;PDIA3;IKBKG;PSMA3
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.518058136574678,-0.9431672139898744,0.6,0.9411841558017261,1.0,5/12,18.56%,IRF7;FES;CD74;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.6102065914113228,0.9430275351468872,0.5833333333333334,0.9836407548949966,1.0,1/5,5.33%,EIF3E
prerank,Reactome_2022__Alpha-Linolenic (Omega3) And Linoleic (Omega6) Acid Metabolism R-HSA-2046104,0.49888852915079446,0.9429865821849513,0.5,0.98318413525942,1.0,3/12,14.18%,ABCD1;ELOVL2;ACOX1
prerank,Reactome_2022__Kinesins R-HSA-983189,0.4129308373277069,0.9428974336868463,0.4838709677419355,0.9828569884954323,1.0,3/32,3.98%,KIF21B;KIF15;KIF21A
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.5419692232924262,-0.9428955643201308,0.5230769230769231,0.9415466875535349,1.0,3/8,16.85%,HLA-DRA;HLA-DRB1;BCL6
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.424610261537531,-0.9426376582906278,0.5972222222222222,0.9418793039775788,1.0,14/48,18.28%,CCNB2;BLM;CCNI2;CCND1;GADD45A;CCNB1;CCNE2;HERC5;CDKN3;CCND2;CDC37;CDKN2D;CCNF;CDKN1A
prerank,CellMarker_Augmented_2021__Follicular Helper (Tfh) T cell:Salivary Gland,-0.5061985947648798,-0.9425337489297835,0.6140350877192983,0.941852639816678,1.0,4/19,4.12%,CD5;TAGAP;GPR171;SLA
prerank,Reactome_2022__FGFR3 Mutant Receptor Activation R-HSA-2033514,-0.6329903208253629,-0.9425215851740106,0.6296296296296297,0.9415797674779005,1.0,1/5,10.73%,FGF1
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.5715138629670012,0.942243982533794,0.5405405405405406,0.9841283267507273,1.0,1/7,0.25%,LEPR
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.3956941091672031,-0.9421878383483859,0.6707317073170732,0.9421048217070224,1.0,8/95,8.06%,GGT5;ALOX12;ACOT1;ACSM5;ACOT4;ACSL5;FA2H;ANGPTL3
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3653105829942756,0.9421128021415951,0.5909090909090909,0.9838911800721517,1.0,16/83,13.78%,FBXO48;PSMD10;PSMA1;PSMD11;FBXL14;DMAC2;CUL1;PSMB5;FBXL3;FBXO9;BTRC;PSMD14;FBXO38;CUL2;FBXO27;PSMD12
prerank,Reactome_2022__Ca2+ Activated K+ Channels R-HSA-1296052,-0.584090406636312,-0.9420495418105161,0.6226415094339622,0.9421640870674566,1.0,1/6,16.38%,KCNMB4
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.3398179858751962,0.9419880615257117,0.65,0.9836671760967306,1.0,14/75,12.84%,WNT7A;AGER;BMP2;SERPINF2;DUSP19;MID1;MAP3K4;HMGB1;TIRAP;MAP4K2;TAOK2;SASH1;SH3RF1;TAOK3
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.4819657017341032,-0.9419418935635072,0.576271186440678,0.9421758949239649,1.0,3/17,5.16%,PKP2;ITGA5;CTNNA3
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.5035765918817239,-0.9419090401051818,0.5373134328358209,0.9419595597952515,1.0,4/17,25.25%,SUN3;EMD;SUN1;VPS4A
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,-0.49279776489087473,-0.9418917020281428,0.5645161290322581,0.9416959723439349,1.0,3/17,14.80%,INPP5D;IL3RA;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.3910518023349325,-0.9418019548691481,0.6309523809523809,0.9415628326128628,1.0,28/109,17.63%,GGT5;PLK2;RAMP3;NLRP12;ADCY7;KLF4;GIPR;IGF1;RHBDF2;ADCY5;SYK;MYH9;GNG2;TNFRSF1A;CXCL17;RXFP1;VIP;PTH1R;GLP1R;PTH2R;PRKCD;ADCY3;HLA-DRB1;MVK;CD200;ADCY8;TEK;GPER1
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5854270689240693,0.941755034748696,0.6,0.9837522119473654,1.0,2/5,12.24%,AKT1;TICAM1
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,0.370115459251442,0.9416668163587366,0.5454545454545454,0.9834385295418752,1.0,10/74,6.89%,SEM1;CCNE1;PSMD10;CDC25A;PSMA1;PSMD11;AKT2;CUL1;AKT1;PSMB5
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.4481336290721589,-0.9413137528484432,0.5901639344262295,0.9424361697954037,1.0,4/34,6.99%,ANXA1;WDR62;GCM2;HAP1
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.6005372408139844,-0.9412231871067555,0.6,0.9423235929797643,1.0,4/7,18.13%,WARS1;XRCC1;HPF1;TINF2
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,-0.381022015637456,-0.9411511886820876,0.6341463414634146,0.9422317942741992,1.0,13/116,7.37%,THBS1;OGN;CSPG4;ADAMTS10;THSD4;SPON2;SBSPON;ADAMTSL2;THSD7B;BGN;OMD;LFNG;PAPSS2
prerank,Reactome_2022__Transport Of RCbl Within Body R-HSA-9758890,0.5394666851495054,0.9411143806711286,0.5238095238095238,0.9842818357903862,1.0,1/7,3.66%,CD320
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.5585509749530833,0.9410287009844253,0.5294117647058824,0.9839617866639433,1.0,4/6,41.39%,TENT4B;TUT4;LIN28B;DIS3L2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.399618698977215,-0.9410287000479429,0.5697674418604651,0.9422139828350403,1.0,17/86,20.15%,ANK3;KCNB1;RAMP3;CEMIP;AKAP5;YWHAH;PPP3CC;PDZK1;PRKCH;SLC51B;NMT1;ITGA3;GPER1;BBC3;MYO1C;STAC2;CASP8
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.5601207291771998,-0.9409418247007596,0.5789473684210527,0.9420779336898732,1.0,4/8,24.99%,IL18;CD74;RSAD2;RARA
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.4317248437137738,-0.9408428740082406,0.5882352941176471,0.9420247188311524,1.0,2/30,4.36%,IFI6;HK2
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,-0.3890387447380865,-0.9407828073722162,0.5774647887323944,0.9418740440648664,1.0,19/91,17.19%,CALD1;RAMP3;ADCY7;ITPR3;MYH11;PRKCG;CACNA1C;ADCY5;PRKCQ;MYH9;PRKCH;MYLK3;PPP1R14A;PRKCD;ADCY3;GUCY1A1;KCNMB4;ADCY8;PRKCB
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,0.37910223043021085,0.9407641944852665,0.5555555555555556,0.9841234846252349,1.0,2/50,1.12%,CD247;MYO10
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.5329512669222136,0.9406135732198442,0.5121951219512195,0.9839514284409245,1.0,4/8,24.15%,SOX9;HEY1;HEY2;ROCK2
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),0.534420219904951,0.9405365425591024,0.52,0.9836256980652054,1.0,3/5,27.02%,KAT7;WRNIP1;TICRR
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.5084966976808835,-0.940233100185457,0.5692307692307692,0.9429314121135156,1.0,8/20,22.15%,HTR2B;ITPR3;HTR2C;RYR2;HTR2A;ITPR1;PTPRC;ERO1A
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,-0.4452722597773241,-0.9402288714524856,0.5857142857142857,0.9426388266013768,1.0,10/41,20.47%,RAB11A;ATP1A1;ATP1B1;SLC8A3;PRKCG;PTH1R;PRKCB;CLTB;DNM1;ATP1B3
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.4708048928391162,-0.9401804647809962,0.578125,0.9424644881640345,1.0,3/26,7.83%,ART3;PARP14;PARP9
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.3995159807466065,-0.9401527373943037,0.6052631578947368,0.9422489514419746,1.0,20/88,13.60%,SLC28A2;ALDOB;NR1I3;L1CAM;SLC51A;SPON2;RBP2;ART3;ASPN;GFRA2;CEACAM1;ACSL5;VIL1;CA1;TMC4;CDH19;CD55;PDZK1;CYP3A4;SLC51B
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.631155977826215,-0.939860179372576,0.6792452830188679,0.942582191615944,1.0,2/7,7.01%,GAP43;APOD
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",-0.3778492416823595,-0.9395730281601936,0.5662650602409639,0.9428827848514643,1.0,20/98,17.58%,SOCS3;ADCY7;ITPR3;PRKCG;IGF1;STAT1;SST;SHC2;CREB5;CACNA1C;ADCY5;FOS;PIK3CB;PIK3CD;JUNB;ADCY3;IRS2;ADCY8;PRKCB;CREB3
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.5075038218764647,0.9394321241743018,0.6216216216216216,0.9858825894253596,1.0,4/12,22.01%,NCSTN;APEH;IDE;MME
prerank,CellMarker_Augmented_2021__Keratinocyte:Skin,-0.6379973561024,-0.9392746874470278,0.609375,0.9432863616365089,1.0,1/5,7.03%,CD44
prerank,CellMarker_Augmented_2021__Germ cell:Ovary,-0.6041188297058069,-0.9389788054510273,0.66,0.9436749489739275,1.0,2/5,12.97%,NLRP5;GPC3
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.5720063682173941,-0.9389343839290598,0.5964912280701754,0.9435065055737042,1.0,1/8,16.59%,CLN3
prerank,CellMarker_Augmented_2021__Progenitor cell:Prostate,-0.46740133271274564,-0.9388950406521883,0.515625,0.9433028282647974,1.0,4/28,3.93%,GPR87;EPS8L2;ITGA2;OVOL2
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.3961434206449665,0.9387147558219626,0.6,0.9873044162481635,1.0,5/31,14.85%,REEP6;GAS1;NUP214;SCFD1;AAAS
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),-0.6224917209684029,-0.938416745799202,0.5396825396825397,0.9442268675228682,1.0,2/5,4.67%,CHST4;TPST1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.4195481487588129,-0.9384016412133825,0.6493506493506493,0.9439553986491467,1.0,17/72,21.28%,KCNB1;NNAT;ABCA12;BMP8A;ITPR3;GIPR;CELA2A;CACNA1C;ADCY5;GLP1R;IRS2;MYRIP;GPER1;DOC2B;KCNC2;ITPR1;SFRP1
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),-0.601332740686822,-0.9383883524635407,0.631578947368421,0.9436752743397308,1.0,2/5,9.10%,HPN;MYO3A
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,0.34916693697661705,0.9383664600174578,0.5714285714285714,0.9875981774240467,1.0,30/106,21.57%,RAB33B;AKT2;AKT1;TRAPPC11;RAB27A;RAB8B;TRAPPC12;RAB1B;CCZ1B;MON1A;TRAPPC8;RAB39B;RAB4A;SBF2;RAB7B;GDI2;ALS2;RAB21;RAB8A;RAB9A;DENND5B;DENND4C;GAPVD1;RIC1;RAB3IP;TRAPPC13;RAB3GAP1;RAB18;TBC1D7;RAB31
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.47841441287872255,0.9383224692364923,0.46511627906976744,0.9871367930416047,1.0,1/16,0.25%,LEPR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.46722169326797536,-0.9382843232371784,0.5166666666666667,0.9436482792504612,1.0,4/23,7.93%,KCNQ1;PLN;CAV3;ATP1B1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.6081986931111342,-0.9382500825894423,0.6363636363636364,0.9431504824648952,1.0,4/5,24.22%,STAT1;SOAT1;TGFB1;PPARG
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.6081986931111342,-0.9382500825894423,0.6363636363636364,0.9431504824648952,1.0,4/5,24.22%,STAT1;SOAT1;TGFB1;PPARG
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.44930348079638205,-0.9382209581314181,0.5538461538461539,0.942909165647179,1.0,4/22,14.82%,TLR2;APP;EIF2B2;MYRF
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5266959350515854,0.9381080797850768,0.5555555555555556,0.9871937719124887,1.0,4/10,25.53%,HSPA1A;SACS;SNCAIP;DNAJB2
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,-0.42775736780254325,-0.9378613246782126,0.5802469135802469,0.9435463441472585,1.0,8/58,12.25%,EPS8L2;CDH23;MYO15A;SYP;MYO3A;LHFPL5;MYH9;MYO1E
prerank,"Reactome_2022__Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",-0.3486639970856628,-0.9378550443297664,0.6836734693877551,0.9432580678011477,1.0,73/552,17.43%,ERCC6L;ARHGAP4;DOCK8;STMN2;TAGAP;VRK2;RHOBTB2;RPS27;ARHGEF3;KIF14;PLEKHG6;DEPDC1B;ARHGAP9;PLEKHG2;ARHGAP15;CENPH;TRIP10;RND2;ANLN;STEAP3;ARHGAP39;ARHGEF17;BASP1;YWHAH;CENPE;BAIAP2;MYH11;BAIAP2L1;ZWILCH;ARHGDIG;SRF;WAS;LMNB1;PLD2;CDC42EP1;NHS;PFN2;CDC42EP3;NUF2;SPC24;ARHGEF18;EPSTI1;RHOF;RHPN1;KIF2C;TPM4;MYH9;OBSCN;FLOT1;RNASE1;CENPN;UBXN11;CENPU;NOXA1;SLITRK5;PPP1R14A;PDZD2;DLC1;VAV1;RASGRF2;DDRGK1;PRKCD;RHOD;ALDH3A2;MCAM;ERBIN;ARHGAP22;EMD;DOCK10;PDE5A;PRKCB;CDC37;CENPP
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.41769737492647874,0.9378385629996706,0.5277777777777778,0.9873209712344427,1.0,3/20,8.97%,SNX18;GULP1;SPIRE2
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.46244289409278216,0.9377519517180625,0.5135135135135135,0.9870010130126874,1.0,5/19,25.89%,PPP1R1B;STYXL1;PPP4R4;PPP1R8;MASTL
prerank,Reactome_2022__Prolactin Receptor Signaling R-HSA-1170546,0.5358862989918579,0.9377417469272646,0.5853658536585366,0.9864963277731496,1.0,2/10,9.33%,CUL1;BTRC
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.3297946846811291,0.9376982837447332,0.6086956521739131,0.986107027695437,1.0,26/143,15.33%,BRINP3;INTS13;PSMD10;PSMA1;ANGEL2;PSMD11;TTL;ANAPC1;CUL1;PSMB5;FBXO5;ZNF268;ERCC2;GAS1;THAP1;HSF1;BTRC;PLK1;EIF4E;UBE2D1;PSMD14;ERCC3;PSMD12;BRINP2;CDC26;HNRNPU
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.4885564164824624,0.9376788343099912,0.6086956521739131,0.985616163244816,1.0,2/17,10.45%,QRICH2;PARVA
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.49954671838513853,-0.9372206715979062,0.5454545454545454,0.9445406011832477,1.0,1/17,0.81%,C3
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,0.40002625363543054,0.9371905638196295,0.5833333333333334,0.9864065339949715,1.0,11/36,23.77%,AKT2;AKT1;PRKAB1;PPM1A;EIF4E;SLC38A9;PRKAA1;EIF4EBP1;RPS6KB1;LAMTOR3;RPTOR
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.5154673349530337,-0.9371307863195487,0.5714285714285714,0.944431218028858,1.0,2/15,11.44%,BIRC3;DDX60
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.4390762756522661,-0.9370895969218568,0.5454545454545454,0.944263225555073,1.0,4/20,10.55%,RAB11A;ATAD5;CCND1;CCNB1
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,-0.4429807903157353,-0.9367389851411091,0.5588235294117647,0.9448608476030639,1.0,5/33,13.19%,RPS27A;BIRC3;UBC;FADD;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.47178103744745525,0.9365591759648221,0.5365853658536586,0.9873743201131467,1.0,4/11,20.40%,RALB;PIP4K2B;PIP4K2C;RAB3GAP1
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),0.6018697325836749,0.9363951840026485,0.6818181818181818,0.9872654351728478,1.0,1/6,7.37%,SLC4A7
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,0.38116709319643793,0.9363192173051054,0.5185185185185185,0.9869149608042731,1.0,5/32,6.69%,FLT3;SOCS6;NRAS;AKT2;AKT1
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,-0.46009887978372416,-0.9362262055299182,0.5806451612903226,0.9457630283677386,1.0,6/23,21.25%,MYH11;MYH9;RNASE1;LIMK2;MYL6;RRAS
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.5202084016160429,0.9361914794735495,0.5217391304347826,0.9866793103340845,1.0,4/13,11.32%,TMEM100;SOX9;FOXJ1;VEZF1
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,-0.43378953811338067,-0.936059469652539,0.5675675675675675,0.9458673718156954,1.0,7/41,12.25%,EPS8L2;CDH23;MYO15A;MYO3A;LHFPL5;MYH9;MYO1E
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.527835999729283,-0.9357489222785305,0.5507246376811594,0.9462881134394309,1.0,5/14,22.86%,ATAD5;GLI1;DDRGK1;ZNF16;PAF1
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,0.3268892965803676,0.9354620139770338,0.5333333333333333,0.9881213012380641,1.0,22/118,16.57%,LEPR;UQCRHL;NDUFC2-KCTD14;CEBPA;ADIPOR1;EIF2S1;NDUFB1;AKT2;MAPK10;AKT1;PRKAB1;MAPK8;CASP3;MAPK12;NDUFV3;PIK3CA;NDUFA8;NFKB1;PIK3R1;COX7A2L;UQCRC2;EIF2AK3
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5025569467478584,0.935063176619287,0.5813953488372093,0.9886980571555494,1.0,5/10,32.26%,WHAMM;ABI2;WASF3;NCKAP1;BRK1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.3637976510668613,0.9349611132018704,0.5454545454545454,0.9878706055816554,1.0,9/57,16.01%,CD247;MYO10;YES1;WIPF2;NCK1;WASL;PIK3CA;PIK3R1;ABI1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3637976510668613,0.9349611132018704,0.5454545454545454,0.9878706055816554,1.0,9/57,16.01%,CD247;MYO10;YES1;WIPF2;NCK1;WASL;PIK3CA;PIK3R1;ABI1
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.5606660463136484,0.9348327477599452,0.5641025641025641,0.9877048139736109,1.0,2/6,22.65%,OTUB2;TRIP12
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5062325380043741,0.9345187137385865,0.6857142857142857,0.9880207394395473,1.0,3/15,10.63%,NAF1;CCT7;CCT3
prerank,CellMarker_Augmented_2021__Astrocyte:Undefined,-0.5753493077724929,-0.9343931492870015,0.631578947368421,0.9490227373895121,1.0,1/6,7.25%,GFAP
prerank,Reactome_2022__Inactivation Of CDC42 And RAC1 R-HSA-428543,-0.5895349982038071,-0.9343506427010795,0.6111111111111112,0.9488477630181497,1.0,2/7,12.88%,ARHGAP39;RNASE1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.29873939130451743,0.9343391530420293,1.0,0.9878740464123443,1.0,30/309,8.00%,FGF6;NGF;EPHA6;VEGFD;ATP6V0D2;GALNT3;NCSTN;EFNA2;VEGFC;CASS4;EFNB2;FLT3;MUC20;PDK4;SPRED1;ATP6V1A;GIT1;EGFR;AKT2;PDGFD;PDGFC;ATP6V1G1;YES1;AKT1;GTF2F2;FRK;AP3S1;CNKSR1;EFS;SHC4
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,0.4571106644975095,0.934303898033438,0.46875,0.9874300603778513,1.0,5/16,15.34%,TAB3;MAPK10;UBE2N;MAPK8;MAP2K4
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),-0.6000456673633506,-0.9342978096278378,0.5932203389830508,0.9486787534076188,1.0,1/5,9.64%,SQOR
prerank,CellMarker_Augmented_2021__Enterocyte Progenitor cell:Small Intestine,-0.39124269917517945,-0.9342781395834835,0.5555555555555556,0.9484483924751302,1.0,21/76,18.59%,CD24;ALDOB;RBP2;POF1B;GCNT1;GLRX;RARRES1;FBP1;HHLA2;SEC11C;GCHFR;SLC51B;MFSD2A;TREH;PIGH;CDK5;ENPP4;AQP1;CTSA;SLC7A7;OCIAD2
prerank,CellMarker_Augmented_2021__Cartilage Progenitor cell:Cartilage,-0.39320312158146237,-0.9341972591349144,0.6410256410256411,0.9483439778964993,1.0,13/95,13.68%,COL4A1;CALD1;COL4A2;LAMB1;COL27A1;MAP1B;TEAD2;EFNB3;DAB2IP;TUSC3;AMOTL2;CRMP1;FRAS1
prerank,Reactome_2022__Disease R-HSA-1643685,-0.3402833189086262,-0.9341486609536682,0.8,0.9481460381880129,1.0,221/1347,18.05%,GGT5;ST6GAL1;CP;IL1R1;THBS1;OGN;CDKN2A;C3;BLM;AMN;ALDOB;PCSK2;TGFBR2;RPL19;TLR2;KREMEN2;RPL3;B2M;CSPG4;ADAMTS10;RPS27A;THSD4;RPL39L;RPL36AL;RPS27;SFTPD;HLA-A;SLC17A5;RPS14;SPON2;RPS4X;PLK2;SBSPON;RAMP3;RPL27A;SH3GL2;ADAMTSL2;ZDHHC9;NLRP12;F8;ADCY7;TPST1;GNG3;RPL35;APP;NOD1;RPL7A;ABCA12;THSD7B;BGN;RPL37A;HLA-C;NDUFA2;RPL27;BRCA1;KCNH8;TLR3;PARP14;PMS2;SLC24A1;CYP1B1;OMD;ITPR3;CCND1;LFNG;YWHAH;PAPSS2;RPL9;PSMB9;RPL21;ANAPC11;PARP9;EGF;BAIAP2;ATP1B1;IFNGR2;RPL13A;WAS;GIPR;LMNB1;AP1S1;SYT1;SNRPD2;RHBDF2;STAT1;POLR2I;GYG2;RPA3;WNT5A;SH3GL3;IRF7;RPS11;RPS16;CD9;TAF10;ISG15;TGFA;RPLP1;CYP4F22;THBS2;SLC3A1;RPS13;PGK1;FGF1;PSMB6;RPL38;HLA-B;ADCY5;SYK;FN1;HLA-E;RPS3A;DCTN1;SLC24A5;IL18;PTRH2;RPS8;RPL10A;TPM4;GALK1;PSMC3;MYH9;CYP21A2;RPLP2;RPS23;CCNE2;MYO1E;GNG2;IFIH1;OGG1;RPS21;DUSP16;RPS7;TUSC3;ELMO1;C1QTNF1;UBC;FADD;SLCO2A1;RNASE1;GPC3;FGF7;HLA-F;KPNA7;TAC4;SLC20A2;RPL8;GALNT12;RXFP1;RNF213;NOXA1;PTH1R;EGFL7;NR4A1;NMT1;RPS6;GLP1R;ELOB;PTH2R;BLNK;RPS15;ST6GALNAC2;B4GALT7;PIK3CB;RDH12;RPL26L1;RPS9;UBE2S;SERPING1;PSMA8;ADAMTS4;RPL12;VAV1;APH1A;RPL5;GNE;CHST6;CDK2;CCND2;TLN1;MGAT5;CAPN1;GUCY2C;PSMA7;FAU;SYT2;FGF22;MUC6;RPL23;RPL4;CEBPD;PML;ERBIN;TSC2;HDAC7;SV2B;LRIG1;IRS2;CBX1;ADCY8;SH3KBP1;VCL;GPC1;MYO18A;CDC37;MTA1;NOTCH3;GOLGB1;PSME1;MRC1;CDK5;RPL18A;RIPK2;RBX1;RPL41;BCL11A;RPL7;RPS12;TGFB1;CTSA;PAH
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.4078644398718191,-0.9341290304186631,0.5584415584415584,0.9478838992028756,1.0,6/69,6.29%,RECQL4;BLM;MEIOB;ZSWIM7;POLQ;BRCA1
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.319699675177349,0.9340225021215685,0.45,0.9876444048850886,1.0,14/111,9.92%,SPSB4;POU6F2;ASCL1;CSPG5;EFNA2;POU3F2;SNAP91;EGFR;TSHZ1;BTBD17;PBX1;RHBDL3;CNTFR;ERBB4
prerank,CellMarker_Augmented_2021__Hepatocyte:Embryoid Body,-0.49174367301290584,-0.9340193282124934,0.5147058823529411,0.9478557544040865,1.0,7/19,18.65%,HPN;GC;SERPIND1;F10;ITIH2;PAH;ABCC6P1
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,-0.458401395652207,-0.9337770172977339,0.6307692307692307,0.9481052132408748,1.0,3/20,8.45%,TRPC3;ITPR3;SLC8A3
prerank,Reactome_2022__Synthesis Of PIPs At ER Membrane R-HSA-1483248,-0.6104934466681118,-0.9335088657920354,0.6842105263157895,0.9484100156371247,1.0,1/5,6.95%,SBF1
prerank,Reactome_2022__Polo-like Kinase Mediated Events R-HSA-156711,-0.5405671590920176,-0.9332439956374813,0.5245901639344263,0.9487613492260296,1.0,3/12,11.85%,CCNB2;CCNB1;FOXM1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.33073998444904545,0.9331778219131971,0.6666666666666666,0.9892682736980409,1.0,30/147,15.53%,NR1D1;PPARGC1A;TFB2M;NR2E1;TFB1M;RARB;MAML3;KAT2B;ESRRG;GTF2F2;UBTF;RORB;BRF2;ERCC2;NRBF2;AR;NR3C1;GTF2A2;NOTCH2;TAF12;ESRRA;POLR1F;ERCC3;GTF2H5;TAF4;GTF2H2;RRN3;TAF8;TAF2;POLR2C
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,0.37697422992936935,0.9331658401088689,0.5555555555555556,0.9887737066731491,1.0,14/51,16.56%,ERCC8;COPS2;COPS8;ERCC6;ERCC2;COPS7A;ERCC3;GTF2H5;GTF2H2;POLR2C;EP300;AQR;PPIE;HMGN1
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,-0.43706398226825405,-0.9329720812238814,0.581081081081081,0.9491241397449363,1.0,3/43,1.56%,NR4A3;PGR;NR1I3
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,0.3582339153308408,0.9329133931175562,0.4782608695652174,0.9888732786222241,1.0,10/37,15.59%,SEM1;DNA2;RFC3;XRCC2;HUS1;RRAD;RAD9B;ATRIP;PALB2;RAD51B
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.4439503132554938,-0.9327005781231659,0.5652173913043478,0.9494429287226859,1.0,4/35,2.77%,EFNA1;MET;PKP2;PROX1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.3990327924070356,0.9325680549031297,0.45454545454545453,0.989174699661764,1.0,8/28,18.80%,RAB27A;SNF8;VPS37A;VTA1;CHMP2B;VPS37B;VPS4B;CHMP6
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex6:Brain,-0.4561857922003512,-0.9325534557154244,0.5606060606060606,0.9494464403596928,1.0,8/32,15.30%,ABO;SULF1;ZNF385D;ITGA8;HCRTR2;CNTNAP3;SEMA3E;DLC1
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.3664516979407403,-0.9325239261322238,0.6071428571428571,0.9492370470665845,1.0,16/154,12.77%,THBS1;SOCS3;NR4A3;RPS27A;LMO2;RSPO3;GATA1;LDB2;CCND1;PSMB9;ZFPM1;PSMB6;PRKCQ;RUNX2;PSMC3;UBC
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.42392395609256306,-0.9324729720228823,0.589041095890411,0.9490773492753062,1.0,2/39,3.31%,ARIH2;TRIM5
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.5554597344709417,0.9321910503441324,0.6511627906976745,0.9897091715001571,1.0,2/5,14.00%,PPP1R10;MDK
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,0.3202789671470203,0.9321150193485763,0.4375,0.9893604567831785,1.0,34/173,22.45%,U2AF1;SF3A1;NUDT21;SNRPF;SF3B4;GTF2F2;HNRNPC;WDR33;CWC27;SMNDC1;LSM8;CSTF3;CPSF6;SNRPN;PAPOLA;SNRPB2;CPSF7;LSM5;TFIP11;RBM17;LSM7;HNRNPU;POLR2C;AQR;PPIE;PPWD1;SNRNP27;DHX15;RBMX;PPIL6;CPSF2;CRNKL1;PPIH;PLRG1
prerank,Reactome_2022__Regulation Of Gene Expression In Beta Cells R-HSA-210745,0.49392840532408744,0.9321134684875285,0.5853658536585366,0.9888231080061441,1.0,3/9,11.90%,AKT2;AKT1;MAP4K2
prerank,Reactome_2022__PECAM1 Interactions R-HSA-210990,-0.5855895221400361,-0.9320398006719284,0.6379310344827587,0.9497746592802093,1.0,1/9,3.56%,INPP5D
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.31005552660690905,0.9319977771763451,0.5454545454545454,0.9885697313695353,1.0,31/231,13.90%,OTUD3;KDM1B;PSMD10;CDC25A;TNFAIP3;PSMA1;PSMD11;KEAP1;KAT2B;COPS2;USP13;COPS8;BRCC3;USP38;USP40;USP12;PSMB5;INO80D;VCP;AR;YY1;USP27X;OTUB2;UBE2D1;PSMD14;COPS7A;NFRKB;ADRB2;KAT2A;PSMD12;DESI2
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.6044913633781676,0.931839361420146,0.575,0.9884047482929272,1.0,3/5,36.41%,MARK2;TTBK2;PPP2CB
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,-0.4520535329816897,-0.9317677154736371,0.5694444444444444,0.950124798249069,1.0,5/29,12.36%,RAB11A;ADCY7;GNG3;ADCY5;GNG2
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.4159817336914936,-0.9317024199693443,0.5443037974683544,0.9499678856644813,1.0,9/42,20.30%,STMN2;YWHAH;MAG;PAQR3;GRIN2B;CRMP1;PTPRO;DPYSL3;STX1B
prerank,Reactome_2022__Folding Of Actin By CCT/TriC R-HSA-390450,0.5225321848699809,0.9316975774272088,0.5263157894736842,0.9881581752725421,1.0,2/9,10.63%,CCT7;CCT3
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.4147984885027277,-0.931198922187529,0.6103896103896104,0.9508418918296188,1.0,3/63,2.20%,RFTN1;TGFBR2;ZFP36
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.5266340110530533,0.9311318324932037,0.5945945945945946,0.9890812105647382,1.0,3/9,14.24%,AKT1;QDPR;DHFR
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,0.38699327452537136,0.9310562940761826,0.53125,0.9887340037464499,1.0,6/46,6.89%,SEM1;PSMD10;CDC25A;PSMA1;PSMD11;PSMB5
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),-0.6387730846535422,-0.931053441358459,0.6666666666666666,0.9506064857894443,1.0,1/5,5.70%,STPG4
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),-0.6387730846535422,-0.931053441358459,0.6666666666666666,0.9506064857894443,1.0,1/5,5.70%,STPG4
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,-0.44129482814557563,-0.9308613019169679,0.547945205479452,0.9507899949297155,1.0,5/31,12.36%,RAB11A;ADCY7;GNG3;ADCY5;GNG2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.5952691419583289,0.930809013099626,0.6285714285714286,0.9888707247282843,1.0,2/5,10.55%,TNFAIP3;TIRAP
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreas,-0.38246217314331915,-0.9307065187801559,0.618421052631579,0.9508250667798155,1.0,25/97,22.64%,APP;EFNB3;SCARA3;ARHGAP39;ARHGEF17;PFN2;NYAP1;NUAK1;DAB2IP;AMOTL2;PHYHIP;SEZ6L2;PTPRF;GPC1;LARP6;PTPN21;FHOD3;LAMA5;EPB41L4B;ANTXR1;SCG2;MAPK8IP1;EPB41L1;SLC4A3;B4GALNT4
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.3885786622241406,0.9306654645728711,0.5555555555555556,0.988649545024313,1.0,8/49,14.37%,TMEM100;BMP2;SOX9;SMAD5;ZFYVE16;ADAMTS12;ACVR2A;GDF9
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,0.3154668938077353,0.9305924831388366,0.6111111111111112,0.9882404252295465,1.0,29/144,16.31%,TBC1D4;UQCRHL;AGER;NDUFC2-KCTD14;PDK4;NDUFB1;AKT2;MAPK10;AKT1;VDAC2;PLCB4;CPT2;MPC2;MAPK8;ATP5PB;MPC1;MAPK12;ATP5MC2;SLC25A5;PPP1CC;NDUFV3;PIK3CA;NDUFA8;NFKB1;PIK3R1;ATP5MC1;COX7A2L;UQCRC2;ATP5F1A
prerank,Reactome_2022__Telomere C-strand Synthesis Initiation R-HSA-174430,0.4988813649235487,0.9305881901471422,0.5135135135135135,0.9877063707946288,1.0,2/11,14.92%,STN1;POT1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4127289800148181,0.930556278913325,0.6097560975609756,0.9872480975373005,1.0,5/19,20.90%,HSPA1A;NCK1;OPA1;EIF2AK3;BCL2L11
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,0.3537888439739261,0.9304421125229491,0.5909090909090909,0.9870032533759869,1.0,12/57,16.99%,GRPEL2;SAMM50;CS;TOMM22;CHCHD3;COX19;COQ2;ATP5MC1;TIMM23;GFER;ATP5F1A;MTX2
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,0.40265874151373315,0.9304134669479134,0.5217391304347826,0.986570910365887,1.0,7/27,11.84%,NUDT21;SNRPF;WDR33;CSTF3;CPSF6;PAPOLA;CPSF7
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.5402001220650008,0.9301563881524129,0.5555555555555556,0.9866207196469594,1.0,2/6,14.66%,HS3ST5;SERPINE2
prerank,Reactome_2022__TRAIL Signaling R-HSA-75158,-0.5718850910841888,-0.9299512832543388,0.6296296296296297,0.9521887915035849,1.0,3/6,20.15%,FADD;TNFRSF10A;CASP8
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3630486200064814,0.9298562269606497,0.5142857142857142,0.9868205236683616,1.0,6/50,6.89%,PSMD10;PSMA1;PSMD11;ATF5;CUL1;PSMB5
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.46726329736154737,-0.9298146793894951,0.6231884057971014,0.9521972472904332,1.0,3/18,12.58%,APLNR;PRKCH;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.38331725332129724,0.929661765308651,0.6153846153846154,0.9867139248358215,1.0,3/46,4.38%,SLC6A13;EFNB2;EIF2S1
prerank,CellMarker_Augmented_2021__Stem cell:Gastrointestinal Tract,0.3234990219496915,0.9295439682461455,0.6666666666666666,0.9863826169528658,1.0,32/95,23.55%,SOCS6;TSPAN12;SOX9;CADPS2;SMAD5;CLDN12;FAM171B;ATP2C1;ARHGAP5;ALCAM;PLCB4;TWF1;SLC30A9;EPS8;ABCD3;ZNF214;SH3RF1;WASL;LGR4;ACSL3;PIK3C2A;TMTC3;ADGRA3;MAGI3;ZMYND11;SLC12A2;MIB1;DDAH1;UBTD2;MAP4K3;TM9SF3;SNX7
prerank,CellMarker_Augmented_2021__Hepatic Progenitor-Like cell:Pluripotent Stem Cell,-0.43017597551412656,-0.9294996156358728,0.6142857142857143,0.9527345121120767,1.0,12/47,16.20%,CP;C3;ALDOB;C1RL;MMP14;RARRES1;ALPL;RNASE1;ITGA9;SERPING1;VWA5A;GUCY2C
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,0.3485673490516209,0.9292960605826553,0.45454545454545453,0.9865010793695274,1.0,8/58,11.84%,U2AF1;NUDT21;SNRPF;WDR33;CSTF3;CPSF6;PAPOLA;CPSF7
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.6114092987596546,0.9292362721720033,0.5714285714285714,0.9860891553150763,1.0,1/5,6.72%,LMO3
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.4170156446672558,-0.9291715365889488,0.581081081081081,0.953140732223928,1.0,14/48,22.37%,IRF1;IFI35;PLSCR1;PARP9;BIRC3;HLA-E;USP18;CDC37;NMI;SLC15A4;NLRC3;CASP8;ADAM8;ERAP1
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,-0.3572882364073881,-0.9289920402391065,0.6629213483146067,0.9532534192432541,1.0,32/214,17.44%,CCNB2;ERCC6L;CDKN2A;BLM;RPS27A;RPS27;CENPH;BRCA1;YWHAH;PSMB9;CENPE;ANAPC11;ZWILCH;NUF2;RPA3;SPC24;CCNB1;PSMB6;KIF2C;PSMC3;CCNE2;UBC;CENPN;CENPU;UBE2S;PSMA8;CDK2;PSMA7;CDC7;WEE1;CENPP;PSME1
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,0.3695333585848076,0.9289644296469761,0.5,0.986226353456244,1.0,10/76,6.89%,SEM1;CCNE1;PSMD10;CDC25A;PSMA1;PSMD11;AKT2;CUL1;AKT1;PSMB5
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,-0.41328888900618377,-0.9288973150648309,0.5882352941176471,0.9531889616495484,1.0,4/30,7.79%,RIMBP2;PLB1;AKR1C1;LDLR
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.6138464230191418,-0.9286476148884357,0.6721311475409836,0.9534814848710532,1.0,2/7,6.59%,RFTN1;TLR3
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.5831956935266137,0.928308198552877,0.574468085106383,0.9862199953213788,1.0,1/5,5.70%,FLAD1
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.5831956935266137,0.928308198552877,0.574468085106383,0.9862199953213788,1.0,1/5,5.70%,FLAD1
prerank,Reactome_2022__Vitamin B2 (Riboflavin) Metabolism R-HSA-196843,0.5831956935266137,0.928308198552877,0.574468085106383,0.9862199953213788,1.0,1/5,5.70%,FLAD1
prerank,KEGG_2021_Human__Apelin signaling pathway,-0.38524486531394314,-0.9281680137282831,0.6233766233766234,0.9543598390908443,1.0,21/107,17.53%,KLF2;APLNR;ADCY7;GNG3;ITPR3;CCND1;SLC8A3;ADCY5;LIPE;GNG2;NOS1;MYLK3;RPS6;APLN;PLAT;ADCY3;GABARAPL1;ADCY8;RYR2;NOTCH3;SPP1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.45940062289431,-0.9280626981601326,0.6338028169014085,0.9543618010911994,1.0,1/27,0.18%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.4013837612217075,-0.9279756139388516,0.65,0.9542709858480771,1.0,4/84,6.27%,THBS1;RPS4X;YBX3;PLD1
prerank,CellMarker_Augmented_2021__Natural Memory B cell:Undefined,-0.47407173155178384,-0.9278866013571633,0.5862068965517241,0.9541918204461666,1.0,4/23,6.48%,CD5;TAGAP;ARHGAP9;ACAP1
prerank,CellMarker_Augmented_2021__CD4+ T cell:Colon,-0.4515312174757548,-0.9273503116473154,0.5333333333333333,0.955181863060877,1.0,7/26,14.05%,CD5;TAGAP;GPR171;ARHGAP9;P2RY10;SP140;THEMIS
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3821868562246382,0.9272991583818013,0.6571428571428571,0.9882418402312192,1.0,5/26,8.12%,CSPG5;CHST11;CSGALNACT1;CHST7;BCAN
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.5257970278209224,-0.9271578576402267,0.6065573770491803,0.9553283948157959,1.0,2/13,11.12%,SHTN1;DAB2IP
prerank,KEGG_2021_Human__TGF-beta signaling pathway,-0.4022063211001676,-0.9270119595892137,0.6097560975609756,0.955376383475079,1.0,4/71,6.69%,THBS1;TGFBR2;THSD4;BMP8A
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.4850457156087801,0.9268941293033544,0.5277777777777778,0.9886199744441888,1.0,3/9,14.67%,AKT2;AKT1;GPLD1
prerank,Reactome_2022__Gap Junction Trafficking And Regulation R-HSA-157858,-0.5152797775805341,-0.9268319100653811,0.609375,0.9555053953908532,1.0,3/15,19.82%,GJB7;CLTB;DNM1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.43835905163307576,-0.9268014759047883,0.6268656716417911,0.9552928525438088,1.0,2/33,0.81%,RECQL4;BLM
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,0.36059753317482435,0.9267887632647405,0.6521739130434783,0.9883576143459254,1.0,11/63,11.34%,SEM1;BMP2;PPARGC1A;PSMD10;PSMA1;PSMD11;CUL1;PSMB5;NR3C1;ESRRA;PSMD14
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3736924061355236,0.9267748586416116,0.5833333333333334,0.9878533142946099,1.0,7/35,15.29%,BMP2;GREM1;TWSG1;GDF11;ACVR2A;GDF9;GDF10
prerank,Reactome_2022__LRR FLII-interacting Protein 1 (LRRFIP1) Activates Type I IFN Production R-HSA-3134973,0.5927098312298346,0.9266748462572739,0.5952380952380952,0.9875420009393656,1.0,1/5,15.95%,EP300
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.6053144627300763,-0.926620319514188,0.6774193548387096,0.955407345557267,1.0,1/7,2.20%,ZFP36
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.45192325323553567,-0.9265828879058756,0.5692307692307692,0.955163152275978,1.0,14/29,27.22%,SEPTIN5;SYT4;SYT1;RIMS2;SYT5;SYT2;SYT13;RAB15;SYT12;RIMS1;SYT17;RIMS3;RAB3A;UNC13D
prerank,Reactome_2022__Cytosolic tRNA Aminoacylation R-HSA-379716,-0.4704927397828744,-0.9264806822945845,0.6323529411764706,0.9550607773389528,1.0,1/23,2.59%,WARS1
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,0.35360733371114916,0.9264268488726431,0.5357142857142857,0.9876218905638734,1.0,9/34,15.59%,SEM1;DNA2;RFC3;XRCC2;HUS1;RRAD;RAD9B;ATRIP;RAD51B
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.4849179931403572,0.9264121331614903,0.4857142857142857,0.9871188206131791,1.0,3/11,20.11%,ACVR2A;MAGI2;SMAD7
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.5580806192068826,0.9263602507733897,0.6428571428571429,0.9867402483163312,1.0,1/7,0.44%,WNT7A
prerank,CellMarker_Augmented_2021__Neuron:Spinal Cord,-0.3833031708048542,-0.9262299666967517,0.6081081081081081,0.9554353598048946,1.0,14/97,13.52%,TAGLN3;STMN2;TTLL7;ATRNL1;MAP1B;EFNB3;GAP43;SYT1;PFN2;PLPPR5;NUAK1;TMEFF2;CRMP1;NLGN1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.4975728137077652,0.9260531389489431,0.5517241379310345,0.9870186528010152,1.0,2/11,4.92%,AFG1L;COX10
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.4214754334363038,0.9259309942536021,0.5294117647058824,0.9867767421034501,1.0,7/28,10.28%,CPAMD8;ADAMTS18;FREM2;ZDHHC16;SMG9;PBX1;ATF6
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,-0.505018136719666,-0.9254338554767894,0.5692307692307692,0.9570550290945767,1.0,3/15,12.77%,RPS27A;NDUFA2;UBC
prerank,CellMarker_Augmented_2021__Definitive Zone cell:Adrenal Gland,-0.3868737045692337,-0.9254032733586137,0.6388888888888888,0.9562472258827073,1.0,29/97,21.63%,STMN2;NEFL;NEFM;PLP1;ZDHHC22;LRRTM1;ELAVL4;GAP43;ZNF536;TCEAL2;CACNA1C;STMN4;SCN3B;TMEM132C;CNTN2;KCNC1;GDAP1L1;RAB3C;RTN1;JPH4;TCEAL5;CELF4;ST8SIA3;PTPN5;PAK5;NAP1L3;VSTM2B;OPCML;DCX
prerank,CellMarker_Augmented_2021__Natural Killer cell:Breast,-0.3868737045692337,-0.9254032733586137,0.6388888888888888,0.9562472258827073,1.0,29/97,21.63%,STMN2;NEFL;NEFM;PLP1;ZDHHC22;LRRTM1;ELAVL4;GAP43;ZNF536;TCEAL2;CACNA1C;STMN4;SCN3B;TMEM132C;CNTN2;KCNC1;GDAP1L1;RAB3C;RTN1;JPH4;TCEAL5;CELF4;ST8SIA3;PTPN5;PAK5;NAP1L3;VSTM2B;OPCML;DCX
prerank,CellMarker_Augmented_2021__Chromaffin cell:Adrenal Gland,-0.3868737045692337,-0.9254032733586137,0.6388888888888888,0.9562472258827073,1.0,29/97,21.63%,STMN2;NEFL;NEFM;PLP1;ZDHHC22;LRRTM1;ELAVL4;GAP43;ZNF536;TCEAL2;CACNA1C;STMN4;SCN3B;TMEM132C;CNTN2;KCNC1;GDAP1L1;RAB3C;RTN1;JPH4;TCEAL5;CELF4;ST8SIA3;PTPN5;PAK5;NAP1L3;VSTM2B;OPCML;DCX
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.3449413143425726,0.925065835216755,0.6153846153846154,0.9886387533458997,1.0,12/64,17.11%,NGF;SOX8;LIG4;CAPRIN2;DCT;SPEN;ROBO1;TIAM2;DRD2;CAPRIN1;FAIM;MAP6
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.5338493162803788,0.9248351194564788,0.6060606060606061,0.988184859039287,1.0,4/8,31.14%,LYRM7;UQCC1;UQCRFS1;UQCC2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.5338493162803788,0.9248351194564788,0.6060606060606061,0.988184859039287,1.0,4/8,31.14%,LYRM7;UQCC1;UQCRFS1;UQCC2
prerank,CellMarker_Augmented_2021__Lymphoid cell:Undefined,0.45310795331376746,0.9246832518816724,0.5625,0.9880478510638949,1.0,3/18,4.45%,FLT3;LRRC36;KLRG1
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.39161103341644904,0.924656558109673,0.5405405405405406,0.9876084786260534,1.0,5/27,11.80%,ACE2;EHF;CAPN13;SLC26A3;KRT8
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,0.3334904460862371,0.9244451002449106,0.5416666666666666,0.9876138525100486,1.0,13/78,14.75%,SEM1;CCNE1;PSMD10;PSMA1;PSMD11;ANAPC1;CUL1;PSMB5;UBE2D1;PSMD14;ORC5;PSMD12;CDC26
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,0.3699163702750719,0.9244369695635677,0.5945945945945946,0.9871073569522335,1.0,9/53,11.34%,SEM1;PSMD10;PSMA1;PSMD11;CUL1;PSMB5;BTRC;PRKACB;PSMD14
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.29067721359988036,0.9243694153196499,0.875,0.9867863225660278,1.0,22/194,10.19%,FGF6;LEPR;EPHA6;VEGFD;DSCAM;AGER;BMP2;VEGFC;FLT3;BCL10;SOX9;TESK1;EGFR;AKT2;P2RY1;AKT1;RALB;AR;STK4;ERBB4;CDK2AP1;SLC4A4
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,0.36809057581844773,0.9243030908287071,0.5789473684210527,0.9864286751624732,1.0,9/53,11.34%,SEM1;PSMD10;PSMA1;PSMD11;CUL1;PSMB5;BTRC;PRKACB;PSMD14
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.5760234677197914,-0.9242949231742774,0.6271186440677966,0.958479313782743,1.0,2/7,12.25%,PODXL;MYO1E
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.4424102349984155,-0.924290367869764,0.52,0.9581943859277324,1.0,9/35,17.39%,EPN1;SH3GL2;EGF;TGFA;DAB2IP;MVP;SH3KBP1;SNX6;ZFYVE28
prerank,Reactome_2022__Activated NTRK3 Signals Thru PI3K R-HSA-9603381,0.5948641149095631,0.9242587192902021,0.6666666666666666,0.9859913755318508,1.0,3/5,25.99%,PIK3CA;PIK3R1;IRS1
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.34127360589045874,0.9242043074906341,0.5862068965517241,0.9855607043500394,1.0,10/73,9.30%,SPSB4;MEX3A;CSPG5;EFNA2;POU3F2;SNAP91;KLHL23;BTBD17;RHBDL3;CNTFR
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression Linked To Lipogenesis R-HSA-9029558,-0.5244123779995757,-0.9241383083749116,0.6212121212121212,0.9582499475076144,1.0,5/9,23.29%,ANGPTL3;FASN;SREBF1;RXRB;SCD
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.36770658321332217,0.9241068211084281,0.47058823529411764,0.9853826628392967,1.0,4/45,7.35%,TMEM100;BMP2;SMAD5;ZFYVE16
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,0.3603579079343431,0.9241039451778631,0.48,0.9848482904624858,1.0,15/62,16.56%,POLD3;SLC19A1;ERCC8;RFC3;ERCC6;ERCC2;ERCC3;GTF2H5;GTF2H2;POLK;POLR2C;EP300;AQR;PPIE;HMGN1
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Undefined,0.5257144971339166,0.9240998673861606,0.5555555555555556,0.9837935631742806,1.0,1/5,2.43%,FLT3
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Undefined,0.5257144971339166,0.9240998673861606,0.5555555555555556,0.9837935631742806,1.0,1/5,2.43%,FLT3
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.3683577607871044,0.9240429657028861,0.6296296296296297,0.9834327545838105,1.0,11/31,33.74%,SESN2;SESN3;DYRK3;KPTN;SESN1;SIK3;LARS1;ITFG2;KLHL22;PIP4P1;SZT2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.45778321127232613,-0.9239949034833165,0.6081081081081081,0.9583314228072927,1.0,7/29,15.96%,ANXA1;CCND1;GLI1;HYAL1;LSM11;DDRGK1;CCND2
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,0.3715448791366207,0.9239772220862521,0.5652173913043478,0.9831030047782034,1.0,6/48,12.98%,CD247;MYO10;YES1;WIPF2;NCK1;WASL
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Undefined,-0.5226941754326802,-0.9239450416402302,0.5441176470588235,0.9581448005524283,1.0,2/11,11.32%,IFITM3;PRDM1
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,-0.39289968303478534,-0.9237838023660342,0.5949367088607594,0.9582377833451214,1.0,10/64,15.59%,ARHGEF3;GNG3;PLEKHG2;ARHGEF38;ARHGEF17;ARHGEF18;GNG2;OBSCN;VAV1;RASGRF2
prerank,CellMarker_Augmented_2021__Conventional Dendritic cell:Undefined,-0.5953383174765509,-0.9237715774333537,0.6779661016949152,0.9580080985638432,1.0,2/7,5.90%,TLR2;PDCD1LG2
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.3126379687693709,0.923767585772169,0.5555555555555556,0.9831414322070803,1.0,41/114,30.67%,FASTKD1;GTF2F2;HNRNPC;TP53RK;NOVA1;FASTKD2;LSM8;DROSHA;PAPOLA;NUFIP1;TFIP11;SYNCRIP;RNASEL;HNRNPU;POLR2C;THOC1;AGO3;CLP1;PCBP3;RBMX;DKC1;PPP1R8;RNGTT;NOL9;RBM39;ADARB1;MTREX;PAPOLG;HNRNPD;POLR2A;ALKBH1;M1AP;POLR2K;TENT2;LSM1;POLR2D;FTO;SNRNP40;HNRNPH1;POLR2E;PTBP1
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.5210133441511982,0.9237520265628,0.5833333333333334,0.9826651476659101,1.0,4/7,40.95%,MAGI2;LEMD3;ACVR1;SKI
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.4138628463628436,-0.9237237034280099,0.5606060606060606,0.95779295339903,1.0,11/37,20.15%,IRF1;TLR3;GADD45A;PIEZO2;MAP3K14;FADD;TNFRSF1A;LTBR;AQP1;TNFRSF10A;CASP8
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.5422853584719652,-0.9236606604689026,0.5901639344262295,0.9570562536460181,1.0,1/9,0.81%,BLM
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.5422853584719652,-0.9236606604689026,0.5901639344262295,0.9570562536460181,1.0,1/9,0.81%,BLM
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.5422853584719652,-0.9236606604689026,0.5901639344262295,0.9570562536460181,1.0,1/9,0.81%,BLM
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,-0.4292835619550956,-0.9235686318053532,0.6,0.957008475741245,1.0,5/50,9.26%,DOCK8;DEPDC1B;STEAP3;WAS;CDC42EP1
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,0.3697800178643187,0.9235387861458041,0.5925925925925926,0.9827282650008112,1.0,8/37,15.61%,CCNE1;H2BC21;H2BC4;H2AC6;H1-2;EP400;POT1;ASF1A
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.4532811236991252,-0.9235181281620592,0.5945945945945946,0.9568600980888279,1.0,7/35,17.28%,CLDN16;POF1B;CLDN20;CLDN18;WDR1;MICALL2;VCL
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.530630308632954,-0.9234458283555333,0.6166666666666667,0.956714686120521,1.0,1/9,0.55%,TYMS
prerank,"Reactome_2022__Base-Excision Repair, AP Site Formation R-HSA-73929",0.4157297925119552,0.9234208931775494,0.5714285714285714,0.9825097752118834,1.0,4/24,14.92%,H2BC21;H2BC4;H2AC6;POT1
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,-0.41399526802713604,-0.9231955357956664,0.5921052631578947,0.956985999297245,1.0,3/51,6.82%,CP;RPS27A;STEAP3
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,0.3701957679182453,0.923144533065616,0.5652173913043478,0.9827197188935541,1.0,3/39,3.57%,FGF6;SPRED1;NRAS
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,0.35418673342772283,0.9231074098952411,0.5789473684210527,0.9822752584455466,1.0,20/56,20.46%,CYP4F3;ALDH1A1;CYP4F12;CYP7B1;PTGIS;CYP4V2;VDAC2;CYP3A43;CYP46A1;ADH5;CYP2U1;CES2;NCOA2;NQO2;MAOA;MTARC2;ACSS1;ALDH2;EPHX1;SMOX
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,-0.5010495682943288,-0.9230521750612131,0.5964912280701754,0.9570445830439658,1.0,4/22,12.77%,RPS27A;GYG2;PYGL;UBC
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.5481055141097393,-0.9229846737914403,0.5873015873015873,0.9568935054265467,1.0,2/9,14.82%,VIL1;WDR1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.4716695183602576,-0.9229006342158647,0.5070422535211268,0.9568372537596151,1.0,4/21,13.39%,RPS27A;RPA3;UBC;RPA1
prerank,Reactome_2022__Reduction Of Cytosolic Ca++ Levels R-HSA-418359,0.5055565919299821,0.9228525712667953,0.475,0.982314007805291,1.0,1/9,2.53%,SRI
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.3582869198742024,-0.9228209152935548,0.7126436781609196,0.9567150310286122,1.0,17/163,16.23%,THBS1;TYMS;RPS4X;APP;PLD1;RPL13A;RPS6KA1;PATL2;EIF2B2;OGFOD1;RPL10;IGFBP5;GLE1;SAMD4A;RPL5;RBM3;RBM4B
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.5702502650753122,0.9227410193482158,0.6470588235294118,0.982138962650251,1.0,1/6,7.43%,VCP
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.4043031258345995,-0.9225043150633319,0.6025641025641025,0.9571092907889845,1.0,10/63,14.76%,RPS27A;APP;NLRC5;IRF7;ISG15;IFIH1;UBC;FADD;HERC5;PDZD2
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.38461263363592857,-0.9223643985437985,0.6626506024096386,0.9571361980301114,1.0,22/84,19.26%,P2RY12;ADGRE5;RAMP3;ADCY7;AKAP5;GIPR;S1PR3;LGR5;ADCY5;GPR12;RXFP1;CNR1;VIP;PTH1R;HTR1E;GLP1R;PTH2R;ADCY3;ADCY8;GPER1;ADM;ADGRG2
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.49159147029096495,0.9223003969993525,0.6052631578947368,0.9826477465079276,1.0,3/16,8.21%,C1D;MPHOSPH6;RPF1
prerank,KEGG_2021_Human__Steroid hormone biosynthesis,-0.4756275984739527,-0.9220959880703226,0.5970149253731343,0.9574899456043822,1.0,8/22,22.09%,AKR1C1;CYP1B1;CYP21A2;CYP3A4;CYP3A7-CYP3A51P;CYP3A5;HSD17B7;HSD11B1
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Association With Co-factors R-HSA-6804759,-0.5685499455546398,-0.9220778468993899,0.6666666666666666,0.9572415560188041,1.0,1/11,1.13%,POU4F1
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Peripheral Blood,0.39197744089101877,0.9220466126726468,0.5,0.9827533399482957,1.0,2/24,3.07%,C1ORF162;LRRN3
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.4607359736607569,0.9219574947978326,0.5135135135135135,0.9824868804584438,1.0,3/15,18.80%,CHMP2B;VPS4B;CHMP6
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.4259536887187182,0.9219311829136463,0.5483870967741935,0.9820013203206402,1.0,2/20,6.31%,PHC1;UBE2N
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,0.36042070936582915,0.9219168318801012,0.5384615384615384,0.9815162820099598,1.0,10/35,15.59%,SEM1;DNA2;RFC3;XRCC2;HUS1;RRAD;RAD9B;ATRIP;PALB2;RAD51B
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,0.31855253024481334,0.9218387312963803,0.5625,0.9811109027333611,1.0,23/150,9.33%,PIP5K1B;SEM1;CXXC4;PSMD10;MEN1;CCDC88C;PSMA1;H2BC21;PSMD11;SOX9;PYGO2;H2BC4;AKT2;FZD8;AKT1;PSMB5;RNF146;PYGO1;CSNK1E;XPO1;CSNK2A2;H2AC6;BTRC
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.334986564163765,-0.92163205199352,0.8085106382978723,0.9579904796042155,1.0,59/735,12.14%,PRAME;KLF2;LEF1;EFNA1;CDKN2A;FOSB;SKOR1;SP100;SIX3;POU4F1;NR4A3;SUV39H1;NR1I3;MAEL;HIC1;CIITA;ZFP36;RPS27A;PROX1;MLIP;CIC;RPS14;IRF1;ATF3;MSX2;PRDX5;KLF4;ZNF750;BRCA1;GFI1B;GATA1;LDB2;NKX6-2;BASP1;CCND1;PLK3;ZFP69;HEXIM1;PARP9;ZFPM1;ZNF536;GADD45A;FBP1;STAT1;MAFK;WNT5A;IRF7;DAB2IP;PRDM1;ZNF20;AEBP1;ZBTB32;SOX15;BAP1;FOXM1;SBNO2;RPL10;RUNX2;EID2
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",-0.4971072197753045,-0.9215112034336712,0.6,0.9579970314874757,1.0,7/16,23.55%,UNC13C;GRIK1;GRID2;GRIK2;SLC17A7;CDH8;GRIK4
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,0.37715246263299085,0.9214945911721788,0.59375,0.9814725772373024,1.0,6/49,6.89%,SEM1;PSMD10;HSPA1A;PSMA1;PSMD11;PSMB5
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.44038375444023126,0.921493288626375,0.5714285714285714,0.9809460361550936,1.0,3/11,27.92%,MYCBP2;PTEN;ARHGAP35
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.5894279841709033,-0.9214780363055952,0.5714285714285714,0.957771624155487,1.0,2/5,18.88%,ST6GALNAC2;ST8SIA3
prerank,KEGG_2021_Human__ErbB signaling pathway,0.34359872127347174,0.9209310305695845,0.6071428571428571,0.9818422531904537,1.0,28/78,25.09%,NRAS;EGFR;AKT2;MAPK10;AKT1;SHC4;ERBB4;NCK1;MAPK8;PIK3CA;SHC3;PIK3R1;MAP2K4;CRKL;NCK2;BAD;ELK1;ABL2;MAP2K2;NRG3;EIF4EBP1;BRAF;RPS6KB1;PTK2;SOS2;SOS1;CBLB;ARAF
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.5122067128207838,-0.9208738331911788,0.6307692307692307,0.958783069842609,1.0,2/15,14.52%,ATG9A;WDR45
prerank,KEGG_2021_Human__Mineral absorption,-0.4273094646121446,-0.9208588263695543,0.6231884057971014,0.9585318026669899,1.0,11/42,21.18%,STEAP1;ATP1A1;ATP1B1;SLC8A3;MT1H;ATOX1;TF;STEAP2;ATP1B3;FTH1;HEPHL1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.3441712339495702,0.9206965371431632,0.68,0.9819781980579602,1.0,11/57,11.53%,POU6F2;REEP6;RDH10;EYS;CRYGS;OAT;CRYBB2;TYR;ZIC2;ATF6;OPA1
prerank,GO_Biological_Process_2021__mammary gland duct morphogenesis (GO:0060603),0.6120595094638229,0.9205103600137975,0.6444444444444445,0.9819682875572209,1.0,3/5,33.08%,CSF1R;LRP5;LRP6
prerank,Reactome_2022__RET Signaling R-HSA-8853659,-0.46116779805946534,-0.9204430370218427,0.578125,0.959144714388186,1.0,6/30,17.04%,DOK1;GFRA2;DOK6;RAP1GAP;PIK3CB;IRS2
prerank,Reactome_2022__Immune System R-HSA-168256,-0.3365162802076986,-0.9204278290728677,0.83,0.9588877701535478,1.0,212/1314,18.86%,CXCL2;ANXA1;GBP2;IL1R1;RASGRP1;IFI6;SOCS3;C3;TRIM22;SP100;IL13RA1;GBP1;C1R;RASGRP2;TLR2;MX1;FYB1;B2M;CIITA;ICAM1;RPS27A;TIMP2;ARIH2;IFIT1;IFITM3;LNX1;HLA-A;IL12A;ADGRE5;TRIM5;IRF1;INPP5D;ATP8B4;STAT4;IFI35;SH3GL2;PRDX4;ASB16;IL15;SIGLEC1;CD160;COLEC12;FSCN1;ARHGAP9;PRDX5;APP;CTSC;TMC6;NOD1;AKR1C1;NLRC5;PDCD1LG2;CCL2;HLA-C;NDUFA2;KCNH8;HLA-DRA;CEACAM1;TLR3;NPDC1;BST2;GBP7;GLYAT;CD44;TIMP1;ITPR3;CCND1;TNFRSF14;IFIT3;PSMB9;CENPE;ANAPC11;CLEC12A;BAIAP2;F13A1;CHI3L1;TRIM17;IFNGR2;FBXL18;CA1;WAS;RPS6KA1;LMNB1;AP1S1;IRAG2;IL1RAPL1;PLD2;HERC6;OSMR;STAT1;IL4R;FBXW12;SPSB1;TCP1;IRF7;PLPP4;CTSS;FBXO32;PTPN7;ISG15;PILRA;PSMB6;PYGL;BIRC3;HLA-B;PRKCQ;SYK;FN1;CD55;HLA-E;IL17RE;RHOF;FBXW10;DCTN1;IL18;TMBIM1;KIF2C;PSMC3;MYH9;TNIP2;SIGIRR;CTSZ;MAP3K14;CFH;MYO1E;HECW2;IFIH1;ELMO1;UBC;FADD;CD63;RNASE1;TSPAN32;ASB14;RAP1GAP;TNFRSF1A;HLA-F;KPNA7;IFIT2;SLC11A1;HERC5;CLEC5A;IL7;RNF213;FOS;C1S;EGFL7;PRICKLE1;BTN3A1;IL3RA;ELOB;BLNK;PDZD2;PIK3CB;UBE2S;CD74;SERPING1;PSMA8;DLC1;LTBR;VAV1;IL1RAP;PRKCD;IL27RA;ATOX1;CAPN1;PSMA7;HLA-DRB1;FRMPD3;DEFB109B;MUC6;ANXA2;CEBPD;STAT6;PML;USP18;BCL6;CD200;NDN;AURKAIP1;IRS2;PFKL;PRKCB;SH3KBP1;VCL;PSME1;ALPK1;MRC1;ENPP4;RIPK2;RBX1;FBXL13;COTL1;TGFB1;CARD11;SLC15A4;CTSA;HRNR;CCNF;GSDME;CDKN1A;HSPA5;HEBP2;LRRC7;PGRMC1;DDX41;CD4;PTGES2;LAMA5;NLRC3;RAG1;IL15RA
prerank,CellMarker_Augmented_2021__Early Transit-Amplifying Prostate Epithelial cell:Prostate,-0.45290493403558035,-0.9202126286082165,0.6060606060606061,0.9588059693336864,1.0,6/22,16.14%,GPR87;PSCA;SLC4A11;KPNA7;CXCL17;RHOD
prerank,CellMarker_Augmented_2021__Late Transit-Amplifying Prostate Epithelial cell:Prostate,-0.45290493403558035,-0.9202126286082165,0.6060606060606061,0.9588059693336864,1.0,6/22,16.14%,GPR87;PSCA;SLC4A11;KPNA7;CXCL17;RHOD
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.5296820263608182,-0.9200594035907168,0.59375,0.9588379728413048,1.0,2/11,6.56%,BRCA1;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.4081635024908519,-0.9199928970169291,0.6268656716417911,0.9586985590793932,1.0,9/50,16.44%,ANXA1;RAB11A;CCND1;ANAPC11;CCNB1;HYAL1;LSM11;CCND2;CDC7
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.4585226046151539,0.9199551147220802,0.6153846153846154,0.983117373566005,1.0,6/19,29.18%,SLAIN2;TUBG1;TPX2;TUBGCP3;CLASP2;TUBGCP5
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.39011663465106516,-0.9199435992091876,0.5925925925925926,0.958516394393729,1.0,8/84,9.94%,RECQL4;BLM;MEIOB;ZSWIM7;POLQ;BRCA1;GINS2;RPA3
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,-0.3737084118776327,-0.9198653643024268,0.5842696629213483,0.9584142778375734,1.0,18/146,13.97%,IL1R1;TUBB6;MYO1F;CLDN16;TUBB1;CLDN20;CLDN18;BAIAP2;MYH11;BAIAP2L1;ARPC5L;IL18;MYH9;LPAR4;MYO1E;FADD;TNFRSF1A;FOS
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.5235119185042394,-0.919537152377512,0.6212121212121212,0.9588202367366947,1.0,1/12,3.31%,TRIM5
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.4823183105920259,0.919383050496314,0.53125,0.9841318056165771,1.0,2/11,12.63%,NT5C1A;NUDT15
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.4069409458821479,0.9193313048666282,0.5945945945945946,0.9838176843947074,1.0,7/20,28.98%,CYP7B1;CYP46A1;SCP2;ABCB11;OSBPL3;OSBPL6;OSBPL1A
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lung,-0.4419063043554958,-0.9192210473874595,0.6129032258064516,0.9586109302107464,1.0,4/26,6.48%,MYO1F;NLRP12;ARHGAP9;ACAP1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Gut,-0.4419063043554958,-0.9192210473874595,0.6129032258064516,0.9586109302107464,1.0,4/26,6.48%,MYO1F;NLRP12;ARHGAP9;ACAP1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Splenic Red Pulp,-0.4419063043554958,-0.9192210473874595,0.6129032258064516,0.9586109302107464,1.0,4/26,6.48%,MYO1F;NLRP12;ARHGAP9;ACAP1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.5751595485324896,-0.9191923244001334,0.6065573770491803,0.9583749665379029,1.0,1/7,2.27%,NDST4
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.5174721498848104,-0.9190832476190868,0.5925925925925926,0.9582958775540843,1.0,1/9,4.15%,ST18
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.38075566690817475,0.9189427085168329,0.5151515151515151,0.9843217639788662,1.0,13/39,18.61%,WASHC5;PI4K2A;EXOC8;ZFYVE16;RAB22A;PHETA1;WASL;CHMP2B;ALS2;RNF26;VPS11;DNAJC13;EPS15
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.4428314172345824,-0.9186542579176203,0.5833333333333334,0.9590230402331248,1.0,9/33,24.91%,B4GALNT1;FA2H;CYP4F22;ST8SIA3;B3GALT4;ST6GALNAC3;CERS5;ST8SIA4;CERS4
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.4595439694347189,0.9186480514862405,0.6153846153846154,0.9846133792041101,1.0,2/17,6.13%,BMP2;TCAP
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.32138408552017117,0.9186169041914221,0.6363636363636364,0.9841542610293832,1.0,25/103,24.23%,ATP6V0D2;ATP6V1A;EXOC8;ATP6V1G1;AKT1;PRKAB1;SESN2;MAPK8;CASP3;PIK3CA;QSOX1;SESN3;SNX5;SLC38A9;RUFY4;GPSM1;ERN1;PRKAA1;SMG1;LAMTOR3;ATP6V0A2;EXOC7;USP36;RPTOR;UBQLN1
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.503060569214242,-0.918564302056367,0.5932203389830508,0.9589181705157406,1.0,6/16,16.59%,TMCC2;KLK6;ADAM19;ACHE;APH1A;CLN3
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,-0.4182661730670799,-0.918446389554953,0.6285714285714286,0.9589243992217796,1.0,3/38,6.19%,KIF14;DEPDC1B;RND2
prerank,Reactome_2022__Signal Transduction R-HSA-162582,-0.3355260249510569,-0.9184380720691208,0.88,0.9586516997491557,1.0,268/1818,17.70%,CXCL2;LEF1;ANXA1;EPN1;GRIN2D;THBS1;RASGRP1;P2RY13;P2RY6;HPN;COL4A1;ERCC6L;SOCS3;NPY;FLRT3;TAC3;ARHGAP4;C3;FOSB;APLNR;SPARC;PGR;GPR183;DOCK8;TGFBR2;RASGRP2;P2RY12;COL4A2;KREMEN2;RGSL1;STMN2;RDH13;TAGAP;LAMB1;RPS27A;PDE4A;ACKR4;VRK2;NEFL;P2RY14;RHOBTB2;RPS27;WNT8B;ITGA2;COL4A4;ARHGEF3;ADGRE5;KIF14;GNRHR;RAMP3;GPNMB;SH3GL2;PLEKHG6;CHRM1;ZDHHC9;ADCY7;DOK1;DEPDC1B;COL6A2;ARHGAP9;GNG3;RASGEF1A;ITGA5;APP;PLEKHG2;ARHGAP15;GFRA2;GPR18;TRPC3;CCL2;ARHGEF38;CENPH;THBS3;TRIP10;RALGDS;RND2;RSPO3;ANLN;KCNH8;UTS2;STEAP3;PTK6;ARHGAP39;APOD;ARHGEF17;BASP1;GFAP;ITPR3;CCND1;LFNG;YWHAH;PSMB9;PDHX;CENPE;NOTUM;PDE6B;EGF;BAIAP2;MYH11;RIT2;ANGPTL3;BAIAP2L1;PLPPR1;GRM6;ZWILCH;PRKCG;ARHGDIG;SRF;WAS;ITGA8;ST3GAL6;LTBP4;GIPR;RPS6KA1;LMNB1;PLD2;IGF1;CDC42EP1;MAG;NHS;S1PR3;PFN2;CDC42EP3;NUF2;STAT1;PLPPR5;POLR2I;WNT5A;SH3GL3;CHRM3;PPP3CC;GABRB2;PTPN7;SST;TGFA;THBS2;PDK3;SHC2;SPC24;ARHGEF18;MCHR2;FGF1;LGR5;PSMB6;EPSTI1;IFT122;BIRC3;DAB2IP;ADCY5;HHIP;PRKCQ;SYK;FN1;IER3;PRDM1;CD55;RHOF;LPAR6;RHPN1;PTRH2;KIF2C;TPM4;PSMC3;MYH9;GLI1;LPAR4;GREM2;GNG2;PRKCH;OBSCN;PAQR3;FLOT1;DUSP16;ELMO1;RSPO4;C1QTNF1;UBC;GRIN2B;FADD;STRADB;AMOTL2;P2RY10;RNASE1;FGF7;LDHD;TNFRSF1A;CENPN;SPINT2;FES;UBXN11;RXFP1;CENPU;NOXA1;PTH1R;FOS;HTR1E;GABRG2;SLITRK5;NR4A1;ITGA3;PRICKLE1;PPP1R14A;RPS6;IL3RA;TAS1R1;GLP1R;GRM7;PTH2R;CBY1;PDZD2;PIK3CB;SFRP2;PSMA8;DLC1;APLN;VAV1;RGS17;IL1RAP;APH1A;RASGRF2;DDRGK1;PLAT;GABRA1;PRKCD;STMN1;CDK2;SH2B2;TLN1;RHOD;PSMA7;ALDH3A2;F3;FGF22;COL9A2;MCAM;FASN;STAT6;PML;ERBIN;ARHGAP22;EMD;TSC2;DOCK10;PDE5A;HDAC7;HTR2C;LRIG1;IRS2;OXTR;ADCY8;PRKCB;CHRM5;TEK;SH3KBP1;VCL;RGR;CCL28;CDC37;MTA1;NOTCH3;CENPP;PSME1;CDK5;GPER1;ANOS1;RIPK2;RBX1;LTBP1
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.5438582823995702,-0.9184111208600322,0.609375,0.9584218461409143,1.0,5/9,15.76%,ALOX12;CEACAM1;CD9;C1QTNF1;PRKCD
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.4078978772224577,-0.9181872173887462,0.5897435897435898,0.9586643082955116,1.0,8/55,9.54%,PLEKHG2;LMOD1;BAIAP2;BAIAP2L1;VIL1;CDC42EP1;PFN2;CDC42EP3
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.42129027240742256,0.9181854161283721,0.5581395348837209,0.9845787227585654,1.0,12/19,31.90%,BRCC3;KAT2A;USP3;USP49;USP22;ENY2;TRRAP;USP36;USP15;USP7;UIMC1;EPOP
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.4980445244548921,0.9181848706131326,0.5365853658536586,0.9840536141064274,1.0,1/9,1.24%,NR1D1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.31433650353145426,0.9181828315154518,0.6428571428571429,0.9835351073843289,1.0,23/112,21.51%,NUP42;AIFM2;HSPA1A;NUP37;ABCD1;BAG2;NUP54;HSF1;ATR;NDC1;NUP214;RAE1;AAAS;NUP188;EP300;NUP205;CCAR2;DYRK3;NUP210;NUP85;NUP153;NUP50;SMG1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.4323240351725185,0.9181314908805637,0.6857142857142857,0.9831318921267895,1.0,2/24,8.16%,KDM1B;KDM5A
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.3956996122925261,0.9176691046111831,0.53125,0.983863813759003,1.0,1/21,0.60%,RGCC
prerank,Reactome_2022__Fertilization R-HSA-1187000,-0.5411977575088834,-0.917650790252431,0.6557377049180327,0.9595265195402791,1.0,2/11,10.25%,ADAM21;CD9
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.45481292936931533,-0.917597351668528,0.6911764705882353,0.9593591488070656,1.0,5/30,13.10%,PROX1;SULF1;ITGA8;STAT1;PAX8
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.49465486468627096,-0.9175406421135404,0.6,0.9591748290804537,1.0,1/11,0.55%,TYMS
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.5945754280393729,-0.9175356313053253,0.5961538461538461,0.958896869780754,1.0,2/5,23.70%,ARL13A;ZDHHC3
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.39960581371818643,-0.9175022534721099,0.5714285714285714,0.9586730416691277,1.0,7/51,14.25%,ANXA1;THSD7B;MINK1;MYH9;DMTN;FGF7;PDLIM4
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.5721054281013803,-0.91737132588186,0.6842105263157895,0.9586850064024907,1.0,4/7,29.81%,DND1;TGFB1;PPARG;NCOR1
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.295644582019922,0.9172791918088028,1.0,0.9844019174275989,1.0,30/207,12.89%,FGF6;LEPR;VEGFD;AGER;BMP2;VEGFC;MEN1;OCLN;PPP1R15B;CCDC88C;FBLN1;SOX9;TESK1;EGFR;AKT2;P2RY1;AKT1;RALB;ANKRD54;STK4;TWF1;ERBB4;SESN2;CDK2AP1;CSF1R;EFNA5;DVL2;ACVR2A;SIRPA;PPP2R5A
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.45280901722561423,0.9172709733746993,0.5,0.983908445672183,1.0,1/11,2.91%,ADRA1A
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,0.36151113227696263,0.9172601514200717,0.6666666666666666,0.9834154986076287,1.0,14/42,23.28%,GTF2F2;ERCC2;GTF2A2;TAF12;ERCC3;GTF2H5;TAF4;GTF2H2;TAF2;POLR2C;TAF3;GTF2H3;TAF13;GTF2B
prerank,Reactome_2022__PD-1 Signaling R-HSA-389948,0.5261973439123822,0.9172573584206355,0.574468085106383,0.9828929611482199,1.0,1/8,0.40%,CD247
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.5096126943470157,-0.9171636588967,0.625,0.9588559126726764,1.0,6/18,18.54%,SYNPO2L;TNNT1;OBSCN;MYLK3;WDR1;FHOD3
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.5943419482765083,0.9171187854979537,0.6,0.9827080791684027,1.0,1/5,5.93%,PEX13
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.48843052980320323,-0.9170585442501177,0.6949152542372882,0.9587826892437423,1.0,2/17,1.91%,SIX3;B2M
prerank,Reactome_2022__IRAK1 Recruits IKK Complex R-HSA-937039,0.49955829756043485,0.9168212140150456,0.5531914893617021,0.9830287757733459,1.0,1/9,6.31%,UBE2N
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.47282939885894215,-0.9167945059041922,0.6212121212121212,0.9590413978506837,1.0,6/19,13.97%,KCNH8;CCND1;EGF;SRF;TGFA;FOS
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),-0.5964985748576029,-0.9167729642806478,0.6458333333333334,0.9584952479326083,1.0,2/5,23.13%,TCP1;WRAP53
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),-0.5964985748576029,-0.9167729642806478,0.6458333333333334,0.9584952479326083,1.0,2/5,23.13%,TCP1;WRAP53
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.3902814283138543,0.9167664681606907,0.6153846153846154,0.9826636199717038,1.0,11/30,25.88%,HSPA1A;HSF1;RHBDD1;DNAJB14;DAXX;ERN1;TM7SF3;DNAJC18;HSPA13;DNAJB12;BAK1
prerank,CellMarker_Augmented_2021__1-Cell Stage Cell (Blastomere):Embryo,0.38330081934211746,0.916732038840048,0.6,0.9822087002569472,1.0,6/34,16.96%,ARHGEF16;TUBG1;PPIL2;CIAPIN1;FTL;BLCAP
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",0.322668645993276,0.9167044951294883,0.7619047619047619,0.9817542627040503,1.0,29/91,23.01%,DMAC2L;COX18;NDUFB1;TACO1;NDUFAF3;UCP3;NDUFAF4;NDUFAF2;LRPPRC;ATP5PB;ETFDH;ATP5MC2;COX19;NDUFV3;NDUFA8;TIMMDC1;ATP5MC1;COX7A2L;UQCRC2;ATP5F1A;NDUFS1;NDUFV1;NDUFAF7;NDUFB4;NDUFAF5;ATP5F1C;CCNI;SDHB;SLC25A14
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,0.2774601153742152,0.9165793330072051,0.8571428571428571,0.9815104363777563,1.0,98/389,17.63%,ZNF300;ZNF615;ZNF415;ZNF783;ZNF559-ZNF177;ZNF441;ZNF195;ZNF212;ZNF778;ZNF107;ZNF658;ZNF426;ZNF624;EIF2S1;ZNF556;ZNF555;ZNF616;AKT2;ZNF707;ZNF613;ZNF304;ZNF74;ZNF577;ZNF484;ZNF684;AKT1;ZNF786;ZNF320;ZNF680;ZNF268;ZNF211;ZNF782;ZNF561;ZNF595;ZNF12;ZNF133;ZNF587;ZNF510;ZNF543;ZNF155;ZNF766;ZNF665;TRADD;ZNF875;ZNF181;ZNF347;ZNF677;EIF2AK4;ZNF676;ZNF761;ZNF669;ZNF33A;ZNF736;ZNF792;ZNF793;CASP3;ZNF214;TICAM1;ZNF254;ZNF283;PPP1CC;ZNF14;SRSF8;ZNF382;ZNF324B;ZNF354B;ZNF527;PIK3CA;ZNF230;ZNF324;ZNF764;RNASEL;ZNF530;ZNF416;ZNF429;ZNF189;NFKB1;PIK3R1;ZNF43;ZNF519;ZNF558;POU2F1;ZNF91;ZNF425;ZNF471;ZNF25;ZNF34;EIF2AK3;ZNF492;BAD;ZNF470;ZNF688;ZFP82;ZNF248;ZNF589;ZNF611;ZNF879;ZNF41
prerank,KEGG_2021_Human__Relaxin signaling pathway,-0.3741058664283521,-0.9165575237786686,0.6707317073170732,0.9587056290377941,1.0,19/100,17.95%,COL4A1;TGFBR2;COL4A2;COL4A4;ADCY7;GNG3;SHC2;CREB5;ADCY5;GNG2;NOS1;RXFP1;FOS;PIK3CB;PIK3CD;ADCY3;ADCY8;CREB3;TGFB1
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.5300944243452155,-0.9161559312658261,0.576271186440678,0.9593011973325073,1.0,3/8,3.84%,CD5;SKAP1;GPR171
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.394383064845947,-0.9160177262946938,0.625,0.9593129422439659,1.0,13/61,15.75%,FLRT3;POU4F1;SLITRK1;LRRC4;WNT5A;GABRB2;PCDHB5;ACHE;GRID2;NLGN1;GABRG2;BDNF;GABRA1
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.42715541741861807,-0.9158805276709139,0.6027397260273972,0.9593558262860088,1.0,3/34,9.28%,L1CAM;SHTN1;MAG
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.5498472964123524,-0.9158689797631463,0.6,0.959090146826347,1.0,4/8,25.60%,SYK;HLA-F;GAB2;STX4
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.5597033793124223,0.9158127490011432,0.717391304347826,0.9828690100374742,1.0,1/6,1.24%,NR1D1
prerank,CellMarker_Augmented_2021__CD1C+ A Dendritic cell:Blood,-0.4685246165479277,-0.9157844266800387,0.5645161290322581,0.9590000737126152,1.0,7/16,27.47%,ITGA5;CREB5;ADAM8;PTAFR;PER1;SMN1;SLC2A3
prerank,Reactome_2022__Molybdenum Cofactor Biosynthesis R-HSA-947581,0.5835605062470457,0.9157548158570364,0.7045454545454546,0.9819913300126472,1.0,2/6,16.94%,GPHN;MOCS2
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.5835605062470457,0.9157548158570364,0.7045454545454546,0.9819913300126472,1.0,2/6,16.94%,GPHN;MOCS2
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.3794044408156413,-0.9155643222250149,0.6296296296296297,0.9591929454304152,1.0,21/118,11.90%,C1QL1;TAGLN3;STMN2;CSPG4;SNCB;PLP1;NNAT;LRRTM1;GAP43;NKX6-2;GFAP;TCEAL6;ZNF536;IGSF21;CA10;NYAP1;HAPLN2;HPCA;ADCY5;STMN4;C11ORF87
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.5370775222448345,0.9155247632967958,0.6486486486486487,0.9821013638562772,1.0,1/6,2.88%,SERPINF2
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,0.3039479939491886,0.9155126759706292,0.6842105263157895,0.9816124962669426,1.0,15/124,9.80%,SEM1;PSMD10;DERL2;ADCY1;PSMA1;PSMD11;CUL1;GPC5;PSMB5;VCP;GAS1;INTU;DZIP1;BTRC;PRKACB
prerank,KEGG_2021_Human__Tryptophan metabolism,-0.43851770413501656,-0.9153729467821923,0.6666666666666666,0.9593149990814269,1.0,3/33,6.92%,KMO;MAOB;CYP1B1
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,-0.4814746365261328,-0.915327289070028,0.5909090909090909,0.9591259881774312,1.0,2/17,12.77%,RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.45408042814661365,-0.915197970587228,0.576271186440678,0.959134934938933,1.0,2/21,4.80%,FSCN1;CLRN1
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.32556156642154294,0.9151277829638282,0.7307692307692307,0.9821355575678326,1.0,16/95,15.34%,PSMD10;BCL10;TAB3;PSMA1;PSMD11;CUL1;MAPK10;PSMB5;BTRC;MAPK8;PSMD14;PIK3CA;PSMD12;NFKB1;PIK3R1;MAP2K4
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.4375041209238192,-0.9151125497044847,0.625,0.9590223808983275,1.0,10/31,24.22%,KLF4;SRF;FOS;APLN;ETS1;TGFB1;SPI1;GNL3;STAT3;PPARG
prerank,KEGG_2021_Human__Salivary secretion,-0.40415375135516984,-0.9150563527966026,0.5875,0.9588816488479543,1.0,14/58,17.19%,PRH2;ADCY7;ATP1A1;ITPR3;ATP1B1;PRKCG;CHRM3;ADCY5;NOS1;SLC4A2;ADCY3;GUCY1A1;ADCY8;PRKCB
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.4373994660616254,-0.9150344858172939,0.6338028169014085,0.9586280514868842,1.0,2/40,0.33%,CCBE1;THBS1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.5174321212615031,-0.9149988774324668,0.6153846153846154,0.9584395345302599,1.0,3/12,11.60%,ATP1A1;ATP1B1;TMPRSS3
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.5323007888425217,-0.9149893529644763,0.6176470588235294,0.9581721141316324,1.0,1/11,1.53%,P2RY12
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.31845079852543196,0.9146902471267708,0.5263157894736842,0.9825922699713385,1.0,19/129,14.00%,LIMD1;AMER2;BMP2;PSMD10;BICC1;CCDC88C;PSMA1;GREM1;PSMD11;SOX9;PSMB5;STK4;KLHL12;INVS;PSMD14;DVL2;PSMD12;TMEM170B;MDK
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,0.36874065485700824,0.9145554249951815,0.6129032258064516,0.9824865331401257,1.0,8/34,12.70%,DERL2;MOGS;VCP;UGGT1;PRKCSH;ENGASE;DERL1;GANAB
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.4617429904809959,0.9144441912449964,0.55,0.9822972546248717,1.0,6/16,23.92%,EP400;ING3;SPHK2;RUVBL1;TRRAP;EPC1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.3277898434957006,0.9143773341382279,0.6296296296296297,0.9819409573848834,1.0,13/112,8.78%,NR1D1;PSMD10;ADIPOR1;PSMA1;PSMD11;ELOVL6;ACACB;PMVK;PSMB5;RUBCNL;PRKAB1;NFYC;CHD9
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,0.34236898950812716,0.9143678116700662,0.5806451612903226,0.9814477499369697,1.0,10/55,10.97%,LEPR;PPARGC1A;ADIPOR1;AKT2;ACACB;MAPK10;AKT1;PRKAB1;TRADD;MAPK8
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,-0.43099902407590174,-0.914308297989876,0.6533333333333333,0.9594480523144417,1.0,5/37,8.92%,STAG3;BRCA1;SYCE2;SYCE1;LMNB1
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Peripheral Blood,-0.44558770631631833,-0.914235799583911,0.5692307692307692,0.9590343251027542,1.0,8/21,8.69%,MYO1F;CD5;TAGAP;TMC8;SLA;ARHGAP9;CLEC12A;WAS
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Blood,-0.44558770631631833,-0.914235799583911,0.5692307692307692,0.9590343251027542,1.0,8/21,8.69%,MYO1F;CD5;TAGAP;TMC8;SLA;ARHGAP9;CLEC12A;WAS
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.48399258334447814,-0.9141434664429183,0.576271186440678,0.95898126508586,1.0,4/11,23.00%,BRCA1;SET;SPI1;TAF7
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6240475061101306,-0.9138390558157058,0.6981132075471698,0.9594157150467906,1.0,1/5,8.26%,VIL1
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Adipose Tissue,-0.4825902733702579,-0.913678355906372,0.5833333333333334,0.9594104598785391,1.0,6/20,11.39%,ICAM1;KLF4;THY1;CD44;CD9;CD55
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.5816925715155745,-0.9136763663114394,0.6551724137931034,0.9588369110887744,1.0,1/6,2.99%,SFTPD
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.5816925715155745,-0.9136763663114394,0.6551724137931034,0.9588369110887744,1.0,1/6,2.99%,SFTPD
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.3664229797577823,-0.9136095303001303,0.7045454545454546,0.9587530324020348,1.0,13/136,9.57%,TRIM22;APLNR;TRIM61;PROX1;TRIM5;APP;YBX3;NELL1;LDLR;ATP1B1;TRIM17;IGF1;NFKBID
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation Of Saturated Fatty Acids R-HSA-77286,0.5109143910151838,0.9134141690827253,0.6129032258064516,0.9833175150052453,1.0,2/11,15.48%,ACADM;ACADS
prerank,CellMarker_Augmented_2021__Stem cell:Dental Pulp,-0.5458527957044143,-0.9134070319914862,0.65,0.9588858470061365,1.0,4/9,21.37%,THY1;CD44;MCAM;PTPRC
prerank,Reactome_2022__Vitamin D (Calciferol) Metabolism R-HSA-196791,-0.5592818698190922,-0.9133700012954853,0.6271186440677966,0.9586726202790841,1.0,1/9,3.19%,GC
prerank,Reactome_2022__Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,-0.5159549426668033,-0.913264602078548,0.6176470588235294,0.9586197972790602,1.0,3/12,15.16%,F8;SERPIND1;SERPING1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.28150070187870724,0.9131179994451473,1.0,0.9834680688565339,1.0,46/337,14.48%,DGKB;LMTK3;LIMD1;CDKL1;CCNE1;BMP2;GK;PDK4;PASK;DGKE;PIK3R4;COPS2;ACVR1C;COPS8;CDK8;MAPK10;AKT1;FRK;PRKAB1;TP53RK;CSNK2A1;POMK;CSNK1E;STK4;PRKACB;MAPK6;PLK1;EIF2AK4;MAPK8;STK38L;MAP4K5;MAP4K2;PRKG1;TAOK2;FGGY;ACVR2A;TRIB2;TAOK3;WNK3;STK17B;SGK2;PIK3CA;MORC3;RNASEL;NEK1;PRKD1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.5209231563083556,-0.9131091611670862,0.6129032258064516,0.9586653910310456,1.0,1/12,6.29%,BRCA1
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,0.3709073977288892,0.9129644356790307,0.5526315789473685,0.9833562455997968,1.0,8/47,11.34%,SEM1;PSMD10;PSMA1;PSMD11;CUL1;PSMB5;BTRC;PSMD14
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.5342683995904356,0.9129510520535936,0.6666666666666666,0.9828633311322177,1.0,3/6,30.39%,LRPPRC;MAP1S;RHOT1
prerank,Reactome_2022__Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,-0.5010108845977588,-0.9127835100976543,0.6166666666666667,0.9590790870290274,1.0,2/13,12.77%,RPS27A;UBC
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.4956440696017591,0.9127253315718605,0.53125,0.9828233820486042,1.0,3/12,18.80%,CHMP2B;VPS4B;CHMP6
prerank,CellMarker_Augmented_2021__Sertoli cell:Fetal Gonad,-0.35403852657891466,-0.9126533949399872,0.7684210526315789,0.9590823754130146,1.0,41/381,14.19%,PRAME;GBP2;S100A10;IFI6;SHTN1;TCEA3;PDPN;GMPR;SLC39A14;SERPINF1;PRDX4;HK2;SCN9A;F8;FSCN1;BEX1;ATP1A1;MAP1B;SYNGR2;ATP1B1;TSPYL2;HR;ZYX;TCEAL2;PDK3;C1ORF115;CDH19;CD55;B3GNT2;LIPH;GNG2;MVP;TRIM47;RNASE1;GSE1;SPINT2;HERC5;RASL12;SLC4A2;RELL1;MYLK3
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.45967502924598447,0.9123114902992682,0.6046511627906976,0.9834260892750566,1.0,6/13,23.50%,NOTCH2;HEYL;ROBO1;HEY1;HEY2;JAG1
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,-0.3866435936089523,-0.9121449276200466,0.5526315789473685,0.9598607962757827,1.0,12/82,18.03%,SH3GL2;CTSC;HLA-DRA;CENPE;AP1S1;CTSS;DCTN1;KIF2C;PRICKLE1;CD74;HLA-DRB1;CTSA
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.385111002116177,-0.9120795544425443,0.6753246753246753,0.9597262743412727,1.0,5/86,7.39%,SIX3;IHO1;PLK2;RAB11A;PLK3
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.5491108502936874,-0.912064439441169,0.717391304347826,0.9594655288167441,1.0,2/8,18.59%,LRRC19;OCIAD2
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,-0.39801144701154556,-0.9119680180518173,0.5822784810126582,0.959370489663881,1.0,20/83,23.65%,KCNB1;ADCY7;GNG3;AKAP5;ITPR3;CHRM3;CACNA1C;ADCY5;GNG2;GLP1R;SYT5;FASN;ADCY8;CD36;KCNC2;ITPR1;GNB4;GNB5;GNA14;AHCYL1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.39994087410974233,-0.9119240387058456,0.6111111111111112,0.9591773298918118,1.0,2/44,2.09%,AMN;ANK3
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.3504374254400887,0.9118605308444878,0.7419354838709677,0.983921117867439,1.0,14/44,23.21%,NGF;PLCB4;PIK3C2G;CSF1R;PIK3C3;PIK3CA;ADAP2;PIK3R1;PIK3C2A;PLCB1;PI4KB;RPS6KB1;PLCH1;EZR
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,0.37386517771452726,0.9117763807223893,0.5925925925925926,0.9835834823066667,1.0,10/54,13.78%,SEM1;PSMD10;DERL2;PSMA1;PSMD11;PSMB5;VCP;PSMD14;DERL1;PSMD12
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.41186432874587803,-0.9115071481426246,0.6197183098591549,0.9597947105357306,1.0,10/49,15.64%,RPL3;RPL7A;RPL24;RPL10A;RPL10;MRTO4;RPL26L1;PES1;MRPL20;RPL5
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5550369749868281,-0.9113248891473429,0.6379310344827587,0.9599155194254002,1.0,1/7,10.92%,LPCAT4
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.5165870331702482,-0.9112837110789962,0.5666666666666667,0.9597419878615603,1.0,3/12,15.12%,NR4A3;WNT5A;CD74
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Limbal Epithelium,-0.4828460057129689,-0.9110633648994418,0.6545454545454545,0.959941187864065,1.0,4/14,5.89%,GPR87;FAT2;ZNF750;DUOXA1
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.49647276397126494,-0.911012429651683,0.625,0.9597733545506625,1.0,2/14,11.21%,LMOD1;ARPC5L
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.4930173946499643,0.9107813213488938,0.6486486486486487,0.9855096368849136,1.0,2/11,9.40%,AKT1;QDPR
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.5376128751433932,0.9105761486061664,0.6857142857142857,0.985456530877658,1.0,2/10,12.58%,ACVR1C;ACVR2A
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.6010272059685076,-0.910494292633581,0.671875,0.9605352309415207,1.0,1/6,9.32%,ATG9A
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.3702139879507457,0.9104644160162417,0.5357142857142857,0.9852669856728546,1.0,9/41,16.33%,WNT7A;WDR91;METTL18;AKT1;EIF4E;SSH1;NFKB1;DDX25;METAP1
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Peripheral Blood,0.4182761719022039,0.9103479341561876,0.5555555555555556,0.9850361186816912,1.0,2/23,0.40%,C1ORF162;CD247
prerank,Reactome_2022__Assembly Of Active LPL And LIPC Lipase Complexes R-HSA-8963889,-0.49703826295506404,-0.910220594462027,0.6166666666666667,0.9608515793598453,1.0,1/11,8.06%,ANGPTL3
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.474571946907164,0.9101836617074871,0.5,0.9849952003538933,1.0,9/13,43.83%,DESI2;SENP6;ATG7;UBA3;NAE1;UBA1;DESI1;UBA6;SAE1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.38491571937654445,-0.9100851210712112,0.6052631578947368,0.9608739115440458,1.0,12/69,11.73%,CLDN16;KCNJ2;LETM2;HTR2B;SLC24A2;ATP1A1;SLC24A1;GCM2;ATP1B1;SLC8A3;TMPRSS3;SLC24A5
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,-0.3788053556245991,-0.9100610958256508,0.6219512195121951,0.9606248721149284,1.0,21/87,16.65%,SOCS3;IL13RA1;IL12A;STAT4;IL15;GFAP;CCND1;EGF;IFNGR2;OSMR;STAT1;THPO;IL4R;PIM1;IL7;IL3RA;PIK3CB;PIK3CD;CCND2;IL27RA;STAT6
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.475060895198783,-0.9100168318692222,0.6612903225806451,0.9604347120744643,1.0,3/21,3.84%,CD5;TAGAP;GPR171
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,-0.5022889039567155,-0.9099498326535296,0.6666666666666666,0.9603173576246916,1.0,4/12,22.72%,GNG3;GNG2;GNB4;GNB5
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.5480893993386444,-0.90993422256166,0.5901639344262295,0.9600547339055052,1.0,3/8,24.22%,ADAM19;NODAL;PPARG
prerank,CellMarker_Augmented_2021__Mast Cell progenitor:Bone Marrow,0.3415751634492758,0.9099146464561857,0.7619047619047619,0.9836665075683141,1.0,15/77,15.97%,HMMR;CDC25A;RFWD3;EIF2S1;XPO1;STIL;NDC1;LRPPRC;PSMD14;PARPBP;G3BP1;DDX21;CAPRIN1;URB2;NUP205
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Peripheral Blood,0.3415751634492758,0.9099146464561857,0.7619047619047619,0.9836665075683141,1.0,15/77,15.97%,HMMR;CDC25A;RFWD3;EIF2S1;XPO1;STIL;NDC1;LRPPRC;PSMD14;PARPBP;G3BP1;DDX21;CAPRIN1;URB2;NUP205
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Subcutaneous Adipose Tissue,0.3415751634492758,0.9099146464561857,0.7619047619047619,0.9836665075683141,1.0,15/77,15.97%,HMMR;CDC25A;RFWD3;EIF2S1;XPO1;STIL;NDC1;LRPPRC;PSMD14;PARPBP;G3BP1;DDX21;CAPRIN1;URB2;NUP205
prerank,CellMarker_Augmented_2021__Erythroblast:Blood,0.3415751634492758,0.9099146464561857,0.7619047619047619,0.9836665075683141,1.0,15/77,15.97%,HMMR;CDC25A;RFWD3;EIF2S1;XPO1;STIL;NDC1;LRPPRC;PSMD14;PARPBP;G3BP1;DDX21;CAPRIN1;URB2;NUP205
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.3751902011598008,0.9098623988791451,0.6666666666666666,0.9833189403221,1.0,1/28,0.54%,RNF6
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,0.36140931585935543,0.9098304191630161,0.59375,0.9828889982511751,1.0,6/48,6.89%,SEM1;PSMD10;ELOC;PSMA1;PSMD11;PSMB5
prerank,CellMarker_Augmented_2021__Suppressor T cell:Peripheral Blood,0.434014776853934,0.9098152493414412,0.5833333333333334,0.9824122504775658,1.0,2/22,0.40%,C1ORF162;CD247
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.3732367375716143,-0.9097744553363984,0.6376811594202898,0.9600940362881278,1.0,10/40,17.76%,RPE65;PLB1;RBP2;AKR1C1;GPC3;ADH4;RDH12;ALDH3A2;GPC1;LRP2
prerank,CellMarker_Augmented_2021__Paneth cell:Pyloric Gland,-0.5120208607827288,-0.9097082025594438,0.5970149253731343,0.9599266095789172,1.0,4/12,6.44%,ALDOB;RBP2;MEP1B;LRRC19
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.4245071047880614,0.9097070526230665,0.6176470588235294,0.982178048869041,1.0,3/15,10.13%,CEL;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.31900251209994857,0.9095517144807407,0.6666666666666666,0.98202079856091,1.0,36/107,27.23%,MTERF3;PIK3R4;VCP;RUBCNL;PRKAB1;SNF8;CSNK2A1;VPS37A;CSNK2A2;VTA1;TOMM22;PGAM5;PIK3C3;CHMP2B;VPS39;TBC1D5;VPS37B;PIP4K2B;VPS4B;SNAP29;CHMP6;HDAC10;PRKAA1;BECN1;VIPAS39;EI24;TMEM74;UBQLN1;DYNLL2;MFN2;LIX1L;VPS16;VPS25;VAMP7;ATG3;VPS41
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.49135718299520775,-0.9095031687990913,0.6551724137931034,0.9601167208117675,1.0,4/19,15.28%,ANK3;SYT1;RIMS2;GRIK2
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.4030291016326664,0.9094320874869651,0.5833333333333334,0.9819403794418816,1.0,6/27,8.58%,ADRA1A;SLC35G1;MCU;MAIP1;JPH1;CACNB3
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.43694712759420856,-0.9091340529354648,0.5921052631578947,0.960719881863016,1.0,7/51,12.16%,CTSC;DENND3;VLDLR;SPATA18;CTSS;DAB2IP;CTSZ
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.5091750474992568,-0.909133981646387,0.6349206349206349,0.9604324133166776,1.0,4/20,15.10%,RPS27A;ANAPC11;UBC;UBE2S
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.5588679187469253,-0.909118118296427,0.6774193548387096,0.960195336319993,1.0,3/8,13.87%,WNT5A;SYK;NOXA1
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.6122843231917,-0.908827788260308,0.6491228070175439,0.9605357534345802,1.0,1/5,6.59%,TLR3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.6003304283425767,-0.9087792105982913,0.603448275862069,0.9603517651425022,1.0,1/5,10.73%,FGF1
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.4905674945406401,-0.9087522495181077,0.5686274509803921,0.9601232872337028,1.0,3/14,7.30%,CIITA;CEACAM1;SLC18A2
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.412951822430496,-0.9087143281821782,0.5945945945945946,0.95992281226848,1.0,7/52,13.02%,DHCR24;GC;AKR1C1;CYP1B1;HSD17B14;CYP21A2;CYP3A4
prerank,KEGG_2021_Human__Butanoate metabolism,-0.47341811959038543,-0.908590230296813,0.6212121212121212,0.959897963049025,1.0,7/22,23.47%,ACSM5;GAD1;GAD2;ALDH5A1;HMGCS1;ACAT2;ACSM3
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),0.5595094515734909,0.9085858826458076,0.6744186046511628,0.983539958669835,1.0,1/7,5.97%,TPK1
prerank,Reactome_2022__Cleavage Of Damaged Pyrimidine R-HSA-110329,0.41788577054886816,0.9084755396762108,0.5588235294117647,0.9833410060836267,1.0,4/23,14.92%,H2BC21;H2BC4;H2AC6;POT1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.3277046927440119,0.9084391306563973,0.8,0.9829302809161212,1.0,29/99,25.57%,PHC1;UBE2N;PRMT6;MIER3;KAT2A;PRDM5;HDAC2;EP300;EYA1;EYA2;EHMT1;PHF20L1;HDAC10;USP3;KAT6B;MIER2;USP22;ENY2;RUVBL1;TRRAP;MTA2;USP36;UBE2A;SIRT2;PRMT1;NAA50;RPS6KA4;PADI4;BAZ1B
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,-0.41698037801321725,-0.9081977564965305,0.6027397260273972,0.9605554481558183,1.0,7/54,13.61%,GRIN2A;TRPC3;MOBP;SST;GAD1;GRIN2B;GAD2
prerank,KEGG_2021_Human__Yersinia infection,0.3040506161305623,0.9080969771114642,0.631578947368421,0.9833262623544666,1.0,20/110,16.06%,PIP5K1B;ACTR3C;ACTR3B;AKT2;MAPK10;ARHGEF12;AKT1;WIPF2;ARHGEF28;MAPK8;TICAM1;MAPK12;WASL;PIK3CA;RPS6KA3;NFKB1;PIK3R1;MAP2K4;CRKL;GNAQ
prerank,Reactome_2022__TYSND1 Cleaves Peroxisomal Proteins R-HSA-9033500,0.5319234599989026,0.9080291707212069,0.6,0.982921853324747,1.0,2/7,14.18%,PHYH;ACOX1
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163,-0.513874262498615,-0.907842015215971,0.5538461538461539,0.9610705492800701,1.0,3/14,12.77%,RPS27A;NDUFA2;UBC
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,0.33924022388903724,0.9077144296280919,0.7058823529411765,0.9831410538301257,1.0,7/30,14.28%,SEM1;DNA2;RFC3;HUS1;RRAD;RAD9B;ATRIP
prerank,Reactome_2022__Post-transcriptional Silencing By Small RNAs R-HSA-426496,0.574726614616286,0.9074152708251292,0.6666666666666666,0.9834011597907317,1.0,6/7,41.61%,AGO3;TNRC6B;TNRC6C;AGO4;AGO2;TNRC6A
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.439737467994593,-0.9073388002921204,0.6216216216216216,0.961852541243639,1.0,8/35,21.86%,RHOBTB2;RND2;RHOF;NLGN1;RHOD;FHOD3;RHOBTB1;FHOD1
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.3418713127645603,0.9073352466290362,0.625,0.9830913095096334,1.0,13/72,16.49%,DAO;CARNMT1;ALDH7A1;GLUD1;BLMH;IDO1;GLS;QDPR;PIPOX;DBT;ACADSB;DDO;GLUL
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.5426622816344044,0.9072450281221086,0.6097560975609756,0.9827700401159841,1.0,2/5,16.19%,MGLL;ABHD6
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.48797264484468966,0.9071350850095881,0.6388888888888888,0.9825195070474783,1.0,2/14,5.99%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.5607835445051229,0.9071268277806275,0.6041666666666666,0.9820346754420717,1.0,1/6,10.68%,LIN7C
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.43624417208237726,-0.907084666745647,0.6086956521739131,0.9621443492694413,1.0,6/25,16.72%,SLC51A;AKR1C1;CEACAM1;SLC51B;SLCO1A2;ATP8B1
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,-0.44555081917595174,-0.9069492408267125,0.6029411764705882,0.9621021846223979,1.0,6/25,12.39%,RASGRP1;RASGRP2;TRPC3;ITPR3;PRKCQ;PRKCH
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Brown Adipose Tissue,-0.36757900630605034,-0.9068839968259673,0.5833333333333334,0.9619543737389883,1.0,6/99,6.11%,KCNT2;FLRT3;PROX1;MAOB;CTNNA3;MAP1B
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.40934456271846026,-0.9067386323884747,0.618421052631579,0.9620068107468952,1.0,16/59,22.27%,LMOD1;SYNPO2L;TNNT1;ZYX;MYH9;OBSCN;MYLK3;ALKBH4;WDR1;MYO18A;FHOD3;EPB41L4B;EPB41L4A;SORBS1;MYOZ2;EPB41L1
prerank,Reactome_2022__MASTL Facilitates Mitotic Progression R-HSA-2465910,-0.5592026033616837,-0.9066485938343344,0.59375,0.9619341539206197,1.0,1/8,10.55%,CCNB1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.3409090768860056,-0.9065748384191339,0.7078651685393258,0.9618004168863369,1.0,41/238,17.95%,RASGRP1;MET;ZFP36;RPS27A;NEFL;ZDHHC9;RASGEF1A;HTR2B;GFRA2;CCL2;RALGDS;PSMB9;EGF;RIT2;IGF1;MINK1;PTPN7;TGFA;SHC2;FGF1;PSMB6;DAB2IP;PRKCQ;IL18;PSMC3;TNIP2;PAQR3;UBC;GRIN2B;FGF7;IL3RA;PIK3CB;PSMA8;RASGRF2;PSMA7;FGF22;IRS2;TEK;PSME1;RBX1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5526833688464958,-0.9065337060444018,0.6041666666666666,0.9616028766991362,1.0,2/8,9.37%,RSPO3;PLEKHA4
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.6041009462885689,-0.9064642470721984,0.7068965517241379,0.9614915314089311,1.0,2/5,11.40%,HLA-A;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.5697148207144951,-0.906455087379287,0.6323529411764706,0.9612275800951386,1.0,2/8,12.43%,NLRP12;MVP
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.5639433643873963,-0.9064012284125487,0.6333333333333333,0.9610470368716848,1.0,2/8,13.52%,LRRC4;NLGN1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3762836467124848,-0.9063479353731322,0.5432098765432098,0.9608943431374576,1.0,10/76,16.36%,SH3GL2;HLA-DRA;CENPE;AP1S1;CTSS;DCTN1;KIF2C;CD74;MARCHF1;HLA-DRB1
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,0.4613087015514762,0.9063154325982412,0.5757575757575758,0.9836075252605863,1.0,7/13,36.41%,PPP2R5A;PPP2R1B;LRP8;PPP2R5B;PPP2R1A;PPP2R5E;PPP2CB
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.6243952929780896,0.9059449086818879,0.6923076923076923,0.984042320108159,1.0,2/6,9.80%,MYOM1;PRKACB
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Gonad,-0.35352439414553494,-0.9057115861298781,0.6666666666666666,0.9620147233637323,1.0,28/178,19.17%,ST6GAL1;TUBB6;PLK2;LDHA;ITM2A;COL6A2;ITGA5;THY1;LDB2;FN1;FANCI;HLA-E;AEBP1;PROCR;GPC3;CENPN;CENPU;SERPING1;STMN1;DPYSL2;MAN1A1;ANXA2;CBX1;COTL1;A2M;TSPAN4;SMTN;MYO1C
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.3929546509099095,-0.9057075742280783,0.6764705882352942,0.9617315224619098,1.0,1/66,0.11%,LEF1
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,-0.46561351830900616,-0.9055849365660402,0.5882352941176471,0.9616896308616935,1.0,5/23,17.15%,ADCY7;GNG3;ADCY5;GNG2;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.2920791751512219,0.9055204320261909,0.7142857142857143,0.9843595686444307,1.0,14/164,7.50%,FGF6;LEPR;VEGFD;AGER;BMP2;VEGFC;SOX9;TESK1;EGFR;AKT2;P2RY1;UBE2N;AKT1;RALB
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR3 R-HSA-5654708,0.43024146764297133,0.9055031059093831,0.5172413793103449,0.9838806401202187,1.0,6/17,23.66%,NRAS;PIK3CA;PIK3R1;FGF17;PIGU;SOS1
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),-0.5589403716012149,-0.9053162997725969,0.6206896551724138,0.9617638173846643,1.0,1/6,3.86%,BHMT
prerank,Reactome_2022__Choline Catabolism R-HSA-6798163,-0.5589403716012149,-0.9053162997725969,0.6206896551724138,0.9617638173846643,1.0,1/6,3.86%,BHMT
prerank,Reactome_2022__CD28 Dependent Vav1 Pathway R-HSA-389359,-0.5456078417676835,-0.905295954902801,0.59375,0.9615197970542353,1.0,3/8,25.06%,RNASE1;VAV1;FYN
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.42517534258072576,-0.9051465683333133,0.6142857142857143,0.9615416922611946,1.0,5/37,10.55%,DUSP1;EGF;IGF1;TGFA;CCNB1
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.40272952084299135,-0.9050963654699031,0.6621621621621622,0.9614251933221357,1.0,8/71,8.20%,FMO6P;P2RY14;CLDN16;CYP4Z1;ZNF750;DCDC1;EGF;SPAG17
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.4215609268380023,0.9050855343746276,0.5806451612903226,0.9844900854342887,1.0,6/25,16.65%,TNFAIP3;ZDHHC11;APOBEC3F;EIF2AK4;MUL1;IFNLR1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.46626312582005186,-0.9049904515690252,0.6142857142857143,0.961355799135864,1.0,5/23,17.91%,PLEKHG2;WAS;PFN2;WDR1;COTL1
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.34852664819378765,-0.904941518696283,0.71875,0.9612089986265313,1.0,66/402,17.64%,EPN1;THBS1;HPN;COL4A1;FLRT3;FOSB;SPARC;PGR;COL4A2;LAMB1;RPS27A;ITGA2;COL4A4;SH3GL2;COL6A2;THBS3;RALGDS;KCNH8;PTK6;GFAP;ITPR3;EGF;BAIAP2;RIT2;SRF;RPS6KA1;IGF1;STAT1;POLR2I;SH3GL3;GABRB2;TGFA;THBS2;SHC2;FGF1;PRDM1;ELMO1;UBC;GRIN2B;RNASE1;FGF7;SPINT2;FES;FOS;GABRG2;ITGA3;PIK3CB;VAV1;APH1A;PLAT;GABRA1;PRKCD;STMN1;SH2B2;F3;FGF22;COL9A2;STAT6;ERBIN;LRIG1;IRS2;PRKCB;SH3KBP1;CDC37;CDK5;ANOS1
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Lung,-0.46579764106108806,-0.9047588864014502,0.6212121212121212,0.961366452923213,1.0,11/27,13.52%,TJP3;POF1B;FUT2;CEACAM1;PTK6;TMC4;ILDR1;CLCA4;CAPN8;LIPH;CXCL17
prerank,Reactome_2022__Methionine Salvage Pathway R-HSA-1237112,-0.6249248234258168,-0.9046052918615453,0.7037037037037037,0.9614768200733738,1.0,1/5,0.48%,APIP
prerank,Reactome_2022__WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,-0.48123487793534186,-0.9045357912374996,0.576271186440678,0.9613466953324533,1.0,4/15,19.33%,PRKCG;WNT5A;PRKCB;CLTB
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.4406915733568093,-0.9044682796272698,0.5915492957746479,0.9611669190026945,1.0,7/23,10.15%,MYO1F;ICAM1;TAGAP;IGSF6;CLEC12A;IL4R;CTSS
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.4460366766305272,-0.9044677444859034,0.6388888888888888,0.960882297469084,1.0,6/33,19.49%,ATG9A;MAP1LC3A;PINK1;WDR45;GABARAPL1;GABARAPL2
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,-0.4140646707843178,-0.9044473708560482,0.7397260273972602,0.96063373834172,1.0,15/60,17.19%,ICAM1;HLA-A;HLA-C;IFNGR2;PRKCG;SH3BP2;PPP3CC;SHC2;HLA-B;SYK;HLA-E;PIK3CB;VAV1;PIK3CD;PRKCB
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.34641923300782707,0.9043686593957018,0.6521739130434783,0.9859582345216426,1.0,20/64,20.89%,NUP42;NUP37;GIT1;NUP54;CBFA2T3;SLC4A4;NDC1;NUP214;RAE1;AAAS;NUP188;ZBTB20;EP300;NUP205;JMJD8;NUP210;NUP85;PRKAA1;NUP153;NUP50
prerank,KEGG_2021_Human__Gap junction,-0.37927688389323944,-0.904232256438135,0.6626506024096386,0.9608876920973157,1.0,15/75,19.00%,TUBB6;ADCY7;TUBB1;HTR2B;ITPR3;EGF;PRKCG;ADCY5;ADCY3;GUCY1A1;HTR2C;ADCY8;PRKCB;HTR2A;PDGFRA
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.43756872213312664,-0.9042263669572321,0.6712328767123288,0.960619962406695,1.0,11/37,17.17%,ST6GAL1;GCNT1;CHST4;GALNT15;B3GNT5;GALNT10;B3GNT2;GALNT12;ST6GALNAC2;MUC6;GALNT8
prerank,CellMarker_Augmented_2021__T Helper cell:Blood,-0.43199498216136634,-0.9042225637409173,0.5970149253731343,0.9603413566145803,1.0,8/32,8.69%,MYO1F;TAGAP;TMC8;SLA;ARHGAP9;ACAP1;CLEC12A;WAS
prerank,KEGG_2021_Human__Steroid biosynthesis,-0.4774299702424879,-0.9041590653656123,0.5873015873015873,0.9601897745169414,1.0,1/15,0.92%,DHCR24
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),-0.6442268122910779,-0.9040844453878439,0.711864406779661,0.9600658519110344,1.0,1/5,9.42%,FRMPD4
prerank,Reactome_2022__Caspase-mediated Cleavage Of Cytoskeletal Proteins R-HSA-264870,0.4647804311190106,0.9039801367379371,0.6341463414634146,0.9864315965551147,1.0,2/12,11.67%,GAS2;CASP3
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,-0.3557474752767774,-0.9039223406918535,0.6470588235294118,0.9601073729290078,1.0,21/139,17.44%,ERCC6L;RPS27A;RPS27;CENPH;PSMB9;CENPE;ANAPC11;ZWILCH;NUF2;SPC24;PSMB6;KIF2C;PSMC3;UBC;CENPN;CENPU;UBE2S;PSMA8;PSMA7;CENPP;PSME1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.40153974516702623,-0.9038168244457337,0.6338028169014085,0.9600579425732926,1.0,11/45,20.15%,RASGRP1;GPR183;TPD52;LAT2;AKAP17A;BLNK;PIK3CD;PRKCB;RAG1;KLF6;CASP8
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.43886455128791296,-0.9037977664958055,0.6065573770491803,0.959812968713958,1.0,6/30,22.47%,ABCA5;ANGPTL3;SQLE;SOAT1;APOL2;IDH2
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.3265906546276806,0.903786068397624,0.7142857142857143,0.9863964104051024,1.0,14/85,12.84%,WNT7A;AGER;SERPINF2;MEN1;DUSP19;EGFR;HMGB1;TIRAP;MAP4K2;TAOK2;MARVELD3;SH3RF1;SIRPA;TAOK3
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,0.3484164791489394,0.9036798788612294,0.625,0.9861744839162269,1.0,6/49,7.84%,SEM1;PSMD10;PSMA1;PSMD11;PSMB5;RNF146
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5375632261917751,-0.9034824473256914,0.6153846153846154,0.9602455575347295,1.0,5/14,17.54%,BAIAP2;BAIAP2L1;FES;TEK;CDK5
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.5092875889109691,0.903455514266166,0.5714285714285714,0.9862211390082254,1.0,2/7,8.94%,AKT1;HMGB1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5356862008493278,-0.9033629290742741,0.5932203389830508,0.9602374239473027,1.0,2/9,16.45%,APOD;F3
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),-0.5432590936142725,-0.9032757217641487,0.6451612903225806,0.960182509345833,1.0,3/13,16.07%,CHST4;CHST6;MGAT3
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.5864235425027242,0.9032057205642235,0.631578947368421,0.9863318844951605,1.0,1/5,10.97%,MAPK8
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.5752017009768817,0.9029955090636596,0.72,0.9862676831469036,1.0,2/5,26.18%,CXCL12;RAPGEF2
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.520956731919098,0.902775189854782,0.5957446808510638,0.9862676202573504,1.0,1/6,7.46%,ALCAM
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.513903081582335,-0.9022686864790741,0.6086956521739131,0.9620590361460747,1.0,1/13,1.31%,TYMP
prerank,CellMarker_Augmented_2021__Stem cell:Salivary Gland,-0.3857145057308544,-0.9022254518222628,0.6987951807228916,0.9618633420830022,1.0,21/92,20.15%,ANXA1;SP100;B2M;S100A6;PARP14;CD44;BIRC3;PRDM1;DDX60;B3GNT2;RUNX2;SP140L;ANXA2;ETS1;NMI;PLP2;TNFRSF10A;GBP3;SAMD9L;GLIPR1;CASP8
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.5062607492664345,0.9021229230716177,0.5384615384615384,0.9874202696475665,1.0,1/11,3.55%,PGM2
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,-0.4100865492422372,-0.90212272203535,0.6119402985074627,0.9618684895091273,1.0,6/56,8.56%,MET;LDHA;SLC16A3;HK2;LDHAL6A;PDK1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.3974230320129681,-0.9020918055112093,0.6296296296296297,0.9616564737829137,1.0,9/62,18.73%,ANK3;SEPTIN5;ANLN;SEPTIN4;ALKBH4;STMN1;SEPTIN9;SEPTIN1;SEPTIN14
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.5746393424924642,0.9018068039219228,0.64,0.9877512861912169,1.0,2/5,13.02%,MOGAT1;PLA2G15
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.4421964792593914,-0.9016858442937441,0.6323529411764706,0.9622057934897836,1.0,4/27,11.74%,BRCA1;WDR54;LRPAP1;PINK1
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.5776406323067937,-0.9016622006062964,0.6610169491525424,0.9619938033092174,1.0,1/8,0.94%,DUSP1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.2970288720269794,0.9013624423248504,0.9411764705882353,0.9881924633466916,1.0,26/163,14.81%,RGCC;HMMR;PSMD10;PSMA1;RIOK2;PSMD11;ANAPC1;CUL1;PSMB5;FBXO5;ERCC2;HAUS1;CSNK1E;CEP290;CEP152;BTRC;PLK1;PCM1;UBE2D1;PSMD14;ERCC3;ALMS1;PSMD12;CDC26;CEP192;TUBG1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),-0.49959221299957307,-0.9011777583548398,0.6,0.96272671124827,1.0,1/15,1.45%,TGFBR2
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,-0.3922401082415928,-0.9011638690222945,0.6153846153846154,0.9624680168989769,1.0,4/46,7.83%,ST6GAL1;RPS27A;PARP14;PARP9
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.5158968729711529,0.9010892549329164,0.6,0.9884239264106381,1.0,4/12,19.36%,LIMD1;EDC3;RC3H1;PATL1
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.38734407846562896,0.9010684289270986,0.6538461538461539,0.9879463513674988,1.0,5/32,9.61%,DNA2;PRIMPOL;RFWD3;SMARCAL1;ATR
prerank,KEGG_2021_Human__Systemic lupus erythematosus,-0.4274892559246061,-0.9010340917712021,0.6376811594202898,0.9624674876509883,1.0,4/38,6.44%,C3;C1R;GRIN2A;HLA-DRA
prerank,CellMarker_Augmented_2021__Neutrophil:Bronchoalveolar System,-0.462162195256979,-0.9009019461630982,0.6376811594202898,0.9622030826169777,1.0,9/24,13.52%,TJP3;CEACAM1;TMC4;TGFA;CAPN8;IL18;LIPH;KPNA7;CXCL17
prerank,CellMarker_Augmented_2021__Neutrophil:Sputum,-0.462162195256979,-0.9009019461630982,0.6376811594202898,0.9622030826169777,1.0,9/24,13.52%,TJP3;CEACAM1;TMC4;TGFA;CAPN8;IL18;LIPH;KPNA7;CXCL17
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex4:Brain,-0.5450428121946151,-0.9008783363590105,0.6666666666666666,0.9619777552425828,1.0,2/10,7.37%,ANXA1;PAPSS2
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),-0.5562756884835055,-0.9008609841585885,0.6379310344827587,0.9617224028443145,1.0,3/7,16.53%,SULF1;MYO1E;MCAM
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,0.31177826009470755,0.9007031614467336,0.6666666666666666,0.9884099780194664,1.0,44/359,13.86%,FGF6;KSR2;SEM1;NCSTN;FLT3;PSMD10;DERL2;SPRED1;NRAS;PSMA1;DUSP6;MAML3;PSMD11;TRIM24;KAT2B;EGFR;AKT2;CDK8;CUL1;FZD8;YES1;AKT1;GTF2F2;PSMB5;CNKSR1;VCP;STRN;LMO7;WDCP;ERBB4;ATIC;CPSF6;HEYL;AP3B1;PSMD14;SHOC2;PPP2R5A;PPP1CC;KAT2A;SPRED2;PIK3CA;PSMD12;KANK1;TENT4A
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.44203704889163337,0.9006175163085283,0.5384615384615384,0.9881476432354648,1.0,7/14,37.37%,PCBP4;RBMX;SRSF9;PTBP1;SAP18;U2AF2;SFSWAP
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),-0.4961813240886971,-0.9005448234089855,0.5882352941176471,0.9621989899808375,1.0,3/15,16.07%,CHST4;CHST6;MGAT3
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.43682387987055044,0.9005227566368558,0.5789473684210527,0.9878623732701793,1.0,7/18,31.04%,EIF3M;DENR;EIF2D;EIF2S3;EIF5;EIF2B3;EIF4A2
prerank,Reactome_2022__Purine Catabolism R-HSA-74259,0.44789512633515355,0.9003307318674142,0.6,0.9877977174588575,1.0,3/12,18.95%,NT5C1A;NUDT15;NUDT9
prerank,CellMarker_Augmented_2021__T Helper cell:Eye,-0.4494810698916751,-0.9003020383341636,0.6612903225806451,0.962157004060134,1.0,8/28,10.15%,MYO1F;GPR183;TAGAP;SLA;SIGLEC1;ARHGAP9;CLEC12A;CTSS
prerank,CellMarker_Augmented_2021__T Helper cell:Salivary Gland,-0.4494810698916751,-0.9003020383341636,0.6612903225806451,0.962157004060134,1.0,8/28,10.15%,MYO1F;GPR183;TAGAP;SLA;SIGLEC1;ARHGAP9;CLEC12A;CTSS
prerank,Reactome_2022__Apoptosis R-HSA-109581,-0.35695081660668865,-0.9002990059839292,0.6781609195402298,0.9618772535861392,1.0,28/150,18.80%,APIP;CDKN2A;RPS27A;NDUFA2;SEPTIN4;YWHAH;PSMB9;LMNB1;PPP3CC;PSMB6;UNC5B;PRKCQ;BMX;PSMC3;UBC;FADD;NMT1;PSMA8;PRKCD;PSMA7;FASN;PSME1;DAPK3;MAPT;GSDME;PLEC;TNFRSF10A;BBC3
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.42098829887439065,-0.9001152313091345,0.6417910447761194,0.9620219901664777,1.0,8/45,13.20%,OVOL2;MSX2;ABCA12;CCND1;BAIAP2L1;AMOTL2;EMP2;RHBDF1
prerank,Reactome_2022__ChREBP Activates Metabolic Gene Expression R-HSA-163765,0.5472116441095513,0.9000263479458166,0.6666666666666666,0.988092417233154,1.0,1/6,5.97%,ACACB
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,-0.3800897844915926,-0.8999692138878154,0.7160493827160493,0.9620352771647858,1.0,17/62,25.65%,GNG3;TRPC3;ITPR3;SLC8A3;GNG2;GUCY1A1;KCNMB4;PDE5A;P2RX6;PDE1A;ITPR1;P2RX7;GNB4;GNB5;PECAM1;PRKG2;SLC8A2
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.4364219056595301,0.8999241846578727,0.5348837209302325,0.987755484521244,1.0,3/17,8.31%,CHRNA4;KCNA2;SYT3
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.5571425056859354,-0.89985830342773,0.6037735849056604,0.9619993090773217,1.0,3/6,24.39%,UBXN1;AQP11;SVIP
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.42871073302299717,-0.8998519149042864,0.647887323943662,0.9617527549002413,1.0,4/32,7.79%,ABCA5;ABCA8;AKR1C1;LDLR
prerank,Reactome_2022__G Beta:Gamma Signaling Thru BTK R-HSA-8964315,-0.50804865130585,-0.8997456747804008,0.6825396825396826,0.9617004845907425,1.0,4/11,22.72%,GNG3;GNG2;GNB4;GNB5
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.5923854025339713,-0.899745132316812,0.6333333333333333,0.9611396659328029,1.0,4/6,33.97%,DPAGT1;DHDDS;MVD;DOLK
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.5923854025339713,-0.899745132316812,0.6333333333333333,0.9611396659328029,1.0,4/6,33.97%,DPAGT1;DHDDS;MVD;DOLK
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.47366629236274743,0.8995378906868069,0.6153846153846154,0.9881425299996139,1.0,5/15,20.90%,USP13;NCK1;PIK3R1;ERN1;BCL2L11
prerank,CellMarker_Augmented_2021__Lymphocyte:Undefined,-0.4434923557476982,-0.8995345234077707,0.6290322580645161,0.9612815898423617,1.0,9/25,14.75%,TAGAP;IRF1;GPR171;GAB3;CTSS;HLA-E;P2RY10;APOL3;SRGN
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.38734347771159783,-0.8994391134760898,0.6625,0.961207669497498,1.0,18/78,24.63%,TYMS;HAP1;RPL13A;PATL2;IGF1;IGFBP5;SAMD4A;RTN1;ORMDL2;RTN2;DAPK3;SHMT1;RTN4;EIF4A3;EIF2AK2;ENC1;EIF4ENIF1;SPHK1
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,0.335986478792941,0.8993712542783164,0.6956521739130435,0.9880605048448351,1.0,11/78,12.98%,EPHA6;NCSTN;EFNA2;EFNB2;GIT1;YES1;AP2B1;ARHGEF28;EFNA5;EPHB4;WASL
prerank,Reactome_2022__Alpha-protein Kinase 1 Signaling Pathway R-HSA-9645460,-0.5361521712883581,-0.8992870597308487,0.5625,0.9612211637629846,1.0,3/10,17.47%,RPS27A;UBC;ALPK1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Undefined,-0.5012600762336041,-0.8992608306742428,0.5806451612903226,0.9610108266154,1.0,4/10,12.97%,PODXL;KLF4;CD9;GPC3
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3829754005025744,-0.8991402712895695,0.6463414634146342,0.9609998117666829,1.0,14/86,17.95%,SKOR1;TGFBR2;RPS27A;ADAMTSL2;ASPN;VWC2;EID2;LDLRAD4;UBC;VEPH1;VASN;SNX6;LRP2;TGFB1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.4258832755240125,0.8991302995507557,0.6428571428571429,0.9881462751749212,1.0,7/16,16.11%,GDAP1;MFF;SLC25A46;OPA1;DNM3;MUL1;MTFR1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.3765638687763667,0.8991231337531899,0.6428571428571429,0.9876539364353615,1.0,9/32,17.26%,VCP;GLRB;TRPV1;DERL1;DRD2;DHFR;KAT7;RCN3;RHBDD1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.4447817829169476,-0.8991154480786824,0.6619718309859155,0.9608142140262323,1.0,4/25,13.10%,ARG2;CYP1B1;NOS1;GCHFR
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3009926592845521,0.8990885558554058,0.7857142857142857,0.9872603131576342,1.0,26/153,14.58%,BET1;GOLT1A;PEF1;TMED5;TMEM115;PGAP1;SEC22B;TRAPPC11;TRAPPC12;KLHL12;RAB1B;COG6;ATL2;ANK2;ERGIC3;TRAPPC8;COPB2;VTI1A;VAPA;CAPZA1;SCFD1;CNIH1;SEC24A;DCTN5;VAPB;TMED3
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.4864107623053623,-0.899020079892274,0.6612903225806451,0.9607187211259518,1.0,5/25,15.79%,STMN2;PFN2;KANK3;PRKCD;STMN1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.5783359724149506,-0.8989782266094272,0.6296296296296297,0.960538766783744,1.0,2/6,17.95%,EID2;TGFB1
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.5916777073278291,-0.898894999263404,0.6346153846153846,0.960457038021748,1.0,1/5,3.76%,MAOB
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.4264788655496031,-0.898822184670776,0.6119402985074627,0.9603590083890899,1.0,13/38,27.52%,TMC8;KIF14;RPL13A;LDLRAD4;HSPA5;NLRC3;PMEPA1;SVIP;HDAC6;NOP53;ANKRD27;ULK1;SMAD6
prerank,Reactome_2022__Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,-0.488063429384478,-0.8988141653531615,0.6212121212121212,0.9601030454797181,1.0,2/15,12.77%,RPS27A;UBC
prerank,CellMarker_Augmented_2021__CD4-CD28+ T cell:Peripheral Blood,-0.5547446516375475,-0.8987317542613589,0.6382978723404256,0.9597113528545889,1.0,2/5,25.05%,PTPRC;FAS
prerank,CellMarker_Augmented_2021__CD4-CD28- T cell:Peripheral Blood,-0.5547446516375475,-0.8987317542613589,0.6382978723404256,0.9597113528545889,1.0,2/5,25.05%,PTPRC;FAS
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,-0.44224529670007223,-0.8986096563853264,0.6521739130434783,0.959711632480903,1.0,3/27,7.25%,SPARC;PGR;GFAP
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Blood,-0.5690172879042592,-0.8985628014493643,0.5961538461538461,0.9595377809824256,1.0,2/7,17.25%,CD44;TEK
prerank,CellMarker_Augmented_2021__Osteoblast:Bone,-0.5322335748880663,-0.8983832821229268,0.6666666666666666,0.959584351112206,1.0,4/14,13.93%,THY1;CD44;RUNX2;PTH1R
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.35445887539595294,0.8981247379482908,0.6071428571428571,0.9891479499965496,1.0,7/41,9.38%,POLD3;PRIMPOL;RFC3;UBE2N;VCP;WDR33;MSH2
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.377522819922799,-0.8981076581535168,0.64,0.9598973766483442,1.0,10/75,17.67%,LEF1;RPS27A;PSMB9;PSMB6;PSMC3;UBC;PSMA8;PSMA7;PSME1;RBX1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.42098635839030907,-0.8980333418884675,0.6376811594202898,0.9597779913705003,1.0,4/26,12.78%,ICAM1;BRCA1;TMBIM1;FADD
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.447025073006446,-0.8979953177069979,0.676923076923077,0.9595771469089609,1.0,1/23,1.55%,SUV39H1
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.5942729050513705,-0.8979455626869629,0.6610169491525424,0.959384569956254,1.0,1/5,18.14%,MAPT
prerank,Reactome_2022__Atorvastatin ADME R-HSA-9754706,-0.5794838036461188,-0.8976244558730571,0.6842105263157895,0.9597190173899106,1.0,2/6,13.02%,ABCB1;CYP3A4
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.43362966807685344,-0.8975397059189226,0.6301369863013698,0.9596161145685939,1.0,10/28,25.61%,RAMP3;SYT1;RIMS2;GRIK2;ANXA2;CLSTN2;RIMS1;ECE1;WLS;RIMS3
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.35997923947266647,-0.8974014037983016,0.6923076923076923,0.9595919910269654,1.0,23/124,18.28%,TYMS;CDKN2A;RPS27A;POLE3;PTK6;CCND1;PSMB9;POLE4;RPA3;CCNB1;PSMB6;PSMC3;CCNE2;UBC;CDK2;CCND2;MAX;PSMA7;CDC7;WEE1;PSME1;CDKN2D;CDKN1A
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.4436772369355629,-0.8972297725174008,0.5970149253731343,0.9596927104210996,1.0,5/23,8.14%,RIMBP2;ALDOB;GC;SLC18A2;PLPPR1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.4247651301309723,-0.8970431077681992,0.6153846153846154,0.9598367773415123,1.0,4/32,9.67%,ZFP36;GATA1;ZFPM1;STAT1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.32283912483917043,0.8969346919226849,0.8,0.9913684050260828,1.0,15/97,12.57%,GNL3L;PSMD10;BCL10;HSPA1A;TNFAIP3;BAG2;UBE2N;AKT1;COMMD1;DCUN1D1;UBE2D1;RCHY1;SASH1;DERL1;PRMT3
prerank,Reactome_2022__Degradation Of Cysteine And Homocysteine R-HSA-1614558,0.43669595170335085,0.8969021242170746,0.6046511627906976,0.9909561870363426,1.0,3/10,13.88%,SUOX;CSAD;ADO
prerank,Reactome_2022__Abacavir Transmembrane Transport R-HSA-2161517,-0.5825603892609342,-0.89689438497034,0.6774193548387096,0.959899397671974,1.0,3/5,22.80%,ABCB1;ABCG2;SLC22A1
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.41710490557169555,-0.8968082463939536,0.6323529411764706,0.959802014592835,1.0,9/34,20.37%,TP53I3;STEAP3;NDRG1;BCL2L14;FASN;BCL6;TNFRSF10A;BBC3;ZNF420
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,-0.40066032138339547,-0.8963300710670624,0.6493506493506493,0.9604500803411657,1.0,16/45,22.72%,KCNJ2;ADCY7;GNG3;GABRB2;ADCY5;GNG2;GABRG2;GABRA1;ADCY8;GABBR2;GABRA6;GABRG3;GABRA3;KCNJ6;GNB4;GNB5
prerank,CellMarker_Augmented_2021__Stromal cell:Bone Marrow,0.49271359671136744,0.8962734357479802,0.6578947368421053,0.992141436183629,1.0,2/10,7.46%,ITGA1;ALCAM
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.4971404825996023,-0.8962570838040076,0.6417910447761194,0.9603607230471484,1.0,3/14,12.57%,PLK2;BRCA1;CEP76
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),0.4428837279493938,0.8962511188739116,0.5666666666666667,0.9917061939900379,1.0,4/17,15.55%,NCSTN;VCP;MAPK12;RCN3
prerank,Reactome_2022__Cellular Hexose Transport R-HSA-189200,-0.5078152057819827,-0.8961795858389292,0.6333333333333333,0.960238910347667,1.0,5/14,27.47%,SLC5A4;SLC50A1;SLC5A10;SLC5A9;SLC2A3
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.4652641114654036,-0.8960505514084397,0.625,0.9602038293826997,1.0,6/19,16.72%,SLC51A;AKR1C1;CEACAM1;SLC51B;SLCO1A2;ATP8B1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.3403906259178456,-0.8960214278898576,0.8172043010752689,0.9599765455143834,1.0,74/391,19.00%,THBS1;TRIM22;MET;P2RY12;TLR2;NOS1AP;PTP4A3;TRIM5;PLK2;RAMP3;IFI35;NLRP12;APP;HTR2B;NOD1;LRRC19;TLR3;BST2;SEPTIN4;HEXIM1;EGF;RIT2;CHI3L1;NEUROD2;IGF1;THPO;WNT5A;TGFA;FGF1;UNC5B;BIRC3;DAB2IP;FN1;SELP;DDX60;PINK1;IL18;SHISA5;TNIP2;MAP3K14;F10;FADD;FGF7;TNFRSF1A;NLGN1;APOL3;RPS15;PIK3CB;BOK;CD74;LTBR;VAV1;RELN;PIK3CD;HLA-DRB1;F3;FGF22;RPL23;IRS2;PRKCB;TEK;ALPK1;GPER1;RIPK2;LRP2;NMI;TGFB1;CARD11;NUPR1;GSDME;RPS20;CD4;BBC3;PDGFRA
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.4429647720721219,-0.8960134640069176,0.6142857142857143,0.959711501377022,1.0,2/23,5.04%,TRAM1L1;APP
prerank,Reactome_2022__Chondroitin Sulfate Biosynthesis R-HSA-2022870,0.42047720167648517,0.895992387937443,0.7096774193548387,0.9919798318313213,1.0,5/19,8.12%,CSPG5;CHST11;CSGALNACT1;CHST7;BCAN
prerank,Reactome_2022__Sema4D Mediated Inhibition Of Cell Attachment And Migration R-HSA-416550,-0.5587186486895482,-0.8959880632113428,0.7,0.9594790806118317,1.0,3/8,28.20%,RNASE1;RRAS;RNMT
prerank,CellMarker_Augmented_2021__Plasma cell:Undefined,-0.5021224243148676,-0.8959223610679108,0.5689655172413793,0.9593820453812116,1.0,2/9,11.32%,CD9;PRDM1
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.5526212236501821,-0.8957732269671723,0.6271186440677966,0.9594365033051079,1.0,3/8,11.93%,CHI3L1;ST3GAL6;SBNO2
prerank,KEGG_2021_Human__Thermogenesis,0.29524140099573315,0.8957471699389331,0.8181818181818182,0.9920574628706981,1.0,35/176,16.77%,UQCRHL;NDUFC2-KCTD14;PPARGC1A;PLIN1;NRAS;ADCY1;COX18;NDUFB1;COX10;NDUFAF3;PRKAB1;SIRT6;DPF1;PRKACB;CPT2;NDUFAF4;NDUFAF2;COX11;ATP5PB;PRKG1;MAPK12;ATP5MC2;COX19;NDUFV3;NDUFA8;RPS6KA3;ADCY10;MGLL;ATP5MC1;COX7A2L;UQCRC2;SMARCA2;ATP5F1A;CPT1A;ACSL3
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.42418232229461883,-0.8956204204316359,0.6323529411764706,0.9594665986427586,1.0,7/34,17.95%,CEMIP;APP;EGF;CHI3L1;DMTN;RIPK2;TGFB1
prerank,CellMarker_Augmented_2021__AXL+SIGLEC6+ Dendritic cell:Blood,-0.4111861192911007,-0.8955465945086362,0.6533333333333333,0.9593426247541631,1.0,11/62,12.25%,S100A10;CD5;SCN9A;SIGLEC1;KLF4;TBC1D9;BAIAP2;MYH11;NDRG1;RUNX2;MYO1E
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.37168347733850665,-0.895331252910245,0.625,0.9595213332487399,1.0,19/84,17.25%,HPN;NR4A3;LAMB1;PROX1;HTR2B;EGF;IGF1;WNT5A;TGFA;FGF1;FGF7;VIP;EGFL7;NR4A1;HYAL1;PIK3CD;PTPRN;F3;TEK
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.5218232485708756,-0.895219156141405,0.6818181818181818,0.9594973559224393,1.0,6/12,19.00%,ALOX12;CEACAM1;CD9;C1QTNF1;PRKCD;PDGFRA
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR3 R-HSA-5654227,-0.5950272555890533,-0.8952051911537768,0.6724137931034483,0.9592438656649922,1.0,1/6,10.73%,FGF1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.5660803062515039,0.8950028508287865,0.6052631578947368,0.9932972844860396,1.0,4/6,38.35%,DCP1A;DDX1;DDX3X;DHX9
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.5661033187592985,-0.8947501961209634,0.6964285714285714,0.959932659477747,1.0,3/6,34.46%,RAB3A;CAST;PCLO
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,0.3055766404852111,0.8945707012916455,0.7391304347826086,0.9938342395037009,1.0,30/133,14.94%,SEM1;NUP42;ABCA1;PSMD10;DERL2;NUP37;PSMA1;PSMD11;BSG;ABCD1;NUP54;PSMB5;VCP;SLC3A2;HEPH;SLC26A3;SLC4A4;NDC1;MAP4K5;PSMD14;ABCC2;NUP214;MAP4K2;DERL1;PSMD12;SLC26A2;SLC22A5;SLC24A4;AAAS;NUP188
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.4857429348656853,-0.8945643710937216,0.640625,0.9600489190920377,1.0,3/20,12.44%,SP100;APOD;DMTN
prerank,Reactome_2022__Synthesis Of Pyrophosphates In Cytosol R-HSA-1855167,-0.5299682737974014,-0.8944698854396289,0.5967741935483871,0.9599546696202339,1.0,2/8,24.67%,NUDT4;NUDT11
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5491874329747689,-0.8943208606936685,0.5964912280701754,0.9599683623359018,1.0,4/7,29.43%,WNT5A;WNT3;WNT9B;CTNNB1
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.49153440077509225,0.8943113539672053,0.5510204081632653,0.9940027796477409,1.0,2/10,6.30%,LIG4;RABL3
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,-0.38699730720631803,-0.8940444576346077,0.6805555555555556,0.9603029201804899,1.0,25/79,19.50%,SLC6A15;SLC17A5;SLC32A1;SLC24A1;SLC4A9;SLC38A4;SLC9A2;SLC8A3;SLC3A1;SLC7A2;SLC24A5;SLC43A2;SLC20A2;SLC38A1;SLC4A2;SLC25A26;SLC12A7;SLC4A10;SLC9A5;CTNS;SLC15A4;SLC7A7;SLC25A29;SLC1A6;SLC17A7
prerank,Reactome_2022__Regulation Of HMOX1 Expression And Activity R-HSA-9707587,-0.5829330703311224,-0.8940382421200624,0.6545454545454545,0.9600415497809581,1.0,1/5,9.81%,MAFK
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.5469462684670447,-0.8939328750945669,0.6296296296296297,0.9599716650516849,1.0,4/10,18.14%,NEFL;HAP1;SYBU;MAPT
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,-0.4738820145817473,-0.8939203805887234,0.603448275862069,0.9597159294803432,1.0,3/14,17.41%,LFNG;ST3GAL6;NOTCH3
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.395321756772137,0.8938241392008505,0.64,0.9946652241082223,1.0,2/26,4.15%,WNT7A;NLGN3
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.5215249667125599,0.8936765570055719,0.6190476190476191,0.9945460650438783,1.0,2/8,12.23%,POMK;FGGY
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.3986503310865087,-0.8935933504400806,0.75,0.9601390526034115,1.0,16/78,20.29%,SCN1B;STMN2;VLDLR;PTK6;RIT2;PLPPR5;WNT5A;DAB2IP;FES;BDNF;RELN;LRRC7;ALK;DPYSL3;CX3CL1;CAMK1D
prerank,CellMarker_Augmented_2021__Sertoli cell:Seminal Plasma,-0.404325006136369,-0.8935548453545967,0.6447368421052632,0.9599426518056046,1.0,7/48,8.14%,CP;PROX1;MAOB;ACSM5;SERPIND1;ANGPTL3;PLPPR1
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,-0.407248355044378,-0.8935047446376122,0.6666666666666666,0.9598001992312498,1.0,11/51,15.79%,SPARC;PGR;RPS27A;GFAP;EGF;GABRB2;UBC;GABRG2;APH1A;GABRA1;STMN1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.37634542156786965,-0.8935035537117811,0.7215189873417721,0.9595232805355687,1.0,20/73,18.31%,CCNB2;CDKN2A;BLM;PSRC1;PROX1;CCNI2;CCND1;HEXIM1;GADD45A;CCNB1;CCNE2;TFAP4;HERC5;CDKN3;CCND2;CDC37;CDKN2D;CCNF;CDKN1A;SPDYA
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.5813662859066431,-0.8934887382351797,0.6153846153846154,0.9592868744392213,1.0,2/5,23.00%,SPI1;TAF7
prerank,Reactome_2022__Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,0.40462391730279834,0.8934818541016274,0.6097560975609756,0.994524593765238,1.0,5/19,8.12%,CSPG5;SDC4;SDC3;GPC5;BCAN
prerank,"Reactome_2022__Defective CHST14 Causes EDS, Musculocontractural Type R-HSA-3595174",-0.5324115280844146,-0.8934176169776795,0.6612903225806451,0.9591662495038967,1.0,2/8,5.96%,CSPG4;BGN
prerank,CellMarker_Augmented_2021__Cholinergic neuron:Undefined,0.351444945643957,0.8933499222229074,0.42857142857142855,0.9943310540853235,1.0,6/77,2.06%,SPSB4;CHRNA4;ASCL1;EFNA2;TMEM229A;ADGRA1
prerank,Reactome_2022__CREB Phosphorylation R-HSA-199920,-0.5382139640204877,-0.8932380056204777,0.625,0.959325312597323,1.0,1/6,8.87%,RPS6KA1
prerank,Reactome_2022__Defective CHSY1 Causes TPBS R-HSA-3595177,-0.5333875926648662,-0.8931948602105414,0.6417910447761194,0.959126798040196,1.0,2/8,5.96%,CSPG4;BGN
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.3538176270929807,-0.8931513380728895,0.6976744186046512,0.9589122753272967,1.0,30/257,15.68%,TYMS;APLNR;POU4F1;PGR;ZFP36;CENPV;GPNMB;OVOL2;SH3GL2;NLRP12;APP;KLF4;PARP14;PARP9;RPL13A;PATL2;IGF1;RPS13;PINK1;PTRH2;IGFBP5;SLC11A1;CCDC3;SRGN;SFRP2;MSR1;NUDT16;SAMD4A;APLN;DDRGK1
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",0.4289698289783517,0.8929511126290401,0.59375,0.9950149259416154,1.0,6/17,17.60%,PPEF1;GUCA1B;NMT2;METAP1;CAMKMT;GNGT1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.505823058373943,-0.8929471715821622,0.6515151515151515,0.9590578425499653,1.0,3/10,17.28%,S1PR3;TNFRSF1A;VCL
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.5550498080566824,0.8928031044642729,0.725,0.9948557172869176,1.0,2/5,38.73%,PTEN;LRRK2
prerank,Reactome_2022__Killing Mechanisms R-HSA-9664420,-0.5389991865726507,-0.8926529075380696,0.671875,0.9594772512952815,1.0,3/9,13.87%,WNT5A;RNASE1;NOXA1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.37743802818230243,-0.8926116772166605,0.6842105263157895,0.9592762368043309,1.0,18/99,18.28%,CDKN2A;PSRC1;TP53TG5;BST2;FBP1;TSPYL2;BTG1;CRLF3;MT1H;SLIT3;HYAL1;SFRP2;TCHP;PML;BCL6;TGFB1;CDKN2D;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.4727218418052448,-0.8924851683712817,0.6078431372549019,0.9590113992661139,1.0,1/12,1.22%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.4727218418052448,-0.8924851683712817,0.6078431372549019,0.9590113992661139,1.0,1/12,1.22%,GBP1
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.45100752508101855,0.8923583204667461,0.6111111111111112,0.9953037995786165,1.0,7/16,20.08%,PI4K2A;PIK3R4;MTMR10;PIK3C3;FIG4;PIK3C2A;PIKFYVE
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.5247130806986953,0.8921930088783679,0.5961538461538461,0.9952762750769504,1.0,2/6,24.00%,STIM2;STIM1
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,0.34381624222382445,0.8921171184639297,0.75,0.9949397979567829,1.0,9/62,14.81%,HAUS1;CSNK1E;CEP290;CEP152;PLK1;PCM1;ALMS1;CEP192;TUBG1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.36060807104180165,-0.8920611959928811,0.6551724137931034,0.9596717596580514,1.0,12/141,11.74%,ENPP2;SCX;VLDLR;BASP1;VIL1;NEUROD2;SRF;RPS6KA1;NLRP5;WNT5A;DAB2IP;PINK1
prerank,CellMarker_Augmented_2021__FGFR1HighNME5- Epithelial cell:Esophagus,0.29532654376667566,0.8920074722255867,0.8571428571428571,0.9946036603695322,1.0,24/160,14.17%,ACP3;DCHS1;SDHAF4;JAM2;KCTD15;CA2;ELOVL6;AOX1;CSAD;GAS1;PI15;ZFHX4;ZNF587;ZSCAN22;GARNL3;ZNF761;PCDH9;GABBR1;IKBIP;TMEM132A;FECH;GALT;FLRT2;ADAM22
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.5167822669202536,-0.8917215365010184,0.578125,0.9601654760367484,1.0,2/9,13.10%,ZIC1;PAX8
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.5398684695054423,-0.891649911495829,0.6197183098591549,0.9600449799524416,1.0,1/10,1.31%,TYMP
prerank,CellMarker_Augmented_2021__Neural Crest cell:Germ,-0.3789910641326343,-0.8914485323011153,0.6296296296296297,0.9602140083142751,1.0,18/88,17.19%,RASGRP2;ADAMTS10;CDH23;LZTS1;C10ORF105;LRRC4;GFRA2;IFFO1;NELL2;AEBP1;GNG2;ELMO1;WDR86;JPH4;CCND2;SH2D3C;GALNT8;PRKCB
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,-0.3691401836063266,-0.8912546150739804,0.7692307692307693,0.9603239934044462,1.0,17/116,17.58%,SCN1B;KCNQ1;ADCY7;PLN;ATP1A1;ATP1B1;SLC8A3;CREB5;CACNA1C;ADCY5;TPM4;CACNB1;ADCY3;ADCY8;RYR2;PPP1R1A;CREB3
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.4974971980285853,0.8911039882513274,0.6097560975609756,0.9963142214761648,1.0,1/8,2.65%,MTTP
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.4317576808095057,0.8910976704264355,0.5625,0.9953103784318562,1.0,1/14,2.52%,FHDC1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.4317576808095057,0.8910976704264355,0.5625,0.9953103784318562,1.0,1/14,2.52%,FHDC1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.5067919225059283,-0.8907222600096997,0.696969696969697,0.961210709690334,1.0,2/15,3.62%,POU4F1;RAMP3
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.4031648047061161,-0.8906951006405143,0.6376811594202898,0.9609963277643726,1.0,3/40,5.06%,L1CAM;SHTN1;SLITRK1
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,0.327065848307472,0.8906610903537789,0.625,0.9959507058796903,1.0,7/75,6.89%,SEM1;TNFSF13B;PSMD10;PSMA1;PSMD11;CUL1;PSMB5
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),-0.5825491958626812,-0.8905417800559517,0.7,0.9610658376481083,1.0,1/5,21.31%,ST6GALNAC3
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,-0.39412979282660787,-0.8905103889731941,0.6329113924050633,0.9608837358689172,1.0,12/61,19.36%,ARHGEF3;DEPDC1B;ANLN;ARHGAP39;ARHGEF17;ARHGDIG;FLOT1;DLC1;MCAM;ERBIN;RHPN2;MYO9A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Skin,0.3141819238868723,0.8905041545502247,0.7142857142857143,0.9957061786775424,1.0,14/85,11.65%,PCDH19;CXXC4;TSPAN11;SOX21;FREM2;LRRN1;MAPK10;PBX1;MEGF10;FOXJ1;ERBB4;NRXN1;GPM6B;SALL3
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,0.331140738769819,0.8904910411360337,0.6,0.9952395307107503,1.0,10/48,15.34%,NRAS;AKT2;MAPK10;AKT1;PLA2G4C;MAPK8;MAPK12;PIK3CA;PIK3R1;MAP2K4
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,0.3989142801395896,0.8897474289151123,0.6666666666666666,0.9964887044302974,1.0,3/40,2.60%,ABCA1;PLIN1;KDM1B
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.47875752677257677,-0.8897132011045176,0.6779661016949152,0.9623070551980326,1.0,3/17,3.84%,CD5;TAGAP;GPR171
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.417248436924002,0.8892807070049134,0.6153846153846154,0.9971955044437597,1.0,3/18,9.92%,NRAS;EGFR;ERBB4
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.3357336709886353,0.8891911022665874,0.7307692307692307,0.9969451501732016,1.0,5/59,6.93%,SPSB4;MEX3A;PLEKHG4B;PHC1;DNMT3B
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.3728751842515271,-0.8891862279644182,0.6746987951807228,0.9630742418633039,1.0,17/107,12.84%,COL4A1;COL4A2;SEMA3B;PLP1;LRRTM1;THY1;GFRA2;LMOD1;MAP1B;EFNB3;SCARA3;EDIL3;NUAK1;DAB2IP;IGFBP5;TUSC3;AMOTL2
prerank,Reactome_2022__Defective C1GALT1C1 Causes TNPS R-HSA-5083632,0.4951384423277905,0.8891214369266311,0.6041666666666666,0.9965869322696151,1.0,3/6,19.60%,MUC20;C1GALT1;C1GALT1C1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.40445741579291594,0.8889651738463447,0.6111111111111112,0.9964793197787579,1.0,9/22,17.28%,SLC26A7;CA2;SLC39A8;SLC4A7;SLC4A4;CYB5R4;CA3;CYB5R1;CA12
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4045269703240833,0.8888637899967389,0.6896551724137931,0.9961899094516967,1.0,4/16,6.69%,RGCC;PSMD10;EGFR;AKT1
prerank,GO_Biological_Process_2021__positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),0.5580945361041071,0.8888307136431817,0.6842105263157895,0.9957757917285317,1.0,1/5,2.48%,MYORG
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.2881705037247755,0.8887447567071955,0.7692307692307693,0.9955267758768455,1.0,28/223,13.90%,OTUD3;KDM1B;PSMD10;CDC25A;TNFAIP3;PSMA1;PSMD11;KEAP1;KAT2B;USP13;BRCC3;USP38;USP40;USP12;PSMB5;INO80D;VCP;AR;YY1;USP27X;OTUB2;UBE2D1;PSMD14;NFRKB;ADRB2;KAT2A;PSMD12;DESI2
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,0.38006810233506066,0.8886960864416659,0.6363636363636364,0.9952098972261173,1.0,5/20,16.53%,STK4;CASP3;DVL2;AMOTL1;MOB1B
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.46540525024653034,-0.8886385577773016,0.6212121212121212,0.9640388641534422,1.0,8/21,31.04%,CAV3;VAV1;RARG;RDX;DEPTOR;VAV2;MSN;PLEK
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.49920038942513756,0.8885819124383113,0.627906976744186,0.9950124724441247,1.0,2/8,17.77%,GREM1;ECM1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.4699259746892624,-0.8884644674929134,0.6984126984126984,0.9640940362515735,1.0,1/23,0.55%,PIF1
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.39820516825913826,-0.8884362145296875,0.647887323943662,0.9639006378396483,1.0,4/33,7.79%,RIMBP2;PLB1;AKR1C1;LDLR
prerank,CellMarker_Augmented_2021__Endothelial cell:Liver,-0.4055950252956966,-0.888277154281944,0.6712328767123288,0.9639424594462158,1.0,14/56,18.56%,IL1R1;FOSB;F8;BST2;LDB2;RASGEF1B;DLC1;RELN;MGAT5;KLHL28;MCAM;HYI;MRC1;CD4
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.39239046135139644,-0.8881390211245518,0.6578947368421053,0.9639789152387856,1.0,7/56,15.13%,HPN;RFTN1;MMP14;RPS6KA1;HYAL1;MFSD2A;SFRP2
prerank,CellMarker_Augmented_2021__Oogenesis Phase Fetal Germ cell:Fetal Gonad,-0.3246422017708555,-0.8881366688896928,0.87,0.9637136214063478,1.0,114/708,17.40%,EPN1;CCBE1;RASGRP1;RFTN1;MAEL;MYOF;ANK3;BCAS1;SHTN1;KCNB1;SERPINF1;FAT2;STAG3;ELAVL2;IMPDH1;TESC;PHEX;COBLL1;FBLN7;SH3GL2;ARG2;ARHGAP15;CCNI2;DYSF;VLDLR;MAP1B;ACOT4;KCNH8;CALN1;SPOCK3;SBF1;HAP1;YWHAH;GLRX;ZNF215;LDHAL6A;FA2H;BAIAP2;CFAP58;BAIAP2L1;SLCO3A1;TMEM163;UNC13C;LRRK1;GADD45A;NLRP5;HERC6;NLRP2;PFN2;POLE4;STAT1;FBXW12;MINK1;WEE2;SH3GL3;FBXO32;FSD2;TGFA;EPSTI1;HHLA2;DNAH3;ADCY5;FN1;RADIL;MAP1LC3A;PSMG4;B3GNT2;GAD1;BAALC;MYO1E;GNG2;SNX30;MVP;POMZP3;ACOT2;SQLE;KPNA7;GSE1;ITGA9;RPA1;TDRD1;UBXN11;PCGF3;VEPH1;EMILIN2;C1S;SLC25A26;PRICKLE1;SEMA3E;SLC12A7;LSM11;SSR4;PDZD2;TTC39A;BOK;GRIK2;SAMD4A;PDGFRL;RASGRF2;RELN;MAN1A1;ITIH2;MAX;MICALL2;CDH17;FAR2;USP18;SLC29A4;TSC2;HIPK4;RCAN3;FBXL2;SH3KBP1;CHRNE
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.5396382444693397,-0.888056831808937,0.5862068965517241,0.9635979659274105,1.0,1/7,1.32%,GPR183
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.36021086954019943,-0.8877648160187103,0.6666666666666666,0.963906690065829,1.0,19/112,17.44%,RECQL4;BLM;RPS27A;HELB;POLE3;PSMB9;GINS2;POLE4;RPA3;PSMB6;PSMC3;UBC;RPA1;PSMA8;CDK2;PSMA7;CDC7;POLD1;PSME1
prerank,CellMarker_Augmented_2021__Stem cell:Endometrium,-0.5467762094992021,-0.8876291410837913,0.6984126984126984,0.963887089011691,1.0,2/9,10.74%,THY1;LGR5
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.4728537695531033,-0.8875589315097504,0.6716417910447762,0.9637581475878482,1.0,5/19,20.15%,BIRC3;FLOT1;CDC37;NUPR1;CASP8
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,0.3351161807895051,0.887438034854154,0.7777777777777778,0.9974916441991827,1.0,12/86,11.34%,SEM1;PSMD10;BCL10;TAB3;PSMA1;PSMD11;CUL1;UBE2N;PSMB5;BTRC;UBE2D1;PSMD14
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.4458511374834318,-0.8873662729386562,0.6119402985074627,0.9638159243335825,1.0,9/22,20.03%,IFI35;APP;DYSF;SYK;SBNO2;SLC11A1;NMI;MAPT;CX3CL1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.39101882619138134,0.8872408133654439,0.6875,0.9975143085357441,1.0,3/23,5.74%,POLD3;LIG4;RFC3
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.5355697346209014,0.8872235078502089,0.5319148936170213,0.9970667826599353,1.0,1/6,10.69%,NIPBL
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.2928471468885894,0.887104750393853,0.6875,0.9969197813768123,1.0,22/146,11.34%,RAD54B;SEM1;DNA2;LIG4;KPNA2;RFWD3;SMARCAD1;SMARCAL1;BRCC3;UBE2N;VCP;SMC6;YY1;DCLRE1B;RAD52;HMGB1;XRCC2;HUS1;TDP2;MAPK8;CYREN;PSMD14
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.48758389849338823,-0.8870570373224612,0.6428571428571429,0.9641722138216552,1.0,7/18,18.44%,PROX1;MMP14;IGF1;MYLK3;TGFB1;NIBAN2;AKAP6
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,0.33893554098587164,0.8869268146194883,0.6538461538461539,0.9968238579936436,1.0,12/72,11.34%,SEM1;PSMD10;PSMA1;PSMD11;ANAPC1;CUL1;PSMB5;FBXO5;BTRC;PLK1;UBE2D1;PSMD14
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,-0.35057159907396984,-0.8869197503836046,0.7386363636363636,0.9641978613401536,1.0,18/177,12.64%,AGPAT4;DGAT2L6;PLAAT4;MTMR7;PLB1;INPP5D;VAC14;SBF1;DDHD2;PLD2;PLEKHA4;LPCAT4;ACHE;BMX;LIPI;LIPH;SLC44A3;PITPNM2
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.45225305556900186,0.8868796261578198,0.6590909090909091,0.9964282523070622,1.0,1/13,13.72%,SMG7
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.48494627707551413,0.886764449955817,0.6,0.9962026422887341,1.0,2/7,7.99%,RCC2;SMC6
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovium,-0.5774768590455844,-0.8866870582485257,0.6610169491525424,0.9643167364628022,1.0,2/7,7.03%,THY1;CD44
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.47579903225375936,0.8865997948692586,0.5116279069767442,0.9961128704074032,1.0,2/8,5.13%,IL17D;SOX9
prerank,Reactome_2022__Zinc Transporters R-HSA-435354,0.47828019895243873,0.8864954221747475,0.6944444444444444,0.9958989378224755,1.0,4/11,5.68%,SLC39A10;SLC30A7;SLC30A6;SLC39A8
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.4261367519858965,-0.8864883017580159,0.6323529411764706,0.9644195638732734,1.0,2/32,2.70%,SOCS3;ITPKC
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.5051205259153874,0.8864690236078908,0.6578947368421053,0.9954537765143182,1.0,1/9,3.79%,RARB
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.466830739676468,0.8863000189238397,0.5555555555555556,0.9953419429941729,1.0,3/14,10.14%,PDK4;ADIPOR1;GNB3
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,0.34281678744218974,0.886160150619009,0.72,0.9951061560367931,1.0,12/68,11.34%,SEM1;PSMD10;PSMA1;PSMD11;ANAPC1;CUL1;PSMB5;FBXO5;BTRC;PLK1;UBE2D1;PSMD14
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.472502157376458,0.8861348745327268,0.6041666666666666,0.9946958720465895,1.0,1/7,7.52%,GMPS
prerank,CellMarker_Augmented_2021__Follicular Helper (Tfh) T cell:Undefined,-0.5548793162089743,-0.8860485232097195,0.6415094339622641,0.9650441910877161,1.0,4/7,22.98%,BCL6;CD4;IL12RB2;STAT3
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.3291293169179416,-0.8860112021669255,0.797752808988764,0.9648512942234312,1.0,34/385,13.10%,KLF2;LEF1;BLM;SP100;CIITA;PSRC1;SKAP1;IRF1;TESC;CASZ1;KLF4;SCX;DNAJC2;BRCA1;TEAD2;GATA1;YWHAH;ZIC1;PARP9;EGF;RPS6KA1;CRLF3;IGF1;STAT1;MLLT11;WNT5A;IRF7;CREB5;FOXM1;RUNX2;GLI1;NOS1;FGF7;PAX8
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.4460454577400927,0.885957805112186,0.5625,0.9946916222593278,1.0,4/11,29.88%,DNAJC13;MAP2K2;USP7;MAPK1
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,0.3520718197538657,0.8858938780224065,0.6451612903225806,0.9943607844440105,1.0,8/51,10.14%,ACE2;EXOC8;SLC30A7;SLC30A6;RAB27A;EXOC6;KCTD11;GNB3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.48966937246761244,-0.8858706219844873,0.7313432835820896,0.9648341350223498,1.0,1/18,0.55%,PIF1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.44332781988939907,-0.8858211538704509,0.5970149253731343,0.9646653504959125,1.0,6/21,20.46%,CD44;CD74;SFRP2;CDKN2D;ZNF385A;TAF9B
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.41166251047326685,0.8857798885031039,0.4838709677419355,0.9941934902114418,1.0,3/15,8.94%,AGER;JAM2;HMGB1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.4932035007039685,-0.8857759470052843,0.6949152542372882,0.9644727266658977,1.0,2/15,6.03%,TYMS;HROB
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.39662507698347704,-0.8857533554691042,0.6486486486486487,0.9642217201892823,1.0,8/38,19.43%,SEPTIN4;PINK1;BCL2L2;BOK;NUPR1;GSDME;BBC3;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.5473134762035043,0.8856175076537873,0.6904761904761905,0.9941219923297918,1.0,2/6,26.48%,NFKB1;RELA
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),-0.5786944976816009,-0.885561101492651,0.64,0.9643190535687288,1.0,1/5,3.77%,TJP3
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.4321946438766599,0.8855219944718609,0.6060606060606061,0.9933554187798945,1.0,9/19,32.38%,DBT;ACADSB;BCKDHB;HIBCH;HIBADH;ECHS1;IVD;HSD17B10;ALDH6A1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.4321946438766599,0.8855219944718609,0.6060606060606061,0.9933554187798945,1.0,9/19,32.38%,DBT;ACADSB;BCKDHB;HIBCH;HIBADH;ECHS1;IVD;HSD17B10;ALDH6A1
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Umbilical Cord Blood,-0.4865908203963271,-0.8850696617206021,0.6610169491525424,0.965003580094103,1.0,3/15,3.84%,CD5;TAGAP;GPR171
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.4845450056066656,-0.8849623971059292,0.6567164179104478,0.964922651402317,1.0,5/13,23.21%,RAB11FIP5;HYAL1;GPR68;SLC9A1;HVCN1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.5594227628207424,-0.8848209066190948,0.6491228070175439,0.9646095992743814,1.0,2/5,8.24%,RPE65;GRM6
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.5594227628207424,-0.8848209066190948,0.6491228070175439,0.9646095992743814,1.0,2/5,8.24%,RPE65;GRM6
prerank,Reactome_2022__Constitutive Signaling By Overexpressed ERBB2 R-HSA-9634285,0.4717907123974033,0.884741706919412,0.5757575757575758,0.994699913680337,1.0,1/10,3.57%,NRAS
prerank,Reactome_2022__SARS-CoV-2 Targets Host Intracellular Signaling And Regulatory Pathways R-HSA-9755779,0.43921536700921804,0.8847231062045174,0.5833333333333334,0.9942633857560236,1.0,2/11,6.69%,AKT2;AKT1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.4640928996751823,-0.8846283110657154,0.6142857142857143,0.9647279174492414,1.0,1/23,1.83%,PLAAT4
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.5477613332927175,0.8845566410875708,0.7142857142857143,0.9941639733083426,1.0,3/7,24.58%,WAPL;ESPL1;ERCC4
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.5099892385079282,-0.8845146302421917,0.6666666666666666,0.9647532974239548,1.0,2/11,17.46%,ACOT4;ACOT8
prerank,KEGG_2021_Human__Chagas disease,-0.37525219335378307,-0.8842637975820116,0.691358024691358,0.965020058569511,1.0,11/72,15.85%,C3;TGFBR2;TLR2;IL12A;CCL2;IFNGR2;FADD;TNFRSF1A;FOS;PIK3CB;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.35594564931143946,-0.8840138069680828,0.7439024390243902,0.9652548446801252,1.0,29/113,23.61%,TRIM22;TLR2;RPS27A;TRIM5;APP;NOD1;SLCO3A1;WNT5A;PRKCQ;IL18;PRKCH;FLOT1;UBC;IL1RAP;DDRGK1;PRKCB;RIPK2;CARD11;ALK;CD36;CX3CL1;TRIM62;IKBKG;ADAM8;EIF2AK2;STAT3;NFKB2;CARD14;TRIML2
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.3665743184201395,-0.8838813518960569,0.6904761904761905,0.9652137734587077,1.0,12/93,13.97%,TLR2;RPS27A;APP;NOD1;NLRC5;NDUFA2;KCNH8;RPS6KA1;TNIP2;SIGIRR;UBC;FOS
prerank,KEGG_2021_Human__Epstein-Barr virus infection,-0.350669196321484,-0.8838320892622645,0.6987951807228916,0.9650190002036754,1.0,27/151,16.36%,TLR2;B2M;ICAM1;HLA-A;HLA-C;HLA-DRA;CD44;CCND1;GADD45A;STAT1;IRF7;ISG15;ENTPD3;HLA-B;SYK;HLA-E;PSMC3;MAP3K14;CCNE2;FADD;HLA-F;BLNK;PIK3CB;PIK3CD;CDK2;CCND2;HLA-DRB1
prerank,KEGG_2021_Human__Glioma,-0.39367611325301394,-0.8838198557971466,0.6811594202898551,0.9647845923469414,1.0,14/66,19.00%,CDKN2A;CCND1;EGF;PRKCG;GADD45A;IGF1;TGFA;SHC2;PIK3CB;PIK3CD;PRKCB;GADD45B;CDKN1A;PDGFRA
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,-0.39199582792731424,-0.8837750169156087,0.6410256410256411,0.9646059452110292,1.0,10/62,17.53%,TLR2;IL12A;TLR3;STAT1;IRF7;FADD;FOS;PIK3CB;PIK3CD;SPP1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.38208660848608317,-0.8836979899700961,0.6835443037974683,0.9644803631196763,1.0,15/70,17.04%,RASGRP1;EPS8L2;KIF14;RASGEF1A;DENND3;FBP1;IGF1;ARHGEF18;DAB2IP;FOXM1;DLC1;VAV1;ARFGAP1;ERBIN;IRS2
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.4298859518076904,-0.883630328983543,0.6712328767123288,0.9643283780387832,1.0,1/24,0.81%,BLM
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.3343518359443042,0.8834856993762633,0.7142857142857143,0.9959715870841191,1.0,7/53,9.03%,PPP1R10;PHC1;RNF2;EED;FBXO5;YAF2;RBBP4
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.4557055770884848,0.8833889423656547,0.6111111111111112,0.9957368880591818,1.0,5/14,24.07%,TNFAIP3;RNF26;IFNLR1;ELMOD2;ITCH
prerank,KEGG_2021_Human__Rap1 signaling pathway,-0.34489281115355264,-0.883255042222898,0.7529411764705882,0.9648963753501796,1.0,31/169,17.25%,THBS1;EFNA1;MET;RASGRP2;FYB1;SKAP1;GRIN2A;ADCY7;PFN4;RALGDS;EGF;PRKCG;IGF1;PFN2;FGF1;ADCY5;RAPGEF5;LPAR4;GRIN2B;FGF7;RAP1GAP;CNR1;PIK3CB;VAV1;PIK3CD;TLN1;ADCY3;FGF22;ADCY8;PRKCB;TEK
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.5736383353225141,-0.8832338534267077,0.6833333333333333,0.9646596888479146,1.0,3/5,22.80%,SLC18A2;SLC29A4;SLC22A1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),-0.5068037421870826,-0.8830259693084425,0.62,0.9647775901459535,1.0,1/11,3.02%,PTP4A3
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.4663975753923477,-0.883025369094512,0.6229508196721312,0.9645040495760229,1.0,3/19,13.20%,IL12A;RHBDF2;RHBDF1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4035317939363175,0.882903198640857,0.6410256410256411,0.9963484841004195,1.0,7/21,18.23%,PNLDC1;CNOT9;CNOT2;CNOT8;CNOT6L;CNOT1;CNOT4
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.4114935796054146,0.8824314918851431,0.5882352941176471,0.9969426749033026,1.0,14/29,21.24%,ZDHHC16;ZDHHC14;ZDHHC11;ZDHHC18;ZDHHC13;ZDHHC20;ZDHHC5;ZDHHC21;GLUL;GOLGA7;ZDHHC11B;PORCN;CLIP3;ZDHHC6
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,-0.373354652881335,-0.8824044500394231,0.7323943661971831,0.9654599735074069,1.0,11/57,14.84%,RIMBP2;RPE65;PLB1;AKR1C1;SLC24A1;LDLR;PDE6B;PRKCQ;GPC3;NMT1;RDH12
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.38888583490530443,0.8823767281808002,0.7777777777777778,0.9966126859774368,1.0,6/28,20.01%,GRPEL2;PEX2;TIMM23;PEX6;CHCHD4;PEX12
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.4343186510077397,-0.8822017859138604,0.7101449275362319,0.9655352609707372,1.0,5/26,17.67%,RPS27A;RPA3;UBC;RPA1;RBX1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),-0.5687536264662937,-0.8821360723008884,0.6538461538461539,0.9654097002224357,1.0,2/6,23.13%,WNT5A;ROBO2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.3808395081637544,-0.8820400606535498,0.6578947368421053,0.9653132663241663,1.0,4/76,5.22%,DHCR24;SNCB;RAMP3;HTR2B
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.536109193559644,0.8819245906131572,0.625,0.9970606957965287,1.0,1/6,2.91%,AFG1L
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.45665133052690166,-0.88153964534981,0.6666666666666666,0.9661305630830116,1.0,6/16,20.36%,IFI35;NLRP12;HDAC7;NMI;NLRC3;SPI1
prerank,Reactome_2022__Abacavir ADME R-HSA-2161522,-0.5632602155151665,-0.8815144126645035,0.6842105263157895,0.9659178226070658,1.0,3/7,22.80%,ABCB1;ABCG2;SLC22A1
prerank,Reactome_2022__Signaling By FGFR3 In Disease R-HSA-5655332,0.45773246070526374,0.8814751606455351,0.6060606060606061,0.9975921437172974,1.0,6/14,23.66%,NRAS;PIK3CA;PIK3R1;FGF17;PIGU;SOS1
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.3569566502614731,-0.8813376656996209,0.7529411764705882,0.9659796780572147,1.0,18/118,16.95%,RASGRP2;TMC8;KIF14;ANGPTL7;CEACAM1;GFAP;RIT2;LTBP4;WNT5A;DAB2IP;PRKCQ;PINK1;BAP1;SLITRK4;ALKBH4;ARFGAP1;TSC2;NUBP1
prerank,KEGG_2021_Human__Spinocerebellar ataxia,-0.35222165026244845,-0.8813351998876195,0.7375,0.9657143318028563,1.0,20/125,16.31%,GRIN2D;GRIN3A;CIC;GRIN2A;TRPC3;VLDLR;GRIA3;GRIA1;ITPR3;PRKCG;PSMB6;PSMC3;GRIN2B;PIK3CB;PSMA8;RELN;KCND3;PIK3CD;PSMA7;BEAN1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Bone Marrow,-0.429806474077793,-0.8810921503312721,0.6212121212121212,0.9659713992475668,1.0,5/32,7.03%,A4GALT;PODXL;THY1;ABCB1;CD44
prerank,Reactome_2022__Gap Junction Assembly R-HSA-190861,-0.5966680592497211,-0.8809877672050879,0.6607142857142857,0.9659092504693421,1.0,1/5,7.05%,GJB7
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.5395017395498762,0.8808462742580835,0.5862068965517241,0.9983410483632515,1.0,2/5,18.51%,VPS4B;CEP120
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.4319750731863692,0.8805107034761231,0.6666666666666666,0.9985138055648709,1.0,2/19,6.39%,RPP40;ERI1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.46684795050039,-0.8803548377398053,0.6507936507936508,0.9668541667384574,1.0,9/16,27.71%,DAB2IP;B4GALT7;EMD;NLRC3;FTH1;SFRP1;TRIM32;TP53;GSTP1
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.4693473804556366,-0.8803226537601535,0.5967741935483871,0.9666363115577741,1.0,3/16,12.77%,RPS27A;TNIP2;UBC
prerank,Reactome_2022__Cleavage Of Damaged Purine R-HSA-110331,0.44476522720495815,0.8802331166426697,0.5555555555555556,0.9985747176515216,1.0,4/17,14.92%,H2BC21;H2BC4;H2AC6;POT1
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,0.3763170976255545,0.8801928032478116,0.6060606060606061,0.9981890900532363,1.0,5/43,6.89%,SEM1;PSMD10;PSMA1;PSMD11;PSMB5
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,0.3546728008402177,0.8801903282253148,0.7096774193548387,0.9976978552648242,1.0,7/54,6.89%,SEM1;CCNE1;PSMD10;PSMA1;PSMD11;CUL1;PSMB5
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.5685912864497127,0.8801802064846048,0.6666666666666666,0.9972294057609047,1.0,2/5,31.30%,HDAC2;SIRT1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.39040450890663925,-0.8801113443013759,0.691358024691358,0.966826960219895,1.0,13/72,19.00%,RHOBTB2;FSCN1;RND2;BST2;BAIAP2;RHOF;DMTN;SEMA3E;DLC1;PRKCD;RHOD;DAPK3;PDGFRA
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.511554387185523,0.880072550291308,0.7045454545454546,0.9969620364060402,1.0,2/7,8.63%,NCOA3;SMYD5
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.5187841431965186,-0.8799974190206841,0.639344262295082,0.9667567381192305,1.0,3/8,14.15%,GABRB2;HRH1;GABRG2
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.5236857920982042,0.8799757084965164,0.7,0.9967562001109544,1.0,1/7,12.08%,SASH1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),-0.5764503419130447,-0.8798693314754362,0.6981132075471698,0.9664321389809186,1.0,2/5,13.56%,SLC39A14;SLC11A1
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),-0.5764503419130447,-0.8798693314754362,0.6981132075471698,0.9664321389809186,1.0,2/5,13.56%,SLC39A14;SLC11A1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.43069130804032973,-0.8798423579376452,0.6338028169014085,0.966198919795117,1.0,3/22,18.14%,MAP1B;AEBP1;MAPT
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.5002083512187512,-0.8797941750777594,0.6140350877192983,0.9660237141524196,1.0,1/10,3.86%,BHMT
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.4918709510389341,0.8797749966590015,0.627906976744186,0.9967287193084834,1.0,3/10,24.38%,GREM1;MAP2K2;RNF13
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.2979206102886199,0.8797416437290112,0.8125,0.9963117464687831,1.0,29/134,19.67%,FASTKD1;PSMD10;PDE12;RIDA;HSPA1A;PSMA1;EXOSC1;PSMD11;AKT1;PSMB5;PCBP4;XPO1;EXOSC6;DIS3;PSMD14;NUP214;ZC3H14;PSMD12;PAIP1;HNRNPU;RC3H1;CSDC2;EXOSC8;YTHDF2;FXR2;PCID2;FASTKD3;RC3H2;PUM2
prerank,CellMarker_Augmented_2021__Somatic Stem cell:Endometrium,0.29685828386144697,0.8796324950679841,0.7692307692307693,0.9935799083101475,1.0,18/95,12.16%,PCDH19;TSPAN11;EFNB2;PPARGC1A;ADAMTS9;STXBP6;ALDH7A1;FREM1;FBLN1;SOX9;EGFR;DZIP1;SALL1;CNTFR;ANK2;PRKG1;ROBO1;PTPRG
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Gland,0.29685828386144697,0.8796324950679841,0.7692307692307693,0.9935799083101475,1.0,18/95,12.16%,PCDH19;TSPAN11;EFNB2;PPARGC1A;ADAMTS9;STXBP6;ALDH7A1;FREM1;FBLN1;SOX9;EGFR;DZIP1;SALL1;CNTFR;ANK2;PRKG1;ROBO1;PTPRG
prerank,CellMarker_Augmented_2021__Stem cell:Gastric Gland,0.29685828386144697,0.8796324950679841,0.7692307692307693,0.9935799083101475,1.0,18/95,12.16%,PCDH19;TSPAN11;EFNB2;PPARGC1A;ADAMTS9;STXBP6;ALDH7A1;FREM1;FBLN1;SOX9;EGFR;DZIP1;SALL1;CNTFR;ANK2;PRKG1;ROBO1;PTPRG
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Gastrointestinal Tract,0.29685828386144697,0.8796324950679841,0.7692307692307693,0.9935799083101475,1.0,18/95,12.16%,PCDH19;TSPAN11;EFNB2;PPARGC1A;ADAMTS9;STXBP6;ALDH7A1;FREM1;FBLN1;SOX9;EGFR;DZIP1;SALL1;CNTFR;ANK2;PRKG1;ROBO1;PTPRG
prerank,CellMarker_Augmented_2021__Ovarian Somatic cell:Ovary,0.29685828386144697,0.8796324950679841,0.7692307692307693,0.9935799083101475,1.0,18/95,12.16%,PCDH19;TSPAN11;EFNB2;PPARGC1A;ADAMTS9;STXBP6;ALDH7A1;FREM1;FBLN1;SOX9;EGFR;DZIP1;SALL1;CNTFR;ANK2;PRKG1;ROBO1;PTPRG
prerank,CellMarker_Augmented_2021__Corneal Limbal Stem cell:Limbal Epithelium,0.29685828386144697,0.8796324950679841,0.7692307692307693,0.9935799083101475,1.0,18/95,12.16%,PCDH19;TSPAN11;EFNB2;PPARGC1A;ADAMTS9;STXBP6;ALDH7A1;FREM1;FBLN1;SOX9;EGFR;DZIP1;SALL1;CNTFR;ANK2;PRKG1;ROBO1;PTPRG
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.5132972662722435,-0.879587903651852,0.6610169491525424,0.9661405658026118,1.0,3/10,13.35%,SPOCK3;WAS;SPINT2
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.3884739287385438,-0.8792798302716576,0.5942028985507246,0.9664703422785715,1.0,11/51,18.28%,CCNB2;RPS27A;PSMB9;CCNB1;PSMB6;PSMC3;UBC;PSMA8;PSMA7;PSME1;CDKN1A
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.49987518919809903,-0.8791295747574573,0.6615384615384615,0.9665291691532958,1.0,2/12,13.78%,BRCA1;PCGF3
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.47038886864748297,0.879091762840438,0.631578947368421,0.9943193681212789,1.0,1/13,2.36%,ABCA1
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,-0.4188044669715383,-0.8789316764942492,0.609375,0.9666746879705813,1.0,5/33,7.37%,OGN;CSPG4;BGN;OMD;PAPSS2
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.4532845498210336,-0.878868377196063,0.6521739130434783,0.9665442590557164,1.0,5/23,15.96%,ANXA1;CCND1;HYAL1;LSM11;CCND2
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.4286443249323732,0.8786560948861387,0.6842105263157895,0.9948308503964505,1.0,11/24,29.35%,NUDT16L1;EXOSC6;DIS3;TENT4B;EXOSC8;POP1;EXOSC5;MTREX;ZCCHC8;DIS3L;XRN1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.41651565888886877,-0.8786040599547795,0.7049180327868853,0.9669076955615487,1.0,5/25,17.79%,P2RY12;DMTN;RHOD;VCL;PTPRO
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.5846406969151923,0.8786002832652273,0.7209302325581395,0.9945163607857601,1.0,3/5,32.28%,SETD3;SETD2;SETD5
prerank,KEGG_2021_Human__Metabolism of xenobiotics by cytochrome P450,-0.4224564010427818,-0.8784823627041587,0.6944444444444444,0.9669138167905947,1.0,10/34,23.77%,AKR1C1;GSTM5;CYP1B1;CYP3A4;ADH4;CYP3A5;HSD11B1;GSTK1;GSTO1;CYP2D6
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.5069449730937914,-0.8782637913976968,0.6727272727272727,0.9670774390428724,1.0,2/10,5.68%,ICAM1;THY1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.5165960511833952,0.8781517489993574,0.6666666666666666,0.9951490693035632,1.0,8/11,32.84%,HNRNPU;YTHDF2;HES5;ZFP36L2;JAG1;ESRRB;REST;N4BP2L2
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.4328660780448994,-0.8781071680969871,0.6285714285714286,0.9671806094926538,1.0,3/25,11.12%,ZFP36;VIL1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),-0.568394263015458,-0.8779586926754454,0.6764705882352942,0.9672679803141091,1.0,5/8,27.22%,SYK;FES;GAB2;ADGRE2;UNC13D
prerank,KEGG_2021_Human__Wnt signaling pathway,-0.3528924088422708,-0.8778907228162841,0.7590361445783133,0.9670877702907269,1.0,16/131,15.96%,LEF1;WNT8B;SERPINF1;RSPO3;CCND1;NOTUM;PRKCG;WNT5A;PPP3CC;LGR5;SFRP4;RSPO4;PRICKLE1;CBY1;SFRP2;CCND2
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.5112297489238624,-0.8778761691551595,0.6,0.9668473527774599,1.0,2/7,17.30%,HTR2B;RYR2
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),-0.4848147359930989,-0.8769993757138566,0.6065573770491803,0.9684263119478801,1.0,5/13,24.64%,SLC9A2;SLC9A5;SLC9A7;SLC9A1;SLC9A9
prerank,Reactome_2022__Synthesis Of PG R-HSA-1483148,0.5606561893112562,0.8769716081024637,0.6578947368421053,0.9973862141412972,1.0,2/6,9.32%,PLD6;PRKCSH
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.3796237461281813,-0.8765913627905735,0.620253164556962,0.9689613655289753,1.0,11/64,10.78%,KCNB1;AIPL1;MYO15A;SLC24A2;SRRM4;SLC7A14;XKR4;PDE6B;GRM6;UNC13C;CDH7
prerank,Reactome_2022__Loss Of MECP2 Binding Ability To NCoR/SMRT Complex R-HSA-9022537,-0.5237795652808421,-0.8765589360175928,0.6440677966101694,0.9687546831905777,1.0,4/7,37.64%,TBL1X;NCOR1;GPS2;NCOR2
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.32508846290883053,0.8765525956995891,0.64,0.9969884384317961,1.0,10/56,13.91%,BET1;PEF1;SEC22B;PPP6R1;KLHL12;RAB1B;SCFD1;CNIH1;SEC24A;SEC23IP
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.32508846290883053,0.8765525956995891,0.64,0.9969884384317961,1.0,10/56,13.91%,BET1;PEF1;SEC22B;PPP6R1;KLHL12;RAB1B;SCFD1;CNIH1;SEC24A;SEC23IP
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.32508846290883053,0.8765525956995891,0.64,0.9969884384317961,1.0,10/56,13.91%,BET1;PEF1;SEC22B;PPP6R1;KLHL12;RAB1B;SCFD1;CNIH1;SEC24A;SEC23IP
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreas,0.3105980438308556,0.876279105482207,0.75,0.9970936318677744,1.0,14/87,11.65%,PCDH19;ST6GAL2;FREM1;LRRN1;ESRRG;INTU;PBX1;FAT3;HEPH;MEGF10;ATP1A2;NRXN1;GPM6B;SALL3
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.42073178489584373,0.8762272717721041,0.7142857142857143,0.9967459852308339,1.0,4/25,5.13%,WNT7A;BMP2;RUNX1;SOX9
prerank,CellMarker_Augmented_2021__Ciliated cell:Lung,-0.35262090531136486,-0.8759841310183891,0.7444444444444445,0.9697110315631813,1.0,25/188,14.73%,RSPH4A;PSCA;PPP1R14C;ATF3;PRDX5;DNAAF8;ARHGAP39;BASP1;LXN;ANKRD65;KIF9;TSPAN19;POLR2I;RPA3;CIBAR2;CTSS;WDR54;IGFBP7;FAM81B;RBKS;CCDC181;DALRD3;DRC1;CBY1;AKAP14
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.440340462620853,0.87580963653427,0.6097560975609756,0.997254044936587,1.0,6/12,36.22%,PLXNA3;SEMA3A;PLXNA2;PLXNB2;PLXNB3;NRP1
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.5313579867107524,0.8757554638672521,0.6666666666666666,0.9968735636814031,1.0,2/5,16.77%,ATP2C1;ACSL3
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Undefined,-0.5639254121738545,-0.8756495680759352,0.6666666666666666,0.9701588652570622,1.0,3/5,23.75%,MOG;SOX10;MBP
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.3951619310472189,0.8754161166931671,0.625,0.9970282265395842,1.0,10/28,26.63%,ERCC6;ATR;INTS7;HUS1;ATRIP;HINFP;CLSPN;RAD1;USP28;CLOCK
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,0.3065734143416569,0.8753123118423711,0.75,0.9968245595242061,1.0,18/91,15.19%,H2BC18;AGER;H4C8;H2BC21;H2BC4;AKT2;AKT1;VDAC2;PLCB4;HMGB1;H2AC6;MAPK12;SLC25A5;H3-3B;PIK3CA;NFKB1;PIK3R1;HDAC2
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,-0.38727750678415945,-0.8752703583956374,0.7236842105263158,0.970606447570817,1.0,8/54,11.74%,NPY;ABCA6;KLF4;GLYAT;GADD45A;BTG1;FBXO32;PINK1
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.35816532710196197,-0.8749780209617747,0.6883116883116883,0.9709333979856494,1.0,17/112,14.38%,KCNT2;STMN2;RCAN2;THY1;LMOD1;MAP1B;EFNB3;GAP43;LDB2;EDIL3;SHC2;ADCY5;IGFBP5;CRMP1;RASL12;RGS7BP;CCDC3
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.4844496988708318,-0.8749563590281312,0.625,0.9707081386912354,1.0,4/15,19.63%,TYMP;CRMP1;DPYSL2;DPYSL3
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.5338965756667459,0.8748138602589276,0.627906976744186,0.9975133501826828,1.0,1/6,3.58%,HSPA1A
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.44091982971338955,0.8747438488171771,0.5714285714285714,0.9972215637672082,1.0,3/17,8.13%,MYORG;SELENON;ZBTB18
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.3801613035774083,-0.8746809302311238,0.7222222222222222,0.9709564120783194,1.0,3/55,3.30%,THBS1;SP100;TMC8
prerank,Reactome_2022__Adenylate Cyclase Activating Pathway R-HSA-170660,-0.4947680999865704,-0.8746546580258995,0.6206896551724138,0.9707260430909505,1.0,3/8,17.15%,ADCY7;ADCY5;ADCY8
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.48641240862851126,-0.8745334951370278,0.6333333333333333,0.9707441368987445,1.0,2/15,3.79%,SIX3;POF1B
prerank,Reactome_2022__Processive Synthesis On C-strand Of Telomere R-HSA-174414,0.4034543748936483,0.8741611107635483,0.5813953488372093,0.9981571022750304,1.0,2/17,1.45%,POLD3;DNA2
prerank,CellMarker_Augmented_2021__Eosinophil:Bronchoalveolar System,-0.47466268409598816,-0.8737707730012912,0.6206896551724138,0.9720349006599754,1.0,6/17,18.05%,HPN;NOTUM;THPO;F10;ITIH2;PAH
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.4871764533336807,0.8737334236194128,0.6388888888888888,0.9987837464256631,1.0,2/7,16.77%,ATP2C1;ACSL3
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.5082907789418994,0.873718957535717,0.6666666666666666,0.9983488440418691,1.0,2/7,17.02%,CACNB3;CACNA2D1
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,0.3469282024640748,0.8736703958581559,0.6571428571428571,0.998018757397436,1.0,9/53,11.34%,SEM1;PSMD10;PSMA1;PSMD11;CUL1;PSMB5;BTRC;PRKACB;PSMD14
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.5262948490908619,0.8734167887156341,0.6666666666666666,0.9982601341890496,1.0,2/5,38.73%,PRKN;LRRK2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.5278190571357677,0.8733805336341381,0.7,0.9978810082478122,1.0,2/5,21.44%,PIK3C2A;EDNRB
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.5690901305846843,0.873323201357609,0.7111111111111111,0.997557113810144,1.0,2/5,36.93%,AXIN1;GSK3B
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.49673798058864704,0.873311867956142,0.6,0.9971074054922362,1.0,4/9,18.13%,ZC3H8;FOXJ1;TOX;CAMK4
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.41064457794788595,-0.8732501430067818,0.7313432835820896,0.9727162115326663,1.0,12/48,16.14%,EPS8L2;OVOL2;LSR;MMP14;BAIAP2L1;RARRES1;RUNX2;SLC44A3;BTN3A1;LAMA3;ITGB4;RHOD
prerank,KEGG_2021_Human__Insulin resistance,0.30475851779315993,0.8732439281322913,0.8333333333333334,0.9967567926669402,1.0,16/92,14.84%,TBC1D4;PPP1R3D;PPARGC1A;TRIB3;AKT2;ACACB;MAPK10;AKT1;PRKAB1;PYGM;MAPK8;PPP1CC;PIK3CA;RPS6KA3;NFKB1;PIK3R1
prerank,KEGG_2021_Human__Gastric cancer,-0.35947705521649376,-0.8731081294900431,0.7051282051282052,0.9727311209832776,1.0,22/115,18.28%,LEF1;MET;TGFBR2;WNT8B;CTNNA3;ABCB1;CCND1;EGF;GADD45A;WNT5A;SHC2;FGF1;CCNE2;FGF7;PIK3CB;PIK3CD;CDK2;FGF22;CDH17;GADD45B;TGFB1;CDKN1A
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.44063042387710105,-0.873040999248937,0.6290322580645161,0.972607633185998,1.0,5/24,17.91%,RPL35;RPL7A;RPL10A;PES1;RPL7
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,-0.34144411158264726,-0.8728542258243429,0.7613636363636364,0.972679993051213,1.0,29/206,18.17%,ERCC6L;RPS27;KIF14;CENPH;YWHAH;CENPE;BAIAP2;MYH11;ZWILCH;SRF;WAS;PFN2;NUF2;SPC24;RHPN1;KIF2C;MYH9;RNASE1;CENPN;CENPU;NOXA1;PPP1R14A;PDZD2;PRKCD;RHOD;PRKCB;CENPP;LIMK2;RHPN2
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.5007902030931968,-0.8726925660423933,0.6721311475409836,0.9727209966222676,1.0,1/10,6.29%,BRCA1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),-0.4792509532451106,-0.872485640033503,0.6166666666666667,0.972858507300816,1.0,4/11,17.15%,ADCY7;ADCY5;ADCY3;ADCY8
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.3973810774755835,0.8723987488748248,0.7037037037037037,0.9981541582495367,1.0,7/47,9.85%,TBC1D4;EXOC8;AKT2;AKT1;EXOC6;PRKAB1;RALA
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.517031038627036,-0.8721620661515957,0.7017543859649122,0.9731393915555604,1.0,2/12,6.84%,IFITM3;BST2
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.5547512559169003,0.8721253160865218,0.6829268292682927,0.9982140670336992,1.0,1/5,0.30%,ACE2
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),-0.5442606769927714,-0.8721034691916687,0.7288135593220338,0.972982065235267,1.0,1/7,8.12%,DRAXIN
prerank,Reactome_2022__Adenylate Cyclase Inhibitory Pathway R-HSA-170670,-0.4799979428944046,-0.8718884970010989,0.65,0.9731376347809997,1.0,3/11,17.15%,ADCY7;ADCY5;ADCY8
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.3418722897812605,-0.871739308872112,0.8023255813953488,0.9731784531998928,1.0,23/189,12.16%,GGT5;PRSS48;HPN;PCSK2;MMEL1;PHEX;MMP19;CTSC;MMP14;SVBP;TMPRSS11D;PRSS57;ADAM19;CELA2A;FOLH1;CTSS;MMP25;CELA2B;AEBP1;MMP24;TMPRSS3;CAPN8;CTSZ
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.34854146767202193,0.8717385205618186,0.6666666666666666,0.9986023101439752,1.0,5/38,9.05%,QRICH2;COMMD1;CSNK2A1;XPO1;CSNK2A2
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.4556039604857052,-0.8716330398560682,0.7361111111111112,0.9731489063514851,1.0,5/21,13.13%,GRIN2D;GRIN2A;INSYN2A;GRIN2B;GRID2
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,0.3067838588698039,0.8714845705085014,0.6785714285714286,0.9987385326727445,1.0,19/89,15.95%,SEM1;PSMD10;PSMA1;PSMD11;KEAP1;AKT2;CUL1;AKT1;PSMB5;VCP;CSNK2A2;BTRC;SESN2;PSMD14;PRDX1;PSMD12;MUL1;FBXL17;EP300
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.49043336702061846,0.8714444311414529,0.6097560975609756,0.9983442352885255,1.0,4/7,41.39%,AGO3;AGO4;AGO2;DICER1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.5311497250957898,-0.8713676524950608,0.6949152542372882,0.9731002774340172,1.0,2/9,22.57%,PPP3CC;NFATC2
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.5311497250957898,-0.8713676524950608,0.6949152542372882,0.9731002774340172,1.0,2/9,22.57%,PPP3CC;NFATC2
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.5055980701926279,0.8711107955342645,0.6904761904761905,0.9985733607528945,1.0,2/8,5.99%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.4719371048185006,0.8710760344722569,0.7142857142857143,0.9981631350584781,1.0,5/13,20.09%,ABCA1;RELCH;STARD4;NPC2;SERAC1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.325666016940197,0.870934131495808,0.96,0.9979990055136767,1.0,11/49,21.51%,RALB;SESN2;ADRB2;SLC25A5;PIP4K2B;SESN3;RUFY4;PIP4K2C;GPSM1;RAB3GAP1;FYCO1
prerank,Reactome_2022__GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,-0.5276737385125003,-0.8709339190985145,0.7096774193548387,0.9736694890092702,1.0,2/11,16.06%,FN1;TLN1
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,0.41883214416738856,0.8709156201918272,0.5555555555555556,0.9975730791915668,1.0,1/20,0.37%,CPAMD8
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.3286859505041067,-0.870816381503687,0.7789473684210526,0.9736398381294964,1.0,43/354,11.84%,ZIC4;FLRT3;TAGLN3;MET;POU4F1;L1CAM;WDR62;NRSN1;WNT8B;PROX1;SH3GL2;CHRM1;SLITRK1;GFRA2;UGT8;SRRM4;VLDLR;NINJ2;EFNB3;NELL1;LDB2;HAP1;NRGN;ZIC1;KLK6;MOG;MOBP;NEUROD2;GRIK1;RAPGEFL1;HAPLN2;EIF2B2;SH3GL3;B3GNT5;CHRM3;SCN2A;PCDHA1;PCDHB5;FN1;RAPGEF5;ACHE;DCTN1;NUMBL
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.480218218216968,0.8705554189279329,0.6818181818181818,0.9979766872183095,1.0,1/8,1.56%,AGER
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.3161105932442278,-0.8703001165389035,0.875,0.9743022407906502,1.0,44/531,11.97%,KLF2;EFNA1;FOSB;SKOR1;SP100;POU4F1;NR4A3;SUV39H1;NR1I3;HIC1;CIITA;ZFP36;RPS27A;PROX1;MLIP;RPS14;ATF3;MSX2;KLF4;ZNF750;GFI1B;GATA1;LDB2;CCND1;PLK3;ZFP69;HEXIM1;PARP9;ZFPM1;ZNF536;SRF;GADD45A;FBP1;STAT1;MAFK;IRF7;DAB2IP;PRDM1;ZNF20;AEBP1;ZBTB32;SOX15;FOXM1;RPL10
prerank,Reactome_2022__RAS Processing R-HSA-9648002,0.4108239463855659,0.8702781081811201,0.625,0.9981236562945164,1.0,3/17,6.17%,ABHD17A;NRAS;ABHD17B
prerank,KEGG_2021_Human__Melanoma,0.32204490642768313,0.8702605336667889,0.8333333333333334,0.9976655872356232,1.0,8/57,6.69%,FGF6;MITF;NRAS;EGFR;AKT2;PDGFD;PDGFC;AKT1
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.5875991761049577,0.8701671955240403,0.6285714285714286,0.9969249863535362,1.0,1/5,18.86%,PCID2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.5875991761049577,0.8701671955240403,0.6285714285714286,0.9969249863535362,1.0,1/5,18.86%,PCID2
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.4536522380492503,0.870026361598769,0.5813953488372093,0.9967565611064158,1.0,2/12,11.05%,GLUD1;IREB2
prerank,CellMarker_Augmented_2021__Goblet Progenitor cell:Large Intestine,-0.5453857364652779,-0.8699400886501774,0.7,0.9747275905343598,1.0,5/9,25.30%,ICA1;CHKB;SLC39A7;TSPAN15;ELAPOR1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.36460603048581575,-0.8698236914184885,0.6455696202531646,0.9746586665870125,1.0,9/74,16.36%,SH3GL2;HLA-DRA;CENPE;AP1S1;CTSS;DCTN1;KIF2C;CD74;HLA-DRB1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.4004470365799754,-0.86972875152003,0.6891891891891891,0.9745923805263789,1.0,14/41,19.24%,SLC51A;SLC16A3;AKR1C1;CEACAM1;SLCO3A1;SLC16A11;SLC16A4;SLCO2A1;SLC16A14;SLC51B;SLCO1A2;ATP8B1;ABCG2;CD36
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.44012539882178614,-0.8696522813467622,0.6470588235294118,0.9745027427146783,1.0,4/24,11.18%,GPNMB;THY1;CCL2;PRKCQ
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.35846760124753047,0.8695372223816906,0.7407407407407407,0.9972355457733755,1.0,8/51,13.78%,PSMD10;PDK4;PSMA1;PSMD11;PSMB5;PSMD14;SIRT5;PSMD12
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.4087612058811317,0.8694080994652169,0.625,0.9970453873259087,1.0,3/18,5.58%,CEL;CYP4F3;CYP4F12
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.43402025067395167,-0.8693243692822992,0.7058823529411765,0.9749171706033927,1.0,8/32,16.45%,TLR2;NOD1;TLR3;CHI3L1;SYK;FADD;CD74;F3
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),0.5562088076190993,0.8693047382101807,0.75,0.9967847711948638,1.0,4/6,39.14%,ELAC2;HSD17B10;PTCD1;TRMT10C
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.479944396351869,-0.8691646679308799,0.6811594202898551,0.9750119002797214,1.0,2/17,7.95%,LAMB1;MYH11
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.5255200174035733,-0.8690636511814089,0.6268656716417911,0.9749429931224609,1.0,1/8,13.60%,SLC51B
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,-0.34378835649615186,-0.8686435764572841,0.7738095238095238,0.9755360661129359,1.0,20/124,18.28%,MET;NR4A3;TGFBR2;LMO2;GRIA3;GADD45A;IGF1;KLF3;BIRC3;RUNX2;PAX8;PLAT;CCND2;MAX;PML;BCL6;GADD45B;NUPR1;ETV6;CDKN1A
prerank,KEGG_2021_Human__mTOR signaling pathway,0.29275492002471853,0.8686428143310901,0.8461538461538461,0.9977735906294954,1.0,17/131,14.84%,WNT7A;ATP6V1A;NRAS;AKT2;FZD8;ATP6V1G1;AKT1;MIOS;SLC3A2;SESN2;LPIN3;EIF4E;DVL2;WDR24;PIK3CA;RPS6KA3;PIK3R1
prerank,KEGG_2021_Human__Ras signaling pathway,0.3018947956772091,0.8686128593334883,0.8571428571428571,0.9973663020539253,1.0,27/169,11.97%,FGF6;NGF;KSR2;VEGFD;EFNA2;VEGFC;FLT3;NRAS;RASA4B;EGFR;AKT2;PDGFD;PDGFC;MAPK10;AKT1;RALB;SHC4;STK4;PLA2G4C;PRKACB;RALA;GNB3;MAPK8;RASA2;CSF1R;SHOC2;EFNA5
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),0.571146643984431,0.8685100643341197,0.6410256410256411,0.997230705555717,1.0,2/5,22.44%,CCDC88A;LZTFL1
prerank,Reactome_2022__CREB3 Factors Activate Genes R-HSA-8874211,0.536608340476638,0.8684284460281265,0.6829268292682927,0.9969433823093843,1.0,5/7,45.83%,CREB3L3;MBTPS2;CREB3L4;CREB3L2;CREBRF
prerank,CellMarker_Augmented_2021__B1 cell:Salivary Gland,-0.4833253597423703,-0.8683896503840113,0.6666666666666666,0.9754966626238233,1.0,3/15,3.84%,CD5;TAGAP;GPR171
prerank,CellMarker_Augmented_2021__T cell:Salivary Gland,-0.4833253597423703,-0.8683896503840113,0.6666666666666666,0.9754966626238233,1.0,3/15,3.84%,CD5;TAGAP;GPR171
prerank,Reactome_2022__CS/DS Degradation R-HSA-2024101,-0.4939371127244479,-0.8682082019522861,0.6617647058823529,0.9755859120666514,1.0,2/10,5.96%,CSPG4;BGN
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,-0.38480323307374886,-0.8680957364085561,0.6805555555555556,0.9755584285285547,1.0,7/55,15.30%,DEPDC1B;TRIP10;STEAP3;CDC42EP1;CDC42EP3;OBSCN;DLC1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.510888508456556,-0.8678845021936074,0.6567164179104478,0.9757538931493084,1.0,2/11,18.70%,SLC51B;INSIG1
prerank,Reactome_2022__Metabolism R-HSA-1430728,-0.3176091531908099,-0.8677627142094685,0.96,0.9757522934351424,1.0,162/1618,13.31%,ENPP2;GGT5;AWAT1;APIP;ABO;TYMS;RIMBP2;OGN;DHCR24;AGPAT4;B3GALT2;AMN;ALDOB;FABP3;DGAT2L6;RPL19;RPL3;PLAAT4;MTMR7;CSPG4;KMO;RPS27A;NDST4;RPL39L;RPL36AL;ITPKC;ALOX12;RPS27;SLC51A;KCNB1;GMPR;PLB1;GC;RPS14;RPS4X;ACOT1;LDHA;INPP5D;RPL27A;MAOB;BHMT;SLC16A3;VAC14;DUOX1;ACSM5;ADCY7;TPST1;ARG2;ARHGAP9;CEMIP;GNG3;RPL35;B4GALNT1;SLC25A21;RPL7A;AKR1C1;HS3ST3A1;UGT8;BGN;RPL37A;NDUFA2;RPL27;ACOT4;GSTM5;FUT2;PARP14;CYP1B1;OMD;SBF1;NDUFB9;GLYAT;CD44;ACSL5;AKAP5;ITPR3;PAPSS2;RPL9;GLRX;COX4I1;PSMB9;RPL21;PDHX;UROD;LDHAL6A;FA2H;LDLR;PARP9;SGPP2;DBI;DDHD2;NDUFB11;NUDT13;RPL13A;CA1;ST3GAL6;FBP1;PLD2;BLVRB;PLEKHA4;HSD17B14;SQOR;FOLH1;GYG2;CARNS1;HELZ2;GPT2;CHRM3;RPS11;SLC19A3;RPS16;GAPDHS;RPLP1;CYP4F22;PDK3;RPS13;PGK1;TMLHE;PSMB6;CACNA1C;ENTPD3;PYGL;LPCAT4;RPL38;ADCY5;ACHE;RPS3A;BMX;B3GNT2;LIPI;NAMPT;RPS8;RPL10A;GALK1;RBKS;LIPE;PSMC3;LIPH;CYP21A2;UQCRQ;RPLP2;RPS23;CHST15;NUDT4;GNG2;GLYATL2;RPS21;OLAH;SLC44A3;RPS7;PITPNM2;PLCH2;MTHFD2;UBC;ACOT2;SQLE;GPC3;PPARGC1B;CYP3A4;GCHFR;LDHD;TAC4;NDUFB10
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Blood,0.38053180667711894,0.867710517433273,0.7352941176470589,0.9975886687591362,1.0,1/26,0.05%,C1ORF162
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Liver,0.38053180667711894,0.867710517433273,0.7352941176470589,0.9975886687591362,1.0,1/26,0.05%,C1ORF162
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.4256930354844393,-0.8676982765660992,0.704225352112676,0.9755848832384475,1.0,4/34,6.72%,APLNR;CEMIP;THY1;JPH3
prerank,Reactome_2022__Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,0.405986395592675,0.867509982576431,0.6486486486486487,0.9975452916005949,1.0,6/19,11.69%,CSPG5;SDC4;SDC3;GPC5;BCAN;HSPG2
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.5462514618824007,-0.8674825367027644,0.7368421052631579,0.9757749975043442,1.0,4/9,23.40%,RAB11A;STX1B;GRIP2;STX3
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.4337681218651712,-0.8673275306238252,0.6811594202898551,0.9758148230897123,1.0,1/29,0.37%,S100A10
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.4703018256181777,0.8673248386892017,0.5833333333333334,0.9975019558720044,1.0,2/13,7.30%,PUS7L;PUS10
prerank,KEGG_2021_Human__Hedgehog signaling pathway,0.35814982248754945,0.867271669455298,0.6538461538461539,0.9971610838578548,1.0,7/50,9.80%,MOSMO;CUL1;DISP1;GAS1;CSNK1E;BTRC;PRKACB
prerank,CellMarker_Augmented_2021__Basal cell:Airway Epithelium,-0.37629846359855457,-0.8672135226157957,0.7432432432432432,0.9757640239766796,1.0,26/83,25.29%,MAP3K6;TRIP10;STEAP3;CCND1;SRPX2;P4HA2;CDC42EP1;CD63;RHBDF1;SLC4A2;ITGA3;BOK;PXDC1;GPC1;TSPAN4;SMTN;MYO1C;AGRN;CD276;RRAS;FBLIM1;GIPC1;PTTG1IP;CYB5R3;HYAL2;LMNA
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.5348107674338555,0.8671196444066326,0.7045454545454546,0.9969989985125272,1.0,2/6,13.32%,PGM2;GALT
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.45601886179944945,0.867058796916963,0.5681818181818182,0.9966586914489679,1.0,1/11,5.50%,USP13
prerank,Reactome_2022__PTK6 Expression R-HSA-8849473,-0.568487109834903,-0.8669747591425497,0.7115384615384616,0.9759772216285821,1.0,1/5,6.91%,PTK6
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.41512839025753345,-0.8667517220885803,0.6349206349206349,0.9761618416989948,1.0,4/29,12.44%,FSCN1;CLRN1;WAS;DMTN
prerank,CellMarker_Augmented_2021__Responder T cell:Blood,-0.4200523200604275,-0.8666831972382394,0.6323529411764706,0.9760127019239164,1.0,6/28,6.44%,MYO1F;GPR183;TAGAP;SLA;ARHGAP9;HLA-DRA
prerank,Reactome_2022__Activated NTRK2 Signals Thru CDK5 R-HSA-9032845,-0.5423068369042277,-0.8666298393252686,0.65625,0.9758403728704488,1.0,2/5,17.54%,RNASE1;CDK5
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.47684705588633447,-0.8665668793288579,0.6842105263157895,0.9757198405051115,1.0,6/12,31.47%,UAP1;GFPT2;UAP1L1;GNPNAT1;GNPDA1;AMDHD2
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.3546161879390448,-0.8664722594149167,0.6933333333333334,0.9756045436188534,1.0,22/101,21.99%,ARHGAP4;RHOBTB2;CNTNAP1;THY1;CCL2;RND2;PLD2;RHOF;DMTN;DPYSL2;ANK1;RHOD;SH3KBP1;SYNE3;PLCE1;PAK5;PAK6;RHOBTB1;PACSIN1;ARHGAP10;SH3D19;NEDD9
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,0.3398269739155566,0.8662568824131303,0.7741935483870968,0.9981124271686524,1.0,4/38,10.63%,CCNE1;CCT7;FBXL3;CCT3
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5176107354360103,0.8660939751452492,0.6976744186046512,0.9979987219775732,1.0,2/8,7.43%,PPARGC1A;VCP
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.3818305203022961,0.8660649684613598,0.5882352941176471,0.997588255939198,1.0,8/28,24.64%,HSPA1A;UGGT1;DNAJB14;CHCHD4;DNAJC18;DNAJB5;HSPA13;DNAJB12
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.5509013109689257,-0.8659580034657355,0.6842105263157895,0.9763806615573245,1.0,1/6,6.29%,BRCA1
prerank,Reactome_2022__p75NTR Recruits Signaling Complexes R-HSA-209543,0.47590323696901604,0.8659539697660426,0.6341463414634146,0.9974101678543644,1.0,1/12,0.43%,NGF
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.45531452893469476,0.8658517574644696,0.6,0.997172931880962,1.0,3/14,3.97%,RGCC;SERPINF2;RUNX1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.39122319361461927,0.8656679198770129,0.6896551724137931,0.9971407385147945,1.0,7/19,26.76%,MSH2;AEN;EP300;DYRK2;CDIP1;USP28;PHLDA3
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.4018438883954313,-0.8654092431169744,0.6712328767123288,0.9771718470953311,1.0,2/37,4.67%,PIF1;HELB
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,0.35480730510936787,0.8653900934681228,0.6857142857142857,0.9971624493412236,1.0,3/30,5.74%,POLD3;SLC19A1;RFC3
prerank,Reactome_2022__N-glycan Trimming And Elongation In cis-Golgi R-HSA-964739,0.4932499743309427,0.865179996212299,0.6410256410256411,0.9971249067426678,1.0,3/5,12.48%,MOGAT1;MAN1A2;MANEA
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.30672389694228763,0.8651748615700386,0.8695652173913043,0.9966783493402477,1.0,16/87,15.85%,WNT7A;PDE3A;ID1;SOX9;TWSG1;LPXN;SMAD5;NR3C1;PTPRK;TGFBRAP1;SOX5;GDF9;GDF10;CRKL;WWOX;CGN
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Dental Pulp,-0.5431288789035411,-0.8650222429293513,0.7333333333333333,0.9777095394010171,1.0,2/8,7.03%,THY1;CD44
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.3820651184520072,0.8647812260748944,0.5161290322580645,0.9970391690769722,1.0,11/28,38.53%,HDAC2;AGO3;CAMK4;TNRC6B;CAMK2D;LBR;TNRC6C;AGO4;CREB1;CAMK2A;AGO2
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.5238956970804488,-0.8647136380727689,0.6875,0.9780636489365457,1.0,1/11,6.59%,TLR3
prerank,KEGG_2021_Human__Intestinal immune network for IgA production,-0.4706364127594439,-0.864676204620473,0.6206896551724138,0.9778678592714739,1.0,9/17,18.86%,IL15;HLA-DRA;MAP3K14;CCR10;LTBR;HLA-DRB1;CCL28;TGFB1;IL15RA
prerank,Reactome_2022__Reproduction R-HSA-1474165,-0.3780381199883448,-0.8645414786536777,0.7297297297297297,0.9778889023335194,1.0,9/68,10.25%,BLM;STAG3;BRCA1;SYCE2;SYCE1;ADAM21;LMNB1;RPA3;CD9
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.3699562945582967,-0.8645356804503164,0.676056338028169,0.9776313651503981,1.0,12/76,17.67%,KLF2;RPS27A;ATF3;PSMB9;PSMB6;PSMC3;UBC;ELOB;PSMA8;PSMA7;PSME1;RBX1
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.4840418651578233,-0.8643493881350259,0.6615384615384615,0.9776808268450021,1.0,5/13,31.21%,EIF2B2;INHA;EIF2B4;EIF2B5;COL9A3
prerank,Reactome_2022__MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,-0.4405516801175824,-0.8641763859569335,0.6666666666666666,0.977743150763149,1.0,3/17,12.77%,GRIN2A;TRPC3;GRIN2B
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.3597436513692887,-0.864003717727123,0.7236842105263158,0.9778518298527693,1.0,17/114,10.37%,TAGLN3;STMN2;IFIT1;S100A6;PLP1;ZDHHC22;SLITRK1;RND2;TLR3;EFNB3;GAP43;GFAP;ZIC1;ZNF536;NYAP1;PLPPR5;ISG15
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.3687044683713403,-0.8640002787684745,0.75,0.9775894345044397,1.0,20/73,18.82%,SLC6A15;SLC25A45;PDPN;SLC51A;AKR1C1;CEACAM1;SLC26A8;SLC38A4;SLC7A14;SLC3A1;SLC7A2;SLC43A2;SLC51B;SLC38A1;MFSD2A;SLCO1A2;ATP8B1;SLC7A7;SLC25A29;ABCG2
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.5812180614260043,-0.863896573202415,0.6470588235294118,0.9769858967918131,1.0,1/5,15.88%,MAN1A1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.5812180614260043,-0.863896573202415,0.6470588235294118,0.9769858967918131,1.0,1/5,15.88%,MAN1A1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.5812180614260043,-0.863896573202415,0.6470588235294118,0.9769858967918131,1.0,1/5,15.88%,MAN1A1
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.43692886891627214,-0.8638941664526096,0.6885245901639344,0.9767240300070746,1.0,6/23,23.98%,DND1;SLC11A1;VIP;AXIN2;MEIOC;EIF4ENIF1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.48791834222010894,-0.8638739070630175,0.7,0.9764803182460612,1.0,3/16,7.96%,PKP2;PROX1;ZFPM1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.3630737158374847,-0.8636804287765051,0.7631578947368421,0.9765788469000382,1.0,9/84,12.98%,SUV39H1;RPS27A;CENPV;CENPH;POLE3;NUF2;SOX15;UBC;FAM50A
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.4430060148458503,-0.8636082868516493,0.5909090909090909,0.9764561708212403,1.0,6/21,16.24%,CYP1B1;IGF1;CYP3A4;ADH4;RDH12;ALDH3A2
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.40605820545789234,-0.8635382865811605,0.6428571428571429,0.9763258499473092,1.0,3/28,14.98%,POU4F1;NDRG1;BOK
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.5507061557821296,-0.8632650007034877,0.7321428571428571,0.9760817329767386,1.0,3/8,22.39%,EGF;MGAT3;RDX
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.5507061557821296,-0.8632650007034877,0.7321428571428571,0.9760817329767386,1.0,3/8,22.39%,EGF;MGAT3;RDX
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.5507061557821296,-0.8632650007034877,0.7321428571428571,0.9760817329767386,1.0,3/8,22.39%,EGF;MGAT3;RDX
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.4918463247854011,-0.8632544484300864,0.6575342465753424,0.9758360997921909,1.0,2/11,10.16%,TYMP;SLC19A3
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.4769997679103556,0.863252702954241,0.7837837837837838,0.9998892606151597,1.0,5/13,20.81%,CCNE1;KAT7;HNRNPU;PDCD2;GJA1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.5469681127347104,0.8632227451290289,0.7368421052631579,0.9994957735554735,1.0,1/6,2.36%,ABCA1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.4421932477980921,0.863166549143693,0.631578947368421,0.9991456357856986,1.0,4/13,31.00%,SNAPC3;SPIN1;RPAP2;NIFK
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.3292527380431046,0.862971539978158,0.7368421052631579,0.9990267180177489,1.0,9/84,7.02%,ACE2;TFCP2L1;PPARGC1A;MUC20;EHF;LARP1B;MYO5B;ESRRG;FRK
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.345921384734617,0.8628553487926601,0.8076923076923077,0.9987630051467732,1.0,11/40,26.84%,GRPEL2;AKT2;PEX2;TIMM23;PEX6;CHCHD4;PEX12;SEC61A1;PEX16;SEC61A2;PEX5
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.42066740439538586,0.8627949350111888,0.7058823529411765,0.9984083468745226,1.0,3/17,5.99%,ABCD2;PLIN5;ABCD1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.47958335614438374,-0.8627201437027603,0.7076923076923077,0.9765712987315911,1.0,1/16,2.79%,SHTN1
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,-0.3798936826710575,-0.8626044594652504,0.7123287671232876,0.976556656677372,1.0,5/54,12.77%,TOMM7;RPS27A;MAP1LC3A;PINK1;UBC
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.37281314519578135,-0.8624082086030846,0.7532467532467533,0.9766497886668143,1.0,11/78,12.43%,WARS1;CAMK2N2;THY1;CAV3;CEACAM1;PTK6;SLC8A3;GADD45A;DAB2IP;SH3BP5;MVP
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.4452815231555146,0.8623320386212475,0.7317073170731707,0.9990245234844108,1.0,2/14,1.13%,WNT7A;SLIT1
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,-0.34145099951092356,-0.8618177870769519,0.7872340425531915,0.9775406314406314,1.0,38/236,17.31%,ABO;OGN;B3GALT2;ALDOB;CSPG4;RPS27A;NDST4;CEMIP;HS3ST3A1;BGN;FUT2;OMD;CD44;PAPSS2;ST3GAL6;FBP1;GYG2;GAPDHS;PGK1;PYGL;B3GNT2;GALK1;RBKS;CHST15;UBC;GPC3;TAC4;B4GALT7;CHSY3;GLYCTK;PFKFB4;CHST6;HS3ST3B1;HS6ST1;PFKL;RHD;PFKFB3;GPC1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.39108344672984563,0.8618122954878817,0.6176470588235294,0.99980089761215,1.0,9/27,16.77%,ABCD2;ACACB;ABCD1;MID1IP1;CPT2;ABCD3;SPX;CPT1A;ACSL3
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.3550075227095037,0.861789952057297,0.6296296296296297,0.9993819699830758,1.0,4/49,2.65%,ATP11C;PRELID2;ABCA1;MTTP
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.33061407524499653,0.8617064030173782,0.6666666666666666,0.9990330437239107,1.0,13/58,14.20%,POLD3;DNA2;PDE12;RFC3;ERCC2;DCP1B;DNASE1L2;EDC3;ERCC3;EXD2;GTF2H5;GTF2H2;POLK
prerank,Reactome_2022__TFAP2 (AP-2) Family Regulates Transcription Of Growth Factors And Their Receptors R-HSA-8866910,0.47346868643107387,0.8615905061868285,0.5833333333333334,0.9988717581508828,1.0,2/10,8.49%,EGFR;YY1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),-0.5566933290617857,-0.8613126467576278,0.6444444444444445,0.978200184208249,1.0,1/7,10.01%,WNT5A
prerank,CellMarker_Augmented_2021__Eosinophil:Peripheral Blood,-0.5755732625547221,-0.8611735024515992,0.75,0.9782081841797144,1.0,3/5,30.73%,IL3RA;IL5;CD14
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Corpus,0.329371551356266,0.8611643981077747,0.7894736842105263,0.9993311346690523,1.0,10/66,10.66%,SOX21;LYPD6B;RUNX1;MID1;SOX9;EGFR;CADPS2;MYO5B;FOXJ1;PTPRK
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,0.34354893683598114,0.8611532276589895,0.8636363636363636,0.9988971789565408,1.0,7/63,6.89%,SEM1;CCNE1;PSMD10;PSMA1;PSMD11;ANAPC1;PSMB5
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.43749818124289663,-0.8609972131272954,0.6451612903225806,0.978339205503875,1.0,7/21,15.93%,PLN;CAV3;JPH3;HPCA;NOS1;JPH4;CACNB1
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),-0.5472989504888783,-0.8609051421841624,0.6415094339622641,0.9782600435883153,1.0,2/5,19.04%,ARR3;ADM
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.4397070050562929,0.8607964333423893,0.6,0.9991744082370333,1.0,10/15,38.20%,UHMK1;CDC123;YTHDF2;RPS6KB1;POLR2D;MTOR;YTHDF3;RPS6KB2;DDX3X;KHDRBS1
prerank,KEGG_2021_Human__Hepatitis B,-0.3489559443686848,-0.860522063391548,0.7951807228915663,0.9787547299566604,1.0,20/131,18.28%,TGFBR2;TLR2;STAT4;TLR3;PRKCG;STAT1;IRF7;CREB5;CCNE2;IFIH1;FADD;FOS;PIK3CB;PIK3CD;CDK2;STAT6;PRKCB;CREB3;TGFB1;CDKN1A
prerank,Reactome_2022__Pyrimidine Salvage R-HSA-73614,0.4965210684206073,0.8604944067750897,0.6216216216216216,0.9994460345665315,1.0,1/8,5.09%,UCK1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.5448968900700674,-0.8604862100909593,0.6545454545454545,0.9785653776361433,1.0,2/6,11.79%,HLA-E;IL18
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4105562077082663,0.8604689508463452,0.6285714285714286,0.9990339945304383,1.0,1/14,6.78%,NOL11
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.48799002044820466,0.8604570650707712,0.6060606060606061,0.9985903226955585,1.0,5/8,29.99%,GTF2H5;GTF2H3;CDK12;CCNH;CDK13
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.4804793497981419,0.8604210055448053,0.6585365853658537,0.9982110778654125,1.0,1/8,0.44%,WNT7A
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.3549078669259978,0.8602713615047757,0.6333333333333333,0.9980081329428313,1.0,4/38,2.79%,SOX8;BMP2;ZNF358;LIG4
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.44328629312126083,-0.8598733203113893,0.6142857142857143,0.9794565430564736,1.0,2/15,11.74%,SVBP;PINK1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.6040607880992235,-0.8598051642548894,0.7377049180327869,0.9793438876570708,1.0,4/5,36.37%,ULK1;ULK2;FGF13;DCC
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.4732254517535671,-0.859668344209052,0.6984126984126984,0.9793234114998078,1.0,3/15,22.33%,FOLH1;ASS1;NIT2
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.5910637855493,0.8595458250328628,0.6744186046511628,0.9991216674475117,1.0,1/5,6.42%,CSAD
prerank,KEGG_2021_Human__Drug metabolism,-0.38542408886020607,-0.8594894625254275,0.6712328767123288,0.9794257361255162,1.0,4/56,6.51%,TYMP;IMPDH1;MAOB;GSTM5
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.5814446557851878,0.8592925144210781,0.6956521739130435,0.9991262227292446,1.0,2/5,24.70%,FYCO1;KIF3B
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.4228641921032417,-0.858853474194799,0.6617647058823529,0.9803975254690975,1.0,5/23,17.44%,EFNA1;USP50;GRIN2B;APH1A;PSME1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.3464556246245515,0.8587557838002395,0.7142857142857143,0.9997483690347151,1.0,12/47,17.54%,GNL3L;NAF1;CCT7;STN1;MAP3K4;HNRNPC;ATR;CCT3;POT1;HNRNPU;PKIB;TENT4B
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.3385745318185569,0.858683202789453,0.6666666666666666,0.9994386515391469,1.0,8/42,9.72%,AGER;CARD18;TNFAIP3;GIT1;FOXP1;STMP1;TMEM106A;TRIM16
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.4522669403683037,-0.8585979818760682,0.6181818181818182,0.9805889845174884,1.0,1/14,3.46%,IMPDH1
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.342952088075404,0.8584873560878489,0.76,0.9993473078476175,1.0,6/43,11.69%,HS3ST5;SDC4;SDC3;GPC5;EXT2;HSPG2
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.48962342911496654,-0.8581890468441918,0.6268656716417911,0.9810819481037356,1.0,2/9,7.93%,ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.46411931508843435,0.8581451913660026,0.6410256410256411,0.9996547952752575,1.0,3/11,14.00%,SIRT6;HMGB1;MDK
prerank,Reactome_2022__Biosynthesis Of Maresins R-HSA-9018682,-0.5715885936676837,-0.8581105303125196,0.72,0.9810022516338074,1.0,3/5,27.12%,CYP3A4;ALOX5;CYP2E1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.44112772521722404,-0.8580511434857064,0.7058823529411765,0.9808459604511817,1.0,8/23,20.77%,RPS27A;NOD1;IFIH1;UBC;ALPK1;RIPK2;CASP8;IKBKG
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3703923326236376,-0.8579579242605908,0.7297297297297297,0.9807536026812606,1.0,3/62,6.69%,THBS1;SULF1;BMP8A
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),-0.47308614458656834,-0.8578599484024853,0.6491228070175439,0.9806357633398112,1.0,2/8,15.12%,EGF;CD74
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.5396083591006258,-0.8572123311291575,0.6818181818181818,0.981505811783469,1.0,1/8,21.74%,OLFM1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.4815748533773977,-0.8571389977828113,0.6515151515151515,0.9813929347536059,1.0,3/12,15.90%,CCND1;PLK3;CDK2
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.5214983863564083,0.8571170938531917,0.6829268292682927,1.0,1.0,2/7,9.15%,AUP1;PLA2G4C
prerank,Reactome_2022__GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,0.3644643620748491,0.8567432292882777,0.7105263157894737,1.0,1.0,5/25,8.12%,CSPG5;SDC4;SDC3;GPC5;BCAN
prerank,Reactome_2022__Negative Feedback Regulation Of MAPK Pathway R-HSA-5674499,0.5305105944870654,0.8566476806891894,0.6808510638297872,1.0,1.0,3/5,29.88%,MAP2K2;BRAF;MAPK1
prerank,"Reactome_2022__PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",-0.4854349735012916,-0.856567241103754,0.7258064516129032,0.9822291355950934,1.0,3/13,12.88%,PTK6;ELMO1;RNASE1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3419114866305677,0.8563389772500205,0.76,1.0,1.0,8/59,8.86%,NGF;CNOT9;HCLS1;TENM1;EGFR;AKT1;STK4;CAPRIN2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.402960215825727,0.8562837833949108,0.6764705882352942,1.0,1.0,4/14,13.82%,NR1D1;TNFAIP3;TIRAP;RAB7B
prerank,Reactome_2022__G1/S-Specific Transcription R-HSA-69205,-0.43604206021053815,-0.8562331544948529,0.6774193548387096,0.9826491604967628,1.0,1/20,0.55%,TYMS
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.5192201750768978,-0.8562326553702897,0.6458333333333334,0.9823805303271353,1.0,3/7,34.74%,IFT88;PLS1;PDZD7
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.3560934229894194,0.8561490715048913,0.8,1.0,1.0,8/32,19.78%,TESK1;AKT1;SESN2;PLK1;KAT7;GLUL;EIF2AK3;PYHIN1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.5507099932098085,-0.8559071992807873,0.6949152542372882,0.9827314605404649,1.0,1/6,8.66%,SRF
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.41676373848131765,-0.8556706541255346,0.6617647058823529,0.9828579459045703,1.0,6/26,17.99%,IFI35;PLSCR1;SCIMP;DDX60;NMI;SLC15A4
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.44273193166521696,-0.8555786292675405,0.7323943661971831,0.982762717974814,1.0,9/19,19.43%,F8;F10;C1QTNF1;SERPING1;PLAT;F3;A2M;PDGFRA;PLAUR
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Large Intestine,0.2851950839855026,0.8553058038610554,0.9375,1.0,1.0,12/86,13.25%,ADAM32;MORC4;SPATA6L;C4ORF36;FRK;CCDC90B;ZNF268;INTU;BRWD1;BMS1P1;ALG11;ZC3H14
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.48866943415758995,-0.8550227868587094,0.7192982456140351,0.9836226440779245,1.0,5/15,28.63%,PARP9;WRAP53;SHLD1;DTX3L;KDM4D
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.3697468967637296,-0.8548378570340285,0.7534246575342466,0.9837284126097351,1.0,5/63,12.22%,GOLGA8O;RAB11A;GOLGA8B;MAPRE2;HAUS7
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),-0.5212570941194574,-0.8548327061302402,0.65625,0.9834650188779274,1.0,1/7,2.86%,SMTNL1
prerank,Reactome_2022__Metabolism Of Porphyrins R-HSA-189445,0.42394053925808434,0.8548138816605373,0.6578947368421053,1.0,1.0,7/19,16.76%,ALAS1;HMBS;COX10;ABCC2;FECH;FLVCR1;BLVRA
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,-0.3792095291952744,-0.8547443469823495,0.6987951807228916,0.9833977226329493,1.0,7/75,12.77%,ANO2;RPS27A;TRPC3;BEST1;ANO9;CLCA4;UBC
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.4225501506400565,0.8546735655619226,0.6388888888888888,1.0,1.0,6/13,29.35%,EXOSC6;DIS3;EXOSC8;EXOSC5;DIS3L;XRN1
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.4428181581250982,-0.8546576175244825,0.6911764705882353,0.9832897565457336,1.0,1/21,3.86%,BHMT
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.3728760429809438,0.8546142241934723,0.7692307692307693,1.0,1.0,5/35,5.13%,WNT7A;BMP2;SNORC;RUNX1;SOX9
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.4062252336943183,-0.8544991722285682,0.7564102564102564,0.9833370007666191,1.0,4/41,9.53%,S100A10;SYNPO2L;VIL1;PFN2
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.552975472079509,-0.8544529930417863,0.7377049180327869,0.9831782546525151,1.0,1/5,11.00%,NUAK1
prerank,CellMarker_Augmented_2021__Megakaryocyte:Blood,0.4011881227432924,0.8544179814853142,0.6285714285714286,1.0,1.0,1/20,0.05%,C1ORF162
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.427360183085543,-0.8543636482960559,0.711864406779661,0.9830399317080201,1.0,4/19,20.64%,MYH11;MYH9;LIMK2;MYL6
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.49007755628833477,0.8541244241518667,0.6428571428571429,1.0,1.0,2/7,9.28%,BMP2;SALL1
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,0.30192573083540375,0.8540436282540782,0.7647058823529411,1.0,1.0,7/76,10.13%,DGKB;DGKE;LYPLA2;PTDSS1;CHPT1;PLA2G4C;LPIN3
prerank,Reactome_2022__TCR Signaling R-HSA-202403,0.3054824103332595,0.853756307983558,0.8214285714285714,1.0,1.0,17/92,14.84%,CD247;SEM1;PSMD10;BCL10;PSMA1;PSMD11;CUL1;UBE2N;PSMB5;BTRC;NCK1;UBE2D1;PSMD14;PIK3CA;PSMD12;NFKB1;PIK3R1
prerank,Reactome_2022__p75NTR Signals Via NF-kB R-HSA-193639,0.448289000983169,0.8536923453635615,0.5945945945945946,1.0,1.0,1/15,0.43%,NGF
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.3593696061665098,0.8536584839781426,0.6875,1.0,1.0,4/22,6.69%,RITA1;BEND6;EGFR;AKT1
prerank,CellMarker_Augmented_2021__Epithelial cell:Kidney,0.47102660546664804,0.8536571459003729,0.6,1.0,1.0,2/10,13.67%,OCLN;CDH2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.3952544489108669,-0.8535714648883052,0.6323529411764706,0.9842613260931491,1.0,5/29,10.01%,NLRP12;APP;USP50;NLRP2;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.5243742755375969,-0.8535604024415094,0.6818181818181818,0.9840033708309429,1.0,5/9,28.78%,HLA-F;TGFB1;CUEDC2;TGFB2;TGFB3
prerank,CellMarker_Augmented_2021__8-Cell Stage Cell (Blastomere):Embryo,0.4509774629973531,0.8535479752530596,0.6,1.0,1.0,7/14,38.94%,HDAC2;EIF1AD;SERTAD1;LBHD1;MED31;DHX9;TBC1D13
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,-0.4655478745687637,-0.8535356729642469,0.7536231884057971,0.9837912761144674,1.0,4/13,22.72%,GNG3;GNG2;GNB4;GNB5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.4553338189577875,-0.8534039290796253,0.5714285714285714,0.9837316555519351,1.0,4/16,11.20%,TLR2;TLR3;SCIMP;SYK
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.4525262512734718,-0.8532317296985283,0.6923076923076923,0.9838066143012404,1.0,6/13,25.60%,HLA-E;GPI;PTPRC;XBP1;CD22;STX4
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,0.36932410968542106,0.852992180747248,0.5806451612903226,1.0,1.0,3/28,5.74%,POLD3;SLC19A1;RFC3
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.4007112661034786,-0.8529692689346812,0.71875,0.984008428714265,1.0,6/29,17.62%,SEMA3B;HTR2B;FN1;RADIL;SEMA3E;SEMA4G
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4245329591376945,-0.8528397668604676,0.7164179104477612,0.9840071542264481,1.0,6/26,20.15%,YWHAH;PPP3CC;NMT1;BOK;BBC3;CASP8
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.39910866926192745,-0.8527792453830143,0.6944444444444444,0.9838308585703627,1.0,6/44,7.03%,OGN;CSPG4;CEMIP;BGN;OMD;CD44
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.5133455033025945,-0.8524538924270216,0.6491228070175439,0.9842860876858953,1.0,1/7,16.59%,CLN3
prerank,Reactome_2022__Synthesis Of 5-Eicosatetraenoic Acids R-HSA-2142688,0.4709721893946529,0.8524056184143082,0.6285714285714286,1.0,1.0,2/8,17.84%,PON2;PON1
prerank,Reactome_2022__ROBO Receptors Bind AKAP5 R-HSA-9010642,-0.5240364554019332,-0.8522989719342445,0.6428571428571429,0.9843303718221317,1.0,1/7,7.29%,AKAP5
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.46224824018688304,0.8521941161851422,0.6285714285714286,1.0,1.0,4/10,23.65%,MOXD1;SMOX;SRM;SAT1
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,0.3701248567098897,0.8521117538929951,0.7333333333333333,1.0,1.0,6/30,15.53%,H2BC21;H2BC4;H2AC6;H3-3B;POT1;POLR2C
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.42521732332227724,-0.8518700043155065,0.7384615384615385,0.9848333729299334,1.0,3/23,9.88%,SLC39A14;TMC8;MT1H
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.48493753814140317,-0.8518514091872091,0.6470588235294118,0.9846418416384558,1.0,5/11,15.76%,ALOX12;CEACAM1;CD9;C1QTNF1;PRKCD
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.46087648069204384,0.8516824080393187,0.627906976744186,1.0,1.0,4/7,13.27%,AGER;TWSG1;SH3RF1;TARM1
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.36863023697715686,-0.8516576328087652,0.7857142857142857,0.9848405124290299,1.0,22/80,22.76%,COL4A1;CALD1;COL4A2;PDPN;P3H2;WNT5A;AMOTL2;PDLIM4;PLAT;NOTCH3;PCDH18;PTPN21;GFPT2;DPYSL3;NXN;ANTXR1;WWTR1;CD276;SFRP1;FBLIM1;CNN3;SLIT2
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.3985933966908469,-0.8515151351333423,0.7538461538461538,0.9848770006841401,1.0,5/33,17.76%,TGFBR2;KLF4;NOS1;EMD;LRP2
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,-0.32386872027046737,-0.8515006895839162,0.8478260869565217,0.9846273837532903,1.0,38/251,18.91%,ST6GAL1;ANK3;KDELR3;RPS27A;SLC17A5;GMPPB;F8;CTSC;GRIA1;ST3GAL6;TGFA;CD55;COPZ2;DCTN1;CTSZ;MAN1C1;TUSC3;UBC;F5;EGFL7;ST6GALNAC2;ANKRD28;GNE;MAN1A1;UBXN1;ANK1;MGAT5;PMM1;ARFGAP1;TRAPPC2L;GOLGB1;CFAP73;CTSA;MAN2A2;PTGES2;UAP1;ST8SIA3;GFPT2
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.4615100626973498,0.8515003658523745,0.6875,1.0,1.0,4/13,22.51%,IWS1;DDX25;PCID2;ENY2
prerank,KEGG_2021_Human__Nitrogen metabolism,0.47902983270856914,0.8514924929723262,0.6153846153846154,1.0,1.0,5/11,17.28%,CA2;GLUD1;CA3;GLUL;CA12
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,-0.36295704166255033,-0.8513993001887947,0.7407407407407407,0.9845247027335924,1.0,19/98,17.31%,OGN;CSPG4;NDST4;CEMIP;HS3ST3A1;BGN;OMD;CD44;PAPSS2;ST3GAL6;B3GNT2;CHST15;GPC3;B4GALT7;CHSY3;CHST6;HS3ST3B1;HS6ST1;GPC1
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.42629625259070225,-0.8513331559380768,0.6451612903225806,0.9843917131643664,1.0,1/18,1.11%,APLNR
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,0.34109972649747045,0.8511509896340806,0.7333333333333333,1.0,1.0,13/52,19.94%,NCSTN;MAML3;KAT2B;CDK8;CUL1;HEYL;KAT2A;HDAC2;EP300;HEY1;HDAC10;HEY2;HES5
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.33947662075497115,0.8511380511414836,0.7391304347826086,1.0,1.0,13/56,20.24%,GNL3L;TESK1;AKT1;TRAPPC12;SESN2;PLK1;TMEM35A;CENPQ;KAT7;EIF2AK3;CCDC88A;PYHIN1;PRKAA1
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,-0.37728438044313933,-0.850738970631039,0.684931506849315,0.9851618875707948,1.0,7/41,13.13%,CDH6;CLDN16;CLDN20;CLDN18;CDH19;CDH9;CDH12
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.3979184115502495,-0.8506568821542211,0.6666666666666666,0.9850692610786932,1.0,8/33,17.54%,MX1;SNCB;SYT1;NLGN1;SYT5;SNCG;SYT2;CDK5
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.3424808065577855,-0.8505314802782562,0.7951807228915663,0.9850044960772261,1.0,15/126,14.31%,ANXA1;TGFBR2;STMN2;ZFP36;OVOL2;KLF4;CCL2;CD44;VIL1;WNT5A;DAB2IP;RUNX2;NOS1;NR4A1;HYAL1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.2879219693118016,0.8503298046984976,0.8888888888888888,1.0,1.0,23/222,10.22%,G0S2;LEPR;RGCC;KSR2;SOX8;BMP2;PPARGC1A;ABCA1;ADRA1A;ADIPOR1;SOX9;ELOVL6;PDGFC;ESRRG;FBXO5;NCOA3;PRKAB1;SIRT6;HSF1;FOXJ1;TRIM16;CPT2;ZNF703
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.4985689935015542,-0.8502425300390493,0.65,0.9852860490729863,1.0,2/10,14.52%,ATG9A;WDR45
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.3014943798173277,0.8501903551937767,0.8947368421052632,1.0,1.0,16/96,12.57%,BMP2;GNL3L;CARD18;MEN1;TRIB3;STYX;BAG2;AKT1;RALB;CSNK1E;STK4;CAPRIN2;PLK1;MAPK8;DERL1;TFIP11
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.5391333020663227,-0.8501371547619413,0.7321428571428571,0.9852515835615244,1.0,1/6,7.87%,TENM4
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.5471384063355107,0.8500248221420335,0.7209302325581395,1.0,1.0,1/5,5.93%,PEX13
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,0.3210484200505512,0.8498836070371603,0.6785714285714286,1.0,1.0,6/59,6.89%,SEM1;PSMD10;PSMA1;PSMD11;CUL1;PSMB5
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In4:Brain,-0.5402049717042929,-0.8498483031896926,0.7903225806451613,0.9855960731898301,1.0,2/6,7.95%,TRPC3;MYH11
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.525803512419866,-0.8498160212677647,0.6909090909090909,0.9853797021417599,1.0,1/10,3.28%,ABCA8
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.3802571416997084,-0.8494740535297396,0.7317073170731707,0.9857264954494906,1.0,5/70,8.11%,RECQL4;KREMEN2;PRDX4;TEAD2;BAIAP2L1
prerank,CellMarker_Augmented_2021__CD141+CLEC9A+ Dendritic cell:Blood,0.3146401473861337,0.8494075776435414,0.75,1.0,1.0,12/70,15.62%,RGS10;PRELID2;FLT3;NDRG2;IDO1;CPNE3;PDE4DIP;HAVCR2;DSE;FHIP1B;SLC24A4;ID2
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.28441821991190824,0.8493526446768308,0.9,1.0,1.0,21/132,15.59%,HMMR;PSMD10;CDC25A;PSMA1;RCC2;PSMD11;CUL1;PSMB5;FBXO5;HAUS1;CSNK1E;CEP290;CEP152;PLK1;PCM1;PSMD14;ALMS1;PSMD12;CEP192;TUBG1;RAD51B
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.5379990805325413,-0.8492589203580705,0.7368421052631579,0.9858964076040554,1.0,2/7,15.09%,ARG2;ASS1
prerank,Reactome_2022__MECP2 Regulates Transcription Of Neuronal Ligands R-HSA-9022702,-0.5123376656687069,-0.8491710788553282,0.7068965517241379,0.9857987358502214,1.0,1/7,10.36%,SST
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.45628688995378164,0.8491671193746877,0.717948717948718,1.0,1.0,5/12,24.83%,S1PR1;HEY1;RBPJ;TGFBR1;BMP7
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.47688125313024476,-0.8491399263174294,0.6610169491525424,0.9853387256630028,1.0,6/11,31.47%,UAP1;GFPT2;UAP1L1;GNPNAT1;GNPDA1;AMDHD2
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.47688125313024476,-0.8491399263174294,0.6610169491525424,0.9853387256630028,1.0,6/11,31.47%,UAP1;GFPT2;UAP1L1;GNPNAT1;GNPDA1;AMDHD2
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.5346802876309696,-0.8486231317297152,0.6615384615384615,0.9860960596628594,1.0,4/6,23.12%,XRCC1;PRKCD;RNF112;SP1
prerank,CellMarker_Augmented_2021__CD8+ T cell:Lymphoid Tissue,-0.4546477572497312,-0.8485387911267239,0.7457627118644068,0.985958107044383,1.0,3/15,3.84%,CD5;SKAP1;GPR171
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.4798420518359261,0.8484240438737084,0.65,1.0,1.0,1/12,1.39%,NCSTN
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,-0.4110311060578381,-0.8481790919625374,0.703125,0.9863897715462443,1.0,3/29,12.88%,RPS27A;UBC;RNASE1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.3322940427573615,-0.8481066239959845,0.7738095238095238,0.9862795277282326,1.0,28/209,16.14%,TLCD2;RSPH4A;PKP2;CALD1;ANK3;STAG3;FSCN1;TEAD2;BAIAP2;BAIAP2L1;SPAG17;NEFH;VIL1;SYCE2;SYCE1;WAS;CFAP74;WNT5A;DMTN;TEX11;NLGN1;TFAP4;ELOB;CD74;ADD2;IL1RAP;LRGUK;RHOD
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.4037601914206228,-0.8480919530763517,0.6891891891891891,0.9860282940825591,1.0,7/18,22.75%,MLLT11;PINK1;GPER1;BBC3;PLAUR;FAM162A;HRK
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Corneal Epithelium,0.2926254644661755,0.8480033738708636,1.0,1.0,1.0,10/93,12.79%,SPSB4;TSPAN11;EFS;GAS1;PCBP4;CNTFR;EBF4;HEYL;CASKIN2;DRD2
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Liver,0.2926254644661755,0.8480033738708636,1.0,1.0,1.0,10/93,12.79%,SPSB4;TSPAN11;EFS;GAS1;PCBP4;CNTFR;EBF4;HEYL;CASKIN2;DRD2
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Corneal Epithelium,0.2926254644661755,0.8480033738708636,1.0,1.0,1.0,10/93,12.79%,SPSB4;TSPAN11;EFS;GAS1;PCBP4;CNTFR;EBF4;HEYL;CASKIN2;DRD2
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Laryngeal Squamous Epithelium,0.2926254644661755,0.8480033738708636,1.0,1.0,1.0,10/93,12.79%,SPSB4;TSPAN11;EFS;GAS1;PCBP4;CNTFR;EBF4;HEYL;CASKIN2;DRD2
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,-0.356067625604229,-0.8479429394321888,0.7974683544303798,0.9860592186729076,1.0,16/70,19.82%,MET;ITGA5;CTNNA3;CAV3;SHC2;ARPC5L;FN1;ELMO1;PIK3CB;PIK3CD;VCL;SEPTIN9;SEPTIN1;CLTB;ARPC3;DNM1
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,0.3453965661317958,0.8477978781612453,0.7333333333333333,1.0,1.0,9/49,13.78%,SEM1;PSMD10;PSMA1;PSMD11;PSMB5;KLHL12;PSMD14;DVL2;PSMD12
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3208148131018585,0.8476524497886943,0.76,1.0,1.0,15/47,20.79%,RGCC;CNOT9;PCBP4;PLAGL1;CNOT2;CRADD;E2F4;EP300;CNOT8;CNOT6L;CNOT1;CNOT4;MDM2;TRIAP1;CASP2
prerank,Reactome_2022__Defective CHST3 Causes SEDCJD R-HSA-3595172,-0.5316575508726457,-0.8475298191934731,0.6984126984126984,0.9865457721902336,1.0,2/8,5.96%,CSPG4;BGN
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.4580211386350902,0.8474781980786239,0.6590909090909091,1.0,1.0,2/11,12.49%,PIK3R4;PIK3C3
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),-0.5202158641656405,-0.8473951672582031,0.6607142857142857,0.986531239861886,1.0,2/6,20.40%,FADD;HES1
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.5190797654462362,-0.84733898773517,0.7017543859649122,0.9863456259499368,1.0,3/7,27.42%,PSMC3;PSMC4;TP53
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.4579983384946757,0.8473247586430083,0.6190476190476191,1.0,1.0,2/13,3.97%,LEPR;RUNX1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.2745895879948304,0.8473125264003349,1.0,1.0,1.0,41/239,15.61%,CHRNA4;POLD3;DNA2;UBE2T;LIG4;KPNA2;TOP3B;PRIMPOL;MEN1;SMARCAD1;LTO1;RFC3;STN1;SMARCAL1;UBE2N;TRIM28;VCP;CSNK1E;DCLRE1B;RAD52;HMGB1;DNASE1L2;TOP1MT;MSH2;ATR;XRCC2;HUS1;ORC5;NUDT15;ERCC3;THAP9;EXD2;DDX21;RAD9B;POLK;ATRIP;MSH3;POT1;ALKBH3;RAD51B;ASF1A
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.34004299563704943,-0.8472964779361531,0.8192771084337349,0.9861500507837511,1.0,26/141,17.53%,SOCS3;STMN2;RCAN2;GRIN2A;PLP1;GRIA3;OPALIN;GAP43;GFAP;TCEAL6;IGSF21;CA10;TCEAL2;FGF1;SYNM;ADCY5;C11ORF87;BAALC;SYNPR;RGS7BP;TMEM132C;CNTN2;PHYHIP;TCEAL5;ADCY8;ETS1
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.4380939437414232,-0.847288976758534,0.6764705882352942,0.9858891998073377,1.0,2/14,12.36%,GNG3;GNG2
prerank,Reactome_2022__FBXW7 Mutants And NOTCH1 In Cancer R-HSA-2644605,0.5214699113997656,0.8472750654579912,0.6730769230769231,1.0,1.0,1/5,5.98%,CUL1
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.3476402271272641,-0.8468532647431243,0.8,0.9864229091614057,1.0,16/92,17.65%,RPS27A;APP;NOD1;NLRC5;KCNH8;TLR3;RPS6KA1;IRF7;BIRC3;TNIP2;UBC;FADD;FOS;USP18;ALPK1;RIPK2
prerank,Reactome_2022__Sulfur Amino Acid Metabolism R-HSA-1614635,-0.46411642760691524,-0.8465531594065728,0.746268656716418,0.9867326463796411,1.0,3/20,9.64%,APIP;BHMT;SQOR
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,0.34270318202145406,0.8465383988678925,0.8,1.0,1.0,5/44,6.89%,SEM1;PSMD10;PSMA1;PSMD11;PSMB5
prerank,KEGG_2021_Human__Melanogenesis,-0.35876379116431606,-0.8464573745858219,0.7777777777777778,0.98664270824062,1.0,6/78,11.16%,LEF1;WNT8B;ADCY7;PRKCG;WNT5A;ADCY5
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.43419270063728904,-0.8463728659757288,0.7333333333333333,0.9865302109498556,1.0,1/21,1.95%,GRIN3A
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.5400646922143004,0.8463012352228997,0.7441860465116279,1.0,1.0,3/6,24.42%,APEH;VPS4B;ABCE1
prerank,"Reactome_2022__Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",-0.4414092144244308,-0.846273227392161,0.6896551724137931,0.9864403757488281,1.0,2/12,12.75%,SEC11C;C1QTNF1
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,-0.38164569952109434,-0.8462488629277771,0.7027027027027027,0.9861999527395642,1.0,16/45,23.14%,SLC32A1;SYN3;SLC18A2;SYN2;CPLX1;SYT1;GAD1;GAD2;PPFIA1;SH2D3C;SLC1A6;SLC17A7;ALDH5A1;ARL6IP5;SLC22A1;RIMS1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.39034595451377047,0.8462000322624388,0.7631578947368421,1.0,1.0,6/24,9.38%,SOX8;SOX9;LHFPL2;NCOA4;AR;MSH2
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.4954331429124951,-0.846178797050376,0.7090909090909091,0.9858198648925157,1.0,3/8,16.90%,WDR1;ANK1;CRB2
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.4954331429124951,-0.846178797050376,0.7090909090909091,0.9858198648925157,1.0,3/8,16.90%,WDR1;ANK1;CRB2
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.5146843688016893,-0.8461710096249854,0.6984126984126984,0.9855722770395143,1.0,3/9,15.47%,GCNT1;SELP;ADD2
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.39433711375383296,0.8460650359917244,0.5862068965517241,1.0,1.0,2/24,4.42%,POU3F1;POU3F2
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.4075240675980294,-0.8459390714132852,0.5789473684210527,0.9858514818723707,1.0,7/18,25.05%,APP;SCN2A;CDK5;TRPC5;FAM162A;SIAH1;FAS
prerank,Reactome_2022__tRNA Modification In Mitochondrion R-HSA-6787450,0.49779727765689813,0.8458308586628005,0.6595744680851063,1.0,1.0,2/8,16.15%,TRIT1;MTO1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.5908421086253222,-0.8455947863298138,0.7142857142857143,0.986253390786509,1.0,1/5,0.67%,KCNQ1
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,0.3628492556142032,0.845467606715846,0.8125,1.0,1.0,12/35,21.79%,ANKRD26;ARHGAP5;HOMER2;PIK3R1;VANGL1;PICALM;TXNL1;CKAP4;CCDC88A;RBMX;PTPN13;KTN1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.5125559955556045,0.8453646699480667,0.7,1.0,1.0,2/7,14.00%,PPP1R10;MDK
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.39754162755753353,-0.8453643271784975,0.7236842105263158,0.9864069347741412,1.0,8/48,14.21%,PLK2;ANGPTL3;WNT5A;DAB2IP;HECW2;GPC3;VIP;OAZ2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.33553360646435565,-0.8453407128562901,0.8313253012048193,0.9861995493702703,1.0,27/138,20.77%,TRIM22;TRIM5;PLK2;HTR2B;NOD1;BST2;BIRC3;PINK1;SHISA5;TNIP2;MAP3K14;FADD;TNFRSF1A;APOL3;CD74;LTBR;HLA-DRB1;PRKCB;ALPK1;RIPK2;CARD11;CD4;LGALS1;CX3CL1;CASP8;TRIM62;IKBKG
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),-0.5583728224581311,-0.8452738774406284,0.7090909090909091,0.9860774524483604,1.0,2/6,24.13%,PTPRF;PTPRD
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.2911639196604786,0.8451004910508153,0.9411764705882353,1.0,1.0,25/108,21.24%,GDAP1;SRPRB;ZDHHC14;ZDHHC11;TRAK2;MFF;VPS37A;ZDHHC18;AP1S3;TOMM22;TAOK2;ZDHHC20;VPS37B;ZDHHC21;TIMM23;GOLGA7;ZDHHC11B;PEX6;ZFAND6;RAB3IP;ICMT;PEX12;PIKFYVE;KATNB1;ZDHHC6
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.4788729886515523,0.8450046354412944,0.7674418604651163,1.0,1.0,1/11,0.08%,MEOX2
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.5219161842099898,0.8449654751882947,0.7142857142857143,1.0,1.0,2/5,9.89%,ACADM;ABHD1
prerank,KEGG_2021_Human__Endocytosis,-0.32511286078426765,-0.8448780464021729,0.8555555555555555,0.9865289596939794,1.0,17/220,11.40%,EPN1;TGFBR2;HLA-A;RAB11A;SH3GL2;RAB11FIP5;HLA-C;PLD1;CAV3;ACAP1;LDLR;PLD2;RAB11FIP1;SH3GL3;HLA-B;ARPC5L;HLA-E
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.4549631923299062,-0.8448157669189422,0.676923076923077,0.9863918167172292,1.0,1/18,1.55%,SUV39H1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.40838267758418867,0.8448087515449401,0.6875,1.0,1.0,4/16,16.77%,ELOVL6;ELOVL2;HACD2;ACSL3
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Abdominal Adipose Tissue,0.3418783582899636,0.8447590940201395,0.6785714285714286,1.0,1.0,4/52,5.17%,SPSB4;MEX3A;FREM1;TRIM24
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Abdominal Adipose Tissue,0.3418783582899636,0.8447590940201395,0.6785714285714286,1.0,1.0,4/52,5.17%,SPSB4;MEX3A;FREM1;TRIM24
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,0.3435162700245807,0.8447254744745932,0.8529411764705882,1.0,1.0,5/45,6.89%,SEM1;PSMD10;PSMA1;PSMD11;PSMB5
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.447345575173264,0.8446669743270102,0.65625,1.0,1.0,4/13,24.99%,LPIN3;CEPT1;ETNPPL;CHKA
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.29172513664575045,0.84434134794905,0.9333333333333333,1.0,1.0,21/147,14.00%,LIMD1;CXXC4;AMER2;BMP2;PSMD10;BICC1;CCDC88C;PSMA1;GREM1;PSMD11;SOX9;PSMB5;STK4;KLHL12;INVS;PSMD14;TAX1BP3;DVL2;PSMD12;TMEM170B;MDK
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.2785605397788007,0.8441905162630226,0.9333333333333333,1.0,1.0,26/153,15.51%,DGKB;PIP5K1B;PLD6;DGKE;PI4K2A;PIK3R4;ABHD5;CPNE3;CSNK2A1;PTDSS1;CHPT1;CSNK2A2;PLA2G4C;SACM1L;LPIN3;PIK3C2G;PLEKHA3;PIK3C3;RAB4A;PIK3CA;GNPAT;FIG4;PIK3R1;PIP4K2B;DGKH;CPNE1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.3973371438849268,-0.8439053181322144,0.7397260273972602,0.9878968406447783,1.0,3/40,8.69%,HELB;POLQ;WAS
prerank,Reactome_2022__RUNX3 Regulates CDKN1A Transcription R-HSA-8941855,-0.5432726386216171,-0.8438610700112308,0.660377358490566,0.9877143588946455,1.0,4/6,30.06%,TGFB1;CDKN1A;TP53;SMAD3
prerank,KEGG_2021_Human__Vitamin digestion and absorption,-0.4509634237147399,-0.8437740505550072,0.7384615384615385,0.9876045286366981,1.0,4/16,10.16%,PLB1;RBP2;FOLH1;SLC19A3
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,0.30664881692741613,0.8437119067356549,0.68,1.0,1.0,9/78,10.96%,ACE2;S1PR1;KEAP1;SIGMAR1;NR3C1;AP2B1;RBBP4;ATP1A2;NCK1
prerank,KEGG_2021_Human__Axon guidance,-0.32931767790081845,-0.843397238061799,0.8295454545454546,0.9880300091972138,1.0,20/166,17.77%,EFNA1;MET;L1CAM;SEMA3B;LRRC4;TRPC3;EFNB3;WNT5A;PPP3CC;UNC5B;SLIT3;FES;SEMA3E;PIK3CB;PIK3CD;DPYSL2;RHOD;CDK5;SEMA4G;LIMK2
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.40048043223055224,0.8431410832808525,0.5609756097560976,1.0,1.0,7/19,21.00%,TFB2M;TFB1M;ZCCHC4;METTL15;NSUN3;FBL;MRM3
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.4492243540569437,-0.8430691115316656,0.746268656716418,0.9883677438868749,1.0,5/14,17.19%,RNASE1;NOXA1;PDZD2;PRKCD;PRKCB
prerank,CellMarker_Augmented_2021__Oral Keratinocyte Stem cell:Oral Mucosa,-0.37132554074019075,-0.8428876110161116,0.7435897435897436,0.9884628134026381,1.0,13/57,17.21%,MET;EPS8L2;ITGA2;OSMR;HR;SLC44A3;AMOTL2;RHBDF1;ITGA3;LAMA3;ITGB4;RHOD;PTPRF
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,-0.3858537727387958,-0.8428276043548686,0.8026315789473685,0.9882879219807189,1.0,4/49,10.55%,CCNB2;VRK2;LMNB1;CCNB1
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,-0.4645282948219467,-0.8424524288747209,0.7272727272727273,0.9886777846011185,1.0,4/14,22.72%,GNG3;GNG2;GNB4;GNB5
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.5138531791628906,0.8422734532455473,0.7073170731707317,1.0,1.0,2/6,14.52%,MSH2;MSH3
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.44882380196820776,0.8422575015588237,0.5681818181818182,1.0,1.0,2/9,4.42%,ASCL1;POU3F2
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.4182591053673379,-0.8420906620557218,0.7123287671232876,0.989054949263991,1.0,1/22,2.93%,GMPR
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.4838676674954857,-0.8420107730906731,0.6551724137931034,0.9889624460338532,1.0,4/9,17.15%,ADCY7;ADCY5;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.3451822759132539,-0.8419706398177675,0.8414634146341463,0.9887751256732,1.0,14/110,16.99%,SOCS3;MTMR7;ITPKC;INPP5D;VAC14;SBF1;PLEKHA4;BMX;PITPNM2;PIK3CB;PGAP2;PIK3CD;PIGA;PIGH
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.3766182784073511,0.8419222630471328,0.7,1.0,1.0,1/22,0.97%,DSCAM
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,0.2963192106262962,0.8419187294603365,0.7777777777777778,1.0,1.0,19/78,20.89%,GOLT1A;NUP42;NUP37;NUP54;PRKACB;NDC1;MAP4K5;NUP214;MAP4K2;AAAS;NUP188;NUP205;SLC37A1;G6PC3;PCNX4;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.52061524900383,0.8418037921819433,0.6428571428571429,1.0,1.0,2/5,11.43%,DCP1B;EDC3
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.41139723889258595,-0.841659571104425,0.7530864197530864,0.9891095325199557,1.0,3/33,6.56%,PROX1;BRCA1;CEACAM1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.3548161905183522,-0.8415739625335319,0.7948717948717948,0.9890021179973181,1.0,17/84,17.02%,KCNQ1;RIMBP2;APLNR;ANK3;MAOB;SHC2;LGR5;ADCY5;IGFBP5;SLC44A3;ITGA9;RASL12;TMEM132C;ZNF704;RAI2;SYT13;LRIG1
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.43241850426215545,0.8414973313974928,0.6216216216216216,1.0,1.0,3/14,9.15%,PLIN5;AUP1;PLA2G4C
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.4637308686468315,-0.8413988875297992,0.6290322580645161,0.9890394412194725,1.0,5/16,17.95%,CCL2;PLK3;IGF1;TSC2;TGFB1
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,-0.3869878965175898,-0.841300595590499,0.7,0.9890019298599575,1.0,4/39,8.45%,PLN;ITPR3;ATP1B1;SLC8A3
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.4411306823159534,0.841232545207809,0.75,1.0,1.0,4/12,35.04%,SNX2;SNX1;SURF4;TRAPPC10
prerank,CellMarker_Augmented_2021__Interneuron:Embryonic Prefrontal Cortex,0.385634846180943,0.8412125075861999,0.6896551724137931,1.0,1.0,6/21,14.00%,PHLDA1;UBE2T;ERBB4;PDE4DIP;ARX;MDK
prerank,KEGG_2021_Human__Fanconi anemia pathway,-0.37958879791482303,-0.8411367262644525,0.6933333333333334,0.9890816167991554,1.0,6/45,13.39%,BLM;BRCA1;PMS2;RPA3;FANCI;RPA1
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.5349058620223879,0.841126892241524,0.6666666666666666,1.0,1.0,1/6,1.36%,DCHS1
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.27602237990767214,0.8410473680421141,1.0,1.0,1.0,71/445,16.55%,SPSB4;RNF6;ERCC8;RNF25;FBXO45;KLHL8;SPSB2;IRF2BP1;UBE2T;PSMD10;BCL10;RFWD3;ELOC;PSMA1;MSL2;MKRN3;PSMD11;TRIM24;KEAP1;PHC1;FBXL14;PEX13;CUL1;UBE2N;PSMB5;COMMD1;VCP;BLMH;RNF103-CHMP3;RNF146;RNF14;FBXO30;FBXL3;LMO7;FBXO9;UBE2G1;FBXO15;BTRC;PLK1;KLHL12;DTX4;RNF114;UBE2D1;RCHY1;PSMD14;RNF141;SASH1;DERL1;SH3RF1;CUL2;TSPAN17;FBXO27;TMEM129;PSMD12;FBXO10;UBE4A;MUL1;PEX2;PPIL2;RNF26;UBE3B;FBXO21;RNF11;CBLL1;RC3H1;FBXL17;MARCHF7;TRIM3;VPS11;KLHL24;HERC2
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.49686749681924086,-0.8410454789131518,0.7017543859649122,0.9889967569479531,1.0,4/10,25.60%,STX19;STX1B;STX3;STX4
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.4215410601604705,-0.8408898309117507,0.6323529411764706,0.9890440090043833,1.0,3/17,12.44%,GADD45A;PAQR3;DMTN
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.4164107092637888,-0.8407271703006675,0.7230769230769231,0.9891012004450072,1.0,5/31,18.14%,NEFL;HAP1;DCTN1;SYBU;MAPT
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.3018175607925628,0.8406347387710462,0.8461538461538461,1.0,1.0,27/70,30.04%,U2AF1;NUDT21;WDR33;CSTF3;CPSF6;PAPOLA;CPSF7;MTPAP;THOC3;THOC1;TENT4B;CLP1;RPRD1B;CPSF2;SSU72;PAPOLG;SRSF9;CSTF1;MAGOH;RPRD2;SRSF2;TENT2;POLR2D;SCAF8;MAGOHB;PABPC1;CSTF2T
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.37735406176823616,0.8406171914145011,0.6285714285714286,1.0,1.0,4/21,4.32%,PSMD10;SPRED1;SMYD2;KMT5A
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.44715800926729954,-0.8405725270205341,0.7321428571428571,0.9891284754481192,1.0,5/20,15.79%,TYMS;SPON2;CCNB1;P2RY10;STMN1
prerank,Reactome_2022__FRS-mediated FGFR3 Signaling R-HSA-5654706,0.4204562435905118,0.8405283971614016,0.6153846153846154,1.0,1.0,1/12,3.57%,NRAS
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.3919390772907744,-0.8404873687148916,0.7532467532467533,0.9890287547434614,1.0,8/46,13.56%,MYOF;DYSF;SRF;IGF1;WNT5A;FGF1;MYH9;SLC11A1
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.4566940382490482,0.8402576142569536,0.6923076923076923,1.0,1.0,2/11,2.51%,GABRA4;GABRG1
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.40818252810228445,-0.8397627645315632,0.7121212121212122,0.9901637115673707,1.0,6/27,14.44%,RPS14;HELB;RPS16;RPS8;RPS21;TSR2
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.531011957225269,-0.8395158409316268,0.7307692307692307,0.9903350141218709,1.0,1/5,10.12%,SCIMP
prerank,CellMarker_Augmented_2021__T cell:Ascites,-0.4378527015134949,-0.8394554911055051,0.65,0.9902126608796669,1.0,6/20,4.84%,MYO1F;CD5;TAGAP;GPR171;SLA;ARHGAP9
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.3876056292023996,-0.8394249438656721,0.6557377049180327,0.9900306807988724,1.0,5/28,17.79%,P2RY12;DMTN;RHOD;VCL;PTPRO
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.3762192225120129,-0.8393249590449164,0.7733333333333333,0.9899407985257543,1.0,7/61,11.12%,CDKN2A;NLRP12;KLF4;NLRC5;CYP1B1;NLRP2;DAB2IP
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.2567905170680532,0.8392527737037581,1.0,1.0,1.0,64/351,20.88%,LIMD1;MACIR;FHDC1;CEP19;SPAG16;BBS9;EIF2S1;RAB23;SSX2IP;EXOC8;CEP20;GORASP2;EXOC6;HAUS1;STX7;SNF8;INTU;DZIP1;CNGA4;CEP290;AUP1;VPS37A;RAB8B;PTPN23;PLA2G4C;FOXJ1;VTA1;PARVA;RAB1B;PCM1;EDC3;PRRC2C;PIK3C3;G3BP1;CHMP2B;SCLT1;TEKT5;E2F4;TTC8;VPS37B;NEK1;UNC119B;TCTN3;IQCB1;RAB8A;RC3H1;TMEM237;VPS4B;UBXN10;MKKS;SNAP29;EXOC5;YTHDF2;CHMP6;RUFY4;GOLGA8N;PATL1;RAB3IP;SEPTIN6;UBAP2L;WDR11;BBS2;TMEM138;CEP83
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.4439520329346711,-0.8391011369498401,0.7397260273972602,0.9900920911084412,1.0,5/22,10.38%,DOK1;PTK6;HAP1;EGF;TGFA
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.37895165564569105,0.8387435522686197,0.6551724137931034,1.0,1.0,6/22,21.58%,PDE12;CSTF3;POP1;TOE1;ERN1;ZC3H12C
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),-0.48224763395757664,-0.838717352598956,0.6666666666666666,0.9905937137878863,1.0,1/8,3.00%,SLC39A14
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.3756567721196797,-0.8386788194070576,0.75,0.9903944344636132,1.0,3/64,5.04%,TRAM1L1;SHTN1;APP
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.34616739195469537,0.8386218544314508,0.6774193548387096,1.0,1.0,6/41,9.72%,ASCL1;BRINP3;SOX9;RORB;ADNP2;TRIM16
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.29967198701301134,0.8385828751659907,0.75,1.0,1.0,27/109,15.08%,PCDH19;TSPAN11;ADGRA1;SNAP91;SPRY1;PDGFD;ADGRB3;MAPK10;TMEM47;EFS;GRIA2;NOVA1;FAT3;MEGF10;ATP1A2;PCDH17;CNTFR;GPM6B;ANK2;EMX2;TMEM35A;SLC6A1;SHC3;FAIM2;NDRG4;SLC35F1;PURG
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.5871320534086494,-0.8383067703847913,0.7586206896551724,0.9908410645570004,1.0,3/5,31.23%,MAPT;HDAC6;BAG3
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.31923220172775224,0.8381481740971357,0.7916666666666666,1.0,1.0,4/66,3.46%,FGF6;GALNT3;SPRED1;NDNF
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.34921710923531885,-0.8380136450493458,0.7468354430379747,0.9910912842294027,1.0,19/75,20.35%,POU4F1;KCNB1;KIF14;CCL2;PRKCG;MAG;UNC5B;PINK1;GRID2;BDNF;NRBP2;CLN3;SNX6;CDK5;NUPR1;VSTM2L;FOXB1;SET;NSMF
prerank,CellMarker_Augmented_2021__Progenitor cell:Undefined,0.3116662274754283,0.8378660635106182,0.8260869565217391,1.0,1.0,14/84,16.34%,KPNA2;POFUT1;CCT7;OSTC;SIGMAR1;PSMB5;ALCAM;CCT3;PRDX1;GANAB;LRRC42;TCTN3;STT3A;LRRC59
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,-0.3379370597302409,-0.8376907557297065,0.8352941176470589,0.9914406721599863,1.0,17/131,13.97%,TLR2;RPS27A;APP;NOD1;NLRC5;NDUFA2;KCNH8;TLR3;RPS6KA1;IRF7;CTSS;BIRC3;TNIP2;SIGIRR;UBC;FADD;FOS
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.44044076603130233,-0.8375660500412588,0.7678571428571429,0.9914200746378753,1.0,2/16,9.91%,PTP4A3;TCP1
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.48215089388770377,-0.8373706181167803,0.7619047619047619,0.9915582858764924,1.0,3/9,8.11%,GAS2L3;BAIAP2;BAIAP2L1
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.42732003039934563,-0.8373367806404352,0.6956521739130435,0.9911029184815479,1.0,5/19,20.15%,YWHAH;PPP3CC;NMT1;BBC3;CASP8
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.42732003039934563,-0.8373367806404352,0.6956521739130435,0.9911029184815479,1.0,5/19,20.15%,YWHAH;PPP3CC;NMT1;BBC3;CASP8
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.5075178636942641,-0.8370894934070878,0.7166666666666667,0.9912782923642217,1.0,1/10,3.62%,RAMP3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.41477779974218476,-0.8370469872232885,0.7236842105263158,0.9911164864069009,1.0,5/41,16.68%,HIC1;BRCA1;BCL2L2;BOK;PML
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),0.5376997317874624,0.836955658845165,0.6818181818181818,1.0,1.0,3/5,23.79%,HEY1;HEY2;RBPJ
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),0.5376997317874624,0.836955658845165,0.6818181818181818,1.0,1.0,3/5,23.79%,HEY1;HEY2;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.5149546933232035,-0.8366366820773662,0.6545454545454545,0.9913133572701462,1.0,1/6,11.45%,MAPRE2
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.5149546933232035,-0.8366366820773662,0.6545454545454545,0.9913133572701462,1.0,1/6,11.45%,MAPRE2
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.47951401560786955,-0.8365580300351035,0.7045454545454546,0.9911863433488938,1.0,3/6,8.52%,COL5A1;ITGA5;PLET1
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,0.3804304469279524,0.8365140362863892,0.6875,1.0,1.0,3/18,9.92%,NRAS;EGFR;ERBB4
prerank,Reactome_2022__Signaling By NODAL R-HSA-1181150,0.41703980322568046,0.8363676915457353,0.6285714285714286,1.0,1.0,2/14,12.58%,ACVR1C;ACVR2A
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,-0.3611796195666062,-0.8363441381955679,0.7866666666666666,0.9913317509533935,1.0,8/59,13.97%,RPS27A;NOD1;KCNH8;RPS6KA1;IL17RE;TNIP2;UBC;FOS
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.44729510941908024,0.8363182068383364,0.5789473684210527,1.0,1.0,4/11,19.81%,TTL;AGBL1;GPLD1;ICMT
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.40031410085038666,-0.8360278939503131,0.7466666666666667,0.9917048079822717,1.0,7/37,17.84%,DUSP1;CAV3;DAB2IP;PAQR3;PIK3CB;PRKCD;HIPK3
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,0.327596168810853,0.8360234350424072,0.85,1.0,1.0,12/43,15.59%,SEM1;DNA2;RFC3;MSH2;XRCC2;HUS1;RRAD;RAD9B;ATRIP;PALB2;MSH3;RAD51B
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.5511163362524022,-0.8359909534593387,0.75,0.9912479759647037,1.0,1/5,12.81%,CD63
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.5511163362524022,-0.8359909534593387,0.75,0.9912479759647037,1.0,1/5,12.81%,CD63
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.3903183246124954,-0.83570429411092,0.6712328767123288,0.9915613987460884,1.0,8/35,18.04%,PODXL;CEACAM1;MINK1;RNASE10;SPINT2;PTPRR;TGFB1;FERMT3
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.3993699959599523,-0.8356628650341025,0.6805555555555556,0.9913776498249645,1.0,4/29,5.98%,CDH23;SCN9A;CLRN1;CCL2
prerank,CellMarker_Augmented_2021__Nephron Epithelial cell:Kidney,-0.49985698211352814,-0.8354554093390507,0.7540983606557377,0.991458503259687,1.0,2/9,4.35%,CLDN16;PODXL
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.3734184549414146,-0.8353525109477659,0.7558139534883721,0.9914256315672227,1.0,5/62,7.50%,CTAGE14P;ART3;CTNNA3;GCM2;SYNPO2L
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.4819098391220762,0.8352890182247313,0.6444444444444445,1.0,1.0,1/6,7.52%,GMPS
prerank,Reactome_2022__Meiosis R-HSA-1500620,-0.3623573692600859,-0.835223564821485,0.7662337662337663,0.9914718396659247,1.0,7/57,9.94%,BLM;STAG3;BRCA1;SYCE2;SYCE1;LMNB1;RPA3
prerank,CellMarker_Augmented_2021__Epithelial cell:Cornea,-0.5101842140698376,-0.8352089904229318,0.6851851851851852,0.9912314980788043,1.0,2/6,9.26%,GPR87;TMPRSS11F
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.4333831165352803,0.8351922734485856,0.696969696969697,1.0,1.0,5/16,21.18%,NUDT21;CPSF6;CPSF7;FARSB;PKD2
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.4937540655173851,-0.8351014874424174,0.7868852459016393,0.991146855387653,1.0,6/15,30.69%,SNRNP200;SNRPC;WBP4;DDX23;NCBP2;PSIP1
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.5632428713308294,-0.8350824525250232,0.7192982456140351,0.990933883163534,1.0,2/5,17.95%,EGF;TGFB1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.43249929870262493,-0.8348611590613011,0.7101449275362319,0.9910937043448351,1.0,4/16,17.15%,ADCY7;ADCY5;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4763811103301565,0.8346924377342044,0.6170212765957447,1.0,1.0,2/10,10.09%,BTRC;PLK1
prerank,KEGG_2021_Human__Parkinson disease,-0.3304319001621707,-0.8345398279653596,0.8214285714285714,0.9914533028853786,1.0,20/196,13.31%,TUBB6;DUSP1;RPS27A;MAOB;SEPTIN5;COX7A1;TUBB1;NDUFA2;NDUFB9;ITPR3;SLC18A2;COX4I1;NDUFB11;PSMB6;ADCY5;PINK1;PSMC3;UQCRQ;UBC;NDUFB10
prerank,Reactome_2022__GP1b-IX-V Activation Signaling R-HSA-430116,0.5281902711466023,0.8344854943496459,0.6829268292682927,1.0,1.0,1/6,14.84%,PIK3R1
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,0.31718763596329497,0.834249431163553,0.7857142857142857,1.0,1.0,14/69,13.78%,SEM1;PSMD10;RUNX1;PSMA1;H2BC21;PSMD11;LMO1;H2BC4;PSMB5;H2AC6;PSMD14;KMT2A;H3-3B;PSMD12
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.4916096555791408,-0.8340482363035399,0.6949152542372882,0.9921358592002902,1.0,1/12,1.31%,FABP3
prerank,Reactome_2022__Cohesin Loading Onto Chromatin R-HSA-2470946,0.4711158919840634,0.8340464130013348,0.717948717948718,1.0,1.0,4/10,29.42%,NIPBL;WAPL;SMC3;PDS5B
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.4306791442968999,0.834037250935021,0.7209302325581395,1.0,1.0,2/13,12.98%,SNAP91;WASL
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.46510962644069487,0.8339103422998719,0.6818181818181818,1.0,1.0,2/8,7.22%,SIGMAR1;DISP1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.46510962644069487,0.8339103422998719,0.6818181818181818,1.0,1.0,2/8,7.22%,SIGMAR1;DISP1
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.3346055955017138,0.8338334155515843,0.6666666666666666,1.0,1.0,4/30,12.58%,BMP2;FBXO5;GPM6B;ACVR2A
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.42836398142792304,-0.8338153912501549,0.6268656716417911,0.9923790840854388,1.0,2/24,6.56%,C3;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.5137692854387168,0.8338012510504171,0.7045454545454546,1.0,1.0,3/6,14.00%,NOTCH2;STXBP4;MDK
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.5508373763245454,-0.8337649203222343,0.7586206896551724,0.9922129116327861,1.0,3/5,16.72%,ABCB1;PDZK1;ATP8B1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.3423036972328776,0.8336131506341744,0.7878787878787878,1.0,1.0,14/34,27.65%,PHC1;RNF2;EED;YAF2;RBBP4;MGA;PHC3;EHMT1;PCGF2;EPC1;FOXO4;E2F6;TFDP2;EZH2
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.34663355903429083,-0.833573959970276,0.7285714285714285,0.9923524650415071,1.0,15/80,18.28%,CDKN2A;GPNMB;KLF4;CCL2;GFI1B;PSMB9;PSMB6;PSMC3;PSMA8;PSMA7;WEE1;PSME1;RBX1;CDKN2D;CDKN1A
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.48693106674425657,-0.8334162219979139,0.6727272727272727,0.9923983061879074,1.0,4/9,32.22%,SREBF1;SEC14L2;SREBF2;RAN
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.40447088498692507,-0.8329795417735248,0.7313432835820896,0.9930550762690074,1.0,4/28,10.01%,WNT8B;TESC;PTK6;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.3111430635210593,0.832876294693114,0.7272727272727273,1.0,1.0,10/56,12.84%,WNT7A;AGER;SERPINF2;DUSP19;HMGB1;TIRAP;MAP4K2;TAOK2;SH3RF1;TAOK3
prerank,Reactome_2022__Amine Ligand-Binding Receptors R-HSA-375280,-0.42375270813237553,-0.8328156465530653,0.75,0.993046524527778,1.0,6/20,18.00%,CHRM1;CHRM3;HTR1E;HTR2C;CHRM5;HTR2A
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Large Intestine,-0.40405452263040365,-0.8327931531684098,0.7058823529411765,0.9928508485762395,1.0,4/29,10.74%,PKP2;ITPKC;SLC38A4;LGR5
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),-0.5263722974976295,-0.8325929555698158,0.6545454545454545,0.9929063560753484,1.0,2/5,22.98%,HES1;STAT3
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,0.3156172082763837,0.8324024442185931,0.8518518518518519,1.0,1.0,10/76,11.34%,SEM1;PSMD10;PSMA1;PSMD11;PSMB5;NCOA3;XPO1;PRKACB;MAPK6;PSMD14
prerank,Reactome_2022__Endogenous Sterols R-HSA-211976,0.37863278053383304,0.8322744291361933,0.71875,1.0,1.0,4/18,11.56%,CYP7B1;PTGIS;CYP4V2;CYP46A1
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.46443597415072735,-0.8321016951860674,0.7352941176470589,0.9935844472320389,1.0,4/13,17.15%,APP;AKAP5;RELN;ADCY8
prerank,CellMarker_Augmented_2021__Endocrine cell:Undefined,-0.3695304811581794,-0.8320930012095036,0.7323943661971831,0.9930751625388258,1.0,18/50,20.68%,DUOX1;THY1;FUT2;RARRES1;LRRK1;MACC1;B3GNT5;SPINT2;PDLIM4;VWA5A;F3;CD200;NDN;TEK;SHROOM4;C2CD2;DPYSL3;TMEM200A
prerank,CellMarker_Augmented_2021__Endocrine cell:Embryonic Stem Cell,-0.3695304811581794,-0.8320930012095036,0.7323943661971831,0.9930751625388258,1.0,18/50,20.68%,DUOX1;THY1;FUT2;RARRES1;LRRK1;MACC1;B3GNT5;SPINT2;PDLIM4;VWA5A;F3;CD200;NDN;TEK;SHROOM4;C2CD2;DPYSL3;TMEM200A
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.40779180700762574,0.8320535518266121,0.7631578947368421,1.0,1.0,4/19,12.09%,MCU;MAIP1;LETM1;MICU2
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.40929142797195434,0.8318348620592443,0.631578947368421,1.0,1.0,5/17,13.02%,AGMO;GK;MOGAT1;LPIN3;PLA2G15
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.35924768327083606,-0.8317457296695506,0.7297297297297297,0.9934059574871765,1.0,13/58,18.19%,CDKN2A;DUSP1;BTG3;HEXIM1;TSPYL2;BTG1;TFAP4;NR4A1;NUDT6;GPER1;GMNC;TGFB1;NUPR1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.35496142117295526,0.8315350456407805,0.85,1.0,1.0,4/28,10.03%,CHST11;CSGALNACT1;GAL3ST4;EXT2
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.4587118534665704,0.8314789743554276,0.6976744186046512,1.0,1.0,2/8,17.71%,ERI1;EXOSC8
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.4587118534665704,0.8314789743554276,0.6976744186046512,1.0,1.0,2/8,17.71%,ERI1;EXOSC8
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.3434643731233445,-0.8314236996864026,0.7631578947368421,0.9937562446672535,1.0,3/71,5.04%,CP;SLC39A14;APP
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.3461733175460675,-0.8314101949111428,0.8378378378378378,0.9935214197769505,1.0,27/105,20.39%,FLRT3;RIMBP2;STMN2;RCAN2;PROX1;MAOB;SYT4;ATP1B1;PLPPR1;SST;SHC2;IGFBP5;GPC5-AS1;APOBEC2;RGS7BP;SEMA3E;PCP4;SYT13;FGF12;SYBU;PPP1R9A;ST8SIA3;CNTN4;ABCC9;PLPPR4;PAK5;PCDHB4
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.4419571750267075,0.831403914778779,0.6410256410256411,1.0,1.0,4/8,17.67%,CNOT9;CNOT2;VPS11;CNOT1
prerank,Reactome_2022__ERBB2 Activates PTK6 Signaling R-HSA-8847993,-0.4761596020462887,-0.83129496243247,0.6491228070175439,0.9934587107781419,1.0,2/10,7.85%,PTK6;EGF
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,0.27543051053375267,0.8312466789106193,1.0,1.0,1.0,45/327,13.80%,SPSB4;RNF6;SEM1;RNF25;SPSB2;PSMD10;ANAPC13;KBTBD7;ELOC;ASB13;PSMA1;PIK3R4;PSMD11;KEAP1;FBXL14;ANAPC1;CUL1;UBE2N;SEC22B;PSMB5;ASB8;BLMH;RNF14;FBXO30;FBXL3;LMO7;FBXO9;ASB7;HMGB1;UBE2G1;FBXO15;BTRC;MRC2;TIRAP;RNF114;UBE2D1;RCHY1;PSMD14;SH3RF1;PIK3C3;CUL2;FBXO27;SEC24A;PSMD12;FBXO10
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.367087930427628,-0.8310729586787562,0.8133333333333334,0.9935876327536282,1.0,5/53,7.17%,MET;TIMP2;HTR2B;NELL1;TIMP1
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5651650264852669,-0.830970910391647,0.8113207547169812,0.9932609614993927,1.0,1/5,2.09%,ANK3
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.5651650264852669,-0.830970910391647,0.8113207547169812,0.9932609614993927,1.0,1/5,2.09%,ANK3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.344313732350927,-0.8307690324801662,0.7857142857142857,0.9933088370605243,1.0,22/105,17.95%,THBS1;MET;P2RY12;RAMP3;EGF;CHI3L1;THPO;TGFA;FGF1;PINK1;IL18;F10;FGF7;PIK3CB;VAV1;PIK3CD;F3;FGF22;IRS2;TEK;LRP2;TGFB1
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,0.33914323460423146,0.8305983154283091,0.7272727272727273,1.0,1.0,8/54,11.34%,SEM1;PSMD10;PSMA1;PSMD11;CUL1;PSMB5;BTRC;PSMD14
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.44882725371799403,-0.8305873270138074,0.6825396825396826,0.9933566874306214,1.0,3/15,19.36%,WNT5A;MFSD2A;MYO9A
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),0.5051459124698421,0.8305555968916937,0.7450980392156863,1.0,1.0,1/5,5.84%,FAM3A
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3402039845023831,-0.8304493820853928,0.7647058823529411,0.993348090098902,1.0,12/108,12.54%,CDKN2A;SP100;PROX1;NLRP12;KLF4;NLRC5;CYP1B1;NLRP2;DAB2IP;SFRP4;SIGIRR;PIM1
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,0.3841644585495797,0.830264926051873,0.7419354838709677,1.0,1.0,5/17,14.84%,NRAS;STRN;PIK3CA;KANK1;PIK3R1
prerank,CellMarker_Augmented_2021__Basophil:Blood,-0.5175865958400757,-0.8301612960603005,0.7192982456140351,0.9936043682010672,1.0,2/6,14.46%,CD63;IL3RA
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,0.35032038056360365,0.8300819102338991,0.7,1.0,1.0,5/48,6.89%,SEM1;PSMD10;PSMA1;PSMD11;PSMB5
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.5110556260733613,0.8300739932855083,0.6666666666666666,1.0,1.0,2/6,13.32%,PGM2;GALT
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.33419351581106727,0.8300440383152702,0.7777777777777778,1.0,1.0,9/40,24.54%,SIRT6;MIER3;SIRT5;PRDM5;HDAC2;HDAC10;MIER2;MTA2;SIRT2
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.3620347489212047,-0.8299825079561229,0.775,0.9936202289161999,1.0,10/57,18.28%,B2M;IFIT1;TMC8;ZFPM1;LRPAP1;CTSZ;IFIT2;PRKCD;PTPRF;CDKN1A
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.41684207334823403,-0.8298954769467499,0.6290322580645161,0.9935159715463228,1.0,4/23,13.19%,EFNA1;ELN;SLIT3;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.3698023481543029,-0.8295862903129314,0.8648648648648649,0.993818564463853,1.0,18/86,21.38%,KCNB1;IL12A;ITPR3;GIPR;IGF1;RHBDF2;CELA2A;CACNA1C;ACHE;RHBDF1;GLP1R;MYO18A;TGFB1;KCNC2;TMED10;RSAD2;ITPR1;ADAM8
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.3193032241720642,0.8295224298192275,0.8387096774193549,1.0,1.0,6/61,6.72%,NR1D1;BMP2;TRIB3;ANKRD26;AKT1;LMO3
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Peripheral Blood,0.36001265596152876,0.8293166504742893,0.6129032258064516,1.0,1.0,2/33,1.81%,TBC1D4;CCDC141
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.43302542495437113,-0.8290160560589246,0.7910447761194029,0.9945889353519982,1.0,6/23,19.95%,ANK3;UNC13C;DCTN1;CACNB1;AGRN;DOK7
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.3597749509218367,-0.8290107955056254,0.7215189873417721,0.9943350991475727,1.0,18/78,17.49%,OGN;CSPG4;CEMIP;HS3ST3A1;BGN;OMD;ST3GAL6;B3GNT2;CHST15;GPC3;HYAL1;B4GALT7;CHSY3;CHST6;HS3ST3B1;HS6ST1;GPC1;PXYLP1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.3623475041144036,0.8285673636724472,0.7419354838709677,1.0,1.0,10/35,30.02%,ATF5;EFNA5;MARK2;MAP6;KLHL42;PRKAA1;MEMO1;CLASP2;BICD2;TRAF3IP1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.36152952604707367,0.8282049554590982,0.6923076923076923,1.0,1.0,6/23,19.35%,MOSMO;VCP;BTRC;KCTD21;HERC4;GLI3
prerank,"Reactome_2022__Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",0.38745941340365214,0.8281440108342943,0.7567567567567568,1.0,1.0,5/19,8.12%,CSPG5;SDC4;SDC3;GPC5;BCAN
prerank,Reactome_2022__Synthesis Of PE R-HSA-1483213,0.44772354508754936,0.8280709040252209,0.631578947368421,1.0,1.0,4/12,24.99%,LPIN3;CEPT1;ETNPPL;CHKA
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.47208901420109206,-0.8277882046137004,0.6885245901639344,0.9961260149820658,1.0,1/11,8.20%,SPAG17
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.5733760741594802,-0.827726184598025,0.7962962962962963,0.9959575886805131,1.0,2/5,12.60%,ARG2;NOS1
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.31758022555817755,0.8276454314435501,0.8387096774193549,1.0,1.0,5/55,6.89%,PSMD10;PSMA1;PSMD11;CUL1;PSMB5
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.3642595990332085,0.8275471431047707,0.6764705882352942,1.0,1.0,6/28,17.74%,FLT3;RABL3;MSH2;SLC25A5;DCAF1;CEBPG
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,-0.3826091907978435,-0.8275315211621289,0.8125,0.9959703554215923,1.0,10/48,16.46%,NDST4;CHST4;HS3ST3A1;B3GNT2;CHST15;B4GALT7;CHSY3;CHST6;HS3ST3B1;HS6ST1
prerank,KEGG_2021_Human__Pathways of neurodegeneration,-0.311671085809237,-0.827418876826194,0.9263157894736842,0.99589992704698,1.0,39/382,13.31%,GRIN2D;TUBB6;RPS27A;NEFL;NEFM;WNT8B;SEPTIN5;CHRM1;GRIN2A;COX7A1;APP;TUBB1;TRPC3;NDUFA2;GRIA3;HAP1;NDUFB9;GRIA1;ITPR3;COX4I1;NEFH;NDUFB11;PRKCG;WNT5A;CHRM3;PPP3CC;PSMB6;CACNA1C;DNAH3;DCTN1;PINK1;PSMC3;UQCRQ;NOS1;UBC;GRIN2B;FADD;TNFRSF1A;NDUFB10
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,0.30851512333400666,0.8274020018678315,0.8,1.0,1.0,7/67,5.89%,POLD3;SLC19A1;DNA2;H2BC21;H2BC4;RFC3;STN1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.48732712610312756,-0.8273361321436958,0.7666666666666667,0.9958124130781681,1.0,3/12,21.46%,FSCN1;MYO9A;PATJ
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,0.3162801882902179,0.827231802047669,0.8181818181818182,1.0,1.0,16/76,15.40%,PIP5K1B;PI4K2A;PIK3R4;GDE1;MTMR10;PLEKHA6;SACM1L;PIK3C2G;PLEKHA3;PIK3C3;RAB4A;PIK3CA;SBF2;FIG4;PIK3R1;PIP4K2B
prerank,"Reactome_2022__GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",0.39077970797820033,0.8272298863924048,0.6976744186046512,1.0,1.0,1/18,0.41%,SLC6A13
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,0.27370916430645176,0.8272019264976769,1.0,1.0,1.0,41/192,17.60%,ABCA1;PLIN1;KDM1B;PDK4;KPNA2;NRAS;RARB;RUNX1;ALDH1A1;H2BC21;RDH10;KAT2B;H2BC4;EGFR;AKT2;AKT1;GTF2F2;NCOA3;STRN;YY1;XPO1;H2AC6;NRIP1;ERBB4;GTF2A2;GNB3;RDH14;UHMK1;AKR1C3;H3-3B;PIK3CA;KANK1;ZDHHC21;PIK3R1;POLR2C;POU2F1;EP300;CPT1A;NCOA2;AGO3;GNGT1
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,0.3700301040261843,0.827149302208302,0.7777777777777778,1.0,1.0,6/25,15.67%,NRAS;NCK1;PIK3CA;PIK3R1;CRKL;NCK2
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.46829739965348904,-0.8268890737274202,0.7115384615384616,0.9963289674804546,1.0,3/11,20.05%,PARP9;NAMPT;NNMT
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.438668161232165,-0.826670128525787,0.7272727272727273,0.9964663079896953,1.0,4/14,17.15%,ADCY7;ADCY5;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.4741753297299275,0.826448393912252,0.7142857142857143,1.0,1.0,1/7,0.33%,SLC2A5
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,-0.35624654640710274,-0.826445106088879,0.7272727272727273,0.9965400285273726,1.0,8/66,13.34%,CP;SLC17A5;SLC24A1;SLC3A1;SLC24A5;SLCO2A1;TAC4;SLC20A2
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),-0.5488001450112414,-0.826429021443006,0.7090909090909091,0.996296053730125,1.0,5/6,18.19%,NR4A3;SGPP2;NR4A1;PTPRN;NUPR1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),-0.47463615862587294,-0.8264152901327677,0.6885245901639344,0.9960619782278296,1.0,2/12,5.96%,CSPG4;BGN
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.36685534882889453,0.8262186125009195,0.7105263157894737,1.0,1.0,4/23,12.58%,ABCB10;HSPA1A;ANKRD54;ACVR2A
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.4193346032897328,-0.8261084189596055,0.782608695652174,0.9963115875378947,1.0,2/17,6.29%,BLM;BRCA1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.3436297098814225,-0.8260682691670292,0.7875,0.9961240208105286,1.0,14/64,19.94%,SP100;PLK2;PLK3;GADD45A;ARID3A;CCNB1;NDRG1;FOXM1;TFAP4;PML;RPS6KA6;CDKN1A;KAT5;ZNF385A
prerank,Reactome_2022__Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.43372595680745885,-0.8259147492539675,0.7323943661971831,0.9961220648514403,1.0,3/18,16.80%,APP;ALDH3A2;EMD
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.5167472344695287,0.8258860877106141,0.75,1.0,1.0,1/7,1.56%,AGER
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.46451015310931354,-0.8256409836655778,0.7142857142857143,0.9963202158682416,1.0,5/11,19.12%,CEACAM1;APOD;CCDC3;GPER1;ALK
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.3396170019793082,0.8256302969936264,0.7931034482758621,1.0,1.0,22/47,26.55%,CDC25A;EIF2S1;YY1;ATR;PTPRK;EIF2AK4;POLK;SMPD1;EP300;NOC2L;RHBDD1;GNGT1;TRIAP1;USP47;N4BP1;PARP1;ZBTB1;ERCC4;BAK1;SDE2;INO80;USP28
prerank,CellMarker_Augmented_2021__Megakaryocyte Erythroid cell:Undefined,-0.38787671371094773,-0.8255744635515267,0.7777777777777778,0.9959088846971546,1.0,6/34,13.00%,IL13RA1;CD5;CD160;CD9;SELP;CCR10
prerank,CellMarker_Augmented_2021__T cell:Undefined,-0.38787671371094773,-0.8255744635515267,0.7777777777777778,0.9959088846971546,1.0,6/34,13.00%,IL13RA1;CD5;CD160;CD9;SELP;CCR10
prerank,CellMarker_Augmented_2021__Intermediate Progenitor cell:Undefined,0.3265214248141762,0.8255219949236291,0.8,1.0,1.0,7/80,4.15%,GLCCI1;ASCL1;ABCD2;SLIT1;KIF21B;KCNA2;NLGN3
prerank,KEGG_2021_Human__Tight junction,0.2761048519128751,0.8253035380392258,0.9166666666666666,1.0,1.0,21/127,17.31%,ACTR3C;RAP2C;ACTR3B;OCLN;RUNX1;JAM2;HCLS1;MAPK10;LLGL1;PRKAB1;RAB8B;PRKACB;MAPK8;MARVELD3;MPDZ;RAB8A;PARD6G;AMOTL1;CGN;PARD6B;WHAMM
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.356127099737575,-0.8251791928651631,0.7764705882352941,0.9963775987143231,1.0,12/72,18.23%,DUSP1;GBP1;PSCA;CAV3;DAB2IP;FOXM1;PAQR3;PIK3CB;PRKCD;PTPRR;GPER1;RPS6KA6
prerank,CellMarker_Augmented_2021__Neural cell:Embryoid Body,-0.34959454662309347,-0.8250151017986992,0.7222222222222222,0.9964389609288775,1.0,12/82,13.52%,TAGLN3;PLP1;ZDHHC22;SYT4;RND2;EFNB3;GAP43;PLPPR5;TCEAL2;CRMP1;GRID2;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.3463832029868494,-0.8247709745643388,0.8028169014084507,0.9966976984598341,1.0,6/59,13.35%,DUSP1;PODXL;CYP1B1;ARHGDIG;DMTN;SPINT2
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,-0.30363513596029285,-0.8247425271342326,0.9375,0.9964909309241687,1.0,88/537,18.84%,CP;SLC28A2;AMN;SLC6A15;ABCA6;ANO2;ABCA5;RPS27A;SLC39A14;SLC17A5;ABCA8;ATP8B4;RAB11A;SLC16A3;LSR;ADCY7;LPA;GNG3;ABCA12;SLC32A1;PLN;TRPC3;VLDLR;BEST1;ABCB1;SLC24A1;SLC4A9;STEAP3;SLC5A4;APOD;SLC18A2;ANO9;SLC38A4;PSMB9;SLC9A2;LDLR;ATP1B1;ANGPTL3;SLCO3A1;NIPAL2;SLC8A3;CA1;ABCA10;CLCA4;SLC3A1;PSMB6;ADCY5;SLC7A2;SLC24A5;PSMC3;SLC43A2;GNG2;SLC44A3;TUSC3;UBC;SLCO2A1;MCUB;SLC20A2;SLC11A1;SLC38A1;SLC4A2;SLC25A26;SLC22A4;SLC12A7;SLC14A2;SLC4A10;PSMA8;ADD2;SLC9A5;SLCO1A2;PSMA7;ATP8B1;SLC29A4;ADCY8;RYR2;SLC28A3;PSME1;SOAT1;CTNS;SLC50A1;ABCC1;SLC15A4;SLC39A7;SLC7A7;SLC25A29;TF;ABCG2;SLC1A6
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,0.41756893611601814,0.8246676598748957,0.8260869565217391,1.0,1.0,5/18,18.24%,EFNB2;GIT1;EPHB4;NCK2;EFNB1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.5074957510897886,0.8246525141393429,0.717948717948718,1.0,1.0,1/7,0.89%,CFAP53
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.5142003843916136,0.8246366894071878,0.7441860465116279,1.0,1.0,3/5,28.21%,PMPCA;IMMP2L;MIPEP
prerank,Reactome_2022__Dermatan Sulfate Biosynthesis R-HSA-2022923,-0.4900449230476446,-0.8244538893821121,0.7017543859649122,0.9966740082243365,1.0,2/11,5.96%,CSPG4;BGN
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.39846498556625287,-0.8243427895285144,0.7777777777777778,0.9966061623425633,1.0,2/32,6.99%,NEFL;HAP1
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.4606021170333898,0.8240689567623697,0.725,1.0,1.0,3/7,26.86%,KMT2A;KMT2C;SETD4
prerank,GO_Biological_Process_2021__lactation (GO:0007595),-0.4832246750208773,-0.8240529261080364,0.696969696969697,0.9968986702476597,1.0,3/8,18.59%,APLN;OXTR;FOXB1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.3826117031101435,0.8239841269822277,0.6842105263157895,1.0,1.0,4/20,22.66%,INSC;PLK1;GJA1;UBXN2B
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.4072506279720787,-0.8239583752959689,0.7540983606557377,0.9968429708893485,1.0,8/28,19.00%,BAIAP2;BAIAP2L1;FES;SEMA3E;TEK;CDK5;DAPK3;PDGFRA
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,0.33527578609592673,0.8238800088339286,0.7931034482758621,1.0,1.0,6/49,6.89%,SEM1;PSMD10;PSMA1;PSMD11;CUL1;PSMB5
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,0.277306675583806,0.8237675281172623,0.9444444444444444,1.0,1.0,18/98,15.95%,NGF;ASCL1;ID1;NRAS;DUSP6;RALB;AP2B1;RALA;RRAD;MAPK12;DNM3;PIK3CA;SHC3;RPS6KA3;PIK3R1;CRKL;ID2;EP300
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),0.5065394388007773,0.8236489206263777,0.6923076923076923,1.0,1.0,1/5,6.32%,AOX1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Blood,-0.42981710840136533,-0.8235812024654593,0.7580645161290323,0.9972909964339378,1.0,4/25,7.03%,A4GALT;PODXL;THY1;CD44
prerank,KEGG_2021_Human__Shigellosis,-0.3184629696046395,-0.8233248840530564,0.8941176470588236,0.9974833570169751,1.0,30/193,19.59%,IL1R1;C3;RPS27A;HK2;ITGA5;NOD1;PFN4;CD44;ITPR3;PFN2;PRKCQ;ARPC5L;IL18;ELMO1;UBC;TNFRSF1A;PIK3CB;PRKCD;PIK3CD;TLN1;CAPN1;GABARAPL1;VCL;SEPTIN9;RIPK2;RBX1;PLCE1;CAPNS1;GABARAPL2;ARPC3
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.3172355388734645,-0.8233071580125224,0.8888888888888888,0.9972548736292872,1.0,33/178,20.77%,TRIM22;TRIM5;PLK2;NLRP12;HTR2B;NOD1;BST2;STAT1;WNT5A;BIRC3;DAB2IP;PINK1;SHISA5;TNIP2;CARD19;MAP3K14;FADD;TNFRSF1A;APOL3;CD74;LTBR;HLA-DRB1;PRKCB;ALPK1;RIPK2;CARD11;CD4;NLRC3;LGALS1;CX3CL1;CASP8;TRIM62;IKBKG
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.38715264121322895,-0.8230479541224579,0.7671232876712328,0.9974690260288883,1.0,1/42,0.33%,THBS1
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,0.33400334321636405,0.82302010021295,0.8125,1.0,1.0,5/46,6.89%,SEM1;PSMD10;PSMA1;PSMD11;PSMB5
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.36511631238005265,-0.8229568232927748,0.7916666666666666,0.9973694966282555,1.0,14/67,18.14%,DHCR24;KIF14;SNCB;GPNMB;WNT5A;CTSZ;GRIN2B;GRID2;HLA-F;FOS;SNCG;CD200;CDK5;MAPT
prerank,KEGG_2021_Human__Taste transduction,-0.3727223184301922,-0.8226917596978466,0.7027027027027027,0.9975810774235232,1.0,15/36,21.22%,SCN9A;ITPR3;CHRM3;SCN2A;CACNA1C;HTR1E;TAS1R1;GABRA1;ADCY8;GABBR2;PDE1C;PDE1A;GABRA6;GABRA3;HTR3E
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.5626105089843663,-0.822303024870782,0.74,0.9980209219499562,1.0,3/5,18.51%,PDZK1;SLC22A4;SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.44467186880819254,0.8222975679082891,0.7142857142857143,1.0,1.0,4/11,21.74%,CCT7;CCT3;DKC1;MEPCE
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.44467186880819254,0.8222975679082891,0.7142857142857143,1.0,1.0,4/11,21.74%,CCT7;CCT3;DKC1;MEPCE
prerank,Reactome_2022__Formation Of Annular Gap Junctions R-HSA-196025,-0.48364154167834916,-0.8221460070197028,0.7076923076923077,0.998081632499344,1.0,2/8,19.82%,CLTB;DNM1
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.43249226233252763,0.8221380107322045,0.6923076923076923,1.0,1.0,4/14,15.62%,BMP2;MDK;SERPINE2;ID2
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.33953894300162835,-0.8221315447336016,0.8170731707317073,0.9978314960572805,1.0,15/115,13.97%,TLR2;RPS27A;APP;NOD1;NLRC5;NDUFA2;KCNH8;RPS6KA1;IRF7;BIRC3;TNIP2;SIGIRR;UBC;FADD;FOS
prerank,CellMarker_Augmented_2021__Type I pneumocyte:Undefined,0.3071000985319658,0.8220920409196006,0.8,1.0,1.0,5/56,6.18%,EHF;ARHGEF16;TRIM29;EGFR;MYO5B
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),0.473479299647681,0.8219777349564944,0.6341463414634146,1.0,1.0,2/6,18.44%,RFT1;NPC2
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Ovarian Cortex,-0.37432172038174977,-0.8219509259146962,0.7746478873239436,0.9979286385039339,1.0,7/38,16.50%,ZNF850;DRAXIN;LRRK1;SHISA9;PCDH11X;CHST6;GLB1L3
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.36779324448321876,0.8219107792347822,0.5882352941176471,1.0,1.0,1/21,0.33%,SLC2A5
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,0.3509338987591164,0.821686282086573,0.7586206896551724,1.0,1.0,10/35,16.89%,GIT1;NCK1;CEP97;SH3RF1;WASL;PIK3R1;NCK2;VANGL1;TXNL1;PARD6B
prerank,CellMarker_Augmented_2021__Colorectal Stem cell:Colorectum,0.5043438947709592,0.8214470105615025,0.7631578947368421,1.0,1.0,1/5,3.98%,ALDH1A1
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.36304289295783104,-0.8213561829577721,0.8311688311688312,0.9987368359538848,1.0,10/49,19.00%,PRDX5;APOD;PLK3;ROMO1;FOS;TXNRD2;HYAL1;PTPRN;MAPT;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.3711092376255939,-0.8213370844120509,0.7714285714285715,0.9985109877798248,1.0,7/38,12.36%,TLR2;APP;TLR3;WNT5A;SCIMP;SYK;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.5066773255733693,0.8211906195868744,0.6808510638297872,1.0,1.0,2/6,36.93%,PARD6A;GSK3B
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,0.29187977814271204,0.8211659017583449,0.9285714285714286,1.0,1.0,10/79,12.05%,SEM1;PSMD10;PSMA1;PSMD11;FZD8;PSMB5;NCOA3;AP2B1;PSMD14;DVL2
prerank,Reactome_2022__SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.43021805747091624,-0.8208569601199547,0.6714285714285714,0.9991269815821272,1.0,1/18,1.55%,SUV39H1
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),-0.5239674634381691,-0.820533874175734,0.7586206896551724,0.9995437978135671,1.0,2/6,27.42%,CDKN1A;TP53
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,0.3247513196516596,0.8204822837226439,0.7777777777777778,1.0,1.0,6/57,6.89%,SEM1;PSMD10;PSMA1;PSMD11;FZD8;PSMB5
prerank,Reactome_2022__Organic Anion Transporters R-HSA-428643,-0.5536118821956217,-0.8203142321504473,0.7843137254901961,0.9996815846869885,1.0,1/5,3.24%,SLC17A5
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",-0.41036560482602025,-0.8202361497290539,0.7538461538461538,0.9995744933310148,1.0,4/30,8.63%,GRIA3;GRIA1;AKAP5;PRKCG
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.5559615562485652,0.8201567921322008,0.8529411764705882,1.0,1.0,2/5,33.02%,MTRES1;NEMF
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.34080937068613876,0.8199048883450558,0.7666666666666667,1.0,1.0,4/39,7.43%,POLD3;PRIMPOL;RFC3;VCP
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),0.4879474505691987,0.8198229454126491,0.7435897435897436,1.0,1.0,2/5,29.38%,NOL8;WRN
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.29890657344776284,-0.8197692419576723,0.97,1.0,1.0,115/835,17.95%,ANXA1;CP;THBS1;SOCS3;C3;DUSP1;SERPINA10;B3GALT2;CHGB;TGFBR2;MTMR7;LAMB1;VRK2;PLK2;PHEX;ART3;RAB11A;ASB16;CHST4;MAP3K6;APP;FLG;CCL2;PIM3;FUT2;PARP14;PTK6;SBF1;NUAK2;TIMP1;PP2D1;GLRX;PSMB9;SERPIND1;NOTUM;PARP9;F13A1;FBXL18;PDK1;PRKCG;ST3GAL6;MAK;FAM20C;FBXW12;SPSB1;FAM20A;MINK1;B3GNT5;CHRM3;FBXO32;PPP3CC;PTPN7;ISG15;PDK3;IGFBP7;OGFOD1;PSMB6;USP6;NUAK1;SYK;FN1;FBXW10;BMX;B3GNT2;GAD1;PINK1;SHISA5;BAP1;LIPE;PSMC3;PRSS23;IGFBP5;PRKCH;PIM1;DUSP16;STRADB;GPC3;ASB14;HERC5;F5;NEK10;MYLK3;WDR45;ELOB;ST6GALNAC2;B4GALT7;AATK;UBE2S;COQ8B;PSMA8;GLYCTK;PLAT;PRKCD;PIK3CD;CDK2;ITIH2;PSMA7;NRBP2;PTPRR;ALG1L2;PIGH;FBXL2;PRKCB;PTPRF;PSME1;SPP1;CDK5;RBX1;LTBP1;LIMK2;PTPRO;FBXL13;HIPK3;DAPK3;TGFB1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.41817897598804016,-0.8197344479604062,0.8235294117647058,0.9999055554802713,1.0,4/25,14.68%,SULF1;NOTUM;SFRP4;PPIB
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Intestine,-0.344254513277774,-0.8196266068921312,0.8421052631578947,0.9998251307275801,1.0,16/82,14.33%,MET;LAMB1;ITGA2;PLK2;MMP14;CCND1;SRPX2;P4HA2;OSMR;EMP1;FN1;HRH1;AMOTL2;RHBDF1;DSTN;ITGA3
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,-0.3519667878518231,-0.8193453750376505,0.7662337662337663,1.0,1.0,8/73,12.36%,TUBB6;GNG3;PFDN6;TCP1;GAPDHS;FBXW10;CCNE2;GNG2
prerank,CellMarker_Augmented_2021__Basophil:Peripheral Blood,-0.5214555265559463,-0.8192899371023725,0.7454545454545455,0.999843536966133,1.0,2/5,14.46%,CD63;IL3RA
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,0.381021842456639,0.8192398188057705,0.8333333333333334,1.0,1.0,8/22,23.66%,NRAS;EGFR;ERBB4;PIK3CA;PIK3R1;NRG3;PIGU;SOS1
prerank,Reactome_2022__NF-kB Is Activated And Signals Survival R-HSA-209560,0.4750023393584587,0.8192104998556086,0.6764705882352942,1.0,1.0,1/12,0.43%,NGF
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,0.3271989721908415,0.8191109882367666,0.7307692307692307,1.0,1.0,10/44,17.79%,NAPSA;ARFIP2;GOLGA1;COG6;NAA30;VTI1A;RAB9A;RHOBTB3;VAMP3;RIC1
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,-0.3123487888824537,-0.8190242730662194,0.8539325842696629,0.9999979361852129,1.0,37/215,17.67%,GRIN2D;RASGRP1;RPS27A;NEFL;ZDHHC9;ARHGAP9;RASGEF1A;GFRA2;RALGDS;PSMB9;EGF;PTPN7;TGFA;SHC2;FGF1;PSMB6;DAB2IP;PRKCQ;FN1;PSMC3;PAQR3;DUSP16;UBC;GRIN2B;FGF7;IL3RA;PIK3CB;PSMA8;RASGRF2;TLN1;PSMA7;FGF22;IRS2;TEK;VCL;PSME1;RBX1
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.49926514213023937,0.8190162365329393,0.6829268292682927,1.0,1.0,5/8,15.21%,LEPR;GNB3;EIF2AK4;UCN;SGIP1
prerank,Reactome_2022__HIV Elongation Arrest And Recovery R-HSA-167287,0.33309622216242274,0.818970291677742,0.7647058823529411,1.0,1.0,14/31,30.40%,ELOC;GTF2F2;ELOA;POLR2C;CCNT1;NELFA;CCNT2;CTDP1;TCEA1;POLR2A;POLR2K;POLR2D;SUPT16H;POLR2E
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.44005158351037615,-0.8188477519854744,0.6666666666666666,1.0,1.0,5/14,24.09%,CD44;CD74;ZNF385A;TAF9B;PTTG1IP
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,0.3372976951439852,0.8187546025768093,0.8285714285714286,1.0,1.0,7/46,11.34%,SEM1;PSMD10;PSMA1;PSMD11;PSMB5;BTRC;PSMD14
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4434902279324635,0.818720668696981,0.7931034482758621,1.0,1.0,2/9,18.84%,HOMER2;DYRK2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.4434902279324635,0.818720668696981,0.7931034482758621,1.0,1.0,2/9,18.84%,HOMER2;DYRK2
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.45586725187842264,0.818582651627378,0.7142857142857143,1.0,1.0,2/10,5.99%,PDE3B;ABCD1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.4330394752545937,-0.8182416815170593,0.7903225806451613,1.0,1.0,1/24,0.55%,TYMS
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.352603707151231,-0.8181965629059798,0.8028169014084507,1.0,1.0,17/75,20.50%,MET;VAC14;NLRC5;LDB2;TSPYL2;EMP2;CD74;HLA-DRB1;IRS2;TEK;MAPT;CD4;PLCE1;PDGFRA;ALK;ZNF16;CDKN1C
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,-0.3290117365215027,-0.8180945238466413,0.8539325842696629,1.0,1.0,29/114,20.30%,ADCY7;GNG3;SLC32A1;NDUFA2;GRIA3;NDUFB9;GRIA1;ITPR3;NDUFB11;PRKCG;GABRE;GABRB2;GABRD;CACNA1C;ADCY5;GNG2;NDUFB10;CNR1;GABRG2;GABRA1;ADCY3;ADCY8;PRKCB;NDUFA6;SLC17A7;NDUFA3;GABRA6;GABRG3;GABRA3
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.29921118133238084,0.8180659241441747,0.9047619047619048,1.0,1.0,16/56,20.79%,RGCC;CNOT9;RFWD3;PCBP4;PLAGL1;CNOT2;CRADD;E2F4;EP300;CNOT8;CNOT6L;CNOT1;CNOT4;MDM2;TRIAP1;CASP2
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.40039524152439576,-0.8179642226069493,0.7910447761194029,1.0,1.0,13/42,18.05%,SERPINA10;ALDOB;BHMT;ANGPTL3;DIO1;SLC3A1;SLC16A11;PDZK1;CYP3A4;ADH4;ITIH2;CYP3A5;PAH
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.4195703861463465,-0.8179536604957928,0.7230769230769231,1.0,1.0,8/22,19.50%,SLC32A1;SLC18A2;CPLX1;PLD2;CPLX2;NLGN1;CDK5;SLC17A7
prerank,Reactome_2022__Unwinding Of DNA R-HSA-176974,-0.5076813476915107,-0.8179375314016748,0.71875,1.0,1.0,1/8,8.34%,GINS2
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.4766709715801828,-0.8176984489261,0.6984126984126984,1.0,1.0,3/13,18.53%,BRCA1;RAI2;CELF4
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,-0.3797296865891304,-0.8176934770543065,0.8,1.0,1.0,9/42,18.95%,GMPPB;HK2;GALK1;GPI;GNE;PMM1;UAP1;GFPT2;UAP1L1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.35410243677276365,-0.817646065500608,0.8333333333333334,1.0,1.0,5/65,10.43%,A4GALT;ABCA8;FA2H;SGPP2;CYP4F22
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.4366470648244122,0.817598652129618,0.6578947368421053,1.0,1.0,1/11,1.02%,TMEM100
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Premolar,-0.5373959692590192,-0.8175187792939997,0.7076923076923077,0.9999873587003816,1.0,4/6,30.73%,CD9;PTPRC;ENG;CD14
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,0.3421501868250075,0.8173675332160545,0.75,1.0,1.0,8/53,11.34%,SEM1;PSMD10;PSMA1;PSMD11;CUL1;PSMB5;BTRC;PSMD14
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,-0.35283050166804314,-0.8173055723369933,0.8051948051948052,1.0,1.0,9/68,14.76%,MX1;RPS27A;IFIT1;STAT1;ISG15;UBC;KPNA7;HERC5;PDZD2
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.47222940621891535,-0.8172474899378588,0.7272727272727273,0.999901901893287,1.0,2/11,19.59%,ARPC5L;ARPC3
prerank,KEGG_2021_Human__Dilated cardiomyopathy,-0.3457578770686908,-0.8172280476745509,0.8125,0.9996530408944867,1.0,20/71,17.95%,ITGA2;ADCY7;ITGA5;PLN;SLC8A3;ITGA8;IGF1;ITGA11;CACNA1C;ADCY5;TPM4;ITGA9;ITGA3;CACNB1;ITGB4;ADCY3;EMD;ADCY8;RYR2;TGFB1
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,0.31966562350487543,0.817198296473848,0.9166666666666666,1.0,1.0,11/63,14.75%,SEM1;PSMD10;PSMA1;PSMD11;ANAPC1;PSMB5;PLK1;UBE2D1;PSMD14;PSMD12;CDC26
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,0.26876848875336035,0.8171649174633736,0.95,1.0,1.0,15/90,14.90%,HAUS1;CSNK1E;CEP290;CEP152;PLK1;PCM1;CEP97;ALMS1;C2CD3;SCLT1;TCTN3;IQCB1;CEP192;TUBG1;RAB8A
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.42337334019491063,0.8170682034138463,0.7142857142857143,1.0,1.0,5/8,23.80%,ADO;TST;PON1;CTH;TXN2
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.40480625814898463,0.8170643019236934,0.7222222222222222,1.0,1.0,4/16,9.69%,SLC30A4;SLC30A6;SLC39A8;SLC30A9
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.3498214685647949,0.8168139457864956,0.8787878787878788,1.0,1.0,3/22,8.54%,ZNF658;SLC30A4;MT1E
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,0.33566894893111415,0.8165893191481141,0.7647058823529411,1.0,1.0,3/53,1.14%,CPAMD8;WNT7A;CALCB
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.4012827921319624,-0.8161516536049572,0.8181818181818182,1.0,1.0,1/32,1.13%,POU4F1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.3522349212478645,-0.8161038425605751,0.7808219178082192,1.0,1.0,4/60,4.84%,RFTN1;RAB11A;ZDHHC9;ZDHHC22
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,-0.3389351492663212,-0.8159245141930014,0.8152173913043478,1.0,1.0,7/80,12.77%,TGFBR2;RPS27A;ITGA8;LTBP4;STAT1;ARHGEF18;UBC
prerank,Reactome_2022__Metabolism Of Proteins R-HSA-392499,-0.29355067847516353,-0.8157060486163407,1.0,1.0,1.0,211/1507,18.69%,ST6GAL1;CP;THBS1;SOCS3;CDKN2A;C3;BLM;TUBB6;GCNT7;SP100;SERPINA10;PGR;PCSK2;CHGB;TGFBR2;RPL19;NRN1;RPL3;HIC1;B2M;ANK3;PSCA;LAMB1;ADAMTS10;KDELR3;RPS27A;THSD4;WARS1;RPL39L;RPL36AL;RPS27;SFTPD;HLA-A;SLC17A5;RPS14;SPON2;RPS4X;GMPPB;SBSPON;RPL27A;CNTN5;GCNT1;ART3;RAB11A;ADAMTSL2;ASB16;CHST4;F8;TPST1;GNG3;RPL35;APP;KLF4;TTLL7;CTSC;NOD1;RPL7A;THY1;THSD7B;RPL37A;RPL27;BRCA1;GRIA1;TIMP1;SVBP;RPL9;PSMB9;SERPIND1;RPL21;NOTUM;SGPP2;RNF181;FBXL18;PLET1;RPL13A;ST3GAL6;FAM20C;PFDN6;IGF1;FBXW12;SPSB1;FAM20A;TCP1;EIF2B2;B3GNT5;RPS11;FBXO32;RPS16;GAPDHS;TAF10;TGFA;RPLP1;THBS2;IGFBP7;TFPT;RPS13;PSMB6;ALPL;BIRC3;RPL38;HLA-B;FN1;DLGAP3;CD55;FBXW10;ACHE;GALNT10;RPS3A;COPZ2;B3GNT2;DCTN1;SHISA5;PTRH2;RPS8;RPL10A;PSMC3;PRSS23;TNIP2;RPLP2;RPS23;CTSZ;CCNE2;IGFBP5;MAN1C1;GNG2;IFIH1;SEC11C;RPS21;RPS7;TUSC3;C1QTNF1;UBC;GPC3;ASB14;RPL8;GALNT12;F5;TTLL6;MBD6;EGFL7;RPS6;ELOB;RPS15;ST6GALNAC2;SSR4;ANKRD28;SPRN;RPL26L1;RPS9;UBE2S;PSMA8;ADAMTS4;RPL12;APH1A;MRPL20;RPL5;GNE;RAB3C;EEF1A2;MAN1A1;UBXN1;ANK1;PIGA;GARS1;ITIH2;MGAT5;PSMA7;FAU;EEF1AKMT2;PMM1;PFDN1;ARFGAP1;TRAPPC2L;MUC6;RPL23;RPL4;PML;USP18;HDAC7;AURKAIP1;PIGH;GALNT8;MTA1;GOLGB1;PSME1;RPL18A;CFAP73;MYRIP;RIPK2;RBX1;RPL41;LTBP1;ADGRF5;FBXL13;RPL7;RPS12;TGFB1;CTSA;CCNF;PIGC;MAN2A2;RAB15;EEF2KMT;GALNTL6;RPS20;COPS5;PAPPA;TF;PTGES2;UAP1;ADAMTS8
prerank,CellMarker_Augmented_2021__Switched Memory B cell:Blood,0.44678430668109637,0.8156136737394126,0.75,1.0,1.0,1/9,0.40%,CD247
prerank,CellMarker_Augmented_2021__Plasma cell:Sinonasal Mucosa,0.44678430668109637,0.8156136737394126,0.75,1.0,1.0,1/9,0.40%,CD247
prerank,CellMarker_Augmented_2021__Memory B cell:Peripheral Blood,0.44678430668109637,0.8156136737394126,0.75,1.0,1.0,1/9,0.40%,CD247
prerank,CellMarker_Augmented_2021__Non-switched B cell:Blood,0.44678430668109637,0.8156136737394126,0.75,1.0,1.0,1/9,0.40%,CD247
prerank,CellMarker_Augmented_2021__Memory B cell:Liver,0.44678430668109637,0.8156136737394126,0.75,1.0,1.0,1/9,0.40%,CD247
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.2769631653016923,0.8155555128496591,1.0,1.0,1.0,65/263,23.14%,TBC1D4;ABHD17A;TMED5;ARFIP1;ID1;OCLN;RAB23;COX18;SCFD2;TBC1D12;EGFR;ARL5A;RABL3;SEPTIN11;STX7;DNAJC27;ARFIP2;FOXJ1;C17ORF75;RAB22A;RAB1B;PTPRK;NIPBL;AP3B1;ANK2;TRAPPC8;RAB28;COPB2;SNX31;SCFD1;SEC23IP;NAPB;TBC1D5;SEC31B;TMED3;RAB21;SNX27;TBC1D8B;ARCN1;HERC2;RIC1;DMD;EVI5L;TBC1D22B;HEY2;SEPTIN6;TMED2;PRRT1;ITSN1;WDR11;BBS2;TBCK;GJA1;RAB18;VPS29;RAB31;AMOT;PIGU;RUNDC1;RABL2A;ERP29;LAMTOR3;TLK1;TM9SF3;SNX17
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.4173331043029916,0.815300995591922,0.8048780487804879,1.0,1.0,3/12,10.09%,RIOK2;ANAPC1;PLK1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.3844124952420865,0.81513792982445,0.717948717948718,1.0,1.0,11/24,31.30%,KAT2B;NAA11;EP300;GTF2B;NAA50;CLOCK;NAT10;NAA15;NAA35;DSCC1;SIRT1
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.42471279357650527,0.8149963653260923,0.6170212765957447,1.0,1.0,4/13,15.88%,TNFAIP3;FOXJ1;SAMSN1;TNFSF4
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,0.30982412329271225,0.8149515336944879,0.8888888888888888,1.0,1.0,20/70,23.80%,COX18;AKT2;TACO1;AKT1;PRKAB1;SESN2;RRM2B;LRPPRC;PRDX1;COX19;COX7A2L;SESN3;AGO3;SLC38A9;PRKAA1;UBL4A;LAMTOR3;TNRC6B;RPTOR;TXN2
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.40835515549287765,-0.8149218249699367,0.6756756756756757,1.0,1.0,1/25,2.47%,IFIT1
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.42282363919680876,0.8148384610178317,0.7045454545454546,1.0,1.0,1/10,2.57%,NAF1
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),-0.5579835377008882,-0.8146485115104186,0.7222222222222222,1.0,1.0,2/6,16.93%,LFNG;DOCK10
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,-0.3110447142286639,-0.8145541036210994,0.8735632183908046,1.0,1.0,37/219,17.67%,GRIN2D;RASGRP1;RPS27A;NEFL;ZDHHC9;ARHGAP9;RASGEF1A;GFRA2;RALGDS;PSMB9;EGF;PTPN7;TGFA;SHC2;FGF1;PSMB6;DAB2IP;PRKCQ;FN1;PSMC3;PAQR3;DUSP16;UBC;GRIN2B;FGF7;IL3RA;PIK3CB;PSMA8;RASGRF2;TLN1;PSMA7;FGF22;IRS2;TEK;VCL;PSME1;RBX1
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,-0.4215633460161709,-0.8143648215378252,0.803030303030303,1.0,1.0,5/18,19.10%,APP;LMNB1;CAPN1;CDK5;CAPNS1
prerank,Reactome_2022__cGMP Effects R-HSA-418457,-0.4380068852435145,-0.8143011563740936,0.7796610169491526,1.0,1.0,5/13,25.02%,KCNMB4;PDE5A;PDE1A;ITPR1;PRKG2
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,-0.3377585498917213,-0.8142644463471179,0.8433734939759037,1.0,1.0,13/95,13.97%,RPS27A;APP;NOD1;NLRC5;NDUFA2;KCNH8;RPS6KA1;IRF7;BIRC3;TNIP2;UBC;FADD;FOS
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),-0.5133793347051988,-0.8141681568793969,0.7868852459016393,1.0,1.0,1/6,10.14%,CHRM3
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,-0.33457005264636286,-0.8140959793786589,0.8481012658227848,1.0,1.0,18/99,17.67%,IL1R1;RPS27A;APP;NOD1;NLRC5;PSMB9;PSMB6;PSMC3;TNIP2;UBC;PSMA8;IL1RAP;PSMA7;USP18;PSME1;ALPK1;RIPK2;RBX1
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.3605757320581543,0.8140701443004245,0.7297297297297297,1.0,1.0,3/22,15.58%,BMP2;PPP2R5A;SMPD1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.4121234609855872,-0.8139724235354902,0.7213114754098361,1.0,1.0,1/13,2.72%,ALOX12
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.3896615550501363,-0.8139139847103242,0.726027397260274,1.0,1.0,4/35,15.09%,KMO;FOLH1;GPT2;ASS1
prerank,Reactome_2022__Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,-0.4250613470251044,-0.8138570718421745,0.7534246575342466,1.0,1.0,8/18,17.21%,SLITRK1;IL1RAPL1;SLITRK4;SLITRK5;PPFIA1;IL1RAP;IL1RAPL2;PTPRF
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperones R-HSA-381033,0.4500867644093115,0.8138521909448232,0.6744186046511628,1.0,1.0,2/11,10.28%,NFYC;ATF6
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.3000582517840391,0.8137988837342631,0.85,1.0,1.0,12/62,22.01%,LVRN;CARNMT1;GSTT2;APEH;LTA4H;ADAMTS13;GSTM2;DMD;IDE;PCSK5;LNPEP;MME
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.43073062998316436,0.8136256514674316,0.6111111111111112,1.0,1.0,1/9,0.64%,CD200R1
prerank,KEGG_2021_Human__Prion disease,-0.32280528872538555,-0.8135296906443938,0.8604651162790697,1.0,1.0,26/202,16.23%,GRIN2D;TUBB6;GRIN3A;GRIN2A;COX7A1;TUBB1;NDUFA2;CAV3;NDUFB9;ITPR3;COX4I1;NDUFB11;PPP3CC;CREB5;PSMB6;CACNA1C;PSMC3;UQCRQ;GRIN2B;NDUFB10;PIK3CB;PSMA8;PRKCD;PIK3CD;PSMA7;COX7A2
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,-0.4300567225747526,-0.8134954635794137,0.7352941176470589,1.0,1.0,3/20,12.77%,RPS27A;BRCA1;UBC
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.5161002038951966,0.8133715130842504,0.7560975609756098,1.0,1.0,2/5,32.46%,EZR;DLG1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.27826284474454904,0.8133109108861855,1.0,1.0,1.0,16/97,17.33%,TMX1;PPP1R15B;EIF2S1;TRIB3;GORASP2;TMEM33;VCP;ATF6;NCK1;DERL1;PIK3R1;RCN3;EIF2AK3;RHBDD1;UFM1;TMTC3
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.4278858697448329,0.813074489421376,0.7837837837837838,1.0,1.0,9/13,28.65%,ADAT2;DPH3;MTO1;ELP4;ELP3;URM1;ALKBH1;ALKBH8;CTU1
prerank,Reactome_2022__FLT3 Signaling By CBL Mutants R-HSA-9706377,-0.5319855429547251,-0.8128789748138942,0.7580645161290323,1.0,1.0,2/6,12.77%,RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.2982746413481867,-0.8127774713161953,0.9473684210526315,1.0,1.0,65/669,13.19%,KLF2;LEF1;MET;POU4F1;NR4A3;PGR;NR1I3;TLR2;PLAG1;CIITA;FOSL2;RPS27A;LMO2;BARX2;PROX1;MLIP;SKAP1;IRF1;ATF3;MAFF;ST18;CASZ1;APP;KLF4;SCX;ZNF750;BEX1;NLRC5;BRCA1;GATA1;TLR3;LDB2;POU2F3;PLSCR1;ZFPM1;SRF;WAS;RPS6KA1;CRLF3;IGF1;MACC1;STAT1;HELZ2;WNT5A;IRF7;FGF1;DAB2IP;CSRNP1;ADIRF;NAMPT;LAGE3;SOX15;IL18;FOXM1;SBNO2;RUNX2;PSMC3;TNIP2;GLI1;NOS1;UBC;FADD;PPARGC1B;PAX8;TNFRSF1A
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.4772062556106913,-0.8127332279794458,0.7368421052631579,1.0,1.0,1/11,1.90%,HIC1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.2932698899899116,0.8126384539687973,1.0,1.0,1.0,32/119,19.48%,NR1D1;PPARGC1A;NR2E1;RARB;MAML3;KAT2B;ESRRG;GTF2F2;RORB;ERCC2;NRBF2;AR;NR3C1;GTF2A2;NOTCH2;TAF12;ESRRA;ERCC3;GTF2H5;TAF4;GTF2H2;TAF8;TAF2;POLR2C;NR2F1;NR1D2;NR3C2;DR1;TAF3;HDAC10;THRB;MED23
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.2571353955029854,0.8125957672005519,1.0,1.0,1.0,34/231,13.91%,CD247;BET1;PPARGC1A;PEF1;MCU;TSPAN33;MITF;SAMM50;MEN1;OCLN;SOX9;PYGO2;LPXN;CUL1;TCAP;SEC22B;LLGL1;PYGO1;PPP6R1;HSF1;WDCP;MDN1;TRADD;KLHL12;RAB1B;PDE4DIP;KMT2A;OPA1;CAPZA1;WASL;SCFD1;CNIH1;SEC24A;SEC23IP
prerank,Reactome_2022__Adaptive Immune System R-HSA-1280218,-0.3004422940650144,-0.8125925635763536,0.9489795918367347,1.0,1.0,64/543,15.23%,RASGRP1;SOCS3;C3;RASGRP2;TLR2;FYB1;B2M;ICAM1;RPS27A;ARIH2;LNX1;HLA-A;INPP5D;SH3GL2;ASB16;SIGLEC1;CD160;COLEC12;CTSC;PDCD1LG2;HLA-C;NDUFA2;HLA-DRA;NPDC1;ITPR3;TNFRSF14;PSMB9;CENPE;ANAPC11;FBXL18;WAS;AP1S1;HERC6;FBXW12;SPSB1;CTSS;FBXO32;PILRA;PSMB6;HLA-B;PRKCQ;SYK;HLA-E;FBXW10;DCTN1;KIF2C;PSMC3;MAP3K14;HECW2;UBC;RNASE1;ASB14;RAP1GAP;HLA-F;HERC5;RNF213;PRICKLE1;BTN3A1;ELOB;BLNK;PIK3CB;UBE2S;CD74;PSMA8
prerank,CellMarker_Augmented_2021__Mast cell:Kidney,-0.34964387972636213,-0.8123684535370522,0.7764705882352941,1.0,1.0,9/72,11.48%,GMPR;MAOB;SVOPL;BEX1;SLC18A2;TSPYL2;CD9;VWC2;ADIRF
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.4086882043582688,-0.8122491010789094,0.7758620689655172,1.0,1.0,3/25,8.20%,P2RY12;KIF17;NEFH
prerank,KEGG_2021_Human__Hippo signaling pathway,-0.32900452585279494,-0.8122326165495668,0.7790697674418605,1.0,1.0,11/131,11.02%,LEF1;TGFBR2;WNT8B;CTNNA3;TEAD2;BMP8A;CCND1;YWHAH;WNT5A;FGF1;BIRC3
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.4017487127379879,-0.8122321609368807,0.696969696969697,1.0,1.0,7/23,17.54%,SNCB;SYT1;NLGN1;SYT5;SNCG;SYT2;CDK5
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.5221718300211458,-0.8120867120391418,0.76,1.0,1.0,3/7,17.69%,CD55;SUSD4;CR1L
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.3239864456489549,-0.811921883009111,0.8390804597701149,1.0,1.0,22/107,20.03%,ARHGAP4;SULF1;THY1;PODN;BST2;CYP1B1;TIMP1;CLIC4;PFN2;DAB2IP;IGFBP5;LDLRAD4;TMEFF2;CD74;SFRP2;DLC1;PTPRR;VCL;MCTP1;PHLDB2;DPYSL3;CX3CL1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.2906547910424492,0.8118450555380263,0.90625,1.0,1.0,13/76,15.12%,TBC1D4;ARHGEF16;TBC1D12;CXCL13;FOXJ1;ARHGEF26;GARNL3;TAX1BP3;TIAM2;SYDE2;MTSS2;TBC1D5;TBC1D8B
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.3308637390682023,0.811701192723539,0.8064516129032258,1.0,1.0,6/42,10.43%,GDAP1;GRPEL2;MFF;AKT1;RALA;TOMM22
prerank,CellMarker_Augmented_2021__Erythroid cell:Umbilical Cord Blood,-0.3512131234478939,-0.8116575316706286,0.8589743589743589,1.0,1.0,8/78,8.69%,KIF14;POLQ;ATAD5;BRCA1;GYPE;AMMECR1;CENPE;CA1
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.295954252923178,-0.8115673416809801,0.967391304347826,1.0,1.0,16/362,7.62%,PRAME;LEF1;CDKN2A;SIX3;SUV39H1;MAEL;CIITA;PROX1;CIC;IRF1;MSX2;KLF4;BRCA1;NKX6-2;BASP1;HEXIM1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3797244074917765,-0.8115200832809198,0.7142857142857143,1.0,1.0,3/31,11.85%,DUSP1;PINK1;FOXM1
prerank,Reactome_2022__Defective LFNG Causes SCDO3 R-HSA-5083630,-0.5639468288049017,-0.8109955659816785,0.82,1.0,1.0,2/5,17.41%,LFNG;NOTCH3
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,0.27049220132126706,0.8108849968240432,0.9545454545454546,1.0,1.0,24/161,14.90%,SEM1;PHLDA1;HMMR;PSMD10;CDC25A;PSMA1;PSMD11;CUL1;PSMB5;HAUS1;CSNK1E;CEP290;XPO1;RBBP4;CEP152;BTRC;PLK1;PCM1;PSMD14;ALMS1;PSMD12;CEP192;TUBG1;RAB8A
prerank,Reactome_2022__Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,-0.4318781118623915,-0.8107579951796432,0.7868852459016393,1.0,1.0,6/17,25.02%,GUCY1A1;KCNMB4;PDE5A;PDE1A;ITPR1;PRKG2
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),0.43170219141106125,0.8107510968363615,0.6904761904761905,1.0,1.0,3/7,24.64%,DNAJB14;DNAJC18;DNAJB12
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.3511786594264111,-0.8105439139149659,0.7792207792207793,1.0,1.0,10/77,15.90%,BLM;RPS27A;BRCA1;PLK3;RPA3;TAF10;NUAK1;UBC;PDZD2;CDK2
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.39453565220589465,-0.8104917991311329,0.7352941176470589,1.0,1.0,8/35,17.27%,GPR183;MMP14;SYK;TNIP2;IL7;CD74;IRS2;SH3KBP1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.3075158845586397,0.8104783362264661,0.8695652173913043,1.0,1.0,10/29,27.12%,SESN2;SESN3;PRKAA1;MINAR1;TBC1D7;KPTN;NPRL3;EPM2A;NPRL2;SESN1
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.3308074201646213,0.8104151361922595,0.8181818181818182,1.0,1.0,1/39,0.30%,ACE2
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,-0.381854099120269,-0.8103944995934392,0.8026315789473685,1.0,1.0,1/33,0.52%,CCNB2
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.3466207314324624,0.8103789739649211,0.6857142857142857,1.0,1.0,7/27,18.80%,SNF8;VPS37A;VTA1;CHMP2B;VPS37B;VPS4B;CHMP6
prerank,KEGG_2021_Human__Cholesterol metabolism,-0.37469523488646117,-0.8103148810353558,0.7638888888888888,1.0,1.0,9/34,22.52%,LPA;LDLR;ANGPTL3;LRPAP1;SOAT1;LRP2;CD36;SCARB1;ABCG5
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.4252025469369451,0.8102580375893091,0.6666666666666666,1.0,1.0,6/13,37.11%,TNFSF4;NECTIN2;KMT5B;RIF1;TP53BP1;PAXIP1
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),-0.439129132036621,-0.8101659088681376,0.6949152542372882,1.0,1.0,3/11,24.42%,MFSD2A;MYO9A;ERMN
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,0.26211097416545415,0.8101202042773551,1.0,1.0,1.0,27/159,18.06%,KIF21B;RAB33B;KIF15;KIF21A;NAPSA;SEC22B;CYTH3;ARFIP2;MAN1A2;GOLGA1;RAB1B;COG6;NAA30;KIF6;COPB2;VTI1A;CAPZA1;DCTN5;TMED3;RAB9A;ARCN1;KIF1B;RHOBTB3;VAMP3;SNAP29;RIC1;GALNT1
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,0.3490387507283937,0.8098940957561045,0.7333333333333333,1.0,1.0,4/37,7.43%,POLD3;SLC19A1;RFC3;VCP
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.346913448002402,0.8098347528151414,0.7435897435897436,1.0,1.0,2/21,2.79%,PDE3A;LIG4
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,-0.3792214056446527,-0.8097874201407211,0.7878787878787878,1.0,1.0,11/37,23.65%,ADCY7;ITPR3;PRKCG;ADCY5;PRKCD;ADCY8;PDE1C;PDE1A;ITPR1;GRK2;AHCYL1
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,0.3343289234902591,0.8096238809126408,0.78125,1.0,1.0,2/31,2.59%,FANCF;UBE2T
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,0.37505015356781835,0.8095608752805418,0.8,1.0,1.0,4/19,11.33%,SLC19A1;RFC3;VCP;RCHY1
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,0.34670430516326867,0.8090332848701834,0.7,1.0,1.0,8/37,14.20%,POLD3;SLC19A1;RFC3;ERCC2;ERCC3;GTF2H5;GTF2H2;POLK
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Embryo,-0.4310348689662993,-0.8086648694617169,0.7384615384615385,1.0,1.0,6/19,18.05%,ALDOB;GC;ANGPTL3;CYP3A4;ITIH2;PAH
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Embryonic Stem Cell,-0.4310348689662993,-0.8086648694617169,0.7384615384615385,1.0,1.0,6/19,18.05%,ALDOB;GC;ANGPTL3;CYP3A4;ITIH2;PAH
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.41309738828785725,-0.8085044839794014,0.8032786885245902,1.0,1.0,5/17,12.77%,NLRP12;USP50;PSMB9;BIRC3;GRIN2B
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.38443050897107944,0.8084271580379919,0.7368421052631579,1.0,1.0,1/19,0.40%,CD247
prerank,CellMarker_Augmented_2021__FGFR1LowNME5- Epithelial cell:Esophagus,-0.373506875845255,-0.8082553336722312,0.8450704225352113,1.0,1.0,2/40,2.65%,FABP3;RPL39L
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.5394430322323742,-0.8082145790327776,0.8363636363636363,1.0,1.0,1/5,6.35%,ACOT4
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.5372637000544838,-0.8078519935835047,0.8,1.0,1.0,3/5,33.48%,PARP10;PPIA;GPS2
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.3804541015753436,-0.80769421242937,0.7866666666666666,1.0,1.0,3/32,9.94%,BLM;BRCA1;RPA3
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),-0.4768585700937681,-0.8076059379362653,0.6739130434782609,1.0,1.0,2/10,13.75%,TTLL7;TTLL6
prerank,Reactome_2022__Molecules Associated With Elastic Fibres R-HSA-2129379,0.3811901159222226,0.8074508551211276,0.7307692307692307,1.0,1.0,2/18,4.67%,BMP2;FBLN1
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,0.311696710271217,0.8073004639087974,0.9565217391304348,1.0,1.0,7/63,8.58%,ITGA1;ITGA10;SGCD;CACNG2;CACNB4;PRKAB1;CACNB3
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.37301254320404276,-0.8071637940662914,0.7972972972972973,1.0,1.0,2/42,6.37%,ANK3;ANLN
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.2985904075443289,0.8070793161893549,0.9642857142857143,1.0,1.0,6/70,8.62%,CD200R1;PPARGC1A;PDE12;HSPA1A;AKT1;ADNP2
prerank,Reactome_2022__SHC-mediated cascade:FGFR3 R-HSA-5654704,0.41583011513191015,0.8069185765146473,0.7058823529411765,1.0,1.0,1/10,3.57%,NRAS
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.2941067262787645,-0.8066645770596022,0.9263157894736842,1.0,1.0,29/429,12.29%,PRAME;LEF1;TYMS;CDKN2A;SIX3;SUV39H1;MAEL;CIITA;PROX1;CIC;IRF1;MSX2;KLF4;BRCA1;NKX6-2;BASP1;HEXIM1;DBI;RPL13A;TSPYL2;PATL2;WNT5A;DAB2IP;BAP1;FOXM1;SBNO2;RUNX2;EID2;IGFBP5
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.4609899010995324,-0.8066031188564968,0.7727272727272727,1.0,1.0,1/14,2.46%,NOS1AP
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.34017655874302255,-0.8065954820332082,0.8607594936708861,1.0,1.0,10/96,7.50%,FABP3;NEXN;ART3;COX7A1;CTNNA3;PLN;LMOD1;VLDLR;CAV3;SYNPO2L
prerank,Reactome_2022__POLB-Dependent Long Patch Base Excision Repair R-HSA-110362,0.4709889030432094,0.8065648403098435,0.717391304347826,1.0,1.0,1/7,4.43%,POLG2
prerank,Reactome_2022__Diseases Of Mismatch Repair (MMR) R-HSA-5423599,-0.49476764833688325,-0.8065454111348652,0.6666666666666666,1.0,1.0,1/5,6.62%,PMS2
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.49495930665112176,-0.806542028474707,0.7619047619047619,1.0,1.0,1/8,5.52%,AKR1C1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.40354831098973104,-0.8064765623148081,0.7714285714285715,1.0,1.0,1/30,0.81%,BLM
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.32723434296414433,-0.8064510152188527,0.813953488372093,1.0,1.0,10/120,15.64%,RPL3;RPS27;RPS14;SNRPD2;RPL24;RPL38;RPL10;RPS15;MRPL20;RPL5
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.40394563584180376,0.8064442907943298,0.7142857142857143,1.0,1.0,3/15,5.89%,DNA2;EGFR;STN1
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.39970292833402854,-0.8064156916979531,0.7352941176470589,1.0,1.0,6/21,17.72%,RAB11A;ADCY7;ADCY5;ADCY3;ADCY8;AQP1
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.2694921972270108,0.8064059825887261,0.9615384615384616,1.0,1.0,25/111,19.67%,PSMD10;HSPA1A;PSMA1;EXOSC1;PSMD11;AKT1;PSMB5;PCBP4;XPO1;EXOSC6;DIS3;PSMD14;NUP214;ZC3H14;PSMD12;RC3H1;CNOT8;CSDC2;CNOT1;EXOSC8;YTHDF2;FXR2;PCID2;RC3H2;PUM2
prerank,KEGG_2021_Human__Huntington disease,0.25235543801840193,0.8063224520043994,1.0,1.0,1.0,40/252,16.31%,SEM1;UQCRHL;NDUFC2-KCTD14;PPARGC1A;DNAH7;PSMA1;PIK3R4;NDUFB1;PSMD11;MAPK10;PSMB5;VDAC2;NRBF2;GRIA2;PLCB4;AP2B1;MAPK8;PSMD14;ATP5PB;CASP3;DNAH12;ATP5MC2;PIK3C3;SLC25A5;KCNJ10;NDUFV3;TAF4;PSMD12;NDUFA8;DCTN5;TUBB2B;ATP5MC1;HDAC2;POLR2C;COX7A2L;UQCRC2;EP300;GNAQ;NRF1;ATP5F1A
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.34999616436321845,0.8062135341798526,0.6818181818181818,1.0,1.0,4/33,8.47%,PDE3B;GIT1;EGFR;CBFA2T3
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.44169565173658426,-0.8062010677199135,0.796875,1.0,1.0,1/12,8.06%,ANGPTL3
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.5487791354775575,-0.8060000029878621,0.8095238095238095,1.0,1.0,3/5,23.55%,CLN3;AQP1;AQP11
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),-0.523932122176974,-0.8059956702649999,0.8333333333333334,1.0,1.0,1/5,10.53%,PDK3
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),-0.4551453068541071,-0.8059761866787062,0.71875,1.0,1.0,2/13,5.96%,CSPG4;BGN
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.38886488081585746,0.8059544020896844,0.6875,1.0,1.0,6/15,26.99%,CASK;SERPINE2;AJAP1;SLC12A2;PTEN;CLASP2
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.2859458025475551,0.8058306250230564,0.896551724137931,1.0,1.0,11/60,14.78%,ATP13A5;CALCB;SLC24A3;SELENON;ATP2C1;STIM2;ATP13A4;ANK2;RGN;VAPB;SLC24A4
prerank,KEGG_2021_Human__One carbon pool by folate,-0.43675634805950947,-0.8058113438707147,0.765625,1.0,1.0,1/18,0.55%,TYMS
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.3394401014429534,-0.8056674802847695,0.8641975308641975,1.0,1.0,18/95,18.28%,CCNB2;BLM;CCNI2;THY1;CCND1;SLC8A3;GADD45A;CCNB1;DAB2IP;CCNE2;HERC5;MTCP1;CDKN3;CCND2;CDC37;CDKN2D;CCNF;CDKN1A
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.3051657361984218,0.8056612295382338,0.8148148148148148,1.0,1.0,7/46,11.56%,ARV1;ABCA1;CYP7B1;PMVK;CYP4V2;INSIG2;CYP46A1
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,-0.4299966467957511,-0.8056445188722758,0.7846153846153846,1.0,1.0,2/19,8.87%,KCNH8;RPS6KA1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.3501083228207098,-0.8055827183047508,0.8028169014084507,1.0,1.0,8/43,17.28%,CDH22;CDH6;CDH7;CDH19;CDH9;CDH12;CDH17;VCL
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,0.31236977154707063,0.8054676031268135,0.8095238095238095,1.0,1.0,17/53,21.98%,DAO;PEX13;PHYH;EHHADH;UBE2D1;PIPOX;ECH1;GNPAT;ACOX1;PEX2;DDO;IDE;PEX6;ZFAND6;PEX12;MLYCD;NUDT7
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",-0.4420305219514856,-0.8050276389423175,0.7647058823529411,1.0,1.0,1/16,2.20%,ZFP36
prerank,Reactome_2022__Constitutive Signaling By EGFRvIII R-HSA-5637810,0.40779927488305767,0.8050119683403137,0.78125,1.0,1.0,4/14,14.84%,NRAS;EGFR;PIK3CA;PIK3R1
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),0.4679988231418084,0.8050067197615315,0.6666666666666666,1.0,1.0,3/7,12.70%,CYP4F3;CYP4F12;HSD17B6
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.43450882179606576,-0.8049733139719465,0.6964285714285714,1.0,1.0,1/13,3.97%,RAB11A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.43450882179606576,-0.8049733139719465,0.6964285714285714,1.0,1.0,1/13,3.97%,RAB11A
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),0.5021171679164018,0.8049197393095535,0.7291666666666666,1.0,1.0,1/5,20.22%,FBH1
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,-0.36488969207805977,-0.8048513060632461,0.7702702702702703,1.0,1.0,1/36,1.24%,PGR
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.38040258430870577,0.8047810781802597,0.8666666666666667,1.0,1.0,1/21,1.98%,PPARGC1A
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,0.27966158921604306,0.804608103954749,0.8846153846153846,1.0,1.0,7/76,8.17%,SEM1;PSMD10;PSMA1;PSMD11;PSMB5;GAS1;DZIP1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.4080775619650279,0.8045794573441484,0.7027027027027027,1.0,1.0,5/18,14.54%,GANC;MAN1A2;PRKCSH;GANAB;ST8SIA5
prerank,KEGG_2021_Human__Thiamine metabolism,0.43918890169998526,0.8045495858028301,0.7575757575757576,1.0,1.0,2/11,5.97%,AK1;TPK1
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,0.31762133949681115,0.804503129943951,0.7419354838709677,1.0,1.0,8/60,8.11%,SEM1;CCNE1;PSMD10;CDC25A;PSMA1;PSMD11;PSMB5;PCBP4
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),0.46465168935516327,0.8044183555531363,0.7551020408163265,1.0,1.0,2/9,3.82%,ABCB10;ALAS1
prerank,CellMarker_Augmented_2021__Clara cell:Undefined,-0.337420148937933,-0.8041664966481824,0.7901234567901234,1.0,1.0,2/93,2.00%,CD99L2;MTMR7
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.4428221982255539,-0.8041460581424601,0.7222222222222222,1.0,1.0,1/12,10.88%,IFT122
prerank,Reactome_2022__Calcineurin Activates NFAT R-HSA-2025928,-0.5127734479095026,-0.8039034636686534,0.7719298245614035,1.0,1.0,2/7,31.95%,NFATC2;PPIA
prerank,Reactome_2022__Synthesis Of UDP-N-acetyl-glucosamine R-HSA-446210,-0.48216694817682615,-0.8038624500899093,0.7192982456140351,1.0,1.0,4/8,31.47%,UAP1;GFPT2;GNPNAT1;AMDHD2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.25139070000669717,0.8036707198046139,1.0,1.0,1.0,41/241,18.25%,MACIR;RAP2C;FHDC1;CEP19;S1PR1;SPAG16;BBS9;RAB23;SSX2IP;EXOC8;CEP20;EXOC6;INTU;DZIP1;CNGA4;CEP290;ARFIP2;RAB8B;PTPN23;FOXJ1;PARVA;PCM1;DNM3;SCLT1;TEKT5;TTC8;NEK1;UNC119B;TCTN3;IQCB1;RAB8A;TMEM237;UBXN10;WHAMM;MKKS;TNIK;ARHGEF6;SNAP29;EXOC5;FGD4;CCDC88A
prerank,Reactome_2022__Class C/3 (Metabotropic Glutamate/Pheromone Receptors) R-HSA-420499,-0.48486890910989366,-0.8036094015994871,0.6470588235294118,1.0,1.0,4/8,19.43%,GRM6;TAS1R1;GRM7;GABBR2
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.34784504407446426,-0.8034020711469202,0.7972972972972973,1.0,1.0,8/62,17.58%,ARHGAP9;ARHGAP15;ATP5IF1;DAB2IP;NOS1;RAP1GAP;VAV1;CFAP73
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.3541639026765011,-0.803009960976086,0.8208955223880597,1.0,1.0,9/49,17.95%,CDKN2A;RPS27A;PSMB9;PSMB6;PSMC3;UBC;PSMA7;PSME1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.43628745599347873,-0.802803835763444,0.8,1.0,1.0,1/17,1.70%,KREMEN2
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.4029230026504176,-0.8027437089186887,0.7714285714285715,1.0,1.0,6/23,24.71%,THY1;NLGN1;LRRC7;AGRN;ITGAL;DNAJA3
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,0.3485715623246322,0.8025479707688606,0.8333333333333334,1.0,1.0,13/31,28.78%,GTF2F2;ERCC2;ERCC3;GTF2H5;GTF2H2;POLR2C;GTF2H3;NELFA;CTDP1;CCNH;POLR2A;POLR2K;POLR2D
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,-0.3776866963595363,-0.8024414718488269,0.7402597402597403,1.0,1.0,8/31,18.62%,FOSB;KCNH8;SRF;SH3GL3;FOS;F3;CDK5;TF
prerank,KEGG_2021_Human__Breast cancer,-0.32266113051853584,-0.8021031215346297,0.8641975308641975,1.0,1.0,11/115,10.73%,LEF1;PGR;WNT8B;BRCA1;CCND1;EGF;GADD45A;IGF1;WNT5A;SHC2;FGF1
prerank,CellMarker_Augmented_2021__Esophageal Mucosal cell:Esophagus,0.29535432624912483,0.8020737338493219,1.0,1.0,1.0,34/99,21.25%,PCDH19;CNTN1;EML1;ADGRB3;MAPK10;FAM171B;TMEM47;NOVA1;PBX1;DZIP1;FAT3;MEGF10;ATP1A2;GPM6B;ANK2;TMEM35A;CDH11;PTPRG;TENM3;MPDZ;SHC3;NDRG4;KIF1B;LIFR;CACNA2D1;MAP6;ABI2;CSRNP3;CHN1;ID4;ITSN1;MARK1;GJA1;PTPRZ1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestine,0.29535432624912483,0.8020737338493219,1.0,1.0,1.0,34/99,21.25%,PCDH19;CNTN1;EML1;ADGRB3;MAPK10;FAM171B;TMEM47;NOVA1;PBX1;DZIP1;FAT3;MEGF10;ATP1A2;GPM6B;ANK2;TMEM35A;CDH11;PTPRG;TENM3;MPDZ;SHC3;NDRG4;KIF1B;LIFR;CACNA2D1;MAP6;ABI2;CSRNP3;CHN1;ID4;ITSN1;MARK1;GJA1;PTPRZ1
prerank,CellMarker_Augmented_2021__Small Intestinal Stem cell:Small Intestinal Crypt,0.29535432624912483,0.8020737338493219,1.0,1.0,1.0,34/99,21.25%,PCDH19;CNTN1;EML1;ADGRB3;MAPK10;FAM171B;TMEM47;NOVA1;PBX1;DZIP1;FAT3;MEGF10;ATP1A2;GPM6B;ANK2;TMEM35A;CDH11;PTPRG;TENM3;MPDZ;SHC3;NDRG4;KIF1B;LIFR;CACNA2D1;MAP6;ABI2;CSRNP3;CHN1;ID4;ITSN1;MARK1;GJA1;PTPRZ1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Esophagus,0.29535432624912483,0.8020737338493219,1.0,1.0,1.0,34/99,21.25%,PCDH19;CNTN1;EML1;ADGRB3;MAPK10;FAM171B;TMEM47;NOVA1;PBX1;DZIP1;FAT3;MEGF10;ATP1A2;GPM6B;ANK2;TMEM35A;CDH11;PTPRG;TENM3;MPDZ;SHC3;NDRG4;KIF1B;LIFR;CACNA2D1;MAP6;ABI2;CSRNP3;CHN1;ID4;ITSN1;MARK1;GJA1;PTPRZ1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Colon,0.29535432624912483,0.8020737338493219,1.0,1.0,1.0,34/99,21.25%,PCDH19;CNTN1;EML1;ADGRB3;MAPK10;FAM171B;TMEM47;NOVA1;PBX1;DZIP1;FAT3;MEGF10;ATP1A2;GPM6B;ANK2;TMEM35A;CDH11;PTPRG;TENM3;MPDZ;SHC3;NDRG4;KIF1B;LIFR;CACNA2D1;MAP6;ABI2;CSRNP3;CHN1;ID4;ITSN1;MARK1;GJA1;PTPRZ1
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.33271726439546784,-0.8019851571703525,0.8641975308641975,1.0,1.0,19/98,17.76%,AMN;ABCA6;ABCA5;ABCA8;RAMP3;ABCA12;SLC18A2;ABCA10;MYH9;ARRDC2;SLCO2A1;SLC22A4;MFSD2A;ARRDC3;SLC35F3;SLCO1A2;SLC29A4;SLC50A1;LRP2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.33875034684806693,-0.8018868594548655,0.8375,1.0,1.0,22/100,17.12%,PHEX;SULF1;MMP14;CD44;PAPSS2;NOTUM;COL11A2;CHI3L1;IGF1;COL10A1;WNT5A;HAPLN2;ALPL;HHIP;PTH1R;HYAL1;PPIB;ADAMTS4;TLL1;DDRGK1;COL9A2;DEAF1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.426274847054938,-0.801656425167237,0.7213114754098361,1.0,1.0,3/18,14.77%,HK2;RBKS;GPI
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,-0.40785224869224135,-0.8016274132726208,0.76,1.0,1.0,4/26,10.72%,ALDOB;FBP1;GAPDHS;PGK1
prerank,Reactome_2022__Activation Of RAC1 Downstream Of NMDARs R-HSA-9619229,0.45071608551999404,0.8015597986359932,0.7333333333333333,1.0,1.0,1/7,5.26%,GIT1
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),0.5199229152536238,0.8013939991025179,0.8,1.0,1.0,1/5,18.82%,DMC1
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.3786975758964373,-0.8013808571370997,0.7605633802816901,1.0,1.0,4/39,5.62%,RPS27A;APP;NOD1;NLRC5
prerank,Reactome_2022__RA Biosynthesis Pathway R-HSA-5365859,-0.4400936517786058,-0.8013561006926626,0.7142857142857143,1.0,1.0,1/10,2.02%,RDH13
prerank,Reactome_2022__Pentose Phosphate Pathway R-HSA-71336,0.4353534500309418,0.8010917808705379,0.7894736842105263,1.0,1.0,1/11,3.55%,PGM2
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.3892241890632758,-0.801027101862701,0.7922077922077922,1.0,1.0,3/35,9.53%,S100A10;SYNPO2L;PFN2
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.48721443422975724,0.8010088612569941,0.7446808510638298,1.0,1.0,5/8,47.08%,GBA2;ABHD10;GUSB;FUCA2;GLA
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.41578725574725384,-0.800989276535897,0.7432432432432432,1.0,1.0,11/25,24.05%,DHCR24;SQLE;MVK;FDPS;INSIG1;MSMO1;HMGCS1;HSD17B7;ACAT2;IDI1;LSS
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.47091965140172,0.8008660879281396,0.7647058823529411,1.0,1.0,1/11,1.26%,NIPAL1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.4350284414580894,-0.8008340512822353,0.7397260273972602,1.0,1.0,5/17,17.28%,EGF;SFRP4;CD63;APLN;AHI1
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,-0.32708889200188757,-0.8008135133017292,0.8404255319148937,1.0,1.0,10/137,11.32%,CDKN2A;BLM;POU4F1;RPS27A;BRCA1;PLK3;RPA3;TAF10;NUAK1;PRDM1
prerank,CellMarker_Augmented_2021__Oligodendrocyte Precursor cell:Brain,-0.3389456326222659,-0.800711533190694,0.8904109589041096,1.0,1.0,21/102,15.98%,STMN2;LRRTM2;GRIN2A;PLP1;GRIA3;CSMD2;GAP43;GRIA1;GFAP;ZNF536;CA10;GABRB2;SCN2A;SCN1A;STMN4;SYNPR;GRIN2B;GRID2;CNTN2;RAB3C;CNTNAP5
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.4211956051160337,0.8005613095532924,0.7894736842105263,1.0,1.0,6/18,17.89%,SRI;ATP1A2;CASQ1;ANK2;GSTM2;DMD
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.3393672528330709,0.8005283789212273,0.7352941176470589,1.0,1.0,5/36,7.43%,BCO2;AKT2;ABCD1;AKT1;VCP
prerank,Reactome_2022__Synthesis Of Dolichyl-phosphate R-HSA-446199,-0.537183943118943,-0.8003740177831355,0.7,1.0,1.0,3/5,33.97%,DHDDS;MVD;DOLK
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.3902101125485458,-0.8003529921901079,0.7710843373493976,1.0,1.0,4/28,10.43%,ST6GAL1;ACOT4;GLYAT;CYP4F22
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,-0.3384087668143196,-0.8001652153380417,0.803030303030303,1.0,1.0,8/70,12.77%,RASGRP1;RASGRP2;RPS27A;PSMB9;PSMB6;PRKCQ;PSMC3;UBC
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.43866411041463804,0.7999117932579927,0.7073170731707317,1.0,1.0,2/10,10.63%,CCT7;CCT3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.5252382382795582,0.7999010416727587,0.8717948717948718,1.0,1.0,1/5,17.40%,AGO3
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.4347583963919295,-0.7998599930324625,0.6885245901639344,1.0,1.0,1/12,3.97%,RAB11A
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.4347583963919295,-0.7998599930324625,0.6885245901639344,1.0,1.0,1/12,3.97%,RAB11A
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,-0.38029964495545476,-0.7998172356832521,0.7058823529411765,1.0,1.0,5/31,17.46%,SLC51A;AKR1C1;SLC51B;SLCO1A2;ACOT8
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.3968583096260516,-0.7997356790014746,0.7307692307692307,1.0,1.0,8/31,15.68%,SULF1;SCX;CD44;COL11A2;CHI3L1;NAMPT;HYAL1;DDRGK1
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperone Genes R-HSA-381183,0.4645071821765214,0.7996660170414825,0.6904761904761905,1.0,1.0,2/9,10.28%,NFYC;ATF6
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.42073239909935073,0.7996535505176414,0.6774193548387096,1.0,1.0,4/9,21.11%,SLC12A9;CA12;SLC12A8;SLC12A2
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.42073239909935073,0.7996535505176414,0.6774193548387096,1.0,1.0,4/9,21.11%,SLC12A9;CA12;SLC12A8;SLC12A2
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,0.3164464215916165,0.7995746765228987,0.8666666666666667,1.0,1.0,7/56,8.69%,THUMPD1;IMP4;RCL1;KRR1;DCAF13;NOL11;TBL3
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.47111351335557416,-0.7995421988775319,0.7704918032786885,1.0,1.0,1/8,16.59%,CLN3
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,-0.426018153671614,-0.7994987575185788,0.75,1.0,1.0,9/22,23.64%,DHCR24;SQLE;MVK;FDPS;SREBF1;MSMO1;HMGCS1;SH3D19;IDI1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.4607288902579056,-0.7992021345921323,0.7543859649122807,1.0,1.0,2/10,3.45%,SIX3;KIF14
prerank,CellMarker_Augmented_2021__Radial Glial cell:Undefined,-0.44773863221967486,-0.7991943284108639,0.7407407407407407,1.0,1.0,1/10,7.25%,GFAP
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.44949483704547577,-0.7991438916206366,0.7272727272727273,1.0,1.0,3/13,20.57%,HEXIM1;NELFE;SUPT5H
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,0.3768272591464763,0.799105466621162,0.7878787878787878,1.0,1.0,3/26,4.65%,NCSTN;CNTN1;MAML3
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.4769301829103415,-0.7989493555235655,0.7068965517241379,1.0,1.0,1/8,10.01%,WNT5A
prerank,Reactome_2022__Protein Folding R-HSA-391251,-0.34279994911711553,-0.7989398293461435,0.8311688311688312,1.0,1.0,8/78,12.36%,TUBB6;GNG3;PFDN6;TCP1;GAPDHS;FBXW10;CCNE2;GNG2
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.5063522906437792,0.7988577808025519,0.7954545454545454,1.0,1.0,1/7,16.16%,CPEB3
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,0.3814131654389456,0.7986471244499199,0.7586206896551724,1.0,1.0,8/21,23.66%,NRAS;EGFR;ERBB4;PIK3CA;PIK3R1;NRG3;PIGU;SOS1
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,-0.4003683504864764,-0.7985836374877956,0.7678571428571429,1.0,1.0,1/22,2.23%,RPS27A
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.3587615267309364,-0.7985517201714828,0.7605633802816901,1.0,1.0,9/58,17.65%,ZFP36;RPS27A;NOD1;MINK1;TNIP2;UBC;SH2D3A;SH2D3C;RIPK2
prerank,Reactome_2022__Attachment Of GPI Anchor To uPAR R-HSA-162791,0.4765084854465661,0.7984008948247838,0.7073170731707317,1.0,1.0,3/6,25.16%,PGAP1;PIGU;PIGT
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.42584126866721544,0.7983194067401359,0.7777777777777778,1.0,1.0,1/11,1.56%,AGER
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3151598496851255,0.7981817669284873,1.0,1.0,1.0,13/65,17.60%,LIMD1;PSMD10;ELOC;PSMA1;PSMD11;PSMB5;PSMD14;EGLN3;CUL2;PSMD12;EP300;BACH1;VHL
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.42071112089450324,0.7981355116315384,0.7567567567567568,1.0,1.0,3/9,28.27%,POGLUT1;SMO;NF1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.38778855919125266,-0.7976329983688424,0.8857142857142857,1.0,1.0,3/34,4.36%,KCNB1;SLC39A14;HK2
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.5331085441786402,-0.797554661800665,0.7083333333333334,1.0,1.0,1/5,11.67%,SFRP4
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.35341078666700665,0.7972964714282433,0.7142857142857143,1.0,1.0,1/21,0.48%,DAO
prerank,KEGG_2021_Human__Phototransduction,-0.4558295141922152,-0.797278909837261,0.7169811320754716,1.0,1.0,2/8,7.81%,SLC24A1;PDE6B
prerank,Reactome_2022__Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.40776934323530734,-0.7972375944987976,0.782608695652174,1.0,1.0,6/21,22.15%,PRDX5;GLYAT;TXNRD2;ATOX1;CCS;ERO1A
prerank,Reactome_2022__TRIF-mediated Programmed Cell Death R-HSA-2562578,-0.4722995800669799,-0.7971843581414906,0.7704918032786885,1.0,1.0,3/7,20.15%,NDUFA2;FADD;CASP8
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,0.3239080898974247,0.7970176853201892,0.8064516129032258,1.0,1.0,4/45,7.43%,POLD3;SLC19A1;RFC3;VCP
prerank,Reactome_2022__G2/M Transition R-HSA-69275,0.2705501838187807,0.7968296068613686,1.0,1.0,1.0,24/160,14.90%,SEM1;PHLDA1;HMMR;PSMD10;CDC25A;PSMA1;PSMD11;CUL1;PSMB5;HAUS1;CSNK1E;CEP290;XPO1;RBBP4;CEP152;BTRC;PLK1;PCM1;PSMD14;ALMS1;PSMD12;CEP192;TUBG1;RAB8A
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.440455465857059,0.7967208953309214,0.7435897435897436,1.0,1.0,1/9,1.08%,CHAMP1
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.4942262018729169,-0.7966932004229774,0.711864406779661,1.0,1.0,3/6,18.37%,COX7A1;COX7A2;HIGD1B
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,-0.35057706463495014,-0.7966277364685133,0.8169014084507042,1.0,1.0,9/68,16.80%,VRK2;DEPDC1B;ARHGAP39;ARHGDIG;CDC42EP1;VAV1;MCAM;ERBIN;EMD
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.46328435158700454,0.7966173806299547,0.7837837837837838,1.0,1.0,2/11,4.69%,RUNX1;IL17D
prerank,CellMarker_Augmented_2021__CD4+ Memory T cell:Peripheral Blood,-0.44099600483507584,-0.7965764631684163,0.746031746031746,1.0,1.0,2/13,2.08%,CD5;TAGAP
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,0.2831823286230307,0.7964965144623554,0.9473684210526315,1.0,1.0,15/94,14.75%,SEM1;PSMD10;PSMA1;H2BC21;PSMD11;H2BC4;ANAPC1;PSMB5;H2AC6;UBE2D1;PSMD14;ORC5;H3-3B;PSMD12;CDC26
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.44478403528261545,-0.7964409665534704,0.7090909090909091,1.0,1.0,3/11,11.20%,LDLR;CD9;SYK
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.41357729489856243,0.7963160358903639,0.75,1.0,1.0,1/11,2.78%,BCL10
prerank,Reactome_2022__Activation Of AMPK Downstream Of NMDARs R-HSA-9619483,0.44475176523232707,0.7962326755749147,0.6808510638297872,1.0,1.0,2/8,20.24%,PRKAB1;PRKAA1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.41269163840561496,-0.7961542799965615,0.7534246575342466,1.0,1.0,11/26,24.05%,DHCR24;SQLE;MVK;FDPS;INSIG1;MSMO1;HMGCS1;HSD17B7;ACAT2;IDI1;LSS
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),0.4083963183833751,0.796094442122722,0.6842105263157895,1.0,1.0,2/13,10.83%,FOXJ2;FOXJ3
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.5015423172889436,0.7960639260392413,0.7916666666666666,1.0,1.0,1/5,10.69%,NIPBL
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.4049137095459636,0.7960541359895388,0.6944444444444444,1.0,1.0,4/13,31.30%,ADRB2;PKIB;RAPGEF2;SIRT1
prerank,Reactome_2022__Sperm Motility And Taxes R-HSA-1300642,0.5194214268992273,0.7960070750092204,0.7674418604651163,1.0,1.0,3/5,26.56%,CATSPERB;CATSPER2;CATSPERG
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.40682677639628423,-0.7958756328981356,0.8253968253968254,1.0,1.0,1/18,0.33%,THBS1
prerank,Reactome_2022__Mitochondrial tRNA Aminoacylation R-HSA-379726,0.3918086651652852,0.7957865561371346,0.8378378378378378,1.0,1.0,5/18,18.88%,CARS2;YARS2;KARS1;NARS2;LARS2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.46468876643550605,-0.7956671927383165,0.847457627118644,1.0,1.0,3/10,25.69%,ROMO1;TIMM10;TIMM22
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.4574581462642431,-0.7955759425114762,0.7313432835820896,1.0,1.0,2/11,5.96%,CSPG4;BGN
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.2979423215976213,0.7955413899592272,0.8,1.0,1.0,20/113,15.78%,PSMD10;GSKIP;PSMA1;PSMD11;EGFR;GPC5;PSMB5;VCP;GID8;RNF146;CSNK1E;CAPRIN2;PPM1A;PSMD14;ZEB2;CSNK1G3;PSMD12;KANK1;NFKB1;LGR4
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.31633841636135634,-0.7953532822111533,0.8620689655172413,1.0,1.0,34/165,19.45%,ALDOB;PLAAT4;ITPKC;PLB1;INPP5D;HK2;HTR2B;ANGPTL3;PLPPR1;PRKCG;FBP1;PLPPR5;PGK1;ALPL;LPCAT4;NUDT4;DUSP16;PLCH2;GPI;PIK3CB;HDHD2;PFKFB4;PIK3CD;PFKL;PFKFB3;PXYLP1;CDK5;LIMK2;TGFB1;PLCE1;GFPT2;ALK;PPA1;DUSP8
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.31654201919038094,-0.795272652831857,0.925531914893617,1.0,1.0,22/147,15.13%,HPN;EFNA1;KREMEN2;GPNMB;OVOL2;IL15;NLRP12;ZNF750;RAB11FIP5;TIMP1;TNNT1;SRF;PFN2;RAB11FIP1;LRPAP1;DAB2IP;PROCR;LDLRAD4;SLC11A1;ARRDC3;SRGN;SFRP2
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.43518401913250887,0.7952482928052599,0.625,1.0,1.0,4/7,17.32%,PIK3C2G;PIK3C3;PIK3CA;PIK3C2A
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,-0.4416686772046629,-0.7951955642949918,0.7313432835820896,1.0,1.0,4/19,12.77%,RPS27A;EGF;TGFA;UBC
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,0.39825956185468014,0.7944997737846463,0.6470588235294118,1.0,1.0,2/16,6.13%,MYBPC1;TCAP
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Eye,-0.3311913084791834,-0.794135555469096,0.8313253012048193,1.0,1.0,11/92,12.92%,C1QL1;TAGLN3;RPE65;MAP1B;GAP43;IL1RAPL1;PFN2;FGF1;GAD1;GRIN2B;CNTNAP3P2
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.2723075115537792,0.7938133697870635,0.9523809523809523,1.0,1.0,17/119,12.54%,EPHA6;FLT3;NAF1;POLG2;GREM1;TRIB3;DCUN1D2;EGFR;RFC3;MAP3K4;UBE2N;DCUN1D1;ERBB4;PLK1;CSF1R;EPM2AIP1;EPHB4
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.3160635196378507,0.7934022446336647,0.90625,1.0,1.0,7/49,13.97%,LEPR;TAB3;AKT1;EIF4E;DAP;PIK3CA;QSOX1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.29848296406335734,-0.7933953740232643,0.9222222222222223,1.0,1.0,28/277,13.06%,CP;SOCS3;C3;SERPINA10;CHGB;LAMB1;RAB11A;ASB16;APP;TIMP1;PSMB9;SERPIND1;NOTUM;FBXL18;FAM20C;FBXW12;SPSB1;FBXO32;IGFBP7;PSMB6;FN1;FBXW10;SHISA5;PSMC3;PRSS23;IGFBP5;GPC3;ASB14
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),0.49285557396542634,0.7931264846371708,0.7906976744186046,1.0,1.0,3/6,23.65%,SMOX;SRM;SAT1
prerank,KEGG_2021_Human__Arginine biosynthesis,-0.44699286441210806,-0.7931122213767351,0.7619047619047619,1.0,1.0,4/13,15.09%,ARG2;GPT2;NOS1;ASS1
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,0.293837397343596,0.7924650557594805,0.9,1.0,1.0,9/59,13.91%,BET1;NAPSA;SEC22B;PPP6R1;RAB1B;SCFD1;CNIH1;SEC24A;SEC23IP
prerank,CellMarker_Augmented_2021__Large Granular lymphocyte:Peripheral Blood,-0.33725478501642703,-0.7924421277457896,0.9135802469135802,1.0,1.0,21/81,25.89%,TRAM1L1;B4GALNT1;EFNB3;DCTN1;CRMP1;DIRAS1;STMN1;FSD1;CHST10;MYL6B;NAP1L3;MAPK8IP1;ZCCHC18;FADS2;CRISPLD1;NRSN2;APLP1;NUDT11;TSPYL4;WASF1;SV2A
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.4221776608517882,-0.7924294033807924,0.7741935483870968,1.0,1.0,2/14,11.77%,IGF1;SOX15
prerank,Reactome_2022__Gap Junction Degradation R-HSA-190873,-0.4628092252333423,-0.7924054603197113,0.71875,1.0,1.0,2/9,19.82%,CLTB;DNM1
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.40614425890763034,-0.792402278713313,0.7142857142857143,1.0,1.0,5/21,17.41%,RPS27A;EGF;UBC;APH1A;NOTCH3
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,-0.4341917636577645,-0.7922592170574191,0.7761194029850746,1.0,1.0,2/17,10.55%,GADD45A;CCNB1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.38828676591618566,-0.7919101049537517,0.7922077922077922,1.0,1.0,2/35,2.68%,RSPH4A;PSRC1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.4681667617193147,-0.7918994290823879,0.7878787878787878,1.0,1.0,1/9,3.52%,PLK2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.36499570507009826,0.7918798735797975,0.7837837837837838,1.0,1.0,6/28,14.92%,NUDT16L1;ERCC6;HSF1;CYREN;TFIP11;POT1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.37993883817012747,0.7915552236468364,0.75,1.0,1.0,1/25,0.54%,RNF6
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.29913675390123823,0.7910524984446436,0.96,1.0,1.0,4/53,4.92%,UQCRHL;AFG1L;NDUFB1;COX10
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.34580473285711877,-0.791031310342501,0.8375,1.0,1.0,9/59,13.02%,HPN;ALDOB;GC;BHMT;GLYAT;FBP1;ALPL;PDZK1;CYP3A4
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.3247383064055305,0.790977588021185,0.84,1.0,1.0,6/46,9.61%,FANCF;UBE2T;RFWD3;VCP;DCLRE1B;ATR
prerank,KEGG_2021_Human__N-Glycan biosynthesis,-0.3582697299854821,-0.7908452483166126,0.7974683544303798,1.0,1.0,1/49,0.17%,ST6GAL1
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.29989416726955714,0.7907990294377639,1.0,1.0,1.0,4/52,4.92%,UQCRHL;AFG1L;NDUFB1;COX10
prerank,Reactome_2022__Hyaluronan Metabolism R-HSA-2142845,-0.45650942260028765,-0.7906920214722684,0.7619047619047619,1.0,1.0,2/11,7.03%,CEMIP;CD44
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.4996080667370698,0.7904161744128324,0.7058823529411765,1.0,1.0,4/6,38.65%,USP7;UHRF2;ZNF445;HELLS
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.3642794585700028,-0.7903535941715141,0.8133333333333334,1.0,1.0,4/41,11.85%,RASGRP1;SCIMP;DAB2IP;FOXM1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.3764168378525109,-0.7903520677845035,0.8311688311688312,1.0,1.0,5/43,9.36%,TEKT2;RSPH4A;CCDC39;SPAG17;ODAD1
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,-0.3833075325504335,-0.7901802091936946,0.8208955223880597,1.0,1.0,3/42,5.04%,B2M;RPS27A;APP
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.28789726193092163,0.7899887537881409,0.8888888888888888,1.0,1.0,9/85,8.17%,SLC26A7;CHRNA4;SLC24A3;SLC15A2;SLC25A18;TRPM3;VDAC2;CHRNB4;GLRB
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,0.34294079643367403,0.7899505141523742,0.8181818181818182,1.0,1.0,2/28,1.30%,GALNT3;GALNT14
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.5352237784671043,-0.7899165690489087,0.7413793103448276,1.0,1.0,3/5,20.77%,RAB11A;LIMK2;IKBKG
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.35703799949048975,0.7898645052157239,0.7037037037037037,1.0,1.0,4/30,9.00%,PDE3A;ADCY1;SOX9;PDE7B
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.42825022366597854,0.7898036282116143,0.71875,1.0,1.0,2/11,12.35%,ZNF502;VAPA
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.43611500413773424,-0.7897892761243974,0.7894736842105263,1.0,1.0,5/12,30.45%,KAT5;FAM161A;CAMK1;DIP2B;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.4234487772939593,-0.7896959800714488,0.7213114754098361,1.0,1.0,3/16,9.24%,B2M;CAV3;IGF1
prerank,Reactome_2022__Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,0.325165956231765,0.7896406480776572,0.8235294117647058,1.0,1.0,13/29,30.40%,ELOC;GTF2F2;ELOA;POLR2C;CCNT1;NELFA;CTDP1;TCEA1;POLR2A;POLR2K;POLR2D;SUPT16H;POLR2E
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,0.24891373426091543,0.7893336721069311,1.0,1.0,1.0,23/166,14.90%,BBS10;BBS9;EXOC8;EXOC6;HAUS1;CSNK1E;CNGA4;CEP290;CEP152;PLK1;PCM1;CCT3;CEP97;ALMS1;C2CD3;SCLT1;TTC8;UNC119B;TCTN3;IQCB1;CEP192;TUBG1;RAB8A
prerank,Reactome_2022__Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,-0.40059738731373806,-0.7890884089284066,0.8333333333333334,1.0,1.0,3/19,12.08%,CYP1B1;CYP4F22;CYP21A2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.4236414735603136,0.7890599042775021,0.7380952380952381,1.0,1.0,2/11,10.63%,CCT7;CCT3
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",-0.34766118191703255,-0.7890596074197302,0.8235294117647058,1.0,1.0,5/57,7.30%,CP;SLC6A15;SLC39A14;SLC16A3;SLC18A2
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.41137570992402306,-0.7890420063967535,0.7638888888888888,1.0,1.0,11/28,24.05%,DHCR24;SQLE;MVK;FDPS;INSIG1;MSMO1;HMGCS1;HSD17B7;ACAT2;IDI1;LSS
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.5004303884638581,-0.7890191333310067,0.7894736842105263,1.0,1.0,1/9,6.29%,BRCA1
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.3621759867097536,-0.7889645692576234,0.76,1.0,1.0,7/38,17.65%,RPS27A;NOD1;MINK1;UBC;SH2D3A;SH2D3C;RIPK2
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,0.26456847464360367,0.7886944194784831,0.9666666666666667,1.0,1.0,11/72,15.49%,BET1;TMEM115;NAPSA;RAB1B;COG6;ANK2;COPB2;CAPZA1;DCTN5;TMED3;ARCN1
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.39580961330209136,-0.7886564477631277,0.7285714285714285,1.0,1.0,9/27,22.78%,THY1;FN1;DLC1;LAMA3;ITGB4;RHOD;PLEC;SORBS1;DST
prerank,Reactome_2022__G1/S Transition R-HSA-69206,-0.3196539464273159,-0.7886511600274745,0.8607594936708861,1.0,1.0,19/109,17.44%,TYMS;RPS27A;POLE3;PTK6;CCND1;PSMB9;POLE4;RPA3;CCNB1;PSMB6;PSMC3;CCNE2;UBC;CDK2;MAX;PSMA7;CDC7;WEE1;PSME1
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.33042148634002094,0.7884310229883691,0.8421052631578947,1.0,1.0,2/24,11.53%,HSPA1A;OPA1
prerank,CellMarker_Augmented_2021__Neural Crest Stem cell:Hair Follicle,-0.3353605248318919,-0.7883822643819324,0.8607594936708861,1.0,1.0,23/85,23.53%,SPARC;LZTS1;BEX1;GAP43;IFFO1;CMTM3;AEBP1;GNG2;CRMP1;APBA2;STK32B;CCDC184;PCDH18;CHST10;NAP1L3;SFRP1;BCAT1;ZCCHC18;ITM2C;TCEAL7;NACAD;CRISPLD1;BEX4
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.5282788536590759,-0.788320349415012,0.7777777777777778,1.0,1.0,2/5,25.06%,BDNF;FYN
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.45757451102654834,-0.7882791351851155,0.7358490566037735,1.0,1.0,1/11,3.46%,IMPDH1
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.5083129451228834,-0.7880901237038265,0.7169811320754716,1.0,1.0,3/7,29.81%,TGFB1;STAT3;NCOR1
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,0.32243820043897803,0.787698567144522,1.0,1.0,1.0,10/57,14.75%,SEM1;PSMD10;PSMA1;PSMD11;ANAPC1;PSMB5;UBE2D1;PSMD14;PSMD12;CDC26
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.4984092745463485,0.7875740210451795,0.7692307692307693,1.0,1.0,2/6,20.11%,GSTM2;CRYZ
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,-0.32176337264686045,-0.7875633382027833,0.9090909090909091,1.0,1.0,22/122,17.67%,IL1R1;RPS27A;APP;NOD1;NLRC5;PSMB9;IL1RAPL1;PTPN7;PSMB6;IL18;PSMC3;TNIP2;SIGIRR;UBC;PSMA8;IL1RAP;PSMA7;USP18;PSME1;ALPK1;RIPK2;RBX1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.4566386278049206,-0.787475863753424,0.7894736842105263,1.0,1.0,1/10,2.20%,ZFP36
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.4779832571834054,0.7872489044491009,0.7254901960784313,1.0,1.0,2/5,15.88%,HMGB1;TNFSF4
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.4813781874258254,-0.7871494822388345,0.7183098591549296,1.0,1.0,2/7,7.35%,TIMP1;CCND1
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.30748633828772204,-0.7871212045173355,0.9058823529411765,1.0,1.0,25/188,18.31%,CCNB2;CDKN2A;PLK2;CCNI2;ABCB1;CCND1;PLK3;CRLF3;CCNB1;DCTN1;FOXM1;CCNE2;HAUS7;CEP76;CDKN3;UBE2S;CDK2;CCND2;MAX;CDC7;WEE1;CDKN2D;CCNF;CDKN1A;SPDYA
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,0.3991853107146071,0.786983641061785,0.75,1.0,1.0,2/11,8.11%,CCNE1;PCBP4
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),0.48840561327383514,0.786842876549448,0.7333333333333333,1.0,1.0,2/5,4.42%,ASCL1;POU3F2
prerank,Reactome_2022__EPHA-mediated Growth Cone Collapse R-HSA-3928663,-0.4335885141661212,-0.7868361943608051,0.7457627118644068,1.0,1.0,5/14,25.06%,MYH11;MYH9;MYL6;NGEF;FYN
prerank,KEGG_2021_Human__T cell receptor signaling pathway,0.29078372890842424,0.7867892331081189,0.9230769230769231,1.0,1.0,14/76,15.67%,CD247;BCL10;NRAS;AKT2;MAPK10;AKT1;NCK1;MAPK8;MAPK12;PIK3CA;NFKBIB;NFKB1;PIK3R1;NCK2
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.3557227769974284,-0.7867660997119696,0.8533333333333334,1.0,1.0,12/52,21.38%,TLR2;NNAT;IGF1;ACHE;IRS2;MYO18A;MYRIP;GPER1;TGFB1;DOC2B;TMED10;ADAM8
prerank,Reactome_2022__YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,-0.47933056705847743,-0.7862620833412967,0.7575757575757576,1.0,1.0,2/10,12.02%,TEAD2;RUNX2
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4648588910355348,-0.7862599674322612,0.7571428571428571,1.0,1.0,4/11,16.59%,SYN3;HAP1;NLGN1;CLN3
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.4259358910342657,0.7862114702547044,0.627906976744186,1.0,1.0,4/11,25.83%,APOBEC3F;TASOR;RESF1;SETDB1
prerank,Reactome_2022__Mismatch Repair (MMR) Directed By MSH2:MSH6 (MutSalpha) R-HSA-5358565,0.43092242759375415,0.7861404494040822,0.825,1.0,1.0,1/12,0.67%,POLD3
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,-0.3453660703572091,-0.7859949399676313,0.8493150684931506,1.0,1.0,15/60,20.77%,IL12A;STAT4;HLA-DRA;IFNGR2;STAT1;IL4R;PPP3CC;PRKCQ;FOS;HLA-DRB1;STAT6;NOTCH3;CD4;IL12RB2;IKBKG
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Undefined,-0.4866478376662905,-0.7859764044823919,0.7777777777777778,1.0,1.0,3/8,16.86%,CD5;SELP;CD200
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.39480717488019934,0.7855563784422838,0.7297297297297297,1.0,1.0,3/12,12.02%,GUCA1B;ERBB4;SLC22A2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.507256758353403,0.7855137466971704,0.7857142857142857,1.0,1.0,2/5,14.00%,XG;MDK
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),0.507256758353403,0.7855137466971704,0.7857142857142857,1.0,1.0,2/5,14.00%,XG;MDK
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.5390053125948927,-0.7854748061553724,0.803921568627451,1.0,1.0,2/6,20.15%,CAPN1;CASP8
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.31836085733657044,0.7852188075520278,0.8518518518518519,1.0,1.0,12/40,25.51%,ADAMTS9;UBE2G1;DNASE1L2;STT3B;FBXO27;DFFB;DNASE1L1;IDE;PPP1R8;RAB12;MTREX;HNRNPD
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.39045567667086906,-0.7851804105526283,0.7647058823529411,1.0,1.0,3/30,7.85%,RAB11FIP5;CAV3;EGF
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.33580366350539553,-0.7851136642359868,0.8441558441558441,1.0,1.0,15/84,16.87%,TLR2;HIC1;DEPDC1B;SULF1;APP;RSPO3;NOTUM;SFRP4;RSPO4;GPC3;ITGA3;CBY1;SFRP2;EMD;TSC2
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.37714419936590116,-0.78505901208722,0.8115942028985508,1.0,1.0,5/35,12.77%,RPS27A;PTPN7;PAQR3;DUSP16;UBC
prerank,KEGG_2021_Human__Inositol phosphate metabolism,0.2925245866230215,0.7850493091436613,0.8214285714285714,1.0,1.0,12/68,15.40%,PIP5K1B;INPP1;PI4K2A;PLCB4;IPMK;SACM1L;PIK3C2G;PIK3C3;PIK3CA;FIG4;MINPP1;PIP4K2B
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),-0.49037938819044796,-0.7847396756692502,0.711864406779661,1.0,1.0,4/6,35.19%,SPI1;KLF7;PLAAT3;TRPM4
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.32666880983855506,-0.7847170905160784,0.7972972972972973,1.0,1.0,10/92,13.39%,WARS1;SKAP1;FSCN1;USP50;RPA3;ISG15;DAB2IP;SYK;PSMC3;RPA1
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,0.30994311541296493,0.7846550248055524,0.8518518518518519,1.0,1.0,7/38,17.40%,GIT1;NCK1;PIK3R1;NCK2;VANGL1;TXNL1;ARHGEF6
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),-0.4859254746003502,-0.7842870813108046,0.7741935483870968,1.0,1.0,4/6,22.80%,ABCB1;ABCC1;ABCG2;SLC22A1
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.3827852195457161,-0.7840684814533537,0.8082191780821918,1.0,1.0,3/33,11.48%,BLM;GADD45A;ADIRF
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.4411585773715976,0.7839155927059989,0.717391304347826,1.0,1.0,3/7,22.31%,SPX;ACSL3;RPS6KB1
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,0.2605355587449883,0.7838711398716556,1.0,1.0,1.0,30/149,17.23%,SEM1;PSMD10;SOD3;PSMA1;TXNIP;COX18;PSMD11;KEAP1;AKT2;TACO1;CUL1;AKT1;PSMB5;VCP;CHD9;CSNK2A2;BTRC;SESN2;LRPPRC;PSMD14;PRDX1;COX19;PSMD12;MUL1;COX7A2L;FBXL17;EP300;PRDX3;BLVRA;NCOA2
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.48504505833105294,0.7838112952081123,0.7631578947368421,1.0,1.0,1/5,8.98%,PTPN23
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.43270304142449384,0.7833140166904214,0.6944444444444444,1.0,1.0,2/8,13.68%,AKT1;PIK3CA
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.2774460989198658,0.7832495175441633,1.0,1.0,1.0,11/83,10.13%,TBC1D4;PDE3B;ADCY1;TRIB3;KAT2B;AKT2;AKT1;RAB8B;PRKACB;INSIG2;LPIN3
prerank,KEGG_2021_Human__VEGF signaling pathway,0.3071172081801012,0.7829383713052638,0.8620689655172413,1.0,1.0,10/46,18.68%,NRAS;AKT2;AKT1;PLA2G4C;MAPK12;PIK3CA;PIK3R1;BAD;SPHK2;MAP2K2
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.3770048446194125,-0.7828819857227242,0.78125,1.0,1.0,5/31,10.76%,TYMP;KIF14;NKX6-2;TENM4;HES7
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.39103553976426497,-0.7828573622204339,0.7971014492753623,1.0,1.0,6/30,19.66%,NDUFA2;NDUFB9;NDUFB11;NDUFB10;NDUFA6;NDUFA3
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.3396940141446813,0.7828428941311418,0.7941176470588235,1.0,1.0,3/27,14.17%,NCOA4;ZFYVE16;MFSD1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.36005511442761456,-0.7828327137074048,0.8767123287671232,1.0,1.0,5/42,12.15%,BLM;ATAD5;EGF;TSPYL2;GLI1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.5100305677048006,0.782751679921676,0.7857142857142857,1.0,1.0,1/6,2.91%,ADRA1A
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.41280183441547363,-0.7825085615958667,0.855072463768116,1.0,1.0,2/26,7.79%,FABP3;LDLR
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,0.34225939273697464,0.7824966722499591,0.7272727272727273,1.0,1.0,6/25,19.75%,YES1;RBM14-RBM4;ZNF521;HEY1;GLI3;HEY2
prerank,KEGG_2021_Human__Lysine degradation,0.31939665391882166,0.7824457264490432,0.8928571428571429,1.0,1.0,7/60,12.10%,PRDM6;ALDH7A1;SMYD2;KMT5A;EHHADH;KMT2A;PIPOX
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.49703300521388283,-0.7824045870346795,0.78125,1.0,1.0,1/8,11.67%,SFRP4
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.36016639799589545,-0.7823263311137486,0.7833333333333333,1.0,1.0,5/31,15.27%,FABP3;CAV3;LIPI;LIPH;PNPLA3
prerank,CellMarker_Augmented_2021__Microglial cell:Optic Nerve,-0.3841954147122006,-0.7822607500163706,0.7540983606557377,1.0,1.0,6/24,8.69%,MYO1F;TAGAP;SLA;ARHGAP9;CLEC12A;WAS
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.4302589691551931,-0.7821508870904085,0.75,1.0,1.0,6/17,21.46%,FSCN1;CLIC4;ERBIN;CRB2;LRRC7;PATJ
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Heart,-0.33091564272643514,-0.7820135356375865,0.8701298701298701,1.0,1.0,12/77,13.68%,FLRT3;TRAM1L1;SLC6A15;EFNB3;ARHGAP39;PFN2;DAB2IP;KCNB2;SLC44A3;TUSC3;AMOTL2;FRAS1
prerank,Reactome_2022__Post-translational Protein Modification R-HSA-597592,-0.2831823341078343,-0.781986871164023,1.0,1.0,1.0,86/1117,12.36%,ST6GAL1;CP;THBS1;SOCS3;CDKN2A;C3;BLM;TUBB6;GCNT7;SP100;SERPINA10;PGR;CHGB;TGFBR2;NRN1;HIC1;ANK3;PSCA;LAMB1;ADAMTS10;KDELR3;RPS27A;THSD4;HLA-A;SLC17A5;SPON2;GMPPB;SBSPON;CNTN5;GCNT1;ART3;RAB11A;ADAMTSL2;ASB16;CHST4;F8;TPST1;APP;TTLL7;CTSC;NOD1;THY1;THSD7B;BRCA1;GRIA1;TIMP1;SVBP;PSMB9;SERPIND1;NOTUM;SGPP2;RNF181;FBXL18;PLET1;ST3GAL6;FAM20C;FBXW12;SPSB1;FAM20A;B3GNT5;FBXO32;TAF10;TGFA;THBS2;IGFBP7;TFPT;PSMB6;ALPL;BIRC3;HLA-B;FN1;CD55;FBXW10;GALNT10;COPZ2;B3GNT2;DCTN1;SHISA5;PTRH2;PSMC3;PRSS23;TNIP2;CTSZ;IGFBP5;MAN1C1;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.25473663077381303,0.7818431859855507,1.0,1.0,1.0,26/226,13.46%,NGF;NCSTN;BMP2;PHLDA1;AIFM2;BCL10;ARHGEF16;DUSP6;ACVR1C;ARHGEF12;C3ORF38;IP6K2;ZNF268;STK4;HMGB1;USP27X;TRADD;ATF6;ARHGEF26;MAPK8;CASP3;TIAM2;CRADD;ERCC3;STK17B;PNMA3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.3239386094947263,-0.781821258550572,0.8518518518518519,1.0,1.0,4/89,6.27%,THBS1;RPS4X;KLF4;PLD1
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),-0.5430468280655028,-0.7817304097484966,0.8360655737704918,1.0,1.0,3/5,26.83%,RHD;AQP1;RHCG
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.40271362441020375,-0.7815370505534757,0.8166666666666667,1.0,1.0,2/18,7.62%,CDKN2A;HEXIM1
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.4097968375930753,0.7814917426573641,0.71875,1.0,1.0,2/13,7.30%,MTHFS;GLUD1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3724228700235588,-0.7814718786628285,0.8260869565217391,1.0,1.0,7/31,19.45%,SEPTIN4;RPS7;BOK;NUPR1;GSDME;BBC3;EIF5A
prerank,CellMarker_Augmented_2021__Beta cell:Pancreas,-0.42443150857454903,-0.781290796177752,0.7758620689655172,1.0,1.0,1/11,1.09%,SIX3
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,-0.35841988324253543,-0.7812221062143446,0.7846153846153846,1.0,1.0,9/50,17.44%,CDKN2A;RPS27A;PSMB9;PSMB6;PSMC3;UBC;PSMA8;PSMA7;PSME1
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.317072491560748,-0.7812002693206308,0.8666666666666667,1.0,1.0,21/98,18.00%,CDH23;HTR2B;SLC24A2;PLN;TRPC3;CAV3;SLC24A1;GCM2;ATP1B1;SLC8A3;HCRTR2;SLC24A5;MCUB;PTH1R;CLN3;PML;HTR2C;ADCY8;RYR2;GPER1;HTR2A
prerank,Reactome_2022__PI3K Events In ERBB2 Signaling R-HSA-1963642,0.4279252058248667,0.7810827187059214,0.7555555555555555,1.0,1.0,6/13,21.80%,EGFR;ERBB4;PIK3CA;PIK3R1;NRG3;PIGU
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.38969238704393083,-0.7809509615733284,0.8,1.0,1.0,9/37,16.65%,CD5;TAGAP;GPR171;IL4R;P2RY10;CCR10;THEMIS;LTBR;STAT6
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.5545958926611625,-0.7809048191117588,0.8507462686567164,1.0,1.0,2/5,30.69%,SNRPC;PSIP1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.3720039818166729,-0.7808664391268425,0.775,1.0,1.0,13/42,20.30%,ANO2;GLRA2;ANO9;GABRE;GABRB2;GABRD;GABRG2;SLC12A7;GABRA1;GLRA1;GABRA6;GABRG3;GABRA3
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.5183544866635521,-0.7807884167520458,0.7758620689655172,1.0,1.0,1/6,13.72%,IL7
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.4573123563160906,0.7807449056070467,0.7435897435897436,1.0,1.0,3/7,24.69%,EXOSC6;EXOSC8;EXOSC5
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.4573123563160906,0.7807449056070467,0.7435897435897436,1.0,1.0,3/7,24.69%,EXOSC6;EXOSC8;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.36439952769056455,-0.7807394652779129,0.8181818181818182,1.0,1.0,5/32,10.01%,NLRP12;APP;USP50;NLRP2;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.3847041131992364,-0.7806932661681192,0.7910447761194029,1.0,1.0,5/21,19.00%,P2RY12;EEF1A2;TEK;TGFB1;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.2714698079712271,0.7803803369732933,1.0,1.0,1.0,31/182,15.62%,NGF;RGCC;ASCL1;TMEM100;BRINP3;BMP2;SERPINF2;BEND6;SOX9;NUDT21;AKT1;LMO3;FBXO5;ZNF268;RANBP3L;KCTD11;AR;ZNF703;HEYL;ZC4H2;SOX5;MAPK12;ACVR2A;CDH2;MDK;RPS6KA3;PRKD1;BRINP2;NFKB1;CPNE1;ID2
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.39002118088743376,0.7800689658404718,0.7105263157894737,1.0,1.0,4/18,10.09%,BAG2;FBXO5;BTRC;PLK1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.40184168375419627,-0.7798945888661605,0.7391304347826086,1.0,1.0,6/20,25.60%,HLA-E;GPI;PTPRC;XBP1;SHLD1;STX4
prerank,Reactome_2022__Nucleotide Salvage R-HSA-8956321,-0.43158916436798367,-0.7795104203050102,0.8571428571428571,1.0,1.0,1/17,2.93%,GMPR
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.427022160740764,0.7794499535459886,0.6904761904761905,1.0,1.0,4/10,25.83%,APOBEC3F;TASOR;RESF1;SETDB1
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.38358814772981575,0.7793426155429095,0.7931034482758621,1.0,1.0,2/16,8.15%,LLGL1;FMNL3
prerank,KEGG_2021_Human__Prolactin signaling pathway,-0.35020190607079665,-0.7791399626644826,0.8333333333333334,1.0,1.0,9/53,15.96%,SOCS3;IRF1;CCND1;STAT1;SHC2;FOS;PIK3CB;PIK3CD;CCND2
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.4018688121315923,-0.7791182240533017,0.8387096774193549,1.0,1.0,6/18,18.82%,ABCA8;ABCB1;SLC22A4;SLC29A4;ABCC1;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.5113575249521134,0.7791043502257368,0.8043478260869565,1.0,1.0,2/5,10.55%,HMGB1;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.3980659948032307,0.7790866429502725,0.7567567567567568,1.0,1.0,1/13,5.96%,ANP32B
prerank,Reactome_2022__PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.39650133099116247,-0.7789669148003399,0.8,1.0,1.0,3/24,13.55%,MAEL;POLR2I;TDRD1
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.40257959339695376,-0.7788789226474084,0.7761194029850746,1.0,1.0,10/25,24.64%,SLC4A9;SLC9A2;SLC4A2;SLC4A10;SLC9A5;CLN3;SLC9A7;SLC4A3;SLC9A1;SLC9A9
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.4740485835668813,-0.7788544842970037,0.75,1.0,1.0,1/10,8.20%,SPAG17
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,0.2801015872329013,0.7788494150801241,0.85,1.0,1.0,10/71,16.01%,CD247;MYO10;YES1;PRKCSH;WIPF2;NCK1;WASL;PIK3CA;PIK3R1;ABI1
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,0.39850345154574784,0.778778258348577,0.7555555555555555,1.0,1.0,3/12,9.28%,FOXP1;PBX1;SALL1
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.35299733812573864,-0.7786537537368495,0.8,1.0,1.0,12/39,16.60%,TJP3;PLEKHG6;KLF4;FBP1;TGFA;IL18;HRH1;TNFAIP2;ST6GALNAC2;RDH12;LTBR;CEBPD
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.45240607839553454,-0.7785252315345883,0.7931034482758621,1.0,1.0,4/11,7.77%,C3;MRAP2;SLC39A14;KLK6
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),0.4933378133708922,0.778169824594812,0.8292682926829268,1.0,1.0,2/7,10.47%,APOBEC3F;EXOSC6
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 27-Hydroxycholesterol R-HSA-193807,0.396739056911668,0.7780289605528973,0.7222222222222222,1.0,1.0,4/10,17.23%,CYP7B1;PTGIS;AKR1C3;NCOA2
prerank,Reactome_2022__mRNA Capping R-HSA-72086,0.36388086481403,0.7779789357998739,0.8076923076923077,1.0,1.0,12/28,28.78%,GTF2F2;ERCC2;ERCC3;GTF2H5;GTF2H2;POLR2C;GTF2H3;RNGTT;CCNH;POLR2A;POLR2K;POLR2D
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.3988915663288075,-0.7777333001231378,0.7536231884057971,1.0,1.0,2/16,10.82%,AKAP5;CACNA1C
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.32834758461077834,0.777682239709025,0.7878787878787878,1.0,1.0,7/23,19.21%,SLC47A1;SLC25A18;SLC3A2;SLC22A2;SLC25A22;SLC36A4;SLC25A38
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.450313975986194,-0.7775309282706752,0.7727272727272727,1.0,1.0,5/12,19.04%,KCNQ1;SCN3B;APLN;RYR2;ADM
prerank,Reactome_2022__Mismatch Repair (MMR) Directed By MSH2:MSH3 (MutSbeta) R-HSA-5358606,0.41517342139745006,0.7774910265236534,0.7804878048780488,1.0,1.0,1/12,0.67%,POLD3
prerank,KEGG_2021_Human__Chronic myeloid leukemia,-0.34263155515657756,-0.7774808028076043,0.8285714285714286,1.0,1.0,10/72,18.28%,CDKN2A;TGFBR2;CCND1;GADD45A;SHC2;PIK3CB;PIK3CD;GADD45B;TGFB1;CDKN1A
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.30969162677089257,-0.7773369713059313,0.8875,1.0,1.0,22/93,18.19%,APP;LRRC4;SYN3;GRM6;SLC8A3;CPLX1;SYT1;GRIK1;CPLX2;RIMS2;DLGAP3;GRID2;NLGN1;NPTX2;BDNF;GRM7;GRIK2;RELN;KCNMB4;CLN3;CDK5;MCTP1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.481129933323048,-0.7773223019251416,0.74,1.0,1.0,1/5,11.74%,PINK1
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.3957030355100172,-0.7772847811358897,0.7301587301587301,1.0,1.0,5/17,22.98%,FN1;RPS6;RBX1;ALK;STAT3
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3957172358260067,-0.7772291870707467,0.8125,1.0,1.0,1/19,1.53%,P2RY12
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,0.25344465419171264,0.7771048971603849,1.0,1.0,1.0,16/102,16.06%,S1PR1;NRAS;AKT2;MAPK10;AKT1;PLCB4;TRADD;MAPK8;MAPK12;PPP2R5A;SGMS2;PIK3CA;NFKB1;PIK3R1;SMPD1;GNAQ
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.3361913646712067,-0.7770631592783737,0.8604651162790697,1.0,1.0,12/76,18.92%,TYMS;NELL1;RPL13A;PATL2;DAB2IP;IGFBP5;SAMD4A;PLAT;CLN3;CDK5;DAPK3;SHMT1
prerank,Reactome_2022__Diseases Associated With Visual Transduction R-HSA-2474795,-0.4783278854258094,-0.7770344060331473,0.75,1.0,1.0,1/6,14.84%,RDH12
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.43873990425566917,-0.7767410550935225,0.7666666666666667,1.0,1.0,5/11,21.76%,CYP1B1;PDK1;PRKCD;STK24;ARL6IP5
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,0.3023099348019292,0.7766986555972665,0.9166666666666666,1.0,1.0,9/62,11.34%,SEM1;PSMD10;PSMA1;PSMD11;ANAPC1;PSMB5;PLK1;UBE2D1;PSMD14
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,0.32087677747758475,0.7765040942480118,0.7916666666666666,1.0,1.0,10/43,18.57%,SMYD2;KMT5A;EED;RBBP4;KMT2A;NFKB1;AEBP2;SETD3;ASH2L;EHMT1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.392667889412237,0.7764446550892111,0.8666666666666667,1.0,1.0,6/15,24.88%,STIL;PCM1;C2CD3;CEP192;CEP83;PIBF1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.3373149542949863,-0.7764312153372911,0.8947368421052632,1.0,1.0,18/100,18.28%,CDKN2A;PSRC1;TP53TG5;BST2;FBP1;TSPYL2;BTG1;CRLF3;MAG;SLIT3;HYAL1;SFRP2;TCHP;PML;BCL6;TGFB1;CDKN2D;CDKN1A
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.4766105400999565,0.7763390297048606,0.6585365853658537,1.0,1.0,1/5,6.63%,LETM1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.35731248723725473,0.7762424350124632,0.8157894736842105,1.0,1.0,5/24,22.66%,INSC;PLK1;GJA1;ESPL1;UBXN2B
prerank,CellMarker_Augmented_2021__Cardiovascular Progenitor cell:Heart,0.3038850868896763,0.7761023812654216,0.9285714285714286,1.0,1.0,3/63,2.72%,SPSB4;ADAMTS9;RGS5
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.30402096746496066,0.7760682325465871,0.8709677419354839,1.0,1.0,8/52,16.01%,VEGFD;VEGFC;NCK1;PIK3CA;PRKD1;PIK3R1;NCK2;ABI1
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.42449977636313435,0.7760165287509604,0.6875,1.0,1.0,3/10,26.62%,SERTAD2;ARID1B;SERTAD1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.4509531885691943,-0.7759634491170491,0.7884615384615384,1.0,1.0,1/13,3.46%,IMPDH1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),-0.5415330287745151,-0.7757537691251679,0.7586206896551724,1.0,1.0,1/5,10.14%,CHRM3
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.4177946161620557,-0.7753395873292068,0.7936507936507936,1.0,1.0,6/14,21.14%,PVALEF;TNNT1;KCNB2;DAPK3;PLCE1;MYL5
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,-0.296335814076431,-0.775150007183671,0.9425287356321839,1.0,1.0,39/252,17.67%,GRIN2D;RASGRP1;RPS27A;NEFL;ZDHHC9;ARHGAP9;RASGEF1A;GFRA2;RALGDS;PSMB9;EGF;CDC42EP3;PTPN7;TGFA;SHC2;FGF1;PSMB6;DAB2IP;PRKCQ;FN1;PSMC3;PAQR3;DUSP16;UBC;GRIN2B;RNASE1;FGF7;IL3RA;PIK3CB;PSMA8;RASGRF2;TLN1;PSMA7;FGF22;IRS2;TEK;VCL;PSME1;RBX1
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.4270074816345497,-0.7751057284559808,0.8225806451612904,1.0,1.0,4/14,19.24%,ABCA8;LDLR;MSR1;CD36
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.319258914338321,0.7749574978389722,0.8,1.0,1.0,9/41,18.02%,FLT3;TTL;EGFR;ERBB4;CSF1R;ABI1;ABI2;EFEMP1;ABL2
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.34533248745613504,-0.7747504804401946,0.8571428571428571,1.0,1.0,7/69,13.97%,TGFBR2;RPS27A;ZYX;ARHGEF18;EID2;UBC;FOS
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,0.3639820693534075,0.7746528647535985,0.7142857142857143,1.0,1.0,3/24,5.74%,POLD3;SLC19A1;RFC3
prerank,Reactome_2022__Dectin-2 Family R-HSA-5621480,0.4276537961931409,0.7745328172889234,0.7560975609756098,1.0,1.0,1/8,2.45%,MUC20
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.3444114224071406,0.7742580149471735,0.7575757575757576,1.0,1.0,3/22,8.35%,ATP11C;ABCA1;RFT1
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,0.30476108872273155,0.7739679488210393,0.96,1.0,1.0,10/60,14.75%,SEM1;PSMD10;PSMA1;PSMD11;ANAPC1;PSMB5;UBE2D1;PSMD14;PSMD12;CDC26
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,0.30476108872273155,0.7739679488210393,0.96,1.0,1.0,10/60,14.75%,SEM1;PSMD10;PSMA1;PSMD11;ANAPC1;PSMB5;UBE2D1;PSMD14;PSMD12;CDC26
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.4639062825446533,-0.7739444079187612,0.7413793103448276,1.0,1.0,3/6,22.76%,SLIT3;SH2B3;SLIT2
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.5106162204234177,-0.7739328246746943,0.7959183673469388,1.0,1.0,2/5,13.10%,FGF1;PAX8
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.507740615050492,-0.7739040368379502,0.9074074074074074,1.0,1.0,1/9,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.44303661291963115,-0.7732945001237811,0.8035714285714286,1.0,1.0,1/10,11.32%,PRDM1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.4239590533889752,0.7732504116251138,0.6842105263157895,1.0,1.0,2/10,12.79%,DCT;DRD2
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.4078445841283934,-0.77319208999392,0.7903225806451613,1.0,1.0,2/19,12.02%,SRF;PSMC3
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.468243445291159,-0.773146975811896,0.7936507936507936,1.0,1.0,2/9,15.90%,PRKCD;CDK2
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.351376253280191,-0.7730047006555609,0.8461538461538461,1.0,1.0,9/54,13.97%,GNG3;KCNH8;CCND1;EGF;SRF;S1PR3;TGFA;GNG2;FOS
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.39210455220722484,-0.7728901197511261,0.7903225806451613,1.0,1.0,6/24,20.77%,RPS27A;NOD1;UBC;RIPK2;CASP8;IKBKG
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.4091764381791211,-0.7728402475222338,0.711864406779661,1.0,1.0,4/17,20.77%,RAB11A;CDK5;LIMK2;IKBKG
prerank,Reactome_2022__Calcitonin-like Ligand Receptors R-HSA-419812,0.48784224798771186,0.7727533136694986,0.7608695652173914,1.0,1.0,2/5,7.51%,CALCB;CALCRL
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,0.28585977780154603,0.7726159507345378,1.0,1.0,1.0,11/75,12.22%,SEM1;KDM1B;PSMD10;PSMA1;PSMD11;PSMB5;INO80D;YY1;H2AC6;PSMD14;NFRKB
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,-0.2919964896921512,-0.7725812590996338,0.96875,1.0,1.0,29/294,13.31%,GRIN2D;TUBB6;NEFL;NEFM;GRIN2A;COX7A1;TUBB1;PFN4;NDUFA2;HAP1;NDUFB9;GRIA1;ITPR3;COX4I1;NEFH;NDUFB11;PFN2;PPP3CC;NUP210L;PSMB6;DNAH3;DCTN1;PINK1;PSMC3;UQCRQ;NOS1;GRIN2B;TNFRSF1A;NDUFB10
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.3285046678441671,-0.772445851792622,0.8414634146341463,1.0,1.0,8/58,20.77%,RPS27A;TLR3;IRF7;UBC;STAT6;DDX41;NLRC3;IKBKG
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.45280088210111524,0.7721725425358348,0.7727272727272727,1.0,1.0,1/7,7.15%,FBXO5
prerank,KEGG_2021_Human__GnRH signaling pathway,-0.3258124531383403,-0.7718932561786512,0.875,1.0,1.0,12/73,17.19%,GNRHR;ADCY7;MMP14;PLD1;ITPR3;PLD2;CACNA1C;ADCY5;PRKCD;ADCY3;ADCY8;PRKCB
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.2799557202897384,0.7718108324328989,0.8571428571428571,1.0,1.0,13/69,23.19%,HSPA1A;RBM23;ZPR1;CLK4;RBM12B;PIK3R1;QKI;METTL4;RRP1B;ERN1;MBNL1;RBM39;JMJD6
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.4061850243950407,0.7717908310740088,0.7428571428571429,1.0,1.0,1/13,0.62%,SLITRK2
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.3955150557144639,0.7717274535813569,0.7906976744186046,1.0,1.0,2/14,8.28%,NCOA4;AR
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.3568786706678539,-0.7716910708882833,0.7837837837837838,1.0,1.0,9/38,17.54%,CCL2;GRM6;SYT1;GRIK1;NLGN1;GRM7;RELN;CLN3;CDK5
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,0.38050500517772295,0.771362391142352,0.84,1.0,1.0,12/26,28.78%,GTF2F2;ERCC2;ERCC3;GTF2H5;GTF2H2;POLR2C;GTF2H3;RNGTT;CCNH;POLR2A;POLR2K;POLR2D
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.3798705916788628,-0.7712612219871587,0.803030303030303,1.0,1.0,8/28,18.19%,APP;IGF1;GAPDHS;PINK1;PRXL2C;PFKFB4;PFKFB3;NUPR1
prerank,CellMarker_Augmented_2021__Epithelial cell:Amniotic Membrane,-0.3660406587021925,-0.771203140894617,0.8472222222222222,1.0,1.0,8/37,13.35%,TJP3;OVOL2;PLEKHG6;LSR;TMC4;ILDR1;BSPRY;SPINT2
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.3837486241579139,-0.771058259465688,0.7761194029850746,1.0,1.0,5/22,12.88%,B2M;HLA-A;AP1S1;ELMO1;RNASE1
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.45011806824294387,-0.7710149304646233,0.75,1.0,1.0,1/7,7.81%,PDE6B
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Stomach,-0.36962460445105105,-0.7709612537855942,0.7837837837837838,1.0,1.0,10/39,19.81%,PTP4A3;PLD1;GPT2;PITPNM2;UBE2S;ZNF571;MTA1;ANKRD37;C2CD2;PWWP2B
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,0.28103810704232507,0.7705933732711912,0.9130434782608695,1.0,1.0,11/91,11.34%,SEM1;PSMD10;ADCY1;PSMA1;PSMD11;CUL1;PSMB5;INTU;BTRC;PRKACB;PSMD14
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.4180552154723571,0.770425333216507,0.775,1.0,1.0,2/8,8.47%,GIT1;CBFA2T3
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.4180552154723571,0.770425333216507,0.775,1.0,1.0,2/8,8.47%,GIT1;CBFA2T3
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.36693904437997243,-0.7703578354424828,0.8208955223880597,1.0,1.0,4/40,12.67%,ITPKC;INPP5D;NUDT4;PLCH2
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.470143143466012,0.7702056565813912,0.7708333333333334,1.0,1.0,5/6,34.31%,VCP;WAPL;VCPIP1;SETD2;RB1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.3424457704210393,-0.7701659476392454,0.7926829268292683,1.0,1.0,1/61,0.17%,ST6GAL1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.31515472642489595,-0.7701434509697461,0.9078947368421053,1.0,1.0,12/108,16.21%,LEF1;PSMB9;PDE6B;WNT5A;PSMB6;SFRP4;PSMC3;GNG2;PRICKLE1;SFRP2;PSMA8;PSMA7
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.30979369905306064,-0.7701330454844004,0.868421052631579,1.0,1.0,16/94,17.96%,RASGRP1;RPS27A;ITPR3;PSMB9;PSMB6;SYK;PSMC3;UBC;BLNK;PSMA8;VAV1;PSMA7;PRKCB;SH3KBP1;PSME1;CARD11
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.39502395148659225,-0.7699754135174162,0.8507462686567164,1.0,1.0,5/26,17.37%,RPS27A;EGF;UBC;ERBIN;CDC37
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.4162378331501485,-0.7699602946692418,0.8032786885245902,1.0,1.0,3/13,18.89%,GLI1;PIM1;TBX20
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),-0.4560394662712809,-0.7698909098013161,0.7962962962962963,1.0,1.0,4/7,18.14%,KCNB1;GRID2;ADCY8;MAPT
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.357243642409799,-0.7696989521533819,0.8235294117647058,1.0,1.0,1/35,1.24%,PGR
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,-0.357457014927382,-0.769607240678837,0.8823529411764706,1.0,1.0,2/43,0.81%,PIF1;BLM
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.43795663976507265,0.7695534926620591,0.675,1.0,1.0,4/6,35.38%,ZBTB1;MED1;ATF4;TFCP2
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.3503204591063592,0.7695202294796238,0.7307692307692307,1.0,1.0,13/30,28.78%,GTF2F2;ERCC2;ERCC3;GTF2H5;GTF2H2;POLR2C;GTF2H3;RNGTT;CMTR2;CCNH;POLR2A;POLR2K;POLR2D
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.3503204591063592,0.7695202294796238,0.7307692307692307,1.0,1.0,13/30,28.78%,GTF2F2;ERCC2;ERCC3;GTF2H5;GTF2H2;POLR2C;GTF2H3;RNGTT;CMTR2;CCNH;POLR2A;POLR2K;POLR2D
prerank,Reactome_2022__Heme Degradation R-HSA-189483,-0.42729595626272676,-0.7690868857679215,0.7169811320754716,1.0,1.0,4/9,24.14%,BLVRB;ABCC1;ABCG2;HMOX1
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,0.3101597491248076,0.7690237002581399,1.0,1.0,1.0,10/58,14.75%,SEM1;PSMD10;PSMA1;PSMD11;ANAPC1;PSMB5;UBE2D1;PSMD14;PSMD12;CDC26
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.4965230257339571,-0.7689936036451925,0.7543859649122807,1.0,1.0,3/7,24.33%,GCKR;ABCG2;PNP
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.27956315797896325,-0.7687384174628635,1.0,1.0,1.0,78/886,13.19%,KLF2;LEF1;BLM;SP100;MET;POU4F1;NR4A3;PGR;NR1I3;TLR2;PLAG1;CIITA;FOSL2;RPS27A;LMO2;PSRC1;BARX2;PROX1;MLIP;SKAP1;IRF1;TESC;ATF3;MAFF;ST18;CASZ1;APP;KLF4;SCX;DNAJC2;ZNF750;BEX1;NLRC5;BRCA1;TEAD2;GATA1;TLR3;LDB2;YWHAH;POU2F3;ZIC1;PLSCR1;PARP9;EGF;ZFPM1;SRF;WAS;RPS6KA1;CRLF3;IGF1;MACC1;STAT1;MLLT11;HELZ2;WNT5A;IRF7;CREB5;FGF1;DAB2IP;CSRNP1;ADIRF;NAMPT;LAGE3;SOX15;IL18;FOXM1;SBNO2;RUNX2;PSMC3;TNIP2;GLI1;NOS1;UBC;FADD;PPARGC1B;FGF7;PAX8;TNFRSF1A
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.49767496841618597,0.7686867425465393,0.7941176470588235,1.0,1.0,3/7,35.69%,DKC1;TRUB1;RPUSD2
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.5133381907941553,-0.7684325069861128,0.7959183673469388,1.0,1.0,3/6,20.15%,FADD;TNFRSF1A;CASP8
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.3655922843026724,-0.76837878740258,0.8,1.0,1.0,7/28,20.19%,APP;RPL10;RBM3;PRKCD;RBM4B;PGAM1;TMED10
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,0.29330558558205655,0.7682008753919671,0.88,1.0,1.0,1/61,0.37%,ITGA1
prerank,Reactome_2022__Antimicrobial Peptides R-HSA-6803157,-0.41036206248897406,-0.7681762612213808,0.85,1.0,1.0,6/17,18.56%,TLR2;TSPAN32;SLC11A1;ATOX1;DEFB109B;CD4
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.4089823475592274,-0.7679612633870608,0.8529411764705882,1.0,1.0,2/15,7.22%,SVIL;BASP1
prerank,Reactome_2022__Cell Cycle R-HSA-1640170,-0.28418763009531306,-0.7679156825581186,0.98989898989899,1.0,1.0,68/534,18.28%,CCNB2;PIF1;TYMS;ERCC6L;CDKN2A;BLM;TUBB6;RPS27A;VRK2;RPS27;STAG3;CENPH;BRCA1;POLE3;PTK6;CCND1;YWHAH;PSMB9;MIS18A;CENPE;ANAPC11;MZT2B;GINS2;SYCE2;SYCE1;ZWILCH;FBXL18;LMNB1;NUF2;POLE4;POLR2I;NCAPD3;RPA3;SPC24;CCNB1;PSMB6;DCTN1;FOXM1;KIF2C;PSMC3;CCNE2;HAUS7;CEP76;UBC;CENPN;CENPU;NOP10;ANKRD28;UBE2S;PSMA8;CDK2;CCND2;MAX;PSMA7;CDC7;OIP5;EMD;WEE1;LRIG1;PRKCB;POLD1;CENPP;PSME1;RBX1;CHTF18;CDKN2D;TINF2;CDKN1A
prerank,CellMarker_Augmented_2021__Endothelial cell:Plasma,-0.3485610253893198,-0.7678876253766345,0.8356164383561644,1.0,1.0,9/33,12.98%,MYO1F;ARHGAP9;GAB3;IGSF6;CLEC12A;RCSD1;WAS;SELP;TSPAN32
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.4434252739126106,-0.7678636715332385,0.7777777777777778,1.0,1.0,1/8,10.89%,ENTPD3
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.38623756271806936,-0.7676598981250538,0.7966101694915254,1.0,1.0,1/18,3.46%,IMPDH1
prerank,KEGG_2021_Human__Morphine addiction,-0.32477424135827004,-0.7675634260242418,0.8481012658227848,1.0,1.0,25/76,22.78%,PDE4A;ADCY7;GNG3;SLC32A1;PRKCG;GABRE;GABRB2;GABRD;ADCY5;GNG2;GABRG2;GABRA1;ADCY3;ADCY8;PRKCB;GABBR2;PDE1C;PDE1A;GABRA6;GABRG3;GABRA3;KCNJ6;GNB4;GNB5;GRK2
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),-0.44369382820085923,-0.767507164097033,0.734375,1.0,1.0,2/9,16.79%,OAZ2;SLC29A4
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.41401237033247845,0.767404967501278,0.6857142857142857,1.0,1.0,9/13,34.72%,SLC25A18;SLC25A22;SLC25A14;SLC25A12;SLC13A5;LRRC8D;SLC1A2;SLC25A11;SLC25A13
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,-0.30956258557097405,-0.7672461412442898,0.9746835443037974,1.0,1.0,17/116,17.44%,CCNB2;BLM;RPS27A;BRCA1;YWHAH;PSMB9;RPA3;CCNB1;PSMB6;PSMC3;UBC;PSMA8;CDK2;PSMA7;CDC7;WEE1;PSME1
prerank,Reactome_2022__G-protein Activation R-HSA-202040,-0.41997619373668854,-0.7671542782933641,0.75,1.0,1.0,5/15,23.62%,GNG3;GNG2;GNB4;GNB5;GNA14
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.44825568400069754,-0.7671210509381012,0.7758620689655172,1.0,1.0,4/12,32.22%,SREBF1;SEC14L2;SREBF2;RAN
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.31863007014277006,-0.767068063281929,0.9404761904761905,1.0,1.0,14/89,17.65%,RPS27A;APP;NOD1;NLRC5;NDUFA2;KCNH8;RPS6KA1;IRF7;TNIP2;UBC;FOS;USP18;ALPK1;RIPK2
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.31863007014277006,-0.767068063281929,0.9404761904761905,1.0,1.0,14/89,17.65%,RPS27A;APP;NOD1;NLRC5;NDUFA2;KCNH8;RPS6KA1;IRF7;TNIP2;UBC;FOS;USP18;ALPK1;RIPK2
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,-0.3130762328013799,-0.7669650176395327,0.9358974358974359,1.0,1.0,17/120,17.58%,ANK3;KDELR3;F8;CTSC;GRIA1;TGFA;CD55;COPZ2;DCTN1;CTSZ;F5;ANKRD28;ANK1;ARFGAP1;TRAPPC2L;GOLGB1;CFAP73
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.47006687484466037,0.7667282319019854,0.7380952380952381,1.0,1.0,2/6,11.93%,BTRC;CRH
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.2874767853091964,0.7666877831445966,1.0,1.0,1.0,31/128,15.99%,DAO;SLITRK2;AMER2;ADGRA1;GABRG1;KCNA2;NTSR2;EGFR;ADGRB3;P2RY1;MAPK10;CHL1;TRPM3;GRIA2;BTBD17;ATP1A2;NRXN1;SLC4A4;CADM2;GPM6B;KCNJ10;SLCO1C1;ZEB2;SLC6A1;FAIM2;PMP2;ELAVL3;GRM3;GDF10;KIF1B;GPR37L1
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.40576458686678607,-0.7666857980893634,0.7741935483870968,1.0,1.0,3/14,17.91%,RPL35;PES1;RPL7
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.3302642106105611,0.7666845577159505,0.9444444444444444,1.0,1.0,3/29,6.16%,NAF1;GREM1;MAP3K4
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.4434665424082688,-0.7666785691571422,0.7586206896551724,1.0,1.0,2/8,12.99%,PDPN;EMP2
prerank,CellMarker_Augmented_2021__Exhausted T cell:Undefined,-0.5502273078638648,-0.7665755965530855,0.8070175438596491,1.0,1.0,1/5,4.54%,CD160
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.36144659813816804,0.766571484989199,0.8,1.0,1.0,4/12,9.05%,ZNF207;SMC6;CSNK2A1;CSNK2A2
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.26381524920194216,0.7663557420512986,1.0,1.0,1.0,30/135,18.99%,SAMM50;STXBP6;HSPA1A;BBS10;PSMD11;RAB5IF;MID1IP1;TTC12;HSF1;DNAJC28;CASQ1;NDC1;NCK1;PDE4DIP;POMP;TMEM35A;ADRB2;SGIP1;COX7A2L;NCK2;NUP205;PSMG2;VAMP3;PICALM;PIK3C2A;MKKS;DMD;DNAJB14;EPS15;CHCHD4
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,-0.4121901327116109,-0.7663328512260374,0.8059701492537313,1.0,1.0,2/16,13.58%,RNASE1;FES
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.42029182692168643,0.7661183504570032,0.7073170731707317,1.0,1.0,1/11,1.09%,PDE3A
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.29346578827011505,0.7659886748041189,0.8857142857142857,1.0,1.0,2/30,3.84%,NR1D1;TNFAIP3
prerank,Reactome_2022__Mismatch Repair R-HSA-5358508,0.40980681745006736,0.7658096113064892,0.8095238095238095,1.0,1.0,1/13,0.67%,POLD3
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Skin,-0.4447520398369168,-0.7657767561683418,0.7457627118644068,1.0,1.0,1/9,16.86%,CD200
prerank,KEGG_2021_Human__Chemical carcinogenesis,-0.29610955416724594,-0.7657446141758615,0.9090909090909091,1.0,1.0,28/152,17.58%,PGR;NR1I3;AIPL1;ADCY7;KLF4;GSTM5;CYP1B1;CCND1;EGF;PRKCG;RPS6KA1;CREB5;CACNA1C;ADCY5;CYP3A4;FGF7;KPNA7;FOS;CYP3A7-CYP3A51P;PIK3CB;PIK3CD;ADCY3;FGF22;BCL6;ADCY8;PRKCB;CYP3A5;CREB3
prerank,CellMarker_Augmented_2021__Unrestricted Somatic Stem cell:Embryo,-0.4949428931493508,-0.765645747668298,0.6833333333333333,1.0,1.0,1/5,5.68%,THY1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex8:Brain,-0.3522856431375515,-0.7654877453786884,0.8333333333333334,1.0,1.0,16/53,17.70%,TESC;GAS2L3;CTNNA3;MAMDC2;SPOCK3;ITGA11;CREB5;SYNPR;FRAS1;THEMIS;CRTAC1;STK32B;SNTB1;MGAT5;ATP8B1;LTBP1
prerank,Reactome_2022__Cellular Responses To Stimuli R-HSA-8953897,-0.28339282158585755,-0.765478245033599,0.9897959183673469,1.0,1.0,91/614,18.41%,CDKN2A;PGR;RPL19;RPL3;KDELR3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;SNCB;RPL27A;ATF3;PRDX5;RPL35;DNAJC2;RPL7A;CCL2;RPL37A;RPL27;PTK6;GLYAT;RPL9;COX4I1;PSMB9;RPL21;ANAPC11;RPL13A;TSPYL2;RPS6KA1;LMNB1;BLVRB;MAFK;MT1H;MINK1;RPA3;HELZ2;RPS11;RPS16;RPLP1;IGFBP7;RPS13;PSMB6;RPL38;RPS3A;DCTN1;RPS8;RPL10A;PSMC3;RPLP2;RPS23;CCNE2;RPS21;RPS7;UBC;CABIN1;RPL8;FOS;TXNRD2;RPS6;ELOB;RPS15;RPL26L1;RPS9;UBE2S;PSMA8;RPL12;RPL5;PRKCD;CDK2;TLN1;ATOX1;PSMA7;FAU;ARFGAP1;RPL23;RPL4;PSME1;ETS1;RPL18A;RBX1;RPL41;ABCC1;RPL7;RPS12;CDKN2D;TINF2;CDKN1A;HSPA5;RPS20
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,0.29553627867403565,0.765101364283224,0.8518518518518519,1.0,1.0,11/41,18.88%,GATC;MTFMT;VARS1;CARS2;QRSL1;YARS2;KARS1;SEPSECS;NARS2;FARSB;LARS2
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.43096464136107837,-0.7650624392738016,0.8208955223880597,1.0,1.0,1/13,3.94%,ATF3
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,0.318114157917983,0.7649853236071734,0.9090909090909091,1.0,1.0,5/46,6.89%,SEM1;PSMD10;PSMA1;PSMD11;PSMB5
prerank,Reactome_2022__Fatty Acids Bound To GPR40 (FFAR1) Regulate Insulin Secretion R-HSA-434316,0.5072967225704419,0.7649632404887736,0.8695652173913043,1.0,1.0,3/5,25.43%,GNAQ;PLCB1;GNA11
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.2891115542198143,0.7645951557537315,0.8695652173913043,1.0,1.0,11/65,15.90%,KIF21B;KIF15;KIF21A;NAPSA;SEC22B;RAB1B;KIF6;COPB2;TMED3;ARCN1;KIF1B
prerank,Reactome_2022__Beta-oxidation Of pristanoyl-CoA R-HSA-389887,-0.474795343216108,-0.7645523734720782,0.8,1.0,1.0,3/8,31.50%,ACOT8;SYCP2;ACOX2
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.45506366031274326,0.7644793997802277,0.7708333333333334,1.0,1.0,1/6,7.07%,CXCL13
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.38912869011366436,-0.7643967910529708,0.803030303030303,1.0,1.0,6/22,20.77%,RPS27A;NOD1;UBC;RIPK2;CASP8;IKBKG
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.35369880208687315,-0.7642180262000733,0.8701298701298701,1.0,1.0,10/48,19.40%,IL15;PTK6;SYK;BMX;FES;AATK;RELN;TEK;PDGFRA;GHR
prerank,Reactome_2022__Defective GALNT12 Causes CRCS1 R-HSA-5083636,0.4789669597174668,0.7641978528416763,0.7708333333333334,1.0,1.0,1/5,2.45%,MUC20
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.41868978595202383,-0.764187173484637,0.8676470588235294,1.0,1.0,2/12,13.10%,BASP1;PAX8
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.447632795011075,-0.7641453069575957,0.7884615384615384,1.0,1.0,2/13,11.47%,ANGPTL7;AEBP1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.33223264351553217,0.7641247474880066,0.78125,1.0,1.0,4/23,6.87%,SMYD2;KMT5A;METTL18;VCPKMT
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,-0.3209242225286829,-0.7637565388497785,0.9,1.0,1.0,5/77,10.89%,TYMS;GMPR;GLRX;NUDT13;ENTPD3
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),0.45205522305538615,0.763704242147473,0.7894736842105263,1.0,1.0,2/6,27.19%,EP300;GCK
prerank,KEGG_2021_Human__Long-term depression,-0.34055495580818196,-0.7636579174090691,0.8674698795180723,1.0,1.0,9/51,17.19%,GRIA3;GRIA1;ITPR3;PRKCG;IGF1;NOS1;GRID2;GUCY1A1;PRKCB
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.3120102366966327,-0.7636509895032016,0.9358974358974359,1.0,1.0,16/111,16.21%,RASGRP1;RASGRP2;RPS27A;ITPR3;PSMB9;PSMB6;PRKCQ;SYK;PSMC3;UBC;RNASE1;FOS;PIK3CB;PSMA8;VAV1;PSMA7
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.246647747428304,0.7635976994868983,1.0,1.0,1.0,38/273,14.90%,MACIR;FHDC1;CEP19;SPAG16;BBS10;BBS9;RAB23;SSX2IP;EXOC8;CEP20;EXOC6;HAUS1;INTU;DZIP1;CSNK1E;CNGA4;CEP290;RAB8B;PTPN23;CEP152;FOXJ1;PLK1;PARVA;PCM1;CEP97;ALMS1;C2CD3;SCLT1;TEKT5;E2F4;TTC8;NEK1;UNC119B;TCTN3;IQCB1;CEP192;TUBG1;RAB8A
prerank,KEGG_2021_Human__GABAergic synapse,-0.3120995815170278,-0.7633132222157364,0.8987341772151899,1.0,1.0,25/74,20.30%,ADCY7;GNG3;SLC32A1;HAP1;PRKCG;GABRE;GABRB2;GABRD;CACNA1C;ADCY5;GAD1;GNG2;GAD2;SLC38A1;GABRG2;GABRA1;ADCY3;GABARAPL1;ADCY8;PRKCB;GABBR2;GABARAPL2;GABRA6;GABRG3;GABRA3
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.30439012371827573,0.7630726381632102,0.9444444444444444,1.0,1.0,11/44,20.54%,MOSMO;VCP;GAS1;INTU;BTRC;TUBD1;FBXL17;KCTD21;HERC4;GLI3;WDR11
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.4061532872139321,0.7627385748884538,0.8333333333333334,1.0,1.0,1/9,1.24%,NR1D1
prerank,Reactome_2022__PKA Activation R-HSA-163615,-0.4153662811783443,-0.76267950077946,0.8412698412698413,1.0,1.0,3/15,17.15%,ADCY7;ADCY5;ADCY8
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.2555837195895392,0.7625227601722923,0.9523809523809523,1.0,1.0,14/88,14.81%,HAUS1;CSNK1E;CEP290;CEP152;PLK1;PCM1;CEP97;ALMS1;C2CD3;SCLT1;TCTN3;IQCB1;CEP192;TUBG1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.4343031667435801,0.7625094485399987,0.8,1.0,1.0,6/10,20.59%,COMMD1;GPM6B;TAX1BP3;LEPROTL1;PICALM;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.49082520480039776,-0.762228460287548,0.8769230769230769,1.0,1.0,2/8,7.41%,ANK3;GLRX
prerank,Reactome_2022__Signaling By ERBB2 ECD Mutants R-HSA-9665348,0.3773711000449085,0.7619636648373107,0.7586206896551724,1.0,1.0,4/15,14.84%,NRAS;EGFR;PIK3CA;PIK3R1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.2619655524036792,0.7618313628672081,1.0,1.0,1.0,29/138,18.38%,WNT7A;ASCL1;NDNF;RUNX1;FUT9;POU3F2;HES6;EML1;PEX13;FZD8;TAFA1;ERCC6;ADNP2;HEYL;GPM6A;EMX2;CASP3;SH3RF1;PRUNE1;TUBB2B;LHX2;MARK2;LRP12;ACSL3;OLIG1;CEP85L;HEY1;DTNB;YTHDF2
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,0.3263177515790142,0.7612899442814884,0.8,1.0,1.0,2/31,3.57%,GALNT3;NRAS
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.3242156208653822,0.7612756292647735,0.7666666666666667,1.0,1.0,4/37,7.64%,RGCC;BRINP3;ANGEL2;GAS1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.3151793999750112,0.7612416339532885,0.8823529411764706,1.0,1.0,2/34,4.38%,EFNB2;EIF2S1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.3663048307644938,-0.7611704999276458,0.8461538461538461,1.0,1.0,4/41,12.67%,ITPKC;INPP5D;NUDT4;PLCH2
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,-0.34108282447878013,-0.7609209455906591,0.875,1.0,1.0,7/56,13.97%,RPS27A;NOD1;KCNH8;RPS6KA1;TNIP2;UBC;FOS
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.2735517014387008,0.7609198771596496,0.9565217391304348,1.0,1.0,11/79,15.48%,NR1D1;MACIR;TNFAIP3;PTGIS;SIRPA;CASK;DRD2;ENPP3;MUL1;RNF26;AJAP1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.3574397071137855,0.7608875020987274,0.775,1.0,1.0,4/14,12.99%,AR;NR3C1;ATP1A2;AKR1C3
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.398517447889819,-0.76079157022574,0.8333333333333334,1.0,1.0,4/23,15.88%,RPS27A;MAN1C1;UBC;MAN1A1
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.46812037603029333,0.760651948669748,0.8,1.0,1.0,2/7,5.81%,ABCB10;SLC25A37
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.3527755327316574,0.7605474464586114,0.7878787878787878,1.0,1.0,4/21,9.17%,ATP6V1A;DMAC2L;UCP3;ATP1A2
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,0.3023114026313194,0.7604451499237809,0.9230769230769231,1.0,1.0,3/33,6.46%,SOCS6;NRAS;YES1
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.47220418819731474,0.7603243718301942,0.7727272727272727,1.0,1.0,1/6,2.36%,ABCA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3287925653528755,0.7601404740848398,0.9032258064516129,1.0,1.0,7/33,14.20%,POLD3;RFC3;ERCC2;ERCC3;GTF2H5;GTF2H2;POLK
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.4118910928254656,-0.760068532365077,0.7794117647058824,1.0,1.0,1/18,2.23%,RPS27A
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.41710123120426706,0.7600625269808928,0.7837837837837838,1.0,1.0,7/11,33.28%,ATL2;VAPB;STX18;VCPIP1;STEEP1;MOSPD3;BNIP1
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,0.33052825267818065,0.7598126734771204,0.967741935483871,1.0,1.0,11/30,28.91%,SLC4A7;VCP;DBT;VANGL1;VAMP3;WDR11;ROCK2;PKN2;FAM91A1;RALGAPA1;CSK
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.46749706233031385,-0.7596244701139212,0.7575757575757576,1.0,1.0,2/8,11.12%,PIK3IP1;DAB2IP
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.32315867789990194,-0.7596025207147369,0.9315068493150684,1.0,1.0,10/67,17.11%,PHEX;ST3GAL6;CHRM3;USP6;BAP1;B4GALT7;UBE2S;PLAT;PIGH;FBXL2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.37659428643902565,0.7594464492363899,0.7692307692307693,1.0,1.0,2/14,14.92%,ATR;POT1
prerank,CellMarker_Augmented_2021__Morula Cell (Blastomere):Embryo,-0.3216095381990227,-0.7590810973406289,0.8846153846153846,1.0,1.0,8/82,10.29%,RPS27A;RPL39L;LDHA;KLF4;RPL21;FA2H;KLF3;HDDC2
prerank,Reactome_2022__Activation Of RAC1 R-HSA-428540,0.3862410510812768,0.7590683156721474,0.7560975609756098,1.0,1.0,6/11,25.12%,NCK1;ROBO1;NCK2;SOS2;SOS1;PKN2
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.44123218815346066,-0.7585974927068925,0.8870967741935484,1.0,1.0,3/9,15.37%,APOBEC2;APOBEC3H;NUDT16
prerank,Reactome_2022__Vesicle-mediated Transport R-HSA-5653656,-0.2818858617415764,-0.7584772368227415,0.9893617021276596,1.0,1.0,42/538,12.88%,EPN1;COL4A1;SPARC;COL4A2;ANK3;KDELR3;RPS27A;NAA38;RAB11A;SH3GL2;F8;COLEC12;APP;CTSC;DENND3;TRIP10;SBF1;GJB7;GRIA1;YWHAH;CENPE;LDLR;EGF;TPD52;AP1S1;SYT1;KIF9;WNT5A;SH3GL3;TGFA;M6PR;GOLGA8B;CD55;COPZ2;DCTN1;KIF2C;MYH9;CTSZ;MYO1E;MAN1C1;UBC;RNASE1
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,0.3559906123397721,0.7583240316647307,0.8666666666666667,1.0,1.0,3/27,6.31%,TAB3;TNFAIP3;UBE2N
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.4196520640116998,0.7578068066911529,0.75,1.0,1.0,4/8,15.88%,RUNX1;HMGB1;SH3RF1;TNFSF4
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.3535541800648015,0.757494874544964,0.7222222222222222,1.0,1.0,6/24,12.99%,SOX8;SOX9;NCOA4;AR;MSH2;AKR1C3
prerank,Reactome_2022__Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.3831325781301111,0.7574864491809954,0.7931034482758621,1.0,1.0,2/17,6.31%,TAB3;UBE2N
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.45631920181394303,-0.7571119102277257,0.8448275862068966,1.0,1.0,6/10,33.48%,CCDC3;RFFL;GSTP1;TRAIP;GAS6;GPS2
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.3031010452842073,-0.7568400472271378,0.9418604651162791,1.0,1.0,19/146,18.23%,TGFBR2;VRK2;PLK2;PRKCG;RPS6KA1;SBK1;PDK3;PRKCQ;PINK1;PRKCH;STK32B;PRKCD;CDK2;CDC7;HIPK4;PRKCB;CDK5;HIPK3;RPS6KA6
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.43148852963875695,-0.7568029830907219,0.7636363636363637,1.0,1.0,2/12,18.55%,HEXIM1;NELFE
prerank,CellMarker_Augmented_2021__Mitotic Arrest Phase Fetal Germ cell:Fetal Gonad,-0.27954739988199157,-0.756681885632893,1.0,1.0,1.0,57/781,12.66%,PRAME;LEF1;GBP2;EFNA1;IL13RA1;DOCK8;CCDC122;MAEL;ABCA5;CTHRC1;SERPINF1;CIC;HLA-A;STAG3;ELAVL2;IMPDH1;PLK2;TESC;CYP4X1;ART3;SH3GL2;C5ORF47;CLGN;YBX3;ACOT4;ARHGAP39;SURF2;C12ORF57;NOTUM;TSACC;C5ORF58;BAIAP2;ATP1B1;BAIAP2L1;DDHD2;P4HA2;TSPYL2;NELL2;TAGLN2;CDC42EP3;POLE4;STAT1;EIF2B2;RASGEF1B;ISG15;NDRG1;SHISA9;DNAH3;FN1;TDRD5;CD55;RBKS;MYH9;SIGIRR;SNX30;PAQR3;CCDC73
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.3447130744340261,0.7564814906823077,0.7714285714285715,1.0,1.0,6/28,19.67%,LIMD1;PRKRA;CNOT8;AGO3;CNOT1;PUM2
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.3985021926120099,-0.7563441309702634,0.8450704225352113,1.0,1.0,2/20,10.92%,PLSCR1;LPCAT4
prerank,CellMarker_Augmented_2021__Ionocyte cell:Lung,-0.28433866764611426,-0.7559600140582676,0.9651162790697675,1.0,1.0,23/243,13.07%,LEF1;THBS1;TGFBR2;RCAN2;CLGN;APP;PALM2AKAP2;ATP1A1;TBC1D9;SVIL;NCALD;TPD52;IGF1;FBXO32;CD9;PDK3;CHST15;IGFBP5;TRIM47;SEC11C;CORO7;GPR160;SP110
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,-0.40400772342194596,-0.7558446215124542,0.84375,1.0,1.0,1/20,2.23%,RPS27A
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.3790272021779627,-0.755604725738596,0.7384615384615385,1.0,1.0,8/20,26.88%,TRIM5;PML;TRIM62;CHMP2A;TRIM25;VPS4A;TRIM32;DDB1
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,-0.31294754929861024,-0.7555971643046807,0.9154929577464789,1.0,1.0,11/91,12.77%,ABCA6;ABCA5;RPS27A;ABCA8;ABCA12;ABCB1;PSMB9;ABCA10;PSMB6;PSMC3;UBC
prerank,Reactome_2022__MET Activates PTPN11 R-HSA-8865999,0.4691109814987786,0.7554938679525769,0.7674418604651163,1.0,1.0,2/5,23.66%,PIGU;SOS1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.24886747972086115,0.7554461345686007,1.0,1.0,1.0,28/246,13.46%,NGF;NCSTN;BMP2;PHLDA1;AIFM2;BCL10;ARHGEF16;DUSP6;ACVR1C;ARHGEF12;PTGIS;C3ORF38;IP6K2;ZNF268;STK4;HMGB1;USP27X;TRADD;ATF6;ARHGEF26;MAPK8;TP53BP2;CASP3;TIAM2;CRADD;ERCC3;STK17B;PNMA3
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,-0.37492583938791324,-0.7552893935175227,0.7692307692307693,1.0,1.0,3/17,12.77%,RPS27A;RPA3;UBC
prerank,Reactome_2022__PKA Activation In Glucagon Signaling R-HSA-164378,-0.4140938503364407,-0.7552662571761117,0.7538461538461538,1.0,1.0,3/14,17.15%,ADCY7;ADCY5;ADCY8
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.3550959443425612,-0.7552504628803514,0.8266666666666667,1.0,1.0,4/38,13.10%,PROX1;SULF1;ITGA8;PAX8
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.26706749087030124,0.7549698737944348,1.0,1.0,1.0,16/95,15.34%,PSMD10;BCL10;TAB3;PSMA1;PSMD11;CUL1;MAPK10;PSMB5;BTRC;MAPK8;PSMD14;PIK3CA;PSMD12;NFKB1;PIK3R1;MAP2K4
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.3679042016733218,0.7548888587152203,0.8518518518518519,1.0,1.0,5/17,16.63%,BMP2;TRIB3;PRMT3;AKR1C3;ERLIN1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.30743471220974367,-0.754729447537878,0.9310344827586207,1.0,1.0,22/145,20.30%,SCN1B;STMN2;PTK6;RIT2;IL1RAPL1;MAG;PLPPR5;WNT5A;DAB2IP;PAQR3;CRMP1;FES;BDNF;MFSD2A;RELN;CDK5;PTPRO;LRRC7;DPYSL3;CX3CL1;CAMK1D;STX1B
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.45334749040780503,-0.7539509794128751,0.7413793103448276,1.0,1.0,1/9,2.46%,NOS1AP
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.4123949073207088,0.7539485670542024,0.6857142857142857,1.0,1.0,2/6,17.09%,FOXP1;NOC2L
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.4600421587785379,0.7539466646168894,0.7435897435897436,1.0,1.0,2/6,18.18%,SLC25A18;SLC25A22
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.4104189494242279,-0.7538034686218457,0.8548387096774194,1.0,1.0,5/16,23.62%,GNG3;GNG2;GNB4;GNB5;GNA14
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3633489773982993,-0.7537925914647982,0.8513513513513513,1.0,1.0,1/42,0.37%,S100A10
prerank,Reactome_2022__Insulin Processing R-HSA-264876,0.35114503849829104,0.753506499981401,0.7631578947368421,1.0,1.0,5/24,7.47%,EXOC8;SLC30A7;SLC30A6;RAB27A;EXOC6
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.3371537944472323,-0.7530680569681523,0.8615384615384616,1.0,1.0,10/63,13.56%,GRIN3A;CDH23;RAMP3;TRPC3;SLC24A1;NIPAL2;SLC8A3;CACNA1C;TUSC3;SLC11A1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.2876076496853454,0.7530589369899141,1.0,1.0,1.0,8/77,8.86%,NGF;CNOT9;HCLS1;TENM1;EGFR;AKT1;STK4;CAPRIN2
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),0.4682743386959491,0.7530166361761829,0.7045454545454546,1.0,1.0,1/6,12.79%,DRD2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.40845056629761156,-0.7523809020106964,0.8676470588235294,1.0,1.0,2/15,5.96%,CSPG4;BGN
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.4889594381478134,0.7523497280692558,0.7708333333333334,1.0,1.0,3/7,32.44%,SNAP29;VAMP8;STX17
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.4363875921098694,-0.7523234243372053,0.7457627118644068,1.0,1.0,2/11,7.96%,PROX1;ZFPM1
prerank,Reactome_2022__Role Of ABL In ROBO-SLIT Signaling R-HSA-428890,0.45947567088120217,0.7521811824369748,0.8717948717948718,1.0,1.0,5/7,35.59%,ROBO1;ABL2;CLASP2;CAP1;CLASP1
prerank,CellMarker_Augmented_2021__Epithelial cell:Embryoid Body,-0.30863760154652725,-0.7520123912433576,0.872093023255814,1.0,1.0,24/97,23.17%,COL4A1;COL4A2;PDPN;SULF1;SCARA3;WNT5A;IGFBP5;TUSC3;AMOTL2;COL12A1;NOTCH3;PCDH18;PTPN21;SVEP1;DPYSL3;PPP2R3A;ANTXR1;KIAA1217;SFRP1;SH3D19;EPB41L1;SLIT2;DST;BOC
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),-0.48312779633549663,-0.7517835924536252,0.8333333333333334,1.0,1.0,4/6,30.14%,TAC4;GRK2;TAC1;TACR1
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,0.31220476930991237,0.7516628123365794,0.8571428571428571,1.0,1.0,12/46,19.94%,MAML3;KAT2B;CDK8;CUL1;HEYL;KAT2A;HDAC2;EP300;HEY1;HDAC10;HEY2;HES5
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.31297006573539193,-0.7514982154796802,0.9358974358974359,1.0,1.0,17/79,18.59%,POU4F1;KIF14;GPNMB;CCL2;PRKCG;MAG;UNC5B;PINK1;HLA-F;BDNF;NRBP2;CLN3;CD200;SNX6;CDK5;VSTM2L;FOXB1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.41253442296936293,-0.7512699268695798,0.8142857142857143,1.0,1.0,3/15,11.60%,ATP1A1;ATP1B1;TMPRSS3
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.2851542232018958,0.7512269323604838,0.9230769230769231,1.0,1.0,16/55,21.80%,ZDHHC16;ZDHHC14;PIGP;ZDHHC18;ZDHHC13;PIK3C3;ZDHHC20;ZDHHC5;ZDHHC21;GPLD1;GLUL;DPM1;PORCN;ZDHHC6;PIGF;PIGU
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.41575002957786916,-0.7510580811246103,0.8095238095238095,1.0,1.0,4/14,17.95%,CEMIP;CD44;HYAL1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),-0.5097172619595548,-0.7508754493764387,0.8076923076923077,1.0,1.0,3/5,41.84%,SIX4;AKIRIN1;MSTN
prerank,KEGG_2021_Human__Necroptosis,0.2647738474335562,0.750866680523673,1.0,1.0,1.0,21/100,16.86%,TNFAIP3;MAPK10;GLUD1;VDAC2;RNF103-CHMP3;HMGB1;H2AC6;PLA2G4C;TRADD;PYGM;MAPK8;PGAM5;TICAM1;SLC25A5;CHMP2B;CFLAR;SPATA2;SMPD1;GLUL;VPS4B;FTL
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.4425465657775255,-0.750578487083989,0.8421052631578947,1.0,1.0,2/10,14.82%,VIL1;WDR1
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.2670147952243207,0.7504651655476466,1.0,1.0,1.0,20/53,28.62%,ELOVL6;ELOVL4;ELOVL2;HACD2;VAPA;SGMS2;PRKD1;VAPB;SPHK2;PLPP3;PPM1L;CERS3;SGMS1;ST3GAL2;PLPP1;DEGS1;ACER3;ELOVL7;CERS6;SGPP1
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,0.38108457341861846,0.7503747592093815,0.7714285714285715,1.0,1.0,4/16,14.84%,TRIM24;CPSF6;PIK3CA;PIK3R1
prerank,CellMarker_Augmented_2021__PROM1High Progenitor cell:Large Intestine,-0.3223465327856482,-0.7501668562276085,0.9295774647887324,1.0,1.0,10/90,12.84%,CCBE1;COL8A1;LAMB1;GJC1;MAP1B;P4HA2;P4HA3;FN1;APCDD1L;AMOTL2
prerank,Reactome_2022__RSK Activation R-HSA-444257,-0.4705248511095412,-0.7501618929527931,0.7796610169491526,1.0,1.0,2/7,18.23%,RPS6KA1;RPS6KA6
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.39255759229110043,-0.7499114413597885,0.8524590163934426,1.0,1.0,2/14,16.10%,APP;ATOX1
prerank,CellMarker_Augmented_2021__Colonic Stem cell:Colon,-0.31279675113104877,-0.7498768588815568,0.9024390243902439,1.0,1.0,25/89,24.37%,LAMB1;TEAD2;EFNB3;SCARA3;ARHGAP39;PFN2;DAB2IP;TUSC3;AMOTL2;RHBDF1;FRAS1;PTPRF;GPC1;NOTCH3;PTPN21;NXN;ANTXR1;LAPTM4B;MYO1B;FBLIM1;CNN3;PTK7;GLI2;SMARCA1;TANC1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.3826097420639712,-0.7497809792403212,0.8032786885245902,1.0,1.0,4/20,21.03%,RPS27A;UBC;RBX1;CETN2
prerank,Reactome_2022__Cellular Responses To Stress R-HSA-2262752,-0.2775489381685516,-0.7496435697636102,1.0,1.0,1.0,89/604,18.41%,CDKN2A;PGR;RPL19;RPL3;KDELR3;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;RPL27A;ATF3;PRDX5;RPL35;DNAJC2;RPL7A;CCL2;RPL37A;RPL27;PTK6;GLYAT;RPL9;COX4I1;PSMB9;RPL21;ANAPC11;RPL13A;TSPYL2;RPS6KA1;LMNB1;BLVRB;MAFK;MINK1;RPA3;HELZ2;RPS11;RPS16;RPLP1;IGFBP7;RPS13;PSMB6;RPL38;RPS3A;DCTN1;RPS8;RPL10A;PSMC3;RPLP2;RPS23;CCNE2;RPS21;RPS7;UBC;CABIN1;RPL8;FOS;TXNRD2;RPS6;ELOB;RPS15;RPL26L1;RPS9;UBE2S;PSMA8;RPL12;RPL5;PRKCD;CDK2;TLN1;ATOX1;PSMA7;FAU;ARFGAP1;RPL23;RPL4;PSME1;ETS1;RPL18A;RBX1;RPL41;ABCC1;RPL7;RPS12;CDKN2D;TINF2;CDKN1A;HSPA5;RPS20
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,0.3078367671068229,0.7496245567192149,0.9714285714285714,1.0,1.0,9/34,25.05%,PRMT6;H2AC6;PRMT3;SMARCA2;WDR77;PBRM1;PRMT1;SMARCC1;ARID1B
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.4410881144858518,0.7493664388758913,0.8,1.0,1.0,3/8,13.07%,SRI;ATP1A2;SPX
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.36273558859622995,-0.7493590851817653,0.875,1.0,1.0,1/28,0.18%,ANXA1
prerank,CellMarker_Augmented_2021__Ectoderm cell:Germ,-0.3081024674005688,-0.7492854888648227,0.8589743589743589,1.0,1.0,14/96,17.17%,ADAMTS10;CIC;CDH23;C10ORF105;LRRC4;GFRA2;GNG2;TMEM132C;AATK;RTN1;JPH4;SH2D3C;CRB2;GALNT8
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.4165205295005221,0.7492527116131598,0.8148148148148148,1.0,1.0,2/9,11.23%,CASQ1;ANK2
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.43294520646506446,0.7491069515335742,0.75,1.0,1.0,4/8,32.26%,ABI2;WASF3;NCKAP1;BRK1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.3264655381295518,-0.7490493429734428,0.9342105263157895,1.0,1.0,14/78,18.96%,ST6GAL1;GCNT1;CHST4;GALNT15;B3GNT5;GALNT10;B3GNT2;GALNT12;ST6GALNAC2;SDF2L1;MUC6;GALNT8;GALNTL6;MUCL1
prerank,KEGG_2021_Human__Sulfur metabolism,-0.44431153383067046,-0.7489955853119252,0.7894736842105263,1.0,1.0,2/10,9.64%,PAPSS2;SQOR
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.37741850243870667,-0.7488840630265773,0.8412698412698413,1.0,1.0,2/20,7.62%,CDKN2A;HEXIM1
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.39533141392923,0.748650738175222,0.775,1.0,1.0,2/10,10.49%,RAP2C;RAB1B
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.3446930264141477,-0.7485619129479699,0.8387096774193549,1.0,1.0,2/23,4.46%,TJP3;LSR
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.3169413935071798,-0.7484596179773187,0.9452054794520548,1.0,1.0,26/119,24.39%,TRIM22;TRIM5;PLK2;APP;IGF1;GAPDHS;PLEKHF1;PRXL2C;PIK3CB;PFKFB4;PRKCD;IRS2;PFKFB3;KAT5;TRIM65;OPTN;ADAM8;P2RX7;SH3D19;RDX;PFKFB2;MTLN;DXO;TRIML2;PTTG1IP;SVIP
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.3766180435264682,-0.7483940496351917,0.8695652173913043,1.0,1.0,1/27,1.55%,SUV39H1
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.3724652052841735,-0.7483397543704234,0.8958333333333334,1.0,1.0,3/17,10.55%,RAB11A;CCND1;CCNB1
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.29656581806664734,0.7482401577053742,1.0,1.0,1.0,21/64,24.73%,PSMD10;BCL10;DCUN1D2;COMMD1;DCUN1D1;UBE2D1;RCHY1;DERL1;DCUN1D5;MUL1;NDFIP1;PIAS4;MALT1;SMAD7;TBC1D7;SENP2;DCUN1D4;UBQLN1;HSPBP1;FBXW7;AXIN1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.2776090045723063,-0.7480395836650443,1.0,1.0,1.0,68/776,13.09%,LEF1;HPN;TRIM22;SKOR1;APLNR;POU4F1;PGR;TLR2;PLAG1;SPIN2A;HIC1;TRIM61;ANK3;NOS1AP;ZNF114;WARS1;PROX1;SFTPD;PTP4A3;TRIM5;MYT1;ELAVL2;RAMP3;TESC;OVOL2;SH3GL2;CASZ1;APP;KLF4;SCX;YBX3;SRRM4;BRCA1;LRRC19;TEAD2;TLR3;PARP14;NELL1;NKX6-2;PLSCR1;PARP9;EGF;ATP1B1;MOG;ZNF536;TRIM17;BTG1;IGF1;NFKBID;ADAM19;WNT5A;RIMS2;FGF1;HHLA2;PRKCQ;FN1;PRDM1;SFRP4;PINK1;SOX15;PTRH2;SBNO2;OGG1;RPS7;C1QTNF1;FAM50A;PPARGC1B;FGF7
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.28662077927669455,0.7479442747583578,0.9473684210526315,1.0,1.0,7/69,11.45%,RGCC;GNL3L;SDC4;VCP;SNF8;TIRAP;SMPD3
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.41328059338181855,0.7478258036984239,0.7894736842105263,1.0,1.0,1/11,5.94%,MFF
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.3907431175762587,-0.7477737762663565,0.8,1.0,1.0,6/24,19.62%,ANK3;NOS1;CD63;VIP;KCNAB3;KCNIP4
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3326107380821361,-0.7476787893078999,0.918918918918919,1.0,1.0,12/74,18.28%,CDKN2A;WARS1;SH3GL2;FBP1;DAB2IP;PAQR3;IRS2;TGFB1;CDKN2D;MAPT;NUPR1;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),-0.4757588785243562,-0.7474260938658724,0.7627118644067796,1.0,1.0,1/5,7.39%,TNFRSF14
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),-0.48570624626426184,-0.747321757420788,0.7222222222222222,1.0,1.0,1/5,3.00%,SLC39A14
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.3092777143665069,-0.7472356845530536,0.8666666666666667,1.0,1.0,10/88,12.84%,TRAM1L1;C1QL1;B4GALNT1;MAP1B;EFNB3;SCARA3;PFN2;DAB2IP;TUSC3;AMOTL2
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.4230092624999312,0.7470174514055047,0.8292682926829268,1.0,1.0,2/5,23.28%,WDR70;RNF20
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.2873750087506689,0.7467550824134964,1.0,1.0,1.0,8/58,15.38%,NR1D1;MACIR;TNFAIP3;PTGIS;SIRPA;ENPP3;MUL1;RNF26
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.3530621165759792,-0.7466540641842699,0.8769230769230769,1.0,1.0,6/41,14.47%,TGFBR2;TEAD2;ZFPM1;IFT122;RPL10;MFSD2A
prerank,KEGG_2021_Human__Prostate cancer,-0.3219347001922379,-0.7462794555877358,0.8701298701298701,1.0,1.0,14/82,19.00%,LEF1;CCND1;EGF;IGF1;TGFA;CREB5;CCNE2;PIK3CB;PLAT;PIK3CD;CDK2;CREB3;CDKN1A;PDGFRA
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.3158450494497029,0.7462271639907391,0.9032258064516129,1.0,1.0,9/26,29.35%,ERI1;SNRPF;MTPAP;TENT4B;CPSF2;SNRPB;TENT2;LSM1;XRN1
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,0.29451868498904277,0.7462098382746833,0.875,1.0,1.0,10/43,18.09%,KPNA2;H2BC21;H2BC4;BRCC3;UBE2N;MAPK8;EYA1;HERC2;PIAS4;EYA2
prerank,Reactome_2022__Metabolism Of RNA R-HSA-8953854,-0.27349284208616353,-0.7460140167855448,0.9895833333333334,1.0,1.0,66/605,16.54%,ENPP2;RPL19;RPL3;ZFP36;RPS27A;RPL39L;RPL36AL;RPS27;RPS14;RPS4X;ELAVL2;RPL27A;COLEC12;RPL35;EMG1;RPL7A;RPL37A;RPL27;CD44;RPL9;PSMB9;RPL21;CTU2;NOB1;RPL13A;SNRPD2;POLR2I;RPS11;RPS16;RPLP1;RPS13;PSMB6;RPL38;RPS3A;LAGE3;RPS8;RPL10A;PSMC3;RPLP2;RPS23;RPS21;RPS7;UBC;RPL8;DHX38;APOBEC2;ZNF473;NOP10;RPS6;LSM11;GLE1;RPS15;APOBEC3H;RPL26L1;DIMT1;RPS9;PSMA8;RPL12;THOC6;PES1;RPL5;PRKCD;PSMA7;FAU;RPL23;RPL4
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),-0.49382125960868306,-0.7458116053037751,0.7966101694915254,1.0,1.0,2/5,16.90%,THY1;CRB2
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),-0.49382125960868306,-0.7458116053037751,0.7966101694915254,1.0,1.0,2/5,16.90%,THY1;CRB2
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.41296696361804974,0.745391442171749,0.8461538461538461,1.0,1.0,3/9,30.10%,LTA4H;MGST2;CYP2C8
prerank,Reactome_2022__SHC1 Events In EGFR Signaling R-HSA-180336,0.4154607873306514,0.7453652720810094,0.7058823529411765,1.0,1.0,2/8,5.64%,NRAS;EGFR
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4410094453988528,-0.7452989707228677,0.6964285714285714,1.0,1.0,1/7,5.89%,DUOXA1
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),-0.4347688363277904,-0.7452662318705984,0.8431372549019608,1.0,1.0,2/13,10.72%,P3H2;OGFOD1
prerank,Reactome_2022__Triglyceride Catabolism R-HSA-163560,-0.4072202477130432,-0.7451431782740333,0.875,1.0,1.0,1/15,1.31%,FABP3
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.4546911203862894,-0.7451048448387763,0.8363636363636363,1.0,1.0,1/9,1.11%,APLNR
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.2968443763331948,0.7447260629883113,0.8823529411764706,1.0,1.0,5/36,9.03%,PHC1;RNF2;EED;YAF2;RBBP4
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.3089796044464612,0.7447189578538193,0.8571428571428571,1.0,1.0,6/32,12.89%,RAP2C;TESK1;PDGFD;PDGFC;TAOK2;PPP2R5A
prerank,CellMarker_Augmented_2021__Epiblast cell:Embryo,-0.33628400415378074,-0.7446379173778501,0.8181818181818182,1.0,1.0,18/61,24.93%,VSNL1;FBP1;UNC5B;MAN1C1;PITPNM2;DND1;RASD1;GPRC5C;NRBP2;FAM124A;CASP8;WNT3;ST6GALNAC3;LAPTM4B;NODAL;CAPG;NGEF;MUC4
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Endometrium,-0.4828408130475392,-0.74444212062379,0.746031746031746,1.0,1.0,1/6,5.68%,THY1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.3400709964072231,-0.7444416515415024,0.803030303030303,1.0,1.0,3/26,18.12%,PLK2;CEP76;CCNF
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.45648430959729813,0.744202150246899,0.7272727272727273,1.0,1.0,1/6,24.10%,ADARB1
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.42806512668224556,0.7441335526910308,0.8048780487804879,1.0,1.0,1/8,3.90%,BCO2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.29070734294393025,0.7440444220726561,0.9375,1.0,1.0,14/60,16.85%,NGF;ANP32B;VCP;TRADD;SLC22A2;ROBO1;EGLN3;CRADD;DAP;CFLAR;MUL1;BCL2L13;EIF2AK3;BAD
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,0.3002050208171146,0.7439508409683161,0.9285714285714286,1.0,1.0,5/37,14.90%,RAB33B;RAB8B;RAB4A;RAB7B;RAB8A
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.29632520085640146,0.7438801262106103,0.95,1.0,1.0,12/39,19.83%,CEBPA;RUNX1;HCLS1;TIRAP;CASP3;SLC25A5;PRDX3;FLVCR1;SNRK;SLC25A38;PRKX;DYRK3
prerank,CellMarker_Augmented_2021__Luteinizing Granulosa cell:Ovarian Follicle,-0.3306255497569257,-0.7437909515556942,0.8974358974358975,1.0,1.0,17/59,22.23%,GRIN2A;CTNNA3;LRRTM1;C1ORF105;GRIA3;LRRC53;GABRB2;GRID2;HTR1E;CNTNAP5;RYR2;LRP2;BMPER;PTPN5;CDH8;MTUS2;CLSTN2
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,-0.3335635621091208,-0.7436337789317164,0.9459459459459459,1.0,1.0,10/69,15.85%,RASGRP1;TLR2;EGF;IFNGR2;STAT1;PPP3CC;PRKCQ;FOS;PIK3CB;PIK3CD
prerank,KEGG_2021_Human__Cardiac muscle contraction,-0.3277250823403887,-0.7435018461500783,0.9342105263157895,1.0,1.0,11/56,17.30%,COX7A1;ATP1A1;COX4I1;ATP1B1;SLC8A3;CACNA1C;TPM4;UQCRQ;CACNB1;COX7A2;RYR2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.32988061334277463,-0.7433259179523695,0.8641975308641975,1.0,1.0,8/67,14.21%,PLK2;PLK3;WNT5A;DAB2IP;HECW2;GPC3;VIP;OAZ2
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.42393510397986756,-0.7432335301746248,0.8676470588235294,1.0,1.0,1/12,2.77%,PROX1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.4428403650935152,-0.7429787385544946,0.8524590163934426,1.0,1.0,3/10,14.82%,VIL1;DSTN;WDR1
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.34168917488272166,-0.7429342300977219,0.90625,1.0,1.0,7/47,16.15%,ANXA1;STEAP3;SVBP;RIMS2;VIP;RAB3C;PTPRN
prerank,CellMarker_Augmented_2021__Amacrine cell:Eye,0.3055992304853363,0.7429337854053643,0.8260869565217391,1.0,1.0,2/62,0.99%,SPSB4;PCDH19
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.3017444981132948,0.7428318086203084,0.8666666666666667,1.0,1.0,10/65,11.34%,PSMD10;PSMA1;PSMD11;COPS8;CUL1;AKT1;PSMB5;BTRC;TIRAP;PSMD14
prerank,KEGG_2021_Human__Insulin signaling pathway,0.25356443752779706,0.742799504796702,1.0,1.0,1.0,29/114,20.52%,PPP1R3D;PPARGC1A;PDE3B;NRAS;AKT2;ACACB;MAPK10;AKT1;PRKAB1;SHC4;PRKACB;EIF4E;PYGM;MAPK8;SOCS4;PPP1R3F;PPP1CC;PIK3CA;SHC3;PIK3R1;CRKL;BAD;G6PC3;ELK1;MAP2K2;PPP1R3C;PYGB;PRKAA1;EIF4EBP1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.37533269425595484,-0.7427326806923991,0.8387096774193549,1.0,1.0,5/30,13.58%,TESC;GATA1;STAT1;THPO;FES
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.3559620534871749,-0.7426444782810961,0.8493150684931506,1.0,1.0,7/33,18.39%,SLC25A21;ABCB1;SLC38A4;SLC38A11;SLC38A1;ABCC1;SLC7A7
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.34374957382493526,-0.7421374152471707,0.8955223880597015,1.0,1.0,6/34,14.44%,RPS14;HELB;NOB1;RPS16;RPS8;TSR2
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.42756304717919,-0.741847577826352,0.7846153846153846,1.0,1.0,2/12,8.03%,TLR3;CHI3L1
prerank,KEGG_2021_Human__Fatty acid elongation,0.34461080957973833,0.7416651422205331,0.8787878787878788,1.0,1.0,5/24,10.74%,THEM4;ELOVL6;ELOVL4;ELOVL2;HACD2
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.4196436431744673,-0.7415860020622213,0.75,1.0,1.0,4/9,22.35%,USP50;NLRC3;CD36;EIF2AK2
prerank,Reactome_2022__Sodium/Calcium Exchangers R-HSA-425561,0.43114803984766076,0.7414286782146765,0.8,1.0,1.0,2/10,2.53%,SLC24A3;SRI
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.26056032588922934,0.7413769783229556,1.0,1.0,1.0,15/63,19.94%,NR1D1;SOCS6;TNFAIP3;VCP;ADAMTS12;RSPRY1;ATE1;CTSV;FBXL17;VPS4B;RHBDD1;IDE;ZYG11B;MDM2;MALT1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.3478087965675676,-0.7408761888679813,0.9102564102564102,1.0,1.0,2/41,2.09%,GBP1;PSCA
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.4960718564041802,0.7408274317317093,0.8292682926829268,1.0,1.0,1/5,13.44%,ENPP3
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,0.34046275042598206,0.7408071042201141,0.9117647058823529,1.0,1.0,4/26,6.23%,HS3ST5;SDC4;SDC3;GPC5
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,0.2923604973856553,0.7407955260784387,0.8846153846153846,1.0,1.0,4/25,15.34%,NRAS;MAPK10;MAPK8;MAP2K4
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.46726197846179,-0.7406977869201559,0.82,1.0,1.0,3/6,26.54%,EDF1;PECAM1;KDM6B
prerank,Reactome_2022__SHC-related Events Triggered By IGF1R R-HSA-2428933,0.43066311325827844,0.7405255579949346,0.75,1.0,1.0,1/7,3.57%,NRAS
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.3992778910674462,0.740511177728712,0.8235294117647058,1.0,1.0,6/14,23.50%,NOTCH2;HEYL;ROBO1;HEY1;HEY2;JAG1
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.4640740520057567,0.7404126369022402,0.7551020408163265,1.0,1.0,2/5,13.55%,CEP152;E2F4
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.4507489879552302,0.7404109234924386,0.8627450980392157,1.0,1.0,4/6,29.09%,CUL1;CAND1;FBXL7;CAND2
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,0.3721625034822565,0.740042970435429,0.7567567567567568,1.0,1.0,2/17,2.94%,NCSTN;CNTN1
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,0.28923603348391597,0.7399507988502758,0.9583333333333334,1.0,1.0,6/61,6.89%,SEM1;PSMD10;PSMA1;PSMD11;ANAPC1;PSMB5
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.27819431004973294,-0.7396692038696782,0.9894736842105263,1.0,1.0,53/337,19.43%,C3;TLR2;B2M;TIMP2;ADGRE5;IMPDH1;ATP8B4;PRDX4;ARHGAP9;CTSC;TMC6;HLA-C;PLD1;CEACAM1;BST2;CD44;CLEC12A;CHI3L1;IRAG2;CTSS;MMP25;PYGL;HLA-B;SYK;CD55;RHOF;TMBIM1;PSMC3;CTSZ;MVP;CD63;SLC11A1;CLEC5A;GPI;PRKCD;CAPN1;FRMPD3;ANXA2;PFKL;VCL;PGAM1;ENPP4;COTL1;SLC15A4;CTSA;HRNR;HEBP2;LRRC7;PGRMC1;PTGES2;CD36;FLG2;PLAUR
prerank,CellMarker_Augmented_2021__Astrocyte:Embryonic Prefrontal Cortex,-0.28627200287172955,-0.7396577343130912,0.989247311827957,1.0,1.0,25/317,11.04%,CD24;EFNA1;TAGLN3;TMSB10;B2M;IFITM3;PDPN;HLA-A;RAMP3;TP53I3;BEX1;HLA-C;THBS3;ELAVL4;TIMP1;GFAP;RIT2;DBI;ELN;SYT1;CDC42EP1;MLLT11;CD9;ALPL;HLA-B
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,-0.38099650485889625,-0.7395218608465235,0.7903225806451613,1.0,1.0,3/16,12.77%,RPS27A;RPA3;UBC
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.3969414974017078,-0.7389552645643194,0.796875,1.0,1.0,4/15,17.95%,CEMIP;CD44;HYAL1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.26341761064189795,0.7389322887648231,1.0,1.0,1.0,10/65,17.84%,HSPA1A;AR;HSF1;WASHC2C;TFIP11;WASL;PRKD1;EP300;CARMIL2;PON1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.4963813775654017,-0.7388764648345428,0.8461538461538461,1.0,1.0,5/7,29.59%,MVK;IDI1;DHDDS;HMGCR;MVD
prerank,Reactome_2022__Na+/Cl- Dependent Neurotransmitter Transporters R-HSA-442660,0.40573433497916617,0.7387087436392327,0.8235294117647058,1.0,1.0,1/11,0.41%,SLC6A13
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,-0.3596233462983603,-0.7386363390106069,0.8955223880597015,1.0,1.0,5/34,12.77%,RPS27A;NOD1;TNIP2;IFIH1;UBC
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.4518858157430112,-0.7385899808728194,0.7903225806451613,1.0,1.0,2/8,18.13%,OGG1;TINF2
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.41044270571828056,-0.7384531644807104,0.8245614035087719,1.0,1.0,1/13,2.77%,PROX1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.3573662510127658,0.7384052653823863,0.7560975609756098,1.0,1.0,2/18,5.13%,SOX8;SOX9
prerank,Reactome_2022__Metabolism Of Lipids R-HSA-556833,-0.2762087433078762,-0.738313751438156,0.9897959183673469,1.0,1.0,46/586,13.02%,GGT5;AWAT1;DHCR24;AGPAT4;FABP3;DGAT2L6;PLAAT4;MTMR7;ALOX12;SLC51A;PLB1;GC;ACOT1;INPP5D;VAC14;ARHGAP9;B4GALNT1;AKR1C1;UGT8;ACOT4;CYP1B1;SBF1;ACSL5;FA2H;SGPP2;DBI;DDHD2;PLD2;PLEKHA4;HSD17B14;HELZ2;CYP4F22;LPCAT4;ACHE;BMX;LIPI;LIPE;LIPH;CYP21A2;OLAH;SLC44A3;PITPNM2;ACOT2;SQLE;PPARGC1B;CYP3A4
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Undefined,-0.3974455518715931,-0.7383136914903288,0.8032786885245902,1.0,1.0,3/14,5.68%,ITGA2;ITGA5;THY1
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.48743369385711555,-0.738183774829984,0.8076923076923077,1.0,1.0,1/5,13.64%,SLC38A1
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.388427149553337,0.7371534237674144,0.7894736842105263,1.0,1.0,2/13,2.56%,PLD6;TEX15
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.30003224055835026,0.7371425080769126,0.9310344827586207,1.0,1.0,8/34,22.90%,QRICH2;CSNK2A1;CSNK2A2;EIF3H;FHIT;CCAR2;N4BP1;PDCL3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3643268720239129,-0.7370710348379842,0.8484848484848485,1.0,1.0,5/23,21.03%,RPS27A;UBC;RBX1;COPS5;CETN2
prerank,Reactome_2022__M Phase R-HSA-68886,-0.28369605283349464,-0.7369471998047009,1.0,1.0,1.0,26/306,13.76%,CCNB2;ERCC6L;TUBB6;RPS27A;VRK2;RPS27;CENPH;PSMB9;CENPE;ANAPC11;MZT2B;ZWILCH;LMNB1;NUF2;NCAPD3;SPC24;CCNB1;PSMB6;DCTN1;KIF2C;PSMC3;HAUS7;CEP76;UBC;CENPN;CENPU
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.34388687007013563,0.7366852657441763,0.9629629629629629,1.0,1.0,4/25,11.56%,AGER;ADCY1;EIF2AK4;CYP46A1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.3280275520057758,0.7363696552352155,0.8918918918918919,1.0,1.0,7/27,16.85%,MCU;GLUD1;CRH;DRD2;UCN;SLC30A8;BAD
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.43585855113491384,0.7362521208312977,0.8571428571428571,1.0,1.0,2/7,9.17%,SRI;ATP1A2
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,-0.36302265581637455,-0.7360492726753969,0.8153846153846154,1.0,1.0,2/27,6.29%,BLM;BRCA1
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.36302265581637455,-0.7360492726753969,0.8153846153846154,1.0,1.0,2/27,6.29%,BLM;BRCA1
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,0.3548659306740058,0.7359718937228008,0.84375,1.0,1.0,5/19,19.75%,YES1;ZNF521;HEY1;GLI3;HEY2
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.44708194084091335,-0.7357611412158438,0.796875,1.0,1.0,2/10,6.56%,SH3GL2;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.43213353084602124,-0.735747549418791,0.8125,1.0,1.0,2/13,6.56%,BRCA1;CEACAM1
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,0.3346681048204154,0.7356820223458846,0.8780487804878049,1.0,1.0,2/26,2.94%,NCSTN;CNTN1
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.49928831661070483,-0.7355354967337193,0.8095238095238095,1.0,1.0,2/6,25.06%,BDNF;FYN
prerank,CellMarker_Augmented_2021__GABAergic neuron:Undefined,-0.4711231756871986,-0.7354746575247219,0.7758620689655172,1.0,1.0,3/5,19.43%,GAD1;GAD2;GABBR2
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Myeloid Cells R-HSA-8939246,0.45495660951629713,0.7354614307206233,0.8541666666666666,1.0,1.0,1/6,3.97%,RUNX1
prerank,KEGG_2021_Human__Acute myeloid leukemia,-0.3347453357834884,-0.7354438099697296,0.8888888888888888,1.0,1.0,1/58,0.11%,LEF1
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.3465721714090701,0.7354414925853957,0.78125,1.0,1.0,3/19,10.84%,ZDHHC11;APOBEC3F;EIF2AK4
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.4268335110048847,-0.7354225853851052,0.7941176470588235,1.0,1.0,1/10,16.59%,CLN3
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,0.260601768384485,0.7353879640856351,1.0,1.0,1.0,21/74,22.77%,COX18;NDUFB1;TACO1;NDUFAF3;NDUFAF4;NDUFAF2;LRPPRC;ETFDH;COX19;NDUFV3;NDUFA8;TIMMDC1;COX7A2L;UQCRC2;NDUFS1;NDUFV1;NDUFAF7;NDUFB4;NDUFAF5;CCNI;SDHB
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.3155398673356414,-0.7353519359957148,0.948051948051948,1.0,1.0,9/73,14.76%,MX1;RPS27A;IFIT1;STAT1;ISG15;UBC;KPNA7;HERC5;PDZD2
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.37413162787833676,-0.7350518172786624,0.875,1.0,1.0,3/20,6.99%,DOK1;PTK6;HAP1
prerank,Reactome_2022__Transport Of Nucleotide Sugars R-HSA-727802,0.45138414706856933,0.7349732974548027,0.8857142857142857,1.0,1.0,5/8,42.47%,SLC35B3;SLC35D1;SLC35D2;SLC35A2;SLC35B4
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,-0.3222149240622557,-0.7348859578298795,0.9518072289156626,1.0,1.0,17/88,18.13%,PIF1;BLM;CENPH;MIS18A;POLR2I;RPA3;CENPN;CENPU;NOP10;ANKRD28;CDK2;OIP5;LRIG1;POLD1;CENPP;CHTF18;TINF2
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.2578309241886196,0.7348779667417007,0.9166666666666666,1.0,1.0,12/128,6.69%,RTRAF;SPRED1;MEN1;DUSP19;GSKIP;OCLN;PPP1R15B;FBLN1;GREM1;TRIB3;TESK1;AKT1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.4299874602709064,-0.7346997433578519,0.82,1.0,1.0,4/8,24.14%,BLVRB;ABCC1;ABCG2;HMOX1
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.4299874602709064,-0.7346997433578519,0.82,1.0,1.0,4/8,24.14%,BLVRB;ABCC1;ABCG2;HMOX1
prerank,KEGG_2021_Human__Measles,-0.3034895882684116,-0.7345549965658045,0.9506172839506173,1.0,1.0,14/93,15.96%,TLR2;MX1;IL12A;CCND1;STAT1;IRF7;CCNE2;IFIH1;FADD;FOS;PIK3CB;PIK3CD;CDK2;CCND2
prerank,CellMarker_Augmented_2021__Neuronal Progenitor cell:Undefined,-0.3165412691663174,-0.7342647458479433,0.9253731343283582,1.0,1.0,12/94,9.78%,TAGLN3;SNCB;SH3GL2;ZDHHC22;SLITRK1;ATRNL1;SYT4;MAP1B;EFNB3;GAP43;SYT1;PLPPR5
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.32847362631737614,0.733976377951045,0.8787878787878788,1.0,1.0,4/20,16.77%,ELOVL6;ELOVL2;HACD2;ACSL3
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,0.35065469281728345,0.7336373650922232,0.8461538461538461,1.0,1.0,9/22,32.95%,EIF4E;SLC38A9;EIF4EBP1;RPS6KB1;LAMTOR3;RPTOR;RHEB;MTOR;MLST8
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.2916386643553463,-0.7334309149750922,0.9176470588235294,1.0,1.0,12/158,12.09%,THBS1;DUSP1;APLNR;IFI35;NLRP12;CAV3;STAT1;PIK3IP1;DAB2IP;PINK1;BCL2L2;CARD19
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.363132749454236,-0.7334051912134316,0.8360655737704918,1.0,1.0,1/24,2.23%,RPS27A
prerank,Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941,-0.4023962501650248,-0.7332158551822199,0.8135593220338984,1.0,1.0,5/13,28.66%,STAT6;DDX41;NLRC3;MRE11;CGAS
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),-0.4650024332823587,-0.7330464564477749,0.7678571428571429,1.0,1.0,3/5,22.76%,SLIT3;SH2B3;SLIT2
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.32609629444112004,-0.7328109651650813,0.8734177215189873,1.0,1.0,8/53,18.19%,RIT2;LRPAP1;CALY;FLOT1;GPC3;ARFGAP1;TSC2;MCTP1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.4484619131281941,0.7327592395467034,0.7567567567567568,1.0,1.0,1/5,10.13%,NRXN1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.4484619131281941,0.7327592395467034,0.7567567567567568,1.0,1.0,1/5,10.13%,NRXN1
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,0.35757960837844494,0.7327384103162019,0.7142857142857143,1.0,1.0,2/16,11.18%,AIFM2;TP53BP2
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",-0.2733015102260198,-0.7325354157404771,1.0,1.0,1.0,52/423,17.67%,CCNB2;TYMS;ERCC6L;CDKN2A;TUBB6;RPS27A;VRK2;RPS27;CENPH;POLE3;PTK6;CCND1;PSMB9;CENPE;ANAPC11;MZT2B;GINS2;ZWILCH;FBXL18;LMNB1;NUF2;POLE4;NCAPD3;RPA3;SPC24;CCNB1;PSMB6;DCTN1;FOXM1;KIF2C;PSMC3;CCNE2;HAUS7;CEP76;UBC;CENPN;CENPU;UBE2S;PSMA8;CDK2;CCND2;MAX;PSMA7;CDC7;EMD;WEE1;LRIG1;PRKCB;POLD1;CENPP;PSME1;RBX1
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.30357538073907825,-0.7324770189302329,0.9523809523809523,1.0,1.0,13/88,17.65%,RPS27A;APP;NOD1;NLRC5;NDUFA2;KCNH8;RPS6KA1;TNIP2;UBC;FOS;USP18;ALPK1;RIPK2
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.26655714070317194,0.7324398084965742,1.0,1.0,1.0,9/106,6.89%,RGCC;LIMD1;PSMD10;NDNF;ELOC;PSMA1;PSMD11;PTGIS;PSMB5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.40774896235076485,-0.7323264189659586,0.8135593220338984,1.0,1.0,4/12,22.98%,ISG15;SYK;HSPD1;STAT3
prerank,CellMarker_Augmented_2021__Macrophage:Intervertebral Disc,-0.36876552368193544,-0.7322583257076085,0.8769230769230769,1.0,1.0,7/26,10.15%,MYO1F;SLA;SIGLEC1;HLA-DRA;IGSF6;CLEC12A;CTSS
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.41106146377542085,-0.7321322334462866,0.8431372549019608,1.0,1.0,2/11,7.96%,PROX1;ZFPM1
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.4794045436231473,0.731653491149919,0.8181818181818182,1.0,1.0,2/5,12.67%,AKT1;SIRPA
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.26989218927144965,0.7315689266532771,1.0,1.0,1.0,15/106,13.78%,H2BC18;PSMD10;PSMA1;H2BC21;PSMD11;SOX9;ANP32B;PSMB5;ERCC2;PSMD14;ORC5;ERCC3;GTF2H5;GTF2H2;PSMD12
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.3057815330499221,0.7314425691603443,0.84,1.0,1.0,6/46,8.86%,BMP2;MEN1;TRIB3;RALB;STK4;CAPRIN2
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,0.26247444138267123,0.7312946181904535,1.0,1.0,1.0,9/73,14.81%,HAUS1;CSNK1E;CEP290;CEP152;PLK1;PCM1;ALMS1;CEP192;TUBG1
prerank,CellMarker_Augmented_2021__Goblet cell:Large Intestine,-0.3801095881071203,-0.7311483772170608,0.8787878787878788,1.0,1.0,4/24,13.21%,BCAS1;SLC17A5;CAPN8;HLA-F
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,-0.3096839037452696,-0.7311421507416387,0.9634146341463414,1.0,1.0,28/112,23.90%,DHCR24;SLC51A;GC;AKR1C1;HSD17B14;HELZ2;CYP21A2;SQLE;SLC51B;SLCO1A2;MVK;FASN;ACOT8;FDPS;LRP2;INSIG1;SREBF1;MSMO1;HMGCS1;CD163L1;SH3D19;SLC27A5;HSD11B1;NFYB;SCD;IDI1;SYCP2;TBL1X
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),-0.4516804489757017,-0.7311085074524053,0.8245614035087719,1.0,1.0,1/6,11.20%,SYK
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.41290116562296897,0.7309629698907067,0.8974358974358975,1.0,1.0,4/11,20.97%,TESK1;CEP97;EVI5L;TBC1D7
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.2925534435243095,0.7308783608878888,0.9666666666666667,1.0,1.0,23/58,26.55%,CDC25A;EIF2S1;YY1;ATR;PTPRK;EIF2AK4;POLK;SMPD1;EP300;NOC2L;RHBDD1;TRIAP1;USP47;MME;N4BP1;PARP1;ZBTB1;ERCC4;CUL4B;BAK1;SDE2;INO80;USP28
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.456457455576598,0.7307762938371227,0.7857142857142857,1.0,1.0,3/6,21.21%,CACNA1S;GSTM2;RYR1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.456457455576598,0.7307762938371227,0.7857142857142857,1.0,1.0,3/6,21.21%,CACNA1S;GSTM2;RYR1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.3345132593585456,0.7307434800517173,0.8461538461538461,1.0,1.0,7/25,20.27%,ABHD17A;ABHD17B;ABHD17C;ARHGAP44;ABI2;PDLIM5;LZTS3
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.27478459610180717,-0.7305170677889958,0.9789473684210527,1.0,1.0,52/335,19.43%,C3;TLR2;B2M;TIMP2;ADGRE5;IMPDH1;ATP8B4;PRDX4;ARHGAP9;CTSC;TMC6;HLA-C;PLD1;CEACAM1;BST2;CD44;CLEC12A;CHI3L1;IRAG2;CTSS;MMP25;PYGL;HLA-B;CD55;RHOF;TMBIM1;PSMC3;CTSZ;MVP;CD63;SLC11A1;CLEC5A;GPI;PRKCD;CAPN1;FRMPD3;ANXA2;PFKL;VCL;PGAM1;ENPP4;COTL1;SLC15A4;CTSA;HRNR;HEBP2;LRRC7;PGRMC1;PTGES2;CD36;FLG2;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.4317382637596515,-0.7304023135888464,0.859375,1.0,1.0,2/9,21.16%,CDC7;STOML2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.3280044337669262,-0.73039915920422,0.8405797101449275,1.0,1.0,12/57,17.25%,APLNR;PROX1;HTR2B;EGF;WNT5A;VIP;EGFL7;NR4A1;APLN;PIK3CD;F3;TEK
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.35757235445743596,-0.7301214950334995,0.8378378378378378,1.0,1.0,12/31,20.30%,GRIN2D;GRIN2A;GABRE;INSYN2A;GRIN2B;GRID2;GABRG2;GABRA1;GLRA1;GABRA6;GABRG3;GABRA3
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.35538512953930235,0.7300168367588852,0.8378378378378378,1.0,1.0,2/16,6.09%,PDK4;ZNF304
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.2739978455943631,-0.7300157148482302,0.968421052631579,1.0,1.0,52/338,19.43%,C3;TLR2;B2M;TIMP2;ADGRE5;IMPDH1;ATP8B4;PRDX4;ARHGAP9;CTSC;TMC6;HLA-C;PLD1;CEACAM1;BST2;CD44;CLEC12A;CHI3L1;IRAG2;CTSS;MMP25;PYGL;HLA-B;CD55;RHOF;TMBIM1;PSMC3;CTSZ;MVP;CD63;SLC11A1;CLEC5A;GPI;PRKCD;CAPN1;FRMPD3;ANXA2;PFKL;VCL;PGAM1;ENPP4;COTL1;SLC15A4;CTSA;HRNR;HEBP2;LRRC7;PGRMC1;PTGES2;CD36;FLG2;PLAUR
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.3936918700650638,-0.7299195668399115,0.90625,1.0,1.0,5/16,20.40%,MYH11;MYLK3;FHOD3;PDGFRA;CXADR
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.3859495790534826,-0.7296898621322815,0.8333333333333334,1.0,1.0,1/11,6.29%,BRCA1
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.3125403285481049,-0.72919109606795,0.9473684210526315,1.0,1.0,12/69,17.44%,RPS27A;PSMB9;ANAPC11;CCNB1;PSMB6;PSMC3;UBC;UBE2S;PSMA8;CDK2;PSMA7;PSME1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.3395990523402953,-0.7290135461678658,0.8933333333333333,1.0,1.0,7/29,13.52%,ICAM1;TENM4;IGSF21;IL1RAPL1;SELP;GRID2;NLGN1
prerank,Reactome_2022__Bicarbonate Transporters R-HSA-425381,-0.4352331646518072,-0.7288270175662767,0.7704918032786885,1.0,1.0,3/8,15.00%,SLC4A9;SLC4A2;SLC4A10
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.4184477892485505,0.7285715750307596,0.8108108108108109,1.0,1.0,1/8,7.32%,MID1IP1
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.44725085171706014,-0.7285393464494869,0.8070175438596491,1.0,1.0,3/9,24.11%,FLOT1;EHD1;CAMK1
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,0.3212064409484155,0.72831137412923,0.9375,1.0,1.0,4/31,10.74%,ELOVL6;ELOVL4;ELOVL2;HACD2
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.33368205176598337,0.7282818018862298,0.8809523809523809,1.0,1.0,2/22,3.13%,CHRNA4;KCNA2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.3678711311272424,0.7282715833172521,0.8421052631578947,1.0,1.0,4/15,24.54%,SPRED1;SPRED2;SMAD7;SIRT2
prerank,Reactome_2022__Nef Mediated CD4 Down-regulation R-HSA-167590,0.45549692140897113,0.7280973649965203,0.8292682926829268,1.0,1.0,1/7,8.89%,AP2B1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex3:Brain,-0.2997358253761768,-0.7280948704494736,0.9625,1.0,1.0,28/101,19.86%,PCSK2;SLC24A2;TRPC3;SRRM4;GRIA1;ZNF385D;XKR4;ZNF536;CA10;DOK6;GABRB2;VWC2;SCN1A;STMN4;SYNPR;SCN3B;GRID2;TMEM132C;SLITRK5;CNTN2;RAB3C;GABRA1;RYR2;FGF12;CELF4;PTCHD1;CNTN4;PTPN5
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.3357506097718461,-0.7280122387428584,0.8918918918918919,1.0,1.0,9/50,18.62%,FOSB;KCNH8;SRF;RPS6KA1;SH3GL3;FOS;F3;CDK5;TF
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,0.28408261180490796,0.727986350413222,0.96,1.0,1.0,6/51,9.82%,ELOVL6;ACACB;PMVK;NFYC;CHD9;INSIG2
prerank,Reactome_2022__Hyaluronan Uptake And Degradation R-HSA-2160916,0.39430943149986625,0.7279587918815636,0.7631578947368421,1.0,1.0,1/9,2.46%,HMMR
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.3806254928185605,-0.7274228984625136,0.8545454545454545,1.0,1.0,5/18,22.79%,PARP9;NAMPT;NNMT;NMNAT3;QPRT
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.3863235943439912,-0.7271944897769419,0.828125,1.0,1.0,1/19,2.77%,PROX1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.3602792473187188,0.727186012181176,0.8529411764705882,1.0,1.0,4/17,25.72%,RNF2;UBE2A;RNF168;CUL4B
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.41925223623047786,-0.7271841221375641,0.847457627118644,1.0,1.0,4/13,18.45%,DAB2IP;DDRGK1;HSPA5;COPS5
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.38579829603475363,0.727161052134007,0.8372093023255814,1.0,1.0,1/11,2.88%,SERPINF2
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.3015636436003127,0.7271361354159844,0.8235294117647058,1.0,1.0,17/62,24.38%,ERCC8;UBE2T;RNF146;RNF141;SH3RF1;RNF11;MARCHF7;KLHL24;TRIM52;CNOT4;UBE3D;MDM2;RNF208;UBE2A;ITCH;MARCHF5;RNF13
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,0.28321013681556806,0.7269493576534447,0.9545454545454546,1.0,1.0,17/47,25.55%,NAPSA;AP3S1;AP1B1;AP1S3;HOMER2;AP3B1;TBC1D8B;SNX5;PICALM;FTL;PIK3C2A;BLOC1S4;ACBD3;SNX2;AP1M1;ARRB1;SORT1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.34533730843622357,0.7268554309608821,0.8387096774193549,1.0,1.0,1/16,0.89%,CFAP53
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.4611787930848322,-0.7267688550613337,0.7894736842105263,1.0,1.0,4/6,39.85%,RTN4RL1;INPP5F;CERS2;PTPRS
prerank,Reactome_2022__Neurofascin Interactions R-HSA-447043,-0.4676677637086164,-0.7259660340165927,0.8333333333333334,1.0,1.0,1/7,3.07%,CNTNAP1
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.42254970915675716,0.7258144918772456,0.7619047619047619,1.0,1.0,1/8,5.99%,ABCD1
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.33845159867180147,0.7257905637006473,0.8275862068965517,1.0,1.0,3/15,15.95%,GIT1;CBFA2T3;EP300
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.2970529380110838,0.7257156110375931,1.0,1.0,1.0,5/48,6.69%,GNL3L;HSPA1A;TNFAIP3;BAG2;AKT1
prerank,Reactome_2022__Innate Immune System R-HSA-168249,-0.2677488758842455,-0.7256840190119369,0.9896907216494846,1.0,1.0,111/692,19.27%,RASGRP1;C3;C1R;RASGRP2;TLR2;B2M;RPS27A;TIMP2;HLA-A;ADGRE5;ATP8B4;PRDX4;ARHGAP9;PRDX5;APP;CTSC;TMC6;NOD1;AKR1C1;NLRC5;HLA-C;NDUFA2;KCNH8;CEACAM1;TLR3;BST2;GLYAT;CD44;ITPR3;PSMB9;CLEC12A;BAIAP2;CHI3L1;WAS;RPS6KA1;IRAG2;PLD2;IRF7;PLPP4;CTSS;ISG15;PSMB6;PYGL;BIRC3;HLA-B;PRKCQ;SYK;CD55;HLA-E;RHOF;TMBIM1;PSMC3;MYH9;TNIP2;SIGIRR;CTSZ;MAP3K14;CFH;MYO1E;IFIH1;ELMO1;UBC;FADD;CD63;RNASE1;TSPAN32;SLC11A1;HERC5;CLEC5A;FOS;C1S;EGFL7;PDZD2;PIK3CB;SERPING1;PSMA8;DLC1;VAV1;PRKCD;ATOX1;CAPN1;PSMA7;FRMPD3;DEFB109B;MUC6;ANXA2;STAT6;USP18;PFKL;VCL;PSME1;ALPK1;ENPP4;RIPK2;COTL1;CARD11;SLC15A4;CTSA;HRNR;GSDME;HEBP2;LRRC7;PGRMC1;DDX41;CD4;PTGES2;NLRC3;MUCL1;PSTPIP1;CD36;FLG2
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.3522191112121639,-0.725307201230201,0.9012345679012346,1.0,1.0,3/37,9.14%,LDLR;PRKCG;PFDN6
prerank,CellMarker_Augmented_2021__Primitive Streak cell:Primitive Streak,-0.34036387043417954,-0.7248372493484789,0.8767123287671232,1.0,1.0,8/52,10.54%,PIF1;ZNF114;GJC1;RND2;DRAXIN;GINS2;CHRNA5;SPC24
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.4708063398767689,0.7247539581385245,0.8627450980392157,1.0,1.0,2/6,5.81%,ABCB10;SLC25A37
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.44568069182885317,0.72461684584759,0.8125,1.0,1.0,2/7,18.68%,EGFR;MAP2K2
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,0.29827397093705876,0.7245681038093019,0.9354838709677419,1.0,1.0,11/42,19.94%,NCSTN;MAML3;KAT2B;EGFR;PBX1;HEYL;KAT2A;EP300;HEY1;HEY2;HES5
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),-0.4706294594016801,-0.7243902189979181,0.8301886792452831,1.0,1.0,1/6,4.75%,SULF1
prerank,Reactome_2022__GRB2 Events In EGFR Signaling R-HSA-179812,0.4285105383016603,0.7243038119578658,0.8125,1.0,1.0,2/7,5.64%,NRAS;EGFR
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.29619371285395407,0.724179144519759,0.9655172413793104,1.0,1.0,10/38,18.69%,MYO10;TENM1;ARAP1;RALA;GPM6A;TENM2;WASL;PIK3R1;ARHGAP44;FXR2
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.35876575142841743,0.7240550943128687,0.9090909090909091,1.0,1.0,2/17,6.13%,MYBPC1;TCAP
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.35876575142841743,0.7240550943128687,0.9090909090909091,1.0,1.0,2/17,6.13%,MYBPC1;TCAP
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.3025432265935166,-0.7240364966607712,0.9634146341463414,1.0,1.0,7/77,11.88%,PSRC1;KIF14;RAB11A;CENPE;NCAPD3;CCNB1;KIF2C
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.3682616851411895,-0.7234079504558938,0.8484848484848485,1.0,1.0,8/32,18.75%,NLRC5;ISG15;SUSD4;SERPING1;USP18;NMI;A2M;NLRC3
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.43511925417897335,-0.723301563103338,0.8059701492537313,1.0,1.0,1/8,6.08%,DYSF
prerank,Reactome_2022__Vitamin C (Ascorbate) Metabolism R-HSA-196836,-0.46439951031144605,-0.7232133508696736,0.7878787878787878,1.0,1.0,3/6,27.47%,GSTO1;CYB5R3;SLC2A3
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.3235440795182722,-0.7230324424644046,0.9333333333333333,1.0,1.0,12/65,15.59%,RPS27A;ARHGEF3;PLEKHG2;ARHGEF38;ARHGEF17;ARHGEF18;OBSCN;UBC;RNASE1;VAV1;APH1A;RASGRF2
prerank,Reactome_2022__TNF Signaling R-HSA-75893,-0.332798499765529,-0.7229866298552783,0.9264705882352942,1.0,1.0,5/42,13.19%,RPS27A;BIRC3;UBC;FADD;TNFRSF1A
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.4660520023728398,0.7229454133690674,0.8666666666666667,1.0,1.0,2/6,3.54%,PPARGC1A;ADIPOR1
prerank,Reactome_2022__PKA-mediated Phosphorylation Of CREB R-HSA-111931,-0.38366753176598273,-0.7227917081524059,0.890625,1.0,1.0,3/17,17.15%,ADCY7;ADCY5;ADCY8
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,-0.33244892259815073,-0.7226737985015468,0.8,1.0,1.0,11/46,19.54%,CSPG4;NDST4;HS3ST3A1;BGN;GPC3;B4GALT7;HS3ST3B1;HS6ST1;GPC1;AGRN;IDUA
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.39664711134191083,-0.722318944868438,0.803030303030303,1.0,1.0,1/15,2.20%,ZFP36
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.3568812516101944,-0.7222112020221123,0.8356164383561644,1.0,1.0,2/23,5.98%,ATF3;CCL2
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,-0.2712091089089255,-0.7221049505500813,0.9791666666666666,1.0,1.0,50/329,18.63%,C3;TLR2;B2M;TIMP2;HLA-A;ADGRE5;ATP8B4;PRDX4;ARHGAP9;PRDX5;CTSC;TMC6;HLA-C;NDUFA2;CEACAM1;BST2;GLYAT;CD44;CLEC12A;CHI3L1;IRAG2;CTSS;PYGL;HLA-B;CD55;RHOF;TMBIM1;PSMC3;CTSZ;CD63;RNASE1;SLC11A1;CLEC5A;EGFL7;DLC1;PRKCD;CAPN1;FRMPD3;ANXA2;PFKL;VCL;ENPP4;COTL1;SLC15A4;CTSA;HRNR;HEBP2;LRRC7;PGRMC1;PTGES2
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.3329409362500635,0.7221043772484498,0.9259259259259259,1.0,1.0,4/30,9.29%,CFAP53;ODAD3;FOXJ1;STIL
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,0.3407671538525503,0.7220769345190244,0.7878787878787878,1.0,1.0,6/18,17.60%,PPEF1;GUCA1B;NMT2;METAP1;CAMKMT;GNGT1
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,0.3006083901949496,0.7218950707295925,0.7391304347826086,1.0,1.0,5/34,11.84%,CCT7;COPS2;HNRNPC;TWF1;CPSF7
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.44134781836923676,0.7217589499671624,0.8604651162790697,1.0,1.0,1/5,12.58%,ACVR2A
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,0.26342510715110323,0.7215674409127941,1.0,1.0,1.0,9/73,14.81%,HAUS1;CSNK1E;CEP290;CEP152;PLK1;PCM1;ALMS1;CEP192;TUBG1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.3060108121996609,-0.7215075423903312,0.9647058823529412,1.0,1.0,9/107,11.12%,SCN1B;STMN2;SLITRK1;PTK6;RIT2;IL1RAPL1;PLPPR5;WNT5A;DAB2IP
prerank,Reactome_2022__RHO GTPases Activate KTN1 R-HSA-5625970,-0.4448104622929716,-0.7212906452239335,0.8333333333333334,1.0,1.0,1/10,12.88%,RNASE1
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,-0.37086826978599846,-0.7210318590971507,0.8783783783783784,1.0,1.0,7/23,20.15%,NDUFA2;UNC5B;FADD;FASN;DAPK3;TNFRSF10A;CASP8
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.319727639194052,-0.7207806718154975,0.8947368421052632,1.0,1.0,6/57,10.55%,PSRC1;PROX1;APP;PTK6;CCND1;CCNB1
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.2966952914392314,-0.7206504055809805,0.9176470588235294,1.0,1.0,12/84,17.65%,RPS27A;APP;NOD1;NLRC5;KCNH8;RPS6KA1;TNIP2;UBC;FOS;USP18;ALPK1;RIPK2
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.37963765260678706,0.7206500389119239,0.7931034482758621,1.0,1.0,8/17,24.87%,TRAK2;MUL1;MARK2;MSTO1;MARK1;ZBED3;NECTIN2;MFN2
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.3256011483004344,0.7206075897805246,0.8378378378378378,1.0,1.0,6/27,9.38%,SOX8;SOX9;NCOA4;AR;SALL1;MSH2
prerank,KEGG_2021_Human__Renin secretion,-0.3132540974214397,-0.7205669660652021,0.8933333333333333,1.0,1.0,12/46,21.56%,KCNJ2;ITPR3;PPP3CC;CLCA4;CACNA1C;ADCY5;GUCY1A1;AQP1;PDE1C;PDE1A;ITPR1;CALM3
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.28881827303988317,0.7205150813447309,0.9310344827586207,1.0,1.0,3/27,12.58%,BMP2;GPM6B;ACVR2A
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.466136989913975,-0.7200984469907764,0.7924528301886793,1.0,1.0,3/5,37.29%,DPM3;DPY19L1;DPY19L2
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.466136989913975,-0.7200984469907764,0.7924528301886793,1.0,1.0,3/5,37.29%,DPM3;DPY19L1;DPY19L2
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.39833742929605026,-0.7198821535387457,0.8484848484848485,1.0,1.0,3/18,12.77%,RPS27A;EGF;UBC
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.4141120151165142,-0.7197354765374456,0.8301886792452831,1.0,1.0,1/9,12.53%,SEC11C
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.4420555873620776,-0.7196716856741426,0.7777777777777778,1.0,1.0,1/6,16.44%,CDC7
prerank,CellMarker_Augmented_2021__Endothelial cell:Bone Marrow,-0.42517033846231134,-0.7195669188578855,0.819672131147541,1.0,1.0,4/10,17.25%,S1PR3;SELP;MCAM;TEK
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.37257560243735327,0.719509185962384,0.8918918918918919,1.0,1.0,10/17,36.93%,PPP1R1B;STYXL1;PPP4R4;ROCK2;MASTL;CRY2;PTPA;ROCK1;IKBKB;GSK3B
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.4064190949845712,-0.7194066320577657,0.8833333333333333,1.0,1.0,2/13,12.23%,CAV3;SLC43A2
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.35037352332722527,0.7193558820890068,0.8913043478260869,1.0,1.0,4/16,21.45%,MITF;MED30;MED4;SUB1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.46114701486255405,0.7193293382887038,0.7954545454545454,1.0,1.0,2/5,12.50%,HMGB1;FBXO38
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.3761368775306607,-0.719321082027859,0.8518518518518519,1.0,1.0,4/18,12.60%,CAV3;C12ORF57;SLC8A3;NOS1
prerank,Reactome_2022__Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,-0.39353688840676826,-0.7183807016610905,0.8412698412698413,1.0,1.0,3/15,13.16%,PDHX;PDK3;LDHD
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),0.46342213775483865,0.7183465124360341,0.8918918918918919,1.0,1.0,1/6,0.44%,WNT7A
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.2961097986224778,-0.7181905210618398,0.9647058823529412,1.0,1.0,14/93,17.65%,RPS27A;APP;NOD1;NLRC5;NDUFA2;KCNH8;RPS6KA1;IRF7;TNIP2;UBC;FOS;USP18;ALPK1;RIPK2
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.3529371866414801,-0.718182658347212,0.9027777777777778,1.0,1.0,4/30,18.14%,PLEKHG2;PFN2;COTL1;MAPT
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.4078632599662215,-0.7175132816450805,0.8888888888888888,1.0,1.0,3/15,11.93%,GPR183;SNX10;SBNO2
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.3883577026303887,-0.717438671866567,0.8484848484848485,1.0,1.0,4/12,23.13%,USP50;PML;ETS1;WRAP53
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,-0.39805513564724615,-0.7173310075089314,0.8688524590163934,1.0,1.0,3/15,9.05%,KLF4;GADD45A;BTG1
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.32422256202748617,-0.7173019162799504,0.927536231884058,1.0,1.0,5/56,6.56%,WARS1;CAMK2N2;THY1;CAV3;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.33399543446800384,0.7169401493252355,0.7894736842105263,1.0,1.0,6/19,21.18%,SRI;ATP1A2;DRD2;GSTM2;GPR35;PKD2
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.4003338671368492,0.7169306217069289,0.8536585365853658,1.0,1.0,2/8,12.04%,ZNF703;ROBO1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.3193165258885288,-0.7165593193756608,0.9027777777777778,1.0,1.0,6/46,19.49%,WNT8B;MAP1LC3A;RPL23;CLN3;GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.3205588715106315,-0.7165096204594389,0.8955223880597015,1.0,1.0,15/57,20.22%,POU4F1;KIF14;CCL2;PRKCG;MAG;UNC5B;PINK1;BDNF;NRBP2;CLN3;SNX6;VSTM2L;FOXB1;CX3CL1;SET
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.325559570965027,-0.716165845871227,0.9066666666666666,1.0,1.0,15/53,24.05%,DHCR24;ABCA5;ANGPTL3;SQLE;MVK;SOAT1;FDPS;INSIG1;MSMO1;HMGCS1;HSD17B7;ACAT2;APOL2;IDI1;LSS
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.3933278686477165,-0.7161481725563204,0.8387096774193549,1.0,1.0,1/13,6.47%,POLE3
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,-0.32051823659990025,-0.7161385389347124,0.8904109589041096,1.0,1.0,12/43,23.65%,ADCY7;ITPR3;PRKCG;ADCY5;PRKCD;ADCY8;PDE1C;PDE1A;ITPR1;GRK2;GNA14;AHCYL1
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.4432641789556054,-0.7160842834040156,0.8703703703703703,1.0,1.0,4/7,33.09%,CD4;HYAL2;PPIA;GAS6
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.4432641789556054,-0.7160842834040156,0.8703703703703703,1.0,1.0,4/7,33.09%,CD4;HYAL2;PPIA;GAS6
prerank,CellMarker_Augmented_2021__Natural Killer cell:Undefined,-0.34797997601024766,-0.7159642063122367,0.8840579710144928,1.0,1.0,3/30,4.54%,ITGA2;IL15;CD160
prerank,Reactome_2022__Reversible Hydration Of Carbon Dioxide R-HSA-1475029,0.3886152264830377,0.7158951832880267,0.7346938775510204,1.0,1.0,4/7,22.54%,CA2;CA3;CA12;CA5B
prerank,KEGG_2021_Human__Fatty acid biosynthesis,-0.395174030945881,-0.7158366137767965,0.8194444444444444,1.0,1.0,4/16,16.65%,ACSL5;OLAH;OXSM;FASN
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.3797609224700599,0.71573743392576,0.868421052631579,1.0,1.0,4/11,17.84%,KMT2A;WNK3;SGK2;PON1
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.31379532996690207,-0.7153596782234568,0.8732394366197183,1.0,1.0,12/58,18.28%,CDKN2A;RPS27A;PSMB9;PSMB6;PSMC3;CCNE2;UBC;PSMA8;CDK2;PSMA7;PSME1;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),0.44364079875739276,0.7149585535293626,0.851063829787234,1.0,1.0,1/6,31.34%,GPATCH3
prerank,Reactome_2022__PI5P Regulates TP53 Acetylation R-HSA-6811555,0.39854767759516446,0.7148437710349826,0.8275862068965517,1.0,1.0,4/9,19.32%,PIP4K2B;EP300;ING3;PIP4K2C
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.4224856412784495,0.7146814241698008,0.8333333333333334,1.0,1.0,1/7,3.40%,PDE3B
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.4424636950778225,0.7146717146488564,0.7948717948717948,1.0,1.0,1/8,5.44%,RNF2
prerank,KEGG_2021_Human__Mitophagy,-0.31524789854474095,-0.7144283131019052,0.9342105263157895,1.0,1.0,5/62,12.77%,TOMM7;RPS27A;ATG9A;PINK1;UBC
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.31044167575507225,0.7143346183884812,0.9117647058823529,1.0,1.0,7/24,14.84%,TENM1;ARAP1;RALA;GPM6A;TENM2;WASL;PIK3R1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.37861501036857753,-0.7141209552700915,0.8493150684931506,1.0,1.0,4/19,17.95%,LTBP4;EID2;ITGA3;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.40750610894860645,-0.7137728872107457,0.8548387096774194,1.0,1.0,3/14,9.24%,NLRP12;CEACAM1;IGF1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3793187519830175,-0.7137675223172866,0.8513513513513513,1.0,1.0,3/21,11.37%,CAV3;ATP1B1;KCNG1
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,-0.3812110406651114,-0.7134944097388368,0.8923076923076924,1.0,1.0,2/20,2.78%,LAMB1;ITGA2
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.41149103579383317,0.7134233223116837,0.7560975609756098,1.0,1.0,1/6,11.49%,KMT2A
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.3346568722443181,-0.7132449543087176,0.9090909090909091,1.0,1.0,3/36,13.10%,SCX;POLR2I;PAX8
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.41517258090101006,-0.7130999948145004,0.9076923076923077,1.0,1.0,3/12,23.02%,WAS;FHOD1;SLC9A1
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,-0.39507378759795475,-0.7127345496654709,0.8245614035087719,1.0,1.0,4/14,20.83%,LMNB1;CABIN1;CDKN1A;H1-4
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.4222842876972379,-0.712644859255811,0.8571428571428571,1.0,1.0,1/7,8.69%,WAS
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.3732547739601359,-0.712394395508926,0.8421052631578947,1.0,1.0,7/16,28.78%,APLN;OXTR;FOXB1;WNT3;GLI2;NRG1;TGFB3
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,0.25092075080811443,0.7122015116120152,1.0,1.0,1.0,28/126,17.40%,CCNE1;ID1;H2BC21;PHC1;RNF2;H2BC4;ANAPC1;MAPK10;EED;RBBP4;H2AC6;MAPK8;UBE2D1;H1-2;H3-3B;EP400;RPS6KA3;NFKB1;CDC26;POT1;MAP2K4;CDKN2C;ASF1A;ETS2;SCMH1;PHC3;TNIK;AGO3
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.3541848728780703,0.7121350108327721,0.8837209302325582,1.0,1.0,2/22,5.64%,LIMD1;EGFR
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.4067559316909479,-0.7121071280478222,0.8064516129032258,1.0,1.0,1/13,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.31230530527307643,-0.7120494760966769,0.8783783783783784,1.0,1.0,18/58,19.26%,ADGRE5;RAMP3;ADCY7;S1PR3;LGR5;ADCY5;GNG2;GPR12;RXFP1;CNR1;VIP;PTH1R;GLP1R;ADCY3;ADCY8;GPER1;ADM;ADGRG2
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.27853042347933904,-0.7119409013230872,1.0,1.0,1.0,42/184,23.72%,TRIM22;TLR2;RPS27A;TRIM5;APP;NOD1;BEX1;SLCO3A1;NEUROD2;SRF;WNT5A;PRKCQ;IL18;PRKCH;FLOT1;UBC;PPARGC1B;IL1RAP;DDRGK1;RELN;CD200;ADCY8;PRKCB;RIPK2;CARD11;COPS5;ALK;CD36;ARID5B;CX3CL1;CAMK1D;TRIM62;IKBKG;ADAM8;STK3;EIF2AK2;NODAL;STAT3;NFKB2;CARD14;TRIML2;IKBKE
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.44891205193734207,-0.7116630768805151,0.8813559322033898,1.0,1.0,3/7,25.01%,ATP1B1;ATP1B3;WNK4
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.28975274300822534,-0.7115178790230386,0.9655172413793104,1.0,1.0,24/140,17.95%,THBS1;MET;P2RY12;RAMP3;EGF;CHI3L1;THPO;TGFA;FGF1;PINK1;IL18;F10;FGF7;PIK3CB;VAV1;PIK3CD;F3;FGF22;TSC2;IRS2;TEK;GPER1;LRP2;TGFB1
prerank,Reactome_2022__Other Interleukin Signaling R-HSA-449836,0.37376542181480055,0.7115024634322977,0.8857142857142857,1.0,1.0,4/14,21.25%,CASP3;CSF1R;IFNLR1;PTPRZ1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.43083908816237204,-0.7114735469578921,0.8181818181818182,1.0,1.0,3/8,24.09%,RPS7;EIF5A;PTTG1IP
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,-0.33296067278828534,-0.7113985554047589,0.9333333333333333,1.0,1.0,5/46,12.78%,IL12A;IRF7;ISG15;IFIH1;FADD
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.34491871677604913,-0.7112051672606771,0.8947368421052632,1.0,1.0,4/22,18.19%,ICAM1;TNIP2;TEK;NUPR1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.3492839352446036,-0.7111169208080641,0.8493150684931506,1.0,1.0,2/35,8.19%,BLM;DONSON
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4214058258223212,-0.7110014223461647,0.847457627118644,1.0,1.0,1/11,13.60%,SLC51B
prerank,KEGG_2021_Human__Propanoate metabolism,0.30302315040846245,0.7106039452514069,0.9444444444444444,1.0,1.0,11/31,21.12%,ACACB;SUCLA2;EHHADH;ECHDC1;ACOX1;DBT;ACADS;ACSS1;BCKDHB;HIBCH;MLYCD
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.30518408253108553,-0.7105454042364502,0.9358974358974359,1.0,1.0,11/86,15.80%,WARS1;NEUROD2;FRMPD4;DAB2IP;SYK;CALY;DCTN1;FLOT1;GPC3;HYAL1;RELN
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.4298483738685877,0.7105325202701519,0.8292682926829268,1.0,1.0,2/7,14.75%,CA2;NFKB1
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,0.30708978387580743,0.7103730382306472,0.92,1.0,1.0,5/38,8.78%,ELOVL6;ACACB;PMVK;NFYC;CHD9
prerank,Reactome_2022__RUNX2 Regulates Genes Involved In Cell Migration R-HSA-8941332,-0.4352839276727736,-0.7102958135213864,0.76,1.0,1.0,2/7,12.02%,ITGA5;RUNX2
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.3614734647662322,-0.7101337741354286,0.8923076923076924,1.0,1.0,1/25,0.55%,PIF1
prerank,Reactome_2022__Phosphate Bond Hydrolysis By NTPDase Proteins R-HSA-8850843,-0.44650875853940664,-0.7100147079843717,0.8367346938775511,1.0,1.0,1/7,10.89%,ENTPD3
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.3512087795451368,0.7097331377673853,0.8181818181818182,1.0,1.0,3/19,7.61%,SRI;SELENON;JPH1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.34197878211233923,0.7097287904310053,0.8611111111111112,1.0,1.0,3/18,14.23%,KPNA2;CHMP2B;VPS37B
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.30841685735318874,0.709374253077414,0.8787878787878788,1.0,1.0,4/27,12.50%,TENM1;CEP290;PCM1;UHMK1
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,0.2731993548751095,0.7091602640861994,0.9375,1.0,1.0,11/64,14.80%,UBE2T;BCL10;H2BC4;PEX13;UBE2N;VCP;UBE2G1;UBE2D1;DERL1;TMEM129;PEX2
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.33366364667689036,-0.7084960540618139,0.890625,1.0,1.0,3/40,7.35%,RASGRP1;CD44;LFNG
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.3346188807010352,-0.7084621515756467,0.9,1.0,1.0,1/30,1.88%,MAEL
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.38477080154853777,-0.7083987994189559,0.8688524590163934,1.0,1.0,2/13,20.22%,RPL23;SET
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,-0.3624050969925251,-0.708046605372118,0.9041095890410958,1.0,1.0,1/22,2.71%,RHOBTB2
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.38485059677566114,-0.7079438030225277,0.8688524590163934,1.0,1.0,6/17,24.63%,ITPR3;PRKCD;PRKCB;ITPR1;AHCYL1;SPHK1
prerank,Reactome_2022__Receptor Mediated Mitophagy R-HSA-8934903,0.40148350539381616,0.7078706933967671,0.8333333333333334,1.0,1.0,2/9,11.76%,CSNK2A2;PGAM5
prerank,Reactome_2022__Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,-0.37052912015100836,-0.7077959431185197,0.8833333333333333,1.0,1.0,2/21,6.29%,BLM;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.3660835587172383,0.707735192441269,0.8181818181818182,1.0,1.0,2/9,15.53%,CAPRIN2;CAPRIN1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.27505246515839465,0.7076013102161535,1.0,1.0,1.0,28/121,17.32%,FEZF2;ASCL1;AMER2;ADGRA1;FUT9;POU3F2;SNAP91;ADGRB3;GRIA2;NOVA1;FAT3;STIM2;UNC79;NRXN1;CADM2;GPM6B;ANK2;SOX5;ROBO1;ELAVL3;NDRG4;SLC35F1;GRM3;PURG;KIF1B;RBFOX1;CACNA1B;ABI2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3154359345265952,-0.7073696617231147,0.9583333333333334,1.0,1.0,6/58,12.44%,PODXL;FSCN1;PLD1;GAP43;WAS;DMTN
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.43788628671147367,-0.7071106575849975,0.8596491228070176,1.0,1.0,2/6,22.62%,FLOT1;EHD1
prerank,Reactome_2022__RHO GTPases Activate Rhotekin And Rhophilins R-HSA-5666185,-0.39231489972954087,-0.707104091761121,0.7777777777777778,1.0,1.0,2/8,18.17%,RHPN1;RHPN2
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.4034479815339336,0.7070771673417211,0.8378378378378378,1.0,1.0,2/8,23.68%,TASOR;FZD5
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,0.26901039221665346,0.7070629955887202,1.0,1.0,1.0,13/77,17.32%,NRAS;TRIB3;THEM4;AKT2;AKT1;PRKACB;NCK1;MAPK12;PIK3CA;PIK3R1;NCK2;ABI1;ABI2
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.3868654825046744,0.7070358620662871,0.868421052631579,1.0,1.0,6/13,34.31%,NIPBL;NAA50;POGZ;PDS5B;DSCC1;RB1
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.4395156597922927,0.7065968585832758,0.8163265306122449,1.0,1.0,1/6,16.41%,PDZD8
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.32219070845039816,0.706284014132157,0.88,1.0,1.0,2/21,8.89%,PIK3R4;AP2B1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.26180447161760484,0.7058791161213378,0.9655172413793104,1.0,1.0,19/85,18.31%,NGF;BCL10;ACVR1C;ANP32B;VCP;HMGB1;TRADD;SLC22A2;ROBO1;EGLN3;CRADD;DAP;CFLAR;MUL1;BCL2L13;EIF2AK3;BAD;PRR7;PDCD2
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.34930207183955064,0.7058178103760372,0.8387096774193549,1.0,1.0,7/24,21.01%,BMP2;HES6;HEYL;HEY1;HEY2;HES5;PCSK5
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.37711921154499795,0.7057718257678394,0.8787878787878788,1.0,1.0,3/9,33.08%,MBNL1;MYH3;LRP6
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.43121699711634526,-0.7057703024511477,0.84375,1.0,1.0,4/10,36.78%,STK24;RTN4RL1;INPP5F;CERS2
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.3684681625923677,0.7057632725268435,0.8571428571428571,1.0,1.0,3/11,12.31%,AKT2;AKT1;EPM2AIP1
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,-0.32120112546926394,-0.7057074024911162,0.9705882352941176,1.0,1.0,6/40,14.95%,ST6GAL1;LFNG;GALNT15;GALNT10;GALNT12;GALNT17
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,-0.31108671899489365,-0.705609615184601,0.9583333333333334,1.0,1.0,5/57,10.55%,BLM;BRCA1;YWHAH;RPA3;CCNB1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.3416741962279514,0.7054434274203196,0.8285714285714286,1.0,1.0,2/18,3.66%,TNFSF13B;CD320
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.4083932120534182,0.7053243378745752,0.8205128205128205,1.0,1.0,3/6,23.65%,HDAC10;SRM;SAT1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.3422531967602444,-0.7052488945740912,0.8787878787878788,1.0,1.0,5/35,12.44%,RPS14;GATA1;ZFPM1;ATP5IF1;DMTN
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.30200113353354124,0.7051111346109724,0.9285714285714286,1.0,1.0,8/32,18.23%,ADCY1;NCOA4;AR;NR3C1;AKR1C3;TNFSF4;ADAM15;SPHK2
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.3761634000667784,0.705110533215176,0.851063829787234,1.0,1.0,1/8,6.83%,PTGIS
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.34177297232345444,-0.7046423775657875,0.9253731343283582,1.0,1.0,3/36,11.85%,PARP9;WAS;FOXM1
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.46860646589101335,-0.7045930606763386,0.8163265306122449,1.0,1.0,1/6,6.79%,SCARA3
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,-0.2969424686652953,-0.7040895968276545,0.9642857142857143,1.0,1.0,14/81,14.60%,PDE4A;RAMP3;ADCY7;GNG3;ITGA5;GIPR;ADCY5;PTRH2;GNG2;C1QTNF1;RXFP1;PTH1R;GLP1R;PTH2R
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,-0.3083298578502205,-0.7040864465507995,0.9358974358974359,1.0,1.0,6/63,12.16%,SH3GL2;APP;TPD52;AP1S1;M6PR;CTSZ
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.41105046816356267,0.7039831054206239,0.8181818181818182,1.0,1.0,3/7,26.53%,RBPJ;CCM2;STARD13
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.4394563737726278,-0.7037731746198299,0.84375,1.0,1.0,1/7,16.44%,CDC7
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.2895583758903511,0.7037279747494116,0.95,1.0,1.0,6/42,13.22%,CYP7B1;PMVK;INSIG2;CYP46A1;AKR1C3;SCP2
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.4476809237415489,-0.7037043933239091,0.9122807017543859,1.0,1.0,5/7,29.91%,AKAP6;CALM3;GSTO1;TRDN;JPH2
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,-0.3148840519199263,-0.7036031725627693,0.948051948051948,1.0,1.0,11/70,15.85%,IL12A;IRF1;ITPR3;PLK3;STAT1;PPP3CC;SYK;MAP3K14;PIK3CB;PRKCD;PIK3CD
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.4712391346618193,-0.7029647290539245,0.8076923076923077,1.0,1.0,3/5,33.52%,TRIM25;CLPB;OAS3
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,0.30148167271516263,0.7028071750801235,0.9090909090909091,1.0,1.0,4/24,17.40%,PRKRA;DROSHA;POLR2C;AGO3
prerank,CellMarker_Augmented_2021__Neural Stem cell:Inferior Colliculus,0.25048182515916795,0.7025458549436603,1.0,1.0,1.0,14/93,14.86%,PCDH19;TSPAN11;SOX21;MID1;EFS;PBX1;MEGF10;SALL1;CNTFR;ANK2;SALL3;MPDZ;NDRG4;TUBB2B
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,-0.3140231078292266,-0.7024023483747798,0.9428571428571428,1.0,1.0,12/47,23.65%,ADCY7;ITPR3;PRKCG;ADCY5;PRKCD;ADCY8;PDE1C;PDE1A;ITPR1;GRK2;GNA14;AHCYL1
prerank,CellMarker_Augmented_2021__Stem cell:Esophagus,-0.2907640449504961,-0.7023851777590212,0.95,1.0,1.0,28/99,23.17%,PLP1;THY1;MAP1B;EFNB3;SCARA3;GAP43;SHC2;LGR5;NUAK1;DAB2IP;IGFBP5;AMOTL2;CRMP1;FRAS1;CCDC3;PCDH18;PTPN21;FHOD3;DPYSL3;ANTXR1;PLPPR4;PCDHB4;EPB41L1;TCEAL7;CNN3;NACAD;SLIT2;BOC
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.42649002481893633,-0.702307735698961,0.8070175438596491,1.0,1.0,3/8,25.01%,ATP1B1;ATP1B3;WNK4
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.3624548995645701,-0.7018607943245582,0.8955223880597015,1.0,1.0,5/23,23.62%,GNG3;GNG2;GNB4;GNB5;GNA14
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,0.32367745830918543,0.7017463437627104,0.8823529411764706,1.0,1.0,6/18,19.56%,EXOC8;EXOC6;CNGA4;RAB8A;EXOC5;RAB3IP
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.34265664754927094,-0.7016051115614976,0.9090909090909091,1.0,1.0,6/27,17.88%,ATP8B4;ABCB1;PLSCR1;MFSD2A;ATP8B1;ABCC1
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.43638556928475725,0.7009471482783618,0.8958333333333334,1.0,1.0,2/5,12.02%,SLC47A1;SLC22A2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.30549661437540954,0.7008330232612132,0.9310344827586207,1.0,1.0,7/35,14.20%,POLD3;RFC3;ERCC2;ERCC3;GTF2H5;GTF2H2;POLK
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.3255208475157939,-0.7008176063238545,0.9166666666666666,1.0,1.0,9/38,17.49%,B3GALT2;HS3ST3A1;B3GNT2;GPC3;B4GALT7;HS3ST3B1;HS6ST1;GPC1;PXYLP1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.3289046938822641,-0.7007979897602935,0.9264705882352942,1.0,1.0,13/40,23.30%,DOK1;GFI1B;GATA1;BLVRB;PRSS57;FES;EMP3;RASSF1;FERMT3;IKBKG;CCS;DPM3;MFSD2B
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3648843235163558,-0.7007650159036,0.8529411764705882,1.0,1.0,7/23,17.04%,RASGRP1;RASGEF1A;IGF1;VAV1;RELN;ERBIN;IRS2
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,-0.32163597626002904,-0.7006933922380264,0.9605263157894737,1.0,1.0,10/48,20.44%,CDKN2A;APP;LMNB1;FADD;CAPN1;CDK5;GSDME;CAPNS1;CASP8;H2AZ1
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.42387422526477436,-0.7006293106496141,0.875,1.0,1.0,5/9,28.43%,PRKCB;CD36;ZDHHC3;PPARG;LRP1
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.4113107137107204,-0.7002449480066234,0.8666666666666667,1.0,1.0,2/10,11.66%,HES7;BMX
prerank,Reactome_2022__Aryl Hydrocarbon Receptor Signaling R-HSA-8937144,-0.47721489613298684,-0.700118335460571,0.8125,1.0,1.0,1/6,16.98%,AURKAIP1
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.2629100115925668,0.7000818665872472,1.0,1.0,1.0,25/81,26.13%,STXBP6;EXOC8;LLGL1;COMMD1;EXOC6;AP1B1;AP1S3;SCFD1;FTL;GOLGA7;EXOC5;EPS15;KLHL20;BLOC1S4;MYO5A;ARL3;ACBD3;SCAMP2;MON2;AP1M1;EXOC6B;ARRB1;SORT1;RABIF;SCAMP1
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.41178601147201543,-0.69988234112345,0.8225806451612904,1.0,1.0,1/8,17.19%,PRKCB
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.36519713110386565,0.6998413009016696,0.7368421052631579,1.0,1.0,2/12,6.09%,PDK4;ZNF304
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,0.24901581759356567,0.699806331778853,1.0,1.0,1.0,13/98,15.90%,KIF21B;KIF15;KIF21A;NAPSA;SEC22B;RAB1B;KIF6;COPB2;CAPZA1;DCTN5;TMED3;ARCN1;KIF1B
prerank,Reactome_2022__CASP8 Activity Is Inhibited R-HSA-5218900,-0.4190954629074626,-0.6997706645358722,0.9047619047619048,1.0,1.0,4/9,20.15%,FADD;FASN;TNFRSF10A;CASP8
prerank,Reactome_2022__Dimerization Of Procaspase-8 R-HSA-69416,-0.4190954629074626,-0.6997706645358722,0.9047619047619048,1.0,1.0,4/9,20.15%,FADD;FASN;TNFRSF10A;CASP8
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,0.347036416486322,0.6994298416127777,0.8529411764705882,1.0,1.0,5/15,10.19%,CA2;GLUD1;GLS;ATP1A2;SLC4A4
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.3050108706288698,-0.6992904707714437,0.9726027397260274,1.0,1.0,8/54,17.44%,RPS27A;PSMB9;PSMB6;PSMC3;UBC;PSMA8;PSMA7;PSME1
prerank,CellMarker_Augmented_2021__Stem cell:Pancreas,-0.2972765078267786,-0.6991767497143232,1.0,1.0,1.0,15/76,20.50%,ZNF850;FSIP2;SHISA9;LGR5;NOS1;GRID2;ZNF814;PCDH11X;CHST6;SLCO1A2;GLB1L3;PTCHD1;CSPG4P12;CNTNAP2;CDH8
prerank,CellMarker_Augmented_2021__Astrocyte:Brain,-0.2765543129505852,-0.699005050399762,0.9753086419753086,1.0,1.0,20/148,18.10%,FOSB;L1CAM;ZFP36;ATF3;ANLN;GRIA1;GFAP;IGFBP7;HLA-E;MTHFD2;FOS;RASSF4;JUNB;ITGB4;F3;KCNH7;LRIG1;PFKFB3;GADD45B;IER2
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.4511046517821471,-0.6987788385008346,0.8909090909090909,1.0,1.0,3/5,27.81%,MAPT;BEX4;TPPP
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,-0.3681669601049872,-0.6985710086721207,0.9491525423728814,1.0,1.0,2/22,6.29%,BLM;BRCA1
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Bone Marrow,0.44154099618434717,0.6985642174532851,0.8269230769230769,1.0,1.0,1/5,2.43%,FLT3
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.4474038780856714,-0.6985041553891905,0.76,1.0,1.0,1/5,4.06%,SH3GL2
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.334296927007702,0.6983680764903872,0.9,1.0,1.0,1/20,2.00%,RAB33B
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),-0.4204099769646585,-0.698146662298927,0.875,1.0,1.0,2/7,7.79%,AKR1C1;LDLR
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.3846237030598179,0.6980790187810587,0.8717948717948718,1.0,1.0,2/14,5.71%,DSCAM;BSG
prerank,Reactome_2022__Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,-0.39814156055715855,-0.6977865459926977,0.9375,1.0,1.0,4/13,24.32%,GALK1;GNE;DPM3;DHDDS
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.4435554444684501,0.697346757895775,0.918918918918919,1.0,1.0,3/5,38.73%,MIA3;BCAP31;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.43241906134218944,-0.6970477815766738,0.8360655737704918,1.0,1.0,1/7,11.44%,DDX60
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,0.3503022227851357,0.696921493731145,0.8,1.0,1.0,2/13,3.36%,FLT3;SOCS6
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,-0.2991880097491475,-0.6969071465345189,0.9125,1.0,1.0,2/68,2.23%,CDKN2A;RPS27A
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),-0.44718982876774327,-0.6967806529113231,0.85,1.0,1.0,3/5,32.65%,PPARG;CTBP2;PER2
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.2730989313764682,0.6967220995459186,0.96875,1.0,1.0,8/58,11.49%,PSMD10;RUNX1;PSMA1;PSMD11;LMO1;PSMB5;PSMD14;KMT2A
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.4391178283487891,-0.6965631689862487,0.8656716417910447,1.0,1.0,4/6,30.81%,TGFB1;TGFB2;TGFB3;MSN
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.31862596085631434,0.6964351785523798,0.8205128205128205,1.0,1.0,6/26,17.50%,CSNK2A1;CHPT1;CSNK2A2;LPIN3;PCTP;CEPT1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.3682405617312693,0.6964201404578518,0.8529411764705882,1.0,1.0,3/11,16.66%,ACADM;CPT2;CPT1A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.41972745361608077,0.6962546673787418,0.75,1.0,1.0,3/5,40.04%,EPB41L2;EPB41;NUMA1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.3544549311334218,-0.6962460173671503,0.9014084507042254,1.0,1.0,5/31,15.10%,RPS27A;ANLN;ANAPC11;UBC;UBE2S
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.4184152187980964,0.6962096134612099,0.8974358974358975,1.0,1.0,3/7,26.69%,QDPR;ASRGL1;KYNU
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,0.286498099496431,0.6962082470776629,0.9142857142857143,1.0,1.0,5/25,17.23%,CYP7B1;PTGIS;CYP46A1;AKR1C3;NCOA2
prerank,Reactome_2022__CaM Pathway R-HSA-111997,-0.33515657485035183,-0.696171332867547,0.9375,1.0,1.0,7/31,19.75%,ADCY7;PRKCG;ADCY5;PRKCD;ADCY8;PDE1C;PDE1A
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.31062263513901356,0.6958558084886828,0.9428571428571428,1.0,1.0,6/23,24.64%,HSPA1A;DNAJB14;DNAJC18;DNAJB5;HSPA13;DNAJB12
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,-0.34519455491738504,-0.6951975868350208,0.85,1.0,1.0,3/27,11.73%,PARP14;PARP9;NAMPT
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.3596713471861599,-0.6948073987725324,0.9310344827586207,1.0,1.0,6/18,23.37%,PSMB9;PSMB6;PSMA8;PSMA7;PSMA3;ENC1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),-0.4508899912459877,-0.6947628247605172,0.8867924528301887,1.0,1.0,5/5,54.93%,MTMR1;MTMR3;MTMR4;MTMR2;MTMR9
prerank,Reactome_2022__Signaling By MAPK Mutants R-HSA-9652817,0.4129667388609361,0.6945928364829068,0.8235294117647058,1.0,1.0,1/6,4.54%,DUSP6
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.4265468348959602,-0.6943410595234534,0.8545454545454545,1.0,1.0,4/8,21.77%,THPO;ANXA2;ZNF385A;SH2B3
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.30194796490625275,0.6942692616617963,0.9375,1.0,1.0,3/25,6.23%,SDC4;SDC3;GPC5
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.40326027414215676,0.6941349708639458,0.825,1.0,1.0,1/7,9.07%,MEGF10
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.30822272785308147,-0.6941134070204108,0.9722222222222222,1.0,1.0,13/54,30.11%,RPS27A;UBC;DDRGK1;LGALS8;DYNC1LI2;HDAC6;SQSTM1;ULK1;ULK2;PARK7;RETREG1;ATG14;CFTR
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.3735558630771143,-0.6939635569354637,0.9324324324324325,1.0,1.0,1/19,2.16%,LAMB1
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.36692990706073636,-0.6935205908831019,0.847457627118644,1.0,1.0,3/20,18.89%,SULF1;CRB2;TBX20
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.31419495210485693,0.6931864979636067,0.8372093023255814,1.0,1.0,2/21,5.13%,SOX8;SOX9
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.368062109284355,-0.6929145484503455,0.796875,1.0,1.0,2/14,10.26%,YWHAH;PPP3CC
prerank,Reactome_2022__Cation-coupled Chloride Cotransporters R-HSA-426117,-0.44501473407219805,-0.6928749404283696,0.855072463768116,1.0,1.0,1/6,14.49%,SLC12A7
prerank,CellMarker_Augmented_2021__Flk1+ Mesodermal cell:Pluripotent Stem Cell,-0.2952690579315693,-0.6924124277031695,0.987012987012987,1.0,1.0,18/88,22.27%,FLRT3;PKP2;NOS1AP;ATP1B1;DAB2IP;SLC44A3;FRAS1;CKMT1B;ZNF704;PTPRF;RHPN2;PPP1R9A;EPB41L4B;KIAA1217;CXADR;SH3D19;TOX3;EPB41L1
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",0.28170302575229555,0.6922598374367733,0.9444444444444444,1.0,1.0,4/44,6.31%,TAB3;TNFAIP3;TXNIP;UBE2N
prerank,Reactome_2022__TRAF3-dependent IRF Activation Pathway R-HSA-918233,-0.38521345422087677,-0.6921200357546875,0.8636363636363636,1.0,1.0,2/13,12.36%,IRF7;IFIH1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.35081111992776615,-0.6920436662031694,0.9375,1.0,1.0,6/26,19.00%,P2RY12;PIK3IP1;DAB2IP;TEK;TGFB1;PDGFRA
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.3081310388692841,-0.6920157254815709,0.9102564102564102,1.0,1.0,10/58,15.76%,NR4A3;BAIAP2;WAS;PLD2;PLPP4;SYK;ELMO1;PIK3CB;VAV1;PRKCD
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),-0.41135921183839175,-0.6919264733855176,0.8709677419354839,1.0,1.0,4/9,24.96%,SLC29A4;ANTXR1;SLC22A1;RAB40B
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.447930292416601,-0.691830098155249,0.8846153846153846,1.0,1.0,1/7,14.79%,PNKD
prerank,"Reactome_2022__Tetrahydrobiopterin (BH4) Synthesis, Recycling, Salvage And Regulation R-HSA-1474151",0.4101033617684788,0.6917513194729108,0.9230769230769231,1.0,1.0,2/9,14.24%,AKT1;DHFR
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.28090909369446004,0.691704832560044,0.96,1.0,1.0,10/31,25.55%,VCP;MRRF;MTIF2;DENR;GFM2;UFM1;DYRK3;EIF2D;ZFAND1;ATG2B
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.259750065585979,0.6916546415072617,1.0,1.0,1.0,11/75,14.81%,HMMR;ATF5;HAUS1;CSNK1E;CEP290;CEP152;PLK1;PCM1;ALMS1;CEP192;TUBG1
prerank,Reactome_2022__Zinc Influx Into Cells By SLC39 Gene Family R-HSA-442380,-0.4490259263555526,-0.6910497938902022,0.8166666666666667,1.0,1.0,1/5,3.00%,SLC39A14
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),0.452563561035324,0.6910213113125009,0.8979591836734694,1.0,1.0,3/6,47.08%,GBA2;FUCA2;GLA
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),0.452563561035324,0.6910213113125009,0.8979591836734694,1.0,1.0,3/6,47.08%,GBA2;FUCA2;GLA
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),-0.46040697007692044,-0.6907348345596396,0.8461538461538461,1.0,1.0,3/5,32.63%,P2RX7;SHANK3;ANO6
prerank,Reactome_2022__Free Fatty Acids Regulate Insulin Secretion R-HSA-400451,0.3937709045056918,0.6904276992752694,0.8947368421052632,1.0,1.0,4/8,25.43%,GNAQ;ACSL3;PLCB1;GNA11
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,-0.3871138300456342,-0.6900792134702163,0.96875,1.0,1.0,5/13,20.15%,NDUFA2;FADD;FASN;TNFRSF10A;CASP8
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.3597720274271883,0.6899558392967987,0.9117647058823529,1.0,1.0,3/14,10.13%,NLGN3;CACNG2;NRXN1
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.30464906693819016,-0.6899211963042816,0.9384615384615385,1.0,1.0,7/69,12.77%,CDKN2A;RPS27A;PSMB9;MAFK;PSMB6;PSMC3;UBC
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),0.39463142354693437,0.689798583788754,0.926829268292683,1.0,1.0,1/9,7.15%,FBXO5
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.47296974043336787,-0.6896659148883316,0.8461538461538461,1.0,1.0,2/5,30.38%,PAF1;CTR9
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.47296974043336787,-0.6896659148883316,0.8461538461538461,1.0,1.0,2/5,30.38%,PAF1;CTR9
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.37103627782748977,-0.689644592683489,0.873015873015873,1.0,1.0,3/21,18.26%,BHMT;EEF1AKMT2;EEF2KMT
prerank,Reactome_2022__Xenobiotics R-HSA-211981,-0.41860970013950094,-0.6895302094167164,0.8852459016393442,1.0,1.0,3/10,17.36%,CYP3A4;CYP3A7-CYP3A51P;CYP3A5
prerank,KEGG_2021_Human__Arginine and proline metabolism,-0.31736193328926243,-0.6894116839025008,0.8888888888888888,1.0,1.0,9/41,16.24%,MAOB;ARG2;P4HA2;CARNS1;P4HA3;NOS1;CNDP1;CKMT1B;ALDH3A2
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.3661413912110598,0.6893403978174543,0.9259259259259259,1.0,1.0,3/12,12.31%,AKT2;AKT1;EPM2AIP1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.30904575616943186,-0.6892166508345818,0.9342105263157895,1.0,1.0,17/64,22.58%,B3GALT2;GCNT1;FUT2;ST3GAL6;IGF1;B3GNT5;B3GNT2;ST6GALNAC2;B4GALT7;ALG1L2;ST8SIA3;B3GALT4;CHST10;CHST9;CHST12;B3GALNT1;ST8SIA1
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.29023431958680224,-0.689204253472323,0.9705882352941176,1.0,1.0,11/72,17.96%,RASGRP1;RPS27A;PSMB9;PSMB6;PSMC3;UBC;PSMA8;PSMA7;PRKCB;PSME1;CARD11
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541,-0.37371921569743977,-0.688904070230971,0.8656716417910447,1.0,1.0,2/14,12.36%,IRF7;IFIH1
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.3685363749612536,-0.6888605585946301,0.859375,1.0,1.0,4/15,17.15%,ADCY7;ADCY5;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.2978576959904148,-0.6888114749836205,0.9629629629629629,1.0,1.0,9/57,12.36%,TLR2;NLRP12;APP;TLR3;WNT5A;SCIMP;HLA-B;SYK;IFIH1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.3239658913036949,-0.6887615316859662,0.8307692307692308,1.0,1.0,8/27,20.48%,IFT122;PRICKLE1;DLC1;TSC2;DEAF1;LRP2;TGFB1;SEMA4C
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.3239658913036949,-0.6887615316859662,0.8307692307692308,1.0,1.0,8/27,20.48%,IFT122;PRICKLE1;DLC1;TSC2;DEAF1;LRP2;TGFB1;SEMA4C
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.32703852395943855,-0.6887015070888479,0.9620253164556962,1.0,1.0,5/47,12.77%,RPS27A;HLA-A;RNF181;HLA-B;UBC
prerank,Reactome_2022__TRP Channels R-HSA-3295583,-0.36991275052193995,-0.6886201196892905,0.8769230769230769,1.0,1.0,1/16,5.91%,TRPC3
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.3035535914538423,-0.6881152335281228,0.9753086419753086,1.0,1.0,5/60,12.77%,BLM;RPS27A;BRCA1;RPA3;UBC
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.4088133537949093,0.6880257969366059,0.8780487804878049,1.0,1.0,1/6,3.46%,NDNF
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.3340185102483034,0.6880022536480982,0.8918918918918919,1.0,1.0,8/19,26.62%,PPARGC1A;KAT7;BRD7;SPHK2;TADA2B;RPS6KA4;ARRB1;SMAD4
prerank,CellMarker_Augmented_2021__Neural Crest cell:Undefined,0.40975015308048035,0.6879989107332534,0.8837209302325582,1.0,1.0,1/11,0.65%,ASCL1
prerank,Reactome_2022__Role Of LAT2/NTAL/LAB On Calcium Mobilization R-HSA-2730905,-0.3774782050234836,-0.6878912845070363,0.9,1.0,1.0,6/12,26.93%,SYK;PIK3CB;GAB2;SLC7A8;FYN;SHC1
prerank,Reactome_2022__APEX1-Independent Resolution Of AP Sites Via Single Nucleotide Replacement Pathway R-HSA-5649702,0.4005723931423972,0.6878729324250096,0.9166666666666666,1.0,1.0,1/7,4.43%,POLG2
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.36760024965351246,-0.6877533946576744,0.9122807017543859,1.0,1.0,3/13,18.65%,DCTN1;CLMN;SYNE3
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.32275194860182477,0.6875384440096822,0.96875,1.0,1.0,4/17,23.21%,CYTH3;FERMT1;GOLPH3;EZR
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.36200705589656107,-0.6874903303811292,0.8533333333333334,1.0,1.0,2/19,4.06%,STMN2;SH3GL2
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.41209582144615525,-0.6874414109108885,0.84375,1.0,1.0,3/10,15.47%,GCNT1;SELP;ADD2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.42244284906597923,0.6866783677813032,0.7954545454545454,1.0,1.0,1/7,2.88%,SERPINF2
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,-0.2720410466786763,-0.6864883678171747,1.0,1.0,1.0,19/124,17.58%,ADCY7;PLN;ATP1A1;ITPR3;ATP1B1;SLC8A3;SRF;PPP3CC;CREB5;CACNA1C;ADCY5;MYLK3;ADCY3;GUCY1A1;KCNMB4;PDE5A;IRS2;ADCY8;CREB3
prerank,CellMarker_Augmented_2021__Epithelial cell:Blood,-0.32279451609667803,-0.6863169023051109,0.9027777777777778,1.0,1.0,10/43,20.01%,EPS8L2;OVOL2;BAIAP2L1;SLC44A3;RHBDF1;ITGB4;RHOD;PTPRF;LAMA5;EPB41L4B
prerank,CellMarker_Augmented_2021__Cancer cell:Lung,-0.32279451609667803,-0.6863169023051109,0.9027777777777778,1.0,1.0,10/43,20.01%,EPS8L2;OVOL2;BAIAP2L1;SLC44A3;RHBDF1;ITGB4;RHOD;PTPRF;LAMA5;EPB41L4B
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.3480210321387846,0.6862800704524024,0.9,1.0,1.0,5/12,23.01%,XPR1;SLC37A1;SLC20A1;SLC25A3;SLC25A14
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.3480210321387846,0.6862800704524024,0.9,1.0,1.0,5/12,23.01%,XPR1;SLC37A1;SLC20A1;SLC25A3;SLC25A14
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.35185580590165877,-0.6861946957400504,0.9041095890410958,1.0,1.0,11/27,26.38%,CCDC39;ODAD1;SPAG1;DRC1;CFAP73;DNAH17;DNAAF1;ODAD4;CFAP100;CCDC40;DNAI2
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.3700167122225682,-0.6859479487620024,0.9122807017543859,1.0,1.0,2/15,18.13%,OGG1;TINF2
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.43327045615844584,-0.6858720415587621,0.7868852459016393,1.0,1.0,1/6,6.29%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.36594265812795496,-0.6857186960117821,0.88,1.0,1.0,2/22,9.24%,ARG2;IGF1
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,-0.38613949842539486,-0.6852274819110483,0.921875,1.0,1.0,3/16,8.69%,FYB1;HLA-DRA;WAS
prerank,Reactome_2022__Glycolysis R-HSA-70171,0.2534018329946438,0.6851972975596778,1.0,1.0,1.0,15/62,20.89%,NUP42;NUP37;NUP54;PRKACB;NDC1;MAP4K5;NUP214;MAP4K2;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,CellMarker_Augmented_2021__Leydig cell:Fetal Gonad,-0.25755963002383325,-0.685144486554756,1.0,1.0,1.0,32/327,12.71%,PKP2;LAMB1;RPS14;S100A6;MATN2;ADCY7;STEAP1;RPL35;RPL7A;ATRNL1;TRIP10;RPL27;ZNF385D;PAPSS2;GLRX;PDHX;NETO2;GADD45A;PLEKHA4;PFN2;STAT1;CD9;PTPN7;PGK1;EPSTI1;HHIP;SLC7A2;RPS8;PRSS23;RPS7;RPS18;MTHFD2
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.37085756140703335,-0.6851160531889581,0.9180327868852459,1.0,1.0,1/12,6.29%,BRCA1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.29658948531607543,-0.6851040555194193,1.0,1.0,1.0,15/63,21.77%,TGFBR2;ARIH2;ZFPM1;WNT5A;RUNX2;SFRP2;TEK;TGFB1;ETV6;GLRX5;RRAS;SFRP1;PTPRC;KIRREL3;SH2B3
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,-0.32984310758874513,-0.6846842249904934,0.9682539682539683,1.0,1.0,7/33,19.75%,ADCY7;PRKCG;ADCY5;PRKCD;ADCY8;PDE1C;PDE1A
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.3188633046790167,-0.6846598825677565,0.9117647058823529,1.0,1.0,1/41,2.20%,ZFP36
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.3369145453356869,-0.684487985136664,0.8985507246376812,1.0,1.0,1/20,2.72%,ALOX12
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.27965565277644866,-0.6842941259751125,0.9696969696969697,1.0,1.0,13/89,17.44%,ST18;TNFRSF14;PSMB9;STAT1;PSMB6;BIRC3;PSMC3;MAP3K14;TNFRSF1A;PSMA8;LTBR;PSMA7;PSME1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.40228875530225067,-0.6837774135610767,0.8909090909090909,1.0,1.0,1/8,10.01%,WNT5A
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.4540505420236873,-0.6836905461936483,0.8153846153846154,1.0,1.0,1/6,8.69%,WAS
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),-0.4259079890520405,-0.68343765502437,0.8421052631578947,1.0,1.0,2/6,7.79%,AKR1C1;LDLR
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.39997135954678664,0.6834197689390038,0.7948717948717948,1.0,1.0,2/5,20.99%,HMGB1;APLF
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.3495053829947351,-0.6831251697170112,0.9552238805970149,1.0,1.0,6/25,19.21%,LZTS1;PINK1;NRBP2;TSC2;NUPR1;PHF23
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.3261381425609194,-0.6830854683658044,0.9285714285714286,1.0,1.0,2/33,4.67%,F8;TPST1
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,0.3280083239889903,0.6830393819783382,0.8918918918918919,1.0,1.0,1/20,1.26%,NIPAL1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.30215549749902937,-0.6830195218383412,0.9428571428571428,1.0,1.0,6/42,18.14%,RAB11FIP5;EGF;GPC3;BDNF;GPC1;MAPT
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),0.2862734389412967,0.6830144936256177,0.9696969696969697,1.0,1.0,7/25,19.77%,PSMD10;FBXO5;MARCHF7;THOC1;TPT1;MDM2;CCAR2
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,-0.2913975034977125,-0.6826119893543947,0.9473684210526315,1.0,1.0,13/86,15.59%,RPS27A;ARHGEF3;PLEKHG2;ARHGEF38;ARHGEF17;MAG;ARHGEF18;OBSCN;UBC;RNASE1;VAV1;APH1A;RASGRF2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.2985103443757717,-0.6826032242297893,0.92,1.0,1.0,4/64,11.78%,THBS1;IGF1;PINK1;BCL2L2
prerank,Reactome_2022__Phenylalanine Metabolism R-HSA-8964208,0.43577809214367835,0.6823925946986585,0.8297872340425532,1.0,1.0,2/5,22.54%,QDPR;ASRGL1
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.43577809214367835,0.6823925946986585,0.8297872340425532,1.0,1.0,2/5,22.54%,QDPR;ASRGL1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.3034185641461166,-0.682248384126985,0.9473684210526315,1.0,1.0,6/53,17.84%,TGFBR2;SBK1;PRKCD;HIPK4;CDK5;HIPK3
prerank,Reactome_2022__Type I Hemidesmosome Assembly R-HSA-446107,-0.4372425147268819,-0.6819375575120132,0.8448275862068966,1.0,1.0,3/6,22.78%,ITGB4;PLEC;DST
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.31723934415406874,-0.6818954824940672,0.9324324324324325,1.0,1.0,5/38,13.10%,SLC39A14;ATP5IF1;DAB2IP;NOS1;GCHFR
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.38728594733274146,-0.6818598141244807,0.9285714285714286,1.0,1.0,1/14,3.46%,IMPDH1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.2832642952297532,-0.6818438794459097,1.0,1.0,1.0,10/95,15.85%,MTMR7;INPP5D;VAC14;MTMR11;SBF1;PLEKHA4;BMX;PITPNM2;PIK3CB;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.29217301605684753,0.6815212435007082,0.9444444444444444,1.0,1.0,2/25,7.58%,ERCC6;ERCC2
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.3259235457903288,0.6814475664191735,0.8275862068965517,1.0,1.0,4/22,11.25%,CHST11;CSGALNACT1;GAL3ST4;ADAMTS12
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,0.3330682830871652,0.6814408481084556,0.8809523809523809,1.0,1.0,2/17,8.98%,PTPN4;PTPN23
prerank,CellMarker_Augmented_2021__T cell:Colorectum,-0.3755428455218482,-0.6814254571972463,0.85,1.0,1.0,2/15,3.84%,CD5;GPR171
prerank,CellMarker_Augmented_2021__T cell:Bone Marrow,-0.3755428455218482,-0.6814254571972463,0.85,1.0,1.0,2/15,3.84%,CD5;GPR171
prerank,CellMarker_Augmented_2021__T cell:Synovium,-0.3755428455218482,-0.6814254571972463,0.85,1.0,1.0,2/15,3.84%,CD5;GPR171
prerank,CellMarker_Augmented_2021__T cell:Optic Nerve,-0.3755428455218482,-0.6814254571972463,0.85,1.0,1.0,2/15,3.84%,CD5;GPR171
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.45826137045898424,-0.6813479255092695,0.8,1.0,1.0,2/6,26.55%,NFATC2;ENG
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gall Bladder,-0.2996368763301686,-0.6812699518676483,0.9125,1.0,1.0,7/50,15.71%,PODXL;RND2;LRRK1;GRID2;FRAS1;PCDH11X;CHST6
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.44221999147156743,-0.6810170177260662,0.7962962962962963,1.0,1.0,1/6,11.81%,BAP1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.37045060566237875,-0.6809045369736827,0.8695652173913043,1.0,1.0,3/14,16.42%,TNFRSF1A;PRKCD;ORMDL2
prerank,Reactome_2022__Release Of Hh-Np From Secreting Cell R-HSA-5362798,-0.44277637243036017,-0.6808682018453918,0.7678571428571429,1.0,1.0,1/5,7.65%,NOTUM
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.3815173030868194,0.6808066427653259,0.8636363636363636,1.0,1.0,2/8,27.08%,SNX5;CARMIL1
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.44550514695700005,-0.6806988705274367,0.819672131147541,1.0,1.0,1/7,8.87%,RPS6KA1
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.42260865895816957,-0.6802968282660071,0.8363636363636363,1.0,1.0,4/6,28.12%,SFRP1;TP53;MEOX1;LMBR1L
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.3267107011114404,0.6802630586423819,0.8648648648648649,1.0,1.0,3/13,17.02%,SRI;ANK2;CACNA2D1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.3601229277602249,-0.6799470166522228,0.8783783783783784,1.0,1.0,2/23,9.24%,ARG2;IGF1
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.2915323191215679,-0.6798790167710077,0.972972972972973,1.0,1.0,6/73,9.24%,MET;B2M;APP;PARP9;EGF;IGF1
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.3157758696690041,0.6796651959505526,0.8857142857142857,1.0,1.0,4/21,9.69%,SLC39A10;SLC39A8;MT1E;SLC30A9
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.3065119110898186,0.6796516759189414,0.8620689655172413,1.0,1.0,3/18,14.84%,NRAS;PIK3CA;PIK3R1
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.4360275839118359,-0.6792046400577737,0.896551724137931,1.0,1.0,3/6,27.13%,AHI1;DNAAF1;CITED2
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.3248484866054418,-0.6791650895974392,0.8970588235294118,1.0,1.0,9/32,20.50%,CCND1;ANAPC11;CCNE2;UBE2S;CDK2;CCND2;CDKN1A;ANAPC15;CDKN1C
prerank,Reactome_2022__Tie2 Signaling R-HSA-210993,0.36283207066096357,0.6790850242057206,0.8787878787878788,1.0,1.0,5/13,23.66%,NRAS;PIK3CA;PIK3R1;GRB14;SOS1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.3126928291600496,0.6788405886846504,0.9210526315789473,1.0,1.0,5/27,13.65%,BBS10;CEP290;PCM1;C2CD3;TTC8
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.333161805374977,0.6787671403336567,0.9375,1.0,1.0,2/12,12.99%,PTGIS;AKR1C3
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.29884586309234545,0.6787458436695244,0.967741935483871,1.0,1.0,6/43,13.78%,PSMD10;PSMA1;PSMD11;PSMB5;PSMD14;PSMD12
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,-0.32029905517140445,-0.6786169918502657,0.9558823529411765,1.0,1.0,1/38,2.59%,WARS1
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In WNT Signaling R-HSA-8939256,-0.434868788725171,-0.6784553707990171,0.8813559322033898,1.0,1.0,1/5,6.36%,RSPO3
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.385662948726214,0.6784379705565222,0.8055555555555556,1.0,1.0,1/9,3.02%,RIDA
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.3988163545766231,0.6782434776424096,0.9024390243902439,1.0,1.0,1/7,4.81%,HCLS1
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,-0.35943628265339683,-0.6781974553284342,0.9333333333333333,1.0,1.0,3/17,12.77%,RPS27A;RPA3;UBC
prerank,CellMarker_Augmented_2021__Decidual cell:Placenta,-0.29967562822634924,-0.678082259630699,0.9726027397260274,1.0,1.0,9/61,14.45%,MET;SLC39A14;PLK2;CCND1;SRPX2;OSMR;FN1;AMOTL2;BDNF
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.3281854061779686,-0.6780362004209384,0.9565217391304348,1.0,1.0,1/28,1.55%,SUV39H1
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression To Control Bile Acid Homeostasis R-HSA-9623433,-0.4144864730603345,-0.6779450784620672,0.8524590163934426,1.0,1.0,3/8,29.81%,RXRB;FABP6;NCOR1
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.4196049535321274,0.6779274148608161,0.8695652173913043,1.0,1.0,2/5,12.35%,EIF2AK4;VAPA
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.37239630129179396,0.677795018527203,0.8536585365853658,1.0,1.0,2/10,9.38%,BTN3A3;MSH2
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.4294642960309847,0.6776441855745089,0.868421052631579,1.0,1.0,1/6,13.26%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.4294642960309847,0.6776441855745089,0.868421052631579,1.0,1.0,1/6,13.26%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.4142669757830375,0.6772424109553203,0.8333333333333334,1.0,1.0,4/5,24.54%,RCC2;HNRNPU;BECN1;SIRT2
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.3896113139853211,-0.6768390595279472,0.8656716417910447,1.0,1.0,2/10,16.59%,DCTN1;CLN3
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.44657847986758453,0.676811001957806,0.8260869565217391,1.0,1.0,2/6,24.69%,EXOSC6;EXOSC5
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.3835278670921052,0.6766621983473273,0.8478260869565217,1.0,1.0,1/10,5.64%,EGFR
prerank,KEGG_2021_Human__Estrogen signaling pathway,-0.2844040779210511,-0.6765428942173345,0.9375,1.0,1.0,15/92,17.63%,PGR;ADCY7;ITPR3;TGFA;SHC2;CREB5;ADCY5;FOS;PIK3CB;PRKCD;PIK3CD;ADCY3;ADCY8;CREB3;GPER1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.3956770727927921,-0.6764898199066853,0.9166666666666666,1.0,1.0,2/7,17.28%,TNFRSF1A;VCL
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.2975819474084927,0.6763790549111595,0.96875,1.0,1.0,6/20,24.98%,GPHN;SCP2;MOCS2;LIAS;NOXRED1;DHRS11
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.290817136802186,-0.6762774147111758,0.9873417721518988,1.0,1.0,8/90,11.74%,WARS1;TMC8;GFAP;KIF9;DAB2IP;SYK;SELP;PINK1
prerank,CellMarker_Augmented_2021__Stem cell:Hair Follicle,-0.44734498248935706,-0.6762767487626353,0.8703703703703703,1.0,1.0,3/5,17.02%,LGR5;CD200;LRIG1
prerank,KEGG_2021_Human__Sulfur relay system,-0.40274433900233,-0.6761102629683223,0.828125,1.0,1.0,1/8,8.05%,CTU2
prerank,Reactome_2022__TNFR1-induced Proapoptotic Signaling R-HSA-5357786,0.3691213751414749,0.6760856120069075,0.8918918918918919,1.0,1.0,2/12,9.85%,TNFAIP3;TRADD
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.38869446652247674,-0.6759141789052581,0.8524590163934426,1.0,1.0,1/9,7.29%,AKAP5
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.38869446652247674,-0.6759141789052581,0.8524590163934426,1.0,1.0,1/9,7.29%,AKAP5
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.38897324461375143,0.6758044748992771,0.9,1.0,1.0,2/9,20.11%,ZNF703;SMAD7
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,0.3030729122282376,0.6756679796024583,0.9259259259259259,1.0,1.0,9/22,30.67%,GTF2F2;TIAL1;POLR2C;POLR2A;POLR2K;POLR2D;HNRNPH1;POLR2E;PTBP1
prerank,KEGG_2021_Human__Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,0.3095496882927929,0.675376884070148,0.9642857142857143,1.0,1.0,6/23,25.16%,PGAP1;PIGP;GPLD1;PIGF;PIGU;PIGT
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.42406242608203193,0.675373331589773,0.8636363636363636,1.0,1.0,2/5,9.05%,CSNK2A1;CSNK2A2
prerank,CellMarker_Augmented_2021__T cell:Placenta,-0.37818846830122615,-0.6753223572881243,0.873015873015873,1.0,1.0,2/14,3.84%,CD5;GPR171
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),0.4469000473017495,0.6752546804142487,0.8372093023255814,1.0,1.0,2/5,11.25%,FOXP1;ADAMTS12
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Liver,-0.3897397306814561,-0.6751303321021399,0.8813559322033898,1.0,1.0,2/12,3.84%,CD5;GPR171
prerank,CellMarker_Augmented_2021__CD8+ Cytotoxic T cell:Peripheral Blood,-0.3897397306814561,-0.6751303321021399,0.8813559322033898,1.0,1.0,2/12,3.84%,CD5;GPR171
prerank,CellMarker_Augmented_2021__CD8+ T cell:Liver,-0.3897397306814561,-0.6751303321021399,0.8813559322033898,1.0,1.0,2/12,3.84%,CD5;GPR171
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.28866371778145344,-0.67492888537809,0.9875,1.0,1.0,19/94,20.76%,FLRT3;C1QL1;EFNB3;ATP1B1;SHC2;DAB2IP;SLC7A2;SLC44A3;ASS1;CKMT1B;SEZ6L2;PTPRF;PRR36;EPB41L4B;KIAA1217;NKAIN1;HES1;CXADR;CD276
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3677974736073254,-0.674913565949907,0.8153846153846154,1.0,1.0,3/14,16.36%,CD55;IL18;HLA-DRB1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.31806805780813185,0.6748356659537592,0.9142857142857143,1.0,1.0,1/14,1.20%,RGS10
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.44889636770760455,-0.6746085873714793,0.8823529411764706,1.0,1.0,2/5,17.95%,FLOT1;TGFB1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.2867064692446385,-0.6744329118248024,0.9726027397260274,1.0,1.0,15/73,18.35%,SLC39A14;HTR2B;SLC24A2;SLC24A1;GCM2;ATP1B1;SLC8A3;MT1H;SLC24A5;SLC11A1;PTH1R;HTR2C;RYR2;HTR2A;SLC39A7
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.33817948268695963,-0.6741858629841714,0.9180327868852459,1.0,1.0,2/14,10.89%,CMPK2;ENTPD3
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),-0.47549850835483337,-0.6741644908829907,0.890625,1.0,1.0,1/5,10.43%,PLEKHM1
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,0.31711142991691527,0.6741107243635758,1.0,1.0,1.0,9/28,17.74%,EIF2S1;EXOSC1;NFYC;ATF6;EXOSC6;DIS3;EIF2AK3;EXOSC8;CEBPG
prerank,CellMarker_Augmented_2021__T cell:Kidney,-0.3731974237043155,-0.6739720559905363,0.8214285714285714,1.0,1.0,2/16,3.84%,CD5;GPR171
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.32622827754516937,0.6731758005791093,0.9428571428571428,1.0,1.0,4/16,14.76%,SLC47A1;SLC25A19;SLC22A2;SLC22A5
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.34416204321154176,-0.672617583738115,0.921875,1.0,1.0,5/21,17.15%,ABCA12;PIM3;ADCY5;HLA-DRB1;ADCY8
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.3587735962367601,0.6725284367309597,0.9069767441860465,1.0,1.0,1/8,7.52%,GMPS
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,0.3082004165620693,0.6724627010509581,0.88,1.0,1.0,2/24,6.69%,AKT2;AKT1
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.4022957386698546,-0.6720595471880372,0.8703703703703703,1.0,1.0,1/7,10.01%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.4022957386698546,-0.6720595471880372,0.8703703703703703,1.0,1.0,1/7,10.01%,WNT5A
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.33881758162713504,-0.6719811136987532,0.9857142857142858,1.0,1.0,10/30,24.64%,SLC4A9;SLC9A2;SLC4A2;SLC4A10;SLC9A5;CLN3;SLC9A7;SLC4A3;SLC9A1;SLC9A9
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.4483492748980885,-0.6719588406517355,0.8181818181818182,1.0,1.0,1/5,16.53%,RPL23
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),-0.30596951256783184,-0.671722245256861,0.9726027397260274,1.0,1.0,9/57,19.21%,SKOR1;SULF1;VWC2;SFRP4;ITGA3;CRB2;LRP2;TBX20;BMPER
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.44246005560681756,-0.6716158101081237,0.8225806451612904,1.0,1.0,2/5,21.28%,GNG2;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.3729119402418693,0.6715308089967276,0.8478260869565217,1.0,1.0,2/7,11.18%,PTGIS;TP53BP2
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),-0.41824931016705796,-0.6711443805440291,0.8909090909090909,1.0,1.0,3/5,32.40%,CDK6;EIF2B5;MT3
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.25889189180398015,0.6711335115140747,0.9523809523809523,1.0,1.0,6/55,10.59%,TENM1;APBB3;MYOM1;ATP2C1;CEP290;PCM1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.34070609476960934,-0.6710631262186627,0.9428571428571428,1.0,1.0,5/22,17.19%,PRKCQ;TNS2;PRKCD;TSC2;PRKCB
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),-0.39930024356385274,-0.6710556978644265,0.8688524590163934,1.0,1.0,2/10,18.05%,CARNS1;PAH
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.35490795032023836,-0.6709089616261382,0.9264705882352942,1.0,1.0,3/23,9.24%,POU4F1;EGF;IGF1
prerank,KEGG_2021_Human__Riboflavin metabolism,0.37759726841004543,0.6707244706474725,0.8222222222222222,1.0,1.0,2/7,13.44%,FLAD1;ENPP3
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.4023465101903713,0.6706247361166554,0.8780487804878049,1.0,1.0,4/7,40.35%,ELAC2;TRMT10A;TRMT10C;PNPT1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.2487524957005679,0.6706037622636227,1.0,1.0,1.0,10/74,11.49%,PSMD10;RUNX1;PSMA1;PSMD11;LMO1;NUDT21;PSMB5;SMYD5;PSMD14;KMT2A
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.32415877348299277,-0.6703736295215716,0.9130434782608695,1.0,1.0,1/22,1.70%,KREMEN2
prerank,CellMarker_Augmented_2021__IL-17Ralpha T cell:Peripheral Blood,-0.3811371123796367,-0.6702292740583536,0.8666666666666667,1.0,1.0,2/13,3.84%,CD5;GPR171
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.386261718769911,-0.670178491171861,0.8305084745762712,1.0,1.0,1/11,7.29%,AKAP5
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,-0.3026014829055713,-0.6700704013464511,0.975,1.0,1.0,7/45,17.37%,RPS27A;PTK6;EGF;UBC;PRKCD;ERBIN;CDC37
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.30192354696510176,-0.6700044156871998,0.961038961038961,1.0,1.0,6/52,11.74%,SUV39H1;SLC8A3;SCN2A;NDRG1;PGK1;PINK1
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,-0.28144430801328507,-0.6699762709079646,1.0,1.0,1.0,11/87,16.58%,FYB1;CDH6;CLDN16;CLDN20;CLDN18;CDH19;CDH9;CDH12;PIK3CB;ITGB4;CDH17
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.39599517849363786,0.6698319908815609,0.7659574468085106,1.0,1.0,1/6,5.79%,SFXN2
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),-0.4223066972912346,-0.6698221431861452,0.8363636363636363,1.0,1.0,2/7,10.53%,AKR1C1;PDK3
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.2587995871836155,0.6697179914495567,0.967741935483871,1.0,1.0,8/62,11.49%,PSMD10;RUNX1;PSMA1;PSMD11;LMO1;PSMB5;PSMD14;KMT2A
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.32107089351633367,-0.6696661381070061,0.9365079365079365,1.0,1.0,8/30,20.48%,IFT122;PRICKLE1;DLC1;TSC2;DEAF1;LRP2;TGFB1;SEMA4C
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.3503754058384744,0.6695770096534474,0.9523809523809523,1.0,1.0,1/10,3.46%,NDNF
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,0.2695937269790641,0.6693261447848851,1.0,1.0,1.0,5/41,12.30%,GAS2;OCLN;HMGB1;CASP3;H1-2
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.308031898111935,-0.6690946311673596,0.9876543209876543,1.0,1.0,1/45,0.81%,BLM
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.2905270769936089,-0.6688672368439025,0.987012987012987,1.0,1.0,7/90,8.85%,WARS1;CAMK2N2;THY1;CAV3;CEACAM1;CENPE;TSPYL2
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.41560221801139074,-0.6688061211707862,0.8636363636363636,1.0,1.0,3/7,24.93%,MUC6;CXADR;MUC4
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,-0.3312188050852756,-0.6685331586544779,0.9253731343283582,1.0,1.0,1/25,2.23%,RPS27A
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.3307840694395965,-0.6684533208752315,0.8928571428571429,1.0,1.0,2/18,13.75%,TTLL7;TTLL6
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.31570511524592815,0.6684234467318834,0.896551724137931,1.0,1.0,2/25,3.66%,TNFSF13B;CD320
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.3021649936629853,-0.6683132680740332,0.9873417721518988,1.0,1.0,12/60,14.60%,RAMP3;ADCY7;GNG3;GIPR;ADCY5;PTRH2;GNG2;C1QTNF1;RXFP1;PTH1R;GLP1R;PTH2R
prerank,Reactome_2022__PTK6 Regulates Cell Cycle R-HSA-8849470,-0.41622956690231927,-0.6678369718554384,0.8679245283018868,1.0,1.0,3/6,15.90%,PTK6;CCND1;CDK2
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.38776131268359143,-0.6677292354615652,0.9193548387096774,1.0,1.0,1/12,7.89%,SGPP2
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.3278890048190875,-0.6676281715964951,0.9113924050632911,1.0,1.0,4/27,15.76%,CAV3;PFN2;KANK3;PRKCD
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.41706774258299834,-0.6676171027452301,0.8936170212765957,1.0,1.0,1/6,6.33%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.39386021276698435,-0.6674834330062651,0.859375,1.0,1.0,2/8,15.50%,NOS1;APLN
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.34040952212408826,-0.6674463573133553,0.9264705882352942,1.0,1.0,2/21,4.84%,ZDHHC9;ZDHHC22
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.34040952212408826,-0.6674463573133553,0.9264705882352942,1.0,1.0,2/21,4.84%,ZDHHC9;ZDHHC22
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.31585569964479604,-0.6672753558691357,0.9736842105263158,1.0,1.0,8/32,25.78%,PRKCG;DDRGK1;UBXN1;GABARAPL2;RPL11;GIPC1;AQP11;NOP53
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.37476606293449,-0.6672561705618362,0.8431372549019608,1.0,1.0,1/14,1.94%,ICAM1
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.4261548585661925,-0.667247536569716,0.8596491228070176,1.0,1.0,2/8,18.89%,ZFPM1;TBX20
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.3109006192725423,-0.6671622781571818,0.9295774647887324,1.0,1.0,5/42,16.35%,KDELR3;TSPYL2;DCTN1;TLN1;ARFGAP1
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,0.29808962877573664,0.6671498540213581,0.8461538461538461,1.0,1.0,4/24,11.18%,AKT2;AKT1;MAPK8;TP53BP2
prerank,Reactome_2022__Surfactant Metabolism R-HSA-5683826,-0.3766308785879203,-0.6669266603909456,0.921875,1.0,1.0,1/13,2.99%,SFTPD
prerank,Reactome_2022__Lysine Catabolism R-HSA-71064,-0.37173756403069835,-0.6667447680444615,0.8688524590163934,1.0,1.0,2/12,13.16%,SLC25A21;LDHD
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.35499089799618677,-0.6665708577967642,0.9193548387096774,1.0,1.0,2/14,9.88%,GLRA2;MT1H
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.4209557710299061,-0.6665567873695905,0.8,1.0,1.0,1/6,6.92%,CYP1B1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.25124233124968537,-0.666280655726929,1.0,1.0,1.0,54/408,18.23%,TGFBR2;TLR2;VRK2;PLK2;PRDX4;MAP3K6;APP;CCL2;PIM3;TLR3;PTK6;NUAK2;PDK1;PRKCG;MAK;FAM20C;RPS6KA1;MYO3A;SBK1;FAM20A;MINK1;PDK3;NUAK1;DAB2IP;PRKCQ;SYK;BMX;PINK1;LIPE;PRKCH;PIM1;STRADB;FES;NEK10;MYLK3;STK32B;AATK;COQ8B;GLYCTK;PRKCD;RELN;PIK3CD;CDK2;CDC7;NRBP2;HIPK4;PRKCB;TEK;CDK5;LIMK2;HIPK3;DAPK3;TGFB1;RPS6KA6
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,-0.3173134509661958,-0.6659950676657016,0.9054054054054054,1.0,1.0,9/40,17.15%,NPY;ADCY7;ADCY5;LIPE;PIK3CB;PIK3CD;ADCY3;IRS2;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.3815800303924739,-0.6659896213100939,0.9019607843137255,1.0,1.0,1/12,6.29%,BRCA1
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.28948006392118797,0.6659267363668534,1.0,1.0,1.0,12/35,22.55%,BMP2;SOX9;TCAP;HEYL;NIPBL;EPHB4;FLRT2;CHD7;HEY1;HEY2;MDM4;PTK2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.4370405749207646,-0.6658302264253156,0.8813559322033898,1.0,1.0,2/6,21.28%,BTG1;SFRP1
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),-0.43914845144160497,-0.6657123716066954,0.8548387096774194,1.0,1.0,2/6,16.52%,OLAH;OXSM
prerank,Reactome_2022__Mucopolysaccharidoses R-HSA-2206281,0.36276312112164844,0.6656837453964847,0.8717948717948718,1.0,1.0,4/8,29.17%,GALNS;ARSB;GNS;GLB1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.3165794215781881,0.6653210696099973,0.9393939393939394,1.0,1.0,1/20,2.08%,ADAMTS9
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.28027737527941377,0.6651758721615493,1.0,1.0,1.0,11/34,27.72%,ZNF207;CEP192;AAAS;TOGARAM1;TPX2;KIF3B;PIBF1;MAP9;KIFC2;CLASP2;SMC3
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.3353111154110645,-0.6650362926163991,0.9166666666666666,1.0,1.0,3/29,10.01%,KREMEN2;NOTUM;WNT5A
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),-0.4285868994216208,-0.6647831626943105,0.8333333333333334,1.0,1.0,1/5,19.40%,GHR
prerank,CellMarker_Augmented_2021__Germ cell:Gonad,-0.29917058258348883,-0.6647485976928006,0.971830985915493,1.0,1.0,3/46,4.67%,ZNF850;SPINK9;HELB
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,-0.25739668242958835,-0.664730136185186,1.0,1.0,1.0,26/310,12.77%,CDKN2A;BLM;POU4F1;RPS27A;PLK2;TP53I3;PRDX5;BRCA1;PMS2;STEAP3;YWHAH;PLK3;COX4I1;GADD45A;ARID3A;POLR2I;RPA3;TAF10;CCNB1;NDRG1;NUAK1;FANCI;PRDM1;CCNE2;BCL2L14;UBC
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.2868325819429879,-0.6643656735526798,0.9759036144578314,1.0,1.0,10/81,15.85%,PLK2;GFAP;PRKCG;WNT5A;DAB2IP;HECW2;GPC3;VIP;OAZ2;EEF1A2
prerank,CellMarker_Augmented_2021__Sertoli cell:Undefined,-0.3958925017044099,-0.6641657610229507,0.8518518518518519,1.0,1.0,1/9,6.53%,GATA1
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,-0.27092840542836,-0.6638853692613375,1.0,1.0,1.0,10/140,10.38%,FOSB;PGR;GNG3;KCNH8;CCND1;EGF;SRF;S1PR3;POLR2I;TGFA
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.36358418962744976,-0.6636567131531721,0.8983050847457628,1.0,1.0,1/12,5.41%,SLC25A21
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.36358418962744976,-0.6636567131531721,0.8983050847457628,1.0,1.0,1/12,5.41%,SLC25A21
prerank,Reactome_2022__GAB1 Signalosome R-HSA-180292,-0.37873708646317156,-0.6636544716413073,0.9253731343283582,1.0,1.0,2/12,10.38%,EGF;TGFA
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.4282436449871649,-0.6632268849823846,0.875,1.0,1.0,2/6,17.63%,CD200;GPER1
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,-0.2928508392410155,-0.6630985680863004,0.987012987012987,1.0,1.0,8/67,16.75%,DEPDC1B;ANLN;ARHGAP39;ARHGEF17;FLOT1;DLC1;MCAM;ERBIN
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.3635253417235533,-0.662979981324798,0.9473684210526315,1.0,1.0,6/15,20.50%,CCND1;CCNE2;CDK2;CCND2;CDKN1A;CDKN1C
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.31908168575202417,-0.6628675536769513,0.9264705882352942,1.0,1.0,5/45,11.12%,SHTN1;CNTNAP1;NYAP1;MINK1;DAB2IP
prerank,"Reactome_2022__WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",-0.37470500220072267,-0.6627735585890663,0.9454545454545454,1.0,1.0,2/11,19.33%,WNT5A;CLTB
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.33667673719454755,-0.6626279992840565,0.918918918918919,1.0,1.0,3/27,15.10%,RPS27A;UBC;UBE2S
prerank,Reactome_2022__Metallothioneins Bind Metals R-HSA-5661231,-0.4062663382964644,-0.6626062211605679,0.8833333333333333,1.0,1.0,1/8,9.88%,MT1H
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.39126764523833707,-0.6625771766338022,0.9411764705882353,1.0,1.0,4/10,22.29%,LDLR;MFSD2A;SREBF1;SCARB1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.30704777413830153,0.6623481482626478,0.926829268292683,1.0,1.0,1/15,1.20%,RGS10
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.34366165905128876,-0.6616544879156758,0.9142857142857143,1.0,1.0,1/18,2.27%,NDST4
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3306216319908384,-0.6614633260845061,0.9436619718309859,1.0,1.0,5/23,17.19%,PRKCQ;TNS2;PRKCD;TSC2;PRKCB
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.33773231853298885,0.6613500511189762,0.9354838709677419,1.0,1.0,4/16,20.01%,RCC2;RRP1B;GPSM1;TMED2
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.3938633782715928,-0.6612040409251675,0.8947368421052632,1.0,1.0,3/11,22.98%,IL7;IRS2;STAT3
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.3938633782715928,-0.6612040409251675,0.8947368421052632,1.0,1.0,3/11,22.98%,IL7;IRS2;STAT3
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.4084009695384816,0.6610106655362754,0.8421052631578947,1.0,1.0,2/6,25.15%,RBPMS2;FOXO4
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.369895582415779,-0.6609143197991016,0.8833333333333333,1.0,1.0,3/12,17.95%,CCL2;IL18;TGFB1
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Liver,0.2737137832999117,0.6605833316049227,1.0,1.0,1.0,6/43,14.00%,ITGA1;ALCAM;GPM6B;NXT1;LRRC17;MDK
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.2817891850934766,-0.660496927913009,0.9743589743589743,1.0,1.0,10/98,13.97%,TGFBR2;RPS27A;SCX;BMP8A;ZYX;ARHGEF18;RUNX2;EID2;UBC;FOS
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.3059290196717871,0.6601745774830382,0.9230769230769231,1.0,1.0,4/25,17.53%,KCNE1;KCNIP3;WNK3;DPP6
prerank,Reactome_2022__Recycling Of eIF2:GDP R-HSA-72731,0.3495783595645465,0.6600052220953039,0.8333333333333334,1.0,1.0,1/8,4.38%,EIF2S1
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.3139781266883767,0.6596610314738471,0.896551724137931,1.0,1.0,2/30,5.16%,NCSTN;NAPSA
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3655994339918474,0.659574075644663,0.9142857142857143,1.0,1.0,5/11,20.90%,TMEM33;ATF6;PIK3R1;ERN1;BCL2L11
prerank,Reactome_2022__Signaling By Retinoic Acid R-HSA-5362517,0.31526194776666394,0.659540180419414,0.96875,1.0,1.0,4/27,4.70%,PDK4;RARB;ALDH1A1;RDH10
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.26206424952039664,0.6592375730772784,0.9655172413793104,1.0,1.0,8/35,22.40%,BMP2;FBXO5;ACVR2A;PRKD1;ZHX3;BMPR1B;HGF;WNT7B
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.3873004640756177,-0.6589104936249319,0.864406779661017,1.0,1.0,4/8,28.43%,PRKCB;CD36;PPARG;LRP1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.2472385102697272,0.658812622365146,1.0,1.0,1.0,21/57,30.40%,KPNA2;PDE12;GTF2F2;VAPB;POLR2C;PPIE;CCNT1;NELFA;PPIH;CTDP1;ADARB1;PKN2;POLR2A;NR5A2;POLR2K;PPID;POLR2D;SRPK2;CNOT7;PABPC1;POLR2E
prerank,KEGG_2021_Human__Alzheimer disease,-0.25041093869304365,-0.6587900440904072,1.0,1.0,1.0,32/284,16.23%,GRIN2D;TUBB6;WNT8B;CHRM1;GRIN2A;COX7A1;APP;TUBB1;NDUFA2;NDUFB9;ITPR3;COX4I1;NDUFB11;WNT5A;CHRM3;PPP3CC;PSMB6;CACNA1C;PSMC3;UQCRQ;NOS1;GRIN2B;FADD;TNFRSF1A;NDUFB10;PIK3CB;PSMA8;APH1A;PIK3CD;CAPN1;PSMA7;COX7A2
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.4045124043049808,-0.6586713917481486,0.9137931034482759,1.0,1.0,2/7,22.28%,MMP24;CTNND1
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.4178991141400922,-0.6585525917458914,0.8813559322033898,1.0,1.0,1/8,6.90%,GAP43
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.312840480583006,-0.6580461147758071,0.9871794871794872,1.0,1.0,14/56,20.30%,ANO2;GLRA2;ANO9;GABRE;GABRB2;GABRD;SLC20A2;GABRG2;SLC12A7;GABRA1;GLRA1;GABRA6;GABRG3;GABRA3
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.31706513691794513,-0.657831868481459,0.9552238805970149,1.0,1.0,1/29,2.23%,RPS27A
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),0.38133890554502486,0.6577279614182011,0.9117647058823529,1.0,1.0,3/5,22.80%,GPLD1;ACSL3;ABCB11
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,-0.3446034547766419,-0.6575949910281124,0.9375,1.0,1.0,4/16,15.54%,SYK;BLNK;PIK3CB;VAV1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.2927197950741469,0.657496143916612,0.9166666666666666,1.0,1.0,3/24,15.38%,TNFAIP3;MUL1;RNF26
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.31043507820519445,-0.6573542189958319,0.9565217391304348,1.0,1.0,1/39,2.59%,WARS1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.30455424816610954,-0.6571327281045772,0.948051948051948,1.0,1.0,9/49,19.49%,PRKCG;DAB2IP;PINK1;PSMC3;RHBDF1;DDRGK1;PSME1;NUPR1;GABARAPL2
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.29646409860005074,-0.6569943793023915,0.9714285714285714,1.0,1.0,3/39,12.77%,RPS27A;RPA3;UBC
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.2952389998677064,-0.6568791579219028,0.9710144927536232,1.0,1.0,8/46,17.44%,BHMT;PSMB9;PSMB6;PSMC3;OAZ2;PSMA8;PSMA7;PSME1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.2837632370915306,0.6565750167510901,1.0,1.0,1.0,5/35,20.01%,UBE2T;KLHL12;MARCHF7;UBE3D;PEX12
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.3171107272924518,-0.6565556789362341,0.9066666666666666,1.0,1.0,4/35,13.59%,NLRC5;ISG15;IFIH1;HERC5
prerank,Reactome_2022__Phenylalanine And Tyrosine Metabolism R-HSA-8963691,0.3658234200629617,0.6564418083990108,0.8936170212765957,1.0,1.0,4/9,31.52%,QDPR;ASRGL1;FAH;ATAT1
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,0.32517734363811823,0.6563883129544296,0.967741935483871,1.0,1.0,4/22,14.75%,AGER;HMGB1;NFKBIB;NFKB1
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.4044804871801482,-0.6557778587274593,0.9333333333333333,1.0,1.0,3/7,31.44%,BCAT1;BCAT2;HMGCLL1
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.33654591953657775,0.6557134773598711,0.9166666666666666,1.0,1.0,2/10,11.18%,PTGIS;TP53BP2
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.4002522167906716,-0.6556276722051851,0.8923076923076924,1.0,1.0,2/8,10.53%,PDK1;PDK3
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.4002522167906716,-0.6556276722051851,0.8923076923076924,1.0,1.0,2/8,10.53%,PDK1;PDK3
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.4214058384739842,-0.655602297875064,0.8709677419354839,1.0,1.0,2/7,21.28%,BTG1;SFRP1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.3657899851639138,-0.6555653518903468,0.9333333333333333,1.0,1.0,3/13,22.98%,STAT6;GHR;STAT3
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.2730913003658354,-0.6553783333616253,0.9864864864864865,1.0,1.0,13/80,18.28%,SIX3;PSMB9;ANAPC11;CCNB1;PSMB6;PSMC3;TFAP4;NEK10;UBE2S;PSMA8;PSMA7;PSME1;CDKN1A
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.2684395006050263,-0.6553231911661616,0.9879518072289156,1.0,1.0,8/122,12.57%,CCNB2;ABCB1;PLK3;CCNB1;DCTN1;FOXM1;HAUS7;CEP76
prerank,CellMarker_Augmented_2021__Purkinje cell:Brain,-0.2876279989956938,-0.6552567799353672,0.9873417721518988,1.0,1.0,5/91,11.72%,CNTNAP1;SBF1;ARHGEF17;DMWD;DCTN1
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.42017332743900004,0.6551687176574275,0.8837209302325582,1.0,1.0,3/5,30.50%,ATP8A1;TMEM30A;ATP11B
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),0.416715535697081,0.655141060016283,0.8421052631578947,1.0,1.0,1/5,4.04%,FUT9
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.26708688041425677,-0.6550863235268266,0.9880952380952381,1.0,1.0,8/121,12.57%,CCNB2;ABCB1;PLK3;CCNB1;DCTN1;FOXM1;HAUS7;CEP76
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.3182466778076363,-0.6550439346330824,0.9552238805970149,1.0,1.0,8/39,18.05%,RPS27A;HROB;RPA3;ISG15;UBC;RPA1;POLD1;CDKN2D
prerank,GO_Biological_Process_2021__negative regulation of ceramide biosynthetic process (GO:1900060),-0.4580623083487628,-0.6550392517295069,0.9454545454545454,1.0,1.0,2/5,24.63%,ORMDL2;SPHK1
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,-0.3055733143216541,-0.6549800206789439,0.9436619718309859,1.0,1.0,9/50,15.59%,ARHGEF3;PLEKHG2;ARHGEF38;ARHGEF17;ARHGEF18;OBSCN;RNASE1;VAV1;RASGRF2
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.2664491078785529,0.6549737867806515,0.9545454545454546,1.0,1.0,12/70,16.38%,RAB33B;SPATA4;TMEM33;MFF;PRMT6;PDE4DIP;ZEB2;MUL1;MIEF2;MARK2;EP300;VPS11
prerank,KEGG_2021_Human__Asthma,-0.3872454588905812,-0.6548044377950382,0.85,1.0,1.0,2/7,16.36%,HLA-DRA;HLA-DRB1
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,-0.32178489786292,-0.6547869121320067,0.9090909090909091,1.0,1.0,5/25,16.58%,CDH6;CDH19;CDH9;CDH12;CDH17
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),0.39758154175320715,0.6547510082428735,0.8863636363636364,1.0,1.0,1/5,10.45%,PARVA
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),-0.38140668528109667,-0.6544714754274963,0.8421052631578947,1.0,1.0,1/7,5.75%,SLC4A11
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.4382258535161949,-0.6538486931485475,0.8833333333333333,1.0,1.0,5/5,56.20%,CLU;HSP90AA1;NAB2;HSP90AB1;EGR1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.3048225245364476,0.6535479105175602,0.9696969696969697,1.0,1.0,2/17,9.92%,RUNX1;ERBB4
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,-0.32552983456894263,-0.6535451914255517,0.9696969696969697,1.0,1.0,1/27,2.23%,RPS27A
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.3321869373188949,-0.6534676144233328,0.9285714285714286,1.0,1.0,2/20,5.61%,PDPN;ABCA12
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.35915560536544555,-0.653292200850131,0.9032258064516129,1.0,1.0,4/16,17.99%,VLDLR;MFSD2A;CLN3;SLC15A4
prerank,KEGG_2021_Human__Oxytocin signaling pathway,-0.26528557382741724,-0.6532014534065981,1.0,1.0,1.0,25/119,22.57%,KCNJ2;ADCY7;ITPR3;CCND1;PRKCG;PPP3CC;CACNA1C;ADCY5;FOS;MYLK3;CACNB1;ADCY3;GUCY1A1;OXTR;ADCY8;PRKCB;RYR2;CDKN1A;CAMK1D;MYL6B;MYL6;ITPR1;CALM3;KCNJ6;NFATC2
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.3748748270655651,0.6531808666128183,0.9347826086956522,1.0,1.0,2/9,18.04%,MUL1;PIAS4
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In2:Brain,-0.2710636530661362,-0.6524763032994638,1.0,1.0,1.0,31/100,20.50%,TTLL7;CTNNA3;ATRNL1;SLC24A2;SRRM4;MAP1B;IL1RAPL1;RIMS2;SCN1A;SYNPR;GRIN2B;SCN3B;GRID2;GAD2;PCDH11X;GABRG2;SYT16;GABRA1;CNTNAP5;SLCO1A2;LRRC9;FBXL2;FGF12;RPS6KA6;AKAP6;CELF4;ST8SIA3;HCN1;PTPN5;MCF2L2;CDH8
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.2803937167246673,-0.6523497445447217,1.0,1.0,1.0,8/54,21.31%,KCNB1;MAP1LC3A;MFSD2A;WDR45;SREBF1;SFRP1;KLF10;STK24
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.2966961948048256,-0.652332142543635,0.9466666666666667,1.0,1.0,2/36,10.88%,KIF17;IFT122
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.4075375183059939,-0.6520986741377869,0.7936507936507936,1.0,1.0,2/6,21.28%,GNG2;SFRP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.3635102901735445,-0.652045425375414,0.9,1.0,1.0,6/16,23.48%,ATP1B1;CACNA1C;RYR2;CALM3;SLC9A1;GSTO1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.3415353351786369,-0.651978039584336,0.9272727272727272,1.0,1.0,1/16,6.29%,BRCA1
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.3647662594572496,0.6519408179697036,0.8780487804878049,1.0,1.0,3/8,24.83%,SALL1;PKD2;BMP7
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),0.4097251278735411,0.6518880830978305,0.8936170212765957,1.0,1.0,1/5,6.69%,AKT1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.29452770497239766,-0.6518798703436574,0.9444444444444444,1.0,1.0,2/39,8.98%,SUN3;IRAG2
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.3100981045587108,-0.6517627904894255,0.9571428571428572,1.0,1.0,9/34,20.50%,CCND1;ANAPC11;CCNE2;UBE2S;CDK2;CCND2;CDKN1A;ANAPC15;CDKN1C
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.32544439522393515,0.6513970695042506,0.9767441860465116,1.0,1.0,1/18,1.98%,PPARGC1A
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.30703444546587094,-0.6512242281840254,0.9701492537313433,1.0,1.0,1/35,2.59%,WARS1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.34913636835994905,0.6511009994290912,0.9142857142857143,1.0,1.0,1/11,2.91%,ADRA1A
prerank,Reactome_2022__Autophagy R-HSA-9612973,-0.26710820493071297,-0.6510758941705307,1.0,1.0,1.0,11/117,16.87%,TOMM7;RPS27A;GFAP;ATG9A;MAP1LC3A;PINK1;UBC;RNASE1;WDR45;GABARAPL1;TSC2
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.3993478233958149,0.6510262124458474,0.8717948717948718,1.0,1.0,1/6,16.38%,VPS11
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.39232904219190956,0.6509291644573155,0.8913043478260869,1.0,1.0,3/6,18.99%,TMX3;PRDX3;CHCHD4
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.2938867052129155,0.650905811213985,1.0,1.0,1.0,6/34,14.25%,SOX8;PEF1;ERBB4;KLHL12;CDH2;TAPT1
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.39783955786502,0.6508997360495987,0.8958333333333334,1.0,1.0,2/5,18.58%,SLC3A2;SLC36A4
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.39240323457638704,0.6505772726695034,0.9111111111111111,1.0,1.0,3/7,26.98%,QDPR;ASRGL1;FAH
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.24740644715791396,-0.6504487923566429,1.0,1.0,1.0,20/285,13.76%,PRAME;TRIM22;RPS27A;ARIH2;TRIM5;BRCA1;PSMB9;ANAPC11;FBXL18;HERC6;FBXW12;SPSB1;FBXO32;PSMB6;FBXW10;PSMC3;HECW2;UBC;HERC5;RNF213
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.30390341871989424,0.650360120268596,0.8666666666666667,1.0,1.0,12/24,29.87%,WDR33;CSTF3;PAPOLA;MTPAP;TENT4B;CLP1;CPSF2;SSU72;PAPOLG;TENT2;SCAF8;PABPC1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.30390341871989424,0.650360120268596,0.8666666666666667,1.0,1.0,12/24,29.87%,WDR33;CSTF3;PAPOLA;MTPAP;TENT4B;CLP1;CPSF2;SSU72;PAPOLG;TENT2;SCAF8;PABPC1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.37707043778923555,-0.6501311099379788,0.8709677419354839,1.0,1.0,3/10,24.87%,SELP;ETS1;ALOX5
prerank,CellMarker_Augmented_2021__Hepatocyte:Liver,0.3648176407344008,0.6496729700600357,0.8205128205128205,1.0,1.0,2/7,11.80%,ABCC2;KRT8
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.3131408125005623,0.6496555754380853,0.9230769230769231,1.0,1.0,3/15,17.98%,KANSL2;KAT7;MCRS1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.3131408125005623,0.6496555754380853,0.9230769230769231,1.0,1.0,3/15,17.98%,KANSL2;KAT7;MCRS1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.3295022329456083,-0.6496108431379568,0.9324324324324325,1.0,1.0,4/20,17.31%,SULF1;HS3ST3B1;HS6ST1;GPC1
prerank,KEGG_2021_Human__Lysosome,-0.2744947140769324,-0.6495890625536364,1.0,1.0,1.0,14/105,19.54%,SLC17A5;CTSC;AP1S1;CTSS;M6PR;CTSZ;CD63;SLC11A1;HYAL1;CLN3;CTNS;CTSA;CLTB;IDUA
prerank,Reactome_2022__Peroxisomal Lipid Metabolism R-HSA-390918,0.2725223026015213,0.6493542835609222,1.0,1.0,1.0,7/25,21.98%,ABCD1;PHYH;EHHADH;ACOX1;SLC25A17;MLYCD;NUDT7
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.2939765779530943,0.6491396042541718,0.9090909090909091,1.0,1.0,3/26,10.74%,ELOVL6;ELOVL2;HACD2
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.357059947370633,-0.6489973282368243,0.9354838709677419,1.0,1.0,4/17,26.51%,FGF1;SREBF1;SEC14L2;SREBF2
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.38062491961725164,-0.6489291864599986,0.9180327868852459,1.0,1.0,3/10,17.36%,NOS1;CYP3A4;CYP3A5
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,-0.2834245951807414,-0.6488937678700744,0.9866666666666667,1.0,1.0,9/61,16.58%,CDH6;CLDN16;CLDN20;CLDN18;CDH19;CDH9;CDH12;ITGB4;CDH17
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.2619277558237554,-0.64856811760142,1.0,1.0,1.0,20/133,17.95%,TLR2;DEPDC1B;SULF1;RSPO3;PSMB9;EGF;LRRK1;PLEKHA4;LGR5;PSMB6;SFRP4;PSMC3;RSPO4;GPC3;SFRP2;PSMA8;PSMA7;PSME1;DAPK3;TGFB1
prerank,Reactome_2022__Glycogen Breakdown (Glycogenolysis) R-HSA-70221,-0.361837094012487,-0.648452025881664,0.9206349206349206,1.0,1.0,2/14,10.90%,GYG2;PYGL
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,-0.2972289248278889,-0.6481150826457589,0.9452054794520548,1.0,1.0,6/44,18.34%,KDELR3;TSPYL2;DCTN1;TLN1;ARFGAP1;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.27979951179616913,-0.6481094433786464,0.975609756097561,1.0,1.0,9/72,18.14%,WARS1;SH3GL2;DBI;DAB2IP;PAQR3;XRCC1;TGFB1;TINF2;MAPT
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,-0.31958749939175757,-0.6480014109803068,0.927536231884058,1.0,1.0,3/27,8.73%,ITGA5;ITGA8;LTBP4
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),0.39545824414307806,0.6476471925577076,0.8958333333333334,1.0,1.0,1/6,4.85%,GREM1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.28401413974635215,0.6474105954508942,0.9354838709677419,1.0,1.0,10/30,25.30%,COMMD1;GPM6B;TAX1BP3;LEPROTL1;PICALM;NEDD4L;LZTFL1;UBXN2B;ROCK2;LATS1
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.3786829443790809,0.6472281509243096,0.8571428571428571,1.0,1.0,4/7,41.07%,CTH;CDO1;MTR;CBS
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Fetal Kidney,-0.23715170630680718,-0.647156774718932,1.0,1.0,1.0,418/3959,18.13%,CLIC1;LEF1;GBP2;IL1R1;RASGRP1;S100A10;TMEM204;HPN;IFI6;TYMS;SCN1B;TAMALIN;SOCS3;CDKN2A;ARHGAP4;BLM;RFTN1;DUSP1;SP100;IPCEF1;AGPAT4;B3GALT2;NR4A3;MYO1F;GBP1;SPARC;DOCK8;RPL19;RASGRP2;TOMM7;RPL3;TMSB10;PLAAT4;B2M;ICAM1;FOSL2;TRIM61;ABCA5;TAGAP;ZFP36;WDR62;RPS27A;PDE4A;BCAS1;ARIH2;IFITM3;RPL36AL;NAA38;RPS27;C20ORF144;COL4A4;ARHGEF3;CTHRC1;HLA-A;ADGRE5;SKAP1;STAG3;RGL4;RPS14;TMC8;SPON2;RPS4X;IRF1;S100A6;BTG3;LDHA;INPP5D;RPL27A;MATN2;STAT4;GPR171;RAB11A;IFI35;MAFF;EVI2A;SLA;SLC16A3;CHI3L2;ITM2A;CD160;COL27A1;TPST1;HELB;ARHGAP9;PRDX5;RASGEF1A;RPL35;EMG1;CTSC;TMC6;DNAJC2;ARHGAP15;RPL7A;ZNF585B;GPR18;PIM3;RPL37A;HLA-C;NDUFA2;RALGDS;BEST1;ABCB1;RPL27;BRCA1;ACOT4;POLE3;ACAP1;PARP14;PMS2;SVIL;BST2;LDB2;NDUFB9;CD44;PDXDC1;SURF2;C12ORF57;AKAP5;TNFRSF14;RPL9;GLRX;COX4I1;CMTM3;PSMB9;RPL21;PDHX;ANAPC11;HEXIM1;ENOSF1;PLSCR1;MZT2B;RNF181;DBI;DRAXIN;PRCD;GRM6;SLCO3A1;NCALD;NDUFB11;NOB1;ZNF829;RCSD1;UNC13C;RPL13A;SH3BP2;WAS;TSPYL2;RPS6KA1;LMNB1;TPD52;LAT2;IRAG2;BTG1;SBK1;SNRPD2;PFDN6;CRLF3;CRELD2;ATG9A;ODAD1;GPR82;SMYD4;TAGLN2;NFKBID;NUF2;POLE4;IL4R;PLPPR5;POLR2I;PIK3IP1;TCP1;RAB11FIP1;NCAPD3;RPA3;BBLN;HELZ2;IRF7;RASGEF1B;KLF3;RPS11;RPS16;NAP1L5;ZYX;PPP3CC;HDDC2;TAF10;RPL24;PTPN7;ISG15;RPLP1;WDR54;SNX10;PDK3;SPAG1;LRPAP1;RPS13;PGK1;PSMB6;M6PR;ROMO1;LPCAT4;GOLGA8B;BIRC3;RPL38;HLA-B;SYNM;PRKCQ;ARPC5L;P4HTM;APOL6;PRDM1;CD55;HLA-E;NOL7;CSRNP1;DDX60;MAPRE2;RHOF;TMPRSS3;SH3BP5;GALNT10;RPS3A;BMX;MAP1LC3A;ITPRIP;PSMG4;B3GNT2;DCTN1;NAMPT;LAGE3;SHISA5;BAP1;TMBIM1;RPS8;RPL10A;TPM4;RPL10;RUNX2;PSMC3;BAALC;MYH9;TNIP2;SIGIRR;PDZK1;UQCRQ;RPLP2;RPS23;HAUS7;NUDT4;CFH;TC2N;GNG2;IFIH1;OGG1;PRKCH;ARRDC2;SEC11C;PIM1;RPS21;CORO7;CEP76;OLAH;DUSP16;RPS7;RPS18;ELMO1;UBC;CABIN1;CD63;P2RY10;ACOT2;TESPA1;PLEKHF1;FAM50A;TSPAN32;SP110;GCHFR;MEA1;HLA-F;NDUFB10;RPA1;RPL8;DHX38;SP140L;APOL3;SLC38A1;RNF213;AKAP17A;DALRD3;ZNF574;SP140;NARF;RASD1;FOS;THEMIS;NOP10;FAHD2B;NR4A1;NMT1;SLC25A26;APBA2;BTN3A1;CCDC25;TSR2;RPS6;WDR45;RPS15;ZNFX1;KANK3;PPIB;SSR4;SRGN;GPI;APOBEC3H;WDR1;HDHD2;SLC14A2;SLC4A10;RPS9;UBE2S;CD74;SFRP2;TMEM208;PSMA8;RPL12;PLAC9;CD37;VAV1;APH1A;MRPL20;RPL5;RBM3;MICALL1;GNE;DDRGK1;PLAT;SDF2L1;PIK3CD;JUNB;UBXN1;JADE2;SH2D3A;CCND2;GSS;TLN1;IL27RA;TRANK1;ATOX1;SAMD3;SRA1;CAPN1;MAX;PSMA7;FAU;COX7A2;SNAI3;PFDN1;TRAPPC2L;MVK;KLHL28;ANXA2;MCAM;RPL23;RPL4;PTPRR;CEBPD;EMP3;STAT6;GABARAPL1;PML;SLC7A6OS;EMD;CDCA7;TSC2;EID1;TEX30;DOCK10;HDAC7;AURKAIP1;IRS2;ANKZF1;PFKFB3;SH3KBP1;AHI1;CDC37;ZFYVE28;MTA1;GOLGB1;PSME1;RNASEH2C;ETS1;RPL18A;CREB3;PGAM1;SLC50A1;FDPS;RBX1;RPL41;GADD45B;ASMTL;RASSF1;NMI;COTL1;RPL7;RPS12;TGFB1;DDX24;CARD11;TMED1;SLC15A4;PLP2;SPECC1L;FERMT3;CDKN2D;ITIH5;IER2;CCNF;TINF2
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.30180434554722524,0.646998276839814,0.918918918918919,1.0,1.0,9/22,24.89%,AKT1;EIF4EBP2;CCDC88A;EIF4EBP1;SMG1;RPS6KB1;MEAK7;RPTOR;NPRL3
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.37836730097121707,-0.6469310879887906,0.9285714285714286,1.0,1.0,1/12,7.17%,TIMP1
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,-0.3484959486776929,-0.6462153887621245,0.9298245614035088,1.0,1.0,2/17,11.79%,IRF1;IL18
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.32399819341829045,-0.6461446369574784,0.9393939393939394,1.0,1.0,5/27,17.37%,PTK6;EGF;PTPRR;ERBIN;CDC37
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.27269881749253316,-0.6459139588833719,0.9743589743589743,1.0,1.0,23/86,25.54%,MET;VAC14;CENPE;CD74;RELN;EEF1A2;HLA-DRB1;TEK;MAPT;CDKN1A;SPDYA;CD4;PDGFRA;ALK;ZNF16;PTPRC;EPHA10;MMD2;MAP2K3;TYRO3;NBN;MRE11;NTRK3
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.37417427340551024,0.645804708145395,0.9523809523809523,1.0,1.0,4/8,31.30%,HDAC10;SIRT2;HDAC9;SIRT1
prerank,Reactome_2022__Myogenesis R-HSA-525793,0.3015763945037781,0.6455940215166478,0.972972972972973,1.0,1.0,4/22,24.25%,MAPK12;CDH2;TCF12;CDON
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,0.31725925885544454,0.6455262890799612,0.9767441860465116,1.0,1.0,3/17,18.68%,DUSP6;DUSP12;MAP2K2
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,-0.29788123508253755,-0.6454764558491921,0.9333333333333333,1.0,1.0,5/48,9.99%,PTK6;COX4I1;BLVRB;MAFK;HELZ2
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),0.36358634247588917,0.6453253025425634,0.8222222222222222,1.0,1.0,1/5,12.81%,SLC25A5
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.37482833278840155,0.6451270182101848,0.94,1.0,1.0,6/8,38.54%,UBQLN1;USP14;NFE2L2;UBQLN2;BCAP31;SGTA
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.32987682477062596,0.6451221892870806,1.0,1.0,1.0,4/17,14.81%,STIL;PCM1;C2CD3;CEP192
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.3130763085218861,0.6451180804430401,0.9696969696969697,1.0,1.0,6/18,25.98%,ALDH7A1;PIPOX;DDO;SDSL;GOT2;OGDH
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,-0.30151031456686656,-0.6448424347011412,1.0,1.0,1.0,2/39,5.81%,B4GALNT1;UGT8
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.2831388213118071,0.6447767216097192,0.9642857142857143,1.0,1.0,1/24,5.44%,RNF2
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3284915114466783,-0.6446642407901738,0.974025974025974,1.0,1.0,6/25,21.23%,LTBP4;SFRP4;EID2;ITGA3;TGFB1;PCSK6
prerank,Reactome_2022__DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,-0.4125884316975845,-0.6444325006483913,0.8688524590163934,1.0,1.0,1/7,10.08%,IRF7
prerank,Reactome_2022__Activation Of SMO R-HSA-5635838,0.3252237254360971,0.6443246442506545,0.9117647058823529,1.0,1.0,4/14,25.32%,GAS1;SMOX;CDON;ARRB1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.38362627916029945,-0.6442502747051267,0.875,1.0,1.0,5/9,26.76%,DLGAP3;NPTX2;DLGAP2;BEGAIN;NPTX1
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,-0.27322240646178075,-0.6442425897616797,0.9875,1.0,1.0,5/90,10.38%,FOSB;PGR;CCND1;POLR2I;TGFA
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3935509006670849,-0.6439290275000459,0.9,1.0,1.0,4/10,30.11%,HLA-DRB1;ADCY8;STX4;CFTR
prerank,KEGG_2021_Human__Histidine metabolism,-0.3539145063192919,-0.6439182656979134,0.9090909090909091,1.0,1.0,4/15,16.24%,MAOB;CARNS1;CNDP1;ALDH3A2
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.45975406274141983,-0.6438583076620896,0.9807692307692307,1.0,1.0,2/6,21.63%,SYK;GAB2
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.310917292826271,-0.6436948063168375,0.9027777777777778,1.0,1.0,3/30,12.88%,BAIAP2;WAS;RNASE1
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,-0.26736966335010337,-0.6434275286316988,0.9885057471264368,1.0,1.0,8/133,7.93%,ANO2;RPS27A;ATP8B4;PLN;TRPC3;BEST1;ANO9;ATP1B1
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.3699866593140883,0.6432874582401085,0.8780487804878049,1.0,1.0,3/8,25.32%,KAT7;IWS1;ARRB1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.29377696953466265,0.643152992476849,0.9166666666666666,1.0,1.0,5/21,24.15%,GPM6B;EFNA5;SLK;PTK2;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.4337301363977577,-0.6430817601165112,0.96,1.0,1.0,2/6,21.59%,PDZK1;P2RX7
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.4075517656740649,-0.6427411079198958,0.8571428571428571,1.0,1.0,3/6,17.04%,PRKCQ;BCL6;IRS2
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,0.26563795220307695,0.6427207629759331,0.9655172413793104,1.0,1.0,4/35,14.75%,POLR3B;POLR3F;NFKBIB;NFKB1
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,-0.32709521445712025,-0.6424512748353663,0.9154929577464789,1.0,1.0,6/26,18.28%,RPS27A;UBC;MYO18A;GOLGB1;ETV6;CDKN1A
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.3717830321116955,0.6420251639497869,0.9069767441860465,1.0,1.0,2/8,13.82%,HMGB1;RAB7B
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.364794483979989,0.6414742518475794,0.8717948717948718,1.0,1.0,3/8,28.59%,NIPBL;CHD8;KIT
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.2567471525947228,-0.6412301885055092,1.0,1.0,1.0,12/128,10.81%,DUSP1;MTMR7;SBF1;PP2D1;SGPP2;PLPPR1;FBP1;PLPPR5;PLPP4;PPP3CC;PTPN7;ALPL
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.35284596551363445,-0.6408044405855978,0.8793103448275862,1.0,1.0,1/14,6.59%,TLR3
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.3195411486329935,-0.6406814353183685,1.0,1.0,1.0,2/19,11.12%,FBP1;DAB2IP
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.30407611182531913,-0.640614432549437,0.9743589743589743,1.0,1.0,3/29,10.88%,FSIP2;SNX10;IFT122
prerank,CellMarker_Augmented_2021__Platelet:Undefined,-0.3532234223447258,-0.6402281862562658,0.9384615384615385,1.0,1.0,6/14,29.58%,CD9;TGFB1;CD36;PECAM1;CD151;ITGAV
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.41346244474707783,-0.6400783322323025,0.896551724137931,1.0,1.0,5/6,24.01%,GAD1;GAD2;PAH;BCAT1;BCAT2
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,0.28080221869723543,0.6398953600416647,0.9666666666666667,1.0,1.0,10/33,28.80%,CAPZA1;DCTN5;GALNT1;RAB3GAP1;RAB18;GALNT2;DYNLL2;PAFAH1B2;CAPZA2;BICD2
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.2605702226442575,0.6397091731146466,0.9,1.0,1.0,8/34,22.56%,PIK3R4;SESN2;PIK3C3;SESN3;EIF2AK3;PRKAA1;KPTN;BECN1
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.36921908375423984,-0.6396792345060631,0.8955223880597015,1.0,1.0,1/10,6.29%,BRCA1
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.3896017923546024,0.6393716943720531,0.8,1.0,1.0,2/6,18.79%,PHYH;PDSS2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),0.3391497781893072,0.6393546178273707,0.85,1.0,1.0,1/11,11.91%,TMEM35A
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.26845748880325176,0.6392531965426148,0.9333333333333333,1.0,1.0,12/26,30.64%,EAF2;HNRNPU;ZMYND11;NELFA;WDR43;CDK12;RNF168;RECQL5;LARP7;CDK13;SUPT16H;LDB1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.2671045253894311,0.6390039666942483,0.9655172413793104,1.0,1.0,5/42,10.07%,SPRED1;CCDC88C;KAT2B;RABL3;SESN2
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),0.38743266124929665,0.6389282982648082,0.85,1.0,1.0,1/6,5.23%,CA2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.34733356480861227,0.6386177875547216,0.9166666666666666,1.0,1.0,5/14,15.88%,RUNX1;SOX12;KAT2A;MDK;TNFSF4
prerank,CellMarker_Augmented_2021__Villous cytotrophoblast:Placenta,-0.2711372206802026,-0.6386126803026209,0.961038961038961,1.0,1.0,6/84,11.88%,RECQL4;GINS2;NUF2;NCAPD3;FANCI;KIF2C
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.32106129884948487,-0.638468711424046,0.935064935064935,1.0,1.0,2/30,6.29%,APLNR;BRCA1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.2569658956166111,-0.6384089727821599,1.0,1.0,1.0,15/120,19.86%,DUSP1;MTMR7;SBF1;PP2D1;PPP3CC;PTPN7;DUSP16;TNS2;PTPRR;PTPRF;PTPRO;PTPN21;DUSP8;PPP2R3A;PTPN5
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,0.23307667488978073,0.6381070300003513,1.0,1.0,1.0,15/56,22.30%,ELOC;GTF2F2;ELOA;ERCC2;MSH2;ERCC3;GTF2H5;GTF2H2;POLR2C;CCNT1;GTF2H3;NELFA;CCNT2;CTDP1;CDK12
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.3822083549903537,-0.6380390630347094,0.9107142857142857,1.0,1.0,3/8,18.05%,ACHE;NOS1;PAH
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.41793235474181695,0.6379817233019414,0.8367346938775511,1.0,1.0,1/5,13.67%,CDH2
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),-0.43323400601878165,-0.6379341205373283,0.921875,1.0,1.0,1/5,6.37%,ANLN
prerank,Reactome_2022__Membrane Trafficking R-HSA-199991,-0.23702763051314332,-0.6371176055751532,1.0,1.0,1.0,38/516,12.88%,EPN1;ANK3;KDELR3;RPS27A;NAA38;RAB11A;SH3GL2;F8;APP;CTSC;DENND3;TRIP10;SBF1;GJB7;GRIA1;YWHAH;CENPE;LDLR;EGF;TPD52;AP1S1;SYT1;KIF9;WNT5A;SH3GL3;TGFA;M6PR;GOLGA8B;CD55;COPZ2;DCTN1;KIF2C;MYH9;CTSZ;MYO1E;MAN1C1;UBC;RNASE1
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.39801814762869914,-0.6368819439309388,0.9152542372881356,1.0,1.0,1/8,3.20%,SKAP1
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.31875883383785986,0.6367377068960489,0.8461538461538461,1.0,1.0,1/11,6.31%,UBE2N
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.3236597053046376,-0.6365168955823841,0.9605263157894737,1.0,1.0,5/23,15.80%,MINK1;SHISA9;SHISA8;NLGN1;RELN
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.374233024456415,-0.6360194322419545,0.8596491228070176,1.0,1.0,2/9,21.79%,GSS;CHAC2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.35512694159741204,0.6357689365736187,0.8918918918918919,1.0,1.0,2/7,18.13%,FOXP1;CAMK4
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.3783706507989756,0.6356690483204587,0.9166666666666666,1.0,1.0,2/6,18.13%,TICAM1;CAMK4
prerank,CellMarker_Augmented_2021__Macrophage:Bone Marrow,-0.41777481428555213,-0.6356591036903625,0.9122807017543859,1.0,1.0,1/5,17.51%,MRC1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.3052072132843322,0.635644800500482,0.8857142857142857,1.0,1.0,1/17,5.44%,RNF2
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 24-Hydroxycholesterol R-HSA-193775,-0.38180082881067373,-0.6353513585575256,0.9264705882352942,1.0,1.0,1/9,5.52%,AKR1C1
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.3467703939628692,0.6353058404036844,0.9736842105263158,1.0,1.0,3/9,28.14%,ABL2;PDP2;PDP1
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.3388648581845209,-0.6348639078564629,0.9,1.0,1.0,2/13,17.54%,NLGN1;CDK5
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.40988786799752835,-0.6343489802290404,0.9354838709677419,1.0,1.0,4/7,29.80%,PIK3CD;MYO1C;PRKD2;HSPB1
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.3668510881362782,0.633831950027674,0.8444444444444444,1.0,1.0,1/6,10.17%,SLC26A3
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.31082741615080633,0.6335263751631139,0.9166666666666666,1.0,1.0,4/15,18.13%,EIF2AK4;KAT2A;CPEB3;CAMK4
prerank,KEGG_2021_Human__Purine metabolism,-0.2526164715051406,-0.6334388861241508,1.0,1.0,1.0,18/106,19.75%,PDE4A;GMPR;IMPDH1;ADCY7;PAPSS2;PDE6B;ENTPD3;ADCY5;NUDT16;ADCY3;GUCY2C;GUCY1A1;PDE5A;ADCY8;ENPP4;PDE1C;AK5;PDE1A
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),-0.4390009776711855,-0.6332965566331128,0.9310344827586207,1.0,1.0,2/5,28.09%,ULK1;ULK2
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.30499833803018,-0.63297776311418,0.9516129032258065,1.0,1.0,1/26,4.39%,SIGLEC1
prerank,CellMarker_Augmented_2021__Stem cell:Undefined,-0.4058576577925028,-0.6329045757919993,0.9137931034482759,1.0,1.0,2/6,10.74%,CD44;LGR5
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.36976562065473084,0.6328046696175591,0.9473684210526315,1.0,1.0,4/9,21.65%,RORB;CEP290;RP1;ARL3
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.2456214946980413,0.632540307963187,1.0,1.0,1.0,13/50,21.88%,NDUFB1;DMAC2;NDUFAF3;NDUFAF4;NDUFAF2;NDUFV3;NDUFA8;TIMMDC1;NDUFS1;NDUFV1;NDUFAF7;NDUFB4;NDUFAF5
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.2456214946980413,0.632540307963187,1.0,1.0,1.0,13/50,21.88%,NDUFB1;DMAC2;NDUFAF3;NDUFAF4;NDUFAF2;NDUFV3;NDUFA8;TIMMDC1;NDUFS1;NDUFV1;NDUFAF7;NDUFB4;NDUFAF5
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.3346285267986566,0.6321703804955882,0.9761904761904762,1.0,1.0,3/14,12.84%,MID1;TAOK2;TAOK3
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),-0.3942501872320426,-0.632104801711609,0.8846153846153846,1.0,1.0,3/5,19.74%,GAD1;GAD2;ALDH5A1
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.3708001923080919,-0.6318123309253395,0.8653846153846154,1.0,1.0,1/7,9.07%,PATL2
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),-0.29320799629136624,-0.6317836047573933,0.9571428571428572,1.0,1.0,1/42,0.88%,SKOR1
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.39507064348015186,-0.6317219279137146,0.8928571428571429,1.0,1.0,2/7,21.54%,RARG;FBN2
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.3049252532228095,-0.6315750974782719,0.9743589743589743,1.0,1.0,1/31,2.23%,RPS27A
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.32479759336786496,-0.6314662800395612,0.9428571428571428,1.0,1.0,5/18,23.62%,GNG3;GNG2;GNB4;GNB5;GNA14
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.29600398440526204,-0.6312586692753338,0.9875,1.0,1.0,3/42,10.43%,ABCA12;FA2H;CYP4F22
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,-0.2577409876265609,-0.6310698120452436,1.0,1.0,1.0,8/100,12.77%,TGFBR2;RPS27A;ITGA8;LTBP4;STAT1;ARHGEF18;GREM2;UBC
prerank,CellMarker_Augmented_2021__4-Cell Stage Cell (Blastomere):Embryo,-0.2993581676563045,-0.630945452586332,0.9342105263157895,1.0,1.0,1/29,4.70%,ARG2
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.328234595541166,0.6305156090830919,0.9393939393939394,1.0,1.0,1/18,1.39%,NCSTN
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),0.34302657866366976,0.6295327188218902,0.9375,1.0,1.0,3/14,7.43%,PDE12;ABCD1;VCP
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.2705316517541324,-0.6294172241717684,0.974025974025974,1.0,1.0,10/56,18.86%,PTK6;EGF;VIL1;TGFA;MVP;PTPRR;ERBIN;CDC37;TGFB1;PLCE1
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.27693115823597564,0.6292941336893729,0.9705882352941176,1.0,1.0,7/28,17.60%,CCT7;CSNK2A2;GNB3;CCT3;RGS7;GNAQ;GNGT1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.29838644757046207,-0.6291625701996362,0.9859154929577465,1.0,1.0,3/23,17.28%,EMP2;FGF7;VCL
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),-0.4315665097865044,-0.6288607958175223,0.8775510204081632,1.0,1.0,1/5,20.40%,HES1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.24755801678539294,-0.6283840207719446,1.0,1.0,1.0,20/156,18.23%,TGFBR2;VRK2;PLK2;PRKCG;RPS6KA1;SBK1;PDK3;PRKCQ;PINK1;PRKCH;STK32B;PRKCD;CDK2;CDC7;HPF1;HIPK4;PRKCB;CDK5;HIPK3;RPS6KA6
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.37179863031113836,0.6280714745951528,0.88,1.0,1.0,2/6,16.76%,THOC3;THOC1
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.37179863031113836,0.6280714745951528,0.88,1.0,1.0,2/6,16.76%,THOC3;THOC1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.2946728577380281,-0.6280463633044673,1.0,1.0,1.0,9/37,19.17%,APP;HLA-DRA;C12ORF57;TUSC3;MFSD2A;MGAT3;SHROOM4;CTNS;PTCHD1
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.3547192846208171,-0.6279601253666983,0.8214285714285714,1.0,1.0,1/12,6.59%,TLR3
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.25592745010453183,0.6277883342922965,1.0,1.0,1.0,9/37,17.94%,SOX9;EGFR;AKT1;PIK3CA;SHC3;PIK3R1;NCK2;PIK3C2A;EFEMP1
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.3386467645224663,-0.6277623449451488,0.9130434782608695,1.0,1.0,1/12,5.52%,AKR1C1
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.3404366935870284,-0.6276135475953455,0.9384615384615385,1.0,1.0,1/18,2.23%,RPS27A
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.39784067697694775,-0.6276052069775082,0.803921568627451,1.0,1.0,5/5,60.23%,ARF6;PIP5K1A;INPP5K;RAC1;AIF1L
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,-0.2558023567767381,-0.6273639817966977,1.0,1.0,1.0,5/126,7.60%,SOCS3;RPS27A;RHOBTB2;BRCA1;ANAPC11
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.24509154617042134,0.627268518883865,0.9565217391304348,1.0,1.0,12/59,19.83%,GALNT3;AKT1;CSNK2A1;CSNK2A2;MAPK8;WNK3;PRKD1;MARK2;GALNT1;DYRK2;NLK;DYRK3
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.28021240653121715,-0.6270404866355983,0.987012987012987,1.0,1.0,10/51,19.12%,FN1;DCTN1;TPM4;MYH9;RNF213;RPS6;VCL;RBX1;BCL11A;ALK
prerank,KEGG_2021_Human__Apoptosis,-0.2614489631428962,-0.6268981743183198,1.0,1.0,1.0,21/117,18.80%,CTSC;SEPTIN4;ITPR3;GADD45A;LMNB1;CTSS;BIRC3;DAB2IP;CTSZ;MAP3K14;FADD;TNFRSF1A;FOS;IL3RA;PIK3CB;BOK;PIK3CD;CAPN1;GADD45B;TNFRSF10A;BBC3
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.41616265528305646,-0.6268830706738924,0.864406779661017,1.0,1.0,2/6,12.35%,CENPE;HECW2
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.36954034997138724,-0.6267001051628217,0.9354838709677419,1.0,1.0,1/9,12.04%,MYH9
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.37810060342297835,-0.6263957649983615,0.8596491228070176,1.0,1.0,2/8,17.36%,CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.37810060342297835,-0.6263957649983615,0.8596491228070176,1.0,1.0,2/8,17.36%,CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.37810060342297835,-0.6263957649983615,0.8596491228070176,1.0,1.0,2/8,17.36%,CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.3595754259337968,-0.6260007987617757,0.9344262295081968,1.0,1.0,2/11,16.90%,THY1;CRB2
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,0.25847614363320176,0.6257950733644739,1.0,1.0,1.0,5/22,17.60%,AKT2;AKT1;GNB3;ARHGEF6;GNGT1
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.31849065985773545,0.6256837394655368,1.0,1.0,1.0,3/13,21.51%,ADRB2;UBQLN4;FYCO1
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.36255012630382005,-0.6255805304848429,0.9076923076923077,1.0,1.0,2/13,25.23%,SLC15A4;SHLD1
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.40816530618738145,-0.6255570301216373,0.8909090909090909,1.0,1.0,1/5,7.17%,TIMP1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.35597042636321946,-0.6252498049271603,0.9259259259259259,1.0,1.0,2/10,17.81%,TSPYL2;GMNC
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.3720701759134526,0.6244577248361362,0.925,1.0,1.0,2/8,7.15%,BAG2;FBXO5
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.3535986124204204,0.6243736688575711,0.9459459459459459,1.0,1.0,1/7,4.85%,GREM1
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.31995159946878127,0.6241439836374821,0.8863636363636364,1.0,1.0,2/10,12.02%,GUCA1B;SLC22A2
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.30906063634124525,0.623981625216939,0.9393939393939394,1.0,1.0,3/18,14.38%,SGCD;ZBTB18;CFLAR
prerank,Reactome_2022__APOBEC3G Mediated Resistance To HIV-1 R-HSA-180689,0.3887527083210426,0.6238674461277397,0.8947368421052632,1.0,1.0,1/6,15.21%,SGIP1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.2491167825354549,-0.6237891100456303,1.0,1.0,1.0,6/202,5.22%,DEPP1;TRIM22;MET;TRIM5;PLK2;HTR2B
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,-0.2615264911425857,-0.623741557196865,1.0,1.0,1.0,16/114,17.54%,FOSB;SH3GL2;RALGDS;KCNH8;RIT2;SRF;RPS6KA1;SH3GL3;SHC2;GRIN2B;RNASE1;FOS;PIK3CB;F3;IRS2;CDK5
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.386360101254247,-0.6232958799823531,0.9310344827586207,1.0,1.0,2/5,32.27%,XBP1;CDKN2B
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.32991557452175024,0.6229307610509076,0.967741935483871,1.0,1.0,3/9,31.30%,SNX5;IRS1;SIRT1
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,0.3044575864394765,0.6227588437037825,0.9259259259259259,1.0,1.0,7/21,23.66%,NRAS;PIK3CA;PIK3R1;PIGU;NTRK2;TIAM1;SOS1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.33619577560251107,-0.6226869367759701,0.9365079365079365,1.0,1.0,6/18,30.17%,CDK5;NUPR1;TGFB2;DDIT3;CTNNB1;MCL1
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.3717892150682224,-0.622629132944612,0.875,1.0,1.0,1/11,4.38%,CCDC39
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.40931072512854916,-0.6225570971629006,0.9137931034482759,1.0,1.0,2/6,32.40%,HDAC6;MT3
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.2824817137672506,0.6222585256913312,0.9642857142857143,1.0,1.0,2/25,8.91%,SF3B4;SMNDC1
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.34251919856298596,0.622092086427496,0.9,1.0,1.0,3/9,22.31%,SPX;ACSL3;RPS6KB1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.3125834843115,-0.6218584703392795,0.9705882352941176,1.0,1.0,7/29,19.71%,NNAT;HLA-DRB1;IRS2;ADCY8;MYRIP;GPER1;DOC2B
prerank,Reactome_2022__SLBP Independent Processing Of Histone Pre-mRNAs R-HSA-111367,-0.35940350329985293,-0.6216289536341874,0.9032258064516129,1.0,1.0,2/9,14.51%,ZNF473;LSM11
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.3274502964514532,0.6214847988917488,0.9024390243902439,1.0,1.0,5/10,29.35%,EXOSC6;EXOSC8;PCID2;EXOSC5;XRN1
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,0.28657001363699824,0.6208094855955927,0.95,1.0,1.0,4/18,14.75%,DTX4;TICAM1;NFKBIB;NFKB1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.3696041228825217,0.6207590408982342,0.9047619047619048,1.0,1.0,2/8,15.51%,CPNE3;CPNE1
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.38428894023840393,-0.6207304976022925,0.9152542372881356,1.0,1.0,3/8,22.78%,ARR3;ADM;GRK2
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.33915331085404976,-0.6205839936248241,0.9074074074074074,1.0,1.0,1/11,7.83%,PARP9
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.25393589299051866,-0.6202831839846769,1.0,1.0,1.0,20/135,20.67%,POU4F1;TP53I3;STEAP3;SEPTIN4;STAT1;NDRG1;BIRC3;PINK1;BCL2L14;PAX8;SRA1;BCL6;CDK5;DAPK3;RARG;TNFRSF10A;ALK;LGALS1;ZNF420;RTN4
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.30728351853713143,-0.6199550543957609,0.9714285714285714,1.0,1.0,3/26,13.97%,KCNH8;RPS6KA1;FOS
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.3486200879328478,-0.6193320345266751,0.9180327868852459,1.0,1.0,1/8,17.28%,VCL
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.3673708343893015,-0.6193038088195166,0.9193548387096774,1.0,1.0,2/12,25.23%,TGFB1;SHLD1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.3291616106895253,-0.6192923628002578,0.9594594594594594,1.0,1.0,7/19,30.67%,IGF1;AKAP6;MYOZ2;SLC9A1;FHL2;EFHB;HOMER3
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.40201737952845973,-0.6192429220756231,0.9310344827586207,1.0,1.0,1/7,7.01%,APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.40201737952845973,-0.6192429220756231,0.9310344827586207,1.0,1.0,1/7,7.01%,APOD
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.3816972102252831,-0.619131677620316,0.8571428571428571,1.0,1.0,6/6,61.85%,PRPS1;PRPS2;G6PD;PRPSAP1;TKT;PRPSAP2
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.3267851561804622,0.6184127178095843,0.8846153846153846,1.0,1.0,3/11,15.94%,HAVCR2;ENPP3;RC3H1
prerank,Reactome_2022__Lysosphingolipid And LPA Receptors R-HSA-419408,-0.40406387837410473,-0.6183214328157967,0.9038461538461539,1.0,1.0,3/8,9.78%,PLPPR1;S1PR3;PLPPR5
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.24937984855008571,-0.6179608873782166,1.0,1.0,1.0,13/135,13.31%,LDHA;SLC16A3;NDUFA2;NDUFB9;COX4I1;PDHX;LDHAL6A;LDLR;NDUFB11;PDK3;UQCRQ;LDHD;NDUFB10
prerank,Reactome_2022__Cobalamin (Cbl) Metabolism R-HSA-9759218,-0.38508229251780085,-0.6176328640112537,0.9285714285714286,1.0,1.0,6/6,61.51%,MMADHC;MMAB;MMACHC;MMUT;MTRR;MTR
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.36982416452033506,-0.6175846135856898,0.9672131147540983,1.0,1.0,3/9,20.15%,FADD;TGFB1;CASP8
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.34942822997272843,-0.6174468103726979,0.9375,1.0,1.0,3/12,11.74%,HK2;ISG15;PINK1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.31323845485858315,-0.6169052670553883,0.9180327868852459,1.0,1.0,4/24,15.00%,SLC4A11;SLC4A9;SLC4A2;SLC4A10
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.3161978426250305,-0.6168305420370397,0.9852941176470589,1.0,1.0,3/16,20.18%,AKR1C1;CD74;PNPLA8
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.41045730367120137,-0.6164487571547839,0.9361702127659575,1.0,1.0,1/6,3.35%,IRF1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.2765601748775372,0.6160553113329706,0.9545454545454546,1.0,1.0,6/29,20.44%,NAF1;PAIP1;HNRNPU;ZCCHC17;DKC1;NSUN2
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,-0.33538327257109213,-0.6159616919820705,0.9242424242424242,1.0,1.0,3/17,16.68%,CCND1;CCND2;PML
prerank,Reactome_2022__SLBP Dependent Processing Of Replication-Dependent Histone Pre-mRNAs R-HSA-77588,-0.35308520706368807,-0.6157040807892515,0.95,1.0,1.0,2/10,14.51%,ZNF473;LSM11
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.31211385261179414,0.6156657526965659,0.8888888888888888,1.0,1.0,2/19,16.82%,PRKD1;PICALM
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.3728877876778804,0.6156067995532449,0.8333333333333334,1.0,1.0,1/5,9.38%,MSH2
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.38598798168752324,-0.6156000895515525,0.8928571428571429,1.0,1.0,3/5,30.47%,MACROH2A2;NOP53;FLNA
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),-0.3816596634045553,-0.6155852422837133,0.9491525423728814,1.0,1.0,2/7,24.50%,PHF23;HDAC6
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.2534069292839549,0.6153333342072904,1.0,1.0,1.0,14/46,26.87%,ERCC6;ATR;SESN2;INTS7;HUS1;ATRIP;HINFP;TRIAP1;MDM4;CLSPN;RAD1;USP28;CLOCK;BID
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,-0.30605873199666467,-0.6152203485684795,0.9310344827586207,1.0,1.0,5/23,16.89%,ACHE;SLC44A3;MFSD2A;SH2D3C;CHKB
prerank,KEGG_2021_Human__Glyoxylate and dicarboxylate metabolism,0.27444053449236794,0.6149816048007551,1.0,1.0,1.0,4/24,19.11%,CS;CAT;GLUL;ACSS1
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.3666046884564385,0.614960085584121,0.9230769230769231,1.0,1.0,1/8,6.33%,ZNF502
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.2641621977403243,0.6148519960480633,1.0,1.0,1.0,4/31,11.53%,PSMD10;MFF;AKT1;OPA1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.273551211411593,0.6146301220930016,0.9666666666666667,1.0,1.0,6/24,21.80%,PGAP1;PIGP;GPLD1;DPM1;PIGF;PIGU
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.37386781065847396,0.6144898193067669,0.8604651162790697,1.0,1.0,1/6,13.10%,SLCO1C1
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.37386781065847396,0.6144898193067669,0.8604651162790697,1.0,1.0,1/6,13.10%,SLCO1C1
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),-0.38237116673513993,-0.6141909275546814,0.8771929824561403,1.0,1.0,3/6,34.00%,HDAC5;NRG1;RBM24
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.35097740221744045,-0.6140557451252174,0.9242424242424242,1.0,1.0,2/9,15.76%,TNFRSF1A;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.35097740221744045,-0.6140557451252174,0.9242424242424242,1.0,1.0,2/9,15.76%,TNFRSF1A;PRKCD
prerank,Reactome_2022__Acyl Chain Remodeling Of CL R-HSA-1482798,-0.39868098517567413,-0.6139073211487694,0.8983050847457628,1.0,1.0,6/6,60.15%,HADHA;PLA2G4A;HADHB;TAFAZZIN;PLA2G6;LCLAT1
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.4052738192499129,0.6138673164773428,0.9607843137254902,1.0,1.0,2/5,13.07%,SRI;SPX
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.3092986735262394,-0.6138346503521938,0.9866666666666667,1.0,1.0,4/23,15.80%,CCL2;EGF;TGFA;RELN
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.35766363496543085,-0.6135218383431397,0.9830508474576272,1.0,1.0,2/11,21.35%,MICALL1;PACSIN1
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.3157546314304403,-0.6129361770967935,0.9875,1.0,1.0,6/31,17.43%,CENPH;MIS18A;CENPN;CENPU;OIP5;CENPP
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.32843407046084505,0.6128522677539856,0.9736842105263158,1.0,1.0,3/11,16.49%,ATP1A2;SLC22A2;GLUL
prerank,Reactome_2022__Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.3425527252252464,-0.6125835751912558,0.9701492537313433,1.0,1.0,2/19,10.73%,POLR2I;FGF1
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,-0.319109819466831,-0.6123187215170186,0.953125,1.0,1.0,3/25,12.85%,ACOT1;ACOT4;ACOT2
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.30908741514119287,-0.6122725526283872,0.9365079365079365,1.0,1.0,3/27,12.77%,RPS27A;TNIP2;UBC
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.3543579734183079,-0.6121970971114531,0.8709677419354839,1.0,1.0,1/13,4.26%,MSX2
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,0.27253744764427656,0.6117666294170641,0.9411764705882353,1.0,1.0,9/26,30.56%,PRKAB1;PPM1A;SLC38A9;PRKAA1;LAMTOR3;RPTOR;RHEB;PRKAB2;MTOR
prerank,Reactome_2022__DCC Mediated Attractive Signaling R-HSA-418885,0.3008151257832432,0.6117354386573703,0.9354838709677419,1.0,1.0,2/14,12.98%,NCK1;WASL
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2900657920574144,0.6116678235458806,0.9142857142857143,1.0,1.0,8/18,25.72%,ERCC2;ERCC3;GTF2H5;GTF2H2;GTF2H3;PARP1;ERCC4;CUL4B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2900657920574144,0.6116678235458806,0.9142857142857143,1.0,1.0,8/18,25.72%,ERCC2;ERCC3;GTF2H5;GTF2H2;GTF2H3;PARP1;ERCC4;CUL4B
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.2857995214737446,0.6100181485908087,1.0,1.0,1.0,5/19,17.31%,RCC2;PTPRK;TAOK2;THSD1;WHAMM
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.2662212011523061,0.6100016725976882,0.9722222222222222,1.0,1.0,5/29,17.66%,PPARGC1A;KMT2A;IWS1;NOC2L;BRD7
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.36366721324193696,-0.6099504651594665,0.9577464788732394,1.0,1.0,3/14,17.95%,RPS13;NUDT16;TGFB1
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.3503364215566386,-0.60988888186068,0.9444444444444444,1.0,1.0,4/10,32.48%,ADA;MTHFD1;PRPS1;PRPS2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3253540367136938,-0.6093773724315066,0.9402985074626866,1.0,1.0,7/17,32.14%,BCL2L2;BOK;FAS;ITGAV;BCL2L1;MCL1;MOAP1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.3319309083433237,-0.6093023847718682,0.8870967741935484,1.0,1.0,2/12,15.37%,ENTPD3;NUDT16
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.3228467221782621,-0.6092217863773516,0.9649122807017544,1.0,1.0,1/13,12.39%,OGG1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.3820343141384527,-0.6092039692527468,0.8983050847457628,1.0,1.0,3/7,22.35%,NELL1;SFRP1;EIF2AK2
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.28422488089604536,-0.6092033212248501,0.9615384615384616,1.0,1.0,3/33,14.21%,ABCA12;PLK3;OAZ2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.3020198606635682,-0.6089742253224875,0.9705882352941176,1.0,1.0,3/23,14.68%,P3H2;OGFOD1;PPIB
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.27532175151751864,-0.6089044448915137,1.0,1.0,1.0,4/50,9.28%,SLITRK1;THY1;EFNB3;MAG
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.2491364590739804,-0.6085074005239656,1.0,1.0,1.0,23/103,22.28%,ATP1A1;ARHGEF17;ATP1B1;UNC5B;DAB2IP;SLC43A2;SLC44A3;RAP1GAP;RHBDF1;GPRC5C;ASS1;PTPRF;GPC1;PTPN21;LAMA5;PARM1;AGRN;EPB41L4B;KIAA1217;ARHGEF37;TSPAN15;EPB41L1;CTNND1
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.3389731948851614,-0.6084136873509322,0.9,1.0,1.0,3/9,17.15%,ADCY5;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.3389731948851614,-0.6084136873509322,0.9,1.0,1.0,3/9,17.15%,ADCY5;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),-0.40325836870773324,-0.6084118540485192,0.9772727272727273,1.0,1.0,1/5,9.68%,THPO
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.2997796816012051,0.6077330770627828,0.9714285714285714,1.0,1.0,4/22,10.82%,TTL;PPP1R10;HSF1;EIF4E
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.31042405683906593,0.6076418564534198,1.0,1.0,1.0,1/10,2.70%,PSMD10
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.3096201443926194,-0.6075974580397382,0.9818181818181818,1.0,1.0,2/22,16.59%,HAP1;CLN3
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.22929144608257654,0.6075437469917117,1.0,1.0,1.0,26/134,20.19%,FLT3;PASK;RIOK2;EGFR;AKT1;STK4;ATR;ERBB4;EIF2AK4;CSF1R;TAOK2;UHMK1;EPHB4;TAOK3;WNK3;STK17B;PRKD1;MARK2;EIF2AK3;TNIK;SLK;CAMK4;MAP2K2;PRKX;PIKFYVE;ERN1
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.22897983692391907,0.6074891906320914,1.0,1.0,1.0,10/74,15.49%,KIF15;TMEM115;SEC22B;RAB1B;DNAJC28;ERGIC3;COPB2;SCFD1;TMED3;ARCN1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.27438835857258864,-0.6074777221395369,0.9857142857142858,1.0,1.0,5/40,16.23%,APP;PARP9;RPL10;RBM3;RBM4B
prerank,Reactome_2022__Interleukin-1 Processing R-HSA-448706,-0.39313685300148266,-0.6074223593907043,0.9298245614035088,1.0,1.0,2/5,23.30%,IL18;NFKB2
prerank,KEGG_2021_Human__Other glycan degradation,0.31994953250775876,0.6070829688137042,0.9333333333333333,1.0,1.0,7/15,39.95%,ENGASE;NEU3;GLB1;GBA2;NEU1;HEXB;MAN2B1
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.4141957579570277,-0.6070225338529457,0.8846153846153846,1.0,1.0,3/5,28.68%,SLIT3;SLIT2;MYO9B
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,-0.2492673725246806,-0.6069011555045146,1.0,1.0,1.0,23/125,20.77%,RPS27A;ARHGEF3;PLEKHG2;ARHGEF38;ARHGEF17;MAG;ARHGEF18;BIRC3;OBSCN;UBC;FADD;RNASE1;TNFRSF1A;VAV1;APH1A;RASGRF2;FASN;RIPK2;TNFRSF10A;BEX3;CASP8;RTN4;IKBKG
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),-0.3768538772062998,-0.6067669530159572,0.9464285714285714,1.0,1.0,2/6,25.36%,CFAP73;CFAP100
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.38537410995681104,-0.6067113179365458,0.9230769230769231,1.0,1.0,6/6,61.48%,ACVR1B;VEGFA;C1QBP;SMURF2;SYDE1;AGO2
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.3376565763475186,0.6066468308116663,0.9210526315789473,1.0,1.0,3/8,15.40%,RUBCNL;VPS39;PIP4K2B
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.3392730768170121,0.6065785643678997,0.925,1.0,1.0,2/8,16.63%,INSIG2;ERLIN1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.3392730768170121,0.6065785643678997,0.925,1.0,1.0,2/8,16.63%,INSIG2;ERLIN1
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.35837854818111414,-0.6063705402885597,0.9354838709677419,1.0,1.0,2/9,13.02%,NOS1;CYP3A4
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.3608692036468331,-0.6059770185159086,1.0,1.0,1.0,1/9,5.98%,CCL2
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.2614323849591364,-0.60596375180189,1.0,1.0,1.0,6/79,13.59%,IRF1;NLRC5;IRF7;ISG15;IFIH1;HERC5
prerank,Reactome_2022__HDR Thru MMEJ (alt-NHEJ) R-HSA-5685939,0.3434638857705143,0.6051072503185129,0.9117647058823529,1.0,1.0,2/9,14.20%,RAD52;POLK
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.2756233644658894,-0.6050728895024557,0.9868421052631579,1.0,1.0,11/47,25.92%,RAMP3;AKAP5;PRKCH;ITGA3;GPER1;STAC2;SORBS1;STX3;SQSTM1;STX4;CNPY4
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.30935654326586515,0.6050336601870799,0.9583333333333334,1.0,1.0,3/12,23.65%,PARP11;PARP1;PARP6
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.369597178607131,-0.6048571949445747,0.9,1.0,1.0,2/7,20.20%,GARS1;DARS2
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.3172993684525916,0.6048319134155731,0.96875,1.0,1.0,2/13,17.47%,MAP3K4;PKIB
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.3506945104980379,0.6045543359998867,0.9302325581395349,1.0,1.0,1/8,16.57%,EIF2AK3
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,-0.2609607054578805,-0.6045113799237655,0.9880952380952381,1.0,1.0,8/80,18.03%,B4GALNT1;UGT8;FA2H;SGPP2;EGFL7;ALDH3A2;ORMDL2;CTSA
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.40219860675817376,-0.6042404816251088,0.9137931034482759,1.0,1.0,1/5,8.00%,DBI
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.24812556457968085,-0.6042115706838066,1.0,1.0,1.0,4/81,12.29%,TYMS;RPL13A;PATL2;IGFBP5
prerank,KEGG_2021_Human__Sphingolipid metabolism,-0.27626372595311777,-0.6039011165462175,1.0,1.0,1.0,2/44,7.89%,UGT8;SGPP2
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.2915679565009295,-0.6037894726430415,0.9493670886075949,1.0,1.0,3/33,12.85%,ACOT1;DBI;ACOT2
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.327919270033464,0.603287483092814,0.9361702127659575,1.0,1.0,7/8,37.82%,FERMT1;PTEN;CLASP2;FERMT2;MTOR;CLASP1;RREB1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),-0.40051336825814127,-0.6031961780721675,0.9464285714285714,1.0,1.0,1/6,10.12%,SCIMP
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.39868098517567413,-0.6028341569515339,0.8928571428571429,1.0,1.0,6/6,60.15%,HADHA;PLA2G4A;PLA2G5;HADHB;PLA2G6;LCLAT1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.2718277748731918,-0.60269169534902,0.9733333333333334,1.0,1.0,6/47,18.34%,KDELR3;TSPYL2;DCTN1;TLN1;ARFGAP1;HSPA5
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),-0.2805874206144845,-0.6019675073861427,0.9876543209876543,1.0,1.0,1/60,0.62%,DEPP1
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.31137542396781964,-0.6019450803373849,0.9558823529411765,1.0,1.0,1/19,4.08%,MEIOB
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.33132080338215175,-0.6017455891945683,0.9016393442622951,1.0,1.0,1/15,6.59%,TLR3
prerank,CellMarker_Augmented_2021__Beta cell:Pancreatic Islet,-0.2539601825265745,-0.601329976358828,1.0,1.0,1.0,10/75,14.40%,MRAP2;PIK3IP1;RAPH1;ENTPD3;NECAB1;SLC43A2;APCDD1L;ELMO1;NPTX2;SUSD4
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.3477856581528779,0.600665690821133,0.9534883720930233,1.0,1.0,3/9,10.55%,FOXP1;HMGB1;TIRAP
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.40200497338140073,0.6005837028171487,0.9318181818181818,1.0,1.0,3/5,35.81%,PTPN2;NR1H2;NR1H3
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.2563868165281902,-0.6005820050256996,1.0,1.0,1.0,15/72,23.55%,BLM;POLQ;RNF213;BOK;KCNC1;HLA-DRB1;ADCY8;CARD11;KCNC2;STOML2;RNF112;EHD1;SLC9A1;CHMP2A;AQP11
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.3480867711611143,-0.6004573669052107,0.8983050847457628,1.0,1.0,5/11,32.44%,TGFB1;NODAL;TGFB3;BMP6;RBPMS
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.32311599530832774,-0.5997468912229871,0.9436619718309859,1.0,1.0,4/15,24.99%,PDCD1LG2;HLA-DRB1;INHA;RARA
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.368052633488,-0.5996657791584429,0.9545454545454546,1.0,1.0,2/10,15.08%,BMX;AATK
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.3120131664248819,0.5992366908799863,0.96,1.0,1.0,5/8,32.95%,SMG1;RPTOR;NPRL3;MTOR;MLST8
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.24667120642161355,-0.5991221365781326,1.0,1.0,1.0,23/112,22.71%,B3GALT2;FUT2;ST3GAL6;B3GNT5;GALNT10;B3GNT2;MAN1C1;TUSC3;ST6GALNAC2;B4GALT7;MGAT3;MGAT5;PMM1;ALG1L2;ST8SIA3;GFPT2;TMEM258;B3GALT4;DPAGT1;POMGNT2;B3GALNT1;ST8SIA1;DPM3
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3378486184502843,-0.599113781464207,0.9393939393939394,1.0,1.0,4/14,24.22%,APLN;GPER1;CDKN1A;PPARG
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,0.2646965025376882,0.5985314609417163,1.0,1.0,1.0,10/25,30.21%,NT5C1A;NUDT15;NT5M;NUDT9;ENTPD1;NT5E;ENTPD4;UPP2;NT5C3A;ENTPD6
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.3774849914583293,-0.5984893389263923,0.9310344827586207,1.0,1.0,2/6,19.24%,USP50;CD36
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.32437804790350305,0.5983129933382916,0.9534883720930233,1.0,1.0,4/8,31.39%,DRD2;GPR35;DRD4;CBARP
prerank,Reactome_2022__E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,-0.3744329865416597,-0.5979383546534645,0.8235294117647058,1.0,1.0,1/6,10.55%,CCNB1
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.3303941890694684,0.5978909580049216,0.9285714285714286,1.0,1.0,4/7,35.81%,DISP3;NR1H2;PRKN;NR1H3
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.4016825517380594,0.597438850478191,0.9487179487179487,1.0,1.0,2/5,31.68%,HMGCL;IVD
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,-0.3292296298537548,-0.5963675008691977,0.9310344827586207,1.0,1.0,5/12,24.14%,APP;PSTPIP1;P2RX7;NFKB2;HMOX1
prerank,KEGG_2021_Human__Pyruvate metabolism,-0.2731022192907815,-0.5958556629703073,1.0,1.0,1.0,6/36,18.48%,LDHA;LDHAL6A;LDHD;ADH4;ALDH3A2;PCK2
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Ovary,-0.3190753818025313,-0.5956295452933147,0.953125,1.0,1.0,4/17,16.50%,C4ORF51;GRID2;SLCO1A2;GLB1L3
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.2334453371387115,-0.5946573750984966,1.0,1.0,1.0,22/152,20.67%,EFNA1;TESC;ZSWIM7;ATP1B1;IGF1;PFN2;TCP1;PINK1;TNIP2;FLOT1;RPS7;PPIB;RPL5;PRKCD;RPL23;CDC37;CDKN1A;RPL11;UBE2B;TAF9B;ATP1B3;RTN4
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.26468965145484935,-0.5944854928737566,0.9864864864864865,1.0,1.0,6/56,13.02%,ALOX12;ACSM5;LIPI;LIPH;OLAH;CYP3A4
prerank,Reactome_2022__Signaling By PDGFRA Extracellular Domain Mutants R-HSA-9673770,0.3212416197846032,0.5943624659973259,1.0,1.0,1.0,3/10,14.84%,NRAS;PIK3CA;PIK3R1
prerank,CellMarker_Augmented_2021__Activated CD4+ T cell:Blood,-0.40156509316513583,-0.5943229333111191,0.8813559322033898,1.0,1.0,2/6,21.37%,CD4;PTPRC
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",-0.403445678540281,-0.5939200334334043,0.9242424242424242,1.0,1.0,2/5,13.52%,HAP1;NLGN1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.26614847791653135,-0.5936162775298313,0.9733333333333334,1.0,1.0,15/59,21.63%,CD160;HTR2B;IGF1;NYAP1;PITPNM2;PLCH2;PIK3CB;PIK3CD;IRS2;HTR2A;PLCE1;PDGFRA;NYAP2;PTAFR;GAB2
prerank,KEGG_2021_Human__Tyrosine metabolism,-0.2968885690791041,-0.593503618181552,0.9393939393939394,1.0,1.0,1/18,3.76%,MAOB
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.38159970362495826,-0.593198062193958,0.9107142857142857,1.0,1.0,2/5,21.62%,EXOSC7;EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.38159970362495826,-0.593198062193958,0.9107142857142857,1.0,1.0,2/5,21.62%,EXOSC7;EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.38159970362495826,-0.593198062193958,0.9107142857142857,1.0,1.0,2/5,21.62%,EXOSC7;EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.38159970362495826,-0.593198062193958,0.9107142857142857,1.0,1.0,2/5,21.62%,EXOSC7;EXOSC10
prerank,CellMarker_Augmented_2021__Common Myeloid progenitor:Undefined,0.38498084962867984,0.5931737916111969,0.9333333333333333,1.0,1.0,1/5,2.43%,FLT3
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.2400660037146794,0.5931351975672945,0.9655172413793104,1.0,1.0,8/31,23.77%,IPO5;GLRB;SESN2;CPEB3;SLC38A9;LAMTOR3;MEAK7;RPTOR
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.38080268591233757,-0.5929203798427618,0.8947368421052632,1.0,1.0,1/6,11.18%,PRKCQ
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.35289288140996167,-0.5928174705839654,0.9649122807017544,1.0,1.0,3/9,19.87%,COPS9;RPL5;RPL11
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.36208082298140926,0.5921326481013224,0.95,1.0,1.0,1/5,10.47%,EIF5A2
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,-0.2509173089019302,-0.5921273395401508,1.0,1.0,1.0,14/102,17.41%,RCAN2;PLN;ATP1A1;CCND1;ATP1B1;DIO1;PRKCG;STAT1;PIK3CB;PIK3CD;TSC2;PFKL;PRKCB;NOTCH3
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.3752107157029816,-0.5916003970483299,0.9183673469387755,1.0,1.0,3/5,21.16%,SLC15A4;RTN4;RSAD2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.3237966929621868,0.5914388163345407,0.9777777777777777,1.0,1.0,1/8,7.42%,COMMD1
prerank,Reactome_2022__Caspase Activation Via Dependence Receptors In Absence Of Ligand R-HSA-418889,-0.35527082143148,-0.5914381480110087,0.9242424242424242,1.0,1.0,2/10,17.86%,UNC5B;DAPK3
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.3023148473617367,-0.5912249892716076,0.9692307692307692,1.0,1.0,11/28,28.23%,SEMA3B;SLIT3;SEMA3E;LRTM1;SEMA4G;SEMA4C;SLIT2;SEMA6D;LGR6;SEMA3C;SEMA3D
prerank,Reactome_2022__ERBB2 Regulates Cell Motility R-HSA-6785631,0.34038864596410057,0.5910041282243327,0.9714285714285714,1.0,1.0,2/12,9.92%,EGFR;ERBB4
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.31622325478234964,-0.5905142299302402,0.9552238805970149,1.0,1.0,3/16,21.37%,GLI1;SFRP1;TXNDC15
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Heart,0.3295663074679279,0.5901256749115424,0.8333333333333334,1.0,1.0,1/5,11.67%,CASP3
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,-0.24616751547314095,-0.5900483970931399,1.0,1.0,1.0,9/103,16.87%,TOMM7;RPS27A;ATG9A;MAP1LC3A;PINK1;UBC;WDR45;GABARAPL1;TSC2
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.3459671752485547,0.5898355616075334,0.8717948717948718,1.0,1.0,1/7,19.75%,MCM6
prerank,Reactome_2022__ALK Mutants Bind TKIs R-HSA-9700645,-0.3598991717364236,-0.5893727525797517,0.9310344827586207,1.0,1.0,3/11,19.12%,FN1;BCL11A;ALK
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.23414799939525,-0.5892815406105638,1.0,1.0,1.0,14/302,10.08%,RECQL4;BLM;SUV39H1;HIC1;HELB;POLQ;HROB;BRCA1;POLE3;CCND1;PLK3;GADD45A;SPATA18;IRF7
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.3176904811276211,-0.5882078961137457,0.9552238805970149,1.0,1.0,6/18,21.54%,RYR2;RARG;TBX20;PDGFRA;HES1;FBN2
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,0.2781486107259759,0.5880149664076317,1.0,1.0,1.0,4/18,17.23%,CHD9;EP300;CPT1A;NCOA2
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.3714432414993054,-0.5878547271001113,0.9629629629629629,1.0,1.0,1/7,17.94%,ARL13A
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.29337342429855984,0.5876762076747908,1.0,1.0,1.0,4/14,31.09%,PANK2;NUDT7;SLC25A16;PPCS
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.33146159580960666,0.5873814234485925,0.8837209302325582,1.0,1.0,2/8,28.12%,GPR37L1;NFE2L2
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.33238387392259894,-0.5870116748634135,0.9508196721311475,1.0,1.0,3/12,19.21%,PINK1;NUPR1;PHF23
prerank,KEGG_2021_Human__B cell receptor signaling pathway,-0.26506172321035903,-0.5867726419485026,0.9850746268656716,1.0,1.0,10/56,17.96%,INPP5D;PPP3CC;SYK;FOS;BLNK;PIK3CB;VAV1;PIK3CD;PRKCB;CARD11
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.36339267884192195,0.5862637496001871,0.9523809523809523,1.0,1.0,2/5,16.85%,DUSP12;BAD
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.30725096357643944,0.5861017460511528,1.0,1.0,1.0,2/13,8.83%,MT1E;HSF1
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.2661693875168818,-0.5860055658059733,1.0,1.0,1.0,2/42,6.29%,RPS27A;BRCA1
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3368047317591689,0.5853417234021168,0.9622641509433962,1.0,1.0,1/8,4.99%,RCC2
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),0.3359813361923216,0.5852624899513468,0.9333333333333333,1.0,1.0,4/10,29.56%,DENR;EIF2D;EIF2S3;EIF5
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.29289633307298824,-0.5851994055749273,0.9692307692307692,1.0,1.0,2/29,4.68%,HELB;POLQ
prerank,Reactome_2022__Inflammasomes R-HSA-622312,-0.2968636928130383,-0.5849922529727292,0.953125,1.0,1.0,5/17,24.14%,APP;PSTPIP1;P2RX7;NFKB2;HMOX1
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.3223014010019024,-0.584910428994849,0.9375,1.0,1.0,1/8,7.10%,CMPK2
prerank,Reactome_2022__Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,0.3349223126919094,0.5847269505561842,0.9545454545454546,1.0,1.0,1/6,11.18%,TP53BP2
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.36509478732130934,0.5845512933641074,0.8421052631578947,1.0,1.0,1/6,5.88%,TMEM33
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),-0.37811685513647647,-0.5845408771593348,0.9642857142857143,1.0,1.0,4/6,29.91%,NLGN1;LHFPL4;SHISA7;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.2737730085033813,-0.5843390528446879,0.9875,1.0,1.0,3/31,10.37%,NELL1;WNT5A;ISG15
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.3326525294939093,-0.5834863048991745,0.9344262295081968,1.0,1.0,1/10,8.06%,ANGPTL3
prerank,CellMarker_Augmented_2021__Marginal Zone B cell:Undefined,-0.3776076511955384,-0.5831655490379004,0.9264705882352942,1.0,1.0,3/6,21.37%,CD9;EBF1;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.3329815847226184,-0.5829558952985318,0.9827586206896551,1.0,1.0,1/12,9.05%,BTG1
prerank,Reactome_2022__NrCAM Interactions R-HSA-447038,-0.3457153700065856,-0.5829234964362722,0.9661016949152542,1.0,1.0,2/7,15.92%,CNTN2;ANK1
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.3177226277372263,-0.5828633675767919,0.9846153846153847,1.0,1.0,15/15,68.26%,GPR137C;GPR137;TELO2;SEH1L;RRAGB;CLEC16A;LAMTOR5;RRAGD;PIH1D1;RRAGA;GPR137B;PIP4P1;KLHL22;LARS1;SIK3
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.38415665646646124,-0.5823515653707456,0.9516129032258065,1.0,1.0,2/5,20.54%,XRCC1;REC8
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.3280079653224185,-0.5817866938034155,0.971830985915493,1.0,1.0,3/16,15.47%,SVIL;VIL1;ADD2
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.3280079653224185,-0.5817866938034155,0.971830985915493,1.0,1.0,3/16,15.47%,SVIL;VIL1;ADD2
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.2637425726430449,0.5813777522627652,1.0,1.0,1.0,7/18,28.62%,ASAH2B;SPHK2;PLPP3;NAAA;PLPP1;ACER3;SGPP1
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.2920580888658716,-0.5806539281766673,0.9848484848484849,1.0,1.0,5/24,19.38%,PDE6B;RBM4B;PML;MTA1;BHLHE40
prerank,CellMarker_Augmented_2021__Dendritic Cell progenitor:Bone Marrow,-0.3384687333437019,-0.5804629737664335,0.9310344827586207,1.0,1.0,2/9,14.46%,SIGLEC1;IL3RA
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2418155834009367,0.5804062512772,1.0,1.0,1.0,8/44,19.99%,HSPA1A;TNFAIP3;TRADD;CFLAR;SPATA2;CPNE1;SPPL2A;CLIP3
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.2986790129510968,-0.5803167037665935,0.9523809523809523,1.0,1.0,4/17,18.34%,HK2;PINK1;PML;HSPA5
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.4115689070954953,-0.5801706449536135,1.0,1.0,1.0,1/5,15.68%,DDRGK1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.4115689070954953,-0.5801706449536135,1.0,1.0,1.0,1/5,15.68%,DDRGK1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.4115689070954953,-0.5801706449536135,1.0,1.0,1.0,1/5,15.68%,DDRGK1
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),0.32867285750764164,0.5800742281716632,0.9230769230769231,1.0,1.0,2/7,14.45%,AGBL1;AGBL2
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.3645960327907247,-0.5799809653398853,0.9387755102040817,1.0,1.0,4/6,32.40%,STAT3;CDK6;EIF2B5;MT3
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation In TLR7/8 Or 9 Signaling R-HSA-975110,-0.36742237966967883,-0.5792741031980135,0.8620689655172413,1.0,1.0,1/6,10.08%,IRF7
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.33312095191636937,0.5782338677655943,0.95,1.0,1.0,2/8,25.55%,SLC2A10;SORT1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.2632997231709929,-0.5781347364318928,1.0,1.0,1.0,2/48,6.11%,CCK;MAP1B
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.3165305698550536,0.5780747220404928,0.9411764705882353,1.0,1.0,2/14,7.15%,BAG2;FBXO5
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.26254916168860737,-0.5779992940920705,0.9861111111111112,1.0,1.0,10/41,25.48%,ZFP36;ADIRF;PIM1;SFRP2;ZNF385A;SFRP1;PPARG;VSTM2A;XBP1;AAMDC
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.28794849534035455,0.5777997518310978,0.9722222222222222,1.0,1.0,5/16,24.94%,MT1E;HSF1;DAXX;LOXL2;MT1A
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.3913735673711522,-0.5776350393517775,0.9152542372881356,1.0,1.0,1/5,14.31%,HYAL1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.2648028607989033,-0.5774175262469224,1.0,1.0,1.0,6/32,23.10%,PSRC1;DCTN1;ANKRD53;FSD1;DRG1;CHMP2A
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.2847562654734416,0.5772510219689881,0.9714285714285714,1.0,1.0,5/19,20.02%,EIF2S1;PRRC2C;G3BP1;YTHDF2;UBAP2L
prerank,Reactome_2022__PI-3K cascade:FGFR3 R-HSA-5654710,0.31057255355182867,0.5754017689431504,1.0,1.0,1.0,4/11,21.80%,PIK3CA;PIK3R1;FGF17;PIGU
prerank,Reactome_2022__MECP2 Regulates Transcription Factors R-HSA-9022707,0.38137874559648804,0.5752555105626664,0.8809523809523809,1.0,1.0,1/5,16.67%,RBFOX1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.32477725089306386,-0.5750130045251136,0.9838709677419355,1.0,1.0,4/15,24.22%,ANGPTL3;EEF1A2;SORBS1;PPARG
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.2717172782050827,0.5748840615401399,0.9032258064516129,1.0,1.0,5/18,29.88%,MAP3K4;PKIB;HNRNPD;USP7;MAPK1
prerank,Reactome_2022__Establishment Of Sister Chromatid Cohesion R-HSA-2468052,0.32980821619569933,0.5747635739404078,0.8695652173913043,1.0,1.0,3/9,29.42%,WAPL;SMC3;PDS5B
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.3707248745185012,-0.5745511244299379,0.9591836734693877,1.0,1.0,6/6,62.95%,CELSR1;BRSK1;BRSK2;FUZ;NPHP1;VANGL2
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.36142382871943346,0.573947992395623,0.9090909090909091,1.0,1.0,3/5,28.33%,LRRC17;SBDS;LRP5
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.33062114290270994,0.5735704988156689,0.8947368421052632,1.0,1.0,2/9,28.12%,GPR37L1;NFE2L2
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,-0.2622297198791053,-0.5733920541435649,1.0,1.0,1.0,3/45,12.77%,RPS27A;STAT1;UBC
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3256769892831486,-0.5732350059309463,0.9710144927536232,1.0,1.0,2/10,21.70%,ECHDC3;SORBS1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.28040923989024624,-0.5729816313447995,0.9827586206896551,1.0,1.0,2/28,10.32%,HELB;TAF10
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.38508229251780085,-0.5727850463189904,0.9672131147540983,1.0,1.0,6/6,61.51%,MTHFD1;MTHFR;GOT1;MTRR;PLOD2;MTR
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.30378404223566446,-0.5723403879471852,0.9661016949152542,1.0,1.0,3/12,24.87%,NUPR1;AQP11;ALOX5
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,-0.27104838176521395,-0.5720655532572455,1.0,1.0,1.0,5/34,18.45%,RPS27A;TFPT;UBC;RBX1;COPS5
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.30738183848918715,0.5719412847652876,0.9117647058823529,1.0,1.0,4/10,30.99%,NDFIP1;SNX3;SNX12;TERF1
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.3226119429114236,-0.5712853685781304,0.9552238805970149,1.0,1.0,1/8,7.10%,CMPK2
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,0.27271505856059663,0.5709913826481117,0.9285714285714286,1.0,1.0,4/16,17.23%,CYP7B1;PTGIS;AKR1C3;NCOA2
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),0.3464203427249659,0.5706938740698664,0.8780487804878049,1.0,1.0,4/6,34.33%,SLC25A14;SLC13A5;SLC13A3;SLC25A11
prerank,Reactome_2022__Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.3185777662935666,-0.5706308413301195,0.9516129032258065,1.0,1.0,3/16,18.16%,PIGA;PIGH;PIGC
prerank,Reactome_2022__Defective RIPK1-mediated Regulated Necrosis R-HSA-9693928,-0.37994845637347446,-0.5705146969691031,0.9107142857142857,1.0,1.0,2/5,20.15%,FADD;CASP8
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.3135152034949473,-0.5696108179996132,0.9848484848484849,1.0,1.0,2/17,13.10%,SGPP2;GCHFR
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.2802781479448181,0.569195860936066,0.9523809523809523,1.0,1.0,1/13,7.15%,FBXO5
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.29077875197168945,-0.5690294238902444,0.9545454545454546,1.0,1.0,4/21,16.36%,PDCD1LG2;ISG15;SYK;HLA-DRB1
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),-0.36379025291911504,-0.5688631323149068,0.9642857142857143,1.0,1.0,2/5,18.92%,TMLHE;SHMT1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),-0.36379025291911504,-0.5688631323149068,0.9642857142857143,1.0,1.0,2/5,18.92%,TMLHE;SHMT1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.27577484770901634,0.5688175098460966,1.0,1.0,1.0,4/21,18.13%,RUNX1;KAT2A;MDK;CAMK4
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.31416368264571926,-0.5687469976935028,0.9682539682539683,1.0,1.0,3/19,19.16%,HAP1;SEPTIN9;CEP135
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",-0.28435282472407775,-0.5687217275185195,1.0,1.0,1.0,9/29,23.87%,FOLH1;GPT2;GAD1;GAD2;ASS1;GFPT2;ALDH5A1;NIT2;ADSS1
prerank,KEGG_2021_Human__Selenocompound metabolism,-0.31909496507359303,-0.5685616019386857,0.9206349206349206,1.0,1.0,2/14,14.04%,PAPSS2;TXNRD2
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),-0.38003065286077997,-0.568202065790004,1.0,1.0,1.0,2/5,16.59%,CEACAM1;PTPRR
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),-0.377631744260217,-0.5680474057167245,0.9583333333333334,1.0,1.0,1/6,9.57%,NFKBID
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,-0.2392810453914138,-0.5679874713684355,1.0,1.0,1.0,5/80,11.72%,KDELR3;ATF3;CCL2;TSPYL2;DCTN1
prerank,KEGG_2021_Human__Renal cell carcinoma,-0.2556906990617087,-0.5678048963925723,1.0,1.0,1.0,11/63,20.62%,MET;TGFA;ELOB;PIK3CB;PIK3CD;ETS1;RBX1;TGFB1;CDKN1A;PAK5;PAK6
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.34099147996538315,0.56731146508328,0.9411764705882353,1.0,1.0,1/7,4.94%,KLKB1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.31452019182518026,0.5670230698172076,0.9024390243902439,1.0,1.0,5/9,26.72%,SOCS4;CHMP6;CBLB;VPS25;CBL
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.2965910863247561,0.5670006129812629,1.0,1.0,1.0,3/13,14.67%,PLIN5;ABHD5;GPLD1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.2526009618185905,-0.5660307551104353,0.9871794871794872,1.0,1.0,12/47,25.92%,RAMP3;AKAP5;PRKCH;ITGA3;CLN3;GPER1;STAC2;SORBS1;STX3;SQSTM1;STX4;CNPY4
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.25729237011536715,-0.5659789054247881,1.0,1.0,1.0,8/50,20.53%,ATG9A;MAP1LC3A;WDR45;GABARAPL1;GABARAPL2;ATG16L2;TMEM41B;RAB19
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.26838632655914163,0.5652268815953299,0.972972972972973,1.0,1.0,1/14,2.70%,PSMD10
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),-0.30053538177630806,-0.5648876931697814,0.9696969696969697,1.0,1.0,4/10,31.65%,CNTN4;RTN4;EPHB2;SEMA5A
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.27196246118260536,-0.5647897590731217,1.0,1.0,1.0,7/41,16.65%,CYP1B1;PDK3;PINK1;FOXM1;FLOT1;CNDP1;FASN
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.3031119380432803,-0.5647210835728589,0.967741935483871,1.0,1.0,5/17,27.99%,FASN;FAR2;SCD;CBR4;DGAT1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.25344780793390276,0.5643980343279983,0.972972972972973,1.0,1.0,5/23,26.47%,AKT1;CCDC88A;MARK1;EFHC2;PTEN
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.35436291403705245,0.564385888182648,0.9772727272727273,1.0,1.0,1/5,14.75%,NFKB1
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.2706034281182346,-0.5643052260577867,1.0,1.0,1.0,2/25,11.73%,HELZ2;NAMPT
prerank,CellMarker_Augmented_2021__Cancer cell:Undefined,0.3157599194407043,0.5639436807149669,0.9047619047619048,1.0,1.0,1/7,3.98%,ALDH1A1
prerank,CellMarker_Augmented_2021__Endothelial cell:Lung,-0.37349499221231724,-0.5636586944292151,0.9423076923076923,1.0,1.0,3/6,25.58%,MCAM;PECAM1;EMCN
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression To Limit Cholesterol Uptake R-HSA-9031525,-0.37007588617925313,-0.5629442771438545,0.9047619047619048,1.0,1.0,1/5,21.94%,RXRB
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,-0.31548624128215036,-0.5628553470759327,1.0,1.0,1.0,3/17,15.10%,ANAPC11;CCNB1;UBE2S
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.3044986407974393,0.5623337655975643,0.9285714285714286,1.0,1.0,3/10,19.32%,PYGM;UGP2;PPP1R3C
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.2811159702736854,-0.5623059493019354,0.9692307692307692,1.0,1.0,5/25,19.38%,PDE6B;RBM4B;PML;MTA1;BHLHE40
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),0.370626925294107,0.5621143732517218,0.9130434782608695,1.0,1.0,2/5,25.19%,FBL;FBLL1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.234990009507375,-0.5617808572891018,1.0,1.0,1.0,21/139,20.46%,BLM;POU4F1;BRCA1;PLK3;HEXIM1;RPA3;TAF10;NUAK1;PRDM1;RPA1;RPS15;RPL5;CDK2;RPL23;PML;CDK5;RPS20;KAT5;RPL11;ZNF385A;TAF9B
prerank,Reactome_2022__Beta-oxidation Of Very Long Chain Fatty Acids R-HSA-390247,-0.31926338008232447,-0.5612050767711879,0.9661016949152542,1.0,1.0,3/11,18.90%,ACOT4;ACOT8;ACOT6
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Lymph,-0.23562643537710345,-0.5611900057127261,1.0,1.0,1.0,1/93,0.95%,IL13RA1
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Liver,-0.23562643537710345,-0.5611900057127261,1.0,1.0,1.0,1/93,0.95%,IL13RA1
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Kidney,-0.23562643537710345,-0.5611900057127261,1.0,1.0,1.0,1/93,0.95%,IL13RA1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.29504038432564894,-0.5609697348344088,0.9692307692307692,1.0,1.0,7/21,22.76%,PFN2;RAP1GAP;TCHP;PRKCD;LIMK2;ODF2L;SLIT2
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.27300127155975296,-0.5608515618797489,0.9861111111111112,1.0,1.0,5/32,17.19%,PRKCQ;TNS2;PRKCD;TSC2;PRKCB
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.32191459054167354,-0.5607761305469473,0.9833333333333333,1.0,1.0,1/12,6.99%,HAP1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.3133137582537931,-0.5607594196655322,0.9836065573770492,1.0,1.0,5/16,24.22%,CCL2;APLN;COL4A3;SP1;PPARG
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.29391707793672156,0.5607201122897599,1.0,1.0,1.0,2/11,12.35%,EIF2AK4;VAPA
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.2613581128578295,0.5604822335594346,1.0,1.0,1.0,4/27,15.62%,MEGF10;MAPK12;CDH2;ID2
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.29472862576160663,-0.5603203422422324,1.0,1.0,1.0,2/17,12.36%,GNG3;GNG2
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.338743082271571,-0.5599289933442475,0.9672131147540983,1.0,1.0,1/10,7.95%,MYH11
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.3282503669799095,-0.5592096226468832,0.9696969696969697,1.0,1.0,2/16,11.12%,NELL1;DAB2IP
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.33128680394562493,-0.5587292293249819,0.9516129032258065,1.0,1.0,3/10,21.13%,CYP3A4;SPP1;HSD17B7
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.30986738099180566,0.5586375531847754,0.9705882352941176,1.0,1.0,4/12,24.16%,THAP1;PRKX;ERN1;LOXL2
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.35913150061285243,-0.5586238695842104,0.9482758620689655,1.0,1.0,7/7,64.11%,TRERF1;WBP2;YAP1;NEDD4;SRC;UBE3A;UBR5
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.29698248573148855,-0.5584404810941687,0.9666666666666667,1.0,1.0,1/12,5.98%,CCL2
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.321476469345482,0.5581627014955275,0.95,1.0,1.0,4/9,32.28%,PRKAA1;KLF15;SIRT1;SETD5
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.2688047588506254,-0.5579710757695421,1.0,1.0,1.0,5/29,19.14%,NLRP5;CRB2;RPS6KA6;NIBAN2;PHLDB2
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,-0.2557833509187179,-0.5577803139838315,1.0,1.0,1.0,5/39,14.39%,YWHAH;MYH11;MYH9;RNASE1;PPP1R14A
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.3545569220851629,-0.5575865323072253,0.9824561403508771,1.0,1.0,1/6,10.00%,WEE2
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.2995937923232744,0.5571710615569869,0.95,1.0,1.0,5/10,32.98%,ALKBH3;ASCC3;ALKBH1;FTO;ASCC2
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.2995937923232744,0.5571710615569869,0.95,1.0,1.0,5/10,32.98%,ALKBH3;ASCC3;ALKBH1;FTO;ASCC2
prerank,Reactome_2022__Creatine Metabolism R-HSA-71288,0.3232915339981402,0.5571332193833387,0.9736842105263158,1.0,1.0,5/9,34.19%,GAMT;CKB;SLC6A12;SLC6A8;CKMT2
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),-0.32399561741472116,-0.5569285804446551,0.9365079365079365,1.0,1.0,5/15,26.38%,ODAD1;DNAH17;DNAAF1;ODAD4;DNAI2
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.3376628293508521,0.5567414543085125,0.9459459459459459,1.0,1.0,3/7,37.12%,ISYNA1;PPIP5K2;IPPK
prerank,Reactome_2022__TP53 Regulates Transcription Of Death Receptors And Ligands R-HSA-6803211,0.320319687447348,0.5561301951557323,0.9487179487179487,1.0,1.0,2/7,15.68%,TP53BP2;TMEM219
prerank,Reactome_2022__Phosphate Bond Hydrolysis By NUDT Proteins R-HSA-2393930,0.36669490819054495,0.55607064860086,1.0,1.0,1.0,2/5,18.95%,NUDT15;NUDT9
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.318600293103376,-0.5549498390191907,0.9666666666666667,1.0,1.0,3/15,18.16%,PIGA;PIGH;PIGC
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.3328488092326741,-0.5543664790828371,0.9672131147540983,1.0,1.0,2/11,17.89%,SCIMP;NMI
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),0.28863859314738444,0.5542277938775679,1.0,1.0,1.0,1/9,12.30%,H1-2
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.27684835897981225,-0.5540848211775289,0.9848484848484849,1.0,1.0,6/28,19.36%,WDR1;ANK1;ERBIN;CRB2;LRRC7;MYO9A
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.27744048733634735,-0.5538463003423152,1.0,1.0,1.0,7/32,19.21%,BRCA1;CAV3;PINK1;TCHP;LIMK2;NUPR1;PHF23
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.2704621846651234,0.5536739167915246,1.0,1.0,1.0,5/22,19.39%,AK1;ENPP3;FHIT;AK4;DCK
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.3634486149533385,-0.55350192605931,0.8936170212765957,1.0,1.0,1/5,22.47%,IDH2
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,-0.2805135740975188,-0.5533357958005711,1.0,1.0,1.0,8/30,21.31%,LMNB1;PRKCQ;BMX;PRKCD;MAPT;PLEC;CASP8;STK24
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.3259550884230724,0.5532193685943474,0.975609756097561,1.0,1.0,4/10,27.08%,SPIRE2;CARMIL2;PLS3;CARMIL1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.22201129129135036,0.5530335987419128,1.0,1.0,1.0,4/37,14.92%,SIRT6;SPIRE2;OTUB2;POT1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.29906032116368664,0.5529821974773268,0.9705882352941176,1.0,1.0,3/9,33.38%,CEBPG;VAMP7;ARL8B
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.3281314343858165,0.5527764941601221,0.9459459459459459,1.0,1.0,2/10,15.61%,RBBP4;ASF1A
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.265486099471001,0.5526411835418525,1.0,1.0,1.0,1/16,3.99%,ADCY1
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),-0.3486048675004686,-0.5525242983937235,0.9516129032258065,1.0,1.0,2/6,22.80%,SLC29A4;SLC22A1
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,0.233646965805282,0.5521364853497273,1.0,1.0,1.0,3/46,6.82%,SNRPF;SF3B4;GTF2F2
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.3023044911259833,0.5515415672309313,0.9767441860465116,1.0,1.0,1/9,10.28%,ATF6
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),-0.3063800083264283,-0.551446876923162,0.9692307692307692,1.0,1.0,1/8,7.10%,CMPK2
prerank,GO_Biological_Process_2021__cardiac muscle cell myoblast differentiation (GO:0060379),0.35157694306682835,0.5509473938773303,0.9361702127659575,1.0,1.0,2/5,29.47%,RBPJ;REST
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.33486481707225824,-0.550878799595466,0.9571428571428572,1.0,1.0,1/8,11.74%,PINK1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.3233697675305206,0.5508733398587079,0.95,1.0,1.0,1/7,10.68%,LIN7C
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.34321737100163435,-0.5507937054769204,0.9402985074626866,1.0,1.0,8/8,65.70%,C5AR1;CLU;HSP90AA1;NAB2;HSP90AB1;EGR1;SORL1;RB1
prerank,KEGG_2021_Human__beta-Alanine metabolism,-0.2837007120026091,-0.5506669899465662,0.9846153846153847,1.0,1.0,5/22,16.24%,CARNS1;GAD1;GAD2;CNDP1;ALDH3A2
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.2911969773320217,0.5504497427818561,0.9777777777777777,1.0,1.0,1/10,8.83%,HSF1
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.3374225687345059,0.5495154987323098,0.9791666666666666,1.0,1.0,1/5,27.65%,FERMT2
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.3158705039119939,-0.5491964563480225,0.9692307692307692,1.0,1.0,1/11,10.04%,GPT2
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.31185692055065733,-0.5484451515672851,0.9701492537313433,1.0,1.0,4/8,36.03%,AKAP8;CDK9;AKAP8L;RPS6KA5
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.2739793031551698,0.547621453478404,0.95,1.0,1.0,2/11,24.15%,PICALM;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),-0.3393796735592452,-0.5471725410872422,0.9019607843137255,1.0,1.0,1/6,7.39%,TNFRSF14
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.3378751086944739,-0.5470549929240922,0.9607843137254902,1.0,1.0,1/8,11.74%,PINK1
prerank,Reactome_2022__TNFR1-mediated Ceramide Production R-HSA-5626978,-0.3459437538802642,-0.546735812738388,0.9310344827586207,1.0,1.0,1/5,13.19%,TNFRSF1A
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.301844932274638,-0.54640094543767,0.9333333333333333,1.0,1.0,12/12,69.84%,PARP2;PARK7;MT3;HDAC1;HLCS;SIRT7;HELLS;UFL1;SETD5;SIRT1;CHD1;MBD2
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.30844466881712895,-0.5459478959780943,0.9701492537313433,1.0,1.0,2/13,14.58%,GRM6;GRM7
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.2672350188680652,-0.5452620125512523,1.0,1.0,1.0,1/35,2.20%,ZFP36
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.29165045797549316,0.5452537723496602,1.0,1.0,1.0,2/10,18.83%,PIK3C3;PORCN
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.23564657141947537,0.5448916472089458,1.0,1.0,1.0,3/30,15.78%,TRAK2;LRPPRC;TMEM201
prerank,KEGG_2021_Human__Glucagon signaling pathway,-0.2443601204075796,-0.544077819545138,1.0,1.0,1.0,7/80,10.90%,LDHA;ITPR3;LDHAL6A;FBP1;PPP3CC;CREB5;PYGL
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.3343255705363918,-0.5439948034041704,0.9818181818181818,1.0,1.0,7/7,66.59%,STK25;RIPOR1;ARHGAP21;PDCD10;COPG1;YWHAZ;CDC42
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.3127277635758423,-0.5435420391808298,0.9682539682539683,1.0,1.0,3/13,16.23%,COX7A1;PINK1;COX7A2
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.34788978274455584,-0.5433771683740509,0.9649122807017544,1.0,1.0,2/6,25.10%,TMED10;ARFGAP3
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.34788978274455584,-0.5433771683740509,0.9649122807017544,1.0,1.0,2/6,25.10%,TMED10;ARFGAP3
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.34788978274455584,-0.5433771683740509,0.9649122807017544,1.0,1.0,2/6,25.10%,TMED10;ARFGAP3
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.25632126488805385,-0.5433241106333679,1.0,1.0,1.0,3/34,11.74%,GFAP;DAB2IP;PINK1
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),-0.3501740359614599,-0.5427319292049118,0.9833333333333333,1.0,1.0,1/6,15.09%,ASS1
prerank,"Reactome_2022__Regulation Of Glycolysis By Fructose 2,6-Bisphosphate Metabolism R-HSA-9634600",-0.3218697041353802,-0.5414218315979573,0.9838709677419355,1.0,1.0,3/10,23.06%,PFKFB4;PFKFB3;PFKFB2
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.3067808151326016,0.5412789302198933,0.9782608695652174,1.0,1.0,1/10,10.14%,GNB3
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.364596708299288,-0.5412787776612268,0.9661016949152542,1.0,1.0,6/6,63.56%,PHF19;SUPT6H;PHF1;MACROH2A1;MTF2;OGT
prerank,CellMarker_Augmented_2021__Myeloid cell:Peripheral Blood,-0.35886564684099115,-0.5412192393334503,0.9622641509433962,1.0,1.0,2/5,21.37%,IL3RA;PTPRC
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.3485528475314902,-0.541121335926306,0.9375,1.0,1.0,3/6,24.92%,SOX15;TGFB1;MRTFB
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.30266038700922715,0.5405369852180623,1.0,1.0,1.0,3/8,33.74%,ABL2;ECSIT;SZT2
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.27821753888760337,-0.5403946163057485,0.9857142857142858,1.0,1.0,2/29,12.15%,CC2D2A;GLI1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.2967858310377384,-0.5398354325425851,1.0,1.0,1.0,7/13,28.87%,CMPK2;AK5;NMNAT3;PNP;AK7;NMNAT2;ME1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.34218377862713417,0.5397522112099874,0.926829268292683,1.0,1.0,1/8,10.01%,ENGASE
prerank,Reactome_2022__STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,-0.3311930717723055,-0.539503658468012,0.9824561403508771,1.0,1.0,1/9,11.32%,PRDM1
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.3231557811649284,-0.5391028234851839,0.9672131147540983,1.0,1.0,2/8,16.59%,ADCY3;CLN3
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.22093152429841223,0.5386134994682188,1.0,1.0,1.0,8/36,27.56%,SNRPF;AAR2;CLNS1A;WDR77;GEMIN4;SART3;SNRPB;COIL
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.25344689345394017,0.5385253578981887,0.9714285714285714,1.0,1.0,2/13,23.30%,AAR2;SART3
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.27643624076039347,0.5384062181194128,1.0,1.0,1.0,6/20,24.86%,NT5C1A;PRTFDC1;MLYCD;PDE9A;NUDT7;NT5E
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.2971083264251487,-0.5383227088859361,0.9848484848484849,1.0,1.0,1/16,7.01%,APOD
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.30213987202005116,-0.5376906985641291,0.95,1.0,1.0,1/12,8.69%,WAS
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.37443828421359787,-0.537261764695028,0.9818181818181818,1.0,1.0,5/5,62.57%,KDM6B;KDM6A;PHF8;KDM7A;UTY
prerank,GO_Biological_Process_2021__aspartate metabolic process (GO:0006531),-0.3555586399423333,-0.5365813067850027,0.9682539682539683,1.0,1.0,1/5,15.09%,ASS1
prerank,Reactome_2022__IRF3-mediated Induction Of Type I IFN R-HSA-3270619,-0.32319781577062723,-0.5365717741516994,0.9473684210526315,1.0,1.0,3/10,25.46%,DDX41;NLRC3;MRE11
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.2613145344554326,0.5348456950110925,0.9743589743589743,1.0,1.0,1/11,10.41%,PAPOLA
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.2776308214773968,0.5341285429033846,0.9743589743589743,1.0,1.0,7/13,28.65%,DPH3;MTO1;ELP4;ELP3;URM1;ALKBH8;CTU1
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.3233713709112556,0.5336669518496434,0.95,1.0,1.0,2/6,29.87%,TLK1;MAP1S
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.3042494018706734,-0.5334495267034942,0.9464285714285714,1.0,1.0,1/10,8.66%,SRF
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.3134669694132465,0.5334248699545163,1.0,1.0,1.0,3/5,33.88%,RNF20;KDM1A;RNF40
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.2310264109253718,-0.5334245240418076,1.0,1.0,1.0,10/51,24.26%,RAB11A;PLK3;DCTN1;LIMK2;MAPT;FSD1;HOOK2;DST;CLIP2;TRDN
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),-0.33940723680075957,-0.5322883215311832,0.94,1.0,1.0,3/6,23.58%,DCX;STAT3;NKD1
prerank,Reactome_2022__Butyrophilin (BTN) Family Interactions R-HSA-8851680,0.3111226908138149,0.5322626159984585,0.9069767441860465,1.0,1.0,1/6,8.95%,BTN3A3
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.2989170589159419,-0.5322300886851777,1.0,1.0,1.0,3/16,17.95%,ASPN;SRGN;TGFB1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.3376588426990622,-0.5321216097760113,0.9552238805970149,1.0,1.0,4/8,32.55%,DDRGK1;DDIT3;TMSB4X;ZNF593
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.3310009229090114,-0.5313017931612131,0.9811320754716981,1.0,1.0,3/7,29.54%,AK5;DHODH;CTPS1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.3064837850890526,0.5312931133392315,0.9210526315789473,1.0,1.0,2/8,31.30%,PKIB;SIRT1
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.34671724540414356,-0.5312647719946212,0.9830508474576272,1.0,1.0,5/5,65.34%,TMEM107;NPHP4;TCTN1;TCTN2;SPATA7
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.25827891220661914,0.5309259622669715,1.0,1.0,1.0,2/22,13.67%,MAPK12;CDH2
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.31149092318223043,-0.5304593706569151,0.9696969696969697,1.0,1.0,2/9,20.90%,B4GALT7;CHST9
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),0.29591394252691683,0.5295896149597287,0.9230769230769231,1.0,1.0,6/9,34.74%,DRD2;SNCAIP;DRD4;RNF180;PNMT;PRKN
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.31851367612940074,-0.5294735155151302,0.9836065573770492,1.0,1.0,3/10,25.76%,SLC50A1;SLC5A10;SLC5A9
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.3300369656121286,-0.529327649079226,0.9636363636363636,1.0,1.0,1/6,15.91%,JADE2
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.22823971987353536,0.5288123623247973,1.0,1.0,1.0,10/29,27.68%,DNASE1L2;NUDT15;DFFB;DNASE1L1;NUDT9;ENTPD1;PPP1R8;MTREX;HNRNPD;ENTPD4
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.2909929367812737,0.5281753015857763,0.9583333333333334,1.0,1.0,9/9,70.92%,RYK;LRP6;NR4A2;MANF;CDNF;LMX1B;VEGFA;CTNNB1;WNT9B
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),-0.34245394400170537,-0.5281735059402268,0.9310344827586207,1.0,1.0,2/5,22.80%,SLC29A4;SLC22A1
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.28947341207866817,-0.5281070911108838,1.0,1.0,1.0,4/19,19.24%,NOS1AP;HPCA;CACNB1;STAC2
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.28806770797018977,-0.528058427805205,0.9701492537313433,1.0,1.0,2/18,15.80%,IL1RAPL1;RELN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.2824650692806844,0.5280541233855472,0.9375,1.0,1.0,4/13,17.89%,ATP1A2;ANK2;GSTM2;DMD
prerank,Reactome_2022__Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.2845034996244481,-0.5270858635449357,1.0,1.0,1.0,2/18,13.16%,LDLR;LDHD
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,-0.304485284984494,-0.5270824455733936,1.0,1.0,1.0,4/15,22.98%,IL7;IRS2;RAG1;STAT3
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.20017122842685467,0.5268347045788234,1.0,1.0,1.0,15/47,32.16%,NOVA1;NSRP1;HNRNPU;RBFOX1;FXR2;RBMX;RBM15;MBNL1;MAGOH;REST;PTBP1;RBM15B;HNRNPL;SAP18;CELF1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.23715736663122294,-0.525933115978492,1.0,1.0,1.0,7/54,19.43%,YBX3;PINK1;BCL2L2;SFRP2;CREB3;CDKN2D;PLAUR
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.32003625541525754,0.5258000994993292,0.9428571428571428,1.0,1.0,2/6,16.12%,SASH1;MARCHF7
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,-0.2476247814724905,-0.5257294839377371,1.0,1.0,1.0,4/41,16.42%,FA2H;SGPP2;ALDH3A2;ORMDL2
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),0.27579197154049767,0.5257141745261298,0.9523809523809523,1.0,1.0,2/9,19.53%,POT1;DAXX
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),0.27579197154049767,0.5257141745261298,0.9523809523809523,1.0,1.0,2/9,19.53%,POT1;DAXX
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),-0.327446816632817,-0.5253454356476814,0.9661016949152542,1.0,1.0,1/5,11.32%,PRDM1
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.31004321308627775,-0.5252002020041757,0.9824561403508771,1.0,1.0,2/8,18.19%,PINK1;NUPR1
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.3270343835338779,-0.5247099717757409,0.9107142857142857,1.0,1.0,2/7,15.09%,NOS1;ASS1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.27817242356186433,-0.524089753876933,0.9857142857142858,1.0,1.0,1/17,6.51%,GSTM5
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.27817242356186433,-0.524089753876933,0.9857142857142858,1.0,1.0,1/17,6.51%,GSTM5
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.25270118694673427,0.5238394193220303,1.0,1.0,1.0,2/21,10.49%,TBC1D12;RAB1B
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.26372563601660615,0.5229495419871493,1.0,1.0,1.0,1/17,6.69%,AKT1
prerank,Reactome_2022__Beta Oxidation Of lauroyl-CoA To decanoyl-CoA-CoA R-HSA-77310,0.32360665304931413,0.5223438495753772,0.9777777777777777,1.0,1.0,5/5,67.65%,ECHS1;HADH;HADHB;HADHA;ACADL
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.3396452847358806,0.521728561087944,0.9761904761904762,1.0,1.0,3/8,16.45%,NIPBL;ID2;RBPMS2
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.3290141093221921,-0.5215963856129329,0.9846153846153847,1.0,1.0,2/8,17.58%,CXCL17;CREB3
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),-0.3414566689530283,-0.5205569290028785,0.94,1.0,1.0,1/5,19.21%,PHF23
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.3299734070638985,0.5201463192826269,0.9361702127659575,1.0,1.0,3/5,40.35%,HSD17B10;TRMT10C;PNPT1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.2921851180365588,-0.5200071091599047,1.0,1.0,1.0,3/9,24.64%,HSPA5;COPS5;XBP1
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,0.227501332020668,0.5193544559906571,1.0,1.0,1.0,7/30,24.15%,YES1;ARHGEF28;WASL;ITSN1;PTK2;TIAM1;ROCK2
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),0.34692124304502625,0.5190397333788631,0.9387755102040817,1.0,1.0,1/5,19.21%,SLC25A38
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.27994658109607273,-0.5186097687924445,0.9583333333333334,1.0,1.0,5/19,25.25%,DCTN1;EMD;GPER1;CHMP2A;VPS4A
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.25499580482858514,0.5185028776848127,1.0,1.0,1.0,4/15,18.61%,SGIP1;PICALM;PIK3C2A;EPS15
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771",-0.2761721960642468,-0.5184571428166562,0.9122807017543859,1.0,1.0,1/11,12.53%,SEC11C
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.2703835233213727,-0.518292276531896,1.0,1.0,1.0,4/23,22.15%,DAB2IP;BBC3;ITPR1;ERO1A
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.23573487666713705,0.51822519320871,1.0,1.0,1.0,1/26,5.78%,SF3A1
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.32850650789617986,0.5172619552301958,0.95,1.0,1.0,3/6,21.74%,METTL4;DKC1;MEPCE
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.29213578432412834,-0.5156632201919162,1.0,1.0,1.0,4/11,33.65%,MYO9A;ZDHHC7;MSN;CAMSAP3
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.29374478468723336,-0.5149096571971216,1.0,1.0,1.0,3/9,21.62%,RPS21;EXOSC7;EXOSC10
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),-0.3554483209865486,-0.5139326951227327,1.0,1.0,1.0,2/5,17.99%,BIRC3;SLC15A4
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),0.2822458270106221,0.5137083935562182,0.9302325581395349,1.0,1.0,6/6,71.79%,SMO;PTPRJ;CDHR2;YAP1;FAP;PAK1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),-0.2803607747516616,-0.5121746399929368,0.9827586206896551,1.0,1.0,2/12,20.67%,CNTN4;RTN4
prerank,Reactome_2022__Scavenging By Class F Receptors R-HSA-3000484,-0.3510942515319521,-0.5118881333284012,0.9814814814814815,1.0,1.0,5/5,64.91%,HYOU1;CALR;HSP90AA1;SCARF1;HSPH1
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.3272692772117038,-0.5118788983931489,0.9508196721311475,1.0,1.0,1/5,17.19%,PRKCB
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.23851841324021403,-0.5109131215577281,0.9876543209876543,1.0,1.0,9/36,22.34%,LTBP4;FADD;PLAT;CLN3;AURKAIP1;CDK5;PLAUR;CASP8;GSAP
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.31352518825520986,-0.5105171734929809,0.9642857142857143,1.0,1.0,9/9,68.67%,TSPAN6;RIOK3;C1QBP;DHX58;TKFC;SEC14L1;NPLOC4;UFD1;GPATCH3
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.24715295216959646,0.5104926156966066,0.9696969696969697,1.0,1.0,17/17,75.31%,GTF3C3;SPIN1;NIFK;GTF3C4;TCOF1;TAF1B;SIRT7;MARS1;GTF3C2;GTF3C5;GTF3C1;BRF1;GTF3A;POLR1E;CAVIN1;POLR1G;GTF3C6
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.27489088838653425,0.5089275416193576,0.9761904761904762,1.0,1.0,4/9,29.35%,EXOSC6;EXOSC8;EXOSC5;XRN1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.293862341325848,0.508807250754405,1.0,1.0,1.0,1/7,19.75%,HEY2
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.24628476000383923,-0.5084548270337897,1.0,1.0,1.0,6/38,22.02%,ALOX12;SQLE;ACOT8;INSIG1;MSMO1;SLC27A5
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.2578834265817489,-0.5081046434443985,1.0,1.0,1.0,1/24,5.52%,AKR1C1
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.297454560909844,0.5078601832573596,0.9512195121951219,1.0,1.0,2/6,21.21%,ANK2;RYR1
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,-0.2360451581481697,-0.5069762372326092,1.0,1.0,1.0,4/43,13.31%,NDUFA2;NDUFB9;NDUFB11;NDUFB10
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.32263910128651674,-0.5057814728792072,0.9807692307692307,1.0,1.0,3/7,19.24%,BIRC3;SLC15A4;CD36
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.2922262984197582,-0.5050142851840124,1.0,1.0,1.0,6/15,29.06%,PINK1;BCL6;BBC3;NFYB;CITED2;DDIT3
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.3007276443117911,0.5035864554844874,0.9607843137254902,1.0,1.0,2/6,31.08%,GTF3C3;GTF3C4
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.25410657360918953,0.5020855183385653,0.975,1.0,1.0,1/15,7.15%,FBXO5
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.31558430759386,0.5019339520915155,0.9736842105263158,1.0,1.0,1/5,24.07%,ITCH
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.3423683810903474,-0.5012351260623226,0.9811320754716981,1.0,1.0,1/5,14.68%,PPIB
prerank,Reactome_2022__Branched-chain Amino Acid Catabolism R-HSA-70895,0.23407516262723105,0.4991392864833242,1.0,1.0,1.0,10/20,32.38%,DBT;ACADSB;PPM1K;BCKDHB;HIBCH;HIBADH;ECHS1;IVD;HSD17B10;ALDH6A1
prerank,Reactome_2022__SUMOylation Of Immune Response Proteins R-HSA-4755510,-0.2869238759317294,-0.49806542051138963,0.9848484848484849,1.0,1.0,4/10,25.85%,IKBKG;NFKB2;IKBKE;PIAS3
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.2152446125583935,0.4975635521089057,1.0,1.0,1.0,5/27,22.84%,STYX;EIF3H;FHIT;CCAR2;N4BP1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.29497133153659116,-0.4974224599229649,1.0,1.0,1.0,3/10,21.79%,FADD;CASP8;INHA
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.2516494424008874,0.4967885883152124,1.0,1.0,1.0,13/13,74.85%,PARP1;ERCC4;TERF1;TERF2;PINX1;TNKS2;TNKS;ERCC1;SMG6;ATM;TERF2IP;SLX4;NBN
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.2925738948798476,0.4967864584591689,0.9814814814814815,1.0,1.0,3/7,24.14%,HEY2;JAG1;ZFPM2
prerank,Reactome_2022__DNA Damage Reversal R-HSA-73942,0.2684947490589746,0.4936484069542702,1.0,1.0,1.0,4/8,32.98%,ALKBH3;ASCC3;FTO;ASCC2
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.3128508262150203,0.4929762467673656,0.9523809523809523,1.0,1.0,4/6,32.53%,SIRT2;EZH2;DPY30;RIF1
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.32301646245015486,-0.492855127797524,0.9830508474576272,1.0,1.0,2/6,29.18%,CHMP2A;FCHO2
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.26370513446602256,0.49244465177568647,0.9545454545454546,1.0,1.0,4/10,22.72%,DCP1B;EDC3;PATL1;DCP1A
prerank,Reactome_2022__MAPK1 (ERK2) Activation R-HSA-112411,0.2761447738204236,0.4923782457116283,0.9607843137254902,1.0,1.0,2/8,29.88%,MAP2K2;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.2947342408688155,-0.4913637216707318,0.984375,1.0,1.0,2/10,21.97%,ADAM8;SH3D19
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.3158487168691752,0.4898417632121511,0.9814814814814815,1.0,1.0,2/5,24.83%,DHFR;BMP7
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.22291619171903698,-0.4895076524018585,1.0,1.0,1.0,8/52,20.53%,ATG9A;MAP1LC3A;WDR45;GABARAPL1;GABARAPL2;ATG16L2;TMEM41B;RAB19
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.27679878288779725,-0.4893936248471005,1.0,1.0,1.0,3/17,20.46%,ANAPC11;UBE2S;ANAPC15
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.295130192418361,-0.48800721896913657,0.9830508474576272,1.0,1.0,2/8,18.89%,ZFPM1;TBX20
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.2960290793881467,-0.48793570396672575,1.0,1.0,1.0,1/8,12.35%,HECW2
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.23690768903753,-0.48789308477828497,1.0,1.0,1.0,1/36,3.86%,BHMT
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.22297823552411633,-0.48755866404923515,1.0,1.0,1.0,11/47,25.81%,ACSM5;LIPI;LIPH;OXSM;ACOT8;SLC27A5;ACMSD;ACSM3;XBP1;ALOX5;CBR4
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.28495615822947307,-0.48753994662426287,1.0,1.0,1.0,4/14,19.49%,DDRGK1;RYR2;HSPA5;GABARAPL2
prerank,Reactome_2022__Uptake And Function Of Anthrax Toxins R-HSA-5210891,0.27126962780184466,0.48731429311800845,0.9705882352941176,1.0,1.0,2/11,18.68%,MAP2K4;MAP2K2
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.26400914122941455,-0.4872733508301304,1.0,1.0,1.0,2/17,12.08%,HSD17B14;CYP21A2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.32974383325066525,0.48665461633140855,0.9722222222222222,1.0,1.0,1/5,13.93%,NAPB
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.307522818901288,-0.48642784761368657,0.9821428571428571,1.0,1.0,2/6,26.55%,HES1;ENG
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.26350188521203094,-0.4859297066435867,0.9838709677419355,1.0,1.0,1/12,9.00%,NLRP5
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.2627987698369137,0.4859240486703838,1.0,1.0,1.0,1/10,6.55%,SLC25A18
prerank,Reactome_2022__MET Activates RAP1 And RAC1 R-HSA-8875555,-0.27477915610598674,-0.48537692783710407,1.0,1.0,1.0,1/11,12.88%,RNASE1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.28418840833479253,0.48511908176452223,0.975609756097561,1.0,1.0,7/7,71.59%,ADI1;SMS;MTR;MTRR;MTHFR;MSRA;MTHFD1
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.3062102767082282,0.48509813426350956,0.9545454545454546,1.0,1.0,3/5,29.28%,ALKBH3;ALKBH1;FTO
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.21619327586494266,0.4850727442265829,1.0,1.0,1.0,8/23,27.41%,SLC25A18;SLC3A2;SLC25A22;SLC36A4;SLC7A9;SFXN1;SLC1A4;SLC25A12
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.2863972252143044,-0.48482755739093303,0.9833333333333333,1.0,1.0,2/10,22.63%,SH2B2;FPR3
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.32247090652377364,-0.4847258651365941,0.9622641509433962,1.0,1.0,2/5,20.04%,CD4;DCAF15
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.26389206232183954,-0.4845946916399458,1.0,1.0,1.0,1/16,10.55%,CCNB1
prerank,Reactome_2022__Acetylcholine Regulates Insulin Secretion R-HSA-399997,-0.2992989662817198,-0.4842001064856007,0.953125,1.0,1.0,1/8,10.14%,CHRM3
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.288466028484707,-0.4841385010791586,0.95,1.0,1.0,8/8,71.17%,NEU4;GBA3;NAGA;GLA;GM2A;HEXB;NEU1;NEU3
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.21976686584205282,0.48400296470035015,1.0,1.0,1.0,8/29,26.91%,VCP;RUBCNL;SNAP29;VIPAS39;UBQLN1;LIX1L;VPS16;VAMP7
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.28567840545657086,0.4829659409780471,0.9767441860465116,1.0,1.0,4/6,39.95%,NAGK;GNPDA2;NPL;RENBP
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.25377458980660383,-0.48185868485602207,0.9833333333333333,1.0,1.0,1/15,12.57%,CORO7
prerank,Reactome_2022__Ligand-receptor Interactions R-HSA-5632681,-0.3117082707602044,-0.48125835619508306,1.0,1.0,1.0,1/5,11.17%,HHIP
prerank,Reactome_2022__Phase 1 - Inactivation Of Fast Na+ Channels R-HSA-5576894,-0.30965752791999657,-0.4795593186231157,0.9827586206896551,1.0,1.0,2/6,19.62%,KCND3;KCNIP4
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.2692788281421911,0.4793398124139295,1.0,1.0,1.0,4/12,17.89%,TCAP;CDH2;PIK3CA;DMD
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.2612665281024328,-0.4792318510357408,1.0,1.0,1.0,3/18,20.46%,ANAPC11;UBE2S;ANAPC15
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),-0.27831699720764136,-0.47905991237496526,1.0,1.0,1.0,3/11,19.40%,IGF1;TSC2;GHR
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.25909192381122687,-0.4777402935735315,1.0,1.0,1.0,5/12,28.60%,ALKBH4;HPF1;PARG;CDK9;SETD1A
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.29424245934469817,-0.4772599724775722,0.9807692307692307,1.0,1.0,2/7,22.62%,FLOT1;EHD1
prerank,Reactome_2022__Reversal Of Alkylation Damage By DNA Dioxygenases R-HSA-73943,0.28532933695935464,0.47700902710563126,1.0,1.0,1.0,4/7,32.98%,ALKBH3;ASCC3;FTO;ASCC2
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.2903508644401066,-0.4764933667914063,0.9850746268656716,1.0,1.0,1/10,13.52%,NLGN1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.29257241726417665,-0.476161175586473,0.9818181818181818,1.0,1.0,2/5,24.18%,AK5;DHODH
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.2934320240314095,0.4761505020069792,0.9777777777777777,1.0,1.0,4/6,34.19%,GAMT;CKB;SLC6A8;CKMT2
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.3015334841217813,0.4753578178588839,0.9736842105263158,1.0,1.0,4/6,28.62%,NFKB1;ROCK2;RELA;SLC30A10
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.2391280386130923,0.47533416028554576,1.0,1.0,1.0,4/11,34.36%,CDK12;CDK13;SUPT16H;CDC73
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.2582645454060079,0.47486607212039617,1.0,1.0,1.0,3/8,23.28%,ZC3H14;CCNT1;RNF20
prerank,KEGG_2021_Human__Terpenoid backbone biosynthesis,-0.2600666801272081,-0.4746631852724395,1.0,1.0,1.0,9/19,29.59%,MVK;FDPS;HMGCS1;ACAT2;IDI1;DHDDS;RCE1;HMGCR;MVD
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.2535500377871849,0.4745152440752212,1.0,1.0,1.0,5/13,25.54%,AK1;ENPP3;AK4;AK3;CMPK1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.2332399383100202,-0.4733587791001469,1.0,1.0,1.0,7/29,26.17%,DAB2IP;BCL2L14;BDNF;CX3CL1;FAS;RPS3;DEPTOR
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.2409902471825,-0.4721230715366312,1.0,1.0,1.0,5/25,20.65%,ZFPM1;WNT5A;GPER1;TGFB1;WWTR1
prerank,Reactome_2022__Neurotransmitter Clearance R-HSA-112311,0.2662544591526988,0.4718510223834853,0.9777777777777777,1.0,1.0,3/8,19.38%,SLC22A2;MAOA;ALDH2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.284850284730889,-0.4710198104396783,0.9642857142857143,1.0,1.0,1/7,17.31%,GPC1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.27705147659624135,0.4696899228006727,0.9782608695652174,1.0,1.0,6/6,72.30%,CARMIL1;MAPKAPK2;SNX33;MAPKAPK3;DOCK2;RAB34
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.2882480961561304,0.4678784649985369,0.9782608695652174,1.0,1.0,1/7,11.38%,ABCC2
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.24015710534595452,0.4678279915576814,1.0,1.0,1.0,1/15,10.35%,RRM2B
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.2570506004072753,-0.46746693984034166,0.96875,1.0,1.0,3/16,20.46%,ANAPC11;UBE2S;ANAPC15
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),0.2043944896864967,0.4670921338483236,1.0,1.0,1.0,9/25,30.40%,GTF2F2;POLR2C;CCNT1;NELFA;CTDP1;POLR2A;POLR2K;POLR2D;POLR2E
prerank,Reactome_2022__Beta Oxidation Of butanoyl-CoA To acetyl-CoA R-HSA-77352,0.32030181394410634,0.46669017034218846,1.0,1.0,1.0,1/5,15.48%,ACADS
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.22460159411977143,-0.4646879049771433,1.0,1.0,1.0,8/33,25.06%,GLRA2;GLRA1;NSMF;SPAAR;LAMTOR2;NEURL1;XBP1;FYN
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.2578047530964238,-0.4642066597797297,1.0,1.0,1.0,2/14,20.18%,LPCAT4;PNPLA8
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.2703335062867846,0.4616278664160819,0.9743589743589743,1.0,1.0,1/7,15.48%,ACADS
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.2956967684449561,-0.46117761136682106,0.95,1.0,1.0,2/6,21.28%,GNG2;SFRP1
prerank,Reactome_2022__IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,-0.2708034565705201,-0.46077247017137074,0.9827586206896551,1.0,1.0,1/11,9.17%,OSMR
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),0.28938201402910557,0.46046986734433704,0.9772727272727273,1.0,1.0,3/5,34.33%,SLC25A14;SLC13A5;SLC25A11
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.2504783341773308,0.4590221771593835,0.9772727272727273,1.0,1.0,1/10,10.57%,WASHC2C
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.288466028484707,-0.45823950284693554,1.0,1.0,1.0,8/8,71.17%,NEU4;MAN2C1;MAN2B2;GBA3;MANBA;MAN2B1;NEU1;NEU3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.2967531017394176,-0.45627490464375287,0.9821428571428571,1.0,1.0,2/7,26.55%,GPER1;ENG
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.2079642096193063,0.4562680542394166,1.0,1.0,1.0,6/19,29.80%,ABL2;PDPK1;GNA13;KIT;ARF4;ESR1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.2902830463962651,0.4562376144799151,1.0,1.0,1.0,5/5,70.98%,DDAH1;TMBIM6;HYOU1;ENO1;NOL3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.24835652270394976,-0.45577691400740783,1.0,1.0,1.0,6/14,31.83%,SFRP2;CDKN2D;RPS3;TRIM32;BCL2L1;DDIAS
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.2922843469125713,0.45537276037649416,1.0,1.0,1.0,6/6,70.78%,FBXW7;PRKN;NONO;HIF1A;MCL1;PARK7
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.27272230671478526,-0.455041663744403,0.9545454545454546,1.0,1.0,2/9,23.20%,KLRD1;TUBB4B
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.2870316330103888,0.4534251916901577,1.0,1.0,1.0,6/6,71.31%,SMAD4;BMPR1A;CDH3;HIF1A;SMAD3;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.25508147084799715,0.4523568693314211,0.975,1.0,1.0,2/11,14.66%,PRKG1;NDRG4
prerank,Reactome_2022__Disorders Of Developmental Biology R-HSA-9675151,0.23908220457730034,0.45226770537836447,1.0,1.0,1.0,12/12,76.11%,CAMK4;MECP2;CALM1;TBL1XR1;SIN3A;PRKCA;HDAC3;HDAC1;NCOR2;GPS2;NCOR1;TBL1X
prerank,KEGG_2021_Human__Pantothenate and CoA biosynthesis,-0.23733029698310582,-0.45028014467376193,1.0,1.0,1.0,4/14,24.01%,ALDH3A2;BCAT1;DPYD;BCAT2
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),-0.2884155237817333,-0.4502476611742063,0.9649122807017544,1.0,1.0,5/5,71.17%,NEU4;GM2A;HEXB;NEU1;NEU3
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.24301505125006162,-0.4502049111767754,1.0,1.0,1.0,1/18,10.69%,RPS13
prerank,Reactome_2022__Metabolism Of Steroid Hormones R-HSA-196071,0.2389291116903378,0.4498019091764378,1.0,1.0,1.0,9/17,29.69%,STARD3NL;STARD4;HSD17B11;AKR1B1;FDX1;HSD17B12;CYP11A1;STARD3;SRD5A1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.3006946190540828,-0.4494998455158752,1.0,1.0,1.0,1/5,19.14%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.3006946190540828,-0.4494998455158752,1.0,1.0,1.0,1/5,19.14%,PHLDB2
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.272339928792389,0.4476531303138386,1.0,1.0,1.0,7/7,72.78%,ATG2B;ATG7;RB1CC1;ATG2A;ATG13;ULK2;ULK1
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.272339928792389,0.4476531303138386,1.0,1.0,1.0,7/7,72.78%,ATG2B;ATG7;RB1CC1;ATG2A;ATG13;ULK2;ULK1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.24437174400225944,0.4450974823035075,1.0,1.0,1.0,4/11,29.96%,EPS8;CTDP1;CLASP2;SPAST
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.20457144214830245,0.4449053332596063,1.0,1.0,1.0,5/27,21.80%,PGAP1;PIGP;DPM1;PIGF;PIGU
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),0.28473176854464455,0.444207872720913,0.9555555555555556,1.0,1.0,3/5,34.33%,SLC25A14;SLC13A3;SLC25A11
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.2692330767056028,-0.4434116778010798,1.0,1.0,1.0,4/10,28.66%,CLN3;RAB20;RAB34;RAB39A
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.2690662707747167,-0.4432113396553812,0.9850746268656716,1.0,1.0,3/8,33.65%,MYO9A;MSN;CAMSAP3
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.24982484820177486,-0.44287778873482875,1.0,1.0,1.0,12/12,75.04%,SET;HMGA1;ARID1A;SMARCD3;SMARCA4;SMARCB1;SMARCD2;SMARCD1;GRWD1;SUPT16H;ARID2;SMARCC1
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.24982484820177486,-0.44287778873482875,1.0,1.0,1.0,12/12,75.04%,SET;HMGA1;ARID1A;SMARCD3;SMARCA4;SMARCB1;SMARCD2;SMARCD1;GRWD1;SUPT16H;ARID2;SMARCC1
prerank,Reactome_2022__Signal Attenuation R-HSA-74749,-0.2703874661793949,-0.44279107656221767,1.0,1.0,1.0,2/9,26.93%,IRS2;SHC1
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.28129559381383135,0.4427069339784623,1.0,1.0,1.0,5/5,71.88%,RPS6KA4;FMR1;MAPK3;RPS6KA5;CDK9
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.28611152798830924,0.44203935710344866,0.9722222222222222,1.0,1.0,2/5,33.48%,PTPN2;HIP1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.26610198598240703,-0.4395502241857474,0.9830508474576272,1.0,1.0,3/9,23.00%,TMEFF2;TGFB1;TAF7
prerank,KEGG_2021_Human__Maturity onset diabetes of the young,-0.2719313605323061,-0.43727684836264363,1.0,1.0,1.0,7/7,72.82%,HES1;ONECUT1;NKX2-2;HNF4G;PAX6;NR5A2;GCK
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.2515466324267538,0.43688530158901806,1.0,1.0,1.0,6/6,74.85%,ERCC4;TERF2;ERCC1;SMG6;ATM;NBN
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.21666848493462587,-0.4365441400141668,1.0,1.0,1.0,5/18,29.23%,PINK1;SREBF1;HDAC6;SREBF2;PARK7
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.25162886461420575,-0.4361741154437478,1.0,1.0,1.0,3/10,30.38%,PAF1;DTX3L;CTR9
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.2143914099100086,0.4358029475456033,1.0,1.0,1.0,8/14,38.35%,RBM17;SRSF9;SCNM1;CDK13;SFPQ;DDX5;RSRC1;DHX9
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.2490051325115245,-0.4347038926010684,1.0,1.0,1.0,4/11,28.66%,CLN3;RAB20;RAB34;RAB39A
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),-0.2573591325806144,-0.43459510409322416,1.0,1.0,1.0,2/10,21.79%,GSS;CHAC2
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.24933966438501598,0.43317832303064363,0.9722222222222222,1.0,1.0,2/10,25.66%,TAMM41;PGS1
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.2507630019891825,0.43255690338243924,0.98,1.0,1.0,2/7,31.08%,GTF3C3;GTF3C4
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),-0.25021671120805855,-0.43253660801926996,1.0,1.0,1.0,1/11,12.54%,PIM1
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.2802614684253531,-0.4319950993575887,1.0,1.0,1.0,6/6,71.99%,GMFB;PICK1;DNAI3;CORO1B;CTNNA2;GMFG
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.2802614684253531,-0.4319950993575887,1.0,1.0,1.0,6/6,71.99%,GMFB;PICK1;DNAI3;CORO1B;CTNNA2;GMFG
prerank,Reactome_2022__Methylation R-HSA-156581,-0.25255008474052165,-0.4312733967431691,1.0,1.0,1.0,3/10,23.48%,NNMT;TRMT112;GSTO1
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.26551100215957496,0.4306772856366019,1.0,1.0,1.0,7/7,73.46%,RBPJ;TGFBR1;BMPR1A;NOTCH1;TGFB2;NRG1;ENG
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.2275911216707626,0.4298096652831935,1.0,1.0,1.0,3/11,31.09%,PANK2;SLC25A16;PPCS
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.2275911216707626,0.4298096652831935,1.0,1.0,1.0,3/11,31.09%,PANK2;SLC25A16;PPCS
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.2275911216707626,0.4298096652831935,1.0,1.0,1.0,3/11,31.09%,PANK2;SLC25A16;PPCS
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),-0.27425787886420677,-0.4293817645267087,0.9818181818181818,1.0,1.0,1/6,18.14%,MAPT
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.22619812036658693,0.42936680634709967,1.0,1.0,1.0,9/9,77.39%,EIPR1;RAB11B;SORL1;ACTN2;ATP9A;EHD2;INPP5F;ARHGAP1;EHD1
prerank,KEGG_2021_Human__Glycosaminoglycan degradation,-0.24519624710855248,-0.4290881887989324,1.0,1.0,1.0,4/12,29.45%,HYAL1;IDUA;HYAL2;SGSH
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.2618526559075333,-0.42818252470936713,0.9836065573770492,1.0,1.0,3/7,27.18%,NMNAT3;QPRT;NMNAT2
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.24801540975951436,-0.427460809371582,1.0,1.0,1.0,8/8,75.22%,HES1;TGFB2;SIX4;PTCH1;BMPR2;BMPR1A;BMP7;TGFBR1
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,-0.22573472997618987,-0.42736895783501955,1.0,1.0,1.0,4/21,22.98%,PRDM1;PIK3CB;ALK;STAT3
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.2539248809255256,-0.42613670681675286,1.0,1.0,1.0,4/12,29.75%,DDRGK1;ULK1;ULK2;RETREG1
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.2223977270478909,0.42475066158363456,0.9736842105263158,1.0,1.0,4/10,23.65%,HDAC10;SMOX;SRM;SAT1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.23660334242887782,-0.42464815367313974,1.0,1.0,1.0,3/20,22.12%,POLR2I;TINF2;POLR2J
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.23660334242887782,-0.42464815367313974,1.0,1.0,1.0,3/20,22.12%,POLR2I;TINF2;POLR2J
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),0.21843279551827416,0.4244044662168353,1.0,1.0,1.0,6/13,30.67%,NUDT15;ENPP3;ENTPD1;ENTPD4;ENTPD6;DCTPP1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),0.24819052066308664,0.4239437632012436,1.0,1.0,1.0,8/8,75.19%,BECN1;PRKN;AMBRA1;PHB2;MAP1LC3B;ATG13;ATG14;SQSTM1
prerank,Reactome_2022__Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,-0.22075847826960038,-0.42385908425729524,1.0,1.0,1.0,4/22,22.12%,POLR2I;NELFE;SUPT5H;POLR2J
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.19049352450885837,-0.4230816578692974,1.0,1.0,1.0,9/42,29.03%,SNRPD2;CELF4;SNRNP200;PRPF6;SRSF5;DDX23;SMN1;TXNL4A;NOL3
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.1910756468027178,0.42304169739323133,1.0,1.0,1.0,2/24,15.99%,AKT1;GPR37L1
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.2470231146392716,0.4228866304699917,1.0,1.0,1.0,8/8,75.31%,GTF3C3;GTF3C4;GTF3C2;GTF3C5;GTF3C1;BRF1;POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2143534448873066,0.4223222735917878,1.0,1.0,1.0,4/18,29.42%,KCTD17;RAP1GDS1;BAK1;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.2753988399759886,0.42078048931219575,1.0,1.0,1.0,2/6,22.55%,PIK3R1;PTK2
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.2684293468744528,-0.4180025623108531,1.0,1.0,1.0,7/7,73.17%,SQSTM1;MAP1LC3B;ATM;PJVK;NBR1;USP30;PEX5
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.2281244527464831,0.41781752712212017,1.0,1.0,1.0,9/9,77.20%,EP300;GCK;PGP;CRY1;CLK2;BCKDK;NCOR1;MST1;ACMSD
prerank,Reactome_2022__BH3-only Proteins Associate With And Inactivate Anti-Apoptotic BCL-2 Members R-HSA-111453,0.24100002998208947,0.41597648211727617,1.0,1.0,1.0,3/7,26.87%,BAD;BCL2L11;BID
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.2407834624496239,0.4141764738524655,1.0,1.0,1.0,3/9,31.23%,BDH2;HMGCL;BDH1
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.2611904642102988,-0.4136050369288062,1.0,1.0,1.0,1/5,21.37%,PTPRC
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.19831762068719685,0.4134165849453233,1.0,1.0,1.0,7/17,34.37%,EPS8;ABI2;TIAM1;NCKAP1;BRK1;HACE1;FARP2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.2584184417858185,-0.4124967075196904,1.0,1.0,1.0,5/5,74.17%,SMC5;MACROH2A1;SLF1;SLF2;NSMCE2
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.2584184417858185,-0.4124967075196904,1.0,1.0,1.0,5/5,74.17%,SMC5;MACROH2A1;SLF1;SLF2;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.2584184417858185,-0.4124967075196904,1.0,1.0,1.0,5/5,74.17%,SMC5;MACROH2A1;SLF1;SLF2;NSMCE2
prerank,KEGG_2021_Human__Synthesis and degradation of ketone bodies,-0.2514466932982002,-0.41184323919172444,0.9482758620689655,1.0,1.0,2/8,21.71%,HMGCS1;ACAT2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.2538965574787988,0.4116729142183982,1.0,1.0,1.0,2/6,26.93%,RNF34;FZD3
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.19163950095498616,-0.4103157476113438,1.0,1.0,1.0,8/34,28.71%,DLC1;PRKCD;TGFB1;NSMF;CALM3;PPP1R16B;PPP1R7;HSP90B1
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.2490797343334814,0.409805170016919,1.0,0.9999219687948608,1.0,3/8,31.23%,BDH2;HMGCL;BDH1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.25532535745550045,0.40962595236940136,0.9807692307692307,0.9996228956407852,1.0,5/5,74.47%,TMEM108;ZDHHC17;DOK5;AGT;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.24935540449150664,0.40895690141815666,1.0,0.9990180541536812,1.0,2/6,28.27%,HES5;NF1
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.24935540449150664,0.40895690141815666,1.0,0.9990180541536812,1.0,2/6,28.27%,HES5;NF1
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.2705639425137778,-0.4080318358104588,1.0,1.0,1.0,3/5,33.48%,SQSTM1;ATG14;GPS2
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant R-HSA-2660826,-0.2602541857128575,-0.4078989769106058,1.0,1.0,1.0,2/6,29.04%,JAG2;ADAM17
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.2407467184617899,-0.40704735420167804,0.9827586206896551,1.0,1.0,1/10,12.02%,PSMC3
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.2786092568395656,-0.4059247073185749,0.9814814814814815,1.0,1.0,2/5,29.54%,DHODH;CTPS1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.2413897900127157,0.3991345343928528,1.0,0.999417320786826,1.0,1/6,15.38%,RNF26
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.2658885322439452,0.3980651921172971,1.0,0.9991914530845475,1.0,5/5,73.42%,RPS6KA4;VRK1;HMGA2;RPS6KA5;MST1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),-0.2711918488530951,-0.39651704819467476,1.0,1.0,1.0,1/5,24.22%,PPARG
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.26356276761294617,-0.39554194416448546,1.0,1.0,1.0,3/7,27.22%,FES;ADGRE2;UNC13D
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.2327486664295091,-0.39312507584770706,1.0,1.0,1.0,2/7,23.98%,STAT3;EIF4ENIF1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.2327486664295091,-0.39312507584770706,1.0,1.0,1.0,2/7,23.98%,STAT3;EIF4ENIF1
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.21621034991804888,-0.3925568332488219,1.0,1.0,1.0,4/12,29.04%,CAMK1D;SLIT2;MST1;ADAM17
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.2598577455840472,-0.3912583797922046,1.0,1.0,1.0,2/5,24.01%,BCAT1;BCAT2
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.23476535138921317,0.3906865666887611,1.0,0.999219959613876,1.0,8/8,76.53%,RGN;GSTO2;CYB5A;SLC23A2;SLC2A1;SLC2A3;CYB5R3;GSTO1
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.25294059314215644,-0.38308881269570827,1.0,1.0,1.0,1/5,17.35%,SNX6
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),-0.21547903420539205,-0.38171193338828224,1.0,1.0,1.0,1/13,12.54%,PIM1
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.22672438809894963,-0.3802828634386242,1.0,1.0,1.0,4/9,31.86%,CTNS;GIPC1;MFSD12;ASIP
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.22400607157452276,-0.3800205011500998,1.0,1.0,1.0,11/11,77.62%,HSPA5;SEC62;SEC61B;SEC61G;SGTB;CHMP4B;SGTA;SEC63;GET3;SEC61A2;SEC61A1
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),-0.2372697329608118,-0.3775734679718991,1.0,1.0,1.0,2/6,27.09%,RPUSD1;RPUSD3
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.1852113196376351,-0.37657707930360684,1.0,1.0,1.0,3/21,23.24%,OGG1;TINF2;PARP2
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.2280401859701892,0.37518055308331005,1.0,0.9994408742693244,1.0,2/7,20.24%,EP300;PRKAA1
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.2364793219757621,-0.37335379660159207,0.9827586206896551,1.0,1.0,1/7,18.34%,HSPA5
prerank,Reactome_2022__IkBA Variant Leads To EDA-ID R-HSA-5603029,-0.22789811957881567,-0.3665014470952048,1.0,1.0,1.0,2/7,23.30%,IKBKG;NFKB2
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.2173954765438452,-0.36100482150553675,1.0,1.0,1.0,3/8,29.43%,AXIN2;DDX11;CTNNB1
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.20058394160583942,-0.3609490079540634,1.0,1.0,1.0,15/15,79.96%,EMC1;EMC3;EMC9;CAMLG;EMC6;EMC4;EMC10;BAG6;EMC7;SGTA;GET3;EMC2;EMC8;UBL4A;MMGT1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.20995858565151984,-0.3599218580581364,1.0,1.0,1.0,5/10,33.67%,EMC1;EMC3;EMC9;EMC6;EMC4
prerank,Reactome_2022__Synthesis Of Ketone Bodies R-HSA-77111,-0.21880937549031781,-0.3574456997551774,1.0,1.0,1.0,1/7,17.49%,SOAT1
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.2151395986941737,-0.35486699017810475,1.0,1.0,1.0,5/9,30.38%,NELFE;SUPT5H;BARD1;CDK9;CTR9
prerank,Reactome_2022__Ketone Body Metabolism R-HSA-74182,-0.21382066308598557,-0.35117692446162463,1.0,1.0,1.0,1/8,17.49%,SOAT1
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.22663865055740384,-0.3448958394109391,1.0,1.0,1.0,7/7,77.35%,KIF11;RANBP1;CHEK1;NSFL1C;CEP85;MAP9;UBXN2B
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.1923234213163153,-0.34447449130877333,1.0,1.0,1.0,3/15,25.81%,FASN;SCD;CBR4
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.2032918928383821,-0.3233404547349197,1.0,0.9999762022443114,1.0,7/7,79.68%,PAH;MTHFD1;SDS;CPS1;ALDH18A1;CAD;SDSL
